Psyllid ID: psy9090
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 488 | 2.2.26 [Sep-21-2011] | |||||||
| P10676 | 1501 | Neither inactivation nor | no | N/A | 0.987 | 0.321 | 0.480 | 1e-133 | |
| Q8NEV4 | 1616 | Myosin-IIIa OS=Homo sapie | yes | N/A | 0.944 | 0.285 | 0.387 | 7e-93 | |
| Q8WXR4 | 1341 | Myosin-IIIb OS=Homo sapie | no | N/A | 0.989 | 0.360 | 0.373 | 6e-88 | |
| Q1EG27 | 1305 | Myosin-IIIb OS=Mus muscul | no | N/A | 0.989 | 0.370 | 0.359 | 4e-86 | |
| Q8K3H5 | 1613 | Myosin-IIIa OS=Mus muscul | yes | N/A | 0.948 | 0.287 | 0.384 | 7e-86 | |
| Q23356 | 1096 | Serine/threonine-protein | yes | N/A | 0.348 | 0.155 | 0.494 | 4e-47 | |
| P83510 | 1323 | Traf2 and NCK-interacting | no | N/A | 0.368 | 0.136 | 0.470 | 2e-46 | |
| Q9UKE5 | 1360 | TRAF2 and NCK-interacting | no | N/A | 0.368 | 0.132 | 0.470 | 3e-46 | |
| Q8N4C8 | 1332 | Misshapen-like kinase 1 O | no | N/A | 0.368 | 0.135 | 0.481 | 5e-46 | |
| Q9JM52 | 1308 | Misshapen-like kinase 1 O | no | N/A | 0.368 | 0.137 | 0.481 | 6e-46 |
| >sp|P10676|NINAC_DROME Neither inactivation nor afterpotential protein C OS=Drosophila melanogaster GN=ninaC PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 474 bits (1221), Expect = e-133, Method: Compositional matrix adjust.
Identities = 246/512 (48%), Positives = 330/512 (64%), Gaps = 30/512 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E+HIA+I++E + L+ NHV+HRD+RG N+LLTK+G VK+ DFGLSR+ +T K
Sbjct: 117 MREEHIAYIIRETCRAAIELNRNHVLHRDIRGDNILLTKNGRVKLCDFGLSRQVDSTLGK 176
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +GSP WMAPE++ R DVWALGIT IEL DGKPPF DMHPTRA+FQ
Sbjct: 177 RGTCIGSPCWMAPEVVSAMESREPDITVRADVWALGITTIELADGKPPFADMHPTRAMFQ 236
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEND------- 173
I+RNPPP L R +NWSQ DFI+E LEKN E+RP M E++EHPF+T L EN+
Sbjct: 237 IIRNPPPTLMRPTNWSQQINDFISESLEKNAENRPMMVEMVEHPFLTELIENEDEMRSDI 296
Query: 174 ---LHLST-VNCQYKDQEL--------------QTMHVEDLAALETISEDNIVQELEERH 215
L LS V YK+ EL + M+ EDLAALE ++NI++ L R
Sbjct: 297 AEMLELSRDVKTLYKEPELFVDRGYVKRFDEKPEKMYPEDLAALENPVDENIIESLRHRI 356
Query: 216 NSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHE 275
YSF+GD+LL +N N + ++H KY+FKSRS+N+PHI++VAD AYQDM+HH+
Sbjct: 357 LMGESYSFIGDILLSLNSNEIKQEFPQEFHAKYRFKSRSENQPHIFSVADIAYQDMLHHK 416
Query: 276 EAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQN 335
E QHIVL+GE+ +GK+T+ + L+KHL +LG G ++E + I + NAGTP+N +
Sbjct: 417 EPQHIVLSGESYSGKSTNARLLIKHLCYLGDGNRGATGRVESSIKAILMLVNAGTPVNND 476
Query: 336 STRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGEL 395
STR VL +TFG +GK+SGA+F +Y LEK RV D Q NFHIFYYFYD + +L
Sbjct: 477 STRCVLQYCLTFGKTGKMSGAVFNMYMLEKLRV-ATTDGTQHNFHIFYYFYDFINQQNQL 535
Query: 396 DKYFLSPGRKYRYLRA--DVTDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIF 453
+Y L R YRYLR +V KL K R+ P+ NV +++E L DI+F+ Q+E
Sbjct: 536 KEYNLKADRNYRYLRVPPEVPPSKL-KYRRDDPEGNVERYREFENILRDIDFNHKQLETV 594
Query: 454 SNVLAAILLIGEVEFESSAENTAELANPEVAA 485
VLAAIL IG + F + + AE+ N ++ +
Sbjct: 595 RKVLAAILNIGNIRFRQNGK-YAEVENTDIVS 625
|
Required for photoreceptor cell function. The ninaC proteins combines putative serine/threonine-protein kinase and myosin activities. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=2 SV=2 | Back alignment and function description |
|---|
Score = 341 bits (875), Expect = 7e-93, Method: Compositional matrix adjust.
Identities = 196/506 (38%), Positives = 288/506 (56%), Gaps = 45/506 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
MSE IA+IL E + G+ LH N IHRD++G+N+LLT +G VK+VDFG+S + +T +
Sbjct: 122 MSEPLIAYILHEALMGLQHLHNNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRHR 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R D W+LGITAIELGDG PP D+HP RALF+
Sbjct: 182 RNTSVGTPFWMAPEVIACEQQLDTTYDARCDTWSLGITAIELGDGDPPLADLHPMRALFK 241
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNPPP L + WS + DFI++CL K+ E RP +SELL+H FIT + D+ L
Sbjct: 242 IPRNPPPKLRQPELWSAEFNDFISKCLTKDYEKRPTVSELLQHKFITQIEGKDVMLQKQL 301
Query: 181 CQY-------------KDQELQTMH-------------VEDLAALETISEDNIVQELEER 214
++ + + + T V+DLA LE + E+ + ++LE+
Sbjct: 302 TEFIGIHQCMGGTEKARRERIHTKKGNFNRPLISNLKDVDDLATLEILDENTVSEQLEKC 361
Query: 215 HNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHH 274
++ Y +VGD+L+ +NP L LY TK+ Y R+ + PHI+A+AD YQ M+ +
Sbjct: 362 YSRDQIYVYVGDILIALNPFQSLGLYSTKHSKLYIGSKRTASPPHIFAMADLGYQSMITY 421
Query: 275 EEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAK-VGEKIEKCVNVIHAIGNAGTPIN 333
Q IV++GE+ AGKT + L++ L LG+ + + EKI + N++ A GNA T IN
Sbjct: 422 NSDQCIVISGESGAGKTENAHLLVQQLTVLGKANNRTLQEKILQVNNLVEAFGNACTIIN 481
Query: 334 QNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAG 393
NS+R Y+++ F SSG + GA Y LEK RV ++ + NFHIFYY Y +
Sbjct: 482 DNSSRFGKYLEMKFTSSGAVVGAQISEYLLEKSRVI-HQAIGEKNFHIFYYIYAGLAEKK 540
Query: 394 ELDKYFLSPGRKYRYLR-------ADVTDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFD 446
+L Y L + RYL+ D+ ++ K ++++ I Q I F
Sbjct: 541 KLAHYKLPENKPPRYLQNDHLRTVQDIMNNSFYK----------SQYELIEQCFKVIGFT 590
Query: 447 DIQMEIFSNVLAAILLIGEVEFESSA 472
Q+ ++LAAIL +G +EF S A
Sbjct: 591 MEQLGSIYSILAAILNVGNIEFSSVA 616
|
Probable actin-based motor with a protein kinase activity. Probably plays a role in vision and hearing. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8WXR4|MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 6e-88, Method: Compositional matrix adjust.
Identities = 193/517 (37%), Positives = 291/517 (56%), Gaps = 34/517 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E I++IL + G+ LH N +IHRD++G+N+LLT +G VK+VDFG+S + +T +
Sbjct: 128 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 187
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R DVW+LGITAIELGDG PP DMHP + LF+
Sbjct: 188 RNTSVGTPFWMAPEVIACEQQYDSSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 247
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNPPP L W + + FI++CL K+ E RP ++ LL+HPFI + L L
Sbjct: 248 IPRNPPPTLLHPEKWCEEFNHFISQCLIKDFERRPSVTHLLDHPFIKGVHGKVLFLQKQL 307
Query: 181 CQ-YKDQELQT---------------MHVE---------DLAALETISEDNIVQELEERH 215
+ +DQ+ Q HVE DL LE + ED I+ +L++R+
Sbjct: 308 AKVLQDQKHQNPVAKTRHERMHTRRPYHVEDAEKYCLEDDLVNLEVLDEDTIIHQLQKRY 367
Query: 216 NSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHE 275
Y++VGD+L+ +NP +L++Y ++ Y R+ N PHI+A AD+AYQ M+
Sbjct: 368 ADLLIYTYVGDILIALNPFQNLSIYSPQFSRLYHGVKRASNPPHIFASADAAYQCMVTLS 427
Query: 276 EAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAK-VGEKIEKCVNVIHAIGNAGTPINQ 334
+ Q IV++GE+ +GKT S +++HL FLG+ + + EKI + +++ A GN+ T IN
Sbjct: 428 KDQCIVISGESGSGKTESAHLIVQHLTFLGKANNQTLREKILQVNSLVEAFGNSCTAIND 487
Query: 335 NSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGE 394
NS+R Y+++ F +G + GA Y LEK RV + + NFHIFYY Y + +
Sbjct: 488 NSSRFGKYLEMMFTPTGVVMGARISEYLLEKSRVI-KQAAREKNFHIFYYIYAGLHHQKK 546
Query: 395 LDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFS 454
L + L + RY+ AD T + + ++ +F+ I I F D ++
Sbjct: 547 LSDFRLPEEKPPRYI-ADETGRVMHD--ITSKESYRRQFEAIQHCFRIIGFTDKEVHSVY 603
Query: 455 NVLAAILLIGEVEFE--SSAENT--AELANPEVAANG 487
+LA IL IG +EF SS T +E+ N E N
Sbjct: 604 RILAGILNIGNIEFAAISSQHQTDKSEVPNAEALQNA 640
|
Probable actin-based motor with a protein kinase activity. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1EG27|MYO3B_MOUSE Myosin-IIIb OS=Mus musculus GN=Myo3b PE=2 SV=2 | Back alignment and function description |
|---|
Score = 319 bits (817), Expect = 4e-86, Method: Compositional matrix adjust.
Identities = 186/517 (35%), Positives = 290/517 (56%), Gaps = 34/517 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E I++IL + G+ LH + +IHRD++G+N+LLT +G VK+VDFG+S + +T +
Sbjct: 116 LDEAVISYILYGALLGLQHLHCHRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 175
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R DVW+LGITAIELGDG PP +MHP + LF+
Sbjct: 176 RNTSVGTPFWMAPEVIACEQQYDSSYDARCDVWSLGITAIELGDGDPPLFEMHPVKMLFK 235
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNPPP L +W + + FI++CL K+ E RP ++ LL+HPFI L L
Sbjct: 236 IPRNPPPTLLHPDSWCEEFNHFISQCLIKDFEKRPSVTHLLDHPFIKGTQGKVLCLQKQL 295
Query: 181 CQ-YKDQELQT---------MHV---------------EDLAALETISEDNIVQELEERH 215
+ +DQ+ + MH +DL LE + ED I+ L++R+
Sbjct: 296 AKVLQDQKHRNPVAKTRHERMHTGRPHRVEDAGKCCLEDDLVNLEVLDEDTIIYWLQKRY 355
Query: 216 NSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHE 275
Y++VGD+L+ +NP +L++Y ++ Y RS N PHI+A AD+AYQ ++
Sbjct: 356 ADALIYTYVGDILIALNPFQNLSIYSPQFSRLYHGVKRSSNPPHIFASADNAYQCLVTFS 415
Query: 276 EAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAK-VGEKIEKCVNVIHAIGNAGTPINQ 334
+ Q IV++GE+ +GKT S +++HL FLG+ + + +KI + +++ A GNA T IN
Sbjct: 416 KDQCIVISGESGSGKTESAHLIVQHLTFLGKADNQTLRQKILQVNSLVEAFGNARTAIND 475
Query: 335 NSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGE 394
NS+R Y+++ F +G + GA Y LEK RV + + NFHIFYY Y + +
Sbjct: 476 NSSRFGKYLEMMFTPTGAVMGARISEYLLEKSRVI-QQAAGEKNFHIFYYIYAGLYHQKK 534
Query: 395 LDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFS 454
L ++ L + RY+ + +E+ T +F+ I I F D ++
Sbjct: 535 LAEFRLPEEKPPRYIAGETERVMQDITSKESYRT---QFEAIQHCFKIIGFADKEVHSVY 591
Query: 455 NVLAAILLIGEVEFESSAE----NTAELANPEVAANG 487
+LA IL IG +EF + + + +E+ NPE N
Sbjct: 592 RILAGILNIGSIEFAAISSQHQTDKSEVPNPEALENA 628
|
Probable actin-based motor with a protein kinase activity. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8K3H5|MYO3A_MOUSE Myosin-IIIa OS=Mus musculus GN=Myo3a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 7e-86, Method: Compositional matrix adjust.
Identities = 194/504 (38%), Positives = 274/504 (54%), Gaps = 41/504 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
MSE IA+IL E + G+ LH N IHRD++G+N+LLT +G VK+VDFG+S + ++T +
Sbjct: 122 MSEPVIAYILHEALMGLQHLHSNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLSSTRHR 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
T +G+P WMAPE++ C + YD R D W+LGITAIELGDG PP ++HP RALF+
Sbjct: 182 LNTSVGTPFWMAPEVIACEQQLDTTYDARCDTWSLGITAIELGDGDPPLAELHPMRALFK 241
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNPPP L + WS + DFI++CL K+ E RP +S+LL+H FIT + D+ L
Sbjct: 242 IPRNPPPKLRQPELWSAEFNDFISKCLTKDYEKRPTVSDLLKHKFITQIEGKDVILQKQL 301
Query: 181 CQYKD-------------QELQTMH-------------VEDLAALETISEDNIVQELEER 214
++ D + + T V+DLA L+ + E L
Sbjct: 302 MEFIDIHQCLGSTEKARHERIHTKKGNLNRSLISSLKDVDDLATLDVLDEPTASPHLHPC 361
Query: 215 HNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHH 274
H+ + V D+L+ +NP L +Y K Y R+ N PHI+A+AD YQ M+ +
Sbjct: 362 HSRDQIHIHVADILIALNPFQSLGIYSPKLSRLYIGAKRTANPPHIFAMADLGYQSMVTY 421
Query: 275 EEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAK-VGEKIEKCVNVIHAIGNAGTPIN 333
Q IV++GE+ AGKT S L++ L LG+ + + EKI + N++ A GNA T IN
Sbjct: 422 NADQCIVISGESGAGKTESAHLLVQQLTVLGKANNRTLQEKILQMNNLVEAFGNACTIIN 481
Query: 334 QNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAG 393
NS+R Y+++ F SSG + GA Y LEK RV ++ + NFHIFYY Y +
Sbjct: 482 DNSSRFGKYLEMKFTSSGAVVGAQISEYLLEKSRVI-HQAMGEKNFHIFYYIYGGLAEKK 540
Query: 394 ELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDI----- 448
+L Y + RYL+ D R D F + LI+ F I
Sbjct: 541 KLALYKSPEHKPPRYLQND--------NLRTVQDMMNNSFYKSQYELIEQCFKVIGFTME 592
Query: 449 QMEIFSNVLAAILLIGEVEFESSA 472
Q+ +VLAAIL +G +EF S A
Sbjct: 593 QLASVYSVLAAILNVGNIEFSSVA 616
|
Probable actin-based motor with a protein kinase activity. Probably plays a role in vision and hearing. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q23356|MIG15_CAEEL Serine/threonine-protein kinase mig-15 OS=Caenorhabditis elegans GN=mig-15 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 189 bits (480), Expect = 4e-47, Method: Compositional matrix adjust.
Identities = 84/170 (49%), Positives = 113/170 (66%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+ IA+I +EI+ G+ LH++ VIHRD++G NVLLT EVK+VDFG+S + T +
Sbjct: 123 LKEEWIAYICREILRGLYHLHQSKVIHRDIKGQNVLLTDSAEVKLVDFGVSAQLDKTVGR 182
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ C YD+R D+W+LGITA+E+ +G PP DMHP RALF
Sbjct: 183 RNTFIGTPYWMAPEVIACDESPEATYDSRSDLWSLGITALEMAEGHPPLCDMHPMRALFL 242
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
I RNPPP L R W++ + FI L K+ RPY LL HPFI P
Sbjct: 243 IPRNPPPKLKRNKKWTKKFETFIETVLVKDYHQRPYTGALLRHPFIKEQP 292
|
Involved in cell migration and signal transduction. Important in several developmental processes including epidermal development, Q neuroblast migrations and muscle arm targeting. Required with ina-1/pat-3 to stabilize the commissural axons growth cone along a precise direction and are required for the cell to respond appropriately when signaling in the growth cone must change. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P83510|TNIK_MOUSE Traf2 and NCK-interacting protein kinase OS=Mus musculus GN=Tnik PE=1 SV=2 | Back alignment and function description |
|---|
Score = 187 bits (474), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 87/185 (47%), Positives = 120/185 (64%), Gaps = 5/185 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+ IA+I +EI+ G+ LH++ VIHRD++G NVLLT++ EVK+VDFG+S + T +
Sbjct: 125 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 184
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ C YD + D+W+LGITAIE+ +G PP DMHP RALF
Sbjct: 185 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 244
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNP P L ++ WS+ + FI CL KN RP +L++HPFI P V
Sbjct: 245 IPRNPAPRL-KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE----RQVR 299
Query: 181 CQYKD 185
Q KD
Sbjct: 300 IQLKD 304
|
Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. Recruited to promoters of Wnt target genes and required to activate their expression. May act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-terminal pathway. May play a role in the response to environmental stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. More generally, it may play a role in cytoskeletal rearrangements and regulate cell spreading. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UKE5|TNIK_HUMAN TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (473), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 87/185 (47%), Positives = 120/185 (64%), Gaps = 5/185 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+ IA+I +EI+ G+ LH++ VIHRD++G NVLLT++ EVK+VDFG+S + T +
Sbjct: 125 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 184
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ C YD + D+W+LGITAIE+ +G PP DMHP RALF
Sbjct: 185 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 244
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNP P L ++ WS+ + FI CL KN RP +L++HPFI P V
Sbjct: 245 IPRNPAPRL-KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE----RQVR 299
Query: 181 CQYKD 185
Q KD
Sbjct: 300 IQLKD 304
|
Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. Recruited to promoters of Wnt target genes and required to activate their expression. May act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-terminal pathway. May play a role in the response to environmental stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. More generally, it may play a role in cytoskeletal rearrangements and regulate cell spreading. Phosphorylates SMAD1 on Thr-322. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8N4C8|MINK1_HUMAN Misshapen-like kinase 1 OS=Homo sapiens GN=MINK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 5e-46, Method: Compositional matrix adjust.
Identities = 89/185 (48%), Positives = 119/185 (64%), Gaps = 5/185 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA+I +EI+ G+ LH + VIHRD++G NVLLT++ EVK+VDFG+S + T +
Sbjct: 125 LKEDCIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 184
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ C YD R D+W+LGITAIE+ +G PP DMHP RALF
Sbjct: 185 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 244
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNPPP L ++ WS+ ++DFI CL K RP +LL+ PFI P V
Sbjct: 245 IPRNPPPRL-KSKKWSKKFIDFIDTCLIKTYLSRPPTEQLLKFPFIRDQPTE----RQVR 299
Query: 181 CQYKD 185
Q KD
Sbjct: 300 IQLKD 304
|
Isoform 4 can activate the JNK pathway. Involved in the regulation of actin cytoskeleton reorganization, cell-matrix adhesion, cell-cell adhesion and cell migration. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JM52|MINK1_MOUSE Misshapen-like kinase 1 OS=Mus musculus GN=Mink1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 185 bits (470), Expect = 6e-46, Method: Compositional matrix adjust.
Identities = 89/185 (48%), Positives = 118/185 (63%), Gaps = 5/185 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA+I +EI+ G+ LH + VIHRD++G NVLLT++ EVK+VDFG+S + T +
Sbjct: 125 LKEDCIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 184
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ C YD R D+W+LGITAIE+ +G PP DMHP RALF
Sbjct: 185 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 244
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNPPP L ++ WS+ + DFI CL K RP +LL+ PFI P V
Sbjct: 245 IPRNPPPRL-KSKKWSKKFTDFIDTCLIKTYLSRPPTEQLLKFPFIRDQPTE----RQVR 299
Query: 181 CQYKD 185
Q KD
Sbjct: 300 IQLKD 304
|
Serine/threonine kinase which acts as a negative regulator of Ras-related Rap2-mediated signal transduction to control neuronal structure and AMPA receptor trafficking. Required for normal synaptic density, dendrite complexity, as well as surface AMPA receptor expression in hippocampal neurons. Can activate the JNK and MAPK14/p38 pathways and mediates stimulation of the stress-activated protein kinase MAPK14/p38 MAPK downstream of the Raf/ERK pathway. Phosphorylates: TANC1 upon stimulation by RAP2A, MBP and SMAD1. Has an essential function in negative selection of thymocytes, perhaps by coupling NCK1 to activation of JNK1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 488 | ||||||
| 340709079 | 1586 | PREDICTED: neither inactivation nor afte | 0.987 | 0.303 | 0.533 | 1e-157 | |
| 340709081 | 1589 | PREDICTED: neither inactivation nor afte | 0.987 | 0.303 | 0.533 | 1e-157 | |
| 380016490 | 1349 | PREDICTED: neither inactivation nor afte | 0.987 | 0.357 | 0.527 | 1e-157 | |
| 328792346 | 1587 | PREDICTED: neither inactivation nor afte | 0.987 | 0.303 | 0.525 | 1e-157 | |
| 350419389 | 1589 | PREDICTED: neither inactivation nor afte | 0.987 | 0.303 | 0.533 | 1e-157 | |
| 332020102 | 1571 | Neither inactivation nor afterpotential | 0.983 | 0.305 | 0.527 | 1e-156 | |
| 383865054 | 1583 | PREDICTED: neither inactivation nor afte | 0.987 | 0.304 | 0.526 | 1e-156 | |
| 158298612 | 1581 | AGAP009730-PA [Anopheles gambiae str. PE | 0.981 | 0.302 | 0.537 | 1e-153 | |
| 170040124 | 1557 | myosin IIIA [Culex quinquefasciatus] gi| | 0.989 | 0.310 | 0.529 | 1e-153 | |
| 322788655 | 1553 | hypothetical protein SINV_08357 [Solenop | 0.989 | 0.311 | 0.519 | 1e-152 |
| >gi|340709079|ref|XP_003393142.1| PREDICTED: neither inactivation nor afterpotential protein C-like isoform 1 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 273/512 (53%), Positives = 360/512 (70%), Gaps = 30/512 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E+HI FILKE+I MV+L+E++V+HRD+RGSN+LLT++GEVK+VDFGLS+ K
Sbjct: 153 MREEHIGFILKEVIQAMVYLNEHNVMHRDIRGSNILLTREGEVKLVDFGLSKMFQGEMGK 212
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +GSPSWMAPE+ +GY +R DVWA+GITAIEL DGKPPF+DMHPTRALFQ
Sbjct: 213 RYTCIGSPSWMAPEVAMSKGNSSEGYGSRADVWAVGITAIELADGKPPFQDMHPTRALFQ 272
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS--- 177
IVRNPPP LYR SNWSQ++ DFIAECLEKNPE+RP+M+E+ EHPF+ ND L+
Sbjct: 273 IVRNPPPNLYRPSNWSQNFNDFIAECLEKNPENRPFMAEIAEHPFLADSSANDFLLAKEI 332
Query: 178 ----TVNC-------------------QYKDQELQTMHVEDLAALETISEDNIVQELEER 214
T C ++ L+ M +EDLAALET++ED I+ EL ER
Sbjct: 333 KILMTDVCAKGKHVRRPEVIVRKGFLKTHQTDPLEPMFMEDLAALETLTEDTILDELHER 392
Query: 215 HNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHH 274
++SF+GD+LL +NPN ++YG+ YH KY+FKSRSDN PHIY+VADSAYQD++H+
Sbjct: 393 LRQGYYHSFIGDILLILNPNEQQDIYGSDYHTKYQFKSRSDNAPHIYSVADSAYQDVLHN 452
Query: 275 EEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQ 334
EEAQHI+LAGE+ +GKTT+L HL++HL++LG+ +G ++ + + VIHA NA TP+N
Sbjct: 453 EEAQHILLAGESNSGKTTNLMHLVRHLMYLGKSLQDIGARLMRAIKVIHAFSNAATPLNP 512
Query: 335 NSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGE 394
NSTR VL ++ T+GSSGK SGAIFWLYQLEKWRV+ RD Q+NFH+ YYFYD ++A +
Sbjct: 513 NSTRCVLELETTYGSSGKASGAIFWLYQLEKWRVS-TRDRNQSNFHVLYYFYDGLDAISK 571
Query: 395 LDKYFLSPGRKYRYLRADV--TDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEI 452
L +Y L PGR+ RYLR T+ K R P NVAKF+E+ +NL +E ++ E
Sbjct: 572 LKQYHLPPGRRMRYLRISEKGTERKRSFKVRNDPRGNVAKFEELKENLTILEMEEY-CET 630
Query: 453 FSNVLAAILLIGEVEFESSAENTAELANPEVA 484
+LAAIL +GE+ F A++ N + A
Sbjct: 631 IWRILAAILNLGEIRFVEGNNGEADMDNNDAA 662
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340709081|ref|XP_003393143.1| PREDICTED: neither inactivation nor afterpotential protein C-like isoform 2 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1444), Expect = e-157, Method: Compositional matrix adjust.
Identities = 273/512 (53%), Positives = 360/512 (70%), Gaps = 30/512 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E+HI FILKE+I MV+L+E++V+HRD+RGSN+LLT++GEVK+VDFGLS+ K
Sbjct: 153 MREEHIGFILKEVIQAMVYLNEHNVMHRDIRGSNILLTREGEVKLVDFGLSKMFQGEMGK 212
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +GSPSWMAPE+ +GY +R DVWA+GITAIEL DGKPPF+DMHPTRALFQ
Sbjct: 213 RYTCIGSPSWMAPEVAMSKGNSSEGYGSRADVWAVGITAIELADGKPPFQDMHPTRALFQ 272
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS--- 177
IVRNPPP LYR SNWSQ++ DFIAECLEKNPE+RP+M+E+ EHPF+ ND L+
Sbjct: 273 IVRNPPPNLYRPSNWSQNFNDFIAECLEKNPENRPFMAEIAEHPFLADSSANDFLLAKEI 332
Query: 178 ----TVNC-------------------QYKDQELQTMHVEDLAALETISEDNIVQELEER 214
T C ++ L+ M +EDLAALET++ED I+ EL ER
Sbjct: 333 KILMTDVCAKGKHVRRPEVIVRKGFLKTHQTDPLEPMFMEDLAALETLTEDTILDELHER 392
Query: 215 HNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHH 274
++SF+GD+LL +NPN ++YG+ YH KY+FKSRSDN PHIY+VADSAYQD++H+
Sbjct: 393 LRQGYYHSFIGDILLILNPNEQQDIYGSDYHTKYQFKSRSDNAPHIYSVADSAYQDVLHN 452
Query: 275 EEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQ 334
EEAQHI+LAGE+ +GKTT+L HL++HL++LG+ +G ++ + + VIHA NA TP+N
Sbjct: 453 EEAQHILLAGESNSGKTTNLMHLVRHLMYLGKSLQDIGARLMRAIKVIHAFSNAATPLNP 512
Query: 335 NSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGE 394
NSTR VL ++ T+GSSGK SGAIFWLYQLEKWRV+ RD Q+NFH+ YYFYD ++A +
Sbjct: 513 NSTRCVLELETTYGSSGKASGAIFWLYQLEKWRVS-TRDRNQSNFHVLYYFYDGLDAISK 571
Query: 395 LDKYFLSPGRKYRYLRADV--TDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEI 452
L +Y L PGR+ RYLR T+ K R P NVAKF+E+ +NL +E ++ E
Sbjct: 572 LKQYHLPPGRRMRYLRISEKGTERKRSFKVRNDPRGNVAKFEELKENLTILEMEEY-CET 630
Query: 453 FSNVLAAILLIGEVEFESSAENTAELANPEVA 484
+LAAIL +GE+ F A++ N + A
Sbjct: 631 IWRILAAILNLGEIRFVEGNNGEADMDNNDAA 662
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380016490|ref|XP_003692216.1| PREDICTED: neither inactivation nor afterpotential protein C-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1443), Expect = e-157, Method: Compositional matrix adjust.
Identities = 270/512 (52%), Positives = 359/512 (70%), Gaps = 30/512 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E+HI FIL+E+I M++L+EN+V+HRD+RGSN+LLTK+GE+K+VDFGLSR K
Sbjct: 103 MREEHIGFILREVIQAMIYLNENNVMHRDIRGSNILLTKEGEIKLVDFGLSRTCQAEIGK 162
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +GSPSWMAPE+ +GY NR DVWA+GITAIEL DGKPPF+DMHPTRALFQ
Sbjct: 163 RYTCVGSPSWMAPEVAISKGNNSEGYGNRADVWAIGITAIELADGKPPFQDMHPTRALFQ 222
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTV- 179
I+RNPPP L R SNWSQ++ DFI+ECLEKNPE+RP+M E++EHPF+ LP+ND L+
Sbjct: 223 IIRNPPPTLNRPSNWSQNFNDFISECLEKNPENRPFMGEIIEHPFLAELPDNDFLLTKEI 282
Query: 180 ------NCQYKDQE-------------------LQTMHVEDLAALETISEDNIVQELEER 214
C+ QE L+ M +EDLAALET++ED I+ EL ER
Sbjct: 283 KILMMDACEKGKQERKLEILVRKGFLKTHQTDPLEPMFMEDLAALETLTEDAILDELHER 342
Query: 215 HNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHH 274
++SF+GD+LL +NPN ++YG+ +H KY+FKSRSDN PHIY+VADSAYQD+MH+
Sbjct: 343 LRQGYYHSFIGDILLILNPNEQQDIYGSDFHTKYQFKSRSDNAPHIYSVADSAYQDVMHN 402
Query: 275 EEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQ 334
EAQHI+LAGE+ +GKTT++ HL++HL++LG+ +G + K + +I A NA TP+N
Sbjct: 403 NEAQHILLAGESNSGKTTNMMHLIRHLMYLGKSLQDIGGRFIKAIKMIQAFSNAATPLNP 462
Query: 335 NSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGE 394
NSTR +L +Q T+G+SGK SG IFWLYQLEKWRV+ RD Q+NFH+ YYFYD M+A +
Sbjct: 463 NSTRCLLQVQTTYGTSGKASGGIFWLYQLEKWRVS-TRDRNQSNFHVLYYFYDGMDAVNK 521
Query: 395 LDKYFLSPGRKYRYLRADV--TDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEI 452
L Y L PGR+ RYLR T+ K R P NVAKF+E+ ++L +E ++ E+
Sbjct: 522 LKHYHLPPGRRMRYLRISEKGTERKRSFKVRNDPRGNVAKFEELKEDLKILEMEE-HCEM 580
Query: 453 FSNVLAAILLIGEVEFESSAENTAELANPEVA 484
VLAAIL++GE+ F A++ N + A
Sbjct: 581 IWKVLAAILILGEIRFIEDNNGEADMDNNDAA 612
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328792346|ref|XP_393429.3| PREDICTED: neither inactivation nor afterpotential protein C isoform 1 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1443), Expect = e-157, Method: Compositional matrix adjust.
Identities = 269/512 (52%), Positives = 360/512 (70%), Gaps = 30/512 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E+HI+FILKE+I M++L+EN+V+HRD+RGSN+LLTK+GE+K+VDFGLSR + K
Sbjct: 150 MREEHISFILKEVIQAMIYLNENNVMHRDIRGSNILLTKEGEIKLVDFGLSRTCQSEIGK 209
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +GSPSWMAPE+ +GY NR DVWA+GITAIEL DGKPPF+DMHPTRALFQ
Sbjct: 210 RYTCVGSPSWMAPEVAISKGNNSEGYGNRADVWAIGITAIELADGKPPFQDMHPTRALFQ 269
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTV- 179
I+RNPPP L R SNWSQ++ DFI+ECLEKNPE+RP+M E++EHPF+ LP+ND L+
Sbjct: 270 IIRNPPPTLNRPSNWSQNFNDFISECLEKNPENRPFMGEIIEHPFLADLPDNDFLLTKEI 329
Query: 180 ------NCQYKDQE-------------------LQTMHVEDLAALETISEDNIVQELEER 214
C+ QE L+ M +EDLAALET++ED I+ EL ER
Sbjct: 330 KILMMDACEKGKQERKLEILVRKSFLKTHQTDPLEPMFMEDLAALETLTEDAILDELHER 389
Query: 215 HNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHH 274
++SF+GD+LL +NPN ++YG+ +H KY+FKSRSDN PHIY+VADSAYQD+MH+
Sbjct: 390 LRQGYYHSFIGDILLILNPNEQQDIYGSDFHTKYQFKSRSDNAPHIYSVADSAYQDVMHN 449
Query: 275 EEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQ 334
EAQHI+LAGE+ +GKTT++ +L++HL++LG+ +G + + + +I A NA TP+N
Sbjct: 450 NEAQHILLAGESNSGKTTNMMYLIQHLMYLGKSLQDIGGRFIRAIKIIQAFSNAATPLNP 509
Query: 335 NSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGE 394
NSTR VL +Q T+GSSGK SG IFWLYQLEKWRV+ RD Q+NFH+ YYFYD M+A +
Sbjct: 510 NSTRCVLQVQTTYGSSGKASGGIFWLYQLEKWRVS-TRDRNQSNFHVLYYFYDGMDAINK 568
Query: 395 LDKYFLSPGRKYRYLRADV--TDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEI 452
L +Y L PGR+ RYLR T+ K R P NV KF++ ++L +E ++ E+
Sbjct: 569 LKQYHLPPGRRMRYLRISEKGTERKRSFKVRNDPRGNVTKFEDFKESLKILEMEE-HCEM 627
Query: 453 FSNVLAAILLIGEVEFESSAENTAELANPEVA 484
VLAAIL++GE+ F A++ N + A
Sbjct: 628 IWKVLAAILILGEIRFIEDNNGEADMDNNDAA 659
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350419389|ref|XP_003492164.1| PREDICTED: neither inactivation nor afterpotential protein C-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1442), Expect = e-157, Method: Compositional matrix adjust.
Identities = 273/512 (53%), Positives = 360/512 (70%), Gaps = 30/512 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E+HI FILKE+I MV+L+E++V+HRD+RGSN+LLTK+GEVK+VDFGLS+ K
Sbjct: 153 MREEHIGFILKEVIQAMVYLNEHNVMHRDIRGSNILLTKEGEVKLVDFGLSKMFEGEMGK 212
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +GSPSWMAPE+ +GY +R DVWA+GITAIEL DGKPPF+DMHPTRALFQ
Sbjct: 213 RYTCIGSPSWMAPEVAMSKGNSSEGYGSRADVWAIGITAIELADGKPPFQDMHPTRALFQ 272
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS--- 177
IVRNPPP LYR SNWSQ++ DFIAECLEKNPE+RP+M+E+ EHPF+ +D L+
Sbjct: 273 IVRNPPPNLYRPSNWSQNFNDFIAECLEKNPENRPFMAEIAEHPFLADSSADDFLLAKEI 332
Query: 178 ----TVNC-------------------QYKDQELQTMHVEDLAALETISEDNIVQELEER 214
T C ++ L+ M +EDLAALET++ED I+ EL ER
Sbjct: 333 KILMTDVCAKGKHVRRPEVIVRKGFLKTHQTDPLEPMFMEDLAALETLTEDTILDELHER 392
Query: 215 HNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHH 274
++SF+GD+LL +NPN ++YG+ YH KY+FKSRSDN PHIY+VADSAYQD++H+
Sbjct: 393 LRQGYYHSFIGDILLILNPNEQQDIYGSDYHTKYQFKSRSDNAPHIYSVADSAYQDVLHN 452
Query: 275 EEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQ 334
EEAQHI+LAGE+ +GKTT+L HL++HL++LG+ +G ++ + + VIHA NA TP+N
Sbjct: 453 EEAQHILLAGESNSGKTTNLMHLVRHLMYLGKSLQDIGARLMRAIKVIHAFSNAATPLNP 512
Query: 335 NSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGE 394
NSTR VL ++ T+GSSGK SGAIFWLYQLEKWRV+ RD Q+NFH+ YYFYD ++A +
Sbjct: 513 NSTRCVLELETTYGSSGKASGAIFWLYQLEKWRVS-TRDRNQSNFHVLYYFYDGLDAISK 571
Query: 395 LDKYFLSPGRKYRYLRADV--TDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEI 452
L +Y L PGR+ RYLR T+ K R P NVAKF+E+ +NL +E ++ E
Sbjct: 572 LKQYHLPPGRRMRYLRISEKGTERKRSFKVRNDPRGNVAKFEELKENLTILEMEEY-CET 630
Query: 453 FSNVLAAILLIGEVEFESSAENTAELANPEVA 484
+LAAIL +GE+ F A++ N + A
Sbjct: 631 IWKILAAILNLGEIRFVEGNNGEADMDNHDAA 662
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332020102|gb|EGI60548.1| Neither inactivation nor afterpotential protein C [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 559 bits (1440), Expect = e-156, Method: Compositional matrix adjust.
Identities = 271/514 (52%), Positives = 367/514 (71%), Gaps = 34/514 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+HIAF+LKE+I ++ LHE++VIHRD+RG+N++LTK+GEVK+VDFGLSR N +K
Sbjct: 152 IQEEHIAFVLKEVIKALIHLHEHNVIHRDIRGNNIVLTKEGEVKLVDFGLSRTMKNELEK 211
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
++T++GSPSWMAPE++ VDGYD+R+DVWA+GITAIE+ DGK PFE+MHPTRALFQ
Sbjct: 212 RRTYIGSPSWMAPEMIGSKDSGVDGYDSRVDVWAIGITAIEMADGKAPFENMHPTRALFQ 271
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS--- 177
IVRNPPP LYR +NWS++ DFI+ECLEKNPE+RPYM E++EHPF++ LPEND L+
Sbjct: 272 IVRNPPPTLYRPTNWSKNLNDFISECLEKNPENRPYMMEIIEHPFLSELPENDYPLTQEI 331
Query: 178 ---TVNCQYK--------------------DQELQTMHVEDLAALETISEDNIVQELEER 214
T++ K D+ + M EDLAAL+T++ED I+ EL +R
Sbjct: 332 KALTMDLSEKGRKQRKTELIVRQGFLKTHQDESPEQMLTEDLAALDTLTEDVILDELRDR 391
Query: 215 HNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHH 274
+++F+GD+LL +NPN ++YG +H KY+ KSRSDN PHIY+VADSA+QD+M +
Sbjct: 392 LRRGEYHTFIGDILLILNPNEENDIYGVHHHAKYQCKSRSDNAPHIYSVADSAFQDVMLN 451
Query: 275 EEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQ 334
EE QHI+LAGE+ +GKTT++ HL++HL+FLG+G G ++ + + +IHA NAGTP+N
Sbjct: 452 EELQHILLAGESNSGKTTNMLHLVEHLMFLGKGLHDTGARVLQAIKIIHAFTNAGTPLNA 511
Query: 335 NSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGE 394
+STR +L Q TFGS+GK SGAIFWLYQLEKWRV+ RD QANFH+FYYFYD +EA
Sbjct: 512 DSTRCILQTQTTFGSTGKASGAIFWLYQLEKWRVS-TRDRNQANFHVFYYFYDDLEATEN 570
Query: 395 LDKYFLSPGRKYRYLRADVTDDKLPKGP----RETPDTNVAKFQEIYQNLIDIEFDDIQM 450
L YFL GRK RYLR +TD + K R P NV KF+E+ + ++ ++
Sbjct: 571 LKSYFLPSGRKLRYLR--ITDKNIEKKRAFKVRSDPQNNVIKFKELTEYFKFMDMEEYCD 628
Query: 451 EIFSNVLAAILLIGEVEFESSAENTAELANPEVA 484
I+ +LAAIL++GE+ F AEL + E+A
Sbjct: 629 TIWK-ILAAILILGEIRFVEGNNGEAELDDNEIA 661
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383865054|ref|XP_003707990.1| PREDICTED: neither inactivation nor afterpotential protein C-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1435), Expect = e-156, Method: Compositional matrix adjust.
Identities = 270/513 (52%), Positives = 356/513 (69%), Gaps = 31/513 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E+HI FIL+E+I M FLHEN+V+HRD+RGSN+LLTK+GEVK+VDFGLSR K
Sbjct: 151 MREEHIGFILREVIQAMAFLHENNVMHRDIRGSNILLTKEGEVKLVDFGLSRTVKGEMGK 210
Query: 61 KKTFLGSPSWMAPEIMRC-GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ T +GSP WMAPE+ G+ GY NR DVWA+GITAIEL DGKPPF+DMHPTRALF
Sbjct: 211 RYTCIGSPCWMAPEVAASKGNTSDAGYGNRADVWAIGITAIELADGKPPFQDMHPTRALF 270
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS-- 177
QIVRNPPP LYR SNWSQ++ DFIAECLEKNP++RP+M+E+ EHPF+ +PEND ++
Sbjct: 271 QIVRNPPPNLYRPSNWSQNFNDFIAECLEKNPDNRPFMAEIAEHPFLADIPENDFLMTKE 330
Query: 178 ---------TVNCQYKDQE---------------LQTMHVEDLAALETISEDNIVQELEE 213
T Q + E L+ M +EDLAALET++ED I+ EL +
Sbjct: 331 IKVLMMDAGTKGKQERRPEVIVRKGFLKTHQTDPLEPMFMEDLAALETLTEDAILDELHD 390
Query: 214 RHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMH 273
R ++SF+GD+LL +NPN ++YG+ YH KY+FKSRSDN PH+Y+VADSA+QD++H
Sbjct: 391 RLRQGYYHSFIGDILLILNPNEKQDIYGSDYHTKYQFKSRSDNAPHVYSVADSAFQDVLH 450
Query: 274 HEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPIN 333
++E QHI+LAGE+ +GKTT++ HL++HL++LG+ G ++ + + V+HA NA TP+N
Sbjct: 451 NDEPQHILLAGESNSGKTTNMMHLIQHLMYLGKSLQDTGARLMRAIKVLHAFCNAATPLN 510
Query: 334 QNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAG 393
NSTR V +Q T+GSSGK SG IFWLYQLEKWRV+ RD Q+NFH+FYYFYD ++
Sbjct: 511 PNSTRCVFQVQTTYGSSGKASGGIFWLYQLEKWRVS-TRDRNQSNFHVFYYFYDGLDVTN 569
Query: 394 ELDKYFLSPGRKYRYLRADV--TDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQME 451
+L +Y LS GR+ RYLR T+ K R P NV KF+E+ +NL +E ++ E
Sbjct: 570 KLKQYNLSSGRRMRYLRISEKGTERKRSFKVRNDPRGNVTKFEELRENLKILEMEEY-CE 628
Query: 452 IFSNVLAAILLIGEVEFESSAENTAELANPEVA 484
LAAIL +GEV F A++ N + A
Sbjct: 629 TIWKTLAAILCLGEVRFVEGNNGEADMDNHDAA 661
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|158298612|ref|XP_318814.4| AGAP009730-PA [Anopheles gambiae str. PEST] gi|157013968|gb|EAA14178.4| AGAP009730-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1413), Expect = e-153, Method: Compositional matrix adjust.
Identities = 273/508 (53%), Positives = 355/508 (69%), Gaps = 29/508 (5%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE +A+IL+E+ +V+LHE+H++HRD+RGSN+LLTKDGEVK+ D+GL+R+T +T K+
Sbjct: 120 SELQLAYILREVSRALVYLHEHHIVHRDVRGSNILLTKDGEVKLCDYGLARDTKSTLGKR 179
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
T +GSP WMAPE++ + D YDNR DVWALGITAIELGDGKPPF DMH TRA+FQI
Sbjct: 180 GTCIGSPCWMAPEVVTSSKSDKDVYDNRSDVWALGITAIELGDGKPPFADMHATRAMFQI 239
Query: 122 VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS---- 177
VRNPPP LYR SNWSQ Y DFIAECLEKNP+HRP++ E++EHPF+T +PEND HLS
Sbjct: 240 VRNPPPTLYRQSNWSQEYNDFIAECLEKNPDHRPFIMEVIEHPFLTQVPENDYHLSQELK 299
Query: 178 ------------------TVNCQYKDQEL--QTMHVEDLAALETISEDNIVQELEERHNS 217
V K E + +HVEDLAALE +SE+ I++E+ +R+ +
Sbjct: 300 MLAESVQSTQLPKKEEVAVVRGMLKSAEARPEKLHVEDLAALEQLSEETILEEITQRYKN 359
Query: 218 KNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEA 277
N Y+FVGDVL+ +NPN + Y +H KY FKSRSDN PH++A+ADSAYQDM+HHEE
Sbjct: 360 GNTYTFVGDVLISLNPNETIPEYVRGFHSKYMFKSRSDNAPHVFAIADSAYQDMLHHEEP 419
Query: 278 QHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQNST 337
QHI+LAGE+ +GKTT+LK L+KHL LG+G V E+I + A+ NAGTP+N NST
Sbjct: 420 QHIILAGESYSGKTTNLKLLMKHLGVLGEGNPGVYERIVNGYKALSALTNAGTPLNPNST 479
Query: 338 RHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDK 397
R ++ Q+TFGS+GKLSGAIFW+Y LEK R++ + Q+NFHIFYYFYD M+A L
Sbjct: 480 RSIVQAQLTFGSTGKLSGAIFWVYLLEKLRISST-NMNQSNFHIFYYFYDTMDAEERLLD 538
Query: 398 YFLSPGRKYRYLRAD--VTDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSN 455
+ L GR YRYLR ++ DKL K R+ NV F+E + L+ +E +E
Sbjct: 539 FSLEGGRNYRYLRISDGMSSDKL-KYCRDDIAGNVRAFKEFEEQLLALEISQDILETIYR 597
Query: 456 VLAAILLIGEVEFESSAENTAELANPEV 483
LAAILL+GEV F+ + + EL + EV
Sbjct: 598 TLAAILLLGEVRFKET-DGMTELESFEV 624
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|170040124|ref|XP_001847861.1| myosin IIIA [Culex quinquefasciatus] gi|167863673|gb|EDS27056.1| myosin IIIA [Culex quinquefasciatus] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1407), Expect = e-153, Method: Compositional matrix adjust.
Identities = 270/510 (52%), Positives = 354/510 (69%), Gaps = 27/510 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE+ IA+IL+E +++LHENH+IHRD+RG N+LLT+DGEVK+ DFGLSR+ +T K
Sbjct: 118 VSEEQIAYILRETAKALIYLHENHIIHRDVRGHNILLTRDGEVKLCDFGLSRDIKSTLGK 177
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +GSP WMAPEI+ G + + YDNR DVWALGITAIELGDGKPPF +MHPTR +FQ
Sbjct: 178 RGTCIGSPCWMAPEIITSGKNDNEVYDNRSDVWALGITAIELGDGKPPFHEMHPTRIMFQ 237
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLST-- 178
IVRNPPP LYR +NW+Q+Y DFI ECLEKNP+HRP+ E++EHPF+T LPEND H+
Sbjct: 238 IVRNPPPTLYRPANWTQNYNDFINECLEKNPDHRPFSMEIIEHPFLTELPENDYHIGQEL 297
Query: 179 ---------VNCQYKDQ-------------ELQTMHVEDLAALETISEDNIVQELEERHN 216
V +KD+ + + MHVEDLAALET+SE+ I+ EL +R+
Sbjct: 298 RMLAESVQDVLLIHKDEMKFMKGALKGPDNKTEKMHVEDLAALETLSEETILDELIQRYK 357
Query: 217 SKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEE 276
S + Y+FVGDVLL +NPNT + +H KY KSRSDN PHI+A+ADSAYQDM+HHEE
Sbjct: 358 SGSTYTFVGDVLLSMNPNTEMPDLPRGFHSKYNCKSRSDNSPHIFAIADSAYQDMLHHEE 417
Query: 277 AQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQNS 336
QHI+++GE+ +GKTT+ K LKHL +LG+G + V +KI+ V+ A+ NAGTP+N +S
Sbjct: 418 PQHIIMSGESYSGKTTNAKLCLKHLAYLGEGNSGVAQKIQSGYKVLSALVNAGTPLNSDS 477
Query: 337 TRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELD 396
TR ++ Q+TFGS+GKLSGAIFW+Y LEK R++ + Q+NFHIFYYFYDAMEA L
Sbjct: 478 TRAIVQTQMTFGSTGKLSGAIFWVYLLEKLRISST-NMNQSNFHIFYYFYDAMEAEQRLR 536
Query: 397 KYFLSPGRKYRYLR-ADVTDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSN 455
+ L GR YRYLR + T K R+ NV F + Q L+ +E +E F
Sbjct: 537 DFSLERGRNYRYLRIPESTAGTKLKYVRDDIQGNVTAFHDFEQLLLGLEISPELVETFYR 596
Query: 456 VLAAILLIGEVEFESSAENTAELANPEVAA 485
LA++LL+GEV F + + EL + EV
Sbjct: 597 TLASVLLLGEVRFRDN-DGVTELEDYEVVG 625
|
Source: Culex quinquefasciatus Species: Culex quinquefasciatus Genus: Culex Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322788655|gb|EFZ14256.1| hypothetical protein SINV_08357 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 544 bits (1402), Expect = e-152, Method: Compositional matrix adjust.
Identities = 267/514 (51%), Positives = 359/514 (69%), Gaps = 31/514 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+HIAFIL+E+I ++ LHE+++IHRD+RG+N++LTK+GEVK+VDFGLSR N +K
Sbjct: 145 IREEHIAFILREVIKALIHLHEHNIIHRDIRGNNIVLTKEGEVKLVDFGLSRTMTNELEK 204
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVD-GYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ +++GSPSWMAPE++ D GYD+R+DVWA+GITAIEL D K PFEDMHPTRALF
Sbjct: 205 RHSYIGSPSWMAPEMVGSKDSGADSGYDSRVDVWAIGITAIELADSKAPFEDMHPTRALF 264
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS-- 177
QIVRNPPP LYR +NWS++ DFI+ECLEKNPE+RPYM E++EHPF++ LPEND L+
Sbjct: 265 QIVRNPPPTLYRPANWSKNLNDFISECLEKNPENRPYMMEIIEHPFLSELPENDYPLTQE 324
Query: 178 ----TVNCQYKDQEL--------------------QTMHVEDLAALETISEDNIVQELEE 213
T+ K ++L + M EDLAAL+ I+ED I+ EL E
Sbjct: 325 IKALTMTLSEKSRKLRKSELIVRKGFLKTRQDEPPEQMLTEDLAALDIITEDIILNELRE 384
Query: 214 RHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMH 273
R +++F+GD+LL +NPN ++YG +H KY+ KSRSDN PHIY+VADSA+Q++M
Sbjct: 385 RLERGEYHTFIGDILLVLNPNEEHDIYGDHHHAKYQSKSRSDNAPHIYSVADSAFQNVML 444
Query: 274 HEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPIN 333
+E++QHI+LAGE+ +GKTT++ HL++HL+FLG+G G + + + +IHA NA TP+N
Sbjct: 445 NEDSQHILLAGESNSGKTTNMLHLMEHLMFLGKGLRDTGAIVLRAIKIIHAFTNAATPLN 504
Query: 334 QNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAG 393
NSTR +L Q TFGS+GK SGAIFWLYQLEKWRV+ RD Q+NFHIFYYFYD +EA+
Sbjct: 505 ANSTRCILQTQTTFGSTGKASGAIFWLYQLEKWRVS-TRDRNQSNFHIFYYFYDGLEASE 563
Query: 394 ELDKYFLSPGRKYRYLRA--DVTDDKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQME 451
L YFL GRK RYLR T+ K R P N K +E+ + ++ ++ E
Sbjct: 564 NLQTYFLPSGRKLRYLRIIDKGTEKKRGFKVRNDPQNNAIKLKELEECFKYMDIEE-HCE 622
Query: 452 IFSNVLAAILLIGEVEFESSAENTAELANPEVAA 485
I +LAAIL++GE+ F AEL N E+A
Sbjct: 623 IIWKILAAILILGEIRFVEGNNGEAELDNNEIAT 656
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 488 | ||||||
| FB|FBgn0002938 | 1501 | ninaC "neither inactivation no | 0.696 | 0.226 | 0.415 | 4.2e-120 | |
| UNIPROTKB|E2RQX5 | 1613 | MYO3A "Uncharacterized protein | 0.379 | 0.114 | 0.497 | 2.2e-83 | |
| UNIPROTKB|F5H0U9 | 664 | MYO3A "Myosin-IIIa" [Homo sapi | 0.360 | 0.265 | 0.522 | 2.5e-83 | |
| UNIPROTKB|Q8NEV4 | 1616 | MYO3A "Myosin-IIIa" [Homo sapi | 0.360 | 0.108 | 0.522 | 2.7e-83 | |
| UNIPROTKB|F1RTW9 | 596 | MYO3A "Uncharacterized protein | 0.360 | 0.295 | 0.502 | 1.7e-82 | |
| UNIPROTKB|E1C7H7 | 1624 | MYO3A "Uncharacterized protein | 0.411 | 0.123 | 0.475 | 3.2e-82 | |
| RGD|1560083 | 1614 | Myo3a "myosin IIIA" [Rattus no | 0.379 | 0.114 | 0.491 | 4.1e-82 | |
| UNIPROTKB|E1BP01 | 1626 | MYO3A "Uncharacterized protein | 0.360 | 0.108 | 0.508 | 8.7e-82 | |
| UNIPROTKB|E1C190 | 1119 | MYO3B "Uncharacterized protein | 0.360 | 0.157 | 0.482 | 1.2e-81 | |
| ZFIN|ZDB-GENE-041026-4 | 1775 | myo3a "myosin IIIA" [Danio rer | 0.448 | 0.123 | 0.445 | 1.9e-81 |
| FB|FBgn0002938 ninaC "neither inactivation nor afterpotential C" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 669 (240.6 bits), Expect = 4.2e-120, Sum P(2) = 4.2e-120
Identities = 145/349 (41%), Positives = 214/349 (61%)
Query: 142 FIAECLEKNPEHRPYMSELLE--HPFITSLPENDLHLSTVNCQYKDQELQTMHVEDLAAL 199
F+ E +E E R ++E+LE T E +L + + D++ + M+ EDLAAL
Sbjct: 281 FLTELIENEDEMRSDIAEMLELSRDVKTLYKEPELFVDRGYVKRFDEKPEKMYPEDLAAL 340
Query: 200 ETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPH 259
E ++NI++ L R YSF+GD+LL +N N + ++H KY+FKSRS+N+PH
Sbjct: 341 ENPVDENIIESLRHRILMGESYSFIGDILLSLNSNEIKQEFPQEFHAKYRFKSRSENQPH 400
Query: 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSXXXXXXXXIFLGQGAAKVGEKIEKCV 319
I++VAD AYQDM+HH+E QHIVL+GE+ +GK+T+ +LG G ++E +
Sbjct: 401 IFSVADIAYQDMLHHKEPQHIVLSGESYSGKSTNARLLIKHLCYLGDGNRGATGRVESSI 460
Query: 320 NVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANF 379
I + NAGTP+N +STR VL +TFG +GK+SGA+F +Y LEK RV D Q NF
Sbjct: 461 KAILMLVNAGTPVNNDSTRCVLQYCLTFGKTGKMSGAVFNMYMLEKLRVA-TTDGTQHNF 519
Query: 380 HIFYYFYDAMEAAGELDKYFLSPGRKYRYLRA--DVTDDKLPKGPRETPDTNVAKFQEIY 437
HIFYYFYD + +L +Y L R YRYLR +V KL K R+ P+ NV +++E +
Sbjct: 520 HIFYYFYDFINQQNQLKEYNLKADRNYRYLRVPPEVPPSKL-KYRRDDPEGNVERYRE-F 577
Query: 438 QNLI-DIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAA 485
+N++ DI+F+ Q+E VLAAIL IG + F + + AE+ N ++ +
Sbjct: 578 ENILRDIDFNHKQLETVRKVLAAILNIGNIRFRQNGKY-AEVENTDIVS 625
|
|
| UNIPROTKB|E2RQX5 MYO3A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 2.2e-83, Sum P(2) = 2.2e-83
Identities = 92/185 (49%), Positives = 126/185 (68%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
MSE IA+IL E + G+ LH N IHRD++G+N+LLT +G VK+VDFG+S + +T +
Sbjct: 122 MSEPIIAYILHEALLGLQHLHNNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRYR 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R D W+LGITAIELGDG PP D+HP RALF+
Sbjct: 182 RNTSVGTPFWMAPEVIACEQQLDTTYDARCDTWSLGITAIELGDGDPPLADLHPMRALFK 241
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNPPP L + WS + DFI++CL K+ E RP +S+LL+H FIT + D+ L
Sbjct: 242 IPRNPPPKLRQPEIWSAEFNDFISKCLTKDYEKRPTVSDLLQHKFITQIEGKDVMLQKQL 301
Query: 181 CQYKD 185
++ D
Sbjct: 302 MEFID 306
|
|
| UNIPROTKB|F5H0U9 MYO3A "Myosin-IIIa" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 2.5e-83, Sum P(2) = 2.5e-83
Identities = 92/176 (52%), Positives = 123/176 (69%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
MSE IA+IL E + G+ LH N IHRD++G+N+LLT +G VK+VDFG+S + +T +
Sbjct: 122 MSEPLIAYILHEALMGLQHLHNNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRHR 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R D W+LGITAIELGDG PP D+HP RALF+
Sbjct: 182 RNTSVGTPFWMAPEVIACEQQLDTTYDARCDTWSLGITAIELGDGDPPLADLHPMRALFK 241
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
I RNPPP L + WS + DFI++CL K+ E RP +SELL+H FIT + D+ L
Sbjct: 242 IPRNPPPKLRQPELWSAEFNDFISKCLTKDYEKRPTVSELLQHKFITQIEGKDVML 297
|
|
| UNIPROTKB|Q8NEV4 MYO3A "Myosin-IIIa" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 2.7e-83, Sum P(2) = 2.7e-83
Identities = 92/176 (52%), Positives = 123/176 (69%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
MSE IA+IL E + G+ LH N IHRD++G+N+LLT +G VK+VDFG+S + +T +
Sbjct: 122 MSEPLIAYILHEALMGLQHLHNNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRHR 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R D W+LGITAIELGDG PP D+HP RALF+
Sbjct: 182 RNTSVGTPFWMAPEVIACEQQLDTTYDARCDTWSLGITAIELGDGDPPLADLHPMRALFK 241
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
I RNPPP L + WS + DFI++CL K+ E RP +SELL+H FIT + D+ L
Sbjct: 242 IPRNPPPKLRQPELWSAEFNDFISKCLTKDYEKRPTVSELLQHKFITQIEGKDVML 297
|
|
| UNIPROTKB|F1RTW9 MYO3A "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 476 (172.6 bits), Expect = 1.7e-82, Sum P(2) = 1.7e-82
Identities = 90/179 (50%), Positives = 123/179 (68%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M+E IA+IL+E + G+ LH N IHRD++G+N+LLT +G VK+VDFG+S + +T+ +
Sbjct: 122 MNELIIAYILREALLGLQHLHNNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTWHR 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R D W+LGITAIELGDG PP D+HP RALF+
Sbjct: 182 RNTSVGTPFWMAPEVIACEQQLDTTYDARCDTWSLGITAIELGDGDPPLADLHPMRALFK 241
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAE---CLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
I RNPPP L + WS + DFI+ CL K+ E RP +S+LL+H FIT + D L
Sbjct: 242 IPRNPPPKLRQPELWSAEFNDFISNQCRCLTKDYEKRPTVSDLLQHKFITQIEGKDAML 300
|
|
| UNIPROTKB|E1C7H7 MYO3A "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 3.2e-82, Sum P(2) = 3.2e-82
Identities = 96/202 (47%), Positives = 130/202 (64%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M+E IA+IL E + G+ LHEN IHRD++G+N+LLT +G VK+VDFG+S + +T +
Sbjct: 122 MNELIIAYILHEALMGLQHLHENKTIHRDIKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R D W+LGITAIELGDG PP D+HP RALF+
Sbjct: 182 RNTSVGTPFWMAPEVIACEQQLDSSYDARCDAWSLGITAIELGDGDPPLADLHPMRALFK 241
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNPPP L + WS + DFI +CL K+ E RP +S LL+H FI + + L
Sbjct: 242 IPRNPPPTLQQPELWSSEFNDFINKCLTKDYEKRPTVSSLLQHDFIKQIEGKENVLQRQL 301
Query: 181 CQYKDQELQTMHVEDLAALETI 202
++ D Q M V + A E I
Sbjct: 302 MEFIDVH-QQMGVTEKARFERI 322
|
|
| RGD|1560083 Myo3a "myosin IIIA" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 4.1e-82, Sum P(2) = 4.1e-82
Identities = 91/185 (49%), Positives = 125/185 (67%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
MSE IA+IL E + G+ LH N IHRD++G+N+LLT +G VK+VDFG+S + ++T +
Sbjct: 122 MSEPIIAYILHEALMGLQHLHSNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLSSTRHR 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
T +G+P WMAPE++ C + YD R D W+LGITAIELGDG PP ++HP RALF+
Sbjct: 182 LNTSVGTPFWMAPEVIACEQQLDTTYDARCDTWSLGITAIELGDGDPPLAELHPMRALFK 241
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I RNPPP L + WS + DFI++CL K+ E RP +S+LL+H FIT + D L
Sbjct: 242 IPRNPPPKLRQPELWSAEFNDFISKCLTKDYEKRPTVSDLLKHKFITQIEGRDAILQKQL 301
Query: 181 CQYKD 185
++ D
Sbjct: 302 MEFID 306
|
|
| UNIPROTKB|E1BP01 MYO3A "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 8.7e-82, Sum P(2) = 8.7e-82
Identities = 91/179 (50%), Positives = 123/179 (68%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
MSE IA+IL+E + G+ LH N IHRD++G+N+LLT +G VK+VDFG+S + +T+ +
Sbjct: 122 MSEPIIAYILREALLGLQHLHNNKTIHRDIKGNNILLTTEGGVKLVDFGVSAQLTSTWHR 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R D W+LGITAIELGDG PP D+HP RALF+
Sbjct: 182 RNTSVGTPFWMAPEVIACEQQLDTTYDARCDTWSLGITAIELGDGDPPLADLHPMRALFK 241
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAE---CLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
I RNPPP L + WS + DFI+ CL K+ E RP +S+LL+H FIT + D L
Sbjct: 242 IPRNPPPKLRQPEIWSAEFNDFISNQCRCLTKDYEKRPTVSDLLQHTFITQVEGKDAML 300
|
|
| UNIPROTKB|E1C190 MYO3B "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 1.2e-81, Sum P(2) = 1.2e-81
Identities = 85/176 (48%), Positives = 119/176 (67%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E I++IL + G+ LH N +IHRD++G+N+LLT +G VK+VDFG+S + +T +
Sbjct: 143 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 202
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R DVW+LGITAIELGDG PP DMHP + LF+
Sbjct: 203 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 262
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
I RNPPP L W + + FI++CL K+ E RP ++ LLEHPFI + D+ L
Sbjct: 263 IPRNPPPTLLHPEKWCRGFNHFISQCLIKDFEKRPTVTHLLEHPFIKQVHGKDMSL 318
|
|
| ZFIN|ZDB-GENE-041026-4 myo3a "myosin IIIA" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 1.9e-81, Sum P(2) = 1.9e-81
Identities = 99/222 (44%), Positives = 137/222 (61%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E IAFIL E + G+ LH N IHRD++G+N+LLT G +K+VDFG+S + NT +
Sbjct: 122 MEEPIIAFILHEALMGLQHLHVNKTIHRDVKGNNILLTTGGGIKLVDFGVSAQLTNTRLR 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ T +G+P WMAPE++ C +++D YD R DVW+LGITAIELGDG PP ++HP RALF
Sbjct: 182 RNTSVGTPFWMAPEVIAC-EQQLDSTYDERCDVWSLGITAIELGDGDPPLAELHPMRALF 240
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTV 179
+I RNPPP L++ WS + DFI +CL K+ E RP + +LL+H FI + + L
Sbjct: 241 KIPRNPPPTLHQPELWSNDFNDFIRKCLIKDFELRPNVLDLLQHVFIKQIVGREKTLQKQ 300
Query: 180 NCQYKDQELQTMHVEDLAALETISEDNIVQELEERHNSKNHY 221
+ D Q +E + L D+ + E H KN Y
Sbjct: 301 LMELIDLNQQMGIIEKTSLLGKSDRDSDSRH-ERIHTKKNSY 341
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 488 | |||
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-96 | |
| cd00124 | 679 | cd00124, MYSc, Myosin motor domain | 9e-77 | |
| smart00242 | 677 | smart00242, MYSc, Myosin | 9e-72 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-71 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-68 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-65 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-64 | |
| cd01379 | 653 | cd01379, MYSc_type_III, Myosin motor domain, type | 2e-63 | |
| pfam00063 | 679 | pfam00063, Myosin_head, Myosin head (motor domain) | 5e-62 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-61 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-61 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-60 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-59 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-57 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-54 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-51 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-50 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-49 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-48 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-48 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-47 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-45 | |
| COG5022 | 1463 | COG5022, COG5022, Myosin heavy chain [Cytoskeleton | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-45 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-44 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-44 | |
| cd01378 | 674 | cd01378, MYSc_type_I, Myosin motor domain, type I | 1e-43 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-43 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-43 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-40 | |
| cd01384 | 674 | cd01384, MYSc_type_XI, Myosin motor domain, plant- | 1e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-39 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-39 | |
| cd01385 | 692 | cd01385, MYSc_type_IX, Myosin motor domain, type I | 3e-39 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-39 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-38 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-38 | |
| cd01377 | 693 | cd01377, MYSc_type_II, Myosin motor domain, type I | 7e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-38 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-37 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-37 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-36 | |
| cd01380 | 691 | cd01380, MYSc_type_V, Myosin motor domain, type V | 3e-36 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-36 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-36 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-35 | |
| cd01383 | 677 | cd01383, MYSc_type_VIII, Myosin motor domain, plan | 8e-35 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-34 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-34 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-33 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-32 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-32 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-32 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-31 | |
| cd01381 | 671 | cd01381, MYSc_type_VII, Myosin motor domain, type | 3e-31 | |
| cd01382 | 717 | cd01382, MYSc_type_VI, Myosin motor domain, type V | 3e-31 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-30 | |
| cd01387 | 677 | cd01387, MYSc_type_XV, Myosin motor domain, type X | 3e-30 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-29 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-29 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-27 | |
| cd01386 | 767 | cd01386, MYSc_type_XVIII, Myosin motor domain, typ | 6e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-26 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-26 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-25 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-24 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-23 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-21 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-21 | |
| PTZ00014 | 821 | PTZ00014, PTZ00014, myosin-A; Provisional | 4e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-21 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-20 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-20 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-20 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-19 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-19 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-19 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-12 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-11 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 290 bits (744), Expect = 9e-96
Identities = 98/166 (59%), Positives = 126/166 (75%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+ IA+IL+E + G+ +LHEN VIHRD++G N+LLTK+ EVK+VDFG+S + +T +
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ C + YD R DVW+LGITAIEL DGKPP DMHP RALF+
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I RNPPP L NWS+ + DFI+ECL KN E RP+M ELLEHPFI
Sbjct: 230 IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|238071 cd00124, MYSc, Myosin motor domain | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 9e-77
Identities = 101/301 (33%), Positives = 160/301 (53%), Gaps = 17/301 (5%)
Query: 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFK 251
V+DLA+L ++E ++ L +R+ Y++ G +L+ +NP L YG + KY+ K
Sbjct: 1 GVDDLASLPHLNEATVLNNLRQRYKKDLIYTYAGPILIAVNPYKDLPNYGPETIRKYRGK 60
Query: 252 SRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAA-K 310
SRS+ PH++A+AD AY++M+ Q I+++GE+ AGKT + K ++K+L L
Sbjct: 61 SRSELPPHVFAIADRAYRNMLRDRRNQSIIISGESGAGKTENTKLIMKYLASLAGSNDTG 120
Query: 311 VGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTG 370
+ EKI ++ A GNA T N NS+R ++++ F +GK+SGA Y LEK RV
Sbjct: 121 IEEKILAANPILEAFGNAKTVRNNNSSRFGKFIELQFDETGKISGAKITTYLLEKSRVV- 179
Query: 371 NRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPD-TN 429
+++P + NFHIFY E K L YRYL G + +
Sbjct: 180 SQEPGERNFHIFYQLLAGASPE-ERKKLGLKRPESYRYLN--------QGGCNDVDGIDD 230
Query: 430 VAKFQEIYQNLIDIEF-DDIQMEIFSNVLAAILLIGEVEFESSAE---NTAELANPEVAA 485
+F+E+ + L + F ++ IF +LAAIL +G +EF+S AE+ N EV +
Sbjct: 231 AEEFEELKEALKSLGFSEEEIESIFR-ILAAILHLGNIEFKSVGGEGQEAAEVKNTEVLS 289
Query: 486 N 486
Sbjct: 290 K 290
|
This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 679 |
| >gnl|CDD|214580 smart00242, MYSc, Myosin | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 9e-72
Identities = 94/304 (30%), Positives = 159/304 (52%), Gaps = 24/304 (7%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
VEDL L ++E ++ L++R+ Y+++G VL+ +NP L +Y + KY+ KS
Sbjct: 8 VEDLVLLTYLNEPAVLHNLKKRYLKDLIYTYIGLVLVAVNPYKQLPIYTDEVIKKYRGKS 67
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312
R + PH++A+AD+AY++M++ +E Q I+++GE+ AGKT + K ++++L + +VG
Sbjct: 68 RGELPPHVFAIADNAYRNMLNDKENQSIIISGESGAGKTENTKKIMQYLASVSGSNTEVG 127
Query: 313 ---EKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVT 369
++I + ++ A GNA T N NS+R ++++ F + GK+ GA Y LEK RV
Sbjct: 128 SVEDQILESNPILEAFGNAKTLRNNNSSRFGKFIEIHFDAKGKIIGAKIETYLLEKSRVV 187
Query: 370 ----GNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRET 425
G R N+HIFY + L YRYL +
Sbjct: 188 SQAKGER-----NYHIFYQLLAGASEE-LKKELGLKSPEDYRYLNQGGCLTV------DG 235
Query: 426 PDTNVAKFQEIYQNLIDIEF-DDIQMEIFSNVLAAILLIGEVEFESSAENTAE--LANPE 482
D + +F+E + + F ++ Q IF +LAAIL +G +EFE + A + + E
Sbjct: 236 ID-DAEEFKETLNAMRVLGFSEEEQESIFK-ILAAILHLGNIEFEEGRNDNAASTVKDKE 293
Query: 483 VAAN 486
+N
Sbjct: 294 ELSN 297
|
Large ATPases. ATPase; molecular motor. Muscle contraction consists of a cyclical interaction between myosin and actin. The core of the myosin structure is similar in fold to that of kinesin. Length = 677 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 6e-71
Identities = 79/165 (47%), Positives = 117/165 (70%), Gaps = 6/165 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E IA++ KE++ G+ +LH N +IHRD++ +N+LLT DGEVK++DFGLS + ++T +
Sbjct: 95 LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR 154
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
T +G+P WMAPE++ YD + D+W+LGITAIEL +GKPP+ ++ P +ALF+
Sbjct: 155 N-TMVGTPYWMAPEVINGKP-----YDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPF 165
I N PPGL WS + DF+ +CL+KNPE RP +LL+HPF
Sbjct: 209 IATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 2e-68
Identities = 77/166 (46%), Positives = 116/166 (69%), Gaps = 5/166 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E+ IA IL + + G+ +LH N IHRD++ N+LL ++G+ K+ DFG+S + +T K
Sbjct: 96 LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ +E+ GY+N+ D+W+LGITAIE+ +GKPP+ D+HP RA+F
Sbjct: 156 RNTVIGTPFWMAPEVI----QEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM 210
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I PPP L WS + DF+ +CL K+PE RP +LL+HPFI
Sbjct: 211 IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 6e-65
Identities = 82/167 (49%), Positives = 117/167 (70%), Gaps = 4/167 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE IA++ +E + G+ +LHE IHRD++G+N+LLT+DG+VK+ DFG+S + T K
Sbjct: 98 LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+K+F+G+P WMAPE+ K GYD + D+WALGITAIEL + +PP D+HP RALF
Sbjct: 158 RKSFIGTPYWMAPEVAAVERK--GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL 215
Query: 121 IVRN--PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPF 165
I ++ PPP L WS + DFI +CL K+P+ RP ++LL+HPF
Sbjct: 216 ISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 1e-64
Identities = 78/173 (45%), Positives = 119/173 (68%), Gaps = 6/173 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E +IAFIL+E++ G+ +LHE IHRD++ +N+LL+++G+VK+ DFG+S + +T K
Sbjct: 95 LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE+++ GYD + D+W+LGITAIEL G+PP D+HP R LF
Sbjct: 155 RNTFVGTPFWMAPEVIKQS-----GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL 209
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEND 173
I +N PP L + +S+ + DF++ CL K+P+ RP ELL+H FI +
Sbjct: 210 IPKNNPPSLEG-NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTS 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|238675 cd01379, MYSc_type_III, Myosin motor domain, type III myosins | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 2e-63
Identities = 106/299 (35%), Positives = 169/299 (56%), Gaps = 9/299 (3%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
++DLA LE + ED IV++L++R+ + Y++VGD+L+ +NP L LY T++ Y +
Sbjct: 2 MDDLATLEVLDEDTIVEQLQKRYETNQIYTYVGDILIAVNPFQQLGLYTTQHSRLYTGQK 61
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAK-V 311
RS N PHI+A+AD+AYQ ++ + + Q IV++GE+ +GKT S L++ L LG+ + +
Sbjct: 62 RSSNPPHIFAIADAAYQSLVTYNQDQCIVISGESGSGKTESAHLLVQQLTVLGKANNRTL 121
Query: 312 GEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGN 371
EKI + +++ A GNA T IN NS+R Y+++ F SG + GA Y LEK RV
Sbjct: 122 QEKILQVNSLVEAFGNARTGINDNSSRFGKYLEMKFTRSGAVVGARISEYLLEKSRVVHQ 181
Query: 372 RDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVA 431
+ + NFHIFYY Y + +L +Y L + RYL+ + T +
Sbjct: 182 AEG-EKNFHIFYYIYAGLAEEKKLAEYKLPESKTPRYLQNEAT---RVVQDITSNKFYKD 237
Query: 432 KFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAEN----TAELANPEVAAN 486
+F++I Q I F D ++ +LAAIL +G++EF S A + ++N N
Sbjct: 238 QFEQIEQCFRVIGFTDEEVGSVYRILAAILNLGDIEFGSVASEHQTDKSRVSNVAALEN 296
|
Myosin III has been shown to play a role in the vision process in insects and in hearing in mammals. Myosin III, an unconventional myosin, does not form dimers. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 653 |
| >gnl|CDD|215687 pfam00063, Myosin_head, Myosin head (motor domain) | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 5e-62
Identities = 96/299 (32%), Positives = 152/299 (50%), Gaps = 18/299 (6%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
VEDLAAL ++E +++ L++R+ Y++ G VL+ +NP L +Y + +Y+ K
Sbjct: 1 VEDLAALTQLNETSVLHNLKKRYTGDLIYTYSGLVLISVNPYKRLPIYTEEPIGEYRGKR 60
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312
R + PHI+A+AD AY+ M+ +E Q IV++GE+ AGKT + K L+++L +
Sbjct: 61 RGELPPHIFALADRAYRHMLRDKENQCIVISGESGAGKTENTKKLMQYLASVSGSTPSAV 120
Query: 313 EKIEKCV----NVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRV 368
+E + ++ A GNA T N NS+R ++++ F ++G + G Y LEK RV
Sbjct: 121 GPLEDQILQSNPILEAFGNAKTLRNNNSSRFGKFIEIQFDATGSIVGGNIETYLLEKSRV 180
Query: 369 TGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDT 428
+ P + NFHIFY A E + L + Y YL G P
Sbjct: 181 V-YQTPGERNFHIFYQLLAGASAQ-EKKELGLKDPKDYAYLSQS--------GCYTVPGI 230
Query: 429 N-VAKFQEIYQNLIDIEFDDI-QMEIFSNVLAAILLIGEVEFESS-AENTAELANPEVA 484
+ +F++ L I F D Q IF VLAAIL +G ++F+ E A + + E
Sbjct: 231 DDAEEFKDTRSALKIIGFTDEEQRSIFR-VLAAILHLGNIKFKQDQNEEQAVVEDTEEL 288
|
Length = 679 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 1e-61
Identities = 73/172 (42%), Positives = 118/172 (68%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E I ++ ++++ + FLH + VIHRDL+ N+LLT DG+VK+ DFG+S + +T K
Sbjct: 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ C + + YD + D+W+LGIT IEL +PP +++P R L +
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK 219
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
I+++ PP L + S WS + DF+ CL K+P+ RP +ELL+HPF++ +N
Sbjct: 220 ILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 3e-61
Identities = 88/166 (53%), Positives = 118/166 (71%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E IA+IL E + G+ LH N IHRD++G+N+LLT +G VK+VDFG+S + +T +
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 180
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R DVW+LGITAIELGDG PP D+HP RALF+
Sbjct: 181 RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I RNPPP L++ WS + DFI +CL K+ E RP +S+LL+H FI
Sbjct: 241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 1e-60
Identities = 68/167 (40%), Positives = 105/167 (62%), Gaps = 5/167 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M+E IA++ +E++ G+ +LH +VIHRD++ N+LL+KDG VK+ DFG + + K
Sbjct: 113 MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ + +G+P WMAPE+++ Y ++D+W+LGI IE+ +G+PP+ P RALF
Sbjct: 173 RNSVVGTPYWMAPEVIK-RKD----YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL 227
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
I P L WS + DF+ +CL K+PE RP ELL+HPF+
Sbjct: 228 ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 1e-59
Identities = 86/166 (51%), Positives = 116/166 (69%), Gaps = 1/166 (0%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA+I +EI+ G+ LH + VIHRD++G NVLLT++ EVK+VDFG+S + T +
Sbjct: 118 LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ C YD R D+W+LGITAIE+ +G PP DMHP RALF
Sbjct: 178 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I RNPPP L ++ WS+ ++DFI CL KN RP +LL+HPFI
Sbjct: 238 IPRNPPPKL-KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 192 bits (488), Expect = 2e-57
Identities = 83/166 (50%), Positives = 115/166 (69%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E I++IL + G+ LH N +IHRD++G+N+LLT +G VK+VDFG+S + +T +
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ C + YD R DVW+LGITAIELGDG PP DMHP + LF+
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I RNPPP L W + + FI++CL K+ E RP ++ LLEHPFI
Sbjct: 245 IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 7e-55
Identities = 82/166 (49%), Positives = 115/166 (69%), Gaps = 1/166 (0%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+ IA+I +EI+ G+ LH++ VIHRD++G NVLLT++ EVK+VDFG+S + T +
Sbjct: 108 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 167
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ C YD + D+W+LGITAIE+ +G PP DMHP RALF
Sbjct: 168 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 227
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I RNP P L ++ WS+ + FI CL KN RP +L++HPFI
Sbjct: 228 IPRNPAPRL-KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 3e-54
Identities = 62/167 (37%), Positives = 93/167 (55%), Gaps = 7/167 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE F L++I++ + +LH ++HRDL+ N+LL +DG VK+ DFGL+R+ +K
Sbjct: 94 LSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EK 152
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
TF+G+P +MAPE++ GY +D+W+LG+ EL GKPPF LF+
Sbjct: 153 LTTFVGTPEYMAPEVLLG-----KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK 207
Query: 121 IVRNPPPGLYRAS-NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+ P P + S D I + L K+PE R E L+HPF
Sbjct: 208 KIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 9e-51
Identities = 70/172 (40%), Positives = 114/172 (66%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E I I ++++ + +LH +IHRDL+ NVLLT DG++K+ DFG+S + T +
Sbjct: 107 LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ +F+G+P WMAPE++ C + YD + D+W+LGIT IE+ +PP +++P R L +
Sbjct: 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
I ++ PP L + S WS + DF+ L+K+PE RP ++LLEHPF++S+ N
Sbjct: 227 IAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 2e-50
Identities = 73/171 (42%), Positives = 103/171 (60%), Gaps = 11/171 (6%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS----RETANTF 58
E IA +LKE++ G+ +LH N IHRD++ N+LL +DG VKI DFG+S T
Sbjct: 101 EAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
+KTF+G+P WMAPE+M ++V GYD + D+W+ GITAIEL G P+ P + L
Sbjct: 161 KVRKTFVGTPCWMAPEVM----EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL 216
Query: 119 FQIVRNPPPGL-YRASN--WSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
++N PP L A +S+ + I+ CL+K+P RP ELL+H F
Sbjct: 217 MLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 69/167 (41%), Positives = 111/167 (66%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E I + K+ + + +LHEN +IHRDL+ N+L T DG++K+ DFG+S + T +
Sbjct: 100 LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ +F+G+P WMAPE++ C + YD + DVW+LGIT IE+ +PP +++P R L +
Sbjct: 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
I ++ PP L + S WS + DF+ +CLEKN + R ++LL+HPF+T
Sbjct: 220 IAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 1e-48
Identities = 79/182 (43%), Positives = 118/182 (64%), Gaps = 7/182 (3%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E IA +LKEI+ G+ +LH IHRD++ +NVLL++ G+VK+ DFG++ + +T K+
Sbjct: 100 EFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV 122
TF+G+P WMAPE++ + YD++ D+W+LGITAIEL G+PP DMHP R LF I
Sbjct: 160 TFVGTPFWMAPEVI-----QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP 214
Query: 123 RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVNCQ 182
+N PP L +S+ + +FI CL K+P RP ELL+H FI + +L+ + +
Sbjct: 215 KNNPPTL--TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDR 272
Query: 183 YK 184
+K
Sbjct: 273 FK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-48
Identities = 79/184 (42%), Positives = 119/184 (64%), Gaps = 7/184 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E +IA IL+EI+ G+ +LH IHRD++ +NVLL++ G+VK+ DFG++ + +T K
Sbjct: 98 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE+++ YD + D+W+LGITAIEL G+PP D+HP R LF
Sbjct: 158 RNTFVGTPFWMAPEVIK-----QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL 212
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I +N PP L +S+ + +F+ CL K+P RP ELL+H FIT + L+ +
Sbjct: 213 IPKNSPPTL--EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELI 270
Query: 181 CQYK 184
+YK
Sbjct: 271 DRYK 274
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-47
Identities = 73/167 (43%), Positives = 108/167 (64%), Gaps = 4/167 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE IA++ +E + G+ +LH +HRD++G+N+LLT +G VK+ DFG+S + T K
Sbjct: 103 LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+K+F+G+P WMAPE+ K GY+ D+WA+GITAIEL + +PP D+HP RALF
Sbjct: 163 RKSFIGTPYWMAPEVAAVERK--GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220
Query: 121 IVRN--PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPF 165
+ ++ PP L WS + F+ L KNP+ RP +LL+HPF
Sbjct: 221 MTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 78/184 (42%), Positives = 118/184 (64%), Gaps = 7/184 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA IL+EI+ G+ +LH IHRD++ +NVLL++ GEVK+ DFG++ + +T K
Sbjct: 98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE+++ YD++ D+W+LGITAIEL G+PP ++HP + LF
Sbjct: 158 RNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I +N PP L N+S+ +F+ CL K P RP ELL+H FI + +L+ +
Sbjct: 213 IPKNNPPTL--EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELI 270
Query: 181 CQYK 184
+YK
Sbjct: 271 DRYK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|227355 COG5022, COG5022, Myosin heavy chain [Cytoskeleton] | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-45
Identities = 93/308 (30%), Positives = 160/308 (51%), Gaps = 19/308 (6%)
Query: 184 KDQELQTMHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTK 243
+ + + V+DL L ++E ++ LE+R+N+ Y++ G VL+ +NP L +Y
Sbjct: 59 RIKLPKFDGVDDLTELSYLNEPAVLHNLEKRYNNGQIYTYSGLVLIAVNPYRDLGIYTDD 118
Query: 244 YHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIF 303
Y K+R + EPH++A+A+ AY++++ +E Q I+++GE+ AGKT + K ++++L
Sbjct: 119 IIQSYSGKNRLELEPHVFAIAEEAYRNLLSEKENQTIIISGESGAGKTENAKRIMQYLAS 178
Query: 304 LGQGAAKVGEKIEKCV---N-VIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFW 359
+ + IEK + N ++ A GNA T N NS+R Y+++ F +G++ GA
Sbjct: 179 VTSSSTVEISSIEKQILATNPILEAFGNAKTVRNDNSSRFGKYIKIEFDENGEICGAKIE 238
Query: 360 LYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGEL--DKYFLSPGRKYRYLRADVTDDK 417
Y LEK RV +++ + N+HIFY + E L + Y YL + DK
Sbjct: 239 TYLLEKSRVV-HQNKNERNYHIFYQL---LAGDPEELKKLLLLQNPKDYIYL-SQGGCDK 293
Query: 418 LPKGPRETPDTNVAKFQEIYQNLIDIEFD-DIQMEIFSNVLAAILLIGEVEFESSAENTA 476
+ G + + F+ L I D + Q +IF +LAAIL IG +EF+ A
Sbjct: 294 ID-GIDDAKE-----FKITLDALKTIGIDEEEQDQIF-KILAAILHIGNIEFKEDRNGAA 346
Query: 477 ELANPEVA 484
++ V
Sbjct: 347 IFSDNSVL 354
|
Length = 1463 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 59/161 (36%), Positives = 98/161 (60%), Gaps = 11/161 (6%)
Query: 10 LKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTFDKKKTFLGS 67
++I+ G+ +LH N ++HRD++G+N+L+ DG VK+ DFG ++ T + + G+
Sbjct: 107 TRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PTRALFQIVRNP- 125
P WMAPE++R Y D+W+LG T IE+ GKPP+ ++ P AL++I +
Sbjct: 167 PYWMAPEVIRGE-----EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE 221
Query: 126 PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
PP + + S+ DF+ +CL ++P+ RP ELL+HPF+
Sbjct: 222 PPEI--PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 64/165 (38%), Positives = 101/165 (61%), Gaps = 7/165 (4%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E +A + +++ G+ +LHE VIHRD++ +N+L TKDG VK+ DFG++ + +
Sbjct: 97 PESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
+ +G+P WMAPE++ E+ G D+W+LG T IEL G PP+ D++P ALF+I
Sbjct: 157 ASVVGTPYWMAPEVI-----EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211
Query: 122 VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
V++ P L S DF+ +C +K+P RP +LL+HP+I
Sbjct: 212 VQDDHPPL--PEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-44
Identities = 70/167 (41%), Positives = 109/167 (65%), Gaps = 4/167 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE IA++ +E + G+ +LH +HRD++G+N+LLT +G+VK+ DFG++ + T K
Sbjct: 103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+K+F+G+P WMAPE+ ++ GY+ D+WA+GITAIEL + +PP D+HP RALF
Sbjct: 163 RKSFIGTPYWMAPEVAAV--EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220
Query: 121 IVRN--PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPF 165
+ ++ PP L + WS + +F+ L KNP+ RP LL H F
Sbjct: 221 MSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-44
Identities = 69/178 (38%), Positives = 105/178 (58%), Gaps = 14/178 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA I + G+ +LH + IHRD++ N+LLT+ G VK+ DFG +A+
Sbjct: 112 LQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG----SASLVSP 167
Query: 61 KKTFLGSPSWMAPEI---MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
+F+G+P WMAPE+ M G YD ++DVW+LGIT IEL + KPP +M+ A
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEGQ-----YDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT-SLPENDL 174
L+ I +N P L +++WS ++ +F+ CL+K P+ RP ELL+H F+ P +
Sbjct: 223 LYHIAQNDSPTL-SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVI 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|238674 cd01378, MYSc_type_I, Myosin motor domain, type I myosins | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-43
Identities = 104/316 (32%), Positives = 153/316 (48%), Gaps = 50/316 (15%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
V+DL L ISE+ IV+ L++R + Y+++G VL+ +NP L +Y + YK KS
Sbjct: 2 VDDLVLLSKISEEAIVENLKKRFQNDLIYTYIGPVLISVNPFKQLPIYTDETIELYKGKS 61
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKV- 311
R + PHIYA+AD+AY+ M E Q ++++GE+ AGKT + K +++++ A V
Sbjct: 62 RYELPPHIYALADNAYRSMKSENENQCVIISGESGAGKTEAAKKIMQYI-------AAVS 114
Query: 312 --GEKIEKCVNVI-------HAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQ 362
G+K+E+ +VI A GNA T N NS+R YM++ F G G Y
Sbjct: 115 GGGQKVERVKDVILQSNPLLEAFGNAKTLRNNNSSRFGKYMEIQFDFKGDPVGGKITNYL 174
Query: 363 LEKWRVT----GNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYL------RAD 412
LEK RV G R NFHIFY L + L Y YL D
Sbjct: 175 LEKSRVVSQNKGER-----NFHIFYQLLAGASEQ-LLRELGLQKPEYYYYLNQSQCYTVD 228
Query: 413 VTDDKLPKGPRETPDTNVAKFQEIYQ--NLIDIEFDDIQMEIFSNVLAAILLIGEVEFES 470
DDK F+E +I +D Q EIF ++AAIL +G V+F
Sbjct: 229 GIDDK-------------KDFKETQNAMKVIGF-SEDEQDEIFR-IVAAILHLGNVQFAE 273
Query: 471 SAENTAELANPEVAAN 486
+ + A +++ +V
Sbjct: 274 NGDGAAVISDKDVLDF 289
|
Myosin I generates movement at the leading edge in cell motility, and class I myosins have been implicated in phagocytosis and vesicle transport. Myosin I, an unconventional myosin, does not form dimers. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 674 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 65/167 (38%), Positives = 102/167 (61%), Gaps = 12/167 (7%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E I ++I+ G+ +LH+ + +HRD++G+N+L+ +G VK+ DFG++++ F K
Sbjct: 101 EPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAK 159
Query: 63 TFLGSPSWMAPE-IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
+F GSP WMAPE I + G GY D+W+LG T +E+ GKPP+ + A+F+I
Sbjct: 160 SFKGSPYWMAPEVIAQQG-----GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI 214
Query: 122 VRNP--PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
R+ PP + S DFI +CL+++P RP +ELLEHPF+
Sbjct: 215 GRSKELPP---IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 6e-43
Identities = 60/168 (35%), Positives = 106/168 (63%), Gaps = 5/168 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E++I+ I++E++ + ++H+ VIHRD++ +N+L+T G VK+ DFG++ K
Sbjct: 98 IAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ E YD + D+W+LGIT E+ G PP+ D+ RA+
Sbjct: 158 RSTFVGTPYWMAPEVIT----EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
I ++ PP L + +S+ +F+A CL++ P+ R ELL+ +I +
Sbjct: 214 IPKSKPPRL-EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 9e-43
Identities = 61/171 (35%), Positives = 92/171 (53%), Gaps = 10/171 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE I +I+ G+ +LH N +IHRDL+ N+LL ++G VKI DFGL+++ +
Sbjct: 95 LSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS 154
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
TF+G+P +MAPE++ G +GY ++DVW+LG+ EL GKPPF Q
Sbjct: 155 LTTFVGTPWYMAPEVLLGG----NGYGPKVDVWSLGVILYELLTGKPPFSG-ENILDQLQ 209
Query: 121 IVRNPPPGLYRASNWSQHYV-----DFIAECLEKNPEHRPYMSELLEHPFI 166
++R D I +CL K+P RP E+L+HP+
Sbjct: 210 LIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 67/166 (40%), Positives = 97/166 (58%), Gaps = 5/166 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E IA + +E + + FLH N VIHRD++ N+LL DG VK+ DFG + K
Sbjct: 112 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ Y ++D+W+LGI AIE+ +G+PP+ + +P RAL+
Sbjct: 172 RSTMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I N P L S + DF+ CLE + E R ELL+HPF+
Sbjct: 227 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|238680 cd01384, MYSc_type_XI, Myosin motor domain, plant-specific type XI myosin, involved in organelle transport | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-39
Identities = 90/293 (30%), Positives = 151/293 (51%), Gaps = 29/293 (9%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHL-NLYGTKYHFKYKFK 251
V+D+ L + E ++Q L+ R+ Y++ G++L+ +NP L +LY +YK
Sbjct: 3 VDDMTKLSYLHEPGVLQNLKTRYELNEIYTYTGNILIAVNPFQRLPHLYDVHMMEQYKGA 62
Query: 252 SRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKV 311
+ + PH++A+AD+AY+ M++ ++Q I+++GE+ AGKT + K L+++L ++G A
Sbjct: 63 ALGELSPHVFAIADAAYRAMINEGKSQSILVSGESGAGKTETTKMLMRYLAYMGGRAGVE 122
Query: 312 GEKIEKCV----NVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWR 367
G +E+ V V+ A GNA T N NS+R ++++ F G++SGA Y LE+ R
Sbjct: 123 GRTVEQQVLESNPVLEAFGNAKTVRNNNSSRFGKFVEIQFDDYGRISGAAIRTYLLERSR 182
Query: 368 VTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLR-------ADVTDDKLPK 420
V DP + N+H FY A ++ KY L +++ YL V D +
Sbjct: 183 VCQISDP-ERNYHCFYQLCAAPPE--DVKKYKLGDPKEFHYLNQSNCFELDGVDDAEEYL 239
Query: 421 GPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAE 473
R D + I ++ Q IF V+AAIL +G +EF E
Sbjct: 240 ATRRAMDV------------VGISEEE-QDAIFR-VVAAILHLGNIEFAKGEE 278
|
This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 674 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 68/171 (39%), Positives = 105/171 (61%), Gaps = 10/171 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLH-ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ E +A+I ++I+ G+ +LH + H+IHRD++ SN+L+ GEVKI DFG+S+ NT D
Sbjct: 96 IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF---EDMHPTR 116
+ TF+G+ ++M+PE ++ E Y D+W+LG+T +E GK PF
Sbjct: 156 QCNTFVGTVTYMSPERIQG---ESYSYAA--DIWSLGLTLLECALGKFPFLPPGQPSFFE 210
Query: 117 ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
+ I PPP L A +S + DFI+ CL+K+P+ RP +ELL+HPFI
Sbjct: 211 LMQAICDGPPPSL-PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 66/173 (38%), Positives = 101/173 (58%), Gaps = 14/173 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ E+ + I ++ G+ +LHE H +IHRD++ SN+L+ G++K+ DFG+S + N
Sbjct: 97 IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN--S 154
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF--EDMHPT-- 115
KTF+G+ S+MAPE ++ Y + D+W+LG++ IEL G+ P+ E+ P
Sbjct: 155 LAKTFVGTSSYMAPERIQGND-----YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209
Query: 116 -RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
L IV PPP L + +S + DF+ CL K+P RP ELLEHPFI
Sbjct: 210 FELLQYIVNEPPPRL-PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|238681 cd01385, MYSc_type_IX, Myosin motor domain, type IX myosins | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-39
Identities = 98/304 (32%), Positives = 156/304 (51%), Gaps = 19/304 (6%)
Query: 189 QTMHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKY 248
Q +DL L ++E +++ L R + Y++ G +L+ +NP L +Y KY Y
Sbjct: 5 QQREYDDLCNLPELTEGTLLKNLRHRFLQGHIYTYAGSILVAVNPFKFLPIYNPKYVRLY 64
Query: 249 KFKSRSDN-EPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQ- 306
+ + R PHI+A+AD AY +M+ + Q IV++GE+ +GKT S L+ HL L Q
Sbjct: 65 ENQQRLGKLPPHIFAIADVAYYNMLRKKVNQCIVISGESGSGKTESTNFLIHHLTALSQK 124
Query: 307 GAAKVG--EKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLE 364
G A G + I V+ A GNA T N NS+R ++QV + +G + GA+ Y LE
Sbjct: 125 GYAGSGVEQTILSAGPVLEAFGNAKTAHNNNSSRFGKFIQVNYRENGMVRGAVVEKYLLE 184
Query: 365 KWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRE 424
K R+ +++ + N+H+FYY E + FL Y YL + K+ G E
Sbjct: 185 KSRIV-SQEKDERNYHVFYYLLLGASEE-ERKQEFLLKQPDYFYLNQH--NLKIEDGEDE 240
Query: 425 TPDTNVAKFQEIYQNLIDIEF-DDIQMEIFSNVLAAILLIGEVEFESSA----ENTAELA 479
+ F+ + Q + + F Q +IF VL+A+LL+G V ++ A + + E+
Sbjct: 241 KHE-----FERLKQAMEMVGFLAATQKQIF-AVLSAVLLLGNVTYKKRATYHRDESLEVG 294
Query: 480 NPEV 483
NPEV
Sbjct: 295 NPEV 298
|
Myosin IX is a processive single-headed motor, which might play a role in signalling. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 692 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 62/167 (37%), Positives = 95/167 (56%), Gaps = 7/167 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M+E+ IA + ++ + FLH VIHRD++ ++LLT DG VK+ DFG + + +
Sbjct: 112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171
Query: 61 KKTFLGSPSWMAPE-IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+K+ +G+P WMAPE I R Y +D+W+LGI IE+ DG+PP+ + P +A+
Sbjct: 172 RKSLVGTPYWMAPEVISR------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK 225
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+I N PP L S F+ L ++P R +ELL HPF+
Sbjct: 226 RIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 66/166 (39%), Positives = 97/166 (58%), Gaps = 5/166 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E IA + +E + + FLH N VIHRD++ N+LL DG VK+ DFG + K
Sbjct: 112 MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ Y ++D+W+LGI AIE+ +G+PP+ + +P RAL+
Sbjct: 172 RSTMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I N P L S + DF+ CLE + + R ELL+HPF+
Sbjct: 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-38
Identities = 68/166 (40%), Positives = 97/166 (58%), Gaps = 5/166 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E IA + +E + + FLH N VIHRD++ NVLL DG VK+ DFG + K
Sbjct: 112 MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ Y ++D+W+LGI AIE+ +G+PP+ + +P RAL+
Sbjct: 172 RSTMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I N P L S + DF+ CLE + E R ELL+HPF+
Sbjct: 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|238673 cd01377, MYSc_type_II, Myosin motor domain, type II myosins | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 7e-38
Identities = 94/311 (30%), Positives = 153/311 (49%), Gaps = 36/311 (11%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
VED+A L ++E +++ L ER+ S Y++ G + +NP L +Y + Y+ K
Sbjct: 7 VEDMAELTHLNEASVLHNLRERYYSDLIYTYSGLFCVAVNPYKRLPIYTEEVVEMYRGKK 66
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312
R + PHI+A+AD+AY+ M+ E Q I++ GE+ AGKT + K ++++L + + K
Sbjct: 67 REEMPPHIFAIADNAYRSMLQDRENQSILITGESGAGKTENTKKVIQYLASVAASSKKKK 126
Query: 313 EK------IEKCV---NVI-HAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGA-IFWLY 361
+ +E + N I A GNA T N NS+R ++++ FG++GK++GA I Y
Sbjct: 127 QSGKGQGTLEDQILQANPILEAFGNAKTVRNDNSSRFGKFIRIHFGNTGKIAGADIET-Y 185
Query: 362 QLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLS-PGRKYRYLRADVT-----D 415
LEK RV + + N+HIFY + L+ YRYL D
Sbjct: 186 LLEKSRVV-FQASGERNYHIFYQLLSGAD-PELKSMLLLTGNPNDYRYLSQGELTIPGVD 243
Query: 416 DKLPKGPRETPDTNVAKFQEIYQNLIDIEF-DDIQMEIFSNVLAAILLIGEVEFES-SAE 473
D +F+ + + F D+ + IF ++AAIL +G ++F+ E
Sbjct: 244 D-------------AEEFKLTDEAFDILGFSDEEKNSIF-KIVAAILHLGNIKFKQRQRE 289
Query: 474 NTAELANPEVA 484
AEL E A
Sbjct: 290 EQAELDGTEEA 300
|
Myosin II mediates cortical contraction in cell motility, and is the motor in smooth and skeletal muscle. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 693 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-38
Identities = 52/166 (31%), Positives = 95/166 (57%), Gaps = 7/166 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
E+ I ++ + +LH ++HRD++ N+ LT +G VK+ DFG+S+ ++T D
Sbjct: 100 FPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
KT +G+P +++PE+ C +K Y+ + D+W+LG EL K PFE + +
Sbjct: 160 AKTVVGTPYYLSPEL--CQNK---PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK 214
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I++ P + S +S + ++ L+K+PE RP ++++L+ PFI
Sbjct: 215 ILKGQYPPI--PSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 64/173 (36%), Positives = 102/173 (58%), Gaps = 7/173 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E+ IA + + ++ + +LH VIHRD++ ++LLT DG VK+ DFG + + K
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+K+ +G+P WMAPE++ Y +D+W+LGI IE+ DG+PP+ P +A+ +
Sbjct: 174 RKSLVGTPYWMAPEVI-----SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 228
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI--TSLPE 171
+ +PPP L A S DF+ L + P+ R ELL+HPF+ T LPE
Sbjct: 229 LRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 3e-37
Identities = 66/166 (39%), Positives = 106/166 (63%), Gaps = 7/166 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA I + G+ +LH +++IHRD++ N+LLT+ G+VK+ DFG +A+
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG----SASIASP 177
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+F+G+P WMAPE++ + YD ++DVW+LGIT IEL + KPP +M+ AL+
Sbjct: 178 ANSFVGTPYWMAPEVILA--MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 235
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I +N P L +++ WS ++ +F+ CL+K P+ RP ELL+H F+
Sbjct: 236 IAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 65/169 (38%), Positives = 96/169 (56%), Gaps = 5/169 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ E + I I+ + +LH VIHRD++ SNVL+ ++G+VK+ DFG+S ++
Sbjct: 100 IPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PTRAL 118
K G +MAPE + GYD + DVW+LGIT IEL G+ P++ P + L
Sbjct: 160 KTID-AGCKPYMAPERIN-PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL 217
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
Q+V P P L A +S + DF+ +CL+KN + RP ELL+HPF
Sbjct: 218 KQVVEEPSPQL-PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|238676 cd01380, MYSc_type_V, Myosin motor domain, type V myosins | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 3e-36
Identities = 93/303 (30%), Positives = 150/303 (49%), Gaps = 30/303 (9%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
+DL L + E ++ L R K Y++ G VL+ INP L +YG + Y +
Sbjct: 2 KDDLTNLSYLHEPAVLHNLRVRFIQKQIYTYSGIVLVAINPYARLPIYGEEIIQAYSGQR 61
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312
+ + +PHI+A+A+ AY+ M E+ Q I+++GE+ AGKT S K+++++ +G ++
Sbjct: 62 KGELDPHIFAIAEEAYKQMTRDEKNQSIIVSGESGAGKTVSAKYIMRYFASVGGSDSREV 121
Query: 313 EK--IEKCV---NVI-HAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKW 366
+ +E+ V N I A GNA T N NS+R Y+Q+ F G++ GA Y LEK
Sbjct: 122 SETQVEEKVLASNPIMEAFGNAKTTRNDNSSRFGKYIQILFDKRGRIIGANMRTYLLEKS 181
Query: 367 RVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYL------RADVTDDKLPK 420
RV + P + N+HIFY + EL + L K+ YL + DD
Sbjct: 182 RVV-FQAPGERNYHIFYQLCAGAPSQ-ELKELHLGHADKFNYLNQGGAPTIEGVDDA--- 236
Query: 421 GPRETPDTNVAKFQEIYQNLIDIEFD-DIQMEIFSNVLAAILLIGEVEFESSAENTAELA 479
F Q L + + QM+IF +LAA+L +G +E E++ N +
Sbjct: 237 ----------EDFNATVQALTLLGISEEQQMDIFK-LLAALLHLGNIEIEAT-RNDSSSI 284
Query: 480 NPE 482
+P+
Sbjct: 285 SPK 287
|
Myosins V transport a variety of intracellular cargo processively along actin filaments, such as membraneous organelles and mRNA. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 691 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 63/166 (37%), Positives = 104/166 (62%), Gaps = 7/166 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA + + G+ +LH +++IHRD++ N+LL++ G VK+ DFG +A+
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAP 167
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
F+G+P WMAPE++ + YD ++DVW+LGIT IEL + KPP +M+ AL+
Sbjct: 168 ANXFVGTPYWMAPEVILA--MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I +N P L ++ +WS+++ +F+ CL+K P+ RP LL+H F+
Sbjct: 226 IAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 65/166 (39%), Positives = 104/166 (62%), Gaps = 7/166 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA I + G+ +LH +++IHRD++ N+LLT+ G+VK+ DFG +A+
Sbjct: 118 LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG----SASKSSP 173
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+F+G+P WMAPE++ + YD ++DVW+LGIT IEL + KPP +M+ AL+
Sbjct: 174 ANSFVGTPYWMAPEVILA--MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 231
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I +N P L +++ W+ + F+ CL+K P+ RP +ELL H F+
Sbjct: 232 IAQNDSPTL-QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 4e-36
Identities = 65/166 (39%), Positives = 96/166 (57%), Gaps = 5/166 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E IA + +E + + FLH N VIHRD++ N+LL DG VK+ DFG + K
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ Y ++D+W+LGI AIE+ +G+PP+ + +P RAL+
Sbjct: 173 RSTMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I N P L S + DF+ CL+ + E R ELL+H F+
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 58/169 (34%), Positives = 98/169 (57%), Gaps = 8/169 (4%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
EQ + F ++++ G+ +LH ++HRDL+ N+L+ DG KI DFG+S+++ + +D +
Sbjct: 107 EQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ 166
Query: 63 --TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ GS WMAPE++ + GY ++D+W+LG +E+ G+ P+ D A+F+
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQ---GYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
Query: 121 I---VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+ PP + N S +DF+ C NP++RP ELL+HPFI
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|238679 cd01383, MYSc_type_VIII, Myosin motor domain, plant-specific type VIII myosins, a subgroup which has been associated with endocytosis, cytokinesis, cell-to-cell coupling and gating at plasmodesmata | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 8e-35
Identities = 95/308 (30%), Positives = 155/308 (50%), Gaps = 39/308 (12%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
V+DL L ++E +++ L+ R++ Y+ G VL+ +NP + LYG Y Y+ KS
Sbjct: 10 VDDLMQLSYLNEPSVLYNLQYRYSQDLIYTKAGPVLVAVNPFKEVPLYGNDYIEAYRKKS 69
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312
PH+YA+AD+AY +MM E Q I+++GE+ AGKT + K +++L LG G + +
Sbjct: 70 NDS--PHVYAIADTAYNEMMRDEVNQSIIISGESGAGKTETAKIAMQYLASLG-GGSGIE 126
Query: 313 EKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRV---- 368
+I + ++ A GNA T N NS+R +++ F +GK+SGA + LEK RV
Sbjct: 127 YEILQTNPILEAFGNAKTSRNDNSSRFGKLIEIHFSETGKISGAKIQTFLLEKSRVVQCA 186
Query: 369 TGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLR-------ADVTDDKLPKG 421
G R ++HIFY A + +K L +Y+YL+ V D +
Sbjct: 187 RGER-----SYHIFYQLCAGAPPALK-EKLNLKSASEYKYLKQSCCYSINGVDDAQ---- 236
Query: 422 PRETPDTNVAKFQEIYQ--NLIDIEFDDIQMEIFSNVLAAILLIGEVEFES-SAENTAEL 478
+F + + +++ I +D Q +F+ +LAA+L +G V F EN E
Sbjct: 237 ----------RFHTLVEALDIVHISKED-QENVFA-MLAAVLWLGNVSFTVIDNENHVEP 284
Query: 479 ANPEVAAN 486
E +
Sbjct: 285 VADEALST 292
|
This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 677 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 64/174 (36%), Positives = 97/174 (55%), Gaps = 16/174 (9%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E+ + I + ++ G+ +LH +IHRD++ SN+LLT+ G+VK+ DFG+S E N+
Sbjct: 103 GEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-- 160
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE-----DMHPTR 116
TF G+ +MAPE ++ Y DVW+LG+T +E+ + PF + P
Sbjct: 161 GTFTGTSFYMAPERIQGKP-----YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE 215
Query: 117 ALFQIVRNPPPGLY----RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
L IV P P L WS+ + DFI +CLEK+P RP ++LEHP+I
Sbjct: 216 LLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 7e-34
Identities = 58/164 (35%), Positives = 91/164 (55%), Gaps = 15/164 (9%)
Query: 11 KEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA------NTFDKKKTF 64
K+I+ G+ +LH N V+HRD++G+NV+L +G +K++DFG +R A + K+
Sbjct: 109 KQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 65 LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI--V 122
G+P WMAPE++ GY + D+W++G T E+ GKPP M A+F I
Sbjct: 169 HGTPYWMAPEVIN-----ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223
Query: 123 RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
R P L ++S +DF+ CL ++ RP +LL H F+
Sbjct: 224 RGLMPRL--PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 9e-34
Identities = 55/171 (32%), Positives = 90/171 (52%), Gaps = 17/171 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
SE+ F EI+ + +LH +I+RDL+ N+LL DG +K+ DFGL++E ++ +
Sbjct: 90 FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
TF G+P ++APE++ GY +D W+LG+ E+ GKPPF + +++
Sbjct: 150 TNTFCGTPEYLAPEVLLGK-----GYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYE 203
Query: 121 -IVRNPP--PGLYRASNWSQHYVDFIAECLEKNPEHR---PYMSELLEHPF 165
I+++P P S D I+ L+K+P R E+ HPF
Sbjct: 204 KILKDPLRFP-----EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 55/162 (33%), Positives = 90/162 (55%), Gaps = 15/162 (9%)
Query: 11 KEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE-----TANTFDKKKTFL 65
++I+ G+ +LH N ++HRD++G+N+L G VK+ DFG S+ ++ T K+
Sbjct: 111 RQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG--MKSVT 168
Query: 66 GSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP 125
G+P WM+PE++ G GY + DVW++G T +E+ KPP+ + A+F+I P
Sbjct: 169 GTPYWMSPEVIS-GE----GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP 223
Query: 126 P-PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
P L S+ S +F+ +N + RP ELL H F+
Sbjct: 224 TNPQL--PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 59/167 (35%), Positives = 94/167 (56%), Gaps = 5/167 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M+E+ IA + ++ + LH VIHRD++ ++LLT DG VK+ DFG + + +
Sbjct: 113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+K+ +G+P WMAPE++ Y +D+W+LGI IE+ DG+PP+ + P +A+
Sbjct: 173 RKSLVGTPYWMAPELI-----SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 227
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
I N PP L S F+ L ++P R +ELL+HPF+
Sbjct: 228 IRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 54/165 (32%), Positives = 80/165 (48%), Gaps = 39/165 (23%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-GEVKIVDFGLSRETANTFD 59
+SE I IL +I+ G+ +LH N +IHRDL+ N+LL D G+VK+ DFGLS+ +
Sbjct: 89 LSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
KT +G+P++MAPE++ Y + D+W+LG+ EL
Sbjct: 149 LLKTIVGTPAYMAPEVLLGKGY----YSEKSDIWSLGVILYEL----------------- 187
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHP 164
D I + L+K+PE RP E+LEH
Sbjct: 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 62/180 (34%), Positives = 99/180 (55%), Gaps = 9/180 (5%)
Query: 3 EQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E + I ++ G+ FL E H +IHRD++ +NVL+ +G+VK+ DFG+S +
Sbjct: 101 EDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--A 158
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
KT +G S+MAPE ++ G + Y + DVW+LG++ +E+ G+ P+ Q
Sbjct: 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ 218
Query: 121 ---IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS 177
IV PP L S +S DF+A+CL K P RP ++LLEHP++ D+ ++
Sbjct: 219 LSAIVDGDPPTL--PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMA 276
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 58/166 (34%), Positives = 95/166 (57%), Gaps = 5/166 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M+E+ IA + ++ + +LH VIHRD++ ++LLT DG +K+ DFG + + K
Sbjct: 115 MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+K+ +G+P WMAPE++ Y +D+W+LGI IE+ DG+PP+ + P +A+ +
Sbjct: 175 RKSLVGTPYWMAPEVI-----SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I N PP + + S F+ L + P R ELL+HPF+
Sbjct: 230 IRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 63/171 (36%), Positives = 99/171 (57%), Gaps = 16/171 (9%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANTFDKK 61
EQ I F K+I+ G+ +LH+N ++HRD++G NVL+ T G VKI DFG S+ A
Sbjct: 107 EQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM-HPTRALFQ 120
+TF G+ +MAPE++ G + GY D+W+LG T +E+ GKPPF ++ P A+F+
Sbjct: 167 ETFTGTLQYMAPEVIDKGPR---GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK 223
Query: 121 IVRNPPPGLYRA-----SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+ G+++ + S +FI C E +P+ R +LL+ PF+
Sbjct: 224 V------GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|238677 cd01381, MYSc_type_VII, Myosin motor domain, type VII myosins | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 96/300 (32%), Positives = 145/300 (48%), Gaps = 27/300 (9%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
VED+ L + E I++ L R+ K Y++ G +L+ +NP L +Y YK KS
Sbjct: 2 VEDMITLGDLHEAGILRNLLIRYKKKLIYTYTGSILVAVNPYQILPIYTADEIKLYKNKS 61
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312
+ PHI+A++D+AY +M ++ Q I+++GE+ AGKT S K +L++L + + +
Sbjct: 62 IGELPPHIFAISDNAYTNMQREKKNQCIIISGESGAGKTESTKLILQYLAAISGKHSWIE 121
Query: 313 EKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWR-VTGN 371
++I + ++ A GNA T N NS+R Y+ + F G + GA Y LEK R V
Sbjct: 122 QQILEANPILEAFGNAKTIRNDNSSRFGKYIDIHFNKRGAIEGAKIEQYLLEKSRIVRQA 181
Query: 372 RDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYL------RADVTDDKLPKGPRET 425
RD + N+HIFY + E ++ L Y YL + DD
Sbjct: 182 RD--ERNYHIFYCMLAGLSTD-EKERLKLGEASDYHYLAQGGCITCEGRDD--------- 229
Query: 426 PDTNVAKFQEIYQNLIDIEF-DDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVA 484
F +I + + F D EIF +LAAIL IG + FE A LA EV
Sbjct: 230 ----AKDFADIRSAMKVLMFTDQEIWEIFK-LLAAILHIGNLRFE--ATEVDNLAACEVD 282
|
Myosins in this group have been associated with functions in sensory systems such as vision and hearing. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 671 |
| >gnl|CDD|238678 cd01382, MYSc_type_VI, Myosin motor domain, type VI myosins | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 82/301 (27%), Positives = 149/301 (49%), Gaps = 28/301 (9%)
Query: 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHL-NLYGTKYHFKYKF 250
VED +L ++E ++ + R++ Y++V ++L+ +NP + LY + KY+
Sbjct: 5 DVEDNCSLMYLNEATLLNNIRVRYSKDKIYTYVANILIAVNPYFDIPKLYSSDTIKKYQG 64
Query: 251 KSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAK 310
KS PH++A+AD AY+DM + +Q I+++GE+ AGKT + K +L++L
Sbjct: 65 KSLGTLPPHVFAIADKAYRDMKVLKMSQSIIVSGESGAGKTENTKFVLRYLTESYGSGQD 124
Query: 311 VGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRV-T 369
+ ++I + ++ A GNA T N NS+R ++++ F + G Y LEK R+
Sbjct: 125 IDDRIVEANPLLEAFGNAKTVRNNNSSRFGKFVEIHFNEKNSVVGGFVSHYLLEKSRICV 184
Query: 370 GNRDPLQANFHIFYYFYDAMEAAGEL-DKYFLSPGRKYRYLRADVT-------DDKLPKG 421
+ + + N+HIFY A+ ++ +K LS +RYL T DK
Sbjct: 185 QSAE--ERNYHIFYRLCAG--ASEDIREKLHLSSPDDFRYLNRGCTRYFANKETDKQILQ 240
Query: 422 PRETPDTNVAKF--------QEIYQNLID----IEFDDIQ-MEIFSNVLAAILLIGEVEF 468
R++P+ +Q + I DD + +++F V+A +L +G ++F
Sbjct: 241 NRKSPEHLKKGALKDPLLDDYGDFQRMCVALKKIGLDDTEKLDLFR-VVAGVLHLGNIDF 299
Query: 469 E 469
E
Sbjct: 300 E 300
|
Myosin VI is a monomeric myosin, which moves towards the minus-end of actin filaments, in contrast to most other myosins. It has been implicated in endocytosis, secretion, and cell migration. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the minus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 717 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 58/158 (36%), Positives = 88/158 (55%), Gaps = 4/158 (2%)
Query: 13 IITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWM 71
I+ + +L E H VIHRD++ SN+LL G VK+ DFG+S ++ K ++ G ++M
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYM 181
Query: 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVRNPPPGLY 130
APE + YD R DVW+LGI+ +EL G+ P+++ L +I++ PP L
Sbjct: 182 APERID-PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP 240
Query: 131 RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
+S + F+ CL K+ RP ELL+HPFI
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|238683 cd01387, MYSc_type_XV, Myosin motor domain, type XV myosins | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 78/288 (27%), Positives = 144/288 (50%), Gaps = 11/288 (3%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
VED+ LE + E ++ L+ R Y+++G +L+ +NP +YG + +Y ++
Sbjct: 3 VEDMTQLEDLQETTVLWNLKLRFERNLIYTYIGSILVSVNPYKMFPIYGPEQVQQYAGRA 62
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQ-GAAKV 311
+N PH++A+A+ A+ M+ ++ Q ++++GE+ +GKT + K +L++L + Q G+A +
Sbjct: 63 LGENPPHLFAIANLAFAKMLDAKQNQCVIISGESGSGKTEATKLILRYLAAMNQGGSAVI 122
Query: 312 GEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGN 371
E+I + ++ A GNA T N NS+R ++++ G + GAI Y LEK R+
Sbjct: 123 TEQILEATPLLEAFGNAKTVRNDNSSRFGKFVEIFL-EGGVIVGAITSQYLLEKSRIV-F 180
Query: 372 RDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVA 431
+ + N+HIFY + A + L Y YL + K +
Sbjct: 181 QAKNERNYHIFYELLAGLPAQ-LRQAFSLQEAETYYYLNQGGNCEIAGKSDAD------- 232
Query: 432 KFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELA 479
F+ + + + F + +LA+IL +G V FE + E+A
Sbjct: 233 DFRRLLAAMEVLGFSSEDQDSIFRILASILHLGNVYFEKRETDAQEVA 280
|
In vertebrates, myosin XV appears to be expressed in sensory tissue and play a role in hearing. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 677 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 41/203 (20%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IAFILK+++ + ++H IHR ++ S++LL+ DG+V + S +
Sbjct: 98 LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157
Query: 61 KKTFLGSP-------SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113
++ P W++PE+++ + + GY+ + D++++GITA EL +G PF+DM
Sbjct: 158 QRVVHDFPKSSVKNLPWLSPEVLQ---QNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214
Query: 114 PTRALFQIVRNPPPGLYRASN-------------------------------WSQHYVDF 142
T+ L + VR P L S +S+H+ F
Sbjct: 215 ATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQF 274
Query: 143 IAECLEKNPEHRPYMSELLEHPF 165
+ CL+++PE RP S+LL H F
Sbjct: 275 VELCLQRDPESRPSASQLLNHSF 297
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 49/161 (30%), Positives = 91/161 (56%), Gaps = 7/161 (4%)
Query: 11 KEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFG----LSRETANTFDKKKTFLG 66
+++ G+ +LH + ++HRD++ +N+ L +G +K+ DFG L T ++ ++ G
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165
Query: 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL-FQIVRNP 125
+P++MAPE++ G + G+ D+W+LG +E+ GK P+ ++ + F +
Sbjct: 166 TPAYMAPEVITGG--KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH 223
Query: 126 PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
P + + S DF+ CLE +P+ RP SELL+HPF+
Sbjct: 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 61/148 (41%), Positives = 85/148 (57%), Gaps = 6/148 (4%)
Query: 22 ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHK 81
E +IHRD++ SN+LL ++G +K+ DFG+S + ++ K + G +MAPE R
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE--RIDPS 182
Query: 82 EVDGYDNRIDVWALGITAIELGDGKPPFED-MHPTRALFQIVRNPPPGLYRASN--WSQH 138
DGYD R DVW+LGIT E+ GK P+ L Q+V+ PP L + +S
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPS 242
Query: 139 YVDFIAECLEKNPEHRPYMSELLEHPFI 166
+V+FI CL K+ RP ELLEHPFI
Sbjct: 243 FVNFINLCLIKDESKRPKYKELLEHPFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 9e-29
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 25/184 (13%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA----- 55
+ E + EI+ + +LH N +IHRDL+ N+L+ +G +K+ DFGLS+
Sbjct: 90 LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149
Query: 56 ---NTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM 112
+ + K +G+P ++APE++ G+ +D W+LG E G PPF
Sbjct: 150 NLNDDEKEDKRIVGTPDYIAPEVILG-----QGHSKTVDWWSLGCILYEFLVGIPPFHGE 204
Query: 113 HPTRALFQIVRN----PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM---SELLEHPF 165
P +FQ + N P + S +D I++ L +PE R E+ HPF
Sbjct: 205 TP-EEIFQNILNGKIEWPEDV----EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259
Query: 166 ITSL 169
+
Sbjct: 260 FKGI 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 9e-29
Identities = 63/181 (34%), Positives = 102/181 (56%), Gaps = 21/181 (11%)
Query: 9 ILKEIITGMVFLH-ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS 67
I ++ G+ +L+ + ++HRD++ SN+L+ G++K+ DFG+S E N+ TF+G+
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGT 165
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFED-----------MHPTR 116
++M+PE ++ G K Y + DVW+LGI+ IEL GK PF M
Sbjct: 166 STYMSPERIQ-GGK----YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220
Query: 117 ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE-HPFITSLPENDLH 175
L QIV+ PPP L +S++ + DF+ CL K+P RP +L PFI +L +++
Sbjct: 221 LLQQIVQEPPPRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVD 279
Query: 176 L 176
L
Sbjct: 280 L 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (287), Expect = 4e-28
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFD 59
+SE FIL +I++ + +LH +IHRD++ N+LL +DG VK++DFGL++ +
Sbjct: 98 LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157
Query: 60 K------KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113
T +G+P +MAPE++ + + D+W+LGIT EL G PPFE
Sbjct: 158 TSSIPALPSTSVGTPGYMAPEVLL--GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
Query: 114 PTRALFQIVRN----------PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ A Q ++ P S+ D + + L K+P++R S L H
Sbjct: 216 NSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
Query: 164 PFITSLPENDLHLSTVN 180
+ L + LS +
Sbjct: 276 DLLAHLKLKESDLSDLL 292
|
Length = 384 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 50/166 (30%), Positives = 74/166 (44%), Gaps = 26/166 (15%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+ +I GM +L + +HRDL N L+T++ VKI DFGLSR+ +K G
Sbjct: 107 MALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR-GGGK 165
Query: 69 S---WMAPEIMRCGHKEVDGYDNRI----DVWALGITAIEL-GDGKPPFEDMHPTRALFQ 120
WMAPE ++ D + DVW+ G+ E+ G+ P+ M L
Sbjct: 166 LPIKWMAPESLK---------DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL 216
Query: 121 IV---RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ R P P N + + +C +PE RP SEL+E
Sbjct: 217 LEDGYRLPRP-----ENCPDELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 3e-27
Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S + + +I GM +L +HRDL N L+ +D VKI DFGLSR+ +
Sbjct: 102 LSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY 161
Query: 61 KKTFLG-SP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELG-DGKPPFEDMHPTRA 117
+K G P WMAPE ++ G + ++ DVW+ G+ E+ G P+ +
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGI-----FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE- 215
Query: 118 LFQIVRN------P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ + +R P P LY + + C + +PE RP SEL+E
Sbjct: 216 VLEYLRKGYRLPKPEYCPDELY----------ELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 57/160 (35%), Positives = 89/160 (55%), Gaps = 14/160 (8%)
Query: 11 KEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN---TFDKKKTFLGS 67
++I+ GM +LH N ++HRD++G+N+L G VK+ DFG S+ + ++ G+
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-- 125
P WM+PE++ +GY + DVW+LG T +E+ KPP+ + A+F+I P
Sbjct: 173 PYWMSPEVISG-----EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227
Query: 126 PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPF 165
P S+ S+H DF+ C+ HRP ELL HPF
Sbjct: 228 PQ---LPSHISEHARDFLG-CIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|238682 cd01386, MYSc_type_XVIII, Myosin motor domain, type XVIII myosins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 3/195 (1%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
VEDLA+L ++E +++ L +R+ + ++ G LL +NP L LY K ++
Sbjct: 2 VEDLASLVYLNESSVLHTLRQRYAANLIHTCAGPDLLVLNPMAPLALYSEKVPSMFRGCK 61
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKV- 311
D PHIY++A +AY+ ++ Q I+ G + AGKTTS KH L++L
Sbjct: 62 AEDMPPHIYSLAQTAYRALLETRRDQSIIFLGRSGAGKTTSCKHALEYLALAAGSVDGRV 121
Query: 312 -GEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTG 370
EK+ ++ A GN T +N N+TR + + F +G+++ A LE+ RV
Sbjct: 122 SVEKVRALFTILEAFGNVSTALNGNATRFTQILSLDFDQTGQIASASLQTMLLERSRV-A 180
Query: 371 NRDPLQANFHIFYYF 385
R + NF +F
Sbjct: 181 RRPNGETNFVVFSQL 195
|
This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the filament (power stroke). Release of ADP completes the cycle. Length = 767 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 58/163 (35%), Positives = 95/163 (58%), Gaps = 13/163 (7%)
Query: 10 LKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET-ANTFDKKK-----T 63
+++I+ G+ +LH +IHRD++G+N+L+ G +KI DFG+S++ AN+ K +
Sbjct: 112 VRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 64 FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR 123
GS WMAPE+++ Y + D+W+LG +E+ GK PF D +A+F+I
Sbjct: 172 LQGSVFWMAPEVVK-----QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 124 NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
N P + SN S +DF+ + E + RP +ELL+HPF+
Sbjct: 227 NASPEI--PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 50/152 (32%), Positives = 74/152 (48%), Gaps = 15/152 (9%)
Query: 16 GMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP-SWMAPE 74
GM +L + IHRDL N L+ ++ VKI DFGLSR+ + +K P WMAPE
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173
Query: 75 IMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIV---RNPPPGLY 130
++ G + ++ DVW+ G+ E+ G+ P+ M L + R P P
Sbjct: 174 SLKEGK-----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQP--- 225
Query: 131 RASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
N D + +C ++PE RP SEL+E
Sbjct: 226 --PNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 16 GMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP-SWMAPE 74
GM +L + IHRDL N L+ ++ VKI DFGLSR+ + K P WMAPE
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 75 IMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIV---RNPPPGLY 130
++ G + ++ DVW+ G+ E+ G+ P+ M L + R P P
Sbjct: 175 SLKEGK-----FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKP--- 226
Query: 131 RASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
N + +C ++PE RP SEL+E
Sbjct: 227 --PNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 53/167 (31%), Positives = 88/167 (52%), Gaps = 16/167 (9%)
Query: 10 LKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE-VKIVDFG----LSRETANTFDKKKTF 64
++++ G+ +LHEN +IHRD++G+N+L+ G+ ++I DFG L+ + + +
Sbjct: 109 TEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 65 LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE-DMHPTR--ALFQI 121
LG+ ++MAPE++R + Y DVW++G IE+ KPP+ + H +F+I
Sbjct: 169 LGTIAFMAPEVLRG-----EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223
Query: 122 VR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
P + + S D CLE PE RP ELL+HP
Sbjct: 224 ASATTAPSI--PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 57/173 (32%), Positives = 96/173 (55%), Gaps = 15/173 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E + I ++ G+ +L ++HRD++ SN+L+ G+VK+ DFG+S + N+
Sbjct: 92 IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH------- 113
KT++G+ ++MAPE + + Y DVW+LGI+ +EL G+ P+ +
Sbjct: 150 AKTYVGTNAYMAPERISG-----EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM 204
Query: 114 PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
P + L IV PP L +S+ +V FI +C+ K P+ RP L++HPFI
Sbjct: 205 PLQLLQCIVDEDPPVL-PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 48/168 (28%), Positives = 92/168 (54%), Gaps = 13/168 (7%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E+ + + L +I++ + ++H+ ++HRD++ N+ LTK G +K+ DFG+S+ + +
Sbjct: 99 EEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
+T +G+P +M+PE+ C + Y+ + D+WALG EL K F+ +P + +I
Sbjct: 159 ETVVGTPYYMSPEL--CQGVK---YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213
Query: 122 V---RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
V P +Y S + + L+++PE RP E+L+ P +
Sbjct: 214 VQGNYTPVVSVY-----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 57/170 (33%), Positives = 95/170 (55%), Gaps = 9/170 (5%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
EQ +A + ++I++G+ +LH H++HRD++ SN+L+ VKI DFG+SR A T D
Sbjct: 166 DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225
Query: 62 KTFLGSPSWMAPEIMRC--GHKEVDGYDNRIDVWALGITAIELGDGKPPF---EDMHPTR 116
+ +G+ ++M+PE + H DGY D+W+LG++ +E G+ PF
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAG--DIWSLGVSILEFYLGRFPFGVGRQGDWAS 283
Query: 117 ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+ I + PP + S+ + FI+ CL++ P R +LL+HPFI
Sbjct: 284 LMCAICMSQPPEAPATA--SREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 59/170 (34%), Positives = 81/170 (47%), Gaps = 15/170 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F EI+ G+ FLHE +I+RDL+ NVLL +G +KI DFG+ +E
Sbjct: 94 DEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
TF G+P ++APEI+ Y +D WALG+ E+ G+ PFE LFQ
Sbjct: 154 STFCGTPDYIAPEILS-----YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-LFQS 207
Query: 122 VRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHR----PY-MSELLEHPF 165
+ R W S+ + L KNPE R P ++ HPF
Sbjct: 208 ILEDEV---RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 13/167 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E + +I+ G+ LH ++HRD++ N+ L VKI D G+++ ++ +
Sbjct: 98 LPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
T +G+P +++PE+ C K Y+ + DVWALG+ E GK PF+ + + +
Sbjct: 158 ANTIVGTPYYLSPEL--CEDKP---YNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
Query: 121 IVRN---PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHP 164
I+R P +Y SQ I +CL K+ RP +LL +P
Sbjct: 213 IIRGVFPPVSQMY-----SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 58/190 (30%), Positives = 98/190 (51%), Gaps = 14/190 (7%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE-TANTFDKK 61
E + + EI+ + LH+ +I+RD++ N+LL +G V + DFGLS+E A ++
Sbjct: 104 ESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF--EDMHPTRALF 119
+F G+ +MAPE++R G G+D +D W+LG+ EL G PF + +++
Sbjct: 164 YSFCGTIEYMAPEVIRGGS---GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
Query: 120 --QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR---PYMSELLEHPFITSLPENDL 174
+I+++ PP S DFI + LEK+P+ R E+ HPF + +DL
Sbjct: 221 SRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL 277
Query: 175 HLSTVNCQYK 184
+ +K
Sbjct: 278 AAKRIPAPFK 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 19/157 (12%)
Query: 20 LHENH--------VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWM 71
L+E H V+HRDL+ +N+ L + VK+ DFGL++ + KT++G+P +M
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177
Query: 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYR 131
+PE + YD + D+W+LG EL PPF R Q+ G +R
Sbjct: 178 SPEQLN-HMS----YDEKSDIWSLGCLIYELCALSPPFT----ARNQLQLASKIKEGKFR 228
Query: 132 --ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+S + I L +P+ RP ELL+ P I
Sbjct: 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 45/201 (22%)
Query: 3 EQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E + I ++ G+ +L E H ++HRD++ SN+L+ GE+K+ DFG+S + ++
Sbjct: 98 ENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A 155
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGK---PP-----FEDMH 113
+F+G+ S+M+PE ++ H Y + D+W+LG++ +E+ G+ PP E M
Sbjct: 156 NSFVGTRSYMSPERLQGTH-----YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
Query: 114 PTR------------------------ALFQ----IVRNPPPGLYRASNWSQHYVDFIAE 145
A+F+ IV PPP L + +S + DF+ +
Sbjct: 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGA-FSDEFQDFVDK 269
Query: 146 CLEKNPEHRPYMSELLEHPFI 166
CL+KNP+ R + EL +HPFI
Sbjct: 270 CLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 55/174 (31%), Positives = 88/174 (50%), Gaps = 20/174 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
SE+ + F + EI+ + +LH +IHRD++ N+LL + G V I DF ++ + T D
Sbjct: 97 FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDT 154
Query: 61 KKT-FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---- 115
T G+P +MAPE++ + GY +D W+LG+TA E GK P+ T
Sbjct: 155 LTTSTSGTPGYMAPEVLC--RQ---GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209
Query: 116 -RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR--PYMSELLEHPFI 166
RA + P + WS +D I + LE++P+ R + +L HP+
Sbjct: 210 IRAKQETADVLYP-----ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 54/164 (32%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
EQ I I +++ G+ LHE ++HRDL+ +N+LL + VKI D G+S+ K
Sbjct: 102 EQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AK 159
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE--DMHPTRALFQ 120
T +G+P +MAPE+ + Y + D+W+LG E+ PPFE M R Q
Sbjct: 160 TQIGTPHYMAPEVWKG-----RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ 214
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHP 164
+ PP +SQ +FI L+ P+ RP ++L P
Sbjct: 215 RGKYPPI----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+H F EI + FLHE +I+RDL+ NVLL +G +K+ D+G+ +E D
Sbjct: 93 LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE--------DM 112
TF G+P+++APEI+R + Y +D WALG+ E+ G+ PF+ D
Sbjct: 153 TSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
Query: 113 HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR------PYMSELLEHPFI 166
+ LFQ++ + R+ + V + L K+P+ R ++ HPF
Sbjct: 208 NTEDYLFQVILEKQIRIPRSLSVKASSV--LKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265
Query: 167 TSLPENDLHLSTVNCQYKDQ 186
++ + L V YK
Sbjct: 266 RNIDWDLLEQKQVLPPYKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 3e-23
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 64/209 (30%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S I I+ +++ G+ + H + ++HRDL+ N+L+ +DG +K+ DFGL+R
Sbjct: 95 LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR-------- 146
Query: 61 KKTFLGSPS----------WM-APEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPP 108
G P W APEI+ G K Y +D+W++G I A E+ GKP
Sbjct: 147 ---AFGIPLRTYTHEVVTLWYRAPEIL-LGSKH---YSTAVDIWSVGCIFA-EMITGKPL 198
Query: 109 F-----EDMHPTRALFQIVR-----NP--PPGLYRASNWSQHY----------------- 139
F D LF+I + PG+ + ++ +
Sbjct: 199 FPGDSEIDQ-----LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDP 253
Query: 140 --VDFIAECLEKNPEHRPYMSELLEHPFI 166
+D +++ L+ NP R E L+HP+
Sbjct: 254 EGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+H F EI + FLHE +I+RDL+ NVLL DG +K+ D+G+ +E D
Sbjct: 93 LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE------DMHP 114
TF G+P+++APEI+R + Y +D WALG+ E+ G+ PF+ DM+
Sbjct: 153 TSTFCGTPNYIAPEILRG-----EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207
Query: 115 TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR------PYMSELLEHPFITS 168
LFQ++ P + R + +V + L K+P+ R S++ H F S
Sbjct: 208 EDYLFQVILEKPIRIPRFLSVKASHV--LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265
Query: 169 LPENDLHLSTVNCQYKDQ 186
+ + L V +K Q
Sbjct: 266 IDWDLLEKKQVTPPFKPQ 283
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-23
Identities = 52/164 (31%), Positives = 87/164 (53%), Gaps = 20/164 (12%)
Query: 11 KEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN---TFDKKKTFLGS 67
++I+ G+ +LH N ++HRD++G+N+L G VK+ DFG S+ + K+ G+
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-- 125
P WM+PE++ +GY + D+W++G T +E+ KPP+ + A+F+I P
Sbjct: 173 PYWMSPEVISG-----EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 227
Query: 126 ---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
PP + S H DF+ + + RP ELL H F+
Sbjct: 228 PVLPPHV------SDHCRDFLKRIFVE-AKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 62/174 (35%), Positives = 93/174 (53%), Gaps = 19/174 (10%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F EII G+ FLH+ +I+RDL+ NVLL KDG +KI DFG+ +E N K
Sbjct: 94 DEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF----EDMHPTRA 117
TF G+P ++APEI++ G K Y+ +D W+ G+ E+ G+ PF ED
Sbjct: 154 STFCGTPDYIAPEILK-GQK----YNESVDWWSFGVLLYEMLIGQSPFHGEDED-----E 203
Query: 118 LFQIVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMS-ELLEHPFITSL 169
LF + N P R W S+ D +++ E++P R + ++ +HPF +
Sbjct: 204 LFDSILNDRPHFPR---WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 50/165 (30%), Positives = 94/165 (56%), Gaps = 7/165 (4%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E I +I + +H+ ++HRD++ N+ LTKDG +K+ DFG++R +T +
Sbjct: 99 PEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
+T +G+P +++PEI C ++ Y+N+ D+WALG E+ K FE + + +I
Sbjct: 159 RTCIGTPYYLSPEI--CENRP---YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213
Query: 122 VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+R P + +S++S + +++ ++NP RP ++ +LE FI
Sbjct: 214 IRGSYPPV--SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWM 71
+I + +LHE H++HRDL+ NV LT+ +K+ D G++R N D T +G+P +M
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYM 169
Query: 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYR 131
+PE+ Y+ + DVWALG E+ K F +++I+ P +
Sbjct: 170 SPELF-----SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM-- 222
Query: 132 ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
++S + IA L K PE RP + +L P+I
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-22
Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 12/160 (7%)
Query: 11 KEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK---KTFLGS 67
++I+ G+ +LH N ++HRD++G+N+L G VK+ DFG S+ K+ G+
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP- 126
P WM+PE++ +GY + DVW++ T +E+ KPP+ + A+F+I P
Sbjct: 173 PYWMSPEVISG-----EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK 227
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
P L S DF+ + + + RP LL HPF+
Sbjct: 228 PML--PDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-21
Identities = 53/166 (31%), Positives = 91/166 (54%), Gaps = 8/166 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE + +++ G+ ++H+ ++HRDL+ N+ L K+ +KI DFG+SR + D
Sbjct: 103 LSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDL 161
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
TF G+P +M+PE ++ H+ GYD++ D+W+LG E+ FE + + +
Sbjct: 162 ATTFTGTPYYMSPEALK--HQ---GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR 216
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
IV P P L +S+ + L K+P RP +E+L +PFI
Sbjct: 217 IVEGPTPSL--PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 41/203 (20%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+++ HI + L +I+ G+ +LH +VIHRDL+ SN+L+ + ++KI DFGL+R D+
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
Query: 61 K--KTFLGSPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIEL--------GD----- 104
K T W APE++ + Y ID+W++G EL G
Sbjct: 160 KGFLTEYVVTRWYRAPELLLSSSR----YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ 215
Query: 105 --------GKPPFEDMHP---TRALFQIVRNPPPGLYRASNWSQHY-------VDFIAEC 146
G P ED+ +A +++ P S+ + +D + +
Sbjct: 216 LNLIVEVLGTPSEEDLKFITSEKAR-NYLKSLPK--KPKKPLSKLFPGASPEAIDLLEKM 272
Query: 147 LEKNPEHRPYMSELLEHPFITSL 169
L +P+ R E L HP++ L
Sbjct: 273 LVFDPKKRITADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E H F EI G+ FLH +I+RDL+ NV+L +G +KI DFG+ +E +
Sbjct: 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV 122
TF G+P ++APEI+ Y +D WA G+ E+ G+PPF D LFQ +
Sbjct: 160 TFCGTPDYIAPEII-----AYQPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSI 213
Query: 123 RNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
++ S+ V L K+P R ++ EH F
Sbjct: 214 MEHNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAF 259
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 23/195 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE F EI++ + +LH V++RDL+ N++L KDG +KI DFGL +E +
Sbjct: 93 SEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
KTF G+P ++APE++ E + Y +D W LG+ E+ G+ PF + + LF++
Sbjct: 153 KTFCGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFEL 206
Query: 122 -----VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPFITSLPE 171
+R P S +A L+K+P+ R E++EH F S+
Sbjct: 207 ILMEEIRFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259
Query: 172 NDLHLSTVNCQYKDQ 186
D+ + +K Q
Sbjct: 260 QDVVQKKLEPPFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240229 PTZ00014, PTZ00014, myosin-A; Provisional | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 77/281 (27%), Positives = 139/281 (49%), Gaps = 25/281 (8%)
Query: 211 LEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYK-FKSRSDNEPHIYAVADSAYQ 269
L+ R+ Y+ +L+ INP L + +Y+ K PH++ A A +
Sbjct: 116 LKHRYLKNQIYTTADPLLVAINPFKDLGNTTNDWIRRYRDAKDSDKLPPHVFTTARRALE 175
Query: 270 DMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCV---N-VIHAI 325
++ +++Q I+++GE+ AGKT + K ++++ F + + KI+ + N V+ A
Sbjct: 176 NLHGVKKSQTIIVSGESGAGKTEATKQIMRY--FASSKSGNMDLKIQNAIMAANPVLEAF 233
Query: 326 GNAGTPINQNSTRHVLYMQVTFGSSGKL-SGAIFWLYQLEKWRVTGNRDPLQANFHIFYY 384
GNA T N NS+R +MQ+ G G + G+I + LEK RV ++ + ++HIFY
Sbjct: 234 GNAKTIRNNNSSRFGRFMQLQLGEEGGIRYGSIV-AFLLEKSRVV-TQEDDERSYHIFYQ 291
Query: 385 FYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVAKFQEIYQNLIDIE 444
+ +KY L +Y+Y+ D +P D V F+E+ ++ +
Sbjct: 292 LLKGANDEMK-EKYKLKSLEEYKYINPKCLD--VP----GIDD--VKDFEEVMESFDSMG 342
Query: 445 FDDIQME-IFSNVLAAILLIGEVEFESSAE----NTAELAN 480
+ Q+E IFS +L+ +LL+G VE E E + A +++
Sbjct: 343 LSESQIEDIFS-ILSGVLLLGNVEIEGKEEGGLTDAAAISD 382
|
Length = 821 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 7e-21
Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 40/196 (20%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
SE I I+ +I+ G+ +H++ HRDL+ N+L++ VKI DFGL+RE +
Sbjct: 96 FSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---- 151
Query: 61 KKTFLG--SPSWM-APEI-MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE-----D 111
+ + S W APEI +R Y + +D+WALG EL +P F D
Sbjct: 152 RPPYTDYVSTRWYRAPEILLRSTS-----YSSPVDIWALGCIMAELYTLRPLFPGSSEID 206
Query: 112 M---------HPTRAL------------FQIVRNPPPGLYRA-SNWSQHYVDFIAECLEK 149
PT+ F+ + P L++ N S +D I + L
Sbjct: 207 QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRW 266
Query: 150 NPEHRPYMSELLEHPF 165
+P+ RP S+ L+HP+
Sbjct: 267 DPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
+E+ F EI++ + +LH V++RD++ N++L KDG +KI DFGL +E +
Sbjct: 93 TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
KTF G+P ++APE++ E + Y +D W LG+ E+ G+ PF + R I
Sbjct: 153 KTFCGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207
Query: 122 ----VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPFITSLPEN 172
+R P S +A L+K+P+ R E++EH F S+
Sbjct: 208 LMEEIRFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260
Query: 173 DLHLSTVNCQYKDQ---ELQTMHVEDLAALETIS 203
D+ + +K Q E+ T + +D ++I+
Sbjct: 261 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSIT 294
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 30/230 (13%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE H F + E+ + LHE IHRDL+ N L+ G +K+ DFGLS
Sbjct: 98 LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTY 154
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ +GSP +MAPE++R GYD +D W+LG E G PPF P
Sbjct: 155 ANSVVGSPDYMAPEVLRG-----KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209
Query: 121 IVR-----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS--ELLEHPFITSLPEND 173
+ P N S D I + + +P R + S ++ HPF + N+
Sbjct: 210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN-DPSRR-FGSLEDIKNHPFFKEVDWNE 267
Query: 174 LHLSTVNCQYK-------DQELQTMHVEDLAALETISEDNIVQELEERHN 216
L + K + E+ T + +D + +++ V E ++
Sbjct: 268 LR------ELKPPFVPELESEIDTGYFDDFENEDDMAKYKDVHEKKKAAG 311
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 52/159 (32%), Positives = 81/159 (50%), Gaps = 15/159 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
E F + ++ +LH +I+RDL+ N+LL +G VK+VDFG +++ + K
Sbjct: 90 FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-QK 148
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF--EDMHPTRAL 118
TF G+P ++APEI+ GYD +D W+LGI EL G+PPF +D P
Sbjct: 149 TWTFCGTPEYVAPEII-LNK----GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY 203
Query: 119 FQIVRNPPPGLYR---ASNWSQHYVDFIAECLEKNPEHR 154
I++ G + + + D I + L +NPE R
Sbjct: 204 NDILK----GNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 55/171 (32%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E F E+ ++FLH + VI+RDL+ N+LL +G K+ DFG+ +E
Sbjct: 95 EPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV 122
TF G+P ++APEI+ +E++ Y +D WALG+ E+ G+PPFE + LF+ +
Sbjct: 155 TFCGTPDYIAPEIL----QELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFESI 208
Query: 123 RNPPPGLYRASNW-SQHYVDFIAECLEKNPEHR-------PYMSELLEHPF 165
+ LY W S+ V + + KNP R + +HPF
Sbjct: 209 LHDDV-LYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 39/204 (19%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S+ HI F++ +I+ G+ ++H +IHRDL+ SN+ + +D E+KI+DFGL+R T D+
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD---DE 171
Query: 61 KKTFLGSPSWMAPEIMRC-GHKEVDGYDNRIDVWALGITAIELGDGKPPF---EDMHPTR 116
++ + + APEIM H Y+ +D+W++G EL GK F + + +
Sbjct: 172 MTGYVATRWYRAPEIMLNWMH-----YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK 226
Query: 117 ALFQIVRNPPPGLY------RASNWSQHY-------------------VDFIAECLEKNP 151
+ +V P L A N+ Q +D + + L +P
Sbjct: 227 RIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDP 286
Query: 152 EHRPYMSELLEHPFITSL--PEND 173
+ R +E L HP++ PE++
Sbjct: 287 DKRITAAEALAHPYLAEYHDPEDE 310
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 57/217 (26%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEV---------KIVDFGLS 51
MSE IA+IL+ ++ + ++H +HR ++ S++L++ DG+V +++ G
Sbjct: 98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157
Query: 52 RETANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFED 111
+ F K + W++PE+++ + + GYD + D++++GITA EL +G PF+D
Sbjct: 158 LRVVHDFPKYSVKV--LPWLSPEVLQ---QNLQGYDAKSDIYSVGITACELANGHVPFKD 212
Query: 112 MHPTRALFQ--------------------------------IVRNPPPGLYRASN----- 134
M T+ L + + + R SN
Sbjct: 213 MPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSS 272
Query: 135 ------WSQHYVDFIAECLEKNPEHRPYMSELLEHPF 165
+S H+ F+ +CL++NP+ RP S LL H F
Sbjct: 273 HPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 56/160 (35%), Positives = 84/160 (52%), Gaps = 11/160 (6%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS 67
F EII G+ FLH +++RDL+ N+LL DG +KI DFG+ +E K TF G+
Sbjct: 100 FYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP 127
P ++APEI+ G K Y+ +D W+ G+ E+ G+ PF H LFQ +R P
Sbjct: 160 PDYIAPEIL-LGQK----YNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP 213
Query: 128 GLYRASNW-SQHYVDFIAECLEKNPEHR-PYMSELLEHPF 165
R W ++ D + + + PE R ++ +HPF
Sbjct: 214 CYPR---WLTREAKDILVKLFVREPERRLGVKGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE F ++ G+ +LHEN +++RDL+ N+LL +G VKI DFGL +E D+
Sbjct: 99 SEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
TF G+P ++APE++ Y +D W LG+ E+ G+ PF I
Sbjct: 159 STFCGTPEFLAPEVL-----TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
Query: 122 VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE-----LLEHPF 165
V + Y S+ + + L +NPE R E + + PF
Sbjct: 214 VNDEVR--Y-PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 6e-20
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 33/195 (16%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+E I +K+++ G+ +LH N ++HRD++GSN+L+ DG +K+ DFGL+R
Sbjct: 97 FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156
Query: 61 KKTFLGSPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF------EDMH 113
T W PE++ G Y +D+W++G EL GKP F E +
Sbjct: 157 DYTNRVITLWYRPPELL-LGATR---YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212
Query: 114 --------PTRA------------LFQIVRNPPPGL--YRASNWSQHYVDFIAECLEKNP 151
PT + + L + +D + + L +P
Sbjct: 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDP 272
Query: 152 EHRPYMSELLEHPFI 166
+ R + L+H +
Sbjct: 273 KKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 50/197 (25%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-- 59
E+ F EI+ + +LH +IHRDL+ N+LL KD +KI DFG TA D
Sbjct: 100 DEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFG----TAKVLDPN 155
Query: 60 ----------------------KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGI 97
+ +F+G+ +++PE++ K G + D+WALG
Sbjct: 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN--EKPA-GKSS--DLWALGC 210
Query: 98 TAIELGDGKPPFEDMHPTRALFQIVRN-----PPPGLYRASNWSQHYVDFIAECLEKNPE 152
++ GKPPF + FQ + PP N+ D I + L +P+
Sbjct: 211 IIYQMLTGKPPFRGSNEYL-TFQKILKLEYSFPP-------NFPPDAKDLIEKLLVLDPQ 262
Query: 153 HRP----YMSELLEHPF 165
R EL HPF
Sbjct: 263 DRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 53/211 (25%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ EQ + + +I G+ +L E H ++HRD++ SN+L+ GE+K+ DFG+S + ++
Sbjct: 100 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE--------- 110
+F+G+ S+M+PE ++ H Y + D+W++G++ +E+ G+ P
Sbjct: 159 -ANSFVGTRSYMSPERLQGTH-----YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212
Query: 111 -------------------------------DMHPTRALFQ----IVRNPPPGLYRASNW 135
D P A+F+ IV PPP L + +
Sbjct: 213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL-PSGVF 271
Query: 136 SQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+ DF+ +CL KNP R + +L+ H FI
Sbjct: 272 GAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 8e-20
Identities = 60/179 (33%), Positives = 84/179 (46%), Gaps = 18/179 (10%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E F EI + + +LH ++++RDL+ N+LL G V + DFGL +E D
Sbjct: 95 EPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV 122
TF G+P ++APE++R YDN +D W LG E+ G PPF I+
Sbjct: 155 TFCGTPEYLAPEVIR-----KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
Query: 123 RNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR----PYMSELLEHPFITSLPENDL 174
P PG + WS + E LEK+ + R E+ EHPF SL DL
Sbjct: 210 HKPLVLRPGASLTA-WS-----ILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-20
Identities = 57/176 (32%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS 67
F L EI + LH+ +I+RDL+ N+LL G VK+ DFGL +E+ + TF G+
Sbjct: 104 FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGT 163
Query: 68 PSWMAPEI-MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR--- 123
+MAPEI MR GH + +D W+LG ++ G PPF + + + +I++
Sbjct: 164 IEYMAPEILMRSGHGKA------VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL 217
Query: 124 NPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPFITSLPENDL 174
N PP L + D + + L++NP R +E+ HPF + +DL
Sbjct: 218 NLPPYL------TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL 267
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 54/222 (24%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
MSE I IL + G+ +LH+N IHR+++ S++L++ DG V + K
Sbjct: 98 MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157
Query: 61 KKTFLGSPS-------WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113
K P W++PE++R +++ GY+ + D++++GITA EL G+ PF+DM
Sbjct: 158 AKVVYDFPQFSTSVLPWLSPELLR---QDLYGYNVKSDIYSVGITACELATGRVPFQDML 214
Query: 114 PTRALFQIVRNPP----------------------------PGLYRAS------------ 133
T+ L Q ++ PP + A
Sbjct: 215 RTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT 274
Query: 134 ----NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171
+S + + + CL+++PE RP S LL H F + E
Sbjct: 275 PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 20/194 (10%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE F + E++ + LH+ +++RDL+ N+LL G + + DFGLS+
Sbjct: 94 SEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF-----EDMHPTR 116
TF G+ ++APE++ + GY +D W+LG+ E+ G PF + M+
Sbjct: 154 NTFCGTTEYLAPEVLL----DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
Query: 117 ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR----PYMSELLEHPFITSLPEN 172
A F VR P L S F+ L +NP+HR EL EHPF + +
Sbjct: 210 A-FGKVRFPKNVL------SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWD 262
Query: 173 DLHLSTVNCQYKDQ 186
L + +K
Sbjct: 263 LLSKKQITPPFKPI 276
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 17/178 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
E F +II+G+ LH+ +I+RDL+ NVLL DG V+I D GL+ E + K
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK 153
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF----EDMHPTR 116
K + G+P +MAPE+++ + YD +D +ALG+T E+ + PF E +
Sbjct: 154 TKGYAGTPGFMAPELLQG-----EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 208
Query: 117 ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPFITSL 169
+I+ + + +S F L K+PE R L HP L
Sbjct: 209 LKQRILNDS---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 27/180 (15%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E + E++ G+ LH+ +IHRD++ N+L+ + G +K+ DFGLSR N +
Sbjct: 94 LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLEN 150
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
KK F+G+P ++APE + G D D W+LG E G PPF P A+F
Sbjct: 151 KK-FVGTPDYLAPETI-----LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-DAVFD 203
Query: 121 IVRNPPPGLYRASNW--------SQHYVDFIAECLEKNPEHR---PYMSELLEHPFITSL 169
+ L R NW S VD I L +P R E+ HPF S+
Sbjct: 204 NI------LSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 55/168 (32%), Positives = 89/168 (52%), Gaps = 19/168 (11%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS 67
F EI+ G+ FLH +I+RDL+ NV+L +DG +KI DFG+ +E ++ TF G+
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF----EDMHPTRALFQIVR 123
P ++APEI++ G K Y +D W+ G+ E+ G+ PF ED LF+ +R
Sbjct: 160 PDYIAPEILQ-GLK----YTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----ELFESIR 209
Query: 124 NPPPGLYRASNW-SQHYVDFIAECLEKNPEHR-PYMSELLEHPFITSL 169
P R W ++ D + + E++P R + + HPF ++
Sbjct: 210 VDTPHYPR---WITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 48/166 (28%), Positives = 95/166 (57%), Gaps = 8/166 (4%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEV-KIVDFGLSRETANTFDK 60
SE I +I G+ +H+ ++HRD++ N+ L+K+G V K+ DFG++R+ ++ +
Sbjct: 99 SEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
T +G+P +++PEI C ++ Y+N+ D+W+LG EL K PFE + + + +
Sbjct: 159 AYTCVGTPYYLSPEI--CQNRP---YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I + + + N+S+ I++ + +P RP ++ +L+ PF+
Sbjct: 214 ICQGYFAPI--SPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 32/185 (17%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
L +I+ G+ F H +++IHRD++ N+L+++ G VK+ DFG +R A + ++ +
Sbjct: 105 YLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV------ 122
+ APE++ K Y +D+WA+G E+ G+P F L+ I+
Sbjct: 165 WYRAPELLVGDTK----YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL 220
Query: 123 ---------RNPP-------------PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
+NP P R S +D +CL +P+ RP S+L
Sbjct: 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280
Query: 161 LEHPF 165
L H F
Sbjct: 281 LHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 40/207 (19%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E+HI + L +++ G+ ++H +VIHRDL+ SN+L+ +D E++I DFG++R +++ +
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 61 KKTFLG---SPSWM-APEIMRCGHKEVDGYDNRIDVWALG-ITAIELGD----------- 104
K F+ + W APE++ + Y ID+W++G I A LG
Sbjct: 164 HKYFMTEYVATRWYRAPELLL----SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219
Query: 105 ---------GKPPFEDMHP-----TRALFQIVRNPPP----GLYRASNWSQHYVDFIAEC 146
G P E ++ R Q + P ++ S +D +++
Sbjct: 220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFP--KASPEALDLLSQM 277
Query: 147 LEKNPEHRPYMSELLEHPFITSLPEND 173
L+ +PE R + + L+HPF+ + D
Sbjct: 278 LQFDPEERITVEQALQHPFLAQYHDPD 304
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 16/193 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE-TANTFDK 60
EQ + EI+ + LH+ +I+RD++ N+LL +G V + DFGLS+E + ++
Sbjct: 103 KEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER 162
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF----EDMHPTR 116
+F G+ +MAP+I+R G G+D +D W++G+ EL G PF E
Sbjct: 163 AYSFCGTIEYMAPDIVRGGDG---GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE 219
Query: 117 ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPFITSLPE 171
+I+++ PP S ++ D I L K+P+ R E+ +HPF +
Sbjct: 220 ISRRILKSEPPYPQEMSALAK---DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276
Query: 172 NDLHLSTVNCQYK 184
+DL V +K
Sbjct: 277 DDLAAKKVPAPFK 289
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 44/110 (40%), Positives = 62/110 (56%), Gaps = 9/110 (8%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--K 60
E H F EI G+ FLH +I+RDL+ NV+L +G +KI DFG+ +E N +D
Sbjct: 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVT 157
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE 110
KTF G+P ++APEI+ Y +D WA G+ E+ G+ PFE
Sbjct: 158 TKTFCGTPDYIAPEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 2 SEQHIAFILKEIITGMVFLH-ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
SE F EI++ + +LH E +V++RDL+ N++L KDG +KI DFGL +E
Sbjct: 93 SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
KTF G+P ++APE++ E + Y +D W LG+ E+ G+ PF + + LF+
Sbjct: 153 MKTFCGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFE 206
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPFITSLPENDLH 175
++ R S ++ L+K+P+ R E+++H F + D++
Sbjct: 207 LILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVY 264
Query: 176 LSTVNCQYKDQ---ELQTMHVEDLAALETIS 203
+ +K Q E T + ++ + I+
Sbjct: 265 EKKLVPPFKPQVTSETDTRYFDEEFTAQMIT 295
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 42/116 (36%), Positives = 63/116 (54%), Gaps = 10/116 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS-RETANTFDK 60
E F +++ + +LH +++RDL+ N+LL DG +KI DFG + R T+
Sbjct: 99 PEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY-- 156
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR 116
T G+P ++APEI+ K GY +D WALGI E+ G PPF D +P +
Sbjct: 157 --TLCGTPEYLAPEIIL--SK---GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 21/183 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+H F EI + +LHE +I+RDL+ NVLL +G +K+ D+G+ +E D
Sbjct: 93 LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE--------DM 112
TF G+P+++APEI+R + Y +D WALG+ E+ G+ PF+ D
Sbjct: 153 TSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
Query: 113 HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR------PYMSELLEHPFI 166
+ LFQ++ + R+ S + L K+P+ R +++ HPF
Sbjct: 208 NTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265
Query: 167 TSL 169
++
Sbjct: 266 RNV 268
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E I ++ G+ +HE V+HRD++ N+ LT++G+VK+ DFG +R +
Sbjct: 99 EDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV 122
T++G+P ++ PEI E Y+N+ D+W+LG EL K PF+ + ++
Sbjct: 159 TYVGTPYYVPPEIW-----ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC 213
Query: 123 R---NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
+ P P Y ++ + I + ++NP RP + +L
Sbjct: 214 QGSYKPLPSHY---SYELRSL--IKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+++ H + +I+ G+ ++H +V+HRDL+ N+L+ D E+KI DFGL+R + +
Sbjct: 102 LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161
Query: 61 KKTFL----GSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFED---MH 113
F+ + + APEIM Y IDVW++G EL KP F+ +
Sbjct: 162 NAGFMTEYVATRWYRAPEIML----SFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD 217
Query: 114 PTRALFQIVRNPPPGLYR--ASNWSQHYV-----------------------DFIAECLE 148
+ Q++ P S +Q+Y+ D + + L
Sbjct: 218 QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLA 277
Query: 149 KNPEHRPYMSELLEHPFI 166
+P R + E LEHP++
Sbjct: 278 FDPTKRISVEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 58/183 (31%), Positives = 80/183 (43%), Gaps = 30/183 (16%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F +II G+ LH+ +++RDL+ NVLL G V+I D GL+ E K
Sbjct: 93 PEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGK 149
Query: 62 KT--FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---- 115
K G+P +MAPE+++ EV YD +D +ALG T E+ G+ PF
Sbjct: 150 KIKGRAGTPGYMAPEVLQ---GEV--YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
Query: 116 ----RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPFI 166
R L V P +S D L+K+PE R E+ EHP
Sbjct: 205 ELKRRTLEMAVEYP-------DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
Query: 167 TSL 169
L
Sbjct: 258 KDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
SE F EI++ + +LH +++RDL+ N++L KDG +KI DFGL +E
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
KTF G+P ++APE++ E + Y +D W LG+ E+ G+ PF + + LF+
Sbjct: 152 MKTFCGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFE 205
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPFITSLPENDLH 175
++ R S ++ L K+P R E++ H F T + D++
Sbjct: 206 LILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVY 263
Query: 176 LSTVNCQYKDQ---ELQTMHVEDLAALETIS 203
+ +K Q E T + ++ +TI+
Sbjct: 264 DKKLVPPFKPQVTSETDTRYFDEEFTAQTIT 294
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE + F EII + LH+ +++RD++ N+LL +G V + DFGLS+E + +K+
Sbjct: 103 SEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL-SEEKE 161
Query: 62 KT--FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF----EDMHPT 115
+T F G+ +MAPEI+R G+ +D W+LGI EL G PF E +
Sbjct: 162 RTYSFCGTIEYMAPEIIRGK----GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
Query: 116 RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPFITSLP 170
+I++ PP +Q D + + L K+P+ R SE+ EHPF L
Sbjct: 218 EVSRRILKCDPPFPSFIGPEAQ---DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
Query: 171 ENDLHLSTVNCQYKDQELQTMHVEDLA 197
L L VN ++ + V + A
Sbjct: 275 WEALALRKVNPPFRPSIRNELDVGNFA 301
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 38/107 (35%), Positives = 64/107 (59%), Gaps = 8/107 (7%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS 67
F EI+ + +LH +++RDL+ N+LL K+G +K+ DFG +++ D+ T G+
Sbjct: 105 FYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWTLCGT 161
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP 114
P ++APE++ + G++ +D WALGI E+ G PPF D +P
Sbjct: 162 PEYLAPEVI-----QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 55/201 (27%)
Query: 13 IITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWM 71
++ G+ +L E H ++HRD++ SN+L+ GE+K+ DFG+S + ++ +F+G+ S+M
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYM 169
Query: 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE--------------------- 110
+PE ++ H Y + D+W++G++ +EL G+ P
Sbjct: 170 SPERLQGTH-----YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224
Query: 111 ---------------------DMHPTRALFQ----IVRNPPPGLYRASNWSQHYVDFIAE 145
D P A+F+ IV PPP L ++ + +F+ +
Sbjct: 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGV-FTPDFQEFVNK 283
Query: 146 CLEKNPEHRPYMSELLEHPFI 166
CL KNP R + L+ H FI
Sbjct: 284 CLIKNPAERADLKMLMNHTFI 304
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 17/168 (10%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS 67
F E++ + LH+ +VI+RDL+ N+LL G + + DFGL + DK TF G+
Sbjct: 97 FYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-- 125
P ++APE++ GH GY +D W LG+ E+ G PPF D + +I++ P
Sbjct: 157 PEYLAPELL-LGH----GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211
Query: 126 -PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS---ELLEHPFITSL 169
P G R + D + L ++P R + E+ HPF + L
Sbjct: 212 FPDGFDRDAK------DLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E F EI + ++FLH+ +I+RDL+ NVLL +G K+ DFG+ +E
Sbjct: 95 EARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV 122
TF G+P ++APEI+ + Y +D WA+G+ E+ G PFE LF+ +
Sbjct: 155 TFCGTPDYIAPEIL-----QEMLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAI 208
Query: 123 RNPPPGLYRASNW-SQHYVDFIAECLEKNPEHR------PYMSELLEHPFITSLPENDLH 175
N +Y W SQ VD + + KNP R +L HPF L L+
Sbjct: 209 LNDEV-VY--PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN 265
Query: 176 LSTVNCQYKDQELQTMHVEDLAAL--ETISEDNIVQELEERH 215
+ ++ + ED++ + I ED ++ +EE
Sbjct: 266 RRQIEPPFRP---RIKSREDVSNFDPDFIKEDPVLTPIEESL 304
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 53/177 (29%), Positives = 80/177 (45%), Gaps = 12/177 (6%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F EI + + +LH ++I+RDL+ N+LL G V + DFGL +E
Sbjct: 94 PEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
TF G+P ++APE++R K+ YD +D W LG E+ G PPF I
Sbjct: 154 STFCGTPEYLAPEVLR---KQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
Query: 122 VRNPPPGLYRASNWSQHYVDFIAECLEKNPE----HRPYMSELLEHPFITSLPENDL 174
+ P L N S + L+K+ + E+ H F +S+ +DL
Sbjct: 209 LNKP---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 37/196 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E I L +++ G+ F H + ++HRDL+ N+L+ +G +K+ DFGL+R +
Sbjct: 95 LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154
Query: 61 KKTFLGSPSWMAPEIM-RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
++ + + APE++ GY +D+W++G EL +P F LF
Sbjct: 155 YTHYVVTRWYRAPELLLGDK-----GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
Query: 120 QI-----------------------------VRNPPPGLYRASNWSQHYVDFIAECLEKN 150
+I P P L+ N S +D +++ L +
Sbjct: 210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF--PNASPQALDLLSQMLHYD 267
Query: 151 PEHRPYMSELLEHPFI 166
P R + L HP+
Sbjct: 268 PHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 44/118 (37%), Positives = 62/118 (52%), Gaps = 6/118 (5%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E F EI G+ FLH +I+RDL+ NV+L +G +KI DFG+ +E +
Sbjct: 100 EPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
TF G+P ++APEI+ Y +D WA G+ E+ G+PPF D LFQ
Sbjct: 160 TFCGTPDYIAPEII-----AYQPYGKSVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 42/195 (21%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + I ++++++ G+ FLH + ++HRDL+ N+L+T DG+VKI DFGL+R +F+
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR--IYSFEM 161
Query: 61 KKTFLGSPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE---DMHPTR 116
T + W APE++ Y +D+W++G EL +P F +
Sbjct: 162 ALTSVVVTLWYRAPEVLL-----QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD 216
Query: 117 ALFQIVRNPPPGLYRASNW--------------------------SQHYVDFIAECLEKN 150
+F ++ P W + +D + + L N
Sbjct: 217 KIFDVIGLPS-----EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFN 271
Query: 151 PEHRPYMSELLEHPF 165
P R E L+HP+
Sbjct: 272 PHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 21/179 (11%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DK 60
E + +++ + +H H+IHRD++ +N+LL +G VK+ DFG S+ A T D
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF--EDMHPTRAL 118
+TF G+P ++APEI R Y + D+++LG+ EL K PF E+M
Sbjct: 202 GRTFCGTPYYVAPEIWR-----RKPYSKKADMFSLGVLLYELLTLKRPFDGENME----- 251
Query: 119 FQIVRNPPPGLYR--ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHP----FITSLPE 171
+++ G Y + S + + L +P+ RP S+LL P FI+ L E
Sbjct: 252 -EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLE 309
|
Length = 496 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 11/164 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTF 58
+ + + ++ GM +L H +HRDL NVLL + KI DFG+SR + +
Sbjct: 92 IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
Query: 59 DKKKTFLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTR 116
+ T P W APE + G + ++ DVW+ G+T E G P+ +M
Sbjct: 152 YRATTAGRWPLKWYAPECINYGK-----FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206
Query: 117 ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
+ + L R Q + C + PE RP SEL
Sbjct: 207 VIAMLESGER--LPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 44/149 (29%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS-RETANTFDKKKTFLG 66
F E++ +LH +I+RDL+ N+LL G VK+ DFG + + TF T G
Sbjct: 122 FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCG 177
Query: 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP 126
+P ++APE++ + G+ +D W +G+ E G PPF D P R +I+
Sbjct: 178 TPEYLAPEVI-----QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA--- 229
Query: 127 PGLYRASNWSQHYV-DFIAECLEKNPEHR 154
G + NW D + L+ + R
Sbjct: 230 -GRLKFPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 15/179 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
+E+ + F L E+ + LH +I+RDL+ N+LL ++G +K+ DFGLS+E+ + K
Sbjct: 96 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155
Query: 62 KTFLGSPSWMAPEIM-RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+F G+ +MAPE++ R GH D W+ G+ E+ G PF+ +
Sbjct: 156 YSFCGTVEYMAPEVVNRRGH------TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPFITSLPENDL 174
I++ L S + ++NP +R + E+ HPF +++ N L
Sbjct: 210 ILKAK---LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL 265
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 36/199 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S+ H + L +++ G+ ++H +V+HRDL+ SN+LL + ++KI DFGL+R T+ D
Sbjct: 105 LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF 164
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF---EDMHPTRA 117
++ + + APE++ Y IDVW++G EL KP F + +H +
Sbjct: 165 MTEYVVTRWYRAPELLLN----CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL 220
Query: 118 LFQI--------------------VRNPPPGLYRASNWSQHY-------VDFIAECLEKN 150
+ ++ +R+ P ++++ + +D + + L +
Sbjct: 221 ITELLGSPSEEDLGFIRNEKARRYIRSLPY--TPRQSFARLFPHANPLAIDLLEKMLVFD 278
Query: 151 PEHRPYMSELLEHPFITSL 169
P R + E L HP++ SL
Sbjct: 279 PSKRITVEEALAHPYLASL 297
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 49/206 (23%), Positives = 77/206 (37%), Gaps = 53/206 (25%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
+ I + + G+ +LH N ++HRDL+ +N+L+ DG +K+ DFGL+R
Sbjct: 100 TPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR--------- 150
Query: 62 KTFLGSPS----------WM-APEI-MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
GSP+ W APE+ H Y +D+W++G EL P
Sbjct: 151 --SFGSPNRKMTHQVVTRWYRAPELLFGARH-----YGVGVDMWSVGCIFAELLLRVPFL 203
Query: 110 EDMHPTRAL---FQIV----------------------RNPPPGLYRASNWSQHYVDFIA 144
L F+ + P P S +D +
Sbjct: 204 PGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQ 263
Query: 145 ECLEKNPEHRPYMSELLEHPFITSLP 170
L NP R + LEHP+ ++ P
Sbjct: 264 RLLTLNPNKRITARQALEHPYFSNDP 289
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 42/156 (26%), Positives = 82/156 (52%), Gaps = 14/156 (8%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWM 71
++ + + +H ++HRD++ +NV +T G VK+ D GL R ++ + +G+P +M
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE-DMHPTRALFQIVRN----PP 126
+PE + +GY+ + D+W+LG E+ + PF D +L + + P
Sbjct: 174 SPERIH-----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL 228
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P A ++S+ D ++ C+ +PE RP +S +L+
Sbjct: 229 P----ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 35/197 (17%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S HI + L +I+ G+ ++H +V+HRDL+ SN+LL + ++KI DFGL+R D
Sbjct: 103 LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 61 KKT---FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH---- 113
++ + + APEIM GY ID+W++G E+ +P F
Sbjct: 163 TGFLTEYVATRWYRAPEIML----NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ 218
Query: 114 ----------PTRALFQIVRNPPPGLY-------RASNWSQHY-------VDFIAECLEK 149
P++ + + Y W++ + +D + + L
Sbjct: 219 LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTF 278
Query: 150 NPEHRPYMSELLEHPFI 166
NP R + E L HP++
Sbjct: 279 NPHKRITVEEALAHPYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 54/181 (29%), Positives = 84/181 (46%), Gaps = 18/181 (9%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F E+ + + +LH ++I+RDL+ N+LL G V + DFGL +E +
Sbjct: 94 LEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
TF G+P ++APE++R KE YD +D W LG E+ G PPF ++ I
Sbjct: 154 STFCGTPEYLAPEVLR---KE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI 208
Query: 122 VRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR----PYMSELLEHPFITSLPENDL 174
+ P P G A+ D + L K+ R E+ H F + + +DL
Sbjct: 209 LHKPLQLPGGKTVAA------CDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDL 262
Query: 175 H 175
+
Sbjct: 263 Y 263
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 48/159 (30%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN-------TFDKKKTF 64
+I GM +L IHRDL N+LL D +VKI DFGL R K F
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 65 LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR 123
+W APE +R + + DVW G+T E+ G+ P+ + ++ L +I +
Sbjct: 165 ----AWCAPESLRTRT-----FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215
Query: 124 NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
L R Q + + +C NP RP + L E
Sbjct: 216 EGER-LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 43/199 (21%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS---------- 51
SE+ F E++ + +LH +++RDL+ N+LL + G + + DF LS
Sbjct: 101 SEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160
Query: 52 --------------RETANTF-----DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDV 92
+ TF + +F+G+ ++APE++ DG+ + +D
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-----DGHGSAVDW 215
Query: 93 WALGITAIELGDGKPPFEDMHPTRALFQIVRNPP--PGLYRASNWSQHYVDFIAECLEKN 150
W LGI E+ G PF+ + I++ PG S+ ++ D I + L K+
Sbjct: 216 WTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSAR---DLIRKLLVKD 272
Query: 151 PEHR----PYMSELLEHPF 165
P R +E+ +HPF
Sbjct: 273 PSKRLGSKRGAAEIKQHPF 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 48/172 (27%), Positives = 90/172 (52%), Gaps = 17/172 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+++ H+ F++ +I+ G+ ++H +IHRDL+ SN+ + +D E+KI+DFGL+R T D+
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DE 173
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
++ + + APEIM Y+ +D+W++G EL G+ F L
Sbjct: 174 MTGYVATRWYRAPEIMLNWMH----YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229
Query: 121 IVR---NPPPGLYR--ASNWSQHYVDFIAECLEKNPEH-----RPYMSELLE 162
I+R P L + +S +++Y+ + + + N + P +LLE
Sbjct: 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 281
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 9e-16
Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 36/196 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + + +++ + + H +++IHRD++ N+L+++ G +K+ DFG +R
Sbjct: 97 LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156
Query: 61 KKTFLGSPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE--------- 110
T + W APE++ Y +DVWA+G EL DG+P F
Sbjct: 157 PLTDYVATRWYRAPELLVGDTN----YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212
Query: 111 -------DMHP-------TRALFQIVRNPPPG-------LYRASNWSQHYVDFIAECLEK 149
+ P + F V P P Y S +DF+ CL
Sbjct: 213 LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGK-VSSPALDFLKACLRM 271
Query: 150 NPEHRPYMSELLEHPF 165
+P+ R ELL+HP+
Sbjct: 272 DPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 9e-16
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 17/158 (10%)
Query: 11 KEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP-- 68
++ M +L N IHRDL N L+ +D VK+ DFGL+R + D+ + G+
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD--DQYTSSQGTKFP 164
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRNPP 126
W PE+ + ++ DVW+ G+ E+ +GK P+E + ++V +
Sbjct: 165 VKWAPPEVFDYSR-----FSSKSDVWSFGVLMWEVFSEGKMPYE----RFSNSEVVESVS 215
Query: 127 PG--LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
G LYR + C + PE RP +LL
Sbjct: 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP--- 68
++ GM +L ++VIHRDL N L+ ++ VK+ DFG++R + D+ + G+
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD--DQYTSSTGTKFPV 165
Query: 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRNPPP 127
W +PE+ Y ++ DVW+ G+ E+ +GK P+E+ R+ ++V
Sbjct: 166 KWSSPEVFSFSK-----YSSKSDVWSFGVLMWEVFSEGKTPYEN----RSNSEVVETINA 216
Query: 128 G--LYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
G LY+ SQ + + C ++ PE RP S LL
Sbjct: 217 GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP--- 68
+I GM +L + IHRDL N+L+ ++ KI DFGL+R + D+ G+
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFPI 168
Query: 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRNPPP 127
W APE G + + DVW+ GI E+ G+ P+ M L Q+ R
Sbjct: 169 KWTAPEAANYGR-----FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG--- 220
Query: 128 GLYR---ASNWSQHYVDFIAECLEKNPEHRP---YMSELLE 162
YR N + D + +C +K+PE RP Y+ LE
Sbjct: 221 --YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 28/159 (17%)
Query: 16 GMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-SWMAP 73
GM FL IHRDL NVL+T+D +KI DFGL+R+ + +KT G P WMAP
Sbjct: 144 GMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP 203
Query: 74 EIMRCGHKEVDGYDNRI-----DVWALGITAIE---LGDGKPPFEDMHPTRALFQIVRNP 125
E + +R+ DVW+ G+ E LG G P +P + ++ +
Sbjct: 204 EAL----------FDRVYTHQSDVWSFGVLLWEIFTLG-GSP-----YPGIPVEELFKLL 247
Query: 126 PPG--LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
G + + N +Q + +C + P RP +L+E
Sbjct: 248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 39/205 (19%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS----------- 51
E+ F + E++ + +H+ IHRD++ N+L+ DG +K+ DFGL
Sbjct: 100 EETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159
Query: 52 ------------RETANTFDKKKTF------LGSPSWMAPEIMRCGHKEVDGYDNRIDVW 93
D K+ +G+P ++APE++R Y D W
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-----GTPYGLECDWW 214
Query: 94 ALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASN--WSQHYVDFIAECLEKNP 151
+LG+ E+ G PPF +I+ N L + S +D I L +P
Sbjct: 215 SLGVILYEMLYGFPPFYSDTLQETYNKII-NWKESLRFPPDPPVSPEAIDLICRLL-CDP 272
Query: 152 EHR-PYMSELLEHPFITSLPENDLH 175
E R E+ HPF + +L
Sbjct: 273 EDRLGSFEEIKSHPFFKGIDWENLR 297
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 12/176 (6%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E F EI + + +LH ++++RDL+ N+LL G + + DFGL +E
Sbjct: 95 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV 122
TF G+P ++APE++ HK+ YD +D W LG E+ G PPF + I+
Sbjct: 155 TFCGTPEYLAPEVL---HKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
Query: 123 RNPPPGLYRASNWSQHYVDFIAECLEKNPEHR----PYMSELLEHPFITSLPENDL 174
P +N ++H ++ + L+K+ R E+ H F + + +DL
Sbjct: 210 NKPLQLKPNITNSARHLLEGL---LQKDRTKRLGAKDDFMEIKNHIFFSPINWDDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 35/109 (32%), Positives = 62/109 (56%), Gaps = 5/109 (4%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E + ++ ++ G+ ++H N ++HRDL+ +N+L++ DG +KI DFGL+R + +
Sbjct: 97 PEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156
Query: 62 KTFLGSPSW-MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
+ + W APE++ K YD +D+WA+G EL +G P F
Sbjct: 157 YSHQVATRWYRAPELLYGARK----YDPGVDLWAVGCIFAELLNGSPLF 201
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 42/109 (38%), Positives = 59/109 (54%), Gaps = 6/109 (5%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE + ++ +++ G+ +LHEN +IHRDL+ SN+LLT G +KI DFGL+R K
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP-AKP 164
Query: 62 KTFLGSPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
T W APE++ G Y ID+WA+G EL KP
Sbjct: 165 MTPKVVTLWYRAPELL-LGCTT---YTTAIDMWAVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 48/156 (30%), Positives = 66/156 (42%), Gaps = 22/156 (14%)
Query: 16 GMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-SWMAP 73
GM +L + IHRDL N L+ ++ +KI DFG+SRE L P W AP
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP 164
Query: 74 EIMRCGHKEVDGYDNRIDVWALGITAIE---LGDGKPPFEDMHPTRALFQIVRN---PPP 127
E + G Y + DVW+ GI E LGD P+ M + +I P P
Sbjct: 165 EALNYGR-----YTSESDVWSYGILLWETFSLGDT--PYPGMSNQQTRERIESGYRMPAP 217
Query: 128 GLYRASNWSQHYVDFIAE-CLEKNPEHRPYMSELLE 162
L + + C +PE+RP SE+
Sbjct: 218 QL------CPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 46/164 (28%), Positives = 68/164 (41%), Gaps = 32/164 (19%)
Query: 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF----DK 60
+ + ++ GM +L E + IHRDL N+L+ +D K+ DFGL+R DK
Sbjct: 105 SLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK 164
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALF 119
K + W APE G + + DVW+ GI E+ G+ P+ M+
Sbjct: 165 KIPY----KWTAPEAASHGT-----FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD 215
Query: 120 QIVRN---P-----PPGLYRASNWSQHYVDFIAECLEKNPEHRP 155
QI P P +Y+ + EC PE RP
Sbjct: 216 QITAGYRMPCPAKCPQEIYK----------IMLECWAAEPEDRP 249
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 35/191 (18%)
Query: 6 IAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFL 65
+ ++ ++++G+ LH+N ++HRDL+ SN+LL G +KI DFGL+RE + K T L
Sbjct: 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPYTQL 166
Query: 66 GSPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR- 123
W APE++ G KE Y ID+W++G EL KP F L +I +
Sbjct: 167 VVTLWYRAPELL-LGAKE---YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL 222
Query: 124 -----------------------NPPPGL-----YRASNWSQHYVDFIAECLEKNPEHRP 155
P + A + S + D + L +P R
Sbjct: 223 LGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI 282
Query: 156 YMSELLEHPFI 166
+ L+HP+
Sbjct: 283 SAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 52/195 (26%), Positives = 88/195 (45%), Gaps = 37/195 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ +Q I + L +I+ G+ ++H V+HRDL+ SN+L+ ++ ++KI DFGL+R D
Sbjct: 105 LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ----DP 160
Query: 61 KKT-FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ T ++ + + APEIM K YD +D+W+ G E+ +GKP F
Sbjct: 161 QMTGYVSTRYYRAPEIMLTWQK----YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFS 216
Query: 120 QIV----------------------------RNPPPGLYRASNWSQHYVDFIAECLEKNP 151
I R P P + N +D + + L +P
Sbjct: 217 IITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDP 276
Query: 152 EHRPYMSELLEHPFI 166
+ R +E L HP++
Sbjct: 277 QKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 42/147 (28%), Positives = 85/147 (57%), Gaps = 14/147 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S++H+ F++ +++ G+ ++H +IHRDL+ SNV + +D E++I+DFGL+R+ D+
Sbjct: 115 LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---DE 171
Query: 61 KKTFLGSPSWMAPEIM-RCGHKEVDGYDNRIDVWALGITAIELGDGKPPF---EDMHPTR 116
++ + + APEIM H Y+ +D+W++G EL GK F + + +
Sbjct: 172 MTGYVATRWYRAPEIMLNWMH-----YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK 226
Query: 117 ALFQIVRNPPPGLYR--ASNWSQHYVD 141
+ ++V P P + + +S ++ Y+
Sbjct: 227 RIMEVVGTPSPEVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 45/203 (22%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + H +I+ +++ + ++H +VIHRDL+ SN+LL D VK+ DFGL+R + +
Sbjct: 104 LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR----SLSE 159
Query: 61 KKTFLGSPS--------WM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF-- 109
+ +P W APEI+ + Y +D+W++G E+ GKP F
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEILLGSTR----YTKGVDMWSVGCILGEMLLGKPLFPG 215
Query: 110 -------------------EDMHPTRALF--QIVRNPPPGLYRA-----SNWSQHYVDFI 143
ED+ ++ F ++ + P + S +D +
Sbjct: 216 TSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLL 275
Query: 144 AECLEKNPEHRPYMSELLEHPFI 166
+ L NP R E LEHP++
Sbjct: 276 KKLLVFNPNKRLTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS-RETANTFDKK 61
E F L E++ + +H+ +HRD++ NVL+ + G +K+ DFG + R TAN
Sbjct: 101 EDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
K +G+P ++APE++ + + G Y D W+LG+ A E+ G+ PF + +
Sbjct: 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN 220
Query: 121 IVRNPP----PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174
I+ P + S ++D I + L + R L HPF + + N++
Sbjct: 221 IMNFQRFLKFPEDPKV---SSDFLDLI-QSLLCGQKERLGYEGLCCHPFFSKIDWNNI 274
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-S 69
EI GM +L +HRDL N ++ +D VKI DFG++R+ T +K G P
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 70 WMAPEIMRCGHKEVDG-YDNRIDVWALGITAIEL 102
WMAPE ++ DG + + DVW+ G+ E+
Sbjct: 187 WMAPESLK------DGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 11/169 (6%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS--PS 69
++ GM +L IHRDL NVL+T+D +KI DFGL+R+ N KKT G
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPG 128
WMAPE + V Y ++ DVW+ G+ E+ G P+ + P LF++++
Sbjct: 202 WMAPEAL---FDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEGHR- 254
Query: 129 LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE-HPFITSLPENDLHL 176
+ + +N + + EC P RP +L+E + ++ D +L
Sbjct: 255 MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYL 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 2 SEQHIAFILKEIITGMVFLH-ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+E+ I I +++ + +LH E ++HRDL +N++L +D +V I DFGL+++ K
Sbjct: 111 TEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESK 169
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ +G+ + PEI++ + Y + DVWA G ++ +PPF + +
Sbjct: 170 LTSVVGTILYSCPEIVKN-----EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK 224
Query: 121 IVRNPPPGLYRASN---WSQHYVDFIAECLEKNPEHRP 155
IV +Y +S+ D I CL + E RP
Sbjct: 225 IVE----AVYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 46/208 (22%), Positives = 86/208 (41%), Gaps = 52/208 (25%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E I + +++ G+ +LHENH++HRD++ +N+L+ G +KI DFGL+R +D
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR----PYDG 167
Query: 61 KKTFLGSPSWM---------------APEIMRCGHKEVDGYDNRIDVWALGITAIELGDG 105
PE++ G + Y +D+W +G E+
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELL-LGERR---YTTAVDIWGIGCVFAEMFTR 223
Query: 106 KPPFE---DMHPTRALFQIVRNPP----------PGLYRASNWSQHY------------- 139
+P + D+ +F++ P PG + +Y
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPG-CEGVHSFTNYPRTLEERFGKLGP 282
Query: 140 --VDFIAECLEKNPEHRPYMSELLEHPF 165
+D +++ L +P R S+ LEHP+
Sbjct: 283 EGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 58/177 (32%), Positives = 85/177 (48%), Gaps = 12/177 (6%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS--PS 69
++ GM +L IHRDL NVL+T+D +KI DFGL+R + KKT G
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVK 201
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPG 128
WMAPE + V Y ++ DVW+ GI E+ G P+ + P LF+++R
Sbjct: 202 WMAPEAL---FDRV--YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLREGHR- 254
Query: 129 LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE--HPFITSLPENDLHLSTVNCQY 183
+ + SN + + EC P RP +L+E + ++ E L LS QY
Sbjct: 255 MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQY 311
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 45/169 (26%), Positives = 70/169 (41%), Gaps = 25/169 (14%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPS-- 69
+I GM +L IHRDL N+L+ + VKI DFGL++ DK ++ P
Sbjct: 117 QICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK--VLPEDKDYYYVKEPGES 174
Query: 70 ---WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-----GDGKPPFEDM------HPT 115
W APE +R + + DVW+ G+T EL PP E +
Sbjct: 175 PIFWYAPECLR-----TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229
Query: 116 RALFQIVR--NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+ +++ L R + D + C E P+ RP ++L+
Sbjct: 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 9/167 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEV-KIVDFGLSRETANTFD 59
+ E I +I+ + +H ++HRDL+ N+LL K V KI DFG+S+ + +
Sbjct: 98 LDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKS 156
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
K T +G+P +++PE+ C E Y+ + D+WALG EL K FE + +
Sbjct: 157 KAYTVVGTPCYISPEL--C---EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+I+ + + +S I L +P RP +S+++ P
Sbjct: 212 KIMSGTFAPI--SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 32/171 (18%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
Q + F L ++ GM +L E + +HRDL NVL+++D K+ DFGL++E + D K
Sbjct: 102 AQQLGFAL-DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK 160
Query: 63 TFLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQ 120
P W APE +R K+ + + DVW+ GI E+ G+ P+ + P + +
Sbjct: 161 L----PVKWTAPEALR--EKK---FSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVP 210
Query: 121 IVRN------P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
V P PP +Y + +C E +P RP +L E
Sbjct: 211 HVEKGYRMEAPEGCPPEVY----------KVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 32/193 (16%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E I I+ + + + F H+++ IHRD++ N+L+TK G++K+ DFG +R D
Sbjct: 97 VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKP------------- 107
++ + + APE++ G + Y +DVWA+G EL G+P
Sbjct: 157 YTDYVATRWYRAPELL-VGDTQ---YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212
Query: 108 ---PFEDMHP-------TRALFQIVRNPPPGLY-----RASNWSQHYVDFIAECLEKNPE 152
D+ P T F+ + P P + N S + F+ CL+ +P
Sbjct: 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPT 272
Query: 153 HRPYMSELLEHPF 165
R ELLEHP+
Sbjct: 273 ERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 41/156 (26%), Positives = 82/156 (52%), Gaps = 14/156 (8%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWM 71
++ + + +H V+HRD++ +NV +T G VK+ D GL R ++ + +G+P +M
Sbjct: 114 QLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF-EDMHPTRALFQIVRN---PP- 126
+PE + H+ +GY+ + D+W+LG E+ + PF D +L Q + PP
Sbjct: 174 SPERI---HE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P ++S+ + ++ C+ +P+ RP + + +
Sbjct: 229 PT----EHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+ +++ GM +L N IHRDL N L++ G VK+ DFG++R + D+ + G+
Sbjct: 105 MCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAK 162
Query: 69 ---SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN 124
W PE+ Y ++ DVW+ G+ E+ +GK PFE ++ +++V
Sbjct: 163 FPVKWSPPEVF-----NFSKYSSKSDVWSFGVLMWEVFTEGKMPFE----KKSNYEVVEM 213
Query: 125 PPPG--LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
G LYR S + + C + PE RP +ELL
Sbjct: 214 ISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS--PS 69
++ GM +L IHRDL NVL+T++ +KI DFGL+R+ N KKT G
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK 204
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPG 128
WMAPE + V Y ++ DVW+ G+ E+ G P+ + P LF++++
Sbjct: 205 WMAPEAL---FDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHR- 257
Query: 129 LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+ + +N + + +C P HRP +L+E
Sbjct: 258 MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 52/184 (28%), Positives = 78/184 (42%), Gaps = 29/184 (15%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS-----------------RET 54
E + + +LH ++HRDL+ N+L+T G +K+ DFGLS ++T
Sbjct: 109 ETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 55 ANTFDKKKTFLGSPSWMAPE-IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113
DK+ G+P ++APE I+R GY +D WA+GI E G PF
Sbjct: 169 REFLDKQ--VCGTPEYIAPEVILR------QGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
Query: 114 PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS---ELLEHPFITSLP 170
P Q++ + D I+ L +NP R E+ +H F L
Sbjct: 221 PEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280
Query: 171 ENDL 174
N L
Sbjct: 281 WNGL 284
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 11 KEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP-- 68
K++ GM +L IHRDL N L+ G VK+ DFGLSR + D+ + +GS
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFP 164
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPP 126
W PE++ + ++ DVWA G+ E+ GK P+E + + + ++ +
Sbjct: 165 VRWSPPEVLL-----YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR 219
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
LYR S+ + C + E RP +LL
Sbjct: 220 --LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 50/214 (23%), Positives = 79/214 (36%), Gaps = 53/214 (24%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E + IL +I+ G+ LH+ + +HRDL +N+ + G KI DFGL+R
Sbjct: 116 LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 61 KKTFLGSPS--------------WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGK 106
+ APE++ K Y +D+W++G EL GK
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK----YHFAVDMWSVGCIFAELLTGK 231
Query: 107 PPFEDMHPTRAL---FQIVRNPPPGLYRASNWSQHY------------------------ 139
P F + L F+++ P NW Q
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNE-----DNWPQAKKLPLYTEFTPRKPKDLKTIFPNAS 286
Query: 140 ---VDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
+D + L+ NP R E L+H + S P
Sbjct: 287 DDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320
|
Length = 335 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA-NTFDKKKTFLGSPSW 70
+I GM F+ + + IHRDLR +N+L++ KI DFGL+R N + ++ W
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPT---RALFQIVRNPP 126
APE + G + + DVW+ GI +E+ G+ P+ M RAL + R P
Sbjct: 170 TAPEAINFG-----SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP- 223
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRP---YMSELLE 162
R N + + + C + PE RP Y+ +L+
Sbjct: 224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 54/211 (25%), Positives = 80/211 (37%), Gaps = 62/211 (29%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE----VKIVDFGLSRETANTFDK--KK 62
+L +I+ G+ +LH N V+HRDL+ +N+L+ +G VKI D GL+R F+ K
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR----LFNAPLKP 168
Query: 63 TFLGSP----SWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF----EDM- 112
P W APE++ G + Y ID+WA+G EL +P F +
Sbjct: 169 LADLDPVVVTIWYRAPELL-LGARH---YTKAIDIWAIGCIFAELLTLEPIFKGREAKIK 224
Query: 113 ------------------HPT----------------RALFQIVRNPPPGLY----RASN 134
PT F+ P L +
Sbjct: 225 KSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284
Query: 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPF 165
D + + LE +P R E LEHP+
Sbjct: 285 PDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 38/184 (20%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE---TANTFDKKKTFLGSP 68
+++ G+ F HEN V+HRDL+ N+L+ K GE+K+ DFGL+R NTF + L
Sbjct: 108 QLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL--- 164
Query: 69 SWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF-----EDM---------H 113
W AP+++ G + Y ID+W++G E+ G+P F ED
Sbjct: 165 -WYRAPDVL-LGSRT---YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT 219
Query: 114 PTRALFQIVRNPP---PGLYRASNWSQHY---------VDFIAECLEKNPEHRPYMSELL 161
PT + + + P P R +D + L+ NPE R + L
Sbjct: 220 PTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279
Query: 162 EHPF 165
+HP+
Sbjct: 280 QHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 45/124 (36%), Positives = 68/124 (54%), Gaps = 11/124 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE+ + F EII G+ +H V++RDL+ +N+LL + G V+I D GL A F KK
Sbjct: 95 SEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL----ACDFSKK 150
Query: 62 KTF--LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
K +G+ +MAPE+++ G YD+ D ++LG +L G PF H T+
Sbjct: 151 KPHASVGTHGYMAPEVLQKG----TAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKH 205
Query: 120 QIVR 123
+I R
Sbjct: 206 EIDR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 45/124 (36%), Positives = 67/124 (54%), Gaps = 11/124 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE + F EII G+ +H V++RDL+ +N+LL + G V+I D GL A F KK
Sbjct: 95 SEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL----ACDFSKK 150
Query: 62 KTF--LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
K +G+ +MAPE+++ G YD+ D ++LG +L G PF H T+
Sbjct: 151 KPHASVGTHGYMAPEVLQKG----VAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKH 205
Query: 120 QIVR 123
+I R
Sbjct: 206 EIDR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS--PS 69
++ GM +L IHRDL NVL+T+D +KI DFGL+R+ + KKT G
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 207
Query: 70 WMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPP 127
WMAPE + D Y ++ DVW+ G+ E+ G P+ + P LF++++
Sbjct: 208 WMAPEAL------FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHR 260
Query: 128 GLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+ + SN + + +C P RP +L+E
Sbjct: 261 -MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 39/203 (19%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE I F++ +++ G+ ++H +IHRDL+ N+ + +D E+KI+DFGL+R+T D
Sbjct: 115 LSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT----DS 170
Query: 61 KKTFLGSPSWM-APE-IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
+ T W APE I+ H Y +D+W++G E+ GKP F+ L
Sbjct: 171 EMTGYVVTRWYRAPEVILNWMH-----YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225
Query: 119 FQI--VRNPPPGLYRA---SNWSQHYVDFIAECLEK-----------------------N 150
+I V P + S +++YV + +K +
Sbjct: 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLD 285
Query: 151 PEHRPYMSELLEHPFITSLPEND 173
E R +E L HP+ + +
Sbjct: 286 AESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 49/149 (32%), Positives = 65/149 (43%), Gaps = 16/149 (10%)
Query: 16 GMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN-TFDKKKTFLGSP-SWMAP 73
GM +L H IHRDL N L+T+ +KI DFG+SRE + + P W AP
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAP 165
Query: 74 EIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDM--HPTR-ALFQIVRNPPPGL 129
E + G Y + DVW+ GI E G P+ ++ TR A+ Q VR P P
Sbjct: 166 EALNYGR-----YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP-- 218
Query: 130 YRASNWSQHYVDFIAECLEKNPEHRPYMS 158
+ C E +P RP S
Sbjct: 219 ---ELCPDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 49/157 (31%), Positives = 69/157 (43%), Gaps = 19/157 (12%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET---ANTFDKKKTFLGSP 68
++ GM FL + IHRDL NVLLT VKI DFGL+R+ +N K L
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL-PV 207
Query: 69 SWMAPE-IMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPP 126
WMAPE I C Y DVW+ GI E+ G P+ M +++++
Sbjct: 208 KWMAPESIFNC------VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG- 260
Query: 127 PGLYRASN---WSQHYVDFIAECLEKNPEHRPYMSEL 160
YR + D + C + +P RP ++
Sbjct: 261 ---YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGL--SRETANTFDKKKTFLGSPS 69
E+ +G+++LH+ IH DL N LT D VKI D+GL + + + K
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167
Query: 70 WMAPEIMRCGHKEVDGYD--NRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN-- 124
W+APE++ +++ D + ++W+LG+T EL P+ D+ + L Q+VR
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227
Query: 125 ---PPPGLYRASNWSQHYVDFIAECLE---KNPEHRPYMSE---LLEH 163
P P L Y D E ++ +PE RP E LL +
Sbjct: 228 IKLPKPQL------DLKYSDRWYEVMQFCWLDPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA-NTFDKKKTFLGSPSW 70
++ GM ++ + IHRDLR +N+L+ KI DFGL+R N + ++ W
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN---PP 126
APE G + + DVW+ GI EL G+ P+ M+ L Q+ R P
Sbjct: 170 TAPEAALYGR-----FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 224
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRP---YMSELLE 162
P S H + + +C +K+PE RP Y+ LE
Sbjct: 225 PQ---DCPISLH--ELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-13
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA-NTFDKKKTFLGSPSW 70
+I +GM ++ + +HRDLR +N+L+ ++ K+ DFGL+R N + ++ W
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELG-DGKPPFEDMHPTRALFQIVRN---PP 126
APE G + + DVW+ GI EL G+ P+ M L Q+ R P
Sbjct: 170 TAPEAALYGR-----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 224
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRP---YMSELLEHPF 165
P + D + +C K PE RP Y+ LE F
Sbjct: 225 P-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 40/146 (27%), Positives = 78/146 (53%), Gaps = 8/146 (5%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWM 71
++ + + +H V+HRD++ +NV +T G VK+ D GL R ++ + +G+P +M
Sbjct: 114 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF--EDMHPTRALFQIVRNPPPGL 129
+PE + H+ +GY+ + D+W+LG E+ + PF + M+ +I + P L
Sbjct: 174 SPERI---HE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228
Query: 130 YRASNWSQHYVDFIAECLEKNPEHRP 155
+ ++S+ + C+ +PE RP
Sbjct: 229 -PSDHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 31/175 (17%)
Query: 4 QHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRET--ANTF 58
+ + F +++ G +L ENH IHRD+ N LLT G KI DFG++R+ A+ +
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTR 116
K + WM PE +DG + ++ DVW+ G+ E+ G P+
Sbjct: 176 RKGGRAMLPIKWMPPEAF------LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
Query: 117 ALFQIVR----NPPPG----LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ + +PP G +YR + +C + PE RP + +LE
Sbjct: 230 VMEFVTGGGRLDPPKGCPGPVYR----------IMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 26/166 (15%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+L+ I +GM +L E + +HRDL N+L+ + K+ DFGLSR ++ T G
Sbjct: 111 MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI 170
Query: 69 S--WMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRALFQI---V 122
W APE + + + DVW+ GI E + G+ P+ DM + +
Sbjct: 171 PIRWTAPEAIAYRK-----FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY 225
Query: 123 RNPPP-----GLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
R PPP LY+ + +C +K+ RP S+++
Sbjct: 226 RLPPPMDCPSALYQ----------LMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 43/214 (20%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S H+ L +I+ G+ +LH ++HRD++ N+L+ + +KI DFGL+R D+
Sbjct: 100 LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEPDE 157
Query: 61 KKTF---LGSPSWMAPEI-MRCGHKEVDGYDNRIDVWALGITAIELGDGK---------- 106
K + + + APEI M H Y + +D+W++G EL +
Sbjct: 158 SKHMTQEVVTQYYRAPEILMGSRH-----YTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
Query: 107 -----------PPFEDMHPTR--ALFQIVRNPP-----PGLYRASNWSQH-YVDFIAECL 147
P E M A I+R P P LY S+ + H V + L
Sbjct: 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRML 272
Query: 148 EKNPEHRPYMSELLEHPFITSLPENDLHLSTVNC 181
+P+ R ++ L HP+ L E L T C
Sbjct: 273 VFDPDKRISAADALAHPY---LDEGRLRYHTCMC 303
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 11/113 (9%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR----ETANT 57
SE HI +K+++ G+ + H+ + +HRD++ SN+LL G++K+ DFGL+R E +
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE 110
+ K L W P + G + Y IDVW+ G EL KP F+
Sbjct: 174 YTNKVITL----WYRPPELLLGEER---YGPAIDVWSCGCILGELFTKKPIFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 52/159 (32%), Positives = 71/159 (44%), Gaps = 17/159 (10%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPS 69
++ GM FL IHRDL N+LL+++ VKI DFGL+R+ D +K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHP----TRALFQIVRN 124
WMAPE + V Y + DVW+ G+ E+ G P+ + R L + R
Sbjct: 247 WMAPETI---FDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 125 PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P Y Q +D C P RP SEL+EH
Sbjct: 302 RAPD-YTTPEMYQTMLD----CWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 47/198 (23%), Positives = 78/198 (39%), Gaps = 37/198 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET-ANTFD 59
+ I ++K ++ G+ ++H N ++HRD++ +N+L+TKDG +K+ DFGL+R +
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175
Query: 60 KKKTFLGSPS--WM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR 116
K + W PE++ G ++ Y ID+W G E+ P +
Sbjct: 176 KPNRYTNRVVTLWYRPPELL-LGERD---YGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231
Query: 117 ALFQIVR-----NP-----------------PPGLYR-------ASNWSQHYVDFIAECL 147
L I + P P G R H +D I + L
Sbjct: 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291
Query: 148 EKNPEHRPYMSELLEHPF 165
+P R L H F
Sbjct: 292 VLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 11/167 (6%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN--TFDK 60
E + + +I+ + +H ++HRDL+ +N+ L G +K+ DFG S++ ++ + D
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+F G+P ++APE+ E Y + D+W+LG+ EL PF+ + Q
Sbjct: 228 ASSFCGTPYYLAPELW-----ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ 282
Query: 121 IVR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
++ P S+ + +D + L KNP RP +LL F+
Sbjct: 283 VLYGKYDPFPCPVSSGMKALLDPL---LSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 36/112 (32%), Positives = 59/112 (52%), Gaps = 10/112 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA---NT 57
MS ++ L +I+ G+ + H V+HRDL+ N+L+ + GE+K+ DFGL+R + T
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
+ + L W P + G E Y +ID+W +G E+ G+P F
Sbjct: 161 YSNEVVTL----WYRPPDVLLGSSE---YSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 16/156 (10%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPS 69
EI GM +L+ N +HRDL N ++ +D VKI DFG++R+ T + K L
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 70 WMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPP 127
WM+PE ++ DG + DVW+ G+ E+ + P++ M Q++R
Sbjct: 187 WMSPESLK------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRFVME 236
Query: 128 G--LYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
G L + N + + C + NP+ RP E++
Sbjct: 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET--ANTFDKKKTFLGSPS 69
+I GM +L E ++HRDL NVL+ + ++KI DFGLSR+ +++ K+
Sbjct: 135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVK 194
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPG 128
WMA E + H Y + DVW+ G+ E+ G P+ + P R LF +++
Sbjct: 195 WMAIESL-FDHI----YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LFNLLKTGYR- 247
Query: 129 LYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
+ R N S+ + + C ++ P+ RP +++
Sbjct: 248 MERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP-SW 70
+I GM F+ + IHRDLR +N+L+++ KI DFGL+R + + P W
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDM-HP--TRALFQIVRNPP 126
APE + G + + DVW+ GI E+ G+ P+ M +P + L + R P
Sbjct: 170 TAPEAINYG-----TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR 224
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRP---YMSELLE 162
P N + + + C ++ PE RP Y+ +LE
Sbjct: 225 P-----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 51/165 (30%), Positives = 75/165 (45%), Gaps = 18/165 (10%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
++Q + F L + GM +L + IHRDL N L+ ++ +KI DFG+SR+ +
Sbjct: 92 TKQLVKFAL-DAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150
Query: 62 KTFLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRALF 119
P W APE + G Y + DVW+ GI E G P+ M +A
Sbjct: 151 SGLKQIPIKWTAPEALNYGR-----YSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE 205
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAE----CLEKNPEHRPYMSEL 160
Q+ + YR S Q D + + C + PE+RP SEL
Sbjct: 206 QVEKG-----YRMSC-PQKCPDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 43/206 (20%)
Query: 4 QHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA---NTFDK 60
++ L +++ G+ + H V+HRDL+ N+L+ + GE+K+ DFGL+R + T+
Sbjct: 104 HNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF------EDMHP 114
+ L W P + G + Y +ID+W +G E+ G+P F E +H
Sbjct: 164 EVVTL----WYRPPDILLGSTD---YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH- 215
Query: 115 TRALFQIVRNPP----PGL-----YRASNWSQHY---------------VDFIAECLEKN 150
+F+I+ P PG+ +++ N+ ++ + +++ L+
Sbjct: 216 --FIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFE 273
Query: 151 PEHRPYMSELLEHPFITSLPENDLHL 176
R E ++HP+ L E L
Sbjct: 274 GRKRISAEEAMKHPYFHCLGERIHKL 299
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 40/139 (28%), Positives = 65/139 (46%), Gaps = 17/139 (12%)
Query: 4 QHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA--NTFDKK 61
++ ++ ++ GM +L + +HRDL NVLL KI DFGLS+ +++ K
Sbjct: 95 SNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154
Query: 62 KTFLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRALF 119
++ P W APE + K + +R DVW+ GIT E G+ P++ M +
Sbjct: 155 RSAGKWPLKWYAPECINF-RK----FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS 209
Query: 120 QIVRNP--------PPGLY 130
I + PP +Y
Sbjct: 210 FIEQGKRLDCPAECPPEMY 228
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 53/165 (32%), Positives = 73/165 (44%), Gaps = 37/165 (22%)
Query: 16 GMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAP 73
GM FL IHRDL N+LL+++ VKI DFGL+R+ D +K WMAP
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244
Query: 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPF------EDM-----HPTRALFQI 121
E + +V Y + DVW+ G+ E+ G P+ E+ TR
Sbjct: 245 ESI---FDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR----- 294
Query: 122 VRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+R P P +Y + +C NPE RP SEL+E
Sbjct: 295 MRAPEYATPEIYSI----------MLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 15/119 (12%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR-----ETANTFDKKKTFLG 66
+I GM +L E ++HRDL NVL+ VKI DFGL++ E + K +
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI- 175
Query: 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN 124
WMA E + Y ++ DVW+ G+T EL G P+E + P + ++
Sbjct: 176 --KWMALESILHRI-----YTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA-NTFDKKKTFLGSPSW 70
+I GM ++ + IHRDLR +N+L+ + KI DFGL+R N + ++ W
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN---PP 126
APE G + + DVW+ GI EL G+ P+ M L Q+ R P
Sbjct: 170 TAPEAALYGR-----FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC 224
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRP---YMSELLE 162
P + S H + + C +K+P+ RP Y+ LE
Sbjct: 225 P---QGCPESLH--ELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 22/172 (12%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPS 69
EI GM +L+ +HRDL N ++ D VKI DFG++R+ T + K L
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 70 WMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPP 127
WMAPE ++ DG + D+W+ G+ E+ + P++ + Q+++
Sbjct: 187 WMAPESLK------DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----QVLKFVMD 236
Query: 128 GLY--RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS 177
G Y + N + D + C + NP+ RP E++ L ++DLH S
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN------LLKDDLHPS 282
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 28/165 (16%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET---ANTFDKKKTFLGSP 68
++ GM FL + +HRDL NVLL + VKI DFGL+R+ +N K TFL
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL-PV 303
Query: 69 SWMAPEIMRCGHKEVDGYDNRI----DVWALGITAIELGD-GKPPFEDMHPTRALFQIVR 123
WMAPE + +DN DVW+ GI E+ G P+ M + ++
Sbjct: 304 KWMAPESI---------FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354
Query: 124 NPPPGLYRAS---NWSQHYVDFIAECLEKNPEHRP---YMSELLE 162
+ YR + + +Q D + +C PE RP ++S+++E
Sbjct: 355 SG----YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET---ANTFDKKKTFLGSP 68
++ GM FL + +HRDL NVL+ + VKI DFGL+R+ +N K TFL
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-PL 305
Query: 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPP 127
WMAPE + + Y DVW+ GI E+ G P+ ++ P F N
Sbjct: 306 KWMAPESIFN-----NLYTTLSDVWSFGILLWEIFTLGGTPYPEL-PMNEQFY---NAIK 356
Query: 128 GLYRAS---NWSQHYVDFIAECLEKNPEHRPYMSELL 161
YR + + S + + +C E+ E RP S+L+
Sbjct: 357 RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 16/167 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT-FD 59
+S + + +I GM L +HRDL N L++ EVK+ LS++ N+ +
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRAL 118
K + L W+APE ++ D + + DVW+ G+ E+ G+ PF + L
Sbjct: 174 KLRNALIPLRWLAPEAVQ-----EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228
Query: 119 FQI----VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
++ + P P + C NP+ RP SEL+
Sbjct: 229 NRLQAGKLELPVP-----EGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 40/199 (20%)
Query: 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET---ANTFDKK 61
++ L +++ G+ ++H+ +++HRDL+ N+L++ GE+K+ DFGL+R ++T+ +
Sbjct: 104 NVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR----A 117
L W P + G E Y +D+W +G +E+ G F M +
Sbjct: 164 VVTL----WYRPPDVLLGSTE---YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER 216
Query: 118 LFQIVRNPP----PG-------------LYRASNWSQ---------HYVDFIAECLEKNP 151
+F ++ P PG LY N Q H D ++ L+ P
Sbjct: 217 IFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFP 276
Query: 152 EHRPYMSELLEHPFITSLP 170
++R L H + + LP
Sbjct: 277 KNRLSAQAALSHEYFSDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 32/182 (17%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
++ +++ G+ FLH + V+HRDL+ N+L+T G++K+ DFGL+R +F T +
Sbjct: 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVT 172
Query: 69 SWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE---DMHPTRALFQIVRN 124
W APE++ Y +D+W++G E+ KP F D+ + ++
Sbjct: 173 LWYRAPEVLL-----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227
Query: 125 PPP-------GLYRASNWS------QHYV--------DFIAECLEKNPEHRPYMSELLEH 163
P L R + S + +V D + +CL NP R L H
Sbjct: 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287
Query: 164 PF 165
P+
Sbjct: 288 PY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 32/165 (19%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWM 71
++ M +L N+ +HRDL NVL+++D K+ DFGL++E ++T D K + W
Sbjct: 110 DVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWT 166
Query: 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNP----- 125
APE +R K+ + + DVW+ GI E+ G+ P+ + P + + V
Sbjct: 167 APEALR--EKK---FSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDA 220
Query: 126 ----PPGLYRASNWSQHYVDFIAECLEKNPEHRPY---MSELLEH 163
PP +Y D + +C + RP + E LEH
Sbjct: 221 PDGCPPVVY----------DVMKQCWHLDAATRPSFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 55/168 (32%), Positives = 73/168 (43%), Gaps = 21/168 (12%)
Query: 11 KEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTFDKKKTFLGSP 68
++I GM +LH H IHRDL NVLL D VKI DFGL++ + + + + SP
Sbjct: 114 QQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 69 S-WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL---GDGK--PP--FEDM-HPTRALF 119
W A E + KE DVW+ G+T EL D K PP FE+M P +
Sbjct: 174 VFWYAVECL----KENKFSYAS-DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM 228
Query: 120 QIVR-----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+VR L N Q + C E + RP L+
Sbjct: 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA-NTFDKKKTFLGSPSW 70
+I GM ++ + IHRDLR +NVL+++ KI DFGL+R N + ++ W
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTR---ALFQIVRNPP 126
APE + G + + DVW+ GI E+ GK P+ M + AL + R P
Sbjct: 171 TAPEAINFG-----SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP- 224
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRP---YMSELLE 162
R N D + C ++ E RP Y+ +L+
Sbjct: 225 ----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 18/163 (11%)
Query: 4 QHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKT 63
Q + F L ++ GM +L ++HRDL N+L+++DG K+ DFGL+R + D K
Sbjct: 101 QLLQFSL-DVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL 159
Query: 64 FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDM---HPTRALF 119
+ W APE ++ HK+ + ++ DVW+ G+ E+ G+ P+ M +
Sbjct: 160 PV---KWTAPEALK--HKK---FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+ R PP A + + C E P+ RP +L E
Sbjct: 212 KGYRMEPPEGCPADVYV-----LMTSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 48/193 (24%), Positives = 79/193 (40%), Gaps = 52/193 (26%)
Query: 10 LKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPS 69
L +I+ G++F H V+HRDL+ N+L+ G +K+ DFGL+R G P
Sbjct: 107 LYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA-----------FGIPV 155
Query: 70 -----------WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
+ APE++ + Y +D+W++G E+ KP F L
Sbjct: 156 RVYTHEVVTLWYRAPEVLLGSPR----YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211
Query: 119 FQIVR---NPP----PGL-----YRAS--NWSQHYV------------DFIAECLEKNPE 152
F+I R P PG+ Y+ + W + + D + + L +P
Sbjct: 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPA 271
Query: 153 HRPYMSELLEHPF 165
R + L HP+
Sbjct: 272 KRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 39/203 (19%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE + +++ +++ G+ ++H +IHRDL+ N+ + +D E+KI+DFGL+R D
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA----DA 169
Query: 61 KKTFLGSPSWM-APE-IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
+ T W APE I+ H Y+ +D+W++G E+ GK F+ L
Sbjct: 170 EMTGYVVTRWYRAPEVILNWMH-----YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 224
Query: 119 FQIVR---NPPPGLYR------ASNW-------------------SQHYVDFIAECLEKN 150
QI++ P P + A ++ S VD + + LE +
Sbjct: 225 TQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELD 284
Query: 151 PEHRPYMSELLEHPFITSLPEND 173
+ R +E LEHP+ S + D
Sbjct: 285 VDKRLTATEALEHPYFDSFRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 18/167 (10%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTF 58
+S I K++ GM +L E +HRDL N L+ ++ VKI DFGLSR +A+ +
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRA 117
+ WM PE + + Y DVWA G+ E+ G P+ M
Sbjct: 187 KASENDAIPIRWMPPESIF-----YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 118 LFQI----VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
++ + V + P N + + C K P RP + +
Sbjct: 242 IYYVRDGNVLSCP------DNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 41/181 (22%), Positives = 68/181 (37%), Gaps = 25/181 (13%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E+ I + + + + LH L + LL DG V SR
Sbjct: 14 LNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSRPD------ 67
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
P +MAPE+++ Y + D+++LGIT E D + P+ + A+ +
Sbjct: 68 -------PYFMAPEVIQGQ-----SYTEKADIYSLGITLYEALDYELPYNEERELSAILE 115
Query: 121 IVRNPPPGL--YRASN---WSQHYV--DFIAECLEKNPEHRPYMSELLEHPFITSLPEND 173
I+ N P SN S DF+ C + P+ R + L H +
Sbjct: 116 ILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLE 175
Query: 174 L 174
L
Sbjct: 176 L 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 4 QHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKT 63
+ + +I G++ LH +++RD++ NVLL G ++ D GL+ E D K
Sbjct: 95 ERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTI 151
Query: 64 F--LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
G+ +MAPEI++ +E Y +D +A+G + E+ G+ PF+D A ++
Sbjct: 152 TQRAGTNGYMAPEILK---EEP--YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206
Query: 122 VRNPPPG--LYRASNWSQHYVDFIAECLEKNPEHR 154
R + N+++ D L K PE R
Sbjct: 207 KRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 15/149 (10%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP-SW 70
++ +GM +L + IHRDL NVL+ ++ K+ DFGL+R + + P W
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKW 170
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN---PP 126
APE + + + DVW+ GI E+ G+ P+ M L Q+ + P
Sbjct: 171 TAPEAAL-----YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC 225
Query: 127 PGLYRASNWSQHYVDFIAECLEKNPEHRP 155
P + D + +C +++P+ RP
Sbjct: 226 P-----PGCPKELYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 38/203 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++ +H F L +++ + ++H +V HRDL+ N+L D ++KI DFGL+R N D
Sbjct: 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN--DT 157
Query: 61 KKT-----FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF------ 109
++ + + APE+ CG Y ID+W++G E+ GKP F
Sbjct: 158 PTAIFWTDYVATRWYRAPEL--CG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214
Query: 110 ------EDM--HPTRALFQIVRNPPPGLY-------RASNWSQHY-------VDFIAECL 147
D+ P+ VRN Y + +SQ + + + L
Sbjct: 215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLL 274
Query: 148 EKNPEHRPYMSELLEHPFITSLP 170
+P+ RP E L P+ L
Sbjct: 275 AFDPKDRPTAEEALADPYFKGLA 297
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 41/156 (26%), Positives = 78/156 (50%), Gaps = 28/156 (17%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA---NT 57
MS ++ + +++ G+ + H+ ++HRDL+ N+L+ + GE+K+ DFGL+R + T
Sbjct: 100 MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF------ED 111
+ + L W P + G E Y ID+W +G E+ G+P F E+
Sbjct: 160 YSNEVVTL----WYRPPDVLLGSTE---YSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212
Query: 112 MHPTRALFQIVRNPP----PGL-----YRASNWSQH 138
+H +F+++ P PG+ +R+ + Q+
Sbjct: 213 LH---LIFRLLGTPTEETWPGITSNEEFRSYLFPQY 245
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 47/166 (28%), Positives = 70/166 (42%), Gaps = 33/166 (19%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP--- 68
++ GM FL + IHRDL N+LLT KI DFGL+R+ N D G+
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN--DSNYVVKGNARLP 279
Query: 69 -SWMAPE-IMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN- 124
WMAPE I C Y DVW+ GI E+ G P+ M +++++
Sbjct: 280 VKWMAPESIFNC------VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG 333
Query: 125 --------PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P +Y D + C + +P RP ++++
Sbjct: 334 YRMLSPECAPSEMY----------DIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 50/184 (27%), Positives = 76/184 (41%), Gaps = 34/184 (18%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
++++ + G+ FLH N ++HRDL+ N+L+T G+VK+ DFGL+R + T +
Sbjct: 113 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR--IYSCQMALTPVVVT 170
Query: 69 SWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKP-------------------- 107
W APE++ Y +D+W++G E+ KP
Sbjct: 171 LWYRAPEVLL-----QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 225
Query: 108 PFEDMHPT-----RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P ED P R F R P P + + E L NP R L+
Sbjct: 226 PPEDDWPRDVTLPRGAFS-PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284
Query: 163 HPFI 166
HPF
Sbjct: 285 HPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 27/163 (16%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPS 69
++ GM FL IHRDL N+LL+++ VKI DFGL+R+ D +K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR----- 123
WMAPE + +V Y + DVW+ G+ E+ G P+ + Q ++
Sbjct: 242 WMAPESI---FDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 124 ----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
N P +YR + C + +P+ RP S L+E
Sbjct: 297 RAPENATPEIYR----------IMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 3/104 (2%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFG--LSRETANTFDKKKTFL 65
F L E++ + +H+ +HRD++ NVLL K+G +++ DFG L T +
Sbjct: 106 FYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-SNVAV 164
Query: 66 GSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
G+P +++PEI++ Y D W+LG+ E+ G+ PF
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 37/206 (17%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANTFD 59
+SE+H + +++ G+ ++H +V+HRDL+ +NV + T+D +KI DFGL+R +
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170
Query: 60 KKKTF---LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR 116
K L + + +P ++ + Y ID+WA G E+ GKP F H
Sbjct: 171 HKGYLSEGLVTKWYRSPRLLL----SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
Query: 117 ALFQIVRNPP--------------PGLYRASNW-------------SQHYVDFIAECLEK 149
+ I+ + P P R + +DF+ + L
Sbjct: 227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTF 286
Query: 150 NPEHRPYMSELLEHPFIT--SLPEND 173
NP R E L HP+++ S P ++
Sbjct: 287 NPMDRLTAEEALMHPYMSCYSCPFDE 312
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E+ F EI G+ LH +++RDL+ N+LL G ++I D GL+ E + +
Sbjct: 101 EERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIR 159
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE 110
+G+ +MAPE+++ + Y D W LG E+ +GK PF
Sbjct: 160 GRVGTVGYMAPEVVKN-----ERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 41/191 (21%), Positives = 77/191 (40%), Gaps = 30/191 (15%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEV-KIVDFGLSRETANTFD 59
+ + I + +++ G+ H++ V+HRDL+ N+L+ K + KI D GL R +
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ + + APE++ Y +D+W++G E+ +P F + L
Sbjct: 167 SYTHEIVTLWYRAPEVLLGSTH----YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL 222
Query: 120 QIVR---NPP----PGLYRASNW------------------SQHYVDFIAECLEKNPEHR 154
I + P PG+ + +W S +D + + L +P R
Sbjct: 223 HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKR 282
Query: 155 PYMSELLEHPF 165
L HP+
Sbjct: 283 ISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 49/164 (29%), Positives = 69/164 (42%), Gaps = 33/164 (20%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP--- 68
++ GM FL + IHRD+ NVLLT KI DFGL+R+ N D G+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN--DSNYVVKGNARLP 277
Query: 69 -SWMAPE-IMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN- 124
WMAPE I C Y + DVW+ GI E+ GK P+ + +++V+
Sbjct: 278 VKWMAPESIFDC------VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG 331
Query: 125 --------PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
PP +Y + C P RP S++
Sbjct: 332 YQMSRPDFAPPEIYS----------IMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 49/161 (30%), Positives = 68/161 (42%), Gaps = 34/161 (21%)
Query: 16 GMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK------KTFLGSP- 68
GM +L +HRDL N +L + VK+ DFGL+R+ +DK+ T P
Sbjct: 110 GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARD---IYDKEYYSVHNHTGAKLPV 166
Query: 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHP---TRALFQIVRN 124
WMA E + + + + DVW+ G+ EL G PP+ D+ T L Q R
Sbjct: 167 KWMALESL-----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL 221
Query: 125 PPP-----GLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
P LY + + C PE RP SEL
Sbjct: 222 LQPEYCPDPLY----------EVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 45/167 (26%), Positives = 69/167 (41%), Gaps = 27/167 (16%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS---RETANT 57
++E++I ++ ++ GM +L E + +HRDL NVLL KI DFGLS N
Sbjct: 92 VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTR 116
+ K W APE M +K + ++ DVW+ G+ E G+ P++ M
Sbjct: 152 YKAKTHGKWPVKWYAPECMNY-YK----FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206
Query: 117 ALFQIVRNP--------PPGLYRASNWSQHYVDFIAECLEKNPEHRP 155
I PP +Y D + C + RP
Sbjct: 207 VTQMIESGERMECPQRCPPEMY----------DLMKLCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 46/186 (24%), Positives = 84/186 (45%), Gaps = 38/186 (20%)
Query: 10 LKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA---NTFDKKKTFLG 66
L +++ G+ + H + V+HRDL+ N+L+ ++G +K+ DFGL+R T+ + L
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL- 163
Query: 67 SPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR-- 123
W APEI+ + Y +D+W++G E+ + +P F LF+I R
Sbjct: 164 ---WYRAPEILLGSRQ----YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL 216
Query: 124 NPP-----PGL------------YRASNWSQHY-------VDFIAECLEKNPEHRPYMSE 159
P PG+ + + S+ +D +++ L +P R
Sbjct: 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276
Query: 160 LLEHPF 165
L+HP+
Sbjct: 277 ALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 6/108 (5%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E F EI G+ LH+ +++RDL+ N+LL G ++I D GL+ K
Sbjct: 101 EGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIK 159
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE 110
+G+ +MAPE+++ + Y D WALG E+ G+ PF+
Sbjct: 160 GRVGTVGYMAPEVVKN-----ERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 24/161 (14%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR-----ETANTFDKKKTFLG 66
+I GM +L E ++HRDL NVL+ VKI DFGL+R ET D K +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI- 175
Query: 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIV--- 122
WMA E + H+ + ++ DVW+ G+T EL G P++ + P R + ++
Sbjct: 176 --KWMALESIL--HRR---FTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKG 227
Query: 123 -RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
R P P + + +C + E RP EL++
Sbjct: 228 ERLPQP-----PICTIDVYMIMVKCWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLT-KDGE----VKIVDFGLSRE--TANTFDKKKTF 64
++ G V+L + H IHRDL N L++ K + VKI DFGL+R+ ++ + K+
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 65 LGSPSWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIE-LGDGKPPFEDMHPTRALFQIV 122
L WMAPE + +DG + + DVW+ G+ E L G+ P+ P +++
Sbjct: 174 LLPVRWMAPESL------LDGKFTTQSDVWSFGVLMWEILTLGQQPY----PALNNQEVL 223
Query: 123 RNPPPG--LYRASNWSQHYVDFIAECLEKNPEHRP 155
++ G L + N + C ++P RP
Sbjct: 224 QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 49/186 (26%), Positives = 80/186 (43%), Gaps = 41/186 (22%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE---TANTFDKKKTFLGSP 68
+++ G+ F H ++V+HRDL+ N+L+ K+GE+K+ DFGL+R + + L
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL--- 163
Query: 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKP-------------------- 107
W P + G K Y ID+W+ G EL + G+P
Sbjct: 164 -WYRPPDVLFGAK---LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 219
Query: 108 PFEDMHPTRALFQIVRNPPPGLYRASNWSQHYV--------DFIAECLEKNPEHRPYMSE 159
P E+ P + ++ P +Y A+ + V D + L NP R E
Sbjct: 220 PTEESWP--GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277
Query: 160 LLEHPF 165
L+HP+
Sbjct: 278 ALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 6/107 (5%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
E+ F EI+ G+ LH + ++RDL+ N+LL G ++I D GL+ + + +
Sbjct: 101 EERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR 159
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
+G+ +MAPE++ Y D W LG E+ +G+ PF
Sbjct: 160 GRVGTVGYMAPEVLNN-----QRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 31/108 (28%), Positives = 59/108 (54%), Gaps = 10/108 (9%)
Query: 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA---NTFDKK 61
++ + +++ G+ ++H H++HRDL+ N+L++ GE+K+ DFGL+R + T+ +
Sbjct: 104 NVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
L W P + G + Y + +D+W G IE+ G+P F
Sbjct: 164 VVTL----WYRPPDVLLGATD---YSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 32/111 (28%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFG--LSRETANTF 58
+ E F + E++ + +H+ H +HRD++ NVLL +G +++ DFG L T
Sbjct: 99 LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
+ +G+P +++PEI++ + Y D W+LG+ E+ G+ PF
Sbjct: 159 -QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 45/206 (21%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + ++++L +++ G+ LH +IHRDL+ SN+++ D +KI+DFGL+R TA T
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TACTNFM 178
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE---------- 110
++ + + APE++ GY +D+W++G EL G F+
Sbjct: 179 MTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK 233
Query: 111 --------DMHPTRALFQIVRN-----PP-PGLYRAS---NW------------SQHYVD 141
L VRN P PG+ +W + D
Sbjct: 234 VIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293
Query: 142 FIAECLEKNPEHRPYMSELLEHPFIT 167
+++ L +P+ R + E L HP+IT
Sbjct: 294 LLSKMLVIDPDKRISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 35/111 (31%), Positives = 61/111 (54%), Gaps = 4/111 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS-RETANTFD 59
+ E+ F E++ + +H IHRD++ N+LL K G +K+ DFG + AN
Sbjct: 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNR-IDVWALGITAIELGDGKPPF 109
+ T +G+P +++PE+++ + DGY R D W++G+ E+ G PF
Sbjct: 199 RCDTAVGTPDYISPEVLK--SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 26/173 (15%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTF 58
++ + I +I +GMV+L H +HRDL N L+ D VKI DFG+SR+ T + +
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRA 117
+ WM PE + + DVW+ G+ E+ GK P+ +
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRK-----FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
Query: 118 --------LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
L Q R P +Y D + C +++P+ R + ++ E
Sbjct: 234 IECITQGRLLQRPRTCPSEVY----------DIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 29/167 (17%)
Query: 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTFDKKK 62
HIA +I GM +L +H +HRDL N L+ + VKI DFGLSR+ +A+ + +
Sbjct: 128 HIAI---QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPF-----ED---MH 113
L WM PE + G + D+W+ G+ E+ G P+ ++ M
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTES-----DIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 114 PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
+R L + P +Y + EC + P RP ++
Sbjct: 240 RSRQLLPCPEDCPARVYA----------LMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 10/108 (9%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS 67
F +I+ +L ++++RDL+ N+LL KDG +K+ DFG ++ + T G+
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGT 191
Query: 68 PSWMAPEI-MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP 114
P ++APEI + GH + D W LGI E+ G PPF P
Sbjct: 192 PEYIAPEILLNVGHGKA------ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 24/168 (14%)
Query: 4 QHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR-----ETANTF 58
Q++ +I GM +L E ++HRDL NVL+ VKI DFGL++ E
Sbjct: 109 QYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRA 117
+ K + WMA E + H+ Y ++ DVW+ G+T EL G P++ + P
Sbjct: 169 EGGKVPI---KWMALESIL--HRI---YTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 219
Query: 118 LFQIVRN----PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
+ I+ P P + + + +C + + RP EL+
Sbjct: 220 ISSILEKGERLPQPPICTIDVYM-----IMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 29/110 (26%), Positives = 58/110 (52%), Gaps = 1/110 (0%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS-RETANTFD 59
+ E F L E++ + +H+ H +HRD++ N+L+ +G +++ DFG + +
Sbjct: 99 LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
+ +G+P +++PEI++ Y D W+LG+ E+ G+ PF
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTFDKKK 62
HIA +I GM +L + +H+DL N+L+ + VKI D GLSRE +A+ + +
Sbjct: 128 HIAI---QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFE--------DMH 113
L WM PE + G D D+W+ G+ E+ G P+ +M
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDS-----DIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
Query: 114 PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
R L + PP +Y + EC ++ P RP ++
Sbjct: 240 RKRQLLPCSEDCPPRMY----------SLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 51/168 (30%), Positives = 73/168 (43%), Gaps = 23/168 (13%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTFDKKKTFLGSPS 69
+I GM +L +HRDL NVL+ + +VKI DFGL++ ET + K L SP
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 70 -WMAPE-IMRCGHKEVDGYDNRIDVWALGITAIEL-----GDGKP--PFEDM----HPTR 116
W APE +++ DVW+ G+T EL + P F M H
Sbjct: 177 FWYAPECLIQSKFYIAS------DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230
Query: 117 ALFQIVRNPPPG--LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+ ++VR G L R N + + +C E P R L+E
Sbjct: 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 31/102 (30%), Positives = 60/102 (58%), Gaps = 6/102 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + ++++L +++ G+ LH +IHRDL+ SN+++ D +KI+DFGL+R TA T
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFM 174
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL 102
++ + + APE++ GY +D+W++G E+
Sbjct: 175 MTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 33/109 (30%), Positives = 62/109 (56%), Gaps = 6/109 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + ++++L +++ G+ LH +IHRDL+ SN+++ D +KI+DFGL+R TA T
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFM 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
++ + + APE++ GY +D+W++G E+ G F
Sbjct: 182 MTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMIKGGVLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 38/118 (32%), Positives = 60/118 (50%), Gaps = 12/118 (10%)
Query: 10 LKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE---TANTFDKKKTFLG 66
L +++ G+ F H + V+HRDL+ N+L+ +G +K+ DFGL+R T+ + L
Sbjct: 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL- 164
Query: 67 SPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR 123
W APEI+ G K Y +D+W+LG E+ + F LF+I R
Sbjct: 165 ---WYRAPEIL-LGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 15/165 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S Q + ++ GM +L + IHRDL N+L+ ++ KI DFGLSR
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYV 178
Query: 61 KKTFLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRAL 118
KKT P WMA E + Y DVW+ G+ E+ G P+ M
Sbjct: 179 KKTMGRLPVRWMAIESL-----NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TC 229
Query: 119 FQIVRNPPPG--LYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
++ P G L + N D + +C + P RP +++L
Sbjct: 230 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 34/109 (31%), Positives = 60/109 (55%), Gaps = 4/109 (3%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT-FDKK 61
E+ F E++ + +H +IHRD++ N+LL K G +K+ DFG + T +
Sbjct: 141 EKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNR-IDVWALGITAIELGDGKPPF 109
T +G+P +++PE+++ + DGY R D W++G+ E+ G PF
Sbjct: 201 DTAVGTPDYISPEVLK--SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 12/108 (11%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLG----S 67
+I GM +L E+ ++HR+L N+LL D V+I DFG++ D KK F
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP--DDKKYFYSEHKTP 174
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHP 114
WMA E + G Y ++ DVW+ G+T E+ G P+ M P
Sbjct: 175 IKWMALESILFGR-----YTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK--- 61
+ I +I +GMV+L H +HRDL N L+ + VKI DFG+SR+ +T +
Sbjct: 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 62 KTFLGSPSWMAPE-IMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALF 119
+T L WM PE I+ + D+W+ G+ E+ GK P+ + T A+
Sbjct: 183 RTML-PIRWMPPESIL------YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154
I + L R + C ++ P+ R
Sbjct: 236 CITQGRE--LERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 33/112 (29%), Positives = 60/112 (53%), Gaps = 10/112 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA---NT 57
+S ++ L +++ G+ + H+ V+HRDL+ N+L+++ GE+K+ DFGL+R + T
Sbjct: 100 LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
+ + L W P + G E Y +D+W +G E+ G+P F
Sbjct: 160 YSNEVVTL----WYRPPDVLLGSTE---YSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 39/144 (27%), Positives = 63/144 (43%), Gaps = 40/144 (27%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGL---------- 50
+SE+ F + E + + +H+ IHRD++ N+LL G VK+ DFGL
Sbjct: 98 LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157
Query: 51 --------------------SRETANTFDKKK-----TFLGSPSWMAPEIMRCGHKEVDG 85
S+ A T+ K + + +G+P ++APE+ G
Sbjct: 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-----QTG 212
Query: 86 YDNRIDVWALGITAIELGDGKPPF 109
Y+ D W+LG+ E+ G PPF
Sbjct: 213 YNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 28/167 (16%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR-ETANTFDKKKTFLGSPSW 70
+I + M +L + + IHRDL N L+ ++ VK+ DFGLSR T +T+ W
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 171
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRAL------FQIVR 123
APE + + + + DVWA G+ E+ G P+ + ++ +++ R
Sbjct: 172 TAPESL-----AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER 226
Query: 124 NP--PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL---LEHPF 165
PP +Y + C + NP RP +E+ E F
Sbjct: 227 PEGCPPKVYE----------LMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 33/119 (27%), Positives = 60/119 (50%), Gaps = 8/119 (6%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWM 71
++I + + H+N ++HRD++ N+L++ + +K+ DFG +R + + T + W
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 72 -APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI--VRNPPP 127
+PE++ Y +D+W++G EL DG+P F LF I V P P
Sbjct: 168 RSPELLLGA-----PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTFDKKKTFLG 66
+L+ I GM +L E + +HRDL N+L+ + K+ DFGLSR E + + LG
Sbjct: 111 MLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 67 SP---SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPT---RALF 119
W APE + + + DVW+ GI E + G+ P+ DM A+
Sbjct: 171 GKIPIRWTAPEAI-----AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE 225
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
Q R PPP + + +C +K+ RP +++
Sbjct: 226 QDYRLPPP-----MDCPTALHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 24/159 (15%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR-----ETANTFDKKKTFLG 66
+I GM++L E ++HRDL NVL+ VKI DFGL+R E D K +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI- 175
Query: 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIV--- 122
WMA E C H + ++ DVW+ G+T EL G P++ + PTR + ++
Sbjct: 176 --KWMALE---CIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKG 227
Query: 123 -RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
R P P + + + +C + + RP EL
Sbjct: 228 ERLPQPPICTIDVYM-----VMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 15/160 (9%)
Query: 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKK 62
HIA +I +GMV+L H +HRDL N L+ + VKI DFG+SR+ +T +
Sbjct: 127 HIA---SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 63 TFLGSPSWMAPE-IMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQ 120
+ WM PE IM + DVW+ G+ E+ GK P+ + T +
Sbjct: 184 HTMLPIRWMPPESIM------YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
I + L R + D + C ++ P+ R + E+
Sbjct: 238 ITQGRV--LERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 10/157 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--F 58
+++ + I ++I GMV+L H +HRDL N L+ ++ VKI DFG+SR+ +T +
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRA 117
+ WM PE + + DVW+LG+ E+ GK P+ +
Sbjct: 177 RVGGHTMLPIRWMPPESIM-----YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154
+ I + L R + D + C ++ P R
Sbjct: 232 IECITQGRV--LQRPRTCPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTFDKKKTFLG 66
I+ +I GM FL +HV+H+DL NVL+ VKI D GL RE A+ + L
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL 102
WM+PE + G +D D+W+ G+ E+
Sbjct: 189 PIRWMSPEAIMYGKFSIDS-----DIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 15/164 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++ Q + ++ TGM +L E IHRDL NVL+ ++ KI DFGLSR
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV 173
Query: 61 KKTFLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRAL 118
KKT P WMA E + Y + DVW+ G+ E+ G P+ M
Sbjct: 174 KKTMGRLPVRWMAIESL-----NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM----TC 224
Query: 119 FQIVRNPPPG--LYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
++ P G + + N + + +C P RP +++
Sbjct: 225 AELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 40/163 (24%), Positives = 62/163 (38%), Gaps = 54/163 (33%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS---------- 51
SE F + E + + +H+ IHRD++ N+L+ + G +K+ DFGLS
Sbjct: 99 SEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158
Query: 52 --------------------------------RETANTFDKKKTFL-----GSPSWMAPE 74
++ T+ K + + G+P ++APE
Sbjct: 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE 218
Query: 75 IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF--EDMHPT 115
I GY D W+LG E G PPF E+ H T
Sbjct: 219 IF-LQQ----GYGQECDWWSLGAIMFECLIGWPPFCSENSHET 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 52/205 (25%)
Query: 6 IAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFL 65
++++L +++ G+ LH +IHRDL+ SN+++ D +KI+DFGL+R TA T +F+
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGT-----SFM 173
Query: 66 GSPS-----WMAPE-IMRCGHKE-VD-------------------GYDNRIDVWALGITA 99
+P + APE I+ G+KE VD G D ID W I
Sbjct: 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD-HIDQWNKIIE- 231
Query: 100 IELGDGKPPFED-MHPTRA----------------LFQIVRNPPPGLYRASNWSQHYVDF 142
+LG F + PT LF V PP + D
Sbjct: 232 -QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290
Query: 143 IAECLEKNPEHRPYMSELLEHPFIT 167
+++ L +PE R + + L+HP+I
Sbjct: 291 LSKMLVIDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 19/162 (11%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS----RETANTFDKKKTFLGS 67
EI G+ +H+++ +H DL N LT D VK+ D+G+ +E + K
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV--P 164
Query: 68 PSWMAPEIMRCGH-----KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQI 121
W+APE++ H E N VWALG+T EL + P+ + L +
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSN---VWALGVTLWELFENAAQPYSHLSDREVLNHV 221
Query: 122 VRNPPPGLYRASNWSQHYVDFIAECLE---KNPEHRPYMSEL 160
+++ L++ Y + E L+ +PE R E+
Sbjct: 222 IKDQQVKLFK-PQLELPYSERWYEVLQFCWLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 6/107 (5%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
EQ F E+ G+ L +++RDL+ N+LL G ++I D GL+ + + +
Sbjct: 101 EQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR 159
Query: 63 TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
+G+ +MAPE++ + Y D W LG E+ G+ PF
Sbjct: 160 GRVGTVGYMAPEVINN-----EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 37/144 (25%), Positives = 63/144 (43%), Gaps = 40/144 (27%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGL---------- 50
++E+ F + E + + +H+ IHRD++ N+LL G VK+ DFGL
Sbjct: 98 LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157
Query: 51 --------------------SRETANTFDKKK-----TFLGSPSWMAPEIMRCGHKEVDG 85
S+ A T+ + + + +G+P ++APE+ G
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-----QTG 212
Query: 86 YDNRIDVWALGITAIELGDGKPPF 109
Y+ D W+LG+ E+ G PPF
Sbjct: 213 YNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 42/162 (25%), Positives = 67/162 (41%), Gaps = 25/162 (15%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+L + +GM +L E +H+ L VL+ D KI F +E DK + +
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE-----DKSEAIYTTM 166
Query: 69 S------WMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPT---RAL 118
S W APE ++ H + + DVW+ GI E + G+ P+ DM +A+
Sbjct: 167 SGKSPVLWAAPEAIQYHH-----FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
R P P N + +C +K RP S++
Sbjct: 222 EDGFRLPAP-----RNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 32/104 (30%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLS-RETANTFDKKKTFLG 66
F E++ + +H IHRD++ N+LL K G +K+ DFG + + T +G
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 67 SPSWMAPEIMRCGHKEVDGYDNR-IDVWALGITAIELGDGKPPF 109
+P +++PE+++ + DGY R D W++G+ E+ G PF
Sbjct: 206 TPDYISPEVLKS--QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 22/159 (13%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS---- 67
+I GM +LH+ VIH+D+ N ++ ++ +VKI D LSR+ F LG
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRD---LFPMDYHCLGDNENR 181
Query: 68 P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNP 125
P WMA E + +KE Y + DVW+ G+ EL G+ P+ ++ P F++
Sbjct: 182 PVKWMALESLV--NKE---YSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYL 232
Query: 126 PPGLYRAS---NWSQHYVDFIAECLEKNPEHRPYMSELL 161
G YR + N +A C +PE RP S+L+
Sbjct: 233 KDG-YRLAQPINCPDELFAVMACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 27/165 (16%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+L+ I +GM +L + +HRDL N+L+ + K+ DFGLSR + + T G
Sbjct: 111 MLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 69 ---SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHP---TRALFQI 121
W APE + + + DVW+ GI E + G+ P+ +M +A+ +
Sbjct: 171 IPIRWTAPEAI-----AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225
Query: 122 VRNPPP-----GLYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
R P P L++ + +C +K+ RP +++
Sbjct: 226 YRLPAPMDCPAALHQ----------LMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 26/173 (15%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN-TFD 59
+ Q + + +I +GM +L IHRDL N +L ++ V + DFGLS++ N +
Sbjct: 109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168
Query: 60 KKKTFLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRA 117
++ P W+A E + V Y + DVW+ G+T E+ G+ P+ + +
Sbjct: 169 RQGRIAKMPVKWIAIESLA---DRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223
Query: 118 LFQI-----VRNPP---PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+ ++ PP GLY ++ C NP+ RP L
Sbjct: 224 YDYLRQGNRLKQPPDCLDGLY----------SLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 52/212 (24%), Positives = 80/212 (37%), Gaps = 55/212 (25%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLG- 66
F + E+ + +H+ IHRD++ N+L+ +DG +K+ DFGL T D K G
Sbjct: 105 FYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGD 164
Query: 67 ---------SPSWMAPEIMRCGHK-----------------------------EV---DG 85
S W P RCG + EV G
Sbjct: 165 HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG 224
Query: 86 YDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR-----NPPPGLYRASNWSQHYV 140
Y D W++G+ E+ G+PPF P +++ + PP + S
Sbjct: 225 YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP----QAKLSPEAS 280
Query: 141 DFIAECLEKNPEHR---PYMSELLEHPFITSL 169
D I + L + PE R E+ HPF ++
Sbjct: 281 DLIIK-LCRGPEDRLGKNGADEIKAHPFFKTI 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN-----TFDKKKTFLG 66
EI G++ LH+N+ IH DL N LLT D VKI D+GLS T D+ L
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL- 166
Query: 67 SPSWMAPEIMRCGHKEVDGYDN--RIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR 123
W+APE++ H + D +VW+LG+T EL + G P+ + + L VR
Sbjct: 167 --RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR 224
Query: 124 N-----PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
P P L S + + + C + PE RP E+
Sbjct: 225 EQQLKLPKPRL--KLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 15/164 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S Q + ++ GM +L + IHRDL N+L+ ++ KI DFGLSR
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYV 166
Query: 61 KKTFLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRAL 118
KKT P WMA E + Y DVW+ G+ E+ G P+ M
Sbjct: 167 KKTMGRLPVRWMAIESL-----NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TC 217
Query: 119 FQIVRNPPPG--LYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
++ P G L + N D + +C + P RP +++
Sbjct: 218 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 45/154 (29%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGL----------- 50
+E+ F + E I + +H+ IHRD++ N+LL G +K+ DFGL
Sbjct: 99 TEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158
Query: 51 ----------------------SRETANTFDKKKTFL-----GSPSWMAPEIMRCGHKEV 83
S+ A T+ + + L G+P ++APE+
Sbjct: 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-----Q 213
Query: 84 DGYDNRIDVWALGITAIELGDGKPPF--EDMHPT 115
GY+ D W+LG+ E+ G PPF ++ T
Sbjct: 214 TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET 247
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 39/195 (20%)
Query: 6 IAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRE---TANTFDKK 61
I L +I+ G+ + H + V+HRDL+ N+L+ + +K+ DFGL+R TF +
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
Query: 62 KTFLGSPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
L W APEI+ Y +D+W++G E+ + KP F LF+
Sbjct: 164 VVTL----WYRAPEILLGSRH----YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
Query: 121 IVR--NPP-----PGLYRASNWSQHY-------------------VDFIAECLEKNPEHR 154
I R P PG+ ++ + VD +++ L +P R
Sbjct: 216 IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKR 275
Query: 155 PYMSELLEHPFITSL 169
LEH + L
Sbjct: 276 ITARAALEHEYFKDL 290
|
Length = 294 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 28/164 (17%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-S 69
+I GM +L + IHRDL N +L +D V + DFGLS++ + ++ + P
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 70 WMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPF---EDMHPTRALFQIVR- 123
W+A E + D Y ++ DVWA G+T E+ G+ P+ E+ L R
Sbjct: 181 WIAIESL------ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL 234
Query: 124 NPPP----GLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P LY D + C +P+ RP ++L E
Sbjct: 235 KQPEDCLDELY----------DLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 9/108 (8%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+L+ I GM +L + + +HRDL N+L+ + E K+ DFGLSR + + T G
Sbjct: 112 MLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGK 171
Query: 69 ---SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDM 112
W APE + + + DVW+ GI E + G+ P+ DM
Sbjct: 172 IPIRWTAPEAI-----AYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 46/214 (21%), Positives = 77/214 (35%), Gaps = 63/214 (29%)
Query: 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK------ 61
F + E+ + +H+ IHRD++ N+L+ +DG +K+ DFGL T D K
Sbjct: 105 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164
Query: 62 -------------------------------------KTFLGSPSWMAPEIMRCGHKEVD 84
+ +G+P+++APE++
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-----LRT 219
Query: 85 GYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV------RNPPPGLYRASNWSQH 138
GY D W++G+ E+ G+PPF P +++ P S+
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQA-----KLSRE 274
Query: 139 YVDFIAECLEKNPEHR---PYMSELLEHPFITSL 169
D I L E R E+ HPF +
Sbjct: 275 ASDLILR-LCCGAEDRLGKNGADEIKAHPFFKGI 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 41/215 (19%), Positives = 79/215 (36%), Gaps = 41/215 (19%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + I + ++ + +LH +IHRD++ N+ L + + DFG + + D
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 61 KKTF--LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF------EDM 112
+ + G+ +PE++ +D Y + D+W+ G+ E+
Sbjct: 242 PQCYGWSGTLETNSPELL-----ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296
Query: 113 HPTRAL-------------------------FQIVRNPP---PGLYRASNWSQHYVDFIA 144
R++ + IV PP P + R IA
Sbjct: 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIA 356
Query: 145 ECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTV 179
+ L + E RP ++L P T P N L+++
Sbjct: 357 KMLTFDQEFRPSAQDILSLPLFTKEPINLLNITPS 391
|
Length = 392 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 34/175 (19%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTFDKKKTFLGSP- 68
+I +GM +L + +HRDL N L+ K+ +KI DFG+SR +++ + + G
Sbjct: 138 QIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ----GRAP 193
Query: 69 ---SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE---LGDGKPPFEDMHPTRALFQIV 122
WMA E + G + + DVWA G+T E L + P+E + Q++
Sbjct: 194 LPIRWMAWESVLLGK-----FTTKSDVWAFGVTLWEILTLCR-EQPYEHLTD----QQVI 243
Query: 123 RNPPPG---------LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
N L R N + + + EC ++ E RP E+ H F+
Sbjct: 244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTFDKKKTFLGSP- 68
++ T + +L +HRD+ NVL++ VK+ DFGLSR E + + K L P
Sbjct: 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PI 172
Query: 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRALFQIVR---- 123
WMAPE + + + DVW G+ E L G PF+ + + +I
Sbjct: 173 KWMAPESI-----NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL 227
Query: 124 ----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
N PP LY + +C +P RP +EL
Sbjct: 228 PMPPNCPPTLY----------SLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 64/221 (28%)
Query: 4 QHIA-FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGL------------ 50
+ +A F + E+ + +H+ IHRD++ N+L+ DG +K+ DFGL
Sbjct: 100 EVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159
Query: 51 ----------SRETANTFD------------------KKK-------TFLGSPSWMAPEI 75
S E ++ +D K+ + +G+P+++APE+
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR-----NPPPGLY 130
+ GY D W++G+ E+ G+PPF PT +++ + PP +
Sbjct: 220 LL-----RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQV- 273
Query: 131 RASNWSQHYVDFIAE--CLEKNPEHRPYMSELLEHPFITSL 169
S VD I + C + R ++ HPF + +
Sbjct: 274 ---KLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 37/145 (25%), Positives = 72/145 (49%), Gaps = 37/145 (25%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKT----- 63
I+K+++ + ++H+ +IHRD++ N+ L DG++ + DFG TA F+K++
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG----TAMPFEKEREAFDYG 327
Query: 64 FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE--------LGDGKPPFEDMHPT 115
++G+ + +PEI+ DGY D+W+ G+ ++ +GDG P
Sbjct: 328 WVGTVATNSPEIL-----AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-----KPG 377
Query: 116 RALFQIVR----------NPPPGLY 130
+ L +I+ +PP L+
Sbjct: 378 KQLLKIIDSLSVCDEEFPDPPCKLF 402
|
Length = 501 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 12/97 (12%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
I K+I+ G+ +LH +IHRD++ N+ + +V I D G ++ FLG
Sbjct: 162 IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA----FLGLA 217
Query: 69 SWM---APEIMRCGHKEVDGYDNRIDVWALGITAIEL 102
+ APE++ D Y+++ D+W+ GI E+
Sbjct: 218 GTVETNAPEVL-----ARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 16/177 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET-ANTFD 59
+S + + +I +GM +L + +HRDL N L+ ++ +KI DFG+SR A +
Sbjct: 135 ISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY 194
Query: 60 KKKTFLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD--GKPPFEDMHPTR 116
+ + P WMA E + G + DVWA G+T E+ + P+ ++ +
Sbjct: 195 RIQGRAVLPIRWMAWECILMGK-----FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
Query: 117 AL---FQIVRNPPPGLY--RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
+ + R+ +Y R Q + + +C ++ RP S++ H F+T
Sbjct: 250 VIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI--HAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN-TFDKKKTFLGS 67
I + ++ + +LHEN +IHRD++ N+ + G+V + DFG + + +K + G+
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGK 106
+ APE++ D Y +D+W+ GI E+
Sbjct: 247 IATNAPELL-----ARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 37/133 (27%), Positives = 61/133 (45%), Gaps = 28/133 (21%)
Query: 1 MSEQHIAFILKEIITGMVFLHE-------NHVIHRDLRGSNVLLTKD----GEV------ 43
+ E I I ++++ + + H V+HRDL+ N+ L+ G++
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 44 -------KIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG 96
KI DFGLS+ + +G+P + +PE++ E YD++ D+WALG
Sbjct: 175 LNGRPIAKIGDFGLSKNIG-IESMAHSCVGTPYYWSPELLL---HETKSYDDKSDMWALG 230
Query: 97 ITAIELGDGKPPF 109
EL GK PF
Sbjct: 231 CIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 19/44 (43%), Positives = 34/44 (77%)
Query: 6 IAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFG 49
I ++++++TG+ LH ++HRD++ N+L+T DG+VKI+DFG
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 22/169 (13%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET-ANTFD 59
+ Q + + +I +GM +L + IHRDL N +L ++ V + DFGLS++ + +
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY 169
Query: 60 KKKTFLGSP-SWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTR 116
++ P W+A E + D Y DVWA G+T E+ G+ P+ + +
Sbjct: 170 RQGCASKLPVKWLALESL------ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223
Query: 117 ALFQIV-----RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160
++ + PP L + + + +C P+ RP L
Sbjct: 224 IYNYLIKGNRLKQPPDCL-------EDVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 48/175 (27%), Positives = 88/175 (50%), Gaps = 26/175 (14%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-KDGEVKIVDFGLSR--ETANTF 58
SE + I+++++ + LH++++IH D++ NVL + + D+GL + T + +
Sbjct: 107 SEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY 166
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF-----EDMH 113
D G+ + +PE ++ GH YD D WA+G+ EL GK PF E++
Sbjct: 167 D------GTLDYFSPEKIK-GHN----YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215
Query: 114 PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR--PYMSELLEHPFI 166
L + + P N S++ DF+ L+ N +R Y +E+++HPF+
Sbjct: 216 LES-LLKRQQKKLP---FIKNVSKNANDFVQSMLKYNINYRLTNY-NEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 30/104 (28%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTF 58
+S ++ ++ +I +GM +L + +HRDL N L+ +KI DFG+SR + + +
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL 102
+ + WMA E + G + DVWA G+T E+
Sbjct: 186 RIQGRAVLPIRWMAWESILLGK-----FTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 20/54 (37%), Positives = 35/54 (64%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN 56
E+ + E+ + +LH + +IHRDL+ N+L++ +G +K+ DFGLS+ T N
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 34/116 (29%), Positives = 55/116 (47%), Gaps = 15/116 (12%)
Query: 65 LGSPSWMAPEIM-RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR 123
LG+P ++APE++ H +D WALG+ E G PPF D P + +FQ +
Sbjct: 541 LGTPDYLAPELLLGKPH------GPAVDWWALGVCLFEFLTGIPPFNDETPQQ-VFQNIL 593
Query: 124 NP----PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLH 175
N P G + S +Q+ ++ + L +P R + EL +HP + +L
Sbjct: 594 NRDIPWPEGEEKLSVNAQNAIEIL---LTMDPTKRAGLKELKQHPLFHGVDWENLQ 646
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKD----GEVKIVDFGLSR---ETANTFDKK 61
+L +I+ G+ +LH N V+HRDL+ +N+L+ + G VKI D G +R
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
+ + + APE++ Y ID+WA+G EL +P F
Sbjct: 173 DPVVVTFWYRAPELLLGARH----YTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKD----GEVKIVDFGLSR---ETANTFDKK 61
+L +I+ G+ +LH N V+HRDL+ +N+L+ + G VKI D G +R
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
+ + + APE++ Y ID+WA+G EL +P F
Sbjct: 173 DPVVVTFWYRAPELLLGARH----YTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 48/198 (24%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E+ + + +++ + +H N + HRD++ N+L+ KD +K+ DFG + K
Sbjct: 98 PEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI-KDDILKLADFG----SCRGIYSK 152
Query: 62 KTFLG--SPSWM-APE-IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP-TR 116
+ S W APE ++ G+ Y ++D+WA+G E+ P F P T
Sbjct: 153 PPYTEYISTRWYRAPECLLTDGY-----YGPKMDIWAVGCVFFEILSLFPLF----PGTN 203
Query: 117 ALFQIVR------NPPPGL------YRASNW-----------------SQHYVDFIAECL 147
L QI + P + R N+ S +D + + L
Sbjct: 204 ELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLL 263
Query: 148 EKNPEHRPYMSELLEHPF 165
+P+ R + L HP+
Sbjct: 264 AYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 50/182 (27%), Positives = 70/182 (38%), Gaps = 54/182 (29%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPS-- 69
+I GM +L +HRDL N+L+ + VKI DFGL++ DK+ + P
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ--DKEYYKVREPGES 173
Query: 70 ---WMAPEIMRCGHKEVDGYDNRI----DVWALGITAIEL-----GDGKPPFEDMH---P 114
W APE + +++ DVW+ G+ EL PP E M
Sbjct: 174 PIFWYAPESLT---------ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN 224
Query: 115 TRALFQIV-----------RNP-PPG----LYRASNWSQHYVDFIAECLEKNPEHRPYMS 158
+ IV R P PPG +Y + EC +P RP S
Sbjct: 225 DKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYA----------IMKECWNNDPSQRPSFS 274
Query: 159 EL 160
EL
Sbjct: 275 EL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 31/156 (19%), Positives = 69/156 (44%), Gaps = 21/156 (13%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE-------VKIVDFGLSRETANTFDKK 61
+ K++ + + +L + ++H ++ G N+L+ + G +K+ D G+ ++
Sbjct: 106 VAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI---TVLSRE 162
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRAL-F 119
+ P W+APE +R G + D W+ G T +E+ +G+ P + + F
Sbjct: 163 ERVERIP-WIAPECIRNGQASLTIA---ADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155
++ P + ++ + I +C +P RP
Sbjct: 219 YQDQHRLPMP----DCAE-LANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 7/104 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTF 58
+S + F+ +I +GM +L + +HRDL N L+ K+ +KI DFG+SR + + +
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL 102
+ + WM+ E + G + DVWA G+T E+
Sbjct: 187 RIQGRAVLPIRWMSWESILLGK-----FTTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 19/79 (24%), Positives = 40/79 (50%), Gaps = 10/79 (12%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG---EVKIVDFGLSRETANTFDKKKT-- 63
++ +++ + H ++HRDL+ N+++++ G K++DFG+ D
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 64 -----FLGSPSWMAPEIMR 77
LG+P++ APE +R
Sbjct: 144 TRTTEVLGTPTYCAPEQLR 162
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 29/107 (27%), Positives = 49/107 (45%), Gaps = 23/107 (21%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--------ETANTFDK 60
I +I + ++H V+HRDL+ N+LL GEV I+D+G + D+
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 61 KKTF----------LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGI 97
+ +G+P +MAPE + G + D++ALG+
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLL-GVPASE----STDIYALGV 219
|
Length = 932 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 17/46 (36%), Positives = 29/46 (63%), Gaps = 5/46 (10%)
Query: 9 ILKEI--ITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52
+ +EI + G LH +IH DL SN++L+ G++ ++DFGL+
Sbjct: 100 LSREIGRLVGK--LHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 36/157 (22%), Positives = 65/157 (41%), Gaps = 23/157 (14%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE--------VKIVDFGLSRETANTFDK 60
+ K++ + FL + + H ++ NVLL ++ + +K+ D G+S T
Sbjct: 105 VAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLP 160
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRAL- 118
K+ L W+ PE + D W+ G T E+ G P + + L
Sbjct: 161 KEILLERIPWVPPECIE----NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155
F R+ P A W++ + I +C++ P+ RP
Sbjct: 217 FYEDRHQLP----APKWTE-LANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 28/113 (24%), Positives = 54/113 (47%), Gaps = 6/113 (5%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGE-VKIVDFGLSRETANTFDKKKTFLGSPSW 70
++ + ++H + HRDL+ N+L+ + +K+ DFG ++ + +++ S +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG-QRSVSYICSRFY 236
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR 123
APE+M Y ID+W+LG E+ G P F L +I++
Sbjct: 237 RAPELMLGA----TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
|
Length = 440 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 37/169 (21%), Positives = 70/169 (41%), Gaps = 36/169 (21%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE-------VKIVDFG-----LSRETAN 56
+ +++ + + +L + +++H ++ N+LL + G +K+ D G LSRE
Sbjct: 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER- 180
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELG-DGKPPFEDMHPT 115
+ W+APE + + D W+ G T +E+ DG+ P ++ P+
Sbjct: 181 --------VERIPWIAPECVP----GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228
Query: 116 ---RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
R + R P P + I++CL P RP +L
Sbjct: 229 EKERFYEKKHRLPEPS-------CKELATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 41/162 (25%), Positives = 63/162 (38%), Gaps = 26/162 (16%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWM 71
E++ + LH ++ RDL +N+LL G +++ F E ++ D +
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE---------- 142
Query: 72 APEIMRCGHKEVDGYDNRI---DVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG 128
A E M C EV G D W+LG EL GK E HP+ N P
Sbjct: 143 AVENMYCA-PEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEW 200
Query: 129 LYRASNWSQHYVDFIAECLEKNPEHRPYM-----SELLEHPF 165
+ S+ + + L+ NP R ++ HPF
Sbjct: 201 V------SEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.004
Identities = 14/41 (34%), Positives = 23/41 (56%), Gaps = 1/41 (2%)
Query: 20 LHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
LH+ ++H DL SN++L+ + +DFGL + DK
Sbjct: 108 LHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVEDK 147
|
Length = 204 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 488 | |||
| COG5022 | 1463 | Myosin heavy chain [Cytoskeleton] | 100.0 | |
| KOG0164|consensus | 1001 | 100.0 | ||
| PTZ00014 | 821 | myosin-A; Provisional | 100.0 | |
| KOG0162|consensus | 1106 | 100.0 | ||
| cd01381 | 671 | MYSc_type_VII Myosin motor domain, type VII myosin | 100.0 | |
| cd01377 | 693 | MYSc_type_II Myosin motor domain, type II myosins. | 100.0 | |
| cd01380 | 691 | MYSc_type_V Myosin motor domain, type V myosins. M | 100.0 | |
| cd01385 | 692 | MYSc_type_IX Myosin motor domain, type IX myosins. | 100.0 | |
| cd01383 | 677 | MYSc_type_VIII Myosin motor domain, plant-specific | 100.0 | |
| cd01378 | 674 | MYSc_type_I Myosin motor domain, type I myosins. M | 100.0 | |
| cd01384 | 674 | MYSc_type_XI Myosin motor domain, plant-specific t | 100.0 | |
| cd01386 | 767 | MYSc_type_XVIII Myosin motor domain, type XVIII my | 100.0 | |
| cd01387 | 677 | MYSc_type_XV Myosin motor domain, type XV myosins. | 100.0 | |
| cd01382 | 717 | MYSc_type_VI Myosin motor domain, type VI myosins. | 100.0 | |
| cd01379 | 653 | MYSc_type_III Myosin motor domain, type III myosin | 100.0 | |
| cd00124 | 679 | MYSc Myosin motor domain. This catalytic (head) do | 100.0 | |
| smart00242 | 677 | MYSc Myosin. Large ATPases. ATPase; molecular moto | 100.0 | |
| KOG0163|consensus | 1259 | 100.0 | ||
| PF00063 | 689 | Myosin_head: Myosin head (motor domain); InterPro: | 100.0 | |
| KOG0161|consensus | 1930 | 100.0 | ||
| KOG0160|consensus | 862 | 100.0 | ||
| KOG4229|consensus | 1062 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0579|consensus | 1187 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0604|consensus | 400 | 99.98 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0594|consensus | 323 | 99.98 | ||
| KOG0663|consensus | 419 | 99.98 | ||
| KOG0660|consensus | 359 | 99.97 | ||
| KOG0696|consensus | 683 | 99.97 | ||
| KOG0201|consensus | 467 | 99.97 | ||
| KOG0591|consensus | 375 | 99.97 | ||
| KOG0600|consensus | 560 | 99.97 | ||
| KOG0610|consensus | 459 | 99.97 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| KOG0597|consensus | 808 | 99.97 | ||
| KOG0986|consensus | 591 | 99.97 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| KOG0658|consensus | 364 | 99.97 | ||
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0585|consensus | 576 | 99.97 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0614|consensus | 732 | 99.97 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| KOG0695|consensus | 593 | 99.97 | ||
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| KOG4717|consensus | 864 | 99.97 | ||
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| KOG0612|consensus | 1317 | 99.97 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| KOG0032|consensus | 382 | 99.97 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0983|consensus | 391 | 99.97 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0595|consensus | 429 | 99.97 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| KOG0574|consensus | 502 | 99.96 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0580|consensus | 281 | 99.96 | ||
| KOG0603|consensus | 612 | 99.96 | ||
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| KOG0589|consensus | 426 | 99.96 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0596|consensus | 677 | 99.96 | ||
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| KOG0611|consensus | 668 | 99.96 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| KOG0577|consensus | 948 | 99.96 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| KOG0192|consensus | 362 | 99.96 | ||
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4279|consensus | 1226 | 99.96 | ||
| KOG0667|consensus | 586 | 99.95 | ||
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| KOG0587|consensus | 953 | 99.95 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| KOG0608|consensus | 1034 | 99.95 | ||
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| KOG0607|consensus | 463 | 99.95 | ||
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0671|consensus | 415 | 99.95 | ||
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.94 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0665|consensus | 369 | 99.94 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.94 | |
| KOG0584|consensus | 632 | 99.94 | ||
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| KOG0662|consensus | 292 | 99.94 | ||
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG4721|consensus | 904 | 99.94 | ||
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| KOG4645|consensus | 1509 | 99.94 | ||
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0666|consensus | 438 | 99.94 | ||
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.94 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0669|consensus | 376 | 99.94 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.93 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.93 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.93 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG1006|consensus | 361 | 99.93 | ||
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| KOG0197|consensus | 468 | 99.93 | ||
| KOG2345|consensus | 302 | 99.93 | ||
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.93 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0193|consensus | 678 | 99.93 | ||
| KOG1989|consensus | 738 | 99.93 | ||
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.93 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.93 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.93 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.93 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG4236|consensus | 888 | 99.93 | ||
| KOG0586|consensus | 596 | 99.93 | ||
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.93 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.93 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.93 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.93 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.92 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.92 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.92 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.92 | |
| KOG1035|consensus | 1351 | 99.92 | ||
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.92 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.92 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.92 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.92 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.92 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.92 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| KOG0668|consensus | 338 | 99.91 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.91 | |
| KOG1027|consensus | 903 | 99.91 | ||
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.91 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.91 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.91 | |
| KOG0664|consensus | 449 | 99.91 | ||
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.9 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.9 | |
| KOG0670|consensus | 752 | 99.9 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG1026|consensus | 774 | 99.89 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.89 | |
| KOG0984|consensus | 282 | 99.89 | ||
| KOG1151|consensus | 775 | 99.89 | ||
| KOG1095|consensus | 1025 | 99.88 | ||
| KOG0194|consensus | 474 | 99.86 | ||
| KOG4257|consensus | 974 | 99.86 | ||
| KOG0576|consensus | 829 | 99.85 | ||
| KOG1187|consensus | 361 | 99.85 | ||
| KOG4250|consensus | 732 | 99.84 | ||
| KOG0199|consensus | 1039 | 99.84 | ||
| KOG0200|consensus | 609 | 99.83 | ||
| KOG1167|consensus | 418 | 99.83 | ||
| KOG0590|consensus | 601 | 99.83 | ||
| KOG1290|consensus | 590 | 99.82 | ||
| KOG0606|consensus | 1205 | 99.82 | ||
| KOG1024|consensus | 563 | 99.82 | ||
| KOG1345|consensus | 378 | 99.81 | ||
| KOG0196|consensus | 996 | 99.81 | ||
| KOG4278|consensus | 1157 | 99.8 | ||
| KOG1094|consensus | 807 | 99.8 | ||
| KOG0603|consensus | 612 | 99.79 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.78 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.77 | |
| KOG1025|consensus | 1177 | 99.76 | ||
| KOG1152|consensus | 772 | 99.75 | ||
| KOG3653|consensus | 534 | 99.73 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| KOG2052|consensus | 513 | 99.69 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.67 | |
| KOG1240|consensus | 1431 | 99.66 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.66 | |
| KOG4158|consensus | 598 | 99.64 | ||
| KOG1033|consensus | 516 | 99.59 | ||
| KOG1164|consensus | 322 | 99.57 | ||
| KOG1165|consensus | 449 | 99.4 | ||
| KOG1163|consensus | 341 | 99.38 | ||
| KOG1023|consensus | 484 | 99.38 | ||
| KOG0590|consensus | 601 | 99.37 | ||
| KOG0606|consensus | 1205 | 99.3 | ||
| KOG0195|consensus | 448 | 99.29 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.27 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.21 | |
| KOG2137|consensus | 700 | 99.11 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.07 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.03 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.02 | |
| KOG1166|consensus | 974 | 99.0 | ||
| KOG1266|consensus | 458 | 98.93 | ||
| KOG0601|consensus | 524 | 98.87 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 98.74 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.61 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.6 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.54 | |
| cd01363 | 186 | Motor_domain Myosin and Kinesin motor domain. Thes | 98.45 | |
| KOG1243|consensus | 690 | 98.43 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.39 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.37 | |
| KOG0601|consensus | 524 | 98.34 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.26 | |
| KOG0027|consensus | 151 | 98.1 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.04 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.0 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.81 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.8 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.76 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.63 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.58 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 97.47 | |
| KOG3087|consensus | 229 | 97.47 | ||
| KOG3741|consensus | 655 | 97.43 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 97.08 | |
| KOG1035|consensus | 1351 | 97.06 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.05 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 97.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.95 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 96.66 | |
| KOG0576|consensus | 829 | 96.63 | ||
| cd05023 | 89 | S-100A11 S-100A11: S-100A11 domain found in protei | 96.4 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.37 | |
| PF00036 | 29 | EF-hand_1: EF hand; InterPro: IPR018248 Many calci | 96.32 | |
| KOG0044|consensus | 193 | 96.13 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 95.92 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 95.83 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 95.73 | |
| PTZ00183 | 158 | centrin; Provisional | 95.69 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 95.62 | |
| PTZ00184 | 149 | calmodulin; Provisional | 95.55 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 95.53 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 95.48 | |
| KOG0028|consensus | 172 | 95.3 | ||
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 95.23 | |
| KOG1826|consensus | 2724 | 95.22 | ||
| KOG0034|consensus | 187 | 95.05 | ||
| KOG0027|consensus | 151 | 95.0 |
| >COG5022 Myosin heavy chain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-85 Score=704.76 Aligned_cols=287 Identities=29% Similarity=0.475 Sum_probs=273.8
Q ss_pred hhhhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHH
Q psy9090 190 TMHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQ 269 (488)
Q Consensus 190 ~~~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~ 269 (488)
...++|+..|..+++++|+++|++||....||||.|-++++|||+.+++||..+.+..|.++.+.+.+||+|+||+.+|+
T Consensus 65 ~~~vdDLt~LSyLNEpsVl~nL~kRY~n~~IYTYSGlvLIAvNPy~~L~iYt~d~i~~Y~~K~r~el~PHvfAIAe~aY~ 144 (1463)
T COG5022 65 FDGVDDLTELSYLNEPAVLHNLEKRYNNGQIYTYSGLVLIAVNPYRDLGIYTDDIIQSYSGKNRLELEPHVFAIAEEAYR 144 (1463)
T ss_pred ccCchhhhhhhccCcHHHHHHHHHHhhcCceeEEeeeEEEEecCcccCCCccHHHHHHhccCccccCCchHHHHHHHHHH
Confidence 45789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCc----hhhhHhhhcchhhhhhhccccCCCCCCCccceeEEE
Q psy9090 270 DMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAA----KVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQV 345 (488)
Q Consensus 270 ~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~----~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~ 345 (488)
.|.+.+++|+|||||||||||||++|.||+|++..+++.. +++++|++.||||||||||||+|||||||||||++|
T Consensus 145 ~lls~~eNQtIiISGESGAGKTe~aK~ImqYlasv~~s~~~~~~~iE~~ILaTNPILEAFGNAkTvRNdNSSRFGKyikI 224 (1463)
T COG5022 145 NLLSEKENQTIIISGESGAGKTENAKRIMQYLASVTSSSTVEISSIEKQILATNPILEAFGNAKTVRNDNSSRFGKYIKI 224 (1463)
T ss_pred HHHhcCCCceEEEecCCCCCchHHHHHHHHHHHHhccCCcchHHHHHHHHHhcchHHHHhccccccccCCcccccceEEE
Confidence 9999999999999999999999999999999999987755 899999999999999999999999999999999999
Q ss_pred EECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCC
Q psy9090 346 TFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRET 425 (488)
Q Consensus 346 ~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~ 425 (488)
.||..|.|+||+|++|||||||||+ |..+|||||||||||+| +++..++.+++..|.+|.||+++.+ ...+
T Consensus 225 ~Fd~~g~I~GA~I~~YLLEKSRVV~-Q~~~ERNYHIFYQll~G-~~~~~k~~~~~~~~~dY~Yl~~~~~-------~~I~ 295 (1463)
T COG5022 225 EFDENGEICGAKIETYLLEKSRVVH-QNKNERNYHIFYQLLAG-DPEELKKLLLLQNPKDYIYLSQGGC-------DKID 295 (1463)
T ss_pred EECCCCceechhhhhhhhhhhhhcc-CCCCccchhhhhhHhcC-ChHHHHHHhhccChHhhHhHhhcCC-------CcCC
Confidence 9999999999999999999999995 99999999999999999 4556777788899999999998743 4578
Q ss_pred CCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCcccccCChhhhc
Q psy9090 426 PDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAA 485 (488)
Q Consensus 426 ~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~~~~~~~~ 485 (488)
++||+++|+.|+.||++|||+++++..||+|||||||||||+|.++.+|++.+.++++++
T Consensus 296 gIdD~kefk~t~~AlktiGi~~eeq~~IF~iLAaILhiGNIef~~~r~g~a~~~~~~~~~ 355 (1463)
T COG5022 296 GIDDAKEFKITLDALKTIGIDEEEQDQIFKILAAILHIGNIEFKEDRNGAAIFSDNSVLD 355 (1463)
T ss_pred CcccHHHHHHHHHHHHHhCCChHHHHHHHHHHHHHHhhcceeeeecccchhhcCCchHHH
Confidence 999999999999999999999999999999999999999999999889999999988776
|
|
| >KOG0164|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-82 Score=634.35 Aligned_cols=275 Identities=31% Similarity=0.516 Sum_probs=255.8
Q ss_pred hhhhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHH
Q psy9090 190 TMHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQ 269 (488)
Q Consensus 190 ~~~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~ 269 (488)
...++|+..++++++++++++|+.||..+.||||+|+++++|||+..++||+++++..|.++...+.+||+|+|||.||+
T Consensus 7 ~~Gv~DfVLle~~~~~~f~~NLrlRf~~g~IYTyIGeV~VsvNPYrql~IYg~~ti~kYkgre~yE~~PHlfAiad~aYr 86 (1001)
T KOG0164|consen 7 EVGVQDFVLLETVSEESFMENLRLRFENGRIYTYIGEVLVSVNPYRQLNIYGPETIEKYKGREFYERPPHLFAIADAAYR 86 (1001)
T ss_pred ccCceeeEeeccccHHHHHHHHHHHHhcCceEEEEccEEEEecchhhcCccCHHHHHHhCCeeecccCchHHHhHHHHHH
Confidence 34788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcC----CC-chhhhHhhhcchhhhhhhccccCCCCCCCccceeEE
Q psy9090 270 DMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQ----GA-AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQ 344 (488)
Q Consensus 270 ~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~----g~-~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~ 344 (488)
.|.+..++|||+|||||||||||++|.||+|++.... |. -.+.+.++++|++|||||||||.||||||||||||.
T Consensus 87 slk~r~rDtcI~ISGESGAGKTEASK~iMqYiAAvtn~~qq~eierVKn~LLqSN~VLEAFGNAKT~RNdNSSRFGKYMD 166 (1001)
T KOG0164|consen 87 SLKRRSRDTCILISGESGAGKTEASKIIMQYIAAVTNASQQGEIERVKNVLLQSNCVLEAFGNAKTNRNDNSSRFGKYMD 166 (1001)
T ss_pred HHHhccCCeEEEEecCCCCCccHHHHHHHHHHHHhcCccccchHHHHHHHHHhcchHHHHhcccccccCCchhhhhccee
Confidence 9999999999999999999999999999999998753 22 368899999999999999999999999999999999
Q ss_pred EEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccC-CCCCCCcccccCccCCCCCCCCC
Q psy9090 345 VTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFL-SPGRKYRYLRADVTDDKLPKGPR 423 (488)
Q Consensus 345 ~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l-~~~~~~~yl~~~~~~~~~~~~~~ 423 (488)
|+||.+|.++||+|++|||||||||. |.+|||||||||||+.|+++. +...++| .++..|.||+++.. .
T Consensus 167 InFDfKGdPvGG~I~nYLLEKSRVv~-Q~~GERNFH~FYQLL~G~~e~-~Lr~l~Ler~~~~Y~ylnqg~~--------~ 236 (1001)
T KOG0164|consen 167 INFDFKGDPVGGHITNYLLEKSRVVK-QQPGERNFHIFYQLLRGGEEQ-LLRQLGLERNPQSYNYLNQGSA--------K 236 (1001)
T ss_pred eeccccCCcccchHhHHHHhhhhhhh-cCcCcchHHHHHHHHcCCcHH-HHHHhccccCcchhhhhhhhhh--------h
Confidence 99999999999999999999999995 999999999999999999775 4555666 58999999998732 2
Q ss_pred CCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCc
Q psy9090 424 ETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAEN 474 (488)
Q Consensus 424 ~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~ 474 (488)
+++++|+.+|+.|+.||++|||+++|++.+++|+|||||||||+|....+.
T Consensus 237 v~sinD~~dfk~V~~Am~vIgFs~eEVe~v~~iiAavLhLGNv~f~~~ed~ 287 (1001)
T KOG0164|consen 237 VSSINDASDFKAVQKAMRVIGFSEEEVESVLSIIAAVLHLGNVEFADNEDS 287 (1001)
T ss_pred hcccccHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhccceEEeecCcc
Confidence 577889999999999999999999999999999999999999999765433
|
|
| >PTZ00014 myosin-A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-80 Score=668.27 Aligned_cols=281 Identities=24% Similarity=0.388 Sum_probs=260.3
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCC-CCCCCChhhHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFK-SRSDNEPHIYAVADSAYQD 270 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~-~~~~~~ph~f~~~d~~~~~ 270 (488)
.++|+..+..++++.++++|+.||..+.+|||+|+++++|||++.+++|.++++..|.+. ...+.|||+|+|||.||+.
T Consensus 97 ~~~Dl~~L~~lnE~~vL~nL~~Ry~~~~IYTy~G~iLIavNPyk~l~~y~~~~~~~Y~~~~~~~~lpPHifavA~~Ay~~ 176 (821)
T PTZ00014 97 TYGDIGLLPHTNIPCVLDFLKHRYLKNQIYTTADPLLVAINPFKDLGNTTNDWIRRYRDAKDSDKLPPHVFTTARRALEN 176 (821)
T ss_pred CcchhhhCCCCCHHHHHHHHHHHHcCCCCeeeECCEEEEECCCCCCCCCcHHHHHHHhCCCCcCCCCCCHHHHHHHHHHH
Confidence 468999999999999999999999999999999999999999999999999999999875 5678899999999999999
Q ss_pred HHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC--chhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEEC
Q psy9090 271 MMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA--AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFG 348 (488)
Q Consensus 271 ~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~--~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~ 348 (488)
|...+++|+|||||||||||||++|.||+|++..+.|. .++++.|+++||+|||||||||+|||||||||||++|+|+
T Consensus 177 m~~~~~~QsIiiSGESGAGKTe~tK~im~yla~~~~~~~~~~ie~~Il~sNpiLEAFGNAKT~rNdNSSRFGKfi~i~F~ 256 (821)
T PTZ00014 177 LHGVKKSQTIIVSGESGAGKTEATKQIMRYFASSKSGNMDLKIQNAIMAANPVLEAFGNAKTIRNNNSSRFGRFMQLQLG 256 (821)
T ss_pred HHhcCCCceEEEEcCCCCCchHHHHHHHHHHHHhccCCCcccHHHHHHHHHHHHHHhhccCcCCCCCcCcceeEEEEEEc
Confidence 99999999999999999999999999999999887664 4699999999999999999999999999999999999999
Q ss_pred CCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCc
Q psy9090 349 SSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDT 428 (488)
Q Consensus 349 ~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~ 428 (488)
..|.|.||+|.+|||||||||+ |.+||||||||||||+|+++ +++++++|.++..|+||+++ +...++.|
T Consensus 257 ~~g~i~Ga~I~~YLLEKSRVv~-q~~gERNfHIFYqLl~G~~~-~~~~~l~L~~~~~y~yL~~~--------~~~~~~~d 326 (821)
T PTZ00014 257 EEGGIRYGSIVAFLLEKSRVVT-QEDDERSYHIFYQLLKGAND-EMKEKYKLKSLEEYKYINPK--------CLDVPGID 326 (821)
T ss_pred CCCcEeeEEEEEEeccCceeee-cCCCCCCEeHHHHHHhCCCH-HHHHHcCCCChHhccccCCC--------CccCCCCc
Confidence 9999999999999999999995 99999999999999999976 56788999999999999854 23357889
Q ss_pred cHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC----CcccccCChh
Q psy9090 429 NVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA----ENTAELANPE 482 (488)
Q Consensus 429 d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~----~~~~~~~~~~ 482 (488)
|+++|++|++||+.|||+++|++.||+|||||||||||+|++.+ ++.+.+.+.+
T Consensus 327 D~~~f~~~~~A~~~lg~s~~e~~~If~ilaaILhLGNi~F~~~~~~~~~~~~~i~~~~ 384 (821)
T PTZ00014 327 DVKDFEEVMESFDSMGLSESQIEDIFSILSGVLLLGNVEIEGKEEGGLTDAAAISDES 384 (821)
T ss_pred hHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcceeEeccccCCCCCceeccCCC
Confidence 99999999999999999999999999999999999999998653 3456665543
|
|
| >KOG0162|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-80 Score=620.71 Aligned_cols=289 Identities=27% Similarity=0.420 Sum_probs=274.3
Q ss_pred hhhhhhhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHH
Q psy9090 187 ELQTMHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADS 266 (488)
Q Consensus 187 ~~~~~~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~ 266 (488)
+.+...++||..|.+++++++.++|++|+....+|||+|.++++|||++.+++|.+..+..|.++.+.+.|||+|++||+
T Consensus 14 ~~k~vGVdDm~LLsKiteesI~eNLkkRf~n~~IfTYIG~VLISVNPFk~m~~ft~~~~~~YqG~~q~E~pPHiyAladn 93 (1106)
T KOG0162|consen 14 KKKHVGVDDMVLLSKITEESINENLKKRFMNGYIFTYIGHVLISVNPFKQMPYFTEKEMELYQGAAQYENPPHIYALADN 93 (1106)
T ss_pred cceeccccceeehhhccHHHHHHHHHHHhhcCceEEEeeeEEEeecchhccccchHHHHHHhhchhhccCCchhhhhHHH
Confidence 35566899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCc---hhhhHhhhcchhhhhhhccccCCCCCCCccceeE
Q psy9090 267 AYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAA---KVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYM 343 (488)
Q Consensus 267 ~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~---~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~ 343 (488)
.|+.|+..+|+|||+||||||||||+++|.||+|++..+.|.- .+.+.|+++||+|||||||||+||+||||||||+
T Consensus 94 mY~nM~~~~EnQCVIISGESGAGKT~aAK~IM~YIs~vS~~g~kvq~vkdiiL~sNPLLEaFG~akTvRNnNSSR~GKY~ 173 (1106)
T KOG0162|consen 94 MYRNMKIDNENQCVIISGESGAGKTVAAKRIMQYISRVSGGGEKVQHVKDIILQSNPLLEAFGNAKTVRNNNSSRFGKYL 173 (1106)
T ss_pred HHHHhhhccccceEEEecCCCCCchHHHHHHHHHHHHhccCCcchhhhhhHhhccchHHHHhcchhhhccCCcccccceE
Confidence 9999999999999999999999999999999999999986643 5789999999999999999999999999999999
Q ss_pred EEEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCC
Q psy9090 344 QVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPR 423 (488)
Q Consensus 344 ~~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~ 423 (488)
+|+|+..|.++||+|++|||||||||. |.++||||||||||++|++. +.+..+++..|+.|.||+.++| ..
T Consensus 174 Ei~Fs~ggeP~ggkisNfLLEKsRVV~-q~~neRnFHIfYQ~~kgAs~-~~r~t~Gi~~pe~Y~Y~~~sg~-------~s 244 (1106)
T KOG0162|consen 174 EIQFSRGGEPDGGKISNFLLEKSRVVM-QNENERNFHIFYQLTKGASQ-EYRQTFGIQEPEYYVYLNASGC-------YS 244 (1106)
T ss_pred EEEecCCCCcCcchhhHHHHhhhhhhh-ccCCccceeeehhhhcCccH-HHHhhhCcCCchheeeeccccc-------ee
Confidence 999999999999999999999999996 99999999999999999976 6688899999999999998754 34
Q ss_pred CCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCcccccCChhhhc
Q psy9090 424 ETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAA 485 (488)
Q Consensus 424 ~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~~~~~~~~ 485 (488)
.++.||.++|++|.+||++||+.++|++.||++||+|||||||.|.+ +++.+.+.+.++++
T Consensus 245 ~D~idd~kdfq~Tl~AM~vIGi~~~eQ~~v~rmva~IL~lGNIsF~E-e~~~a~V~~~~~~~ 305 (1106)
T KOG0162|consen 245 VDDIDDRKDFQETLHAMKVIGINQEEQDEVLRMVAGILHLGNISFIE-EGNYAAVSDKSVLE 305 (1106)
T ss_pred ccccchHHHHHHHHHHheeccCChHHHHHHHHHHHHHHhccceeEEe-eCCcceeccchHHH
Confidence 78899999999999999999999999999999999999999999988 78889999988876
|
|
| >cd01381 MYSc_type_VII Myosin motor domain, type VII myosins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-79 Score=648.89 Aligned_cols=284 Identities=30% Similarity=0.452 Sum_probs=266.3
Q ss_pred hhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q psy9090 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMM 272 (488)
Q Consensus 193 v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~ 272 (488)
++|+..+..++|+.++++|+.||..+.+||++|+++++|||++.+++|.++.+..|.++.....|||+|++|++||+.|.
T Consensus 2 v~Dl~~L~~l~E~~vl~~L~~Ry~~~~iYT~~G~iLiavNP~k~l~~y~~~~~~~y~~~~~~~~~PHifavA~~Ay~~m~ 81 (671)
T cd01381 2 VEDMITLGDLHEAGILRNLLIRYKKKLIYTYTGSILVAVNPYQILPIYTADEIKLYKNKSIGELPPHIFAISDNAYTNMQ 81 (671)
T ss_pred cchhhhCCCCCHHHHHHHHHHHHccCCCeEeeCCEEEEeCCCccCCCCCHHHHHHHhcCCccccCCCHHHHHHHHHHHHH
Confidence 67999999999999999999999999999999999999999999999999999999998888999999999999999999
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECCCCc
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGK 352 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~~~~ 352 (488)
+.+++|+|+|||||||||||++|.+|+|++..+++..++++.|+.+||+|||||||||+|||||||||||++|+|+..|.
T Consensus 82 ~~~~~QsIiisGESGaGKTes~K~i~~yLa~~s~~~~~i~~~il~snpiLEAFGNAkT~~N~NSSRFGK~~~l~F~~~g~ 161 (671)
T cd01381 82 REKKNQCIIISGESGAGKTESTKLILQYLAAISGKHSWIEQQILEANPILEAFGNAKTIRNDNSSRFGKYIDIHFNKRGA 161 (671)
T ss_pred HcCCCceEEEEcCCCCCeehHHHHHHHHHHHhcCCCCcHHHHHHHHHHHHHHhhccccCCCCCccccceeEEEEECCCCc
Confidence 99999999999999999999999999999999887788999999999999999999999999999999999999999999
Q ss_pred eeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCccHHH
Q psy9090 353 LSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVAK 432 (488)
Q Consensus 353 ~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~d~~~ 432 (488)
|+||+|.+|||||||||. |.+||||||||||||+|+++ ++++.++|.++..|+||+++.+ ...++.+|+++
T Consensus 162 i~Ga~i~~yLLEksRV~~-q~~gERnfHIFYqLl~g~~~-~~~~~l~L~~~~~y~yL~~~~~-------~~~~~~dD~~~ 232 (671)
T cd01381 162 IEGAKIEQYLLEKSRIVR-QARDERNYHIFYCMLAGLST-DEKERLKLGEASDYHYLAQGGC-------ITCEGRDDAKD 232 (671)
T ss_pred EEEEEEEEEeccCCceee-cCCCCCcHHHHHHHHcCCCH-HHHHHcCCCChhhceeecCCCC-------ccCCCccHHHH
Confidence 999999999999999995 99999999999999999976 5788899999999999987643 23567889999
Q ss_pred HHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC---CcccccCChhhhc
Q psy9090 433 FQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA---ENTAELANPEVAA 485 (488)
Q Consensus 433 ~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~---~~~~~~~~~~~~~ 485 (488)
|+++++||+.|||+++|+..||+|||||||||||+|.+.+ .+.+++.+.+.++
T Consensus 233 f~~~~~al~~lG~~~~e~~~i~~ilaaILhLGni~F~~~~~~~~~~~~i~~~~~l~ 288 (671)
T cd01381 233 FADIRSAMKVLMFTDQEIWEIFKLLAAILHIGNLRFEATEVDNLAACEVDDTPNLQ 288 (671)
T ss_pred HHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcceEEeeccCCCCCceeeCChHHHH
Confidence 9999999999999999999999999999999999998654 3467787776543
|
Myosins in this group have been associated with functions in sensory systems such as vision and hearing. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydr |
| >cd01377 MYSc_type_II Myosin motor domain, type II myosins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-78 Score=650.97 Aligned_cols=284 Identities=30% Similarity=0.479 Sum_probs=264.5
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++++.+++.|+.||..+.+||++|+++++|||++.+++|.++.+..|.++.....|||+|+||++||+.|
T Consensus 6 ~v~Dl~~L~~l~E~~il~~L~~Ry~~~~iYT~~G~iLIavNP~k~l~ly~~~~~~~Y~~~~~~~~~PHiyaiA~~Ay~~m 85 (693)
T cd01377 6 KVEDMAELTHLNEASVLHNLRERYYSDLIYTYSGLFCVAVNPYKRLPIYTEEVVEMYRGKKREEMPPHIFAIADNAYRSM 85 (693)
T ss_pred CcchhhhCCcCCHHHHHHHHHHHHhcCCcEEeecceeEeecCCccCCCCCHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999988899999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC----------CchhhhHhhhcchhhhhhhccccCCCCCCCccce
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG----------AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVL 341 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g----------~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk 341 (488)
.+.+++|+|||||||||||||++|.||+|++..+.+ ..++++.|+.+||+|||||||||+||||||||||
T Consensus 86 ~~~~~~QsIiiSGESGAGKTes~K~il~yLa~~~~~~~~~~~~~~~~~~i~~~il~snpiLEAFGNAkT~rN~NSSRFGK 165 (693)
T cd01377 86 LQDRENQSILITGESGAGKTENTKKVIQYLASVAASSKKKKQSGKGQGTLEDQILQANPILEAFGNAKTVRNDNSSRFGK 165 (693)
T ss_pred HhcCCCceEEEEcCCCCCchHHHHHHHHHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHhhccccCCCCCccccce
Confidence 999999999999999999999999999999988754 2479999999999999999999999999999999
Q ss_pred eEEEEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCC-CCCcccccCccCCCCCC
Q psy9090 342 YMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPG-RKYRYLRADVTDDKLPK 420 (488)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~-~~~~yl~~~~~~~~~~~ 420 (488)
|++|+|+..|.|+||+|.+|||||||||. |.+||||||||||||+|+++ ++++.+.|.++ ..|+||+++.+
T Consensus 166 ~i~l~f~~~g~i~Ga~i~~yLLEksRVv~-q~~gERNfHIFYqLl~G~~~-~~~~~l~L~~~~~~y~yL~~~~~------ 237 (693)
T cd01377 166 FIRIHFGNTGKIAGADIETYLLEKSRVVF-QASGERNYHIFYQLLSGADP-ELKSMLLLTGNPNDYRYLSQGEL------ 237 (693)
T ss_pred eEEEEECCCCCEEEEEEEEEecccCceee-cCCCCCcHHHHHHHHcCCCH-HHHHHcCCCCchhcCeeeCCCCc------
Confidence 99999999999999999999999999995 99999999999999999976 66788888876 99999987642
Q ss_pred CCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeec-CCcccccCChhhhc
Q psy9090 421 GPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESS-AENTAELANPEVAA 485 (488)
Q Consensus 421 ~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~-~~~~~~~~~~~~~~ 485 (488)
..++.+|+++|+++++||+.|||+++|+..||+|||||||||||+|.+. .++.+++.+.+.+.
T Consensus 238 --~~~~~~d~~~f~~~~~al~~lG~~~~e~~~i~~iLaaILhLGni~F~~~~~~~~~~~~~~~~l~ 301 (693)
T cd01377 238 --TIPGVDDAEEFKLTDEAFDILGFSDEEKNSIFKIVAAILHLGNIKFKQRQREEQAELDGTEEAD 301 (693)
T ss_pred --cCCCCcHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcceEEEecCCCCccccCChHHHH
Confidence 2467889999999999999999999999999999999999999999865 36677887776554
|
Myosin II mediates cortical contraction in cell motility, and is the motor in smooth and skeletal muscle. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydro |
| >cd01380 MYSc_type_V Myosin motor domain, type V myosins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-78 Score=648.95 Aligned_cols=277 Identities=31% Similarity=0.504 Sum_probs=260.0
Q ss_pred hhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q psy9090 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMM 272 (488)
Q Consensus 193 v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~ 272 (488)
++|+..+..++|+.++++|+.||..+.+||++|+++++|||++.+++|.++.+..|.++...+.|||+|+||++||+.|.
T Consensus 2 ~~Dl~~L~~l~E~~vl~~L~~Ry~~~~iYT~~G~iLiavNPyk~l~~Y~~~~~~~y~~~~~~~~~PHifaiA~~Ay~~m~ 81 (691)
T cd01380 2 KDDLTNLSYLHEPAVLHNLRVRFIQKQIYTYSGIVLVAINPYARLPIYGEEIIQAYSGQRKGELDPHIFAIAEEAYKQMT 81 (691)
T ss_pred chhhhhCCCCCHHHHHHHHHHHHcCCCCEEeECCEEEEeCCCCCCCcCCHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHH
Confidence 67999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC------chhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEE
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA------AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVT 346 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~------~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~ 346 (488)
+.+++|+|+|||||||||||++|.||+|++..+.+. .++++.|+++||||||||||||+|||||||||||++|+
T Consensus 82 ~~~~~QsIiiSGESGaGKTes~K~i~~yLa~~~~~~~~~~~~~~i~~~il~snpiLEAFGNAkT~~N~NSSRFGK~~~l~ 161 (691)
T cd01380 82 RDEKNQSIIVSGESGAGKTVSAKYIMRYFASVGGSDSREVSETQVEEKVLASNPIMEAFGNAKTTRNDNSSRFGKYIQIL 161 (691)
T ss_pred hcCCCceEEEEcCCCCCchHHHHHHHHHHHHhcCCCcccccccCHHHHHHHHHHHHHHhhcCCCCCCCCccccceEEEEE
Confidence 999999999999999999999999999999887543 57999999999999999999999999999999999999
Q ss_pred ECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCC
Q psy9090 347 FGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETP 426 (488)
Q Consensus 347 ~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~ 426 (488)
|+..|.|+||+|.+|||||||||. |.+||||||||||||+|++. ++++.++|.++..|+||+++.+ ...++
T Consensus 162 f~~~g~i~Ga~i~~yLLEksRv~~-~~~gErnfHIFYqLl~g~~~-~~~~~l~L~~~~~y~yl~~~~~-------~~~~~ 232 (691)
T cd01380 162 FDKRGRIIGANMRTYLLEKSRVVF-QAPGERNYHIFYQLCAGAPS-QELKELHLGHADKFNYLNQGGA-------PTIEG 232 (691)
T ss_pred ECCCCCEEEEEEEEeeccccceee-cCCCCChhHHHHHHHhCCCH-HHHHHhCCCCHHHCccccCCCC-------ccCCC
Confidence 999999999999999999999995 99999999999999999976 5678899999999999997743 23567
Q ss_pred CccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCccccc
Q psy9090 427 DTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAEL 478 (488)
Q Consensus 427 ~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~ 478 (488)
.+|+++|+++++||+.|||+++|+..||+|||||||||||+|.+.+++.+.+
T Consensus 233 ~~d~~~f~~~~~al~~lg~s~~e~~~I~~iLaaILhLGni~F~~~~~~~~~~ 284 (691)
T cd01380 233 VDDAEDFNATVQALTLLGISEEQQMDIFKLLAALLHLGNIEIEATRNDSSSI 284 (691)
T ss_pred CChHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhccceeeeccCCcccee
Confidence 8899999999999999999999999999999999999999998776555333
|
Myosins V transport a variety of intracellular cargo processively along actin filaments, such as membraneous organelles and mRNA. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an act |
| >cd01385 MYSc_type_IX Myosin motor domain, type IX myosins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-77 Score=641.29 Aligned_cols=287 Identities=31% Similarity=0.505 Sum_probs=262.5
Q ss_pred hhhhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCC-CCCCChhhHHHHHHHH
Q psy9090 190 TMHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS-RSDNEPHIYAVADSAY 268 (488)
Q Consensus 190 ~~~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~-~~~~~ph~f~~~d~~~ 268 (488)
...++|+..+..++++.+++.|+.||..+.+||++|+++++|||++.+++|.++++..|.... ....|||+|++|++||
T Consensus 6 ~~~~~Dl~~L~~lnE~~vl~~L~~Ry~~~~iYT~~G~iLiavNPyk~l~~y~~~~~~~Y~~~~~~~~lpPHiy~iA~~Ay 85 (692)
T cd01385 6 QREYDDLCNLPELTEGTLLKNLRHRFLQGHIYTYAGSILVAVNPFKFLPIYNPKYVRLYENQQRLGKLPPHIFAIADVAY 85 (692)
T ss_pred cCCCChhhhCCCCCHHHHHHHHHHHHhcCCCeEeECCEEEEECCCcCCCCCCHHHHHHHhcCCCcCCCCCCHHHHHHHHH
Confidence 457889999999999999999999999999999999999999999999999999999998876 6788999999999999
Q ss_pred HHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC---CchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEE
Q psy9090 269 QDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG---AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQV 345 (488)
Q Consensus 269 ~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g---~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~ 345 (488)
+.|.+.+++|+|+|||||||||||++|.||+|++..+.. ..++++.|..+||+|||||||||+|||||||||||++|
T Consensus 86 ~~m~~~~~~QsIiisGESGAGKTet~K~il~yL~~~s~~~~~~~~i~~~i~~snpiLEAFGNAkT~~N~NSSRFGK~i~l 165 (692)
T cd01385 86 YNMLRKKVNQCIVISGESGSGKTESTNFLIHHLTALSQKGYAGSGVEQTILSAGPVLEAFGNAKTAHNNNSSRFGKFIQV 165 (692)
T ss_pred HHHHhcCCCceEEEecCCCCCchHHHHHHHHHHHHhccCCccCCcHHHHHHHHHHHHHHhhccccCCCCCccccceeEEE
Confidence 999999999999999999999999999999999987542 35799999999999999999999999999999999999
Q ss_pred EECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCC
Q psy9090 346 TFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRET 425 (488)
Q Consensus 346 ~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~ 425 (488)
+|+..|.|+||+|++|||||||||. |.+||||||||||||+|+++ ++++.+.|.++.+|+||+++.+. ..+
T Consensus 166 ~F~~~g~i~Ga~i~~yLLEksRV~~-q~~gERNfHIFYqll~G~~~-~~~~~~~l~~~~~y~yL~~~~~~-------~~~ 236 (692)
T cd01385 166 NYRENGMVRGAVVEKYLLEKSRIVS-QEKDERNYHVFYYLLLGASE-EERKQEFLLKQPDYFYLNQHNLK-------IED 236 (692)
T ss_pred EECCCCCEEEEEEEEeecccceeee-cCCCCchhHHHHHHHcCCCH-HHHHHhcCCChhcCCeeCCCCCc-------cCC
Confidence 9999999999999999999999995 99999999999999999987 55677777777899999876432 245
Q ss_pred CCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC----CcccccCChhhhc
Q psy9090 426 PDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA----ENTAELANPEVAA 485 (488)
Q Consensus 426 ~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~----~~~~~~~~~~~~~ 485 (488)
+.+|+++|+++++||+.|||++++++.||+|||||||||||+|.+.+ ++.+++.+++.++
T Consensus 237 ~~dd~~~f~~~~~al~~lG~~~~~~~~i~~iLaaILhLGni~F~~~~~~~~~~~~~~~~~~~l~ 300 (692)
T cd01385 237 GEDEKHEFERLKQAMEMVGFLAATQKQIFAVLSAVLLLGNVTYKKRATYHRDESLEVGNPEVVD 300 (692)
T ss_pred CCCHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhccCceeeecccCCCCCceecCCHHHHH
Confidence 78899999999999999999999999999999999999999998643 4567777776544
|
Myosin IX is a processive single-headed motor, which might play a role in signalling. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the hea |
| >cd01383 MYSc_type_VIII Myosin motor domain, plant-specific type VIII myosins, a subgroup which has been associated with endocytosis, cytokinesis, cell-to-cell coupling and gating at plasmodesmata | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-77 Score=637.12 Aligned_cols=281 Identities=31% Similarity=0.477 Sum_probs=259.3
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++|+.++++|+.||..+.+||++|+++++|||++.+++|.++++..|.++. ..|||+|+||++||+.|
T Consensus 9 ~v~Dl~~L~~l~E~~vl~~L~~Ry~~~~iYT~~G~iLiavNPy~~l~ly~~~~~~~y~~~~--~~~PHifaiA~~Ay~~m 86 (677)
T cd01383 9 GVDDLMQLSYLNEPSVLYNLQYRYSQDLIYTKAGPVLVAVNPFKEVPLYGNDYIEAYRKKS--NDSPHVYAIADTAYNEM 86 (677)
T ss_pred CcchhhhCCCCCHHHHHHHHHHHHcCCCCeEEECCEEEEEcCCcCCCCCCHHHHHHhhCCC--CCCCCHHHHHHHHHHHH
Confidence 5789999999999999999999999999999999999999999999999999999998754 46999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECCCC
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSG 351 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~~~ 351 (488)
...+++|+|+|||||||||||++|.||+|++..+.+. .+++.|..+||+|||||||||+|||||||||||++|+|+..|
T Consensus 87 ~~~~~~QsIiisGESGaGKTe~~K~i~~yLa~~~~~~-~i~~~il~snpiLEaFGNAkT~~N~NSSRFGK~~~l~f~~~g 165 (677)
T cd01383 87 MRDEVNQSIIISGESGAGKTETAKIAMQYLASLGGGS-GIEYEILQTNPILEAFGNAKTSRNDNSSRFGKLIEIHFSETG 165 (677)
T ss_pred HHcCCCceEEEecCCCCCcchHHHHHHHHHHhhCCCC-cHHHHHHHHHHHHHHhhccccCCCCCcCccceeEEEEECCCC
Confidence 9999999999999999999999999999999987664 789999999999999999999999999999999999999999
Q ss_pred ceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCccHH
Q psy9090 352 KLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVA 431 (488)
Q Consensus 352 ~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~d~~ 431 (488)
.|+||+|.+|||||||||. |.+||||||||||||+|+++ ++++.++|.++..|+||+++.+ ...++.+|++
T Consensus 166 ~i~ga~i~~yLLEksRv~~-q~~gErNfHIFYqLl~g~~~-~~~~~l~L~~~~~y~yL~~~~~-------~~~~~~dd~~ 236 (677)
T cd01383 166 KISGAKIQTFLLEKSRVVQ-CARGERSYHIFYQLCAGAPP-ALKEKLNLKSASEYKYLKQSCC-------YSINGVDDAQ 236 (677)
T ss_pred cEEEEEEEEEecCCCceec-cCCCCchhHHHHHHHcCCCH-HHHHHhCCCCHHHCceecCCCc-------ccCCCccHHH
Confidence 9999999999999999995 99999999999999999977 5678899999999999987643 2357789999
Q ss_pred HHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCChhhh
Q psy9090 432 KFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVA 484 (488)
Q Consensus 432 ~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~~~~~ 484 (488)
+|+++++||+.|||+++|+..||+|||||||||||+|.+.+ ++.+++.+.+.+
T Consensus 237 ~f~~~~~al~~lG~~~~e~~~I~~iLaaILhLGNi~F~~~~~~~~~~~~~~~~l 290 (677)
T cd01383 237 RFHTLVEALDIVHISKEDQENVFAMLAAVLWLGNVSFTVIDNENHVEPVADEAL 290 (677)
T ss_pred HHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcceEEEecCCCcccccCChHHH
Confidence 99999999999999999999999999999999999998654 334555555433
|
This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates f |
| >cd01378 MYSc_type_I Myosin motor domain, type I myosins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-77 Score=638.00 Aligned_cols=284 Identities=32% Similarity=0.478 Sum_probs=266.1
Q ss_pred hhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q psy9090 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMM 272 (488)
Q Consensus 193 v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~ 272 (488)
++|+..+..++|+.++++|+.||..+.+||++|+++++|||++.+++|.++++..|.++...+.|||+|++|++||+.|.
T Consensus 2 v~Dl~~L~~l~E~~vl~~L~~Ry~~~~iYT~~G~iLiavNPy~~l~ly~~~~~~~Y~~~~~~~~~PHifaiA~~Ay~~m~ 81 (674)
T cd01378 2 VDDLVLLSKISEEAIVENLKKRFQNDLIYTYIGPVLISVNPFKQLPIYTDETIELYKGKSRYELPPHIYALADNAYRSMK 81 (674)
T ss_pred cchhhhCCCCCHHHHHHHHHHHHhcCCCeeccCCcEEEEcCCCCCCCCCHHHHHHHhCCCCCCCCCCHHHHHHHHHHHHH
Confidence 67999999999999999999999999999999999999999999999999999999999888999999999999999999
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC---chhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECC
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA---AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGS 349 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~---~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~ 349 (488)
+.+++|+|+|||||||||||++|.+|+|++..+.+. ..+++.|.+++|+|||||||||+|||||||||||++|+|+.
T Consensus 82 ~~~~~QsIiisGESGaGKTe~~K~il~yL~~~~~~~~~~~~i~~~i~~~npiLEAFGNAkT~~N~NSSRFgk~~~l~f~~ 161 (674)
T cd01378 82 SENENQCVIISGESGAGKTEAAKKIMQYIAAVSGGGQKVERVKDVILQSNPLLEAFGNAKTLRNNNSSRFGKYMEIQFDF 161 (674)
T ss_pred HcCCCceEEEEcCCCCCcchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHHHHHhhccccCCCCCcchhheeEEEEECC
Confidence 999999999999999999999999999999887653 35899999999999999999999999999999999999999
Q ss_pred CCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCcc
Q psy9090 350 SGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTN 429 (488)
Q Consensus 350 ~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~d 429 (488)
.|.|+||+|.+|||||||||. |.+||||||||||||+|+++ ++++.+.|.++..|+||+++.+ ...++.+|
T Consensus 162 ~g~i~ga~i~~yLLEksRVv~-~~~gErnfHIFYqll~g~~~-~~~~~l~L~~~~~y~yL~~~~~-------~~~~~~~d 232 (674)
T cd01378 162 KGDPVGGKITNYLLEKSRVVS-QNKGERNFHIFYQLLAGASE-QLLRELGLQKPEYYYYLNQSQC-------YTVDGIDD 232 (674)
T ss_pred CCCEeeEEEEEeecCCCceee-cCCCCchhHHHHHHHcCCCH-HHHHHhCCCChhhCeeecCCCc-------cCCCCccH
Confidence 999999999999999999995 99999999999999999976 5678899999999999997743 23567889
Q ss_pred HHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCcccccCChhhhc
Q psy9090 430 VAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAA 485 (488)
Q Consensus 430 ~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~~~~~~~~ 485 (488)
+++|+++++||+.|||+++|+..||+|||||||||||+|.+.+++.+.+.+.+.++
T Consensus 233 ~~~f~~~~~al~~lG~s~~e~~~i~~ilaaILhLGni~f~~~~~~~~~~~~~~~l~ 288 (674)
T cd01378 233 KKDFKETQNAMKVIGFSEDEQDEIFRIVAAILHLGNVQFAENGDGAAVISDKDVLD 288 (674)
T ss_pred HHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcceEEeccCCCccccCChHHHH
Confidence 99999999999999999999999999999999999999988776667888876554
|
Myosin I generates movement at the leading edge in cell motility, and class I myosins have been implicated in phagocytosis and vesicle transport. Myosin I, an unconventional myosin, does not form dimers. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 picon |
| >cd01384 MYSc_type_XI Myosin motor domain, plant-specific type XI myosin, involved in organelle transport | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-77 Score=632.87 Aligned_cols=279 Identities=28% Similarity=0.484 Sum_probs=259.2
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCC-CCCchhhhhccCCCCCCCChhhHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLN-LYGTKYHFKYKFKSRSDNEPHIYAVADSAYQD 270 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~-i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~ 270 (488)
.++|+..+..++|+.++++|+.||..+.+||++|+++++|||++.++ +|.++++..|.++...+.|||+|+||++||+.
T Consensus 2 gv~Dl~~L~~l~E~~vl~~L~~Ry~~~~iYT~~G~iLiavNPyk~l~~iy~~~~~~~y~~~~~~~~pPHifaiA~~Ay~~ 81 (674)
T cd01384 2 GVDDMTKLSYLHEPGVLQNLKTRYELNEIYTYTGNILIAVNPFQRLPHLYDVHMMEQYKGAALGELSPHVFAIADAAYRA 81 (674)
T ss_pred CcchHhhCCCCCHHHHHHHHHHHHhcCCCeeeECCEEEEECCCCcCCcCCCHHHHHHhcCCCcCCCCCCHHHHHHHHHHH
Confidence 46899999999999999999999999999999999999999999999 99999999999998889999999999999999
Q ss_pred HHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC----CchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEE
Q psy9090 271 MMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG----AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVT 346 (488)
Q Consensus 271 ~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g----~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~ 346 (488)
|.+.+++|+|+|||||||||||++|.+|+|++..+.+ ..++++.|+.+||+|||||||||+|||||||||||++|+
T Consensus 82 m~~~~~~QsIiisGESGaGKTe~~K~il~yLa~~~~~~~~~~~~i~~~il~~npiLEAFGNAkT~~N~NSSRFGK~~~l~ 161 (674)
T cd01384 82 MINEGKSQSILVSGESGAGKTETTKMLMRYLAYMGGRAGVEGRTVEQQVLESNPVLEAFGNAKTVRNNNSSRFGKFVEIQ 161 (674)
T ss_pred HHHcCCCceEEEECCCCCCchhHHHHHHHHHHhhcCCCCcccccHHHHHHHHHHHHHHhhCCCCCCCCCcchhheeEEEE
Confidence 9999999999999999999999999999999988643 347999999999999999999999999999999999999
Q ss_pred ECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCC
Q psy9090 347 FGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETP 426 (488)
Q Consensus 347 ~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~ 426 (488)
|+..|.|+||+|.+|||||||||. |.+||||||||||||+| ++ ++++.++|.++..|+||+++.+. ..++
T Consensus 162 f~~~g~i~Ga~i~~yLLEksRv~~-~~~gErnfHIFYqLl~g-~~-~~~~~l~L~~~~~y~yL~~~~~~-------~~~~ 231 (674)
T cd01384 162 FDDYGRISGAAIRTYLLERSRVCQ-ISDPERNYHCFYQLCAA-PP-EDVKKYKLGDPKEFHYLNQSNCF-------ELDG 231 (674)
T ss_pred ECCCCcEEEEEEEEEecccCceee-cCCCCCchhHHHHHHcC-CH-HHHHHcCCCChHhCccccCCCCc-------cccc
Confidence 999999999999999999999995 99999999999999999 54 56788999999999999976432 3567
Q ss_pred CccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCC
Q psy9090 427 DTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELAN 480 (488)
Q Consensus 427 ~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~ 480 (488)
.+|+++|+++++||+.|||+++|+..||+|||||||||||+|.+.+ .+++.+.+
T Consensus 232 ~~D~~~f~~~~~al~~lG~~~~e~~~I~~iLaaILhLGni~F~~~~~~~~~~~~~ 286 (674)
T cd01384 232 VDDAEEYLATRRAMDVVGISEEEQDAIFRVVAAILHLGNIEFAKGEEIDSSVLKD 286 (674)
T ss_pred cchHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhccceeeeccCCCCcccccC
Confidence 8899999999999999999999999999999999999999998664 35555544
|
This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new act |
| >cd01386 MYSc_type_XVIII Myosin motor domain, type XVIII myosins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-76 Score=636.43 Aligned_cols=282 Identities=26% Similarity=0.374 Sum_probs=253.2
Q ss_pred hhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q psy9090 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMM 272 (488)
Q Consensus 193 v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~ 272 (488)
++|+..+..++|+.++++|+.||..+.+|||+|+++++|||++.+++|.++++..|.++...+.|||+|+||+.||+.|+
T Consensus 2 v~Dl~~L~~l~E~~il~~L~~Ry~~~~IYT~~G~iLIavNPyk~l~iY~~~~~~~y~~~~~~~~pPHifaiA~~Ay~~m~ 81 (767)
T cd01386 2 VEDLASLVYLNESSVLHTLRQRYAANLIHTCAGPDLLVLNPMAPLALYSEKVPSMFRGCKAEDMPPHIYSLAQTAYRALL 81 (767)
T ss_pred cchhhcCCCCCHHHHHHHHHHHHcCCCCeEeECCeEEEECCCCCCCCCCHHHHHHHhcCCcCCCCCCHHHHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999888999999999999999999
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC---chhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECC
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA---AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGS 349 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~---~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~ 349 (488)
+.+++|+|+|||||||||||++|.||+|++..+.+. .+ .+.|..+||+|||||||||+|||||||||||++|+|+.
T Consensus 82 ~~~~~QsIiiSGESGAGKTe~tK~i~~yla~~~~~~~~~~~-~e~i~~~npiLEAFGNAkT~rNdNSSRFGK~i~l~F~~ 160 (767)
T cd01386 82 ETRRDQSIIFLGRSGAGKTTSCKHALEYLALAAGSVDGRVS-VEKVRALFTILEAFGNVSTALNGNATRFTQILSLDFDQ 160 (767)
T ss_pred HcCCCceEEEecCCCCCcHHHHHHHHHHHHhccCCCCcccH-HHHHHhhchHHHHhhccCcCCCCCcCcceeEEEEEECC
Confidence 999999999999999999999999999999886432 23 46899999999999999999999999999999999999
Q ss_pred CCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCcc
Q psy9090 350 SGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTN 429 (488)
Q Consensus 350 ~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~d 429 (488)
.|.|+||+|++|||||||||. |.+||||||||||||+|++. ++++.++|.++..+.+++.... ...+++.+|
T Consensus 161 ~g~i~Ga~i~~yLLEKSRVv~-q~~gERNFHIFYqLlaG~~~-~~~~~l~L~~~~~~~~~~~~~~------~~~~d~~~D 232 (767)
T cd01386 161 TGQIASASLQTMLLERSRVAR-RPNGETNFVVFSQLLAGVDG-DLRTELHLEQMAESSSFGMGGL------SKPEDKQKA 232 (767)
T ss_pred CCcEeEEEEEEEecccCceee-cCCCCCcchhHHHHHhCCCH-HHHHHhcCCCccccchhhcCCC------CCCcCcccH
Confidence 999999999999999999995 99999999999999999976 6678888887655433332211 112567889
Q ss_pred HHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCcccccCChhhh
Q psy9090 430 VAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVA 484 (488)
Q Consensus 430 ~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~~~~~~~ 484 (488)
+++|++|++||+.|||+++|+..||+|||||||||||+|.+ ..+.+.+.+++.+
T Consensus 233 ~~~f~~~~~Al~~lGfs~~e~~~If~iLaaILhLGNi~f~~-~~~~~~~~~~~~~ 286 (767)
T cd01386 233 AIDFSRLQQAMEVLGISEGEQRAIWRVLAAIYHLGAAGATK-VAGRKQFARPEWA 286 (767)
T ss_pred HHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhccCceeee-cCCccccCCHHHH
Confidence 99999999999999999999999999999999999999976 3455677776544
|
This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the |
| >cd01387 MYSc_type_XV Myosin motor domain, type XV myosins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-76 Score=631.13 Aligned_cols=284 Identities=27% Similarity=0.464 Sum_probs=261.4
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++++.+++.|+.||..+.+||++|+++++|||++.+++|.++.+..|.++...+.|||+|+||++||+.|
T Consensus 2 gv~Dl~~L~~l~E~~vl~~L~~Ry~~~~iYT~~G~iLiavNP~k~l~ly~~~~~~~Y~~~~~~~~~PHifavA~~Ay~~m 81 (677)
T cd01387 2 GVEDMTQLEDLQETTVLWNLKLRFERNLIYTYIGSILVSVNPYKMFPIYGPEQVQQYAGRALGENPPHLFAIANLAFAKM 81 (677)
T ss_pred CcchhhhCCCCCHHHHHHHHHHHHcCCCCeEeECCEEEEECCCCCCCCCCHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Confidence 46899999999999999999999999999999999999999999999999999999999888899999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC-CchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECCC
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG-AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSS 350 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g-~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~~ 350 (488)
.+.+++|+|+|||||||||||++|.+|+|++..+.| ...+++.|.++||+|||||||||+|||||||||||++|+| .+
T Consensus 82 ~~~~~~QsIiisGESGaGKTe~~k~il~yl~~~~~~~~~~i~~~il~snpiLEAFGNAkT~~N~NSSRfGk~~~l~f-~~ 160 (677)
T cd01387 82 LDAKQNQCVIISGESGSGKTEATKLILRYLAAMNQGGSAVITEQILEATPLLEAFGNAKTVRNDNSSRFGKFVEIFL-EG 160 (677)
T ss_pred HhcCCCceEEEEcCCCCCeehHHHHHHHHHHhhcCCCcchHHHHHHHHHHHHHHHhCcCCCCCCCccccceEEEEEe-cC
Confidence 999999999999999999999999999999988654 4678999999999999999999999999999999999999 47
Q ss_pred CceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCccH
Q psy9090 351 GKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNV 430 (488)
Q Consensus 351 ~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~d~ 430 (488)
|.|+||+|.+|||||||||. |.+||||||||||||+|+++ ++++.+.|.++..|+||+++.+. ..++.+|+
T Consensus 161 g~i~Ga~i~~yLLEksRvv~-q~~gErnfHIFYqll~g~~~-~~~~~~~L~~~~~y~yL~~~~~~-------~~~~~~d~ 231 (677)
T cd01387 161 GVIVGAITSQYLLEKSRIVF-QAKNERNYHIFYELLAGLPA-QLRQAFSLQEAETYYYLNQGGNC-------EIAGKSDA 231 (677)
T ss_pred CcEeEEEEEEEecCCCceee-cCCCCchHHHHHHHHhCCCH-HHHHHhcCCCHHhCchhcCCCcc-------cCCCcCHH
Confidence 99999999999999999995 99999999999999999977 56788999999999999876432 23567899
Q ss_pred HHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC---CcccccCChhhhc
Q psy9090 431 AKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA---ENTAELANPEVAA 485 (488)
Q Consensus 431 ~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~---~~~~~~~~~~~~~ 485 (488)
++|+++++||+.|||+++|+..||+|||||||||||+|.+.+ .+.+++.+++.++
T Consensus 232 ~~f~~~~~al~~lg~~~~e~~~i~~iLaaILhLGni~F~~~~~~~~~~~~~~~~~~l~ 289 (677)
T cd01387 232 DDFRRLLAAMEVLGFSSEDQDSIFRILASILHLGNVYFEKRETDAQEVASVVSAREIQ 289 (677)
T ss_pred HHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcCeEEeeccCCCCcccccCCHHHHH
Confidence 999999999999999999999999999999999999998654 2346677765443
|
In vertebrates, myosin XV appears to be expressed in sensory tissue and play a role in hearing. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis caus |
| >cd01382 MYSc_type_VI Myosin motor domain, type VI myosins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-76 Score=631.79 Aligned_cols=287 Identities=27% Similarity=0.428 Sum_probs=261.8
Q ss_pred hhhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCC-CCCchhhhhccCCCCCCCChhhHHHHHHHHH
Q psy9090 191 MHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLN-LYGTKYHFKYKFKSRSDNEPHIYAVADSAYQ 269 (488)
Q Consensus 191 ~~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~-i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~ 269 (488)
..++|+..+..++++.++++|+.||..+.+||++|+++++|||++.++ +|.++++..|.++.....|||+|++|++||+
T Consensus 4 ~~v~Dl~~L~~lnE~~vL~~L~~Ry~~~~iYT~~G~iLiavNPy~~l~~lY~~~~~~~y~~~~~~~~~PHifaiA~~Ay~ 83 (717)
T cd01382 4 KDVEDNCSLMYLNEATLLNNIRVRYSKDKIYTYVANILIAVNPYFDIPKLYSSDTIKKYQGKSLGTLPPHVFAIADKAYR 83 (717)
T ss_pred CCcchhhcCCCCCHHHHHHHHHHHHcCCCCEEeECCEEEEECCCCcccccCCHHHHHHhhCCCcCcCCCcHHHHHHHHHH
Confidence 367899999999999999999999999999999999999999999997 9999999999999888999999999999999
Q ss_pred HHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECC
Q psy9090 270 DMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGS 349 (488)
Q Consensus 270 ~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~ 349 (488)
.|.+.+++|+|+|||||||||||++|.||+|++..+.+..++++.|..+||+|||||||||+|||||||||||++|+|+.
T Consensus 84 ~m~~~~~~QsIiisGESGaGKTes~K~il~yLa~~~~~~~~i~~~il~snpiLEAFGNAkT~~N~NSSRFGK~~~l~f~~ 163 (717)
T cd01382 84 DMKVLKMSQSIIVSGESGAGKTENTKFVLRYLTESYGSGQDIDDRIVEANPLLEAFGNAKTVRNNNSSRFGKFVEIHFNE 163 (717)
T ss_pred HHHhcCCCCeEEEecCCCCChhHHHHHHHHHHHhhccCCccHHHHHHHHHHHHHHhhccccCCCCCcccceeEEEEEECC
Confidence 99999999999999999999999999999999988777788999999999999999999999999999999999999999
Q ss_pred CCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCC-------------
Q psy9090 350 SGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDD------------- 416 (488)
Q Consensus 350 ~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~------------- 416 (488)
.|.|+||+|.+|||||||||. |.+||||||||||||+|+++ ++++.+.|.++..|+||+++....
T Consensus 164 ~g~i~Ga~i~~yLLEksRVv~-~~~gErNfHIFYqLl~G~~~-~~~~~l~L~~~~~y~yL~~~~~~~~~~~~~~~~~~~~ 241 (717)
T cd01382 164 KNSVVGGFVSHYLLEKSRICV-QSAEERNYHIFYRLCAGASE-DIREKLHLSSPDDFRYLNRGCTRYFANKETDKQILQN 241 (717)
T ss_pred CCCEeEEEEEEEeccCCceEe-cCCCCCchHHHHHHHhCCCH-HHHHHhcCCChhhCeeecCCccccccccccccccccc
Confidence 999999999999999999995 99999999999999999976 578889999999999999753210
Q ss_pred ------CCCCCCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC--CcccccC
Q psy9090 417 ------KLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA--ENTAELA 479 (488)
Q Consensus 417 ------~~~~~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~--~~~~~~~ 479 (488)
....+...++.+|+++|++|++||+.|||+++|+..||+|||||||||||+|.+.+ ++.+.+.
T Consensus 242 ~~s~~~~~~~~~~~~~~dD~~~f~~~~~Al~~lg~s~~e~~~i~~iLaaILhLGni~F~~~~~~~~~~~~~ 312 (717)
T cd01382 242 RKSPEHLKKGALKDPLLDDYGDFQRMCVALKKIGLDDTEKLDLFRVVAGVLHLGNIDFEEAGSTSGGCNVK 312 (717)
T ss_pred ccccccccccccCCCCCcHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhcCceeEeccCCCCCcceec
Confidence 00011234678999999999999999999999999999999999999999998654 3344443
|
Myosin VI is a monomeric myosin, which moves towards the minus-end of actin filaments, in contrast to most other myosins. It has been implicated in endocytosis, secretion, and cell migration. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the minus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of |
| >cd01379 MYSc_type_III Myosin motor domain, type III myosins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-76 Score=622.91 Aligned_cols=289 Identities=36% Similarity=0.575 Sum_probs=260.6
Q ss_pred hhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q psy9090 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMM 272 (488)
Q Consensus 193 v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~ 272 (488)
++|+..+..++|+.++++|+.||..+.+||++|+++++|||++.+++|.++.+..|.++.....|||+|++|+.||+.|.
T Consensus 2 ~~Dl~~L~~l~E~~vl~~L~~Ry~~~~iYT~~G~iLiavNPyk~l~ly~~~~~~~y~~~~~~~~~PHifavA~~Ay~~m~ 81 (653)
T cd01379 2 MDDLATLEVLDEDTIVEQLQKRYETNQIYTYVGDILIAVNPFQQLGLYTTQHSRLYTGQKRSSNPPHIFAIADAAYQSLV 81 (653)
T ss_pred cchhhcCCCCCHHHHHHHHHHHHcCCCCeEeECCEEEEECCCCCCCCCCHHHHHhhcCCCCCCCCCcHHHHHHHHHHHHH
Confidence 57999999999999999999999999999999999999999999999999999999998888899999999999999999
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC-CchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECCCC
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG-AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSG 351 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g-~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~~~ 351 (488)
+..++|+|+|||||||||||++|.+|+|++..+.+ ..++++.|..+||+|||||||||+|||||||||||++|+|+.+|
T Consensus 82 ~~~~~QsIiisGESGsGKTet~K~l~~yL~~~~~~~~~~i~~~il~snpiLEAFGNAkT~~N~NSSRFGK~i~l~f~~~g 161 (653)
T cd01379 82 TYNQDQCIVISGESGSGKTESAHLLVQQLTVLGKANNRTLQEKILQVNSLVEAFGNARTGINDNSSRFGKYLEMKFTRSG 161 (653)
T ss_pred hcCCCceEEEecCCCCCchHHHHHHHHHHHHhcCCCCccHHHHHHHHHHHHHHhhccCcCCCCCcccceeEEEEEECCCC
Confidence 99999999999999999999999999999988765 45789999999999999999999999999999999999999999
Q ss_pred ceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCccHH
Q psy9090 352 KLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVA 431 (488)
Q Consensus 352 ~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~d~~ 431 (488)
.|+||+|.+|||||||||. |.+||||||||||||+|++.+++.+.|.|.++..|+||+++.+.. . .+. .+..+|++
T Consensus 162 ~i~Ga~i~~yLLEksRVv~-q~~gERNfHIFYqLl~G~~~~~~~~~~~L~~~~~~~yL~~~~~~~-~-~~~-~~~~~~~~ 237 (653)
T cd01379 162 AVVGARISEYLLEKSRVVH-QAEGEKNFHIFYYIYAGLAEEKKLAEYKLPESKTPRYLQNEATRV-V-QDI-TSNKFYKD 237 (653)
T ss_pred cEEEEEEEEEeccCCceec-cCCCCCceeeHHHHHhCCCHHHHHHhcCCCCccccCccCCCCccc-c-CCC-ccchhHHH
Confidence 9999999999999999995 999999999999999999875555778999999999998764321 0 111 22335688
Q ss_pred HHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC----CcccccCChhhhc
Q psy9090 432 KFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA----ENTAELANPEVAA 485 (488)
Q Consensus 432 ~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~----~~~~~~~~~~~~~ 485 (488)
+|+++++||+.|||+++|++.||+|||||||||||+|++.. .+.+.+.+.+.++
T Consensus 238 ~f~~~~~al~~lg~~~~e~~~I~~iLaaILhLGNi~F~~~~~~~~~~~~~i~~~~~l~ 295 (653)
T cd01379 238 QFEQIEQCFRVIGFTDEEVGSVYRILAAILNLGDIEFGSVASEHQTDKSRVSNVAALE 295 (653)
T ss_pred HHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcceEEEeccccCCCcccccCCHHHHH
Confidence 99999999999999999999999999999999999997653 2346677765443
|
Myosin III has been shown to play a role in the vision process in insects and in hearing in mammals. Myosin III, an unconventional myosin, does not form dimers. This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the |
| >cd00124 MYSc Myosin motor domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-75 Score=625.75 Aligned_cols=284 Identities=35% Similarity=0.551 Sum_probs=264.1
Q ss_pred hhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q psy9090 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMM 272 (488)
Q Consensus 193 v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~ 272 (488)
++|+..+..++++.+++.|+.||..+.+||++|+++++|||++.+++|.++.+..|.++.....|||+|++|++||+.|.
T Consensus 2 ~~Dl~~L~~l~e~~vl~~L~~Ry~~~~iYT~~G~iLiavNPy~~l~~y~~~~~~~y~~~~~~~~pPHifavA~~Ay~~m~ 81 (679)
T cd00124 2 VDDLASLPHLNEATVLNNLRQRYKKDLIYTYAGPILIAVNPYKDLPNYGPETIRKYRGKSRSELPPHVFAIADRAYRNML 81 (679)
T ss_pred CcchhhCCCCCHHHHHHHHHHHHcCCCCeEeECCEEEEECCCCCCCCCCHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999888999999999999999999
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC-CchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECCCC
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG-AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSG 351 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g-~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~~~ 351 (488)
..+++|+|+|||||||||||++|.+|+|++..+.+ ...+++.|..++|+|||||||||++||||||||||++|+|+..|
T Consensus 82 ~~~~~QsIiisGESGaGKTe~~k~il~yl~~~~~~~~~~i~~~i~~~n~iLEaFGNAkT~~N~NSSRfGk~~~l~f~~~g 161 (679)
T cd00124 82 RDRRNQSIIISGESGAGKTENTKLIMKYLASLAGSNDTGIEEKILAANPILEAFGNAKTVRNNNSSRFGKFIELQFDETG 161 (679)
T ss_pred hcCCCceEEEecCCCCCchHHHHHHHHHHHhccCCCcchHHHHHHHHhHHHHHhcccccCCCCCcccceeEEEEEECCCC
Confidence 99999999999999999999999999999998876 56799999999999999999999999999999999999999999
Q ss_pred ceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCccHH
Q psy9090 352 KLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVA 431 (488)
Q Consensus 352 ~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~d~~ 431 (488)
.|+||+|.+|||||||||. |.+||||||||||||+|+++ ++++.++|.++..|+||+++.+. ..++.+|++
T Consensus 162 ~i~ga~i~~yLLEksRv~~-~~~gErnfHIFYqll~g~~~-~~~~~l~L~~~~~y~yL~~~~~~-------~~~~~~d~~ 232 (679)
T cd00124 162 KISGAKITTYLLEKSRVVS-QEPGERNFHIFYQLLAGASP-EERKKLGLKRPESYRYLNQGGCN-------DVDGIDDAE 232 (679)
T ss_pred cEeEEEEEEEEcccceeec-cCCCCCchhHHHHHHcCCCH-HHHHhcCCCCcccCeeeCCCCcc-------cCCCCCHHH
Confidence 9999999999999999995 99999999999999999966 67888999999999999877432 236788999
Q ss_pred HHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCcc---cccCChhhhc
Q psy9090 432 KFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENT---AELANPEVAA 485 (488)
Q Consensus 432 ~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~---~~~~~~~~~~ 485 (488)
+|+++++||+.|||+++|+..||+|||||||||||+|.+.+++. +.+.+.+.++
T Consensus 233 ~f~~~~~al~~lg~~~~e~~~i~~iLaaILhLGni~f~~~~~~~~~~~~~~~~~~l~ 289 (679)
T cd00124 233 EFEELKEALKSLGFSEEEIESIFRILAAILHLGNIEFKSVGGEGQEAAEVKNTEVLS 289 (679)
T ss_pred HHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcCeeEEecCCCCcceeecCCHHHHH
Confidence 99999999999999999999999999999999999998765433 5676666544
|
This catalytic (head) domain has ATPase activity and belongs to the larger group of P-loop NTPases. Myosins are actin-dependent molecular motors that play important roles in muscle contraction, cell motility, and organelle transport. The head domain is a molecular motor, which utilizes ATP hydrolysis to generate directed movement toward the plus end along actin filaments. A cyclical interaction between myosin and actin provides the driving force. Rates of ATP hydrolysis and consequently the speed of movement along actin filaments vary widely, from about 0.04 micrometer per second for myosin I to 4.5 micrometer per second for myosin II in skeletal muscle. Myosin II moves in discrete steps about 5-10 nm long and generates 1-5 piconewtons of force. Upon ATP binding, the myosin head dissociates from an actin filament. ATP hydrolysis causes the head to pivot and associate with a new actin subunit. The release of Pi causes the head to pivot and move the fila |
| >smart00242 MYSc Myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-75 Score=621.96 Aligned_cols=285 Identities=31% Similarity=0.486 Sum_probs=263.7
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++++.+++.|+.||..+.+||++|+++++|||++.+++|.++++..|..+.....|||+|++|++||+.|
T Consensus 7 ~~~Dl~~L~~l~e~~vl~~L~~Ry~~~~iYT~~G~iLiavNP~~~l~~y~~~~~~~y~~~~~~~~~PHifavA~~Ay~~m 86 (677)
T smart00242 7 GVEDLVLLTYLNEPAVLHNLKKRYLKDLIYTYIGLVLVAVNPYKQLPIYTDEVIKKYRGKSRGELPPHVFAIADNAYRNM 86 (677)
T ss_pred CcchhhcCCCCCHHHHHHHHHHHHhhCCccccccceEEEecCCccCCCCCHHHHHHccCCCCCCCCCCHHHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999988899999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC---CchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEEC
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG---AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFG 348 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g---~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~ 348 (488)
.+.+++|+|+|||||||||||++|.+|+|++..+.+ ..++++.|..++|+|||||||||++||||||||||++|+|+
T Consensus 87 ~~~~~~QsIiisGESGaGKTe~~k~il~yl~~~~~~~~~~~~i~~~i~~~n~iLEAFGNAkT~~N~NSSRfgk~~~l~f~ 166 (677)
T smart00242 87 LNDKENQSIIISGESGAGKTENTKKIMQYLAAVSGSNTSVGSVEDQILESNPILEAFGNAKTVRNNNSSRFGKFIEIHFD 166 (677)
T ss_pred HhcCCCceEEEecCCCCcchHHHHHHHHHHHhhcCCCCccccHHHHHHHHHHHHHHhhccccCCCCCccchheeEEEEEC
Confidence 999999999999999999999999999999998765 46799999999999999999999999999999999999999
Q ss_pred CCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCc
Q psy9090 349 SSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDT 428 (488)
Q Consensus 349 ~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~ 428 (488)
..|.|.||+|.+|||||||||. |.+||||||||||||+|+++ ++++.+.|.++..|+||+++.+ ...++.+
T Consensus 167 ~~g~i~ga~i~~yLLEksRv~~-~~~gErnfHIFYqLl~g~~~-~~~~~l~L~~~~~y~yL~~~~~-------~~~~~~~ 237 (677)
T smart00242 167 AKGKIVGAKIETYLLEKSRVVS-QAKGERNYHIFYQLLAGASE-ELKKELGLKSPEDYRYLNQGGC-------LSVDGID 237 (677)
T ss_pred CCCcEeEEEEEEeecCCceEEe-cCCCCCchHHHHHHHcCCCH-HHHHhcCCCChhhCceeCCCCC-------ccCCCCC
Confidence 9999999999999999999995 99999999999999999976 6778899999999999987632 2356778
Q ss_pred cHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCcccc--cCChhhhc
Q psy9090 429 NVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAE--LANPEVAA 485 (488)
Q Consensus 429 d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~--~~~~~~~~ 485 (488)
|+++|+++++||+.|||+++|+..||+|||||||||||+|.+.+++++. +.+.+.++
T Consensus 238 d~~~f~~~~~al~~lG~~~~e~~~I~~iLaaILhLGni~F~~~~~~~~~~~~~~~~~l~ 296 (677)
T smart00242 238 DAEEFKETLNAMRVLGFSEEEQESIFKILAAILHLGNIEFEEGRNDNAASTVKDKEELE 296 (677)
T ss_pred HHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcceeEEecCCCCcccccCCHHHHH
Confidence 9999999999999999999999999999999999999999876644432 55555443
|
Large ATPases. ATPase; molecular motor. Muscle contraction consists of a cyclical interaction between myosin and actin. The core of the myosin structure is similar in fold to that of kinesin. |
| >KOG0163|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-75 Score=586.82 Aligned_cols=289 Identities=27% Similarity=0.435 Sum_probs=263.9
Q ss_pred hhhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCC-CCCchhhhhccCCCCCCCChhhHHHHHHHHH
Q psy9090 191 MHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLN-LYGTKYHFKYKFKSRSDNEPHIYAVADSAYQ 269 (488)
Q Consensus 191 ~~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~-i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~ 269 (488)
.+++|-..+..+++..++.+++-||..+.+||||.+|+++|||+...+ +|.++.+..|.+++....|||+|+|||++|+
T Consensus 57 k~veDNC~Lm~LNEATlL~Nik~RY~k~kIYtYVANILIavNPY~~I~~lYs~etIK~Y~GkSLGq~~PHvFAIADKa~R 136 (1259)
T KOG0163|consen 57 KDVEDNCELMHLNEATLLNNIKLRYYKDKIYTYVANILIAVNPYQEIDGLYSPETIKEYRGKSLGQLPPHVFAIADKAYR 136 (1259)
T ss_pred cccccccceeeccHHHHhhhhhhhhccCchhhhhhhhheeccchhhcccccCHHHHHHhcCCcccCCCCceeeechHHHH
Confidence 367788888999999999999999999999999999999999999986 8999999999999999999999999999999
Q ss_pred HHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECC
Q psy9090 270 DMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGS 349 (488)
Q Consensus 270 ~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~ 349 (488)
.|+..+..|+|++||||||||||++|.+++|++.+-+....++..|+.+||+|||||||||+||+||||||||++|||+.
T Consensus 137 dMr~~k~SQSIIVSGESGAGKTEstK~vLrYLces~gsag~Iq~rileaNPiLEAFGNAKT~RNNNSSRFGKFveiHf~d 216 (1259)
T KOG0163|consen 137 DMRVYKLSQSIIVSGESGAGKTESTKAVLRYLCESWGSAGPIQTRILEANPILEAFGNAKTLRNNNSSRFGKFVEIHFDD 216 (1259)
T ss_pred HHHHHhhcccEEEecCCCCCcchhHHHHHHHHHhccCCCCcHHHHHhccChHHHHhccchhhccCChhhccceEEEEEcC
Confidence 99999999999999999999999999999999988776778999999999999999999999999999999999999999
Q ss_pred CCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCcc--------C-----C
Q psy9090 350 SGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVT--------D-----D 416 (488)
Q Consensus 350 ~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~--------~-----~ 416 (488)
+|.++||-|++||||||||+. |..+|||||||||||||+++ ++++++.|+.|++|+||+.+.+ . +
T Consensus 217 k~~VvGGyvSHYLLEkSRiC~-Qaa~ERNYHiFY~LiAGas~-dl~~kL~L~~pd~f~YL~rG~t~yFan~~t~~ki~~n 294 (1259)
T KOG0163|consen 217 KGQVVGGYVSHYLLEKSRICR-QAAEERNYHIFYQLIAGASP-DLRKKLSLGKPDDFRYLKRGCTQYFANAKTEQKIPGN 294 (1259)
T ss_pred CCceechhhhHHHHHHhHHHH-hhhcccchhHHHHHHcCCCH-HHHHHhccCCchhhhHHhcchhhhccCcchhhcCccc
Confidence 999999999999999999996 99999999999999999987 7889999999999999984411 0 1
Q ss_pred CCC------CCCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC---CcccccCCh
Q psy9090 417 KLP------KGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA---ENTAELANP 481 (488)
Q Consensus 417 ~~~------~~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~---~~~~~~~~~ 481 (488)
..+ +..+++-+||-.+|..+..||..+|.|++|+..||++||||||||||+|++.. .++|.+.+.
T Consensus 295 r~S~~~~~~~~~kD~iidD~~dF~rl~~Al~~~Glsd~Ekl~i~s~vA~vLHLGNieFEE~~ddsrGGC~v~n~ 368 (1259)
T KOG0163|consen 295 RKSKNHQQKGSLKDPIIDDYQDFHRLEKALKLLGLSDTEKLFIWSTVAAVLHLGNIEFEEIPDDSRGGCQVSNG 368 (1259)
T ss_pred ccCccccccCcccCcccccHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHccccchhcccCcCCCceecccC
Confidence 110 22345566999999999999999999999999999999999999999998665 556776654
|
|
| >PF00063 Myosin_head: Myosin head (motor domain); InterPro: IPR001609 Muscle contraction is caused by sliding between the thick and thin filaments of the myofibril | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-72 Score=608.56 Aligned_cols=284 Identities=34% Similarity=0.551 Sum_probs=247.6
Q ss_pred hhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q psy9090 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMM 272 (488)
Q Consensus 193 v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~ 272 (488)
++|+..+..++|+.+++.|+.||..+.+||++|+++++|||++.+++|.++.+..|.++.....|||+|++|++||+.|.
T Consensus 1 veDl~~l~~l~e~~il~~L~~R~~~~~iyT~~G~~Li~vNP~~~l~~y~~~~~~~y~~~~~~~~~PHif~~a~~A~~~m~ 80 (689)
T PF00063_consen 1 VEDLASLSHLNEASILHNLRQRYKKDLIYTYIGPILIAVNPYKPLPLYSDEVMEKYRGKRRQDLPPHIFAVAQRAYRQML 80 (689)
T ss_dssp -SBGGGSSS-SHHHHHHHHHHHHHTT--EEEETTEEEEE--SS--STSSHHHHHHHTTS-GGGS-SSHHHHHHHHHHHHH
T ss_pred CChhhhCCCCCHHHHHHHHHHHHccCCccccCCCeEEEECCchhhhhhhhhhhhhhhhhccccccCccchhhhccccccc
Confidence 57899999999999999999999999999999999999999999999999999999999889999999999999999999
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCc-----hhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEE
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAA-----KVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTF 347 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~-----~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~ 347 (488)
..+++|+|||||||||||||++|.||+|++..+.+.. ++++.|..+++||||||||||++|+||||||||++|+|
T Consensus 81 ~~~~~Q~IiisGeSGsGKTe~~k~il~~L~~~~~~~~~~~~~~i~~~i~~~~~iLeaFGnAkT~~N~nSSRfgk~~~l~f 160 (689)
T PF00063_consen 81 RTRQNQSIIISGESGSGKTETSKLILRYLASLSSSSSSSKSSSIEKKILAANPILEAFGNAKTPRNDNSSRFGKFIELQF 160 (689)
T ss_dssp HHTSEEEEEEEESTTSSHHHHHHHHHHHHHHHSSSSSSTCTTHHHHHHHHHHHHHHHHHEEEESSETTEESSEEEEEEEE
T ss_pred ccccccceeeccccccccccchHHHHHHHhhhcccccccccccccceEEeccchhhhhcccccccCCcccccceEEEEEe
Confidence 9999999999999999999999999999999877654 79999999999999999999999999999999999999
Q ss_pred CCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCC
Q psy9090 348 GSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPD 427 (488)
Q Consensus 348 ~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~ 427 (488)
+..|.++||+|.+|||||||||. |.+||||||||||||+|++. ++++.+.|.++..|+||+++.+ ...++.
T Consensus 161 ~~~~~~~g~~i~~ylLEksRv~~-~~~~ErnfhiFYqll~G~~~-~~~~~l~L~~~~~~~yL~~~~~-------~~~~~~ 231 (689)
T PF00063_consen 161 DDSGQIVGAKIETYLLEKSRVVR-QPPGERNFHIFYQLLAGADD-EERKELRLNDASDYRYLNQSGC-------STIPGI 231 (689)
T ss_dssp ETTSSEEEEEEEEEEE-GGGGT----TTS-SBHHHHHHHHTSSH-HHHHHTT-S-GGGSTTCCTTSS-------SSBTTC
T ss_pred cccccccccceecccccccceee-ccccccccchhhhhhhccch-hhhhcccccccccccceecccc-------cccCCc
Confidence 99999999999999999999995 99999999999999999987 4588899999999999987532 224567
Q ss_pred ccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCChhhhc
Q psy9090 428 TNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVAA 485 (488)
Q Consensus 428 ~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~~~~~~ 485 (488)
+|+++|+++++||+.|||+++++..||+|||||||||||+|++.. ++.+++.+++.++
T Consensus 232 ~d~~~f~~l~~al~~lg~~~~e~~~I~~iLaaILhLGni~F~~~~~~~~~~~~~~~~l~ 290 (689)
T PF00063_consen 232 DDAEEFQELKDALKTLGFSDEEIDDIFRILAAILHLGNIEFVEDESDESAEVENSEELQ 290 (689)
T ss_dssp THHHHHHHHHHHHHHTT--HHHHHHHHHHHHHHHHHTTSSEEEETTSSSEEESTSHHHH
T ss_pred cCHHHhhhhhhhhccccCchhHHHHHHHHHHHHhhhccccccccccccceeechHHHHH
Confidence 899999999999999999999999999999999999999998776 5567788877554
|
Myosin is a major component of thick filaments and exists as a hexamer of 2 heavy chains [], 2 alkali light chains, and 2 regulatory light chains. The heavy chain can be subdivided into the N-terminal globular head and the C-terminal coiled-coil rod-like tail, although some forms have a globular region in their C-terminal. There are many cell-specific isoforms of myosin heavy chains, coded for by a multi-gene family []. Myosin interacts with actin to convert chemical energy, in the form of ATP, to mechanical energy []. The 3-D structure of the head portion of myosin has been determined [] and a model for actin-myosin complex has been constructed []. The globular head is well conserved, some highly-conserved regions possibly relating to functional and structural domains []. The rod-like tail starts with an invariant proline residue, and contains many repeats of a 28 residue region, interrupted at 4 regularly-spaced points known as skip residues. Although the sequence of the tail is not well conserved, the chemical character is, hydrophobic, charged and skip residues occuring in a highly ordered and repeated fashion [].; GO: 0003774 motor activity, 0005524 ATP binding, 0016459 myosin complex; PDB: 1LKX_A 2V26_A 2BKI_A 3L9I_A 2BKH_A 2X51_A 2VB6_A 2VAS_A 1OE9_A 1W8J_A .... |
| >KOG0161|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-72 Score=630.14 Aligned_cols=284 Identities=31% Similarity=0.503 Sum_probs=269.0
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++||+.+..+++++++.+|+.||.+..||||.|..++.|||++.+|||.++++.+|.++.+.++|||+|+|+|.||++|
T Consensus 83 k~eDMa~LT~lNeasVL~nL~~RY~~~lIyTYSGLFcVviNPyk~lpiYt~~v~~~ykgkrr~e~pPHIfavad~AYr~m 162 (1930)
T KOG0161|consen 83 KVEDMAELTFLNEASVLHNLKQRYASDLIYTYSGLFCVVINPYKRLPIYTESVVRMYKGKKREEMPPHIFAVADEAYRNM 162 (1930)
T ss_pred ccccHHHhcccChHHHHhhHHHHHHhChHHHcccceeEEecCCcCCCCCCHHHHHHhcccccccCCchHHHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC-------chhhhHhhhcchhhhhhhccccCCCCCCCccceeEE
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA-------AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQ 344 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~-------~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~ 344 (488)
...+++|+|||+|||||||||+||.+|+|++..+.+. ...+++|...||+|||||||+|++|||||||||||+
T Consensus 163 L~~renQSiLiTGESGAGKTeNTKkVIqyla~va~~~~~~~~~~~~le~qi~q~npvLeaFGNa~tvrn~NssRFgkfir 242 (1930)
T KOG0161|consen 163 LQDRENQSILITGESGAGKTENTKKVIQYLASVASSSTKKVKIEGTLEDQILQANPVLEAFGNAKTVRNDNSSRFGKFIR 242 (1930)
T ss_pred HhcCCCceEeeecCCCCCcchhHHHHHHHHHHHhhccccCCCCCCChHHHHHHhCchHHHhcChhhhcCCCCcccceeEE
Confidence 9999999999999999999999999999999987654 678999999999999999999999999999999999
Q ss_pred EEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCC-CCCCcccccCccCCCCCCCCC
Q psy9090 345 VTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSP-GRKYRYLRADVTDDKLPKGPR 423 (488)
Q Consensus 345 ~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~-~~~~~yl~~~~~~~~~~~~~~ 423 (488)
|+|+..|.|+||.|.+||||||||++ |+++||||||||||++|.++ .++..++|.. +.+|.|+.++.. .
T Consensus 243 I~F~~~G~i~~a~Ie~yLLEKsRv~~-Q~~~Er~yhiFyqlls~~~~-~l~~~l~L~~~~~~Y~f~~~~~~--------~ 312 (1930)
T KOG0161|consen 243 IHFDATGKIAGADIETYLLEKSRVIR-QAPGERNYHIFYQLLSGADP-ELKEELLLSDNVKDYKFLSNGES--------T 312 (1930)
T ss_pred EecCCCCccchhhHHHHHHHHhHhhc-cCcchhHHHHHHHHHhCCCH-HHHHHHhhcccchhhhhhccccC--------C
Confidence 99999999999999999999999995 99999999999999999965 6677777765 899999977632 3
Q ss_pred CCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeec-CCcccccCChhhhc
Q psy9090 424 ETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESS-AENTAELANPEVAA 485 (488)
Q Consensus 424 ~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~-~~~~~~~~~~~~~~ 485 (488)
.++++|+++|+.|..||++|||+++|+.+||+|+|||||||||.|.+. .++++++.+.++|+
T Consensus 313 i~g~dd~eef~~t~~a~~ilgfs~~E~~~~~~i~sailhlGn~~f~~~~~~~qa~~~~~~~a~ 375 (1930)
T KOG0161|consen 313 IPGVDDAEEFQETDEAMDILGFSEEEKISIFRIVSAILHLGNIKFKQEPREEQAEFDNTEVAD 375 (1930)
T ss_pred CCCcchHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhcchhhhccccccccCCCCchHHH
Confidence 789999999999999999999999999999999999999999999876 48999999998886
|
|
| >KOG0160|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-65 Score=537.09 Aligned_cols=281 Identities=31% Similarity=0.497 Sum_probs=262.5
Q ss_pred hhhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCC-CCCchhhhhccCCCCCCCChhhHHHHHHHHH
Q psy9090 191 MHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLN-LYGTKYHFKYKFKSRSDNEPHIYAVADSAYQ 269 (488)
Q Consensus 191 ~~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~-i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~ 269 (488)
..++|+..+..+.++.++.+|..||..+.+||+.|.++++|||+++++ +|.++.+..|. ....+..||+|++++.||+
T Consensus 8 ~~~dDlt~lsyl~epaVL~~L~~Ry~~~~IYty~G~vLiAiNPf~~~~~ly~~~~i~~y~-~~~~~l~ph~favA~~ay~ 86 (862)
T KOG0160|consen 8 MGVDDLTTLSYLHEPAVLHNLAKRYEQNQIYTYKGIVLIAINPFKRLPHLYGKKMISAYQ-AIQGELSPHLFAVAEEAYR 86 (862)
T ss_pred CCccccccCCccCcHHHHHHHHHhhhhcccchhhceeeeeeccccccchhccHHHHHhhc-ccccccCcchhhHHHHHHH
Confidence 477899999999999999999999999999999999999999999999 99999999999 7788899999999999999
Q ss_pred HHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC--CchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEE
Q psy9090 270 DMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG--AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTF 347 (488)
Q Consensus 270 ~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g--~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~ 347 (488)
.|+....+|+|+||||||||||+++|.+|+|++..+.+ .-++|+.|+.+||+|||||||||+|||||||||||++|+|
T Consensus 87 ~m~~~~~~QsIivsGESGAgkT~~aK~~m~yla~v~~~~~~~~vE~~vL~snpi~EafgNakT~rndnsSrFgK~iei~F 166 (862)
T KOG0160|consen 87 DMTPDGVNQSIIVSGESGAGKTETAKYLMEYLASVGGSVEGRSIENKVLASNPILEAFGNAKTTRNDNSSRFGKVIEITF 166 (862)
T ss_pred HhhhccCCceeeeeCCCCCchhHHHHHHHHHHHHHhccchhhHHHHHHHhcCCcchhhccchhhhcccHHHhhhHHHHhh
Confidence 99999999999999999999999999999999999988 6789999999999999999999999999999999999999
Q ss_pred CCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCC
Q psy9090 348 GSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPD 427 (488)
Q Consensus 348 ~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~ 427 (488)
+..|.|.||+|.+|||||||||. +.++|||||||||+|+|.+ +++++|.|..+..|+|++++. +....+.
T Consensus 167 d~~~~I~GA~~~TYLLekSRv~~-~~~~ernyhiFyQlca~~~--~~~~~l~L~~~~~f~yl~q~~-------~~~i~~v 236 (862)
T KOG0160|consen 167 DQQGRISGAKIRTYLLEKSRVVQ-LSAPERNYHIFYQLCAGAP--EELEKLKLGTLRRFSYLNQSA-------CVLISGV 236 (862)
T ss_pred hhhcccccceeeeEEeecceeee-cCccccchHHHHHHhcCCc--hhhhccCcCccccceeccccc-------chhhccc
Confidence 99999999999999999999995 9999999999999999976 567889999999999999874 3346788
Q ss_pred ccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCcccccCChh
Q psy9090 428 TNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPE 482 (488)
Q Consensus 428 ~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~~~~~ 482 (488)
+|+++|..++.||..+|++.++++.||+++||+||||||+|....++++...-.+
T Consensus 237 ~d~~e~~~t~~A~~~vgi~~~~q~~if~lla~ilhlGni~f~~~~~~~~~~~~~~ 291 (862)
T KOG0160|consen 237 SDAEEFLSTTEAMLFVGISESHQELIFRLLAAILHLGNIQFSSGVEETSSSPVDD 291 (862)
T ss_pred ccHHHHHHHHHHHHHhcCChHHHHHHHHHHHHHhccCceEeecccccccccccch
Confidence 9999999999999999999999999999999999999999987765544443333
|
|
| >KOG4229|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-55 Score=474.73 Aligned_cols=288 Identities=34% Similarity=0.523 Sum_probs=266.9
Q ss_pred hhhhhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCC-CCCchhhhhccCCCCCCCChhhHHHHHHH
Q psy9090 189 QTMHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLN-LYGTKYHFKYKFKSRSDNEPHIYAVADSA 267 (488)
Q Consensus 189 ~~~~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~-i~~~ef~~~~~~~~~~~~~ph~f~~~d~~ 267 (488)
+...++|+..+..+++..+..++..||....+|+|++.+++++||+...+ +|...|+..|.++...+.+||+|+++|.+
T Consensus 59 ~~~~~~Dl~~l~~l~e~~~~~nl~~R~~~~~Iy~y~gsil~~lnp~~~~~fiy~~~~~~ly~~~~~ge~~phifa~ad~~ 138 (1062)
T KOG4229|consen 59 QVEDVEDLAQLEDLSEATILENLLVRYKRNPIYEYLGSILVALNPLQPIPFLYLPRFSKLYSGKPLGEDPPHIFAIADLA 138 (1062)
T ss_pred ccccHHHHhhccccchhhhhHHHHHHHccCCceeeechhhhhcCccccccccccHHhhccccccccCCCCcchhhhhhhH
Confidence 33467899999999999999999999999999999999999999999999 99999999999899999999999999999
Q ss_pred HHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhc-CCCchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEE
Q psy9090 268 YQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLG-QGAAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVT 346 (488)
Q Consensus 268 ~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~-~g~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~ 346 (488)
|..|....++|||+||||||+||||+++.++++++..+ +....+++.|+.++|+|||||||+|.+||||||||||+++.
T Consensus 139 y~~m~~~~~~QcivisGesgsGktest~l~~~~Ls~Lsq~~~~~~e~~il~a~~llEafgnA~t~~ndnssrfgk~i~~~ 218 (1062)
T KOG4229|consen 139 YQDMLREKEDQCIVISGESGSGKTESTKLLWQFLSILSQGNNSPVEQLILSANPLLEAFGNAKTPRNDNSSRFGKYIKVN 218 (1062)
T ss_pred HHhhhhhccceeEEEecccCCCCchhhHHHHHHHHHHhcCCCCchhhhhhcchHHHHHhcccCCcccCchhhhhheEEec
Confidence 99999999999999999999999999999999999999 55677889999999999999999999999999999999999
Q ss_pred ECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCC-C
Q psy9090 347 FGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRE-T 425 (488)
Q Consensus 347 ~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~-~ 425 (488)
|...|.+.||+|..||||||||+. |+++||||||||++++|++. .++..+.|+.+++|.||+++... ++ +
T Consensus 219 ~~~~g~i~Gaki~~yllEKsr~~~-q~~~e~nyhify~~~agl~~-~e~~~~~l~~~e~y~yL~~~~~~-------~~~d 289 (1062)
T KOG4229|consen 219 FRKTGIIEGAKIVEYLLEKSRLVI-QAGGERNYHIFYYLLAGLSE-NELKAFVLGEAENYEYLEQGALF-------TISD 289 (1062)
T ss_pred cccCCCCCcchHHHHHHHHHHHHH-hcCCCcccccchhheeccch-hhhhHHhhcCCCCHHHhhccccc-------cccc
Confidence 999999999999999999999996 99999999999999999988 67888999999999999987432 23 6
Q ss_pred CCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC---CcccccCChhhhc
Q psy9090 426 PDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA---ENTAELANPEVAA 485 (488)
Q Consensus 426 ~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~---~~~~~~~~~~~~~ 485 (488)
+.++.++|+++..||.++||.+++++.||+++|||||+|||.|.+.. .+.+++.+.+.+.
T Consensus 290 ~~~~~~~~~~l~~~m~v~~f~~~~~~si~~~la~il~~gni~~~~~~~~~~d~~~v~~~~~v~ 352 (1062)
T KOG4229|consen 290 GEDDVAQFIRLEAAMSVVGFTDKVLGSIFKSLAAILHIGNISYIKFALDQQDSAEVENEEAVE 352 (1062)
T ss_pred hHHHHHhHHHHHHHHHHhccchhHHHHHHHhcccceeecceeHHhhhcccccchhcccchHHH
Confidence 77899999999999999999999999999999999999999997554 4456676665543
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.67 Aligned_cols=181 Identities=33% Similarity=0.584 Sum_probs=163.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|..++.|+.+|+.||.|||++|||||||||+|||++.+|+|+|+|||+|+..........+++||+.|||||++..
T Consensus 122 F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~-- 199 (357)
T KOG0598|consen 122 FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG-- 199 (357)
T ss_pred cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhc--
Confidence 578999999999999999999999999999999999999999999999999977666677788999999999999987
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC----C
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----Y 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----s 156 (488)
.+|+..+|+||||+++|+|++|.+||.+.+.......+.+...+. .+.-++.+++++++++|..||.+|. +
T Consensus 200 ---~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~--~p~~ls~~ardll~~LL~rdp~~RLg~~~d 274 (357)
T KOG0598|consen 200 ---KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL--PPGYLSEEARDLLKKLLKRDPRQRLGGPGD 274 (357)
T ss_pred ---CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC--CCccCCHHHHHHHHHHhccCHHHhcCCCCC
Confidence 789999999999999999999999999999888888888775322 2445899999999999999999996 6
Q ss_pred HHHHhcCcCCCCCCCCcccccccccccccchh
Q psy9090 157 MSELLEHPFITSLPENDLHLSTVNCQYKDQEL 188 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 188 (488)
+.++.+||||++++|+.+......+++.+...
T Consensus 275 ~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~ 306 (357)
T KOG0598|consen 275 AEEIKRHPFFKGINWEKLLAKKLSPPFKPNVT 306 (357)
T ss_pred hHHhhcCcccccCCHHHHHhcCCCCCeecCCC
Confidence 88999999999999999988888888877543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=288.93 Aligned_cols=174 Identities=29% Similarity=0.565 Sum_probs=158.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|..+++|+.||+.||+|||+++|++|||||+|||++.+|++||+|||+++... ..+.+.||||.|+|||++++
T Consensus 141 F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---~rT~TlCGTPeYLAPEii~s-- 215 (355)
T KOG0616|consen 141 FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---GRTWTLCGTPEYLAPEIIQS-- 215 (355)
T ss_pred CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---CcEEEecCCccccChHHhhc--
Confidence 6899999999999999999999999999999999999999999999999998765 34778999999999999987
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
.+|+.++|+|||||++|||+.|.+||.+.++.....+|+... ...|+.+++++++||+++|+.|-.+|.
T Consensus 216 ---k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~---v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlkn 289 (355)
T KOG0616|consen 216 ---KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK---VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKN 289 (355)
T ss_pred ---CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc---ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCC
Confidence 789999999999999999999999999999988888887753 335678899999999999999999993
Q ss_pred CHHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
...+|.+||||+++.|..+....+..++.+
T Consensus 290 G~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 290 GVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred CccccccCcccccccHHHHhhccccCCCCC
Confidence 568999999999999999888877777766
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=294.95 Aligned_cols=167 Identities=35% Similarity=0.730 Sum_probs=149.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
++|.....++.+|++||.|||. ++||||||||+|||++..|+|||||||.++..... ...+++||..|||||.+.+
T Consensus 175 i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g- 251 (364)
T KOG0581|consen 175 IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISG- 251 (364)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcC-
Confidence 5789999999999999999995 99999999999999999999999999999887654 6678999999999999987
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCC-----ChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDM-----HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
..|+.++||||||+.+.|+.+|+.||... ...+.+..|+.+++|..+. ..||+++++||..||++||.+|
T Consensus 252 ----~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~-~~fS~ef~~FV~~CL~Kdp~~R 326 (364)
T KOG0581|consen 252 ----ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE-GEFSPEFRSFVSCCLRKDPSER 326 (364)
T ss_pred ----CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc-ccCCHHHHHHHHHHhcCCcccC
Confidence 68999999999999999999999999764 5567777888777776543 2599999999999999999999
Q ss_pred CCHHHHhcCcCCCCCCCCccc
Q psy9090 155 PYMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 155 ps~~ell~hp~f~~~~~~~~~ 175 (488)
||+.++++|||++........
T Consensus 327 ~s~~qLl~Hpfi~~~~~~~vd 347 (364)
T KOG0581|consen 327 PSAKQLLQHPFIKKFEDPNVD 347 (364)
T ss_pred CCHHHHhcCHHHhhccccccc
Confidence 999999999999987655443
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=302.76 Aligned_cols=168 Identities=30% Similarity=0.525 Sum_probs=142.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC---CcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD---GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+.|...+.+++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|+.... .....+.||||.|.|||++.
T Consensus 273 l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~-~sfm~TlCGTpsYvAPEVl~ 351 (475)
T KOG0615|consen 273 LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE-GSFMKTLCGTPSYVAPEVLA 351 (475)
T ss_pred cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc-ceehhhhcCCccccChhhee
Confidence 4577889999999999999999999999999999999876 6799999999998764 36678999999999999998
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH-HHHHHHhCCCCCC-CCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR-ALFQIVRNPPPGL-YRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
+... ..+..++|+||+||+||-+++|.+||.+..... ...++.++..... .....+|+++++||.+||..||++||
T Consensus 352 ~kg~--~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~ 429 (475)
T KOG0615|consen 352 SKGV--EYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP 429 (475)
T ss_pred cCCe--ecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc
Confidence 7422 334458999999999999999999998766555 6667776654333 12345699999999999999999999
Q ss_pred CHHHHhcCcCCCCCCC
Q psy9090 156 YMSELLEHPFITSLPE 171 (488)
Q Consensus 156 s~~ell~hp~f~~~~~ 171 (488)
|++++|+||||+..+-
T Consensus 430 s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 430 SADEALNHPWFKDAPC 445 (475)
T ss_pred CHHHHhcChhhhcccc
Confidence 9999999999997653
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=309.55 Aligned_cols=159 Identities=35% Similarity=0.636 Sum_probs=146.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.+++++++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|........+..+.||||.|+|||++..
T Consensus 115 ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k-- 192 (592)
T KOG0575|consen 115 LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK-- 192 (592)
T ss_pred CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhcc--
Confidence 689999999999999999999999999999999999999999999999999998877788899999999999999975
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++..+||||+||++|.||+|+|||....-.+...++.... ...|..+|.++++||.+||++||.+|||++++
T Consensus 193 ---~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~---Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~v 266 (592)
T KOG0575|consen 193 ---SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE---YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEV 266 (592)
T ss_pred ---CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC---cccccccCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 778999999999999999999999999987777766666542 33466899999999999999999999999999
Q ss_pred hcCcCCC
Q psy9090 161 LEHPFIT 167 (488)
Q Consensus 161 l~hp~f~ 167 (488)
|.|+||+
T Consensus 267 L~h~Ff~ 273 (592)
T KOG0575|consen 267 LDHPFFK 273 (592)
T ss_pred hcCHhhh
Confidence 9999994
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=301.40 Aligned_cols=171 Identities=27% Similarity=0.514 Sum_probs=149.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-------------CccccccCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-------------DKKKTFLGS 67 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-------------~~~~~~~gt 67 (488)
|+|..+++++.||+.||+|||++|||||||||+|||++.+|++||+|||.++.+.+.. ....+++||
T Consensus 171 fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGT 250 (604)
T KOG0592|consen 171 FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGT 250 (604)
T ss_pred chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeee
Confidence 5788999999999999999999999999999999999999999999999998654221 112568999
Q ss_pred CccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhc
Q psy9090 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECL 147 (488)
Q Consensus 68 ~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 147 (488)
..|.+||++.. ...++.+|+|+|||++|+|+.|.+||.+.++.....+|+.- ....+..+++.+++||+++|
T Consensus 251 AeYVSPElL~~-----~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l---~y~fp~~fp~~a~dLv~KLL 322 (604)
T KOG0592|consen 251 AEYVSPELLND-----SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL---DYEFPEGFPEDARDLIKKLL 322 (604)
T ss_pred ecccCHHHhcC-----CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh---cccCCCCCCHHHHHHHHHHH
Confidence 99999999986 56788999999999999999999999999977766666653 22346778999999999999
Q ss_pred ccCCCCCCCHHHHhcCcCCCCCCCCccccccc
Q psy9090 148 EKNPEHRPYMSELLEHPFITSLPENDLHLSTV 179 (488)
Q Consensus 148 ~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~ 179 (488)
..||.+|+|+++|.+||||.+++|+.+...+.
T Consensus 323 v~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~P 354 (604)
T KOG0592|consen 323 VRDPSDRLTSQQIKAHPFFEGVDWENLWQQTP 354 (604)
T ss_pred ccCccccccHHHHhhCcccccCChhhhhhcCC
Confidence 99999999999999999999999998655543
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=310.96 Aligned_cols=182 Identities=32% Similarity=0.533 Sum_probs=164.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|..++.|++.|+.||+|||++||||||||.+|||+|..|++||+|||+++........+.+++|||.|+|||++.+
T Consensus 465 F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e-- 542 (694)
T KOG0694|consen 465 FSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE-- 542 (694)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhcc--
Confidence 689999999999999999999999999999999999999999999999999987655578899999999999999987
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
..|+.++|+|||||++|+|+.|..||.+.+..+....|+.... ..|..+|.++.++|+++|.++|++|+.
T Consensus 543 ---~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~---~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~ 616 (694)
T KOG0694|consen 543 ---QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFLSKEAIAIMRRLLRKNPEKRLGSGER 616 (694)
T ss_pred ---CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCcccHHHHHHHHHHhccCcccccCCCCC
Confidence 7899999999999999999999999999998877777765422 246778999999999999999999985
Q ss_pred -HHHHhcCcCCCCCCCCcccccccccccccchhhh
Q psy9090 157 -MSELLEHPFITSLPENDLHLSTVNCQYKDQELQT 190 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 190 (488)
+.+|..||||++++|+.+....+.++|.+.....
T Consensus 617 d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~ 651 (694)
T KOG0694|consen 617 DAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGP 651 (694)
T ss_pred CchhhhhCCccccCCHHHHhhccCCCCCCcccCCh
Confidence 5889999999999999999999999887754433
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=267.14 Aligned_cols=162 Identities=30% Similarity=0.515 Sum_probs=142.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC---CcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD---GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
.||..+.++++||+++|.|||.+||||||+||+|+|+-+. .-+||+|||++.... .......++|||.|+|||+++
T Consensus 107 ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvr 185 (355)
T KOG0033|consen 107 YSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLK 185 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhh
Confidence 3788999999999999999999999999999999999643 359999999999887 335667789999999999998
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
. .+|+..+|||+.||+||.|+.|.+||.+.+...+..+|..+... +.+..+.+++++++|+++||..||.+|+|
T Consensus 186 k-----dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt 260 (355)
T KOG0033|consen 186 K-----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT 260 (355)
T ss_pred c-----CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc
Confidence 6 78999999999999999999999999998877877888765432 11234567999999999999999999999
Q ss_pred HHHHhcCcCCCC
Q psy9090 157 MSELLEHPFITS 168 (488)
Q Consensus 157 ~~ell~hp~f~~ 168 (488)
+.++|+|||+++
T Consensus 261 a~EAL~HpWi~~ 272 (355)
T KOG0033|consen 261 ADEALKHPWICN 272 (355)
T ss_pred HHHHhCCchhcc
Confidence 999999999986
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=295.32 Aligned_cols=163 Identities=42% Similarity=0.809 Sum_probs=155.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.+|+.|++++++||+|||.+||+|||||.+|||++.+|.+||+|||+|..+........+.+|||+|||||++..
T Consensus 366 ~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr-- 443 (550)
T KOG0578|consen 366 MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR-- 443 (550)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhh--
Confidence 689999999999999999999999999999999999999999999999999988877677888999999999999975
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..|++++||||||+++.||+-|.+||-..++...++.+..+..|.+..+..+|+.+++|+.+||..||.+|+++.+|
T Consensus 444 ---k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eL 520 (550)
T KOG0578|consen 444 ---KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKEL 520 (550)
T ss_pred ---cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHH
Confidence 78999999999999999999999999999999999999999999998899999999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
|+||||+.
T Consensus 521 L~HpFl~~ 528 (550)
T KOG0578|consen 521 LEHPFLKM 528 (550)
T ss_pred hcChhhhh
Confidence 99999954
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=289.99 Aligned_cols=172 Identities=28% Similarity=0.499 Sum_probs=146.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccc-----------------------c
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN-----------------------T 57 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~-----------------------~ 57 (488)
|+|+++++|+.+++.||..+|+.|+|||||||+|+||+..|++||+|||+|+.... .
T Consensus 238 L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (550)
T KOG0605|consen 238 LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSD 317 (550)
T ss_pred CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcc
Confidence 68999999999999999999999999999999999999999999999999863210 0
Q ss_pred cC------------------------ccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC
Q psy9090 58 FD------------------------KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113 (488)
Q Consensus 58 ~~------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~ 113 (488)
.. .....+|||.|+|||++.+ .+|+..||+||||||+||||.|.+||.+.+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-----kgY~~~cDwWSLG~ImyEmLvGyPPF~s~t 392 (550)
T KOG0605|consen 318 FPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-----KGYGKECDWWSLGCIMYEMLVGYPPFCSET 392 (550)
T ss_pred ccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-----CCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 00 0123589999999999997 779999999999999999999999999999
Q ss_pred hHHHHHHHHhCC-CCCCCCCCCcCHHHHHHHHHhcccCCCCCC---CHHHHhcCcCCCCCCCCcccccc
Q psy9090 114 PTRALFQIVRNP-PPGLYRASNWSQHYVDFIAECLEKNPEHRP---YMSELLEHPFITSLPENDLHLST 178 (488)
Q Consensus 114 ~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~~~~~~~~~~~ 178 (488)
+.+...+++... .-..+.....+++++|||.+||. ||++|. +++||..||||+.++|+.+....
T Consensus 393 p~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~ 460 (550)
T KOG0605|consen 393 PQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMP 460 (550)
T ss_pred HHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCC
Confidence 988887776532 12223345668999999999999 999997 58999999999999999876554
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=267.19 Aligned_cols=168 Identities=29% Similarity=0.557 Sum_probs=144.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|||++.+.||+|+++|+.|||.++||||||||+|||++++..+||+|||++....++ .+....||||+|+|||.+.+.-
T Consensus 120 lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m 198 (411)
T KOG0599|consen 120 LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG-EKLRELCGTPGYLAPETIKCSM 198 (411)
T ss_pred ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc-hhHHHhcCCCcccChhheeeec
Confidence 689999999999999999999999999999999999999999999999999988765 6677889999999999998732
Q ss_pred -cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 -KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 -~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
.+-.+|+..+|+|++||++|.|+.|.+||+.....-.+..+..+... ..+...++|...++||.+||+.||.+|.|++
T Consensus 199 ~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritak 278 (411)
T KOG0599|consen 199 YENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAK 278 (411)
T ss_pred ccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHH
Confidence 23467999999999999999999999999876655545555544321 1123346689999999999999999999999
Q ss_pred HHhcCcCCCCC
Q psy9090 159 ELLEHPFITSL 169 (488)
Q Consensus 159 ell~hp~f~~~ 169 (488)
++|.||||.++
T Consensus 279 e~LaHpff~q~ 289 (411)
T KOG0599|consen 279 EALAHPFFIQI 289 (411)
T ss_pred HHhcChHHHHH
Confidence 99999999654
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=268.27 Aligned_cols=166 Identities=27% Similarity=0.563 Sum_probs=143.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++++.++.|++|++.|+.|||++++|||||||+|||++.+|.+||||||+|+....+....+..+.|.+|+|||.+.+.
T Consensus 98 ~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGD- 176 (396)
T KOG0593|consen 98 VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGD- 176 (396)
T ss_pred CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhccc-
Confidence 4788999999999999999999999999999999999999999999999999887555666777899999999999874
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC-----------------------CCCCCC-----CC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN-----------------------PPPGLY-----RA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~-----------------------~~~~~~-----~~ 132 (488)
.+|+..+||||+||++.||++|.+.|++.+...+++.|... +.+... ..
T Consensus 177 ---tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~ 253 (396)
T KOG0593|consen 177 ---TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKY 253 (396)
T ss_pred ---CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhc
Confidence 68999999999999999999999999999988887776531 001100 12
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
+..+..+.+|+++||..||.+|++.+++|.||||.++-
T Consensus 254 p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 254 PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 34567789999999999999999999999999996543
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=289.21 Aligned_cols=163 Identities=31% Similarity=0.536 Sum_probs=145.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.+++++++||+.|+.|||..+|+||||||+|+|++..+.|||+|||+|..-.++ ....+.||+|+|.|||++.+
T Consensus 109 l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-klLeTSCGSPHYA~PEIV~G-- 185 (786)
T KOG0588|consen 109 LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KLLETSCGSPHYAAPEIVSG-- 185 (786)
T ss_pred CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-ccccccCCCcccCCchhhcC--
Confidence 689999999999999999999999999999999999999999999999999765443 66778899999999999998
Q ss_pred cCCCCC-CCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGY-DNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~-~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
.+| +.++||||+|||||.|++|+.||.+.+...++.++.++. +..|.++|+++++||.+||..||++|+|.++
T Consensus 186 ---~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~---f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~e 259 (786)
T KOG0588|consen 186 ---RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV---FEMPSNISSEAQDLLRRMLDVDPSTRITTEE 259 (786)
T ss_pred ---CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc---ccCCCcCCHHHHHHHHHHhccCccccccHHH
Confidence 455 578999999999999999999999888777777776653 3356889999999999999999999999999
Q ss_pred HhcCcCCCCCCCC
Q psy9090 160 LLEHPFITSLPEN 172 (488)
Q Consensus 160 ll~hp~f~~~~~~ 172 (488)
|++|||+.....-
T Consensus 260 I~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 260 ILKHPFLSGYTSL 272 (786)
T ss_pred HhhCchhhcCCCC
Confidence 9999999876543
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.63 Aligned_cols=160 Identities=31% Similarity=0.550 Sum_probs=140.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC-CcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|+|.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||++...........+.+|||.|+|||++.+
T Consensus 117 l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~- 195 (370)
T KOG0583|consen 117 LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSG- 195 (370)
T ss_pred CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCC-
Confidence 5789999999999999999999999999999999999999 99999999999877323356778899999999999987
Q ss_pred ccCCCC-CC-CccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCc-CHHHHHHHHHhcccCCCCCCC
Q psy9090 80 HKEVDG-YD-NRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 80 ~~~~~~-~~-~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~Rps 156 (488)
.. |+ .++||||+||+||.|++|+.||.+.+.......+..... ..|..+ |+++++|+.+||..||.+|+|
T Consensus 196 ----~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~---~~p~~~~S~~~~~Li~~mL~~~P~~R~t 268 (370)
T KOG0583|consen 196 ----KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF---KIPSYLLSPEARSLIEKMLVPDPSTRIT 268 (370)
T ss_pred ----CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc---cCCCCcCCHHHHHHHHHHcCCCcccCCC
Confidence 33 65 689999999999999999999999877766666555422 234455 999999999999999999999
Q ss_pred HHHHhcCcCCCC
Q psy9090 157 MSELLEHPFITS 168 (488)
Q Consensus 157 ~~ell~hp~f~~ 168 (488)
+.++++||||+.
T Consensus 269 ~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 269 LLEILEHPWFQK 280 (370)
T ss_pred HHHHhhChhhcc
Confidence 999999999986
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=266.72 Aligned_cols=179 Identities=30% Similarity=0.518 Sum_probs=161.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++|..++++-.+|+.||.|||+++||+||||.+|.|++++|+|||+|||+++.-.......+++||||.|+|||++..
T Consensus 265 FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD-- 342 (516)
T KOG0690|consen 265 FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED-- 342 (516)
T ss_pred ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhcc--
Confidence 578899999999999999999999999999999999999999999999999987666677889999999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..|+.++|+|.+||++|||+||+.||...+......-|+.. .+..|..++++++.|+..+|.+||.+|.
T Consensus 343 ---nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e---d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpd 416 (516)
T KOG0690|consen 343 ---NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME---DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPD 416 (516)
T ss_pred ---ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh---hccCCccCCHHHHHHHHHHhhcChHhhcCCCch
Confidence 67999999999999999999999999988766655544433 3345778999999999999999999997
Q ss_pred CHHHHhcCcCCCCCCCCcccccccccccccch
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTVNCQYKDQE 187 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 187 (488)
.+.++.+|+||.+++|+....+.+.++|+++.
T Consensus 417 DakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 417 DAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred hHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 47899999999999999999999999998864
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=281.55 Aligned_cols=172 Identities=40% Similarity=0.882 Sum_probs=162.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.+|..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+...........+++|||+|||||+..+..
T Consensus 127 LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET 206 (1187)
T KOG0579|consen 127 LTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCET 206 (1187)
T ss_pred cchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeecc
Confidence 68999999999999999999999999999999999999999999999999987766666778999999999999998876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
-...+|+.++||||||+.|.+|.-+.+|-...++...+.++-+..+|.+..|..|+..+.|++++||.+||..||++.++
T Consensus 207 ~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql 286 (1187)
T KOG0579|consen 207 FKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQL 286 (1187)
T ss_pred ccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHH
Confidence 66789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCcCCCCCCCC
Q psy9090 161 LEHPFITSLPEN 172 (488)
Q Consensus 161 l~hp~f~~~~~~ 172 (488)
++||||.+++.+
T Consensus 287 l~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 287 LKHPFVQNAPSN 298 (1187)
T ss_pred hhCcccccCCcc
Confidence 999999988765
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=273.88 Aligned_cols=165 Identities=29% Similarity=0.525 Sum_probs=143.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|..|+.|+.||++||+|+|++|+.|||+||+|||+..+..|||+|||+|+..... ...+..+.|.+|+|||++..
T Consensus 107 fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-pPYTeYVSTRWYRAPEvLLr-- 183 (538)
T KOG0661|consen 107 FSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-PPYTEYVSTRWYRAPEVLLR-- 183 (538)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-CCcchhhhcccccchHHhhh--
Confidence 689999999999999999999999999999999999999999999999999988765 55667789999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CC------------------CCCC------CCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PP------------------PGLY------RAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~------------------~~~~------~~~ 133 (488)
...|+.++|+|++|||++|+.+-++.|.+.+..+++.++..- +. |... ..+
T Consensus 184 --s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p 261 (538)
T KOG0661|consen 184 --SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP 261 (538)
T ss_pred --ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc
Confidence 267999999999999999999999999999998888887631 10 0000 123
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
+++.++.+||.+||..||.+|||+.++|+||||..-.
T Consensus 262 ~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 262 NASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred ccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 4789999999999999999999999999999997543
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=272.83 Aligned_cols=166 Identities=33% Similarity=0.680 Sum_probs=139.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-CCcEEEEecCCcccccc---ccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETAN---TFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~---~~~~~~~~~gt~~y~aPE~l 76 (488)
|+|..++.+.+||++||.|||++|||||||||+|||++. ++.+||+|||+++.... .........|||.|||||++
T Consensus 114 l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi 193 (313)
T KOG0198|consen 114 LPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVI 193 (313)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhh
Confidence 689999999999999999999999999999999999999 79999999999887653 11234467899999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCC-CChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFED-MHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
..+ ....+++|||||||++.||+||++||.. ......+..+......+ ..|..+|+++++||.+|+..+|++||
T Consensus 194 ~~g----~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rp 268 (313)
T KOG0198|consen 194 RNG----EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDEAKDFLRKCFKRDPEKRP 268 (313)
T ss_pred cCC----CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHHHHHHHHHHhhcCcccCc
Confidence 841 1223589999999999999999999987 45555566665544222 45677899999999999999999999
Q ss_pred CHHHHhcCcCCCCCCC
Q psy9090 156 YMSELLEHPFITSLPE 171 (488)
Q Consensus 156 s~~ell~hp~f~~~~~ 171 (488)
|++++|+|||.+....
T Consensus 269 ta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 269 TAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHhhChhhhcccc
Confidence 9999999999986443
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=271.93 Aligned_cols=170 Identities=39% Similarity=0.798 Sum_probs=147.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc----ccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK----KTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~----~~~~gt~~y~aPE~l 76 (488)
|+|..|+.|+++++.||.|||++|-||||||+.||||+.+|.|||+|||.+........+. .+++|||+|||||++
T Consensus 123 l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl 202 (516)
T KOG0582|consen 123 LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVL 202 (516)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHh
Confidence 6799999999999999999999999999999999999999999999999876554332222 567999999999996
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC-------CCCCCcCHHHHHHHHHhccc
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL-------YRASNWSQHYVDFIAECLEK 149 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~ 149 (488)
.. ...+|+.|+||||||++..||.+|..||....+.+.+...+.+.+|.. .....++..++.+|..||.+
T Consensus 203 ~q---~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~k 279 (516)
T KOG0582|consen 203 MQ---QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVK 279 (516)
T ss_pred hh---cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhc
Confidence 54 236899999999999999999999999999999998888888776622 12345678899999999999
Q ss_pred CCCCCCCHHHHhcCcCCCCCCCCc
Q psy9090 150 NPEHRPYMSELLEHPFITSLPEND 173 (488)
Q Consensus 150 dP~~Rps~~ell~hp~f~~~~~~~ 173 (488)
||.+|||++++|+|+||+......
T Consensus 280 DP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 280 DPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred CcccCCCHHHHhccHHHhhccchh
Confidence 999999999999999999865443
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=251.07 Aligned_cols=168 Identities=29% Similarity=0.481 Sum_probs=144.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+..+++.|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+++.+..........+-|.+|+|||.+.+.
T Consensus 98 l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGs- 176 (318)
T KOG0659|consen 98 LSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGS- 176 (318)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccc-
Confidence 5678999999999999999999999999999999999999999999999999887765555555789999999999874
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCCCCC----------------------CCCCc
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPPGLY----------------------RASNW 135 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~~----------------------~~~~~ 135 (488)
..|+..+||||+||++.||+.|.+-|.+.+..+++..+.+. +.+..+ ..+..
T Consensus 177 ---r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aa 253 (318)
T KOG0659|consen 177 ---RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAA 253 (318)
T ss_pred ---hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccc
Confidence 67999999999999999999999999999888887777641 111111 11234
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 136 SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 136 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
+.++.+|+.+||..||.+|+|+.|+|+|+||++.|..
T Consensus 254 s~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 254 SSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred cHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 6778999999999999999999999999999986543
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-33 Score=257.02 Aligned_cols=164 Identities=29% Similarity=0.486 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC---CcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD---GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
++|.++..|++||..|+.|||+.+|.||||||+|+|...+ ..+||+|||+++..... ....+.+.||.|.|||++.
T Consensus 158 fTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~-~~L~TPc~TPyYvaPevlg 236 (400)
T KOG0604|consen 158 FTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP-GDLMTPCFTPYYVAPEVLG 236 (400)
T ss_pred chHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC-ccccCCcccccccCHHHhC
Confidence 5799999999999999999999999999999999999754 45999999999987653 4556778999999999996
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH---HHHHHhCCCCCCC--CCCCcCHHHHHHHHHhcccCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA---LFQIVRNPPPGLY--RASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~---~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~ 152 (488)
. ..|+..+|+||+||++|.|+||.+||........ +...++.....++ .....|+.++++|+++|..+|.
T Consensus 237 ~-----eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~Pt 311 (400)
T KOG0604|consen 237 P-----EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPT 311 (400)
T ss_pred c-----hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCch
Confidence 5 6799999999999999999999999977654221 2222222222222 2234589999999999999999
Q ss_pred CCCCHHHHhcCcCCCCCC
Q psy9090 153 HRPYMSELLEHPFITSLP 170 (488)
Q Consensus 153 ~Rps~~ell~hp~f~~~~ 170 (488)
+|.|+.++++|||+.+..
T Consensus 312 eRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 312 ERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hheeHHHhhcCchhcccc
Confidence 999999999999998754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=272.98 Aligned_cols=172 Identities=31% Similarity=0.540 Sum_probs=145.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+.|+|||++.+
T Consensus 92 ~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 169 (323)
T cd05571 92 FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-- 169 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcC--
Confidence 578899999999999999999999999999999999999999999999998754333233445679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..++.++||||+||++|+|++|..||...........+.... ...+..+++++.+||.+||..||++||
T Consensus 170 ---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 243 (323)
T cd05571 170 ---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPE 243 (323)
T ss_pred ---CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCC
Confidence 568899999999999999999999998877655555554432 223567899999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCCcccccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTVN 180 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~~ 180 (488)
++.++++||||.+++|.........
T Consensus 244 ~~~~ll~h~~f~~~~~~~~~~~~~~ 268 (323)
T cd05571 244 DAKEIMEHRFFASINWQDVVQKKLE 268 (323)
T ss_pred CHHHHHcCCCcCCCCHHHHHhCCCC
Confidence 8999999999999988765444333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=259.13 Aligned_cols=167 Identities=27% Similarity=0.554 Sum_probs=140.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHK 81 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 81 (488)
+...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+++...-+......-++|.+|+|||++.+.
T Consensus 118 ~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs-- 195 (323)
T KOG0594|consen 118 PPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGS-- 195 (323)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCC--
Confidence 457899999999999999999999999999999999999999999999998766444445667899999999999873
Q ss_pred CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CC----CCCC------------C-CC-------C
Q psy9090 82 EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PP----PGLY------------R-AS-------N 134 (488)
Q Consensus 82 ~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~----~~~~------------~-~~-------~ 134 (488)
..|+..+||||+|||++||+++++.|.+.....++.++.+- +. |... . +. .
T Consensus 196 --~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~ 273 (323)
T KOG0594|consen 196 --TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPK 273 (323)
T ss_pred --CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccc
Confidence 56999999999999999999999999999888877777641 11 1000 0 11 1
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
.++...+++.+||+.+|.+|.|++.+|.||||...+..
T Consensus 274 ~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 274 LDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred cCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 23578999999999999999999999999999987543
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=255.68 Aligned_cols=166 Identities=27% Similarity=0.475 Sum_probs=144.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.|++.||+|||++.|+||||||+|+|++..|.+|++|||+|+....+....+..+-|.+|+|||.+.+.
T Consensus 174 F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~- 252 (419)
T KOG0663|consen 174 FLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGA- 252 (419)
T ss_pred CchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCC-
Confidence 5688999999999999999999999999999999999999999999999999998877777788899999999999984
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC-------CCCCCCCC---------------------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN-------PPPGLYRA--------------------- 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~--------------------- 132 (488)
..|+.++|+||+|||+.||+++++.|.+.....++.+|.+- .+|.+...
T Consensus 253 ---~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~ 329 (419)
T KOG0663|consen 253 ---KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFG 329 (419)
T ss_pred ---cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhcc
Confidence 67999999999999999999999999999888887777641 11111100
Q ss_pred -CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 133 -SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 133 -~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
..+++...+|+..+|.+||.+|.|+++.|+|.||...|
T Consensus 330 ~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 330 ALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred ccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 11357789999999999999999999999999999854
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=259.97 Aligned_cols=167 Identities=29% Similarity=0.512 Sum_probs=139.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++..++.+++||+.||+|+|+.||+||||||.|+|++.+..+|+||||+|+..... ....+..+.|.+|+|||++..
T Consensus 122 L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~ 201 (359)
T KOG0660|consen 122 LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN 201 (359)
T ss_pred ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc
Confidence 578899999999999999999999999999999999999999999999999877532 122345678999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC----------------------CCCCC------
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP----------------------PPGLY------ 130 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~----------------------~~~~~------ 130 (488)
. ..|+.++||||+|||+.||++|++.|.+.+...++..+..-. .+..+
T Consensus 202 ~----~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~ 277 (359)
T KOG0660|consen 202 S----SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSS 277 (359)
T ss_pred c----ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHH
Confidence 3 679999999999999999999999999887766655554210 01110
Q ss_pred CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 131 RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 131 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
..++.++.+.+|+.+||..||.+|+|++++|+|||+..+..
T Consensus 278 ~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 278 IFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 12356899999999999999999999999999999987643
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=261.52 Aligned_cols=179 Identities=30% Similarity=0.532 Sum_probs=159.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+.|..+.+|+.+|+-||-+||++||++||||.+||+++.+|+|||+|||+++...-......+++|||.|+|||++..
T Consensus 447 FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y-- 524 (683)
T KOG0696|consen 447 FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY-- 524 (683)
T ss_pred cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEe--
Confidence 457889999999999999999999999999999999999999999999999876555566788999999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
++|+.++|+||+||+||||+.|++||.+.+..+....|.... ...|..+|.++.++.+.+|.+.|.+|...
T Consensus 525 ---qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ 598 (683)
T KOG0696|consen 525 ---QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPE 598 (683)
T ss_pred ---cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc---CcCcccccHHHHHHHHHHhhcCCccccCCCCc
Confidence 889999999999999999999999999999877776666542 23467889999999999999999999754
Q ss_pred --HHHhcCcCCCCCCCCcccccccccccccch
Q psy9090 158 --SELLEHPFITSLPENDLHLSTVNCQYKDQE 187 (488)
Q Consensus 158 --~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 187 (488)
.++-.||||+.++|+.+...++.+++++..
T Consensus 599 ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 599 GERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred cccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 689999999999999999999888887754
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-33 Score=270.73 Aligned_cols=162 Identities=46% Similarity=0.956 Sum_probs=148.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.++..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+...........+++|||.|||||++.+
T Consensus 108 ~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~-- 185 (467)
T KOG0201|consen 108 LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ-- 185 (467)
T ss_pred CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhcc--
Confidence 367888999999999999999999999999999999999999999999999888776666789999999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..|+.++||||||++.+||++|.+|+.+.++...++-|-+..+|.+. ..||+.+++||..||++||+.|||+.++
T Consensus 186 ---~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~L 260 (467)
T KOG0201|consen 186 ---SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD--GDFSPPFKEFVEACLDKNPEFRPSAKEL 260 (467)
T ss_pred ---ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc--cccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 78999999999999999999999999999987777777666666553 3899999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
|.|+|++..
T Consensus 261 LKh~FIk~a 269 (467)
T KOG0201|consen 261 LKHKFIKRA 269 (467)
T ss_pred hhhHHHHhc
Confidence 999999873
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=250.55 Aligned_cols=151 Identities=27% Similarity=0.502 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH--CC--CeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE--NH--VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~--~g--ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
++|..+|.++.|++.||..||. .. |+||||||.||+++.+|.|||+|||+++.+.....-..+.+|||.||+||.+
T Consensus 121 ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i 200 (375)
T KOG0591|consen 121 IPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERI 200 (375)
T ss_pred CchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHH
Confidence 5899999999999999999999 44 9999999999999999999999999999887766666788999999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
.. .+|+.++||||+||++|||+.-++||.+.+-...-.+|.....++.+ ...+|.++..+|..|+..||..||+
T Consensus 201 ~~-----~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p-~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 201 HE-----SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP-DEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred hc-----CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc-HHHhhhHHHHHHHHHccCCcccCCC
Confidence 87 78999999999999999999999999999766666666655444332 2567999999999999999999998
Q ss_pred H
Q psy9090 157 M 157 (488)
Q Consensus 157 ~ 157 (488)
.
T Consensus 275 t 275 (375)
T KOG0591|consen 275 T 275 (375)
T ss_pred c
Confidence 5
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=265.66 Aligned_cols=165 Identities=25% Similarity=0.502 Sum_probs=141.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
|++.+|++||+||+.||+|||++||+|||||.+||||+.+|.+||+|||+|+....... ..+..+-|.+|+|||++.+.
T Consensus 215 ft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~ 294 (560)
T KOG0600|consen 215 FTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGA 294 (560)
T ss_pred cChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCC
Confidence 68999999999999999999999999999999999999999999999999996654322 35667889999999999984
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCCCC-----------------------CC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGLYR-----------------------AS 133 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~~~-----------------------~~ 133 (488)
..|+.++|+||+||||.||++|++.|.+.+..+++..|.+ .+....+. ..
T Consensus 295 ----t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~ 370 (560)
T KOG0600|consen 295 ----TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFK 370 (560)
T ss_pred ----cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhc
Confidence 6799999999999999999999999999998888777764 11111111 12
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
.+++...+|+..||..||.+|.|+.++|+|+||+..
T Consensus 371 ~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 371 DFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred cCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 357788999999999999999999999999999543
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=258.70 Aligned_cols=167 Identities=28% Similarity=0.488 Sum_probs=145.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccc------------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN------------------------ 56 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~------------------------ 56 (488)
|+|+.+++|+.+|+.||+|||-.|||+|||||+||||.++|+|.|+||.++.....
T Consensus 176 fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~ 255 (459)
T KOG0610|consen 176 FSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQP 255 (459)
T ss_pred cchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccc
Confidence 68999999999999999999999999999999999999999999999988642100
Q ss_pred -----------c---------------------cCccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhc
Q psy9090 57 -----------T---------------------FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD 104 (488)
Q Consensus 57 -----------~---------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~ellt 104 (488)
. ..+...++||-.|+|||++++ .+.+.++|||+|||++|||+.
T Consensus 256 s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-----~GHgsAVDWWtfGIflYEmLy 330 (459)
T KOG0610|consen 256 SCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-----EGHGSAVDWWTFGIFLYEMLY 330 (459)
T ss_pred cccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-----CCCCchhhHHHHHHHHHHHHh
Confidence 0 011234689999999999998 678899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----HHHHhcCcCCCCCCCCc
Q psy9090 105 GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY----MSELLEHPFITSLPEND 173 (488)
Q Consensus 105 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~~ell~hp~f~~~~~~~ 173 (488)
|..||.+.+..+.+.+++.++. .++.....+..++|||+++|.+||.+|.. +.+|.+||||+.+.|.-
T Consensus 331 G~TPFKG~~~~~Tl~NIv~~~l-~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaL 402 (459)
T KOG0610|consen 331 GTTPFKGSNNKETLRNIVGQPL-KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWAL 402 (459)
T ss_pred CCCCcCCCCchhhHHHHhcCCC-cCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhh
Confidence 9999999999888888887653 33334467899999999999999999997 99999999999999983
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=267.49 Aligned_cols=175 Identities=31% Similarity=0.523 Sum_probs=146.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 93 l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (320)
T cd05590 93 FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-- 170 (320)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC--
Confidence 578899999999999999999999999999999999999999999999998754332233445679999999999975
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..++.++|+|||||++|+|++|+.||...+.......+..... ..+..++.+++++|.+||..||.+||++
T Consensus 171 ---~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~ 244 (320)
T cd05590 171 ---MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---VYPTWLSQDAVDILKAFMTKNPTMRLGSLTL 244 (320)
T ss_pred ---CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 5688899999999999999999999998887666666554322 2345679999999999999999999998
Q ss_pred ---HHHhcCcCCCCCCCCccccccccccc
Q psy9090 158 ---SELLEHPFITSLPENDLHLSTVNCQY 183 (488)
Q Consensus 158 ---~ell~hp~f~~~~~~~~~~~~~~~~~ 183 (488)
+++++||||..+.|..+......+++
T Consensus 245 ~~~~~~~~h~~f~~~~~~~~~~~~~~~~~ 273 (320)
T cd05590 245 GGEEAILRHPFFKELDWEKLNRRQIEPPF 273 (320)
T ss_pred CCHHHHHcCCCcCCCCHHHHHhCCCCCCc
Confidence 99999999999888765444433333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=269.78 Aligned_cols=160 Identities=33% Similarity=0.641 Sum_probs=145.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|+.++.+..|++.||.|||+++|+|||+||.|||++..|.+|+||||+++-..........+.|||.|||||++.+
T Consensus 97 lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e-- 174 (808)
T KOG0597|consen 97 LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE-- 174 (808)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcC--
Confidence 689999999999999999999999999999999999999999999999999987665556677889999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.+|+..+|+|||||++||+.+|++||...........|...+.. .|...|..+.+|++.+|.+||.+|.|+.++
T Consensus 175 ---~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~L 248 (808)
T KOG0597|consen 175 ---QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK---PPSTASSSFVNFLQGLLIKDPAQRLTWTDL 248 (808)
T ss_pred ---CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC---CcccccHHHHHHHHHHhhcChhhcccHHHH
Confidence 78999999999999999999999999987777777777765443 355889999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
+.|||+++
T Consensus 249 l~HpF~k~ 256 (808)
T KOG0597|consen 249 LGHPFWKG 256 (808)
T ss_pred hcChHHhh
Confidence 99999875
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=262.58 Aligned_cols=178 Identities=28% Similarity=0.459 Sum_probs=151.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|+.+.+|+.+|+.||.+||+.+||+|||||+|||+|+.|+|+|+|+|+|..+... ......+||.+|||||++..
T Consensus 284 F~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-~~~~~rvGT~GYMAPEvl~n-- 360 (591)
T KOG0986|consen 284 FDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-KPIRGRVGTVGYMAPEVLQN-- 360 (591)
T ss_pred CchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC-CccccccCcccccCHHHHcC--
Confidence 689999999999999999999999999999999999999999999999999987654 44556699999999999987
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH---HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC--
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP-- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 155 (488)
..|+.+.|+|||||++|+|+.|+.||...... +.+.+.+...... .+..+|++++++.+.+|.+||++|.
T Consensus 361 ---e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e--y~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 361 ---EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE--YSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ---CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh--cccccCHHHHHHHHHHHccCHHHhccC
Confidence 56999999999999999999999999654322 2333333332222 3478899999999999999999998
Q ss_pred ---CHHHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 156 ---YMSELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 156 ---s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
+++++.+||||++++|..+......+++.|.
T Consensus 436 rg~ga~evk~HpfFk~lnw~rleagml~PPfiPd 469 (591)
T KOG0986|consen 436 RGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPD 469 (591)
T ss_pred CCcCcchhhhCcccccCCHhHHhccCCCCCCCCC
Confidence 4679999999999999998888777777553
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=262.61 Aligned_cols=177 Identities=23% Similarity=0.404 Sum_probs=143.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .......||+.|+|||++.+
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-- 175 (285)
T cd05631 99 FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINN-- 175 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhcC--
Confidence 468889999999999999999999999999999999999999999999998765332 22344578999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH---HHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC-
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA---LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps- 156 (488)
..++.++||||+||++|+|++|+.||........ ....+... ....+..++..+.+||++||..||.+||+
T Consensus 176 ---~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 176 ---EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred ---CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 5688999999999999999999999986543222 22222221 12234568999999999999999999997
Q ss_pred ----HHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 157 ----MSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 157 ----~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
++++++||||..++++.+......+++.+
T Consensus 251 ~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05631 251 RGNGAAGVKQHPIFKNINFKRLEANMLEPPFCP 283 (285)
T ss_pred CCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCC
Confidence 89999999999999887765555555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=264.63 Aligned_cols=166 Identities=30% Similarity=0.559 Sum_probs=141.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 90 ~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 167 (312)
T cd05585 90 FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-- 167 (312)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcC--
Confidence 578899999999999999999999999999999999999999999999998754333233445679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC---CH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP---YM 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~ 157 (488)
..++.++||||+||++|+|++|..||.+.........+..... ..+..+++.+++||.+||..||.+|| ++
T Consensus 168 ---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 168 ---HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred ---CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 5688999999999999999999999988776666555554322 23567899999999999999999997 57
Q ss_pred HHHhcCcCCCCCCCCcc
Q psy9090 158 SELLEHPFITSLPENDL 174 (488)
Q Consensus 158 ~ell~hp~f~~~~~~~~ 174 (488)
.+++.||||....+...
T Consensus 242 ~e~l~hp~~~~~~~~~~ 258 (312)
T cd05585 242 QEIKNHPFFSQLSWKKL 258 (312)
T ss_pred HHHHcCCCcCCCCHHHH
Confidence 99999999998765543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=265.57 Aligned_cols=170 Identities=32% Similarity=0.588 Sum_probs=142.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+.|+|||++.+
T Consensus 93 ~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (316)
T cd05592 93 FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-- 170 (316)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC--
Confidence 578899999999999999999999999999999999999999999999998764333233445679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH-HH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM-SE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-~e 159 (488)
..++.++|+|||||++|+|++|..||.+.........+... .+. .+..++.++.+||.+||..+|.+||++ .+
T Consensus 171 ---~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~--~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 171 ---QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPH--FPRWISKEAKDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred ---CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCC--CCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence 56889999999999999999999999988766555554432 222 345678999999999999999999986 58
Q ss_pred HhcCcCCCCCCCCcccccc
Q psy9090 160 LLEHPFITSLPENDLHLST 178 (488)
Q Consensus 160 ll~hp~f~~~~~~~~~~~~ 178 (488)
+++||||..+.|..+....
T Consensus 245 l~~h~~~~~~~~~~~~~~~ 263 (316)
T cd05592 245 IRQHPFFRGIDWERLEKRE 263 (316)
T ss_pred HHcCcccCCCCHHHHHhCC
Confidence 8999999998876544333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=256.14 Aligned_cols=169 Identities=27% Similarity=0.509 Sum_probs=142.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC-CcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|+.-+++-++.||+.||+|||+.||+||||||.|+|+|.+ |.+||||||.|+..... ....+...|..|+|||.+.+.
T Consensus 122 mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~-epniSYicSRyYRaPELifga 200 (364)
T KOG0658|consen 122 MPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG-EPNISYICSRYYRAPELIFGA 200 (364)
T ss_pred CceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC-CCceeEEEeccccCHHHHcCc
Confidence 3455788999999999999999999999999999999975 89999999999988765 445667789999999999874
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC-------------CC------CCCC-------CCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN-------------PP------PGLY-------RAS 133 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~-------------~~------~~~~-------~~~ 133 (488)
..|+.+.||||.||++.||+-|++.|.+.+...++..+++- +. |... ...
T Consensus 201 ----~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~ 276 (364)
T KOG0658|consen 201 ----TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFK 276 (364)
T ss_pred ----cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeeccc
Confidence 77999999999999999999999999998887777666531 00 1110 123
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCCcc
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~ 174 (488)
..++++.+|+.++|.++|.+|.++.+++.||||..+.....
T Consensus 277 ~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~ 317 (364)
T KOG0658|consen 277 RLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNT 317 (364)
T ss_pred CCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCc
Confidence 45789999999999999999999999999999988765543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=265.72 Aligned_cols=169 Identities=30% Similarity=0.505 Sum_probs=144.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||+.|+|||++.+
T Consensus 93 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (321)
T cd05591 93 FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-- 170 (321)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcC--
Confidence 468889999999999999999999999999999999999999999999998754333233445679999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..++.++|||||||++|+|++|+.||...........+..... ..+..+++++.++|.+||..+|++||
T Consensus 171 ---~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~ 244 (321)
T cd05591 171 ---LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---LYPVWLSKEAVSILKAFMTKNPNKRLGCVAS 244 (321)
T ss_pred ---CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence 5688999999999999999999999998887766666655432 23445789999999999999999999
Q ss_pred --CHHHHhcCcCCCCCCCCccccc
Q psy9090 156 --YMSELLEHPFITSLPENDLHLS 177 (488)
Q Consensus 156 --s~~ell~hp~f~~~~~~~~~~~ 177 (488)
+++++++||||..++|..+...
T Consensus 245 ~~~~~~~~~hp~~~~~~~~~~~~~ 268 (321)
T cd05591 245 QGGEDAIKQHPFFKEIDWVLLEQR 268 (321)
T ss_pred CCCHHHHhcCCccCCCCHHHHHhC
Confidence 8999999999999888765433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=266.74 Aligned_cols=169 Identities=30% Similarity=0.530 Sum_probs=142.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 92 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 169 (328)
T cd05593 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-- 169 (328)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcC--
Confidence 578899999999999999999999999999999999999999999999998754332233345679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..++.++|||||||++|+|++|..||...........+.... ...+..+++++.+||.+||..||.+|+
T Consensus 170 ---~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 243 (328)
T cd05593 170 ---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED---IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPD 243 (328)
T ss_pred ---CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC---ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCC
Confidence 568899999999999999999999998877655544444322 223567899999999999999999997
Q ss_pred CHHHHhcCcCCCCCCCCccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLS 177 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~ 177 (488)
++.++++||||....|......
T Consensus 244 ~~~~il~h~~~~~~~~~~~~~~ 265 (328)
T cd05593 244 DAKEIMRHSFFTGVNWQDVYDK 265 (328)
T ss_pred CHHHHhcCCCcCCCCHHHHHhC
Confidence 8999999999999887655433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=265.86 Aligned_cols=171 Identities=30% Similarity=0.550 Sum_probs=143.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+.|+|||++.+
T Consensus 98 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 175 (324)
T cd05587 98 FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-- 175 (324)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcC--
Confidence 478899999999999999999999999999999999999999999999998754322233345679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..++.++|+||+||++|+|++|+.||.+.........+..... ..+..+++.+.+++.+||..||.+|++.
T Consensus 176 ---~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 249 (324)
T cd05587 176 ---QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---SYPKSLSKEAVSICKGLLTKHPAKRLGCGPT 249 (324)
T ss_pred ---CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCC
Confidence 5688999999999999999999999988877666655554322 2345679999999999999999999976
Q ss_pred --HHHhcCcCCCCCCCCccccccc
Q psy9090 158 --SELLEHPFITSLPENDLHLSTV 179 (488)
Q Consensus 158 --~ell~hp~f~~~~~~~~~~~~~ 179 (488)
+++++||||+.++|..+.....
T Consensus 250 ~~~~~~~hp~~~~~~~~~~~~~~~ 273 (324)
T cd05587 250 GERDIREHAFFRRIDWEKLERREI 273 (324)
T ss_pred CHHHHhcCCCcCCCCHHHHHhCCC
Confidence 8999999999998875544333
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=260.94 Aligned_cols=167 Identities=34% Similarity=0.563 Sum_probs=141.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc-----cCccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT-----FDKKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~ 75 (488)
|++.+++.|++.++.||.|||.+|||||||||+|+|++.+|+|||+|||.+...... .......+|||.|+|||.
T Consensus 207 ls~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~ 286 (576)
T KOG0585|consen 207 LSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL 286 (576)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence 578999999999999999999999999999999999999999999999998765221 122334689999999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
+.++.. ....+.+.||||+||+||.|+.|+.||.+....+...+|+..+. .++..+.+.+.+++||.+||.+||++|+
T Consensus 287 c~~~~~-~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri 364 (576)
T KOG0585|consen 287 CSGGNS-FSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRI 364 (576)
T ss_pred hcCCCC-ccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcc-cCCCcccccHHHHHHHHHHhhcChhhee
Confidence 976432 12345789999999999999999999999887777777776543 3334456789999999999999999999
Q ss_pred CHHHHhcCcCCCCC
Q psy9090 156 YMSELLEHPFITSL 169 (488)
Q Consensus 156 s~~ell~hp~f~~~ 169 (488)
++.++..|||...-
T Consensus 365 ~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 365 TLPDIKLHPWVTRD 378 (576)
T ss_pred ehhhheecceeccC
Confidence 99999999999864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=264.83 Aligned_cols=169 Identities=28% Similarity=0.523 Sum_probs=140.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.............||+.|+|||++.+
T Consensus 93 ~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (316)
T cd05620 93 FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG-- 170 (316)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC--
Confidence 467889999999999999999999999999999999999999999999998754322233445679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH-HH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM-SE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-~e 159 (488)
..++.++|+||+||++|+|++|..||.+.........+... .+. .+..++.++++||.+||..||++||++ ++
T Consensus 171 ---~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~dP~~R~~~~~~ 244 (316)
T cd05620 171 ---LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPH--YPRWITKESKDILEKLFERDPTRRLGVVGN 244 (316)
T ss_pred ---CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCC--CCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence 56889999999999999999999999887765555444332 222 244578999999999999999999998 58
Q ss_pred HhcCcCCCCCCCCccccc
Q psy9090 160 LLEHPFITSLPENDLHLS 177 (488)
Q Consensus 160 ll~hp~f~~~~~~~~~~~ 177 (488)
+++||||+.+++..+...
T Consensus 245 ~~~h~~f~~~~~~~~~~~ 262 (316)
T cd05620 245 IRGHPFFKTINWTALEKR 262 (316)
T ss_pred HHcCCCcCCCCHHHHHhC
Confidence 999999999887654333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=265.27 Aligned_cols=177 Identities=31% Similarity=0.523 Sum_probs=148.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 98 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 175 (323)
T cd05616 98 FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY-- 175 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC--
Confidence 578899999999999999999999999999999999999999999999998754332233445679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..++.++|+|||||++|+|++|+.||.+.........+..... ..+..+++++.+++.+||..+|.+|++.
T Consensus 176 ---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~ 249 (323)
T cd05616 176 ---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPE 249 (323)
T ss_pred ---CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCC
Confidence 6688999999999999999999999998887666666654322 2345689999999999999999999974
Q ss_pred --HHHhcCcCCCCCCCCccccccccccccc
Q psy9090 158 --SELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 158 --~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
.++++||||+.++|.........+++.+
T Consensus 250 ~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~ 279 (323)
T cd05616 250 GERDIKEHAFFRYIDWEKLERKEVQPPYKP 279 (323)
T ss_pred CHHHHhcCCCcCCCCHHHHHhCCCCCCcCC
Confidence 8999999999999887665555554443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=260.32 Aligned_cols=165 Identities=28% Similarity=0.496 Sum_probs=141.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... ......||+.|+|||++.+
T Consensus 98 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-- 172 (291)
T cd05612 98 FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVIQS-- 172 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC---CcccccCChhhcCHHHHcC--
Confidence 46888999999999999999999999999999999999999999999999876543 2234579999999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
..++.++|||||||++|+|++|..||.+.........+..... ..+..+++.+++||++||..||.+||+
T Consensus 173 ---~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 246 (291)
T cd05612 173 ---KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKN 246 (291)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---CCCccCCHHHHHHHHHHcCCCHHHccCCccC
Confidence 5678899999999999999999999998877666666655432 234556899999999999999999995
Q ss_pred -HHHHhcCcCCCCCCCCcccc
Q psy9090 157 -MSELLEHPFITSLPENDLHL 176 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~~ 176 (488)
++++++||||..++|.....
T Consensus 247 ~~~~~l~h~~~~~~~~~~~~~ 267 (291)
T cd05612 247 GADDVKNHRWFKSVDWDDVPQ 267 (291)
T ss_pred CHHHHhcCccccCCCHHHHhc
Confidence 99999999999988865433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=264.57 Aligned_cols=172 Identities=30% Similarity=0.504 Sum_probs=144.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 93 ~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (323)
T cd05575 93 FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-- 170 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcC--
Confidence 468889999999999999999999999999999999999999999999998754333233445679999999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..++.++|||||||++|+|++|..||...........+...... .+..+++.+.++|.+||..||.+||++
T Consensus 171 ---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (323)
T cd05575 171 ---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR---LKPNISVSARHLLEGLLQKDRTKRLGAKDD 244 (323)
T ss_pred ---CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHHhhcCHHhCCCCCCC
Confidence 56889999999999999999999999988766666666554322 345679999999999999999999987
Q ss_pred -HHHhcCcCCCCCCCCcccccccc
Q psy9090 158 -SELLEHPFITSLPENDLHLSTVN 180 (488)
Q Consensus 158 -~ell~hp~f~~~~~~~~~~~~~~ 180 (488)
.++++||||....|..+......
T Consensus 245 ~~~il~~~~~~~~~~~~~~~~~~~ 268 (323)
T cd05575 245 FLEIKNHVFFSSINWDDLVNKKIT 268 (323)
T ss_pred HHHHHcCCCcCCCCHHHHhhccCC
Confidence 69999999999888765444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=262.36 Aligned_cols=180 Identities=27% Similarity=0.476 Sum_probs=162.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|.+..+++|+..+++|++|||++|||+|||||+|.+++.+|.+||.|||+++..... .++-+++|||.|.|||++..
T Consensus 517 Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~KTwTFcGTpEYVAPEIILn-- 593 (732)
T KOG0614|consen 517 FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RKTWTFCGTPEYVAPEIILN-- 593 (732)
T ss_pred cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-CceeeecCCcccccchhhhc--
Confidence 456788999999999999999999999999999999999999999999999998765 67789999999999999987
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
.+.+.++|.||||+++|||++|.+||.+.++......|+++..... .|..++..+.+||+++...+|.+|..
T Consensus 594 ---KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~-~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~ 669 (732)
T KOG0614|consen 594 ---KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE-FPRRITKTATDLIKKLCRDNPTERLGYQKG 669 (732)
T ss_pred ---cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh-cccccchhHHHHHHHHHhcCcHhhhccccC
Confidence 6788999999999999999999999999999888888887754333 45778999999999999999999985
Q ss_pred -HHHHhcCcCCCCCCCCcccccccccccccch
Q psy9090 157 -MSELLEHPFITSLPENDLHLSTVNCQYKDQE 187 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 187 (488)
+.+|..|.||.+++|+.+......+++.++.
T Consensus 670 gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~v 701 (732)
T KOG0614|consen 670 GINDIKKHRWFEGFDWEGLRSRTLPPPIIPSV 701 (732)
T ss_pred ChHHHHhhhhhhcCChhhhhhccCCCCccccC
Confidence 7999999999999999998888887776543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=261.48 Aligned_cols=167 Identities=23% Similarity=0.497 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............+|+.|+|||++.+.
T Consensus 100 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 178 (303)
T cd07869 100 LHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS- 178 (303)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCC-
Confidence 4678899999999999999999999999999999999999999999999987543332333455789999999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-HHHHHHHh---CCCCC----------C----------------C
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVR---NPPPG----------L----------------Y 130 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-~~~~~~~~---~~~~~----------~----------------~ 130 (488)
..++.++|+||+||++|+|++|..||.+.... ..+..+.. .+... . .
T Consensus 179 ---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (303)
T cd07869 179 ---TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAW 255 (303)
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHh
Confidence 45788999999999999999999999875432 22222211 11000 0 0
Q ss_pred CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 131 RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 131 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
....+++.+++|+.+||+.||++|||+.++++||||++++.
T Consensus 256 ~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 256 NKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred hccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 01123567899999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=265.57 Aligned_cols=168 Identities=26% Similarity=0.425 Sum_probs=143.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+
T Consensus 128 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~-- 202 (340)
T PTZ00426 128 FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGTPEYIAPEILLN-- 202 (340)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC---CcceecCChhhcCHHHHhC--
Confidence 57889999999999999999999999999999999999999999999999876542 2345679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..++.++|+||+||++|+|++|.+||.+.++......+..... ..+..+++.++++|++||..+|.+|+
T Consensus 203 ---~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~ 276 (340)
T PTZ00426 203 ---VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKK 276 (340)
T ss_pred ---CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCC
Confidence 5678899999999999999999999998877665556554432 23556799999999999999999995
Q ss_pred CHHHHhcCcCCCCCCCCccccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTV 179 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~ 179 (488)
+++++++||||.+++|........
T Consensus 277 ~~~~~~~hp~f~~~~~~~~~~~~~ 300 (340)
T PTZ00426 277 GAQNVKEHPWFGNIDWVSLLHKNV 300 (340)
T ss_pred CHHHHHcCCCcCCCCHHHHHhCCC
Confidence 899999999999998875544433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=263.71 Aligned_cols=167 Identities=31% Similarity=0.545 Sum_probs=142.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............||+.|+|||++.+
T Consensus 92 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 169 (323)
T cd05595 92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-- 169 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccC--
Confidence 578899999999999999999999999999999999999999999999998754332233345679999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..++.++|+|||||++|+|++|+.||...........+..... ..+..+++.+.+||.+||..||.+|+
T Consensus 170 ---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 243 (323)
T cd05595 170 ---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPS 243 (323)
T ss_pred ---CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCC
Confidence 5688999999999999999999999988776655555544322 23457899999999999999999998
Q ss_pred CHHHHhcCcCCCCCCCCccc
Q psy9090 156 YMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~ 175 (488)
++.++++||||.+..|....
T Consensus 244 ~~~~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 244 DAKEVMEHRFFLSINWQDVV 263 (323)
T ss_pred CHHHHHcCCCcCCCCHHHHH
Confidence 89999999999998876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=248.56 Aligned_cols=183 Identities=32% Similarity=0.563 Sum_probs=159.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|||+.++++..+|..||.|||++||++||||.+|+|++..|++||+|+|+++..-.+....++++|||.|+|||++++
T Consensus 348 lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrg-- 425 (593)
T KOG0695|consen 348 LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-- 425 (593)
T ss_pred CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcc--
Confidence 689999999999999999999999999999999999999999999999999987766788899999999999999998
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCC-------CCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFE-------DMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEH 153 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~-------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 153 (488)
..|+.++|+|+|||+++||+.|+.||. +.+....+++++-... ...|..+|-.+..+++..|.+||.+
T Consensus 426 ---eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--iriprslsvkas~vlkgflnkdp~e 500 (593)
T KOG0695|consen 426 ---EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIPRSLSVKASHVLKGFLNKDPKE 500 (593)
T ss_pred ---cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--ccccceeehhhHHHHHHhhcCCcHH
Confidence 789999999999999999999999994 2333455666654332 2345667888889999999999999
Q ss_pred CC------CHHHHhcCcCCCCCCCCcccccccccccccchhhh
Q psy9090 154 RP------YMSELLEHPFITSLPENDLHLSTVNCQYKDQELQT 190 (488)
Q Consensus 154 Rp------s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 190 (488)
|. .+.++..|+||+.++|+.+..+.+.++|+++-...
T Consensus 501 rlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d 543 (593)
T KOG0695|consen 501 RLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDD 543 (593)
T ss_pred hcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccc
Confidence 96 36899999999999999999999999998764433
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=264.10 Aligned_cols=178 Identities=33% Similarity=0.572 Sum_probs=143.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+.|+|||++.+
T Consensus 93 l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (327)
T cd05617 93 LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-- 170 (327)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCC--
Confidence 578899999999999999999999999999999999999999999999998754332233455679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCC------ChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDM------HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
..++.++|+|||||++|+|++|..||... .......+....... ..+..++..+.++|.+||..||.+|
T Consensus 171 ---~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R 245 (327)
T cd05617 171 ---EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--RIPRFLSVKASHVLKGFLNKDPKER 245 (327)
T ss_pred ---CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHc
Confidence 56889999999999999999999999532 222333333333222 2456689999999999999999999
Q ss_pred CC------HHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 155 PY------MSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 155 ps------~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
++ ++++++||||+.++|+.+......+++.+
T Consensus 246 ~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~ 282 (327)
T cd05617 246 LGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKP 282 (327)
T ss_pred CCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccC
Confidence 97 57999999999999886655544444433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=257.56 Aligned_cols=162 Identities=23% Similarity=0.482 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............+++.|+|||++.+.
T Consensus 100 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 178 (288)
T cd07871 100 MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS- 178 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCC-
Confidence 4678899999999999999999999999999999999999999999999987654332333455789999999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCCC------------------------CCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPPG------------------------LYRAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~~------------------------~~~~~ 133 (488)
..++.++|+||+||++|+|++|++||.+....+.+..+... +.+. .....
T Consensus 179 ---~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (288)
T cd07871 179 ---TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAP 255 (288)
T ss_pred ---cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCC
Confidence 45788999999999999999999999887765554444321 0000 00012
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
..++++++||.+||..||.+|||++++++||||
T Consensus 256 ~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 256 RLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=261.19 Aligned_cols=167 Identities=31% Similarity=0.553 Sum_probs=142.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.............|++.|+|||++.+
T Consensus 98 l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 175 (324)
T cd05589 98 FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-- 175 (324)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcC--
Confidence 578899999999999999999999999999999999999999999999998754333233456679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..++.++|+|||||++|+|++|..||.+.........+..... ..+..+++.+.++|.+||..||.+||
T Consensus 176 ---~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 249 (324)
T cd05589 176 ---TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFLSREAISIMRRLLRRNPERRLGSGEK 249 (324)
T ss_pred ---CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCC
Confidence 5688899999999999999999999998877666665554322 23456799999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCCccc
Q psy9090 156 YMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~ 175 (488)
++.++++||||+.+.+....
T Consensus 250 ~~~~l~~~~~f~~~~~~~~~ 269 (324)
T cd05589 250 DAEDVKKQPFFRDINWDDLL 269 (324)
T ss_pred CHHHHhhCCCcCCCCHHHHH
Confidence 68999999999988766543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=262.54 Aligned_cols=163 Identities=26% Similarity=0.521 Sum_probs=140.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+
T Consensus 115 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-- 189 (329)
T PTZ00263 115 FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---RTFTLCGTPEYLAPEVIQS-- 189 (329)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC---CcceecCChhhcCHHHHcC--
Confidence 47888999999999999999999999999999999999999999999999876543 2234679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
..++.++|||||||++|+|++|..||.+.........+..... ..+..++..+++||.+||..||.+||+
T Consensus 190 ---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 263 (329)
T PTZ00263 190 ---KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKG 263 (329)
T ss_pred ---CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCC
Confidence 5678899999999999999999999988776665555554322 234557899999999999999999996
Q ss_pred -HHHHhcCcCCCCCCCCcc
Q psy9090 157 -MSELLEHPFITSLPENDL 174 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~ 174 (488)
+++++.||||++..|..+
T Consensus 264 ~~~~ll~hp~f~~~~~~~~ 282 (329)
T PTZ00263 264 GVADVKNHPYFHGANWDKL 282 (329)
T ss_pred CHHHHhcCCccCCCCHHHH
Confidence 799999999998877654
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=255.90 Aligned_cols=172 Identities=31% Similarity=0.508 Sum_probs=138.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..............||+.|+|||++.+
T Consensus 94 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 171 (280)
T cd05608 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-- 171 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcC--
Confidence 578899999999999999999999999999999999999999999999998765443333345678999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC-CCCCCCCCCcCHHHHHHHHHhcccCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-PPGLYRASNWSQHYVDFIAECLEKNPEHRP---- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---- 155 (488)
..++.++|+||+||++|+|++|+.||................ ......+..+++.+.+++.+||..||++||
T Consensus 172 ---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 248 (280)
T cd05608 172 ---EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRD 248 (280)
T ss_pred ---CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCC
Confidence 568889999999999999999999997654321111111111 112223456899999999999999999999
Q ss_pred -CHHHHhcCcCCCCCCCCccccc
Q psy9090 156 -YMSELLEHPFITSLPENDLHLS 177 (488)
Q Consensus 156 -s~~ell~hp~f~~~~~~~~~~~ 177 (488)
+++++++||||++..|..+...
T Consensus 249 ~~~~~~l~h~~~~~~~~~~~~~~ 271 (280)
T cd05608 249 GNCDGLRTHPLFRDLNWRQLEAG 271 (280)
T ss_pred CCHHHHhcChhhhcCCHhHHhhc
Confidence 7899999999999887755333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=256.38 Aligned_cols=160 Identities=26% Similarity=0.451 Sum_probs=133.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 107 ~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-- 183 (290)
T cd07862 107 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ-- 183 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhC--
Confidence 467899999999999999999999999999999999999999999999998765433 33345578999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC---CCC---------------------CCCCCcC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP---PGL---------------------YRASNWS 136 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~---~~~---------------------~~~~~~s 136 (488)
..++.++||||+||++|+|++|.+||.+......+..+..... +.. .....++
T Consensus 184 ---~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (290)
T cd07862 184 ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 260 (290)
T ss_pred ---CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCC
Confidence 5688899999999999999999999998876666555543210 000 0012457
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 137 QHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 137 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
+.+++|+.+||..||++|||+.++++||||
T Consensus 261 ~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 261 ELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=261.34 Aligned_cols=171 Identities=32% Similarity=0.541 Sum_probs=143.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+.|+|||++.+
T Consensus 93 l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 170 (318)
T cd05570 93 FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY-- 170 (318)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcC--
Confidence 578899999999999999999999999999999999999999999999998753332233345579999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..++.++|+||+||++|+|++|..||.+.........+.... . ..+..++..+.+||++||..||.+|||+
T Consensus 171 ---~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~ 244 (318)
T cd05570 171 ---QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-V--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPT 244 (318)
T ss_pred ---CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-C--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCC
Confidence 568899999999999999999999998877655555544332 1 2345679999999999999999999999
Q ss_pred --HHHhcCcCCCCCCCCccccccc
Q psy9090 158 --SELLEHPFITSLPENDLHLSTV 179 (488)
Q Consensus 158 --~ell~hp~f~~~~~~~~~~~~~ 179 (488)
.+++.||||+...|........
T Consensus 245 ~~~~ll~~~~~~~~~~~~~~~~~~ 268 (318)
T cd05570 245 GEQDIKGHPFFREIDWDKLERKEI 268 (318)
T ss_pred CHHHHhcCCCcCCCCHHHHHhCCC
Confidence 9999999999988765433333
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=260.43 Aligned_cols=167 Identities=31% Similarity=0.532 Sum_probs=142.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 174 (323)
T cd05584 97 FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR-- 174 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccC--
Confidence 467889999999999999999999999999999999999999999999998754333233445679999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..++.++|||||||++|+|++|+.||...........+..... ..+..+++.+.+||.+||..+|++||
T Consensus 175 ---~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 248 (323)
T cd05584 175 ---SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPG 248 (323)
T ss_pred ---CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCC
Confidence 5678899999999999999999999998877666666655432 23556799999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCCccc
Q psy9090 156 YMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~ 175 (488)
++.++++||||....|..+.
T Consensus 249 ~~~~l~~h~~~~~~~~~~~~ 268 (323)
T cd05584 249 DAAEVQSHPFFRHVNWDDLL 268 (323)
T ss_pred CHHHHhcCCCcCCCCHHHHh
Confidence 89999999999988776543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=263.32 Aligned_cols=167 Identities=30% Similarity=0.549 Sum_probs=140.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 92 l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 170 (325)
T cd05594 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED- 170 (325)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc-
Confidence 5788999999999999999997 79999999999999999999999999998754332233345679999999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC----
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP---- 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---- 155 (488)
..++.++|||||||++|+|++|..||.+.........+.... ...+..+++++.+||.+||..||++|+
T Consensus 171 ----~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (325)
T cd05594 171 ----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGP 243 (325)
T ss_pred ----CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCC
Confidence 568899999999999999999999998877655544443322 223456799999999999999999997
Q ss_pred -CHHHHhcCcCCCCCCCCccc
Q psy9090 156 -YMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 156 -s~~ell~hp~f~~~~~~~~~ 175 (488)
++.++++||||....|....
T Consensus 244 ~~~~~il~h~~~~~~~~~~~~ 264 (325)
T cd05594 244 DDAKEIMQHKFFAGIVWQDVY 264 (325)
T ss_pred CCHHHHhcCCCcCCCCHHHHH
Confidence 89999999999998776543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=256.10 Aligned_cols=163 Identities=30% Similarity=0.524 Sum_probs=145.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE-ccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl-~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|+|+.++.|++||+.|+.|||+..+|||||||+|+.+ .+-|-|||.|||++..+.+. ....+.||+..|.|||++.+
T Consensus 115 l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL~TsCGSLAYSAPEILLG- 192 (864)
T KOG4717|consen 115 LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKLTTSCGSLAYSAPEILLG- 192 (864)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-chhhcccchhhccCchhhhc-
Confidence 5789999999999999999999999999999999876 56789999999999888765 66788999999999999998
Q ss_pred ccCCCCCC-CccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYD-NRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~-~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..|+ +++||||||||||-|+||++||...+..+.+..|+.- ....|...|.++++||..||..||.+|.|.+
T Consensus 193 ----DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC---KYtvPshvS~eCrdLI~sMLvRdPkkRAslE 265 (864)
T KOG4717|consen 193 ----DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC---KYTVPSHVSKECRDLIQSMLVRDPKKRASLE 265 (864)
T ss_pred ----CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc---cccCchhhhHHHHHHHHHHHhcCchhhccHH
Confidence 5565 6899999999999999999999988888877777643 2335677899999999999999999999999
Q ss_pred HHhcCcCCCCCCCC
Q psy9090 159 ELLEHPFITSLPEN 172 (488)
Q Consensus 159 ell~hp~f~~~~~~ 172 (488)
+|..++|++..+..
T Consensus 266 eI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 266 EIVSTSWLQAGDRG 279 (864)
T ss_pred HHhccccccCCCCC
Confidence 99999999987654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=260.36 Aligned_cols=170 Identities=29% Similarity=0.526 Sum_probs=141.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 93 ~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (316)
T cd05619 93 FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-- 170 (316)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcC--
Confidence 467889999999999999999999999999999999999999999999998754322233445679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH-H
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS-E 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~-e 159 (488)
..++.++|+||+||++|+|++|..||.+.........+.... +. .+..++.+++++|.+||..+|++||++. +
T Consensus 171 ---~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 244 (316)
T cd05619 171 ---QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PC--YPRWLTREAKDILVKLFVREPERRLGVKGD 244 (316)
T ss_pred ---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC--CCccCCHHHHHHHHHHhccCHhhcCCChHH
Confidence 568899999999999999999999998877655554443322 22 2345789999999999999999999996 8
Q ss_pred HhcCcCCCCCCCCcccccc
Q psy9090 160 LLEHPFITSLPENDLHLST 178 (488)
Q Consensus 160 ll~hp~f~~~~~~~~~~~~ 178 (488)
+++||||+.+.|..+....
T Consensus 245 l~~h~~~~~~~~~~~~~~~ 263 (316)
T cd05619 245 IRQHPFFREIDWSALEERE 263 (316)
T ss_pred HHcCcccCCCCHHHHHhCC
Confidence 9999999998886554333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=261.95 Aligned_cols=169 Identities=32% Similarity=0.575 Sum_probs=138.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++............+||+.|+|||++.+
T Consensus 93 l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (329)
T cd05588 93 LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-- 170 (329)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcC--
Confidence 578999999999999999999999999999999999999999999999998753332233455689999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC--------hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMH--------PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
..++.++|+||+||++|+|++|+.||.... ......+.+..... ..+..++..+.++|.+||..||.
T Consensus 171 ---~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~ 245 (329)
T cd05588 171 ---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKASSVLKGFLNKDPK 245 (329)
T ss_pred ---CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhccCHH
Confidence 568899999999999999999999995311 11223333333222 23556799999999999999999
Q ss_pred CCCC------HHHHhcCcCCCCCCCCcccc
Q psy9090 153 HRPY------MSELLEHPFITSLPENDLHL 176 (488)
Q Consensus 153 ~Rps------~~ell~hp~f~~~~~~~~~~ 176 (488)
+|+| ++++++||||..++|.....
T Consensus 246 ~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~ 275 (329)
T cd05588 246 ERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ 275 (329)
T ss_pred HcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence 9987 78999999999988765443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.70 Aligned_cols=167 Identities=23% Similarity=0.449 Sum_probs=135.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .......||+.|+|||++.+.
T Consensus 167 l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 245 (440)
T PTZ00036 167 LPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG-QRSVSYICSRFYRAPELMLGA 245 (440)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC-CCcccCCCCcCccCHHHhcCC
Confidence 46788999999999999999999999999999999999665 6999999999865433 233455789999999998652
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC---C----------------CCC-------CCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP---P----------------PGL-------YRAS 133 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~---~----------------~~~-------~~~~ 133 (488)
..|+.++||||+||++|+|++|.+||.+......+.++.... . +.. ..+.
T Consensus 246 ----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~ 321 (440)
T PTZ00036 246 ----TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPK 321 (440)
T ss_pred ----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhcc
Confidence 468899999999999999999999998877655555443210 0 000 0122
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
..++++++||.+||..||.+|||+.++++||||..+...
T Consensus 322 ~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 322 GTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 457889999999999999999999999999999887554
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=279.39 Aligned_cols=176 Identities=24% Similarity=0.426 Sum_probs=148.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccc-ccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN-TFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+||+.+++|+..|+.||.-||+.|+|||||||+|||++..|+|||+|||.|-.... +.-.....+|||.|++||+++..
T Consensus 172 ~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~ 251 (1317)
T KOG0612|consen 172 LPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQ 251 (1317)
T ss_pred ChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhh
Confidence 68999999999999999999999999999999999999999999999999877663 33455677999999999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC-CCCCCCCCCcCHHHHHHHHHhcccCCCCCCC--
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-PPGLYRASNWSQHYVDFIAECLEKNPEHRPY-- 156 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-- 156 (488)
......|++.||+||+||++|||+.|..||......+..-+|.... .-.++....+|+++++||.++|. +|+.|..
T Consensus 252 ~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrn 330 (1317)
T KOG0612|consen 252 GDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRN 330 (1317)
T ss_pred cCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-Chhhhcccc
Confidence 4444779999999999999999999999999887766666666432 11222235689999999999985 5889988
Q ss_pred -HHHHhcCcCCCCCCCCccccc
Q psy9090 157 -MSELLEHPFITSLPENDLHLS 177 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~~~ 177 (488)
++++..||||.+++|+.+...
T Consensus 331 giedik~HpFF~g~~W~~iR~~ 352 (1317)
T KOG0612|consen 331 GIEDIKNHPFFEGIDWDNIRES 352 (1317)
T ss_pred cHHHHHhCccccCCChhhhhhc
Confidence 999999999999999765433
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=264.24 Aligned_cols=171 Identities=29% Similarity=0.520 Sum_probs=141.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............+||+.|+|||++.+.
T Consensus 93 ~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 171 (330)
T cd05586 93 FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE- 171 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCC-
Confidence 5788999999999999999999999999999999999999999999999987543332334456799999999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC----C
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----Y 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----s 156 (488)
..++.++|||||||++|+|++|..||...........+..... .. ....+++.+++||++||..||.+|| +
T Consensus 172 ---~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~ 246 (330)
T cd05586 172 ---KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-RF-PKNVLSDEGRQFVKGLLNRNPQHRLGAHRD 246 (330)
T ss_pred ---CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-CC-CCccCCHHHHHHHHHHcCCCHHHCCCCCCC
Confidence 3578899999999999999999999988776555555543322 11 2234689999999999999999998 6
Q ss_pred HHHHhcCcCCCCCCCCccccc
Q psy9090 157 MSELLEHPFITSLPENDLHLS 177 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~~~~ 177 (488)
+.++++||||....|......
T Consensus 247 ~~~ll~h~~~~~~~~~~~~~~ 267 (330)
T cd05586 247 AVELKEHPFFADIDWDLLSKK 267 (330)
T ss_pred HHHHhcCccccCCCHHHHHhC
Confidence 899999999998877654433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=261.15 Aligned_cols=176 Identities=30% Similarity=0.561 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 93 l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (329)
T cd05618 93 LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-- 170 (329)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcC--
Confidence 578899999999999999999999999999999999999999999999998754333233445679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCC--------ChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDM--------HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~--------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
..++.++|+|||||++|+|++|..||... .......+....... ..+...+..+.++|++||..||.
T Consensus 171 ---~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L~~dP~ 245 (329)
T cd05618 171 ---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPK 245 (329)
T ss_pred ---CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHhcCCHH
Confidence 56888999999999999999999999521 111222232222222 23556789999999999999999
Q ss_pred CCCC------HHHHhcCcCCCCCCCCccccccccccc
Q psy9090 153 HRPY------MSELLEHPFITSLPENDLHLSTVNCQY 183 (488)
Q Consensus 153 ~Rps------~~ell~hp~f~~~~~~~~~~~~~~~~~ 183 (488)
+||+ +.++++||||+.++|.........+++
T Consensus 246 ~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~ 282 (329)
T cd05618 246 ERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPF 282 (329)
T ss_pred HcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCc
Confidence 9998 589999999999888755444443333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=259.04 Aligned_cols=176 Identities=29% Similarity=0.525 Sum_probs=147.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 98 l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 175 (323)
T cd05615 98 FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY-- 175 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcC--
Confidence 578999999999999999999999999999999999999999999999998754333233445679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
..++.++|+||+||++|+|++|.+||.+.........+..... ..+..++..+.+++.+||..+|.+|++
T Consensus 176 ---~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~ 249 (323)
T cd05615 176 ---QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---SYPKSLSKEAVSICKGLMTKHPSKRLGCGPE 249 (323)
T ss_pred ---CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHHHHHHHcccCHhhCCCCCCC
Confidence 5688999999999999999999999998877666666654332 234567899999999999999999997
Q ss_pred -HHHHhcCcCCCCCCCCcccccccccccc
Q psy9090 157 -MSELLEHPFITSLPENDLHLSTVNCQYK 184 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~~~~~~~~~~ 184 (488)
.+++++||||..++|..+......+++.
T Consensus 250 ~~~~i~~h~~f~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05615 250 GERDIREHAFFRRIDWDKLENREIQPPFK 278 (323)
T ss_pred CHHHHhcCcccCCCCHHHHhcCCCCcCcc
Confidence 4789999999999887665544444443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=260.04 Aligned_cols=164 Identities=32% Similarity=0.560 Sum_probs=144.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC----CcEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD----GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~----~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
++|..+..+++||+.+++|||+.||+||||||+|+|+... +.+|++|||++..... .......+|||.|+|||++
T Consensus 132 ~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl 210 (382)
T KOG0032|consen 132 YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVL 210 (382)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhh
Confidence 5899999999999999999999999999999999999643 5799999999998776 4567788999999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.. .+|+..+||||+|+++|.|++|.+||.+.+.......+..... ........+|..++++|.+||..||.+|+
T Consensus 211 ~~-----~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ 285 (382)
T KOG0032|consen 211 GG-----RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRL 285 (382)
T ss_pred cC-----CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCC
Confidence 76 6899999999999999999999999999998777777776543 12223456699999999999999999999
Q ss_pred CHHHHhcCcCCCCCC
Q psy9090 156 YMSELLEHPFITSLP 170 (488)
Q Consensus 156 s~~ell~hp~f~~~~ 170 (488)
|+.++|+|||++...
T Consensus 286 ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 286 TAAQALQHPWIKSIG 300 (382)
T ss_pred CHHHHhcCccccCCc
Confidence 999999999998753
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=260.46 Aligned_cols=170 Identities=28% Similarity=0.491 Sum_probs=143.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+.|+|||++.+
T Consensus 93 ~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (325)
T cd05602 93 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-- 170 (325)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC--
Confidence 467889999999999999999999999999999999999999999999998754333233455679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH--
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS-- 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~-- 158 (488)
..++.++|||||||++|+|++|.+||.+.........+...+. ..+..++..+.++|.+||..+|.+|+++.
T Consensus 171 ---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 171 ---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred ---CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 5688999999999999999999999998877666666554432 23456899999999999999999999875
Q ss_pred --HHhcCcCCCCCCCCcccccc
Q psy9090 159 --ELLEHPFITSLPENDLHLST 178 (488)
Q Consensus 159 --ell~hp~f~~~~~~~~~~~~ 178 (488)
++++|+||..++|..+....
T Consensus 245 ~~~i~~~~~~~~~~~~~~~~~~ 266 (325)
T cd05602 245 FMEIKNHIFFSPINWDDLINKK 266 (325)
T ss_pred HHHHhcCcccCCCCHHHHHhCC
Confidence 89999999998887654333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=262.19 Aligned_cols=170 Identities=25% Similarity=0.433 Sum_probs=137.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc----------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---------------------- 58 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---------------------- 58 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 98 l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (363)
T cd05628 98 LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177 (363)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccc
Confidence 5789999999999999999999999999999999999999999999999987542110
Q ss_pred -------------CccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC
Q psy9090 59 -------------DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP 125 (488)
Q Consensus 59 -------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 125 (488)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+........++....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 252 (363)
T cd05628 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWK 252 (363)
T ss_pred cccccchhhhccccccccccCCccccCHHHHcC-----CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc
Confidence 00124579999999999976 568899999999999999999999999887766666665422
Q ss_pred -CCCCCCCCCcCHHHHHHHHHhcccCCC---CCCCHHHHhcCcCCCCCCCCcccc
Q psy9090 126 -PPGLYRASNWSQHYVDFIAECLEKNPE---HRPYMSELLEHPFITSLPENDLHL 176 (488)
Q Consensus 126 -~~~~~~~~~~s~~~~~li~~~L~~dP~---~Rps~~ell~hp~f~~~~~~~~~~ 176 (488)
....+....++++++++|.+|+. +|. .||+++++++||||++++|+.+..
T Consensus 253 ~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~ 306 (363)
T cd05628 253 ETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRE 306 (363)
T ss_pred CcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHh
Confidence 12222234578999999999875 444 458999999999999999886543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=236.44 Aligned_cols=168 Identities=33% Similarity=0.642 Sum_probs=142.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
++|..+-++...++.||.||.. +||+|||+||+|||++..|.|||||||.+-..... .......|-+.|||||.+.-.
T Consensus 188 iPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-kAhtrsAGC~~YMaPERidp~ 266 (391)
T KOG0983|consen 188 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-KAHTRSAGCAAYMAPERIDPP 266 (391)
T ss_pred chHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-cccccccCCccccCccccCCC
Confidence 4678888999999999999975 68999999999999999999999999999776553 334455788999999998643
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
....|+.++||||||+.++||.||+.||.+.+ ..+.+.+++...+|.++....+|+.+++|+..||.+|+.+||...
T Consensus 267 --~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~ 344 (391)
T KOG0983|consen 267 --DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYN 344 (391)
T ss_pred --CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchH
Confidence 24679999999999999999999999998754 356666777666666655556999999999999999999999999
Q ss_pred HHhcCcCCCCCCC
Q psy9090 159 ELLEHPFITSLPE 171 (488)
Q Consensus 159 ell~hp~f~~~~~ 171 (488)
++|+|||+.....
T Consensus 345 ~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 345 KLLEHPFIKRYET 357 (391)
T ss_pred HHhcCcceeecch
Confidence 9999999987543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=260.56 Aligned_cols=169 Identities=34% Similarity=0.538 Sum_probs=142.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 93 ~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (325)
T cd05604 93 FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-- 170 (325)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC--
Confidence 578899999999999999999999999999999999999999999999998754333233445679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..++.++|||||||++|+|++|.+||...........+..... ..+...+..+.++|.+||..+|.+||++
T Consensus 171 ---~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 171 ---QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---VLRPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred ---CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---cCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 5688899999999999999999999998776666666555432 1234578999999999999999999976
Q ss_pred -HHHhcCcCCCCCCCCccccc
Q psy9090 158 -SELLEHPFITSLPENDLHLS 177 (488)
Q Consensus 158 -~ell~hp~f~~~~~~~~~~~ 177 (488)
.++++||||...+|......
T Consensus 245 ~~~i~~h~~f~~~~~~~~~~~ 265 (325)
T cd05604 245 FLEIQEHPFFESLSWTDLEQK 265 (325)
T ss_pred HHHHhcCCCcCCCCHHHHHhC
Confidence 58999999999887655433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=258.78 Aligned_cols=174 Identities=33% Similarity=0.512 Sum_probs=138.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.
T Consensus 102 ~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 181 (332)
T cd05614 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCC
Confidence 5788999999999999999999999999999999999999999999999987643321 223356799999999998752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP- 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 155 (488)
..++.++|||||||++|+|++|..||..... .......+....+. .+..+++.+.++|.+||..||++||
T Consensus 182 ----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~~ 255 (332)
T cd05614 182 ----GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP--FPSFIGPEAQDLLHKLLRKDPKKRLG 255 (332)
T ss_pred ----CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 3477899999999999999999999964321 12222222222222 3456799999999999999999999
Q ss_pred ----CHHHHhcCcCCCCCCCCcccccccc
Q psy9090 156 ----YMSELLEHPFITSLPENDLHLSTVN 180 (488)
Q Consensus 156 ----s~~ell~hp~f~~~~~~~~~~~~~~ 180 (488)
+++++++||||+...|.........
T Consensus 256 ~~~~~~~~~l~h~~~~~~~~~~~~~~~~~ 284 (332)
T cd05614 256 AGPQGASEIKEHPFFKGLDWEALALRKVN 284 (332)
T ss_pred CCCCCHHHHHcCCCcCCCCHHHHHhCCCC
Confidence 8899999999998877655443333
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=262.62 Aligned_cols=173 Identities=23% Similarity=0.364 Sum_probs=142.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+.
T Consensus 139 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 218 (370)
T cd05596 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccC
Confidence 4788999999999999999999999999999999999999999999999987654321 123456799999999998652
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCC--CCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEH--RPY 156 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~--Rps 156 (488)
.. ...++.++|+|||||++|+|++|.+||.+.........+..... ...+....+|.++++||.+||..+|.+ |+|
T Consensus 219 ~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s 297 (370)
T cd05596 219 GG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNG 297 (370)
T ss_pred CC-CCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCC
Confidence 11 13478899999999999999999999998877666666654322 222233457999999999999999988 999
Q ss_pred HHHHhcCcCCCCCCCCcc
Q psy9090 157 MSELLEHPFITSLPENDL 174 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~ 174 (488)
++++++||||+..+|...
T Consensus 298 ~~ell~h~~~~~~~~~~~ 315 (370)
T cd05596 298 VDEIKSHPFFKNDQWTFD 315 (370)
T ss_pred HHHHhcCcccCCCChhhH
Confidence 999999999998777643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=249.74 Aligned_cols=164 Identities=30% Similarity=0.605 Sum_probs=143.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC------CcEEEEecCCccccccccCccccccCCCccccch
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD------GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPE 74 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~------~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE 74 (488)
++|..++.++.||+.||++||+++||||||||.|||++.+ -.+||+|||+++..... ....+.+|+|.|||||
T Consensus 106 l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~-~~a~tlcGSplYMAPE 184 (429)
T KOG0595|consen 106 LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG-SMAETLCGSPLYMAPE 184 (429)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch-hHHHHhhCCccccCHH
Confidence 6899999999999999999999999999999999999865 45899999999988754 5667889999999999
Q ss_pred hhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 75 IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 75 ~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
+++. ..|+.|+|+||+|+++|+|++|++||...++.+....+.++.......+...+....+|+...|..+|..|
T Consensus 185 V~~~-----~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~ 259 (429)
T KOG0595|consen 185 VIMS-----QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDR 259 (429)
T ss_pred HHHh-----ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCcccc
Confidence 9976 78999999999999999999999999999988877766554333333344557778899999999999999
Q ss_pred CCHHHHhcCcCCCCCC
Q psy9090 155 PYMSELLEHPFITSLP 170 (488)
Q Consensus 155 ps~~ell~hp~f~~~~ 170 (488)
.+..+-+.|++...-+
T Consensus 260 ~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 260 ISFEDFFDHPFLAANP 275 (429)
T ss_pred CchHHhhhhhhcccCc
Confidence 9999999999997655
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=256.76 Aligned_cols=168 Identities=30% Similarity=0.520 Sum_probs=141.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.............||+.|+|||++.+
T Consensus 93 ~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 170 (321)
T cd05603 93 FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-- 170 (321)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC--
Confidence 468889999999999999999999999999999999999999999999998754332233445679999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..++.++|+|||||++|+|++|..||...+.......+...+ ...+...+..+.++|.+||..+|.+||++
T Consensus 171 ---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (321)
T cd05603 171 ---EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP---LQLPGGKTVAACDLLVGLLHKDQRRRLGAKAD 244 (321)
T ss_pred ---CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCC
Confidence 568899999999999999999999998887666555555432 22345678999999999999999999875
Q ss_pred -HHHhcCcCCCCCCCCcccc
Q psy9090 158 -SELLEHPFITSLPENDLHL 176 (488)
Q Consensus 158 -~ell~hp~f~~~~~~~~~~ 176 (488)
.++++||||..+.|..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~ 264 (321)
T cd05603 245 FLEIKNHVFFSPINWDDLYH 264 (321)
T ss_pred HHHHhCCCCcCCCCHHHHhc
Confidence 5999999999888765543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=250.77 Aligned_cols=160 Identities=29% Similarity=0.499 Sum_probs=131.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .......||+.|+|||++.+
T Consensus 105 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-- 181 (288)
T cd07863 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQ-- 181 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc-ccCCCccccccccCchHhhC--
Confidence 578899999999999999999999999999999999999999999999998765432 22334578999999999975
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CC----CC--------C---------CCCCCcC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PP----PG--------L---------YRASNWS 136 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~----~~--------~---------~~~~~~s 136 (488)
..++.++||||+||++|+|++|.+||.+........++... +. +. . .....++
T Consensus 182 ---~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (288)
T cd07863 182 ---STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIE 258 (288)
T ss_pred ---CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcC
Confidence 56889999999999999999999999877665554444321 00 00 0 0112457
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 137 QHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 137 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
..+.++|.+||..||++|||+.+++.||||
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 259 ESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=258.70 Aligned_cols=167 Identities=28% Similarity=0.518 Sum_probs=142.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............||+.|+|||++.+
T Consensus 95 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 172 (318)
T cd05582 95 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-- 172 (318)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC--
Confidence 578999999999999999999999999999999999999999999999998765443233445679999999999975
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
..++.++|+|||||++|+|++|+.||...........+..... ..+..+++.+.+||++||..||.+||+
T Consensus 173 ---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~ 246 (318)
T cd05582 173 ---RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---GMPQFLSPEAQSLLRALFKRNPANRLGAGPD 246 (318)
T ss_pred ---CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCC
Confidence 5678899999999999999999999988877666666554322 234567999999999999999999999
Q ss_pred -HHHHhcCcCCCCCCCCccc
Q psy9090 157 -MSELLEHPFITSLPENDLH 175 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~ 175 (488)
+.+++.||||..+.|..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~ 266 (318)
T cd05582 247 GVEEIKRHPFFSTIDWNKLY 266 (318)
T ss_pred CHHHHhCCCCcCCCCHHHHH
Confidence 7889999999998776543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=259.00 Aligned_cols=169 Identities=27% Similarity=0.505 Sum_probs=140.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc----------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---------------------- 58 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---------------------- 58 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 98 l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (350)
T cd05573 98 FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177 (350)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccc
Confidence 5788999999999999999999999999999999999999999999999987654332
Q ss_pred -------CccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC-CCCCC
Q psy9090 59 -------DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-PPGLY 130 (488)
Q Consensus 59 -------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~ 130 (488)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........++.... ....+
T Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 252 (350)
T cd05573 178 RDHKQRRVRANSTVGTPDYIAPEVLRG-----TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFP 252 (350)
T ss_pred cccccccccccccccCccccCHHHHcC-----CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCC
Confidence 12334579999999999976 578899999999999999999999998887666555555411 11222
Q ss_pred CCCCcCHHHHHHHHHhcccCCCCCCC-HHHHhcCcCCCCCCCCccc
Q psy9090 131 RASNWSQHYVDFIAECLEKNPEHRPY-MSELLEHPFITSLPENDLH 175 (488)
Q Consensus 131 ~~~~~s~~~~~li~~~L~~dP~~Rps-~~ell~hp~f~~~~~~~~~ 175 (488)
....+++.+.+||.+||. +|.+||+ ++++++||||+.++|+...
T Consensus 253 ~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~~ 297 (350)
T cd05573 253 PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLR 297 (350)
T ss_pred CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHHh
Confidence 233479999999999997 9999999 9999999999998886543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=249.72 Aligned_cols=161 Identities=24% Similarity=0.509 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......||+.|+|||++.+
T Consensus 97 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 175 (287)
T cd07848 97 VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcC-
Confidence 4688899999999999999999999999999999999999999999999997654321 12234578999999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC--CC-------------------CCCCC-------
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN--PP-------------------PGLYR------- 131 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~--~~-------------------~~~~~------- 131 (488)
..++.++|+||+||++|+|++|++||.+.........+... +. +....
T Consensus 176 ----~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07848 176 ----APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERR 251 (287)
T ss_pred ----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHh
Confidence 56888999999999999999999999877654443332211 00 00000
Q ss_pred -CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 132 -ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 132 -~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
...+|..+.+||++||..||++|||++++++||||
T Consensus 252 ~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 252 YLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11257889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=255.69 Aligned_cols=168 Identities=27% Similarity=0.471 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.
T Consensus 100 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 179 (338)
T cd07859 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHh
Confidence 57889999999999999999999999999999999999999999999999875432211 123457899999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh--------------------------CCCCC--C
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR--------------------------NPPPG--L 129 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~--------------------------~~~~~--~ 129 (488)
+. ...++.++|||||||++|+|++|++||.+.........+.. ...+. .
T Consensus 180 ~~---~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 256 (338)
T cd07859 180 SF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFS 256 (338)
T ss_pred cc---ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchH
Confidence 41 14578899999999999999999999977654332211110 00000 0
Q ss_pred CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 130 YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 130 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
......++.+.++|.+||..||++|||++++++||||+.+..
T Consensus 257 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 257 QKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 011245788899999999999999999999999999987655
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-31 Score=246.18 Aligned_cols=167 Identities=44% Similarity=0.906 Sum_probs=157.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.++..+++.-+.||+|||...-+|||||..|||++.+|+.||+|||.+-.+........+.+|||.|||||++..
T Consensus 126 L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~E-- 203 (502)
T KOG0574|consen 126 LSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEE-- 203 (502)
T ss_pred ccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHH--
Confidence 689999999999999999999999999999999999999999999999999888877777889999999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
-+|+.++||||||+...||..|++||.+-.+...++.+-.+++|.+..|..||.++.+++++||.++|++|.|+-++
T Consensus 204 ---IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L 280 (502)
T KOG0574|consen 204 ---IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRL 280 (502)
T ss_pred ---hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHH
Confidence 67999999999999999999999999999999999999889999998999999999999999999999999999999
Q ss_pred hcCcCCCCCCCC
Q psy9090 161 LEHPFITSLPEN 172 (488)
Q Consensus 161 l~hp~f~~~~~~ 172 (488)
++|||+++.+.-
T Consensus 281 ~~H~FiknA~g~ 292 (502)
T KOG0574|consen 281 CEHTFIKNAPGC 292 (502)
T ss_pred hhhhhhcCCCcc
Confidence 999999986543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=255.39 Aligned_cols=167 Identities=32% Similarity=0.548 Sum_probs=139.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......||+.|+|||++.+
T Consensus 98 l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-- 172 (333)
T cd05600 98 LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRG-- 172 (333)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcC--
Confidence 57889999999999999999999999999999999999999999999999876543 3345679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC----CCC-CCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP----PGL-YRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~----~~~-~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
..++.++|||||||++|+|++|..||...........+..... +.. .....+++++.+||.+||..+|.+||
T Consensus 173 ---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~ 249 (333)
T cd05600 173 ---KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG 249 (333)
T ss_pred ---CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcC
Confidence 5788999999999999999999999988776655544433211 111 01125689999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCCccc
Q psy9090 156 YMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~ 175 (488)
+++++++||||..+++..+.
T Consensus 250 s~~~ll~h~~~~~~~~~~~~ 269 (333)
T cd05600 250 SLEDIKNHPFFKEVDWNELR 269 (333)
T ss_pred CHHHHHhCcccCCCCHHHHh
Confidence 99999999999998776543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=252.10 Aligned_cols=167 Identities=26% Similarity=0.521 Sum_probs=133.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..............+++.|+|||++.+.
T Consensus 101 ~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 179 (309)
T cd07872 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS- 179 (309)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCC-
Confidence 4678899999999999999999999999999999999999999999999987654332333445688999999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CC------------------CC------CCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PP------------------PG------LYRAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~------------------~~------~~~~~ 133 (488)
..++.++|+||+||++|+|++|++||.+.+.......+.+. +. +. .....
T Consensus 180 ---~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (309)
T cd07872 180 ---SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAP 256 (309)
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhcc
Confidence 45788999999999999999999999877654443333221 00 00 00112
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
.+++++++||.+||..||.+|||+.++++||||+....
T Consensus 257 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 257 RLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred CCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 46788999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=257.78 Aligned_cols=173 Identities=24% Similarity=0.393 Sum_probs=138.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ...+..||+.|+|||++...
T Consensus 139 ~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 218 (370)
T cd05621 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhcc
Confidence 47889999999999999999999999999999999999999999999999976543211 23456799999999999752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCC--CCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEH--RPY 156 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~--Rps 156 (488)
. ....++.++|+||+||++|+|++|.+||.+........++..... ...+....++..+++++.+||..+|.+ |++
T Consensus 219 ~-~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~ 297 (370)
T cd05621 219 G-GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNG 297 (370)
T ss_pred C-CCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCC
Confidence 1 113478899999999999999999999998877666666654322 222223456999999999999865544 889
Q ss_pred HHHHhcCcCCCCCCCCcc
Q psy9090 157 MSELLEHPFITSLPENDL 174 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~ 174 (488)
+.++++||||+...|...
T Consensus 298 ~~e~l~hp~~~~~~~~~~ 315 (370)
T cd05621 298 VEEIKQHPFFKNDQWNWD 315 (370)
T ss_pred HHHHhcCcccCCCCcChH
Confidence 999999999998666533
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=232.22 Aligned_cols=158 Identities=34% Similarity=0.594 Sum_probs=141.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++|..++.+++|++.||.|||.++++||||||+|+|++..|.+|++|||.+.... .....+.+||..|.|||...+
T Consensus 121 f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~-- 196 (281)
T KOG0580|consen 121 FDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEG-- 196 (281)
T ss_pred ccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCC--
Confidence 4678899999999999999999999999999999999999999999999987654 356678899999999999987
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++..+|+|++|++.||++.|.+||......+...++.+- ....|..++..+.|||.+||..+|.+|.+..++
T Consensus 197 ---~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~---~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v 270 (281)
T KOG0580|consen 197 ---RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV---DLKFPSTISGGAADLISRLLVKNPIERLALTEV 270 (281)
T ss_pred ---CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---cccCCcccChhHHHHHHHHhccCccccccHHHH
Confidence 67899999999999999999999999988866666666543 233457889999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
+.|||+..
T Consensus 271 ~~hpwI~a 278 (281)
T KOG0580|consen 271 MDHPWIVA 278 (281)
T ss_pred hhhHHHHh
Confidence 99999864
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=259.35 Aligned_cols=153 Identities=25% Similarity=0.423 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE-ccCCcEEEEecCCccccccccCccccccCCCccccchhhcccccC
Q psy9090 4 QHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHKE 82 (488)
Q Consensus 4 ~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl-~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 82 (488)
.++..|++||+.|+.|||++|+|||||||+|||+ +..|+++|+|||.++..... ..+.+-|..|.|||++..
T Consensus 415 ~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~---- 487 (612)
T KOG0603|consen 415 SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAI---- 487 (612)
T ss_pred HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhcc----
Confidence 4677899999999999999999999999999999 69999999999999876543 445567889999999974
Q ss_pred CCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy9090 83 VDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 83 ~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 162 (488)
..|+++|||||||++||+|++|+.||........+...+..+.. ...+|..+++||++||+.||.+||++.+++.
T Consensus 488 -~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 488 -QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF----SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc----ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 78999999999999999999999999766544333333332211 2677999999999999999999999999999
Q ss_pred CcCCCC
Q psy9090 163 HPFITS 168 (488)
Q Consensus 163 hp~f~~ 168 (488)
||||.+
T Consensus 563 h~w~~~ 568 (612)
T KOG0603|consen 563 HPWFLS 568 (612)
T ss_pred Ccchhc
Confidence 999933
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=256.49 Aligned_cols=174 Identities=25% Similarity=0.455 Sum_probs=141.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++...
T Consensus 99 l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 178 (330)
T cd05601 99 FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccc
Confidence 57889999999999999999999999999999999999999999999999976543211 22334789999999998642
Q ss_pred ccC-CCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 80 HKE-VDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 80 ~~~-~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
... ...++.++|||||||++|+|++|..||..........++..... ...+....+++.+.+||.+||. +|.+|||+
T Consensus 179 ~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~ 257 (330)
T cd05601 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGY 257 (330)
T ss_pred cccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCH
Confidence 221 25678899999999999999999999988776666666554322 1222334679999999999997 99999999
Q ss_pred HHHhcCcCCCCCCCCccc
Q psy9090 158 SELLEHPFITSLPENDLH 175 (488)
Q Consensus 158 ~ell~hp~f~~~~~~~~~ 175 (488)
++++.||||..++|..+.
T Consensus 258 ~~l~~h~~~~~~~~~~~~ 275 (330)
T cd05601 258 EGLCCHPFFSKIDWNNIR 275 (330)
T ss_pred HHHhCCCCcCCCCHHHHh
Confidence 999999999998876543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=259.37 Aligned_cols=170 Identities=26% Similarity=0.460 Sum_probs=138.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc----------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---------------------- 58 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---------------------- 58 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||+++......
T Consensus 98 l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (360)
T cd05627 98 LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177 (360)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccc
Confidence 5788999999999999999999999999999999999999999999999986432110
Q ss_pred -------------CccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC
Q psy9090 59 -------------DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP 125 (488)
Q Consensus 59 -------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 125 (488)
......+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+..+.....++....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~ 252 (360)
T cd05627 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWK 252 (360)
T ss_pred cccccccccccccccccccCCCccccCHHHHcC-----CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCC
Confidence 01124579999999999976 678899999999999999999999999888766665555322
Q ss_pred C-CCCCCCCCcCHHHHHHHHHhcccCCCCCC---CHHHHhcCcCCCCCCCCcccc
Q psy9090 126 P-PGLYRASNWSQHYVDFIAECLEKNPEHRP---YMSELLEHPFITSLPENDLHL 176 (488)
Q Consensus 126 ~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~~~~~~~~~ 176 (488)
. ...+....+++.+++||.+|+ .+|.+|+ ++.++++||||..++|..+..
T Consensus 253 ~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~ 306 (360)
T cd05627 253 ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGHIRE 306 (360)
T ss_pred CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHHHhc
Confidence 1 122223347899999999987 4999998 489999999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=257.84 Aligned_cols=168 Identities=27% Similarity=0.472 Sum_probs=138.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--------------------- 59 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--------------------- 59 (488)
|++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 98 l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (364)
T cd05599 98 FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177 (364)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccc
Confidence 57899999999999999999999999999999999999999999999999865421100
Q ss_pred -----------------ccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHH
Q psy9090 60 -----------------KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV 122 (488)
Q Consensus 60 -----------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~ 122 (488)
.....+||+.|+|||++.. ..++.++|||||||++|+|++|.+||.+.........+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~ 252 (364)
T cd05599 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-----TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII 252 (364)
T ss_pred cccccccccchhhcccccccccccCccccCHHHHcC-----CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHH
Confidence 0113469999999999875 568899999999999999999999999887766655555
Q ss_pred hCCC-CCCCCCCCcCHHHHHHHHHhcccCCCCCCC---HHHHhcCcCCCCCCCCcc
Q psy9090 123 RNPP-PGLYRASNWSQHYVDFIAECLEKNPEHRPY---MSELLEHPFITSLPENDL 174 (488)
Q Consensus 123 ~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~~~~~~~ 174 (488)
.... ...+....+++.+++||.+||. +|.+|++ +.++++||||+..+|..+
T Consensus 253 ~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~ 307 (364)
T cd05599 253 NWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHI 307 (364)
T ss_pred cCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 4221 1222233578999999999996 8999997 999999999999887643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=256.66 Aligned_cols=162 Identities=27% Similarity=0.522 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 120 ~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-- 196 (359)
T cd07876 120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILG-- 196 (359)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccC--
Confidence 467889999999999999999999999999999999999999999999998754332 22344578999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---------------------CCCCCC---------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---------------------PPPGLY--------- 130 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---------------------~~~~~~--------- 130 (488)
..++.++|||||||++|+|++|+.||.+.+.......+... ..+...
T Consensus 197 ---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (359)
T cd07876 197 ---MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFP 273 (359)
T ss_pred ---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcc
Confidence 56889999999999999999999999876544332222110 000000
Q ss_pred ---------CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q psy9090 131 ---------RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168 (488)
Q Consensus 131 ---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 168 (488)
.....++.+++||.+||..||++|||+.++++||||..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 274 DWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred ccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 01123577899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=255.54 Aligned_cols=163 Identities=25% Similarity=0.469 Sum_probs=130.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 116 l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-- 192 (355)
T cd07874 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG-- 192 (355)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc-cccCCccccCCccCHHHHcC--
Confidence 467889999999999999999999999999999999999999999999999765432 22345578999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC---------------------CC-----------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP---------------------PG----------- 128 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~---------------------~~----------- 128 (488)
..++.++|+|||||++|+|++|+.||.+..........+.... +.
T Consensus 193 ---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (355)
T cd07874 193 ---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269 (355)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcc
Confidence 5688999999999999999999999987664443332221100 00
Q ss_pred -------CCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 129 -------LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 129 -------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
.......+..+++||.+||..||++|||+.++++||||...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred ccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00011235678999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=250.75 Aligned_cols=162 Identities=26% Similarity=0.472 Sum_probs=123.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE----ccCCcEEEEecCCcccccccc---CccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL----TKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aP 73 (488)
+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... .......||+.|+||
T Consensus 105 l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aP 184 (317)
T cd07868 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCC
Confidence 4678899999999999999999999999999999999 456789999999997654321 122356789999999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---------HHHHHHHHh---CCC----------CC---
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---------TRALFQIVR---NPP----------PG--- 128 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---------~~~~~~~~~---~~~----------~~--- 128 (488)
|++.+. ..++.++|+||+||++|+|++|.+||..... ...+..+.. .+. +.
T Consensus 185 E~~~~~----~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (317)
T cd07868 185 ELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHST 260 (317)
T ss_pred HHHcCC----CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhh
Confidence 998752 4578899999999999999999999964331 111111111 000 00
Q ss_pred --------CC-----------CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 129 --------LY-----------RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 129 --------~~-----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
.. .....+..+.+||.+||..||.+|||++++|+||||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 261 LMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 001224678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=244.65 Aligned_cols=169 Identities=41% Similarity=0.862 Sum_probs=141.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++..............+++.|+|||++....
T Consensus 100 l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 179 (282)
T cd06643 100 LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccC
Confidence 47889999999999999999999999999999999999999999999999876543323334557899999999986432
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....++.++|+||+||++|+|++|.+||...........+.....+....+..++..++++|.+||..+|.+||++.++
T Consensus 180 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (282)
T cd06643 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQL 259 (282)
T ss_pred CCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 22356788999999999999999999999887766666666554444444556789999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++||||+..
T Consensus 260 l~~~~~~~~ 268 (282)
T cd06643 260 LQHPFVTVN 268 (282)
T ss_pred hcCCCEecc
Confidence 999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=258.57 Aligned_cols=167 Identities=26% Similarity=0.505 Sum_probs=136.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc-----------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT----------------------- 57 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~----------------------- 57 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 98 ~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (382)
T cd05625 98 FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177 (382)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccc
Confidence 478899999999999999999999999999999999999999999999997532100
Q ss_pred ------------------------cCccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC
Q psy9090 58 ------------------------FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113 (488)
Q Consensus 58 ------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~ 113 (488)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-----TGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred cccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-----CCCCCeeeEEechHHHHHHHhCCCCCCCCC
Confidence 000123579999999999976 578899999999999999999999999887
Q ss_pred hHHHHHHHHhCC-CCCCCCCCCcCHHHHHHHHHhcccCCCCCCC---HHHHhcCcCCCCCCCCc
Q psy9090 114 PTRALFQIVRNP-PPGLYRASNWSQHYVDFIAECLEKNPEHRPY---MSELLEHPFITSLPEND 173 (488)
Q Consensus 114 ~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~~~~~~ 173 (488)
+......+.... ....+....+++++.++|.+|+ .+|.+|++ ++++++||||+.+++..
T Consensus 253 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 253 PLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred HHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHH
Confidence 766555555422 2222334567999999999986 59999997 99999999999987764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=254.30 Aligned_cols=162 Identities=23% Similarity=0.464 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 123 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-- 199 (364)
T cd07875 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG-- 199 (364)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC-CcccCCcccCCcCCHHHHhC--
Confidence 467889999999999999999999999999999999999999999999999765432 22345578999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC---------------------CCC---------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP---------------------GLY--------- 130 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~---------------------~~~--------- 130 (488)
..++.++|||||||++|+|++|+.||.+.+.......++..... ...
T Consensus 200 ---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (364)
T cd07875 200 ---MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP 276 (364)
T ss_pred ---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCc
Confidence 56889999999999999999999999887665554444321100 000
Q ss_pred ---------CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q psy9090 131 ---------RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168 (488)
Q Consensus 131 ---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 168 (488)
.....+..+++||.+||..||.+|||+.++|+||||..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 277 DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred cccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00112467899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=244.71 Aligned_cols=166 Identities=59% Similarity=1.110 Sum_probs=141.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..............|++.|+|||++....
T Consensus 110 ~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (275)
T cd06608 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDE 189 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccc
Confidence 46788999999999999999999999999999999999999999999999876544333344567899999999986543
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....++.++|+|||||++|+|++|.+||..........++.....+....+..++..+++||.+||..||++|||+.++
T Consensus 190 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 190 QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred cccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 33456788999999999999999999999877766667777666555555555688999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
++|||+
T Consensus 270 l~~~~~ 275 (275)
T cd06608 270 LEHPFI 275 (275)
T ss_pred hcCCCC
Confidence 999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=245.62 Aligned_cols=173 Identities=40% Similarity=0.873 Sum_probs=144.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.+|.|||++|++||||||+||+++.++.++|+|||++..............+++.|+|||++.+..
T Consensus 107 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 186 (292)
T cd06644 107 LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeecccc
Confidence 47889999999999999999999999999999999999999999999999875443323334556889999999986432
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....++.++|+|||||++|+|++|.+||..........++.....+....+..++.++.++|.+||..+|++||+++++
T Consensus 187 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 266 (292)
T cd06644 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266 (292)
T ss_pred ccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 22255788999999999999999999999877766655555554444444566788999999999999999999999999
Q ss_pred hcCcCCCCCCCCc
Q psy9090 161 LEHPFITSLPEND 173 (488)
Q Consensus 161 l~hp~f~~~~~~~ 173 (488)
++||||..+.++.
T Consensus 267 l~~~~~~~~~~~~ 279 (292)
T cd06644 267 LEHPFVSSVTSNR 279 (292)
T ss_pred hcCccccccccch
Confidence 9999999887764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=266.07 Aligned_cols=163 Identities=20% Similarity=0.377 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCC----------------cEEEEecCCccccccccCcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDG----------------EVKIVDFGLSRETANTFDKKKT 63 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~----------------~vkL~Dfg~a~~~~~~~~~~~~ 63 (488)
|++..++.|+.||+.||+|||+ .|||||||||+|||++.++ .+||+|||.+.... .....
T Consensus 228 l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~ 304 (467)
T PTZ00284 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTA 304 (467)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc---ccccc
Confidence 5788899999999999999998 5999999999999998765 49999999875432 22345
Q ss_pred ccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC--CCCC-------------
Q psy9090 64 FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN--PPPG------------- 128 (488)
Q Consensus 64 ~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~--~~~~------------- 128 (488)
.+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+......+..+... ..+.
T Consensus 305 ~~gt~~Y~APE~~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~ 379 (467)
T PTZ00284 305 IVSTRHYRSPEVVLG-----LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARL 379 (467)
T ss_pred ccCCccccCcHHhhc-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHH
Confidence 689999999999976 67899999999999999999999999876654433322211 0000
Q ss_pred ----------CCCC--------------CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 129 ----------LYRA--------------SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 129 ----------~~~~--------------~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
...+ ...++.+.+||.+||.+||.+|||++++|+||||.....
T Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 380 LYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred HhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 0000 011456789999999999999999999999999987533
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=253.69 Aligned_cols=161 Identities=34% Similarity=0.569 Sum_probs=149.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++|+.+..|+.||+.|+.|||+++|+|||||+.||+++.++.|||+|||+++..........+.+|||.|++||++.+
T Consensus 103 f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d-- 180 (426)
T KOG0589|consen 103 FPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD-- 180 (426)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC--
Confidence 589999999999999999999999999999999999999999999999999998876557788999999999999987
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.+|+.++|||||||++|||++-+++|.+.+......++.+....+ .+..++.+++.+|+.||..+|..||++.++
T Consensus 181 ---~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P--lp~~ys~el~~lv~~~l~~~P~~RPsa~~L 255 (426)
T KOG0589|consen 181 ---IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP--LPSMYSSELRSLVKSMLRKNPEHRPSALEL 255 (426)
T ss_pred ---CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC--CCccccHHHHHHHHHHhhcCCccCCCHHHH
Confidence 889999999999999999999999999999999999998876443 467889999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
|.+|....
T Consensus 256 L~~P~l~~ 263 (426)
T KOG0589|consen 256 LRRPHLLR 263 (426)
T ss_pred hhChhhhh
Confidence 99988764
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=247.00 Aligned_cols=175 Identities=26% Similarity=0.450 Sum_probs=141.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... .......|++.|+|||++.+
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-- 175 (285)
T cd05605 99 FDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKN-- 175 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-CccccccCCCCccCcHHhcC--
Confidence 578899999999999999999999999999999999999999999999998765332 22234578999999999975
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHH---HhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC--
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI---VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP-- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 155 (488)
..++.++|+||+||++|+|++|..||.+.........+ +..... ..+..++..+.+||.+||..||++||
T Consensus 176 ---~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05605 176 ---ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE--EYSEKFSEAARSICRQLLTKDPGFRLGC 250 (285)
T ss_pred ---CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc--ccCcccCHHHHHHHHHHccCCHHHhcCC
Confidence 56888999999999999999999999876543322222 222111 12345789999999999999999999
Q ss_pred ---CHHHHhcCcCCCCCCCCccccccccccc
Q psy9090 156 ---YMSELLEHPFITSLPENDLHLSTVNCQY 183 (488)
Q Consensus 156 ---s~~ell~hp~f~~~~~~~~~~~~~~~~~ 183 (488)
+++++++||||...+|..+......+++
T Consensus 251 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 281 (285)
T cd05605 251 RGEGAEEVKAHPFFRTANFKRLEAGMLEPPF 281 (285)
T ss_pred CCCCHHHHhcCcCccCCCHHHHhhCCCCCCC
Confidence 8999999999999888766544444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=252.48 Aligned_cols=164 Identities=29% Similarity=0.561 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+.
T Consensus 115 l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~- 190 (343)
T cd07878 115 LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYVATRWYRAPEIMLNW- 190 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC---CcCCccccccccCchHhcCC-
Confidence 57889999999999999999999999999999999999999999999999876543 23455789999999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CC-------------------CCCCC------C
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PP-------------------PGLYR------A 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~-------------------~~~~~------~ 132 (488)
..++.++|||||||++|+|++|..||.+......+..+... +. +.... .
T Consensus 191 ---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (343)
T cd07878 191 ---MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF 267 (343)
T ss_pred ---ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhc
Confidence 45788999999999999999999999876654444333211 00 00000 1
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
...++.+.+||.+||..||.+|||+.++++||||.....
T Consensus 268 ~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 268 RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 234667899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=245.49 Aligned_cols=168 Identities=24% Similarity=0.438 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... .......|++.|+|||++.+
T Consensus 92 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-- 168 (277)
T cd05607 92 LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGTNGYMAPEILKE-- 168 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccCCCCCccCHHHHcc--
Confidence 356778899999999999999999999999999999999999999999998765432 22234568999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH----HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT----RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
..++.++|+||+||++|+|++|..||...... ........... . .....+++++++||.+||+.||++||+
T Consensus 169 ---~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~li~~~L~~~P~~R~~ 243 (277)
T cd05607 169 ---EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-K-FEHQNFTEESKDICRLFLAKKPEDRLG 243 (277)
T ss_pred ---CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-c-cccccCCHHHHHHHHHHhccCHhhCCC
Confidence 55889999999999999999999999764322 11222222111 1 122467999999999999999999999
Q ss_pred H----HHHhcCcCCCCCCCCcccc
Q psy9090 157 M----SELLEHPFITSLPENDLHL 176 (488)
Q Consensus 157 ~----~ell~hp~f~~~~~~~~~~ 176 (488)
+ ++++.||||+.+++..+..
T Consensus 244 ~~~~~~~~~~h~~f~~~~~~~~~~ 267 (277)
T cd05607 244 SREKNDDPRKHEFFKTINFPRLEA 267 (277)
T ss_pred CccchhhhhcChhhcCCCHHHHhc
Confidence 9 6788999999987765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=254.67 Aligned_cols=172 Identities=22% Similarity=0.353 Sum_probs=138.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++...
T Consensus 139 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 218 (371)
T cd05622 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218 (371)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhcc
Confidence 4788899999999999999999999999999999999999999999999987654321 123456799999999998752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCC--CCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEH--RPY 156 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~--Rps 156 (488)
.. ...++.++|||||||++|+|++|.+||.+.+......++..... ...+....++..++++|.+||..+|.+ |++
T Consensus 219 ~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~ 297 (371)
T cd05622 219 GG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG 297 (371)
T ss_pred CC-CccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCC
Confidence 11 13478899999999999999999999998877666666654322 223334568999999999999844433 789
Q ss_pred HHHHhcCcCCCCCCCCc
Q psy9090 157 MSELLEHPFITSLPEND 173 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~ 173 (488)
++++++||||++.++..
T Consensus 298 ~~ei~~h~~~~~~~~~~ 314 (371)
T cd05622 298 VEEIKRHLFFKNDQWAW 314 (371)
T ss_pred HHHHhcCcccCCCChhH
Confidence 99999999999866543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=256.02 Aligned_cols=168 Identities=26% Similarity=0.468 Sum_probs=135.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc----------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---------------------- 58 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---------------------- 58 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (381)
T cd05626 98 FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177 (381)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccccc
Confidence 5788999999999999999999999999999999999999999999999875321000
Q ss_pred -------------------------CccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC
Q psy9090 59 -------------------------DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113 (488)
Q Consensus 59 -------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~ 113 (488)
....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 252 (381)
T cd05626 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-----KGYTQLCDWWSVGVILFEMLVGQPPFLAPT 252 (381)
T ss_pred ccccccccccccchhhccccccccccccccccCCccccCHHHHcC-----CCCCCccceeehhhHHHHHHhCCCCCcCCC
Confidence 00123579999999999975 568899999999999999999999998877
Q ss_pred hHHHHHHHHhCC-CCCCCCCCCcCHHHHHHHHHhcc--cCCCCCCCHHHHhcCcCCCCCCCCc
Q psy9090 114 PTRALFQIVRNP-PPGLYRASNWSQHYVDFIAECLE--KNPEHRPYMSELLEHPFITSLPEND 173 (488)
Q Consensus 114 ~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~--~dP~~Rps~~ell~hp~f~~~~~~~ 173 (488)
.......+.... ....+....+++++++||.+|+. .+|..|+++.++++||||+.+.|..
T Consensus 253 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 253 PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence 665555554321 22233334679999999999664 4555699999999999999988764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=255.84 Aligned_cols=166 Identities=24% Similarity=0.439 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc-cCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT-FDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ........||+.|+|||++.+
T Consensus 179 l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 257 (391)
T PHA03212 179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR- 257 (391)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC-
Confidence 467889999999999999999999999999999999999999999999998643221 122345679999999999975
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC-------hHHHHHHHHh--------------------------CCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-------PTRALFQIVR--------------------------NPP 126 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~-------~~~~~~~~~~--------------------------~~~ 126 (488)
..|+.++|||||||++|+|++|..||.... ....+..++. ...
T Consensus 258 ----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 333 (391)
T PHA03212 258 ----DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSS 333 (391)
T ss_pred ----CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccC
Confidence 568999999999999999999998875321 1111111111 000
Q ss_pred C-CCCC-----CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 127 P-GLYR-----ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 127 ~-~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
. +... ....+.++.+||.+||..||.+|||++++|+||||..++.
T Consensus 334 ~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 334 RKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred CCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 0 0000 0123567899999999999999999999999999987643
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=242.17 Aligned_cols=165 Identities=49% Similarity=0.978 Sum_probs=135.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.||+|||+++|+||||||+||+++.++.++|+|||++..............|++.|+|||++.+..
T Consensus 108 l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 187 (272)
T cd06637 108 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhcccc
Confidence 47888999999999999999999999999999999999999999999999876543323344567899999999986532
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....++.++|+||+||++|+|++|..||................... .....++..+.+|+.+||..+|.+|||+.++
T Consensus 188 ~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 266 (272)
T cd06637 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266 (272)
T ss_pred CcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC-CCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 223468889999999999999999999998766555444443332222 2344678999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
+.||||
T Consensus 267 l~~~~~ 272 (272)
T cd06637 267 MKHPFI 272 (272)
T ss_pred hhCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=250.33 Aligned_cols=164 Identities=25% Similarity=0.497 Sum_probs=126.3
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcccccC
Q psy9090 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRCGHKE 82 (488)
Q Consensus 5 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~ 82 (488)
.++.|..||++++.++|++||||.||||.|+|+- .|.+||+|||.|........ ...+.+||+.||+||.+......
T Consensus 461 ~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~ 539 (677)
T KOG0596|consen 461 FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSS 539 (677)
T ss_pred HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcccc
Confidence 6889999999999999999999999999999987 48999999999987654322 33566899999999998763222
Q ss_pred ------CCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCC-cCHHHHHHHHHhcccCCCCCC
Q psy9090 83 ------VDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASN-WSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 83 ------~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rp 155 (488)
.-..++++||||||||||+|+.|++||............+..+......+.- -..++.++++.||..||.+||
T Consensus 540 ~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~ 619 (677)
T KOG0596|consen 540 RENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRW 619 (677)
T ss_pred ccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCC
Confidence 2236789999999999999999999997644222222222333221111111 123389999999999999999
Q ss_pred CHHHHhcCcCCCCC
Q psy9090 156 YMSELLEHPFITSL 169 (488)
Q Consensus 156 s~~ell~hp~f~~~ 169 (488)
|+.++|+|||....
T Consensus 620 si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 620 SIPELLQHPFLQIQ 633 (677)
T ss_pred CcHHHhcCcccccc
Confidence 99999999999764
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=243.25 Aligned_cols=170 Identities=42% Similarity=0.914 Sum_probs=143.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..............+++.|+|||.+....
T Consensus 100 l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 179 (280)
T cd06611 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcc
Confidence 57889999999999999999999999999999999999999999999998876544333344567899999999986432
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....++.++|+||+|+++|+|++|.+||..........++.....+....+..++..+.++|.+||..+|.+||++.++
T Consensus 180 ~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 259 (280)
T cd06611 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259 (280)
T ss_pred cCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 22356788999999999999999999999888776666666655555555566789999999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
++||||....
T Consensus 260 l~~~~~~~~~ 269 (280)
T cd06611 260 LKHPFVSDQS 269 (280)
T ss_pred hcChhhcccc
Confidence 9999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=242.04 Aligned_cols=157 Identities=32% Similarity=0.551 Sum_probs=139.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.+++++++||++|+.|||+++++|||||.+|||++.|+.+||+|||++..+... ....++||+|-|.+||++.+
T Consensus 150 LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kfLqTFCGSPLYASPEIvNG-- 226 (668)
T KOG0611|consen 150 LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KFLQTFCGSPLYASPEIVNG-- 226 (668)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cHHHHhcCCcccCCccccCC--
Confidence 689999999999999999999999999999999999999999999999999776554 45678999999999999987
Q ss_pred cCCCCC-CCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGY-DNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~-~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
.+| ++.+|.|||||+||.|+.|..||.+.+......+|.++.. ..+.-+..+.-||+.||..||++|.|+.+
T Consensus 227 ---~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY----rEP~~PSdA~gLIRwmLmVNP~RRATieD 299 (668)
T KOG0611|consen 227 ---TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY----REPETPSDASGLIRWMLMVNPERRATIED 299 (668)
T ss_pred ---CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc----cCCCCCchHHHHHHHHHhcCcccchhHHH
Confidence 555 5789999999999999999999999988877777776532 23344777889999999999999999999
Q ss_pred HhcCcCCC
Q psy9090 160 LLEHPFIT 167 (488)
Q Consensus 160 ll~hp~f~ 167 (488)
+..|=|..
T Consensus 300 iAsHWWvN 307 (668)
T KOG0611|consen 300 IASHWWVN 307 (668)
T ss_pred Hhhhheee
Confidence 99998874
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=243.05 Aligned_cols=167 Identities=50% Similarity=0.955 Sum_probs=139.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++..............|++.|+|||++....
T Consensus 125 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 204 (291)
T cd06639 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCC
Confidence 46788999999999999999999999999999999999999999999999876543322233456889999999986532
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....++.++|+||+||++|+|++|++||...........+.+...+....+..++..+.++|.+||..+|++||++.++
T Consensus 205 ~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 284 (291)
T cd06639 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHL 284 (291)
T ss_pred CcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 22234688999999999999999999999887766666666655555544556678899999999999999999999999
Q ss_pred hcCcCCC
Q psy9090 161 LEHPFIT 167 (488)
Q Consensus 161 l~hp~f~ 167 (488)
++||||+
T Consensus 285 l~~~~~~ 291 (291)
T cd06639 285 LEHPFIK 291 (291)
T ss_pred hcCcccC
Confidence 9999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=255.50 Aligned_cols=168 Identities=28% Similarity=0.461 Sum_probs=134.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--------------------- 59 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--------------------- 59 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (377)
T cd05629 98 FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177 (377)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccccc
Confidence 57889999999999999999999999999999999999999999999999863211000
Q ss_pred --------------------------ccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC
Q psy9090 60 --------------------------KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113 (488)
Q Consensus 60 --------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~ 113 (488)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 252 (377)
T cd05629 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-----QGYGQECDWWSLGAIMFECLIGWPPFCSEN 252 (377)
T ss_pred ccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-----CCCCCceeeEecchhhhhhhcCCCCCCCCC
Confidence 0012469999999999975 568899999999999999999999998877
Q ss_pred hHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCCC---CCHHHHhcCcCCCCCCCCcc
Q psy9090 114 PTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEHR---PYMSELLEHPFITSLPENDL 174 (488)
Q Consensus 114 ~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~ell~hp~f~~~~~~~~ 174 (488)
.......+..... ...+....++.++++||.+||. +|.+| +++.+++.||||+.++|..+
T Consensus 253 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~ 316 (377)
T cd05629 253 SHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTI 316 (377)
T ss_pred HHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 6655555543221 1222223578999999999997 67765 59999999999998887654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=250.31 Aligned_cols=166 Identities=32% Similarity=0.573 Sum_probs=131.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHK 81 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 81 (488)
++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.....
T Consensus 166 ~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 245 (353)
T PLN00034 166 DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN 245 (353)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccc
Confidence 56788899999999999999999999999999999999999999999998766543333445679999999999854221
Q ss_pred CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH---HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 82 EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 82 ~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
....++.++|||||||++|+|++|+.||...... .....+.....+ ..+..++.++++||.+||..||++|||+.
T Consensus 246 ~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ 323 (353)
T PLN00034 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP--EAPATASREFRHFISCCLQREPAKRWSAM 323 (353)
T ss_pred cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC--CCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence 1233456899999999999999999999743221 112222222111 23456789999999999999999999999
Q ss_pred HHhcCcCCCCC
Q psy9090 159 ELLEHPFITSL 169 (488)
Q Consensus 159 ell~hp~f~~~ 169 (488)
++++||||...
T Consensus 324 ell~hp~~~~~ 334 (353)
T PLN00034 324 QLLQHPFILRA 334 (353)
T ss_pred HHhcCcccccC
Confidence 99999999874
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=262.59 Aligned_cols=162 Identities=29% Similarity=0.521 Sum_probs=139.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+
T Consensus 140 l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 219 (496)
T PTZ00283 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219 (496)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC
Confidence 468889999999999999999999999999999999999999999999998765432 122345679999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..|+.++|||||||++|+|++|+.||.+.........+....... .+..+++++.+++.+||..+|.+||++.
T Consensus 220 -----~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~RPs~~ 292 (496)
T PTZ00283 220 -----KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP--LPPSISPEMQEIVTALLSSDPKRRPSSS 292 (496)
T ss_pred -----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcccChhhCcCHH
Confidence 568899999999999999999999999887766666665544332 3567899999999999999999999999
Q ss_pred HHhcCcCCCCC
Q psy9090 159 ELLEHPFITSL 169 (488)
Q Consensus 159 ell~hp~f~~~ 169 (488)
++++|||++..
T Consensus 293 ell~~p~~~~~ 303 (496)
T PTZ00283 293 KLLNMPICKLF 303 (496)
T ss_pred HHHhCHHHHHh
Confidence 99999998764
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=256.81 Aligned_cols=170 Identities=22% Similarity=0.364 Sum_probs=134.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ ......||+.|+|||++.+
T Consensus 182 l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 261 (392)
T PHA03207 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL 261 (392)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcC
Confidence 57889999999999999999999999999999999999999999999999876543211 2234579999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH---HHHHHHHhC--------------------------CCCCC
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---RALFQIVRN--------------------------PPPGL 129 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~---~~~~~~~~~--------------------------~~~~~ 129 (488)
..|+.++|||||||++|+|++|..||.+.... ..+..+++. ..+..
T Consensus 262 -----~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (392)
T PHA03207 262 -----DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY 336 (392)
T ss_pred -----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCc
Confidence 56889999999999999999999999764321 112221110 00000
Q ss_pred CC-----CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCCccc
Q psy9090 130 YR-----ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 130 ~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~ 175 (488)
.. ...++.++.++|.+||..||++|||+.++|.||||...+++.+.
T Consensus 337 ~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 337 TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLN 387 (392)
T ss_pred cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhhc
Confidence 00 12346788999999999999999999999999999988876543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=236.24 Aligned_cols=159 Identities=31% Similarity=0.622 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.|++.||.+||++|++||||||+||+++.++.++|+|||++..............+++.|+|||++.+
T Consensus 99 l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 176 (257)
T cd08223 99 LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-- 176 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcC--
Confidence 478899999999999999999999999999999999999999999999998765443333445678999999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||...+.......+.....+. .+..+++.+.+++.+||..+|++||++.++
T Consensus 177 ---~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 251 (257)
T cd08223 177 ---KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--MPKDYSPELGELIATMLSKRPEKRPSVKSI 251 (257)
T ss_pred ---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CccccCHHHHHHHHHHhccCcccCCCHHHH
Confidence 567889999999999999999999998777665555555544332 245678999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
++||||
T Consensus 252 l~~~~~ 257 (257)
T cd08223 252 LRQPYI 257 (257)
T ss_pred hcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=248.82 Aligned_cols=175 Identities=21% Similarity=0.432 Sum_probs=139.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+.
T Consensus 99 l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 178 (332)
T cd05623 99 LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhcc
Confidence 47888999999999999999999999999999999999999999999999875432211 22345799999999998743
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-C-CCCCCcCHHHHHHHHHhcccCCCC--CC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-L-YRASNWSQHYVDFIAECLEKNPEH--RP 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~-~~~~~~s~~~~~li~~~L~~dP~~--Rp 155 (488)
......++.++|||||||++|+|++|+.||..........++....... . .....+++.+++||.+||..+|.+ |+
T Consensus 179 ~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~ 258 (332)
T cd05623 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQN 258 (332)
T ss_pred ccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCC
Confidence 2222568889999999999999999999999887766666665432211 1 112457999999999999765544 68
Q ss_pred CHHHHhcCcCCCCCCCCccc
Q psy9090 156 YMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~ 175 (488)
+++++++||||..++|..+.
T Consensus 259 ~~~~~~~h~~f~~~~~~~~~ 278 (332)
T cd05623 259 GIEDFKQHPFFTGIDWDNIR 278 (332)
T ss_pred CHHHHhCCCCcCCCCHHHHh
Confidence 99999999999998887543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=254.70 Aligned_cols=168 Identities=26% Similarity=0.483 Sum_probs=135.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc-----------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT----------------------- 57 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~----------------------- 57 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (376)
T cd05598 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177 (376)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccc
Confidence 478889999999999999999999999999999999999999999999997532100
Q ss_pred --------------------cCccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH
Q psy9090 58 --------------------FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117 (488)
Q Consensus 58 --------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~ 117 (488)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 252 (376)
T cd05598 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAET 252 (376)
T ss_pred cccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-----CCCCcceeeeeccceeeehhhCCCCCCCCCHHHH
Confidence 000123579999999999976 5688999999999999999999999998876655
Q ss_pred HHHHHhCC-CCCCCCCCCcCHHHHHHHHHhcccCCCCCC---CHHHHhcCcCCCCCCCCcc
Q psy9090 118 LFQIVRNP-PPGLYRASNWSQHYVDFIAECLEKNPEHRP---YMSELLEHPFITSLPENDL 174 (488)
Q Consensus 118 ~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~~~~~~~ 174 (488)
...+.... ....+....+++.+.++|.+|+ .+|.+|+ ++.++++||||+.+++...
T Consensus 253 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~ 312 (376)
T cd05598 253 QLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASL 312 (376)
T ss_pred HHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHH
Confidence 55544321 1122223467899999999987 5999999 9999999999998876544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=241.28 Aligned_cols=165 Identities=52% Similarity=1.005 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+....
T Consensus 118 ~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~ 197 (282)
T cd06636 118 LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCccc
Confidence 46788899999999999999999999999999999999999999999999876543323334567899999999986432
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....++.++|+|||||++|+|++|..||....+......+.....+. .....++..+.+||.+||..||.+||++.++
T Consensus 198 ~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~el 276 (282)
T cd06636 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK-LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276 (282)
T ss_pred CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC-CcccccCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 223567889999999999999999999998776555555444433222 2345689999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
++||||
T Consensus 277 l~~~~~ 282 (282)
T cd06636 277 LKHPFI 282 (282)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=249.58 Aligned_cols=165 Identities=39% Similarity=0.783 Sum_probs=149.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|-|-+|+.|+.+.+.||+|||+++.||||||..|||++..|.|||+|||.+.... +..+++|||+|||||++...+
T Consensus 123 lqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----PAnsFvGTPywMAPEVILAMD 198 (948)
T KOG0577|consen 123 LQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----PANSFVGTPYWMAPEVILAMD 198 (948)
T ss_pred chHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC----chhcccCCccccchhHheecc
Confidence 4577899999999999999999999999999999999999999999999986543 456899999999999998765
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
. +.|+-++||||||++..+|...+||+..++....++.|-.+..|.+. ...||..+++|+..||.+-|.+|||.+++
T Consensus 199 E--GqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~l 275 (948)
T KOG0577|consen 199 E--GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEEL 275 (948)
T ss_pred c--cccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHH
Confidence 4 67999999999999999999999999999999999999988877764 56899999999999999999999999999
Q ss_pred hcCcCCCCCCCC
Q psy9090 161 LEHPFITSLPEN 172 (488)
Q Consensus 161 l~hp~f~~~~~~ 172 (488)
|.|+|+..-...
T Consensus 276 l~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 276 LKHRFVLRERPP 287 (948)
T ss_pred hhcchhccCCCc
Confidence 999999765443
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=241.89 Aligned_cols=167 Identities=26% Similarity=0.485 Sum_probs=134.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++...... ......|++.|+|||.+..+
T Consensus 94 l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~- 170 (279)
T cd05633 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKG- 170 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCCCcCccCHHHhcCC-
Confidence 578899999999999999999999999999999999999999999999998654332 22334689999999998532
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP--TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP--- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp--- 155 (488)
..++.++|+||+||++|+|++|..||..... .....+..... ....+..++.+++++|.+||..||++||
T Consensus 171 ---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 245 (279)
T cd05633 171 ---TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV--NVELPDSFSPELKSLLEGLLQRDVSKRLGCL 245 (279)
T ss_pred ---CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcC--CcCCccccCHHHHHHHHHHhcCCHHHhcCCC
Confidence 4578899999999999999999999965432 12222222111 1223456799999999999999999999
Q ss_pred --CHHHHhcCcCCCCCCCCccc
Q psy9090 156 --YMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 156 --s~~ell~hp~f~~~~~~~~~ 175 (488)
|++++++||||+.+.+....
T Consensus 246 ~~~~~~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 246 GRGAQEVKEHVFFKGIDWQQVY 267 (279)
T ss_pred CCCHHHHHhCccccCCCHhHHh
Confidence 69999999999998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=246.10 Aligned_cols=162 Identities=28% Similarity=0.635 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ......||+.|+|||++.+
T Consensus 100 ~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~- 176 (331)
T cd06649 100 IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG- 176 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhcC-
Confidence 46888999999999999999986 6999999999999999999999999998765432 2344578999999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh------------------------------------
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR------------------------------------ 123 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~------------------------------------ 123 (488)
..++.++|+|||||++|+|++|+.||........ ..++.
T Consensus 177 ----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T cd06649 177 ----THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAM 251 (331)
T ss_pred ----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhcccccccccCCccccCcccccccccccccccccccch
Confidence 5688999999999999999999999976554332 11111
Q ss_pred -----------CCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 124 -----------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 124 -----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
...+. .....+++++++||.+||..||++|||+.++++||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 252 AIFELLDYIVNEPPPK-LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred hHHHHHHHHHhCCCcC-CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 11111 112246789999999999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=250.77 Aligned_cols=166 Identities=26% Similarity=0.465 Sum_probs=133.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... .......+++.|+|||++.+.
T Consensus 100 l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 179 (372)
T cd07853 100 LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179 (372)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCC
Confidence 5788999999999999999999999999999999999999999999999987543221 122334678999999998752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh-----------------------CCC-CCC-----C
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR-----------------------NPP-PGL-----Y 130 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~-----------------------~~~-~~~-----~ 130 (488)
..++.++||||+||++|+|++|++||.+.++...+..+.. ... ++. .
T Consensus 180 ----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (372)
T cd07853 180 ----RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYT 255 (372)
T ss_pred ----CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcc
Confidence 4578899999999999999999999987766544433321 000 000 1
Q ss_pred CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 131 RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 131 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
.....++++.+||.+||..||.+|||+.++++||||....
T Consensus 256 ~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 256 LSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 1234578899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=242.96 Aligned_cols=167 Identities=25% Similarity=0.485 Sum_probs=133.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..............+++.|+|||++.+.
T Consensus 101 ~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~- 179 (301)
T cd07873 101 INMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS- 179 (301)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCC-
Confidence 4678899999999999999999999999999999999999999999999987644332233344678999999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCC------------------CC------CCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPP------------------GL------YRAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~------------------~~------~~~~ 133 (488)
..++.++|||||||++|+|++|++||...+.......+... +.. .. ....
T Consensus 180 ---~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (301)
T cd07873 180 ---TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAP 256 (301)
T ss_pred ---CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcC
Confidence 45788999999999999999999999877655444332211 000 00 0012
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
..++.+++||.+||..||.+|||++++++||||..+.+
T Consensus 257 ~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 257 RLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 45788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=243.30 Aligned_cols=166 Identities=27% Similarity=0.463 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .......|++.|+|||++.+
T Consensus 99 l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-- 175 (285)
T cd05630 99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKN-- 175 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-ccccCCCCCccccChHHHcC--
Confidence 467889999999999999999999999999999999999999999999998654332 22234578999999999975
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH---HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC-
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps- 156 (488)
..++.++|+||+||++|+|++|..||...... ............ ..+..+++.+++|+.+||..||++|||
T Consensus 176 ---~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 176 ---ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE--EYSEKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred ---CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh--hcCccCCHHHHHHHHHHhhcCHHHccCC
Confidence 56888999999999999999999999765422 122222222211 124567899999999999999999999
Q ss_pred ----HHHHhcCcCCCCCCCCcc
Q psy9090 157 ----MSELLEHPFITSLPENDL 174 (488)
Q Consensus 157 ----~~ell~hp~f~~~~~~~~ 174 (488)
++++++||||+.+.+..+
T Consensus 251 ~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05630 251 QGGGAREVKEHPLFKQINFKRL 272 (285)
T ss_pred CCCchHHHHcChhhhccCHHHH
Confidence 899999999998777644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=245.70 Aligned_cols=174 Identities=22% Similarity=0.424 Sum_probs=137.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++...
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 178 (331)
T cd05597 99 LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhc
Confidence 57889999999999999999999999999999999999999999999999876543222 12234699999999998743
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCC-CCCCCcCHHHHHHHHHhcccCCCC--CC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGL-YRASNWSQHYVDFIAECLEKNPEH--RP 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~-~~~~~~s~~~~~li~~~L~~dP~~--Rp 155 (488)
......++.++||||+||++|+|++|+.||.+.........+..... ... .....+++.++++|++||..++.+ |+
T Consensus 179 ~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~ 258 (331)
T cd05597 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRN 258 (331)
T ss_pred cccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCC
Confidence 22224578899999999999999999999988776655555543221 111 112347899999999998764443 78
Q ss_pred CHHHHhcCcCCCCCCCCcc
Q psy9090 156 YMSELLEHPFITSLPENDL 174 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~ 174 (488)
++.++++||||...+|...
T Consensus 259 ~~~~~l~hp~~~~~~~~~~ 277 (331)
T cd05597 259 GLQDFKDHPFFEGIDWDNI 277 (331)
T ss_pred CHHHHhcCCCCCCCCHHHH
Confidence 9999999999999887654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=235.57 Aligned_cols=161 Identities=47% Similarity=0.988 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..............++..|+|||++.+
T Consensus 96 l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-- 173 (256)
T cd06612 96 LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-- 173 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhc--
Confidence 478899999999999999999999999999999999999999999999998866544323344568899999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|+.||....+......+.....+....+..++..+.++|.+||..+|++|||+.++
T Consensus 174 ---~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~i 250 (256)
T cd06612 174 ---IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQL 250 (256)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHH
Confidence 56788999999999999999999999877665554444433333333455678899999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
+.||||
T Consensus 251 l~~~~~ 256 (256)
T cd06612 251 LQHPFI 256 (256)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=240.27 Aligned_cols=162 Identities=28% Similarity=0.515 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..............+++.|+|||++.+.
T Consensus 98 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 176 (285)
T cd07861 98 MDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGS- 176 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCC-
Confidence 4788999999999999999999999999999999999999999999999987654332223344678899999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CC-----------------CC------CCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PP-----------------PG------LYRASN 134 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~-----------------~~------~~~~~~ 134 (488)
..++.++|+|||||++|+|++|++||.+............. .. +. ......
T Consensus 177 ---~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (285)
T cd07861 177 ---PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKN 253 (285)
T ss_pred ---CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCC
Confidence 45788999999999999999999999876654433332211 00 00 001234
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
++++++++|.+||..||.+|||+.++++||||
T Consensus 254 ~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 254 LDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 68899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=239.92 Aligned_cols=166 Identities=53% Similarity=0.972 Sum_probs=136.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++..............|++.|+|||++....
T Consensus 121 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (286)
T cd06638 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 200 (286)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhh
Confidence 46788999999999999999999999999999999999999999999999876543322334457899999999986432
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....++.++|+||+||++|+|++|..||.................+....+..++..+.++|.+||..+|++|||+.++
T Consensus 201 ~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 280 (286)
T cd06638 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280 (286)
T ss_pred hccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence 22245788999999999999999999999877665555444444333333455678899999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
++|+||
T Consensus 281 l~~~~~ 286 (286)
T cd06638 281 LQHVFI 286 (286)
T ss_pred hhcccC
Confidence 999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=244.52 Aligned_cols=157 Identities=32% Similarity=0.589 Sum_probs=133.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC-CeecccCCCCEEEccCC-cEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g-ivHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|+...+..++.||+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++.............||+.|||||++.+
T Consensus 139 l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~ 218 (362)
T KOG0192|consen 139 LPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRG 218 (362)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcC
Confidence 567788999999999999999999 99999999999999998 9999999999876543223334689999999999985
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh-CCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
. ...|+.++||||+|+++|||+||+.||.+.........+.. ...+.. +...++.+..||..||..||.+||++
T Consensus 219 ~---~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~--p~~~~~~l~~l~~~CW~~dp~~RP~f 293 (362)
T KOG0192|consen 219 E---KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI--PKECPPHLSSLMERCWLVDPSRRPSF 293 (362)
T ss_pred C---CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--CccCCHHHHHHHHHhCCCCCCcCCCH
Confidence 2 26799999999999999999999999999998666666653 333433 44489999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.+++.
T Consensus 294 ~ei~~ 298 (362)
T KOG0192|consen 294 LEIVS 298 (362)
T ss_pred HHHHH
Confidence 98864
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=241.32 Aligned_cols=165 Identities=41% Similarity=0.784 Sum_probs=140.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 112 l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 189 (296)
T cd06655 112 MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-- 189 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcC--
Confidence 578899999999999999999999999999999999999999999999998765443223334568899999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+|||||++|+|++|..||....+......+.....+....+..+++.+.++|.+||..+|.+||++.++
T Consensus 190 ---~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~i 266 (296)
T cd06655 190 ---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKEL 266 (296)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 55788999999999999999999999887766655555444444444556788999999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
+.||||+...
T Consensus 267 l~~~~~~~~~ 276 (296)
T cd06655 267 LQHPFLKLAK 276 (296)
T ss_pred hhChHhhhcc
Confidence 9999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=249.95 Aligned_cols=163 Identities=25% Similarity=0.412 Sum_probs=124.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 154 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-- 230 (357)
T PHA03209 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLAR-- 230 (357)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-cccccccccccccCCeecCC--
Confidence 578899999999999999999999999999999999999999999999998754322 22334579999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCC-CCCChH---------HHHHHHHhC--CCC-CCC-----------------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPF-EDMHPT---------RALFQIVRN--PPP-GLY----------------- 130 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf-~~~~~~---------~~~~~~~~~--~~~-~~~----------------- 130 (488)
..++.++|||||||++|+|+++..|+ ...... ..+.+++.. ..+ ..+
T Consensus 231 ---~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (357)
T PHA03209 231 ---DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASL 307 (357)
T ss_pred ---CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhccc
Confidence 56889999999999999999865554 321110 111111110 000 000
Q ss_pred -----------CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 131 -----------RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 131 -----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
....++..+.+||.+||..||.+|||+.++|+||||+++
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 308 ERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 012346677889999999999999999999999999863
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=244.19 Aligned_cols=162 Identities=26% Similarity=0.458 Sum_probs=123.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE----ccCCcEEEEecCCccccccccC---ccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL----TKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aP 73 (488)
+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|+||
T Consensus 105 l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aP 184 (317)
T cd07867 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCc
Confidence 4678899999999999999999999999999999999 5667899999999976543211 22345789999999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH---------HHHHHHHhC---CC----------CC---
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---------RALFQIVRN---PP----------PG--- 128 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~---------~~~~~~~~~---~~----------~~--- 128 (488)
|++.+. ..++.++||||+||++|+|+||.+||...... ....++... +. +.
T Consensus 185 E~~~~~----~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (317)
T cd07867 185 ELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPT 260 (317)
T ss_pred HHhcCC----CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchh
Confidence 998652 45788999999999999999999999643211 111111100 00 00
Q ss_pred --------C-----------CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 129 --------L-----------YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 129 --------~-----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
. ......+..+.+||.+||..||.+|||+.++|+||||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 261 LQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0011235668899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=241.15 Aligned_cols=164 Identities=40% Similarity=0.768 Sum_probs=137.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 113 ~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 190 (296)
T cd06654 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-- 190 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcC--
Confidence 467789999999999999999999999999999999999999999999998765433222334578899999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+||++|+|++|+.||....+......+.....+....+..++..+.++|.+||..+|++|||+.++
T Consensus 191 ---~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ei 267 (296)
T cd06654 191 ---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (296)
T ss_pred ---CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence 55788999999999999999999999887765554444444433333455678999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++||||...
T Consensus 268 l~~~~~~~~ 276 (296)
T cd06654 268 LQHQFLKIA 276 (296)
T ss_pred hhChhhhcc
Confidence 999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=254.09 Aligned_cols=164 Identities=35% Similarity=0.686 Sum_probs=139.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc-cCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+|..+.+|.+||++||.|||++.|||||||-+|+||+ -.|.+||+|||.++....-.....++.||..|||||++..+
T Consensus 673 NEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG- 751 (1226)
T KOG4279|consen 673 NESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQG- 751 (1226)
T ss_pred chhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccC-
Confidence 5788999999999999999999999999999999997 47899999999999887666778899999999999999764
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH-HHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR-ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..+|+.++|||||||.+.||.||++||....... .++++ .-.....+.|..+|.+++.+|.+|+.++|..||++++
T Consensus 752 --~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~ 828 (1226)
T KOG4279|consen 752 --PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKD 828 (1226)
T ss_pred --CcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHH
Confidence 3679999999999999999999999997654333 33332 2111122246778999999999999999999999999
Q ss_pred HhcCcCCCCC
Q psy9090 160 LLEHPFITSL 169 (488)
Q Consensus 160 ll~hp~f~~~ 169 (488)
+|..||++.-
T Consensus 829 LL~DpFlq~~ 838 (1226)
T KOG4279|consen 829 LLQDPFLQHN 838 (1226)
T ss_pred hccCcccccC
Confidence 9999999764
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=250.51 Aligned_cols=162 Identities=32% Similarity=0.557 Sum_probs=133.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC--cEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG--EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|+...++.++.||+.||.+||+.||||+||||+|||+...+ .||++|||.+...... ..+.+.+..|+|||++.+
T Consensus 286 lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~---vytYiQSRfYRAPEVILG 362 (586)
T KOG0667|consen 286 LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR---VYTYIQSRFYRAPEVILG 362 (586)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc---ceeeeeccccccchhhcc
Confidence 56789999999999999999999999999999999997544 5999999999766543 236678899999999998
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh--CCCC---------------C---C---------
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR--NPPP---------------G---L--------- 129 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~--~~~~---------------~---~--------- 129 (488)
.+|+.+.||||||||++||++|.+.|.+.+..+++..|+. +.++ . .
T Consensus 363 -----lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~ 437 (586)
T KOG0667|consen 363 -----LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSA 437 (586)
T ss_pred -----CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecc
Confidence 7899999999999999999999999999988887777653 0000 0 0
Q ss_pred --------------------CCCCC-----------cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 130 --------------------YRASN-----------WSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 130 --------------------~~~~~-----------~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
..|.. -...+.+||++||..||.+|+|+.++|+|||+....
T Consensus 438 ~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 438 PRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred cccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence 00100 013468999999999999999999999999998643
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=238.59 Aligned_cols=169 Identities=28% Similarity=0.497 Sum_probs=137.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++...... ......|++.|+|||++.++
T Consensus 94 l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~- 170 (278)
T cd05606 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKG- 170 (278)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCC-
Confidence 578999999999999999999999999999999999999999999999998755332 22345789999999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH--HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT--RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP--- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp--- 155 (488)
..++.++|+||+|+++|+|++|..||...... ........... ...+..+++.+.+++.+||..+|.+||
T Consensus 171 ---~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~li~~~l~~~p~~R~~~~ 245 (278)
T cd05606 171 ---VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCL 245 (278)
T ss_pred ---CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC--CCCCCcCCHHHHHHHHHHhhcCHHhccCCC
Confidence 35788999999999999999999999765321 11222222211 223445789999999999999999999
Q ss_pred --CHHHHhcCcCCCCCCCCccccc
Q psy9090 156 --YMSELLEHPFITSLPENDLHLS 177 (488)
Q Consensus 156 --s~~ell~hp~f~~~~~~~~~~~ 177 (488)
++.++++||||+...|+.....
T Consensus 246 ~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 246 GRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred CCCHHHHHhCccccCCCchHhhhc
Confidence 9999999999999888765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=257.22 Aligned_cols=162 Identities=26% Similarity=0.503 Sum_probs=139.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+
T Consensus 166 l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 245 (478)
T PTZ00267 166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER 245 (478)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC
Confidence 4678899999999999999999999999999999999999999999999998654321 12345679999999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|||||||++|+|++|..||.+.........+.....++ .+..++..+.++|.+||..+|++||++.
T Consensus 246 -----~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~ 318 (478)
T PTZ00267 246 -----KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP--FPCPVSSGMKALLDPLLSKNPALRPTTQ 318 (478)
T ss_pred -----CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCccCCHHHHHHHHHHhccChhhCcCHH
Confidence 568899999999999999999999998887777666666544332 3456789999999999999999999999
Q ss_pred HHhcCcCCCCC
Q psy9090 159 ELLEHPFITSL 169 (488)
Q Consensus 159 ell~hp~f~~~ 169 (488)
+++.|+|++.+
T Consensus 319 ~~l~~~~~~~~ 329 (478)
T PTZ00267 319 QLLHTEFLKYV 329 (478)
T ss_pred HHHhCHHHHHH
Confidence 99999999653
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=237.51 Aligned_cols=166 Identities=36% Similarity=0.720 Sum_probs=139.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++|++||||+|+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus 112 ~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 189 (285)
T cd06648 112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-- 189 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcC--
Confidence 467889999999999999999999999999999999999999999999987655433233344568999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||...++......+.....+....+...+..+.++|.+||..+|++||++.++
T Consensus 190 ---~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 266 (285)
T cd06648 190 ---LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAEL 266 (285)
T ss_pred ---CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 56788999999999999999999999887766655555544333333344478999999999999999999999999
Q ss_pred hcCcCCCCCCC
Q psy9090 161 LEHPFITSLPE 171 (488)
Q Consensus 161 l~hp~f~~~~~ 171 (488)
++||||+....
T Consensus 267 l~~~~~~~~~~ 277 (285)
T cd06648 267 LNHPFLAKAGP 277 (285)
T ss_pred ccCcccccCCC
Confidence 99999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=240.00 Aligned_cols=165 Identities=35% Similarity=0.701 Sum_probs=137.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus 115 l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 192 (292)
T cd06658 115 MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR-- 192 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHcc--
Confidence 467889999999999999999999999999999999999999999999998755433333344578999999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||...........+.....+........+..+.+++.+||..+|.+|||++++
T Consensus 193 ---~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 269 (292)
T cd06658 193 ---LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQEL 269 (292)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 56788999999999999999999999887765554444433333333334578899999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
++||||....
T Consensus 270 l~~~~~~~~~ 279 (292)
T cd06658 270 LQHPFLKLAG 279 (292)
T ss_pred hhChhhhccC
Confidence 9999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=238.95 Aligned_cols=172 Identities=25% Similarity=0.428 Sum_probs=138.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .......|++.|+|||++.+
T Consensus 99 ~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~-- 175 (285)
T cd05632 99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNN-- 175 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcC--
Confidence 578899999999999999999999999999999999999999999999998654322 22234578999999999975
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY--- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps--- 156 (488)
..++.++|+||+||++|+|++|..||.+.........+...... ....+..++..+.+|+.+||..+|++||+
T Consensus 176 ---~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 176 ---QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred ---CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 56888999999999999999999999876654333333221111 11224567889999999999999999999
Q ss_pred --HHHHhcCcCCCCCCCCcccccc
Q psy9090 157 --MSELLEHPFITSLPENDLHLST 178 (488)
Q Consensus 157 --~~ell~hp~f~~~~~~~~~~~~ 178 (488)
+.+++.|+||+..++..+....
T Consensus 253 ~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05632 253 EGAGEVKRHPFFRNMNFKRLEAGM 276 (285)
T ss_pred cChHHHHcChhhhcCCHHHHhcCc
Confidence 8899999999998876544333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=233.05 Aligned_cols=160 Identities=33% Similarity=0.659 Sum_probs=132.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc---ccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK---KTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++......... ....+++.|+|||.+.
T Consensus 101 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (263)
T cd06625 101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180 (263)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceec
Confidence 4678899999999999999999999999999999999999999999999987543221111 2346788999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
+ ..++.++|+||+|+++|+|++|+.||..........+....... ...+...+..+.++|.+||..+|.+|||+
T Consensus 181 ~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (263)
T cd06625 181 G-----EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPSA 254 (263)
T ss_pred c-----CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCCH
Confidence 6 45888999999999999999999999877665555444433222 22345678999999999999999999999
Q ss_pred HHHhcCcCC
Q psy9090 158 SELLEHPFI 166 (488)
Q Consensus 158 ~ell~hp~f 166 (488)
.++++||||
T Consensus 255 ~~ll~~~~~ 263 (263)
T cd06625 255 EELLRHFFV 263 (263)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=237.96 Aligned_cols=162 Identities=26% Similarity=0.452 Sum_probs=127.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+++.............+++.|+|||++.+.
T Consensus 96 ~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 174 (284)
T cd07839 96 IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA- 174 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCC-
Confidence 5788999999999999999999999999999999999999999999999987654332333345678899999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCC-CCChHHHHHHHHhC---------------CC----CCC-------CCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFE-DMHPTRALFQIVRN---------------PP----PGL-------YRAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~-~~~~~~~~~~~~~~---------------~~----~~~-------~~~~ 133 (488)
..++.++|+||+||++|+|++|..|+. +.+.......+.+. +. +.. ....
T Consensus 175 ---~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (284)
T cd07839 175 ---KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVP 251 (284)
T ss_pred ---cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcc
Confidence 447889999999999999999988864 33333322222110 00 000 0112
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
.++++++++|.+||..||.+|||+++++.||||
T Consensus 252 ~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 252 KLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=240.72 Aligned_cols=166 Identities=40% Similarity=0.772 Sum_probs=137.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 112 ~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 189 (297)
T cd06656 112 MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-- 189 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcC--
Confidence 467889999999999999999999999999999999999999999999998765433222334568899999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+||++|+|++|..||....+......+.....+....+..++..+++|+.+||..+|++||++.++
T Consensus 190 ---~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (297)
T cd06656 190 ---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL 266 (297)
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 56788999999999999999999999876654443333333333333455678899999999999999999999999
Q ss_pred hcCcCCCCCCC
Q psy9090 161 LEHPFITSLPE 171 (488)
Q Consensus 161 l~hp~f~~~~~ 171 (488)
++||||+....
T Consensus 267 l~~~~~~~~~~ 277 (297)
T cd06656 267 LQHPFLKLAKP 277 (297)
T ss_pred hcCchhccccc
Confidence 99999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=235.14 Aligned_cols=165 Identities=47% Similarity=0.975 Sum_probs=138.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++.............+++.|+|||.+.+
T Consensus 95 ~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-- 172 (274)
T cd06609 95 LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-- 172 (274)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhcc--
Confidence 578899999999999999999999999999999999999999999999999876544334445678899999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|.+||....+......+.....+.. ....++..+.+++.+||..+|++|||++++
T Consensus 173 ---~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~i 248 (274)
T cd06609 173 ---SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSL-EGNKFSKPFKDFVSLCLNKDPKERPSAKEL 248 (274)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCC-cccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 4588999999999999999999999987766555544444433322 222378999999999999999999999999
Q ss_pred hcCcCCCCCCC
Q psy9090 161 LEHPFITSLPE 171 (488)
Q Consensus 161 l~hp~f~~~~~ 171 (488)
++||||.....
T Consensus 249 l~~~~~~~~~~ 259 (274)
T cd06609 249 LKHKFIKKAKK 259 (274)
T ss_pred hhChhhcCCCc
Confidence 99999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=230.48 Aligned_cols=159 Identities=29% Similarity=0.589 Sum_probs=136.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.............|++.|+|||++..
T Consensus 98 ~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 175 (256)
T cd08529 98 LPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED-- 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcC--
Confidence 467888999999999999999999999999999999999999999999998766543333345578899999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||||+++|+|++|+.||...........+.....+.. +..++..+.++|.+||..+|++||++.++
T Consensus 176 ---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 250 (256)
T cd08529 176 ---KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV--SQMYSQQLAQLIDQCLTKDYRQRPDTFQL 250 (256)
T ss_pred ---CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--ccccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 5678899999999999999999999988776666666665544332 33678999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
++|||+
T Consensus 251 l~~~~~ 256 (256)
T cd08529 251 LRNPSL 256 (256)
T ss_pred hhCCCC
Confidence 999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=235.67 Aligned_cols=164 Identities=32% Similarity=0.692 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... ......||+.|+|||++.+
T Consensus 92 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~-- 167 (279)
T cd06619 92 IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISG-- 167 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecC--
Confidence 467889999999999999999999999999999999999999999999998765432 2344578999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH------HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT------RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
..++.++|+||+||++|+|++|..||...... ....+......+.......+++++.++|.+||..+|.+|
T Consensus 168 ---~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 244 (279)
T cd06619 168 ---EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKER 244 (279)
T ss_pred ---CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhC
Confidence 56788999999999999999999999643211 111222222222222334578899999999999999999
Q ss_pred CCHHHHhcCcCCCCCCC
Q psy9090 155 PYMSELLEHPFITSLPE 171 (488)
Q Consensus 155 ps~~ell~hp~f~~~~~ 171 (488)
|+++++++||||.....
T Consensus 245 p~~~eil~~~~~~~~~~ 261 (279)
T cd06619 245 PAPENLMDHPFIVQYND 261 (279)
T ss_pred CCHHHHhcCcccccccC
Confidence 99999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=237.71 Aligned_cols=164 Identities=37% Similarity=0.763 Sum_probs=138.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..............|++.|+|||++.+
T Consensus 114 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 191 (297)
T cd06659 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-- 191 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHcc--
Confidence 468899999999999999999999999999999999999999999999998755433333345678999999999975
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+||++|+|++|+.||...........+.....+.......++..+.++|.+||..+|.+||++.++
T Consensus 192 ---~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~l 268 (297)
T cd06659 192 ---TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQEL 268 (297)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 56788999999999999999999999877766555554443333333345678899999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++||||...
T Consensus 269 l~~~~~~~~ 277 (297)
T cd06659 269 LDHPFLLQT 277 (297)
T ss_pred hhChhhccC
Confidence 999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=235.80 Aligned_cols=168 Identities=29% Similarity=0.524 Sum_probs=141.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... .....+++.|+|||.+.+
T Consensus 98 l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~-- 172 (290)
T cd05580 98 FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILS-- 172 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcC--
Confidence 578899999999999999999999999999999999999999999999998765433 334578899999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..++.++|+||||+++|+|++|..||..........++.... . ..+..++..++++|.+||..+|.+|+
T Consensus 173 ---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~ 246 (290)
T cd05580 173 ---KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK-V--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKN 246 (290)
T ss_pred ---CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-c--cCCccCCHHHHHHHHHHccCCHHHccCcccC
Confidence 457789999999999999999999998777555455554332 1 23456789999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCCccccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTV 179 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~ 179 (488)
+++++++||||..++|..+.....
T Consensus 247 ~~~~l~~~~~~~~~~~~~~~~~~~ 270 (290)
T cd05580 247 GVNDIKNHPWFAGIDWIALLQRKI 270 (290)
T ss_pred CHHHHHcCcccccCCHHHHhhccC
Confidence 899999999999998876544333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=235.50 Aligned_cols=163 Identities=23% Similarity=0.438 Sum_probs=131.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-CCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++|++||||+|+||+++. ++.+||+|||++..............+++.|+|||++.+.
T Consensus 107 ~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 186 (295)
T cd07837 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGS 186 (295)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCC
Confidence 478899999999999999999999999999999999998 8899999999987654332223334578899999988642
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC---CCCC----------------------CCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP---PPGL----------------------YRASN 134 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~---~~~~----------------------~~~~~ 134 (488)
..++.++|+||+|+++|+|++|.+||.+.........+.... .... .....
T Consensus 187 ----~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (295)
T cd07837 187 ----THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD 262 (295)
T ss_pred ----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccc
Confidence 457889999999999999999999998876655544443210 0000 00134
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 167 (488)
+++.+.+||.+||..+|.+||++.+++.||||+
T Consensus 263 ~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 263 LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 688899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=238.43 Aligned_cols=166 Identities=30% Similarity=0.435 Sum_probs=133.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++..............+++.|+|||++.+.
T Consensus 105 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 183 (309)
T cd07845 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC- 183 (309)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCC-
Confidence 5788999999999999999999999999999999999999999999999987654432222333467889999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC---CC---------------CC---------CCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP---PG---------------LY---------RAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~---~~---------------~~---------~~~ 133 (488)
..++.++|+||+||++|+|++|.+||.+.+.......+..... .. .. ...
T Consensus 184 ---~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T cd07845 184 ---TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP 260 (309)
T ss_pred ---CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhcc
Confidence 4578899999999999999999999988776665544433100 00 00 001
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
..++.+.++|.+||..||++|||+++++.||||++.+
T Consensus 261 ~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 261 WLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 2478889999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=237.87 Aligned_cols=170 Identities=26% Similarity=0.482 Sum_probs=139.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--------------------- 59 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--------------------- 59 (488)
+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 100 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (316)
T cd05574 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179 (316)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchh
Confidence 46788999999999999999999999999999999999999999999998765422110
Q ss_pred --------ccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCC
Q psy9090 60 --------KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYR 131 (488)
Q Consensus 60 --------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 131 (488)
......||..|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+..... ....
T Consensus 180 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~ 253 (316)
T cd05574 180 TFSEEPSFRSNSFVGTEEYIAPEVISG-----DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV-TFPG 253 (316)
T ss_pred hhcccccCCCCCCcCccCCcCHHHHcC-----CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc-cCCC
Confidence 1123468889999999976 5578899999999999999999999988776665555553322 2222
Q ss_pred CCCcCHHHHHHHHHhcccCCCCCCC----HHHHhcCcCCCCCCCCcccc
Q psy9090 132 ASNWSQHYVDFIAECLEKNPEHRPY----MSELLEHPFITSLPENDLHL 176 (488)
Q Consensus 132 ~~~~s~~~~~li~~~L~~dP~~Rps----~~ell~hp~f~~~~~~~~~~ 176 (488)
....++.++++|.+||..+|++||| ++++++||||++.+|..+..
T Consensus 254 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 254 SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH 302 (316)
T ss_pred ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence 2336899999999999999999999 99999999999988876655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=232.65 Aligned_cols=163 Identities=44% Similarity=0.884 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||++...
T Consensus 103 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 181 (267)
T cd06645 103 LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE- 181 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccc-
Confidence 5788999999999999999999999999999999999999999999999987654333333455789999999997421
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC-CC-CCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-PP-GLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~-~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
....++.++|+|||||++|+|++|..||....+........... .+ .......++..+.++|.+||..+|++|||++
T Consensus 182 -~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 260 (267)
T cd06645 182 -RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAE 260 (267)
T ss_pred -cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 11457889999999999999999999997665444333332221 11 1112235788999999999999999999999
Q ss_pred HHhcCcC
Q psy9090 159 ELLEHPF 165 (488)
Q Consensus 159 ell~hp~ 165 (488)
++++|||
T Consensus 261 ~ll~~~~ 267 (267)
T cd06645 261 KLLQHPF 267 (267)
T ss_pred HHhcCCC
Confidence 9999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=231.14 Aligned_cols=165 Identities=32% Similarity=0.575 Sum_probs=137.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++...... .......+++.|+|||.+..
T Consensus 90 l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~-- 166 (262)
T cd05572 90 FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-QKTWTFCGTPEYVAPEIILN-- 166 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc-cccccccCCcCccChhHhcC--
Confidence 478889999999999999999999999999999999999999999999998766443 12334578899999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC--hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC--
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMH--PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY-- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-- 156 (488)
..++.++|+||+|+++|+|++|..||.... .......+..... ....+...++.++++|.+||..+|++||+
T Consensus 167 ---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 242 (262)
T cd05572 167 ---KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-KLEFPNYIDKAAKDLIKQLLRRNPEERLGNL 242 (262)
T ss_pred ---CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-CCCCCcccCHHHHHHHHHHccCChhhCcCCc
Confidence 567889999999999999999999997766 4444444443221 22234445899999999999999999999
Q ss_pred ---HHHHhcCcCCCCCCCC
Q psy9090 157 ---MSELLEHPFITSLPEN 172 (488)
Q Consensus 157 ---~~ell~hp~f~~~~~~ 172 (488)
++++++||||++..|+
T Consensus 243 ~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 243 KGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred ccCHHHHhcChhhhCCCCC
Confidence 9999999999988775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=231.57 Aligned_cols=163 Identities=50% Similarity=1.003 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+....
T Consensus 98 l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~ 177 (262)
T cd06613 98 LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccc
Confidence 57889999999999999999999999999999999999999999999999876554322334557888999999986521
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN--PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
. ..++.++|+||+|+++|+|++|.+||....+......+... ..+.......++.++.+++.+||..+|..|||+.
T Consensus 178 ~--~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 255 (262)
T cd06613 178 K--GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTAT 255 (262)
T ss_pred c--CCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHH
Confidence 1 26788999999999999999999999887766555544443 2222223345678899999999999999999999
Q ss_pred HHhcCcC
Q psy9090 159 ELLEHPF 165 (488)
Q Consensus 159 ell~hp~ 165 (488)
+++.|+|
T Consensus 256 ~il~~~~ 262 (262)
T cd06613 256 KLLQHPF 262 (262)
T ss_pred HHhcCCC
Confidence 9999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=241.55 Aligned_cols=174 Identities=21% Similarity=0.421 Sum_probs=138.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+.
T Consensus 99 l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 178 (331)
T cd05624 99 LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhcc
Confidence 47889999999999999999999999999999999999999999999999876543222 12335799999999998753
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCC-CCCCcCHHHHHHHHHhcccCCCC--CC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLY-RASNWSQHYVDFIAECLEKNPEH--RP 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~-~~~~~s~~~~~li~~~L~~dP~~--Rp 155 (488)
......++.++|+||+||++|+|++|+.||...........+..... ...+ ....++..++++|.+||..++.+ |+
T Consensus 179 ~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~ 258 (331)
T cd05624 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQN 258 (331)
T ss_pred ccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCC
Confidence 22224578899999999999999999999988776665555544321 1111 12346899999999999876654 46
Q ss_pred CHHHHhcCcCCCCCCCCcc
Q psy9090 156 YMSELLEHPFITSLPENDL 174 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~ 174 (488)
+++++++||||..++|...
T Consensus 259 ~~~~~~~h~~f~~~~~~~~ 277 (331)
T cd05624 259 GIEDFKKHAFFEGIDWENI 277 (331)
T ss_pred CHHHHhcCCCcCCCCHHHH
Confidence 8999999999999888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=250.35 Aligned_cols=163 Identities=20% Similarity=0.401 Sum_probs=125.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 257 l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG 336 (461)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC
Confidence 57889999999999999999999999999999999999999999999999876432211 1234579999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC-------hHHHHHHHHhCCC---CCC-------------------
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-------PTRALFQIVRNPP---PGL------------------- 129 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~-------~~~~~~~~~~~~~---~~~------------------- 129 (488)
..++.++|||||||++|+|++|..|+.... ....+.+++.... ...
T Consensus 337 -----~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 411 (461)
T PHA03211 337 -----DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARN 411 (461)
T ss_pred -----CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcc
Confidence 568899999999999999999876653221 0122222222110 000
Q ss_pred ----CC------CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q psy9090 130 ----YR------ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168 (488)
Q Consensus 130 ----~~------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 168 (488)
.. ...++..+.+||.+||..||.+|||+.|+|+||||++
T Consensus 412 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 412 RRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 0123568899999999999999999999999999974
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=236.02 Aligned_cols=169 Identities=38% Similarity=0.677 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...... .......|++.|+|||++...
T Consensus 104 l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 104 IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC-CccccccCccCccCHHHhccc
Confidence 46788999999999999999974 9999999999999999999999999998765432 222334688899999998752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-HHHHHHHhCCCCCCCC--CCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVRNPPPGLYR--ASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
. ...++.++|+||+||++|+|++|++||...... ....+......+.... +..++..+.+||.+||..+|++|||
T Consensus 183 ~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 260 (288)
T cd06616 183 A--RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK 260 (288)
T ss_pred c--ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC
Confidence 1 135788999999999999999999999765421 2223333332222221 2347899999999999999999999
Q ss_pred HHHHhcCcCCCCCCCC
Q psy9090 157 MSELLEHPFITSLPEN 172 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~ 172 (488)
+++++.||||+...+.
T Consensus 261 ~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 261 YKELLEHPFIKDYEER 276 (288)
T ss_pred HHHHhcChhhhchhhc
Confidence 9999999999876544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=231.55 Aligned_cols=162 Identities=44% Similarity=0.860 Sum_probs=134.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc----cccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK----KKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~l 76 (488)
+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......... .....|++.|+|||++
T Consensus 99 ~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~ 178 (267)
T cd06610 99 LDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHH
Confidence 467889999999999999999999999999999999999999999999998765433221 2344688999999998
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCC---CCcCHHHHHHHHHhcccCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRA---SNWSQHYVDFIAECLEKNPEH 153 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~ 153 (488)
... ..++.++|+||+||++|+|++|+.||.................+..... ..+++.+.+++.+||..||++
T Consensus 179 ~~~----~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 254 (267)
T cd06610 179 EQV----HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSK 254 (267)
T ss_pred ccc----cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhh
Confidence 752 3578899999999999999999999988776665555555443333222 356899999999999999999
Q ss_pred CCCHHHHhcCcCC
Q psy9090 154 RPYMSELLEHPFI 166 (488)
Q Consensus 154 Rps~~ell~hp~f 166 (488)
|||+.+++.||||
T Consensus 255 Rp~~~~ll~~p~~ 267 (267)
T cd06610 255 RPTAEELLKHKFF 267 (267)
T ss_pred CcCHHHHhhCCCC
Confidence 9999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=235.84 Aligned_cols=161 Identities=36% Similarity=0.706 Sum_probs=129.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhc-cc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR-CG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~-~~ 79 (488)
+++.+++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+..............+++.|+|||++. +
T Consensus 95 ~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 173 (260)
T PF00069_consen 95 LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQG- 173 (260)
T ss_dssp BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 46789999999999999999999999999999999999999999999999875422223445667899999999987 3
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---HHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---TRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
..++.++|+||||+++|+|++|..||..... .....+......+. .......++.+.++|.+||..||++||
T Consensus 174 ----~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~ 249 (260)
T PF00069_consen 174 ----KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRP 249 (260)
T ss_dssp ----SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGST
T ss_pred ----ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCc
Confidence 5678999999999999999999999988732 22222222211110 001111248999999999999999999
Q ss_pred CHHHHhcCcCC
Q psy9090 156 YMSELLEHPFI 166 (488)
Q Consensus 156 s~~ell~hp~f 166 (488)
|+.++++||||
T Consensus 250 ~~~~l~~~~~~ 260 (260)
T PF00069_consen 250 SAEELLKHPWF 260 (260)
T ss_dssp THHHHHTSGGG
T ss_pred CHHHHhcCCCC
Confidence 99999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=254.58 Aligned_cols=168 Identities=54% Similarity=1.024 Sum_probs=161.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|.|+.+++|++.++.|+.+||.+.++|||||-.|||++.+|.|||+|||++...........+.+|||.|||||++.+.+
T Consensus 120 l~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e 199 (953)
T KOG0587|consen 120 LKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDE 199 (953)
T ss_pred hhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeeccc
Confidence 57899999999999999999999999999999999999999999999999998888777888999999999999999877
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....|+..+|+||||++..||.-|.+|+.++.+...++.+.++++|.+..+..|++++.++|..||.+|-.+||+..++
T Consensus 200 ~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 200 SPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred CCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 76778999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
|+|||++.
T Consensus 280 l~hpFi~e 287 (953)
T KOG0587|consen 280 LKHPFITE 287 (953)
T ss_pred ccCCcccc
Confidence 99999984
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=230.60 Aligned_cols=163 Identities=31% Similarity=0.506 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....+++.|+|||.+.+
T Consensus 94 ~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~-- 167 (260)
T cd05611 94 LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILG-- 167 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCcCccChhhhcC--
Confidence 47889999999999999999999999999999999999999999999998865432 234568899999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCCCCC---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEHRPY--- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps--- 156 (488)
..++.++|+||+|+++|+|++|..||...........+..... ........+++.+.++|.+||..+|++||+
T Consensus 168 ---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 244 (260)
T cd05611 168 ---VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANG 244 (260)
T ss_pred ---CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCc
Confidence 4478899999999999999999999988776555444433221 111123357899999999999999999995
Q ss_pred HHHHhcCcCCCCCCCC
Q psy9090 157 MSELLEHPFITSLPEN 172 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~ 172 (488)
+++++.||||+.+.|+
T Consensus 245 ~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 245 YQEIKSHPFFKSINWD 260 (260)
T ss_pred HHHHHcChHhhcCCCC
Confidence 5799999999988774
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=239.11 Aligned_cols=156 Identities=28% Similarity=0.514 Sum_probs=125.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 250 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc
Confidence 45778899999999999999999999999999999999999999999999875432211 1223345678999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+..........+..... ...+...++.+.+++.+||..||++|||+
T Consensus 251 -----~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 324 (338)
T cd05102 251 -----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-MRAPENATPEIYRIMLACWQGDPKERPTF 324 (338)
T ss_pred -----CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 568899999999999999996 99999876544444343333221 22345678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 325 ~el~~ 329 (338)
T cd05102 325 SALVE 329 (338)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=233.26 Aligned_cols=173 Identities=31% Similarity=0.497 Sum_probs=137.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+...... .......++..|+|||++.+
T Consensus 92 ~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-- 168 (277)
T cd05577 92 FPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQG-- 168 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCCcCCHHHhcC--
Confidence 578899999999999999999999999999999999999999999999988755432 22334567889999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEHRP---- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---- 155 (488)
..++.++|+||+|+++|+|++|+.||...........+..... .....+..+++.+.++|.+||..+|.+||
T Consensus 169 ---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 169 ---EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ---CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 4578899999999999999999999976543211122221111 11123456799999999999999999999
Q ss_pred -CHHHHhcCcCCCCCCCCccccccc
Q psy9090 156 -YMSELLEHPFITSLPENDLHLSTV 179 (488)
Q Consensus 156 -s~~ell~hp~f~~~~~~~~~~~~~ 179 (488)
++.++++||||+.++|........
T Consensus 246 ~~~~~ll~h~~~~~~~~~~~~~~~~ 270 (277)
T cd05577 246 GSADEVREHPLFKDLNWRRLEAGML 270 (277)
T ss_pred ccHHHHHhChhhhcCChhhhhcCCC
Confidence 888899999999988876544333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=232.12 Aligned_cols=162 Identities=30% Similarity=0.555 Sum_probs=130.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..............++..|+|||++.+.
T Consensus 97 ~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 175 (286)
T cd07847 97 VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD- 175 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCC-
Confidence 5788999999999999999999999999999999999999999999999987665432233345678899999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC---------------------CCCCC-------CC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP---------------------PPGLY-------RA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~---------------------~~~~~-------~~ 132 (488)
..++.++|+||+|+++|+|++|.+||.+.........+.... .+... ..
T Consensus 176 ---~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd07847 176 ---TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKF 252 (286)
T ss_pred ---CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHh
Confidence 457889999999999999999999998776554443332100 00000 01
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
..++..+.+||.+||..+|++||++.+++.||||
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 253 PNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 2457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=230.07 Aligned_cols=159 Identities=35% Similarity=0.716 Sum_probs=132.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC------ccccccCCCccccch
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD------KKKTFLGSPSWMAPE 74 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~------~~~~~~gt~~y~aPE 74 (488)
+++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++....... ......|++.|+|||
T Consensus 103 l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe 182 (267)
T cd06628 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182 (267)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChh
Confidence 46788999999999999999999999999999999999999999999999876542111 112345788999999
Q ss_pred hhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 75 IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 75 ~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
.+.+ ..++.++|+||+||++|+|++|..||...........+.....+. .+..++..+.++|++||..+|.+|
T Consensus 183 ~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R 255 (267)
T cd06628 183 VVKQ-----TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE--IPSNISSEAIDFLEKTFEIDHNKR 255 (267)
T ss_pred Hhcc-----CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc--CCcccCHHHHHHHHHHccCCchhC
Confidence 9875 567889999999999999999999998876655555544433322 245678999999999999999999
Q ss_pred CCHHHHhcCcCC
Q psy9090 155 PYMSELLEHPFI 166 (488)
Q Consensus 155 ps~~ell~hp~f 166 (488)
|++.++++||||
T Consensus 256 p~~~~il~~~~~ 267 (267)
T cd06628 256 PTAAELLKHPFL 267 (267)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=244.87 Aligned_cols=169 Identities=25% Similarity=0.495 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccc--cc---------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA--NT--------------------- 57 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~--~~--------------------- 57 (488)
|+|+.+++|+.++..|+++.|+.|+|||||||+|||||.+|+|||+|||+|+-+. +.
T Consensus 726 FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~ 805 (1034)
T KOG0608|consen 726 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEW 805 (1034)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhh
Confidence 5789999999999999999999999999999999999999999999999987321 00
Q ss_pred -------------------cCccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHH
Q psy9090 58 -------------------FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118 (488)
Q Consensus 58 -------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~ 118 (488)
.......+||+.|+|||++.. .+|+..||+||.|||||+|+.|++||-+..+.+..
T Consensus 806 ~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-----~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 806 ADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred ccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-----cCccccchhhHhhHHHHHHhhCCCCccCCCCCcce
Confidence 000123589999999999975 78999999999999999999999999877765544
Q ss_pred HHHHh-CCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC---CHHHHhcCcCCCCCCCCccc
Q psy9090 119 FQIVR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRP---YMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 119 ~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~~~~~~~~ 175 (488)
.+++. ...-.+....++|+++.+||.++. .+++.|+ .++++..||||+.++|..+.
T Consensus 881 ~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfsslR 940 (1034)
T KOG0608|consen 881 YKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSLR 940 (1034)
T ss_pred eeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhhh
Confidence 33321 111223334678999999999875 5688887 46789999999999998743
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=232.89 Aligned_cols=162 Identities=26% Similarity=0.447 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++|++||||+|+||+++.++.+||+|||++..............+++.|+|||++.+.
T Consensus 97 l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 175 (284)
T cd07860 97 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC- 175 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecC-
Confidence 4678899999999999999999999999999999999999999999999987654332223344578899999988652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-----------------C---------CCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-----------------L---------YRASN 134 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-----------------~---------~~~~~ 134 (488)
..++.++|+||||+++|+|+||+.||..........++......+ . .....
T Consensus 176 ---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
T cd07860 176 ---KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPP 252 (284)
T ss_pred ---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHccc
Confidence 346788999999999999999999998776555444443211000 0 00124
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
+++.++++|.+||..||.+|||+.+++.||||
T Consensus 253 ~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 253 LDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 57888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=223.58 Aligned_cols=172 Identities=27% Similarity=0.453 Sum_probs=133.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc---EEEEecCCccccccc-------cCccccccCCCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRETANT-------FDKKKTFLGSPSW 70 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkL~Dfg~a~~~~~~-------~~~~~~~~gt~~y 70 (488)
|+|.++..+++.|+.||.+||.+||.||||||+|||-.+..+ ||||||.+.....-. .....+.+|+..|
T Consensus 173 F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEf 252 (463)
T KOG0607|consen 173 FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEF 252 (463)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhh
Confidence 589999999999999999999999999999999999976654 899999887543211 1223466899999
Q ss_pred ccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh--------------HHHHHHHHhCCCCCCCC--CCC
Q psy9090 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP--------------TRALFQIVRNPPPGLYR--ASN 134 (488)
Q Consensus 71 ~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~--------------~~~~~~~~~~~~~~~~~--~~~ 134 (488)
||||+..--......|+.++|.||||+|+|.|++|.+||.+.-. ...++.-++.....++. ...
T Consensus 253 MAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWah 332 (463)
T KOG0607|consen 253 MAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAH 332 (463)
T ss_pred cchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHH
Confidence 99998754333346789999999999999999999999965311 12233333333222221 223
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
+|.++++||..+|..++.+|.++.++++|||+.....+
T Consensus 333 IS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 333 ISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred hhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 58999999999999999999999999999999887554
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=253.08 Aligned_cols=165 Identities=24% Similarity=0.434 Sum_probs=126.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccccc
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCGHK 81 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~ 81 (488)
..+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 266 ~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--- 342 (501)
T PHA03210 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--- 342 (501)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC---
Confidence 456788999999999999999999999999999999999999999999976543211 2234679999999999976
Q ss_pred CCCCCCCccchhhhHHHHHHHhcCCCC-CCCC--ChHHHHHHHHhCCC------C-----------------------CC
Q psy9090 82 EVDGYDNRIDVWALGITAIELGDGKPP-FEDM--HPTRALFQIVRNPP------P-----------------------GL 129 (488)
Q Consensus 82 ~~~~~~~~~DiwslGvil~elltg~~P-f~~~--~~~~~~~~~~~~~~------~-----------------------~~ 129 (488)
..|+.++|||||||++|+|++|..| |... .+...+.+++.... + ..
T Consensus 343 --~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~ 420 (501)
T PHA03210 343 --DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPL 420 (501)
T ss_pred --CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhH
Confidence 5688999999999999999998754 4322 22223333222100 0 00
Q ss_pred CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 130 YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 130 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
.....++..+.++|.+||..||.+|||+.++|.||||......
T Consensus 421 ~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 421 IRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred HHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCch
Confidence 0112346677889999999999999999999999999876543
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=230.23 Aligned_cols=159 Identities=26% Similarity=0.504 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++...... ....+++.|+|||++.+
T Consensus 106 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~- 180 (267)
T PHA03390 106 LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKG- 180 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcC-
Confidence 57899999999999999999999999999999999999998 9999999998755332 23468899999999975
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH-HHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC-H
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA-LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY-M 157 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-~ 157 (488)
..++.++|+||+|+++|+|++|..||........ ...+..........+..+++.+.++|.+||+.+|.+||+ +
T Consensus 181 ----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (267)
T PHA03390 181 ----HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNY 256 (267)
T ss_pred ----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchH
Confidence 5678899999999999999999999975543221 111211112222334568999999999999999999996 6
Q ss_pred HHHhcCcCCCC
Q psy9090 158 SELLEHPFITS 168 (488)
Q Consensus 158 ~ell~hp~f~~ 168 (488)
+++++||||+.
T Consensus 257 ~~~l~h~~~~~ 267 (267)
T PHA03390 257 NEIIKHPFLKI 267 (267)
T ss_pred HHHhcCCcccC
Confidence 99999999963
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=237.82 Aligned_cols=162 Identities=31% Similarity=0.670 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||++...... ......|++.|+|||++.+
T Consensus 100 ~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~- 176 (333)
T cd06650 100 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG- 176 (333)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcC-
Confidence 46788899999999999999985 7999999999999999999999999998755332 2234578999999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHH---------------------------------------
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ--------------------------------------- 120 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~--------------------------------------- 120 (488)
..++.++|+|||||++|+|++|+.||...........
T Consensus 177 ----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (333)
T cd06650 177 ----THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIF 252 (333)
T ss_pred ----CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHH
Confidence 5688899999999999999999999976543222110
Q ss_pred -----HHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 121 -----IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 121 -----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
+.....+.. ....++.++++||.+||..||++|||+.+++.||||+...
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 253 ELLDYIVNEPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred HHHHHHhcCCCccC-CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 011111111 1123578899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=230.42 Aligned_cols=160 Identities=22% Similarity=0.431 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++|++||||+|+||+++. +.+||+|||+++..... .......+++.|+|||.+...
T Consensus 97 ~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~- 173 (282)
T cd07831 97 LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK-PPYTEYISTRWYRAPECLLTD- 173 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC-CCcCCCCCCcccCChhHhhcC-
Confidence 478899999999999999999999999999999999999 99999999998765432 222344678999999987542
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCC------------CCC-----------CCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPP------------GLY-----------RASN 134 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~------------~~~-----------~~~~ 134 (488)
..++.++|+||+||++|+|++|.+||.+.+.......+.. .+.+ ... ....
T Consensus 174 ---~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd07831 174 ---GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPN 250 (282)
T ss_pred ---CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHccc
Confidence 4467899999999999999999999988765444333321 0000 000 0124
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
.+..+.++|.+||.++|++||+++++++||||
T Consensus 251 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 251 ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 57899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=227.45 Aligned_cols=165 Identities=30% Similarity=0.552 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--------ccccccCCCcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--------KKKTFLGSPSWMA 72 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~gt~~y~a 72 (488)
+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......+++.|+|
T Consensus 90 ~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (265)
T cd05579 90 LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccC
Confidence 47889999999999999999999999999999999999999999999999875432211 2234467889999
Q ss_pred chhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 73 PEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 73 PE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
||.+.. ..++.++|+||||+++|++++|..||...........+..... ..+....++..+.+++.+||..+|.
T Consensus 170 Pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~ 243 (265)
T cd05579 170 PEVILG-----QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKLLVPDPE 243 (265)
T ss_pred HHHhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHHHhcCCHh
Confidence 999875 4477899999999999999999999988776665555544222 2222223589999999999999999
Q ss_pred CCCCH---HHHhcCcCCCCCCC
Q psy9090 153 HRPYM---SELLEHPFITSLPE 171 (488)
Q Consensus 153 ~Rps~---~ell~hp~f~~~~~ 171 (488)
+|||+ .++++||||++++|
T Consensus 244 ~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 244 KRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred hcCCCccHHHHhcCccccCCCC
Confidence 99999 99999999998876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=237.05 Aligned_cols=167 Identities=31% Similarity=0.546 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........ ......|++.|+|||.+.
T Consensus 103 l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (336)
T cd07849 103 LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182 (336)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhh
Confidence 57889999999999999999999999999999999999999999999999876533211 122346889999999875
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCC--------------------CCCC----
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPP--------------------PGLY---- 130 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~--------------------~~~~---- 130 (488)
+. ..++.++|+||+||++|+|++|++||.+.........+.. .+. ....
T Consensus 183 ~~----~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T cd07849 183 NS----KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWN 258 (336)
T ss_pred CC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHH
Confidence 42 4578899999999999999999999977654332222111 000 0000
Q ss_pred -CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 131 -RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 131 -~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
.....++.+.++|.+||..+|++|||+.++++||||+....
T Consensus 259 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 259 KLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 01235788999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=231.95 Aligned_cols=169 Identities=38% Similarity=0.696 Sum_probs=134.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++...... .......++..|+|||.+.+.
T Consensus 100 ~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 178 (283)
T cd06617 100 IPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERINPE 178 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc-cccccccCCccccChhhcCCc
Confidence 47889999999999999999997 9999999999999999999999999998765432 122335688899999988642
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
. ....++.++|+||+||++|+|++|+.||.... ....+........+.. ....+|.++.++|.+||..+|.+||++.
T Consensus 179 ~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 256 (283)
T cd06617 179 L-NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL-PAEKFSPEFQDFVNKCLKKNYKERPNYP 256 (283)
T ss_pred c-cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC-CccccCHHHHHHHHHHccCChhhCcCHH
Confidence 1 12457889999999999999999999996532 2333444444333322 2345789999999999999999999999
Q ss_pred HHhcCcCCCCCCCC
Q psy9090 159 ELLEHPFITSLPEN 172 (488)
Q Consensus 159 ell~hp~f~~~~~~ 172 (488)
++++||||.....+
T Consensus 257 ~il~~~~~~~~~~~ 270 (283)
T cd06617 257 ELLQHPFFELHLSK 270 (283)
T ss_pred HHhcCchhhhcccc
Confidence 99999999875443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=228.16 Aligned_cols=161 Identities=35% Similarity=0.696 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc------cCccccccCCCccccch
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT------FDKKKTFLGSPSWMAPE 74 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~------~~~~~~~~gt~~y~aPE 74 (488)
+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...... ........|++.|+|||
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe 178 (265)
T cd06631 99 LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChh
Confidence 468889999999999999999999999999999999999999999999988754211 11123446889999999
Q ss_pred hhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 75 IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 75 ~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
++.+ ..++.++|+||||+++|+|++|..||...........+..........+..++..+.++|++||..+|.+|
T Consensus 179 ~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 253 (265)
T cd06631 179 VINE-----SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER 253 (265)
T ss_pred hhcC-----CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccC
Confidence 9876 56788999999999999999999999876655444443332111112345678999999999999999999
Q ss_pred CCHHHHhcCcCC
Q psy9090 155 PYMSELLEHPFI 166 (488)
Q Consensus 155 ps~~ell~hp~f 166 (488)
|++.++++||||
T Consensus 254 p~~~~~l~~~~~ 265 (265)
T cd06631 254 PSALQLLRHDFL 265 (265)
T ss_pred CCHHHHhcCCCC
Confidence 999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=239.38 Aligned_cols=162 Identities=25% Similarity=0.505 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+
T Consensus 115 l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-- 191 (353)
T cd07850 115 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG-- 191 (353)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC-CCCCCCcccccccCHHHHhC--
Confidence 467889999999999999999999999999999999999999999999999765432 22334568899999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC---------------------C------------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP---------------------P------------ 127 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~---------------------~------------ 127 (488)
..++.++|+|||||++|+|++|+.||...+.......+..... +
T Consensus 192 ---~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (353)
T cd07850 192 ---MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFP 268 (353)
T ss_pred ---CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCc
Confidence 5688999999999999999999999987654433333221000 0
Q ss_pred CCCC-------CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q psy9090 128 GLYR-------ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168 (488)
Q Consensus 128 ~~~~-------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 168 (488)
.... +...++.++++|.+||..||++|||+.++|.||||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 269 DVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred ccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0000 1123567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=232.91 Aligned_cols=162 Identities=27% Similarity=0.477 Sum_probs=130.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+.
T Consensus 103 l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 181 (293)
T cd07843 103 FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA- 181 (293)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCC-
Confidence 5788999999999999999999999999999999999999999999999987665432333445678899999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC----------------------------CCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP----------------------------GLYRA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~ 132 (488)
..++.++|+||+|+++|+|++|.+||..........++...... ....+
T Consensus 182 ---~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (293)
T cd07843 182 ---KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFP 258 (293)
T ss_pred ---ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccc
Confidence 34678999999999999999999999877655444433221000 00011
Q ss_pred CC-cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 133 SN-WSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 133 ~~-~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
.. +++.+.++|++||..+|++|||+.+++.||||
T Consensus 259 ~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 259 ALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11 57889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=227.01 Aligned_cols=159 Identities=31% Similarity=0.612 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..............|++.|+|||++.+
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-- 175 (256)
T cd08218 98 FPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN-- 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCC--
Confidence 467888999999999999999999999999999999999999999999998765443222334568889999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+||++|+|++|..||...........+..+..+. .+..++.++.++|.+||..+|.+||++.++
T Consensus 176 ---~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~v 250 (256)
T cd08218 176 ---RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP--VSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250 (256)
T ss_pred ---CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC--CcccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 557789999999999999999999998877666666666554333 245678999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
++||||
T Consensus 251 l~~~~~ 256 (256)
T cd08218 251 LEKNFI 256 (256)
T ss_pred hhCcCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=231.43 Aligned_cols=162 Identities=25% Similarity=0.474 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc--------------------CCcEEEEecCCccccccccCc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK--------------------DGEVKIVDFGLSRETANTFDK 60 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--------------------~~~vkL~Dfg~a~~~~~~~~~ 60 (488)
++-..++.+.+|+++++++||+.+++|.||||+|||+.+ +..|+++|||.++.... .
T Consensus 189 fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e---~ 265 (415)
T KOG0671|consen 189 FPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE---H 265 (415)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc---C
Confidence 466889999999999999999999999999999999842 33589999999976543 3
Q ss_pred cccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH---HHHHHHhCCCCCCCC------
Q psy9090 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR---ALFQIVRNPPPGLYR------ 131 (488)
Q Consensus 61 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~------ 131 (488)
..+.+.|..|+|||++.+ -+++..|||||+||||+|+.+|...|......+ .+.+++. +.|....
T Consensus 266 hs~iVsTRHYRAPEViLg-----LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~~~ 339 (415)
T KOG0671|consen 266 HSTIVSTRHYRAPEVILG-----LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG-PIPSRMIKKTRKE 339 (415)
T ss_pred cceeeeccccCCchheec-----cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC-CCcHHHhhhhhhH
Confidence 467789999999999998 789999999999999999999999998766544 3333332 1111000
Q ss_pred -------------------------CC----------CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 132 -------------------------AS----------NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 132 -------------------------~~----------~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
+. .--.++.+||++||..||.+|+|+.|+|.||||+....
T Consensus 340 Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~~ 414 (415)
T KOG0671|consen 340 KYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLTP 414 (415)
T ss_pred hhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCCC
Confidence 00 00134689999999999999999999999999987643
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=235.97 Aligned_cols=167 Identities=32% Similarity=0.635 Sum_probs=127.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-------ccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-------KKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aP 73 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+........ ......++..|+||
T Consensus 98 l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (327)
T cd08227 98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177 (327)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccCh
Confidence 57888999999999999999999999999999999999999999999986543221101 11223567789999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC------------------------
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL------------------------ 129 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------------------------ 129 (488)
|++.+. ...|+.++||||+||++|+|++|..||.................+..
T Consensus 178 E~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T cd08227 178 EVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGL 254 (327)
T ss_pred HHhhcc---cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCC
Confidence 998652 13588999999999999999999999976554333322221111000
Q ss_pred -------------------CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 130 -------------------YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 130 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
.....+++.+.+||.+||..||++|||++++++||||+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 255 GESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred CcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00123467899999999999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=231.30 Aligned_cols=167 Identities=26% Similarity=0.396 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+.
T Consensus 99 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 177 (298)
T cd07841 99 LTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGA- 177 (298)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCC-
Confidence 5788999999999999999999999999999999999999999999999987665433333344567899999998542
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC---C-------------------C---CCCCCCc
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP---P-------------------G---LYRASNW 135 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~---~-------------------~---~~~~~~~ 135 (488)
..++.++|+||+||++|+|++|.+||.+........++..... . . .......
T Consensus 178 ---~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T cd07841 178 ---RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAA 254 (298)
T ss_pred ---CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccc
Confidence 4578899999999999999999988877665544444332100 0 0 0011234
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 136 SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 136 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
+..+.++|.+||..+|++|||+.+++.||||++.+.
T Consensus 255 ~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 255 SDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 788999999999999999999999999999998553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=228.00 Aligned_cols=160 Identities=36% Similarity=0.719 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||+|||+++++||||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 103 l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (266)
T cd06651 103 LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182 (266)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhC
Confidence 4678889999999999999999999999999999999999999999999987543211 1122345788999999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
+ ..++.++|+||+||++|+|++|+.||..........+.......+ ..+...++.+++++ +||..+|++||++
T Consensus 183 ~-----~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li-~~~~~~p~~Rp~~ 255 (266)
T cd06651 183 G-----EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP-QLPSHISEHARDFL-GCIFVEARHRPSA 255 (266)
T ss_pred C-----CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC-CCchhcCHHHHHHH-HHhcCChhhCcCH
Confidence 5 567889999999999999999999998776555555444332221 12345688899999 5777899999999
Q ss_pred HHHhcCcCCC
Q psy9090 158 SELLEHPFIT 167 (488)
Q Consensus 158 ~ell~hp~f~ 167 (488)
+++++||||+
T Consensus 256 ~eil~hp~~~ 265 (266)
T cd06651 256 EELLRHPFAQ 265 (266)
T ss_pred HHHhcCcccc
Confidence 9999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=229.67 Aligned_cols=162 Identities=25% Similarity=0.471 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||+|||+++++||||+|+||+++.++.++|+|||++..............+++.|+|||++.+.
T Consensus 96 ~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 174 (283)
T cd07835 96 LDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGS- 174 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecC-
Confidence 4688999999999999999999999999999999999999999999999987554322222334568899999988642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC--------------------------CCCCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP--------------------------PGLYRASN 134 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~ 134 (488)
..++.++|+||+|+++|+|++|.+||..........++.+... ........
T Consensus 175 ---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (283)
T cd07835 175 ---RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPN 251 (283)
T ss_pred ---cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCC
Confidence 3468899999999999999999999987766554444332100 00001245
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
++..+.++|.+||+.+|.+|||+++++.||||
T Consensus 252 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 252 LDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 67889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=228.97 Aligned_cols=166 Identities=36% Similarity=0.770 Sum_probs=135.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.++
T Consensus 98 l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 176 (277)
T cd06917 98 IAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG- 176 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccC-
Confidence 5788999999999999999999999999999999999999999999999987665443334455788999999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||...........+.....+. .....++.++.+++.+||..||++||++.++
T Consensus 177 ---~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~i 252 (277)
T cd06917 177 ---KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPR-LEDNGYSKLLREFVAACLDEEPKERLSAEEL 252 (277)
T ss_pred ---CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCC-CCcccCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 456889999999999999999999998766544333222222222 2223478899999999999999999999999
Q ss_pred hcCcCCCCCCC
Q psy9090 161 LEHPFITSLPE 171 (488)
Q Consensus 161 l~hp~f~~~~~ 171 (488)
+.||||+....
T Consensus 253 l~~~~~~~~~~ 263 (277)
T cd06917 253 LKSKWIKAHSK 263 (277)
T ss_pred hhChHhhcccc
Confidence 99999987543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=231.28 Aligned_cols=168 Identities=28% Similarity=0.449 Sum_probs=136.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---------------Ccccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---------------DKKKTFL 65 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---------------~~~~~~~ 65 (488)
+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++...... .......
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (305)
T cd05609 98 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177 (305)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCc
Confidence 4788899999999999999999999999999999999999999999999876321000 0111245
Q ss_pred CCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHH
Q psy9090 66 GSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAE 145 (488)
Q Consensus 66 gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 145 (488)
+++.|+|||.+.. ..++.++|+|||||++|+|++|..||.+........+......+........+..+.++|.+
T Consensus 178 ~~~~y~aPE~~~~-----~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (305)
T cd05609 178 GTPEYIAPEVILR-----QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISR 252 (305)
T ss_pred cCccccCchhccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHH
Confidence 7889999999865 56789999999999999999999999887766666655544322222233578999999999
Q ss_pred hcccCCCCCCC---HHHHhcCcCCCCCCCCc
Q psy9090 146 CLEKNPEHRPY---MSELLEHPFITSLPEND 173 (488)
Q Consensus 146 ~L~~dP~~Rps---~~ell~hp~f~~~~~~~ 173 (488)
||..+|++||+ +.++++||||...++..
T Consensus 253 ~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 253 LLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred HhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 99999999997 79999999999887764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=225.53 Aligned_cols=159 Identities=31% Similarity=0.534 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-----HCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLH-----ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH-----~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~ 75 (488)
+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++..............+++.|+|||.
T Consensus 102 l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~ 181 (265)
T cd08217 102 IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhh
Confidence 467889999999999999999 899999999999999999999999999999876544332345578999999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
+.. ..++.++|+||||+++|+|++|..||...........+.....+. .+..++..+.+++.+||..+|++||
T Consensus 182 ~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~l~~~p~~Rp 254 (265)
T cd08217 182 LNH-----MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR--IPYRYSSELNEVIKSMLNVDPDKRP 254 (265)
T ss_pred hcC-----CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC--CccccCHHHHHHHHHHccCCcccCC
Confidence 876 457889999999999999999999998876544444444333222 3457789999999999999999999
Q ss_pred CHHHHhcCcCC
Q psy9090 156 YMSELLEHPFI 166 (488)
Q Consensus 156 s~~ell~hp~f 166 (488)
++.++++|||+
T Consensus 255 ~~~~il~~~~~ 265 (265)
T cd08217 255 STEELLQLPLI 265 (265)
T ss_pred CHHHHhhCCCC
Confidence 99999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=228.57 Aligned_cols=163 Identities=43% Similarity=0.880 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..............|++.|+|||.+....
T Consensus 103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 182 (267)
T cd06646 103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHccccc
Confidence 46788999999999999999999999999999999999999999999999986643333334557889999999885321
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN--PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
...++.++|+||+||++|+|++|..||....+......+... ..+.......++..+.++|++||..+|++|||++
T Consensus 183 --~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 260 (267)
T cd06646 183 --NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAE 260 (267)
T ss_pred --CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHH
Confidence 145778999999999999999999999765543332222111 1111122345789999999999999999999999
Q ss_pred HHhcCcC
Q psy9090 159 ELLEHPF 165 (488)
Q Consensus 159 ell~hp~ 165 (488)
++++|+|
T Consensus 261 ~il~~l~ 267 (267)
T cd06646 261 RLLTHLF 267 (267)
T ss_pred HHhcCCC
Confidence 9999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=228.33 Aligned_cols=161 Identities=39% Similarity=0.784 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+....... .....++..|+|||.+.+
T Consensus 97 ~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~y~~PE~~~~- 173 (265)
T cd06605 97 IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQG- 173 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--hhcccCChhccCHHHHcC-
Confidence 4678899999999999999999 999999999999999999999999999987654321 122678899999999876
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC-----hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-----PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
..++.++|+||+|+++|+|++|..||.... .......+.....+.. ....++..++++|.+||..+|++|
T Consensus 174 ----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R 248 (265)
T cd06605 174 ----NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL-PSGKFSPDFQDFVNLCLIKDPRER 248 (265)
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC-ChhhcCHHHHHHHHHHcCCCchhC
Confidence 568899999999999999999999996542 2233333333333322 222378999999999999999999
Q ss_pred CCHHHHhcCcCCCCC
Q psy9090 155 PYMSELLEHPFITSL 169 (488)
Q Consensus 155 ps~~ell~hp~f~~~ 169 (488)
||+.+++.||||+..
T Consensus 249 pt~~~ll~~~~~~~~ 263 (265)
T cd06605 249 PSYKELLEHPFIKKY 263 (265)
T ss_pred cCHHHHhhCchhhcc
Confidence 999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=235.39 Aligned_cols=168 Identities=29% Similarity=0.493 Sum_probs=135.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... .......+++.|+|||.+.
T Consensus 100 l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 179 (330)
T cd07834 100 LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL 179 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeee
Confidence 5788899999999999999999999999999999999999999999999988665432 1233456788999999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC---CCC-------------------------C
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP---PPG-------------------------L 129 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~---~~~-------------------------~ 129 (488)
+. ..++.++|+||+|+++|+|++|.+||.+.........+.... .+. .
T Consensus 180 ~~----~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
T cd07834 180 SS----SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLS 255 (330)
T ss_pred cc----cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhH
Confidence 62 267889999999999999999999998877655444433211 000 0
Q ss_pred CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 130 YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 130 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
......++.+.++|.+||..+|.+|||+.+++.||||+++...
T Consensus 256 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 256 KLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred HhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0012357889999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=229.59 Aligned_cols=166 Identities=41% Similarity=0.881 Sum_probs=139.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 113 l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-- 190 (286)
T cd06614 113 MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-- 190 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcC--
Confidence 467889999999999999999999999999999999999999999999988655433223334567889999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||||+++|+|++|..||....+......+.....+....+..++..++++|.+||..+|.+|||+.++
T Consensus 191 ---~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 267 (286)
T cd06614 191 ---KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267 (286)
T ss_pred ---CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 56788999999999999999999999887766655555554444444444588999999999999999999999999
Q ss_pred hcCcCCCCCCC
Q psy9090 161 LEHPFITSLPE 171 (488)
Q Consensus 161 l~hp~f~~~~~ 171 (488)
++||||+..-+
T Consensus 268 l~~~~~~~~~~ 278 (286)
T cd06614 268 LQHPFLKKACP 278 (286)
T ss_pred hhChHhhccCc
Confidence 99999988543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=230.37 Aligned_cols=166 Identities=27% Similarity=0.454 Sum_probs=131.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-CCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++..............+++.|+|||.+.+.
T Consensus 100 ~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~- 178 (294)
T PLN00009 100 NPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS- 178 (294)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCC-
Confidence 56788899999999999999999999999999999985 5579999999987554332223344678899999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCCCC-----------------C------CCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPPGL-----------------Y------RASN 134 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~-----------------~------~~~~ 134 (488)
..++.++|+||+||++|+|++|.+||..........++... +.... . ....
T Consensus 179 ---~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (294)
T PLN00009 179 ---RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPT 255 (294)
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcC
Confidence 45788999999999999999999999877665555544321 10000 0 1234
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
.++.+++++.+||..+|++||++.++++||||.+++.
T Consensus 256 ~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 256 LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred CChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 6788999999999999999999999999999987653
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=228.82 Aligned_cols=163 Identities=28% Similarity=0.479 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+.
T Consensus 96 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07832 96 LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeecc
Confidence 47889999999999999999999999999999999999999999999999876543311 12345688999999998642
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC---------------------C------CCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG---------------------L------YRA 132 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------------------~------~~~ 132 (488)
..++.++||||+|+++|+|++|.+||.+.........+....... . ...
T Consensus 176 ----~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (286)
T cd07832 176 ----RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIF 251 (286)
T ss_pred ----ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhC
Confidence 456889999999999999999999997766554444433211000 0 001
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 167 (488)
...+..+.++|++||..+|.+|||++++++||||.
T Consensus 252 ~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 252 PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 24568899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=230.43 Aligned_cols=165 Identities=36% Similarity=0.704 Sum_probs=136.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.+|+|||++|++||||+|+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus 113 ~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-- 190 (292)
T cd06657 113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-- 190 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcC--
Confidence 467889999999999999999999999999999999999999999999988755433222334568899999998865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||...........+....++........+..+.+++.+||..+|.+||++.++
T Consensus 191 ---~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~l 267 (292)
T cd06657 191 ---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 267 (292)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHH
Confidence 45788999999999999999999999877655544444333333333345678999999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
+.||||....
T Consensus 268 l~~~~~~~~~ 277 (292)
T cd06657 268 LKHPFLAKAG 277 (292)
T ss_pred hcChHHhccC
Confidence 9999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=222.56 Aligned_cols=159 Identities=50% Similarity=1.035 Sum_probs=134.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.+|.+||++|++||||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+
T Consensus 95 ~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~-- 171 (253)
T cd05122 95 LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVING-- 171 (253)
T ss_pred CCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcC--
Confidence 47888999999999999999999999999999999999999999999999876654321 345578899999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||.................+.......++..+.++|.+||..||++|||+.++
T Consensus 172 ---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~ 248 (253)
T cd05122 172 ---KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQL 248 (253)
T ss_pred ---CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 44788999999999999999999999887655555555544444444444568999999999999999999999999
Q ss_pred hcCcC
Q psy9090 161 LEHPF 165 (488)
Q Consensus 161 l~hp~ 165 (488)
++|||
T Consensus 249 l~~~~ 253 (253)
T cd05122 249 LKHPF 253 (253)
T ss_pred hcCCC
Confidence 99998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=235.00 Aligned_cols=167 Identities=30% Similarity=0.523 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||++..............++..|+|||.+...
T Consensus 105 l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 183 (337)
T cd07858 105 LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC- 183 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcC-
Confidence 5788999999999999999999999999999999999999999999999987654332223345678899999988642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCC------------------------CC-CCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPP------------------------PG-LYRA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~------------------------~~-~~~~ 132 (488)
..++.++|+|||||++|+|++|++||.+.+.......+.. .+. +. ....
T Consensus 184 ---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (337)
T cd07858 184 ---SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLF 260 (337)
T ss_pred ---CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHc
Confidence 3478899999999999999999999977653322221110 000 00 0012
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
...++.++++|++||..+|++|||++++++||||..+..
T Consensus 261 ~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 261 PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred ccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 356889999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=231.04 Aligned_cols=156 Identities=19% Similarity=0.326 Sum_probs=123.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-------CccccccCCCccccch
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-------DKKKTFLGSPSWMAPE 74 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE 74 (488)
++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||+++...... .......||+.|+|||
T Consensus 124 ~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape 203 (294)
T PHA02882 124 NKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD 203 (294)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHH
Confidence 567788999999999999999999999999999999999999999999987653211 1122346999999999
Q ss_pred hhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHH-----HHHhCCCCCCCCCCCcCHHHHHHHHHhccc
Q psy9090 75 IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF-----QIVRNPPPGLYRASNWSQHYVDFIAECLEK 149 (488)
Q Consensus 75 ~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 149 (488)
++.+ ..++.++||||+||++|+|++|.+||.+........ ................++.+.++++.|+..
T Consensus 204 ~~~~-----~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (294)
T PHA02882 204 AHNG-----ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKL 278 (294)
T ss_pred HhCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhC
Confidence 9876 668999999999999999999999997763221111 111111111122345688999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy9090 150 NPEHRPYMSELLE 162 (488)
Q Consensus 150 dP~~Rps~~ell~ 162 (488)
+|++||++.++++
T Consensus 279 ~~~~rp~~~~l~~ 291 (294)
T PHA02882 279 SYEEKPDYDALIK 291 (294)
T ss_pred CCCCCCCHHHHHH
Confidence 9999999999875
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=229.16 Aligned_cols=162 Identities=23% Similarity=0.500 Sum_probs=124.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.............+++.|+|||.+.+.
T Consensus 100 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 178 (291)
T cd07870 100 LHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA- 178 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecC-
Confidence 3577889999999999999999999999999999999999999999999987543322223344678999999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-HHHHHHHh---CCC--------------CCC------------C
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVR---NPP--------------PGL------------Y 130 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-~~~~~~~~---~~~--------------~~~------------~ 130 (488)
..++.++|+|||||++|+|++|..||...... +.+.++.. .+. +.. .
T Consensus 179 ---~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (291)
T cd07870 179 ---TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVW 255 (291)
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhc
Confidence 34778999999999999999999999765432 22222111 000 000 0
Q ss_pred CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 131 RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 131 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
.....+..+.+++.+||..||.+|||+.+++.||||
T Consensus 256 ~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 256 KRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 001125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=231.97 Aligned_cols=165 Identities=41% Similarity=0.782 Sum_probs=135.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..............+++.|+|||.+..
T Consensus 112 l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-- 189 (293)
T cd06647 112 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-- 189 (293)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhcc--
Confidence 467888999999999999999999999999999999999999999999988755433233334568889999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|++++|..||...........+.....+....+...+..++++|.+||..+|++||++.++
T Consensus 190 ---~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i 266 (293)
T cd06647 190 ---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 266 (293)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 55788999999999999999999999876654443333333333333445568889999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
+.||||+...
T Consensus 267 l~h~~~~~~~ 276 (293)
T cd06647 267 LQHPFLKIAK 276 (293)
T ss_pred hcCHHHhcCc
Confidence 9999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=228.15 Aligned_cols=156 Identities=24% Similarity=0.438 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+
T Consensus 121 l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05048 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY 200 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc
Confidence 4567889999999999999999999999999999999999999999999987543221 12233456788999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+|||||++|+|++ |..||.+....+....+.....+. .+..+++++.+|+.+||+.+|.+||++
T Consensus 201 -----~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~l~~~c~~~~p~~Rp~~ 273 (283)
T cd05048 201 -----GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP--CPEDCPARVYALMIECWNEIPARRPRF 273 (283)
T ss_pred -----CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC--CcccCCHHHHHHHHHHccCChhhCcCH
Confidence 568899999999999999998 999998887766655555443332 356789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 274 ~~i~~~ 279 (283)
T cd05048 274 KDIHTR 279 (283)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=235.82 Aligned_cols=164 Identities=29% Similarity=0.538 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||+++.... ......+++.|+|||.+.+.
T Consensus 114 ~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~- 189 (342)
T cd07879 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNW- 189 (342)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC---CCCCceeeecccChhhhcCc-
Confidence 46888999999999999999999999999999999999999999999999875432 22344678899999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC----------------------CCCCC------C
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP----------------------PGLYR------A 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~----------------------~~~~~------~ 132 (488)
..++.++|+|||||++|+|++|+.||.+.........+..... +.... .
T Consensus 190 ---~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (342)
T cd07879 190 ---MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF 266 (342)
T ss_pred ---cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh
Confidence 3478899999999999999999999987765444433322100 00000 1
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
+..++.+.+||.+||..||++||++.+++.||||+.+..
T Consensus 267 ~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 267 PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 245778999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-27 Score=225.93 Aligned_cols=160 Identities=38% Similarity=0.751 Sum_probs=126.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-CCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++..............|++.|+|||.+...
T Consensus 106 ~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 184 (268)
T cd06624 106 NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG- 184 (268)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccc-
Confidence 56778899999999999999999999999999999976 6789999999987554322223344688999999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH-HHHH-HhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA-LFQI-VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
...++.++|+||+|+++|+|++|.+||........ .... .....+ ..+...++++++++.+||..+|.+|||+.
T Consensus 185 --~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 260 (268)
T cd06624 185 --PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP--EIPESLSAEAKNFILRCFEPDPDKRASAH 260 (268)
T ss_pred --cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCC--CCCcccCHHHHHHHHHHcCCCchhCCCHH
Confidence 13477899999999999999999999975433221 1111 111111 12456789999999999999999999999
Q ss_pred HHhcCcCC
Q psy9090 159 ELLEHPFI 166 (488)
Q Consensus 159 ell~hp~f 166 (488)
+++.||||
T Consensus 261 ~ll~~~~~ 268 (268)
T cd06624 261 DLLQDPFL 268 (268)
T ss_pred HHHhCCCC
Confidence 99999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=221.06 Aligned_cols=160 Identities=29% Similarity=0.507 Sum_probs=132.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHK 81 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 81 (488)
..+.+++++.|++.|++|||+.||+||||||+||++..+..+|+.|||+++..... -..+..+.|..|.|||++.+
T Consensus 116 DH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~--- 191 (369)
T KOG0665|consen 116 DHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILG--- 191 (369)
T ss_pred chHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-cccCchhheeeccCchheec---
Confidence 46788999999999999999999999999999999999999999999999865543 34566788999999999987
Q ss_pred CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC---C------------------CC--------CCCC
Q psy9090 82 EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP---P------------------PG--------LYRA 132 (488)
Q Consensus 82 ~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~---~------------------~~--------~~~~ 132 (488)
..|.+.+||||+||++.||++|...|.+.....++.++.... . +. ..+.
T Consensus 192 --~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD 269 (369)
T KOG0665|consen 192 --MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPD 269 (369)
T ss_pred --cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCc
Confidence 558999999999999999999999999877666666554310 0 00 0000
Q ss_pred C----------CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q psy9090 133 S----------NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167 (488)
Q Consensus 133 ~----------~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 167 (488)
. .-+..+++|+.+||..||++|.|++++|+|||++
T Consensus 270 ~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 270 SLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred ccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 1134578999999999999999999999999998
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=230.49 Aligned_cols=167 Identities=33% Similarity=0.659 Sum_probs=129.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-------ccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-------KKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aP 73 (488)
+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||.+........ ......++..|+||
T Consensus 98 ~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (314)
T cd08216 98 LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177 (314)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCH
Confidence 46788999999999999999999999999999999999999999999998765432111 12234567789999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-------------------------
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG------------------------- 128 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~------------------------- 128 (488)
|++... ...++.++|+||+||++|+|++|..||.................+.
T Consensus 178 E~~~~~---~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
T cd08216 178 EVLQQN---LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN 254 (314)
T ss_pred HHhcCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccc
Confidence 998652 1357889999999999999999999998765544333322211100
Q ss_pred ------CCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 129 ------LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 129 ------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
......++.++.+|+.+||..||++|||++++++||||+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 255 NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000112346788999999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=222.76 Aligned_cols=159 Identities=29% Similarity=0.597 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++..............+++.|+|||.+.+
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~-- 175 (256)
T cd08221 98 FEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG-- 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCC--
Confidence 467889999999999999999999999999999999999999999999998765443323345678999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||...........+.....+. .+...+..+.++|.+||..+|.+||++.++
T Consensus 176 ---~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~s~~~l 250 (256)
T cd08221 176 ---VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP--VVSVYSSELISLVHSLLQQDPEKRPTADEV 250 (256)
T ss_pred ---CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--CccccCHHHHHHHHHHcccCcccCCCHHHH
Confidence 457789999999999999999999998877766666665543332 235678999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
++|||+
T Consensus 251 l~~~~l 256 (256)
T cd08221 251 LDQPLL 256 (256)
T ss_pred hhCcCC
Confidence 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=229.12 Aligned_cols=161 Identities=40% Similarity=0.815 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++..... .....+++.|+|||++.+..
T Consensus 112 l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 187 (307)
T cd06607 112 LQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----ANSFVGTPYWMAPEVILAMD 187 (307)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----CCCccCCccccCceeeeccC
Confidence 47888999999999999999999999999999999999999999999998865432 23456888999999885321
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
...++.++||||+|+++|+|++|.+||...........+.....+.. .+..++..++++|.+||..+|++||++.++
T Consensus 188 --~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 264 (307)
T cd06607 188 --EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL-SSNDWSDYFRNFVDSCLQKIPQDRPSSEEL 264 (307)
T ss_pred --CCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC-CchhhCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 14578899999999999999999999988776665555544433332 344688999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
+.||||..
T Consensus 265 l~~~~~~~ 272 (307)
T cd06607 265 LKHRFVLR 272 (307)
T ss_pred hcChhhcc
Confidence 99999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=229.25 Aligned_cols=163 Identities=46% Similarity=0.904 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 175 (277)
T cd06642 98 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-- 175 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCc--
Confidence 467889999999999999999999999999999999999999999999998765443222334568889999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+||++|+|++|..||....+......+.....+. .....+..+.++|.+||..+|.+||++.++
T Consensus 176 ---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 250 (277)
T cd06642 176 ---SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT--LEGQYSKPFKEFVEACLNKDPRFRPTAKEL 250 (277)
T ss_pred ---CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC--CCcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 567889999999999999999999998766544444333332222 234568899999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
+.||||....
T Consensus 251 l~~~~~~~~~ 260 (277)
T cd06642 251 LKHKFITRYT 260 (277)
T ss_pred HHhHHHHHHh
Confidence 9999997644
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=226.53 Aligned_cols=167 Identities=35% Similarity=0.669 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||.|||+ +|++||||||+||+++.++.++|+|||++...... ......+++.|+|||.+.+.
T Consensus 99 ~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 99 IPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSG 176 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCC
Confidence 5788999999999999999997 59999999999999999999999999998765332 23345688899999998653
Q ss_pred cc-CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHH---HHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 80 HK-EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ---IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 80 ~~-~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.. ....++.++|+||+||++|+|++|..||........... +.....+. .+..+++++.++|.+||..+|++||
T Consensus 177 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp 254 (286)
T cd06622 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT--LPSGYSDDAQDFVAKCLNKIPNRRP 254 (286)
T ss_pred CCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC--CCcccCHHHHHHHHHHcccCcccCC
Confidence 21 123468899999999999999999999976544332222 22222222 3455899999999999999999999
Q ss_pred CHHHHhcCcCCCCCCC
Q psy9090 156 YMSELLEHPFITSLPE 171 (488)
Q Consensus 156 s~~ell~hp~f~~~~~ 171 (488)
++.++++||||.....
T Consensus 255 ~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 255 TYAQLLEHPWLVKYKN 270 (286)
T ss_pred CHHHHhcChhhhhccC
Confidence 9999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=228.28 Aligned_cols=162 Identities=25% Similarity=0.524 Sum_probs=124.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.............+++.|+|||++.+.
T Consensus 100 ~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 178 (291)
T cd07844 100 LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGS- 178 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcC-
Confidence 4678899999999999999999999999999999999999999999999986543222222233568899999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC-hHHHHHHHHh---CCCCCC------------------------CCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PTRALFQIVR---NPPPGL------------------------YRA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~-~~~~~~~~~~---~~~~~~------------------------~~~ 132 (488)
..++.++|+||+|+++|+|++|..||.+.. .......+.. .+.+.. ...
T Consensus 179 ---~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (291)
T cd07844 179 ---TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHA 255 (291)
T ss_pred ---cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhC
Confidence 457889999999999999999999997655 2222221111 000000 000
Q ss_pred CCcC--HHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 133 SNWS--QHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 133 ~~~s--~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
..++ ..+.+++.+||..+|.+|||+.++++||||
T Consensus 256 ~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 256 PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1233 788899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-27 Score=224.76 Aligned_cols=163 Identities=40% Similarity=0.779 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||+ .|++||||+|+||+++.++.++|+|||++..............++..|+|||.+..
T Consensus 96 l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~- 174 (264)
T cd06623 96 IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG- 174 (264)
T ss_pred CCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCC-
Confidence 5788999999999999999999 99999999999999999999999999998766544333335568899999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC---hHHHHHHHHhCCCCCCCCCCC-cCHHHHHHHHHhcccCCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH---PTRALFQIVRNPPPGLYRASN-WSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rp 155 (488)
..++.++|+||||+++|+|++|..||.... .......+.....+. .+.. ++..+.++|.+||..+|++||
T Consensus 175 ----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~ 248 (264)
T cd06623 175 ----ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS--LPAEEFSPEFRDFISACLQKDPKKRP 248 (264)
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC--CCcccCCHHHHHHHHHHccCChhhCC
Confidence 467889999999999999999999997763 333344444333322 2334 789999999999999999999
Q ss_pred CHHHHhcCcCCCCCC
Q psy9090 156 YMSELLEHPFITSLP 170 (488)
Q Consensus 156 s~~ell~hp~f~~~~ 170 (488)
|+.++++|||++..+
T Consensus 249 ~~~~ll~~~~~~~~~ 263 (264)
T cd06623 249 SAAELLQHPFIKKAD 263 (264)
T ss_pred CHHHHHhCHHHHhcc
Confidence 999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=239.71 Aligned_cols=160 Identities=28% Similarity=0.538 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEcc-CCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
++.+.++.|++||+.||.|||++. |+|||||.+||+|+. .|.|||+|+|+|+..... .....+|||.|||||+..
T Consensus 140 vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--~aksvIGTPEFMAPEmYE 217 (632)
T KOG0584|consen 140 VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--HAKSVIGTPEFMAPEMYE 217 (632)
T ss_pred CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc--ccceeccCccccChHHHh
Confidence 356789999999999999999997 999999999999974 689999999999876653 334579999999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+..+||||||+++.||+|+..||........+++.+.....+.....--.+++++||.+||.. .+.|||+
T Consensus 218 ------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa 290 (632)
T KOG0584|consen 218 ------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSA 290 (632)
T ss_pred ------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCH
Confidence 579999999999999999999999998887777776666543333222233378999999999999 9999999
Q ss_pred HHHhcCcCCCCC
Q psy9090 158 SELLEHPFITSL 169 (488)
Q Consensus 158 ~ell~hp~f~~~ 169 (488)
.++|.||||..-
T Consensus 291 ~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 291 KELLKDPFFDED 302 (632)
T ss_pred HHHhhChhhccc
Confidence 999999999864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=230.06 Aligned_cols=162 Identities=27% Similarity=0.522 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-----------ccccccCCCc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-----------KKKTFLGSPS 69 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-----------~~~~~~gt~~ 69 (488)
+++..++.++.||++||+|||++|++||||||+||+++.++.++|+|||++........ ......+++.
T Consensus 112 ~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (311)
T cd07866 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRW 191 (311)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccC
Confidence 57889999999999999999999999999999999999999999999999875432211 1123356888
Q ss_pred cccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCCCC----------C------
Q psy9090 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPPGL----------Y------ 130 (488)
Q Consensus 70 y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~----------~------ 130 (488)
|+|||.+.+. ..++.++|+||+||++|+|++|++||.+.........+... +.+.. .
T Consensus 192 y~aPE~~~~~----~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (311)
T cd07866 192 YRPPELLLGE----RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFT 267 (311)
T ss_pred cCChHHhhCC----CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCC
Confidence 9999988642 45788999999999999999999999877665444433321 00000 0
Q ss_pred --------CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 131 --------RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 131 --------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
....+++.+.++|.+||..+|.+|||+.+++.||||
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 268 NYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 012345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=228.36 Aligned_cols=168 Identities=35% Similarity=0.647 Sum_probs=133.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++...... .......+++.|+|||.+.+.
T Consensus 111 l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 111 IPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAKTRSAGCAAYMAPERIDPP 189 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC-CcccCCCCCccccCHhhcCCC
Confidence 4678889999999999999997 69999999999999999999999999998765432 122234578899999998652
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh-HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP-TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
.. ...++.++|+||||+++|+|++|+.||..... .+.+.++.....+.......++.++.+|+.+||..+|.+||+++
T Consensus 190 ~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 268 (296)
T cd06618 190 DP-NPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR 268 (296)
T ss_pred CC-ccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 11 13478899999999999999999999976433 23334444443333333345789999999999999999999999
Q ss_pred HHhcCcCCCCCC
Q psy9090 159 ELLEHPFITSLP 170 (488)
Q Consensus 159 ell~hp~f~~~~ 170 (488)
+++.||||....
T Consensus 269 ~il~~~~~~~~~ 280 (296)
T cd06618 269 ELLQHPFIRRYE 280 (296)
T ss_pred HHhcChhhhccc
Confidence 999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=222.03 Aligned_cols=158 Identities=28% Similarity=0.543 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.|++.+|+|||++|++|+||+|+||+++.++ .++|+|||++...... .......+++.|+|||.+.+
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~- 175 (256)
T cd08220 98 LDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVVGTPCYISPELCEG- 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-ccccccccCCcccCchhccC-
Confidence 46788999999999999999999999999999999998654 5899999998765443 22334568899999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|+||+|+++|+|++|..||...........+....... .+..+++.+.+++.+||..+|.+|||+.+
T Consensus 176 ----~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 176 ----KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP--ISDRYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred ----CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC--CCCCcCHHHHHHHHHHccCChhhCCCHHH
Confidence 557889999999999999999999998877666555555443332 34567999999999999999999999999
Q ss_pred HhcCcCC
Q psy9090 160 LLEHPFI 166 (488)
Q Consensus 160 ll~hp~f 166 (488)
+++||||
T Consensus 250 ll~~p~~ 256 (256)
T cd08220 250 IMAQPIC 256 (256)
T ss_pred HhhCCCC
Confidence 9999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=226.54 Aligned_cols=162 Identities=30% Similarity=0.586 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..............++..|+|||++.+.
T Consensus 97 ~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 175 (286)
T cd07846 97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD- 175 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccc-
Confidence 4678999999999999999999999999999999999999999999999987654432333345678899999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC---------------------CCCC-------CCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP---------------------PPGL-------YRA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~---------------------~~~~-------~~~ 132 (488)
..++.++|+||+|+++|+|++|.+||...........+.... .+.. ...
T Consensus 176 ---~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd07846 176 ---TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRF 252 (286)
T ss_pred ---cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhC
Confidence 346789999999999999999999997665443333322100 0000 012
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
..++..+.+|+.+||..+|++||++.++++||||
T Consensus 253 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 253 PKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred CCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 3568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=201.81 Aligned_cols=165 Identities=25% Similarity=0.491 Sum_probs=137.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|..+.++.++.|++.||.+||++++.|||+||.|.||+.+|.+||+|||+++-++-+....+..+-|.+|.+|.++.+.
T Consensus 98 ~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfga- 176 (292)
T KOG0662|consen 98 LDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA- 176 (292)
T ss_pred CCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeee-
Confidence 4577899999999999999999999999999999999999999999999999877665555666789999999999874
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhC---C----CCCC------------CCCC-------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN---P----PPGL------------YRAS------- 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~---~----~~~~------------~~~~------- 133 (488)
.-|+.+.|+||.||++.|+.. |++.|.+.+...++.++.+. + .|.. +...
T Consensus 177 ---kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp 253 (292)
T KOG0662|consen 177 ---KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVP 253 (292)
T ss_pred ---ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhh
Confidence 669999999999999999975 88889998877777776541 1 1111 1111
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
.++..-++|++++|.-+|.+|++++.+++||||.+.
T Consensus 254 ~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 254 KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred hhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 123445899999999999999999999999999865
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=229.24 Aligned_cols=162 Identities=25% Similarity=0.476 Sum_probs=126.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC----ccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++........ ......++..|+|||.+
T Consensus 116 ~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 195 (310)
T cd07865 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL 195 (310)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHh
Confidence 47889999999999999999999999999999999999999999999999876533211 11234577889999988
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCCC-----------------------
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGLY----------------------- 130 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~~----------------------- 130 (488)
.+. ..++.++|+||+|+++|+|++|.+||.+.........+.. ..++...
T Consensus 196 ~~~----~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (310)
T cd07865 196 LGE----RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVK 271 (310)
T ss_pred cCC----cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhH
Confidence 652 3467899999999999999999999987665433322211 1110000
Q ss_pred ---CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 131 ---RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 131 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
.+...+..++++|.+||..||.+|||++++++||||
T Consensus 272 ~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 272 ERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 011125677899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=221.34 Aligned_cols=159 Identities=31% Similarity=0.624 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+..
T Consensus 100 ~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-- 177 (258)
T cd08215 100 FPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-- 177 (258)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhcc--
Confidence 467889999999999999999999999999999999999999999999998766544333445578899999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++++|++|..||.................+. .+..++..+.+++.+||..+|++|||+.++
T Consensus 178 ---~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 252 (258)
T cd08215 178 ---KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP--IPSQYSSELRNLVSSLLQKDPEERPSIAQI 252 (258)
T ss_pred ---CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 557889999999999999999999998877666665555544333 244678999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
++||||
T Consensus 253 l~~~~~ 258 (258)
T cd08215 253 LQSPFI 258 (258)
T ss_pred hcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=227.13 Aligned_cols=164 Identities=46% Similarity=0.896 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++..............++..|+|||++.+
T Consensus 98 l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~-- 175 (277)
T cd06640 98 FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ-- 175 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhcc--
Confidence 467888999999999999999999999999999999999999999999998765443223334567889999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+|||||++|+|++|.+||....+......+.....+. .+...+..+.+++.+||..+|++||++.++
T Consensus 176 ---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 250 (277)
T cd06640 176 ---SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT--LTGEFSKPFKEFIDACLNKDPSFRPTAKEL 250 (277)
T ss_pred ---CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCC--CchhhhHHHHHHHHHHcccCcccCcCHHHH
Confidence 567889999999999999999999998777655444433332222 234567889999999999999999999999
Q ss_pred hcCcCCCCCCC
Q psy9090 161 LEHPFITSLPE 171 (488)
Q Consensus 161 l~hp~f~~~~~ 171 (488)
+.||||.....
T Consensus 251 l~~~~~~~~~~ 261 (277)
T cd06640 251 LKHKFIVKNAK 261 (277)
T ss_pred HhChHhhhcch
Confidence 99999976544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=225.68 Aligned_cols=162 Identities=28% Similarity=0.535 Sum_probs=130.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+..............++..|+|||.+.+.
T Consensus 95 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~- 173 (283)
T cd05118 95 LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD- 173 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcC-
Confidence 4678899999999999999999999999999999999999999999999987665432222334678899999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC---CC------------------------CCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP---PG------------------------LYRAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~---~~------------------------~~~~~ 133 (488)
..++.++|+||+|+++|+|++|+.||...+.......+..... +. .....
T Consensus 174 ---~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (283)
T cd05118 174 ---KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFP 250 (283)
T ss_pred ---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhh
Confidence 3678899999999999999999999987776554444332100 00 00112
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
..+.+++++|.+||..||.+||++.+++.||||
T Consensus 251 ~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 251 NASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=232.10 Aligned_cols=168 Identities=27% Similarity=0.516 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC----ccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~l 76 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........ ......|+..|+|||.+
T Consensus 104 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (334)
T cd07855 104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183 (334)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHh
Confidence 57889999999999999999999999999999999999999999999999876533211 11244788999999998
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CC-------------------CCC-CC---
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NP-------------------PPG-LY--- 130 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~-------------------~~~-~~--- 130 (488)
.+. ..++.++|+||+||++|+|++|++||.+......+..+.. .+ .+. ..
T Consensus 184 ~~~----~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (334)
T cd07855 184 LSL----PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPW 259 (334)
T ss_pred cCC----cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCH
Confidence 642 3578899999999999999999999977654333222111 00 000 00
Q ss_pred --CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 131 --RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 131 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
.....++.++++|++||+.+|.+|||+.+++.||||.+.+..
T Consensus 260 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 260 SKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 013458899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=225.37 Aligned_cols=160 Identities=28% Similarity=0.475 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++...... .......+++.|+|||++.+
T Consensus 104 l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~PE~~~~-- 180 (287)
T cd07838 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTSVVVTLWYRAPEVLLQ-- 180 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC-cccccccccccccChHHhcc--
Confidence 578899999999999999999999999999999999999999999999998765432 22233457889999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC------------------CCC------CCCCcC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP------------------GLY------RASNWS 136 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~------------------~~~------~~~~~s 136 (488)
..++.++|+||+||++|+|++|.+||.+....+...++...... ... .....+
T Consensus 181 ---~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (287)
T cd07838 181 ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEIC 257 (287)
T ss_pred ---CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhh
Confidence 56788999999999999999999999887766555544431100 000 011345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 137 QHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 137 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
+.+.++|.+||..||.+||++.+++.||||
T Consensus 258 ~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 258 EEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=232.99 Aligned_cols=163 Identities=30% Similarity=0.536 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .....+++.|+|||.+.+.
T Consensus 115 l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~- 190 (343)
T cd07851 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNW- 190 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCC-
Confidence 578899999999999999999999999999999999999999999999998765432 3344678899999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC----------------------CC------CCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP----------------------GL------YRA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~----------------------~~------~~~ 132 (488)
..++.++|+|||||++|+|++|+.||.+.........+...... .. ...
T Consensus 191 ---~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (343)
T cd07851 191 ---MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVF 267 (343)
T ss_pred ---CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHh
Confidence 35778999999999999999999999877665444443321100 00 001
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
...++.+.++|.+||..+|++|||+.++++||||....
T Consensus 268 ~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 268 SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 23588999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=236.94 Aligned_cols=156 Identities=29% Similarity=0.601 Sum_probs=134.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHK 81 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 81 (488)
+......|..+|+.|++|||.+.|||||||.-||||..+..|||+|||.++..... ...-.++||..|||||+++.
T Consensus 210 tp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrn--- 285 (904)
T KOG4721|consen 210 TPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRN--- 285 (904)
T ss_pred CHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhc---
Confidence 45667789999999999999999999999999999999999999999999877654 44557899999999999987
Q ss_pred CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy9090 82 EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161 (488)
Q Consensus 82 ~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell 161 (488)
.+.++|+|||||||+||||+||..||.+.....++..+= ...-.++.|..+++.++=||+.||+-.|..|||+.+++
T Consensus 286 --ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG-sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil 362 (904)
T KOG4721|consen 286 --EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG-SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQIL 362 (904)
T ss_pred --CCcccccceehhHHHHHHHHhcCCCccccchheeEEecc-CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHH
Confidence 789999999999999999999999998876554433322 22234456778899999999999999999999999999
Q ss_pred cCc
Q psy9090 162 EHP 164 (488)
Q Consensus 162 ~hp 164 (488)
.|-
T Consensus 363 ~Hl 365 (904)
T KOG4721|consen 363 LHL 365 (904)
T ss_pred HHH
Confidence 884
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=253.66 Aligned_cols=164 Identities=27% Similarity=0.488 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-------CCeecccCCCCEEEcc-----------------CCcEEEEecCCcccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-------HVIHRDLRGSNVLLTK-----------------DGEVKIVDFGLSRETAN 56 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-------givHrDlkp~NILl~~-----------------~~~vkL~Dfg~a~~~~~ 56 (488)
|++..++.|+.||+.||.|||+. +||||||||+|||++. .+.+||+|||++.....
T Consensus 115 L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccc
Confidence 57889999999999999999985 4999999999999964 23489999999976543
Q ss_pred ccCccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcC
Q psy9090 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWS 136 (488)
Q Consensus 57 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 136 (488)
. .......||+.|+|||++.+. ...++.++|||||||++|+|++|..||........+...+...+ .. .....+
T Consensus 195 ~-s~~~s~vGTp~YmAPEvL~ge---~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p-~l-pi~~~S 268 (1021)
T PTZ00266 195 E-SMAHSCVGTPYYWSPELLLHE---TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP-DL-PIKGKS 268 (1021)
T ss_pred c-ccccccCCCccccCHHHHhcc---CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC-CC-CcCCCC
Confidence 2 223455799999999998642 14578899999999999999999999976655444444443321 11 224568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 137 QHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 137 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
.++.+||..||..+|.+||++.++|.|||++.+.
T Consensus 269 ~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 269 KELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 9999999999999999999999999999998654
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=221.23 Aligned_cols=164 Identities=30% Similarity=0.672 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc----ccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK----KTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~----~~~~gt~~y~aPE~l 76 (488)
+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......... ....+++.|+|||.+
T Consensus 96 ~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 175 (264)
T cd06626 96 LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175 (264)
T ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhc
Confidence 4678899999999999999999999999999999999999999999999987654332211 134678899999998
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh-HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP-TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.+.. ...++.++|+||+|+++|++++|..||..... ......+.....+..+.....++.+.++|.+||..+|.+||
T Consensus 176 ~~~~--~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 253 (264)
T cd06626 176 TGGK--GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP 253 (264)
T ss_pred cCCC--CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCC
Confidence 7631 12378899999999999999999999976533 23333333333333333334589999999999999999999
Q ss_pred CHHHHhcCcCC
Q psy9090 156 YMSELLEHPFI 166 (488)
Q Consensus 156 s~~ell~hp~f 166 (488)
|+.+++.|||+
T Consensus 254 ~~~~i~~~~~~ 264 (264)
T cd06626 254 TASELLQHPFV 264 (264)
T ss_pred CHHHHhcCCCC
Confidence 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=230.63 Aligned_cols=162 Identities=29% Similarity=0.454 Sum_probs=125.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc----CCcEEEEecCCccccccccC---ccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK----DGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~----~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aP 73 (488)
+++..++.++.||+.||+|||+++|+||||||+||+++. ++.+||+|||++........ ......+++.|+||
T Consensus 105 ~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 184 (316)
T cd07842 105 IPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP 184 (316)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCH
Confidence 478899999999999999999999999999999999999 89999999999876543211 22344678899999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH---------HHHHHHh---CCC---------------
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR---------ALFQIVR---NPP--------------- 126 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~---------~~~~~~~---~~~--------------- 126 (488)
|++.+. ..++.++|+|||||++|+|++|.+||.+..... .+..++. .+.
T Consensus 185 E~~~~~----~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (316)
T cd07842 185 ELLLGA----RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDT 260 (316)
T ss_pred HHHhCC----CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchh
Confidence 988652 457889999999999999999999997554321 1111100 000
Q ss_pred ----CCCCCC------------CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 127 ----PGLYRA------------SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 127 ----~~~~~~------------~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
...... ...+..+.+++.+||..||++|||+.++++||||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 261 LMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000000 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=225.83 Aligned_cols=162 Identities=28% Similarity=0.513 Sum_probs=129.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..............+++.|+|||++.+.
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~- 175 (284)
T cd07836 97 LDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS- 175 (284)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCC-
Confidence 4788999999999999999999999999999999999999999999999987554332223344678899999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCC--------------CCC---------CCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPP--------------GLY---------RASN 134 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~--------------~~~---------~~~~ 134 (488)
..++.++|+||+||++|+|++|++||.+....+...++... +.. ..+ ....
T Consensus 176 ---~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
T cd07836 176 ---RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPH 252 (284)
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhh
Confidence 35678999999999999999999999877655444433221 000 000 0123
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
.++.++++|.+||+.+|.+||++.++++||||
T Consensus 253 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 253 ADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 47788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=231.08 Aligned_cols=165 Identities=28% Similarity=0.486 Sum_probs=129.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-CCcEEEEecCCccccccccC---ccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l 76 (488)
+++..++.++.||+.||.|||++|++||||||+||+++. ++.++|+|||++........ ......++..|+|||.+
T Consensus 111 l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 190 (342)
T cd07854 111 LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190 (342)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHH
Confidence 578899999999999999999999999999999999974 55789999999875432211 11233578899999987
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC------------------------C---
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG------------------------L--- 129 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~------------------------~--- 129 (488)
... ..++.++|+|||||++|+|++|+.||.+.........+....+.. .
T Consensus 191 ~~~----~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (342)
T cd07854 191 LSP----NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLR 266 (342)
T ss_pred hCc----cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHH
Confidence 542 457789999999999999999999998776555444433211000 0
Q ss_pred CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 130 YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 130 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
......+.++++||.+||..||.+|||+.+++.||||+.+
T Consensus 267 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 267 DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0112467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=255.56 Aligned_cols=166 Identities=30% Similarity=0.600 Sum_probs=138.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc----CccccccCCCccccchhhc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF----DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~l~ 77 (488)
+|...+.+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|....... .......|||.|||||++.
T Consensus 1332 dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit 1411 (1509)
T KOG4645|consen 1332 DEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVIT 1411 (1509)
T ss_pred hhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhc
Confidence 466778999999999999999999999999999999999999999999998775442 1224558999999999998
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh-HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP-TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+... .+...+.|||||||++.||+||+.||...+. ..+++++-.+..|.. |..+|++.++||..||..||++|++
T Consensus 1412 ~t~~--kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~--P~~ls~~g~dFle~Cl~~dP~~Rw~ 1487 (1509)
T KOG4645|consen 1412 GTKG--KGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI--PERLSSEGRDFLEHCLEQDPKMRWT 1487 (1509)
T ss_pred cccc--CCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC--chhhhHhHHHHHHHHHhcCchhhhH
Confidence 7422 4556789999999999999999999976544 455566655665654 4459999999999999999999999
Q ss_pred HHHHhcCcCCCCCCC
Q psy9090 157 MSELLEHPFITSLPE 171 (488)
Q Consensus 157 ~~ell~hp~f~~~~~ 171 (488)
+.|+++|.|-+.-..
T Consensus 1488 ~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1488 ASQLLEHAFGKSCTD 1502 (1509)
T ss_pred HHHHHHhhccccccc
Confidence 999999999876443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=224.65 Aligned_cols=162 Identities=27% Similarity=0.562 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........ ......+++.|+|||++.+.
T Consensus 97 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 97 LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCC
Confidence 46789999999999999999999999999999999999999999999999876554322 33345678899999998762
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC---C------------------CCC--------C
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP---P------------------PGL--------Y 130 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~---~------------------~~~--------~ 130 (488)
..++.++|+||+|+++|+|++|.+||.+.........+.... . +.. .
T Consensus 177 ----~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (288)
T cd07833 177 ----TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERR 252 (288)
T ss_pred ----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHh
Confidence 267889999999999999999999998765544333322100 0 000 0
Q ss_pred CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 131 RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 131 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
.+..++.++++||++||..+|++|||+++++.||||
T Consensus 253 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 253 YPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 112347889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=230.69 Aligned_cols=166 Identities=30% Similarity=0.497 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC----ccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~l 76 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+++....... ......|++.|+|||.+
T Consensus 102 ~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 181 (332)
T cd07857 102 LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHH
Confidence 46889999999999999999999999999999999999999999999999876542211 12335789999999987
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC-------------------------CCCCC--
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN-------------------------PPPGL-- 129 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~-------------------------~~~~~-- 129 (488)
.+. ..++.++|+||+||++|+|++|.+||...........++.. ..+..
T Consensus 182 ~~~----~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (332)
T cd07857 182 LSF----QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPF 257 (332)
T ss_pred hCC----CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcch
Confidence 642 45788999999999999999999999876543333322210 00000
Q ss_pred -CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 130 -YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 130 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
......+..+.+++.+||..+|.+|||+.+++.|||++...
T Consensus 258 ~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 258 ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 01123478899999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=216.46 Aligned_cols=166 Identities=31% Similarity=0.497 Sum_probs=130.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC----CcEEEEecCCccccccccCc---cccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD----GEVKIVDFGLSRETANTFDK---KKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~----~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aP 73 (488)
++...++.|+.||+.|+.|||++=|+||||||.|||+..+ |.|||+|+|+++.+..+... ....+-|.+|+||
T Consensus 129 lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAP 208 (438)
T KOG0666|consen 129 LPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAP 208 (438)
T ss_pred CCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecCh
Confidence 4677899999999999999999999999999999999877 89999999999987654332 2345678999999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---------HHHHHHH---HhCCCCCCC----C------
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---------TRALFQI---VRNPPPGLY----R------ 131 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---------~~~~~~~---~~~~~~~~~----~------ 131 (488)
|.+.+. ..|+.++|+|++|||+.||+|-.+.|.+... ..++.+| +..+....+ .
T Consensus 209 ELLLGa----~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~ 284 (438)
T KOG0666|consen 209 ELLLGA----RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQT 284 (438)
T ss_pred HHhccc----ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHH
Confidence 999984 6799999999999999999999998854321 1223333 322111110 0
Q ss_pred -----------C----------CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 132 -----------A----------SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 132 -----------~----------~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
+ ..-++...+|+.+||.+||.+|.|++++|+|+||+..+
T Consensus 285 ~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 285 LLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred HHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 0 01145578999999999999999999999999998753
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=220.45 Aligned_cols=159 Identities=29% Similarity=0.606 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc-EEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE-VKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||.|||+++++|+||||+||+++.++. ++|+|||.+..............|++.|+|||++.+
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~- 176 (257)
T cd08225 98 FSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN- 176 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcC-
Confidence 467889999999999999999999999999999999998865 699999998766543333334568899999999865
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|+||+|+++|+|++|..||..........++.....+. ....++..++++|.+||..+|++|||+.+
T Consensus 177 ----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 177 ----RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP--ISPNFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 457889999999999999999999998776665555554443322 23457889999999999999999999999
Q ss_pred HhcCcCC
Q psy9090 160 LLEHPFI 166 (488)
Q Consensus 160 ll~hp~f 166 (488)
++.||||
T Consensus 251 ll~~~~~ 257 (257)
T cd08225 251 ILKRPFL 257 (257)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=221.45 Aligned_cols=156 Identities=28% Similarity=0.521 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++++.+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||++.+
T Consensus 97 ~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-- 174 (255)
T cd08219 97 FPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN-- 174 (255)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHcc--
Confidence 467889999999999999999999999999999999999999999999998765443233345678899999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||...+.......+....... .+..++..+.++|.+||..+|++|||+.++
T Consensus 175 ---~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 249 (255)
T cd08219 175 ---MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP--LPSHYSYELRSLIKQMFKRNPRSRPSATTI 249 (255)
T ss_pred ---CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC--CCcccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence 567889999999999999999999998877665555554443322 245678999999999999999999999999
Q ss_pred hcC
Q psy9090 161 LEH 163 (488)
Q Consensus 161 l~h 163 (488)
+..
T Consensus 250 l~~ 252 (255)
T cd08219 250 LSR 252 (255)
T ss_pred hhc
Confidence 864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=230.47 Aligned_cols=166 Identities=29% Similarity=0.460 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccc--------------ccCccccccC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN--------------TFDKKKTFLG 66 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~--------------~~~~~~~~~g 66 (488)
+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 116 ~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (335)
T PTZ00024 116 LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV 195 (335)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccccccc
Confidence 47888999999999999999999999999999999999999999999999875541 1111223356
Q ss_pred CCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCC--------------
Q psy9090 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGL-------------- 129 (488)
Q Consensus 67 t~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~-------------- 129 (488)
++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.........+.. .+....
T Consensus 196 ~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
T PTZ00024 196 TLWYRAPELLMGA----EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFT 271 (335)
T ss_pred ccCCCCChhcccC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccC
Confidence 7889999998652 3468899999999999999999999988776555444332 111100
Q ss_pred --------CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 130 --------YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 130 --------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
......+..+.++|.+||..+|++|||+++++.||||+..+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 272 PRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred cCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 00124478899999999999999999999999999998754
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=223.87 Aligned_cols=163 Identities=26% Similarity=0.481 Sum_probs=132.0
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~~ 79 (488)
+...+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++....... ......++..|+|||.+.+
T Consensus 117 ~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~- 195 (288)
T cd05061 117 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD- 195 (288)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhcc-
Confidence 3457788999999999999999999999999999999999999999999875432211 1122345678999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||+||++|+|++ |..||.+.........+.....+. .+...++.+.+++.+||..+|++|||+.
T Consensus 196 ----~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ 269 (288)
T cd05061 196 ----GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD--QPDNCPERVTDLMRMCWQFNPKMRPTFL 269 (288)
T ss_pred ----CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 567889999999999999998 789998877665555444433222 2345688999999999999999999999
Q ss_pred HHhc------CcCCCCCCC
Q psy9090 159 ELLE------HPFITSLPE 171 (488)
Q Consensus 159 ell~------hp~f~~~~~ 171 (488)
++++ ||||..++|
T Consensus 270 ~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 270 EIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHHHhhcCCCCCCCCC
Confidence 9986 999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=221.59 Aligned_cols=160 Identities=32% Similarity=0.666 Sum_probs=130.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... .......|+..|+|||.+.
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (265)
T cd06652 103 LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhc
Confidence 4678889999999999999999999999999999999999999999999987543211 1123346888999999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
+ ..++.++|+|||||++|+|++|+.||..........+....... ...+...+..+.++|.+|+. +|++||++
T Consensus 183 ~-----~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~ 255 (265)
T cd06652 183 G-----EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-PVLPPHVSDHCRDFLKRIFV-EAKLRPSA 255 (265)
T ss_pred C-----CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC-CCCchhhCHHHHHHHHHHhc-ChhhCCCH
Confidence 5 45788999999999999999999999877655555554433222 22345678889999999994 89999999
Q ss_pred HHHhcCcCCC
Q psy9090 158 SELLEHPFIT 167 (488)
Q Consensus 158 ~ell~hp~f~ 167 (488)
+++++|||+.
T Consensus 256 ~~il~~~~~~ 265 (265)
T cd06652 256 DELLRHTFVH 265 (265)
T ss_pred HHHhcCcccC
Confidence 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=226.03 Aligned_cols=163 Identities=39% Similarity=0.816 Sum_probs=135.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++.... ......|+..|+|||++....
T Consensus 118 l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 193 (313)
T cd06633 118 LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMAPEVILAMD 193 (313)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC----CCCCccccccccChhhccccC
Confidence 4678889999999999999999999999999999999999999999999886432 223457889999999985311
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
...++.++|+||+||++|+|++|.+||...........+.....+.. ....++..+++|+.+||+.+|.+||++.++
T Consensus 194 --~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~ 270 (313)
T cd06633 194 --EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL-QSNEWTDSFRGFVDYCLQKIPQERPASAEL 270 (313)
T ss_pred --CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 14578899999999999999999999988776666666555433332 234578889999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
+.||||...+
T Consensus 271 l~~~~~~~~~ 280 (313)
T cd06633 271 LRHDFVRRDR 280 (313)
T ss_pred hcCcccCCCc
Confidence 9999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=227.18 Aligned_cols=161 Identities=30% Similarity=0.659 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||.|||+ ++++||||||+|||++.++.++|+|||++...... ......|++.|+|||++.+
T Consensus 96 ~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~- 172 (308)
T cd06615 96 IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG- 172 (308)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccccCCCCcCccChhHhcC-
Confidence 4688899999999999999997 69999999999999999999999999998654332 2345578999999999865
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC---------------------------------
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP--------------------------------- 126 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~--------------------------------- 126 (488)
..++.++|+||+||++|+|++|..||........ ........
T Consensus 173 ----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (308)
T cd06615 173 ----THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIV 247 (308)
T ss_pred ----CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHh
Confidence 4578899999999999999999999965443221 11111100
Q ss_pred ---CCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 127 ---PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 127 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
++......++.++++++.+||..+|++|||+.++++||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 248 NEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0010112357889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=221.71 Aligned_cols=158 Identities=30% Similarity=0.607 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||++||.|||++|++|+||+|+||+++.++.++|+|||++...... .......|+..|+|||.+..
T Consensus 97 l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-- 173 (258)
T cd05578 97 FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEVLCR-- 173 (258)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC-ccccccCCChhhcCHHHHcc--
Confidence 568899999999999999999999999999999999999999999999998765433 12334568889999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH-
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP--TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~- 157 (488)
..++.++|+||+|+++|+|++|..||..... .....+.... .....+..++..+.++|.+||..+|.+||++
T Consensus 174 ---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 174 ---QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred ---cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHHHccCChhHcCCcc
Confidence 4578899999999999999999999987663 2222233222 2222355678999999999999999999999
Q ss_pred -HHHhcCcCC
Q psy9090 158 -SELLEHPFI 166 (488)
Q Consensus 158 -~ell~hp~f 166 (488)
+++++||||
T Consensus 249 ~~~l~~~~~~ 258 (258)
T cd05578 249 LKDLKNHPYF 258 (258)
T ss_pred HHHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=211.20 Aligned_cols=149 Identities=25% Similarity=0.375 Sum_probs=119.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.||+.||+|||+++ ||+|||++.++.+|+ ||++...... ...||+.|+|||++.+
T Consensus 14 l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~~~y~aPE~~~~-- 78 (176)
T smart00750 14 LNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVDPYFMAPEVIQG-- 78 (176)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCcccccChHHhcC--
Confidence 689999999999999999999998 999999999999999 9998765432 2368999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH-HHHHHhCCCCCC----CCCCCcCH--HHHHHHHHhcccCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA-LFQIVRNPPPGL----YRASNWSQ--HYVDFIAECLEKNPEH 153 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~----~~~~~~s~--~~~~li~~~L~~dP~~ 153 (488)
..|+.++||||+||++|+|++|..||........ ...+.....+.. ..+..++. .++++|.+||..+|.+
T Consensus 79 ---~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~ 155 (176)
T smart00750 79 ---QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQR 155 (176)
T ss_pred ---CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhccccc
Confidence 6788999999999999999999999976544322 222222211111 11222344 6899999999999999
Q ss_pred CCCHHHHhcCcCCC
Q psy9090 154 RPYMSELLEHPFIT 167 (488)
Q Consensus 154 Rps~~ell~hp~f~ 167 (488)
||++.++++|+|+.
T Consensus 156 Rp~~~~ll~~~~~~ 169 (176)
T smart00750 156 REAANHYLAHCRAL 169 (176)
T ss_pred ccCHHHHHHHHHHH
Confidence 99999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=218.74 Aligned_cols=159 Identities=39% Similarity=0.800 Sum_probs=134.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.+|.|||++|++||||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 96 l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-- 173 (254)
T cd06627 96 FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-- 173 (254)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcC--
Confidence 478899999999999999999999999999999999999999999999999876544333344568899999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||.................+. .+...++.+.+++.+||..+|++|||+.++
T Consensus 174 ---~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 248 (254)
T cd06627 174 ---SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQKDPNLRPTAKQL 248 (254)
T ss_pred ---CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC--CCCCCCHHHHHHHHHHHhCChhhCcCHHHH
Confidence 447889999999999999999999998776555555544333332 345678999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
+.||||
T Consensus 249 l~~~~~ 254 (254)
T cd06627 249 LKHPWI 254 (254)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=223.23 Aligned_cols=156 Identities=25% Similarity=0.419 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...... .......+++.|+|||.+.+
T Consensus 121 ~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05091 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY 200 (283)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc
Confidence 3567788999999999999999999999999999999999999999999987653221 11233456789999999865
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+.........+....... .+..++..+.+++..||+.+|.+||++
T Consensus 201 -----~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~RP~~ 273 (283)
T cd05091 201 -----GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP--CPDDCPAWVYTLMLECWNEFPSRRPRF 273 (283)
T ss_pred -----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 567889999999999999998 889998877666555555443322 345789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++..
T Consensus 274 ~~i~~~ 279 (283)
T cd05091 274 KDIHSR 279 (283)
T ss_pred HHHHHH
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=223.62 Aligned_cols=155 Identities=27% Similarity=0.484 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....... .......+++.|+|||++.+
T Consensus 117 l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 196 (288)
T cd05093 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 196 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc
Confidence 4788999999999999999999999999999999999999999999999987553221 11223345778999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+|||||++|+|++ |.+||...........+.....+. .+..++..+.+++.+||..+|.+|||+
T Consensus 197 -----~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~ 269 (288)
T cd05093 197 -----RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ--RPRTCPKEVYDLMLGCWQREPHMRLNI 269 (288)
T ss_pred -----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 567889999999999999998 999998877666666665543322 244678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.+++.
T Consensus 270 ~~v~~ 274 (288)
T cd05093 270 KEIHS 274 (288)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=221.49 Aligned_cols=156 Identities=24% Similarity=0.431 Sum_probs=127.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++....... ......+++.|+|||.+..
T Consensus 109 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 188 (272)
T cd05075 109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD 188 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC
Confidence 46788999999999999999999999999999999999999999999999876543211 1122345678999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+|||||++|+|++ |..||.+.........+...... ..+..++..+.++|.+||..+|++|||+
T Consensus 189 -----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~ 261 (272)
T cd05075 189 -----RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL--KQPPDCLDGLYSLMSSCWLLNPKDRPSF 261 (272)
T ss_pred -----CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 568899999999999999999 89999877665555544443322 2345678999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 262 ~~l~~~ 267 (272)
T cd05075 262 ETLRCE 267 (272)
T ss_pred HHHHHH
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=224.06 Aligned_cols=155 Identities=17% Similarity=0.253 Sum_probs=127.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..... .....|++.|+|||++.+.
T Consensus 119 ~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~ 195 (283)
T PHA02988 119 LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDI 195 (283)
T ss_pred CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhc
Confidence 4567888999999999999998 49999999999999999999999999998754332 2345688999999998641
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
...++.++|||||||++|+|++|..||.+.........+..... ....+...++.++++|.+||+.||++|||+++
T Consensus 196 ---~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 271 (283)
T PHA02988 196 ---FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN-SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271 (283)
T ss_pred ---cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHH
Confidence 14688999999999999999999999998876665555543322 22234467899999999999999999999999
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
+++
T Consensus 272 ll~ 274 (283)
T PHA02988 272 ILY 274 (283)
T ss_pred HHH
Confidence 985
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=233.16 Aligned_cols=156 Identities=28% Similarity=0.466 Sum_probs=125.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......+++.|+|||++..
T Consensus 209 l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 288 (374)
T cd05106 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD 288 (374)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC
Confidence 46788999999999999999999999999999999999999999999999876533211 1122335567999999865
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||+||++|+|++ |+.||.................. ...+...++++.+++.+||..+|++|||+
T Consensus 289 -----~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 362 (374)
T cd05106 289 -----CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ-MSRPDFAPPEIYSIMKMCWNLEPTERPTF 362 (374)
T ss_pred -----CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC-ccCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 568899999999999999997 99999876654444444443221 12344568999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 363 ~~l~~ 367 (374)
T cd05106 363 SQISQ 367 (374)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=218.66 Aligned_cols=156 Identities=29% Similarity=0.478 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||+|||++|++||||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+..
T Consensus 102 ~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 181 (262)
T cd00192 102 LSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD 181 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhcc
Confidence 5789999999999999999999999999999999999999999999999997664431 22334567889999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+||||+++|+|++ |..||...........+...... ..+..++.++.+++.+||..+|.+|||+
T Consensus 182 -----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~ 254 (262)
T cd00192 182 -----GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL--PKPEYCPDELYELMLSCWQLDPEDRPTF 254 (262)
T ss_pred -----CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCccCChHHHHHHHHHccCCcccCcCH
Confidence 468889999999999999998 69999888766665555543222 2355678999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 255 ~~l~~~ 260 (262)
T cd00192 255 SELVER 260 (262)
T ss_pred HHHHHh
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=219.44 Aligned_cols=158 Identities=32% Similarity=0.653 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++..............|++.|+|||.+.+
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-- 179 (260)
T cd08222 103 LSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-- 179 (260)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc--
Confidence 468889999999999999999999999999999999975 67999999998765443333445568899999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||...........+.....+.. +..++.++.++|.+||..+|++||++.++
T Consensus 180 ---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 254 (260)
T cd08222 180 ---QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL--PETYSRQLNSIMQSMLNKDPSLRPSAAEI 254 (260)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC--cchhcHHHHHHHHHHhcCChhhCcCHHHH
Confidence 5577899999999999999999999987766555555554433332 45678999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
++||||
T Consensus 255 l~~~~~ 260 (260)
T cd08222 255 LRNPFI 260 (260)
T ss_pred hhCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=208.27 Aligned_cols=166 Identities=25% Similarity=0.449 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc----cCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT----FDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~l 76 (488)
|+..+|+.++.+++.||.|+|.+.|+|||+||+|+||+.+|.+||+|||+++.+... .......+-|.+|++||.+
T Consensus 121 ~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEll 200 (376)
T KOG0669|consen 121 FSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELL 200 (376)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHh
Confidence 467899999999999999999999999999999999999999999999999755322 1223345669999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHH---hCCCCCCCC----------------------
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV---RNPPPGLYR---------------------- 131 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~~~---------------------- 131 (488)
.+. ..|+++.|+|..||++.+|++|.+.+.+.+....+.-|. ....+..++
T Consensus 201 LG~----r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~r 276 (376)
T KOG0669|consen 201 LGD----REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKR 276 (376)
T ss_pred hcc----cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhh
Confidence 984 679999999999999999999999998887655544332 111111110
Q ss_pred -------CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 132 -------ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 132 -------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
+-.-.+++.+|+.+||..||.+|++++++++|.||+.-+
T Consensus 277 kv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 277 KVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred hhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 011135778999999999999999999999999998644
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=223.11 Aligned_cols=163 Identities=39% Similarity=0.739 Sum_probs=130.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+
T Consensus 102 l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~~pE~~~~-- 177 (287)
T cd06621 102 IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--LAGTFTGTSFYMAPERIQG-- 177 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc--ccccccCCccccCHHHhcC--
Confidence 467788999999999999999999999999999999999999999999998755432 1224467889999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCC-----ChHHHHHHHHhCCCCCCCC----CCCcCHHHHHHHHHhcccCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDM-----HPTRALFQIVRNPPPGLYR----ASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~-----~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP 151 (488)
..++.++|+|||||++|+|++|..||... ...+....+.....+.... ...+++.+.++|.+||..+|
T Consensus 178 ---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 254 (287)
T cd06621 178 ---KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDP 254 (287)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCc
Confidence 56888999999999999999999999765 2223233322222221111 13467899999999999999
Q ss_pred CCCCCHHHHhcCcCCCCCC
Q psy9090 152 EHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 152 ~~Rps~~ell~hp~f~~~~ 170 (488)
.+|||+.+++.||||+...
T Consensus 255 ~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 255 TRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred ccCCCHHHHHhCccccccc
Confidence 9999999999999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=229.22 Aligned_cols=157 Identities=29% Similarity=0.504 Sum_probs=126.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ ......++..|+|||++.+
T Consensus 170 l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 249 (337)
T cd05054 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD 249 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC
Confidence 46788999999999999999999999999999999999999999999999976532211 1223455678999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||+||++|+|++ |..||.+..........+..... ...+..+++++.+++.+||+.+|++||++
T Consensus 250 -----~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 250 -----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-MRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred -----CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-CCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 678899999999999999997 99999875544433333332221 12345678999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.++++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=218.68 Aligned_cols=155 Identities=26% Similarity=0.421 Sum_probs=127.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc---cccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK---KKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~l~ 77 (488)
+++..+..++.||+.||+|||++|++||||||.||+++.++.+||+|||++......... .....+++.|+|||.+.
T Consensus 92 ~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05116 92 VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc
Confidence 478889999999999999999999999999999999999999999999998765432111 12223457899999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
. ..++.++|+|||||++|+|++ |.+||...........+.....+. .+..+++++.++|.+||+.||++||+
T Consensus 172 ~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~~~~~~p~~Rp~ 244 (257)
T cd05116 172 Y-----YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME--CPQRCPPEMYDLMKLCWTYGVDERPG 244 (257)
T ss_pred c-----CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC--CCCCCCHHHHHHHHHHhccCchhCcC
Confidence 5 567889999999999999997 999998877665555554433222 34568999999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.+|..
T Consensus 245 ~~~i~~ 250 (257)
T cd05116 245 FAVVEL 250 (257)
T ss_pred HHHHHH
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=218.12 Aligned_cols=160 Identities=38% Similarity=0.776 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++...... .......|++.|+|||.+...
T Consensus 99 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~- 176 (258)
T cd06632 99 FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF-SFAKSFKGSPYWMAPEVIAQQ- 176 (258)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc-ccccccCCCcceeCHHHhcCC-
Confidence 467888999999999999999999999999999999999999999999998765433 223455688999999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|..||...........+...... ...+..+++.+.+++.+||..+|.+||++.++
T Consensus 177 ---~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 252 (258)
T cd06632 177 ---GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL-PPIPDHLSDEAKDFILKCLQRDPSLRPTAAEL 252 (258)
T ss_pred ---CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC-CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 23788999999999999999999999776654444444331111 12345678999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
+.|||+
T Consensus 253 l~~~~~ 258 (258)
T cd06632 253 LEHPFV 258 (258)
T ss_pred hcCCCC
Confidence 999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=216.42 Aligned_cols=158 Identities=34% Similarity=0.616 Sum_probs=133.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+
T Consensus 90 l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-- 167 (250)
T cd05123 90 FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-- 167 (250)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCC--
Confidence 478899999999999999999999999999999999999999999999998765443223445568889999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..++.++|+||||+++|++++|..||...........+... ....+...+..+.++|++||..||++||++
T Consensus 168 ---~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~ 241 (250)
T cd05123 168 ---KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD---PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGA 241 (250)
T ss_pred ---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccH
Confidence 45678999999999999999999999777654444444432 223445568999999999999999999999
Q ss_pred HHHhcCcCC
Q psy9090 158 SELLEHPFI 166 (488)
Q Consensus 158 ~ell~hp~f 166 (488)
+++++||||
T Consensus 242 ~~l~~~~~f 250 (250)
T cd05123 242 EEIKAHPFF 250 (250)
T ss_pred HHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=223.76 Aligned_cols=155 Identities=27% Similarity=0.453 Sum_probs=125.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++...... ........+..|+|||++.+
T Consensus 116 l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-- 192 (297)
T cd05089 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNY-- 192 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccce-eccCCCCcCccccCchhhcc--
Confidence 457788999999999999999999999999999999999999999999998643221 11112223457999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|||||||++|+|++ |..||...........+.....+. .+..++..+++|+.+||..+|.+|||+++
T Consensus 193 ---~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 267 (297)
T cd05089 193 ---SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME--KPRNCDDEVYELMRQCWRDRPYERPPFAQ 267 (297)
T ss_pred ---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 568899999999999999997 999998887766655555443222 34567899999999999999999999999
Q ss_pred HhcC
Q psy9090 160 LLEH 163 (488)
Q Consensus 160 ll~h 163 (488)
+++.
T Consensus 268 i~~~ 271 (297)
T cd05089 268 ISVQ 271 (297)
T ss_pred HHHH
Confidence 9753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=219.13 Aligned_cols=151 Identities=24% Similarity=0.328 Sum_probs=123.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.||.|||++|++||||||+||+++.++.++++|||.+...... .....++..|+|||.+..
T Consensus 82 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~-- 156 (237)
T cd05576 82 IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVGGI-- 156 (237)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCcccCC--
Confidence 578899999999999999999999999999999999999999999999987655432 223355778999998865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..++.++|+||+|+++|+|++|..|+...... + ........+..+++.++++|.+||+.||++||++
T Consensus 157 ---~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 157 ---SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I--NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred ---CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c--ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 56788999999999999999999987543211 0 0011112345578999999999999999999985
Q ss_pred --HHHhcCcCC
Q psy9090 158 --SELLEHPFI 166 (488)
Q Consensus 158 --~ell~hp~f 166 (488)
+++++||||
T Consensus 227 ~~~~~~~h~~~ 237 (237)
T cd05576 227 GVEDIKSHPFF 237 (237)
T ss_pred chHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=219.87 Aligned_cols=162 Identities=28% Similarity=0.548 Sum_probs=129.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++..............++..|+|||.+.+.
T Consensus 95 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 173 (282)
T cd07829 95 LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS- 173 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCC-
Confidence 5788999999999999999999999999999999999999999999999987654432233344567889999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CC-----------------CCC------CCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PP-----------------PGL------YRASN 134 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~-----------------~~~------~~~~~ 134 (488)
..++.++|+|||||++|++++|.+||..........++... +. +.. .....
T Consensus 174 ---~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd07829 174 ---KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPR 250 (282)
T ss_pred ---cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhccc
Confidence 36788999999999999999999999877655444333221 00 000 00123
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
.+..+.++|.+||..+|++||++.+++.||||
T Consensus 251 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 251 LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 47789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=221.18 Aligned_cols=155 Identities=27% Similarity=0.465 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... .......+++.|+|||++.+
T Consensus 119 l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05049 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY 198 (280)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc
Confidence 4677889999999999999999999999999999999999999999999987543211 11223345788999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+.........+.....+. .+..++..+.+++.+||..||++||++
T Consensus 199 -----~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~ 271 (280)
T cd05049 199 -----RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ--RPRTCPSEVYDIMLGCWKRDPQQRINI 271 (280)
T ss_pred -----CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence 568899999999999999998 999998877666655555443322 245678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 272 ~eil~ 276 (280)
T cd05049 272 KDIHE 276 (280)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-27 Score=215.58 Aligned_cols=167 Identities=34% Similarity=0.590 Sum_probs=139.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
++|+.+-.|..-.+.||.||.. .+|||||+||+|||++..|.|||||||.+-.+..... .+.-.|-..|+|||.+...
T Consensus 164 ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA-kT~daGCrpYmAPERi~p~ 242 (361)
T KOG1006|consen 164 IPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA-KTVDAGCRPYMAPERIDPS 242 (361)
T ss_pred CcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH-hhhccCCccccChhccCCc
Confidence 5778888888889999999975 5899999999999999999999999999876654322 2233678899999998653
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh-HHHHHHHHhCCCCCCCCCCC---cCHHHHHHHHHhcccCCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP-TRALFQIVRNPPPGLYRASN---WSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~---~s~~~~~li~~~L~~dP~~Rp 155 (488)
..+|+.++|+||||++|||+.||..|+.+... .+++.+++.+.+|.+..+.. ++..++.+|..||.+|-..||
T Consensus 243 ---~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp 319 (361)
T KOG1006|consen 243 ---DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP 319 (361)
T ss_pred ---cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCc
Confidence 24699999999999999999999999987654 45566677777666655544 799999999999999999999
Q ss_pred CHHHHhcCcCCCCCCC
Q psy9090 156 YMSELLEHPFITSLPE 171 (488)
Q Consensus 156 s~~ell~hp~f~~~~~ 171 (488)
+..+++.+||++....
T Consensus 320 ky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 320 KYDDLKKFPFYRMYAV 335 (361)
T ss_pred chhhhhcCchhhhhhh
Confidence 9999999999986543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=219.15 Aligned_cols=163 Identities=35% Similarity=0.760 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....... .......|+..|+|||.+..
T Consensus 105 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 184 (272)
T cd06629 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhcc
Confidence 4678899999999999999999999999999999999999999999999987543221 11233467889999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCC--CCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLY--RASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~--~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.. ..++.++|+||||+++|++++|..||...........+..... +... ....++..+.++|.+||..+|.+||
T Consensus 185 ~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 261 (272)
T cd06629 185 YS---QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP 261 (272)
T ss_pred cc---CCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCC
Confidence 21 2478899999999999999999999976655444444332211 1111 1234688999999999999999999
Q ss_pred CHHHHhcCcCC
Q psy9090 156 YMSELLEHPFI 166 (488)
Q Consensus 156 s~~ell~hp~f 166 (488)
|++++++|||+
T Consensus 262 s~~~il~~~~~ 272 (272)
T cd06629 262 TARELLQHPFI 272 (272)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=220.01 Aligned_cols=161 Identities=33% Similarity=0.629 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccC----ccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFD----KKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~ 75 (488)
+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++........ ......++..|+|||.
T Consensus 100 ~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~ 179 (268)
T cd06630 100 FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhH
Confidence 47888999999999999999999999999999999998776 599999999876543211 1223467889999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH---HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
+.+ ..++.++|+||+|+++|+|++|..||...... ....+...... ....+...++.+.+++.+||..+|+
T Consensus 180 ~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~ 253 (268)
T cd06630 180 LRG-----EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT-APSIPEHLSPGLRDVTLRCLELQPE 253 (268)
T ss_pred hcc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-CCCCchhhCHHHHHHHHHHcCCCcc
Confidence 865 56788999999999999999999999654322 22222221111 1123445789999999999999999
Q ss_pred CCCCHHHHhcCcCCC
Q psy9090 153 HRPYMSELLEHPFIT 167 (488)
Q Consensus 153 ~Rps~~ell~hp~f~ 167 (488)
+||++.++++||||+
T Consensus 254 ~R~~~~~ll~~~~~~ 268 (268)
T cd06630 254 DRPPSRELLKHPVFR 268 (268)
T ss_pred cCcCHHHHhcCcccC
Confidence 999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=229.63 Aligned_cols=164 Identities=27% Similarity=0.499 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ......+++.|+|||.+.+.
T Consensus 117 l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~- 192 (345)
T cd07877 117 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNW- 192 (345)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc---cccccccCCCccCHHHHhCc-
Confidence 46788999999999999999999999999999999999999999999999875432 22345688999999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC----------------------CCCC------CC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP----------------------PGLY------RA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~----------------------~~~~------~~ 132 (488)
..++.++|+||+||++|+|++|++||...........+..... +... ..
T Consensus 193 ---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (345)
T cd07877 193 ---MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 269 (345)
T ss_pred ---cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhc
Confidence 4578899999999999999999999977655443333221000 0000 01
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
...++.+.++|.+||..+|.+||++.++++||||.+...
T Consensus 270 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 270 IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 135788999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=224.58 Aligned_cols=162 Identities=39% Similarity=0.781 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||++..... .....+++.|+|||.+.+..
T Consensus 112 l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 187 (308)
T cd06634 112 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTPYWMAPEVILAMD 187 (308)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----cccccCCccccCHHHHhhcc
Confidence 46788999999999999999999999999999999999999999999998865432 23456889999999985321
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
...++.++|||||||++|+|++|..||...........+.....+.. ....++..+.++|.+||..+|.+||++.++
T Consensus 188 --~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 264 (308)
T cd06634 188 --EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264 (308)
T ss_pred --cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc-CcccccHHHHHHHHHHhhCCcccCCCHHHH
Confidence 13467899999999999999999999987766555555554433322 234678999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++|||+...
T Consensus 265 l~~~~~~~~ 273 (308)
T cd06634 265 LKHRFVLRE 273 (308)
T ss_pred hhCcccccc
Confidence 999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=217.11 Aligned_cols=160 Identities=36% Similarity=0.765 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+..
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 177 (260)
T cd06606 98 LPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC
Confidence 46888999999999999999999999999999999999999999999999876654322 1344568899999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+||||+++|+|++|..||.... .......+.. .......+..++..++++|.+||..+|.+||++
T Consensus 178 -----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~ 251 (260)
T cd06606 178 -----EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTA 251 (260)
T ss_pred -----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCH
Confidence 447889999999999999999999997765 2222222222 112222355678999999999999999999999
Q ss_pred HHHhcCcCC
Q psy9090 158 SELLEHPFI 166 (488)
Q Consensus 158 ~ell~hp~f 166 (488)
.+++.||||
T Consensus 252 ~~ll~~~~~ 260 (260)
T cd06606 252 DELLQHPFL 260 (260)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=228.11 Aligned_cols=153 Identities=27% Similarity=0.462 Sum_probs=131.0
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc-cccccCCCccccchhhcccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK-KKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~ 80 (488)
+-.+...++.||++|++||+++++|||||...||||+++..+||+|||+++......-. .....-...|.|||++..
T Consensus 301 ~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-- 378 (468)
T KOG0197|consen 301 NLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY-- 378 (468)
T ss_pred chHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh--
Confidence 45678899999999999999999999999999999999999999999999954432111 111122457999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|||||||+|+||+| |+.||.+++..+.+..+-++..- +.|..+|+++.++|..||..+|++|||++.
T Consensus 379 ---~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl--p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 379 ---GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL--PRPEGCPDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred ---CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC--CCCCCCCHHHHHHHHHHhhCCcccCCCHHH
Confidence 679999999999999999998 99999999999988888887643 467789999999999999999999999987
Q ss_pred Hh
Q psy9090 160 LL 161 (488)
Q Consensus 160 ll 161 (488)
+.
T Consensus 454 L~ 455 (468)
T KOG0197|consen 454 LR 455 (468)
T ss_pred HH
Confidence 65
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=210.37 Aligned_cols=161 Identities=27% Similarity=0.455 Sum_probs=124.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEccCCcEEEEecCCccccccccCc---------cccccCCCc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK---------KKTFLGSPS 69 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~---------~~~~~gt~~ 69 (488)
+||.++..|+.+|.+||.+||+.. .+||||||.|||+.+.+.++|.|||.++...-.... ...-..|..
T Consensus 124 ~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~p 203 (302)
T KOG2345|consen 124 VSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIP 203 (302)
T ss_pred cCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCc
Confidence 589999999999999999999999 999999999999999999999999998754321110 112246889
Q ss_pred cccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH-HHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcc
Q psy9090 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR-ALFQIVRNPPPGLYRASNWSQHYVDFIAECLE 148 (488)
Q Consensus 70 y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 148 (488)
|+|||.+..... ...++++|||||||++|.|+.|..||....... .+.-.+.+.....+....+|+.+.++|+.||+
T Consensus 204 yRAPELf~vk~~--~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlq 281 (302)
T KOG2345|consen 204 YRAPELFNVKSH--CTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQ 281 (302)
T ss_pred ccCchheecccC--cccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhc
Confidence 999999876322 456889999999999999999999995321100 00001122233344455689999999999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy9090 149 KNPEHRPYMSELLEH 163 (488)
Q Consensus 149 ~dP~~Rps~~ell~h 163 (488)
.||.+||++.+++.+
T Consensus 282 vdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 282 VDPNQRPTIPELLSK 296 (302)
T ss_pred CCcccCCCHHHHHHH
Confidence 999999999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=221.86 Aligned_cols=155 Identities=27% Similarity=0.471 Sum_probs=127.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+
T Consensus 120 ~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 199 (291)
T cd05094 120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 199 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc
Confidence 4678899999999999999999999999999999999999999999999987543321 11233456788999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+|||||++|+|++ |..||...........+.....+. .+..++..+.+++.+||..+|++|||+
T Consensus 200 -----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~ 272 (291)
T cd05094 200 -----RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE--RPRVCPKEVYDIMLGCWQREPQQRLNI 272 (291)
T ss_pred -----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCC--CCccCCHHHHHHHHHHcccChhhCcCH
Confidence 567889999999999999998 999998877666555544433322 234568899999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 273 ~~v~~ 277 (291)
T cd05094 273 KEIYK 277 (291)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=223.26 Aligned_cols=170 Identities=31% Similarity=0.511 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++....... .......|+..|+|||.+...
T Consensus 102 l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (290)
T cd05613 102 FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCC
Confidence 4678899999999999999999999999999999999999999999999987653321 122345688999999998642
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH---HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP- 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 155 (488)
...++.++|+||+|+++|+|++|..||...... ..+........++ .+..+++.+.+++.+||..+|++||
T Consensus 182 ---~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 182 ---DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred ---CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--CCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 134678899999999999999999999643221 1122222222221 2455789999999999999999997
Q ss_pred ----CHHHHhcCcCCCCCCCCccc
Q psy9090 156 ----YMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 156 ----s~~ell~hp~f~~~~~~~~~ 175 (488)
++++++.||||....|+.+.
T Consensus 257 ~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 257 CGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred CCCCCHHHHHcCcccccCCHHHHh
Confidence 88999999999999886653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=215.41 Aligned_cols=157 Identities=32% Similarity=0.597 Sum_probs=133.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++++.++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... ......+++.|+|||.+.+
T Consensus 100 ~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-- 175 (256)
T cd08530 100 IPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKG-- 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCC--
Confidence 467889999999999999999999999999999999999999999999998765443 2233568889999999876
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+|+++|+|++|+.||...........+.....+.. +..++.++++++.+||..+|++||++.++
T Consensus 176 ---~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 250 (256)
T cd08530 176 ---RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI--PPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250 (256)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--chhhCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 5678899999999999999999999988776555555544433332 34678999999999999999999999999
Q ss_pred hcCcCC
Q psy9090 161 LEHPFI 166 (488)
Q Consensus 161 l~hp~f 166 (488)
++||++
T Consensus 251 l~~p~~ 256 (256)
T cd08530 251 LASPAV 256 (256)
T ss_pred hcCCCC
Confidence 999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=227.27 Aligned_cols=166 Identities=29% Similarity=0.493 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-----CccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-----DKKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~ 75 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......|++.|+|||.
T Consensus 104 ~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 183 (337)
T cd07852 104 LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCcee
Confidence 4567888999999999999999999999999999999999999999999987553321 12233468899999998
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC----------------------------CC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP----------------------------PP 127 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~----------------------------~~ 127 (488)
+.+. ..++.++|+||+|+++|+|++|++||.+........++.... .+
T Consensus 184 ~~~~----~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (337)
T cd07852 184 LLGS----TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKP 259 (337)
T ss_pred eecc----ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccc
Confidence 7642 457789999999999999999999998765444333221110 00
Q ss_pred CCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 128 GLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 128 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
.......++.++.++|.+||..+|++|||+.++++|||+..+.
T Consensus 260 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 260 LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0001123688999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=219.68 Aligned_cols=155 Identities=26% Similarity=0.399 Sum_probs=124.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc--cccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK--KKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~l~~ 78 (488)
+++.++..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++........ .....+++.|+|||.+.+
T Consensus 106 ~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05109 106 IGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc
Confidence 477889999999999999999999999999999999999999999999998765432111 112234678999999865
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||...........+.....+ ..+..++..+.+++.+||..||++||++
T Consensus 186 -----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rp~~ 258 (279)
T cd05109 186 -----RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL--PQPPICTIDVYMIMVKCWMIDSECRPRF 258 (279)
T ss_pred -----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC--CCCccCCHHHHHHHHHHcCCChhhCcCH
Confidence 568899999999999999998 99999776654433333332222 2345678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.+++.
T Consensus 259 ~~l~~ 263 (279)
T cd05109 259 RELVD 263 (279)
T ss_pred HHHHH
Confidence 99985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=233.17 Aligned_cols=159 Identities=30% Similarity=0.473 Sum_probs=130.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccc--cccCccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA--NTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
.......|++||++|+.|||.++|||||||..||++.+++.|||+|||++.... ..........|...|||||+++..
T Consensus 486 dm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmq 565 (678)
T KOG0193|consen 486 DMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQ 565 (678)
T ss_pred hHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhc
Confidence 456678999999999999999999999999999999999999999999986432 122334556788899999999864
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC--CCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP--GLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
+ ..+|++.+||||+||++|||+||..||.......+++++-++... ......+.++++++|+..||..+|++||.+
T Consensus 566 d--~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F 643 (678)
T KOG0193|consen 566 D--DNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLF 643 (678)
T ss_pred c--cCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccH
Confidence 3 478999999999999999999999999966666666665555221 122345667899999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.+||.
T Consensus 644 ~~il~ 648 (678)
T KOG0193|consen 644 PQLLS 648 (678)
T ss_pred HHHHH
Confidence 99886
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=242.42 Aligned_cols=155 Identities=26% Similarity=0.416 Sum_probs=126.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEccCCcEEEEecCCccccccccCcc---------ccccCCCc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK---------KTFLGSPS 69 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~---------~~~~gt~~ 69 (488)
|+|.+|..|++|+++||.+||... |||||||-|||||..+|+.||||||.++......... -....|+.
T Consensus 141 lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~ 220 (738)
T KOG1989|consen 141 LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQ 220 (738)
T ss_pred CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCcc
Confidence 689999999999999999999998 9999999999999999999999999986443222111 12357999
Q ss_pred cccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhccc
Q psy9090 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEK 149 (488)
Q Consensus 70 y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 149 (488)
|+|||++.-. ...+.++|+|||+|||+||-|+....||++.....+ +. ....++..++++..+++||+.||+.
T Consensus 221 YRsPEMIDly--sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI----ln-g~Y~~P~~p~ys~~l~~LI~~mL~~ 293 (738)
T KOG1989|consen 221 YRSPEMIDLY--SGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI----LN-GNYSFPPFPNYSDRLKDLIRTMLQP 293 (738)
T ss_pred ccChHHHhhh--cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE----Ee-ccccCCCCccHHHHHHHHHHHHhcc
Confidence 9999998542 226789999999999999999999999987643322 22 2223344568899999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy9090 150 NPEHRPYMSELLE 162 (488)
Q Consensus 150 dP~~Rps~~ell~ 162 (488)
||.+||++-+++.
T Consensus 294 nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 294 NPDERPNIYQVLE 306 (738)
T ss_pred CcccCCCHHHHHH
Confidence 9999999998875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=219.86 Aligned_cols=158 Identities=30% Similarity=0.541 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--------------------Cc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--------------------DK 60 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--------------------~~ 60 (488)
+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 99 l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (280)
T cd05581 99 LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccc
Confidence 5788999999999999999999999999999999999999999999999987554321 12
Q ss_pred cccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHH
Q psy9090 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYV 140 (488)
Q Consensus 61 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 140 (488)
.....++..|+|||++.. ..++.++|+||||++++++++|..||...........+.... ...+..+++.+.
T Consensus 179 ~~~~~~~~~~~~Pe~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 250 (280)
T cd05581 179 FASFVGTAEYVSPELLNE-----KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE---YSFPPNFPPDAK 250 (280)
T ss_pred cccccCCccccCHHHhCC-----CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC---CCCCCccCHHHH
Confidence 234467889999999875 457889999999999999999999998776544444443221 123456789999
Q ss_pred HHHHHhcccCCCCCCCH----HHHhcCcCC
Q psy9090 141 DFIAECLEKNPEHRPYM----SELLEHPFI 166 (488)
Q Consensus 141 ~li~~~L~~dP~~Rps~----~ell~hp~f 166 (488)
++|.+||..+|.+|||+ +++++||||
T Consensus 251 ~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 251 DLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 99999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=216.83 Aligned_cols=155 Identities=24% Similarity=0.452 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+
T Consensus 101 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 179 (263)
T cd05052 101 VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 179 (263)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc-
Confidence 46778899999999999999999999999999999999999999999999876543211 1112234567999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|||||||++|+|++ |..||.+.........+.....+ ..+...+..+.+++.+||..+|++|||+.
T Consensus 180 ----~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 253 (263)
T cd05052 180 ----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM--ERPEGCPPKVYELMRACWQWNPSDRPSFA 253 (263)
T ss_pred ----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 567889999999999999998 99999887665554444433222 23456789999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 254 ~l~~ 257 (263)
T cd05052 254 EIHQ 257 (263)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=240.42 Aligned_cols=168 Identities=17% Similarity=0.244 Sum_probs=119.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-CCcEEEEecCCccccccc-cCccccccCCCccccchhhcccc
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANT-FDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..... ........+++.|+|||.+....
T Consensus 254 ~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 254 NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccC
Confidence 3457789999999999999999999999999999985 578999999999755322 12234567899999999764321
Q ss_pred cC-----------------CCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC----------CCCCC--
Q psy9090 81 KE-----------------VDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP----------PGLYR-- 131 (488)
Q Consensus 81 ~~-----------------~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~----------~~~~~-- 131 (488)
.. ...++.++||||+||++|+|+++..|+... .....+.+.... +....
T Consensus 334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 411 (566)
T PLN03225 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPD 411 (566)
T ss_pred CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchh
Confidence 11 012455779999999999999977665432 112222211100 00000
Q ss_pred -------CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 132 -------ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 132 -------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
....+...++||.+||..||.+|||+.++|+||||......
T Consensus 412 ~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred hhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence 01113345689999999999999999999999999886554
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=220.41 Aligned_cols=162 Identities=46% Similarity=0.913 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-- 175 (277)
T cd06641 98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-- 175 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhcc--
Confidence 467889999999999999999999999999999999999999999999998765433222334568889999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||+||++|+|++|..||...........+.....+. .+..++..+.+++.+||..+|.+||++.++
T Consensus 176 ---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 250 (277)
T cd06641 176 ---SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT--LEGNYSKPLKEFVEACLNKEPSFRPTAKEL 250 (277)
T ss_pred ---CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC--CCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 456789999999999999999999998766555444443332222 234568899999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++||||...
T Consensus 251 l~~~~~~~~ 259 (277)
T cd06641 251 LKHKFIVRF 259 (277)
T ss_pred HhCHHHhhh
Confidence 999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=222.16 Aligned_cols=162 Identities=29% Similarity=0.479 Sum_probs=128.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+.
T Consensus 113 ~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 192 (302)
T cd07864 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE 192 (302)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCC
Confidence 46889999999999999999999999999999999999999999999999876543221 11223467789999988642
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCC------------------------CCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGL------------------------YRA 132 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~------------------------~~~ 132 (488)
..++.++|+||+||++|+|++|++||...........+.. .+.+.. ...
T Consensus 193 ----~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd07864 193 ----ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF 268 (302)
T ss_pred ----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhc
Confidence 3467899999999999999999999987665544433322 111110 011
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
..++..+.++|.+||..+|.+|||+.+++.||||
T Consensus 269 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 269 SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 2357899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=220.86 Aligned_cols=177 Identities=31% Similarity=0.550 Sum_probs=136.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.|++.+|.|||+.|++||||+|+||+++.++.++|+|||++........ ......|++.|+|||.+.+.
T Consensus 102 ~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (288)
T cd05583 102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181 (288)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCC
Confidence 46788999999999999999999999999999999999999999999999876433211 12234688999999998652
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh----HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP----TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
. ..++.++|+||+|+++|+|++|..||..... ......+.... + ..+..++..+.++|.+||..+|++||
T Consensus 182 ~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~~l~~~p~~R~ 255 (288)
T cd05583 182 S---GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-P--PFPKTMSAEARDFIQKLLEKDPKKRL 255 (288)
T ss_pred C---CCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC-C--CCCcccCHHHHHHHHHHhcCCHhhcc
Confidence 1 2367899999999999999999999964321 22222222222 1 23455788999999999999999999
Q ss_pred C---HHHHhcCcCCCCCCCCccccccccccc
Q psy9090 156 Y---MSELLEHPFITSLPENDLHLSTVNCQY 183 (488)
Q Consensus 156 s---~~ell~hp~f~~~~~~~~~~~~~~~~~ 183 (488)
| +.++++||||+.+.|+.+......+++
T Consensus 256 t~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 286 (288)
T cd05583 256 GANGADEIKNHPFFQGIDWDDLAAKRIPAPF 286 (288)
T ss_pred CcchHHHHhcCcccccCCHHHHhhhccCCCC
Confidence 8 567799999999988766444443333
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=217.96 Aligned_cols=156 Identities=25% Similarity=0.441 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||+++....... ......++..|+|||.+..
T Consensus 110 ~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05035 110 LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 189 (273)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc
Confidence 46788999999999999999999999999999999999999999999999876533211 1112234668999999865
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |.+||.+.........+.....+. .+..++..+.+++.+||..||++|||+
T Consensus 190 -----~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~ 262 (273)
T cd05035 190 -----RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK--QPEDCLDELYDLMYSCWRADPKDRPTF 262 (273)
T ss_pred -----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCcCCCHHHHHHHHHHcCCChhhCcCH
Confidence 567889999999999999999 999998877666555554443322 355779999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++.+
T Consensus 263 ~e~~~~ 268 (273)
T cd05035 263 TKLREV 268 (273)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=222.04 Aligned_cols=163 Identities=40% Similarity=0.811 Sum_probs=135.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++..... .....|++.|+|||.+....
T Consensus 122 l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 197 (317)
T cd06635 122 LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMD 197 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----cccccCCccccChhhhhcCC
Confidence 46788999999999999999999999999999999999999999999998865432 23456889999999985311
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
...++.++|+||+||++|+|++|..||...........+.....+.. ....+++.++++|.+||..+|.+||++.++
T Consensus 198 --~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 274 (317)
T cd06635 198 --EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQDRPTSEEL 274 (317)
T ss_pred --CCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC-CCccccHHHHHHHHHHccCCcccCcCHHHH
Confidence 14578899999999999999999999988776666666655443322 345678999999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
++|+|+....
T Consensus 275 l~~~~~~~~~ 284 (317)
T cd06635 275 LKHMFVLRER 284 (317)
T ss_pred HhChhhhccC
Confidence 9999996543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=229.08 Aligned_cols=157 Identities=27% Similarity=0.472 Sum_probs=126.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|+++.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 211 l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 290 (375)
T cd05104 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN 290 (375)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC
Confidence 46788999999999999999999999999999999999999999999999876543211 1122334567999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||..........+.+...... ..+...+.++++||.+||..||++|||+
T Consensus 291 -----~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 291 -----CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LSPECAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred -----CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-CCCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 568899999999999999997 899998766554455554433211 1234568899999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.++++.
T Consensus 365 ~eil~~ 370 (375)
T cd05104 365 KQIVQL 370 (375)
T ss_pred HHHHHH
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=222.35 Aligned_cols=156 Identities=24% Similarity=0.405 Sum_probs=122.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~~ 79 (488)
++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......+++.|+|||++..
T Consensus 136 ~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 214 (304)
T cd05096 136 SYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM- 214 (304)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-
Confidence 567788999999999999999999999999999999999999999999987553221 11223345788999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc--CCCCCCCCChHHHHHHHHh---CC--CCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD--GKPPFEDMHPTRALFQIVR---NP--PPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt--g~~Pf~~~~~~~~~~~~~~---~~--~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
..++.++||||||+++|+|++ +..||........+..... .. ......+..+++.+.+||.+||..+|+
T Consensus 215 ----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 290 (304)
T cd05096 215 ----GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCR 290 (304)
T ss_pred ----CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCch
Confidence 568899999999999999985 6778877665444333221 11 111123456789999999999999999
Q ss_pred CCCCHHHHhc
Q psy9090 153 HRPYMSELLE 162 (488)
Q Consensus 153 ~Rps~~ell~ 162 (488)
+|||+.++..
T Consensus 291 ~RPs~~~i~~ 300 (304)
T cd05096 291 ERPSFSDIHA 300 (304)
T ss_pred hCcCHHHHHH
Confidence 9999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=217.85 Aligned_cols=154 Identities=27% Similarity=0.492 Sum_probs=127.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~~ 79 (488)
++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++...... .......++..|+|||.+..
T Consensus 117 ~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 195 (277)
T cd05032 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD- 195 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-
Confidence 567889999999999999999999999999999999999999999999987553321 12233456788999999865
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+|||||++|++++ |.+||.+.........+.....+ ..+..++..+.+++.+||..+|++|||+.
T Consensus 196 ----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 269 (277)
T cd05032 196 ----GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL--DLPENCPDKLLELMRMCWQYNPKMRPTFL 269 (277)
T ss_pred ----CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 567889999999999999998 99999887766655555433222 23556799999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 270 ~l~~ 273 (277)
T cd05032 270 EIVS 273 (277)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=215.00 Aligned_cols=155 Identities=28% Similarity=0.495 Sum_probs=126.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc---ccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK---KTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~l~ 77 (488)
+++..+..++.|++.||+|||.++++||||||+||+++.++.+||+|||+++......... ....++..|+|||.+.
T Consensus 92 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05060 92 IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhc
Confidence 4688999999999999999999999999999999999999999999999987654332211 1112346799999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|+||||+++|+|++ |.+||...........+..... ...+..++..++++|.+||..+|.+||+
T Consensus 172 ~-----~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~ 244 (257)
T cd05060 172 Y-----GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER--LPRPEECPQEIYSIMLSCWKYRPEDRPT 244 (257)
T ss_pred C-----CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHhcCChhhCcC
Confidence 5 568889999999999999998 9999988776555444443322 2345667899999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 245 ~~~l~~ 250 (257)
T cd05060 245 FSELES 250 (257)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=218.62 Aligned_cols=155 Identities=27% Similarity=0.493 Sum_probs=125.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~~ 79 (488)
+...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... ......+++.|+|||.+.+
T Consensus 117 ~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 195 (277)
T cd05062 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD- 195 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-
Confidence 4567888999999999999999999999999999999999999999999875432211 1122345778999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+|||||++|+|++ |..||.+.........+.....+. .+...+..+.+++.+||..+|++|||+.
T Consensus 196 ----~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ 269 (277)
T cd05062 196 ----GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD--KPDNCPDMLFELMRMCWQYNPKMRPSFL 269 (277)
T ss_pred ----CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 567889999999999999998 789998877655554444433222 3456788999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++++
T Consensus 270 e~l~~ 274 (277)
T cd05062 270 EIISS 274 (277)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=217.25 Aligned_cols=161 Identities=32% Similarity=0.552 Sum_probs=128.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.++..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...... .......++..|+|||++...
T Consensus 96 ~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~- 173 (283)
T cd07830 96 FSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PPYTDYVSTRWYRAPEILLRS- 173 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-CCcCCCCCcccccCceeeecC-
Confidence 467899999999999999999999999999999999999999999999998765432 223345688899999988642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCC------------------CCC------CCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPP------------------GLY------RAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~------------------~~~------~~~ 133 (488)
..++.++|+||+|+++++|++|.+||..........++... +.. ... ...
T Consensus 174 ---~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (283)
T cd07830 174 ---TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIP 250 (283)
T ss_pred ---cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcc
Confidence 45788999999999999999999999876654444333210 000 000 011
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
..+..+.++|.+||..+|++|||+++++.||||
T Consensus 251 ~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 251 NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 226789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=227.00 Aligned_cols=168 Identities=33% Similarity=0.609 Sum_probs=126.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc-------cccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK-------KKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aP 73 (488)
+++..++.++.||+.||+|||++|++||||||+||+++.++.++++||+.+......... .....++..|+||
T Consensus 98 ~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (328)
T cd08226 98 MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177 (328)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccCh
Confidence 467889999999999999999999999999999999999999999999754322111010 0112345679999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-------------------------
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG------------------------- 128 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~------------------------- 128 (488)
|++.+. ...++.++|+||+||++|+|++|.+||...................
T Consensus 178 E~~~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (328)
T cd08226 178 ELLRQD---LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGI 254 (328)
T ss_pred hhhcCC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhccc
Confidence 998752 1347889999999999999999999998765544443333221100
Q ss_pred -------------------CCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 129 -------------------LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 129 -------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
......+++.+.+||++||..||++|||+.++++||||+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 255 GESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred ccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0011234677899999999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=216.23 Aligned_cols=159 Identities=31% Similarity=0.653 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++...... .......++..|+|||.+.
T Consensus 103 l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (264)
T cd06653 103 LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182 (264)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhc
Confidence 4678889999999999999999999999999999999999999999999987653211 1122356889999999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
+ ..++.++|+|||||++|+|++|..||..........++...+.. ...+..+++.+.++|.+||. +|..||++
T Consensus 183 ~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~i~~~l~-~~~~r~~~ 255 (264)
T cd06653 183 G-----EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK-PMLPDGVSDACRDFLKQIFV-EEKRRPTA 255 (264)
T ss_pred C-----CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC-CCCCcccCHHHHHHHHHHhc-CcccCccH
Confidence 5 45788999999999999999999999887666655555543322 22456788999999999999 57999999
Q ss_pred HHHhcCcCC
Q psy9090 158 SELLEHPFI 166 (488)
Q Consensus 158 ~ell~hp~f 166 (488)
.+++.|||.
T Consensus 256 ~~~~~~~~~ 264 (264)
T cd06653 256 EFLLRHPFV 264 (264)
T ss_pred HHHhcCCCC
Confidence 999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=218.91 Aligned_cols=155 Identities=26% Similarity=0.450 Sum_probs=126.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++....... .......+++.|+|||.+.+
T Consensus 119 l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05092 119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 198 (280)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc
Confidence 4678899999999999999999999999999999999999999999999986543211 11122345678999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+|||||++|+|++ |.+||...........+...... ..+..+++.+.++|.+||..+|.+||++
T Consensus 199 -----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~ 271 (280)
T cd05092 199 -----RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL--ERPRTCPPEVYAIMQGCWQREPQQRMVI 271 (280)
T ss_pred -----CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC--CCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 568899999999999999998 99999877766655555444322 2345678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.+++.
T Consensus 272 ~~l~~ 276 (280)
T cd05092 272 KDIHS 276 (280)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=217.88 Aligned_cols=156 Identities=24% Similarity=0.498 Sum_probs=125.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus 103 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-- 180 (267)
T cd08228 103 IPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-- 180 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhcc--
Confidence 467889999999999999999999999999999999999999999999998765443222334568899999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP--TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||+|+++|+|++|..||..... ......+.....++. .....+..+.++|.+||..+|++||++.
T Consensus 181 ---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 256 (267)
T cd08228 181 ---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL-PTEHYSEKLRELVSMCIYPDPDQRPDIG 256 (267)
T ss_pred ---CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC-ChhhcCHHHHHHHHHHCCCCcccCcCHH
Confidence 5578899999999999999999999965432 222222222222222 2335678999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 257 ~vl~ 260 (267)
T cd08228 257 YVHQ 260 (267)
T ss_pred HHHH
Confidence 9986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=226.39 Aligned_cols=164 Identities=28% Similarity=0.535 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... .....+++.|+|||.+.+.
T Consensus 115 l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~- 190 (343)
T cd07880 115 LSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNW- 190 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCC-
Confidence 578899999999999999999999999999999999999999999999998765332 2344678899999998642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC----------------------CCC------CCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP----------------------PGL------YRA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~----------------------~~~------~~~ 132 (488)
..++.++|+||+|+++|++++|.+||.+.........+..... +.. ...
T Consensus 191 ---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (343)
T cd07880 191 ---MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLL 267 (343)
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhc
Confidence 3477899999999999999999999987665443333322110 000 011
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
...++.+.++|.+||..||++|||+.+++.||||+....
T Consensus 268 ~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 268 PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred cCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 346788999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=219.39 Aligned_cols=162 Identities=26% Similarity=0.482 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+.
T Consensus 97 ~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 176 (287)
T cd07840 97 FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEcc
Confidence 46889999999999999999999999999999999999999999999999876544321 12334567889999987642
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC---CCCCC------------------------CC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP---PPGLY------------------------RA 132 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~---~~~~~------------------------~~ 132 (488)
..++.++|+||||+++|+|++|..||...........+.... .+..+ ..
T Consensus 177 ----~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T cd07840 177 ----TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFF 252 (287)
T ss_pred ----ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHh
Confidence 457889999999999999999999998777655444443211 00000 00
Q ss_pred CC-cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q psy9090 133 SN-WSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166 (488)
Q Consensus 133 ~~-~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 166 (488)
.. .++.+.+++.+||..+|.+||++.++++||||
T Consensus 253 ~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 253 KHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 11 27889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=215.16 Aligned_cols=155 Identities=25% Similarity=0.437 Sum_probs=126.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc---cccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK---KKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......... .....+++.|+|||.+.
T Consensus 92 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05115 92 ITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHc
Confidence 578899999999999999999999999999999999999999999999998754322111 11122356899999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
. ..++.++|+|||||++|++++ |..||...........+.....+. .+...++++.++|.+||..+|++||+
T Consensus 172 ~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~c~~~~~~~Rp~ 244 (257)
T cd05115 172 F-----RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD--CPAECPPEMYALMKDCWIYKWEDRPN 244 (257)
T ss_pred c-----CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 5 567889999999999999996 999998887666555554443322 34567899999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++.+
T Consensus 245 ~~~i~~ 250 (257)
T cd05115 245 FAKVEE 250 (257)
T ss_pred HHHHHH
Confidence 999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=218.53 Aligned_cols=156 Identities=22% Similarity=0.445 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... .......++..|+|||.+.+
T Consensus 121 ~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05090 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200 (283)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc
Confidence 3567788999999999999999999999999999999999999999999997653221 11233445678999999865
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+|||||++|+|++ |.+||.+.........+...... ..+..+++.+++++.+||..+|++||++
T Consensus 201 -----~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 273 (283)
T cd05090 201 -----GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL--PCSEDCPPRMYSLMTECWQEGPSRRPRF 273 (283)
T ss_pred -----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcccCcccCcCH
Confidence 567899999999999999998 99999887665554444433322 2345678999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 274 ~~i~~~ 279 (283)
T cd05090 274 KDIHTR 279 (283)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-27 Score=231.02 Aligned_cols=161 Identities=27% Similarity=0.509 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC---cEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG---EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
|+|..-++++.||+.||+|||-+||+|+||||+|||+.+.. ++||||||+++.+... .-..+.+|||.|+|||+++
T Consensus 661 L~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsVVGTPAYLaPEVLr 739 (888)
T KOG4236|consen 661 LPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSVVGTPAYLAPEVLR 739 (888)
T ss_pred chHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhhcCCccccCHHHHh
Confidence 67888999999999999999999999999999999997654 5999999999988764 3456779999999999998
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC-CCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN-PPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
. ++|+.+-|+||+|||+|--+.|..||...... ..+|-.. -..+..+...+++++.+||..+|+..-.+|.|
T Consensus 740 n-----kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys 812 (888)
T KOG4236|consen 740 N-----KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS 812 (888)
T ss_pred h-----ccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc
Confidence 7 78999999999999999999999999764432 2222111 11111123456899999999999999999999
Q ss_pred HHHHhcCcCCCCC
Q psy9090 157 MSELLEHPFITSL 169 (488)
Q Consensus 157 ~~ell~hp~f~~~ 169 (488)
+++.|.|||+++.
T Consensus 813 vdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 813 VDKSLSHPWLQDY 825 (888)
T ss_pred hHhhccchhhhcc
Confidence 9999999999875
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=233.66 Aligned_cols=164 Identities=26% Similarity=0.449 Sum_probs=141.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+.|.+++.++.|++.|++|||+++|||||||++|||++.+..+||+|||++..+... ....+++|++.|.|||++.+.
T Consensus 152 ~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~~lqt~cgsppyAaPEl~~g~- 229 (596)
T KOG0586|consen 152 MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-LMLQTFCGSPPYAAPELFNGK- 229 (596)
T ss_pred chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-ccccccCCCCCccChHhhcCc-
Confidence 457889999999999999999999999999999999999999999999999988744 566789999999999999873
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..-++.+|+||+|+++|.|++|..||.+.+......+.+.+. +..+..++.++.++|+++|.++|.+|++++++
T Consensus 230 ---~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk---~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqi 303 (596)
T KOG0586|consen 230 ---KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK---YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQI 303 (596)
T ss_pred ---ccCCcceehhhhhhhheeeeecccccCCcccccccchheeee---ecccceeechhHHHHHHhhccCccccCCHHHh
Confidence 334679999999999999999999999887665555555432 23455679999999999999999999999999
Q ss_pred hcCcCCCCCCCC
Q psy9090 161 LEHPFITSLPEN 172 (488)
Q Consensus 161 l~hp~f~~~~~~ 172 (488)
+.|+|.......
T Consensus 304 m~~~W~n~~~~~ 315 (596)
T KOG0586|consen 304 MKDRWRNDLLEA 315 (596)
T ss_pred hhhcccchhhhh
Confidence 999999765443
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=217.77 Aligned_cols=156 Identities=26% Similarity=0.480 Sum_probs=125.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC---cEEEEecCCccccccccC--ccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG---EVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~ 75 (488)
+++..+..++.||+.||+|||+++++||||||+||+++.++ .+||+|||+++....... .......++.|+|||+
T Consensus 113 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 192 (277)
T cd05036 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEA 192 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHH
Confidence 46788899999999999999999999999999999998765 599999999876532111 1112233567999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
+.+ ..++.++|||||||++|+|++ |..||...........+...... ..+..++..+.+++.+||..+|++|
T Consensus 193 ~~~-----~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~R 265 (277)
T cd05036 193 FLD-----GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL--DPPKGCPGPVYRIMTDCWQHTPEDR 265 (277)
T ss_pred Hhc-----CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccC
Confidence 975 568899999999999999996 99999887765555444433222 2345678999999999999999999
Q ss_pred CCHHHHhcC
Q psy9090 155 PYMSELLEH 163 (488)
Q Consensus 155 ps~~ell~h 163 (488)
||+.++++|
T Consensus 266 ps~~~vl~~ 274 (277)
T cd05036 266 PNFATILER 274 (277)
T ss_pred cCHHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=253.53 Aligned_cols=160 Identities=19% Similarity=0.190 Sum_probs=118.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc-------------------EEEEecCCcccccccc---
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE-------------------VKIVDFGLSRETANTF--- 58 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-------------------vkL~Dfg~a~~~~~~~--- 58 (488)
|++.+++.+++||+.||+|||++||+||||||+|||++..|. +|++|||+++......
T Consensus 77 ~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~ 156 (793)
T PLN00181 77 VDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERR 156 (793)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccc
Confidence 578899999999999999999999999999999999965444 5555555554321000
Q ss_pred -------------CccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC
Q psy9090 59 -------------DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP 125 (488)
Q Consensus 59 -------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 125 (488)
.......||+.|+|||++.+ ..|+.++|||||||++|||++|.+|+..... ....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~ 229 (793)
T PLN00181 157 IEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-----SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV 229 (793)
T ss_pred hhhhhccccCCCcccccccCCCcceEChhhhcc-----CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh
Confidence 00112358899999999876 6689999999999999999999998764321 222222222
Q ss_pred CCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 126 PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 126 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
.++.. ....+...+++.+||.++|.+||++.++++||||...
T Consensus 230 ~~~~~--~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 230 LPPQI--LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred cChhh--hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 12111 1124566789999999999999999999999999864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=222.40 Aligned_cols=156 Identities=26% Similarity=0.419 Sum_probs=125.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc--cccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK--KKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....++..|+|||.+..
T Consensus 106 ~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 185 (316)
T cd05108 106 IGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185 (316)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc
Confidence 356788899999999999999999999999999999999999999999999865432111 112234568999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+...... ..+..... ..+.+..++..+.+++.+||..+|.+||++
T Consensus 186 -----~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 258 (316)
T cd05108 186 -----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGE-RLPQPPICTIDVYMIMVKCWMIDADSRPKF 258 (316)
T ss_pred -----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 568899999999999999987 9999987765443 33333221 222345568899999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++.+
T Consensus 259 ~~l~~~ 264 (316)
T cd05108 259 RELIIE 264 (316)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=214.78 Aligned_cols=152 Identities=25% Similarity=0.462 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++...... .....++..|+|||++..
T Consensus 99 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~-- 173 (256)
T cd05082 99 LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALRE-- 173 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc---CCCCccceeecCHHHHcc--
Confidence 367888999999999999999999999999999999999999999999998754332 123345568999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|+|||||++|+|++ |..||...........+.....+ ..+..+++.+.+++.+||..+|++|||+.+
T Consensus 174 ---~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 248 (256)
T cd05082 174 ---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--DAPDGCPPVVYDVMKQCWHLDAATRPSFLQ 248 (256)
T ss_pred ---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 567889999999999999997 99999877655554444433222 234567899999999999999999999999
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
+++
T Consensus 249 l~~ 251 (256)
T cd05082 249 LRE 251 (256)
T ss_pred HHH
Confidence 975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=214.54 Aligned_cols=155 Identities=27% Similarity=0.436 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..............++..|+|||.+..
T Consensus 101 ~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-- 178 (261)
T cd05148 101 LPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH-- 178 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHcc--
Confidence 467788999999999999999999999999999999999999999999998765433222233445678999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|+||||+++|+|++ |..||...........+.....+ ..+...++.+.++|.+||..+|.+|||+.+
T Consensus 179 ---~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (261)
T cd05148 179 ---GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM--PCPAKCPQEIYKIMLECWAAEPEDRPSFKA 253 (261)
T ss_pred ---CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 567889999999999999998 89999887766555555543222 234567899999999999999999999999
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
+++
T Consensus 254 l~~ 256 (261)
T cd05148 254 LRE 256 (261)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=219.67 Aligned_cols=156 Identities=28% Similarity=0.481 Sum_probs=126.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....... ......++..|+|||++.+
T Consensus 129 l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 208 (293)
T cd05053 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD 208 (293)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc
Confidence 46778899999999999999999999999999999999999999999999876543211 1122234567999999865
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|++++ |..||...........+.....+ ..+...+..+.+|+.+||..+|++|||+
T Consensus 209 -----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~ 281 (293)
T cd05053 209 -----RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRM--EKPQNCTQELYHLMRDCWHEVPSQRPTF 281 (293)
T ss_pred -----CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcccCcccCcCH
Confidence 568889999999999999997 99999887765554444443322 2345668999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 282 ~eil~~ 287 (293)
T cd05053 282 KQLVED 287 (293)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=216.15 Aligned_cols=156 Identities=25% Similarity=0.516 Sum_probs=124.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus 103 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~-- 180 (267)
T cd08229 103 IPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-- 180 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcC--
Confidence 477889999999999999999999999999999999999999999999998765433233334578899999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH--HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT--RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||+|+++|+|++|..||.+.... .....+.....++. .+...++.+++++.+||..+|++|||+.
T Consensus 181 ---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 256 (267)
T cd08229 181 ---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL-PSDHYSEELRQLVNMCINPDPEKRPDIT 256 (267)
T ss_pred ---CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC-CcccccHHHHHHHHHhcCCCcccCCCHH
Confidence 56788999999999999999999999754322 22222222222221 2345788999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 257 ~i~~ 260 (267)
T cd08229 257 YVYD 260 (267)
T ss_pred HHHH
Confidence 8764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=216.51 Aligned_cols=155 Identities=25% Similarity=0.400 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+
T Consensus 106 ~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 185 (279)
T cd05111 106 LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc
Confidence 46888999999999999999999999999999999999999999999999875432211 1223456778999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+|||||++|++++ |..||.+.........+..+..+ ..+...+..+.+++.+||..+|++|||+
T Consensus 186 -----~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~ 258 (279)
T cd05111 186 -----GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENVRPTF 258 (279)
T ss_pred -----CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 568899999999999999998 99999887654433333222222 2234567889999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 259 ~el~~ 263 (279)
T cd05111 259 KELAN 263 (279)
T ss_pred HHHHH
Confidence 99876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=221.90 Aligned_cols=155 Identities=27% Similarity=0.447 Sum_probs=123.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+++.++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++...... .......++..|+|||.+.+
T Consensus 121 l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-- 197 (303)
T cd05088 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-- 197 (303)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhc--
Confidence 467889999999999999999999999999999999999999999999998643221 11112234567999998865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|||||||++|+|++ |.+||...........+...... ..+...++.+.+|+.+||..+|++||++++
T Consensus 198 ---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 272 (303)
T cd05088 198 ---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQ 272 (303)
T ss_pred ---cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 567889999999999999998 99999877655444433322111 123456889999999999999999999999
Q ss_pred HhcC
Q psy9090 160 LLEH 163 (488)
Q Consensus 160 ll~h 163 (488)
++.+
T Consensus 273 il~~ 276 (303)
T cd05088 273 ILVS 276 (303)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=215.91 Aligned_cols=154 Identities=27% Similarity=0.450 Sum_probs=123.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++++.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... ........++.|+|||++..
T Consensus 109 l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~-- 185 (270)
T cd05047 109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-- 185 (270)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchh-hhccCCCCccccCChHHHcc--
Confidence 467888999999999999999999999999999999999999999999998533211 11112233567999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|+|||||++|+|++ |..||.+.........+...... ..+...+.++.+++.+||..+|.+|||+.+
T Consensus 186 ---~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 260 (270)
T cd05047 186 ---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQ 260 (270)
T ss_pred ---CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC--CCCCcCCHHHHHHHHHHcccChhhCCCHHH
Confidence 568889999999999999997 99999877665555444433222 233456889999999999999999999999
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
++.
T Consensus 261 il~ 263 (270)
T cd05047 261 ILV 263 (270)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=213.70 Aligned_cols=155 Identities=26% Similarity=0.449 Sum_probs=126.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++........ ......++..|+|||.+.+
T Consensus 99 ~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 177 (260)
T cd05070 99 LKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 177 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-
Confidence 46788999999999999999999999999999999999999999999999875433211 1122235567999999865
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||||+++|+|++ |.+||.+.........+.....+ ..+...+..+.+++.+||..+|++|||+.
T Consensus 178 ----~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 251 (260)
T cd05070 178 ----GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM--PCPQDCPISLHELMLQCWKKDPEERPTFE 251 (260)
T ss_pred ----CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCcCCHHHHHHHHHHcccCcccCcCHH
Confidence 567889999999999999999 99999887766666655544322 23456789999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++.+
T Consensus 252 ~l~~ 255 (260)
T cd05070 252 YLQS 255 (260)
T ss_pred HHHH
Confidence 8864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=213.73 Aligned_cols=156 Identities=27% Similarity=0.489 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc-cccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK-KKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||.++........ .....++..|+|||.+.+
T Consensus 97 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~- 175 (256)
T cd05113 97 FQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY- 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhc-
Confidence 468889999999999999999999999999999999999999999999998754332111 112235567999999975
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||||+++|+|++ |..||...........+.....+ ..+...+..+++++.+||..+|.+||++.
T Consensus 176 ----~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 249 (256)
T cd05113 176 ----SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--YRPHLASEKVYAIMYSCWHEKAEERPTFQ 249 (256)
T ss_pred ----CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 568889999999999999998 99999877766555555544332 23455689999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++.+
T Consensus 250 ~ll~~ 254 (256)
T cd05113 250 QLLSS 254 (256)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=213.41 Aligned_cols=155 Identities=26% Similarity=0.443 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+
T Consensus 99 ~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~- 177 (260)
T cd05069 99 LKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 177 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-
Confidence 35778899999999999999999999999999999999999999999999875533211 1122345678999998865
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||||+++|+|++ |..||.+........++.....+. .+...+..+++++.+||..+|.+||+++
T Consensus 178 ----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05069 178 ----GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP--CPQGCPESLHELMKLCWKKDPDERPTFE 251 (260)
T ss_pred ----CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCcccCHHHHHHHHHHccCCcccCcCHH
Confidence 567889999999999999999 999998877666666555443322 3456789999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 252 ~i~~ 255 (260)
T cd05069 252 YIQS 255 (260)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=213.21 Aligned_cols=156 Identities=25% Similarity=0.468 Sum_probs=126.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc-cccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK-KKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++........ .....++..|+|||.+.+
T Consensus 97 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~- 175 (256)
T cd05059 97 LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY- 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc-
Confidence 467889999999999999999999999999999999999999999999998755332111 111223457999999876
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||||+++|+|++ |..||...........+...... ..+..+++.+.+++.+||..+|++|||+.
T Consensus 176 ----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ 249 (256)
T cd05059 176 ----SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL--YRPKLAPTEVYTIMYSCWHEKPEDRPAFK 249 (256)
T ss_pred ----CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 568889999999999999998 89999877665555555443222 23456799999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
++++.
T Consensus 250 ~~l~~ 254 (256)
T cd05059 250 KLLSQ 254 (256)
T ss_pred HHHHH
Confidence 99863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=212.78 Aligned_cols=155 Identities=29% Similarity=0.482 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.++....... ......++..|+|||.+.+
T Consensus 97 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 175 (256)
T cd05114 97 LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF- 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-
Confidence 46788999999999999999999999999999999999999999999999875432211 1122235568999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||+|+++|+|++ |+.||...........+.....+. .+...+..+.+++.+||..+|.+|||++
T Consensus 176 ----~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~li~~c~~~~p~~Rps~~ 249 (256)
T cd05114 176 ----SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY--RPKLASMTVYEVMYSCWHEKPEGRPTFA 249 (256)
T ss_pred ----CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC--CCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence 567889999999999999999 999998887766666665543322 3445688999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 250 ~l~~ 253 (256)
T cd05114 250 ELLR 253 (256)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=217.46 Aligned_cols=160 Identities=35% Similarity=0.668 Sum_probs=128.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.|++.+|.|||+ ++++||||+|+||+++.++.++|+|||++...... ......|+..|+|||++.+
T Consensus 100 ~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~~~~~~~~~~aPE~~~~- 176 (284)
T cd06620 100 IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQG- 176 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccCccccCcccCCHHHHcc-
Confidence 4678899999999999999997 69999999999999999999999999998654322 2234578999999999865
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-----------HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcc
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-----------RALFQIVRNPPPGLYRASNWSQHYVDFIAECLE 148 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 148 (488)
..++.++|+||+||++|++++|..||...... .....+.....+.. ....++..+.+|+.+||.
T Consensus 177 ----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~ 251 (284)
T cd06620 177 ----GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL-PSSDFPEDLRDFVDACLL 251 (284)
T ss_pred ----CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC-CchhcCHHHHHHHHHHhc
Confidence 46788999999999999999999999765431 22222332222221 122367899999999999
Q ss_pred cCCCCCCCHHHHhcCcCCCC
Q psy9090 149 KNPEHRPYMSELLEHPFITS 168 (488)
Q Consensus 149 ~dP~~Rps~~ell~hp~f~~ 168 (488)
.||++|||+.++++||||.+
T Consensus 252 ~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 252 KDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred CCcccCcCHHHHhcCccccc
Confidence 99999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=214.66 Aligned_cols=155 Identities=22% Similarity=0.360 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||++|++||||||+||+++.++.++++|||.+........ ......+++.|+|||++.+
T Consensus 104 l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 182 (266)
T cd05064 104 LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY- 182 (266)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-
Confidence 57889999999999999999999999999999999999999999999998765322111 1112335678999999876
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||+||++|++++ |..||...........+...... +.+..++..+.+++.+||..+|.+||+++
T Consensus 183 ----~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~RP~~~ 256 (266)
T cd05064 183 ----HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL--PAPRNCPNLLHQLMLDCWQKERGERPRFS 256 (266)
T ss_pred ----CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC--CCCCCCCHHHHHHHHHHcCCCchhCCCHH
Confidence 568899999999999999764 99999888766655555444322 23567889999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 257 ~i~~ 260 (266)
T cd05064 257 QIHS 260 (266)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=213.47 Aligned_cols=155 Identities=26% Similarity=0.486 Sum_probs=127.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... .......++..|+|||++..
T Consensus 99 ~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~- 177 (260)
T cd05067 99 LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY- 177 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-
Confidence 4677889999999999999999999999999999999999999999999987654221 11223345678999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||||+++|++++ |.+||.+.........+...... ..+...+.++.+++.+||..+|++||+++
T Consensus 178 ----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05067 178 ----GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--PRPDNCPEELYELMRLCWKEKPEERPTFE 251 (260)
T ss_pred ----CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 567889999999999999998 99999887766555555443322 23456788999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
+++.
T Consensus 252 ~l~~ 255 (260)
T cd05067 252 YLRS 255 (260)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=211.52 Aligned_cols=156 Identities=30% Similarity=0.513 Sum_probs=127.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++........ ......++..|+|||.+.
T Consensus 94 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~ 173 (257)
T cd05040 94 FLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173 (257)
T ss_pred CcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhc
Confidence 46788999999999999999999999999999999999999999999999876543211 112345677899999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|+|||||++|+|++ |..||......+....+.... .....+...+..+.+++.+||..+|++|||
T Consensus 174 ~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 247 (257)
T cd05040 174 T-----RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-ERLERPEACPQDIYNVMLQCWAHNPADRPT 247 (257)
T ss_pred c-----cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CcCCCCccCCHHHHHHHHHHCCCCcccCCC
Confidence 5 568889999999999999998 999998777666555544322 222234557899999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 248 ~~~~~~ 253 (257)
T cd05040 248 FAALRE 253 (257)
T ss_pred HHHHHH
Confidence 999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=211.95 Aligned_cols=155 Identities=26% Similarity=0.447 Sum_probs=123.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc--ccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK--KTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ....++..|+|||.+.+
T Consensus 91 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 170 (252)
T cd05084 91 LKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY 170 (252)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcC
Confidence 4678899999999999999999999999999999999999999999999987543211110 11122456999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+||||+++|+|++ |..||...........+...... ..+..++..+.+++.+||..+|++|||+
T Consensus 171 -----~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~ 243 (252)
T cd05084 171 -----GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--PCPELCPDAVYRLMERCWEYDPGQRPSF 243 (252)
T ss_pred -----CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC--CCcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 567889999999999999997 99999776655444444333222 2345678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 244 ~~~~~ 248 (252)
T cd05084 244 STVHQ 248 (252)
T ss_pred HHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=212.85 Aligned_cols=155 Identities=27% Similarity=0.458 Sum_probs=126.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||+++++||||||+||+++.++.++|+|||++........ ......++..|+|||.+..
T Consensus 100 ~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 178 (261)
T cd05072 100 VLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF- 178 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc-
Confidence 35677889999999999999999999999999999999999999999999976543211 1122345678999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+|||||++|+|++ |..||...........+...... +....++..+.+++.+||..+|++||+++
T Consensus 179 ----~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (261)
T cd05072 179 ----GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM--PRMENCPDELYDIMKTCWKEKAEERPTFD 252 (261)
T ss_pred ----CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence 567889999999999999998 99999887766655555443322 23346789999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 253 ~i~~ 256 (261)
T cd05072 253 YLQS 256 (261)
T ss_pred HHHH
Confidence 9865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=216.56 Aligned_cols=155 Identities=27% Similarity=0.473 Sum_probs=125.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+
T Consensus 124 l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 203 (290)
T cd05045 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203 (290)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence 45778899999999999999999999999999999999999999999999875432211 1122345678999999865
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+||||+++|+|++ |..||.+..+............. ..+..++..+.+++.+||..+|++||++
T Consensus 204 -----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~ 276 (290)
T cd05045 204 -----HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM--ERPENCSEEMYNLMLTCWKQEPDKRPTF 276 (290)
T ss_pred -----CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 567889999999999999998 99999887765544443332222 2345678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 277 ~~i~~ 281 (290)
T cd05045 277 ADISK 281 (290)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=213.63 Aligned_cols=156 Identities=25% Similarity=0.445 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc--cccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK--KKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++........ .....+++.|+|||.+.+
T Consensus 103 ~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~ 182 (266)
T cd05033 103 FTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182 (266)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc
Confidence 467889999999999999999999999999999999999999999999999876421111 112234578999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+||||+++|+|++ |..||...........+...... +.+..+++.+.+++.+||..+|++||++
T Consensus 183 -----~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~ 255 (266)
T cd05033 183 -----RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL--PPPMDCPSALYQLMLDCWQKDRNERPTF 255 (266)
T ss_pred -----CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 567889999999999999998 99999877766655555443222 2345678999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 256 ~ei~~~ 261 (266)
T cd05033 256 SQIVST 261 (266)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=217.04 Aligned_cols=157 Identities=26% Similarity=0.426 Sum_probs=125.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||+++...... .......+++.|+|||.+.+
T Consensus 127 ~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence 4678899999999999999999999999999999999999999999999987543221 11233456778999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc--CCCCCCCCChHHHHHHHHhC-----CCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD--GKPPFEDMHPTRALFQIVRN-----PPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt--g~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
..++.++|||||||++|+|++ |..||........+...... .......+...+.++.+++.+||..+|
T Consensus 207 -----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 281 (296)
T cd05051 207 -----GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDE 281 (296)
T ss_pred -----CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccCh
Confidence 468899999999999999987 78888776655544444321 111122344567899999999999999
Q ss_pred CCCCCHHHHhc
Q psy9090 152 EHRPYMSELLE 162 (488)
Q Consensus 152 ~~Rps~~ell~ 162 (488)
.+|||+.++++
T Consensus 282 ~~Rpt~~el~~ 292 (296)
T cd05051 282 EDRPTFREIHL 292 (296)
T ss_pred hcCCCHHHHHH
Confidence 99999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=212.51 Aligned_cols=154 Identities=25% Similarity=0.456 Sum_probs=122.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc----CccccccCCCccccchhhc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF----DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~l~ 77 (488)
++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++...... .......+++.|+|||.+.
T Consensus 96 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 175 (262)
T cd05058 96 TVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175 (262)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhc
Confidence 456778899999999999999999999999999999999999999999987543211 1112334567899999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
. ..++.++|||||||++|+|++ |.+||...........+.....+. .+...++.+.+++.+||..+|++||+
T Consensus 176 ~-----~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~ 248 (262)
T cd05058 176 T-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL--QPEYCPDPLYEVMLSCWHPKPEMRPT 248 (262)
T ss_pred c-----CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC--CCCcCCHHHHHHHHHHcCCChhhCCC
Confidence 5 567889999999999999999 567777766555444444332222 23456889999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.+++.
T Consensus 249 ~~~il~ 254 (262)
T cd05058 249 FSELVS 254 (262)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=218.42 Aligned_cols=155 Identities=28% Similarity=0.452 Sum_probs=124.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc--cccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK--KKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~l~~ 78 (488)
+++.++..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+
T Consensus 131 l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (314)
T cd05099 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD 210 (314)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc
Confidence 356778899999999999999999999999999999999999999999999765322111 112234467999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+||||+++|+|++ |..||...........+...... ..+...+.++++++.+||..+|++|||+
T Consensus 211 -----~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~ 283 (314)
T cd05099 211 -----RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRM--DKPSNCTHELYMLMRECWHAVPTQRPTF 283 (314)
T ss_pred -----CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 568889999999999999999 89999887655544444433222 2345678899999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 284 ~~ll~ 288 (314)
T cd05099 284 KQLVE 288 (314)
T ss_pred HHHHH
Confidence 99886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=217.30 Aligned_cols=156 Identities=28% Similarity=0.470 Sum_probs=126.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 134 ~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (304)
T cd05101 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD 213 (304)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc
Confidence 35667889999999999999999999999999999999999999999999876543211 1222345678999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||||+++|+|++ |..||.+.........+...... ..+...+..+++|+.+||..+|.+|||+
T Consensus 214 -----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~ 286 (304)
T cd05101 214 -----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAIPSHRPTF 286 (304)
T ss_pred -----CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcccChhhCCCH
Confidence 568889999999999999998 88999887765555544433322 2345678999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.++++.
T Consensus 287 ~e~l~~ 292 (304)
T cd05101 287 KQLVED 292 (304)
T ss_pred HHHHHH
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=217.47 Aligned_cols=156 Identities=28% Similarity=0.486 Sum_probs=126.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.++..++.||+.||.|||+++++|+||||+|||++.++.++|+|||+++....... ......+++.|+|||.+.+
T Consensus 138 l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 217 (302)
T cd05055 138 LTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN 217 (302)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc
Confidence 46889999999999999999999999999999999999999999999999875533211 1223345778999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||+||++|+|++ |..||................... ..+...++.+.+++.+||..+|++|||+
T Consensus 218 -----~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~ 291 (302)
T cd05055 218 -----CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRPTF 291 (302)
T ss_pred -----CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 567889999999999999998 999998776555554544433221 2334568999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.+++.
T Consensus 292 ~ell~ 296 (302)
T cd05055 292 KQIVQ 296 (302)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=218.71 Aligned_cols=156 Identities=27% Similarity=0.443 Sum_probs=124.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc--cccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK--KKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~l~~ 78 (488)
++..++..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++........ .....+++.|+|||++.+
T Consensus 137 l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (307)
T cd05098 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 216 (307)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc
Confidence 356788999999999999999999999999999999999999999999998755322111 112234568999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+|||||++|+|++ |..||.+.........+...... ..+..++.++++++.+||..+|.+|||+
T Consensus 217 -----~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~ 289 (307)
T cd05098 217 -----RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM--DKPSNCTNELYMMMRDCWHAVPSQRPTF 289 (307)
T ss_pred -----CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCC--CCCCcCCHHHHHHHHHHcccChhhCcCH
Confidence 567889999999999999998 89999876654433333333222 2345678999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 290 ~evl~~ 295 (307)
T cd05098 290 KQLVED 295 (307)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=211.68 Aligned_cols=155 Identities=26% Similarity=0.458 Sum_probs=126.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||.++....... ......++..|+|||....
T Consensus 99 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~- 177 (262)
T cd05071 99 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 177 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhcc-
Confidence 46788899999999999999999999999999999999999999999999875543211 1123345678999998865
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+|||||++|+|++ |.+||.+.........+...... ..+...+..+.+++.+||..+|++||++.
T Consensus 178 ----~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 251 (262)
T cd05071 178 ----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--PCPPECPESLHDLMCQCWRKEPEERPTFE 251 (262)
T ss_pred ----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC--CCccccCHHHHHHHHHHccCCcccCCCHH
Confidence 568899999999999999999 89999887766655555443222 22456789999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 252 ~~~~ 255 (262)
T cd05071 252 YLQA 255 (262)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=211.18 Aligned_cols=155 Identities=25% Similarity=0.462 Sum_probs=126.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc-cccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK-KKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........ ......+..|+|||.+.+
T Consensus 100 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 178 (261)
T cd05068 100 LKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY- 178 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-
Confidence 467889999999999999999999999999999999999999999999998765432111 111223457999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||||+++|+|++ |+.||.+.........+...... ..+..++..+.+++.+||..+|.+||++.
T Consensus 179 ----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 252 (261)
T cd05068 179 ----NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM--PCPPGCPKELYDIMLDCWKEDPDDRPTFE 252 (261)
T ss_pred ----CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCcCCHHHHHHHHHHhhcCcccCCCHH
Confidence 567889999999999999999 99999887766666555444322 23456789999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
+++.
T Consensus 253 ~l~~ 256 (261)
T cd05068 253 TLQW 256 (261)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=212.09 Aligned_cols=156 Identities=28% Similarity=0.543 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-- 180 (267)
T cd08224 103 IPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-- 180 (267)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhcc--
Confidence 467889999999999999999999999999999999999999999999998765433223344568899999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP--TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||+||++|+|++|..||..... ......+.....++. ....++..+.++|.+||..+|++|||+.
T Consensus 181 ---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~p~~Rp~~~ 256 (267)
T cd08224 181 ---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL-PADHYSEELRDLVSRCINPDPEKRPDIS 256 (267)
T ss_pred ---CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC-ChhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence 5688899999999999999999999965432 122223333222222 1235788999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 257 ~il~ 260 (267)
T cd08224 257 YVLQ 260 (267)
T ss_pred HHHH
Confidence 9875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=219.26 Aligned_cols=162 Identities=29% Similarity=0.548 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++..... ......+++.|+|||.+.+.
T Consensus 105 ~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~- 180 (328)
T cd07856 105 LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTW- 180 (328)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---CcCCCcccccccCceeeecc-
Confidence 45778889999999999999999999999999999999999999999999875432 22344678899999987542
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHH---hC--------------------CC--CCC---CCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV---RN--------------------PP--PGL---YRA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~---~~--------------------~~--~~~---~~~ 132 (488)
..++.++|+||+||++|+|++|++||...........+. .. .. ... ...
T Consensus 181 ---~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (328)
T cd07856 181 ---QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKF 257 (328)
T ss_pred ---CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHc
Confidence 457889999999999999999999997765422211111 00 00 000 011
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
..+++.+.++|++||..+|++|||+++++.||||...
T Consensus 258 ~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 258 KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 3467899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=211.76 Aligned_cols=160 Identities=28% Similarity=0.453 Sum_probs=123.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~~ 79 (488)
++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......+++.|+|||++...
T Consensus 98 ~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05042 98 QKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177 (269)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhc
Confidence 456778999999999999999999999999999999999999999999986532211 112233456789999998642
Q ss_pred cc--CCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCC---CCCCCcCHHHHHHHHHhcccCCCC
Q psy9090 80 HK--EVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGL---YRASNWSQHYVDFIAECLEKNPEH 153 (488)
Q Consensus 80 ~~--~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~ 153 (488)
.. ....++.++||||+||++|+|++ |..||.................... ..+..+++.+.+++..|+ .||++
T Consensus 178 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~ 256 (269)
T cd05042 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPET 256 (269)
T ss_pred cccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCccc
Confidence 11 12456789999999999999998 8889987776665555554432222 223467888999999998 59999
Q ss_pred CCCHHHHhc
Q psy9090 154 RPYMSELLE 162 (488)
Q Consensus 154 Rps~~ell~ 162 (488)
|||++++++
T Consensus 257 Rpt~~~v~~ 265 (269)
T cd05042 257 RPTAEEVHE 265 (269)
T ss_pred ccCHHHHHH
Confidence 999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=236.55 Aligned_cols=160 Identities=25% Similarity=0.450 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccc------------------cccCccccc
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA------------------NTFDKKKTF 64 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~------------------~~~~~~~~~ 64 (488)
...+|.+++||++||.|+|+.|||||||||.||+++.++.|||+|||+++... ......+..
T Consensus 696 ~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~ 775 (1351)
T KOG1035|consen 696 RDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQ 775 (1351)
T ss_pred hHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccc
Confidence 35789999999999999999999999999999999999999999999997511 001123566
Q ss_pred cCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCC--CCCCcCHHHHHH
Q psy9090 65 LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLY--RASNWSQHYVDF 142 (488)
Q Consensus 65 ~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l 142 (488)
+||..|+|||++.+... ..|+.|+||||||++++||+. ||...-........++.+.-+.+ ...+--+.-..+
T Consensus 776 VGTalYvAPEll~~~~~--~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 776 VGTALYVAPELLSDTSS--NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASL 850 (1351)
T ss_pred cceeeeecHHHhccccc--ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHH
Confidence 89999999999976421 469999999999999999974 46443333333333333222221 011123455789
Q ss_pred HHHhcccCCCCCCCHHHHhcCcCCC
Q psy9090 143 IAECLEKNPEHRPYMSELLEHPFIT 167 (488)
Q Consensus 143 i~~~L~~dP~~Rps~~ell~hp~f~ 167 (488)
|+.||+.||.+|||+.++|++.|+-
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhhccCCC
Confidence 9999999999999999999999996
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=208.37 Aligned_cols=155 Identities=30% Similarity=0.491 Sum_probs=127.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccc-cccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK-TFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~-~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||++||++|++|+||||+||+++.++.++|+|||++........... ...+++.|+|||.+.+
T Consensus 100 ~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~- 178 (258)
T smart00219 100 LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD- 178 (258)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhcc-
Confidence 47889999999999999999999999999999999999999999999999876543311111 2236789999999864
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||+|+++|+|++ |.+||...........+....... .+...+..+.+++.+||..+|++|||+.
T Consensus 179 ----~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 252 (258)
T smart00219 179 ----GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP--KPENCPPEIYKLMLQCWAEDPEDRPTFS 252 (258)
T ss_pred ----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--CCCcCCHHHHHHHHHHCcCChhhCcCHH
Confidence 567889999999999999998 899998776655555555443332 3445789999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 253 ~ll~ 256 (258)
T smart00219 253 ELVE 256 (258)
T ss_pred HHHh
Confidence 9986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=207.60 Aligned_cols=155 Identities=26% Similarity=0.447 Sum_probs=125.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc-cccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK-KKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++......... .....+++.|+|||++.+
T Consensus 90 ~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 168 (250)
T cd05085 90 LKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY- 168 (250)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc-
Confidence 467888999999999999999999999999999999999999999999998654322111 112234567999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||+|+++|++++ |..||...........+...... ..+..++..+.+++.+||..+|++||++.
T Consensus 169 ----~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 242 (250)
T cd05085 169 ----GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM--SCPQKCPDDVYKVMQRCWDYKPENRPKFS 242 (250)
T ss_pred ----CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 557889999999999999998 99999887766555555443322 23456789999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 243 ~l~~ 246 (250)
T cd05085 243 ELQK 246 (250)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=212.78 Aligned_cols=155 Identities=27% Similarity=0.450 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||+++....... ......++..|+|||++.+
T Consensus 114 l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 193 (280)
T cd05043 114 LSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc
Confidence 46788999999999999999999999999999999999999999999999875532211 1122345668999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|++++ |++||....+......+....... .+...++.+.+++.+||..+|++|||+
T Consensus 194 -----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~ 266 (280)
T cd05043 194 -----KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA--QPINCPDELFAVMACCWALDPEERPSF 266 (280)
T ss_pred -----CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC--CCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence 567899999999999999998 999998876655444333332222 234568999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 267 ~~~~~ 271 (280)
T cd05043 267 SQLVQ 271 (280)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=213.19 Aligned_cols=156 Identities=27% Similarity=0.434 Sum_probs=121.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc---cccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK---KKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........ .....++..|+|||.+.
T Consensus 104 l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 104 LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence 578899999999999999999999999999999999999999999999998765432111 12234566799999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH--------------HHHHHHhCCCCCCCCCCCcCHHHHHHH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR--------------ALFQIVRNPPPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~--------------~~~~~~~~~~~~~~~~~~~s~~~~~li 143 (488)
. ..++.++||||||+++|+|++|..||....... ......... .....+..++..+.+++
T Consensus 184 ~-----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 257 (283)
T cd05080 184 E-----NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG-MRLPCPKNCPQEVYILM 257 (283)
T ss_pred c-----cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC-CCCCCCCCCCHHHHHHH
Confidence 5 567889999999999999999999986533210 000111110 11122456789999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy9090 144 AECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~ 162 (488)
.+||..+|++|||++++++
T Consensus 258 ~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 258 KNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHhccChhhCCCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=210.77 Aligned_cols=151 Identities=18% Similarity=0.448 Sum_probs=119.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc-------EEEEecCCccccccccCccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE-------VKIVDFGLSRETANTFDKKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-------vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 73 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++..... .....++..|+||
T Consensus 102 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aP 177 (262)
T cd05077 102 LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS----RQECVERIPWIAP 177 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC----cccccccccccCh
Confidence 467889999999999999999999999999999999987664 89999998865432 2234578899999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHh-cCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELG-DGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
|.+... ..++.++|||||||++|+|+ +|..||........ ........ ......++++.+||.+||..||.
T Consensus 178 E~~~~~----~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~ 249 (262)
T cd05077 178 ECVEDS----KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQC---MLVTPSCKELADLMTHCMNYDPN 249 (262)
T ss_pred hhhcCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcCc---cCCCCChHHHHHHHHHHcCCChh
Confidence 988632 55788999999999999997 68889876553322 22222211 12233467899999999999999
Q ss_pred CCCCHHHHhcC
Q psy9090 153 HRPYMSELLEH 163 (488)
Q Consensus 153 ~Rps~~ell~h 163 (488)
+||++.+|+++
T Consensus 250 ~Rp~~~~il~~ 260 (262)
T cd05077 250 QRPFFRAIMRD 260 (262)
T ss_pred hCcCHHHHHHh
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=207.92 Aligned_cols=155 Identities=26% Similarity=0.444 Sum_probs=124.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc--ccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK--KTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.|++.+|.|||++|++||||||+||+++.++.++|+|||++.......... ....++..|+|||.+.+
T Consensus 90 ~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 169 (251)
T cd05041 90 LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169 (251)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc
Confidence 3677889999999999999999999999999999999999999999999987544211111 12233567999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+||||+++|+|++ |..||...........+.... ....+...+..+.+++.+||..+|.+|||+
T Consensus 170 -----~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 242 (251)
T cd05041 170 -----GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--RMPAPQLCPEEIYRLMLQCWAYDPENRPSF 242 (251)
T ss_pred -----CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHhccChhhCcCH
Confidence 567889999999999999998 899998776555444443322 222345678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 243 ~ell~ 247 (251)
T cd05041 243 SEIYN 247 (251)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=208.18 Aligned_cols=152 Identities=25% Similarity=0.469 Sum_probs=125.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.++..... .....++..|+|||.+..
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~ape~~~~-- 173 (256)
T cd05039 99 ITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKLPVKWTAPEALRE-- 173 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc---cccCCCcccccCchhhcC--
Confidence 467899999999999999999999999999999999999999999999998765322 112334567999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|+||||+++|++++ |..||...........+.....+ ..+..+++.+.++|.+||..+|++|||+.+
T Consensus 174 ---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 248 (256)
T cd05039 174 ---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM--EAPEGCPPEVYKVMKDCWELDPAKRPTFKQ 248 (256)
T ss_pred ---CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCccCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 567889999999999999997 99999877665554444433222 234567899999999999999999999999
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
+++
T Consensus 249 l~~ 251 (256)
T cd05039 249 LRE 251 (256)
T ss_pred HHH
Confidence 976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=209.17 Aligned_cols=155 Identities=28% Similarity=0.493 Sum_probs=127.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 100 ~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~- 178 (261)
T cd05034 100 LRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY- 178 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhcc-
Confidence 4678889999999999999999999999999999999999999999999987654221 11122234568999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||+|+++|++++ |+.||.+.........+....... .+...+..+.+++.+||..+|++||+++
T Consensus 179 ----~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 252 (261)
T cd05034 179 ----GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP--RPPNCPEELYDLMLQCWDKDPEERPTFE 252 (261)
T ss_pred ----CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 567889999999999999998 999998877666666665543222 2345688999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 253 ~l~~ 256 (261)
T cd05034 253 YLQS 256 (261)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=213.36 Aligned_cols=157 Identities=24% Similarity=0.401 Sum_probs=122.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||+++....... ......+++.|++||+..+
T Consensus 127 ~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL 206 (296)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc
Confidence 35678999999999999999999999999999999999999999999999875533211 1122334678999998765
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc--CCCCCCCCChHHHHHHHHh-----CCCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD--GKPPFEDMHPTRALFQIVR-----NPPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt--g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
..++.++|+|||||++|+|++ |..||.............. ......+.+..+++.+.+|+.+||..||
T Consensus 207 -----~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 281 (296)
T cd05095 207 -----GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNA 281 (296)
T ss_pred -----CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence 568899999999999999998 7889976655443332211 1111122345578999999999999999
Q ss_pred CCCCCHHHHhc
Q psy9090 152 EHRPYMSELLE 162 (488)
Q Consensus 152 ~~Rps~~ell~ 162 (488)
.+||++.++++
T Consensus 282 ~~Rp~~~~i~~ 292 (296)
T cd05095 282 KERPSFQEIHA 292 (296)
T ss_pred ccCCCHHHHHH
Confidence 99999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=208.29 Aligned_cols=152 Identities=24% Similarity=0.464 Sum_probs=124.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ......+..|+|||.+.+
T Consensus 97 ~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~-- 171 (254)
T cd05083 97 VSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKH-- 171 (254)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---CCCCCCCceecCHHHhcc--
Confidence 367788999999999999999999999999999999999999999999998754322 122234568999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|+||||+++|+|++ |++||...........+.....+. .+..++..+.+++.+||..+|.+||++++
T Consensus 172 ---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 246 (254)
T cd05083 172 ---KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME--PPEGCPADVYVLMTSCWETEPKKRPSFHK 246 (254)
T ss_pred ---CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC--CCCcCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 567889999999999999997 999998877655555444432222 24567899999999999999999999999
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
++.
T Consensus 247 l~~ 249 (254)
T cd05083 247 LRE 249 (254)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=214.15 Aligned_cols=156 Identities=26% Similarity=0.428 Sum_probs=124.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
++++.+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....... ......++..|+|||.+.+
T Consensus 106 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (303)
T cd05110 106 IGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185 (303)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc
Confidence 46778899999999999999999999999999999999999999999999976543211 1122345678999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||||+++|+|++ |..||.+...... ..++.... ..+.+..++..+.+++.+||..+|++||++
T Consensus 186 -----~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~ 258 (303)
T cd05110 186 -----RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGE-RLPQPPICTIDVYMVMVKCWMIDADSRPKF 258 (303)
T ss_pred -----CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 568899999999999999987 9999987654433 33333221 122345568899999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++..
T Consensus 259 ~~l~~~ 264 (303)
T cd05110 259 KELAAE 264 (303)
T ss_pred HHHHHH
Confidence 998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=212.02 Aligned_cols=155 Identities=27% Similarity=0.447 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.++..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+
T Consensus 127 l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (288)
T cd05050 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY 206 (288)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence 4577889999999999999999999999999999999999999999999987543221 11122234667999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+|||||++|+|++ |..||.+....+....+...... ..+...+..+.+||.+||..+|++|||+
T Consensus 207 -----~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 279 (288)
T cd05050 207 -----NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSF 279 (288)
T ss_pred -----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 568899999999999999997 88999877766655554433322 2345678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 280 ~el~~ 284 (288)
T cd05050 280 ASINR 284 (288)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=210.25 Aligned_cols=156 Identities=23% Similarity=0.444 Sum_probs=125.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....... ......+++.|++||.+..
T Consensus 110 l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05074 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD 189 (273)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc
Confidence 46778899999999999999999999999999999999999999999999876532211 1223345678999999865
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+|||||++|+|++ |.+||.+.........+...... ..+...++.+.+++.+||..+|++|||+
T Consensus 190 -----~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~ 262 (273)
T cd05074 190 -----NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSF 262 (273)
T ss_pred -----CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 567889999999999999999 89999877655444444433222 2234578999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++.+
T Consensus 263 ~~~~~~ 268 (273)
T cd05074 263 QHLRDQ 268 (273)
T ss_pred HHHHHH
Confidence 998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=208.94 Aligned_cols=155 Identities=27% Similarity=0.518 Sum_probs=124.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-----cEEEEecCCcccccccc--CccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-----EVKIVDFGLSRETANTF--DKKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-----~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aP 73 (488)
+++..+..++.||+.||+|||+++++|+||||+||+++.++ .++|+|||++....... .......++..|+||
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 182 (269)
T cd05044 103 LTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182 (269)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCH
Confidence 35678889999999999999999999999999999999887 89999999987543221 112233456789999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
|.+.+ ..++.++|+|||||++|+|++ |..||...........+...... ..+...+..+.++|.+||..+|.
T Consensus 183 E~~~~-----~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~ 255 (269)
T cd05044 183 ESLLD-----GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL--QKPENCPDKIYQLMTNCWAQDPS 255 (269)
T ss_pred HHHcc-----CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc--CCcccchHHHHHHHHHHcCCCcc
Confidence 99976 567889999999999999998 99999877665544444332222 23456789999999999999999
Q ss_pred CCCCHHHHhc
Q psy9090 153 HRPYMSELLE 162 (488)
Q Consensus 153 ~Rps~~ell~ 162 (488)
+||+++++++
T Consensus 256 ~Rp~~~~i~~ 265 (269)
T cd05044 256 ERPTFDRIQE 265 (269)
T ss_pred cCCCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=212.73 Aligned_cols=155 Identities=30% Similarity=0.549 Sum_probs=124.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..|+.||+.||.|||+++++|++|+|+||+++.++.+||+|||++...... ............|+|||.+..
T Consensus 100 ~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 179 (259)
T PF07714_consen 100 LSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD 179 (259)
T ss_dssp SBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 467889999999999999999999999999999999999999999999998765221 111223346678999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||||+++||+++ |..||...........+.....+. .+..++..+.++|..||..+|++|||+
T Consensus 180 -----~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~C~~~~p~~RPs~ 252 (259)
T PF07714_consen 180 -----GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP--IPDNCPKDIYSLIQQCWSHDPEKRPSF 252 (259)
T ss_dssp -----SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT--SBTTSBHHHHHHHHHHT-SSGGGS--H
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccce--eccchhHHHHHHHHHHcCCChhhCcCH
Confidence 457899999999999999999 789998887777666665443322 355689999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 253 ~~i~~ 257 (259)
T PF07714_consen 253 QEILQ 257 (259)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 99875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=236.63 Aligned_cols=154 Identities=22% Similarity=0.315 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc------------------cCccccc
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT------------------FDKKKTF 64 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~------------------~~~~~~~ 64 (488)
...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++..... .......
T Consensus 112 v~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~ 191 (932)
T PRK13184 112 VGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI 191 (932)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCC
Confidence 4567889999999999999999999999999999999999999999998765110 0111235
Q ss_pred cCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHH
Q psy9090 65 LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIA 144 (488)
Q Consensus 65 ~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 144 (488)
+||+.|+|||++.+ ..++.++||||+||++|+|++|..||................+........+++.+.+++.
T Consensus 192 vGT~~YmAPE~l~g-----~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~ 266 (932)
T PRK13184 192 VGTPDYMAPERLLG-----VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAM 266 (932)
T ss_pred CCCCCCCCHHHhcC-----CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHH
Confidence 79999999999876 5688999999999999999999999987554433332221111122223467899999999
Q ss_pred HhcccCCCCCCCHHHHh
Q psy9090 145 ECLEKNPEHRPYMSELL 161 (488)
Q Consensus 145 ~~L~~dP~~Rps~~ell 161 (488)
+||..||++|++..+.+
T Consensus 267 rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 267 KALAVDPAERYSSVQEL 283 (932)
T ss_pred HHccCChhhCcCHHHHH
Confidence 99999999998754433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=203.67 Aligned_cols=160 Identities=39% Similarity=0.712 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+...... .......++..|++||.+..
T Consensus 84 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pE~~~~-- 160 (244)
T smart00220 84 LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG-GLLTTFVGTPEYMAPEVLLG-- 160 (244)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc-cccccccCCcCCCCHHHHcc--
Confidence 467889999999999999999999999999999999999999999999998766543 23345568889999999874
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCC-cCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASN-WSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|+||+|++++++++|..||..........+.............. ++..+.+++.+||..+|++||++.+
T Consensus 161 ---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 161 ---KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHH
Confidence 567889999999999999999999998744344444444433332222222 7899999999999999999999999
Q ss_pred HhcCcCC
Q psy9090 160 LLEHPFI 166 (488)
Q Consensus 160 ll~hp~f 166 (488)
+++||||
T Consensus 238 ~~~~~~~ 244 (244)
T smart00220 238 ALQHPFF 244 (244)
T ss_pred HhhCCCC
Confidence 9999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=208.70 Aligned_cols=156 Identities=24% Similarity=0.409 Sum_probs=126.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc-cccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK-KKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||+++........ .....+++.|+|||.+..
T Consensus 104 ~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 182 (270)
T cd05056 104 LDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF- 182 (270)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-
Confidence 467889999999999999999999999999999999999999999999998755332111 112234567999998865
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||||+++|++++ |..||...........+...... ..+...+..+.++|.+||..+|.+|||+.
T Consensus 183 ----~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 256 (270)
T cd05056 183 ----RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPTLYSLMTKCWAYDPSKRPRFT 256 (270)
T ss_pred ----CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 567889999999999999885 99999887766655555444332 23456789999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++..
T Consensus 257 ~~~~~ 261 (270)
T cd05056 257 ELKAQ 261 (270)
T ss_pred HHHHH
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=208.06 Aligned_cols=155 Identities=25% Similarity=0.448 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccc---cccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK---TFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~---~~~gt~~y~aPE~l~ 77 (488)
+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........... ....++.|+|||++.
T Consensus 104 ~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 183 (268)
T cd05063 104 FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhh
Confidence 46788999999999999999999999999999999999999999999999875543211111 112345799999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|+||+||++|+|++ |..||...........+.... ..+.+...+..+.+++.+||..+|++||+
T Consensus 184 ~-----~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp~ 256 (268)
T cd05063 184 Y-----RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF--RLPAPMDCPSAVYQLMLQCWQQDRARRPR 256 (268)
T ss_pred c-----CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 5 567889999999999999987 999998777665555554332 22234457899999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 257 ~~~i~~ 262 (268)
T cd05063 257 FVDIVN 262 (268)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=216.32 Aligned_cols=155 Identities=28% Similarity=0.466 Sum_probs=125.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~~ 79 (488)
+...+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....... ......++..|+|||++.+
T Consensus 132 ~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 210 (334)
T cd05100 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD- 210 (334)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-
Confidence 4567788999999999999999999999999999999999999999999875533211 1122234567999999876
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||||+++|+|++ |..||.+.........+.....+. .+...+..+.+++.+||..+|.+|||+.
T Consensus 211 ----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~ 284 (334)
T cd05100 211 ----RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMD--KPANCTHELYMIMRECWHAVPSQRPTFK 284 (334)
T ss_pred ----CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcccChhhCcCHH
Confidence 568889999999999999998 899998877655554444332222 3456788999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++++
T Consensus 285 ell~~ 289 (334)
T cd05100 285 QLVED 289 (334)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=195.30 Aligned_cols=165 Identities=20% Similarity=0.402 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|+.-+++.++.|++.||.|||++||+|||+||.|++|+... .++|+|+|++....+. ......+.+..|--||.+..-
T Consensus 129 l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-~eYnVRVASRyfKGPELLVdy 207 (338)
T KOG0668|consen 129 LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDY 207 (338)
T ss_pred hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC-ceeeeeeehhhcCCchheeec
Confidence 45678999999999999999999999999999999999654 5999999999876554 344455677888999999763
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCC-CCChHHHHHHHHh----------------CCCC---------------
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFE-DMHPTRALFQIVR----------------NPPP--------------- 127 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~-~~~~~~~~~~~~~----------------~~~~--------------- 127 (488)
..|+.+-|+|||||++..|+..+.||. +.+...++.++.+ ...|
T Consensus 208 ----~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~ 283 (338)
T KOG0668|consen 208 ----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWS 283 (338)
T ss_pred ----hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHH
Confidence 668899999999999999999999984 4333444433321 0000
Q ss_pred CCCC---CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 128 GLYR---ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 128 ~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
.+.. ..-.++++.+|+.++|..|..+|+|+++++.||||..+.
T Consensus 284 ~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 284 RFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 0000 112368999999999999999999999999999998654
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=221.08 Aligned_cols=156 Identities=28% Similarity=0.508 Sum_probs=125.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 234 l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 313 (400)
T cd05105 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD 313 (400)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence 46788899999999999999999999999999999999999999999999875432211 1223456788999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||............+..... ...+..++..+.+++.+||..+|++||++
T Consensus 314 -----~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 387 (400)
T cd05105 314 -----NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR-MAKPDHATQEVYDIMVKCWNSEPEKRPSF 387 (400)
T ss_pred -----CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHCccCHhHCcCH
Confidence 568899999999999999996 99999876544444444333221 22345678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++.+
T Consensus 388 ~~l~~ 392 (400)
T cd05105 388 LHLSD 392 (400)
T ss_pred HHHHH
Confidence 88865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=230.00 Aligned_cols=158 Identities=28% Similarity=0.453 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc---CC--cEEEEecCCcccccccc---CccccccCCCccccchhh
Q psy9090 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---DG--EVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 5 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~--~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l 76 (488)
..+.++.|+++||++||+.+||||||||.||||.. ++ .++|+|||+++++.... ....+..||-+|+|||++
T Consensus 607 ~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L 686 (903)
T KOG1027|consen 607 DPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQL 686 (903)
T ss_pred cHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHH
Confidence 34778999999999999999999999999999986 34 58999999999876442 234566899999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDG-KPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.. ..-+.++||+|+||++|+.++| .+||.+... .-.+|+.+...-....+.-..++.+||.+||.++|..||
T Consensus 687 ~~-----~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RP 759 (903)
T KOG1027|consen 687 RE-----DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRP 759 (903)
T ss_pred hc-----cccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCC
Confidence 86 3335589999999999998885 999987542 333444433221111111122899999999999999999
Q ss_pred CHHHHhcCcCCCCC
Q psy9090 156 YMSELLEHPFITSL 169 (488)
Q Consensus 156 s~~ell~hp~f~~~ 169 (488)
++.++|.||+|+..
T Consensus 760 sa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 760 SATDVLNHPLFWDS 773 (903)
T ss_pred CHHHHhCCCccCCh
Confidence 99999999999864
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=206.22 Aligned_cols=156 Identities=28% Similarity=0.496 Sum_probs=125.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
++++.++.++.|++.+|+|||++|++||||||+||+++.++.++|+|||++........ ......++..|+|||.+.+
T Consensus 97 ~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~- 175 (256)
T cd05112 97 FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF- 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-
Confidence 46788999999999999999999999999999999999999999999999875432211 1112234568999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||+|+++|+|++ |..||...........+...... ..+...+..+.+|+.+||..+|++|||+.
T Consensus 176 ----~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 249 (256)
T cd05112 176 ----SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL--YKPRLASQSVYELMQHCWKERPEDRPSFS 249 (256)
T ss_pred ----CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHcccChhhCCCHH
Confidence 567889999999999999998 99999877665555554433222 22445689999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++++
T Consensus 250 ~~l~~ 254 (256)
T cd05112 250 LLLHQ 254 (256)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=206.90 Aligned_cols=151 Identities=20% Similarity=0.416 Sum_probs=118.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc--------EEEEecCCccccccccCccccccCCCcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE--------VKIVDFGLSRETANTFDKKKTFLGSPSWMA 72 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--------vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~a 72 (488)
+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..... .....+++.|+|
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~a 172 (258)
T cd05078 97 INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVP 172 (258)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC----chhccccCCccC
Confidence 467888999999999999999999999999999999987664 69999998765432 234567889999
Q ss_pred chhhcccccCCCCCCCccchhhhHHHHHHHhcC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 73 PEIMRCGHKEVDGYDNRIDVWALGITAIELGDG-KPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 73 PE~l~~~~~~~~~~~~~~DiwslGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
||++.+. ..++.++|+||+|+++|+|++| .+||........ ....... . ..+...+.++.++|.+||+.+|
T Consensus 173 PE~~~~~----~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p 244 (258)
T cd05078 173 PECIENP----QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDR-H--QLPAPKWTELANLINQCMDYEP 244 (258)
T ss_pred chhccCC----CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHcc-c--cCCCCCcHHHHHHHHHHhccCh
Confidence 9998752 3478899999999999999998 466665544332 2222221 1 1233456889999999999999
Q ss_pred CCCCCHHHHhcC
Q psy9090 152 EHRPYMSELLEH 163 (488)
Q Consensus 152 ~~Rps~~ell~h 163 (488)
++|||++++++.
T Consensus 245 ~~Rps~~~il~~ 256 (258)
T cd05078 245 DFRPSFRAIIRD 256 (258)
T ss_pred hhCCCHHHHHHh
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=215.92 Aligned_cols=157 Identities=28% Similarity=0.500 Sum_probs=123.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......+++.|+|||.+.+
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 255 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 255 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC
Confidence 35677889999999999999999999999999999999999999999999876432211 1122345678999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+||||+++|+|++ |..||............+..... ...+...++.+.+++..||..+|++|||+
T Consensus 256 -----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rps~ 329 (343)
T cd05103 256 -----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTF 329 (343)
T ss_pred -----CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 568899999999999999996 99999775543333333322211 12234567899999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.++++|
T Consensus 330 ~eil~~ 335 (343)
T cd05103 330 SELVEH 335 (343)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=210.69 Aligned_cols=156 Identities=22% Similarity=0.367 Sum_probs=121.9
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~~ 79 (488)
++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... .......+++.|+|||.+..
T Consensus 127 ~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 205 (295)
T cd05097 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL- 205 (295)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-
Confidence 567788999999999999999999999999999999999999999999987543221 11122345678999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc--CCCCCCCCChHHHHHHHHh---C--CCCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD--GKPPFEDMHPTRALFQIVR---N--PPPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt--g~~Pf~~~~~~~~~~~~~~---~--~~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
..++.++|+|||||++|+|++ |..||........+..+.. . .......+...++.+.+|+.+||..+|+
T Consensus 206 ----~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 281 (295)
T cd05097 206 ----GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIK 281 (295)
T ss_pred ----CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCch
Confidence 568899999999999999987 7788877665544433321 1 1111122445689999999999999999
Q ss_pred CCCCHHHHhc
Q psy9090 153 HRPYMSELLE 162 (488)
Q Consensus 153 ~Rps~~ell~ 162 (488)
+|||++++++
T Consensus 282 ~RPs~~~i~~ 291 (295)
T cd05097 282 DRPTFNKIHH 291 (295)
T ss_pred hCcCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=205.77 Aligned_cols=154 Identities=26% Similarity=0.482 Sum_probs=124.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhcccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+....... .......++..|+|||++..
T Consensus 100 ~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-- 177 (260)
T cd05073 100 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-- 177 (260)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc--
Confidence 567788999999999999999999999999999999999999999999987553221 11122345567999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|+|||||++|++++ |..||...........+...... ..+...+.++.+++.+||..+|++||++.+
T Consensus 178 ---~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 252 (260)
T cd05073 178 ---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM--PRPENCPEELYNIMMRCWKNRPEERPTFEY 252 (260)
T ss_pred ---CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--CCcccCCHHHHHHHHHHcccCcccCcCHHH
Confidence 567889999999999999998 99999887765555544443222 234567899999999999999999999998
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
++.
T Consensus 253 l~~ 255 (260)
T cd05073 253 IQS 255 (260)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=206.42 Aligned_cols=160 Identities=30% Similarity=0.451 Sum_probs=120.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~~ 79 (488)
++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........ ......+++.|+|||++...
T Consensus 98 ~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05087 98 DPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177 (269)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccc
Confidence 3556788999999999999999999999999999999999999999999864332211 11234567889999998642
Q ss_pred ccC--CCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCC---CCCcCHHHHHHHHHhcccCCCC
Q psy9090 80 HKE--VDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYR---ASNWSQHYVDFIAECLEKNPEH 153 (488)
Q Consensus 80 ~~~--~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~ 153 (488)
... ...++.++|+||+|+++|+|++ |..||...................... ....++.+.+++.+|+ .+|++
T Consensus 178 ~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~ 256 (269)
T cd05087 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQ 256 (269)
T ss_pred cccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCccc
Confidence 111 1246789999999999999996 999998776555444333322221111 2245788999999998 68999
Q ss_pred CCCHHHHhc
Q psy9090 154 RPYMSELLE 162 (488)
Q Consensus 154 Rps~~ell~ 162 (488)
|||+++|+.
T Consensus 257 Rpt~~~l~~ 265 (269)
T cd05087 257 RPSAEEVHL 265 (269)
T ss_pred CCCHHHHHH
Confidence 999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=207.02 Aligned_cols=155 Identities=24% Similarity=0.436 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc---ccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK---KTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~l~ 77 (488)
+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......... ....++..|+|||.+.
T Consensus 103 ~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~ 182 (267)
T cd05066 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhc
Confidence 4678899999999999999999999999999999999999999999999987654321111 1122356799999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|+||||+++|++++ |..||...........+..... .+.+...++.+.+++.+||..+|.+||+
T Consensus 183 ~-----~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 255 (267)
T cd05066 183 Y-----RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR--LPAPMDCPAALHQLMLDCWQKDRNERPK 255 (267)
T ss_pred c-----CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc--CCCCCCCCHHHHHHHHHHcccCchhCCC
Confidence 5 568889999999999999886 9999988776555555544322 2234567899999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 256 ~~~i~~ 261 (267)
T cd05066 256 FEQIVS 261 (267)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=207.56 Aligned_cols=155 Identities=27% Similarity=0.409 Sum_probs=125.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc--ccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK--KTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++......... ....++..|+|||.+..
T Consensus 106 ~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05057 106 IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc
Confidence 4688999999999999999999999999999999999999999999999987654321111 11223567999998865
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+||+|+++|++++ |..||.+.........+.... ....+...+..+.+++.+||..+|..||++
T Consensus 186 -----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~ 258 (279)
T cd05057 186 -----RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE--RLPQPPICTIDVYMVLVKCWMIDAESRPTF 258 (279)
T ss_pred -----CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC--CCCCCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence 567889999999999999998 999998877655444444332 222345578899999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 259 ~~l~~ 263 (279)
T cd05057 259 KELIN 263 (279)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=206.07 Aligned_cols=160 Identities=23% Similarity=0.412 Sum_probs=122.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
++..++.++.||+.||+|||+++++||||||+|||++.++.++|+|||++...... ........+++.|+|||++...
T Consensus 97 ~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 176 (268)
T cd05086 97 QLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176 (268)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccc
Confidence 34567889999999999999999999999999999999999999999987542211 1122345678899999998542
Q ss_pred cc--CCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCC---CCCCcCHHHHHHHHHhcccCCCC
Q psy9090 80 HK--EVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLY---RASNWSQHYVDFIAECLEKNPEH 153 (488)
Q Consensus 80 ~~--~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~ 153 (488)
.. ....++.++|||||||++|+|++ |..||...........+......... .+..+++.+.+++..|| .+|.+
T Consensus 177 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~ 255 (268)
T cd05086 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEK 255 (268)
T ss_pred cCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCccc
Confidence 11 11346789999999999999986 67788777766655555544322211 23357889999999999 67999
Q ss_pred CCCHHHHhc
Q psy9090 154 RPYMSELLE 162 (488)
Q Consensus 154 Rps~~ell~ 162 (488)
||+++++++
T Consensus 256 Rp~~~~i~~ 264 (268)
T cd05086 256 RATAEEVHR 264 (268)
T ss_pred CCCHHHHHH
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=207.48 Aligned_cols=156 Identities=28% Similarity=0.523 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+
T Consensus 110 ~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~- 187 (269)
T cd08528 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKN- 187 (269)
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcC-
Confidence 4678899999999999999996 789999999999999999999999999987654432 3345568899999999975
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|+||||+++|+|++|.+||...........+......+. ....+++.+.++|.+||..||++||++.+
T Consensus 188 ----~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rp~~~e 262 (269)
T cd08528 188 ----EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-PEGMYSEDVTDVITSCLTPDAEARPDIIQ 262 (269)
T ss_pred ----CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC-CcccCCHHHHHHHHHHCCCCCccCCCHHH
Confidence 5578899999999999999999999987765554444444332221 12356899999999999999999999999
Q ss_pred HhcC
Q psy9090 160 LLEH 163 (488)
Q Consensus 160 ll~h 163 (488)
+..+
T Consensus 263 ~~~~ 266 (269)
T cd08528 263 VSAM 266 (269)
T ss_pred HHHH
Confidence 8754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=205.50 Aligned_cols=151 Identities=20% Similarity=0.419 Sum_probs=118.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-------cEEEEecCCccccccccCccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-------EVKIVDFGLSRETANTFDKKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-------~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 73 (488)
+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..... .....++..|+||
T Consensus 98 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aP 173 (259)
T cd05037 98 VSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAP 173 (259)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccCh
Confidence 46788999999999999999999999999999999999888 799999999876433 2234567789999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
|++.... ..++.++|+||+|+++|+|++ |..||................ . .+...+..+.++|.+||..+|.
T Consensus 174 E~~~~~~---~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~li~~~l~~~p~ 246 (259)
T cd05037 174 ECIRNGQ---ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH--R--LPMPDCAELANLINQCWTYDPT 246 (259)
T ss_pred hhhcCCC---CCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC--C--CCCCCchHHHHHHHHHhccChh
Confidence 9987521 367889999999999999999 688887664332222221111 1 1222348899999999999999
Q ss_pred CCCCHHHHhc
Q psy9090 153 HRPYMSELLE 162 (488)
Q Consensus 153 ~Rps~~ell~ 162 (488)
+|||+.++++
T Consensus 247 ~Rpt~~~il~ 256 (259)
T cd05037 247 KRPSFRAILR 256 (259)
T ss_pred hCCCHHHHHH
Confidence 9999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=200.26 Aligned_cols=165 Identities=25% Similarity=0.466 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc-cccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK-KKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~l~~~ 79 (488)
|+...++.+++||+.||+|||+.||.||||||.|.|+++|..+||||||+++........ ...-+-|-+|+|||++.+.
T Consensus 153 Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGa 232 (449)
T KOG0664|consen 153 LTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGA 232 (449)
T ss_pred CCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcc
Confidence 466788999999999999999999999999999999999999999999999876543222 2333567899999999984
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh-----------------------CC--CCCCCC---
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR-----------------------NP--PPGLYR--- 131 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~-----------------------~~--~~~~~~--- 131 (488)
..|+..+||||+|||+.|++..+..|....+.+.+.-+.. .. .|....
T Consensus 233 ----RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYt 308 (449)
T KOG0664|consen 233 ----RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYK 308 (449)
T ss_pred ----hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceee
Confidence 6799999999999999999999999988777666554431 11 111111
Q ss_pred ---CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 132 ---ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 132 ---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
+.....+...++.++|..+|.+|.+..+++.|++....
T Consensus 309 lsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 309 IASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred ecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11223567889999999999999999999999998653
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=208.55 Aligned_cols=157 Identities=25% Similarity=0.396 Sum_probs=120.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++.++..++.||+.||+|||++|++||||||+||+++.++.++|+|||+++....... ......++..|+|||++.
T Consensus 106 ~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 185 (284)
T cd05079 106 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence 46788999999999999999999999999999999999999999999999876543211 122345677899999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh--------------HHHHHHHHhCCCCCCCCCCCcCHHHHHHH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP--------------TRALFQIVRNPPPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~--------------~~~~~~~~~~~~~~~~~~~~~s~~~~~li 143 (488)
+ ..++.++|+|||||++|+|+++..|+..... ........... .....+..++..+.+|+
T Consensus 186 ~-----~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 259 (284)
T cd05079 186 Q-----SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG-KRLPRPPNCPEEVYQLM 259 (284)
T ss_pred c-----CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC-ccCCCCCCCCHHHHHHH
Confidence 5 5678899999999999999998776532110 01111111111 11123456789999999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q psy9090 144 AECLEKNPEHRPYMSELLEH 163 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~h 163 (488)
.+||..+|++|||+++++++
T Consensus 260 ~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 260 RKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHccCCcccCcCHHHHHHH
Confidence 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=231.95 Aligned_cols=107 Identities=28% Similarity=0.482 Sum_probs=87.8
Q ss_pred cCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHH
Q psy9090 65 LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIA 144 (488)
Q Consensus 65 ~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 144 (488)
+||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.........++....+.......++..+.+++.
T Consensus 541 vGT~~Y~APE~l~~-----~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~ 615 (669)
T cd05610 541 LGTPDYLAPELLLG-----KPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIE 615 (669)
T ss_pred eeCccccCHHHcCC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence 46889999999976 5688999999999999999999999998887777766665432221122356888999999
Q ss_pred HhcccCCCCCCCHHHHhcCcCCCCCCCCcccc
Q psy9090 145 ECLEKNPEHRPYMSELLEHPFITSLPENDLHL 176 (488)
Q Consensus 145 ~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~ 176 (488)
+||..+|.+||++.++++||||..++|.....
T Consensus 616 ~lL~~dP~~R~ta~e~l~h~~~~~~~~~~~~~ 647 (669)
T cd05610 616 ILLTMDPTKRAGLKELKQHPLFHGVDWENLQN 647 (669)
T ss_pred HHcccChhHCcCHHHHHhCHhhcCCCHHHhcc
Confidence 99999999999999999999999887654443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=205.71 Aligned_cols=157 Identities=27% Similarity=0.478 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc-cCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT-FDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||++||+||||||+||+++.++.++++|||++...... ........+++.|+|||.+.+
T Consensus 114 l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~- 192 (275)
T cd05046 114 LSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE- 192 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhcc-
Confidence 468889999999999999999999999999999999999999999999998643221 112233456778999999875
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||||+++|+|++ |..||...........+.... .....+..++..+.+++.+||..+|.+|||+.
T Consensus 193 ----~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~ 267 (275)
T cd05046 193 ----DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFS 267 (275)
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 456789999999999999998 889997766555444443222 22223456789999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++..
T Consensus 268 ~~l~~ 272 (275)
T cd05046 268 ELVSA 272 (275)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=204.64 Aligned_cols=155 Identities=25% Similarity=0.458 Sum_probs=123.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc---ccccc--CCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK---KKTFL--GSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~--gt~~y~aPE~ 75 (488)
+++.+++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++......... ..... .+..|+|||.
T Consensus 103 ~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~ 182 (269)
T cd05065 103 FTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182 (269)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhH
Confidence 467889999999999999999999999999999999999999999999988654322111 11111 1347999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
+.+ ..++.++|+||+||++|++++ |..||...........+.... ..+.+..++..+.+++.+||..+|.+|
T Consensus 183 ~~~-----~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R 255 (269)
T cd05065 183 IAY-----RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--RLPPPMDCPTALHQLMLDCWQKDRNAR 255 (269)
T ss_pred hcc-----CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--cCCCcccCCHHHHHHHHHHcCCChhhC
Confidence 875 567889999999999999886 999998877665555543322 222345678899999999999999999
Q ss_pred CCHHHHhc
Q psy9090 155 PYMSELLE 162 (488)
Q Consensus 155 ps~~ell~ 162 (488)
|++.+++.
T Consensus 256 p~~~~i~~ 263 (269)
T cd05065 256 PKFGQIVS 263 (269)
T ss_pred cCHHHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=215.49 Aligned_cols=157 Identities=27% Similarity=0.484 Sum_probs=126.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++....... ......+++.|+|||.+.+
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 315 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence 46678899999999999999999999999999999999999999999999875432211 1223456788999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|+||+||++|+|++ |..||............+..... ...+..++..+.+++.+||..+|.+||++
T Consensus 316 -----~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~ 389 (401)
T cd05107 316 -----NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR-MAKPAHASDEIYEIMQKCWEEKFEIRPDF 389 (401)
T ss_pred -----CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCH
Confidence 567889999999999999998 89999776555544444433221 12345678999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
+++++.
T Consensus 390 ~ell~~ 395 (401)
T cd05107 390 SQLVHL 395 (401)
T ss_pred HHHHHH
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=204.75 Aligned_cols=151 Identities=21% Similarity=0.460 Sum_probs=118.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-------cEEEEecCCccccccccCccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-------EVKIVDFGLSRETANTFDKKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-------~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 73 (488)
+++..+..++.||+.||+|||++||+||||||+|||++..+ .+|++|||++..... .....+++.|+||
T Consensus 114 ~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aP 189 (274)
T cd05076 114 VPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS----REERVERIPWIAP 189 (274)
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccccc----ccccccCCcccCc
Confidence 46788999999999999999999999999999999997644 389999998754322 1233577889999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHH-hcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~el-ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
|.+.+. ..++.++|+|||||++|++ ++|..||....+.... ....... . .+...++.+.++|.+||..+|+
T Consensus 190 e~~~~~----~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~ 261 (274)
T cd05076 190 ECVPGG----NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-RFYEKKH-R--LPEPSCKELATLISQCLTYEPT 261 (274)
T ss_pred hhhcCC----CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-HHHHhcc-C--CCCCCChHHHHHHHHHcccChh
Confidence 988642 4578899999999999998 5799999876544332 2222111 1 2234567899999999999999
Q ss_pred CCCCHHHHhcC
Q psy9090 153 HRPYMSELLEH 163 (488)
Q Consensus 153 ~Rps~~ell~h 163 (488)
+|||+.+++++
T Consensus 262 ~Rps~~~il~~ 272 (274)
T cd05076 262 QRPSFRTILRD 272 (274)
T ss_pred hCcCHHHHHHh
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=205.76 Aligned_cols=156 Identities=24% Similarity=0.411 Sum_probs=119.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc---cccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK---KKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......... .....++..|+|||++.
T Consensus 105 l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 184 (284)
T cd05081 105 LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhc
Confidence 467888999999999999999999999999999999999999999999998765332111 11122345699999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH---------------HHHHHHhCCCCCCCCCCCcCHHHHHH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR---------------ALFQIVRNPPPGLYRASNWSQHYVDF 142 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~s~~~~~l 142 (488)
+ ..++.++|+|||||++|+|++|..|+....... .+...+... ...+.+..++..+.+|
T Consensus 185 ~-----~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 258 (284)
T cd05081 185 E-----SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN-GRLPAPPGCPAEIYAI 258 (284)
T ss_pred c-----CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC-CcCCCCCCCCHHHHHH
Confidence 5 567889999999999999999887764332110 011111111 1122345678999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy9090 143 IAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 143 i~~~L~~dP~~Rps~~ell~ 162 (488)
+.+||..+|++|||+.+++.
T Consensus 259 i~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 259 MKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=214.76 Aligned_cols=160 Identities=26% Similarity=0.424 Sum_probs=124.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
.-..++.|+.|++.||..|..+||+|.||||+|||++... .+||||||.|...... ......-+..|.|||++.+
T Consensus 534 ~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG-- 609 (752)
T KOG0670|consen 534 HIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILG-- 609 (752)
T ss_pred eehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccc--cccHHHHHHhccCcceeec--
Confidence 3457889999999999999999999999999999998654 5899999998765442 1222334568999999998
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHH--HhCCCCCC-----------------------------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI--VRNPPPGL----------------------------- 129 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~--~~~~~~~~----------------------------- 129 (488)
.+|+...|+||+||+||||.||+..|++.+....+.-. ++++.|..
T Consensus 610 ---~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r 686 (752)
T KOG0670|consen 610 ---LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTER 686 (752)
T ss_pred ---CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccc
Confidence 78999999999999999999999999988765443221 11111100
Q ss_pred --------CCC-----------CCc-------CHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q psy9090 130 --------YRA-----------SNW-------SQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168 (488)
Q Consensus 130 --------~~~-----------~~~-------s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 168 (488)
..| ..+ -..+++|+.+||..||++|.|+.++|.||||..
T Consensus 687 ~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 687 EKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred eeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 000 011 145789999999999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=214.24 Aligned_cols=167 Identities=19% Similarity=0.324 Sum_probs=120.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhcccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++..++.++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++........ ......+|+.|+|||.+....
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~ 386 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQ 386 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCC
Confidence 4567889999999999999999999999999999999999999999999865433211 111223478999999986421
Q ss_pred cCCC---------------CC--CCccchhhhHHHHHHHhcCCC-CCCCCChHHHH----------HHHHhCCCCCCCCC
Q psy9090 81 KEVD---------------GY--DNRIDVWALGITAIELGDGKP-PFEDMHPTRAL----------FQIVRNPPPGLYRA 132 (488)
Q Consensus 81 ~~~~---------------~~--~~~~DiwslGvil~elltg~~-Pf~~~~~~~~~----------~~~~~~~~~~~~~~ 132 (488)
.... .| ..+.|+||+||++|+|++|.. ||......... .+............
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~ 466 (507)
T PLN03224 387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLL 466 (507)
T ss_pred CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccc
Confidence 1100 12 235799999999999999876 76532211110 11111122223233
Q ss_pred CCcCHHHHHHHHHhcccCC---CCCCCHHHHhcCcCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNP---EHRPYMSELLEHPFITS 168 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP---~~Rps~~ell~hp~f~~ 168 (488)
...++..++|+.+||..+| .+|+|++++|+||||..
T Consensus 467 d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 467 DRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 4568999999999999866 68999999999999953
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=219.20 Aligned_cols=154 Identities=29% Similarity=0.526 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|+..+...|+.||+.|+.||-++.+|||||-..|+||.++-.|||+|||+++..-.. ........-...|||||.+..
T Consensus 600 L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly 679 (774)
T KOG1026|consen 600 LSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY 679 (774)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc
Confidence 567889999999999999999999999999999999999999999999999865332 011111123468999999987
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++||||+||+|||+++ |..||.+....+.+..+..+.. +..|.++|.++.+||..||..+|++||++
T Consensus 680 -----~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF 752 (774)
T KOG1026|consen 680 -----GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL--LSCPENCPTEVYSLMLECWNENPKRRPSF 752 (774)
T ss_pred -----CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc--ccCCCCCCHHHHHHHHHHhhcCcccCCCH
Confidence 789999999999999999987 9999999998888888776654 56788999999999999999999999999
Q ss_pred HHHh
Q psy9090 158 SELL 161 (488)
Q Consensus 158 ~ell 161 (488)
++|-
T Consensus 753 ~eI~ 756 (774)
T KOG1026|consen 753 KEIH 756 (774)
T ss_pred HHHH
Confidence 9974
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=202.19 Aligned_cols=156 Identities=28% Similarity=0.488 Sum_probs=121.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc---cccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK---KKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~l~ 77 (488)
+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......... .....++..|+|||.+.
T Consensus 106 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 185 (284)
T cd05038 106 INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185 (284)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence 467788999999999999999999999999999999999999999999998765422111 11223456799999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH--------------HHHHHHHhCCCCCCCCCCCcCHHHHHHH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT--------------RALFQIVRNPPPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~s~~~~~li 143 (488)
+ ..++.++|+||||+++|+|++|..|+...... ..+...+... .....+..++.++.+++
T Consensus 186 ~-----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 259 (284)
T cd05038 186 T-----SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG-ERLPRPPSCPDEVYDLM 259 (284)
T ss_pred c-----CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC-CcCCCCccCCHHHHHHH
Confidence 5 46788999999999999999999998653221 1112222221 12223445678999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy9090 144 AECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~ 162 (488)
.+||..+|.+|||+.++++
T Consensus 260 ~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 260 KLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHhccChhhCCCHHHHHH
Confidence 9999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=184.15 Aligned_cols=129 Identities=37% Similarity=0.618 Sum_probs=107.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
++|..+-.|+..++.||.|||++ .++|||+||+|||++..|+||+||||.+-.+.+.... +.-.|.-.|+|||.+...
T Consensus 145 ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk-t~daGCkpYmaPEri~~e 223 (282)
T KOG0984|consen 145 IPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK-TMDAGCKPYMAPERINPE 223 (282)
T ss_pred CchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH-HHhcCCCccCChhhcCcc
Confidence 47888899999999999999975 7999999999999999999999999998776543221 223567789999998764
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCC-CChHHHHHHHHhCCCCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFED-MHPTRALFQIVRNPPPGLYR 131 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~ 131 (488)
.. ...|+.++||||||+.+.||.+++.||.. .++.+++.+++..+.|.++.
T Consensus 224 ~n-~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 224 LN-QKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred cC-cccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 33 34799999999999999999999999964 46678888888887776643
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=201.21 Aligned_cols=167 Identities=28% Similarity=0.482 Sum_probs=133.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEc---cCCcEEEEecCCccccccc-------cCccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANT-------FDKKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~---~~~~vkL~Dfg~a~~~~~~-------~~~~~~~~gt~ 68 (488)
|+|++++.|+.||+.||.||.... |||-||||.|||+. ..|.|||+|||+++..... ....+...||-
T Consensus 565 mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTY 644 (775)
T KOG1151|consen 565 MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTY 644 (775)
T ss_pred hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCcee
Confidence 689999999999999999999875 99999999999995 4578999999999876533 23456678999
Q ss_pred ccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHH---HHhCCCCCCCCCCCcCHHHHHHHHH
Q psy9090 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ---IVRNPPPGLYRASNWSQHYVDFIAE 145 (488)
Q Consensus 69 ~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~~~~li~~ 145 (488)
+|+|||++.-+.. ....+.++||||+|||+|.++.|+.||........+.+ |+....-.++..+..++++++||++
T Consensus 645 WYLPPEcFvVgke-PPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRR 723 (775)
T KOG1151|consen 645 WYLPPECFVVGKE-PPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRR 723 (775)
T ss_pred eecCcceeecCCC-CCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHH
Confidence 9999999875422 25678899999999999999999999976543222221 2222222333445679999999999
Q ss_pred hcccCCCCCCCHHHHhcCcCCCC
Q psy9090 146 CLEKNPEHRPYMSELLEHPFITS 168 (488)
Q Consensus 146 ~L~~dP~~Rps~~ell~hp~f~~ 168 (488)
||.+.-+.|..+.++..||||..
T Consensus 724 CLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 724 CLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred HHHhhhhhhhhHHHHccCccccc
Confidence 99999999999999999999963
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=219.30 Aligned_cols=155 Identities=26% Similarity=0.524 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccc-cccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKK-TFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~-~~~gt~~y~aPE~l~~ 78 (488)
|+..+...++.||+.|++||+++++|||||..+|+|++....|||+|||+|+.+....- ... ...-...|||||.+..
T Consensus 799 L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d 878 (1025)
T KOG1095|consen 799 LSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD 878 (1025)
T ss_pred CCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh
Confidence 56788999999999999999999999999999999999999999999999985432111 111 1122358999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++||++| |..||.+....+.+...+.+. .+..|..++..+.++|..||+.+|++||++
T Consensus 879 -----~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F 951 (1025)
T KOG1095|consen 879 -----GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSF 951 (1025)
T ss_pred -----cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccCCCCCCChHHHHHHHHHccCChhhCccH
Confidence 679999999999999999998 999999999888887777766 455678889999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
..|++
T Consensus 952 ~~i~~ 956 (1025)
T KOG1095|consen 952 RTIVE 956 (1025)
T ss_pred HHHHh
Confidence 99987
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-22 Score=202.41 Aligned_cols=156 Identities=29% Similarity=0.475 Sum_probs=128.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++.............-...|+|||.+..
T Consensus 259 v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~-- 336 (474)
T KOG0194|consen 259 LPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT-- 336 (474)
T ss_pred CCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhcc--
Confidence 456788899999999999999999999999999999999999999999998765422111111123468999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..|++++||||+||++||+.+ |..||.+........++.....+.. .+...+..+..++.+|+..+|+.|||+.+
T Consensus 337 ---~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~-~~~~~p~~~~~~~~~c~~~~p~~R~tm~~ 412 (474)
T KOG0194|consen 337 ---GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP-IPSKTPKELAKVMKQCWKKDPEDRPTMST 412 (474)
T ss_pred ---CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC-CCCCCHHHHHHHHHHhccCChhhccCHHH
Confidence 679999999999999999988 8999999998888888855433222 34466888999999999999999999998
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
+.+
T Consensus 413 i~~ 415 (474)
T KOG0194|consen 413 IKK 415 (474)
T ss_pred HHH
Confidence 865
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-22 Score=200.39 Aligned_cols=154 Identities=24% Similarity=0.432 Sum_probs=127.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc-ccccCCCccccchhhcccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK-KTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~ 80 (488)
+-.....++.||..||.|||++++|||||...|||+.+...|||+|||+++......-.. +...-..-|||||.+.-
T Consensus 489 ~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-- 566 (974)
T KOG4257|consen 489 PLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-- 566 (974)
T ss_pred hHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccch--
Confidence 445667899999999999999999999999999999999999999999999876542211 11122357999999865
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|||.|||++||++. |..||.+....+.+-.+-.+... +.|+++++.+..|+.+||.++|.+||.+.+
T Consensus 567 ---RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl--P~P~nCPp~LYslmskcWayeP~kRPrfte 641 (974)
T KOG4257|consen 567 ---RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL--PCPPNCPPALYSLMSKCWAYEPSKRPRFTE 641 (974)
T ss_pred ---hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC--CCCCCCChHHHHHHHHHhccCcccCCcHHH
Confidence 678999999999999999865 99999988877776666655544 457889999999999999999999999887
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
+..
T Consensus 642 i~~ 644 (974)
T KOG4257|consen 642 IKA 644 (974)
T ss_pred HHH
Confidence 643
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=9e-22 Score=200.28 Aligned_cols=167 Identities=45% Similarity=0.922 Sum_probs=146.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.++.+++++.+.||+|||+.|-+|||||-.|||++..|.+|++|||.+..+.....+...++|||.|||||+-.-+
T Consensus 109 lselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaave- 187 (829)
T KOG0576|consen 109 LSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE- 187 (829)
T ss_pred chhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHH-
Confidence 6799999999999999999999999999999999999999999999999998887776778899999999999986432
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN--PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
....|...||+|++|+...|+-.-++|..+..+...++-..+. .+|.+..+..|++.+.+|++.+|..+|++||+++
T Consensus 188 -rkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptae 266 (829)
T KOG0576|consen 188 -RKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAE 266 (829)
T ss_pred -hcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChh
Confidence 2367999999999999999999999998888877766655543 2344555678999999999999999999999999
Q ss_pred HHhcCcCCCCC
Q psy9090 159 ELLEHPFITSL 169 (488)
Q Consensus 159 ell~hp~f~~~ 169 (488)
.+|.|||+...
T Consensus 267 klL~h~fvs~~ 277 (829)
T KOG0576|consen 267 KLLQHPFVSQT 277 (829)
T ss_pred hheeceeeccc
Confidence 99999998753
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=193.85 Aligned_cols=156 Identities=25% Similarity=0.480 Sum_probs=116.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---CeecccCCCCEEEccCCcEEEEecCCccccccccCccccc-cCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH---VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTF-LGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~-~gt~~y~aPE~l 76 (488)
|++.....|+.+++.||+|||... ||||||||+|||+|++...||+|||+++..........+. .||..|+|||++
T Consensus 171 L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~ 250 (361)
T KOG1187|consen 171 LDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYA 250 (361)
T ss_pred CCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhh
Confidence 578889999999999999999854 9999999999999999999999999996543211222222 799999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC---hHHHHH---HHHhC------CCCCCCCCCCcC-----HHH
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH---PTRALF---QIVRN------PPPGLYRASNWS-----QHY 139 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~---~~~~~~---~~~~~------~~~~~~~~~~~s-----~~~ 139 (488)
.. ...+.++||||+|+++.|++||+.|..... ...... ..+.. ..+.+.. ..++ ..+
T Consensus 251 ~~-----g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~-~~~~~~~~~~~~ 324 (361)
T KOG1187|consen 251 ST-----GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE-GEYPDEKEVKKL 324 (361)
T ss_pred cc-----CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC-CCCChHHHHHHH
Confidence 76 568899999999999999999998886432 111111 11111 1111110 2223 224
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy9090 140 VDFIAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 140 ~~li~~~L~~dP~~Rps~~ell~ 162 (488)
..+..+|+..+|..||++.+++.
T Consensus 325 ~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 325 AELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHHHcCcCCCcCcCHHHHHH
Confidence 57888999999999999999754
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-21 Score=197.77 Aligned_cols=150 Identities=27% Similarity=0.584 Sum_probs=116.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc--cCCc--EEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGE--VKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~--~~~~--vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
|+|.++..++..+..||.|||++|||||||||.||++. .+|+ -||+|||.|+..... ....+.+||+.|.+||++
T Consensus 117 LpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~-s~~~S~vGT~~YLhPel~ 195 (732)
T KOG4250|consen 117 LPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN-SLFTSLVGTEEYLHPELY 195 (732)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC-CeeeeecCchhhcChHHH
Confidence 78999999999999999999999999999999999985 3343 699999999998776 577788999999999998
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh----HHHHHHHHhCCCC------------------CCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP----TRALFQIVRNPPP------------------GLYRASN 134 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~----~~~~~~~~~~~~~------------------~~~~~~~ 134 (488)
.. ...|+..+|.||+||++|++.||..||.-... .+....+....+. .++.+..
T Consensus 196 E~----q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~ 271 (732)
T KOG4250|consen 196 ER----QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNH 271 (732)
T ss_pred hh----ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCccc
Confidence 63 26789999999999999999999999943322 2234444332211 1112222
Q ss_pred cCH----HHHHHHHHhcccCCCCCC
Q psy9090 135 WSQ----HYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 135 ~s~----~~~~li~~~L~~dP~~Rp 155 (488)
.++ .+-.++..+|..+|.+|.
T Consensus 272 Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 272 LSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 332 345788889999999998
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=193.00 Aligned_cols=155 Identities=28% Similarity=0.437 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccc---cccCCCccccchhhccc
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK---TFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~---~~~gt~~y~aPE~l~~~ 79 (488)
-...+.|+.||+.|+.||..+++|||||...|+|+-....|||+|||+.+.+........ ...-...|+|||.++.
T Consensus 211 v~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh- 289 (1039)
T KOG0199|consen 211 VSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH- 289 (1039)
T ss_pred HHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-
Confidence 356789999999999999999999999999999999999999999999987765422221 1112347999999986
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+|++||++|||++ |..||.+.....++.++-. ...+..+..+++.+.++++.||..+|++|||+.
T Consensus 290 ----~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~--~erLpRPk~csedIY~imk~cWah~paDRptFs 363 (1039)
T KOG0199|consen 290 ----RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA--GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFS 363 (1039)
T ss_pred ----ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc--cccCCCCCCChHHHHHHHHHhccCCccccccHH
Confidence 679999999999999999987 8999999998777766653 345566788999999999999999999999999
Q ss_pred HHhcCc
Q psy9090 159 ELLEHP 164 (488)
Q Consensus 159 ell~hp 164 (488)
.|.+.-
T Consensus 364 air~~~ 369 (1039)
T KOG0199|consen 364 AIREDL 369 (1039)
T ss_pred HHHHhH
Confidence 886543
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=200.75 Aligned_cols=155 Identities=30% Similarity=0.514 Sum_probs=124.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc-ccccC--CCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK-KTFLG--SPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~g--t~~y~aPE~l~ 77 (488)
|+..+...+..||+.|++||++..+|||||-..|||+..+..+|++|||+++......... ....+ ...|||||.+.
T Consensus 415 L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~ 494 (609)
T KOG0200|consen 415 LTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF 494 (609)
T ss_pred cCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc
Confidence 4678899999999999999999999999999999999999999999999998543321111 11122 23599999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMH-PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
. ..|+.++||||+|++|||+.+ |..||.+.. .......+..+... ..|...++++.++|+.||..+|++||
T Consensus 495 ~-----~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~--~~P~~c~~eiY~iM~~CW~~~p~~RP 567 (609)
T KOG0200|consen 495 D-----RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRM--EQPEHCSDEIYDLMKSCWNADPEDRP 567 (609)
T ss_pred c-----CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhCCCcccCC
Confidence 6 679999999999999999987 999998865 33443333333322 34666799999999999999999999
Q ss_pred CHHHHhc
Q psy9090 156 YMSELLE 162 (488)
Q Consensus 156 s~~ell~ 162 (488)
++.++.+
T Consensus 568 ~F~~~~~ 574 (609)
T KOG0200|consen 568 TFSECVE 574 (609)
T ss_pred CHHHHHH
Confidence 9998875
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.9e-21 Score=184.32 Aligned_cols=166 Identities=27% Similarity=0.533 Sum_probs=120.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-CCcEEEEecCCccccc---------c------cc------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETA---------N------TF------ 58 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~---------~------~~------ 58 (488)
++-.+++.+++.++.||.++|++|||||||||.|+|.+. .+.-.|+|||++.... . ..
T Consensus 129 l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~ 208 (418)
T KOG1167|consen 129 LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDV 208 (418)
T ss_pred CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcc
Confidence 356789999999999999999999999999999999974 4567899999986110 0 00
Q ss_pred -----------------------CccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh-
Q psy9090 59 -----------------------DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP- 114 (488)
Q Consensus 59 -----------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~- 114 (488)
...-...||++|+|||++... ..-++++||||.|+|+..+++++.||.....
T Consensus 209 ~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~----~~QttaiDiws~GVI~Lslls~~~PFf~a~dd 284 (418)
T KOG1167|consen 209 HCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC----PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDD 284 (418)
T ss_pred cccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc----cCcCCccceeeccceeehhhccccccccCccc
Confidence 000123699999999998753 4567899999999999999999999953221
Q ss_pred HHHHHHHHh--------------CC------C-----------------CCCC-------C----CCCcCHHHHHHHHHh
Q psy9090 115 TRALFQIVR--------------NP------P-----------------PGLY-------R----ASNWSQHYVDFIAEC 146 (488)
Q Consensus 115 ~~~~~~~~~--------------~~------~-----------------~~~~-------~----~~~~s~~~~~li~~~ 146 (488)
...+.++.. +. . .... . ...++..+.+|+.+|
T Consensus 285 ~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~ 364 (418)
T KOG1167|consen 285 ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKC 364 (418)
T ss_pred cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHH
Confidence 111111110 00 0 0000 0 011245789999999
Q ss_pred cccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 147 LEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 147 L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
|..||.+|.|++++|.||||....
T Consensus 365 le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 365 LELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ccCChhhcccHHHHhcCcCCcchh
Confidence 999999999999999999998543
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-21 Score=204.41 Aligned_cols=167 Identities=25% Similarity=0.415 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC----ccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~l 76 (488)
|+..++..+++|++.||+|||+.||.|||+||+|+++..+|.+||+|||.+.....+.. .....+|+..|+|||++
T Consensus 417 ~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~ 496 (601)
T KOG0590|consen 417 LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVL 496 (601)
T ss_pred cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccc
Confidence 45678999999999999999999999999999999999999999999999876544333 34567899999999999
Q ss_pred cccccCCCCCCC-ccchhhhHHHHHHHhcCCCCCCCCChHHHHH-HHHhCC-----CCCCCCCCCcCHHHHHHHHHhccc
Q psy9090 77 RCGHKEVDGYDN-RIDVWALGITAIELGDGKPPFEDMHPTRALF-QIVRNP-----PPGLYRASNWSQHYVDFIAECLEK 149 (488)
Q Consensus 77 ~~~~~~~~~~~~-~~DiwslGvil~elltg~~Pf~~~~~~~~~~-~~~~~~-----~~~~~~~~~~s~~~~~li~~~L~~ 149 (488)
.. ..|++ .+||||.|++++.|.+|+.||.........+ ...... ..+......++...+.+|.+||+.
T Consensus 497 ~~-----~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~ 571 (601)
T KOG0590|consen 497 TG-----KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQL 571 (601)
T ss_pred cc-----cccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccC
Confidence 86 55665 5899999999999999999996554332221 111100 011111234577889999999999
Q ss_pred CCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 150 NPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 150 dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
+|.+|.|+++|++.+||+.+..-
T Consensus 572 ~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 572 DPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred ChhheecHHHHhhChHhhhcceE
Confidence 99999999999999999987643
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-20 Score=182.99 Aligned_cols=102 Identities=28% Similarity=0.611 Sum_probs=73.8
Q ss_pred cCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCC---------ChHHHHHHHHhCCCC--------
Q psy9090 65 LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM---------HPTRALFQIVRNPPP-------- 127 (488)
Q Consensus 65 ~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~---------~~~~~~~~~~~~~~~-------- 127 (488)
+.|..|+|||++.+ .+|++.+||||++|+++||+||...|.-. .....+..++...+.
T Consensus 412 IQTRQYRapEVllG-----sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~ 486 (590)
T KOG1290|consen 412 IQTRQYRAPEVLLG-----SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKY 486 (590)
T ss_pred hhhhhccCcceeec-----CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcc
Confidence 35677999999998 78999999999999999999999988421 111222222211110
Q ss_pred ------------CCCCCCC------------cC----HHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 128 ------------GLYRASN------------WS----QHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 128 ------------~~~~~~~------------~s----~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
.+..... || .++.+|+.-||+.+|++|||+.++|+|||+..++.
T Consensus 487 SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 487 SRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred hHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCC
Confidence 0011112 22 45689999999999999999999999999997654
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=200.40 Aligned_cols=159 Identities=29% Similarity=0.483 Sum_probs=133.5
Q ss_pred HHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---------------CccccccCCCccccchhh
Q psy9090 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---------------DKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 12 qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---------------~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++|||+.||+|||+||+|.+|+.-|++|++|||+++...... -..+..+|||.|+|||++
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 45789999999999999999999999999999999999987432110 112456899999999998
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP- 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 155 (488)
.. .+|+..+|||++|+|+|+.+.|..||.+.++.++.-+.+.....-.......++++++++..+|..+|..|.
T Consensus 231 lr-----qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 231 LR-----QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hh-----hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 75 789999999999999999999999999999988888877654322223455689999999999999999995
Q ss_pred --CHHHHhcCcCCCCCCCCccc
Q psy9090 156 --YMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 156 --s~~ell~hp~f~~~~~~~~~ 175 (488)
.+-++.+|+||+.++|..+.
T Consensus 306 t~ga~evk~h~ff~~LDw~~ll 327 (1205)
T KOG0606|consen 306 TGGALEVKQHGFFQLLDWKSLL 327 (1205)
T ss_pred cchhhhhhhccceeecccchhh
Confidence 56788899999999998543
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-20 Score=175.65 Aligned_cols=154 Identities=25% Similarity=0.402 Sum_probs=128.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+..+.-.++.|+..|++|||++|+||.||...|++|++.-+|||+|=.+++..-+.. .....--....||+||.+..
T Consensus 394 tt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n- 472 (563)
T KOG1024|consen 394 TTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN- 472 (563)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-
Confidence 455677899999999999999999999999999999999999999999988654321 11112223467999999987
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..|+..+|+||||+++|||+| |+.|+..-++.+....+..+.. +..|-++++++..+|.-||...|++||+++
T Consensus 473 ----~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR--laQP~NCPDeLf~vMacCWallpeeRPsf~ 546 (563)
T KOG1024|consen 473 ----SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR--LAQPFNCPDELFTVMACCWALLPEERPSFS 546 (563)
T ss_pred ----hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce--ecCCCCCcHHHHHHHHHHHhcCcccCCCHH
Confidence 679999999999999999987 9999999888776666655543 345778999999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
|+..
T Consensus 547 Qlv~ 550 (563)
T KOG1024|consen 547 QLVI 550 (563)
T ss_pred HHHH
Confidence 9864
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-20 Score=170.54 Aligned_cols=163 Identities=21% Similarity=0.367 Sum_probs=119.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC--CcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD--GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~--~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
-|.-.+.++.|+++||.|||++++||||||.+||||... ..|||||||+.+..+.... ..-.+..|.+||++..-
T Consensus 119 gE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~---~~~~~~~y~~pe~~~~~ 195 (378)
T KOG1345|consen 119 GEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK---YLEYVNNYHAPELCDTV 195 (378)
T ss_pred cHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh---hhhhhcccCCcHHHhhc
Confidence 366778999999999999999999999999999999543 3699999999876654322 22245678999987543
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCC----ChHHHHHHHHhCCCCCCCC-CCCcCHHHHHHHHHhcccCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDM----HPTRALFQIVRNPPPGLYR-ASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~----~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R 154 (488)
..+.-...+..|+|.||+++|.++||.+||... .+.-...++.....+..+. ...+|+.+..+.++-|.++|++|
T Consensus 196 ~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 196 VNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 333334578899999999999999999999632 2223334444444333322 34569999999999999999999
Q ss_pred ---CCHHHHhcCcCCC
Q psy9090 155 ---PYMSELLEHPFIT 167 (488)
Q Consensus 155 ---ps~~ell~hp~f~ 167 (488)
.+++......|..
T Consensus 276 cki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 276 CKIWTAKKMRKCLWKE 291 (378)
T ss_pred chhHHHHHHHHHHHHH
Confidence 4555555555553
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=194.98 Aligned_cols=153 Identities=26% Similarity=0.492 Sum_probs=130.7
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcc-ccccC--CCccccchhhcccc
Q psy9090 4 QHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK-KTFLG--SPSWMAPEIMRCGH 80 (488)
Q Consensus 4 ~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~g--t~~y~aPE~l~~~~ 80 (488)
-++--+++.|+.|++||-+.|.|||||...|||++.+-.+|++|||+++.+....... .+.-| ...|.|||.+..
T Consensus 731 iQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-- 808 (996)
T KOG0196|consen 731 IQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-- 808 (996)
T ss_pred ehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh--
Confidence 3556789999999999999999999999999999999999999999999775543222 22222 358999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
.+++.++||||+|+++||+++ |..||+++...+.+..+..+. .++.|.+++..+..|+..||++|-.+||.+.+
T Consensus 809 ---RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy--RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~q 883 (996)
T KOG0196|consen 809 ---RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY--RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQ 883 (996)
T ss_pred ---cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc--CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHH
Confidence 679999999999999999876 999999999888888887764 34457788999999999999999999999999
Q ss_pred HhcC
Q psy9090 160 LLEH 163 (488)
Q Consensus 160 ll~h 163 (488)
|+.+
T Consensus 884 iV~~ 887 (996)
T KOG0196|consen 884 IVST 887 (996)
T ss_pred HHHH
Confidence 9863
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=181.79 Aligned_cols=149 Identities=24% Similarity=0.528 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccC---CCccccchhhccccc
Q psy9090 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLG---SPSWMAPEIMRCGHK 81 (488)
Q Consensus 5 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~g---t~~y~aPE~l~~~~~ 81 (488)
...+++.||..|+.||..+++|||||...|+|+.++..||++|||+++.+... ....+.| ..-|.|||.+..
T Consensus 366 vLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD--TYTAHAGAKFPIKWTAPEsLAy--- 440 (1157)
T KOG4278|consen 366 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAY--- 440 (1157)
T ss_pred HHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC--ceecccCccCcccccCcccccc---
Confidence 45678899999999999999999999999999999999999999999876543 2222222 457999999875
Q ss_pred CCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 82 EVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 82 ~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|||+|||+|||+.| |-.||.+.+... .+.++.+.. ....|..+++.+..||..||+.+|..||++.++
T Consensus 441 --NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-VY~LLEkgy-RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 441 --NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYGLLEKGY-RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred --cccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHhccc-cccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 678999999999999999987 888999877544 344443321 223467889999999999999999999999887
Q ss_pred hc
Q psy9090 161 LE 162 (488)
Q Consensus 161 l~ 162 (488)
-+
T Consensus 517 Hq 518 (1157)
T KOG4278|consen 517 HQ 518 (1157)
T ss_pred HH
Confidence 43
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=182.80 Aligned_cols=152 Identities=26% Similarity=0.418 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcccccCC
Q psy9090 6 IAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRCGHKEV 83 (488)
Q Consensus 6 ~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~ 83 (488)
...|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++..-.. .......+-...|||||.+..
T Consensus 639 ~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill----- 713 (807)
T KOG1094|consen 639 GVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL----- 713 (807)
T ss_pred hHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHh-----
Confidence 4469999999999999999999999999999999999999999999855332 112223445679999999876
Q ss_pred CCCCCccchhhhHHHHHHH--hcCCCCCCCCChHHHHHHHH---hCCCC--CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 84 DGYDNRIDVWALGITAIEL--GDGKPPFEDMHPTRALFQIV---RNPPP--GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 84 ~~~~~~~DiwslGvil~el--ltg~~Pf~~~~~~~~~~~~~---~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
.+++.++|+|++|+++||+ +|...||...+........- ....+ -...|.-++..+.++|.+||..+.++|||
T Consensus 714 gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPs 793 (807)
T KOG1094|consen 714 GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPS 793 (807)
T ss_pred ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCC
Confidence 6799999999999999997 57899998887655544332 22111 12346677899999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
++++..
T Consensus 794 Fe~lh~ 799 (807)
T KOG1094|consen 794 FEQLHL 799 (807)
T ss_pred HHHHHH
Confidence 999854
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.4e-20 Score=187.20 Aligned_cols=167 Identities=29% Similarity=0.457 Sum_probs=141.9
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHK 81 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 81 (488)
.+...+.+...++.+++++|+.+++|||+|++||+++.+|++++.|||+++...... ..+||..|||||++.+
T Consensus 95 ~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----~~cgt~eymApEI~~g--- 167 (612)
T KOG0603|consen 95 DELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----IACGTYEYRAPEIING--- 167 (612)
T ss_pred HHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----hcccchhhhhhHhhhc---
Confidence 467889999999999999999999999999999999999999999999998765431 1289999999999963
Q ss_pred CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC-----
Q psy9090 82 EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY----- 156 (488)
Q Consensus 82 ~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----- 156 (488)
....+|+||+|+++++|++|..||.. +...+|.+.. ...|...+..+++++..++..+|..|..
T Consensus 168 ----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~---~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~ 236 (612)
T KOG0603|consen 168 ----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE---LEMPRELSAEARSLFRQLFKRNPENRLGAGPDG 236 (612)
T ss_pred ----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc---cCCchhhhHHHHHHHHHHHhhCHHHHhccCcch
Confidence 56789999999999999999999987 4455555432 2346778999999999999999999974
Q ss_pred HHHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 157 MSELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
+.++++|+||..+.|+.+......+++++.
T Consensus 237 ~~eik~h~f~~~i~~~~l~~r~~~~~fkp~ 266 (612)
T KOG0603|consen 237 VDEIKQHEFFQSIDWNELEARSRPPPFKPG 266 (612)
T ss_pred hHHHhccchheeeeHhhHhhcCCCCCCCCc
Confidence 478999999999999988777776666543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-19 Score=204.25 Aligned_cols=153 Identities=20% Similarity=0.344 Sum_probs=111.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHH---HCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLH---ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||....... .....+|+.|+|||++.
T Consensus 777 l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~ 851 (968)
T PLN00113 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRE 851 (968)
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----CCCccccccccCccccc
Confidence 467888999999999999999 6699999999999999998887775 554432211 12336889999999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-HHHHHHHh----CC------CCCCCC----CCCcCHHHHHH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVR----NP------PPGLYR----ASNWSQHYVDF 142 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-~~~~~~~~----~~------~~~~~~----~~~~s~~~~~l 142 (488)
+ ..|+.++||||+||++|||++|+.||...... ..+....+ .. .+.... ......++.++
T Consensus 852 ~-----~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 926 (968)
T PLN00113 852 T-----KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL 926 (968)
T ss_pred C-----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHH
Confidence 5 56899999999999999999999998532110 00111111 00 011100 01112356789
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q psy9090 143 IAECLEKNPEHRPYMSELLEH 163 (488)
Q Consensus 143 i~~~L~~dP~~Rps~~ell~h 163 (488)
+.+||..+|++|||+.++++.
T Consensus 927 ~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 927 ALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHhhCcCCchhCcCHHHHHHH
Confidence 999999999999999999874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=160.04 Aligned_cols=126 Identities=42% Similarity=0.752 Sum_probs=108.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-CCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+..............+...|++||.+...
T Consensus 89 ~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 168 (215)
T cd00180 89 LSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168 (215)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhccc
Confidence 467889999999999999999999999999999999999 8999999999987654432123345678899999998752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.+.|+|++|++++++ ..+.+++.+|+..+|.+||++.+
T Consensus 169 ----~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 169 ----GYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred ----CCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhhCCcccCcCHHH
Confidence 2677899999999999998 67789999999999999999999
Q ss_pred HhcCc
Q psy9090 160 LLEHP 164 (488)
Q Consensus 160 ll~hp 164 (488)
+++|+
T Consensus 211 l~~~~ 215 (215)
T cd00180 211 ILEHL 215 (215)
T ss_pred HhhCC
Confidence 99875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=178.17 Aligned_cols=153 Identities=28% Similarity=0.460 Sum_probs=127.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCcccccc--CCCccccchhhcccc
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFL--GSPSWMAPEIMRCGH 80 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~ 80 (488)
-++...|..||++|+.|||++++|||||-..|+|+.+..++|+.|||+++............. -.+.|+|-|.++.
T Consensus 797 sq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-- 874 (1177)
T KOG1025|consen 797 SQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-- 874 (1177)
T ss_pred HHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc--
Confidence 356778999999999999999999999999999999999999999999987765433332222 3457899998875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..|+.++||||+||.+||++| |..|+.+.... .+...++.... +..|+..+.++..++.+||..|+..||++++
T Consensus 875 ---~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-eI~dlle~geR-LsqPpiCtiDVy~~mvkCwmid~~~rp~fke 949 (1177)
T KOG1025|consen 875 ---RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-EIPDLLEKGER-LSQPPICTIDVYMVMVKCWMIDADSRPTFKE 949 (1177)
T ss_pred ---cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-HhhHHHhcccc-CCCCCCccHHHHHHHHHHhccCcccCccHHH
Confidence 789999999999999999988 99999887754 44555544332 6678888999999999999999999999998
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
+..
T Consensus 950 l~~ 952 (1177)
T KOG1025|consen 950 LAE 952 (1177)
T ss_pred HHH
Confidence 764
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-19 Score=176.73 Aligned_cols=105 Identities=30% Similarity=0.603 Sum_probs=93.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.+++.|++||+.|+++||+.||||||||-+|+.++.+|.+||+|||.+..... .+...++||..|.|||++.+.
T Consensus 667 m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~- 743 (772)
T KOG1152|consen 667 MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGE- 743 (772)
T ss_pred cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCC-
Confidence 68999999999999999999999999999999999999999999999999877654 456788999999999999873
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFED 111 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~ 111 (488)
.-.+...|||+||++||.++....||..
T Consensus 744 ---~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 744 ---KYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ---ccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 2235678999999999999999988853
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-18 Score=167.81 Aligned_cols=158 Identities=29% Similarity=0.475 Sum_probs=111.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC---------CCeecccCCCCEEEccCCcEEEEecCCccccccccCc--cccccCCCc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN---------HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK--KKTFLGSPS 69 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~---------givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~ 69 (488)
++..+.++++..|+.||+|||.- .|+|||||..|||+..++...|+|||++..+...... ....+||..
T Consensus 304 isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~R 383 (534)
T KOG3653|consen 304 ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRR 383 (534)
T ss_pred ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhh
Confidence 36788999999999999999963 5999999999999999999999999999877644222 233689999
Q ss_pred cccchhhcccccCCCC-CCCccchhhhHHHHHHHhcCCC------------CCC---CCCh-HHHHHHH-HhCC-CCCC-
Q psy9090 70 WMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGDGKP------------PFE---DMHP-TRALFQI-VRNP-PPGL- 129 (488)
Q Consensus 70 y~aPE~l~~~~~~~~~-~~~~~DiwslGvil~elltg~~------------Pf~---~~~~-~~~~~~~-~~~~-~~~~- 129 (488)
|||||++.+.-.-... --.+.||||+|.++|||+++.. ||. +.++ .+.++.. ++.. +|..
T Consensus 384 YMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p 463 (534)
T KOG3653|consen 384 YMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIP 463 (534)
T ss_pred hcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCCh
Confidence 9999999763211101 1135899999999999987533 232 1111 1222222 2221 1211
Q ss_pred --CCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 130 --YRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 130 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
+........+++.+..||+.||+.|+|+.
T Consensus 464 ~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 464 DAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred hhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 11222246678999999999999999985
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.7e-18 Score=164.19 Aligned_cols=138 Identities=25% Similarity=0.362 Sum_probs=94.5
Q ss_pred HHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc---cCC
Q psy9090 7 AFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH---KEV 83 (488)
Q Consensus 7 ~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~ 83 (488)
..+..|++..+++||+.|+||+||+|+|++++.+|.++|+||+.....+..... ...+..|.|||...... ...
T Consensus 148 l~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~ 224 (288)
T PF14531_consen 148 LSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNN 224 (288)
T ss_dssp HHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSE
T ss_pred HHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCccc
Confidence 456699999999999999999999999999999999999999876654432111 23457899999875421 012
Q ss_pred CCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 84 DGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 84 ~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
..++.+.|.|+||+++|.|+||..||....+...... ......++++.++.||..||+.||.+|
T Consensus 225 ~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 225 APYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp EEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 3578899999999999999999999976543221111 122233789999999999999999987
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=157.16 Aligned_cols=158 Identities=23% Similarity=0.464 Sum_probs=113.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC--------CCeecccCCCCEEEccCCcEEEEecCCcccccccc----CccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN--------HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF----DKKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~--------givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~gt~ 68 (488)
++.+....++..++.||++||-. .|.|||||..|||+.++|..-|+|+|+|....... ......+||-
T Consensus 305 v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTK 384 (513)
T KOG2052|consen 305 VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTK 384 (513)
T ss_pred CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCcccee
Confidence 45677889999999999999953 49999999999999999999999999997654331 2345678999
Q ss_pred ccccchhhcccccCCCCC--CCccchhhhHHHHHHHhc----------CCCCCCCCCh----HHHHHHHHh--CCCCCCC
Q psy9090 69 SWMAPEIMRCGHKEVDGY--DNRIDVWALGITAIELGD----------GKPPFEDMHP----TRALFQIVR--NPPPGLY 130 (488)
Q Consensus 69 ~y~aPE~l~~~~~~~~~~--~~~~DiwslGvil~ellt----------g~~Pf~~~~~----~~~~~~~~~--~~~~~~~ 130 (488)
.|||||++...- +...+ -..+||||||.++||+.. -++||.+..+ .+.+.+++. ...|..
T Consensus 385 RYMAPEvLdeti-n~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~i- 462 (513)
T KOG2052|consen 385 RYMAPEVLDETI-NMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNI- 462 (513)
T ss_pred eccChHHhhhhc-ChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCC-
Confidence 999999996411 00111 135899999999999864 2678865433 334444432 222322
Q ss_pred CCCCcC-----HHHHHHHHHhcccCCCCCCCHHHHh
Q psy9090 131 RASNWS-----QHYVDFIAECLEKNPEHRPYMSELL 161 (488)
Q Consensus 131 ~~~~~s-----~~~~~li~~~L~~dP~~Rps~~ell 161 (488)
|..|+ ..+..+|+.||..||.-|.|+-.+.
T Consensus 463 -pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 463 -PNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred -CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 23332 3456789999999999999986654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-16 Score=147.85 Aligned_cols=121 Identities=36% Similarity=0.605 Sum_probs=97.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.|++.++.+||+++++|+||+|.||+++.++.++|+|||.+....... .......++..|++||.+..
T Consensus 95 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~- 173 (225)
T smart00221 95 LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLG- 173 (225)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcC-
Confidence 4677889999999999999999999999999999999999999999999887654331 12234567889999999841
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCC-CChHHHHHHHHhCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFED-MHPTRALFQIVRNP 125 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~-~~~~~~~~~~~~~~ 125 (488)
...++.++|+|+||+++++|++|+.||.. ..+...+.+.+...
T Consensus 174 ---~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 174 ---GKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred ---CCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 25677799999999999999999999977 45554454444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-16 Score=169.54 Aligned_cols=158 Identities=18% Similarity=0.205 Sum_probs=111.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccc----cccCCCccccch
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKK----TFLGSPSWMAPE 74 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~----~~~gt~~y~aPE 74 (488)
..-+-+.|+.||+.||..||..||+|||||.+||||++-+.+.|+||...+..--+.+ ... +.....+|+|||
T Consensus 118 ~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPE 197 (1431)
T KOG1240|consen 118 VLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPE 197 (1431)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChH
Confidence 3567889999999999999999999999999999999999999999987765421111 111 122335899999
Q ss_pred hhcccc-----cCCCC-CCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCC-C-CCCCCCcCHHHHHHHHH
Q psy9090 75 IMRCGH-----KEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPP-G-LYRASNWSQHYVDFIAE 145 (488)
Q Consensus 75 ~l~~~~-----~~~~~-~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~-~-~~~~~~~s~~~~~li~~ 145 (488)
.+.... ....+ .+++-||||+||++.||++ |++||.- .++.....+... . .....--+..+++||..
T Consensus 198 RFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~ 273 (1431)
T KOG1240|consen 198 RFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDPEQLLEKIEDVSLRNLILS 273 (1431)
T ss_pred hhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCHHHHHHhCcCccHHHHHHH
Confidence 886521 00122 6788999999999999977 7998853 122222221100 0 00000014467899999
Q ss_pred hcccCCCCCCCHHHHhcC
Q psy9090 146 CLEKNPEHRPYMSELLEH 163 (488)
Q Consensus 146 ~L~~dP~~Rps~~ell~h 163 (488)
|++.||++|.|+++.|+.
T Consensus 274 Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 274 MIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHccCchhccCHHHHHHh
Confidence 999999999999999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-15 Score=149.39 Aligned_cols=167 Identities=34% Similarity=0.571 Sum_probs=127.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccC------ccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFD------KKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~------~~~~~~gt~~y~aP 73 (488)
+++..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+........ ......||+.|++|
T Consensus 98 ~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~p 177 (384)
T COG0515 98 LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177 (384)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCH
Confidence 46788999999999999999999999999999999999988 799999999875443221 24567899999999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---HHHHHHHHhCCCCC-CCCCCCc------CHHHHHHH
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---TRALFQIVRNPPPG-LYRASNW------SQHYVDFI 143 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---~~~~~~~~~~~~~~-~~~~~~~------s~~~~~li 143 (488)
|.+.+.. ...++...|+||+|++++++++|..||..... .......+...... ....... ...+.+++
T Consensus 178 e~~~~~~--~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (384)
T COG0515 178 EVLLGLS--LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLL 255 (384)
T ss_pred HHhcCCC--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHH
Confidence 9987510 03567889999999999999999999877653 23333333222211 1111111 25788999
Q ss_pred HHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 144 AECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
.+++..+|..|.+..+...++|....
T Consensus 256 ~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 256 KKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred HHHHhcCchhcCCHHHHhhchHhhCc
Confidence 99999999999999998888666543
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=147.91 Aligned_cols=155 Identities=24% Similarity=0.320 Sum_probs=109.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc--cCC--cEEEEecCCccccccc------cCccccccCCCccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDG--EVKIVDFGLSRETANT------FDKKKTFLGSPSWM 71 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~--~~~--~vkL~Dfg~a~~~~~~------~~~~~~~~gt~~y~ 71 (488)
+....+.++.|+++|+.|||++||.|||+|.+|||+. .++ .+.++|||.+--.... .......-|....|
T Consensus 339 s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 339 SYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred chHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 3456678999999999999999999999999999984 333 4789999976322110 01112334677889
Q ss_pred cchhhcccccCCCCC-CCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh-CCCCCCCCCCCcCHHHHHHHHHhccc
Q psy9090 72 APEIMRCGHKEVDGY-DNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR-NPPPGLYRASNWSQHYVDFIAECLEK 149 (488)
Q Consensus 72 aPE~l~~~~~~~~~~-~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~ 149 (488)
|||+........... -.++|.|+.|.+.||+++...||.+......-.+-.+ ...|. .+...++.+++++..+|+.
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa--lp~~vpp~~rqlV~~lL~r 496 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA--LPSRVPPVARQLVFDLLKR 496 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC--CcccCChHHHHHHHHHhcC
Confidence 999986532111111 2489999999999999999999987432221111111 11222 3566789999999999999
Q ss_pred CCCCCCCHH
Q psy9090 150 NPEHRPYMS 158 (488)
Q Consensus 150 dP~~Rps~~ 158 (488)
||++|+|+.
T Consensus 497 ~pskRvsp~ 505 (598)
T KOG4158|consen 497 DPSKRVSPN 505 (598)
T ss_pred CccccCCcc
Confidence 999999864
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.2e-16 Score=155.93 Aligned_cols=151 Identities=28% Similarity=0.449 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc------CccccccCCCccccchhh
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF------DKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE~l 76 (488)
...+..++.|+..++.| +|.+|+|+||.||+...+..+||+|||+.+...... .......||..||+||.+
T Consensus 358 ~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi 434 (516)
T KOG1033|consen 358 LSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQI 434 (516)
T ss_pred hhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHH
Confidence 34678899999999999 999999999999999999999999999987654432 234566899999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.+ ..|+.++||||||++|+|++. -..++.- ......+..+..|+.. ..+ .+.-..|+.+||.+.|.+||
T Consensus 435 ~g-----~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~-~~d-~p~e~~ll~~lls~~p~~RP 504 (516)
T KOG1033|consen 435 RG-----QQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEF-LQD-YPEEYTLLQQLLSPSPEERP 504 (516)
T ss_pred hh-----hhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHH-hhc-CcHHHHHHHHhcCCCcccCc
Confidence 87 779999999999999999987 2222221 1112222222222111 112 23446899999999999999
Q ss_pred CHHHHhcCcCC
Q psy9090 156 YMSELLEHPFI 166 (488)
Q Consensus 156 s~~ell~hp~f 166 (488)
++.+.--|+|.
T Consensus 505 ~~~~~~~~~~~ 515 (516)
T KOG1033|consen 505 SAIEVALHEFL 515 (516)
T ss_pred hHHHHhhhhhc
Confidence 87777667664
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=143.25 Aligned_cols=157 Identities=20% Similarity=0.261 Sum_probs=115.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC-----CcEEEEecCCcc--cccccc------C-c-ccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-----GEVKIVDFGLSR--ETANTF------D-K-KKTFL 65 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-----~~vkL~Dfg~a~--~~~~~~------~-~-~~~~~ 65 (488)
|+...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+++ ...... . . ...+.
T Consensus 119 fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~r 198 (322)
T KOG1164|consen 119 FSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFR 198 (322)
T ss_pred cCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCC
Confidence 5678899999999999999999999999999999999865 358999999998 321111 1 1 22456
Q ss_pred CCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCC--CCCCcCHHHHHHH
Q psy9090 66 GSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLY--RASNWSQHYVDFI 143 (488)
Q Consensus 66 gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li 143 (488)
||..|.++.+..+ ...+++.|+||++.++.++..|..||..........+.......... .....+..+..+.
T Consensus 199 GT~ry~S~~~H~~-----~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (322)
T KOG1164|consen 199 GTLRYASINVHLG-----IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKIL 273 (322)
T ss_pred CccccccHHHhCC-----CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHH
Confidence 9999999999876 56788999999999999999999999776543333332222111111 1222356677777
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy9090 144 AECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~ 162 (488)
..+-..+...+|....+..
T Consensus 274 ~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 274 EYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHhhccCCcCCCCHHHHHH
Confidence 7777788888998776654
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-12 Score=122.83 Aligned_cols=152 Identities=20% Similarity=0.380 Sum_probs=109.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-----cEEEEecCCccccccccC-------ccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-----EVKIVDFGLSRETANTFD-------KKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-----~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~ 68 (488)
||.+.++.++.|++.-++|+|++.+|+|||||+|+||...+ .|.++|||+++....+.. ...+..||.
T Consensus 121 FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTA 200 (449)
T KOG1165|consen 121 FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTA 200 (449)
T ss_pred ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccce
Confidence 56788999999999999999999999999999999998654 489999999987654322 235567999
Q ss_pred ccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH--HHHHHhCC---CCCCCCCCCcCHHHHHHH
Q psy9090 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA--LFQIVRNP---PPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 69 ~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~--~~~~~~~~---~~~~~~~~~~s~~~~~li 143 (488)
.||+-....+ ..-+.+.|+=|||-+++..+-|..||.+...... ..+.+... .+.......++.++..-+
T Consensus 201 RYMSINTHlG-----rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl 275 (449)
T KOG1165|consen 201 RYMSINTHLG-----REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYL 275 (449)
T ss_pred eeeEeecccc-----chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHH
Confidence 9999888776 4457789999999999999999999987643222 22222111 111111234566665555
Q ss_pred HHhcccCCCCCCCH
Q psy9090 144 AECLEKNPEHRPYM 157 (488)
Q Consensus 144 ~~~L~~dP~~Rps~ 157 (488)
.-.-..+-.+-|..
T Consensus 276 ~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 276 RYVRRLDFFETPDY 289 (449)
T ss_pred HHHHhcCcccCCCH
Confidence 55545555555554
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-12 Score=119.72 Aligned_cols=153 Identities=14% Similarity=0.322 Sum_probs=113.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc---CCcEEEEecCCccccccccC-------ccccccCCCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---DGEVKIVDFGLSRETANTFD-------KKKTFLGSPSW 70 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y 70 (488)
++.+.+..++-|++.-++|+|.+++|||||||+|+|..- ...+.|+|||+++...+... ......||..|
T Consensus 108 ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRY 187 (341)
T KOG1163|consen 108 FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARY 187 (341)
T ss_pred hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeee
Confidence 456788899999999999999999999999999999963 44689999999987643211 22455789999
Q ss_pred ccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHH---HHHhCC--CCCCCCCCCcCHHHHHHHHH
Q psy9090 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF---QIVRNP--PPGLYRASNWSQHYVDFIAE 145 (488)
Q Consensus 71 ~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~---~~~~~~--~~~~~~~~~~s~~~~~li~~ 145 (488)
.+-....+ ..-+...|+-|+|.+|..+..|..||.+.......+ +|.... .+.......+|.++...+.-
T Consensus 188 ASinAh~g-----~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y 262 (341)
T KOG1163|consen 188 ASINAHLG-----IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNY 262 (341)
T ss_pred hhhhhhhh-----hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHH
Confidence 88776654 334678899999999999999999998875433222 222211 11112245678888888888
Q ss_pred hcccCCCCCCCHH
Q psy9090 146 CLEKNPEHRPYMS 158 (488)
Q Consensus 146 ~L~~dP~~Rps~~ 158 (488)
|-..--++-|...
T Consensus 263 ~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 263 CRGLGFEEKPDYM 275 (341)
T ss_pred HhhcCCCCCCcHH
Confidence 8877777777643
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-12 Score=132.85 Aligned_cols=159 Identities=23% Similarity=0.447 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHHHHHHHHHCCC-eecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcccc
Q psy9090 4 QHIAFILKEIITGMVFLHENHV-IHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 4 ~~~~~i~~qil~aL~~LH~~gi-vHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
--...+++.|+.||.|||.--| .|+.+++.|++++..-.+||+|||+....... ........-...|.|||.++...
T Consensus 48 ~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~ 127 (484)
T KOG1023|consen 48 FFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGAL 127 (484)
T ss_pred HHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccc
Confidence 3456788999999999998766 89999999999999999999999987655321 01111112334689999998742
Q ss_pred cCC--CCCCCccchhhhHHHHHHHhcCCCCCCCC----ChHHHHHHHHhCCC----CCCCCCCCcCHHHHHHHHHhcccC
Q psy9090 81 KEV--DGYDNRIDVWALGITAIELGDGKPPFEDM----HPTRALFQIVRNPP----PGLYRASNWSQHYVDFIAECLEKN 150 (488)
Q Consensus 81 ~~~--~~~~~~~DiwslGvil~elltg~~Pf~~~----~~~~~~~~~~~~~~----~~~~~~~~~s~~~~~li~~~L~~d 150 (488)
... ...+.+.|+||+|++++|+++...||... .+.+.+.++..... |.........+.+..+++.||..+
T Consensus 128 ~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~ 207 (484)
T KOG1023|consen 128 SQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEI 207 (484)
T ss_pred cccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccC
Confidence 111 12467899999999999999999999652 22345555444122 222111234567899999999999
Q ss_pred CCCCCCHHHHhc
Q psy9090 151 PEHRPYMSELLE 162 (488)
Q Consensus 151 P~~Rps~~ell~ 162 (488)
|..||+++++-.
T Consensus 208 P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 208 PEKRPSIEQIRS 219 (484)
T ss_pred hhhCccHHHHHh
Confidence 999999998754
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.8e-14 Score=148.50 Aligned_cols=163 Identities=29% Similarity=0.425 Sum_probs=128.6
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCCeecccCCCCEEEccCC-cEEEEecCCcccccc-cc--CccccccC-CCccccchh
Q psy9090 2 SEQHIAFILKEIITGMVFLH-ENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETAN-TF--DKKKTFLG-SPSWMAPEI 75 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH-~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~-~~--~~~~~~~g-t~~y~aPE~ 75 (488)
+...+..++.|+..++.|+| ..++.|||+||+|.+++.++ .+++.|||+++.... .. ......+| ++.|.|||.
T Consensus 121 ~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~ 200 (601)
T KOG0590|consen 121 SSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEH 200 (601)
T ss_pred CCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCccc
Confidence 45667899999999999999 99999999999999999999 999999999987654 21 12344578 999999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHH-HHHhCC-CCCCCCCCCcCHHHHHHHHHhcccCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF-QIVRNP-PPGLYRASNWSQHYVDFIAECLEKNPEH 153 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~-~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~ 153 (488)
..+. ....+..|+||+|+++..+++|..||.........+ ...... ..........+....+++.++|..+|..
T Consensus 201 ~~~~----~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~ 276 (601)
T KOG0590|consen 201 LSGK----AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSN 276 (601)
T ss_pred ccch----hhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchh
Confidence 8752 234578999999999999999999997654332211 111111 1122234556888999999999999999
Q ss_pred CCCHHHHhcCcCCCC
Q psy9090 154 RPYMSELLEHPFITS 168 (488)
Q Consensus 154 Rps~~ell~hp~f~~ 168 (488)
|.+.+++..+||+..
T Consensus 277 r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 277 RLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccccccccccc
Confidence 999999999999987
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.7e-12 Score=138.17 Aligned_cols=172 Identities=25% Similarity=0.415 Sum_probs=139.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccc------cc-------------------
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA------NT------------------- 57 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~------~~------------------- 57 (488)
++-++.++..+++++++||...+.|+|++|.|+|+..+|+.++.|||...... ..
T Consensus 903 aepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~ 982 (1205)
T KOG0606|consen 903 AEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRP 982 (1205)
T ss_pred cccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccccccccc
Confidence 44567788899999999999999999999999999999999999998432110 00
Q ss_pred -c-----CccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCC
Q psy9090 58 -F-----DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYR 131 (488)
Q Consensus 58 -~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 131 (488)
. .......||+.|.+||.+.+ ......+|+|++|+++++.++|.+||....+......+.....+...-
T Consensus 983 ~l~~~~~~~~~~~~~t~~~laPe~~lg-----~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g 1057 (1205)
T KOG0606|consen 983 QLSADEARRKHAVVGTPDYLAPEILLG-----RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEG 1057 (1205)
T ss_pred ccccchhhccccccCCCcccCCccccc-----ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCC
Confidence 0 01234578999999999987 455678999999999999999999999998877776666655444444
Q ss_pred CCCcCHHHHHHHHHhcccCCCCCCCHH---HHhcCcCCCCCCCCccccccc
Q psy9090 132 ASNWSQHYVDFIAECLEKNPEHRPYMS---ELLEHPFITSLPENDLHLSTV 179 (488)
Q Consensus 132 ~~~~s~~~~~li~~~L~~dP~~Rps~~---ell~hp~f~~~~~~~~~~~~~ 179 (488)
+...+..+++++..+|..+|.+|..+. ++-.|+||+..+|..+.....
T Consensus 1058 ~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~ 1108 (1205)
T KOG0606|consen 1058 PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKA 1108 (1205)
T ss_pred ccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccC
Confidence 566789999999999999999999887 888999999999987755543
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=9e-12 Score=115.50 Aligned_cols=148 Identities=24% Similarity=0.398 Sum_probs=110.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEccCCcEEE--EecCCccccccccCccccccCCCccccchhhcc
Q psy9090 3 EQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGEVKI--VDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkL--~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
..++-.++..|+.|++|||+.. |.--.|....++++++-..+| +|--++-. .....-.|.|++||.++.
T Consensus 288 ~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-------e~gr~y~pawmspealqr 360 (448)
T KOG0195|consen 288 HSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------EVGRAYSPAWMSPEALQR 360 (448)
T ss_pred cchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-------ccccccCcccCCHHHHhc
Confidence 4577889999999999999975 445578888999998776554 45333211 112345689999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh-CCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
... ..--.++|+|||+++++|+.|...||.+..+.+.-.++-- +..+ ..|+.++..+..|+.-|+..||.+||.+
T Consensus 361 kpe--d~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv--~ippgis~hm~klm~icmnedpgkrpkf 436 (448)
T KOG0195|consen 361 KPE--DLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV--HIPPGISRHMNKLMNICMNEDPGKRPKF 436 (448)
T ss_pred Cch--hcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc--cCCCCccHHHHHHHHHHhcCCCCcCCCc
Confidence 322 1123579999999999999999999998888766555532 2222 2467789999999999999999999998
Q ss_pred HHHh
Q psy9090 158 SELL 161 (488)
Q Consensus 158 ~ell 161 (488)
+.++
T Consensus 437 dmiv 440 (448)
T KOG0195|consen 437 DMIV 440 (448)
T ss_pred ceeh
Confidence 7654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.7e-12 Score=115.72 Aligned_cols=103 Identities=19% Similarity=0.166 Sum_probs=78.3
Q ss_pred HHHHHHHHHHHHHHHHCCCeeccc-CCCCEEEccCCcEEEEecCCccccccccCc-------------cccccCCCcccc
Q psy9090 7 AFILKEIITGMVFLHENHVIHRDL-RGSNVLLTKDGEVKIVDFGLSRETANTFDK-------------KKTFLGSPSWMA 72 (488)
Q Consensus 7 ~~i~~qil~aL~~LH~~givHrDl-kp~NILl~~~~~vkL~Dfg~a~~~~~~~~~-------------~~~~~gt~~y~a 72 (488)
..++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||++......... ......++.|+.
T Consensus 94 ~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~ 173 (218)
T PRK12274 94 LAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALT 173 (218)
T ss_pred HHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence 457899999999999999999999 799999999999999999999855433210 011135778888
Q ss_pred chhhcccccCCCCCC-CccchhhhHHHHHHHhcCCCCCCCCC
Q psy9090 73 PEIMRCGHKEVDGYD-NRIDVWALGITAIELGDGKPPFEDMH 113 (488)
Q Consensus 73 PE~l~~~~~~~~~~~-~~~DiwslGvil~elltg~~Pf~~~~ 113 (488)
|+-..-- ...+ ...++++.|+-+|.++|+..|..+..
T Consensus 174 ~~~~~~l----~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 174 PVERRVL----KRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHhhh----ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 8754321 1222 46788899999999999999876543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.5e-11 Score=123.52 Aligned_cols=72 Identities=22% Similarity=0.313 Sum_probs=60.3
Q ss_pred HHHHHHHHHHHHHHHHCCCeeccc-CCCCEEEccCCcEEEEecCCccccccccC--------ccccccCCCccccchhhc
Q psy9090 7 AFILKEIITGMVFLHENHVIHRDL-RGSNVLLTKDGEVKIVDFGLSRETANTFD--------KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 7 ~~i~~qil~aL~~LH~~givHrDl-kp~NILl~~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~l~ 77 (488)
..++.|++++|.|||++||+|||| ||+|||++.++.+||+|||+++....... ......+++.|+|||.+.
T Consensus 114 ~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 114 PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 468899999999999999999999 99999999999999999999986543221 113556888899999986
Q ss_pred c
Q psy9090 78 C 78 (488)
Q Consensus 78 ~ 78 (488)
.
T Consensus 194 ~ 194 (365)
T PRK09188 194 P 194 (365)
T ss_pred h
Confidence 5
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.8e-11 Score=122.25 Aligned_cols=167 Identities=17% Similarity=0.265 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHC-CCeecccCCCCEEEccCCcEEEEecCCccccccccCc---------cccccCCCccccchhhcccc
Q psy9090 11 KEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK---------KKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 11 ~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~---------~~~~~gt~~y~aPE~l~~~~ 80 (488)
.+++.|+.|+|.. ++||++|.|++|.++.+|.+||+.|+++.....+... .....-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-- 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-- 183 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--
Confidence 4556889999975 8999999999999999999999999987654331110 011123457999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHh-cCCCCCCCCChHHHHHHHH--hCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELG-DGKPPFEDMHPTRALFQIV--RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ell-tg~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
...+.++|++|+||++|.+. .|+.-+...... ...... ...........++++++++-+.++|..++..||++
T Consensus 184 ---~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 184 ---TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ---ccccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 45678999999999999998 566555443221 111111 11222222346789999999999999999999999
Q ss_pred HHHhcCcCCCCCCCCccccccccccc
Q psy9090 158 SELLEHPFITSLPENDLHLSTVNCQY 183 (488)
Q Consensus 158 ~ell~hp~f~~~~~~~~~~~~~~~~~ 183 (488)
..++..|||.+..-..+.......+.
T Consensus 260 ~~l~~~~ff~D~~~~aLrfLD~l~~k 285 (700)
T KOG2137|consen 260 DLLLSIPFFSDPGLKALRFLDDLPQK 285 (700)
T ss_pred hhhhcccccCCchhhhhhhccccccc
Confidence 99999999998766666555555553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-10 Score=106.15 Aligned_cols=54 Identities=30% Similarity=0.437 Sum_probs=48.7
Q ss_pred CCHHHHHHHHHHHHHHHHHH-HHCCCeecccCCCCEEEccCCcEEEEecCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFL-HENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA 55 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~L-H~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~ 55 (488)
++++++..++.|++.+|.+| |+.||+||||||+|||++ ++.++|+|||++....
T Consensus 114 ~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 114 LSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 46788999999999999999 799999999999999998 5889999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-10 Score=109.22 Aligned_cols=76 Identities=24% Similarity=0.339 Sum_probs=58.5
Q ss_pred HHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccccCCCCCCC
Q psy9090 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDN 88 (488)
Q Consensus 9 i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~ 88 (488)
...+|+.+|..||+.|++|||+||+||+++.+| ++|+|||..+..... ... ..++.. ..|+.
T Consensus 140 ~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~--~a~----------d~~vle-----r~y~~ 201 (232)
T PRK10359 140 VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQR--KAK----------DRIDLE-----RHYGI 201 (232)
T ss_pred HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccch--hhH----------HHHHHH-----hHhcc
Confidence 467999999999999999999999999999988 999999987644221 000 012222 34667
Q ss_pred ccchhhhHHHHHHH
Q psy9090 89 RIDVWALGITAIEL 102 (488)
Q Consensus 89 ~~DiwslGvil~el 102 (488)
++|+||||+.+..+
T Consensus 202 ~~di~~lg~~~~~~ 215 (232)
T PRK10359 202 KNEIKDLGYYLLIY 215 (232)
T ss_pred cccccceeEeehHH
Confidence 89999999987655
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.5e-10 Score=103.44 Aligned_cols=54 Identities=24% Similarity=0.386 Sum_probs=49.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA 55 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~ 55 (488)
+++.++..++.|++.++.+||+ +||+||||||+||+++ ++.++|+|||+++...
T Consensus 114 ~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 114 LEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 3567889999999999999999 9999999999999999 8999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.2e-10 Score=122.73 Aligned_cols=102 Identities=24% Similarity=0.276 Sum_probs=86.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-------CCcEEEEecCCccccccc--cCccccccCCCccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-------DGEVKIVDFGLSRETANT--FDKKKTFLGSPSWM 71 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-------~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~ 71 (488)
|+|..+.++..||+..|++||..+|||+||||+|+||.. +--++|+|||.+..+.-- .......++|-.+-
T Consensus 791 m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~ 870 (974)
T KOG1166|consen 791 MDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFD 870 (974)
T ss_pred CCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccch
Confidence 567889999999999999999999999999999999953 234899999998654322 23445667889999
Q ss_pred cchhhcccccCCCCCCCccchhhhHHHHHHHhcCCC
Q psy9090 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKP 107 (488)
Q Consensus 72 aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~ 107 (488)
++|+..+ .+++..+|.|.|+.+++-||.|+.
T Consensus 871 C~EM~~g-----rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 871 CIEMREG-----RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred hHHHhcC-----CCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999987 788999999999999999999864
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.4e-09 Score=103.92 Aligned_cols=159 Identities=19% Similarity=0.302 Sum_probs=107.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEccCCcEEEEecCCc--cccccc--cCccccccCCCccccch
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGEVKIVDFGLS--RETANT--FDKKKTFLGSPSWMAPE 74 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkL~Dfg~a--~~~~~~--~~~~~~~~gt~~y~aPE 74 (488)
|++...++|+-||+.||.|||+.. |+|+++..+.|++..+|-||+.--.-. ...... ........+.++|.+||
T Consensus 173 ~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~ 252 (458)
T KOG1266|consen 173 LFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPE 252 (458)
T ss_pred hhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCC
Confidence 356788999999999999999986 999999999999999999987642211 100000 00111224568899999
Q ss_pred hhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCC-CCCh---HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccC
Q psy9090 75 IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE-DMHP---TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKN 150 (488)
Q Consensus 75 ~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~-~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 150 (488)
.-.. ...+..+|||++|....+|..+..--. +... ...+...+.... ...-++++.+||...
T Consensus 253 sg~~-----tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le---------n~lqr~~i~kcl~~e 318 (458)
T KOG1266|consen 253 SGTT-----TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE---------NGLQRGSITKCLEGE 318 (458)
T ss_pred cCcc-----cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc---------CccccCcCcccccCC
Confidence 7543 445668999999999999977654321 1111 111111111111 112246899999999
Q ss_pred CCCCCCHHHHhcCcCCCCCCCCc
Q psy9090 151 PEHRPYMSELLEHPFITSLPEND 173 (488)
Q Consensus 151 P~~Rps~~ell~hp~f~~~~~~~ 173 (488)
|..||++.+++.||..-.++...
T Consensus 319 P~~rp~ar~llfHpllfeVhslk 341 (458)
T KOG1266|consen 319 PNGRPDARLLLFHPLLFEVHSLK 341 (458)
T ss_pred CCCCcchhhhhcCceeeecchHH
Confidence 99999999999999887765543
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.3e-09 Score=112.17 Aligned_cols=161 Identities=20% Similarity=0.223 Sum_probs=122.0
Q ss_pred CCHHHHHHHHHHHHH----HHHHHHHCCCeecccCCCCEEEccC-CcEEEEecCCccccccccCcc-----ccccCCCcc
Q psy9090 1 MSEQHIAFILKEIIT----GMVFLHENHVIHRDLRGSNVLLTKD-GEVKIVDFGLSRETANTFDKK-----KTFLGSPSW 70 (488)
Q Consensus 1 L~e~~~~~i~~qil~----aL~~LH~~givHrDlkp~NILl~~~-~~vkL~Dfg~a~~~~~~~~~~-----~~~~gt~~y 70 (488)
+++..++.++.+..+ ||.++|..+++|-|+||+||++..+ ...+++|||+...+....... ....|...|
T Consensus 215 ~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y 294 (524)
T KOG0601|consen 215 LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIY 294 (524)
T ss_pred CCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceE
Confidence 467889999999999 9999999999999999999999999 789999999988776543221 222577889
Q ss_pred ccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccC
Q psy9090 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKN 150 (488)
Q Consensus 71 ~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 150 (488)
++||...+ -++...|++++|.+..+..++..+...... ..+.++.....+.. .....+..+...+..|++.+
T Consensus 295 ~~ke~~~~------l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~~~ip~e-~~~~~s~~l~~~~~~~~d~~ 366 (524)
T KOG0601|consen 295 AAKELLNG------LATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQGYIPLE-FCEGGSSSLRSVTSQMLDED 366 (524)
T ss_pred eChhhhcc------ccchHhhhcchhhhhHhhHhhcccccCCCC-CCccccccccCchh-hhcCcchhhhhHHHHhcCcc
Confidence 99999874 578899999999999999888776643310 11111111111111 12234566667999999999
Q ss_pred CCCCCCHHHHhcCcCCCCC
Q psy9090 151 PEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 151 P~~Rps~~ell~hp~f~~~ 169 (488)
|-.|++.+.+++|+++.+.
T Consensus 367 ~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 367 PRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhhhhHHHHHhccccccch
Confidence 9999999999999999753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.2e-08 Score=97.22 Aligned_cols=52 Identities=31% Similarity=0.420 Sum_probs=46.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHCC-CeecccCCCCEEEccCCcEEEEecCCccccc
Q psy9090 3 EQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETA 55 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~g-ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~ 55 (488)
+.++..++.||+.+|.+||++| ++||||||+||+++ ++.++|+|||.+....
T Consensus 147 ~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 147 EEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 4457789999999999999999 99999999999999 8899999999886543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=5e-07 Score=89.51 Aligned_cols=156 Identities=16% Similarity=0.195 Sum_probs=106.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccccC
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHKE 82 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 82 (488)
..-+.+..+.|+.+.+-||..|-+-+|+.++|+|+++++.|.|.|-....... ........+|.+.|.+||.-.-..-.
T Consensus 116 w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~-ng~~~~cpVg~~eftPPElQ~~~sf~ 194 (637)
T COG4248 116 WDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA-NGTLHLCPVGVSEFTPPELQTLPSFV 194 (637)
T ss_pred cHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc-CCceEecccCccccCCHHHhcccccc
Confidence 45567889999999999999999999999999999999999999854332222 22344567899999999975421111
Q ss_pred CCCCCCccchhhhHHHHHHHhcC-CCCCCCCChH-----HHHHHHHh-------------CCCCCCCCCCCcCHHHHHHH
Q psy9090 83 VDGYDNRIDVWALGITAIELGDG-KPPFEDMHPT-----RALFQIVR-------------NPPPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 83 ~~~~~~~~DiwslGvil~elltg-~~Pf~~~~~~-----~~~~~~~~-------------~~~~~~~~~~~~s~~~~~li 143 (488)
...-+...|.|.||+++++++.| ++||.+.... ..-..|-. .+.|..+...-+++.+..|.
T Consensus 195 g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF 274 (637)
T COG4248 195 GFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALF 274 (637)
T ss_pred ccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHH
Confidence 12345678999999999999876 9999653210 00001110 11122222233478889999
Q ss_pred HHhccc--CCCCCCCHHH
Q psy9090 144 AECLEK--NPEHRPYMSE 159 (488)
Q Consensus 144 ~~~L~~--dP~~Rps~~e 159 (488)
.+|+.. ++.-|||++.
T Consensus 275 ~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 275 QQAFTESGVATPRPTAKA 292 (637)
T ss_pred HHHhcccCCCCCCCCHHH
Confidence 999865 3568999754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.2e-08 Score=93.00 Aligned_cols=45 Identities=29% Similarity=0.421 Sum_probs=41.8
Q ss_pred HHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccc
Q psy9090 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE 53 (488)
Q Consensus 9 i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~ 53 (488)
.+.||+.+|.+||++||+||||||.|||++.++.++|+|||.+..
T Consensus 147 ~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 147 QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 467899999999999999999999999999999999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.9e-08 Score=89.84 Aligned_cols=51 Identities=27% Similarity=0.385 Sum_probs=46.5
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccc
Q psy9090 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA 55 (488)
Q Consensus 5 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~ 55 (488)
....++.+++.++.++|+.|++||||||+||+++.++.++|+|||.+....
T Consensus 126 ~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 126 DPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 456789999999999999999999999999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.4e-08 Score=89.43 Aligned_cols=45 Identities=16% Similarity=0.231 Sum_probs=37.7
Q ss_pred HHHHHHHHHHH-HHHHHCCCeecccCCCCEEEccC----CcEEEEecCCc
Q psy9090 7 AFILKEIITGM-VFLHENHVIHRDLRGSNVLLTKD----GEVKIVDFGLS 51 (488)
Q Consensus 7 ~~i~~qil~aL-~~LH~~givHrDlkp~NILl~~~----~~vkL~Dfg~a 51 (488)
..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+||+.+
T Consensus 107 ~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 107 VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 35688888888 99999999999999999999743 37999995443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.54 E-value=9.9e-08 Score=87.26 Aligned_cols=51 Identities=27% Similarity=0.361 Sum_probs=46.7
Q ss_pred HHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccc
Q psy9090 4 QHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA 55 (488)
Q Consensus 4 ~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~ 55 (488)
.+++.++.+++.++.++|. .||+||||||+||+++ ++.++|+|||.+....
T Consensus 114 ~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 114 EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 4678899999999999999 9999999999999999 8999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd01363 Motor_domain Myosin and Kinesin motor domain | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.4e-07 Score=84.83 Aligned_cols=89 Identities=20% Similarity=0.265 Sum_probs=66.0
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCc-hhhhHhhhcchhhhhhh-ccccCCCCCCC
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAA-KVGEKIEKCVNVIHAIG-NAGTPINQNST 337 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~-~~~e~i~~~~~~leafg-na~t~~n~nss 337 (488)
+|+........++ ...+++|+..|++|+|||.+..--. ...|-+ ..-+.+.+.....+++. +|.|.+|++||
T Consensus 8 vf~~~~~~v~~~~-~G~n~~i~~yG~tGsGKT~Tm~G~~-----~~~Giip~~~~~~~~ll~~g~~~R~~~~t~~N~~SS 81 (186)
T cd01363 8 VFRDVGPLLQSAL-DGYNVCIFAYGQTGSGKTYTMEGKR-----EGAGIIPRTVTDVIDLMDKGNANRTTAATAMNEHSS 81 (186)
T ss_pred HHHHHHHHHHHHh-CCcceeEEEECCCCCcceEecCCCC-----CCCCcchHHHHHHHHHHhhccccccccccCCCCccC
Confidence 7887777777776 4689999999999999986643110 122322 12223667778889999 99999999999
Q ss_pred ccceeEEEEECCCCcee
Q psy9090 338 RHVLYMQVTFGSSGKLS 354 (488)
Q Consensus 338 rfgk~~~~~~~~~~~~~ 354 (488)
|+..+++|++.......
T Consensus 82 RsH~i~~i~v~~~~~~~ 98 (186)
T cd01363 82 RSHSVFRIHFGGKNALA 98 (186)
T ss_pred cccEEEEEEEEEeecCC
Confidence 99999999997655433
|
These ATPases belong to the P-loop NTPase family and provide the driving force in myosin and kinesin mediated processes. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.2e-06 Score=91.73 Aligned_cols=98 Identities=22% Similarity=0.373 Sum_probs=73.7
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 2 SEQHIAFILKEIITGMVFLH-ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH-~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+...++..+.||+.||.||| +++++|++|.-+.|+++..|++||++|.++..............---.|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-- 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-- 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc--
Confidence 35678899999999999997 678999999999999999999999999887554332211111222234666765532
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGK 106 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~ 106 (488)
-....|.|-|||++++++.|.
T Consensus 180 -----s~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 -----SEWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -----cccchhhhhHHHHHHHHhCcc
Confidence 124579999999999999993
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.7e-07 Score=83.65 Aligned_cols=46 Identities=33% Similarity=0.555 Sum_probs=42.9
Q ss_pred HHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccc
Q psy9090 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET 54 (488)
Q Consensus 8 ~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~ 54 (488)
.++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++...
T Consensus 94 ~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 94 ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 6899999999999999999999999999999 889999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.8e-07 Score=83.83 Aligned_cols=48 Identities=33% Similarity=0.474 Sum_probs=44.3
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccc
Q psy9090 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE 53 (488)
Q Consensus 5 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~ 53 (488)
....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 96 ~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 96 EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 4568899999999999999999999999999999 78999999998764
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.4e-07 Score=94.53 Aligned_cols=154 Identities=21% Similarity=0.242 Sum_probs=111.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC-CcEEEEecCCccccccccCccccccCCCcccc-chhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-GEVKIVDFGLSRETANTFDKKKTFLGSPSWMA-PEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~a-PE~l~~ 78 (488)
|.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.++...- ......+...+.| +|++..
T Consensus 363 ~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~---~~~~~~~~~r~~p~~~~~~e 439 (524)
T KOG0601|consen 363 LDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF---SSGVFHHIDRLYPIAEILLE 439 (524)
T ss_pred cCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce---ecccccccccccccchhhcc
Confidence 4567788999999999999999999999999999999987 6778999998865221 1122233344442 555543
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
...+..+.|++|||.-+.+..++.+.-.... ....+..+..+ .....+.++..+.+.++.+++..||++.
T Consensus 440 ----~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p---~~~~~~~~~q~~~kv~~~~~~~~~~l~~ 509 (524)
T KOG0601|consen 440 ----DYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTP---NLPGLKLQLQVLLKVMINPDRKRRPSAV 509 (524)
T ss_pred ----ccccccccccccccccccccccCcccCcccc---cceeeeccccc---CCCchHHhhhhhhhhhcCCccccchhhh
Confidence 2567789999999999999998876433322 12222222222 2233447888999999999999999999
Q ss_pred HHhcCcCCC
Q psy9090 159 ELLEHPFIT 167 (488)
Q Consensus 159 ell~hp~f~ 167 (488)
++..|+-|.
T Consensus 510 ~l~~~~~~~ 518 (524)
T KOG0601|consen 510 ELSLHSEFY 518 (524)
T ss_pred hhcccchhh
Confidence 988876554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.6e-07 Score=95.72 Aligned_cols=48 Identities=25% Similarity=0.494 Sum_probs=43.9
Q ss_pred HHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccc
Q psy9090 6 IAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET 54 (488)
Q Consensus 6 ~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~ 54 (488)
...++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 430 ~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 430 NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred HHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 46789999999999999999999999999999 6789999999998653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.4e-06 Score=80.05 Aligned_cols=54 Identities=26% Similarity=0.404 Sum_probs=46.3
Q ss_pred CHHHHHHHHHHHHHHHHHH-HHCCCeecccCCCCEEEccCCcEEEEecCCcccccc
Q psy9090 2 SEQHIAFILKEIITGMVFL-HENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN 56 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~L-H~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~ 56 (488)
+++++..+..|++.+|..| |+.|+||+||+|.||++. ++.+.++|||.+....+
T Consensus 122 ~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 122 NDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 3456778889999999998 899999999999999997 57899999998765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0027|consensus | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.1e-07 Score=84.02 Aligned_cols=100 Identities=12% Similarity=0.150 Sum_probs=81.4
Q ss_pred CcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC--------hhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCC
Q psy9090 219 NHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE--------PHIYAVADSAYQDMMHHEEAQHIVLA-GETLAG 289 (488)
Q Consensus 219 ~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~--------ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgag 289 (488)
.....+.+++..+|+++.+.|+..+|...+......... -.+|.++|.+++|+|+..+++.++.+ |+.-
T Consensus 41 ~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~-- 118 (151)
T KOG0027|consen 41 PTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEASSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKL-- 118 (151)
T ss_pred CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccccHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcC--
Confidence 444566777889999999999999999877654332221 12999999999999999999999965 6522
Q ss_pred chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 290 KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 290 kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
..+.++.|++.++.++||.++|++|+.+|..
T Consensus 119 ~~~e~~~mi~~~d~d~dg~i~f~ef~~~m~~ 149 (151)
T KOG0027|consen 119 TDEECKEMIREVDVDGDGKVNFEEFVKMMSG 149 (151)
T ss_pred CHHHHHHHHHhcCCCCCCeEeHHHHHHHHhc
Confidence 2789999999999999999999999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.4e-06 Score=71.10 Aligned_cols=50 Identities=20% Similarity=0.275 Sum_probs=44.8
Q ss_pred HHHHHHHHHHHHHHHHHHHC---CCeecccCCCCEEEccCCcEEEEecCCccc
Q psy9090 4 QHIAFILKEIITGMVFLHEN---HVIHRDLRGSNVLLTKDGEVKIVDFGLSRE 53 (488)
Q Consensus 4 ~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~vkL~Dfg~a~~ 53 (488)
.....++.+++.+|++||.. +++|+|++|.||+++..+.++++|||.+..
T Consensus 86 ~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 45678899999999999985 699999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.1e-07 Score=80.36 Aligned_cols=114 Identities=12% Similarity=0.111 Sum_probs=88.9
Q ss_pred ccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh-h---hHHHHHHHHHHHHhcCC
Q psy9090 201 TISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP-H---IYAVADSAYQDMMHHEE 276 (488)
Q Consensus 201 ~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p-h---~f~~~d~~~~~~~~~~~ 276 (488)
.++...+..-++ -+.......++..++..+|. +...+++++|+.++........++ . +|+++|++.+|+|+.++
T Consensus 36 ~I~~~el~~ilr-~lg~~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~e 113 (160)
T COG5126 36 LIDRNELGKILR-SLGFNPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGE 113 (160)
T ss_pred CCcHHHHHHHHH-HcCCCCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHH
Confidence 344444444444 45566667788888888888 778899999999886554333222 2 99999999999999999
Q ss_pred CcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhc
Q psy9090 277 AQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 277 ~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
+..|+-+ || ..-.|.+..|++.++.+++|.++|++|+..+
T Consensus 114 L~~vl~~lge--~~~deev~~ll~~~d~d~dG~i~~~eF~~~~ 154 (160)
T COG5126 114 LRRVLKSLGE--RLSDEEVEKLLKEYDEDGDGEIDYEEFKKLI 154 (160)
T ss_pred HHHHHHhhcc--cCCHHHHHHHHHhcCCCCCceEeHHHHHHHH
Confidence 9999865 56 2248999999999999999999999999865
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.86 E-value=2.3e-05 Score=70.18 Aligned_cols=46 Identities=28% Similarity=0.381 Sum_probs=40.7
Q ss_pred HHHHHHHHHHHHHHHHCCC-----eecccCCCCEEEccCCcEEEEecCCccc
Q psy9090 7 AFILKEIITGMVFLHENHV-----IHRDLRGSNVLLTKDGEVKIVDFGLSRE 53 (488)
Q Consensus 7 ~~i~~qil~aL~~LH~~gi-----vHrDlkp~NILl~~~~~vkL~Dfg~a~~ 53 (488)
..++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 4567899999999999985 9999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.81 E-value=3.4e-05 Score=74.68 Aligned_cols=50 Identities=20% Similarity=0.274 Sum_probs=44.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-------CCcEEEEecCCcc
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-------DGEVKIVDFGLSR 52 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-------~~~vkL~Dfg~a~ 52 (488)
+.....++.+++..+.-||..||+|+|++|.|||++. ++.+.|+||+.+.
T Consensus 137 ~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 137 PRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 3466789999999999999999999999999999975 4679999999774
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.80 E-value=3.2e-05 Score=72.05 Aligned_cols=52 Identities=23% Similarity=0.347 Sum_probs=46.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC---cEEEEecCCccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG---EVKIVDFGLSRE 53 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkL~Dfg~a~~ 53 (488)
+......++.++...+.-||.+||+|+|++|.|||++.++ .+.++||+.++.
T Consensus 116 ~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 116 DPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred chhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 3566788999999999999999999999999999999887 799999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=4.2e-05 Score=68.51 Aligned_cols=45 Identities=31% Similarity=0.485 Sum_probs=39.9
Q ss_pred HHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccc
Q psy9090 8 FILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE 53 (488)
Q Consensus 8 ~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~ 53 (488)
.+++.+-.-+.-||..||||+||.++||++...+ +.++|||++..
T Consensus 96 ~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 96 DLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred HHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 4778888889999999999999999999998654 99999999864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.63 E-value=8.3e-05 Score=77.33 Aligned_cols=48 Identities=21% Similarity=0.405 Sum_probs=40.8
Q ss_pred HHHHHHHH-HHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccc
Q psy9090 8 FILKEIIT-GMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA 55 (488)
Q Consensus 8 ~i~~qil~-aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~ 55 (488)
.++.+++. .+..+|..|++|+|+||.||+++.+|.++++|||++....
T Consensus 260 ~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 260 ALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 45556655 4788999999999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.58 E-value=6.6e-05 Score=68.63 Aligned_cols=51 Identities=29% Similarity=0.559 Sum_probs=39.4
Q ss_pred HHHHHHHHHHHHHHHH-HHHCCCeecccCCCCEEEccCCcEEEEecCCccccc
Q psy9090 4 QHIAFILKEIITGMVF-LHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA 55 (488)
Q Consensus 4 ~~~~~i~~qil~aL~~-LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~ 55 (488)
++...++.+++..+.. +|..||+|+||++.|||++.+ .+.++|||.+....
T Consensus 106 ~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 106 EEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp STHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred hhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 3567788899885555 689999999999999999876 89999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=97.47 E-value=6.5e-06 Score=65.35 Aligned_cols=63 Identities=14% Similarity=0.061 Sum_probs=53.2
Q ss_pred hhHHHHHH-HHHHHHhcCCCcEEEEc--ccccCCch-hhHHHHHHHHHHhcCCCchhhhHhhhcchhhh
Q psy9090 259 HIYAVADS-AYQDMMHHEEAQHIVLA--GETLAGKT-TSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIH 323 (488)
Q Consensus 259 h~f~~~d~-~~~~~~~~~~~q~i~~s--gesgagkt-e~~k~i~~~~~~~~~g~~~~~e~i~~~~~~le 323 (488)
.+|.++|+ +.+|.|+..+++.++-+ |+- -++ +.++.||+.+|.++||.|+|+||+.+|..+.=
T Consensus 12 ~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~--ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l~~ 78 (89)
T cd05022 12 SNFHKASVKGGKESLTASEFQELLTQQLPHL--LKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGELAK 78 (89)
T ss_pred HHHHHHhCCCCCCeECHHHHHHHHHHHhhhh--ccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHHH
Confidence 38999999 99999999999998854 431 124 78999999999999999999999999887643
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00021 Score=63.83 Aligned_cols=48 Identities=42% Similarity=0.595 Sum_probs=41.9
Q ss_pred HHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc---EEEEecCCcccc
Q psy9090 7 AFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRET 54 (488)
Q Consensus 7 ~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkL~Dfg~a~~~ 54 (488)
..++++|-+.|.-||.++|||+||..+||++..++. +.++|||++...
T Consensus 116 ~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 116 AELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred HHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 678889999999999999999999999999976653 589999997543
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0011 Score=68.04 Aligned_cols=130 Identities=15% Similarity=0.212 Sum_probs=95.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++|+.+|.|+.|+..||.++|+.|+..+-|.|.+||++.+.+++|...|......... + +.+.+
T Consensus 390 ~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-------~-------~~le~-- 453 (655)
T KOG3741|consen 390 APEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-------T-------EPLES-- 453 (655)
T ss_pred chHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-------C-------cchhH--
Confidence 4789999999999999999999999999999999999998888888777654433221 0 11211
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCC-CCCChHHH-HHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPF-EDMHPTRA-LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf-~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..+-|.-.||.++..|.||..-- ........ +..+ ...+|.+++++|.-+...++.+ -++.
T Consensus 454 ------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I----------~~~yS~D~rn~v~yl~s~~~~~-ksI~ 516 (655)
T KOG3741|consen 454 ------QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI----------TTTYSTDLRNVVEYLESLNFRE-KSIQ 516 (655)
T ss_pred ------HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh----------hhhhhHHHHHHHHHHHhcCccc-ccHH
Confidence 13568889999999999996431 11111111 1111 2457899999999999998876 7888
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++.+
T Consensus 517 ~llp~ 521 (655)
T KOG3741|consen 517 DLLPM 521 (655)
T ss_pred HHHHH
Confidence 88764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.00099 Score=61.62 Aligned_cols=51 Identities=16% Similarity=0.225 Sum_probs=44.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc--EEEEecCCccc
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE--VKIVDFGLSRE 53 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--vkL~Dfg~a~~ 53 (488)
+..-..++.++...++-||+.|+.|+|+.+.||+++.+|. ++++||.-++.
T Consensus 127 ~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 127 DEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred hHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 4455789999999999999999999999999999987777 99999976543
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0017 Score=72.48 Aligned_cols=153 Identities=22% Similarity=0.363 Sum_probs=102.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCC---CEEEccCCcEEEE--ecCCccccccccCccccccCCCccccchhh
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGS---NVLLTKDGEVKIV--DFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~---NILl~~~~~vkL~--Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
+-+.++.+..++++||.|+|+....|.-+... +.-.+..+.+... ||+.++..... ........+..+.+||..
T Consensus 284 ~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~-~~~~~~~~~~~~~~~e~~ 362 (1351)
T KOG1035|consen 284 PLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN-EKSFSDLLAEIRNADEDL 362 (1351)
T ss_pred CHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCc-ccchhhcCcccccccccc
Confidence 45678889999999999999997777766555 3444555666666 88877665443 222333445667788877
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
... ........|+|++|..+..+..|..+-.... .....+ +........+++.+|+..++++|++
T Consensus 363 ~~~---~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~---~~~~~l---------~~~~~~~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 363 KEN---TAKKSRLTDLWCLGLLLLQLSQGEDISEKSA---VPVSLL---------DVLSTSELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred ccc---cchhhhhhHHHHHHHHHhhhhhcCccccccc---chhhhh---------ccccchhhhhhhhhhcchhhhhccc
Confidence 541 1222344799999999999888765432111 111111 1111226778999999999999999
Q ss_pred HHHHhcCcCCCCCC
Q psy9090 157 MSELLEHPFITSLP 170 (488)
Q Consensus 157 ~~ell~hp~f~~~~ 170 (488)
+.+++.|+|.+.-.
T Consensus 428 ~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 428 ALELLTHPFLRFPT 441 (1351)
T ss_pred hhhhhhchhccccc
Confidence 99999999987543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00042 Score=73.36 Aligned_cols=36 Identities=19% Similarity=0.421 Sum_probs=31.6
Q ss_pred HHHCCCeecccCCCCEEEccCC----cEEEEecCCccccc
Q psy9090 20 LHENHVIHRDLRGSNVLLTKDG----EVKIVDFGLSRETA 55 (488)
Q Consensus 20 LH~~givHrDlkp~NILl~~~~----~vkL~Dfg~a~~~~ 55 (488)
+...|++|+|+||.||+++.+| .++++|||++....
T Consensus 276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4469999999999999999888 99999999986553
|
|
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=97.03 E-value=5.6e-05 Score=60.79 Aligned_cols=65 Identities=8% Similarity=0.067 Sum_probs=51.4
Q ss_pred hHHHHH-HHHHH-HHhcCCCcEEEEc--cc--ccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 260 IYAVAD-SAYQD-MMHHEEAQHIVLA--GE--TLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 260 ~f~~~d-~~~~~-~~~~~~~q~i~~s--ge--sgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
+|..+| +++.| .|+..+++.++-. |+ ++....+.++.||+.+|.++||.|+|+||+.++.++.=|
T Consensus 15 ~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l~~~ 85 (93)
T cd05026 15 IFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAALTVA 85 (93)
T ss_pred HHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Confidence 799888 78888 5999999987722 21 122235689999999999999999999999999887543
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0013 Score=61.13 Aligned_cols=43 Identities=23% Similarity=0.428 Sum_probs=36.9
Q ss_pred HHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 9 i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
+..+|.+++.-||+.|+.|+|.+|.|++++.+ .++++||+..+
T Consensus 140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 44678889999999999999999999999854 59999997643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.00016 Score=57.46 Aligned_cols=67 Identities=12% Similarity=0.117 Sum_probs=52.4
Q ss_pred hhHHHHH-HHHHH-HHhcCCCcEEEEc--cc-ccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhh
Q psy9090 259 HIYAVAD-SAYQD-MMHHEEAQHIVLA--GE-TLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAI 325 (488)
Q Consensus 259 h~f~~~d-~~~~~-~~~~~~~q~i~~s--ge-sgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leaf 325 (488)
.+|.++| +++.| +|+..+++.++-+ +. .|.-. .+.++.+|+.+|.+++|.++|+||+.++..+.=|.
T Consensus 12 ~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~~~~~~ 84 (88)
T cd05027 12 DVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMVTTAC 84 (88)
T ss_pred HHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHH
Confidence 3899998 79999 6999999998833 00 22212 45599999999999999999999998887765443
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.00054 Score=71.84 Aligned_cols=153 Identities=29% Similarity=0.456 Sum_probs=107.5
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccccCCC
Q psy9090 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHKEVD 84 (488)
Q Consensus 5 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 84 (488)
+...+.+.-+.+++++|+.-=+|+| ||+..+ +..++.+|+......... ...+..+++.++|||+... .
T Consensus 337 ~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~-----~ 405 (829)
T KOG0576|consen 337 QFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQE-----N 405 (829)
T ss_pred hhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhcc-----c
Confidence 4456667777889999988778888 776654 789999999887665542 4567789999999998876 6
Q ss_pred CCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC-CCCCCCCCCcCHHHH-HHHHHhcccCCCCCCCHHHHhc
Q psy9090 85 GYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-PPGLYRASNWSQHYV-DFIAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 85 ~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~-~li~~~L~~dP~~Rps~~ell~ 162 (488)
.+..+.|.|++|+-..++.-|.+|-.... .....+-..+ .+.+.....|++... ++...|+..-|..|+..-.++-
T Consensus 406 ~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacf 483 (829)
T KOG0576|consen 406 TIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACF 483 (829)
T ss_pred ccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHH
Confidence 68889999999988788888887765421 1111110111 011111123433333 3778899999999999999999
Q ss_pred CcCCCCCC
Q psy9090 163 HPFITSLP 170 (488)
Q Consensus 163 hp~f~~~~ 170 (488)
|.+|...+
T Consensus 484 sKvfngCp 491 (829)
T KOG0576|consen 484 SKVFNGCP 491 (829)
T ss_pred HHHhccCc
Confidence 99997754
|
|
| >cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11 | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.00022 Score=56.72 Aligned_cols=61 Identities=13% Similarity=0.149 Sum_probs=47.5
Q ss_pred hHHH-HHHHHHH-HHhcCCCcEEEEcccc-----cCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAV-ADSAYQD-MMHHEEAQHIVLAGET-----LAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~-~d~~~~~-~~~~~~~q~i~~sges-----gagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|.. +|+++++ .|+..|.+.++ +.. +..+ ...++.||+.+|.++||.|+|+||+.++..+.
T Consensus 14 ~F~~y~~~dg~~~~Ls~~Elk~ll--~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~~~l~ 82 (89)
T cd05023 14 VFQKYAGKDGDSYQLSKTEFLSFM--NTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLIGGLA 82 (89)
T ss_pred HHHHHhccCCCcCeECHHHHHHHH--HHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHHH
Confidence 6776 7777765 78888888777 322 2223 57899999999999999999999999887764
|
S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0063 Score=58.01 Aligned_cols=51 Identities=24% Similarity=0.392 Sum_probs=42.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccc
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE 53 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~ 53 (488)
.+.+..++..|++-+.-+-..|+||+|+++-||+++.+|.+.++||--+..
T Consensus 201 ~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 201 VENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred ccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 345667777788877777799999999999999999999999999965443
|
|
| >PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.0019 Score=39.62 Aligned_cols=28 Identities=21% Similarity=0.167 Sum_probs=25.3
Q ss_pred hHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 293 SLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 293 ~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+++.+++.+|.|+||.|+++||+.+|..
T Consensus 1 E~~~~F~~~D~d~dG~I~~~Ef~~~~~~ 28 (29)
T PF00036_consen 1 ELKEAFREFDKDGDGKIDFEEFKEMMKK 28 (29)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHH
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHh
Confidence 3789999999999999999999998764
|
This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D .... |
| >KOG0044|consensus | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.0002 Score=65.06 Aligned_cols=122 Identities=15% Similarity=0.164 Sum_probs=87.8
Q ss_pred HHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChh---hHHHHHHHHHHHHhcCCCcEEEEc
Q psy9090 207 IVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPH---IYAVADSAYQDMMHHEEAQHIVLA 283 (488)
Q Consensus 207 l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph---~f~~~d~~~~~~~~~~~~q~i~~s 283 (488)
...-+..-+.......|..-++...|-++++.|++.||+.++.-..+....+. +|++.|.++.|.|+..|.=.|+-+
T Consensus 49 F~~i~~~~fp~gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rGt~eekl~w~F~lyD~dgdG~It~~Eml~iv~~ 128 (193)
T KOG0044|consen 49 FREIYASFFPDGDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSRGTLEEKLKWAFRLYDLDGDGYITKEEMLKIVQA 128 (193)
T ss_pred HHHHHHHHCCCCCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCCcHHHHhhhhheeecCCCCceEcHHHHHHHHHH
Confidence 33334444445566667777888999999999999999988865555544433 899999999998888764332211
Q ss_pred -----cc-----ccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhhcc
Q psy9090 284 -----GE-----TLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIGNA 328 (488)
Q Consensus 284 -----ge-----sgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafgna 328 (488)
|. -.-+.-+-+..+++.+|.|.||.++++||+..+.. +|++++.-
T Consensus 129 i~~m~~~~~~~~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~~d~~i~~~l~~~ 186 (193)
T KOG0044|consen 129 IYQMTGSKALPEDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCKADPSILRALEQD 186 (193)
T ss_pred HHHHcccccCCcccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhhhCHHHHHHhhhc
Confidence 31 11234566888999999999999999999988764 77777643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.015 Score=53.98 Aligned_cols=31 Identities=29% Similarity=0.423 Sum_probs=26.2
Q ss_pred CCCeecccCCCCEEEcc--CCcEEEEecCCccc
Q psy9090 23 NHVIHRDLRGSNVLLTK--DGEVKIVDFGLSRE 53 (488)
Q Consensus 23 ~givHrDlkp~NILl~~--~~~vkL~Dfg~a~~ 53 (488)
..++|+|++|.||+++. ++.+.++||+.+..
T Consensus 174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 35799999999999998 56789999987653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.00086 Score=53.75 Aligned_cols=69 Identities=14% Similarity=0.220 Sum_probs=54.2
Q ss_pred hhHHHHH-HHHHHH-HhcCCCcEEEEc--cc-ccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhhc
Q psy9090 259 HIYAVAD-SAYQDM-MHHEEAQHIVLA--GE-TLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGN 327 (488)
Q Consensus 259 h~f~~~d-~~~~~~-~~~~~~q~i~~s--ge-sgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafgn 327 (488)
.+|.++| ++++|. |+..+.+.++-. |+ -|... .+.++.||++++.+++|.+++++|+..+.++.=|=++
T Consensus 13 ~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~~~~~~~~ 87 (92)
T cd05025 13 NVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALTVACNN 87 (92)
T ss_pred HHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHHHHH
Confidence 4999997 999994 999999988831 32 12222 5679999999999999999999999988877655443
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.022 Score=53.80 Aligned_cols=52 Identities=23% Similarity=0.350 Sum_probs=44.9
Q ss_pred HHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCcccccc
Q psy9090 4 QHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN 56 (488)
Q Consensus 4 ~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~ 56 (488)
+++..+..++++.+.-|-. .++||+||+.-|||+. ++.+.++|+|-+....+
T Consensus 166 ~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 166 EEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred hhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 3677888999999988877 9999999999999999 88999999998765543
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.00055 Score=60.46 Aligned_cols=96 Identities=8% Similarity=0.036 Sum_probs=71.4
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCC----ChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDN----EPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKH 296 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~----~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~ 296 (488)
..+..++..+|+++.+.|.+.+|+........... -.++|+.+|.+..|.++..+...++.. |+ .-+.+.++.
T Consensus 53 ~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~--~l~~~~~~~ 130 (158)
T PTZ00183 53 EEIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDPREEILKAFRLFDDDKTGKISLKNLKRVAKELGE--TITDEELQE 130 (158)
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC--CCCHHHHHH
Confidence 34556677788888888999999876533211111 123899999999999998888877632 33 124778999
Q ss_pred HHHHHHHhcCCCchhhhHhhhcc
Q psy9090 297 LLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 297 i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
++..++.+++|.|++++|+..+.
T Consensus 131 ~~~~~d~~~~g~i~~~ef~~~~~ 153 (158)
T PTZ00183 131 MIDEADRNGDGEISEEEFYRIMK 153 (158)
T ss_pred HHHHhCCCCCCcCcHHHHHHHHh
Confidence 99999999999999999987664
|
|
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.0011 Score=52.70 Aligned_cols=63 Identities=10% Similarity=0.110 Sum_probs=48.0
Q ss_pred hHHHHHH-HH-HHHHhcCCCcEEEEc----ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 260 IYAVADS-AY-QDMMHHEEAQHIVLA----GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 260 ~f~~~d~-~~-~~~~~~~~~q~i~~s----gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
+|.-++. ++ .|.|+..+++.++-. |+. -..+.+..||+.+|.+++|.++|+||+..+..+.=|
T Consensus 15 ~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k--~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l~~~ 83 (88)
T cd05029 15 IFHKYSGREGDKNTLSKKELKELIQKELTIGSK--LQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGALALI 83 (88)
T ss_pred HHHHHHccCCCCCEECHHHHHHHHHHHHhcCCC--CCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHHHH
Confidence 5666665 55 568888888887731 441 126789999999999999999999999998877544
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.00076 Score=58.76 Aligned_cols=95 Identities=9% Similarity=0.125 Sum_probs=69.8
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCC----CCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSR----SDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHL 297 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~----~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i 297 (488)
.+..++..+|.++.+.+++.+|+........ ...-.++|..+|.+.+|.++..+...++ ...|.+ ..+.++.+
T Consensus 48 ~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l--~~~~~~~~~~~~~~~ 125 (149)
T PTZ00184 48 ELQDMINEVDADGNGTIDFPEFLTLMARKMKDTDSEEEIKEAFKVFDRDGNGFISAAELRHVM--TNLGEKLTDEEVDEM 125 (149)
T ss_pred HHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCcHHHHHHHHHHhhCCCCCCeEeHHHHHHHH--HHHCCCCCHHHHHHH
Confidence 4555667778888888999999976542211 1122359999999999998888877665 222322 36778899
Q ss_pred HHHHHHhcCCCchhhhHhhhcc
Q psy9090 298 LKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 298 ~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
++.++.+++|.++++||+..++
T Consensus 126 ~~~~d~~~~g~i~~~ef~~~~~ 147 (149)
T PTZ00184 126 IREADVDGDGQINYEEFVKMMM 147 (149)
T ss_pred HHhcCCCCCCcCcHHHHHHHHh
Confidence 9999999999999999997764
|
|
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.001 Score=49.41 Aligned_cols=61 Identities=13% Similarity=0.102 Sum_probs=48.5
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|+.+|.+.+|.++..+.+.++ ...|. ..+.++.|++.++.+++|.++++||+..+..+.
T Consensus 3 ~~F~~~D~~~~G~i~~~el~~~l--~~~g~-~~~~~~~i~~~~d~~~~g~i~~~ef~~~~~~~~ 63 (67)
T cd00052 3 QIFRSLDPDGDGLISGDEARPFL--GKSGL-PRSVLAQIWDLADTDKDGKLDKEEFAIAMHLIA 63 (67)
T ss_pred HHHHHhCCCCCCcCcHHHHHHHH--HHcCC-CHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 37888888888888888887766 22333 456789999999999999999999998876543
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.00045 Score=51.44 Aligned_cols=58 Identities=10% Similarity=0.119 Sum_probs=45.0
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-----chhhHHHHHHHHHHhcCCCchhhhHhhhc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-----KTTSLKHLLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-----kte~~k~i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
.+|..+|.+.+|.|+..+.+.++.. .|.. ..+.+..+++.+|.+++|.++++||+.+|
T Consensus 4 ~~F~~~D~d~~G~i~~~el~~~~~~--~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 66 (66)
T PF13499_consen 4 EAFKKFDKDGDGYISKEELRRALKH--LGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM 66 (66)
T ss_dssp HHHHHHSTTSSSEEEHHHHHHHHHH--TTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred HHHHHHcCCccCCCCHHHHHHHHHH--hcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence 3788999999999998888877732 2211 14556677999999999999999999865
|
... |
| >KOG0028|consensus | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.00055 Score=59.02 Aligned_cols=96 Identities=9% Similarity=0.058 Sum_probs=74.9
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChh-----hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPH-----IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLK 295 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph-----~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k 295 (488)
+.+..++..+|-.+.+.|.+++|...+..+..... +| +|.++|-+.+|.|+.+++..+. -|-|--- .+...
T Consensus 69 ~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~d-t~eEi~~afrl~D~D~~Gkis~~~lkrva--keLgenltD~El~ 145 (172)
T KOG0028|consen 69 EEILKLLADVDKEGSGKITFEDFRRVMTVKLGERD-TKEEIKKAFRLFDDDKTGKISQRNLKRVA--KELGENLTDEELM 145 (172)
T ss_pred HHHHHHHHhhhhccCceechHHHHHHHHHHHhccC-cHHHHHHHHHcccccCCCCcCHHHHHHHH--HHhCccccHHHHH
Confidence 44556677777788888999999987665533333 55 9999999999999998888666 3433222 67899
Q ss_pred HHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 296 HLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 296 ~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.||.+++.+++|.++-+||+..|..
T Consensus 146 eMIeEAd~d~dgevneeEF~~imk~ 170 (172)
T KOG0028|consen 146 EMIEEADRDGDGEVNEEEFIRIMKK 170 (172)
T ss_pred HHHHHhcccccccccHHHHHHHHhc
Confidence 9999999999999999999988753
|
|
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.0017 Score=52.21 Aligned_cols=62 Identities=11% Similarity=0.135 Sum_probs=49.1
Q ss_pred hhHHHHHH-HH-HHHHhcCCCcEEEEc--cc-ccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADS-AY-QDMMHHEEAQHIVLA--GE-TLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~-~~-~~~~~~~~~q~i~~s--ge-sgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|.++|. ++ +|.|+..+.+.++-+ |+ -|... .+.++.|++.++.+++|.|+++||+.++..
T Consensus 12 ~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~ 79 (94)
T cd05031 12 LTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAG 79 (94)
T ss_pred HHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 38999997 87 699999999988732 22 23233 567999999999999999999999977654
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.012 Score=67.81 Aligned_cols=143 Identities=13% Similarity=0.012 Sum_probs=95.9
Q ss_pred HHHHHHHHHCC-----CeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccccCCCCCCC
Q psy9090 14 ITGMVFLHENH-----VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDN 88 (488)
Q Consensus 14 l~aL~~LH~~g-----ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~ 88 (488)
+....-+|+.. .+|+++|+-|.+|..+..+|++++|+.+...+.........+++.|+.|++... -.++.
T Consensus 1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-----ik~t~ 1419 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-----IKFTK 1419 (2724)
T ss_pred HhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-----Hhhhh
Confidence 66666666532 789999999999999999999999999844444445566778899999998754 45677
Q ss_pred ccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC---CCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcC
Q psy9090 89 RIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG---LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPF 165 (488)
Q Consensus 89 ~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 165 (488)
++|+|..|+.+|....|-.+|.. .++...++.... ...+.-.|.+.-.....+|-..-..||.-...+..+.
T Consensus 1420 rsdilr~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~ 1494 (2724)
T KOG1826|consen 1420 RSDILRRSLSLYLRSDGNAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDH 1494 (2724)
T ss_pred HHHHHHHHHHHHHHhcccHHHHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccc
Confidence 79999999999999888877632 222223222111 1111122334444445555555667887777666555
Q ss_pred C
Q psy9090 166 I 166 (488)
Q Consensus 166 f 166 (488)
|
T Consensus 1495 ~ 1495 (2724)
T KOG1826|consen 1495 F 1495 (2724)
T ss_pred c
Confidence 5
|
|
| >KOG0034|consensus | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.0014 Score=59.42 Aligned_cols=91 Identities=12% Similarity=0.056 Sum_probs=61.7
Q ss_pred eeeeCCCCCCC-CCCchhhhhccCCCCCCCChh-----hHHHHHHHHHHHHhcCCCcEEEEc--ccccC----CchhhHH
Q psy9090 228 LLFINPNTHLN-LYGTKYHFKYKFKSRSDNEPH-----IYAVADSAYQDMMHHEEAQHIVLA--GETLA----GKTTSLK 295 (488)
Q Consensus 228 l~~Inp~~~~~-i~~~ef~~~~~~~~~~~~~ph-----~f~~~d~~~~~~~~~~~~q~i~~s--gesga----gkte~~k 295 (488)
+...++.+.+. +++.+|+.....-.... +++ +|++.|.+.+|.|+..+.+.|+.. |++.. ....-+.
T Consensus 72 ~~~f~~~~~~~~v~F~~Fv~~ls~f~~~~-~~~~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~i~d 150 (187)
T KOG0034|consen 72 IDRFDTDGNGDPVDFEEFVRLLSVFSPKA-SKREKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLEDIVD 150 (187)
T ss_pred HHHHhccCCCCccCHHHHHHHHhhhcCCc-cHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHHHHH
Confidence 33344444444 88888886543221111 222 999999999999999999987754 54332 1133466
Q ss_pred HHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 296 HLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 296 ~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
.+|.++|.++||.|+++||-..+-
T Consensus 151 ~t~~e~D~d~DG~IsfeEf~~~v~ 174 (187)
T KOG0034|consen 151 KTFEEADTDGDGKISFEEFCKVVE 174 (187)
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHH
Confidence 678899999999999999976543
|
|
| >KOG0027|consensus | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.0021 Score=56.71 Aligned_cols=69 Identities=13% Similarity=0.157 Sum_probs=57.2
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhhccc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAG 329 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafgna~ 329 (488)
.+|+.+|++..|.|+..++..++-+ .|... .+.++.++++++.+++|.|++++|+..|.+.++......
T Consensus 12 ~~F~~fD~d~~G~i~~~el~~~lr~--lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~ 81 (151)
T KOG0027|consen 12 EAFQLFDKDGDGKISVEELGAVLRS--LGQNPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEE 81 (151)
T ss_pred HHHHHHCCCCCCcccHHHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhccccccc
Confidence 3999999999999999999988833 33333 677999999999999999999999999887776555444
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 488 | ||||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-47 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-43 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-42 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-42 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-42 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-42 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-41 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-41 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-41 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-40 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-40 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-40 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-40 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-40 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-35 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-35 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-33 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-33 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-32 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-32 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-32 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-32 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-31 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-31 | ||
| 1lkx_A | 697 | Motor Domain Of Myoe, A Class-I Myosin Length = 697 | 2e-30 | ||
| 4a7f_C | 697 | Structure Of The Actin-Tropomyosin-Myosin Complex ( | 2e-30 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-28 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-28 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-28 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-28 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-28 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-27 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-26 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-26 | ||
| 1oe9_A | 795 | Crystal Structure Of Myosin V Motor With Essential | 2e-25 | ||
| 1w8j_A | 766 | Crystal Structure Of Myosin V Motor Domain - Nucleo | 2e-25 | ||
| 2dfs_A | 1080 | 3-D Structure Of Myosin-V Inhibited State Length = | 3e-25 | ||
| 1qvi_A | 840 | Crystal Structure Of Scallop Myosin S1 In The Pre-P | 3e-24 | ||
| 1b7t_A | 835 | Myosin Digested By Papain Length = 835 | 3e-24 | ||
| 2ycu_A | 995 | Crystal Structure Of Human Non Muscle Myosin 2c In | 3e-24 | ||
| 1kk7_A | 837 | Scallop Myosin In The Near Rigor Conformation Lengt | 3e-24 | ||
| 1dfl_A | 831 | Scallop Myosin S1 Complexed With Mgadp:vanadate-Tra | 3e-24 | ||
| 1dfk_A | 830 | Nucleotide-Free Scallop Myosin S1-Near Rigor State | 3e-24 | ||
| 3mkd_A | 692 | Crystal Structure Of Myosin-2 Dictyostelium Discoid | 4e-24 | ||
| 1yv3_A | 762 | The Structural Basis Of Blebbistatin Inhibition And | 5e-24 | ||
| 2aka_A | 776 | Structure Of The Nucleotide-Free Myosin Ii Motor Do | 5e-24 | ||
| 3mnq_A | 788 | Crystal Structure Of Myosin-2 Motor Domain In Compl | 5e-24 | ||
| 2jhr_A | 788 | Crystal Structure Of Myosin-2 Motor Domain In Compl | 5e-24 | ||
| 1jwy_A | 776 | Crystal Structure Of The Dynamin A Gtpase Domain Co | 5e-24 | ||
| 2xel_A | 776 | Molecular Mechanism Of Pentachloropseudilin Mediate | 5e-24 | ||
| 2y0r_X | 758 | Structural Basis For The Allosteric Interference Of | 5e-24 | ||
| 2y9e_X | 758 | Structural Basis For The Allosteric Interference Of | 5e-24 | ||
| 1w9l_A | 770 | Myosin Ii Dictyostelium Discoideum Motor Domain S45 | 5e-24 | ||
| 1w9k_A | 770 | Dictyostelium Discoideum Myosin Ii Motor Domain S45 | 5e-24 | ||
| 3i5g_A | 839 | Crystal Structure Of Rigor-Like Squid Myosin S1 Len | 6e-24 | ||
| 1w9i_A | 770 | Myosin Ii Dictyostelium Discoideum Motor Domain S45 | 6e-24 | ||
| 1w9j_A | 770 | Myosin Ii Dictyostelium Discoideum Motor Domain S45 | 6e-24 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-24 | ||
| 3myh_X | 762 | Insights Into The Importance Of Hydrogen Bonding In | 1e-23 | ||
| 2x9h_A | 695 | Crystal Structure Of Myosin-2 Motor Domain In Compl | 1e-23 | ||
| 2xo8_A | 776 | Crystal Structure Of Myosin-2 In Complex With Tribr | 1e-23 | ||
| 1d0x_A | 761 | Dictyostelium Myosin S1dc (Motor Domain Fragment) C | 1e-23 | ||
| 1mma_A | 762 | X-Ray Structures Of The Mgadp, Mgatpgammas, And Mga | 1e-23 | ||
| 1fmv_A | 761 | Crystal Structure Of The Apo Motor Domain Of Dictyo | 2e-23 | ||
| 1br2_A | 791 | Smooth Muscle Myosin Motor Domain Complexed With Mg | 2e-23 | ||
| 1br1_A | 820 | Smooth Muscle Myosin Motor Domain-Essential Light C | 2e-23 | ||
| 1mmn_A | 762 | X-Ray Structures Of The Mgadp, Mgatpgammas, And Mga | 2e-23 | ||
| 3dtp_A | 971 | Tarantula Heavy Meromyosin Obtained By Flexible Doc | 3e-23 | ||
| 1mmd_A | 762 | Truncated Head Of Myosin From Dictyostelium Discoid | 3e-23 | ||
| 1mmg_A | 762 | X-Ray Structures Of The Mgadp, Mgatpgammas, And Mga | 3e-23 | ||
| 3j04_A | 909 | Em Structure Of The Heavy Meromyosin Subfragment Of | 3e-23 | ||
| 3dtp_B | 973 | Tarantula Heavy Meromyosin Obtained By Flexible Doc | 3e-23 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-23 | ||
| 1lvk_A | 762 | X-Ray Crystal Structure Of The Mg (Dot) 2'(3')-O-(N | 4e-23 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-23 | ||
| 2os8_A | 840 | Rigor-Like Structures Of Muscle Myosins Reveal Key | 5e-23 | ||
| 1i84_S | 1184 | Cryo-Em Structure Of The Heavy Meromyosin Subfragme | 6e-23 | ||
| 2ec6_A | 838 | Placopecten Striated Muscle Myosin Ii Length = 838 | 9e-23 | ||
| 2w4g_M | 840 | Isometrically Contracting Insect Asynchronous Fligh | 2e-22 | ||
| 1g8x_A | 1010 | Structure Of A Genetically Engineered Molecular Mot | 2e-22 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-22 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-22 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-22 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-21 | ||
| 4db1_A | 783 | Cardiac Human Myosin S1dc, Beta Isoform Complexed W | 2e-21 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-21 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-21 | ||
| 1m8q_A | 840 | Molecular Models Of Averaged Rigor Crossbridges Fro | 3e-21 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-21 | ||
| 2mys_A | 843 | Myosin Subfragment-1, Alpha Carbon Coordinates Only | 3e-21 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-20 | ||
| 2vas_A | 788 | Myosin Vi (Md-Insert2-Cam, Delta-Insert1) Post-Rigo | 5e-20 | ||
| 3l9i_A | 814 | Myosin Vi Nucleotide-Free (Mdinsert2) L310g Mutant | 5e-20 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-20 | ||
| 4anj_A | 1052 | Myosin Vi (Mdinsert2-Gfp Fusion) Pre-Powerstroke St | 5e-20 | ||
| 2x51_A | 789 | M6 Delta Insert1 Length = 789 | 5e-20 | ||
| 4e7z_A | 798 | Myosin Vi (Md) Pre-Powerstroke State, P21 Crystal F | 5e-20 | ||
| 2bkh_A | 814 | Myosin Vi Nucleotide-Free (Mdinsert2) Crystal Struc | 5e-20 | ||
| 2bki_A | 858 | Myosin Vi Nucleotide-Free (Mdinsert2-Iq) Crystal St | 5e-20 | ||
| 4e7s_A | 798 | Myosin Vi D23r I24r R569e (Md) Pre-Powerstroke Stat | 5e-20 | ||
| 2v26_A | 784 | Myosin Vi (Md) Pre-Powerstroke State (Mg.Adp.Vo4) L | 6e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-20 | ||
| 4dbq_A | 788 | Myosin Vi D179y (md-insert2-cam, Delta-insert1) Pos | 8e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-20 | ||
| 4dbp_A | 814 | Myosin Vi Nucleotide-free (mdinsert2) D179y Crystal | 1e-19 | ||
| 4dbr_A | 786 | Myosin Vi D179y (md) Pre-powerstroke State Length = | 1e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-18 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-18 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-18 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-17 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-17 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-17 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-17 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-17 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-15 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-15 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-14 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-13 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-12 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 |
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1LKX|A Chain A, Motor Domain Of Myoe, A Class-I Myosin Length = 697 | Back alignment and structure |
|
| >pdb|4A7F|C Chain C, Structure Of The Actin-Tropomyosin-Myosin Complex (Rigor Atm 3) Length = 697 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OE9|A Chain A, Crystal Structure Of Myosin V Motor With Essential Light Chain - Nucleotide-Free Length = 795 | Back alignment and structure |
|
| >pdb|1W8J|A Chain A, Crystal Structure Of Myosin V Motor Domain - Nucleotide-Free Length = 766 | Back alignment and structure |
|
| >pdb|2DFS|A Chain A, 3-D Structure Of Myosin-V Inhibited State Length = 1080 | Back alignment and structure |
|
| >pdb|1QVI|A Chain A, Crystal Structure Of Scallop Myosin S1 In The Pre-Power Stroke State To 2.6 Angstrom Resolution: Flexibility And Function In The Head Length = 840 | Back alignment and structure |
|
| >pdb|1B7T|A Chain A, Myosin Digested By Papain Length = 835 | Back alignment and structure |
|
| >pdb|2YCU|A Chain A, Crystal Structure Of Human Non Muscle Myosin 2c In Pre-power Stroke State Length = 995 | Back alignment and structure |
|
| >pdb|1KK7|A Chain A, Scallop Myosin In The Near Rigor Conformation Length = 837 | Back alignment and structure |
|
| >pdb|1DFL|A Chain A, Scallop Myosin S1 Complexed With Mgadp:vanadate-Transition State Length = 831 | Back alignment and structure |
|
| >pdb|1DFK|A Chain A, Nucleotide-Free Scallop Myosin S1-Near Rigor State Length = 830 | Back alignment and structure |
|
| >pdb|3MKD|A Chain A, Crystal Structure Of Myosin-2 Dictyostelium Discoideum Motor Domain S456y Mutant In Complex With Adp-Orthovanadate Length = 692 | Back alignment and structure |
|
| >pdb|1YV3|A Chain A, The Structural Basis Of Blebbistatin Inhibition And Specificity For Myosin Ii Length = 762 | Back alignment and structure |
|
| >pdb|2AKA|A Chain A, Structure Of The Nucleotide-Free Myosin Ii Motor Domain From Dictyostelium Discoideum Fused To The Gtpase Domain Of Dynamin 1 From Rattus Norvegicus Length = 776 | Back alignment and structure |
|
| >pdb|3MNQ|A Chain A, Crystal Structure Of Myosin-2 Motor Domain In Complex With Adp- Metavanadate And Resveratrol Length = 788 | Back alignment and structure |
|
| >pdb|2JHR|A Chain A, Crystal Structure Of Myosin-2 Motor Domain In Complex With Adp-Metavanadate And Pentabromopseudilin Length = 788 | Back alignment and structure |
|
| >pdb|1JWY|A Chain A, Crystal Structure Of The Dynamin A Gtpase Domain Complexed With Gdp, Determined As Myosin Fusion Length = 776 | Back alignment and structure |
|
| >pdb|2XEL|A Chain A, Molecular Mechanism Of Pentachloropseudilin Mediated Inhibition Of Myosin Motor Activity Length = 776 | Back alignment and structure |
|
| >pdb|2Y0R|X Chain X, Structural Basis For The Allosteric Interference Of Myosin Function By Mutants G680a And G680v Of Dictyostelium Myosin-2 Length = 758 | Back alignment and structure |
|
| >pdb|2Y9E|X Chain X, Structural Basis For The Allosteric Interference Of Myosin Function By Mutants G680a And G680v Of Dictyostelium Myosin-2 Length = 758 | Back alignment and structure |
|
| >pdb|1W9L|A Chain A, Myosin Ii Dictyostelium Discoideum Motor Domain S456e Bound With Mgadp-Alf4 Length = 770 | Back alignment and structure |
|
| >pdb|1W9K|A Chain A, Dictyostelium Discoideum Myosin Ii Motor Domain S456e With Bound Mgadp-Befx Length = 770 | Back alignment and structure |
|
| >pdb|3I5G|A Chain A, Crystal Structure Of Rigor-Like Squid Myosin S1 Length = 839 | Back alignment and structure |
|
| >pdb|1W9I|A Chain A, Myosin Ii Dictyostelium Discoideum Motor Domain S456y Bound With Mgadp-Befx Length = 770 | Back alignment and structure |
|
| >pdb|1W9J|A Chain A, Myosin Ii Dictyostelium Discoideum Motor Domain S456y Bound With Mgadp-Alf4 Length = 770 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MYH|X Chain X, Insights Into The Importance Of Hydrogen Bonding In The Gamma- Phosphate Binding Pocket Of Myosin: Structural And Functional Studies Of Ser236 Length = 762 | Back alignment and structure |
|
| >pdb|2X9H|A Chain A, Crystal Structure Of Myosin-2 Motor Domain In Complex With Adp-Metavanadate And Pentachlorocarbazole Length = 695 | Back alignment and structure |
|
| >pdb|2XO8|A Chain A, Crystal Structure Of Myosin-2 In Complex With Tribromodichloropseudilin Length = 776 | Back alignment and structure |
|
| >pdb|1D0X|A Chain A, Dictyostelium Myosin S1dc (Motor Domain Fragment) Complexed With M-Nitrophenyl Aminoethyldiphosphate Beryllium Trifluoride. Length = 761 | Back alignment and structure |
|
| >pdb|1MMA|A Chain A, X-Ray Structures Of The Mgadp, Mgatpgammas, And Mgamppnp Complexes Of The Dictyostelium Discoideum Myosin Motor Domain Length = 762 | Back alignment and structure |
|
| >pdb|1FMV|A Chain A, Crystal Structure Of The Apo Motor Domain Of Dictyostellium Myosin Ii Length = 761 | Back alignment and structure |
|
| >pdb|1BR2|A Chain A, Smooth Muscle Myosin Motor Domain Complexed With Mgadp.Alf4 Length = 791 | Back alignment and structure |
|
| >pdb|1BR1|A Chain A, Smooth Muscle Myosin Motor Domain-Essential Light Chain Complex With Mgadp.Alf4 Bound At The Active Site Length = 820 | Back alignment and structure |
|
| >pdb|1MMN|A Chain A, X-Ray Structures Of The Mgadp, Mgatpgammas, And Mgamppnp Complexes Of The Dictyostelium Discoideum Myosin Motor Domain Length = 762 | Back alignment and structure |
|
| >pdb|3DTP|A Chain A, Tarantula Heavy Meromyosin Obtained By Flexible Docking To Tarantula Muscle Thick Filament Cryo-Em 3d-Map Length = 971 | Back alignment and structure |
|
| >pdb|1MMD|A Chain A, Truncated Head Of Myosin From Dictyostelium Discoideum Complexed With Mgadp-Bef3 Length = 762 | Back alignment and structure |
|
| >pdb|1MMG|A Chain A, X-Ray Structures Of The Mgadp, Mgatpgammas, And Mgamppnp Complexes Of The Dictyostelium Discoideum Myosin Motor Domain Length = 762 | Back alignment and structure |
|
| >pdb|3J04|A Chain A, Em Structure Of The Heavy Meromyosin Subfragment Of Chick Smooth Muscle Myosin With Regulatory Light Chain In Phosphorylated State Length = 909 | Back alignment and structure |
|
| >pdb|3DTP|B Chain B, Tarantula Heavy Meromyosin Obtained By Flexible Docking To Tarantula Muscle Thick Filament Cryo-Em 3d-Map Length = 973 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1LVK|A Chain A, X-Ray Crystal Structure Of The Mg (Dot) 2'(3')-O-(N- Methylanthraniloyl) Nucleotide Bound To Dictyostelium Discoideum Myosin Motor Domain Length = 762 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OS8|A Chain A, Rigor-Like Structures Of Muscle Myosins Reveal Key Mechanical Elements In The Transduction Pathways Of This Allosteric Motor Length = 840 | Back alignment and structure |
|
| >pdb|1I84|S Chain S, Cryo-Em Structure Of The Heavy Meromyosin Subfragment Of Chicken Gizzard Smooth Muscle Myosin With Regulatory Light Chain In The Dephosphorylated State. Only C Alphas Provided For Regulatory Light Chain. Only Backbone Atoms Provided For S2 Fragment. Length = 1184 | Back alignment and structure |
|
| >pdb|2EC6|A Chain A, Placopecten Striated Muscle Myosin Ii Length = 838 | Back alignment and structure |
|
| >pdb|1G8X|A Chain A, Structure Of A Genetically Engineered Molecular Motor Length = 1010 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DB1|A Chain A, Cardiac Human Myosin S1dc, Beta Isoform Complexed With Mn-Amppnp Length = 783 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1M8Q|A Chain A, Molecular Models Of Averaged Rigor Crossbridges From Tomograms Of Insect Flight Muscle Length = 840 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2MYS|A Chain A, Myosin Subfragment-1, Alpha Carbon Coordinates Only For The Two Light Chains Length = 843 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2VAS|A Chain A, Myosin Vi (Md-Insert2-Cam, Delta-Insert1) Post-Rigor State Length = 788 | Back alignment and structure |
|
| >pdb|3L9I|A Chain A, Myosin Vi Nucleotide-Free (Mdinsert2) L310g Mutant Crystal Structure Length = 814 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4ANJ|A Chain A, Myosin Vi (Mdinsert2-Gfp Fusion) Pre-Powerstroke State (Mg.Adp.Alf4) Length = 1052 | Back alignment and structure |
|
| >pdb|2X51|A Chain A, M6 Delta Insert1 Length = 789 | Back alignment and structure |
|
| >pdb|4E7Z|A Chain A, Myosin Vi (Md) Pre-Powerstroke State, P21 Crystal Form Length = 798 | Back alignment and structure |
|
| >pdb|2BKH|A Chain A, Myosin Vi Nucleotide-Free (Mdinsert2) Crystal Structure Length = 814 | Back alignment and structure |
|
| >pdb|2BKI|A Chain A, Myosin Vi Nucleotide-Free (Mdinsert2-Iq) Crystal Structure Length = 858 | Back alignment and structure |
|
| >pdb|4E7S|A Chain A, Myosin Vi D23r I24r R569e (Md) Pre-Powerstroke State Length = 798 | Back alignment and structure |
|
| >pdb|2V26|A Chain A, Myosin Vi (Md) Pre-Powerstroke State (Mg.Adp.Vo4) Length = 784 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4DBQ|A Chain A, Myosin Vi D179y (md-insert2-cam, Delta-insert1) Post-rigor State Length = 788 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4DBP|A Chain A, Myosin Vi Nucleotide-free (mdinsert2) D179y Crystal Structure Length = 814 | Back alignment and structure |
|
| >pdb|4DBR|A Chain A, Myosin Vi D179y (md) Pre-powerstroke State Length = 786 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 488 | |||
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-88 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-81 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-77 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-76 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-74 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 5e-74 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 6e-73 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-72 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 8e-67 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-66 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-65 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-64 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-64 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-62 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-57 | |
| 1w9i_A | 770 | Myosin II heavy chain; molecular motor, ATPase, mo | 6e-54 | |
| 1g8x_A | 1010 | Myosin II heavy chain fused to alpha-actinin 3; mo | 1e-53 | |
| 1lkx_A | 697 | Myosin IE heavy chain; myosin motor domain, lever | 4e-52 | |
| 2ycu_A | 995 | Non muscle myosin 2C, alpha-actinin; motor protein | 9e-52 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-51 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-51 | |
| 1w7j_A | 795 | Myosin VA; motor protein, unconventional myosin, m | 2e-51 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-50 | |
| 2v26_A | 784 | Myosin VI; calmodulin-binding, nucleotide-binding, | 2e-50 | |
| 4db1_A | 783 | Myosin-7; S1DC, cardiac, beta isoform, MYH7, myhcb | 2e-50 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-50 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 1e-49 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-49 | |
| 1kk8_A | 837 | Myosin heavy chain, striated muscle; actin-detache | 7e-49 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 3e-48 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 9e-47 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-46 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-45 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-44 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-44 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-43 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-43 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 9e-42 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-40 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-38 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-38 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 6e-38 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 8e-38 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-37 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-37 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 6e-37 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-35 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-35 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-35 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-35 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 6e-35 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-34 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-34 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-34 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-34 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-33 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-33 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 6e-33 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-32 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-32 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 5e-32 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-31 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-31 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-31 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-31 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-31 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-31 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-31 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 6e-31 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 8e-31 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-30 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-30 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-30 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-30 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-30 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-29 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-29 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-29 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-29 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 8e-29 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-29 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 9e-29 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 9e-29 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-28 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-28 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-28 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-28 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-28 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-28 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-28 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-28 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-28 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-28 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-28 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-28 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-28 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-28 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-28 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-28 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-28 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 8e-28 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 9e-28 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-27 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-27 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-27 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-27 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-27 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-27 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-27 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-27 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-27 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-27 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-27 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-27 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 8e-27 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-26 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-26 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-26 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-26 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-26 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-26 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-26 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-25 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-25 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-25 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-25 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-25 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-25 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 5e-25 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-25 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-24 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-24 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-24 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-24 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-24 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-24 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-24 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-23 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-23 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-23 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-23 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-22 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-22 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-22 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-22 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-22 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-22 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-22 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 9e-22 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-21 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-21 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-21 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 9e-21 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 9e-21 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-20 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-20 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-20 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-20 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-20 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-20 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-20 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-20 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-20 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-20 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-20 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 9e-20 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-19 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-19 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-19 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-19 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-19 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 8e-19 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-18 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-18 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-18 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-18 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-18 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-18 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-18 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-18 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-18 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-18 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 7e-18 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 7e-18 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-18 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 9e-18 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 9e-18 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-17 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-17 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-17 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-17 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-17 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-17 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-17 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-17 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-17 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-17 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-17 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-17 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-17 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-17 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-16 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-16 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-16 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-16 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-16 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-16 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-16 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-16 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-16 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-16 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-16 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-16 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-16 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-16 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-16 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-16 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-16 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-16 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-16 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 8e-16 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-16 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-15 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-15 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-15 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-15 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-15 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-14 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 3e-14 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-13 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-12 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 8e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-06 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-04 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 8e-04 |
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 4e-88
Identities = 83/172 (48%), Positives = 116/172 (67%), Gaps = 1/172 (0%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+ IA+I +EI+ G+ LH++ VIHRD++G NVLLT++ EVK+VDFG+S + T +
Sbjct: 126 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE++ C YD + D+W+LGITAIE+ +G PP DMHP RALF
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
I RNP P L ++ WS+ + FI CL KN RP +L++HPFI P
Sbjct: 246 IPRNPAPRL-KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-81
Identities = 69/172 (40%), Positives = 113/172 (65%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E I + ++++ + FLH +IHRDL+ NVL+T +G++++ DFG+S + T K
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ +F+G+P WMAPE++ C + YD + D+W+LGIT IE+ +PP +++P R L +
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 233
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
I ++ PP L S WS + DF+ L+KNPE RP ++LLEHPF++S+ N
Sbjct: 234 IAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 2e-77
Identities = 72/168 (42%), Positives = 111/168 (66%), Gaps = 5/168 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E IA IL+ + G+ +LH IHRD++ N+LL +G K+ DFG++ + +T K
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE+++ GY+ D+W+LGITAIE+ +GKPP+ D+HP RA+F
Sbjct: 182 RNTVIGTPFWMAPEVIQEI-----GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM 236
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
I NPPP + WS ++ DF+ +CL K+PE R ++LL+HPF+ S
Sbjct: 237 IPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 4e-76
Identities = 76/177 (42%), Positives = 114/177 (64%), Gaps = 7/177 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA IL+EI+ G+ +LH IHRD++ +NVLL++ GEVK+ DFG++ + +T K
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ TF+G+P WMAPE+++ YD++ D+W+LGITAIEL G+PP ++HP + LF
Sbjct: 176 RNTFVGTPFWMAPEVIKQS-----AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 230
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS 177
I +N PP L N+S+ +F+ CL K P RP ELL+H FI + +L+
Sbjct: 231 IPKNNPPTL--EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLT 285
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 4e-74
Identities = 59/168 (35%), Positives = 99/168 (58%), Gaps = 5/168 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E+ IA + + ++ + +LH VIHRD++ ++LLT DG VK+ DFG + + K
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+K+ +G+P WMAPE++ Y +D+W+LGI IE+ DG+PP+ P +A+ +
Sbjct: 198 RKSLVGTPYWMAPEVISRS-----LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
+ +PPP L + S DF+ L ++P+ R ELL+HPF+
Sbjct: 253 LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 5e-74
Identities = 66/168 (39%), Positives = 96/168 (57%), Gaps = 5/168 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E IA + +E + + FLH N VIHRD++ N+LL DG VK+ DFG + K
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ Y ++D+W+LGI AIE+ +G+PP+ + +P RAL+
Sbjct: 173 RSTMVGTPYWMAPEVVTRK-----AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
I N P L S + DF+ CLE + E R ELL+H F+
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 6e-73
Identities = 72/179 (40%), Positives = 105/179 (58%), Gaps = 16/179 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD- 59
+ E IA IL+E++ G+ +LH+N IHRD++ N+LL +DG V+I DFG+S A D
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177
Query: 60 ----KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT 115
+KTF+G+P WMAPE+M ++V GYD + D+W+ GITAIEL G P+ P
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVM----EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233
Query: 116 RALFQIVRNPPPGL-------YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
+ L ++N PP L + + + I+ CL+K+PE RP +ELL H F
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-72
Identities = 62/168 (36%), Positives = 104/168 (61%), Gaps = 7/168 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA + + G+ +LH +++IHRD++ N+LL++ G VK+ DFG + +
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAP 206
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+F+G+P WMAPE++ + YD ++DVW+LGIT IEL + KPP +M+ AL+
Sbjct: 207 ANSFVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 264
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
I +N P L ++ +WS+++ +F+ CL+K P+ RP LL+H F+
Sbjct: 265 IAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 8e-67
Identities = 61/181 (33%), Positives = 95/181 (52%), Gaps = 6/181 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ E+ + I + + L EN +IHRD++ SN+LL + G +K+ DFG+S + ++
Sbjct: 122 IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI- 180
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP-TRAL 118
K G +MAPE + GYD R DVW+LGIT EL G+ P+ + L
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASR-QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239
Query: 119 FQIVRNPPPGL--YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
Q+V+ PP L +S +++F+ CL K+ RP ELL+HPFI E + +
Sbjct: 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
Query: 177 S 177
+
Sbjct: 300 A 300
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-66
Identities = 56/179 (31%), Positives = 97/179 (54%), Gaps = 3/179 (1%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ E+ + + I+ + +L E H VIHRD++ SN+LL + G++K+ DFG+S +
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RAL 118
K G ++MAPE + YD R DVW+LGI+ +EL G+ P+++ L
Sbjct: 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS 177
++++ PP L +S + F+ +CL K+ RP ++LLEH FI ++ ++
Sbjct: 240 TKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVA 298
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 1e-65
Identities = 63/179 (35%), Positives = 95/179 (53%), Gaps = 5/179 (2%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ E + I I+ + LH VIHRD++ SNVL+ G+VK+ DFG+S +
Sbjct: 106 IPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV- 164
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM-HPTRAL 118
K G +MAPE + + GY + D+W+LGIT IEL + P++ P + L
Sbjct: 165 AKDIDAGCKPYMAPERINPELNQ-KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS 177
Q+V P P L A +S +VDF ++CL+KN + RP EL++HPF T ++
Sbjct: 224 KQVVEEPSPQL-PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVA 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-64
Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 53/218 (24%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M+E IA+IL+ ++ + ++H +HR ++ S++L++ DG+V + + + +
Sbjct: 125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 61 KKT-------FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113
++ + W++PE+++ + GYD + D++++GITA EL +G PF+DM
Sbjct: 185 QRVVHDFPKYSVKVLPWLSPEVLQQ---NLQGYDAKSDIYSVGITACELANGHVPFKDMP 241
Query: 114 PTRALFQIVRNPPPGL-------------------------------------------Y 130
T+ L + + P L
Sbjct: 242 ATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHP 301
Query: 131 RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
+S H+ F+ +CL++NP+ RP S LL H F
Sbjct: 302 YHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-62
Identities = 40/181 (22%), Positives = 69/181 (38%), Gaps = 11/181 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSR-----ET 54
+ E + L + + G+ +LH ++H D++ NVLL+ DG + DFG +
Sbjct: 147 LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 55 ANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP 114
+ G+ + MAPE++ D ++D+W+ + + +G P+
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMG-----KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261
Query: 115 TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174
+I PPP + + I E L K P HR EL L
Sbjct: 262 GPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
Query: 175 H 175
Sbjct: 322 K 322
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-57
Identities = 63/175 (36%), Positives = 98/175 (56%), Gaps = 8/175 (4%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANTFDK 60
+EQ I F K+I+ G+ +LH+N ++HRD++G NVL+ T G +KI DFG S+ A
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM-HPTRALF 119
+TF G+ +MAPEI+ K GY D+W+LG T IE+ GKPPF ++ P A+F
Sbjct: 180 TETFTGTLQYMAPEIID---KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF 236
Query: 120 QI-VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEND 173
++ + P + + S FI +C E +P+ R ++LL F+ +
Sbjct: 237 KVGMFKVHPEI--PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
|
| >1w9i_A Myosin II heavy chain; molecular motor, ATPase, motor domain, mutant, muscle contraction; HET: ADP; 1.75A {Dictyostelium discoideum} PDB: 1w9j_A* 1w9l_A* 1w9k_A* 1mma_A* 2aka_A 1d0x_A* 1d0y_A* 1d0z_A* 1d1a_A* 1d1b_A* 1d1c_A* 2xel_A* 1yv3_A* 3bz7_A* 3bz8_A* 3bz9_A* 1jwy_A* 1jx2_A* 3mjx_A* 2jhr_A* ... Length = 770 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 6e-54
Identities = 92/346 (26%), Positives = 154/346 (44%), Gaps = 45/346 (13%)
Query: 166 ITSLPENDLHLSTVN---CQYKDQELQTMH------VEDLAALETISEDNIVQELEERHN 216
I S + TV+ Q K + + VED++ L ++E + L R+N
Sbjct: 52 IVSETSDSFTFKTVDGQDRQVKKDDANQRNPIKFDGVEDMSELSYLNEPAVFHNLRVRYN 111
Query: 217 SKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEE 276
Y++ G L+ +NP + +Y + +K + R++ PHI+A++D AY+ M+ +
Sbjct: 112 QDLIYTYSGLFLVAVNPFKRIPIYTQEMVDIFKGRRRNEVAPHIFAISDVAYRSMLDDRQ 171
Query: 277 AQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGE-KIEKCV---NVI-HAIGNAGTP 331
Q +++ GE+ AGKT + K ++++L + G +E+ + N I A GNA T
Sbjct: 172 NQSLLITGESGAGKTENTKKVIQYLASVAGRNQANGSGVLEQQILQANPILEAFGNAKTT 231
Query: 332 INQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQA----NFHIFYYFYD 387
N NS+R ++++ F S+G +SGA Y LEK RV Q+ N+HIFY
Sbjct: 232 RNNNSSRFGKFIEIQFNSAGFISGASIQSYLLEKSRVVF-----QSETERNYHIFYQLLA 286
Query: 388 AMEAAGELDKYFLSPGRKYRYLRA------DVTDDKLPKGPRETPDTNVAKFQEIYQNLI 441
A E L+ + YL D +F+ Q +
Sbjct: 287 GATAE-EKKALHLAGPESFNYLNQSGCVDIKGVSDS-------------EEFKITRQAMD 332
Query: 442 DIEF-DDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAAN 486
+ F + QM IF ++A IL +G ++FE A A L +
Sbjct: 333 IVGFSQEEQMSIFK-IIAGILHLGNIKFEKGAGEGAVLKDKTALNA 377
|
| >1g8x_A Myosin II heavy chain fused to alpha-actinin 3; motor, lever ARM, protein engineering, structural protein; HET: ADP; 2.80A {Dictyostelium discoideum} SCOP: k.1.1.1 Length = 1010 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-53
Identities = 90/346 (26%), Positives = 154/346 (44%), Gaps = 45/346 (13%)
Query: 166 ITSLPENDLHLSTVN---CQYKDQELQTMH------VEDLAALETISEDNIVQELEERHN 216
I S + TV+ Q K + + VED++ L ++E + L R+N
Sbjct: 52 IVSETSDSFTFKTVDGQDRQVKKDDANQRNPIKFDGVEDMSELSYLNEPAVFHNLRVRYN 111
Query: 217 SKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEE 276
Y++ G L+ +NP + +Y + +K + R++ PHI+A++D AY+ M+ +
Sbjct: 112 QDLIYTYSGLFLVAVNPFKRIPIYTQEMVDIFKGRRRNEVAPHIFAISDVAYRSMLDDRQ 171
Query: 277 AQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGE-KIEKCV---NVI-HAIGNAGTP 331
Q +++ GE+ AGKT + K ++++L + G +E+ + N I A GNA T
Sbjct: 172 NQSLLITGESGAGKTENTKKVIQYLASVAGRNQANGSGVLEQQILQANPILEAFGNAKTT 231
Query: 332 INQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQA----NFHIFYYFYD 387
N NS+ ++++ F ++G +SGA Y LEK RV Q+ N+HIFY
Sbjct: 232 RNNNSSEFGKFIEIQFNNAGFISGASIQSYLLEKSRVVF-----QSETERNYHIFYQLLA 286
Query: 388 AMEAAGELDKYFLSPGRKYRYLRA------DVTDDKLPKGPRETPDTNVAKFQEIYQNLI 441
A E L+ + YL D+ +F+ Q +
Sbjct: 287 GATAE-EKKALHLAGPESFNYLNQSGCVDIKGVSDE-------------DEFKITRQAMD 332
Query: 442 DIEF-DDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAAN 486
+ F + QM IF ++A IL +G ++FE A A L +
Sbjct: 333 IVGFSQEEQMSIFK-IIAGILHLGNIKFEKGAGEGAVLKDKTALNA 377
|
| >1lkx_A Myosin IE heavy chain; myosin motor domain, lever ARM, converter domain, contractIle protein; HET: ADP; 3.00A {Dictyostelium discoideum} SCOP: c.37.1.9 Length = 697 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-52
Identities = 93/315 (29%), Positives = 155/315 (49%), Gaps = 41/315 (13%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
V D L I+E+ ++ L RH S N Y+++GDV++ NP +LN+Y Y +
Sbjct: 10 VPDFVLLNQITENAFIENLTMRHKSDNIYTYIGDVVISTNPFKNLNIYKESDIKAYNGRY 69
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312
+ + PH+YA+A+ AY+ M +E Q ++++GE+ AGKT + K +++ L F+ + G
Sbjct: 70 KYEMPPHMYALANDAYRSMRQSQENQCVIISGESGAGKTEASKKIMQFLTFVSSNQSPNG 129
Query: 313 EKIEKCV---N-VIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRV 368
E+I K + N ++ A GNA T N NS+R YM++ F + G G Y LEK RV
Sbjct: 130 ERISKMLLDSNPLLEAFGNAKTLRNDNSSRFGKYMEMQFNAVGSPIGGKITNYLLEKSRV 189
Query: 369 TGNRDPLQA----NFHIFYYFYDAMEAAGELDKYFLSPG-RKYRYLRA------DVTDDK 417
G + +FHIFY + + +LD+ L+P Y YL+ DD
Sbjct: 190 VG-----RTQGERSFHIFYQMLKGLSQS-KLDELGLTPNAPAYEYLKKSGCFDVSTIDDS 243
Query: 418 LPKGPRETPDTNVAKFQEIYQNLIDIEF-DDIQMEIFSNVLAAILLIGEVEF-----ESS 471
+F+ I + + + + Q I+ +LAAIL IG + F + +
Sbjct: 244 -------------GEFKIIVKAMETLGLKESDQNSIWR-ILAAILHIGNITFAEAAEQRT 289
Query: 472 AENTAELANPEVAAN 486
T ++++ + A
Sbjct: 290 GTTTVKVSDTKSLAA 304
|
| >2ycu_A Non muscle myosin 2C, alpha-actinin; motor protein; HET: AOV; 2.25A {Homo sapiens} PDB: 1br1_A* 1br4_A* 1br2_A* Length = 995 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 9e-52
Identities = 84/330 (25%), Positives = 144/330 (43%), Gaps = 45/330 (13%)
Query: 182 QYKDQELQTMH------VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNT 235
+ ++Q M+ ED+A L ++E +++ L ER+ S Y++ G + INP
Sbjct: 45 RLPRDQIQRMNPPKFSKAEDMAELTCLNEASVLHNLRERYYSGLIYTYSGLFCVVINPYK 104
Query: 236 HLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLK 295
L +Y Y+ K R + PH+YAV + AY+ M+ E Q I+ GE+ AGKT + K
Sbjct: 105 QLPIYTEAIVEMYRGKKRHEVPPHVYAVTEGAYRSMLQDREDQSILCTGESGAGKTENTK 164
Query: 296 HLLKHLIFLGQG-----AAKVGEKIEKCV---NVI-HAIGNAGTPINQNSTRHVLYMQVT 346
++++L + V ++E+ + N I A GNA T N NS+R ++++
Sbjct: 165 KVIQYLAHVASSPKGRKEPGVPGELERQLLQANPILEAFGNAKTVKNDNSSRFGKFIRIN 224
Query: 347 FGSSGKLSGAIFWLYQLEKWRVTGNRDPLQA----NFHIFYYFYDAMEAAGELDKYFLSP 402
F +G + GA Y LEK R QA +FHIFY L P
Sbjct: 225 FDVAGYIVGANIETYLLEKSRAIR-----QAKDECSFHIFYQLLGGAGEQ-LKADLLLEP 278
Query: 403 GRKYRYLR----ADVTDDKLPKGPRETPDTNVAKFQEIYQNLIDIEF-DDIQMEIFSNVL 457
YR+L + ++ FQE ++L + F + + + ++
Sbjct: 279 CSHYRFLTNGPSSSPGQER-------------ELFQETLESLRVLGFSHEEIISMLR-MV 324
Query: 458 AAILLIGEVEFESSA-ENTAELANPEVAAN 486
+A+L G + + + A + + A
Sbjct: 325 SAVLQFGNIALKRERNTDQATMPDNTAAQK 354
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 7/218 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
E I +I + +H+ ++HRD++ N+ LTKDG V++ DFG++R +T +
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ +G+P +++PEI C +K Y+N+ D+WALG EL K FE + +
Sbjct: 182 ARACIGTPYYLSPEI--CENK---PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK 236
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
I+ P + ++S +++ ++NP RP ++ +LE FI E L +
Sbjct: 237 IISGSFPPVS--LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA 294
Query: 181 CQYKDQELQTMHVEDLAALETISEDNIVQELEERHNSK 218
++ + + + A S N + + + +K
Sbjct: 295 EEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITK 332
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-51
Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 15/171 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANT 57
M + + ++I+ G+ FLH +IHRDL+ N+ +T G VKI D GL+ +
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
F K +G+P +MAPE+ + YD +DV+A G+ +E+ + P+ +
Sbjct: 186 F--AKAVIGTPEFMAPEMYE------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237
Query: 118 LFQIVRN--PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+++ V + P + I C+ +N + R + +LL H F
Sbjct: 238 IYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >1w7j_A Myosin VA; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Gallus gallus} SCOP: b.34.3.1 c.37.1.9 PDB: 1w7i_A* 1oe9_A* 1w8j_A Length = 795 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-51
Identities = 92/311 (29%), Positives = 138/311 (44%), Gaps = 39/311 (12%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNH-YSFVGDVLLFINPNTHLNLYGTKYHFKYKFK 251
DL AL + E ++ L+ R Y++ G VL+ INP L +YG Y +
Sbjct: 71 ENDLTALSYLHEPAVLHNLKVRFIDSKLIYTYCGIVLVAINPYEQLPIYGEDIINAYSGQ 130
Query: 252 SRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKV 311
+ D +PHI+AVA+ AY+ M E Q I+++GE+ AGKT S K+ +++ + A++
Sbjct: 131 NMGDMDPHIFAVAEEAYKQMARDERNQSIIVSGESGAGKTVSAKYAMRYFATVSGSASEA 190
Query: 312 GEKIEKCV---NVI-HAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWR 367
+E+ V N I +IGNA T N NS+R Y+++ F ++ GA Y LEK R
Sbjct: 191 --NVEEKVLASNPIMESIGNAKTTRNDNSSRFGKYIEIGFDKRYRIIGANMRTYLLEKSR 248
Query: 368 VTGNRDPLQA----NFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRA------DVTDDK 417
V QA N+HIFY + E L + Y + D DD
Sbjct: 249 VVF-----QAEEERNYHIFYQLCASAALP-EFKTLRLGNANYFHYTKQGGSPVIDGIDDA 302
Query: 418 LPKGPRETPDTNVAKFQEIYQNLIDIEF-DDIQMEIFSNVLAAILLIGEVEFESS-AENT 475
+ Q + D QM IF +LA IL +G VEF S +++
Sbjct: 303 -------------KEMVNTRQACTLLGISDSYQMGIFR-ILAGILHLGNVEFASRDSDSC 348
Query: 476 AELANPEVAAN 486
A +
Sbjct: 349 AIPPKHDPLTI 359
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 2e-50
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 51/220 (23%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ EQ + + +I G+ +L E H ++HRD++ SN+L+ GE+K+ DFG+S + ++
Sbjct: 128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF---------- 109
+F+G+ S+M+PE ++ Y + D+W++G++ +E+ G+ P
Sbjct: 186 MANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240
Query: 110 ----------------------------EDMHPTRALF----QIVRNPPPGLYRASNWSQ 137
D P A+F IV PPP L + +S
Sbjct: 241 MFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL-PSGVFSL 299
Query: 138 HYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS 177
+ DF+ +CL KNP R + +L+ H FI ++ +
Sbjct: 300 EFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFA 339
|
| >2v26_A Myosin VI; calmodulin-binding, nucleotide-binding, membrane, vanadate, transport, PRE- powerstroke, transition state, protein transport; HET: ADP; 1.75A {Sus scrofa} PDB: 2bki_A 2bkh_A 3l9i_A 2x51_A 2vb6_A* 2vas_A* Length = 784 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-50
Identities = 80/354 (22%), Positives = 158/354 (44%), Gaps = 44/354 (12%)
Query: 166 ITSLPENDLHLSTVNCQYKD-----QELQTMH------VEDLAALETISEDNIVQELEER 214
I + + L + +N + K ++ VED +L ++E ++ ++ R
Sbjct: 17 IVDIGPDSLTIEPLNQKGKTFLALINQVFPAEEDSKKDVEDNCSLMYLNEATLLHNIKVR 76
Query: 215 HNSKNHYSFVGDVLLFINPNTHL-NLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMH 273
++ Y++V ++L+ +NP + +Y ++ Y+ KS PH++A+AD A++DM
Sbjct: 77 YSKDRIYTYVANILIAVNPYFDIPKIYSSETIKSYQGKSLGTMPPHVFAIADKAFRDMKV 136
Query: 274 HEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPIN 333
+ +Q I+++GE+ AGKT + K +L++L + ++I + ++ A GNA T N
Sbjct: 137 LKLSQSIIVSGESGAGKTENTKFVLRYLTESYGTGQDIDDRIVEANPLLEAFGNAKTVRN 196
Query: 334 QNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQA----NFHIFYYFYDAM 389
NS+R ++++ F + G Y LEK R+ Q N+HIFY
Sbjct: 197 NNSSRFGKFVEIHFNEKSSVVGGFVSHYLLEKSRICV-----QGKEERNYHIFYRLCAGA 251
Query: 390 EAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVAKFQEIYQNLIDI------ 443
++ LS +RYL T K + N + + +
Sbjct: 252 SED-IRERLHLSSPDNFRYLNRGCTRYFANKETDKQILQNRKSPEYLKAGSLKDPLLDDH 310
Query: 444 -EF-------------DDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEV 483
+F D+ ++++F V+A +L +G ++FE + +T+ N +
Sbjct: 311 GDFIRMCTAMKKIGLDDEEKLDLFR-VVAGVLHLGNIDFEEA-GSTSGGCNLKN 362
|
| >4db1_A Myosin-7; S1DC, cardiac, beta isoform, MYH7, myhcb, MYHC-beta, contractIle protein; HET: ANP; 2.60A {Homo sapiens} PDB: 2w4a_M 2w4g_M 2w4h_M 2mys_A* 1m8q_A* 1mvw_A* 1o18_A* 1o19_A* 1o1a_A* 1o1b_A* 1o1c_A* 1o1d_A* 1o1e_A* 1o1f_A* 1o1g_A* Length = 783 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-50
Identities = 82/349 (23%), Positives = 150/349 (42%), Gaps = 44/349 (12%)
Query: 166 ITSLPENDLHLSTVN---CQYKDQELQTMH------VEDLAALETISEDNIVQELEERHN 216
I S + T K+ ++ + +ED+A L + E ++ L++R+
Sbjct: 51 IVSREGGKVTAETEYGKTVTVKEDQVMQQNPPKFDKIEDMAMLTFLHEPAVLYNLKDRYG 110
Query: 217 SKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEE 276
S Y++ G + +NP L +Y + Y+ K RS+ PHI++++D+AYQ M+ E
Sbjct: 111 SWMIYTYSGLFCVTVNPYKWLPVYTPEVVAAYRGKKRSEAPPHIFSISDNAYQYMLTDRE 170
Query: 277 AQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEK-------IEKCV---NVI-HAI 325
Q I++ GE+ AGKT + K ++++ + + + +E + N A
Sbjct: 171 NQSILITGESGAGKTVNTKRVIQYFAVIAAIGDRSKKDQSPGKGTLEDQIIQANPALEAF 230
Query: 326 GNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQA----NFHI 381
GNA T N NS+R ++++ FG++GKL+ A Y LEK RV Q ++HI
Sbjct: 231 GNAKTVRNDNSSRFGKFIRIHFGATGKLASADIETYLLEKSRVIF-----QLKAERDYHI 285
Query: 382 FYYFYDAMEAAGELDKYFLSPG-RKYRYLRADVTDDKLPKGPRETPDTN-VAKFQEIYQN 439
FY + LD ++ Y ++ +G + +
Sbjct: 286 FYQILSNKKPE-LLDMLLITNNPYDYAFIS---------QGETTVASIDDAEELMATDNA 335
Query: 440 LIDIEF-DDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVAAN 486
+ F + + ++ + AI+ G ++F+ E AE E A
Sbjct: 336 FDVLGFTSEEKNSMYK-LTGAIMHFGNMKFKLKQREEQAEPDGTEEADK 383
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 39/166 (23%), Positives = 68/166 (40%), Gaps = 11/166 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E + L++ + + LH ++H D++ +N+ L G K+ DFGL E
Sbjct: 154 LPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GA 212
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ G P +MAPE+++ Y DV++LG+T +E+ + L Q
Sbjct: 213 GEVQEGDPRYMAPELLQ------GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
P + S + LE +P+ R LL P +
Sbjct: 267 GYLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-49
Identities = 92/311 (29%), Positives = 138/311 (44%), Gaps = 39/311 (12%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNH-YSFVGDVLLFINPNTHLNLYGTKYHFKYKFK 251
DL AL + E ++ L+ R Y++ G VL+ INP L +YG Y +
Sbjct: 71 ENDLTALSYLHEPAVLHNLKVRFIDSKLIYTYCGIVLVAINPYEQLPIYGEDIINAYSGQ 130
Query: 252 SRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKV 311
+ D +PHI+AVA+ AY+ M E Q I+++GE+ AGKT S K+ +++ + A++
Sbjct: 131 NMGDMDPHIFAVAEEAYKQMARDERNQSIIVSGESGAGKTVSAKYAMRYFATVSGSASEA 190
Query: 312 GEKIEKCV---NVI-HAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWR 367
+E+ V N I +IGNA T N NS+R Y+++ F ++ GA Y LEK R
Sbjct: 191 --NVEEKVLASNPIMESIGNAKTTRNDNSSRFGKYIEIGFDKRYRIIGANMRTYLLEKSR 248
Query: 368 VTGNRDPLQA----NFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLR------ADVTDDK 417
V QA N+HIFY + E L + Y + D DD
Sbjct: 249 VVF-----QAEEERNYHIFYQLCASAALP-EFKTLRLGNANYFHYTKQGGSPVIDGIDDA 302
Query: 418 LPKGPRETPDTNVAKFQEIYQNLIDIEF-DDIQMEIFSNVLAAILLIGEVEFESS-AENT 475
+ Q + D QM IF +LA IL +G VEF S +++
Sbjct: 303 -------------KEMVNTRQACTLLGISDSYQMGIFR-ILAGILHLGNVEFASRDSDSC 348
Query: 476 AELANPEVAAN 486
A +
Sbjct: 349 AIPPKHDPLTI 359
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-49
Identities = 40/168 (23%), Positives = 82/168 (48%), Gaps = 8/168 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+ + ++ + + +H V+HRD++ +NV +T G VK+ D GL R ++
Sbjct: 133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 192
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF--EDMHPTRAL 118
+ +G+P +M+PE GY+ + D+W+LG E+ + PF + M+
Sbjct: 193 AHSLVGTPYYMSPER--IHEN---GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 247
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+I + P L + ++S+ + C+ +PE RP ++ + +
Sbjct: 248 KKIEQCDYPPL-PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294
|
| >1kk8_A Myosin heavy chain, striated muscle; actin-detached, mechanics of motor, contractIle PROT; HET: ADP; 2.30A {Argopecten irradians} SCOP: b.34.3.1 c.37.1.9 PDB: 1kk7_A* 1qvi_A* 1s5g_A* 1sr6_A 1b7t_A* 1kqm_A* 1kwo_A* 1l2o_A* 1dfl_A* 2w4t_C 2w4v_C 2w4w_C 1dfk_A 2ec6_A 2otg_A* 2os8_A* 2ovk_A 2ekv_A 2ekw_A 2oy6_A* ... Length = 837 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-49
Identities = 88/333 (26%), Positives = 153/333 (45%), Gaps = 50/333 (15%)
Query: 184 KDQELQTMH------VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHL 237
K ++Q+M+ +ED+A + ++E +++ L R+ S Y++ G + +NP L
Sbjct: 70 KKDDIQSMNPPKFEKLEDMANMTYLNEASVLYNLRSRYTSGLIYTYSGLFCIAVNPYRRL 129
Query: 238 NLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHL 297
+Y KY+ K +++ PH+++VAD+AYQ+M+ E Q ++ GE+ AGKT + K +
Sbjct: 130 PIYTDSVIAKYRGKRKTEIPPHLFSVADNAYQNMVTDRENQSCLITGESGAGKTENTKKV 189
Query: 298 LKHLIFLGQGAAKVGEK--------IEKCV---NVI-HAIGNAGTPINQNSTRHVLYMQV 345
+ +L + K E+ +E + N + A GNA T N NS+R ++++
Sbjct: 190 IMYLAKVACAVKKKDEEASDKKEGSLEDQIIQANPVLEAYGNAKTTRNNNSSRFGKFIRI 249
Query: 346 TFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQA----NFHIFYYFYDAMEAAGELDKYFLS 401
FG +GK++GA Y LEK RVT Q N+HIFY D ++
Sbjct: 250 HFGPTGKIAGADIETYLLEKSRVTY-----QQSAERNYHIFYQICSNAIPE-LNDVMLVT 303
Query: 402 PG-RKYRYLRADVT-----DDKLPKGPRETPDTNVAKFQEIYQNLIDIEF-DDIQMEIFS 454
P Y ++ DD +F+ + + F + + +F
Sbjct: 304 PDSGLYSFINQGCLTVDNIDDV-------------EEFKLCDEAFDILGFTKEEKQSMFK 350
Query: 455 NVLAAILLIGEVEF-ESSAENTAELANPEVAAN 486
A+IL +GE++F + E AE A
Sbjct: 351 -CTASILHMGEMKFKQRPREEQAESDGTAEAEK 382
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 3e-48
Identities = 86/330 (26%), Positives = 142/330 (43%), Gaps = 37/330 (11%)
Query: 182 QYKDQELQTMH------VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNT 235
++Q M+ VED+A L ++E +++ L ER+ S Y++ G + INP
Sbjct: 68 TLSKDDIQKMNPPKFSKVEDMAELTCLNEASVLHNLRERYFSGLIYTYSGLFCVVINPYK 127
Query: 236 HLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLK 295
L +Y K YK K R + PHIYA+AD+AY+ M+ E Q I+ GE+ AGKT + K
Sbjct: 128 QLPIYSEKIIDMYKGKKRHEMPPHIYAIADTAYRSMLQDREDQSILCTGESGAGKTENTK 187
Query: 296 HLLKHLIFLGQGAAKVGEKIEKCVN----------------VIHAIGNAGTPINQNSTRH 339
++++L + + ++ A GNA T N NS+R
Sbjct: 188 KVIQYLAVVASSHKGKKDTSITQGPSFSYGELEKQLLQANPILEAFGNAKTVKNDNSSRF 247
Query: 340 VLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYF 399
++++ F +G + GA Y LEK R + + FHIFYY +
Sbjct: 248 GKFIRINFDVTGYIVGANIETYLLEKSRAI-RQAKDERTFHIFYYLIAGASEQ-MRNDLL 305
Query: 400 LSPGRKYRYLRADVTDDKLPKGPRETPDTN-VAKFQEIYQNLIDIEF-DDIQMEIFSNVL 457
L Y +L G P FQE + + + F ++ Q I V+
Sbjct: 306 LEGFNNYTFLS---------NGHVPIPAQQDDEMFQETLEAMTIMGFTEEEQTSILR-VV 355
Query: 458 AAILLIGEVEF-ESSAENTAELANPEVAAN 486
+++L +G + F + + A + + A
Sbjct: 356 SSVLQLGNIVFKKERNTDQASMPDNTAAQK 385
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-47
Identities = 41/166 (24%), Positives = 73/166 (43%), Gaps = 13/166 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + + ++I G+ ++H +I+RDL+ SN+ L +VKI DFGL N K
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GK 177
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ G+ +M+PE + Y +D++ALG+ EL + F
Sbjct: 178 RTRSKGTLRYMSPEQ--ISSQ---DYGKEVDLYALGLILAELLHVCDTAFETS---KFFT 229
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+R+ + + + + + L K PE RP SE+L +
Sbjct: 230 DLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 32/187 (17%), Positives = 74/187 (39%), Gaps = 32/187 (17%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE------------------ 42
E + +L ++ G+ ++H ++H D++ SN+ +++
Sbjct: 112 FKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
Query: 43 -VKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE 101
KI D G ++ + G ++A E++ +E + + D++AL +T +
Sbjct: 172 MFKIGDLGHVTRISSP----QVEEGDSRFLANEVL----QENYTHLPKADIFALALTVVC 223
Query: 102 LGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELL 161
+P + +I + P + SQ + + + + +PE RP L+
Sbjct: 224 AAGAEPLPRNGDQ---WHEIRQGRLPRI--PQVLSQEFTELLKVMIHPDPERRPSAMALV 278
Query: 162 EHPFITS 168
+H + S
Sbjct: 279 KHSVLLS 285
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 50/254 (19%), Positives = 99/254 (38%), Gaps = 24/254 (9%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE-----VKIVDFGLSR---E 53
+L++ +G+ LH +++HRDL+ N+L++ I DFGL +
Sbjct: 116 LGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175
Query: 54 TANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDM 112
++F ++ G+ W+APE++ KE +D+++ G + + +G PF
Sbjct: 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKE--NPTYTVDIFSAGCVFYYVISEGSHPFGKS 233
Query: 113 HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
+A + L+ + + I + + +P+ RP +L+HPF SL +
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293
Query: 173 DLHLSTVNCQYKDQELQTMHVEDLAALETISEDNIVQELEE----------RHNSKNHYS 222
V+ + + + L + LE + + E R
Sbjct: 294 LQFFQDVSDRIEKESLDG---PIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGG 350
Query: 223 FVGDVLLFINPNTH 236
V D+L + H
Sbjct: 351 SVRDLLRAMRNKKH 364
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-44
Identities = 49/234 (20%), Positives = 99/234 (42%), Gaps = 16/234 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN--TF 58
+ K ++ + +H++ ++H DL+ +N L+ DG +K++DFG++ + T
Sbjct: 105 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163
Query: 59 DKKKTFLGSPSWMAPEIMR------CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM 112
K + +G+ ++M PE ++ K + DVW+LG + GK PF+ +
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223
Query: 113 -HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171
+ L I+ + + D + CL+++P+ R + ELL HP++
Sbjct: 224 INQISKLHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282
Query: 172 NDLHLSTVNCQYKDQELQTMHVED-----LAALETISEDNIVQELEERHNSKNH 220
++ + L + + L A +T+ E E +SK
Sbjct: 283 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTF 336
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 8e-44
Identities = 47/228 (20%), Positives = 98/228 (42%), Gaps = 15/228 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN--TF 58
+ K ++ + +H++ ++H DL+ +N L+ DG +K++DFG++ + T
Sbjct: 152 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210
Query: 59 DKKKTFLGSPSWMAPEIM------RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM 112
K + +G+ ++M PE + R K + DVW+LG + GK PF+ +
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 113 -HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171
+ L I+ + + D + CL+++P+ R + ELL HP++
Sbjct: 271 INQISKLHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ---- 325
Query: 172 NDLHLSTVNCQYKDQELQTMHVEDLAALETISEDNIVQELEERHNSKN 219
H + +E++ + + + S + L E ++
Sbjct: 326 IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGE 373
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 11/176 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN--TF 58
+ K ++ + +H++ ++H DL+ +N L+ DG +K++DFG++ + T
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182
Query: 59 DKKKTFLGSPSWMAPEIM------RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM 112
K + +G+ ++M PE + R K + DVW+LG + GK PF+ +
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242
Query: 113 -HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
+ L I+ + + D + CL+++P+ R + ELL HP++
Sbjct: 243 INQISKLHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 38/182 (20%), Positives = 76/182 (41%), Gaps = 25/182 (13%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-- 59
+ ++I+ + ++H +IHRDL+ N+ + + VKI DFGL++ + D
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 60 ------------KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKP 107
+ +G+ ++A E++ Y+ +ID+++LGI E+ P
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVL----DGTGHYNEKIDMYSLGIIFFEM--IYP 227
Query: 108 PF---EDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHP 164
E ++ + L + PP N + I ++ +P RP LL
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFD--DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285
Query: 165 FI 166
++
Sbjct: 286 WL 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-42
Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 12/171 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHE-----NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA 55
+ E+ + ++ ++ + H + V+HRDL+ +NV L VK+ DFGL+R
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167
Query: 56 NTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT 115
+ KTF+G+P +M+PE Y+ + D+W+LG EL PPF
Sbjct: 168 HDTSFAKTFVGTPYYMSPEQ--MNRM---SYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222
Query: 116 RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+I + +S + I L HRP + E+LE+P I
Sbjct: 223 ELAGKIREGKFRRI--PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-40
Identities = 41/180 (22%), Positives = 72/180 (40%), Gaps = 21/180 (11%)
Query: 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKK 62
I +I + FLH ++HRDL+ SN+ T D VK+ DFGL +++
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 63 TFL------------GSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE 110
G+ +M+PE + + Y +++D+++LG+ EL P
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQI-----HGNSYSHKVDIFSLGLILFEL--LYPFST 229
Query: 111 DMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
M R L + P L+ + + + L +P RP ++E+ L
Sbjct: 230 QMERVRTLTDVRNLKFPPLF--TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 16/183 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E + L++I+ G +LH N VIHRDL+ N+ L +D EVKI DFGL+ + ++
Sbjct: 112 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
KK G+P+++APE++ G+ +DVW++G L GKPPFE + +
Sbjct: 172 KKVLCGTPNYIAPEVL-----SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYL 225
Query: 121 IVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT------SLPEND 173
++ Y + I + L+ +P RP ++ELL F T LP
Sbjct: 226 RIKK---NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 282
Query: 174 LHL 176
L +
Sbjct: 283 LTI 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 7/160 (4%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLG 66
I ++ GM +LH +IHRDL+ +N+ L +D VKI DFGL+ E + + + G
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP-TRALFQIVRN- 124
S WMAPE++R ++ + Y + DV+A GI EL G+ P+ +++ + + + R
Sbjct: 185 SILWMAPEVIR--MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS 242
Query: 125 -PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P SN + +AECL+K + RP +L
Sbjct: 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-38
Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 16/169 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF 58
+ E+ + ++ GM +LH + ++HR+L+ N+L+ K VK+ DFGLSR A+TF
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
K+ G+P WMAPE++R + + DV++ G+ EL + P+ +++P + +
Sbjct: 194 LSSKSAAGTPEWMAPEVLRDEP-----SNEKSDVYSFGVILWELATLQQPWGNLNPAQVV 248
Query: 119 FQIVRN----PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ P N + I C P RP + +++
Sbjct: 249 AAVGFKCKRLEIP-----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-38
Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 16/183 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E + L++I+ G +LH N VIHRDL+ N+ L +D EVKI DFGL+ + ++
Sbjct: 138 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
KK G+P+++APE++ G+ +DVW++G L GKPPFE + +
Sbjct: 198 KKVLCGTPNYIAPEVL-----SKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYL 251
Query: 121 IVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT------SLPEND 173
++ Y + I + L+ +P RP ++ELL F T LP
Sbjct: 252 RIKK---NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 308
Query: 174 LHL 176
L +
Sbjct: 309 LTI 311
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
EQ A + E+ + + H VIHRD++ N+LL GE+KI DFG S + +
Sbjct: 106 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SR 163
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ G+ ++ PE++ E +D ++D+W+LG+ E GKPPFE +
Sbjct: 164 RTDLCGTLDYLPPEMI-----EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 218
Query: 121 IVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
I R + ++ ++ D I+ L+ NP RP + E+LEHP+IT
Sbjct: 219 ISR----VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-37
Identities = 55/168 (32%), Positives = 88/168 (52%), Gaps = 10/168 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
SE + +IITGM++LH + ++HRDL SN+LLT++ +KI DFGL+ + +K
Sbjct: 109 FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
T G+P++++PEI + DVW+LG L G+PPF+ +
Sbjct: 169 HYTLCGTPNYISPEIA-----TRSAHGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLN 222
Query: 121 IVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
V Y ++ S D I + L +NP R +S +L+HPF++
Sbjct: 223 KVVL---ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 41/193 (21%), Positives = 78/193 (40%), Gaps = 21/193 (10%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E I ++L I G+ +H HRDL+ +N+LL +G+ ++D G + +
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 61 KKTFL---------GSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFED 111
+ L + S+ APE+ + D R DVW+LG + G+ P++
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSV--QSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 112 MH-PTRALFQIVRN----PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+ ++ V+N P + S + + +P RP++ LL
Sbjct: 249 VFQKGDSVALAVQNQLSIPQSPRH-----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
Query: 167 TSLPENDLHLSTV 179
P H + +
Sbjct: 304 LQPPAPGQHTTQI 316
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 3e-35
Identities = 24/176 (13%), Positives = 48/176 (27%), Gaps = 12/176 (6%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
+ + ++I L ++H N+ + DG + + D +
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--- 248
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT------ 115
P AP + + ++ W LG++ + PF + P
Sbjct: 249 -PASSVPVTYAPREFLNASTA--TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305
Query: 116 RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171
R ++ + I L + R E +E P L
Sbjct: 306 RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 19/200 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ I +EI+ GM +LH ++H+DL+ NV +G+V I DFGL +
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185
Query: 61 KKT-----FLGSPSWMAPEIMRCGHKEVDG----YDNRIDVWALGITAIELGDGKPPFED 111
++ G +APEI+R + + + DV+ALG EL + PF+
Sbjct: 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
Query: 112 MHPTRALFQIVRN---PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
++Q+ + D + C E RP ++L++ +
Sbjct: 246 QPAEAIIWQMGTGMKPNLS----QIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEK 299
Query: 169 LPENDLHLSTVNCQYKDQEL 188
LP+ + LS +K EL
Sbjct: 300 LPKRNRRLSHPGHFWKSAEL 319
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 40/182 (21%), Positives = 73/182 (40%), Gaps = 25/182 (13%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
I +I + FLH ++HRDL+ SN+ T D VK+ DFGL +++
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 62 KTFL------------GSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
G+ +M+PE + + Y +++D+++LG+ EL F
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQI-----HGNNYSHKVDIFSLGLILFELLY---SF 273
Query: 110 EDMHPTRALFQIVRNP--PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
+ VRN P + + + L +P RP ++++E+
Sbjct: 274 STQMERVRIITDVRNLKFPLLF---TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
Query: 168 SL 169
+L
Sbjct: 331 NL 332
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 47/168 (27%), Positives = 83/168 (49%), Gaps = 12/168 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
EQ A ++E+ + + HE VIHRD++ N+L+ GE+KI DFG S + +
Sbjct: 111 FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LR 168
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
++T G+ ++ PE++ E +D ++D+W G+ E G PPF+ T +
Sbjct: 169 RRTMCGTLDYLPPEMI-----EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR 223
Query: 121 IVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
IV + + S D I++ L +P R + ++EHP++
Sbjct: 224 IVN----VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 31/161 (19%), Positives = 60/161 (37%), Gaps = 18/161 (11%)
Query: 9 ILKEIITGMVFLH--ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLG 66
++ GM FLH E + L +V++ +D +I + + +
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMY 170
Query: 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN-- 124
+P+W+APE ++ K D D+W+ + EL + PF D+ ++
Sbjct: 171 APAWVAPEALQ--KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228
Query: 125 --PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P S H + C+ ++P RP ++
Sbjct: 229 RPTIP-----PGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 2e-34
Identities = 29/177 (16%), Positives = 50/177 (28%), Gaps = 17/177 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + ++I + LH ++H LR +++L + G V + F
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR----DGA 258
Query: 61 KKTFLGSPSWMAPEIMRC------GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP 114
+ S + PE+ D WALG+ + P
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318
Query: 115 TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171
I R+ N Q + L E R + +E P L
Sbjct: 319 LGGSEWIFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 30/172 (17%), Positives = 51/172 (29%), Gaps = 8/172 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET-ANTFD 59
+ + ++I + LH ++H LR +++L + G V + F A+
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVS 267
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
P A ++ G D W LG+ + P D
Sbjct: 268 PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE 327
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171
I R+ N Q + L E R + +E P L
Sbjct: 328 WIFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 23/206 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLH-ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ Q I I+K ++ ++H E ++ HRD++ SN+L+ K+G VK+ DFG S +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--K 205
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
K K G+ +M PE +G ++D+W+LGI + PF LF
Sbjct: 206 KIKGSRGTYEFMPPEFFS-NESSYNGA--KVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 120 QIVRN-----PPPGLYRASNWSQHYV------------DFIAECLEKNPEHRPYMSELLE 162
+R P + + DF+ L KNP R + L+
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
Query: 163 HPFITSLPENDLHLSTVNCQYKDQEL 188
H ++ DL + K ++L
Sbjct: 323 HEWLADTNIEDLREFSKELYKKRKKL 348
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 54/167 (32%), Positives = 89/167 (53%), Gaps = 3/167 (1%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE F +++I G+ +LH +IHRD++ SN+L+ +DG +KI DFG+S E +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+G+P++MAPE + K G +DVWA+G+T G+ PF D L
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGK--ALDVWAMGVTLYCFVFGQCPFMDER-IMCLHS 250
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
+++ + ++ D I L+KNPE R + E+ HP++T
Sbjct: 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 48/233 (20%), Positives = 91/233 (39%), Gaps = 27/233 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-------------KDGEVKIVD 47
E + +L++I +G+ LH +IHRDL+ N+L++ ++ + I D
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 48 FGLSR----ETANTFDKKKTFLGSPSWMAPEIMRCGHKEVD--GYDNRIDVWALG-ITAI 100
FGL + ++ G+ W APE++ + ID++++G +
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 101 ELGDGKPPFEDMHPTRALFQIVRN----PPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156
L GK PF D + + I+R + D I++ ++ +P RP
Sbjct: 232 ILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289
Query: 157 MSELLEHPFITSLPENDLHLSTVNCQYKDQELQTMHVEDLAALETISEDNIVQ 209
++L HP + L V+ + E + L + S+ I
Sbjct: 290 AMKVLRHPLFWPKSKKLEFLLKVS-DRLEIENRDPPSALLMKFDAGSDFVIPS 341
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 18/187 (9%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE--VKIVDFGLSRETANTFD 59
E+ I+ I+++I + + +LH + HRD++ N L + + +K+VDFGLS+E +
Sbjct: 166 REKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 60 KK----KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT 115
+ T G+P ++APE++ ++ Y + D W+ G+ L G PF ++
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTNE---SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282
Query: 116 RALFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
V N N+ S D ++ L +N + R L+HP+I+
Sbjct: 283 D-TISQVLN---KKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338
Query: 171 ENDLHLS 177
+ +S
Sbjct: 339 DKIYKMS 345
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 23/168 (13%)
Query: 9 ILKEIITGMVFLHENH---VIHRDLRGSNVLLTKDGE--------VKIVDFGLSRETANT 57
+I GM +LH+ +IHRDL+ SN+L+ + E +KI DFGL+RE T
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
K + G+ +WMAPE++R + DVW+ G+ EL G+ PF +
Sbjct: 170 --TKMSAAGAYAWMAPEVIRASM-----FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222
Query: 118 LFQIVRN--PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ + N P S + + + +C +P RP + +L+
Sbjct: 223 AYGVAMNKLALP---IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
+E+ A I+++I T + FLH +++ HRD++ N+L T KD +K+ DFG ++ET
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-- 183
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
+ +T +P ++APE++ YD D+W+LG I I L G PPF
Sbjct: 184 NALQTPCYTPYYVAPEVLGPE-----KYDKSCDMWSLGVIMYILLC-GFPPFYSNTGQAI 237
Query: 118 LFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT---SL 169
+ R G Y W S+ I L+ +P R +++ + HP+I +
Sbjct: 238 SPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297
Query: 170 PENDLHLSTVNCQYKDQ--ELQTMHVEDLAALETISEDNI 207
P+ LH + V + KD E++ LA + + D +
Sbjct: 298 PQTPLHTARVLQEDKDHWDEVKEEMTSALATMR-VDYDQV 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 29/173 (16%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--------------T 54
K+I +GM +LH ++IHRDL N L+ ++ V + DFGL+R
Sbjct: 113 FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 55 ANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP 114
K+ T +G+P WMAPE++ YD ++DV++ GI E+ D P
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRS-----YDEKVDVFSFGIVLCEIIGRVNADPDYLP 227
Query: 115 TRALFQIV-----RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
F + P N + C + +PE RP +L
Sbjct: 228 RTMDFGLNVRGFLDRYCP-----PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 43/186 (23%), Positives = 71/186 (38%), Gaps = 21/186 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF 58
+S + I + + +H +IHRDL+ N+LL+ G +K+ DFG + ++
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 59 DKKK------------TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGK 106
D T +P + PEI+ + D+WALG L +
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP--IGEKQDIWALGCILYLLCFRQ 250
Query: 107 PPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
PFED R + PP + I L+ NPE R ++E++
Sbjct: 251 HPFEDGAKLRIVNGKYSIPPHDTQ-----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305
Query: 167 TSLPEN 172
+ N
Sbjct: 306 IAAARN 311
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 37/176 (21%), Positives = 75/176 (42%), Gaps = 24/176 (13%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGE-----VKIVDFGLSRE 53
+ ++ +I G+ ++ + ++HRDLR N+ L E K+ DFGLS++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
Query: 54 TANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113
+ ++ LG+ WMAPE + + Y + D ++ + + G+ PF++
Sbjct: 179 SVHS---VSGLLGNFQWMAPETIGAEEES---YTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 114 PTRALFQI------VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ F +R P + + I C +P+ RP+ S +++
Sbjct: 233 YGKIKFINMIREEGLRPTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 55/213 (25%), Positives = 85/213 (39%), Gaps = 25/213 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHE---NHVIHRDLRGSNVLLTKDGEV-KIVDFGLSRETAN 56
+ H + G+ +LH +IHRDL+ N+LL G V KI DFG + +
Sbjct: 99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PT 115
K GS +WMAPE+ + Y + DV++ GI E+ + PF+++ P
Sbjct: 159 HMTNNK---GSAAWMAPEVFEGSN-----YSEKCDVFSWGIILWEVITRRKPFDEIGGPA 210
Query: 116 RALFQIVRN---PP-PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH--PFITSL 169
+ V N PP N + + C K+P RP M E+++ +
Sbjct: 211 FRIMWAVHNGTRPPLI-----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
Query: 170 PENDLHLSTVNCQYKDQELQTMHVEDLAALETI 202
P D L CQ+ + VE
Sbjct: 266 PGADEPLQY-PCQHSLPPGEDGRVEPYVDFAEF 297
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 27/226 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE----VKIVDFGLSRETANT 57
SE+ + +L I + +LH V+HRDL+ SN+L + ++I DFG +++
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHP-- 114
T + +++APE++ GYD D+W+LG + L G PF +
Sbjct: 174 NGLLMTPCYTANFVAPEVLER-----QGYDAACDIWSLGVLLYTMLT-GYTPFANGPDDT 227
Query: 115 TRALFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT-- 167
+ + + G + W S D +++ L +P R + +L HP+I
Sbjct: 228 PEEILARIGS---GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
Query: 168 -SLPENDLHLSTVNCQYK---DQELQTMHVEDLAALETISEDNIVQ 209
LP+ L+ K ++ LE + + Q
Sbjct: 285 DQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQ 330
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
SE ++I++++++ + +H+ V+HRDL+ N+L T + E+KI+DFG +R
Sbjct: 104 SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPF------ED 111
KT + + APE++ +GYD D+W+LG I L G+ PF
Sbjct: 164 QPLKTPCFTLHYAAPELLNQ-----NGYDESCDLWSLGVILYTMLS-GQVPFQSHDRSLT 217
Query: 112 MHPTRALFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+ + ++ G + W SQ D I L +P R MS L + ++
Sbjct: 218 CTSAVEIMKKIKK---GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274
Query: 167 T---SLPENDLHLSTVNCQYKDQELQTM 191
L N L + +
Sbjct: 275 QDGSQLSSNPLMTPDILGSSGAAVHTCV 302
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRE----- 53
+E + +++++ + + FLH + HRDL+ N+L + VKI DF L
Sbjct: 109 NELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 54 --TANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFE 110
+ + + T GS +MAPE++ +E YD R D+W+LG I I L G PPF
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS-GYPPFV 227
Query: 111 DMHPTRALFQIVRNPP---PGLYRA----------SNW---SQHYVDFIAECLEKNPEHR 154
+ + P L+ + +W S D I++ L ++ + R
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQR 287
Query: 155 PYMSELLEHPFIT-SLPENDLHLSTV 179
+++L+HP++ PEN L V
Sbjct: 288 LSAAQVLQHPWVQGCAPENTLPTPMV 313
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANT 57
+ E +++ + +LHEN +IHRDL+ NVLL+ +D +KI DFG S+ T
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTR 116
+T G+P+++APE++ GY+ +D W+LG I I L G PPF +
Sbjct: 171 -SLMRTLCGTPTYLAPEVLVSVGTA--GYNRAVDCWSLGVILFICLS-GYPPFSEHRTQV 226
Query: 117 ALFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171
+L + + G Y W S+ +D + + L +P+ R E L HP++
Sbjct: 227 SLKDQITS---GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283
Query: 172 NDLHLSTVNCQYKDQELQTM 191
++ + + L +
Sbjct: 284 KRKFQDLLSEENESTALPQV 303
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 16/177 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANT 57
+ E +++ + +LHEN +IHRDL+ NVLL+ +D +KI DFG S+ T
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTR 116
+T G+P+++APE++ GY+ +D W+LG I I L G PPF +
Sbjct: 296 -SLMRTLCGTPTYLAPEVLVSVGTA--GYNRAVDCWSLGVILFICLS-GYPPFSEHRTQV 351
Query: 117 ALFQIVRNPPPGLY--RASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
+L + + G Y W S+ +D + + L +P+ R E L HP++
Sbjct: 352 SLKDQITS---GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-31
Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 13/173 (7%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE+ I++ ++ + LH+ +++HRDL+ N+LL D +K+ DFG S + +K
Sbjct: 122 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKL 180
Query: 62 KTFLGSPSWMAPEIMRCGHKEVD-GYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRALF 119
+ G+PS++APEI+ C + GY +D+W+ G I L G PPF L
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLR 239
Query: 120 QIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
I+ G Y+ + W S D ++ L P+ R E L HPF
Sbjct: 240 MIMS----GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 45/167 (26%), Positives = 80/167 (47%), Gaps = 8/167 (4%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E+ + + E++ + +L +IHRD++ N+LL + G V I DF ++ +
Sbjct: 113 KEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQI 171
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE--DMHPTRALF 119
T G+ +MAPE+ ++ GY +D W+LG+TA EL G+ P+ ++ +
Sbjct: 172 TTMAGTKPYMAPEMFSS--RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-PYMSELLEHPF 165
S WSQ V + + LE NP+ R +S++ P+
Sbjct: 230 HTFETTVVTY--PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 27/233 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
+E+ + I+K I + +LH ++ HRD++ N+L T + +K+ DFG ++ET +
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH- 217
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTR- 116
+ T +P ++APE++ YD D+W+LG I I L G PPF H
Sbjct: 218 NSLTTPCYTPYYVAPEVLGPE-----KYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAI 271
Query: 117 --ALFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFI--- 166
+ +R G Y W S+ I L+ P R ++E + HP+I
Sbjct: 272 SPGMKTRIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328
Query: 167 TSLPENDLHLSTVNCQYKD--QELQTMHVEDLAALETISEDNIVQELEERHNS 217
T +P+ LH S V + K+ ++++ LA + E ++++E+ N
Sbjct: 329 TKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNP 381
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 27/191 (14%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
SE+ A +K+I+ + +LHEN ++HRDL+ N+L D +KI DFGLS+ +
Sbjct: 146 SERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
KT G+P + APEI+R Y +D+W++G IT I L G PF D +
Sbjct: 205 VLMKTVCGTPGYCAPEILRG-----CAYGPEVDMWSVGIITYILLC-GFEPFYDERGDQF 258
Query: 118 LFQIVRN------PPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
+F+ + N P W S + D + + + +P+ R + L+HP++T
Sbjct: 259 MFRRILNCEYYFISPW-------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
Query: 169 LPENDLHLSTV 179
N +H+ T
Sbjct: 312 KAANFVHMDTA 322
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 37/213 (17%), Positives = 75/213 (35%), Gaps = 35/213 (16%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT----KDGEVKIVDFGLSRETAN 56
+ E +L++++ GM L EN ++HR+++ N++ K+ DFG +RE +
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVD---GYDNRIDVWALGITAIELGDGKPPFEDMH 113
++ + G+ ++ P++ D Y +D+W++G+T G PF
Sbjct: 169 D-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 114 PTRA----LFQIVRNPPPGLYRA----------------------SNWSQHYVDFIAECL 147
R +++I+ P G +A L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 148 EKNPEHRPYMSELLEHPFITSLPENDLHLSTVN 180
E + E + L + H +
Sbjct: 288 EADQEKCWGFDQFFAETSDI-LHRGNSHHHHHH 319
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 13/173 (7%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE+ I++ ++ + FLH N+++HRDL+ N+LL + ++++ DFG S +K
Sbjct: 198 SEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKL 256
Query: 62 KTFLGSPSWMAPEIMRCGHKEV-DGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRALF 119
+ G+P ++APEI++C E GY +D+WA G I L G PPF +
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQIL-ML 314
Query: 120 QIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
+++ G Y+ + W S D I+ L+ +PE R + L+HPF
Sbjct: 315 RMIME---GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
SE + +++I+ + + H N ++HR+L+ N+LL K VK+ DFGL+ E ++
Sbjct: 103 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
+ F G+P +++PE+++ D Y +D+WA G I I L G PPF D R
Sbjct: 162 EAWHGFAGTPGYLSPEVLKK-----DPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRL 215
Query: 118 LFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL--P 170
QI G Y + W + I L NP+ R + L+ P+I +
Sbjct: 216 YAQIKA----GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271
Query: 171 ENDLHL-STVNC 181
+ +H TV+C
Sbjct: 272 ASAIHRQDTVDC 283
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 4e-29
Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 11/176 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRETANT 57
+ E I +L +I + + +LHEN +IHRDL+ N++L + KI+D G ++E
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
+ F+G+ ++APE++ Y +D W+ G A E G PF
Sbjct: 178 -ELCTEFVGTLQYLAPELLEQ-----KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEND 173
VR + V F + P H + ++ +
Sbjct: 232 WHGKVREKSNEHIVVYDDLTGAVKFSSVL--PTPNHLSGILAGKLERWLQCMLMWH 285
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 17/169 (10%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
F EII G+ FLH +++RDL+ N+LL KDG +KI DFG+ +E K
Sbjct: 116 DLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ- 120
TF G+P ++APEI+ Y++ +D W+ G+ E+ G+ PF LF
Sbjct: 176 NTFCGTPDYIAPEILLG-----QKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHS 229
Query: 121 IVRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR-PYMSELLEHPF 165
I + P L + D + + + PE R ++ +HP
Sbjct: 230 IRMDNPFYPRWL------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 15/173 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
+E A I+K++++G+ +LH+++++HRDL+ N+LL KD +KIVDFGLS N
Sbjct: 134 NEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
K K LG+ ++APE++R YD + DVW++G+ L G PPF L
Sbjct: 193 KKMKERLGTAYYIAPEVLR------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL 246
Query: 119 FQIVRNPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
++ + + + W S+ D I + L+ + + R + LEHP+I
Sbjct: 247 RKVEKGKYT--FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 22/174 (12%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F EII+ ++FLH+ +I+RDL+ NVLL +G K+ DFG+ +E
Sbjct: 122 DEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ- 120
TF G+P ++APEI++ Y +D WA+G+ E+ G PFE LF+
Sbjct: 182 ATFCGTPDYIAPEILQE-----MLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEA 235
Query: 121 IVRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR------PYMSELLEHPF 165
I+ + P L + + + KNP R +L HPF
Sbjct: 236 ILNDEVVYPTWL------HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 50/179 (27%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
SE A I++++++G+ ++H+N ++HRDL+ N+LL KD ++I+DFGLS +
Sbjct: 124 SEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS- 182
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
K K +G+ ++APE++ YD + DVW+ G+ L G PPF + L
Sbjct: 183 KKMKDKIGTAYYIAPEVLH------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
Query: 119 FQIVRNPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174
++ + + W S+ D I + L P R + L+H +I + + +
Sbjct: 237 KKVEKGKYT--FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 9e-29
Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
+E+ + F L E+ + LH +I+RDL+ N+LL ++G +K+ DFGLS+E+ + K
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
+F G+ +MAPE++ G+ D W+ G+ E+ G PF+ + +
Sbjct: 184 YSFCGTVEYMAPEVVNR-----RGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTM 237
Query: 122 VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
+ G+ S + ++NP +R + E+ H F
Sbjct: 238 ILKAKLGM--PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 9e-29
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 21/173 (12%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F L EI + LH+ +I+RDL+ N++L G VK+ DFGL +E+ +
Sbjct: 119 MEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ- 120
TF G+ +MAPEI+ G++ +D W+LG ++ G PPF +
Sbjct: 179 HTFCGTIEYMAPEILMR-----SGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDK 232
Query: 121 IVRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
I++ PP L +Q D + + L++N R E+ HPF
Sbjct: 233 ILKCKLNLPPYL------TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 20/173 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
SE ++A ++K+++ + + H HV+H+DL+ N+L +KI+DFGL+ +
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD- 180
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
+ G+ +MAPE+ + + D+W+ G + L G PF
Sbjct: 181 EHSTNAAGTALYMAPEVFK------RDVTFKCDIWSAGVVMYFLLT-GCLPFTG-TSLEE 232
Query: 118 LFQIVRNPPPGLYR-ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+ Q A + VD + + L K+PE RP +++L H +
Sbjct: 233 VQQKATY---KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 47/190 (24%), Positives = 87/190 (45%), Gaps = 27/190 (14%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT----KDGEVKIVDFGLSRETAN 56
++E LK+I+ G+ +LH + H DL+ N++L + +K++DFG++ +
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPT 115
++ K G+P ++APEI+ + D+W++G IT I L G PF
Sbjct: 165 G-NEFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLS-GASPFLGETKQ 217
Query: 116 RALFQIVR-----NPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
L I + + S+ DFI L K+P+ R +++ LEH +I
Sbjct: 218 ETLTNISAVNYDFDEEY-------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270
Query: 168 SLPENDLHLS 177
++ ++
Sbjct: 271 AIRRRNVRGE 280
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 11/197 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++I G+ +LH ++H+D++ N+LLT G +KI G++
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 61 K--KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
+T GSP++ PEI G G+ ++D+W+ G+T + G PFE + L
Sbjct: 166 DTCRTSQGSPAFQPPEIAN-GLDTFSGF--KVDIWSAGVTLYNITTGLYPFEGDN-IYKL 221
Query: 119 FQIVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHP-FITSLPENDLHL 176
F+ + G Y D + LE P R + ++ +H F P + +
Sbjct: 222 FENIGK---GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278
Query: 177 STVNCQYKDQELQTMHV 193
++M V
Sbjct: 279 PIPPSPDTKDRWRSMTV 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 21/181 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
SE A I+K++ +G+ ++H+++++HRDL+ N+LL KD ++KI+DFGLS
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
K K +G+ ++APE++R YD + DVW+ G I I L G PPF
Sbjct: 178 TKMKDRIGTAYYIAPEVLR------GTYDEKCDVWSAGVILYILLS-GTPPFYG-KNEYD 229
Query: 118 LFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
+ + V G Y W S D I + L +P R ++ LEHP+I
Sbjct: 230 ILKRVET---GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
Query: 173 D 173
+
Sbjct: 287 E 287
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 15/184 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
SE A I+K++ +G+ ++H+++++HRDL+ N+LL KD ++KI+DFGLS
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
K K +G+ ++APE++R YD + DVW+ G+ L G PPF +
Sbjct: 178 TKMKDRIGTAYYIAPEVLR------GTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDI 230
Query: 119 FQIVRNPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLH 175
+ V + W S D I + L +P R ++ LEHP+I
Sbjct: 231 LKRVETGKYA-FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289
Query: 176 LSTV 179
+S +
Sbjct: 290 ISDL 293
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 43/186 (23%), Positives = 76/186 (40%), Gaps = 32/186 (17%)
Query: 9 ILKEIITGMVFLHENH--------VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD- 59
I+ I +G+ LH + HRDL+ N+L+ K+G+ I D GL+ + + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 60 ---KKKTFLGSPSWMAPEIMRC-GHKEVDGYDNRIDVWALGI----------TAIELGDG 105
+G+ +MAPE++ + R+D+WA G+ + + D
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 106 KPPFEDMHPTRALFQIVRN--------PP-PGLYRASNWSQHYVDFIAECLEKNPEHRPY 156
KPPF D+ P F+ +R P P + + + EC +NP R
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 157 MSELLE 162
+ +
Sbjct: 290 ALRIKK 295
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 21/173 (12%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
+E+ F EI++ + +LH V++RD++ N++L KDG +KI DFGL +E +
Sbjct: 103 TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ- 120
KTF G+P ++APE++ + Y +D W LG+ E+ G+ PF + LF+
Sbjct: 163 KTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFEL 216
Query: 121 IVRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
I+ P L S +A L+K+P+ R E++EH F
Sbjct: 217 ILMEEIRFPRTL------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 15/177 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
E A I+K+I++G+ +LH+++++HRD++ N+LL +KIVDFGLS +
Sbjct: 144 DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD- 202
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
K + LG+ ++APE+++ Y+ + DVW+ G+ L G PPF + +
Sbjct: 203 YKLRDRLGTAYYIAPEVLK------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256
Query: 119 FQIVRNPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
++ + + ++W S + I L + R E L +I N
Sbjct: 257 KKVEKGKYY--FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F EI + + +LH ++++RDL+ N+LL G + + DFGL +E
Sbjct: 137 LEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ- 120
TF G+P ++APE++ YD +D W LG E+ G PPF + T ++
Sbjct: 197 STFCGTPEYLAPEVLHK-----QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDN 250
Query: 121 IVRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR----PYMSELLEHPF 165
I+ P P + + + L+K+ R E+ H F
Sbjct: 251 ILNKPLQLKPNI------TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 22/177 (12%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
+E + + EI+ + LH+ +I+RD++ N+LL +G V + DFGLS+E ++
Sbjct: 157 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 62 -KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF--EDMHPTRA- 117
F G+ +MAP+I+R G G+D +D W+LG+ EL G PF + ++A
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDS---GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273
Query: 118 LFQ-IVRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
+ + I+++ P + S D I L K+P+ R E+ EH F
Sbjct: 274 ISRRILKSEPPYPQEM------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 22/189 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
SE + +++I+ + + H+N++IHRD++ VLL VK+ FG++ + +
Sbjct: 128 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
+G+P +MAPE+++ + Y +DVW G I I L G PF
Sbjct: 188 LVAGGRVGTPHFMAPEVVKR-----EPYGKPVDVWGCGVILFILLS-GCLPF--YGTKER 239
Query: 118 LFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE- 171
LF+ + G Y+ W S+ D + L +P R + E L HP++
Sbjct: 240 LFEGIIK---GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRY 296
Query: 172 -NDLHLSTV 179
+HL
Sbjct: 297 AYKIHLPET 305
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 21/183 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT----KDGEVKIVDFGLSRETAN 56
+SE+ +K+I+ G+ +LH + H DL+ N++L +K++DFGL+ E +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPT 115
+ K G+P ++APEI+ + D+W++G IT I L G PF
Sbjct: 172 G-VEFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLS-GASPFLGDTKQ 224
Query: 116 RALFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
L I Y + S+ DFI + L K R + E L HP+IT +
Sbjct: 225 ETLANITA----VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 171 END 173
Sbjct: 281 TQQ 283
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 54/173 (31%), Positives = 79/173 (45%), Gaps = 21/173 (12%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E H F EI G+ FL +I+RDL+ NV+L +G +KI DFG+ +E
Sbjct: 119 KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ- 120
KTF G+P ++APEI+ Y +D WA G+ E+ G+ PFE LFQ
Sbjct: 179 KTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQS 232
Query: 121 IVRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
I+ + P + S+ V + K+P R ++ EH F
Sbjct: 233 IMEHNVAYPKSM------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 44/212 (20%), Positives = 91/212 (42%), Gaps = 17/212 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTF 58
++E+ I + ++ + FLH +++ H D+R N++ + +KI++FG +R+
Sbjct: 99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
D + +P + APE+ + D D+W+LG + + L G PF +
Sbjct: 158 DNFRLLFTAPEYYAPEVHQH-----DVVSTATDMWSLGTLVYVLLS-GINPFLA-ETNQQ 210
Query: 118 LFQIVRNPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL--PEN 172
+ + + N + + S +DF+ L K + R SE L+HP++ +
Sbjct: 211 IIENIMNAEYT-FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269
Query: 173 DLHLSTVNCQYKDQELQTMHVEDLAALETISE 204
+ T+ + L + + + IS
Sbjct: 270 TKVIRTLKHRRYYHTLIKKDLNMVVSAARISC 301
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 53/178 (29%), Positives = 88/178 (49%), Gaps = 21/178 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E+H F EI + +LHE +I+RDL+ NVLL +G +K+ D+G+ +E D
Sbjct: 108 PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA---- 117
TF G+P+++APEI+R + Y +D WALG+ E+ G+ PF+ + +
Sbjct: 168 STFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 118 ----LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR------PYMSELLEHPF 165
LFQ++ + R + S + L K+P+ R +++ HPF
Sbjct: 223 TEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 23/226 (10%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M+E ++II + + H + ++HRDL+ N+LL + VKI DFGLS N
Sbjct: 105 MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS----NIMTD 160
Query: 61 K---KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
KT GSP++ APE++ K G +DVW+ GI + G+ PF+D
Sbjct: 161 GNFLKTSCGSPNYAAPEVIN--GKLYAG--PEVDVWSCGIVLYVMLVGRLPFDDEF-IPN 215
Query: 118 LFQIVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHP-FITSLPENDLH 175
LF+ V + +Y ++ S I + +P R + E+ P F +LP+
Sbjct: 216 LFKKVNS---CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRP 272
Query: 176 LSTVNCQYKDQELQTMHVEDLAALETISEDNIVQELEERHNSKNHY 221
+ V Y D + V L SED IV+ L + N
Sbjct: 273 MEEVQGSYADSRI----VSKLGEAMGFSEDYIVEALRS--DENNEV 312
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 42/249 (16%), Positives = 87/249 (34%), Gaps = 41/249 (16%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT----KDGEVKIVDFGLSRETAN 56
+ E +L++++ GM L EN ++HR+++ N++ K+ DFG +RE +
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVD---GYDNRIDVWALGITAIELGDGKPPFEDMH 113
++ + G+ ++ P++ D Y +D+W++G+T G PF
Sbjct: 169 D-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 114 PTRA----LFQIVRNPPPGLYRA----------------------SNWSQHYVDFIAECL 147
R +++I+ P G +A L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 148 EKNPEHRPYMSELLEHPFITSLPENDLHLSTVNCQYKDQELQTMHVEDLAAL-ETISEDN 206
E + E + L +H+ ++ Q ++ E + +
Sbjct: 288 EADQEKCWGFDQFFAETS-DILHRMVIHVFSLQ-QMTAHKIYIHSYNTATIFHELVYKQT 345
Query: 207 IV----QEL 211
+ QEL
Sbjct: 346 KIISSNQEL 354
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 27/186 (14%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT----KDGEVKIVDFGLSRETAN 56
+SE+ +K+I+ G+ +LH + H DL+ N++L +K++DFGL+ E +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPT 115
+ K G+P ++APEI+ + D+W++G IT I L G PF
Sbjct: 172 G-VEFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLS-GASPFLGDTKQ 224
Query: 116 RALFQIVR-----NPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
L I + + S+ DFI + L K R + E L HP+IT
Sbjct: 225 ETLANITSVSYDFDEEF-------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277
Query: 168 SLPEND 173
+
Sbjct: 278 PVDNQQ 283
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
SE + +++I+ + + H N ++HR+L+ N+LL K VK+ DFGL+ E ++
Sbjct: 126 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
+ F G+P +++PE+++ D Y +D+WA G I I L G PPF D R
Sbjct: 185 EAWHGFAGTPGYLSPEVLKK-----DPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRL 238
Query: 118 LFQIVR-----NPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITS- 168
QI P W + I L NP+ R + L+ P+I +
Sbjct: 239 YAQIKAGAYDYPSPE-------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291
Query: 169 -LPENDLHLSTV 179
+ +H
Sbjct: 292 ERVASAIHRQDT 303
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 52/187 (27%), Positives = 90/187 (48%), Gaps = 27/187 (14%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
+E+ + +++++++ + +LHEN ++HRDL+ N+L ++ ++ I DFGLS+ N
Sbjct: 104 TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
T G+P ++APE++ Y +D W++G IT I L G PPF + ++
Sbjct: 162 GIMSTACGTPGYVAPEVLAQ-----KPYSKAVDCWSIGVITYILLC-GYPPFYEETESKL 215
Query: 118 LFQIVR-----NPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169
+I P W S+ DFI LEK+P R + L HP+I
Sbjct: 216 FEKIKEGYYEFESPF-------WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268
Query: 170 PENDLHL 176
+
Sbjct: 269 TALHRDI 275
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 21/176 (11%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
E A I+K++++ + + H+ +V HRDL+ N L D +K++DFGL+
Sbjct: 104 RESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
+T +G+P +++P+++ Y D W+ G + + L G PPF
Sbjct: 163 KMMRTKVGTPYYVSPQVLE------GLYGPECDEWSAGVMMYVLLC-GYPPFSA-PTDSE 214
Query: 118 LFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
+ +R G + +W S I L K+P+ R + LEH +
Sbjct: 215 VMLKIRE---GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 52/169 (30%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E H F EI G+ FL +I+RDL+ NV+L +G +KI DFG+ +E
Sbjct: 440 KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
KTF G+P ++APEI+ Y +D WA G+ E+ G+ PFE LFQ
Sbjct: 500 KTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQS 553
Query: 122 VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
+ + + S+ V + K+P R ++ EH F
Sbjct: 554 IMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-- 58
M E+ ++I++ + + H+ ++HRDL+ N+LL D +KI DFG S N F
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS----NEFTV 166
Query: 59 -DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
K F G+P + APE+ + K+ DG +DVW+LG+ L G PF+ + +
Sbjct: 167 GGKLDAFCGAPPYAAPELFQ--GKKYDG--PEVDVWSLGVILYTLVSGSLPFDGQN-LKE 221
Query: 118 LFQIVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHP-FITSLPENDLH 175
L + V G YR + S + + L NP R + ++++ E++L
Sbjct: 222 LRERVLR---GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278
Query: 176 LSTVNCQYKDQELQTMHVEDLAALET--ISEDNIVQELEERHNS 217
+ + EL + + + S++ I + L +
Sbjct: 279 ------PFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYD 316
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 54/172 (31%), Positives = 80/172 (46%), Gaps = 15/172 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F +I++G+ LH+ ++I+RDL+ NVLL DG V+I D GL+ E K
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFED---MHPTRAL 118
K + G+P +MAPE++ + YD +D +ALG+T E+ + PF + L
Sbjct: 347 KGYAGTPGFMAPELLLG-----EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
Q V +S DF L+K+PE R L HP
Sbjct: 402 KQRVLEQAVTY--PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 17/187 (9%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
SE + +++I+ ++ H+ V+HR+L+ N+LL K VK+ DFGL+ E
Sbjct: 108 SEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
F G+P +++PE++R D Y +D+WA G I I L G PPF D R
Sbjct: 168 QAWFGFAGTPGYLSPEVLRK-----DPYGKPVDLWACGVILYILLV-GYPPFWDEDQHRL 221
Query: 118 LFQIVRNPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT--SLPEN 172
QI + + W + D I + L NP R +E L+HP+I+ S +
Sbjct: 222 YQQIKAGAYD--FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVAS 279
Query: 173 DLHLSTV 179
+H
Sbjct: 280 CMHRQET 286
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E+H F EI + +LHE +I+RDL+ NVLL +G +K+ D+G+ +E D
Sbjct: 151 PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA---- 117
TF G+P+++APEI+R + Y +D WALG+ E+ G+ PF+ + +
Sbjct: 211 STFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
Query: 118 ----LFQ-IVRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR------PYMSELLEH 163
LFQ I+ P L S + L K+P+ R +++ H
Sbjct: 266 TEDYLFQVILEKQIRIPRSL------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319
Query: 164 PF 165
PF
Sbjct: 320 PF 321
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 19/180 (10%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTF 58
MSE + +++ G+ +HE+ ++H D++ N++ K VKI+DFGL+ +
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
+ K + + APEI+ + D+WA+G + + L G PF
Sbjct: 205 EIVKVTTATAEFAAPEIVDR-----EPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLET 258
Query: 118 LFQIVRNPPPGLY--RASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
L + R + + S DFI L+K P R + + LEHP++ N
Sbjct: 259 LQNVKR----CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 26/180 (14%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL---TKDGEVKIVDFGLSRETANT 57
+SE + ++K+I+ G+ +LH+N+++H DL+ N+LL G++KIVDFG+SR+ +
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTR 116
+ + +G+P ++APEI+ D D+W +G I + L PF
Sbjct: 188 -CELREIMGTPEYLAPEILNY-----DPITTATDMWNIGIIAYMLLT-HTSPFVGEDNQE 240
Query: 117 ALFQIVR-----NPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
I + + + SQ DFI L KNPE RP L H ++
Sbjct: 241 TYLNISQVNVDYSEET-------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 16/172 (9%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F EI G+ LH +++RDL+ N+LL G ++I D GL+
Sbjct: 284 PEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTI 342
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF--EDMHPTRA-L 118
K +G+ +MAPE+++ + Y D WALG E+ G+ PF R +
Sbjct: 343 KGRVGTVGYMAPEVVKN-----ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
++V+ P +S ++ L K+P R E+ EHP
Sbjct: 398 ERLVKEVPEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 40/186 (21%), Positives = 69/186 (37%), Gaps = 32/186 (17%)
Query: 9 ILKEIITGMVFLHEN----------HVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETAN 56
I + + G+ +LHE+ + HRD++ NVLL + I DFGL+ E
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-----------GDG 105
+ +G+ +MAPE++ RID++A+G+ EL +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 106 KPPFEDMHPTRALF---------QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156
PFE+ + R ++ + I EC + + E R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 157 MSELLE 162
+ E
Sbjct: 306 AGCVGE 311
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 15/171 (8%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE + F EII G+ +H V++RDL+ +N+LL + G V+I D GL+ + + K
Sbjct: 290 SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKP 347
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP--TRALF 119
+G+ +MAPE+++ G YD+ D ++LG +L G PF +
Sbjct: 348 HASVGTHGYMAPEVLQKGV----AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
++ L ++S + L+++ R E+ E PF
Sbjct: 404 RMTLTMAVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 17/188 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTF 58
MSE ++++ G+ +HEN+ +H DL+ N++ T + E+K++DFGL+
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
K G+ + APE+ D+W++G ++ I L G PF +
Sbjct: 311 QSVKVTTGTAEFAAPEVAEG-----KPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDET 364
Query: 118 LFQIVRNPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT--SLPEN 172
L + S + S+ DFI + L +P R + + LEHP++T + P
Sbjct: 365 LRNVKSCDW--NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422
Query: 173 DLHLSTVN 180
D + +
Sbjct: 423 DSQIPSSR 430
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 21/183 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT----KDGEVKIVDFGLSRETAN 56
++E+ LK+I+ G+ +LH + H DL+ N++L +KI+DFGL+ +
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPT 115
++ K G+P ++APEI+ + D+W++G IT I L G PF
Sbjct: 171 G-NEFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLS-GASPFLGDTKQ 223
Query: 116 RALFQIVRNPPPGLY--RASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
L + Y + S DFI L K+P+ R + + L+HP+I
Sbjct: 224 ETLANVSA----VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279
Query: 171 END 173
Sbjct: 280 TQQ 282
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 34/186 (18%), Positives = 70/186 (37%), Gaps = 32/186 (17%)
Query: 9 ILKEIITGMVFLHE--------NHVIHRDLRGSNVLLTKDGEVKIVDFGLSR----ETAN 56
+ ++G+ LH + HRDL+ N+L+ K+G I D GL+ +T
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDG-YDNRIDVWALGI----------TAIELGDG 105
T +G+ +M PE++ D+++ G+ + + +
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 106 KPPFEDMHPTRALFQIVRN--------PP-PGLYRASNWSQHYVDFIAECLEKNPEHRPY 156
+ P+ D+ P+ ++ +R P P + + + + EC NP R
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 157 MSELLE 162
+ +
Sbjct: 319 ALRVKK 324
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 24/176 (13%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
E F EI++ + +LH +IHRDL+ N+LL +D ++I DFG ++ + +
Sbjct: 128 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 62 K--TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ +F+G+ +++PE++ D+WALG +L G PPF + +F
Sbjct: 188 RANSFVGTAQYVSPELLTE-----KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IF 241
Query: 120 Q-IVRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHRP------YMSELLEHPF 165
Q I++ P D + + L + R L HPF
Sbjct: 242 QKIIKLEYDFPEKF------FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E+ + ++I++G+ + H + V+HRDL+ NVLL KI DFGLS N
Sbjct: 113 LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS----NMMSD 168
Query: 61 K---KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
+T GSP++ APE++ + G +D+W+ G+ L G PF+D H
Sbjct: 169 GEFLRTSCGSPNYAAPEVIS--GRLYAG--PEVDIWSSGVILYALLCGTLPFDDDH-VPT 223
Query: 118 LFQIVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHP-FITSLPENDLH 175
LF+ + + G++ + + + + L+ +P R + ++ EH F LP+ +
Sbjct: 224 LFKKICD---GIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPK---Y 277
Query: 176 LSTVNCQYKDQELQTMHVEDLAALETISEDNIVQELEER 214
L + Y + ++++ SE+ ++ L R
Sbjct: 278 LFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNR 316
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 22/174 (12%)
Query: 2 SEQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
SE F EI++ + +LH V++RDL+ N++L KDG +KI DFGL +E
Sbjct: 246 SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
KTF G+P ++APE++ + Y +D W LG+ E+ G+ PF + LF+
Sbjct: 306 MKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFE 359
Query: 121 -IVRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
I+ P L ++ L+K+P+ R E+++H F
Sbjct: 360 LILMEEIRFPRTL------GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTF 58
++E +K+I G+ +H+ +++H DL+ N+L ++KI+DFGL+R
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTRA 117
+K K G+P ++APE++ D D+W++G I + L G PF +
Sbjct: 243 EKLKVNFGTPEFLAPEVVNY-----DFVSFPTDMWSVGVIAYMLLS-GLSPFLGDNDAET 296
Query: 118 LFQIVRNPPPGLY--RASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
L I+ + + S+ +FI++ L K R SE L+HP+++ +
Sbjct: 297 LNNILA----CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLH 352
Query: 173 DLHLSTVNCQYKDQELQTMH 192
S ++ Q K
Sbjct: 353 ----SRLSAQKKKNRGSDAQ 368
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 41/182 (22%), Positives = 67/182 (36%), Gaps = 21/182 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANTFD 59
+ E +++ + H V+HRD++ N+L+ + G K++DFG +
Sbjct: 136 LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-- 193
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNR-IDVWALGITAIELGDGKPPFEDMHPTRAL 118
F G+ + PE + Y VW+LGI ++ G PFE
Sbjct: 194 PYTDFDGTRVYSPPEWISRH-----QYHALPATVWSLGILLYDMVCGDIPFERDQ----- 243
Query: 119 FQIVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHP-FITSLPENDLHL 176
+I+ S I CL P RP + E+L P T + L+
Sbjct: 244 -EILE----AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNP 298
Query: 177 ST 178
S
Sbjct: 299 SK 300
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 20/167 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANTFD 59
+ E+ +++ + H V+HRD++ N+L+ GE+K++DFG +T
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV- 204
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNR-IDVWALGITAIELGDGKPPFEDMHPTRAL 118
F G+ + PE +R H+ Y R VW+LGI ++ G PFE
Sbjct: 205 -YTDFDGTRVYSPPEWIR-YHR----YHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 253
Query: 119 FQIVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHP 164
+I+R G S I CL P RP E+ HP
Sbjct: 254 -EIIR----GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 43/226 (19%), Positives = 97/226 (42%), Gaps = 25/226 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E ++I +++++ + +L +IHRD++ N+++ +D +K++DFG + ++
Sbjct: 127 LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA----AYLER 182
Query: 61 K---KTFLGSPSWMAPEIMRCGHKEVDGYD-NRIDVWALGITAIELGDGKPPFEDMHPTR 116
TF G+ + APE++ G+ Y +++W+LG+T L + PF +
Sbjct: 183 GKLFYTFCGTIEYCAPEVLM-GNP----YRGPELEMWSLGVTLYTLVFEENPFCE----- 232
Query: 117 ALFQIVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLH 175
L + V S+ + ++ L+ PE R + +L+ P++T +
Sbjct: 233 -LEETVE----AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADY 287
Query: 176 LSTVNCQYKDQELQTMHVEDLAALETISEDNIVQELEERHNSKNHY 221
+ E + + S ++ Q E +H+
Sbjct: 288 TWEEVFRVNKPESGVLS-AASLEMGNRSLSDVAQAQELCGGEGHHH 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 37/189 (19%), Positives = 69/189 (36%), Gaps = 38/189 (20%)
Query: 9 ILKEIITGMVFLHENH--------VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--- 57
+ +G+ LH + HRDL+ N+L+ K+G I D GL+ +
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 58 -FDKKKTFLGSPSWMAPEIMR----CGHKEVDGYDNRIDVWALGI----------TAIEL 102
+G+ +MAPE++ H E R D++A+G+
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFE---SFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 103 GDGKPPFEDMHPTRALFQIVRN--------PP-PGLYRASNWSQHYVDFIAECLEKNPEH 153
D + P+ D+ P+ + +R P P +++ + + EC N
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320
Query: 154 RPYMSELLE 162
R + +
Sbjct: 321 RLTALRIKK 329
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 38/227 (16%), Positives = 86/227 (37%), Gaps = 14/227 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E +++ G+V+LH + HRD++ N+LL + +KI DFGL+ +
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 61 K--KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PTRA 117
+ G+ ++APE+++ +E +DVW+ GI + G+ P++ +
Sbjct: 162 RLLNKMCGTLPYVAPELLK--RREFHAE--PVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
Query: 118 LFQIVRN---PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174
P + + + L +NP R + ++ + + +
Sbjct: 218 YSDWKEKKTYLNPWKK----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
Query: 175 HLSTVNCQYKDQELQTMHVEDLAALETISEDNIVQELEERHNSKNHY 221
V + + L+ ++ + + ++H+
Sbjct: 274 KRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHH 320
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E + ++I++ + + H + V+HRDL+ NVLL KI DFGLS N
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS----NMMSD 163
Query: 61 K---KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
+T GSP++ APE++ + G +D+W+ G+ L G PF+D H
Sbjct: 164 GEFLRTSCGSPNYAAPEVIS--GRLYAG--PEVDIWSCGVILYALLCGTLPFDDEH-VPT 218
Query: 118 LFQIVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
LF+ +R G++ + ++ + L+ +P R + ++ EH +
Sbjct: 219 LFKKIRG---GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 33/158 (20%), Positives = 71/158 (44%), Gaps = 8/158 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR-ETANTFD 59
+S +I+ G+ H+ ++HRD++ N+L+ + +KI DFG+++ + +
Sbjct: 108 LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ LG+ + +PE + + D D++++GI E+ G+PPF
Sbjct: 168 QTNHVLGTVQYFSPEQAK--GEATDE---CTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222
Query: 120 QIVRNPPPGLYRASN--WSQHYVDFIAECLEKNPEHRP 155
+ +++ P + Q + I EK+ +R
Sbjct: 223 KHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 9/159 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR---ETANT 57
M+ + ++ + + F H+N +IHRD++ +N++++ VK++DFG++R ++ N+
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
+ +G+ +++PE R VD R DV++LG E+ G+PPF P
Sbjct: 173 VTQTAAVIGTAQYLSPEQAR--GDSVDA---RSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227
Query: 118 LFQIVRNPPPGL-YRASNWSQHYVDFIAECLEKNPEHRP 155
+Q VR P R S + + L KNPE+R
Sbjct: 228 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 37/156 (23%), Positives = 64/156 (41%), Gaps = 6/156 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR-ETANTFD 59
++ I+++I + + H HRD++ N+L++ D +VDFG++ T
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ +G+ +MAPE R R D++AL E G PP++ +
Sbjct: 191 QLGNTVGTLYYMAPE--RFSESHATY---RADIYALTCVLYECLTGSPPYQGDQLSVMGA 245
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155
I + P + IA + KNPE R
Sbjct: 246 HINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRY 281
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 36/182 (19%), Positives = 75/182 (41%), Gaps = 15/182 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E +++ G+V+LH + HRD++ N+LL + +KI DFGL+ +
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 61 K--KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PTRA 117
+ G+ ++APE+++ +E +DVW+ GI + G+ P++ +
Sbjct: 162 RLLNKMCGTLPYVAPELLK--RREFHA--EPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
Query: 118 LFQIVRNPPPGLYRASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHP-FITSLPEND 173
+ W + + + L +NP R + ++ + + L +
Sbjct: 218 YSDWKE----KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
Query: 174 LH 175
Sbjct: 274 KR 275
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 40/170 (23%), Positives = 82/170 (48%), Gaps = 7/170 (4%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE-TANTFDK 60
E+ F L E++ + +H+ H +HRD++ N+L+ +G +++ DFG + + +
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+G+P +++PEI++ Y D W+LG+ E+ G+ PF +
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
Query: 121 IVRNPPPGLY--RASNWSQHYVDFIAECLEKNPEHR---PYMSELLEHPF 165
I+ + + + ++ S++ D I L + EHR + + +HPF
Sbjct: 293 IMNHKERFQFPTQVTDVSENAKDLI-RRLICSREHRLGQNGIEDFKKHPF 341
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 22/172 (12%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
SE H F +I+ +LH +I+RDL+ N+L+ + G +++ DFG ++ +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRT 195
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
T G+P +APEI+ GY+ +D WALG+ E+ G PPF P + +I
Sbjct: 196 WTLCGTPEALAPEIILS-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
Query: 122 VRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
V P S D + L+ + R ++++ H +
Sbjct: 251 VSGKVRFPSHF------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 22/172 (12%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
F E+ + +LH +I+RDL+ N+LL K+G +KI DFG ++ D
Sbjct: 104 PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVT 160
Query: 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQI 121
T G+P ++APE++ Y+ ID W+ GI E+ G PF D + + +I
Sbjct: 161 YTLCGTPDYIAPEVVST-----KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 215
Query: 122 VRNP---PPGLYRASNWSQHYVDFIAECLEKNPEHR-----PYMSELLEHPF 165
+ PP ++ D ++ + ++ R ++ HP+
Sbjct: 216 LNAELRFPPFF------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 43/208 (20%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S+ HI + + + + + LH ++VIHRDL+ SN+L+ + ++K+ DFGL+R +
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 61 KKTFLGSPSWM----------APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF- 109
G S M APE+M K Y +DVW+ G EL +P F
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAK----YSRAMDVWSCGCILAELFLRRPIFP 224
Query: 110 -ED-MHPTRALFQIVRNPPP-------------------GLYRASNWSQHY-------VD 141
D H +F I+ P +Y A+ + + +D
Sbjct: 225 GRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGID 284
Query: 142 FIAECLEKNPEHRPYMSELLEHPFITSL 169
+ L +P R E LEHP++ +
Sbjct: 285 LLQRMLVFDPAKRITAKEALEHPYLQTY 312
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 9/172 (5%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE-TANTFDK 60
+ F L EI+ + +H +HRD++ N+LL + G +++ DFG + A+ +
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219
Query: 61 KKTFLGSPSWMAPEI-MRCGHKEVDG-YDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
+G+P +++PEI G G Y D WALG+ A E+ G+ PF
Sbjct: 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279
Query: 119 FQIV--RNPPPGLYRASNWSQHYVDFIAECLEKNPEHR---PYMSELLEHPF 165
+IV + + DFI + L PE R + HPF
Sbjct: 280 GKIVHYKEHLSLPLVDEGVPEEARDFI-QRLLCPPETRLGRGGAGDFRTHPF 330
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 31/155 (20%), Positives = 59/155 (38%), Gaps = 20/155 (12%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ L EI+ + +LH +++ DL+ N++LT++ +K++D G +
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS----RINS 233
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
G+P + APEI+R G D++ +G T L P +
Sbjct: 234 FGYLYGTPGFQAPEIVR------TGPTVATDIYTVGRTLAALTLDLPTRNGRYV-----D 282
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155
+ P L Y + ++ +P R
Sbjct: 283 GLPEDDPVLKT----YDSYGRLLRRAIDPDPRQRF 313
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 43/160 (26%), Positives = 65/160 (40%), Gaps = 16/160 (10%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS- 67
++ + GM +L IHRDL N L+T+ +KI DFG+SRE A+ L
Sbjct: 218 MVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV 277
Query: 68 P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN- 124
P W APE + G Y + DVW+ GI E G P+ ++ + + +
Sbjct: 278 PVKWTAPEALNYGR-----YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG 332
Query: 125 --PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P P + +C P RP S + +
Sbjct: 333 RLPCP-----ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 46/200 (23%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTF 58
+E+ + I+K I + +LH ++ HRD++ N+L T + +K+ DFG
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------- 166
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFEDMHPTR- 116
A E + YD D+W+LG I I L G PPF H
Sbjct: 167 -------------AKETTG------EKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAI 206
Query: 117 --ALFQIVRNPPPGLYR--ASNW---SQHYVDFIAECLEKNPEHRPYMSELLEHPFIT-- 167
+ +R G Y W S+ I L+ P R ++E + HP+I
Sbjct: 207 SPGMKTRIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263
Query: 168 -SLPENDLHLSTVNCQYKDQ 186
+P+ LH S V + K++
Sbjct: 264 TKVPQTPLHTSRVLKEDKER 283
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 46/212 (21%), Positives = 78/212 (36%), Gaps = 58/212 (27%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E + I + + + F H+++ IHRD++ N+L+TK +K+ DFG +R
Sbjct: 99 VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARL------- 151
Query: 61 KKTFLGSPS----------WM-APEI-MRCGHKEVDGYDNRIDVWALG-ITAIELGDGKP 107
L PS W +PE+ + Y +DVWA+G + A EL G P
Sbjct: 152 ----LTGPSDYYDDEVATRWYRSPELLVGDTQ-----YGPPVDVWAIGCVFA-ELLSGVP 201
Query: 108 PF---EDMH-----------PTRALFQIVRNPP-------PGLYRASNWSQHY------- 139
+ D+ Q+ P +
Sbjct: 202 LWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPA 261
Query: 140 VDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171
+ + CL +P R +LL HP+ ++ E
Sbjct: 262 LGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 7/169 (4%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE-TANTFDK 60
E+ F E++ + +H IHRD++ N+LL K G +K+ DFG + +
Sbjct: 166 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
T +G+P +++PE+++ Y D W++G+ E+ G PF +
Sbjct: 226 CDTAVGTPDYISPEVLK-SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 284
Query: 121 IVRNPPPGLYRASNW-SQHYVDFIAECLEKNPEHR---PYMSELLEHPF 165
I+ + + N S+ + I L + E R + E+ H F
Sbjct: 285 IMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRNGVEEIKRHLF 332
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 58/211 (27%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ Q + L +II G+ F H +++IHRD++ N+L+++ G VK+ DFG +R
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART------- 173
Query: 61 KKTFLGSPS----------WM-APEI-MRCGHKEVDGYDNRIDVWALG-ITAIELGDGKP 107
L +P W APE+ + Y +DVWA+G + E+ G+P
Sbjct: 174 ----LAAPGEVYDDEVATRWYRAPELLVGDVK-----YGKAVDVWAIGCLVT-EMFMGEP 223
Query: 108 PF---EDMH-----------PTRALFQIVRNPP-------PGLYRASNWSQHY------- 139
F D+ ++ P P + + Y
Sbjct: 224 LFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVV 283
Query: 140 VDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
+D +CL +P+ RP+ +ELL H F
Sbjct: 284 IDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 53/199 (26%), Positives = 81/199 (40%), Gaps = 36/199 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S QHI + + I+ G+ LHE V+HRDL N+LL + ++ I DF L+RE D
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTA--DA 188
Query: 61 KKTFLGSPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH------ 113
KT + W APE++ + +D+W+ G E+ + K F
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKG----FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244
Query: 114 --------PTRALFQIVRNP--------PPGLYRASNWSQHY-------VDFIAECLEKN 150
P + +P A W+ +D IA+ LE N
Sbjct: 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN 304
Query: 151 PEHRPYMSELLEHPFITSL 169
P+ R + L HP+ SL
Sbjct: 305 PQRRISTEQALRHPYFESL 323
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 24/186 (12%), Positives = 54/186 (29%), Gaps = 27/186 (14%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-----------KDGEVKIVDFG 49
M + + ++ + +H+ +IH D++ N +L + ++D G
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 50 LSRETANTFDKK---KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGK 106
S + F K + + E++ ++ +ID + + T + G
Sbjct: 229 QSIDM-KLFPKGTIFTAKCETSGFQCVEMLSN-----KPWNYQIDYFGVAATVYCMLFGT 282
Query: 107 PPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
L W+ +F L H +LL
Sbjct: 283 YMKVKNEGGECKP---EGLFRRLPHLDMWN----EFFHVMLNIPDCHHLPSLDLLRQKLK 335
Query: 167 TSLPEN 172
++
Sbjct: 336 KVFQQH 341
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL--TKDGEVKIVDFGLSRETANTF 58
SE F +++++G+ + H + HRDL+ N LL + +KI DFG S+ +
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VL 170
Query: 59 DKK-KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
+ K+ +G+P+++APE++ +E DG DVW+ G+T + G PFED R
Sbjct: 171 HSQPKSTVGTPAYIAPEVLL--RQEYDGK--IADVWSCGVTLYVMLVGAYPFEDPEEPRD 226
Query: 118 LFQIVRNPPPGLYR--ASNW-SQHYVDFIAECLEKNPEHRPYMSELLEHP-FITSLPEND 173
+ ++ Y S I+ +P R + E+ H F+ +LP +
Sbjct: 227 YRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADL 286
Query: 174 LHLSTVNCQYKDQELQTMHVED 195
++ S Q+++ E ++
Sbjct: 287 MNESNTGSQFQEPEQPMQSLDT 308
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 41/200 (20%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E I F++ +++ G+ ++H +IHRDL+ N+ + +D E+KI+DFGL+R D
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADS 180
Query: 61 KKTFLGSPSWM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF---EDMH--- 113
+ T W APE++ + Y +D+W++G E+ GK F + +
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMR----YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 236
Query: 114 --------PTRALFQIVRNP---------PPGLYRASNWSQHY-------VDFIAECLEK 149
P Q +++ P +++ V+ + + L
Sbjct: 237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE--LEKKDFASILTNASPLAVNLLEKMLVL 294
Query: 150 NPEHRPYMSELLEHPFITSL 169
+ E R E L HP+ SL
Sbjct: 295 DAEQRVTAGEALAHPYFESL 314
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 44/198 (22%), Positives = 86/198 (43%), Gaps = 37/198 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
SE+ I +++ +++ G+ ++H V+HRDL+ N+ + +D E+KI+DFGL+R D
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR----HADA 178
Query: 61 KKTFLGSPSW-MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF---EDMHPTR 116
+ T W APE++ Y+ +D+W++G E+ GK F + +
Sbjct: 179 EMTGYVVTRWYRAPEVILSWMH----YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234
Query: 117 ALFQIVRNPPP------------------GLYRASNWSQHY-------VDFIAECLEKNP 151
+ ++ P +++Q + D + + LE +
Sbjct: 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 294
Query: 152 EHRPYMSELLEHPFITSL 169
+ R ++ L HPF
Sbjct: 295 DKRLTAAQALTHPFFEPF 312
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 37/198 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+++ H+ F++ +I+ G+ ++H +IHRDL+ SN+ + +D E+KI+DFGL+R TA+
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-- 186
Query: 61 KKTFLGSPSW-MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF---EDMHPTR 116
T + W APEIM Y+ +D+W++G EL G+ F + + +
Sbjct: 187 --TGYVATRWYRAPEIMLNWMH----YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 240
Query: 117 ALFQIVRNPPP------------------GLYRASNWSQHY-------VDFIAECLEKNP 151
+ ++V P N++ + VD + + L +
Sbjct: 241 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 300
Query: 152 EHRPYMSELLEHPFITSL 169
+ R ++ L H +
Sbjct: 301 DKRITAAQALAHAYFAQY 318
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
++ M +L N+ +HRDL NVL+++D K+ DFGL++E ++T D K P
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----P 177
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVR--- 123
W APE +R + + DVW+ GI E+ G+ P+ + + ++ +
Sbjct: 178 VKWTAPEALREKK-----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 232
Query: 124 -----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
PP +Y + + C + RP +L E + + ++LHL
Sbjct: 233 MDAPDGCPPAVY----------EVMKNCWHLDAAMRPSFLQLREQ--LEHIKTHELHL 278
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 49/207 (23%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S HI + L +I+ G+ ++H +V+HRDL+ SN+LL ++KI DFGL+R D
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 61 KKTFLGSPSWM----------APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE 110
++ APEIM Y ID+W++G E+ +P F
Sbjct: 185 T-------GFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNRPIFP 233
Query: 111 DMH--------------PTRALFQIVRNPPPGLYRAS-------NWSQHY-------VDF 142
H P++ + N Y S W++ + +D
Sbjct: 234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 293
Query: 143 IAECLEKNPEHRPYMSELLEHPFITSL 169
+ + L NP R + + L HP++
Sbjct: 294 LDKMLTFNPHKRIEVEQALAHPYLEQY 320
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 71/235 (30%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ H +++ ++I + +LH ++HRD++ SN+LL + VK+ DFGLSR N
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 61 KKTFLGSPSWM---------------------APEIMRCGHKEVDGYDNRIDVWALG-IT 98
S + APEI+ G + Y ID+W+LG I
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL-LGSTK---YTKGIDMWSLGCIL 221
Query: 99 AIELGDGKPPF---------------------EDM-----------------------HP 114
E+ GKP F ED+
Sbjct: 222 G-EILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSN 280
Query: 115 TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169
R +F +N + ++ ++ +D + + L+ NP R ++ L+HPF++
Sbjct: 281 KRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 31/178 (17%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
++ M +L N+ +HRDL NVL+++D K+ DFGL++E ++T D K P
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----P 349
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELG-DGKPPFEDMHPTRALFQIVRN-- 124
W APE +R + + DVW+ GI E+ G+ P+ + + ++ +
Sbjct: 350 VKWTAPEALREKK-----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 404
Query: 125 ---P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
P PP +Y D + C + RP +L E + + ++LHL
Sbjct: 405 MDAPDGCPPAVY----------DVMKNCWHLDAATRPTFLQLRE--QLEHIRTHELHL 450
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 25/164 (15%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+ +I +GM ++ + +HRDLR +N+L+ ++ K+ DFGL+R + + P
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN-- 124
W APE G + + DVW+ GI EL G+ P+ M L Q+ R
Sbjct: 428 IKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 482
Query: 125 ---P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P P L+ D + +C K PE RP L
Sbjct: 483 MPCPPECPESLH----------DLMCQCWRKEPEERPTFEYLQA 516
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 48/214 (22%), Positives = 84/214 (39%), Gaps = 53/214 (24%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++ ++ L +++ G+ + H V+HRDL+ N+L+ + GE+K+ DFGL+R
Sbjct: 97 INMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR-------- 148
Query: 61 KKTFLGSPS----------WM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
P+ W P+I+ G + Y +ID+W +G E+ G+P F
Sbjct: 149 ---AKSIPTKTYDNEVVTLWYRPPDIL-LGSTD---YSTQIDMWGVGCIFYEMATGRPLF 201
Query: 110 --------------------EDMHPTRALFQIVRNPPPGLYRASNWSQHY-------VDF 142
E+ P + + YRA H D
Sbjct: 202 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADL 261
Query: 143 IAECLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
+ + L+ +R + ++HPF SL E L
Sbjct: 262 LTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKL 295
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 25/164 (15%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+ +I +GM ++ + +HRDLR +N+L+ ++ K+ DFGL+R + + P
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN-- 124
W APE G + + DVW+ GI EL G+ P+ M L Q+ R
Sbjct: 345 IKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399
Query: 125 ---P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P P L+ D + +C K PE RP L
Sbjct: 400 MPCPPECPESLH----------DLMCQCWRKEPEERPTFEYLQA 433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 38/196 (19%), Positives = 72/196 (36%), Gaps = 42/196 (21%)
Query: 9 ILKEIITGMVFLHENH---------VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ + G+ +LH + HRDL NVL+ DG I DFGLS
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 60 KK--------KTFLGSPSWMAPEIMRCG--HKEVDGYDNRIDVWALGI---------TAI 100
+ + +G+ +MAPE++ ++ + ++D++ALG+ T +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 101 ELGDG----KPPFEDMHPTRALFQIVRNP----------PPGLYRASNWSQHYVDFIAEC 146
G+ + F+ F+ ++ P S + + I +C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 147 LEKNPEHRPYMSELLE 162
+++ E R E
Sbjct: 296 WDQDAEARLTAQXAEE 311
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 35/199 (17%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANTFDK 60
E+H + +++ G+ ++H +V+HRDL+ +N+ + T+D +KI DFGL+R +
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 61 KKTFLGSPS--WM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH---- 113
K W +P ++ + Y ID+WA G E+ GK F H
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNN----YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233
Query: 114 ----------PTRALFQIVRNPPP------GLYRASNWSQHY-------VDFIAECLEKN 150
Q + + P +Q VDF+ + L +
Sbjct: 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFS 293
Query: 151 PEHRPYMSELLEHPFITSL 169
P R E L HP+++
Sbjct: 294 PMDRLTAEEALSHPYMSIY 312
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 47/261 (18%), Positives = 102/261 (39%), Gaps = 53/261 (20%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + ++++L +++ G+ LH +IHRDL+ SN+++ D +KI+DFGL+R +F
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF----------- 109
++ + + APE++ Y +D+W++G E+ G F
Sbjct: 184 TP-YVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 237
Query: 110 ----------EDM----------------HPTRALFQIVRN--PPPGLYRASNWSQHYVD 141
E M + + ++ + P + D
Sbjct: 238 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297
Query: 142 FIAECLEKNPEHRPYMSELLEHPFITSL-PENDLHLSTVNCQYKDQELQTMHVEDLAALE 200
+++ L + R + E L+HP+I ++ K + + +E+ L
Sbjct: 298 LLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKEL- 356
Query: 201 TISEDNIVQELEERHNSKNHY 221
I +E+ + + +H+
Sbjct: 357 ------IYKEVMDLEHHHHHH 371
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 25/165 (15%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+ +I + M +L + + IHR+L N L+ ++ VK+ DFGLSR P
Sbjct: 323 MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 382
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELG-DGKPPFEDMHPTRALFQIVRN-- 124
W APE + + + DVWA G+ E+ G P+ + ++ + ++
Sbjct: 383 IKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 437
Query: 125 ---P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P P +Y + + C + NP RP +E+ +
Sbjct: 438 MERPEGCPEKVY----------ELMRACWQWNPSDRPSFAEIHQA 472
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 47/200 (23%), Positives = 80/200 (40%), Gaps = 42/200 (21%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + I ++++ + G+ FLH N ++HRDL+ N+L+T G VK+ DFGL+R +
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR----IYSY 172
Query: 61 KKTFLGSPS----WM-APEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPF---ED 111
+ +P W APE++ Y +D+W++G I A E+ KP F +
Sbjct: 173 QMAL--TPVVVTLWYRAPEVL-LQST----YATPVDMWSVGCIFA-EMFRRKPLFCGNSE 224
Query: 112 MHPTRALFQIVRNPP----PGL----------YRASNWSQHY-------VDFIAECLEKN 150
+F ++ PP P + E L N
Sbjct: 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN 284
Query: 151 PEHRPYMSELLEHPFITSLP 170
P R L+H ++
Sbjct: 285 PHKRISAFRALQHSYLHKDE 304
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 44/210 (20%), Positives = 80/210 (38%), Gaps = 31/210 (14%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+L+ I +GM +L + +HRDL N+L+ + K+ DFGL R + + T G
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 69 S---WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVR- 123
W +PE + + + DVW+ GI E+ G+ P+ +M + +
Sbjct: 212 IPIRWTSPEAIAYRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 124 -------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
+ P LY + +C +K+ +RP +++ + L N L
Sbjct: 267 YRLPPPMDCPAALY----------QLMLDCWQKDRNNRPKFEQIVS--ILDKLIRNPGSL 314
Query: 177 STVN--CQYKDQELQTMHVEDLAALETISE 204
+ L D+ T +
Sbjct: 315 KIITSAAARPSNLLLDQSNVDITTFRTTGD 344
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 53/208 (25%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + I L +++ G+ H++ ++HRDL+ N+L+ DG +K+ DFGL+R
Sbjct: 116 LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-------- 167
Query: 61 KKTFLGSPS----------WM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
G P W AP+++ G K+ Y +D+W++G E+ GKP F
Sbjct: 168 ---AFGIPVRSYTHEVVTLWYRAPDVL-MGSKK---YSTSVDIWSIGCIFAEMITGKPLF 220
Query: 110 --------------------EDMHPTRALFQIVRNPPPGLYRASNWSQHY-------VDF 142
P + + ++ WS +D
Sbjct: 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDL 280
Query: 143 IAECLEKNPEHRPYMSELLEHPFITSLP 170
++ L +P R + + HP+ L
Sbjct: 281 LSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 43/221 (19%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + I ++ +++ G+ FLH + V+HRDL+ N+L+T G++K+ DFGL+R +
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR----IYSF 172
Query: 61 KKTFLGSPS----WM-APEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPF---ED 111
+ + W APE++ Y +D+W++G I A E+ KP F D
Sbjct: 173 QMAL--TSVVVTLWYRAPEVL-LQSS----YATPVDLWSVGCIFA-EMFRRKPLFRGSSD 224
Query: 112 MHPTRALFQIVRNPP----PGL----------YRASNWSQHY-------VDFIAECLEKN 150
+ + ++ P P A + D + +CL N
Sbjct: 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284
Query: 151 PEHRPYMSELLEHPFITSLPENDLHLSTVNCQYKD-QELQT 190
P R L HP+ L +L + ++ EL T
Sbjct: 285 PAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNTSELNT 325
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 38/166 (22%), Positives = 69/166 (41%), Gaps = 27/166 (16%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+L+ I GM +L + +HRDL N+L+ + K+ DFGLSR + + T G
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 69 S---WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVR- 123
W APE + + + DVW+ GI E+ G+ P+ ++ + I
Sbjct: 212 IPIRWTAPEAISYRK-----FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266
Query: 124 -------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+ P +Y + +C ++ RP ++++
Sbjct: 267 FRLPTPMDCPSAIY----------QLMMQCWQQERARRPKFADIVS 302
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 40/166 (24%), Positives = 68/166 (40%), Gaps = 27/166 (16%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+L+ + GM +L + +HRDL NVL+ + K+ DFGLSR + D T G
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 69 S---WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVR- 123
W APE + + + DVW+ G+ E+ G+ P+ +M + +
Sbjct: 216 IPIRWTAPEAIAFRT-----FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270
Query: 124 -------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P L+ + +C K+ RP S+++
Sbjct: 271 YRLPAPMGCPHALH----------QLMLDCWHKDRAQRPRFSQIVS 306
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 43/167 (25%), Positives = 67/167 (40%), Gaps = 28/167 (16%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS- 67
++ GM +L IHRDL N+LL VKI DFGL R D
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 68 -P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN 124
P +W APE ++ + + D W G+T E+ G+ P+ ++ ++ L +I +
Sbjct: 186 VPFAWCAPESLKTRT-----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240
Query: 125 ------P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P P +Y + + +C PE RP L +
Sbjct: 241 GERLPRPEDCPQDIY----------NVMVQCWAHKPEDRPTFVALRD 277
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 45/208 (21%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + ++++L +++ G+ LH +IHRDL+ SN+++ D +KI+DFGL+R TA T
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFM 219
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF----------- 109
++ + + APE++ Y +D+W++G E+ K F
Sbjct: 220 MTPYVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 274
Query: 110 ----------EDM----------------HPTRALFQIVRN--PPPGLYRASNWSQHYVD 141
E M + ++ + P + D
Sbjct: 275 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334
Query: 142 FIAECLEKNPEHRPYMSELLEHPFITSL 169
+++ L +P R + + L+HP+I
Sbjct: 335 LLSKMLVIDPAKRISVDDALQHPYINVW 362
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 49/179 (27%), Positives = 75/179 (41%), Gaps = 31/179 (17%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS- 67
+ ++ GM FL + IHRDL N L+ +D VK+ DFG++R + G+
Sbjct: 109 MCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTK 166
Query: 68 -P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN 124
P W APE+ Y ++ DVWA GI E+ GK P++ + + ++ +
Sbjct: 167 FPVKWSAPEVFHYFK-----YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221
Query: 125 -----P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLH 175
P +Y + C + PE RP +LL I L E D H
Sbjct: 222 HRLYRPHLASDTIY----------QIMYSCWHELPEKRPTFQQLLS--SIEPLREKDKH 268
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 25/165 (15%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+ +I + M +L + + IHRDL N L+ ++ VK+ DFGLSR P
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVR--- 123
W APE + + + DVWA G+ E+ G P+ + ++ + +
Sbjct: 176 IKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 230
Query: 124 -----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P +Y + + C + NP RP +E+ +
Sbjct: 231 MERPEGCPEKVY----------ELMRACWQWNPSDRPSFAEIHQA 265
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 8e-19
Identities = 53/192 (27%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS- 67
+ +I GM F+ E + IHRDLR +N+L++ KI DFGL+R + + G+
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAK 171
Query: 68 -P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN 124
P W APE + G + + DVW+ GI E+ G+ P+ M + + R
Sbjct: 172 FPIKWTAPEAINYGT-----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
Query: 125 -----P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH--PFITSLPENDL 174
P P LY + C ++ PE RP L F T+ E
Sbjct: 227 YRMVRPDNCPEELY----------QLMRLCWKERPEDRPTFDYLRSVLEDFFTA-TEG-- 273
Query: 175 HLSTVNCQYKDQ 186
QY+ Q
Sbjct: 274 -------QYQPQ 278
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 29/166 (17%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS- 67
+ ++ GM +L E VIHRDL N L+ ++ +K+ DFG++R + T G+
Sbjct: 109 MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTK 166
Query: 68 -P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVR- 123
P W +PE+ Y ++ DVW+ G+ E+ +GK P+E+ + + I
Sbjct: 167 FPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
Query: 124 -------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+Y + C + PE RP S LL
Sbjct: 222 FRLYKPRLASTHVY----------QIMNHCWRERPEDRPAFSRLLR 257
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 1e-18
Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 53/208 (25%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + + L +++ G+ F H +V+HRDL+ N+L+ ++GE+K+ +FGL+R
Sbjct: 98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-------- 149
Query: 61 KKTFLGSPS----------WM-APEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPP 108
G P W P+++ G K Y ID+W+ G I A G+P
Sbjct: 150 ---AFGIPVRCYSAEVVTLWYRPPDVL-FGAKL---YSTSIDMWSAGCIFAELANAGRPL 202
Query: 109 FEDMHPTRALFQIVR-------------------NPPPGLYRASNWSQHY-------VDF 142
F L +I R P P ++ D
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 143 IAECLEKNPEHRPYMSELLEHPFITSLP 170
+ L+ NP R E L+HP+ +
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 41/166 (24%), Positives = 68/166 (40%), Gaps = 27/166 (16%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS- 67
++ ++ GM +L E++ +HRDL NVLL KI DFGLS+ + K
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 68 -P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN 124
P W APE + + ++ DVW+ G+ E G+ P+ M + + +
Sbjct: 182 WPVKWYAPECINYYK-----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
Query: 125 -----P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P P +Y D + C + E+RP + +
Sbjct: 237 ERMGCPAGCPREMY----------DLMNLCWTYDVENRPGFAAVEL 272
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 41/162 (25%), Positives = 66/162 (40%), Gaps = 26/162 (16%)
Query: 13 IITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-SW 70
I GM +L + ++HRDL NVL+ VKI DFGL++ + G P W
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN----- 124
MA E + Y ++ DVW+ G+T EL G P++ + + + +
Sbjct: 186 MALESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 125 P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P +Y + +C + + RP EL+
Sbjct: 241 PPICTIDVY----------MIMRKCWMIDADSRPKFRELIIE 272
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 69/218 (31%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + + +++ G+ F HEN ++HRDL+ N+L+ K G++K+ DFGL+R
Sbjct: 105 LELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-------- 156
Query: 61 KKTFLGSPS----------WM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
G P W AP+++ G + Y ID+W+ G E+ GKP F
Sbjct: 157 ---AFGIPVNTFSSEVVTLWYRAPDVL-MGSRT---YSTSIDIWSCGCILAEMITGKPLF 209
Query: 110 --------------------EDM----------------HPTRALFQIVRN-PPPGLYRA 132
E + P R L Q+++ L
Sbjct: 210 PGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL--- 266
Query: 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
+ +DF+ L+ NP+ R + L HP+
Sbjct: 267 ---DGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 52/202 (25%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ L +++ G+ + H+ V+HRDL+ N+L+ ++GE+KI DFGL+R
Sbjct: 97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-------- 148
Query: 61 KKTFLGSPS----------WM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
G P W AP+++ G K+ Y ID+W++G E+ +G P F
Sbjct: 149 ---AFGIPVRKYTHEIVTLWYRAPDVL-MGSKK---YSTTIDIWSVGCIFAEMVNGTPLF 201
Query: 110 ---EDMHPTRALFQIVRNPP----PGL------------YRASNWSQHY-------VDFI 143
+ +F+I+ P P + Y W +D +
Sbjct: 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLL 261
Query: 144 AECLEKNPEHRPYMSELLEHPF 165
++ L+ +P R + LEH +
Sbjct: 262 SKMLKLDPNQRITAKQALEHAY 283
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 47/208 (22%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ I +++ ++ G+ ++H N ++HRD++ +NVL+T+DG +K+ DFGL+R F
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA----FSL 176
Query: 61 KKTFLGSPS-------WM-APEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPFE- 110
K + W PE++ G ++ Y ID+W G I A E+ P +
Sbjct: 177 AKNSQPNRYTNRVVTLWYRPPELL-LGERD---YGPPIDLWGAGCIMA-EMWTRSPIMQG 231
Query: 111 --DMH-----------PTRA------------LFQIVRNPPPGL---YRASNWSQHYVDF 142
+ H T ++V+ + +A + +D
Sbjct: 232 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 291
Query: 143 IAECLEKNPEHRPYMSELLEHPFITSLP 170
I + L +P R + L H F S P
Sbjct: 292 IDKLLVLDPAQRIDSDDALNHDFFWSDP 319
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 53/207 (25%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++ HI + + G+ +LH++ ++HRDL+ +N+LL ++G +K+ DFGL++
Sbjct: 109 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-------- 160
Query: 61 KKTFLGSPS----------WM-APEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPP 108
GSP+ W APE++ G + Y +D+WA+G I A EL P
Sbjct: 161 ---SFGSPNRAYTHQVVTRWYRAPELL-FGARM---YGVGVDMWAVGCILA-ELLLRVPF 212
Query: 109 F---EDMHPTRALFQIVRNPP----PGL-----------YRASNWSQHY-------VDFI 143
D+ +F+ + P P + + + +D I
Sbjct: 213 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLI 272
Query: 144 AECLEKNPEHRPYMSELLEHPFITSLP 170
NP R ++ L+ + ++ P
Sbjct: 273 QGLFLFNPCARITATQALKMKYFSNRP 299
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 41/167 (24%), Positives = 65/167 (38%), Gaps = 29/167 (17%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS- 67
+ K++ M +L +HRDL N L+ G VK+ DFGLSR + GS
Sbjct: 125 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--GSK 182
Query: 68 -P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN 124
P W PE++ + ++ D+WA G+ E+ GK P+E + I +
Sbjct: 183 FPVRWSPPEVLMYSK-----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
Query: 125 -----P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P +Y + C + + RP LL +
Sbjct: 238 LRLYRPHLASEKVY----------TIMYSCWHEKADERPTFKILLSN 274
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-S 69
++ GM FL + IHRDL N+LLT KI DFGL+R+ N + P
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 212
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN---- 124
WMAPE + Y DVW+ GI EL G P+ M +++++
Sbjct: 213 WMAPESIFNCV-----YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267
Query: 125 --P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P P +Y D + C + +P RP ++++
Sbjct: 268 LSPEHAPAEMY----------DIMKTCWDADPLKRPTFKQIVQL 301
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 47/178 (26%), Positives = 69/178 (38%), Gaps = 29/178 (16%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS- 67
+L ++ GM +L E + +HRDL NVLL KI DFGLS+
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 68 -P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN 124
P W APE + + +R DVW+ G+T E G+ P++ M + I +
Sbjct: 175 WPLKWYAPECINFRK-----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
Query: 125 -----P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH--PFITSLPEN 172
P PP LY +++C E RP + + SL
Sbjct: 230 KRMECPPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 7e-18
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 15/159 (9%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
++ T + +L +HRD+ NVL++ + VK+ DFGLSR ++ K + P
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIV---R 123
WMAPE + + + DVW G+ E+ G PF+ + + +I R
Sbjct: 556 IKWMAPESINFRR-----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 610
Query: 124 NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P P N + +C +P RP +EL
Sbjct: 611 LPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 42/165 (25%), Positives = 62/165 (37%), Gaps = 29/165 (17%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
+E+HI IL ++ G F+HE+ +IHRDL+ +N LL +D VK+ DFGL+R + D
Sbjct: 127 TEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 62 KTFLGSPSWM----------------------APEIMRCGHKEVDGYDNRIDVWALG-IT 98
+ APE++ Y ID+W+ G I
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN----YTKSIDIWSTGCIF 242
Query: 99 AIELGDGKPPFEDMHPTRALFQ--IVRNPPPGLYRASNWSQHYVD 141
A L + D LF P + D
Sbjct: 243 AELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-S 69
++ GM FL IHRDL N+LL++ VKI DFGL+R+ D + P
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 215
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN---- 124
WMAPE + Y + DVW+ G+ E+ G P+ + + ++
Sbjct: 216 WMAPETIFDRV-----YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270
Query: 125 --P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P P +Y + +C P RP SEL+EH
Sbjct: 271 RAPDYTTPEMY----------QTMLDCWHGEPSQRPTFSELVEH 304
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 44/182 (24%), Positives = 62/182 (34%), Gaps = 34/182 (18%)
Query: 13 IITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSP-S 69
I GM +L IHRDL N+L+ + VKI DFGL++ + K K SP
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL----------------GDGKPPFEDMH 113
W APE + + DVW+ G+ EL G M
Sbjct: 183 WYAPESLTESK-----FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 114 PTRALFQIVRN---PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
+ + N P P + EC N RP +L + +
Sbjct: 238 VFHLIELLKNNGRLPRP-----DGCPDEIYMIMTECWNNNVNQRPSFRDL--ALRVDQIR 290
Query: 171 EN 172
+N
Sbjct: 291 DN 292
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 9e-18
Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 29/166 (17%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLG 66
+I M +L + +HRD+ N+L+ VK+ DFGLSR + + T L
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL- 176
Query: 67 SP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN 124
P WM+PE + + DVW + E+ GK PF + + + +
Sbjct: 177 -PIKWMSPESINFRR-----FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
Query: 125 -----P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P PP LY + C + +P RP +EL+
Sbjct: 231 DRLPKPDLCPPVLY----------TLMTRCWDYDPSDRPRFTELVC 266
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 33/188 (17%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
+I GM F+ + + IHRDLR +N+L++ KI DFGL+R + + P
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELG-DGKPPFEDMHPTRALFQIVRN-- 124
W APE + G + + DVW+ GI +E+ G+ P+ M + + R
Sbjct: 349 IKWTAPEAINFGS-----FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR 403
Query: 125 ---P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLST 178
P P LY + + C + PE RP + L +D + +T
Sbjct: 404 MPRPENCPEELY----------NIMMRCWKNRPEERPTFEYIQSV-----L--DDFYTAT 446
Query: 179 VNCQYKDQ 186
QY++
Sbjct: 447 -ESQYEEI 453
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 48/165 (29%), Positives = 70/165 (42%), Gaps = 29/165 (17%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-S 69
++ GM FL IHRDL N+LL++ VKI DFGL+R+ D + P
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 70 WMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN--- 124
WMAPE + D Y + DVW+ G+ E+ G P+ + + ++
Sbjct: 261 WMAPETIF------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314
Query: 125 ---P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P P +Y + +C P RP SEL+EH
Sbjct: 315 MRAPDYTTPEMY----------QTMLDCWHGEPSQRPTFSELVEH 349
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 37/146 (25%), Positives = 57/146 (39%), Gaps = 32/146 (21%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKK 61
+E HI +L ++ G+ ++H ++HRDL+ +N L+ +D VK+ DFGL+R +
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 62 KTFLGSPSWM---------------------------APEIMRCGHKEVDGYDNRIDVWA 94
SP APE++ Y IDVW+
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN----YTEAIDVWS 269
Query: 95 LG-ITAIELGDGKPPFEDMHPTRALF 119
+G I A L K LF
Sbjct: 270 IGCIFAELLNMIKENVAYHADRGPLF 295
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 45/172 (26%), Positives = 63/172 (36%), Gaps = 31/172 (18%)
Query: 13 IITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSP-S 69
I GM +L +HRDL NVL+ + +VKI DFGL++ + K SP
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL---------------GDGKPPFEDMHP 114
W APE + + DVW+ G+T EL P M
Sbjct: 195 WYAPECLMQSK-----FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 115 TRALFQIVRN---PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
TR + + P P N + +C E P +R L+E
Sbjct: 250 TRLVNTLKEGKRLPCP-----PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 43/179 (24%), Positives = 71/179 (39%), Gaps = 34/179 (18%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT---FDKKKTFL 65
+ +I GM +L + +HRDL N +L D V + DFGLS++ + + +
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 66 GSP-SWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIV 122
P W+A E + D Y ++ DVWA G+T E+ G P+ + ++
Sbjct: 212 --PVKWIAIESLA------DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 123 R--------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH--PFITSLPE 171
+ LY + + C +P RP S L + SLP+
Sbjct: 264 HGHRLKQPEDCLDELY----------EIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 41/191 (21%), Positives = 70/191 (36%), Gaps = 35/191 (18%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTFDKKKTFLG 66
++ GM +L E +HRDL N +L + VK+ DFGL+R + ++
Sbjct: 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 67 S-P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR 123
P W A E ++ + + DVW+ G+ EL G PP+ + P + +
Sbjct: 189 RLPVKWTALESLQTYR-----FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
Query: 124 --------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLH 175
P LY + +C E +P RP L+ + +
Sbjct: 244 GRRLPQPEYCPDSLY----------QVMQQCWEADPAVRPTFRVLVG-----EV--EQIV 286
Query: 176 LSTVNCQYKDQ 186
+ + Y
Sbjct: 287 SALLGDHYVQL 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 47/176 (26%), Positives = 62/176 (35%), Gaps = 41/176 (23%)
Query: 13 IITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSP-S 69
I GM +LH H IHRDL NVLL D VKI DFGL++ + + + SP
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL---------------GDGKPPFEDMHP 114
W APE ++ + DVW+ G+T EL M
Sbjct: 203 WYAPECLKEYK-----FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 115 TRALFQIVRN-----P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
R + R P P +Y + C E RP L+
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVY----------HLMKNCWETEASFRPTFENLIP 303
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 45/168 (26%), Positives = 68/168 (40%), Gaps = 33/168 (19%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR----ETANTFDKKKTF 64
++ T + +L +HRD+ NVL++ + VK+ DFGLSR T K K
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK-- 178
Query: 65 LGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIV 122
P WMAPE + + + DVW G+ E+ G PF+ + + +I
Sbjct: 179 --LPIKWMAPESINFRR-----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
Query: 123 R--------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
N PP LY + +C +P RP +EL
Sbjct: 232 NGERLPMPPNCPPTLY----------SLMTKCWAYDPSRRPRFTELKA 269
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 28/163 (17%)
Query: 13 IITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS--P-S 69
I GM +L E+ ++HR+L NVLL +V++ DFG++ DK+ + + P
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-DKQLLYSEAKTPIK 182
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN---- 124
WMA E + G Y ++ DVW+ G+T EL G P+ + + +
Sbjct: 183 WMALESIHFGK-----YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237
Query: 125 -P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P +Y + +C + RP EL
Sbjct: 238 QPQICTIDVY----------MVMVKCWMIDENIRPTFKELANE 270
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 41/162 (25%), Positives = 66/162 (40%), Gaps = 26/162 (16%)
Query: 13 IITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-SW 70
I GM +L + ++HRDL NVL+ VKI DFGL++ + G P W
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN----- 124
MA E + Y ++ DVW+ G+T EL G P++ + + + +
Sbjct: 186 MALESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 125 P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P +Y + +C + + RP EL+
Sbjct: 241 PPICTIDVY----------MIMVKCWMIDADSRPKFRELIIE 272
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 44/177 (24%), Positives = 60/177 (33%), Gaps = 42/177 (23%)
Query: 13 IITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSP-S 69
I GM +L IHRDL N+L+ + VKI DFGL++ + K K SP
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL----------------GDGKPPFEDMH 113
W APE + + DVW+ G+ EL G M
Sbjct: 214 WYAPESLTESK-----FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 114 PTRALFQIVRN-----P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+ + N P P +Y + EC N RP +L
Sbjct: 269 VFHLIELLKNNGRLPRPDGCPDEIY----------MIMTECWNNNVNQRPSFRDLAL 315
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 5e-17
Identities = 44/166 (26%), Positives = 67/166 (40%), Gaps = 27/166 (16%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS- 67
+L ++ GM +L E + +HR+L NVLL KI DFGLS+
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 68 -P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRN 124
P W APE + + +R DVW+ G+T E G+ P++ M + I +
Sbjct: 501 WPLKWYAPECINFRK-----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555
Query: 125 -----P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
P PP LY +++C E RP + +
Sbjct: 556 KRMECPPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQ 591
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 51/249 (20%), Positives = 90/249 (36%), Gaps = 64/249 (25%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANTFD 59
+ I+ + ++ + F+H + HRD++ N+L+ +KD +K+ DFG +++
Sbjct: 138 IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP--- 194
Query: 60 KKKTFLGSPS-------WM-APEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPF- 109
PS + APE+M G E Y ID+W++G + EL GKP F
Sbjct: 195 ------SEPSVAYICSRFYRAPELM-LGATE---YTPSIDLWSIGCVFG-ELILGKPLFS 243
Query: 110 -EDMH------------PTRALFQIVRNPPPGLY----RASNWSQHY--------VDFIA 144
E PT+ + + +A +W + +D +
Sbjct: 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303
Query: 145 ECLEKNPEHRPYMSELLEHPFITSLPENDLHLSTVNCQY--------------KDQELQT 190
+ L P+ R E + HPF L + N + EL
Sbjct: 304 QILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSI 363
Query: 191 MHVEDLAAL 199
+ L +
Sbjct: 364 IPGNVLNRI 372
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 34/170 (20%), Positives = 60/170 (35%), Gaps = 35/170 (20%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE--------VKIVDFGLSRETANTFDK 60
+ K++ M FL EN +IH ++ N+LL ++ + +K+ D G+S
Sbjct: 118 VAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 61 KKTFLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRAL 118
++ W+ PE + + D W+ G T E G P + R L
Sbjct: 178 QE-----RIPWVPPECIENPKN----LNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 119 FQIVRN------PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
L + I C++ P+HRP ++
Sbjct: 229 QFYEDRHQLPAPKAAELA----------NLINNCMDYEPDHRPSFRAIIR 268
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 50/213 (23%), Positives = 78/213 (36%), Gaps = 58/213 (27%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-----KDGEVKIVDFGLSRETA 55
+S + I L ++I G+ F H +HRDL+ N+LL+ + +KI DFGL+R
Sbjct: 129 VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--- 185
Query: 56 NTFDKKKTFLGSPS----------WM-APEIMRCGHKEVDGYDNRIDVWALGITAIELGD 104
G P W PEI+ G + Y +D+W++ E+
Sbjct: 186 --------AFGIPIRQFTHEIITLWYRPPEIL-LGSRH---YSTSVDIWSIACIWAEMLM 233
Query: 105 GKPPFEDMHPTRALFQIVRN--PP-----PGL------------YRASNWSQHY------ 139
P F LF+I P PG+ +R +
Sbjct: 234 KTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDD 293
Query: 140 --VDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
+D + LE +P R LEHP+ +
Sbjct: 294 EGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 41/168 (24%), Positives = 65/168 (38%), Gaps = 28/168 (16%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTFDKKKTFLG 66
++ GM +L +HRDL N +L + VK+ DFGL+R +
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 67 S-P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIV- 122
P WMA E ++ + + DVW+ G+ EL G PP+ D++ ++
Sbjct: 193 KLPVKWMALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
Query: 123 -------RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P LY + + +C E RP SEL+
Sbjct: 248 GRRLLQPEYCPDPLY----------EVMLKCWHPKAEMRPSFSELVSR 285
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 47/231 (20%), Positives = 77/231 (33%), Gaps = 78/231 (33%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTF 58
S + I+ + LH+N +IH DL+ N+LL +K++DFG S +
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-----CY 251
Query: 59 DKKK--TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR 116
+ ++ T++ S + APE++ G Y ID+W+LG EL G P P
Sbjct: 252 EHQRVYTYIQSRFYRAPEVI-LGA----RYGMPIDMWSLGCILAELLTGYPLL----PGE 302
Query: 117 ------ALFQIVRNPPPG--LYRASNWSQHY----------------------------- 139
A + P L +
Sbjct: 303 DEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRG 362
Query: 140 -----------------------VDFIAECLEKNPEHRPYMSELLEHPFIT 167
+DF+ +CLE +P R + L HP++
Sbjct: 363 KLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 30/165 (18%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTFDKK-KTFLGSP 68
+I GM +L + IHRDL N +L +D V + DFGLSR + + + + + L P
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--P 202
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR--- 123
W+A E + Y DVWA G+T E+ G+ P+ + ++
Sbjct: 203 VKWLALESLADNL-----YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257
Query: 124 -----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+Y D + +C +P+ RP + L
Sbjct: 258 LKQPPECMEEVY----------DLMYQCWSADPKQRPSFTCLRME 292
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 37/195 (18%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGS 67
EI GM +L+ N +HRDL N ++ +D VKI DFG++R+ T D K L
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-DYYRKGGKGLL-- 202
Query: 68 P-SWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR- 123
P WM+PE ++ DG + DVW+ G+ E+ + P++ + + L ++
Sbjct: 203 PVRWMSPESLK------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256
Query: 124 -------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL---LEHPFITSLPEND 173
N P L+ + + C + NP+ RP E+ ++ E
Sbjct: 257 GLLDKPDNCPDMLF----------ELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306
Query: 174 LHLSTVNCQYKDQEL 188
+ S N + +EL
Sbjct: 307 FYYSEENKLPEPEEL 321
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 43/164 (26%), Positives = 65/164 (39%), Gaps = 27/164 (16%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-S 69
++ GM FL +HRDL NVL+T VKI DFGL+R+ + + P
Sbjct: 180 QVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK 239
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN---- 124
WMAPE + G Y + DVW+ GI E+ G P+ + +++++N
Sbjct: 240 WMAPESLFEGI-----YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 294
Query: 125 --P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P +Y + C + RP L
Sbjct: 295 DQPFYATEEIY----------IIMQSCWAFDSRKRPSFPNLTSF 328
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 47/166 (28%), Positives = 69/166 (41%), Gaps = 31/166 (18%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSP 68
++ GM FL + IHRD+ NVLLT KI DFGL+R+ N + K L P
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--P 229
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRN-- 124
WMAPE + Y + DVW+ GI E+ G P+ + +++V++
Sbjct: 230 VKWMAPESIFDCV-----YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284
Query: 125 ----P---PPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P P +Y + C P HRP ++
Sbjct: 285 QMAQPAFAPKNIY----------SIMQACWALEPTHRPTFQQICSF 320
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 38/172 (22%), Positives = 72/172 (41%), Gaps = 40/172 (23%)
Query: 16 GMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKT-----FLGSPSW 70
G+ FLHENH IHRD++ +N+LL + KI DFGL+R + +T +G+ ++
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE---KFAQTVMTSRIVGTTAY 201
Query: 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP--------------TR 116
MAPE +R G + D+++ G+ +E+ G P ++ +
Sbjct: 202 MAPEALR-GEITP-----KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK 255
Query: 117 ALFQIV-----RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ + + ++CL + RP + ++ +
Sbjct: 256 TIEDYIDKKMNDADSTSVEAM-------YSVASQCLHEKKNKRPDIKKVQQL 300
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 37/219 (16%), Positives = 76/219 (34%), Gaps = 60/219 (27%)
Query: 1 MSEQHIAFILKEIITGMVFLH-ENHVIHRDLRGSNVLL------TKDGEVKIVDFGLSRE 53
+ ++ I K+++ G+ ++H +IH D++ NVL+ ++KI D G +
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 54 TANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH 113
+ + + + +PE++ G + D+W+ EL G FE
Sbjct: 188 YDEHY---TNSIQTREYRSPEVL-LGA----PWGCGADIWSTACLIFELITGDFLFEPDE 239
Query: 114 PTRA------LFQIVR---NPPPGLYRASNWSQHY------------------------- 139
+ QI+ P L R +++ +
Sbjct: 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 299
Query: 140 -----------VDFIAECLEKNPEHRPYMSELLEHPFIT 167
DF++ L+ +P R L+ HP++
Sbjct: 300 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 338
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 48/182 (26%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR-----ETANTFDKKKT 63
++ GM FL +HRDL N +L + VK+ DFGL+R E + +K
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 64 FLGSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQI 121
L P WMA E ++ + + DVW+ G+ EL G PP+ D++ +
Sbjct: 257 KL--PVKWMALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 122 V---RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL---LEHPFITSLPENDLH 175
+ R P + + +C E RP SEL + F T + E+ +H
Sbjct: 310 LQGRRLLQP-----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 364
Query: 176 LS 177
++
Sbjct: 365 VN 366
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 48/164 (29%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-S 69
++ GM +L IHRDL NVL+T++ +KI DFGL+R+ N KKT G P
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 70 WMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR---- 123
WMAPE + D Y ++ DVW+ G+ E+ G P+ + +
Sbjct: 225 WMAPEALF------DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278
Query: 124 ----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
N LY + +C P RP +L+E
Sbjct: 279 DKPANCTNELY----------MMMRDCWHAVPSQRPTFKQLVED 312
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 51/238 (21%), Positives = 85/238 (35%), Gaps = 80/238 (33%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-------------------KDG 41
HI + +I + FLH N + H DL+ N+L +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 42 EVKIVDFGLSRETANTFDKKK--TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITA 99
++K+VDFG + T+D + T + + + APE++ G+ DVW++G
Sbjct: 175 DIKVVDFGSA-----TYDDEHHSTLVSTRHYRAPEVI-LAL----GWSQPCDVWSIGCIL 224
Query: 100 IELGDGKPPFEDMHPTR------ALFQIVRNPPPG--LYRAS----------NWSQH--- 138
IE G F PT A+ + + P P + + +W +H
Sbjct: 225 IEYYLGFTVF----PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280
Query: 139 ------------------------YVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
D I + LE +P R + E L+HPF L ++
Sbjct: 281 GRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 33/171 (19%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRETANTFD--KKKT 63
+ ++I G +L ENH IHRD+ N LLT G KI DFG++R+ +K
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-GYYRKGG 244
Query: 64 FLGSP-SWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQ 120
P WM PE ++G + ++ D W+ G+ E+ G P+ L
Sbjct: 245 CAMLPVKWMPPEAF------MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298
Query: 121 IV--------RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ +N P +Y + +C + PE RP + +LE
Sbjct: 299 VTSGGRMDPPKNCPGPVY----------RIMTQCWQHQPEDRPNFAIILER 339
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 43/160 (26%), Positives = 64/160 (40%), Gaps = 17/160 (10%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSP 68
++ GM +L + IHRDL N+L+ ++ KI DFGLSR K L P
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--P 204
Query: 69 -SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIV---R 123
WMA E + Y DVW+ G+ E+ G P+ M ++ R
Sbjct: 205 VRWMAIESLNYSV-----YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259
Query: 124 NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
P N D + +C + P RP +++L
Sbjct: 260 LEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVS 294
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 45/244 (18%), Positives = 77/244 (31%), Gaps = 80/244 (32%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-------------------KDG 41
H+ + ++ + FLHEN + H DL+ N+L K+
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 42 EVKIVDFGLSRETANTFDKKK--TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITA 99
+++ DFG + TFD + T + + + PE++ G+ DVW++G
Sbjct: 180 SIRVADFGSA-----TFDHEHHTTIVATRHYRPPEVI-LEL----GWAQPCDVWSIGCIL 229
Query: 100 IELGDGKPPFEDMHPTR------ALFQIVRNPPPG--LYRASNWSQH------------- 138
E G F T + + + P P ++R
Sbjct: 230 FEYYRGFTLF----QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSD 285
Query: 139 ------------------------YVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174
D + LE +P R ++E L HPF L +
Sbjct: 286 GRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEER 345
Query: 175 HLST 178
T
Sbjct: 346 SFHT 349
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 40/208 (19%), Positives = 74/208 (35%), Gaps = 52/208 (25%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-GEVKIVDFGLSRETANTFD 59
+ ++ + ++ + ++H + HRD++ N+LL D +K+ DFG +++
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 209
Query: 60 KKKTFLGSPS-------WM-APEIM-RCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPF 109
G P+ + APE++ Y + IDVW+ G + A EL G+P F
Sbjct: 210 ------GEPNVSYICSRYYRAPELIFGATD-----YTSSIDVWSAGCVLA-ELLLGQPIF 257
Query: 110 ------------------------EDMHPTRALFQIVRNPPPGLYRA--SNWSQHYVDFI 143
+M+P F+ + + +
Sbjct: 258 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 317
Query: 144 AECLEKNPEHRPYMSELLEHPFITSLPE 171
+ LE P R E H F L +
Sbjct: 318 SRLLEYTPTARLTPLEACAHSFFDELRD 345
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 45/166 (27%), Positives = 67/166 (40%), Gaps = 32/166 (19%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGS 67
++ GM +L IHRDL NVL+T++ +KI DFGL+R+ N D L
Sbjct: 211 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-DYYKKTTNGRL-- 267
Query: 68 P-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR-- 123
P WMAPE + Y ++ DVW+ G+ E+ G P+ + +
Sbjct: 268 PVKWMAPEALFDRV-----YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 322
Query: 124 ------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
N LY + +C P RP +L+E
Sbjct: 323 RMDKPANCTNELY----------MMMRDCWHAVPSQRPTFKQLVED 358
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 4e-16
Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 30/168 (17%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTFDKK-KTFL 65
++ +I GM +L +HV+H+DL NVL+ VKI D GL R A+ + + L
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 66 GSP-SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR 123
P WMAPE + G + D+W+ G+ E+ G P+ + I
Sbjct: 193 --PIRWMAPEAIMYGK-----FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245
Query: 124 --------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ P +Y + EC + P RP ++
Sbjct: 246 RQVLPCPDDCPAWVY----------ALMIECWNEFPSRRPRFKDIHSR 283
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 50/226 (22%), Positives = 82/226 (36%), Gaps = 65/226 (28%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD----GEVKIVDFGLSRETAN 56
+ + +L +I+ G+ +LH N V+HRDL+ +N+L+ + G VKI D G +R
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---- 180
Query: 57 TFDK-KKTFLGSPS-----WM-APEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPP 108
F+ K W APE++ G + Y ID+WA+G I A EL +P
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELL-LGARH---YTKAIDIWAIGCIFA-ELLTSEPI 235
Query: 109 F----EDMHPTRA-----LFQIVR----------------------------NPPPGLYR 131
F ED+ + L +I N
Sbjct: 236 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL 295
Query: 132 ASNWSQHY-------VDFIAECLEKNPEHRPYMSELLEHPFITSLP 170
+H + + L +P R + ++ P+ P
Sbjct: 296 IKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 33/171 (19%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRETANTFD--KKKT 63
+ ++I G +L ENH IHRD+ N LLT G KI DFG++R+ +K
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGG 203
Query: 64 FLGSP-SWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQ 120
P WM PE ++G + ++ D W+ G+ E+ G P+ L
Sbjct: 204 CAMLPVKWMPPEAF------MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257
Query: 121 IV--------RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ +N P +Y + +C + PE RP + +LE
Sbjct: 258 VTSGGRMDPPKNCPGPVY----------RIMTQCWQHQPEDRPNFAIILER 298
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 30/176 (17%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD- 59
+ + + ++ GMV+L H +HRDL N L+ + VKI DFG+SR+ +T D
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-DY 213
Query: 60 -KKKTFLGSP-SWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPT 115
+ P WM PE + + + DVW+ G+ E+ GK P+ + T
Sbjct: 214 YRVGGRTMLPIRWMPPESI------LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267
Query: 116 RALFQIVR--------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
A+ I + PP +Y + C ++ P+ R + ++
Sbjct: 268 EAIDCITQGRELERPRACPPEVY----------AIMRGCWQREPQQRHSIKDVHAR 313
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 28/164 (17%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-S 69
+I GM +L E ++HRDL N+L+ + ++KI DFGLSR+ K G P
Sbjct: 158 QISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK 217
Query: 70 WMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR---- 123
WMA E + D Y + DVW+ G+ E+ G P+ + P R +
Sbjct: 218 WMAIESLF------DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM 271
Query: 124 ----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
N +Y + +C ++ P+ RP +++ +
Sbjct: 272 ERPDNCSEEMY----------RLMLQCWKQEPDKRPVFADISKD 305
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 39/166 (23%), Positives = 58/166 (34%), Gaps = 21/166 (12%)
Query: 13 IITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSP-S 69
I GM +L +HRDL N+L+ + VKI DFGL++ D + SP
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRALFQIVRNPPPG 128
W APE + + + DVW+ G+ EL + R+ P
Sbjct: 196 WYAPESLSDNI-----FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 129 ------------LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
L + + C +P+ RP S L
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 36/170 (21%)
Query: 9 ILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTF 64
I +I +GMV+L H +HRDL N L+ + VKI DFG+SR+ +T D T
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST-DYYRVGGHTM 196
Query: 65 LGSP-SWMAPE-IMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQ 120
L P WM PE IM + DVW+ G+ E+ GK P+ + T +
Sbjct: 197 L--PIRWMPPESIM-------YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247
Query: 121 IVR--------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
I + P +Y D + C ++ P+ R + E+ +
Sbjct: 248 ITQGRVLERPRVCPKEVY----------DVMLGCWQREPQQRLNIKEIYK 287
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 48/164 (29%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 12 EIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGS-P-S 69
++ GM +L IHRDL NVL+T+D +KI DFGL+R+ + KKT G P
Sbjct: 199 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 258
Query: 70 WMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVR---- 123
WMAPE + D Y ++ DVW+ G+ E+ G P+ + +
Sbjct: 259 WMAPEALF------DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 312
Query: 124 ----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
N LY + +C P RP +L+E
Sbjct: 313 DKPSNCTNELY----------MMMRDCWHAVPSQRPTFKQLVED 346
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 46/177 (25%), Positives = 66/177 (37%), Gaps = 34/177 (19%)
Query: 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-- 59
S I +++ GM +L E +HRDL N L+ ++ VKI DFGLSR + D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA-DYY 230
Query: 60 --KKKTFLGSP-SWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGD-GKPPFEDMHP 114
+ P WM PE + Y DVWA G+ E+ G P+ M
Sbjct: 231 KADGNDAI--PIRWMPPESI------FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 115 TRALFQIV--------RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
++ + N P LY + + C K P RP +
Sbjct: 283 EEVIYYVRDGNILACPENCPLELY----------NLMRLCWSKLPADRPSFCSIHRI 329
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 46/210 (21%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-GEVKIVDFGLSRETANTFD 59
M I + +++ + ++H + HRD++ N+LL G +K++DFG ++
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK----ILI 193
Query: 60 KKKTFLG---SPSWMAPEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPPF------ 109
+ + S + APE++ Y ID+W+ G + A EL G+P F
Sbjct: 194 AGEPNVSYICSRYYRAPELIFGATN----YTTNIDIWSTGCVMA-ELMQGQPLFPGESGI 248
Query: 110 ---------------EDMHPTRALFQIVRNPPPGLYRASNWSQHY--------VDFIAEC 146
E + + + P R +S+ + +D I+
Sbjct: 249 DQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQ---IRPHPFSKVFRPRTPPDAIDLISRL 305
Query: 147 LEKNPEHRPYMSELLEHPFITSLPENDLHL 176
LE P R E L HPF L + +
Sbjct: 306 LEYTPSARLTAIEALCHPFFDELRTGEARM 335
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 15/153 (9%), Positives = 34/153 (22%), Gaps = 36/153 (23%)
Query: 7 AFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLG 66
++ + H V S V ++ DG+V +
Sbjct: 132 IRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---------------- 175
Query: 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFED---MHPTRALFQIVR 123
M + + D+ +G + L + P + +
Sbjct: 176 ----MPDA------------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219
Query: 124 NPPPGLYRASNWSQHYVD-FIAECLEKNPEHRP 155
P + A ++ + R
Sbjct: 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIRS 252
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 1 MSEQHIAFILKEIITGMVFLHEN--HVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANT 57
I L ++I + LH +V HRD++ NVL+ DG +K+ DFG +++ +
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP- 184
Query: 58 FDKKKTFLGSPS-------WM-APEIMRCGHKEVDGYDNRIDVWALG-ITAIELGDGKPP 108
P+ + APE++ G++ Y +D+W++G I A E+ G+P
Sbjct: 185 --------SEPNVAYICSRYYRAPELI-FGNQH---YTTAVDIWSVGCIFA-EMMLGEPI 231
Query: 109 F--EDMH------------PTRALFQIVRNPPPGLY----RASNWSQHY----------- 139
F ++ P+R + + + + + WS +
Sbjct: 232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEA 291
Query: 140 VDFIAECLEKNPEHRPYMSELLEHPFITSL 169
D ++ L+ PE R E L HP+ L
Sbjct: 292 YDLLSALLQYLPEERMKPYEALCHPYFDEL 321
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 39/223 (17%), Positives = 81/223 (36%), Gaps = 71/223 (31%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-TKDGEVKIVDFGLSRETANTFD 59
+++ I F + EI+ + + H ++HRD++ NV++ + +++++D+GL+
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE------- 179
Query: 60 KKKTFLGSPSWM----------APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPF 109
F PE++ YD +D+W+LG + K PF
Sbjct: 180 ----FYHPGQEYNVRVASRYFKGPELLVDYQM----YDYSLDMWSLGCMLASMIFRKEPF 231
Query: 110 ------EDMHPTRALFQIVR----------------------NPPPGLYRASNWSQHY-- 139
D L +I + N G + W +
Sbjct: 232 FHGHDNYDQ-----LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 286
Query: 140 ----------VDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
+DF+ + L + + R E +EHP+ ++ ++
Sbjct: 287 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 51/239 (21%), Positives = 82/239 (34%), Gaps = 78/239 (32%)
Query: 1 MSEQHIAFILKEIITGMVFLHEN--HVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETAN 56
+S +++ T ++FL +IH DL+ N+LL K +KIVDFG S
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----- 208
Query: 57 TFDKKK--TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL--GD-------- 104
++ ++ S + +PE++ G YD ID+W+LG +E+ G+
Sbjct: 209 CQLGQRIYQYIQSRFYRSPEVL-LGM----PYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
Query: 105 -----------GKPP-------------FEDMH-------------------PTRALFQI 121
G PP FE + TR L I
Sbjct: 264 VDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNI 323
Query: 122 VRNPPPGLYRASNWS--------QHYVDFIAECLEKNPEHRPYMSELLEHPFIT-SLPE 171
+ G + D I L+ +P+ R L+H F + E
Sbjct: 324 LGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 42/177 (23%), Positives = 69/177 (38%), Gaps = 49/177 (27%)
Query: 16 GMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFL-----GSPSW 70
G+ +LH +IHRD++ N+LL ++ KI DFG+S++ + +T L G+ +
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT---ELDQTHLSTVVKGTLGY 207
Query: 71 MAPEIMRCGH---KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT------------ 115
+ PE G K DV++ G+ E+ + P
Sbjct: 208 IDPEYFIKGRLTEKS--------DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 116 ---RALFQIV------RNPPPGLYRASNWSQHYVDFIAE-CLEKNPEHRPYMSELLE 162
L QIV + P L + + A CL + E RP M ++L
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGD--------TAVKCLALSSEDRPSMGDVLW 308
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 42/236 (17%), Positives = 77/236 (32%), Gaps = 80/236 (33%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---------------------- 38
+ I EI+ + +L + + H DL+ N+LL
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 39 ---KDGEVKIVDFGLSRETANTFDKKK--TFLGSPSWMAPEIMRCGHKEVDGYDNRIDVW 93
K +K++DFG + TF + + + + APE++ G+D D+W
Sbjct: 194 YRTKSTGIKLIDFGCA-----TFKSDYHGSIINTRQYRAPEVI-LNL----GWDVSSDMW 243
Query: 94 ALGITAIEL--GD-------------------GKPP---FEDMHPTRALFQIVRNPPPGL 129
+ G EL G P + T + ++
Sbjct: 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303
Query: 130 YRASNWSQHYV-------------------DFIAECLEKNPEHRPYMSELLEHPFI 166
+ + S + + DF+ L+ +P RP +ELL+H F+
Sbjct: 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 39/175 (22%), Positives = 70/175 (40%), Gaps = 47/175 (26%)
Query: 16 GMVFLHEN---HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKT-----FLGS 67
G+ +LH++ +IHRD++ +N+LL ++ E + DFGL++ D K T G+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTHVTTAVRGT 198
Query: 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE----------------- 110
+APE + G + DV+ G+ +EL G+ F+
Sbjct: 199 IGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 111 DMHPTRALFQIV------RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159
+ + L +V + + + C + +P RP MSE
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQL-------IQVALLCTQSSPMERPKMSE 301
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 45/264 (17%), Positives = 79/264 (29%), Gaps = 105/264 (39%)
Query: 1 MSEQHIAFILKEIITGMVFLH-ENHVIHRDLRGSNVLLT--------------------- 38
+ + I+++++ G+ +LH + +IH D++ N+LL+
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 39 ----------------------------KDGEVKIVDFGLSRETANTFDKKKTFLGSP-S 69
+ +VKI D G + K T
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC----WVHKHFTEDIQTRQ 258
Query: 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA------LFQIVR 123
+ + E++ GY+ D+W+ A EL G FE + I+
Sbjct: 259 YRSLEVLIGS-----GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313
Query: 124 ---NPPPGLYRASNWSQHY------------------------------------VDFIA 144
P L A +S+ + DF+
Sbjct: 314 LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLL 373
Query: 145 ECLEKNPEHRPYMSELLEHPFITS 168
LE PE R +E L HP++ S
Sbjct: 374 PMLELIPEKRATAAECLRHPWLNS 397
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 3e-08
Identities = 48/369 (13%), Positives = 92/369 (24%), Gaps = 117/369 (31%)
Query: 173 DLHLSTVNCQYKD----------QELQTMHVEDL--AALETISEDNIVQE---------- 210
D QYKD V+D+ + L D+I+
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67
Query: 211 --LEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAY 268
+ FV +VL N Y F +P +
Sbjct: 68 FWTLLSKQEEMVQKFVEEVL---RIN---------YKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 269 QDMMHHEE---AQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAI 325
+D ++++ A++ V + L+ L L + + + +I +
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQ----PYLKLRQALLEL--------RPAKNV-----LIDGV 158
Query: 326 GNAGTPINQNSTRHVLYMQV--TFGSSGKLSGAIFW------------LYQLEKWRVTGN 371
+G + + + V ++ K+ IFW L L+K +
Sbjct: 159 LGSG--------KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210
Query: 372 RDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRA-----DVTDDKLPK----GP 422
+ + H EL + S Y +V + K
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSK----PYENCLLVLLNVQNAKAWNAFNLSC 266
Query: 423 R---ETPDTNVAKF------QEIYQNLIDIEFDDIQ-MEIFSNVLA-------------- 458
+ T V F I + + + + L
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN 326
Query: 459 --AILLIGE 465
+ +I E
Sbjct: 327 PRRLSIIAE 335
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 6e-04
Identities = 65/460 (14%), Positives = 148/460 (32%), Gaps = 97/460 (21%)
Query: 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF-QIVRNPPP 127
+W+A ++ +K D +I W + L + P + + L QI N
Sbjct: 164 TWVALDVCL-SYKVQCKMDFKI-FW------LNLKNCNSPETVLEMLQKLLYQIDPNWTS 215
Query: 128 GLYRASNWSQHYVDFIAECLEKNPEHRPYMSELL-----EHPFITSLPENDLHLSTVNCQ 182
+SN AE L + + +PY + LL ++ + ++C+
Sbjct: 216 RSDHSSNIKLRIHSIQAE-LRRLLKSKPYENCLLVLLNVQNA-------KAWNAFNLSCK 267
Query: 183 Y----KDQELQTMHVEDLAALET--ISEDNIVQELEERHNSKNHYSFVGDVLLF------ 230
+ +++ + L+A T IS D+ L K+ D
Sbjct: 268 ILLTTRFKQV----TDFLSAATTTHISLDHHSMTLTPD-EVKSLLLKYLDCRPQDLPREV 322
Query: 231 --INPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLA 288
NP L++ + DN ++ + + I + L
Sbjct: 323 LTTNP-RRLSIIAESIR---DGLATWDN-----------WKHVNCDKLTTIIESSLNVL- 366
Query: 289 GKTTSLKHLLKHL-IFLGQGAAKV---------GEKIEKCVNVIHAIGNAGTPINQNSTR 338
+ + + L +F +A + + I+ V V+ + + + +
Sbjct: 367 -EPAEYRKMFDRLSVF--PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 339 -----HVLYMQVTFGSSGK--LSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYF-Y--DA 388
+Y+++ + L +I Y + K + + P + + + + +
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 389 MEAAGELD---KYFLSPGRKYRYLRADVTDDKLPKGPRETPDTNVAKFQEIYQNLI---D 442
+E + FL +R+L + D + + + + Y+ I D
Sbjct: 484 IEHPERMTLFRMVFLD----FRFLEQKIRHDSTAWNASGSILNTLQQL-KFYKPYICDND 538
Query: 443 IEFDDIQMEI--FSNVLAAILLIGE----VEFESSAENTA 476
+++ + I F + L+ + + AE+ A
Sbjct: 539 PKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEA 578
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 22/125 (17%), Positives = 49/125 (39%), Gaps = 18/125 (14%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL--TKDGEVKIVDFGLSRETANT- 57
+SE+ + + ++ + FLHEN +H ++ N+ + +V + +G + +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 58 ------FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDN--RIDVWALGITAIELGDGKPPF 109
+ G +++ HK G R D+ +LG ++ G P+
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS----MDLHK---GCGPSRRSDLQSLGYCMLKWLYGFLPW 268
Query: 110 EDMHP 114
+ P
Sbjct: 269 TNCLP 273
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 28/131 (21%), Positives = 51/131 (38%), Gaps = 18/131 (13%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL--TKDGEVKIVDFGLSRETANT- 57
+ + + ++ + ++HEN +H D++ +N+LL +V + D+GLS
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 58 ------FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDN--RIDVWALGITAIELGDGKPPF 109
+ +K G+ + + HK G R DV LG + GK P+
Sbjct: 208 NHKQYQENPRKGHNGTIEFTS----LDAHK---GVALSRRSDVEILGYCMLRWLCGKLPW 260
Query: 110 EDMHPTRALFQ 120
E Q
Sbjct: 261 EQNLKDPVAVQ 271
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 29/123 (23%), Positives = 52/123 (42%), Gaps = 18/123 (14%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL--TKDGEVKIVDFGLSRE--TAN 56
S + + + I+ + ++HE+ +H D++ SN+LL +V +VD+GL+
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 57 T-----FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDN--RIDVWALGITAIELGDGKPPF 109
D K+ G+ + + H G R D+ LG I+ G P+
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS----IDAHN---GVAPSRRGDLEILGYCMIQWLTGHLPW 261
Query: 110 EDM 112
ED
Sbjct: 262 EDN 264
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 29/122 (23%), Positives = 56/122 (45%), Gaps = 21/122 (17%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE-----VKIVDFGLSRE-- 53
S + + I ++I+ M ++H ++I+RD++ N L+ + G + I+DF L++E
Sbjct: 102 FSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
Query: 54 TANT-----FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDN--RIDVWALGITAIELGDGK 106
T + + K+ G+ +M+ H G + R D+ ALG + G
Sbjct: 162 DPETKKHIPYREHKSLTGTARYMS----INTHL---GKEQSRRDDLEALGHMFMYFLRGS 214
Query: 107 PP 108
P
Sbjct: 215 LP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 28/124 (22%), Positives = 57/124 (45%), Gaps = 19/124 (15%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL---TKDGEVKIVDFGLSRE--TA 55
S + + + ++I+ + ++H + IHRD++ N L+ K V I+DFGL+++ A
Sbjct: 102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161
Query: 56 NT-----FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDN--RIDVWALGITAIELGDGKPP 108
T + + K G+ + + H G + R D+ +LG + G P
Sbjct: 162 RTHQHIPYRENKNLTGTARYAS----INTHL---GIEQSRRDDLESLGYVLMYFNLGSLP 214
Query: 109 FEDM 112
++ +
Sbjct: 215 WQGL 218
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 27/122 (22%), Positives = 53/122 (43%), Gaps = 21/122 (17%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-----EVKIVDFGLSRE-- 53
S + +A K+++ + +HE +++RD++ N L+ + + +VDFG+ +
Sbjct: 103 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162
Query: 54 TANT-----FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDN--RIDVWALGITAIELGDGK 106
T + +KK G+ +M+ H G + R D+ ALG + G
Sbjct: 163 DPVTKQHIPYREKKNLSGTARYMS----INTHL---GREQSRRDDLEALGHVFMYFLRGS 215
Query: 107 PP 108
P
Sbjct: 216 LP 217
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 488 | |||
| 1lkx_A | 697 | Myosin IE heavy chain; myosin motor domain, lever | 100.0 | |
| 4db1_A | 783 | Myosin-7; S1DC, cardiac, beta isoform, MYH7, myhcb | 100.0 | |
| 1w7j_A | 795 | Myosin VA; motor protein, unconventional myosin, m | 100.0 | |
| 1kk8_A | 837 | Myosin heavy chain, striated muscle; actin-detache | 100.0 | |
| 1w9i_A | 770 | Myosin II heavy chain; molecular motor, ATPase, mo | 100.0 | |
| 2v26_A | 784 | Myosin VI; calmodulin-binding, nucleotide-binding, | 100.0 | |
| 4anj_A | 1052 | Unconventional myosin-VI, green fluorescent prote; | 100.0 | |
| 1g8x_A | 1010 | Myosin II heavy chain fused to alpha-actinin 3; mo | 100.0 | |
| 2ycu_A | 995 | Non muscle myosin 2C, alpha-actinin; motor protein | 100.0 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 100.0 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.98 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.98 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.98 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.98 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.98 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.98 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.98 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.98 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.98 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.98 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.98 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.95 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.95 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.95 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.95 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.95 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.94 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.94 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.94 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.94 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.94 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.94 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.94 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.94 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.94 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.94 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.93 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.93 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.93 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.93 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.93 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.92 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.92 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.9 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.85 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.79 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.46 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.12 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.43 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 98.21 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 97.88 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 97.83 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 97.74 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 97.72 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 97.64 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 97.62 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 97.6 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 97.58 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 97.57 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.4 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 97.39 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 97.31 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 97.22 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 97.2 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 97.2 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 97.19 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 97.16 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 97.16 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 97.14 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 97.12 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 97.11 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.1 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 97.1 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 97.1 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 97.08 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 97.07 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 97.05 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 97.02 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 97.02 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 97.02 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 96.99 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 96.97 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 96.95 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 96.94 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 96.94 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 96.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 96.91 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 96.91 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 96.9 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 96.89 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 96.86 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 96.85 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 96.85 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 96.84 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 96.82 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 96.81 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 96.8 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.79 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 96.79 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 96.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.78 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 96.77 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 96.76 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 96.74 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 96.72 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 96.7 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 96.7 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 96.69 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 96.69 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 96.69 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 96.69 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 96.67 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 96.67 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 96.65 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 96.64 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 96.63 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 96.62 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 96.62 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 96.62 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 96.61 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 96.59 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 96.59 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 96.58 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 96.56 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 96.5 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 96.5 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 96.47 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 96.46 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 96.44 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 96.43 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 96.38 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 96.36 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 96.35 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 96.34 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 96.33 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 96.31 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 96.31 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 96.26 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 96.25 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 96.24 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 96.23 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 96.23 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 96.21 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 96.16 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 96.14 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 96.1 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 96.09 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 96.07 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 96.07 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 96.06 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 96.05 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 96.03 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 96.02 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 96.02 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 96.0 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 95.99 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 95.97 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 95.96 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 95.95 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 95.95 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 95.87 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 95.81 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 95.79 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 95.78 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 95.77 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 95.77 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 95.77 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 95.76 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 95.75 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 95.75 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 95.75 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 95.71 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 95.68 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 95.67 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 95.63 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 95.62 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 95.59 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 95.56 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 95.55 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 95.54 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 95.5 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 95.48 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 95.34 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 95.24 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 95.24 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 95.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.2 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 95.13 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 94.95 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 94.92 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 94.88 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 94.72 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 94.51 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 94.38 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 94.22 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 93.97 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 93.89 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 93.78 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 93.77 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 93.64 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 93.56 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 93.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 93.45 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 93.17 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 93.04 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 93.02 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 92.91 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.91 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 92.79 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 92.4 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 92.11 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 91.95 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 91.92 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 91.14 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 90.7 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 90.57 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 90.48 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 90.48 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 90.39 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 90.25 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 90.1 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 89.85 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 89.8 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 89.8 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 89.73 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 89.71 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 89.68 | |
| 1eg3_A | 261 | Dystrophin; EF-hand like domain, WW domain, struct | 89.65 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 89.55 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 89.47 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 89.42 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 89.25 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 89.14 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 89.11 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 88.84 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 88.62 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 88.59 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 88.48 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 88.41 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 88.28 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 88.21 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 88.18 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 88.15 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 87.73 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 87.43 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 87.06 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 86.94 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 86.88 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 86.75 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 86.69 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 86.64 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 86.46 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 86.41 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 86.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 86.34 | |
| 3bos_A | 242 | Putative DNA replication factor; P-loop containing | 86.12 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 86.09 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 86.05 | |
| 1ex7_A | 186 | Guanylate kinase; substrate-induced FIT, domain mo | 85.81 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 85.81 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 85.72 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 85.71 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 85.47 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 85.39 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 85.14 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 85.1 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 84.48 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 84.2 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 83.95 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 83.94 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 83.64 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 83.54 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 83.3 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 83.22 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 82.87 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 82.78 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 82.68 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 82.65 | |
| 2eyu_A | 261 | Twitching motility protein PILT; pilus retraction | 82.55 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 82.39 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 82.25 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 82.1 | |
| 1jbk_A | 195 | CLPB protein; beta barrel, chaperone; 1.80A {Esche | 81.06 |
| >1lkx_A Myosin IE heavy chain; myosin motor domain, lever ARM, converter domain, contractIle protein; HET: ADP; 3.00A {Dictyostelium discoideum} SCOP: c.37.1.9 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-82 Score=676.54 Aligned_cols=285 Identities=29% Similarity=0.500 Sum_probs=266.0
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++++.++++|+.||..+.+|||+|+++++|||++.+++|.++.+..|.++...+.|||+|+|||+||+.|
T Consensus 9 ~~~Dl~~L~~l~E~~vl~nL~~Ry~~~~IYTy~G~iLiavNPyk~l~iY~~~~~~~Y~g~~~~~~pPHifaiA~~Ay~~m 88 (697)
T 1lkx_A 9 GVPDFVLLNQITENAFIENLTMRHKSDNIYTYIGDVVISTNPFKNLNIYKESDIKAYNGRYKYEMPPHMYALANDAYRSM 88 (697)
T ss_dssp CCSSGGGCSSCSHHHHHHHHHHHHHTTCCEEESSSCEEEECCSSCCSCCSHHHHHHHSSCCGGGSCCCHHHHHHHHHHHH
T ss_pred CCcccccCCCCCHHHHHHHHHHHHhcCCcEEeeCCeEEEEcCCcCCCCCCHHHHHHHhCCCCCCCCchHHHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcC-CC---chhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEE
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQ-GA---AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTF 347 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~-g~---~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~ 347 (488)
...+++|||||||||||||||++|.||+|++..+. +. ..++++|+++||+|||||||||+||||||||||||+|+|
T Consensus 89 ~~~~~nQsIiisGESGAGKTe~tK~i~~yla~~~~~~~~~~~~i~~~il~snpiLEAFGNAkT~rNdNSSRFGKfi~i~F 168 (697)
T 1lkx_A 89 RQSQENQCVIISGESGAGKTEASKKIMQFLTFVSSNQSPNGERISKMLLDSNPLLEAFGNAKTLRNDNSSRFGKYMEMQF 168 (697)
T ss_dssp HHHCCCEEEEEECSTTSSHHHHHHHHHHHHHHHSCSSCHHHHHHHHHHHHHHHHHHHHHBBCCSSCSSCBCSEEEEEEEE
T ss_pred HhcCCCcEEEecCCCCCCchhhHHHHHHHHHhhcCCCCCccccHHHHHHhcchHHHHhcCcccCCCCCcchhheeEEEEE
Confidence 99999999999999999999999999999999986 32 368899999999999999999999999999999999999
Q ss_pred CCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCC-CCCCCcccccCccCCCCCCCCCCCC
Q psy9090 348 GSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLS-PGRKYRYLRADVTDDKLPKGPRETP 426 (488)
Q Consensus 348 ~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~-~~~~~~yl~~~~~~~~~~~~~~~~~ 426 (488)
+..|.|+||+|++|||||||||. |.+||||||||||||+|+++ ++++.++|. ++..|+||+++.+ ...++
T Consensus 169 ~~~g~i~Ga~I~~yLLEKSRVv~-q~~gERnfHIFYqllaG~~~-~~~~~l~L~~~~~~y~yL~~~~~-------~~~~~ 239 (697)
T 1lkx_A 169 NAVGSPIGGKITNYLLEKSRVVG-RTQGERSFHIFYQMLKGLSQ-SKLDELGLTPNAPAYEYLKKSGC-------FDVST 239 (697)
T ss_dssp CTTCCEEEEEEEEECCCGGGGTC-CCTTCCCBHHHHHHHTTSCH-HHHHHHTCCSCGGGSHHHHHTTC-------CCCTT
T ss_pred CCCCCEeeeeeeeeeccCceeee-ecCCCCceeehhHHhcCCCH-HHHHHhcCCCChhhCccccCCCC-------cccCC
Confidence 99999999999999999999995 99999999999999999976 567888897 8999999988743 34578
Q ss_pred CccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEee-----cCCcccccCChhhhc
Q psy9090 427 DTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFES-----SAENTAELANPEVAA 485 (488)
Q Consensus 427 ~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~-----~~~~~~~~~~~~~~~ 485 (488)
.||+++|+++++||++|||+++|+..||+|||||||||||+|++ .+++.+++.+++.++
T Consensus 240 ~dD~~~f~~~~~Am~~lG~~~~e~~~i~~ilaaILhLGNi~F~~~~~~~~~~~~~~v~~~~~l~ 303 (697)
T 1lkx_A 240 IDDSGEFKIIVKAMETLGLKESDQNSIWRILAAILHIGNITFAEAAEQRTGTTTVKVSDTKSLA 303 (697)
T ss_dssp CCHHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHTTCCEEEETTC----CEEEESSHHHHH
T ss_pred CchHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHhcccceEeecccccCCCCcceeCCHHHHH
Confidence 89999999999999999999999999999999999999999987 333678888887665
|
| >4db1_A Myosin-7; S1DC, cardiac, beta isoform, MYH7, myhcb, MYHC-beta, contractIle protein; HET: ANP; 2.60A {Homo sapiens} PDB: 2w4a_M 2w4g_M 2w4h_M 2mys_A* 1m8q_A* 1mvw_A* 1o18_A* 1o19_A* 1o1a_A* 1o1b_A* 1o1c_A* 1o1d_A* 1o1e_A* 1o1f_A* 1o1g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-81 Score=676.21 Aligned_cols=284 Identities=26% Similarity=0.412 Sum_probs=264.8
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++||..+..++|+.++++|+.||..+.+|||+|.++++|||++.++||.++.+.+|.++.+.+.|||+|++||+||+.|
T Consensus 86 ~~eDl~~L~~LnE~svL~nL~~Ry~~~~IYTy~G~iLvavNPyk~l~iY~~~~~~~Y~g~~~~~~pPHifaiA~~Ay~~m 165 (783)
T 4db1_A 86 KIEDMAMLTFLHEPAVLYNLKDRYGSWMIYTYSGLFCVTVNPYKWLPVYTPEVVAAYRGKKRSEAPPHIFSISDNAYQYM 165 (783)
T ss_dssp TCSBGGGCSCCSHHHHHHHHHHHHHTTCCEEEETTEEEEECCSSCCSCSSHHHHHHHTTCCGGGSCCCHHHHHHHHHHHH
T ss_pred CcchhhccccccHHHHHHHHHHHhcCCceEEecCceeEecCCCccCCCCCHHHHHHhcCCCcCCCCchhhHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC-----------CchhhhHhhhcchhhhhhhccccCCCCCCCccc
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG-----------AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHV 340 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g-----------~~~~~e~i~~~~~~leafgna~t~~n~nssrfg 340 (488)
...+++|||||||||||||||++|.||+|++..+.. ..+++++|+++||+|||||||||+|||||||||
T Consensus 166 ~~~~~nQsIiiSGESGAGKTe~tK~im~yla~v~~~~~~~~~~~~~~~~~ve~~il~snpiLEAFGNAkT~rNdNSSRFG 245 (783)
T 4db1_A 166 LTDRENQSILITGESGAGKTVNTKRVIQYFAVIAAIGDRSKKDQSPGKGTLEDQIIQANPALEAFGNAKTVRNDNSSRFG 245 (783)
T ss_dssp HHHTCCEEEEEECSTTSSHHHHHHHHHHHHHHHSBCCCC-------CCSCHHHHHHHHHHHHHHHHEECCSSCTTEECSE
T ss_pred HhhCCCceEEEeCCCCCCCchHHHHHHHhhhhhccCCCccccccccccccHHHHHHHhHHHHHhccCcccCCCCCCCccc
Confidence 999999999999999999999999999999987542 246899999999999999999999999999999
Q ss_pred eeEEEEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccC-CCCCCCcccccCccCCCCC
Q psy9090 341 LYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFL-SPGRKYRYLRADVTDDKLP 419 (488)
Q Consensus 341 k~~~~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l-~~~~~~~yl~~~~~~~~~~ 419 (488)
|||+|+|+.+|.|+||+|++|||||||||+ |.+||||||||||||+|+++ ++++.++| .++..|+||+++.
T Consensus 246 K~i~i~F~~~g~i~Ga~I~~YLLEKSRVv~-q~~gERnfHIFYqLlaG~~~-~~~~~l~L~~~~~~y~yl~~g~------ 317 (783)
T 4db1_A 246 KFIRIHFGATGKLASADIETYLLEKSRVIF-QLKAERDYHIFYQILSNKKP-ELLDMLLITNNPYDYAFISQGE------ 317 (783)
T ss_dssp EEEEEEECTTSBEEEEEEEEECCCGGGGTC-CCTTCCSBHHHHHHHTCSSH-HHHHHTTCCSCGGGCGGGCSSC------
T ss_pred eeEEEEECCCCCEeeeEEEEeecccceeec-cCCCCCcchhHHHHHcCCCH-HHHHHhccCCCHHHCccccCCC------
Confidence 999999999999999999999999999995 99999999999999999976 56777888 4799999998763
Q ss_pred CCCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCChhhhc
Q psy9090 420 KGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVAA 485 (488)
Q Consensus 420 ~~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~~~~~~ 485 (488)
...++.||+++|++|++||++|||+++|+..||+|||||||||||+|++.. ++++++.+.+.++
T Consensus 318 --~~~~~~dD~~~f~~~~~Am~~lGfs~~e~~~i~~ilaaILhLGNi~F~~~~~~~~~~~~~~~~l~ 382 (783)
T 4db1_A 318 --TTVASIDDAEELMATDNAFDVLGFTSEEKNSMYKLTGAIMHFGNMKFKLKQREEQAEPDGTEEAD 382 (783)
T ss_dssp --CCCTTCCHHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHTTCCEEECTTSSCEEESCCHHHH
T ss_pred --cccCCCCcHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhccceeeccCCCcccccCChHHHH
Confidence 236788999999999999999999999999999999999999999998764 5677787777654
|
| >1w7j_A Myosin VA; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Gallus gallus} SCOP: b.34.3.1 c.37.1.9 PDB: 1w7i_A* 1oe9_A* 1w8j_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-81 Score=680.40 Aligned_cols=286 Identities=30% Similarity=0.432 Sum_probs=266.9
Q ss_pred hhhhhhhhhhccchhhHHHHHHhhh-ccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHH
Q psy9090 191 MHVEDLAALETISEDNIVQELEERH-NSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQ 269 (488)
Q Consensus 191 ~~v~dl~~l~~l~e~~l~~~L~~r~-~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~ 269 (488)
..++|+..+..++|+.++++|+.|| ..+.+|||+|.++++|||++.+++|.++.+..|.++...+.|||+|+|||+||+
T Consensus 69 ~~~~Dl~~L~~l~E~svL~nL~~Ry~~~~~IYTy~G~iLiavNPyk~l~iY~~~~~~~Y~g~~~~~~pPHifaiA~~Ay~ 148 (795)
T 1w7j_A 69 VGENDLTALSYLHEPAVLHNLKVRFIDSKLIYTYCGIVLVAINPYEQLPIYGEDIINAYSGQNMGDMDPHIFAVAEEAYK 148 (795)
T ss_dssp TTCSSSTTCSCCSHHHHHHHHHHHHHHHCCCEEEETTEEEEECCSSCCSCCSHHHHHHHTTCCGGGSCCCHHHHHHHHHH
T ss_pred ccccchhhhhcccHHHHHHHHHHHHHhcccchhccCcceEEecCccccCcCCHHHHHHHcCCCccCCCccHhHHHHHHHH
Confidence 3578999999999999999999999 999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC--chhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEE
Q psy9090 270 DMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA--AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTF 347 (488)
Q Consensus 270 ~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~--~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~ 347 (488)
.|...+++|||||||||||||||++|.+|+|++..+.+. .+++++|+++||+|||||||||+||||||||||||+|+|
T Consensus 149 ~m~~~~~nQsIiisGESGAGKTe~tK~i~~yla~~~~~~~~~~ie~~il~snpiLEAFGNAkT~rNdNSSRFGKfi~i~F 228 (795)
T 1w7j_A 149 QMARDERNQSIIVSGESGAGKTVSAKYAMRYFATVSGSASEANVEEKVLASNPIMESIGNAKTTRNDNSSRFGKYIEIGF 228 (795)
T ss_dssp HHHHHTCCEEEEEECSTTSSHHHHHHHHHHHHHHHTCCSSSSCHHHHHHHHHHHHHHHHEECCSSCTTEECSEEEEEEEE
T ss_pred HhHhcCCCeEEEEeCCCCCCcchHHHHHHHHHHhhcCCCCccchHHHHHHHHHHHHHhcCccCCCCCCccccceEEEEEE
Confidence 999999999999999999999999999999999987654 589999999999999999999999999999999999999
Q ss_pred CCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCC
Q psy9090 348 GSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPD 427 (488)
Q Consensus 348 ~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~ 427 (488)
+..|.|+||+|++|||||||||+ |.+||||||||||||+|+++ ++++.++|.++..|+||+++.+ ...++.
T Consensus 229 ~~~g~i~Ga~I~~YLLEKSRVv~-q~~gERNfHIFYqLlag~~~-~~~~~l~L~~~~~y~yl~~~~~-------~~~~~~ 299 (795)
T 1w7j_A 229 DKRYRIIGANMRTYLLEKSRVVF-QAEEERNYHIFYQLCASAAL-PEFKTLRLGNANYFHYTKQGGS-------PVIDGI 299 (795)
T ss_dssp CTTSCEEEEEEEEECCCGGGGTC-CCTTCCSBHHHHHHHHTTTS-GGGGGGCCCCTTTSHHHHTTSC-------CCCTTC
T ss_pred CCCCCEeeeeceEEecccceEec-cCCCCCchHhHHHHHcCCCH-HHHHHccCCChHhCccccCCCC-------CcCCCc
Confidence 99999999999999999999995 99999999999999999976 5678899999999999998743 236788
Q ss_pred ccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCccccc-CChhhhc
Q psy9090 428 TNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAEL-ANPEVAA 485 (488)
Q Consensus 428 ~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~-~~~~~~~ 485 (488)
||+++|+++++||++|||+++|+..||+|||||||||||+|++.+++.+.+ .+++.++
T Consensus 300 dD~~~f~~~~~Am~~lG~s~~e~~~i~~ilaaILhLGNi~F~~~~~~~~~v~~~~~~l~ 358 (795)
T 1w7j_A 300 DDAKEMVNTRQACTLLGISDSYQMGIFRILAGILHLGNVEFASRDSDSCAIPPKHDPLT 358 (795)
T ss_dssp CHHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHHTCCCEEEETTEEECCTTCHHHH
T ss_pred cHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhccCceEeecCCcceeecCChHHHH
Confidence 999999999999999999999999999999999999999998766666666 5555443
|
| >1kk8_A Myosin heavy chain, striated muscle; actin-detached, mechanics of motor, contractIle PROT; HET: ADP; 2.30A {Argopecten irradians} SCOP: b.34.3.1 c.37.1.9 PDB: 1kk7_A* 1qvi_A* 1s5g_A* 1sr6_A 1b7t_A* 1kqm_A* 1kwo_A* 1l2o_A* 1dfl_A* 2w4t_C 2w4v_C 2w4w_C 1dfk_A 2ec6_A 2otg_A* 2os8_A* 2ovk_A 2ekv_A 2ekw_A 2oy6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-81 Score=681.10 Aligned_cols=284 Identities=28% Similarity=0.427 Sum_probs=265.1
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++|+.++++|+.||..+.+|||+|.++++|||++.+++|.++.+..|.++...+.|||+|+|||.||+.|
T Consensus 84 ~~~Dl~~L~~l~E~svL~nL~~Ry~~~~IYTy~G~iLiavNPyk~l~iY~~~~~~~Y~g~~~~~~pPHifaiA~~Ay~~m 163 (837)
T 1kk8_A 84 KLEDMANMTYLNEASVLYNLRSRYTSGLIYTYSGLFCIAVNPYRRLPIYTDSVIAKYRGKRKTEIPPHLFSVADNAYQNM 163 (837)
T ss_dssp TCSBGGGSSCCSHHHHHHHHHHHHHTTCCEEEETTEEEEECCSSCCSTTSHHHHHHHTTCCGGGSCCCHHHHHHHHHHHH
T ss_pred chhhhhhhhcccHHHHHHHHHHHHhcCCceeeccceeEEeCCCcCCCCCCHHHHHHhcCCCcCCCCCcHHHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC------------chhhhHhhhcchhhhhhhccccCCCCCCCcc
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA------------AKVGEKIEKCVNVIHAIGNAGTPINQNSTRH 339 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~------------~~~~e~i~~~~~~leafgna~t~~n~nssrf 339 (488)
...+++|||||||||||||||++|.||+|++..+.+. .+++++|+++||+|||||||||+||||||||
T Consensus 164 ~~~~~nQsIiiSGESGAGKTe~tK~i~~yla~~~~~~~~~~~~~~~~~~~~ie~~il~snpiLEAFGNAkT~rNdNSSRF 243 (837)
T 1kk8_A 164 VTDRENQSCLITGESGAGKTENTKKVIMYLAKVACAVKKKDEEASDKKEGSLEDQIIQANPVLEAYGNAKTTRNNNSSRF 243 (837)
T ss_dssp HHHTSEEEEEEECSTTSSHHHHHHHHHHHHHHHSCCCCCC--------CCCHHHHHHHHHHHHHHHHEECCSSCTTEESS
T ss_pred HhcCCCcEEEEeCCCCCCchhhHHHHHHHHHHhcccCCcccccccccccccHHHHHHHHHHHHHHhcCccCCCCCCCCCc
Confidence 9999999999999999999999999999999887542 4689999999999999999999999999999
Q ss_pred ceeEEEEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccC-CCCCCCcccccCccCCCC
Q psy9090 340 VLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFL-SPGRKYRYLRADVTDDKL 418 (488)
Q Consensus 340 gk~~~~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l-~~~~~~~yl~~~~~~~~~ 418 (488)
||||+|+||.+|.|+||+|++|||||||||. |.+||||||||||||+|+++ ++++.++| .++..|+||+++.
T Consensus 244 GKfi~i~F~~~g~i~Ga~I~~YLLEKSRVv~-q~~gERNfHIFYqLlaG~~~-~~~~~l~L~~~~~~y~yL~~g~----- 316 (837)
T 1kk8_A 244 GKFIRIHFGPTGKIAGADIETYLLEKSRVTY-QQSAERNYHIFYQICSNAIP-ELNDVMLVTPDSGLYSFINQGC----- 316 (837)
T ss_dssp EEEEEEEECTTSSEEEEEEEEECCCGGGGTC-CCTTCCSBHHHHHHTSCSSG-GGHHHHTCCSCGGGCTTTCSSC-----
T ss_pred eeEEEEEECCCCCEeeeEEEEEeccCceeee-ecCCCCceeehHHHHcCCCH-HHHHHhCCCCChhhcccccCCC-----
Confidence 9999999999999999999999999999995 99999999999999999976 56788888 7899999998763
Q ss_pred CCCCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCChhhhc
Q psy9090 419 PKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVAA 485 (488)
Q Consensus 419 ~~~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~~~~~~ 485 (488)
...++.||+++|++|++||++|||+++|+..||+|||||||||||+|++.+ ++++++.+++.++
T Consensus 317 ---~~~~~~dD~~~f~~~~~Am~~lGfs~~e~~~i~~ilAaILhLGNi~F~~~~~~~~~~~~~~~~l~ 381 (837)
T 1kk8_A 317 ---LTVDNIDDVEEFKLCDEAFDILGFTKEEKQSMFKCTASILHMGEMKFKQRPREEQAESDGTAEAE 381 (837)
T ss_dssp ---SCBTTBCHHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHTTCCEEC----CCCEESCSHHHH
T ss_pred ---cccCCcChHHHHHHHHHHHHhcCcCHHHHHHHHHHHHHHHhhccceEEecCCCCccccCCHHHHH
Confidence 236788999999999999999999999999999999999999999998764 5778888887765
|
| >1w9i_A Myosin II heavy chain; molecular motor, ATPase, motor domain, mutant, muscle contraction; HET: ADP; 1.75A {Dictyostelium discoideum} PDB: 1w9j_A* 1w9l_A* 1w9k_A* 1mma_A* 2aka_A 1d0x_A* 1d0y_A* 1d0z_A* 1d1a_A* 1d1b_A* 1d1c_A* 2xel_A* 1yv3_A* 3bz7_A* 3bz8_A* 3bz9_A* 1jwy_A* 1jx2_A* 3mjx_A* 2jhr_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-81 Score=670.74 Aligned_cols=284 Identities=27% Similarity=0.425 Sum_probs=266.6
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++|+.++++|+.||..+.+|||+|.++++|||++.+++|.++.+..|.++...+.|||+|+|||+||+.|
T Consensus 87 ~~~Dl~~L~~l~E~svL~nL~~Ry~~~~IYTy~G~iLvavNPyk~l~iY~~~~~~~Y~~~~~~~~pPHifaiA~~Ay~~m 166 (770)
T 1w9i_A 87 GVEDMSELSYLNEPAVFHNLRVRYNQDLIYTYSGLFLVAVNPFKRIPIYTQEMVDIFKGRRRNEVAPHIFAISDVAYRSM 166 (770)
T ss_dssp TCSBGGGCSCCCHHHHHHHHHHHHHTTCCEEEETTEEEEECCSSCCSCCSHHHHHHHTTCCGGGSCCCHHHHHHHHHHHH
T ss_pred chhhhhhhccCCHHHHHHHHHHHHhcCCceeccCceeEEecCCccccCCCHHHHHHhcCCCcCCCCccHHHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC-----chhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEE
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA-----AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVT 346 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~-----~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~ 346 (488)
...+++|||||||||||||||++|.||+|++..+.+. .+++++|+++||+|||||||||+||||||||||||+|+
T Consensus 167 ~~~~~nQsIiisGESGAGKTe~tK~i~~yla~~~~~~~~~~~~~ie~~il~snpiLEAFGNAkT~rNdNSSRFGKfi~i~ 246 (770)
T 1w9i_A 167 LDDRQNQSLLITGESGAGKTENTKKVIQYLASVAGRNQANGSGVLEQQILQANPILEAFGNAKTTRNNNSSRFGKFIEIQ 246 (770)
T ss_dssp HHHCCCEEEEEECSTTSSHHHHHHHHHHHHHHHHCC------CHHHHHHHHHHHHHHHHHEECCSSCTTEESSEEEEEEE
T ss_pred HhhcCCcEEEEecCCCCcchHHHHHHHHHHHHhccccCCcccCcHHHHHHHHHHHHHHhCCCcCCCCCCcCCcceEEEEE
Confidence 9999999999999999999999999999999887653 57999999999999999999999999999999999999
Q ss_pred ECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcc-cccCccCCCCCCCCCCC
Q psy9090 347 FGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRY-LRADVTDDKLPKGPRET 425 (488)
Q Consensus 347 ~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~y-l~~~~~~~~~~~~~~~~ 425 (488)
|+..|.|+||+|.+|||||||||+ |.+||||||||||||+|+++ ++++.++|.++..|+| |+++. ...+
T Consensus 247 F~~~g~i~Ga~I~~yLLEKSRVv~-q~~gERnfHIFYqLlaG~~~-~~~~~l~L~~~~~y~yll~~g~--------~~~~ 316 (770)
T 1w9i_A 247 FNSAGFISGASIQSYLLEKSRVVF-QSETERNYHIFYQLLAGATA-EEKKALHLAGPESFNYLNQSGC--------VDIK 316 (770)
T ss_dssp ECTTSCEEEEEEEEECCCGGGGTC-CCTTCCSBHHHHHHHHHCCH-HHHHHHTCCCGGGCTTTSSSSC--------CCCT
T ss_pred ECCCCCEeeeEEEEEeccCceeec-ccCCCCcchhHHHHhcCCCH-HHHHHhCCCChhhccccccCCc--------cccC
Confidence 999999999999999999999995 99999999999999999977 5678899999999999 77652 2357
Q ss_pred CCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCcccccCChhhhc
Q psy9090 426 PDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAA 485 (488)
Q Consensus 426 ~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~~~~~~~~ 485 (488)
+.||+++|+++++||++|||+++|+..||+|||||||||||+|+...++++++.+++.++
T Consensus 317 ~~dD~~~f~~~~~Am~~lGf~~~e~~~i~~ilaaILhLGNi~F~~~~~~~~~~~~~~~l~ 376 (770)
T 1w9i_A 317 GVSDSEEFKITRQAMDIVGFSQEEQMSIFKIIAGILHLGNIKFEKGAGEGAVLKDKTALN 376 (770)
T ss_dssp TCCHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCCEECSSSSEECSCCHHHH
T ss_pred CCchHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcCceEecCCCCccccCChHHHH
Confidence 889999999999999999999999999999999999999999995457778888887665
|
| >2v26_A Myosin VI; calmodulin-binding, nucleotide-binding, membrane, vanadate, transport, PRE- powerstroke, transition state, protein transport; HET: ADP; 1.75A {Sus scrofa} PDB: 2bki_A 2bkh_A 3l9i_A 2x51_A 2vb6_A* 2vas_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-80 Score=671.08 Aligned_cols=287 Identities=25% Similarity=0.422 Sum_probs=258.0
Q ss_pred hhhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCC-CCCCchhhhhccCCCCCCCChhhHHHHHHHHH
Q psy9090 191 MHVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHL-NLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQ 269 (488)
Q Consensus 191 ~~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~-~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~ 269 (488)
..++|+..+..++|+.++++|+.||..+.+|||+|+++++|||++.+ ++|.++.+..|.++...+.|||+|+|||+||+
T Consensus 53 ~~~~Dl~~L~~L~E~svL~nL~~Ry~~~~IYTy~G~iLiaVNPyk~l~~iY~~~~~~~Y~g~~~~~~pPHifaiA~~Ay~ 132 (784)
T 2v26_A 53 KDVEDNCSLMYLNEATLLHNIKVRYSKDRIYTYVANILIAVNPYFDIPKIYSSETIKSYQGKSLGTMPPHVFAIADKAFR 132 (784)
T ss_dssp CCCSBGGGSSSCSHHHHHHHHHHHHHTTCCEEEETTEEEEECCSSCCTTTTSHHHHHHHTTCCTTSSCSCHHHHHHHHHH
T ss_pred cccchhhhhhhccHHHHHHHHHHHHhcCceeeeccceEEEecCCcCcCCCCCHHHHHHHhCCCcccCCchHHHHHHHHHH
Confidence 35789999999999999999999999999999999999999999999 69999999999999999999999999999999
Q ss_pred HHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECC
Q psy9090 270 DMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGS 349 (488)
Q Consensus 270 ~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~ 349 (488)
.|...+++|||||||||||||||++|.||+|++..+.+..+++++|+++||+|||||||||+||||||||||||+|+|+.
T Consensus 133 ~m~~~~~nQsIiiSGESGAGKTe~tK~i~~yla~~~~~~~~ie~~il~snpiLEAFGNAKT~rNdNSSRFGKfi~i~F~~ 212 (784)
T 2v26_A 133 DMKVLKLSQSIIVSGESGAGKTENTKFVLRYLTESYGTGQDIDDRIVEANPLLEAFGNAKTVRNNNSSRFGKFVEIHFNE 212 (784)
T ss_dssp HHHHHTCCEEEEEECSTTSSHHHHHHHHHHHHHHHHC------CHHHHTHHHHHHHHEECCSSCTTEECSEEEEEEEECT
T ss_pred HHHhcCCCcEEEEcCCCCCCceehHHHHHHHHHhhcCCCCcHHHHHHHHHHHHHHhCCCcCCCCCCcchhheEEEEEEec
Confidence 99999999999999999999999999999999988666568999999999999999999999999999999999999999
Q ss_pred CCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCC--------CCC--
Q psy9090 350 SGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDD--------KLP-- 419 (488)
Q Consensus 350 ~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~--------~~~-- 419 (488)
.|.|+||+|++|||||||||. |.+||||||||||||+|+++ ++++.++|.++..|+||+++.+.. .++
T Consensus 213 ~g~i~Ga~I~~YLLEKSRVv~-q~~gERNfHIFYqLlaG~~~-~~~~~l~L~~~~~y~yL~~g~~~~~~~~~~~~~i~~~ 290 (784)
T 2v26_A 213 KSSVVGGFVSHYLLEKSRICV-QGKEERNYHIFYRLCAGASE-DIRERLHLSSPDNFRYLNRGCTRYFANKETDKQILQN 290 (784)
T ss_dssp TSCEEEEEEEEECCCCGGGTC-CCTTCCSBHHHHHHHHHSCH-HHHHHTTCCCGGGCHHHHTSCCCCBCCHHHHTTSCGG
T ss_pred CCcEeeeeeeeeeccCCeEee-ecCCCCcchhhHHHHcCCCH-HHHHHcCCCChhhCccccCCCcccccccccccccccc
Confidence 999999999999999999995 99999999999999999986 578889999999999998864210 000
Q ss_pred ---------CCCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC--CcccccC
Q psy9090 420 ---------KGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA--ENTAELA 479 (488)
Q Consensus 420 ---------~~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~--~~~~~~~ 479 (488)
....++++||+++|++|++||++|||+++|+..||+|||||||||||+|++.. ++++.+.
T Consensus 291 ~~s~~~~~~~~~~~~~~dD~~~f~~~~~Am~~lG~~~~e~~~i~~ilaaILhLGNi~F~~~~~~~~~~~v~ 361 (784)
T 2v26_A 291 RKSPEYLKAGSLKDPLLDDHGDFIRMCTAMKKIGLDDEEKLDLFRVVAGVLHLGNIDFEEAGSTSGGCNLK 361 (784)
T ss_dssp GCCHHHHHHCCBCCSSCCHHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHHTCCEEECTTTTSSEEEC
T ss_pred ccccccccccccCCCCCCHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhcccceeeeccCCCCccccc
Confidence 01235678999999999999999999999999999999999999999998742 3445554
|
| >4anj_A Unconventional myosin-VI, green fluorescent prote; motor protein-metal-bindng protein complex, molecular motor, metal-binding protein, transition state; HET: CR2 ADP; 2.60A {Sus scrofa} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-80 Score=685.17 Aligned_cols=279 Identities=26% Similarity=0.420 Sum_probs=258.3
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCC-CCCchhhhhccCCCCCCCChhhHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLN-LYGTKYHFKYKFKSRSDNEPHIYAVADSAYQD 270 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~-i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~ 270 (488)
.++||..|..++|+.++++|+.||..+.||||+|+++++|||++.++ ||.++.+.+|.++...+.|||+|+|||.||+.
T Consensus 58 ~veDl~~L~~LnE~svL~nL~~Ry~~~~IYTy~G~iLIaVNPyk~lp~iY~~~~~~~Y~g~~~~~lpPHIfaiA~~AY~~ 137 (1052)
T 4anj_A 58 DVEDNCSLMYLNEATLLHNIKVRYSKDRIYTYVANILIAVNPYFDIPKIYSSETIKSYQGKSLGTMPPHVFAIADKAFRD 137 (1052)
T ss_dssp CCSBGGGSSSCSHHHHHHHHHHHHHTTCCEEEETTEEEEECCSSCCTTTTSHHHHHHHTTCCBTTBCSCHHHHHHHHHHH
T ss_pred CCcccccCCCCCHHHHHHHHHHHHcCCCcEEeECCEEEEECCCCCccccCCHHHHHHhcCCCCCCCCCcHHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999997 99999999999999999999999999999999
Q ss_pred HHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEECCC
Q psy9090 271 MMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSS 350 (488)
Q Consensus 271 ~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~~~ 350 (488)
|...+++|||||||||||||||++|.||+|++..+.+..+++++|+++||||||||||||+||||||||||||+|+||..
T Consensus 138 M~~~~~nQsIiiSGESGAGKTestK~im~yLa~~~~~~~~ie~~Il~snpiLEAFGNAKT~rNdNSSRFGK~iel~F~~~ 217 (1052)
T 4anj_A 138 MKVLKLSQSIIVSGESGAGKTENTKFVLRYLTESYGTGQDIDDRIVEANPLLEAFGNAKTVRNNNSSRFGKFVEIHFNEK 217 (1052)
T ss_dssp HHHHTCCEEEEEECSTTSSHHHHHHHHHHHHHHHHCC---CTTHHHHTHHHHHHHHEECCSSCTTEESSEEEEEEEECTT
T ss_pred HHHhCCCceEEEecCCCCCHHHHHHHHHHHHHHhcCCCccHHHHHHHHHHHHHhccCCCCCCCCCcCCceeEEEEEECCC
Confidence 99999999999999999999999999999999998888889999999999999999999999999999999999999999
Q ss_pred CceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCC-------------
Q psy9090 351 GKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDK------------- 417 (488)
Q Consensus 351 ~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~------------- 417 (488)
|.|+||+|.+|||||||||+ |.+||||||||||||+|+++ ++++.++|.++..|+||+++.+...
T Consensus 218 G~i~Ga~I~~YLLEKSRVv~-q~~gERNfHIFYqLlaGa~~-~~r~~l~L~~~~~y~yL~qg~~~~~~~~~~~~~~~~~~ 295 (1052)
T 4anj_A 218 SSVVGGFVSHYLLEKSRICV-QGKEERNYHIFYRLCAGASE-DIRERLHLSSPDNFRYLNRGCTRYFANKETDKQILQNR 295 (1052)
T ss_dssp SCEEEEEEEEECCCSGGGTC-CCTTCCSBHHHHHHHHHCCH-HHHHHHTCCCGGGCHHHHTSCCCCBCCHHHHTTSCGGG
T ss_pred CCEEEEEEeccccccCceee-cCCCCCCcccHHHHhcCCCH-HHHHHcCCCChHhCchhcCCCccccccccchhhhcccc
Confidence 99999999999999999995 99999999999999999987 5788899999999999997632110
Q ss_pred ------CCCCCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC
Q psy9090 418 ------LPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA 472 (488)
Q Consensus 418 ------~~~~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~ 472 (488)
..++..+++.||+++|+++++||++|||+++|+..||+|||||||||||+|++..
T Consensus 296 ~~~~~~~~g~~~~~~~dD~~~f~~~~~Am~~lGfs~~e~~~I~~iLAaILhLGNi~F~~~~ 356 (1052)
T 4anj_A 296 KSPEYLKAGSLKDPLLDDHGDFIRMCTAMKKIGLDDEEKLDLFRVVAGVLHLGNIDFEEAG 356 (1052)
T ss_dssp CCHHHHHHCCBCCSSCCHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCEEC--
T ss_pred cchhhccCCCccCCCcchHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcceeEEecC
Confidence 0124457889999999999999999999999999999999999999999997643
|
| >1g8x_A Myosin II heavy chain fused to alpha-actinin 3; motor, lever ARM, protein engineering, structural protein; HET: ADP; 2.80A {Dictyostelium discoideum} SCOP: k.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-79 Score=680.57 Aligned_cols=285 Identities=26% Similarity=0.416 Sum_probs=269.2
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++++.++.+|+.||..+.+|||+|.++++|||++.+++|.++.+..|.++...+.|||+|+|||.||+.|
T Consensus 87 ~~~Dl~~L~~l~e~~vl~nL~~Ry~~~~iYTy~G~ilvavNPyk~l~iy~~~~~~~Y~~~~~~~~pPHifaiA~~Ay~~m 166 (1010)
T 1g8x_A 87 GVEDMSELSYLNEPAVFHNLRVRYNQDLIYTYSGLFLVAVNPFKRIPIYTQEMVDIFKGRRRNEVAPHIFAISDVAYRSM 166 (1010)
T ss_dssp TCSBGGGCSSCCHHHHHHHHHHHHTTTCCEEEETTEEEEECCSSCCSCCSHHHHHHHTTCCTTTSCCCHHHHHHHHHHHH
T ss_pred chhhhhhhhcccHHHHHHHHHHHHhhCCceeccCceeEEecCCccccCCCHHHHHHhcCCCccCCCccHHHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC-----chhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEE
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA-----AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVT 346 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~-----~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~ 346 (488)
...+++|||||||||||||||++|.||+|++..+.+. .+++++|+.+||+|||||||||+||||||||||||+|+
T Consensus 167 ~~~~~~QsIiisGESGAGKTe~~K~i~~yla~~~~~~~~~~~~~ie~~il~snpiLEAFGNAkT~rN~NSSRFGK~i~i~ 246 (1010)
T 1g8x_A 167 LDDRQNQSLLITGESGAGKTENTKKVIQYLASVAGRNQANGSGVLEQQILQANPILEAFGNAKTTRNNNSSEFGKFIEIQ 246 (1010)
T ss_dssp HHHTCCEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCCTTTSSHHHHHHHHHHHHHHHHHEECCSSCTTEECSEEEEEEE
T ss_pred HhcCCCeEEEEeCCCCCCcchHHHHHHHHHHHhcccCCCcccchHHHHHHHHHHHHHHhCCCcCCCCCCccccceEEEEE
Confidence 9999999999999999999999999999999887653 47999999999999999999999999999999999999
Q ss_pred ECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCC
Q psy9090 347 FGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETP 426 (488)
Q Consensus 347 ~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~ 426 (488)
|+..|.|+||+|.+|||||||||. |.+||||||||||||+|+++ ++++.++|.++..|+||+++.+ ...++
T Consensus 247 F~~~g~i~Ga~i~~yLLEksRvv~-q~~~ERnfHIFYqll~g~~~-~~~~~l~L~~~~~y~yl~~~~~-------~~~~~ 317 (1010)
T 1g8x_A 247 FNNAGFISGASIQSYLLEKSRVVF-QSETERNYHIFYQLLAGATA-EEKKALHLAGPESFNYLNQSGC-------VDIKG 317 (1010)
T ss_dssp ECTTSCEEEEEEEEECCCGGGGTC-CCTTCCCBHHHHHHHHHCCH-HHHHHHTCCCGGGCGGGSSSSC-------CCCBT
T ss_pred ECCCCCCcceEEEEEEcCCceeee-ecCCCCcchhHHHHHcCCCH-HHHHHhCCCChHhcchhcCCCc-------cccCC
Confidence 999999999999999999999995 99999999999999999977 5678899999999999998743 34678
Q ss_pred CccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCcccccCChhhhc
Q psy9090 427 DTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAA 485 (488)
Q Consensus 427 ~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~~~~~~~~ 485 (488)
.||+++|++|++||++|||+++|+..||+|||||||||||+|++.+++++++.+++.++
T Consensus 318 ~dD~~~f~~~~~A~~~lg~~~~e~~~i~~ilaaILhLGni~F~~~~~~~~~~~~~~~l~ 376 (1010)
T 1g8x_A 318 VSDEDEFKITRQAMDIVGFSQEEQMSIFKIIAGILHLGNIKFEKGAGEGAVLKDKTALN 376 (1010)
T ss_dssp CCHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHTTCCCBCCTTSSCBCSCCHHHH
T ss_pred CChHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHhccceEEecCCCccccCChHHHH
Confidence 89999999999999999999999999999999999999999987766788888887665
|
| >2ycu_A Non muscle myosin 2C, alpha-actinin; motor protein; HET: AOV; 2.25A {Homo sapiens} PDB: 1br1_A* 1br4_A* 1br2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-79 Score=679.33 Aligned_cols=283 Identities=27% Similarity=0.448 Sum_probs=265.2
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++++.++++|+.||..+.+|||+|.++++|||++.+++|.++.+..|.++...+.|||+|+|||.||+.|
T Consensus 61 ~~~Dl~~L~~l~e~~vl~nL~~Ry~~~~iYTy~G~ilvavNPyk~l~iy~~~~~~~Y~~~~~~~~pPHifaiA~~Ay~~m 140 (995)
T 2ycu_A 61 KAEDMAELTCLNEASVLHNLRERYYSGLIYTYSGLFCVVINPYKQLPIYTEAIVEMYRGKKRHEVPPHVYAVTEGAYRSM 140 (995)
T ss_dssp TCSBGGGCSSCSHHHHHHHHHHHHHTTCCEEEETTEEEEECCSSCCSCCSHHHHHHHTTCCGGGSCCCHHHHHHHHHHHH
T ss_pred ccchhhhhccccHHHHHHHHHHHHhcCceeeecCceeeeeCCccccCCCCHHHHHHhcCCccCCCCchHHHHhHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC---------chhhhHhhhcchhhhhhhccccCCCCCCCcccee
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA---------AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLY 342 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~---------~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~ 342 (488)
...+++|||||||||||||||++|.||+|++..+.+. .+++++|+.+||+|||||||||+|||||||||||
T Consensus 141 ~~~~~~QsIiisGESGAGKTe~~K~i~~yla~~~~~~~~~~~~~~~~~ie~~il~~npiLEAFGNAkT~rN~NSSRFGK~ 220 (995)
T 2ycu_A 141 LQDREDQSILCTGESGAGKTENTKKVIQYLAHVASSPKGRKEPGVPGELERQLLQANPILEAFGNAKTVKNDNSSRFGKF 220 (995)
T ss_dssp HHHCCCEEEEEECBTTSSHHHHHHHHHHHHHHHSCCSSSCSSSCCCC-CCSTTTSHHHHHHHHHEECCSSCTTEESSEEE
T ss_pred HhcCCCcEEEecCCCCCCchhhHHHHHHHHHHhcccCCccccccccccHHHHHHHHHHHHHHhcCccCCCCCCCCccceE
Confidence 9999999999999999999999999999999987653 4789999999999999999999999999999999
Q ss_pred EEEEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCC
Q psy9090 343 MQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGP 422 (488)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~ 422 (488)
|+|+|+.+|.|+||+|.+|||||||||. |.+||||||||||||+|+++ ++++.++|.++..|+||+++..
T Consensus 221 i~i~F~~~g~i~Ga~i~~yLLEksRvv~-q~~~ERnfHIFYqll~g~~~-~~~~~l~L~~~~~y~yl~~~~~-------- 290 (995)
T 2ycu_A 221 IRINFDVAGYIVGANIETYLLEKSRAIR-QAKDECSFHIFYQLLGGAGE-QLKADLLLEPCSHYRFLTNGPS-------- 290 (995)
T ss_dssp EEEEECTTSCEEEEEEEEECCCGGGGTC-CCTTCCCBHHHHHHHHHCCH-HHHHHTTCCCGGGCTTSTTCSC--------
T ss_pred EEEEECCCCCEeeeEEEEEeccCCeeec-cCCCCCcchhHHHHHcCCCH-HHHHHcCCCChHHcccccCCcc--------
Confidence 9999999999999999999999999995 99999999999999999977 5678889999999999987642
Q ss_pred CCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCChhhhc
Q psy9090 423 RETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVAA 485 (488)
Q Consensus 423 ~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~~~~~~ 485 (488)
..++ ||+++|++|++||++|||+++|+..||+|||||||||||+|++.+ ++++++.+++.++
T Consensus 291 ~~~~-dD~~~f~~~~~A~~~lg~~~~e~~~i~~ilaaILhlGni~F~~~~~~~~~~~~~~~~l~ 353 (995)
T 2ycu_A 291 SSPG-QERELFQETLESLRVLGFSHEEIISMLRMVSAVLQFGNIALKRERNTDQATMPDNTAAQ 353 (995)
T ss_dssp SSTT-THHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHGGGCCCEECSSSCCEECSCCHHHH
T ss_pred ccCC-cHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhccceEeecCCCcccccCChHHHH
Confidence 2456 899999999999999999999999999999999999999998765 5678888877665
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-79 Score=684.13 Aligned_cols=285 Identities=30% Similarity=0.431 Sum_probs=266.4
Q ss_pred hhhhhhhhhccchhhHHHHHHhhh-ccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERH-NSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQD 270 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~-~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~ 270 (488)
.++|+..+..++++.++.+|+.|| ..+.+|||+|+++++|||++.+++|.++.+..|.++...+.|||+|+|||.||+.
T Consensus 70 ~~~Dl~~L~~l~e~~vl~nL~~Ry~~~~~iYTy~G~iLiavNPyk~l~iy~~~~~~~Y~~~~~~~~pPHifaiA~~Ay~~ 149 (1080)
T 2dfs_A 70 GENDLTALSYLHEPAVLHNLKVRFIDSKLIYTYCGIVLVAINPYEQLPIYGEDIINAYSGQNMGDMDPHIFAVAEEAYKQ 149 (1080)
T ss_dssp SCSBSTTCSSCSHHHHHHHHHHHHHTTCCCEEEETTEEEEECCSSCCSCSSHHHHHHHTTCCGGGSCCCHHHHHHHHHHH
T ss_pred chhhhhhhhhcchHHHHHHHHHHHHhcCCchhccCceeEEecCCcccccCCHHHHHHhcCCCCCCCCCcHHHHHHHHHHH
Confidence 578999999999999999999999 9999999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCC--chhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEEC
Q psy9090 271 MMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA--AKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFG 348 (488)
Q Consensus 271 ~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~--~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~ 348 (488)
|...+++|||||||||||||||++|.||+|++..+.+. .+++++|+.+||+|||||||||+||||||||||||+|+||
T Consensus 150 m~~~~~~QsIiisGESGAGKTe~~K~i~~yla~~~~~~~~~~ie~~il~snpiLEAFGNAkT~rN~NSSRFGK~i~i~F~ 229 (1080)
T 2dfs_A 150 MARDERNQSIIVSGESGAGKTVSAKYAMRYFATVSGSASEANVEEKVLASNPIMESIGNAKTTRNDNSSRFGKYIEIGFD 229 (1080)
T ss_dssp HHHHTCCEEEEEECSTTSSHHHHHHHHHHHHHHTTTCCTTTCTHHHHHHHHHHHHHHHEEEETTEEEEECSEEEEEEEEC
T ss_pred HHhcCCCcEEEEcCCCCCCccchHHHHHHHHHhhccCCCccchHHHHHHHHHHHHHhcCCcCCCCCCccccceeEEEEEC
Confidence 99999999999999999999999999999999987654 5899999999999999999999999999999999999999
Q ss_pred CCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCc
Q psy9090 349 SSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDT 428 (488)
Q Consensus 349 ~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~ 428 (488)
..|.|+||+|.+|||||||||+ |.+||||||||||||+|+++ ++++.++|.++..|+||+++.+ ...++.|
T Consensus 230 ~~g~i~Ga~i~~yLLEKsRVv~-q~~~ERnfHIFYqllag~~~-~~~~~l~L~~~~~y~yl~~~~~-------~~~~~~d 300 (1080)
T 2dfs_A 230 KRYRIIGANMRTYLLEKSRVVF-QAEEERNYHIFYQLCASAAL-PEFKTLRLGNANYFHYTKQGGS-------PVIDGID 300 (1080)
T ss_dssp TTCCEEEEEEEEECCCCGGGTC-CCTTCCSBHHHHHHHHTTTS-SGGGGTCCCCTTTCTTTSTTSC-------CSCTTCC
T ss_pred CCCCEeeecceeEeecCceeec-cCCCCCcchhHHHHHcCCCh-HHHHHccCCCHHhcCcccCCCC-------CCCCCcc
Confidence 9999999999999999999995 99999999999999999976 5678899999999999998743 2367889
Q ss_pred cHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCccccc-CChhhhc
Q psy9090 429 NVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAEL-ANPEVAA 485 (488)
Q Consensus 429 d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~-~~~~~~~ 485 (488)
|+++|++|+.||++|||+++|+..||+|||||||||||+|++.+++.+.+ .+++.++
T Consensus 301 D~~~f~~~~~A~~~lg~~~~e~~~i~~ilaaILhLGni~F~~~~~~~~~~~~~~~~l~ 358 (1080)
T 2dfs_A 301 DAKEMVNTRQACTLLGISDSYQMGIFRILAGILHLGNVEFASRDSDSCAIPPKHDPLT 358 (1080)
T ss_dssp HHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHTTCCCEEETTTEEECCSSCHHHH
T ss_pred HHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhccCceEEecCCcceeecCChHHHH
Confidence 99999999999999999999999999999999999999998776666665 5555443
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-77 Score=686.08 Aligned_cols=284 Identities=28% Similarity=0.454 Sum_probs=267.2
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++++.++++|+.||..+.||||+|.++++|||++.+++|.++.+..|.++...+.|||+|+|||.||+.|
T Consensus 84 ~~~Dl~~l~~l~e~~vl~~L~~Ry~~~~iyT~~g~~li~vNP~~~l~~y~~~~~~~y~~~~~~~~~PHi~aia~~ay~~m 163 (1184)
T 1i84_S 84 KVEDMAELTCLNEASVLHNLRERYFSGLIYTYSGLFCVVINPYKQLPIYSEKIIDMYKGKKRHEMPPHIYAIADTAYRSM 163 (1184)
T ss_dssp TCSBTTSSSCCCTTHHHHHHHHHHHHTCCEEEETTEEEEECCCSCCSCCSHHHHHHHSSCCSSSSCCCHHHHHHHHHHHH
T ss_pred ccchhhhhccccHHHHHHHHHHHhcCCCcEEecCcceeeeCCCcCCCCCCHHHHHHhcCcccccCCccHhhhHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC----------------CchhhhHhhhcchhhhhhhccccCCCCC
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG----------------AAKVGEKIEKCVNVIHAIGNAGTPINQN 335 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g----------------~~~~~e~i~~~~~~leafgna~t~~n~n 335 (488)
...+++|||||||||||||||++|.||+|++..+.+ ..+++++|+.+||||||||||||+||||
T Consensus 164 ~~~~~~Q~i~isGeSGaGKTe~~k~~~~yla~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~~npileaFGnAkT~rN~N 243 (1184)
T 1i84_S 164 LQDREDQSILCTGESGAGKTENTKKVIQYLAVVASSHKGKKDTSITQGPSFSYGELEKQLLQANPILEAFGNAKTVKNDN 243 (1184)
T ss_dssp HHHTCCEEEECCCSTTSSTTHHHHHHHHHHHHHSSCCSCC------CTTCCCCCSHHHHHHHHHHHHTTTTEEEETTEEE
T ss_pred HhcCCCcEEEEecCCCCCccHHHHHHHHHHHHHhcCCCcccccccccccccccchHHHHHHHHHHHHHHhcCCcCCCCcc
Confidence 999999999999999999999999999999998765 3578999999999999999999999999
Q ss_pred CCccceeEEEEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccC
Q psy9090 336 STRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTD 415 (488)
Q Consensus 336 ssrfgk~~~~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~ 415 (488)
||||||||+|+|+..|.|+||+|.+|||||||||+ |.+||||||||||||+|+++ +++..++|.++..|+||+++.
T Consensus 244 SSRfgk~~~i~f~~~g~i~ga~i~~ylLEksRv~~-q~~~ErnfhiFYqll~g~~~-~~~~~l~l~~~~~~~yl~~~~-- 319 (1184)
T 1i84_S 244 SSRFGKFIRINFDVTGYIVGANIETYLLEKSRAIR-QAKDERTFHIFYYLIAGASE-QMRNDLLLEGFNNYTFLSNGH-- 319 (1184)
T ss_dssp EECSCEEEEEEECSSSCEEEEEEEECCCCCGGGSC-CCTTCCCCTHHHHHHHHCCH-HHHHHTTCCCTTSCSSCTTSS--
T ss_pred ccccceeEEEEECCCCCEeeeEEeEeecCCceeee-ecCCCCchhhHHHHHcCCCH-HHHHHcCCCChHhCCccCCCC--
Confidence 99999999999999999999999999999999995 99999999999999999976 567889999999999998763
Q ss_pred CCCCCCCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCChhhhc
Q psy9090 416 DKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVAA 485 (488)
Q Consensus 416 ~~~~~~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~~~~~~ 485 (488)
...+++||+++|.+|+.||++|||+++++..||+|||||||||||+|.+.. ++++++.+++.++
T Consensus 320 ------~~~~~~~d~~~f~~~~~a~~~lg~~~~e~~~i~~ilaaiLhlGni~f~~~~~~~~~~~~~~~~~~ 384 (1184)
T 1i84_S 320 ------VPIPAQQDDEMFQETLEAMTIMGFTEEEQTSILRVVSSVLQLGNIVFKKERNTDQASMPDNTAAQ 384 (1184)
T ss_dssp ------CCCTTCCHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHTTTCCCBCCTTTSCCBCCCSHHHH
T ss_pred ------cCCCCCChHHHHHHHHHHHHhceeCHHHHHHHHHHHHHHHhhcCceeeccCCCcCcccCChHHHH
Confidence 236788999999999999999999999999999999999999999998654 5778888877654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=337.18 Aligned_cols=176 Identities=27% Similarity=0.491 Sum_probs=154.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.+++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..........+.+||+.|+|||++.+
T Consensus 123 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~-- 200 (304)
T 3ubd_A 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-- 200 (304)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhcc--
Confidence 689999999999999999999999999999999999999999999999999876554455667899999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
..|+.++|||||||++|+|+||++||.+.+..+...++.....+ .+..+|+++++||.+||..||++|||
T Consensus 201 ---~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~L~~dP~~R~ta~~~ 274 (304)
T 3ubd_A 201 ---RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG---MPQFLSPEAQSLLRMLFKRNPANRLGAGPD 274 (304)
T ss_dssp ---SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSTT
T ss_pred ---CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---CCCcCCHHHHHHHHHHcccCHHHCCCCCcC
Confidence 67999999999999999999999999999888888888775432 35678999999999999999999998
Q ss_pred -HHHHhcCcCCCCCCCCcccccccccccc
Q psy9090 157 -MSELLEHPFITSLPENDLHLSTVNCQYK 184 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~~~~~~~~~~ 184 (488)
++|+++||||++++|+.+......+++.
T Consensus 275 ~~~eil~Hp~f~~idw~~l~~~~~~pP~~ 303 (304)
T 3ubd_A 275 GVEEIKRHSFFSTIDWNKLYRREIHPPFK 303 (304)
T ss_dssp THHHHHTSGGGTTCCHHHHHTTCSCCSSC
T ss_pred CHHHHHcCccccCCCHHHHHhCCCCcCcC
Confidence 5899999999999998876666666554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.75 Aligned_cols=169 Identities=27% Similarity=0.477 Sum_probs=150.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|+|.+++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... .....+.+||+.|+|||++.+
T Consensus 129 l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~ 208 (311)
T 4aw0_A 129 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC
Confidence 689999999999999999999999999999999999999999999999999876432 234567799999999999987
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..|+.++|||||||++|+|+||++||.+.+......++...... .+..+|+++++||.+||.+||++|||++
T Consensus 209 -----~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~dli~~lL~~dp~~R~t~~ 280 (311)
T 4aw0_A 209 -----KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD---FPEKFFPKARDLVEKLLVLDATKRLGCE 280 (311)
T ss_dssp -----SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CCTTCCHHHHHHHHHHSCSSGGGSTTSG
T ss_pred -----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCcccCHHHHHHHHHHccCCHhHCcChH
Confidence 67999999999999999999999999998888888887765432 3567899999999999999999999998
Q ss_pred H------HhcCcCCCCCCCCccccc
Q psy9090 159 E------LLEHPFITSLPENDLHLS 177 (488)
Q Consensus 159 e------ll~hp~f~~~~~~~~~~~ 177 (488)
| +++||||++++|+.+...
T Consensus 281 e~~~~~~i~~Hp~F~~idw~~l~~~ 305 (311)
T 4aw0_A 281 EMEGYGPLKAHPFFESVTWENLHQQ 305 (311)
T ss_dssp GGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred HHcCCHHHHCCCCcCCCCHHHhcCC
Confidence 7 589999999999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=335.94 Aligned_cols=164 Identities=36% Similarity=0.711 Sum_probs=149.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..........+.+||+.|+|||++.+
T Consensus 167 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-- 244 (346)
T 4fih_A 167 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-- 244 (346)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC--
Confidence 689999999999999999999999999999999999999999999999999887655556677899999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..|+.++|||||||++|+|++|++||.+.+....+..+.....+....+..+|+++++||.+||..||++|||++|+
T Consensus 245 ---~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~ 321 (346)
T 4fih_A 245 ---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 321 (346)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 67999999999999999999999999999888888888777666555566789999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
|+||||+..
T Consensus 322 l~Hp~~~~~ 330 (346)
T 4fih_A 322 LKHPFLAKA 330 (346)
T ss_dssp TTCGGGGGC
T ss_pred hcCHhhcCC
Confidence 999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=335.92 Aligned_cols=164 Identities=36% Similarity=0.711 Sum_probs=150.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.+++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..........+.+||+.|+|||++.+
T Consensus 244 l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-- 321 (423)
T 4fie_A 244 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-- 321 (423)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCC--
Confidence 689999999999999999999999999999999999999999999999999877655556677899999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..|+.++|||||||++|+|++|++||.+.+....+..+.....+....+..+|+++++||.+||..||++|||+.|+
T Consensus 322 ---~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~el 398 (423)
T 4fie_A 322 ---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 398 (423)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 67999999999999999999999999999888888888777666666667889999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
|+||||+..
T Consensus 399 l~Hp~~~~~ 407 (423)
T 4fie_A 399 LKHPFLAKA 407 (423)
T ss_dssp TTCGGGGGC
T ss_pred hcCHHhcCC
Confidence 999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=317.05 Aligned_cols=159 Identities=29% Similarity=0.441 Sum_probs=130.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....+.+||+.|+|||++.+
T Consensus 109 l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~-- 185 (275)
T 3hyh_A 109 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISG-- 185 (275)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------------CTTSCHHHHSS--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-CccCCeeECcccCChhhhcC--
Confidence 689999999999999999999999999999999999999999999999999866543 34456789999999999986
Q ss_pred cCCCCC-CCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGY-DNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~-~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..| +.++||||+||++|+|+||++||.+.+.......+.....+ .+..+|+++++||.+||..||++|||++|
T Consensus 186 ---~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~L~~dP~~R~s~~e 259 (275)
T 3hyh_A 186 ---KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT---LPKFLSPGAAGLIKRMLIVNPLNRISIHE 259 (275)
T ss_dssp ---SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ---CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 444 67999999999999999999999988877666666654332 35678999999999999999999999999
Q ss_pred HhcCcCCCC
Q psy9090 160 LLEHPFITS 168 (488)
Q Consensus 160 ll~hp~f~~ 168 (488)
+++||||+.
T Consensus 260 il~hpw~k~ 268 (275)
T 3hyh_A 260 IMQDDWFKV 268 (275)
T ss_dssp HHHCHHHHT
T ss_pred HHcCccccc
Confidence 999999964
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.19 Aligned_cols=160 Identities=28% Similarity=0.539 Sum_probs=137.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEcc-CCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
|++.+++.|+.||+.||+|||++| ||||||||+|||++. +|.+||+|||+|+.... ....+.+|||.|+|||++.
T Consensus 126 l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--~~~~~~~GTp~YmAPE~~~ 203 (290)
T 3fpq_A 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--CccCCcccCccccCHHHcC
Confidence 588999999999999999999999 999999999999984 79999999999975433 3455678999999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|+|+||++||.+......+.+.+.....+...+...++++++||.+||..||++|||+
T Consensus 204 ------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~ 277 (290)
T 3fpq_A 204 ------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSI 277 (290)
T ss_dssp ------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred ------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCH
Confidence 35999999999999999999999999876666556555554433333455678999999999999999999999
Q ss_pred HHHhcCcCCCC
Q psy9090 158 SELLEHPFITS 168 (488)
Q Consensus 158 ~ell~hp~f~~ 168 (488)
+++|+||||++
T Consensus 278 ~e~l~Hp~~~~ 288 (290)
T 3fpq_A 278 KDLLNHAFFQE 288 (290)
T ss_dssp HHHHTSGGGC-
T ss_pred HHHhcCccccC
Confidence 99999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=329.22 Aligned_cols=161 Identities=29% Similarity=0.575 Sum_probs=145.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++|.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+++..........+.+||+.|+|||++.+
T Consensus 122 ~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~-- 199 (350)
T 4b9d_A 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-- 199 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCC--
Confidence 478999999999999999999999999999999999999999999999999876554334456789999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..|+.++|||||||++|+|+||++||.+.+....+.++.....++ .+..+|+++++||.+||..||++|||++++
T Consensus 200 ---~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 274 (350)
T 4b9d_A 200 ---KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP--VSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274 (350)
T ss_dssp ---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--CCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 679999999999999999999999999999888888888876554 356789999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
|+||||+.
T Consensus 275 l~hp~~~~ 282 (350)
T 4b9d_A 275 LEKGFIAK 282 (350)
T ss_dssp HTSHHHHT
T ss_pred hcCHHhhc
Confidence 99999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.94 Aligned_cols=313 Identities=21% Similarity=0.363 Sum_probs=215.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc---cCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..... ......+||+.|+|||++.
T Consensus 118 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 196 (486)
T 3mwu_A 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLR 196 (486)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhC
Confidence 57899999999999999999999999999999999995 4567999999999866543 3345568999999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ .|+.++|||||||++|+|++|.+||.+.........+...... ..+....+|+.+++||.+||..||.+|||
T Consensus 197 ~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t 270 (486)
T 3mwu_A 197 G------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270 (486)
T ss_dssp S------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCC
T ss_pred C------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcC
Confidence 4 4889999999999999999999999998887777777665432 22233567999999999999999999999
Q ss_pred HHHHhcCcCCCCCCCCcccccccc---------cccc-cchhhhh----------hhhhhh------------hhhccch
Q psy9090 157 MSELLEHPFITSLPENDLHLSTVN---------CQYK-DQELQTM----------HVEDLA------------ALETISE 204 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~~~~~~~---------~~~~-~~~~~~~----------~v~dl~------------~l~~l~e 204 (488)
+.++|+||||+............. .++. ..+++.. ...+.. .-..++.
T Consensus 271 ~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~F~~~D~d~dG~I~~ 350 (486)
T 3mwu_A 271 ATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDR 350 (486)
T ss_dssp HHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSSBCH
T ss_pred HHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCCCceeeH
Confidence 999999999987654332111100 0110 0011110 001111 1112333
Q ss_pred hhHHHHHHhhhc-------------cCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh---hhHHHHHHHH
Q psy9090 205 DNIVQELEERHN-------------SKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP---HIYAVADSAY 268 (488)
Q Consensus 205 ~~l~~~L~~r~~-------------~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p---h~f~~~d~~~ 268 (488)
+++...+..... .......+..++..+|.++++.|+++||+............. .+|+.+|.+.
T Consensus 351 ~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~ 430 (486)
T 3mwu_A 351 DELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSRERMERAFKMFDKDG 430 (486)
T ss_dssp HHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHHHHHSCTTTTCCHHHHHHHHHHHCSSC
T ss_pred HHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHHHHHHhhhccchHHHHHHHHHHhCCCC
Confidence 344322222111 011234566678889999999999999998776554333222 2999999999
Q ss_pred HHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 269 QDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 269 ~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|.|+..+.+.++- ..|.. ..+.++.+++.+|.++||.++++||+.++...+
T Consensus 431 dG~Is~~El~~~l~--~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~ 483 (486)
T 3mwu_A 431 SGKISTKELFKLFS--QADSSIQMEELESIIEQVDNNKDGEVDFNEFVEMLQNFV 483 (486)
T ss_dssp SSSBCSSCC----------------------CCCCSSCSSSBCHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHH--HcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHhh
Confidence 99999999999883 33322 267789999999999999999999999887654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=352.15 Aligned_cols=311 Identities=21% Similarity=0.341 Sum_probs=225.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE---ccCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL---TKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..... ......+||+.|+|||++.
T Consensus 123 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 201 (484)
T 3nyv_A 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLH 201 (484)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-cccccCCCCccccCceeec
Confidence 5788999999999999999999999999999999999 56788999999998766543 3344567999999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ .|+.++|||||||++|+|++|.+||.+.........+...... ..+....+|+.+++||.+||..||.+|||
T Consensus 202 ~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s 275 (484)
T 3nyv_A 202 G------TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS 275 (484)
T ss_dssp T------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred C------CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcC
Confidence 3 5889999999999999999999999998887777777665432 22233567999999999999999999999
Q ss_pred HHHHhcCcCCCCCCCCcccccccc--------cccc-cchhhhh----------hhhhhhh------------hhccchh
Q psy9090 157 MSELLEHPFITSLPENDLHLSTVN--------CQYK-DQELQTM----------HVEDLAA------------LETISED 205 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~~~~~~~--------~~~~-~~~~~~~----------~v~dl~~------------l~~l~e~ 205 (488)
+.++++||||+...+......... .++. .++++.. ..++... -..++.+
T Consensus 276 ~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~ 355 (484)
T 3nyv_A 276 ARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRA 355 (484)
T ss_dssp HHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEEEHH
T ss_pred HHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHHHHHHHhCcCCCceEeHH
Confidence 999999999986544322111100 0010 0111110 0111111 1123333
Q ss_pred hHHHHHHhhhcc---CC-------cccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCC---ChhhHHHHHHHHHHHH
Q psy9090 206 NIVQELEERHNS---KN-------HYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDN---EPHIYAVADSAYQDMM 272 (488)
Q Consensus 206 ~l~~~L~~r~~~---~~-------~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~---~ph~f~~~d~~~~~~~ 272 (488)
++...+...... .. ....+..++..+|.++++.|.++||+..+........ -..+|+.+|++.+|.|
T Consensus 356 El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I 435 (484)
T 3nyv_A 356 ELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERLERAFRMFDSDNSGKI 435 (484)
T ss_dssp HHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCCSEE
T ss_pred HHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhccccCcHHHHHHHHHHHCCCCCCcC
Confidence 333322222211 00 1344567788889999999999999987654321111 1239999999999999
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
+..+.+.++ +..+ -..+.++.+++.+|.++||.|+++||+.+|..+
T Consensus 436 ~~~El~~~l--~~~~-~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~~~ 481 (484)
T 3nyv_A 436 SSTELATIF--GVSD-VDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKL 481 (484)
T ss_dssp EHHHHHHHH--HHTT-CCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHT
T ss_pred CHHHHHHHH--HhcC-CCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHhh
Confidence 999998877 3311 236789999999999999999999999988765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=317.86 Aligned_cols=165 Identities=25% Similarity=0.440 Sum_probs=141.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccC-----ccccccCCCccccch
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFD-----KKKTFLGSPSWMAPE 74 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE 74 (488)
|+|.+++.|+.||+.||+|||++|||||||||+|||++.+| ++||+|||+|+....... .....+||+.|+|||
T Consensus 147 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE 226 (336)
T 4g3f_A 147 LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHH
Confidence 68999999999999999999999999999999999999988 699999999986643211 223468999999999
Q ss_pred hhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 75 IMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 75 ~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
++.+ ..|+.++|||||||++|+|+||++||.+........++.....+....+..+|+.+++||.+||..||.+|
T Consensus 227 ~~~~-----~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 301 (336)
T 4g3f_A 227 VVMG-----KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301 (336)
T ss_dssp HHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHCC-----CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHC
Confidence 9987 67999999999999999999999999887777777777776655444567889999999999999999999
Q ss_pred CCHHHH-------------hcCcCCCCCC
Q psy9090 155 PYMSEL-------------LEHPFITSLP 170 (488)
Q Consensus 155 ps~~el-------------l~hp~f~~~~ 170 (488)
||+.|+ ++|||+....
T Consensus 302 ~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 302 ASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp CCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred cCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 999997 5799998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=343.87 Aligned_cols=311 Identities=22% Similarity=0.329 Sum_probs=224.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC---CcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD---GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++...... ......+||+.|+|||++.
T Consensus 133 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~ 211 (494)
T 3lij_A 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLR 211 (494)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHc
Confidence 5788999999999999999999999999999999999764 45999999999876543 3345668999999999985
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
..|+.++||||+||++|+|++|.+||.+.........+....... .+....+|+.+++||.+||..||.+|||
T Consensus 212 ------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s 285 (494)
T 3lij_A 212 ------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS 285 (494)
T ss_dssp ------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred ------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCcc
Confidence 358899999999999999999999999988877777776654322 2223567999999999999999999999
Q ss_pred HHHHhcCcCCCCCCCCc---ccc---ccc---ccccc-cchhhhhh----------hhhhh------------hhhccch
Q psy9090 157 MSELLEHPFITSLPEND---LHL---STV---NCQYK-DQELQTMH----------VEDLA------------ALETISE 204 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~---~~~---~~~---~~~~~-~~~~~~~~----------v~dl~------------~l~~l~e 204 (488)
+.++|+||||+...... ... ... ...+. .++++... ..+.. .-..++.
T Consensus 286 ~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~ 365 (494)
T 3lij_A 286 AQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDR 365 (494)
T ss_dssp HHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECH
T ss_pred HHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcH
Confidence 99999999997642110 000 000 01111 11111110 01111 1112333
Q ss_pred hhHHHHHHhhhcc-------CCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhc
Q psy9090 205 DNIVQELEERHNS-------KNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHH 274 (488)
Q Consensus 205 ~~l~~~L~~r~~~-------~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~ 274 (488)
+++...+...... ......+..++..+|.++++.|.++||+..+......... ..+|+.+|++.+|.|+.
T Consensus 366 ~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~ 445 (494)
T 3lij_A 366 QELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLSKDKLESAFQKFDQDGNGKISV 445 (494)
T ss_dssp HHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTCHHHHHHHHHHHCTTCSSEECH
T ss_pred HHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhccccHHHHHHHHHHHCCCCCCcCCH
Confidence 3333333322110 1113455667888999999999999999887654222222 23999999999999999
Q ss_pred CCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 275 EEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 275 ~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+.+.++ +..+ -..+.++.|++.+|.++||.|+++||+.+|..+
T Consensus 446 ~El~~~l--~~~~-~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~ 489 (494)
T 3lij_A 446 DELASVF--GLDH-LESKTWKEMISGIDSNNDGDVDFEEFCKMIQKL 489 (494)
T ss_dssp HHHHHHC---CCS-CCCHHHHHHHHTTCSSSSSSEEHHHHHHHHHHH
T ss_pred HHHHHHH--HhcC-CCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhh
Confidence 9999887 3211 136789999999999999999999999988754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=345.78 Aligned_cols=311 Identities=21% Similarity=0.289 Sum_probs=229.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC---cEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG---EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ......+||+.|+|||++.
T Consensus 143 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 221 (504)
T 3q5i_A 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK 221 (504)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhc
Confidence 57899999999999999999999999999999999998876 6999999999876543 3345668999999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
..|+.++||||+||++|+|++|.+||.+.........+....... ......+|+.+++||.+||..||.+|||
T Consensus 222 ------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t 295 (504)
T 3q5i_A 222 ------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT 295 (504)
T ss_dssp ------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred ------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCC
Confidence 358899999999999999999999999988877777776654321 1122567999999999999999999999
Q ss_pred HHHHhcCcCCCCCCCCcccccc-----c---ccccc-cchhhhh----------hhhhhh------------hhhccchh
Q psy9090 157 MSELLEHPFITSLPENDLHLST-----V---NCQYK-DQELQTM----------HVEDLA------------ALETISED 205 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~~~~~-----~---~~~~~-~~~~~~~----------~v~dl~------------~l~~l~e~ 205 (488)
+.++|+||||+........... . ...+. .++++.. ..++.. .-..++.+
T Consensus 296 ~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~ 375 (504)
T 3q5i_A 296 AEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKK 375 (504)
T ss_dssp HHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHH
T ss_pred HHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHH
Confidence 9999999999875433211000 0 00111 0111110 111111 11224444
Q ss_pred hHHHHHHhhhc-------cCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcC
Q psy9090 206 NIVQELEERHN-------SKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHE 275 (488)
Q Consensus 206 ~l~~~L~~r~~-------~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~ 275 (488)
++...+..... .......+..++..+|.++++.|.++||+..+......... ..+|+.+|.+.+|.|+..
T Consensus 376 El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~ 455 (504)
T 3q5i_A 376 ELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCMDKQILFSEERLRRAFNLFDTDKSGKITKE 455 (504)
T ss_dssp HHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTCHHHHHHHHHHHCTTCCSEECHH
T ss_pred HHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhhhcccCHHHHHHHHHHhcCCCCCcCcHH
Confidence 44443333211 12233456677888999999999999999887654222222 239999999999999999
Q ss_pred CCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 276 EAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 276 ~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
+.+.++ +..+ -..+.++.|++.+|.++||.++++||+.+|..+
T Consensus 456 El~~~l--~~~~-~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~ 498 (504)
T 3q5i_A 456 ELANLF--GLTS-ISEKTWNDVLGEADQNKDNMIDFDEFVSMMHKI 498 (504)
T ss_dssp HHHHHT--TCSC-CCHHHHHHHHHTTCSSCSSSEEHHHHHHHHHHH
T ss_pred HHHHHH--hhCC-CCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh
Confidence 998877 3322 136789999999999999999999999988654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.98 Aligned_cols=177 Identities=27% Similarity=0.423 Sum_probs=151.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|+|..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.... ....+.+|||.|+|||++..+
T Consensus 289 l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~--~~~~t~~GTp~YmAPEvl~~~- 365 (689)
T 3v5w_A 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKG- 365 (689)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CCCCSCCSCGGGCCHHHHSTT-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC--CCCCCccCCcCccCHHHHhCC-
Confidence 68999999999999999999999999999999999999999999999999987654 345577999999999999642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC---hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC-
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMH---PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps- 156 (488)
..|+.++|||||||++|+|++|.+||.+.. .......+.... . ..+..+|+++++||.+||..||.+|++
T Consensus 366 ---~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~-~--~~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 366 ---VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-V--ELPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp ---CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-C--CCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-C--CCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 569999999999999999999999997542 223333333332 2 235678999999999999999999998
Q ss_pred ----HHHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 157 ----MSELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 157 ----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
++++++||||++++|+.+......+++.|.
T Consensus 440 ~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~ 473 (689)
T 3v5w_A 440 LGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 473 (689)
T ss_dssp SSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CCCCHHHHhcCccccCCCHHHHHcCCCCcCccCC
Confidence 799999999999999998888777777663
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.60 Aligned_cols=166 Identities=27% Similarity=0.451 Sum_probs=129.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC-CcEEEEecCCcccccccc---------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-GEVKIVDFGLSRETANTF--------------------- 58 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkL~Dfg~a~~~~~~~--------------------- 58 (488)
|++.+++.+++||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+......
T Consensus 114 l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (361)
T 4f9c_A 114 LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKC 193 (361)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccc
Confidence 6899999999999999999999999999999999999876 899999999997543211
Q ss_pred -------CccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCC-ChHHHHHHHHh-------
Q psy9090 59 -------DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM-HPTRALFQIVR------- 123 (488)
Q Consensus 59 -------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~-~~~~~~~~~~~------- 123 (488)
....+.+||+.|+|||++.+. ..|+.++||||+||++|+|++|++||... +....+.++..
T Consensus 194 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~ 269 (361)
T 4f9c_A 194 SICLSRRQQVAPRAGTPGFRAPEVLTKC----PNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRET 269 (361)
T ss_dssp ------------CCCCGGGCCHHHHTTC----SCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred cccccccccccccccCccccCHHHHcCC----CCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccc
Confidence 112345799999999999752 45899999999999999999999999544 33333333221
Q ss_pred ------------------------------CC---CC-----------CCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 124 ------------------------------NP---PP-----------GLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 124 ------------------------------~~---~~-----------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
.. .+ ........|+++++||.+||..||++|||++|
T Consensus 270 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~e 349 (361)
T 4f9c_A 270 IQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEE 349 (361)
T ss_dssp HHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred hhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 00 00 00112356899999999999999999999999
Q ss_pred HhcCcCCCCCC
Q psy9090 160 LLEHPFITSLP 170 (488)
Q Consensus 160 ll~hp~f~~~~ 170 (488)
+|+||||++++
T Consensus 350 aL~Hp~f~~i~ 360 (361)
T 4f9c_A 350 ALLHPFFKDMS 360 (361)
T ss_dssp HHTSGGGTTC-
T ss_pred HhcCcccCCCC
Confidence 99999999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=314.10 Aligned_cols=167 Identities=25% Similarity=0.459 Sum_probs=139.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc----cCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT----FDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~l 76 (488)
|++.+++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+++..... .....+.+||+.|+|||++
T Consensus 155 l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~ 234 (398)
T 4b99_A 155 LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234 (398)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHh
Confidence 689999999999999999999999999999999999999999999999999865332 1234567999999999998
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCC-------------------CCC----
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPP-------------------GLY---- 130 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~-------------------~~~---- 130 (488)
.+. ..|+.++||||+||++|+|++|++||.+.+....+..+... +.. ...
T Consensus 235 ~~~----~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
T 4b99_A 235 LSL----HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPW 310 (398)
T ss_dssp TTC----SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCH
T ss_pred cCC----CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCH
Confidence 762 45789999999999999999999999998887777666531 110 000
Q ss_pred --CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 131 --RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 131 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
..+.+|+++++||.+||..||.+|||++++|+||||+....
T Consensus 311 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 311 ETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp HHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred HHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 01346899999999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=297.59 Aligned_cols=160 Identities=25% Similarity=0.416 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC------------ccccccCCCcc
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD------------KKKTFLGSPSW 70 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~------------~~~~~~gt~~y 70 (488)
+..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....... ...+.+||+.|
T Consensus 117 ~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 196 (299)
T 4g31_A 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLY 196 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTT
T ss_pred HHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccc
Confidence 456889999999999999999999999999999999999999999999986543211 22346899999
Q ss_pred ccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhccc
Q psy9090 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEK 149 (488)
Q Consensus 71 ~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 149 (488)
+|||++.+ ..|+.++|||||||++|+|++ ||...... ..+..+.....|+ .....++...+||.+||..
T Consensus 197 mAPE~~~~-----~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~--~~~~~~~~~~~li~~~L~~ 266 (299)
T 4g31_A 197 MSPEQIHG-----NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPP--LFTQKYPCEYVMVQDMLSP 266 (299)
T ss_dssp SCHHHHTT-----CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCH--HHHHHCHHHHHHHHHHTCS
T ss_pred cCHHHHcC-----CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCC--CCcccCHHHHHHHHHHcCC
Confidence 99999986 679999999999999999996 77653322 2222333222221 1233467789999999999
Q ss_pred CCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 150 NPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 150 dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
||++|||+.++++||||++++|.
T Consensus 267 dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 267 SPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp SGGGSCCHHHHHTSGGGCCC---
T ss_pred ChhHCcCHHHHhcCHhhCCCCCC
Confidence 99999999999999999988764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=289.68 Aligned_cols=160 Identities=28% Similarity=0.509 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|+..... .......+||+.|+|||++.+
T Consensus 129 l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~ 208 (307)
T 3omv_A 129 FQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhc
Confidence 578999999999999999999999999999999999999999999999999865432 123456689999999999975
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC-C-CCC-CCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-P-PGL-YRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~-~-~~~-~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.. ..+|+.++|||||||++|||+||+.||.+.+....+...+... . |.. ..+..+|+.+.+||.+||..||++||
T Consensus 209 ~~--~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RP 286 (307)
T 3omv_A 209 QD--NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERP 286 (307)
T ss_dssp CS--SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSC
T ss_pred cC--CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCc
Confidence 32 1468999999999999999999999998877665555555432 2 211 23567899999999999999999999
Q ss_pred CHHHHhc
Q psy9090 156 YMSELLE 162 (488)
Q Consensus 156 s~~ell~ 162 (488)
|+.++++
T Consensus 287 s~~ei~~ 293 (307)
T 3omv_A 287 LFPQILS 293 (307)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.28 Aligned_cols=179 Identities=29% Similarity=0.522 Sum_probs=150.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..........+.+||+.|+|||++.+
T Consensus 150 l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-- 227 (396)
T 4dc2_A 150 LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-- 227 (396)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcC--
Confidence 578999999999999999999999999999999999999999999999999864444455667899999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC--------hHH-HHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMH--------PTR-ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~--------~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
..|+.++|||||||++|+|++|++||.... ... ....+.... . ..+..+++++++||++||..||
T Consensus 228 ---~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~--~~p~~~s~~~~~li~~lL~~dP 301 (396)
T 4dc2_A 228 ---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-I--RIPRSLSVKAASVLKSFLNKDP 301 (396)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-C--CCCTTSCHHHHHHHHHHTCSCT
T ss_pred ---CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-c--CCCCcCCHHHHHHHHHHhcCCH
Confidence 678999999999999999999999996431 112 233333332 2 2356789999999999999999
Q ss_pred CCCCCH------HHHhcCcCCCCCCCCcccccccccccccch
Q psy9090 152 EHRPYM------SELLEHPFITSLPENDLHLSTVNCQYKDQE 187 (488)
Q Consensus 152 ~~Rps~------~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 187 (488)
.+||++ +++++||||+.++|+.+......+++.+..
T Consensus 302 ~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~ 343 (396)
T 4dc2_A 302 KERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 343 (396)
T ss_dssp TTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCC
T ss_pred hHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCC
Confidence 999985 799999999999999887777777776643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.27 Aligned_cols=178 Identities=28% Similarity=0.498 Sum_probs=150.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++............+||+.|+|||++.+
T Consensus 121 ~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 198 (353)
T 3txo_A 121 FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-- 198 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHH--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCC--
Confidence 578999999999999999999999999999999999999999999999999865444345567789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..|+.++|||||||++|+|++|.+||.+.+.......+...... .+..+++.+++||++||..||.+||++
T Consensus 199 ---~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~li~~lL~~dP~~R~~~~~~ 272 (353)
T 3txo_A 199 ---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV---YPTWLHEDATGILKSFMTKNPTMRLGSLTQ 272 (353)
T ss_dssp ---HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSGGG
T ss_pred ---CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHHhhhCHHHccCCccc
Confidence 56889999999999999999999999998888777777765432 345689999999999999999999998
Q ss_pred ---HHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 158 ---SELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 158 ---~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
+++++||||+.++|..+......+++.+.
T Consensus 273 ~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~ 304 (353)
T 3txo_A 273 GGEHAILRHPFFKEIDWAQLNHRQIEPPFRPR 304 (353)
T ss_dssp TCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CCHHHHhhCCcccCCCHHHHhcCcCCCCccCC
Confidence 89999999999999887766666666553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=312.83 Aligned_cols=166 Identities=27% Similarity=0.431 Sum_probs=145.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC--CcEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD--GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~--~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|+|.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..... ....+.+||+.|+|||++.+
T Consensus 252 l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~ 330 (573)
T 3uto_A 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEG 330 (573)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCC
Confidence 4789999999999999999999999999999999999854 89999999999877543 34456789999999999987
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|+|++|.+||.+.+....+..+...... .......+|+++++||.+||..||.+|||+
T Consensus 331 -----~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~ 405 (573)
T 3uto_A 331 -----KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 405 (573)
T ss_dssp -----CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred -----CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCH
Confidence 67999999999999999999999999999888877777664322 222345789999999999999999999999
Q ss_pred HHHhcCcCCCCCCCC
Q psy9090 158 SELLEHPFITSLPEN 172 (488)
Q Consensus 158 ~ell~hp~f~~~~~~ 172 (488)
.++|+||||+...+.
T Consensus 406 ~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 406 HQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHSTTTSCCCCT
T ss_pred HHHhcCcCcCCCCCC
Confidence 999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.52 Aligned_cols=178 Identities=30% Similarity=0.520 Sum_probs=154.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++............+||+.|+|||++.+
T Consensus 102 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 179 (337)
T 1o6l_A 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-- 179 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcC--
Confidence 578999999999999999999999999999999999999999999999999865443345567789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..|+.++|||||||++|+|++|.+||.+.........+..... ..+..+++++++||.+||..||.+||
T Consensus 180 ---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~ 253 (337)
T 1o6l_A 180 ---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253 (337)
T ss_dssp ---SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred ---CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCC
Confidence 6789999999999999999999999998887766666665432 23567899999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
+++++++||||+.++|..+......+++.+.
T Consensus 254 ~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~ 284 (337)
T 1o6l_A 254 DAKEVMEHRFFLSINWQDVVQKKLLPPFKPQ 284 (337)
T ss_dssp THHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CHHHHHcCCCcCCCCHHHHHhCCCCCCCCCC
Confidence 8999999999999999887666666666554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.97 Aligned_cols=178 Identities=30% Similarity=0.516 Sum_probs=155.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++............+||+.|+|||++.+
T Consensus 118 ~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 195 (353)
T 2i0e_A 118 FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-- 195 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcC--
Confidence 578999999999999999999999999999999999999999999999999865433344567789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
..|+.++|||||||++|+|++|.+||.+.+.......+...... .+..+++++++||.+||..||.+||+
T Consensus 196 ---~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 269 (353)
T 2i0e_A 196 ---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---YPKSMSKEAVAICKGLMTKHPGKRLGCGPE 269 (353)
T ss_dssp ---CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSCTTSCTTCSTT
T ss_pred ---CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCC
Confidence 67899999999999999999999999998877777777765322 35678999999999999999999995
Q ss_pred -HHHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 157 -MSELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
++++++||||+.++|+.+......+++.+.
T Consensus 270 ~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~ 300 (353)
T 2i0e_A 270 GERDIKEHAFFRYIDWEKLERKEIQPPYKPK 300 (353)
T ss_dssp HHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CHHHHhcCccccCCCHHHHHhCCCCCCcCCC
Confidence 699999999999999988777766676653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=290.66 Aligned_cols=178 Identities=28% Similarity=0.551 Sum_probs=151.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++............+||+.|+|||++.+
T Consensus 115 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 192 (345)
T 1xjd_A 115 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-- 192 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC--
Confidence 578999999999999999999999999999999999999999999999999865433344567789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH-H
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS-E 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~-e 159 (488)
..|+.++|||||||++|+|++|.+||.+.+.......+..... ..+..+++++++||.+||..||.+||++. +
T Consensus 193 ---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~ 266 (345)
T 1xjd_A 193 ---QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGD 266 (345)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred ---CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC---CCCcccCHHHHHHHHHHhcCCHhHcCCChHH
Confidence 5689999999999999999999999998887777666665432 13456899999999999999999999998 9
Q ss_pred HhcCcCCCCCCCCcccccccccccccc
Q psy9090 160 LLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 160 ll~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
+++||||+.++|+.+......+++.+.
T Consensus 267 i~~hp~f~~~~w~~l~~~~~~~p~~p~ 293 (345)
T 1xjd_A 267 IRQHPLFREINWEELERKEIDPPFRPK 293 (345)
T ss_dssp GGGSGGGTTCCHHHHHTTCSCC-----
T ss_pred HHcCccccCCCHHHHhhCCCCCCcCCC
Confidence 999999999999887666666666543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=285.39 Aligned_cols=158 Identities=26% Similarity=0.472 Sum_probs=137.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 125 l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 204 (299)
T 4asz_A 125 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 204 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC
Confidence 57899999999999999999999999999999999999999999999999976543211 2234568999999999987
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|||+| |+.||.+.+..+....+..+..+. .|..+|+++.+||.+||+.||++|||+
T Consensus 205 -----~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~--~p~~~~~~~~~li~~cl~~dP~~RPs~ 277 (299)
T 4asz_A 205 -----RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ--RPRTCPQEVYELMLGCWQREPHMRKNI 277 (299)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC--CCccchHHHHHHHHHHcCCChhHCcCH
Confidence 679999999999999999998 999999998888888887765443 356789999999999999999999999
Q ss_pred HHHhcCcCCC
Q psy9090 158 SELLEHPFIT 167 (488)
Q Consensus 158 ~ell~hp~f~ 167 (488)
++++ +|++
T Consensus 278 ~~i~--~~L~ 285 (299)
T 4asz_A 278 KGIH--TLLQ 285 (299)
T ss_dssp HHHH--HHHH
T ss_pred HHHH--HHHH
Confidence 9984 4554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=286.56 Aligned_cols=156 Identities=25% Similarity=0.438 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+
T Consensus 155 l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 234 (329)
T 4aoj_A 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 234 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence 5788999999999999999999999999999999999999999999999998654321 22345679999999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|||+| |+.||.+.+..+.+..+..+..+. .|..+++++.+||.+||..||++|||+
T Consensus 235 -----~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~--~p~~~~~~~~~li~~cl~~dP~~RPs~ 307 (329)
T 4aoj_A 235 -----RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE--RPRACPPEVYAIMRGCWQREPQQRHSI 307 (329)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred -----CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC--CcccccHHHHHHHHHHcCcChhHCcCH
Confidence 679999999999999999998 899999998888877777765443 456789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
++++++
T Consensus 308 ~ei~~~ 313 (329)
T 4aoj_A 308 KDVHAR 313 (329)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=284.47 Aligned_cols=156 Identities=24% Similarity=0.432 Sum_probs=136.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+
T Consensus 142 l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 221 (308)
T 4gt4_A 142 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY 221 (308)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC
Confidence 578899999999999999999999999999999999999999999999999865432 123345689999999999987
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|||+| |..||.+.+..+....+..+..++ .|..+|+.+.+||.+||..||++|||+
T Consensus 222 -----~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~--~p~~~~~~~~~li~~C~~~dP~~RPs~ 294 (308)
T 4gt4_A 222 -----GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP--CPDDCPAWVYALMIECWNEFPSRRPRF 294 (308)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CcccchHHHHHHHHHHcCCChhHCcCH
Confidence 679999999999999999998 899999998877777776654433 466789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+|+++
T Consensus 295 ~ei~~~ 300 (308)
T 4gt4_A 295 KDIHSR 300 (308)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=286.68 Aligned_cols=178 Identities=29% Similarity=0.528 Sum_probs=148.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++............+||+.|+|||++.+
T Consensus 107 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 184 (345)
T 3a8x_A 107 LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-- 184 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCC--
Confidence 578999999999999999999999999999999999999999999999999864433345567789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCC---------ChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDM---------HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
..|+.++|||||||++|+|++|.+||... ........+.... . ..+..+++.+++||.+||..||
T Consensus 185 ---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-~--~~p~~~s~~~~~li~~lL~~dP 258 (345)
T 3a8x_A 185 ---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-I--RIPRSLSVKAASVLKSFLNKDP 258 (345)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-C--CCCTTSCHHHHHHHHHHTCSST
T ss_pred ---CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-C--CCCCCCCHHHHHHHHHHhcCCH
Confidence 57899999999999999999999999652 2222233333332 2 2356789999999999999999
Q ss_pred CCCCCH------HHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 152 EHRPYM------SELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 152 ~~Rps~------~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
.+||++ .++++||||+.++|+.+......+++.+.
T Consensus 259 ~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~ 299 (345)
T 3a8x_A 259 KERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN 299 (345)
T ss_dssp TTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred hHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCC
Confidence 999995 89999999999999877666666666553
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=309.71 Aligned_cols=178 Identities=30% Similarity=0.513 Sum_probs=158.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++..........+.+||+.|+|||++.+
T Consensus 439 ~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-- 516 (674)
T 3pfq_A 439 FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-- 516 (674)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcC--
Confidence 578999999999999999999999999999999999999999999999999865444345567789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..|+.++|||||||++|+|++|.+||.+.+.......+..... ..+..+++++++||.+||..||.+||++
T Consensus 517 ---~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 590 (674)
T 3pfq_A 517 ---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPE 590 (674)
T ss_dssp ---CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTT
T ss_pred ---CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHHHHHHHccCCHHHCCCCCCC
Confidence 6789999999999999999999999999888777777776432 2356789999999999999999999997
Q ss_pred --HHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 158 --SELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 158 --~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
++|++||||+.++|+.+......+++.+.
T Consensus 591 ~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~ 621 (674)
T 3pfq_A 591 GERDIKEHAFFRYIDWEKLERKEIQPPYKPK 621 (674)
T ss_dssp HHHHHHSSGGGSSCCHHHHTTTCSCCSCCCB
T ss_pred cHHHHhcCccccCCCHHHHHhCCCCCCCCCc
Confidence 99999999999999988877777777664
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.09 Aligned_cols=156 Identities=29% Similarity=0.499 Sum_probs=133.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|+....... ......||+.|+|||++.+
T Consensus 182 l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 261 (353)
T 4ase_A 182 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 261 (353)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence 47889999999999999999999999999999999999999999999999986543322 2345679999999999987
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHH-hCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIV-RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
..|+.++|||||||++|||+| |..||.+......+.+.+ .+..+. .|..+++++.+||.+||..||++|||
T Consensus 262 -----~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~--~p~~~~~~~~~li~~c~~~dP~~RPt 334 (353)
T 4ase_A 262 -----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 334 (353)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -----CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC--CCccCCHHHHHHHHHHcCcChhHCcC
Confidence 679999999999999999998 999998876555444444 343332 45678999999999999999999999
Q ss_pred HHHHhcC
Q psy9090 157 MSELLEH 163 (488)
Q Consensus 157 ~~ell~h 163 (488)
+.++++|
T Consensus 335 ~~eil~~ 341 (353)
T 4ase_A 335 FSELVEH 341 (353)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=287.06 Aligned_cols=178 Identities=26% Similarity=0.477 Sum_probs=155.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++............+||+.|+|||++.+
T Consensus 136 ~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 213 (373)
T 2r5t_A 136 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-- 213 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCC--
Confidence 578899999999999999999999999999999999999999999999999865444345567789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH---
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM--- 157 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--- 157 (488)
..|+.++|||||||++|+|++|.+||.+.+.......+...... .+..++..+++||.+||..||.+||++
T Consensus 214 ---~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 214 ---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ---LKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp ---CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC---CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred ---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC---CCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 67899999999999999999999999998877777777765322 345789999999999999999999986
Q ss_pred -HHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 158 -SELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 158 -~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
.++++||||+.++|+.+......+++.+.
T Consensus 288 ~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~ 317 (373)
T 2r5t_A 288 FMEIKSHVFFSLINWDDLINKKITPPFNPN 317 (373)
T ss_dssp HHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred HHHHhCCccccCCCHHHHHhCCCCCCCCCC
Confidence 69999999999999988776666666553
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=280.05 Aligned_cols=174 Identities=24% Similarity=0.490 Sum_probs=152.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... .....+||+.|+|||++.+
T Consensus 103 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-- 177 (318)
T 1fot_A 103 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVST-- 177 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---ccccccCCccccCHhHhcC--
Confidence 57889999999999999999999999999999999999999999999999976543 3446689999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..|+.++|+|||||++|+|++|.+||.+.+......++..... ..+..+++++++||.+||..||.+||
T Consensus 178 ---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~ 251 (318)
T 1fot_A 178 ---KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQN 251 (318)
T ss_dssp ---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTT
T ss_pred ---CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCC
Confidence 6788999999999999999999999998887777777776532 23567899999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
+++++++||||+.++|+.+......+++.+
T Consensus 252 ~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p 281 (318)
T 1fot_A 252 GTEDVKNHPWFKEVVWEKLLSRNIETPYEP 281 (318)
T ss_dssp TTHHHHTSGGGSSCCHHHHHTTCSCCSCCC
T ss_pred CHHHHhcCccccCCCHHHHHhCCCCCCCCC
Confidence 899999999999999988766666556554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=276.97 Aligned_cols=164 Identities=40% Similarity=0.770 Sum_probs=146.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||+.|+|||++.+
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 190 (297)
T 3fxz_A 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-- 190 (297)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcC--
Confidence 578899999999999999999999999999999999999999999999999876654445566789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..|+.++|||||||++|+|++|..||.+.........+.....+....+..+++.+.+||.+||..||.+|||+.++
T Consensus 191 ---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (297)
T 3fxz_A 191 ---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267 (297)
T ss_dssp ---SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 67899999999999999999999999988887777777665555555667789999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++||||+..
T Consensus 268 l~h~~~~~~ 276 (297)
T 3fxz_A 268 LQHQFLKIA 276 (297)
T ss_dssp TTCGGGGGC
T ss_pred hhChhhccc
Confidence 999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=275.42 Aligned_cols=162 Identities=27% Similarity=0.507 Sum_probs=141.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+
T Consensus 111 l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-- 187 (328)
T 3fe3_A 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQG-- 187 (328)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccC--
Confidence 578999999999999999999999999999999999999999999999999765543 34456789999999999986
Q ss_pred cCCCCC-CCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGY-DNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~-~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..+ +.++||||+||++|+|++|+.||.+.+.......+...... .+..+++++.+||.+||..||.+|||+++
T Consensus 188 ---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~e 261 (328)
T 3fe3_A 188 ---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPFYMSTDCENLLKRFLVLNPIKRGTLEQ 261 (328)
T ss_dssp ---CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred ---CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 344 47899999999999999999999998877777777665332 34567999999999999999999999999
Q ss_pred HhcCcCCCCCCC
Q psy9090 160 LLEHPFITSLPE 171 (488)
Q Consensus 160 ll~hp~f~~~~~ 171 (488)
+++||||+...+
T Consensus 262 il~h~~~~~~~~ 273 (328)
T 3fe3_A 262 IMKDRWINAGHE 273 (328)
T ss_dssp HTTCTTTTTTCT
T ss_pred HhcCHhhcCCCc
Confidence 999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.56 Aligned_cols=185 Identities=21% Similarity=0.324 Sum_probs=154.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...... ....+.+||+.|+|||++.+.
T Consensus 165 ~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 244 (410)
T 3v8s_A 165 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244 (410)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhcc
Confidence 5789999999999999999999999999999999999999999999999997654331 133467899999999999762
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC-CCCCCCCCCcCHHHHHHHHHhcccCCCC--CCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-PPGLYRASNWSQHYVDFIAECLEKNPEH--RPY 156 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rps 156 (488)
.. ...|+.++|||||||++|+|++|.+||.+.+......++.... ....+....+|+++++||.+||..+|.+ ||+
T Consensus 245 ~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~ 323 (410)
T 3v8s_A 245 GG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG 323 (410)
T ss_dssp TT-TCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSC
T ss_pred CC-CcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCC
Confidence 11 1127889999999999999999999999988777777766431 1222234568999999999999999988 999
Q ss_pred HHHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 157 MSELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
++++++||||+.++|..+......+++.+.
T Consensus 324 ~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~ 353 (410)
T 3v8s_A 324 VEEIKRHLFFKNDQWAWETLRDTVAPVVPD 353 (410)
T ss_dssp HHHHHTSGGGCCSSCCSTTGGGSCCSCCCC
T ss_pred HHHHhcCccccCCCHHHHhhcccCCCCCCc
Confidence 999999999999999988777777777654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=281.89 Aligned_cols=174 Identities=26% Similarity=0.491 Sum_probs=152.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... .....+||+.|+|||++.+
T Consensus 138 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---~~~~~~gt~~y~aPE~~~~-- 212 (350)
T 1rdq_E 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILS-- 212 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---CcccccCCccccCHHHhcC--
Confidence 57899999999999999999999999999999999999999999999999986543 2345689999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
..|+.++|||||||++|+|++|.+||.+.+.......+..... ..+..+++.+++||.+||..||.+||+
T Consensus 213 ---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~ 286 (350)
T 1rdq_E 213 ---KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKN 286 (350)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTT
T ss_pred ---CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHhhcCHHhccCCccC
Confidence 5688999999999999999999999999887777777776532 235678999999999999999999998
Q ss_pred -HHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 157 -MSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
++++++||||+.++|..+......+++.+
T Consensus 287 ~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p 316 (350)
T 1rdq_E 287 GVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316 (350)
T ss_dssp TTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CHHHHHhCcCcCCCCHHHHhhccCCCCCCC
Confidence 99999999999999987766666555544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=277.14 Aligned_cols=168 Identities=24% Similarity=0.515 Sum_probs=137.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+.
T Consensus 116 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 194 (311)
T 3niz_A 116 LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS- 194 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCC-
Confidence 5788999999999999999999999999999999999999999999999998765443444556789999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCCC------------------------CCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGLY------------------------RAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~~------------------------~~~ 133 (488)
..++.++|||||||++|+|++|.+||.+.........+.. .+.+..+ ...
T Consensus 195 ---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (311)
T 3niz_A 195 ---KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIP 271 (311)
T ss_dssp ---CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHST
T ss_pred ---CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCc
Confidence 4588999999999999999999999987766555544432 2211110 013
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
.+++++.+||.+||..||++|||++++++||||++++++
T Consensus 272 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 272 GFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp TCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred ccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence 457889999999999999999999999999999987653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=289.93 Aligned_cols=178 Identities=28% Similarity=0.508 Sum_probs=152.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++............+||+.|+|||++.+
T Consensus 245 ~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~- 323 (446)
T 4ejn_A 245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED- 323 (446)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT-
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCC-
Confidence 5789999999999999999998 99999999999999999999999999999865444344566789999999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC----
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP---- 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---- 155 (488)
..|+.++|||||||++|+|++|..||.+.........+...... .+..+++.+.+||.+||..||.+||
T Consensus 324 ----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 396 (446)
T 4ejn_A 324 ----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR---FPRTLGPEAKSLLSGLLKKDPKQRLGGGS 396 (446)
T ss_dssp ----SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCST
T ss_pred ----CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---CCccCCHHHHHHHHHHcccCHHHhCCCCC
Confidence 67899999999999999999999999988877776666654322 3567899999999999999999999
Q ss_pred -CHHHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 156 -YMSELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 156 -s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
+++++++||||+.++|+.+......+++.++
T Consensus 397 ~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~ 428 (446)
T 4ejn_A 397 EDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQ 428 (446)
T ss_dssp TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred CCHHHHHhCccccCCCHHHHhhCcCCCCccCC
Confidence 9999999999999999877666666666553
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=286.83 Aligned_cols=180 Identities=25% Similarity=0.513 Sum_probs=148.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ......+||+.|+|||++....
T Consensus 112 l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~ 190 (384)
T 4fr4_A 112 FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRK 190 (384)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeeccCC
Confidence 578999999999999999999999999999999999999999999999999866443 4456678999999999986421
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC---hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC-
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMH---PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps- 156 (488)
...|+.++|||||||++|+|++|..||.... .......+.... ...+..+++.+.+||.+||..||.+||+
T Consensus 191 --~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~p~~~s~~~~~li~~lL~~dP~~R~s~ 265 (384)
T 4fr4_A 191 --GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV---VTYPSAWSQEMVSLLKKLLEPNPDQRFSQ 265 (384)
T ss_dssp --SCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC---CCCCTTSCHHHHHHHHHHSCSSGGGSCCS
T ss_pred --CCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc---cCCCCcCCHHHHHHHHHHhcCCHhHhccc
Confidence 1458899999999999999999999997433 223333333322 2235678999999999999999999998
Q ss_pred HHHHhcCcCCCCCCCCcccccccccccccc
Q psy9090 157 MSELLEHPFITSLPENDLHLSTVNCQYKDQ 186 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 186 (488)
++++++||||+.++|+.+......+++.+.
T Consensus 266 ~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~ 295 (384)
T 4fr4_A 266 LSDVQNFPYMNDINWDAVFQKRLIPGFIPN 295 (384)
T ss_dssp HHHHHTSGGGTTCCHHHHHTTCSCCCCCCS
T ss_pred HHHHHcChhhhcCCHHHHHhCCCCCCCCCC
Confidence 899999999999999887766666666543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=276.90 Aligned_cols=177 Identities=29% Similarity=0.501 Sum_probs=146.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+.|+|||++.+
T Consensus 118 ~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 195 (327)
T 3a62_A 118 FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-- 195 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC--
Confidence 578899999999999999999999999999999999999999999999998765443334456689999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..++.++|||||||++|+|++|..||.+.........+...... .+..+++.+++||.+||..||.+||
T Consensus 196 ---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~li~~~L~~dp~~R~~~~~~ 269 (327)
T 3a62_A 196 ---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN---LPPYLTQEARDLLKKLLKRNAASRLGAGPG 269 (327)
T ss_dssp ---SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCTTSCHHHHHHHHHHSCSCGGGSTTSSTT
T ss_pred ---CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHHHhcCHhhccCCCCC
Confidence 56889999999999999999999999988877777777664322 3456899999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
++.++++||||+.++|..+......+++.+
T Consensus 270 ~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p 299 (327)
T 3a62_A 270 DAGEVQAHPFFRHINWEELLARKVEPPFKP 299 (327)
T ss_dssp THHHHHHSGGGSSCCHHHHHTTCSCCSCCC
T ss_pred CHHHHHcCCcccCCCHHHHhhccCCCCCCC
Confidence 889999999999999887655555555543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=269.81 Aligned_cols=164 Identities=26% Similarity=0.447 Sum_probs=136.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 117 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-- 193 (308)
T 3g33_A 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQ-- 193 (308)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcC--
Confidence 578999999999999999999999999999999999999999999999999765433 33456689999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCCCCC---------------------CCCCcC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPPGLY---------------------RASNWS 136 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~~---------------------~~~~~s 136 (488)
..++.++|||||||++|+|++|.+||.+........++... +....+ ....++
T Consensus 194 ---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (308)
T 3g33_A 194 ---STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEME 270 (308)
T ss_dssp ---SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCC
T ss_pred ---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCcccc
Confidence 56899999999999999999999999988877766665431 111100 013568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 137 QHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 137 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
+.+.+||.+||..||++|||+.++|+||||+...
T Consensus 271 ~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 271 ESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred HHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 8999999999999999999999999999998743
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-33 Score=286.31 Aligned_cols=183 Identities=20% Similarity=0.425 Sum_probs=148.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++...
T Consensus 172 l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 251 (437)
T 4aw2_A 172 LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251 (437)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhc
Confidence 57899999999999999999999999999999999999999999999999976543322 23446899999999999731
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC-CCCC-CCCCCcCHHHHHHHHHhcccCCCC--CC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-PPGL-YRASNWSQHYVDFIAECLEKNPEH--RP 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~s~~~~~li~~~L~~dP~~--Rp 155 (488)
......|+.++|||||||++|+|++|++||.+.+......++.... .... .....+|+++++||++||..+|++ |+
T Consensus 252 ~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~ 331 (437)
T 4aw2_A 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQN 331 (437)
T ss_dssp HTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTT
T ss_pred ccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCC
Confidence 1112568899999999999999999999999988777776665321 0111 122458999999999999988888 99
Q ss_pred CHHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
+++++++||||++++|+.+. ...+++.+
T Consensus 332 ~~~eil~Hpff~~i~w~~l~--~~~~p~~P 359 (437)
T 4aw2_A 332 GIEDFKKHPFFSGIDWDNIR--NCEAPYIP 359 (437)
T ss_dssp TTHHHHTSGGGTTCCTTTGG--GSCCSCCC
T ss_pred CHHHHhCCCccCCCCHHHHh--hCCCCCCC
Confidence 99999999999999999873 33444443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=277.46 Aligned_cols=166 Identities=29% Similarity=0.482 Sum_probs=142.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC----cEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG----EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ......+||+.|+|||++
T Consensus 112 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~ 190 (361)
T 2yab_A 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIV 190 (361)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHH
Confidence 57899999999999999999999999999999999998877 7999999999876543 334566899999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL-YRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.+ ..|+.++|||||||++|+|++|.+||.+.........+........ .....+++.+++||.+||..||.+||
T Consensus 191 ~~-----~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 265 (361)
T 2yab_A 191 NY-----EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL 265 (361)
T ss_dssp TT-----CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred cC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCc
Confidence 76 6789999999999999999999999999887777766665432211 11246799999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCC
Q psy9090 156 YMSELLEHPFITSLPEN 172 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~ 172 (488)
|+.++++||||+...+.
T Consensus 266 t~~e~l~hp~~~~~~~~ 282 (361)
T 2yab_A 266 TIQEALRHPWITPVDTQ 282 (361)
T ss_dssp CHHHHHTSTTTSCSSHH
T ss_pred CHHHHhcCcCcCCCchh
Confidence 99999999999977654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=268.45 Aligned_cols=165 Identities=25% Similarity=0.505 Sum_probs=132.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+.
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 175 (288)
T 1ob3_A 97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS- 175 (288)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCC-
Confidence 5788999999999999999999999999999999999999999999999987654433334456789999999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCC-----------------------CCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGL-----------------------YRASN 134 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~-----------------------~~~~~ 134 (488)
..++.++|||||||++|+|++|.+||.+........++.. .+.... .....
T Consensus 176 ---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (288)
T 1ob3_A 176 ---KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKG 252 (288)
T ss_dssp ---CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCS
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhh
Confidence 4588999999999999999999999998877666655543 111000 01134
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
+++.+.+||.+||..||++|||+.++++||||++.
T Consensus 253 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 253 LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 68899999999999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=270.43 Aligned_cols=164 Identities=36% Similarity=0.752 Sum_probs=145.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||+.|+|||++.+
T Consensus 138 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 215 (321)
T 2c30_A 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-- 215 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC--
Confidence 578899999999999999999999999999999999999999999999999876554344456789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++||||||+++|+|++|..||...........+.....+.......+++.+.++|.+||..||++|||+.++
T Consensus 216 ---~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 292 (321)
T 2c30_A 216 ---SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQEL 292 (321)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 56889999999999999999999999988877777777766655554556679999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++||||.+.
T Consensus 293 l~hp~~~~~ 301 (321)
T 2c30_A 293 LDHPFLLQT 301 (321)
T ss_dssp HTSGGGGGC
T ss_pred hcChhhccC
Confidence 999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-32 Score=264.95 Aligned_cols=165 Identities=24% Similarity=0.454 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+.
T Consensus 98 l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 176 (292)
T 3o0g_A 98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA- 176 (292)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCC-
Confidence 5789999999999999999999999999999999999999999999999998765444455566899999999999752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCC-CCCChHHHHHHHHh---CCCCC-----------------------CCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPF-EDMHPTRALFQIVR---NPPPG-----------------------LYRAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf-~~~~~~~~~~~~~~---~~~~~-----------------------~~~~~ 133 (488)
..++.++|||||||++|+|++|..|| .+......+..+.. .+... .....
T Consensus 177 ---~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (292)
T 3o0g_A 177 ---KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP 253 (292)
T ss_dssp ---SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTST
T ss_pred ---CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhccc
Confidence 44889999999999999999887774 55555554444432 11100 00123
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
.+++.+++||.+||..||++|||++++++||||+++
T Consensus 254 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 468899999999999999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=281.50 Aligned_cols=182 Identities=25% Similarity=0.400 Sum_probs=145.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....... .....+||+.|+|||++...
T Consensus 159 l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~ 238 (412)
T 2vd5_A 159 IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238 (412)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhc
Confidence 57899999999999999999999999999999999999999999999999986644322 23356899999999998731
Q ss_pred c--cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCC-CCCCcCHHHHHHHHHhcccCCCCC-
Q psy9090 80 H--KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLY-RASNWSQHYVDFIAECLEKNPEHR- 154 (488)
Q Consensus 80 ~--~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~-~~~~~s~~~~~li~~~L~~dP~~R- 154 (488)
. .....|+.++|||||||++|+|++|++||.+.+......++..... ...+ .+..+|+++++||++||. +|.+|
T Consensus 239 ~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rl 317 (412)
T 2vd5_A 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRL 317 (412)
T ss_dssp HTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCT
T ss_pred ccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcC
Confidence 0 0114588999999999999999999999999887776666654210 1111 135689999999999999 99998
Q ss_pred --CCHHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 155 --PYMSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 155 --ps~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
|+++++++||||+.++|+.+.. ..+++.+
T Consensus 318 gr~~~~ei~~Hpff~~i~w~~l~~--~~~p~~p 348 (412)
T 2vd5_A 318 GRGGAGDFRTHPFFFGLDWDGLRD--SVPPFTP 348 (412)
T ss_dssp TTTTHHHHHTSGGGTTCCSTTSTT--SCCSCCC
T ss_pred CCCCHHHHhcCCCcCCCCHHHHhh--cCCCCCC
Confidence 5999999999999999998743 3344444
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=289.14 Aligned_cols=177 Identities=29% Similarity=0.497 Sum_probs=148.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++............+||+.|+|||++.+
T Consensus 286 l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-- 363 (543)
T 3c4z_A 286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-- 363 (543)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT--
T ss_pred ccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcC--
Confidence 578999999999999999999999999999999999999999999999999876554334455689999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC----hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMH----PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
..|+.++|||||||++|+|++|.+||.+.. .......+..... ..+..+++.+++||.+||..||.+||+
T Consensus 364 ---~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~ 437 (543)
T 3c4z_A 364 ---EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV---TYPDKFSPASKDFCEALLQKDPEKRLG 437 (543)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred ---CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc---CCCcccCHHHHHHHHHhccCCHhHCCC
Confidence 678999999999999999999999997653 2334444444322 235678999999999999999999996
Q ss_pred -----HHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 157 -----MSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 157 -----~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
++++++||||+.++|..+......+++.+
T Consensus 438 ~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P 471 (543)
T 3c4z_A 438 FRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVP 471 (543)
T ss_dssp CBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CcccCHHHHHcCccccCCCHHHHHcCCCCCCCCC
Confidence 58999999999999987766555556554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=271.83 Aligned_cols=170 Identities=25% Similarity=0.496 Sum_probs=134.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||+.|+|||++.+.
T Consensus 97 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 175 (324)
T 3mtl_A 97 INMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS- 175 (324)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCC-
Confidence 4788999999999999999999999999999999999999999999999987655443444556789999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCCC------------------------CCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGLY------------------------RAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~~------------------------~~~ 133 (488)
..++.++|||||||++|+|++|.+||.+.........+.. .+.+..+ ...
T Consensus 176 ---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (324)
T 3mtl_A 176 ---TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAP 252 (324)
T ss_dssp ---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCT
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcC
Confidence 4688999999999999999999999998887666555543 1111110 112
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCCcc
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~ 174 (488)
.+++.+.+||.+||..||.+|||++++++||||.++.+...
T Consensus 253 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 293 (324)
T 3mtl_A 253 RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293 (324)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred CCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence 46788999999999999999999999999999998765533
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=280.56 Aligned_cols=167 Identities=28% Similarity=0.477 Sum_probs=135.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc---------------------cC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT---------------------FD 59 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~---------------------~~ 59 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 106 ~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (388)
T 3oz6_A 106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185 (388)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-----------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccc
Confidence 578889999999999999999999999999999999999999999999999754321 11
Q ss_pred ccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC----------
Q psy9090 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL---------- 129 (488)
Q Consensus 60 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---------- 129 (488)
.....+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+......+..+......+.
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 261 (388)
T 3oz6_A 186 ILTDYVATRWYRAPEILLGS----TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSP 261 (388)
T ss_dssp ----CCCGGGGCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCS
T ss_pred cccCCcccCCcCCHHHhcCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCH
Confidence 22345899999999999752 5689999999999999999999999999887776666543110000
Q ss_pred ----------------------------------CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 130 ----------------------------------YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 130 ----------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
......++++.+||.+||..||.+|||++++++||||+.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 262 FAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337 (388)
T ss_dssp SHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred HHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcC
Confidence 011256889999999999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=279.01 Aligned_cols=163 Identities=31% Similarity=0.503 Sum_probs=141.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc---cCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..............||+.|+|||++.
T Consensus 107 ~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~ 186 (444)
T 3soa_A 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186 (444)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhc
Confidence 57899999999999999999999999999999999998 457899999999987665444445678999999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..|+.++|||||||++|+|++|.+||.+.........+...... +......+++.+++||.+||..||.+|||
T Consensus 187 ~-----~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 261 (444)
T 3soa_A 187 K-----DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 261 (444)
T ss_dssp T-----CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred C-----CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC
Confidence 6 57899999999999999999999999998877777777665332 22223567999999999999999999999
Q ss_pred HHHHhcCcCCCC
Q psy9090 157 MSELLEHPFITS 168 (488)
Q Consensus 157 ~~ell~hp~f~~ 168 (488)
+.++|+||||+.
T Consensus 262 a~e~L~hp~~~~ 273 (444)
T 3soa_A 262 AAEALKHPWISH 273 (444)
T ss_dssp HHHHHHSCTTHH
T ss_pred HHHHhcCccccC
Confidence 999999999964
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=269.40 Aligned_cols=168 Identities=26% Similarity=0.493 Sum_probs=139.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+.
T Consensus 105 ~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 183 (317)
T 2pmi_A 105 LELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS- 183 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCC-
Confidence 4678899999999999999999999999999999999999999999999998765443344556899999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCC----------------------------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGL---------------------------- 129 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~---------------------------- 129 (488)
..++.++|||||||++|+|++|.+||.+.........+.. .+....
T Consensus 184 ---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (317)
T 2pmi_A 184 ---RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQP 260 (317)
T ss_dssp ---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGG
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcc
Confidence 4588999999999999999999999998887666555532 111000
Q ss_pred CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 130 YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 130 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
.....+++.+.+||.+||..||.+|||+.++++||||++..+.
T Consensus 261 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 261 HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred cccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 0112468899999999999999999999999999999986554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=277.36 Aligned_cols=169 Identities=25% Similarity=0.465 Sum_probs=140.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc-cCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+.
T Consensus 138 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 216 (394)
T 4e7w_A 138 MPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGA 216 (394)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT-CCCCSSCSCGGGCCHHHHTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC-CCCcccccCcCccCHHHHcCC
Confidence 57889999999999999999999999999999999999 7999999999999876443 334456789999999998652
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC-------------------CCCC-------CCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP-------------------PPGL-------YRAS 133 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~-------------------~~~~-------~~~~ 133 (488)
..|+.++||||+||++|+|++|++||.+......+..+.... .+.. ..+.
T Consensus 217 ----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (394)
T 4e7w_A 217 ----TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRP 292 (394)
T ss_dssp ----SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCT
T ss_pred ----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccc
Confidence 458999999999999999999999999988766666554310 0000 0123
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCCcc
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~ 174 (488)
..++++.+||.+||..||.+|||+.++++||||+.+.+...
T Consensus 293 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 293 RTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp TCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred cCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence 46889999999999999999999999999999998876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=265.12 Aligned_cols=164 Identities=32% Similarity=0.535 Sum_probs=137.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+..
T Consensus 134 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 213 (298)
T 2zv2_A 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR 213 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCC
Confidence 57899999999999999999999999999999999999999999999999987654433345568999999999987521
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
. ..++.++|||||||++|+|++|..||.+.........+..... ..+....+++.+.+||.+||..||++|||+.++
T Consensus 214 ~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~ 290 (298)
T 2zv2_A 214 K--IFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL-EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290 (298)
T ss_dssp C--CEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred C--CCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccC-CCCCccccCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 0 1136789999999999999999999988776655555544332 223345789999999999999999999999999
Q ss_pred hcCcCCC
Q psy9090 161 LEHPFIT 167 (488)
Q Consensus 161 l~hp~f~ 167 (488)
++||||+
T Consensus 291 l~hp~~~ 297 (298)
T 2zv2_A 291 KLHPWVT 297 (298)
T ss_dssp TTCHHHH
T ss_pred hcCcccc
Confidence 9999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=271.21 Aligned_cols=168 Identities=26% Similarity=0.408 Sum_probs=132.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc-----cCCcEEEEecCCccccccccCccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-----KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-----~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~ 75 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..............||+.|+|||+
T Consensus 129 ~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~ 208 (329)
T 3gbz_A 129 VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHH
Confidence 57889999999999999999999999999999999994 4556999999999766544344455678999999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCCCCCC---------------------
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPPGLYR--------------------- 131 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~~~--------------------- 131 (488)
+.+. ..++.++|||||||++|+|++|.+||.+.........+... +....+.
T Consensus 209 ~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
T 3gbz_A 209 LLGS----RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLK 284 (329)
T ss_dssp HTTC----CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHH
T ss_pred hcCC----CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHh
Confidence 9752 45889999999999999999999999988877766666532 1110000
Q ss_pred ---CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 132 ---ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 132 ---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
+..+++++++||.+||..||.+|||++++++||||++.+|+
T Consensus 285 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 285 RVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp HHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 01157889999999999999999999999999999998875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=274.47 Aligned_cols=160 Identities=28% Similarity=0.439 Sum_probs=133.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+
T Consensus 105 l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~-- 181 (336)
T 3h4j_B 105 MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVING-- 181 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCC--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-cccccccCCcCcCCHHHHcC--
Confidence 578999999999999999999999999999999999999999999999999865543 33456689999999999976
Q ss_pred cCCCCC-CCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGY-DNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~-~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..+ ++++|||||||++|+|++|..||.+.........+.. .....+..+|+.+.+||.+||..||.+|||+++
T Consensus 182 ---~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~---~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~e 255 (336)
T 3h4j_B 182 ---KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS---CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQE 255 (336)
T ss_dssp ---SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS---SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ---CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 333 6799999999999999999999977543222111111 112235567999999999999999999999999
Q ss_pred HhcCcCCCCC
Q psy9090 160 LLEHPFITSL 169 (488)
Q Consensus 160 ll~hp~f~~~ 169 (488)
+++||||+..
T Consensus 256 il~hp~~~~~ 265 (336)
T 3h4j_B 256 IRRDPWFNVN 265 (336)
T ss_dssp HTTCHHHHTT
T ss_pred HHhChhhccC
Confidence 9999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=288.79 Aligned_cols=177 Identities=27% Similarity=0.473 Sum_probs=147.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..... ......+||+.|+|||++.+
T Consensus 283 l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APEvl~~-- 359 (576)
T 2acx_A 283 FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKN-- 359 (576)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-CCEECCCSCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC-ccccccCCCccccCHHHHcC--
Confidence 578999999999999999999999999999999999999999999999999876443 23345689999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC--
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP-- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 155 (488)
..|+.++|||||||++|+|++|.+||.+... ...+.+.+...... .+..+|+++++||.+||..||.+||
T Consensus 360 ---~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~--~p~~~s~~~~dLI~~lL~~dP~~R~g~ 434 (576)
T 2acx_A 360 ---ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE--YSERFSPQARSLCSQLLCKDPAERLGC 434 (576)
T ss_dssp ---CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc--CCccCCHHHHHHHHHhccCCHHHcCCC
Confidence 5688999999999999999999999977532 23333333322222 3467899999999999999999999
Q ss_pred ---CHHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 156 ---YMSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 156 ---s~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
+++++++||||+.++|..+......+++.+
T Consensus 435 ~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p 467 (576)
T 2acx_A 435 RGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKP 467 (576)
T ss_dssp SSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CCCCHHHHHhChhhccCCHHHHhcCCCCCCCCC
Confidence 789999999999999987765555555544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=277.90 Aligned_cols=171 Identities=28% Similarity=0.485 Sum_probs=129.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc----------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---------------------- 58 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---------------------- 58 (488)
|++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 153 l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (458)
T 3rp9_A 153 LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232 (458)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccc
Confidence 5789999999999999999999999999999999999999999999999998654221
Q ss_pred -----CccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhc-----------CCCCCCCCCh--------
Q psy9090 59 -----DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-----------GKPPFEDMHP-------- 114 (488)
Q Consensus 59 -----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~ellt-----------g~~Pf~~~~~-------- 114 (488)
......+||+.|+|||++... ..|+.++|||||||++|+|++ |.+||.+...
T Consensus 233 ~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~ 308 (458)
T 3rp9_A 233 TKNLKRQLTGHVVTRWYRAPELILLQ----ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQK 308 (458)
T ss_dssp ------------CCCTTCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC------------
T ss_pred cccccccccCCcccccccChHHhhCC----CCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccc
Confidence 122345789999999987542 568999999999999999998 7777765431
Q ss_pred ------------HHHHHHH---HhCCC-------------------CC------CCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 115 ------------TRALFQI---VRNPP-------------------PG------LYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 115 ------------~~~~~~~---~~~~~-------------------~~------~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
...+..+ +..+. +. .......++++.+||.+||..||.+|
T Consensus 309 ~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 388 (458)
T 3rp9_A 309 AGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKR 388 (458)
T ss_dssp --------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTS
T ss_pred ccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCcccc
Confidence 1111111 11100 00 01124568999999999999999999
Q ss_pred CCHHHHhcCcCCCCCCCCccc
Q psy9090 155 PYMSELLEHPFITSLPENDLH 175 (488)
Q Consensus 155 ps~~ell~hp~f~~~~~~~~~ 175 (488)
||++++|+||||+.+.+....
T Consensus 389 ~t~~e~L~Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 389 ITINECLAHPFFKEVRIAEVE 409 (458)
T ss_dssp CCHHHHHHSGGGTTTCCGGGC
T ss_pred CCHHHHhcCHhhhhcCCCccC
Confidence 999999999999998876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=269.20 Aligned_cols=168 Identities=24% Similarity=0.385 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+.
T Consensus 109 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 187 (346)
T 1ua2_A 109 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA- 187 (346)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCC-
Confidence 4677899999999999999999999999999999999999999999999998765443445566899999999998652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCCCCC----------------------CCCCc
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPPGLY----------------------RASNW 135 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~~----------------------~~~~~ 135 (488)
..++.++|||||||++|+|++|.+||.+......+.++... +....+ ....+
T Consensus 188 ---~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (346)
T 1ua2_A 188 ---RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 264 (346)
T ss_dssp ---SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTC
T ss_pred ---CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccC
Confidence 45889999999999999999999999988877766665531 111000 01345
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 136 SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 136 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
++.+++||.+||..||.+|||+.++++||||+..++.
T Consensus 265 ~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 265 GDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 7899999999999999999999999999999886654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=283.29 Aligned_cols=163 Identities=23% Similarity=0.464 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......+||+.|+|||++.+
T Consensus 161 l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-- 237 (464)
T 3ttj_A 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG-- 237 (464)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C-CCC----CCCTTCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC-cccCCCcccccccCHHHHcC--
Confidence 578899999999999999999999999999999999999999999999999866543 33456789999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC---------------------CCCC-------C
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP---------------------GLYR-------A 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~---------------------~~~~-------~ 132 (488)
..|+.++|||||||++|+|++|++||.+.+....+..++..... .... +
T Consensus 238 ---~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (464)
T 3ttj_A 238 ---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 314 (464)
T ss_dssp ---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSC
T ss_pred ---CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCc
Confidence 57899999999999999999999999998876666655431100 0000 0
Q ss_pred CC-----------cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 133 SN-----------WSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 133 ~~-----------~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
.. .++++++||.+||..||++|||++++|+||||+..
T Consensus 315 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 315 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred ccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00 14678999999999999999999999999999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=266.75 Aligned_cols=165 Identities=28% Similarity=0.477 Sum_probs=140.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC----cEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG----EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... .......||+.|+|||++
T Consensus 111 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~ 189 (326)
T 2y0a_A 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIV 189 (326)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC-CccccccCCcCcCCceee
Confidence 57899999999999999999999999999999999999887 7999999999876433 334456799999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.+ ..++.++|||||||++|+|++|..||.+.........+....... ......+++.+++||.+||..||.+||
T Consensus 190 ~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 264 (326)
T 2y0a_A 190 NY-----EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264 (326)
T ss_dssp TT-----CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred cC-----CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCC
Confidence 75 578999999999999999999999999888766666665433211 111246789999999999999999999
Q ss_pred CHHHHhcCcCCCCCCC
Q psy9090 156 YMSELLEHPFITSLPE 171 (488)
Q Consensus 156 s~~ell~hp~f~~~~~ 171 (488)
|+.++++||||+...+
T Consensus 265 t~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 265 TIQDSLQHPWIKPKDT 280 (326)
T ss_dssp CHHHHHHSTTTSCCSH
T ss_pred CHHHHhcCCCccCCcc
Confidence 9999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=270.74 Aligned_cols=163 Identities=25% Similarity=0.413 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc--CCcEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK--DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... .......||+.|+|||++.+
T Consensus 99 ~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 177 (321)
T 1tki_A 99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhcC
Confidence 578999999999999999999999999999999999987 789999999999876543 33445679999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL-YRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++|.+||.+.........+........ .....+|+++++||.+||..||.+|||+
T Consensus 178 -----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 252 (321)
T 1tki_A 178 -----DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTA 252 (321)
T ss_dssp -----CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred -----CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCH
Confidence 5578899999999999999999999999887777777766543211 1124679999999999999999999999
Q ss_pred HHHhcCcCCCCC
Q psy9090 158 SELLEHPFITSL 169 (488)
Q Consensus 158 ~ell~hp~f~~~ 169 (488)
.++++||||+..
T Consensus 253 ~e~l~hp~~~~~ 264 (321)
T 1tki_A 253 SEALQHPWLKQK 264 (321)
T ss_dssp HHHHHSHHHHSC
T ss_pred HHHhcChhhccC
Confidence 999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=265.42 Aligned_cols=169 Identities=33% Similarity=0.558 Sum_probs=140.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc---CCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... .......||+.|+|||++.
T Consensus 128 ~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 206 (327)
T 3lm5_A 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILN 206 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc-cccccccCCcCccCCeeec
Confidence 578899999999999999999999999999999999987 789999999999876543 2334567999999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|||||||++|+|++|..||.+.........+..... ........+++.+.+||.+||..||.+|||
T Consensus 207 ~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 281 (327)
T 3lm5_A 207 Y-----DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT 281 (327)
T ss_dssp T-----CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred C-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcC
Confidence 6 6788999999999999999999999998887766666554322 222234568999999999999999999999
Q ss_pred HHHHhcCcCCCCCCCCccc
Q psy9090 157 MSELLEHPFITSLPENDLH 175 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~~~~ 175 (488)
++++++||||+..++..+.
T Consensus 282 ~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 282 AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp HHHHTTCGGGCCCCTTCC-
T ss_pred HHHHhCCHhhccccccccc
Confidence 9999999999998887553
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=271.34 Aligned_cols=163 Identities=26% Similarity=0.445 Sum_probs=135.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc---EEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.............+||+.|+|||++.
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 206 (351)
T 3c0i_A 127 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHc
Confidence 478899999999999999999999999999999999987655 99999999987655433345668999999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL-YRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..|+.++|||||||++|+|++|..||.+.. ......+........ .....+++.+++||.+||..||++|||
T Consensus 207 ~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 280 (351)
T 3c0i_A 207 R-----EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT 280 (351)
T ss_dssp T-----CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred C-----CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC
Confidence 6 568899999999999999999999998753 344444544332211 112467999999999999999999999
Q ss_pred HHHHhcCcCCCCC
Q psy9090 157 MSELLEHPFITSL 169 (488)
Q Consensus 157 ~~ell~hp~f~~~ 169 (488)
+.++++||||+..
T Consensus 281 ~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 281 VYEALNHPWLKER 293 (351)
T ss_dssp HHHHHTSHHHHTH
T ss_pred HHHHhcChhhcCC
Confidence 9999999999763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=264.71 Aligned_cols=169 Identities=26% Similarity=0.466 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..............||+.|+|||++.+.
T Consensus 99 ~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 177 (311)
T 4agu_A 99 VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD- 177 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcC-
Confidence 5788999999999999999999999999999999999999999999999998765443444566899999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---C------------------CCC--CC-----CC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---P------------------PPG--LY-----RA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~------------------~~~--~~-----~~ 132 (488)
..++.++||||||+++|+|++|.+||.+.........+... . .+. .. ..
T Consensus 178 ---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 4agu_A 178 ---TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKF 254 (311)
T ss_dssp ---SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHC
T ss_pred ---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhc
Confidence 56789999999999999999999999888766555443321 0 000 00 01
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCCc
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEND 173 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~ 173 (488)
..+++.+.+||.+||..||.+|||++++++||||+++.+..
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 255 PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp TTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred ccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 35788999999999999999999999999999999876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=258.76 Aligned_cols=161 Identities=25% Similarity=0.517 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE---ccCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL---TKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...... .......||+.|+|||++.
T Consensus 121 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~ 199 (285)
T 3is5_A 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFK 199 (285)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhc
Confidence 5788999999999999999999999999999999999 45678999999999765443 3344567999999999985
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||||+++|+|++|..||.+.......................+++.+.+||.+||..||.+|||+
T Consensus 200 ------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 273 (285)
T 3is5_A 200 ------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSA 273 (285)
T ss_dssp ------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCH
T ss_pred ------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCH
Confidence 35788999999999999999999999988876666655554433333345579999999999999999999999
Q ss_pred HHHhcCcCCCC
Q psy9090 158 SELLEHPFITS 168 (488)
Q Consensus 158 ~ell~hp~f~~ 168 (488)
.++++||||++
T Consensus 274 ~e~l~hp~f~~ 284 (285)
T 3is5_A 274 AQVLHHEWFKQ 284 (285)
T ss_dssp HHHHTSGGGGC
T ss_pred HHHhcCHHhhc
Confidence 99999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=270.12 Aligned_cols=162 Identities=28% Similarity=0.510 Sum_probs=138.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC---cEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG---EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... .......||+.|+|||++.
T Consensus 125 ~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 203 (362)
T 2bdw_A 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLK 203 (362)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHHHc
Confidence 57899999999999999999999999999999999998654 5999999999876543 3344568999999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..|+.++|||||||++|+|++|.+||.+.........+...... +......+++.+++||.+||..||.+|||
T Consensus 204 ~-----~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (362)
T 2bdw_A 204 K-----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 278 (362)
T ss_dssp T-----CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC
T ss_pred c-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC
Confidence 6 57899999999999999999999999988877766666654322 11122456999999999999999999999
Q ss_pred HHHHhcCcCCCC
Q psy9090 157 MSELLEHPFITS 168 (488)
Q Consensus 157 ~~ell~hp~f~~ 168 (488)
+.++++||||..
T Consensus 279 ~~e~l~hp~~~~ 290 (362)
T 2bdw_A 279 ADQALKVPWICN 290 (362)
T ss_dssp HHHHTTSHHHHT
T ss_pred HHHHhcCcccCC
Confidence 999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=272.97 Aligned_cols=171 Identities=29% Similarity=0.503 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--------------------- 59 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--------------------- 59 (488)
|++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 126 l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (432)
T 3n9x_A 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205 (432)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--------------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchh
Confidence 57899999999999999999999999999999999999999999999999986543211
Q ss_pred -ccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcC-----------CCCCCCCCh-------------
Q psy9090 60 -KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDG-----------KPPFEDMHP------------- 114 (488)
Q Consensus 60 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg-----------~~Pf~~~~~------------- 114 (488)
.....+||+.|+|||++... ..|+.++|||||||++|+|++| .++|.+...
T Consensus 206 ~~~~~~~gt~~Y~APE~~~~~----~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~ 281 (432)
T 3n9x_A 206 KQLTSHVVTRWYRAPELILLQ----ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVH 281 (432)
T ss_dssp -----CCCCCTTCCHHHHTTC----SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------C
T ss_pred ccccCCCCCccccCHHHHhcC----CCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCccccccccc
Confidence 13566899999999997542 5689999999999999999984 444444321
Q ss_pred ----HHHHHHH---H--------------------hCCCCCCC-----CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy9090 115 ----TRALFQI---V--------------------RNPPPGLY-----RASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 115 ----~~~~~~~---~--------------------~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 162 (488)
...+..+ + ........ ....+++.+.+||.+||..||.+|||++++|+
T Consensus 282 ~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 282 EKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111111 1 11111100 11457999999999999999999999999999
Q ss_pred CcCCCCCCCCccc
Q psy9090 163 HPFITSLPENDLH 175 (488)
Q Consensus 163 hp~f~~~~~~~~~ 175 (488)
||||+++.+....
T Consensus 362 Hp~f~~~~~~~~e 374 (432)
T 3n9x_A 362 HPYLKDVRKKKLE 374 (432)
T ss_dssp CGGGTTTCCTTTC
T ss_pred ChhhhhccCcccC
Confidence 9999998876543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=263.75 Aligned_cols=172 Identities=40% Similarity=0.878 Sum_probs=143.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..............||+.|+|||++....
T Consensus 114 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 193 (302)
T 2j7t_A 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193 (302)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeecccc
Confidence 57889999999999999999999999999999999999999999999998764332222334567999999999985321
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....++.++||||||+++|+|++|..||...........+.....+....+..++..+.++|.+||..||.+|||+.++
T Consensus 194 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 273 (302)
T 2j7t_A 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273 (302)
T ss_dssp TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHH
Confidence 12256889999999999999999999999988887777777776655555667789999999999999999999999999
Q ss_pred hcCcCCCCCCCC
Q psy9090 161 LEHPFITSLPEN 172 (488)
Q Consensus 161 l~hp~f~~~~~~ 172 (488)
++||||+.+.+.
T Consensus 274 l~h~~~~~~~~~ 285 (302)
T 2j7t_A 274 LEHPFVSSITSN 285 (302)
T ss_dssp TTSTTTTTCCCC
T ss_pred hcChHHhhhccc
Confidence 999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=268.31 Aligned_cols=166 Identities=31% Similarity=0.547 Sum_probs=136.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.
T Consensus 125 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 204 (364)
T 3qyz_A 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhc
Confidence 57889999999999999999999999999999999999999999999999976543321 124558999999999876
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CC--------------------CCC-----
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PP--------------------PGL----- 129 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~--------------------~~~----- 129 (488)
+. ..++.++|||||||++|+|++|.+||.+......+..+... +. ...
T Consensus 205 ~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (364)
T 3qyz_A 205 NS----KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 280 (364)
T ss_dssp TB----CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred CC----CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHH
Confidence 52 45889999999999999999999999887766555544321 00 000
Q ss_pred CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 130 YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 130 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
.....+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 281 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 281 RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 01245689999999999999999999999999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=264.87 Aligned_cols=167 Identities=20% Similarity=0.365 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+
T Consensus 102 ~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 181 (323)
T 3tki_A 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181 (323)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc
Confidence 578999999999999999999999999999999999999999999999999755322 122345689999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
. ..++.++|||||||++|+|++|..||.........................+++.+.+||.+||..||.+|||+.
T Consensus 182 ~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 257 (323)
T 3tki_A 182 R----EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257 (323)
T ss_dssp S----SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred C----CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHH
Confidence 2 224678999999999999999999998765543333333332222223456799999999999999999999999
Q ss_pred HHhcCcCCCCCCC
Q psy9090 159 ELLEHPFITSLPE 171 (488)
Q Consensus 159 ell~hp~f~~~~~ 171 (488)
++++||||+....
T Consensus 258 eil~h~~~~~~~~ 270 (323)
T 3tki_A 258 DIKKDRWYNKPLK 270 (323)
T ss_dssp HHTTCTTTTCCCC
T ss_pred HHhhChhhccccc
Confidence 9999999986543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=268.08 Aligned_cols=163 Identities=27% Similarity=0.449 Sum_probs=134.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC----CcEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD----GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~----~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.++.||+.||+|||++||+||||||+|||+... +.+||+|||+++............+||+.|+|||++
T Consensus 113 ~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~ 192 (342)
T 2qr7_A 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192 (342)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHh
Confidence 5789999999999999999999999999999999998543 359999999998765544445567899999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCC---ChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM---HPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~---~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
.+ ..|+.++|||||||++|+|++|.+||... ........+....... ...+..+|+.+++||.+||..||+
T Consensus 193 ~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 267 (342)
T 2qr7_A 193 ER-----QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPH 267 (342)
T ss_dssp HH-----HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTT
T ss_pred cC-----CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChh
Confidence 76 45788999999999999999999999753 3444455554443221 112356799999999999999999
Q ss_pred CCCCHHHHhcCcCCCC
Q psy9090 153 HRPYMSELLEHPFITS 168 (488)
Q Consensus 153 ~Rps~~ell~hp~f~~ 168 (488)
+|||+.++++||||..
T Consensus 268 ~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 268 QRLTAALVLRHPWIVH 283 (342)
T ss_dssp TSCCHHHHTTSHHHHT
T ss_pred HCcCHHHHhcCCeecC
Confidence 9999999999999964
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=275.25 Aligned_cols=168 Identities=23% Similarity=0.424 Sum_probs=137.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC-CcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+.
T Consensus 153 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 231 (420)
T 1j1b_A 153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGA 231 (420)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC-CCceeeeeCCCcCCHHHHcCC
Confidence 5778899999999999999999999999999999999965 56899999999865443 334456899999999998752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---C----------------CCCCC-------CCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---P----------------PPGLY-------RAS 133 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~----------------~~~~~-------~~~ 133 (488)
..|+.++|||||||++|+|++|++||.+......+.+++.. + .+... .+.
T Consensus 232 ----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 307 (420)
T 1j1b_A 232 ----TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307 (420)
T ss_dssp ----SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCT
T ss_pred ----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCC
Confidence 46899999999999999999999999988776666555431 0 00000 123
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCCc
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEND 173 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~ 173 (488)
..++++++||.+||..||.+|||+.++++||||..+.+..
T Consensus 308 ~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347 (420)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred CCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence 4588999999999999999999999999999998765543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=267.34 Aligned_cols=165 Identities=28% Similarity=0.534 Sum_probs=137.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .....+||+.|+|||++.+.
T Consensus 125 l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~- 200 (367)
T 1cm8_A 125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNW- 200 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTT-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCC-
Confidence 57889999999999999999999999999999999999999999999999986543 23456789999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC--CCC--------------------C------CCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN--PPP--------------------G------LYRA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~--~~~--------------------~------~~~~ 132 (488)
..|+.++||||+||++|+|++|++||.+......+..+... .++ . ....
T Consensus 201 ---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (367)
T 1cm8_A 201 ---MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL 277 (367)
T ss_dssp ---TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTC
T ss_pred ---CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHC
Confidence 46889999999999999999999999988776665554321 000 0 0112
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
...++.+.+||.+||..||.+|||+.++++||||+.+...
T Consensus 278 ~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 278 TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 4568999999999999999999999999999999987554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=265.92 Aligned_cols=167 Identities=25% Similarity=0.444 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc----cCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT----FDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++
T Consensus 121 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (351)
T 3mi9_A 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhh
Confidence 578999999999999999999999999999999999999999999999999765421 1223456789999999998
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCCCCCC--------------------
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGLYRAS-------------------- 133 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~-------------------- 133 (488)
.+. ..++.++|||||||++|+|++|.+||.+.........+.. ...+......
T Consensus 201 ~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
T 3mi9_A 201 LGE----RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 276 (351)
T ss_dssp TTC----CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHH
T ss_pred cCC----CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHH
Confidence 752 4578999999999999999999999998877665555443 2221111100
Q ss_pred ------CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 134 ------NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 134 ------~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
..++.+.+||.+||..||++|||++++++||||++.+.
T Consensus 277 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 277 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp HHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred HHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 02677899999999999999999999999999987544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-31 Score=259.52 Aligned_cols=167 Identities=26% Similarity=0.454 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......||+.|+|||++.+
T Consensus 117 ~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-- 193 (326)
T 1blx_A 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ-- 193 (326)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC-CCccccccccceeCHHHHhc--
Confidence 578899999999999999999999999999999999999999999999999765433 23345678999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCC---------------------CCCCCCCcC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPP---------------------GLYRASNWS 136 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~---------------------~~~~~~~~s 136 (488)
..++.++|||||||++|+|++|.+||.+.........+... +.. .......++
T Consensus 194 ---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 1blx_A 194 ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 270 (326)
T ss_dssp ---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC
T ss_pred ---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCC
Confidence 56889999999999999999999999988876666655431 000 001124578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCCc
Q psy9090 137 QHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEND 173 (488)
Q Consensus 137 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~ 173 (488)
+.+++||.+||..||.+|||+.++++||||+++.+..
T Consensus 271 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 271 ELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 9999999999999999999999999999999876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=263.01 Aligned_cols=170 Identities=49% Similarity=0.970 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..............||+.|+|||++....
T Consensus 126 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 205 (326)
T 2x7f_A 126 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 205 (326)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC---
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhcccc
Confidence 57889999999999999999999999999999999999999999999999876654333345567999999999997432
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....++.++|||||||++|+|++|..||...........+.....+.. ....+++.+.+||.+||..||.+|||+.++
T Consensus 206 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 284 (326)
T 2x7f_A 206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL-KSKKWSKKFQSFIESCLVKNHSQRPATEQL 284 (326)
T ss_dssp -----CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC-CccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence 2235688999999999999999999999998887776666666554433 356789999999999999999999999999
Q ss_pred hcCcCCCCCCC
Q psy9090 161 LEHPFITSLPE 171 (488)
Q Consensus 161 l~hp~f~~~~~ 171 (488)
++||||++.++
T Consensus 285 l~hp~~~~~~~ 295 (326)
T 2x7f_A 285 MKHPFIRDQPN 295 (326)
T ss_dssp HTSHHHHCCTT
T ss_pred hhChHHhhCcc
Confidence 99999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=260.21 Aligned_cols=167 Identities=43% Similarity=0.899 Sum_probs=146.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..............||+.|+|||++.+
T Consensus 122 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 199 (314)
T 3com_A 122 LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-- 199 (314)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCC--
Confidence 578899999999999999999999999999999999999999999999999776554344456679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++||||||+++|+|++|..||...........+.....+....+..+++.+.+||.+||..||.+|||+.++
T Consensus 200 ---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~l 276 (314)
T 3com_A 200 ---IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQL 276 (314)
T ss_dssp ---SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred ---CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 56889999999999999999999999988877766666666555555566789999999999999999999999999
Q ss_pred hcCcCCCCCCCC
Q psy9090 161 LEHPFITSLPEN 172 (488)
Q Consensus 161 l~hp~f~~~~~~ 172 (488)
++||||+...+.
T Consensus 277 l~~~~~~~~~~~ 288 (314)
T 3com_A 277 LQHPFVRSAKGV 288 (314)
T ss_dssp TTSHHHHTCCCG
T ss_pred HhCHHHhcCCcc
Confidence 999999876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=265.12 Aligned_cols=166 Identities=32% Similarity=0.494 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc---CCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..... .......||+.|+|||++.
T Consensus 145 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 223 (349)
T 2w4o_A 145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILR 223 (349)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------------CGGGSCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhc
Confidence 578999999999999999999999999999999999975 889999999998765432 2334567999999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHH-HHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF-QIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
+ ..++.++|||||||++|+|++|..||.......... .+....... ......++..+++||.+||..||++||
T Consensus 224 ~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 298 (349)
T 2w4o_A 224 G-----CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL 298 (349)
T ss_dssp T-----CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred C-----CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCc
Confidence 6 568999999999999999999999998766555333 333322211 112356799999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCC
Q psy9090 156 YMSELLEHPFITSLPEN 172 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~ 172 (488)
|+.++++||||.....+
T Consensus 299 t~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 299 TTFQALQHPWVTGKAAN 315 (349)
T ss_dssp CHHHHHHSTTTTSTTCC
T ss_pred CHHHHhcCcccCCCccc
Confidence 99999999999876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=274.39 Aligned_cols=161 Identities=28% Similarity=0.449 Sum_probs=133.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc--EEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE--VKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..... .....+||+.|+|||++.+
T Consensus 197 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~ 273 (429)
T 3kvw_A 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILG 273 (429)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC---cccccCCCCCccChHHHhC
Confidence 578899999999999999999999999999999999999987 99999999975432 3345689999999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC--CCCC----------------------------
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN--PPPG---------------------------- 128 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~--~~~~---------------------------- 128 (488)
..|+.++|||||||++|+|++|.+||.+......+..+... .++.
T Consensus 274 -----~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (429)
T 3kvw_A 274 -----ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLS 348 (429)
T ss_dssp -----BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCC
T ss_pred -----CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccc
Confidence 56899999999999999999999999988876665554421 0000
Q ss_pred ------------------CC--------CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 129 ------------------LY--------RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 129 ------------------~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
.. .+...++.+.+||.+||..||++|||+.++|+||||+..
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 349 DGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp C--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred cccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 00 011236789999999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=261.89 Aligned_cols=157 Identities=24% Similarity=0.397 Sum_probs=128.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+
T Consensus 154 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-- 230 (311)
T 3p1a_A 154 LPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG-- 230 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCCcccCCCccccCHhHhcC--
Confidence 578999999999999999999999999999999999999999999999998766443 33345579999999999863
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.++.++|||||||++|+|++|..|+.... ....+.....+. ..+..+++.+.+||.+||..||++|||+.++
T Consensus 231 ----~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 302 (311)
T 3p1a_A 231 ----SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPP-EFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302 (311)
T ss_dssp ----CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ----CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCc-ccccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 58899999999999999999977775532 233333332221 1235679999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
++||||++
T Consensus 303 l~hp~~~~ 310 (311)
T 3p1a_A 303 LALPVLRQ 310 (311)
T ss_dssp HTSGGGSC
T ss_pred HhCccccC
Confidence 99999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=265.96 Aligned_cols=165 Identities=27% Similarity=0.521 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+.
T Consensus 141 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~- 216 (371)
T 4exu_A 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSW- 216 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc---CcCCcccCccccCHHHhcCC-
Confidence 57899999999999999999999999999999999999999999999999976543 23456789999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCC--C--------------------CCCC------CC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNP--P--------------------PGLY------RA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~--~--------------------~~~~------~~ 132 (488)
..++.++|||||||++|+|++|..||.+........++.... + +... ..
T Consensus 217 ---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (371)
T 4exu_A 217 ---MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 293 (371)
T ss_dssp ---SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHS
T ss_pred ---CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhc
Confidence 468899999999999999999999999887666655554310 0 0000 12
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
..+++.+.+||.+||..||.+|||+.++++||||+.+...
T Consensus 294 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 294 PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp TTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred cccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 3568999999999999999999999999999999987544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=265.90 Aligned_cols=162 Identities=27% Similarity=0.506 Sum_probs=121.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc--EEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE--VKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+
T Consensus 113 ~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 191 (361)
T 3uc3_A 113 FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLR 191 (361)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------------CTTSCHHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcC
Confidence 578999999999999999999999999999999999987765 999999998754332 23345679999999999976
Q ss_pred cccCCCCCCCc-cchhhhHHHHHHHhcCCCCCCCCCh----HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCC
Q psy9090 79 GHKEVDGYDNR-IDVWALGITAIELGDGKPPFEDMHP----TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEH 153 (488)
Q Consensus 79 ~~~~~~~~~~~-~DiwslGvil~elltg~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 153 (488)
..++.+ +|||||||++|+|++|+.||.+... ......+.. .....+....+++.+++||.+||..||.+
T Consensus 192 -----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 265 (361)
T 3uc3_A 192 -----QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS-VKYSIPDDIRISPECCHLISRIFVADPAT 265 (361)
T ss_dssp -----SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT-TCCCCCTTSCCCHHHHHHHHHHSCSCTTT
T ss_pred -----CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc-CCCCCCCcCCCCHHHHHHHHHHccCChhH
Confidence 445444 8999999999999999999976543 233333333 22233334467999999999999999999
Q ss_pred CCCHHHHhcCcCCCCC
Q psy9090 154 RPYMSELLEHPFITSL 169 (488)
Q Consensus 154 Rps~~ell~hp~f~~~ 169 (488)
|||+.++++||||...
T Consensus 266 Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 266 RISIPEIKTHSWFLKN 281 (361)
T ss_dssp SCCHHHHHTSHHHHTT
T ss_pred CcCHHHHHhCcchhcC
Confidence 9999999999999653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=268.35 Aligned_cols=165 Identities=27% Similarity=0.431 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc--CCcEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK--DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++..... .......||+.|+|||++.+
T Consensus 146 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 224 (387)
T 1kob_A 146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDR 224 (387)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-cceeeeccCCCccCchhccC
Confidence 578999999999999999999999999999999999974 567999999999876543 23345579999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++|..||.+.........+...... .......+++.+++||.+||..||.+|||+
T Consensus 225 -----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 299 (387)
T 1kob_A 225 -----EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 299 (387)
T ss_dssp -----CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred -----CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 56889999999999999999999999998877777666654322 122335679999999999999999999999
Q ss_pred HHHhcCcCCCCCCC
Q psy9090 158 SELLEHPFITSLPE 171 (488)
Q Consensus 158 ~ell~hp~f~~~~~ 171 (488)
.++++||||+....
T Consensus 300 ~ell~hp~~~~~~~ 313 (387)
T 1kob_A 300 HDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHTSTTTSSCCT
T ss_pred HHHhhCccccCCcc
Confidence 99999999987543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-31 Score=254.62 Aligned_cols=165 Identities=28% Similarity=0.499 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc---EEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++...... .......||+.|+|||++.
T Consensus 102 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 180 (284)
T 3kk8_A 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLK 180 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-CBCCCSCSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-ccccCCCCCcCCcCchhhc
Confidence 578899999999999999999999999999999999987665 999999999766543 3334567999999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++||||||+++|+|++|..||.+.........+...... +......+++.+.+||.+||..||++|||
T Consensus 181 ~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 255 (284)
T 3kk8_A 181 K-----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 255 (284)
T ss_dssp T-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred C-----CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCC
Confidence 6 56889999999999999999999999988877766666554322 22233567999999999999999999999
Q ss_pred HHHHhcCcCCCCCCC
Q psy9090 157 MSELLEHPFITSLPE 171 (488)
Q Consensus 157 ~~ell~hp~f~~~~~ 171 (488)
+.++++||||+...+
T Consensus 256 ~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 256 ADQALKVPWICNRER 270 (284)
T ss_dssp HHHHTTSHHHHSCCC
T ss_pred HHHHhcCccccCChh
Confidence 999999999987544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=268.08 Aligned_cols=165 Identities=28% Similarity=0.522 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+.
T Consensus 129 l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~- 204 (367)
T 2fst_X 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNW- 204 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc---cCCCcCcCcCccChHHHcCC-
Confidence 57889999999999999999999999999999999999999999999999976543 23456899999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC--CC--------------------CCCC------CC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN--PP--------------------PGLY------RA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~--~~--------------------~~~~------~~ 132 (488)
..|+.++|||||||++|+|++|++||.+.+....+..+... .+ +... ..
T Consensus 205 ---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (367)
T 2fst_X 205 ---MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 281 (367)
T ss_dssp ---CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHT
T ss_pred ---cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHC
Confidence 46889999999999999999999999988776655554431 00 0000 01
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
...++.+.+||.+||..||.+|||+.++|+||||+.....
T Consensus 282 ~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 282 IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 3457889999999999999999999999999999986543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=265.16 Aligned_cols=179 Identities=31% Similarity=0.511 Sum_probs=143.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc-cCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT-FDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+||+.|+|||++.+.
T Consensus 156 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 235 (355)
T 1vzo_A 156 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 235 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCC
Confidence 578899999999999999999999999999999999999999999999998765322 1233456799999999999752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC----hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH----PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
...++.++|||||||++|+|++|..||.... .......+.... +. .+..+++.+.+||.+||..||.+||
T Consensus 236 ---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~L~~dP~~R~ 309 (355)
T 1vzo_A 236 ---DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PP--YPQEMSALAKDLIQRLLMKDPKKRL 309 (355)
T ss_dssp ---C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-CC--CCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred ---CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC-CC--CCcccCHHHHHHHHHHhhhCHHHhc
Confidence 1357889999999999999999999996432 223333333332 22 3467899999999999999999999
Q ss_pred -----CHHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 156 -----YMSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 156 -----s~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
|++++++||||..+.|..+......+++.+
T Consensus 310 ~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p 344 (355)
T 1vzo_A 310 GCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP 344 (355)
T ss_dssp TSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCC
Confidence 999999999999999887766665555543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=271.31 Aligned_cols=163 Identities=28% Similarity=0.450 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc---CCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
|++.+++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..... ......+||+.|+|||++.
T Consensus 158 l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 236 (400)
T 1nxk_A 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLG 236 (400)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC-CccccCCCCCCccCHhhcC
Confidence 578999999999999999999999999999999999997 788999999999865433 3345668999999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH----HHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR----ALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~----~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
+ ..|+.++|||||||++|+|++|..||.+..... ....+..... ........+++++++||.+||..||.
T Consensus 237 ~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 311 (400)
T 1nxk_A 237 P-----EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311 (400)
T ss_dssp C-----CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGG
T ss_pred C-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChh
Confidence 5 678999999999999999999999997654321 2223332221 11122356799999999999999999
Q ss_pred CCCCHHHHhcCcCCCCC
Q psy9090 153 HRPYMSELLEHPFITSL 169 (488)
Q Consensus 153 ~Rps~~ell~hp~f~~~ 169 (488)
+|||+.++++||||...
T Consensus 312 ~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 312 QRMTITEFMNHPWIMQS 328 (400)
T ss_dssp GSCCHHHHHHSHHHHTT
T ss_pred HCcCHHHHhcCccccCC
Confidence 99999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=274.26 Aligned_cols=161 Identities=27% Similarity=0.470 Sum_probs=139.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....+.+||+.|+|||++.+.
T Consensus 113 l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~- 190 (476)
T 2y94_A 113 LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGR- 190 (476)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCC-
Confidence 578999999999999999999999999999999999999999999999999876543 334566899999999999762
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|||||||++|+|++|..||.+........++..... ..+..+++.+.+||.+||..||.+|||+.++
T Consensus 191 ---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~ei 264 (476)
T 2y94_A 191 ---LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---YTPQYLNPSVISLLKHMLQVDPMKRATIKDI 264 (476)
T ss_dssp ---CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ---CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---CCCccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 2236799999999999999999999998877766666665432 2355679999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++||||+..
T Consensus 265 l~hp~~~~~ 273 (476)
T 2y94_A 265 REHEWFKQD 273 (476)
T ss_dssp HTCHHHHTT
T ss_pred HhCHHhhhc
Confidence 999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=264.91 Aligned_cols=164 Identities=28% Similarity=0.465 Sum_probs=115.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC---cEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG---EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++............+||+.|+|||++.
T Consensus 103 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~ 182 (325)
T 3kn6_A 103 FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182 (325)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhc
Confidence 57899999999999999999999999999999999998766 799999999986654444455668899999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh-------HHHHHHHHhCCCCCC-CCCCCcCHHHHHHHHHhccc
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP-------TRALFQIVRNPPPGL-YRASNWSQHYVDFIAECLEK 149 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~-------~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~ 149 (488)
+ ..|+.++|||||||++|+|++|..||..... ......+.....+.. .....+++++++||.+||..
T Consensus 183 ~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 257 (325)
T 3kn6_A 183 Q-----NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTV 257 (325)
T ss_dssp ------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCC
T ss_pred C-----CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCC
Confidence 6 6789999999999999999999999976432 233334433322111 11135799999999999999
Q ss_pred CCCCCCCHHHHhcCcCCCCC
Q psy9090 150 NPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 150 dP~~Rps~~ell~hp~f~~~ 169 (488)
||.+|||+.++++||||+..
T Consensus 258 dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 258 DPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CTTTCCCTTTSTTCGGGCTT
T ss_pred ChhHCCCHHHHhcChhhccC
Confidence 99999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-31 Score=262.88 Aligned_cols=166 Identities=24% Similarity=0.480 Sum_probs=128.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 105 ~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 105 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhh
Confidence 57889999999999999999999999999999999997 68899999999986643321 2335679999999999864
Q ss_pred ccc------CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 79 GHK------EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 79 ~~~------~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
... ....++.++|||||||++|+|++|..||...... .....+.. .......+...++.+.+||.+||..||
T Consensus 184 ~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dp 262 (343)
T 3dbq_A 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEFPDIPEKDLQDVLKCCLKRDP 262 (343)
T ss_dssp CC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-TTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred ccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc-CCcccCCcccCCHHHHHHHHHHcCCCh
Confidence 110 1146788999999999999999999999875443 33333332 222333455668899999999999999
Q ss_pred CCCCCHHHHhcCcCCCC
Q psy9090 152 EHRPYMSELLEHPFITS 168 (488)
Q Consensus 152 ~~Rps~~ell~hp~f~~ 168 (488)
.+|||+.++++||||+.
T Consensus 263 ~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 263 KQRISIPELLAHPYVQI 279 (343)
T ss_dssp TTSCCHHHHHTSHHHHS
T ss_pred hHCCCHHHHHhCccccc
Confidence 99999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=262.87 Aligned_cols=162 Identities=39% Similarity=0.792 Sum_probs=140.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....||+.|+|||++.+..
T Consensus 151 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~ 226 (348)
T 1u5q_A 151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMD 226 (348)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----CCcccCCcceeCHhhhcccc
Confidence 57889999999999999999999999999999999999999999999999876543 23567999999999985321
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
...++.++|||||||++|+|++|.+||...........+.....+.. .+..+++.+.+||.+||..||.+|||++++
T Consensus 227 --~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 303 (348)
T 1u5q_A 227 --EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303 (348)
T ss_dssp --SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 15688999999999999999999999998887777777776654433 346789999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++||||...
T Consensus 304 l~h~~~~~~ 312 (348)
T 1u5q_A 304 LKHRFVLRE 312 (348)
T ss_dssp TTCHHHHSC
T ss_pred hhChhhhcc
Confidence 999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=255.36 Aligned_cols=160 Identities=28% Similarity=0.540 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEc-cCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..... .......||+.|+|||++.
T Consensus 126 ~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~ 203 (290)
T 1t4h_A 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc--cccccccCCcCcCCHHHHh
Confidence 578899999999999999999999 99999999999997 789999999999865433 2334567999999999886
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++|..||......................+...++.+.+||.+||..||.+|||+
T Consensus 204 ------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 277 (290)
T 1t4h_A 204 ------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSI 277 (290)
T ss_dssp ------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred ------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 35889999999999999999999999886665555555544433333455668999999999999999999999
Q ss_pred HHHhcCcCCCC
Q psy9090 158 SELLEHPFITS 168 (488)
Q Consensus 158 ~ell~hp~f~~ 168 (488)
.++++||||++
T Consensus 278 ~ell~h~~f~~ 288 (290)
T 1t4h_A 278 KDLLNHAFFQE 288 (290)
T ss_dssp HHHHTSGGGC-
T ss_pred HHHhhCccccc
Confidence 99999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=269.29 Aligned_cols=169 Identities=30% Similarity=0.621 Sum_probs=130.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-------CccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-------DKKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aP 73 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+||
T Consensus 125 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 204 (389)
T 3gni_B 125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204 (389)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCH
Confidence 5788999999999999999999999999999999999999999999999876432211 122334789999999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC--------------------------
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-------------------------- 127 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-------------------------- 127 (488)
|++.+. ...|+.++|||||||++|+|++|++||.+.........+.....+
T Consensus 205 E~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (389)
T 3gni_B 205 EVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGL 281 (389)
T ss_dssp HHHSTT---SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------------------
T ss_pred HHHhcc---CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccc
Confidence 999752 145889999999999999999999999876554444333221111
Q ss_pred -----------------CCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 128 -----------------GLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 128 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
....+..+++.+++||.+||..||++|||+.++++||||+.+.+.
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 282 SDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 343 (389)
T ss_dssp ------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred ccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence 111234568899999999999999999999999999999987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=260.11 Aligned_cols=165 Identities=27% Similarity=0.505 Sum_probs=133.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 123 ~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~- 198 (353)
T 3coi_A 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSW- 198 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhCc-
Confidence 578999999999999999999999999999999999999999999999999765432 3455789999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---------------------------CCCC-CCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---------------------------PPPG-LYRA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---------------------------~~~~-~~~~ 132 (488)
..++.++|||||||++|+|++|..||.+......+..+... ..+. ....
T Consensus 199 ---~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (353)
T 3coi_A 199 ---MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 275 (353)
T ss_dssp ---SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTC
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhc
Confidence 46788999999999999999999999888766555444321 0000 0112
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
..+++.+.+||.+||..||.+|||+.++++||||+.....
T Consensus 276 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 276 PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315 (353)
T ss_dssp TTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred CCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence 4568999999999999999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=267.25 Aligned_cols=164 Identities=28% Similarity=0.454 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE--ccCCcEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL--TKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl--~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 184 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 262 (373)
T 2x4f_A 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNY 262 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-cccccccCCCcEeChhhccC
Confidence 5788999999999999999999999999999999999 56778999999999876543 33445579999999999975
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++|..||.+......+..+....... ......+++++++||.+||..||.+|||+
T Consensus 263 -----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~ 337 (373)
T 2x4f_A 263 -----DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISA 337 (373)
T ss_dssp -----CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred -----CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCH
Confidence 568899999999999999999999999988877777777653321 11235679999999999999999999999
Q ss_pred HHHhcCcCCCCCC
Q psy9090 158 SELLEHPFITSLP 170 (488)
Q Consensus 158 ~ell~hp~f~~~~ 170 (488)
.++++||||+..+
T Consensus 338 ~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 338 SEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHSHHHHCHH
T ss_pred HHHhcCcCcCCCc
Confidence 9999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=255.66 Aligned_cols=161 Identities=32% Similarity=0.581 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... .......||+.|+|||++.+
T Consensus 106 ~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~-- 181 (279)
T 3fdn_A 106 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEG-- 181 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--ccccccCCCCCccCHhHhcc--
Confidence 57889999999999999999999999999999999999999999999998865433 23345679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++||||||+++|+|++|..||...........+...... .+..+++.+.+||.+||..||.+|||+.++
T Consensus 182 ---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 255 (279)
T 3fdn_A 182 ---RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---FPDFVTEGARDLISRLLKHNPSQRPMLREV 255 (279)
T ss_dssp ---CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---CCTTSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ---CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC---CCCcCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 56788999999999999999999999988876666666553322 345689999999999999999999999999
Q ss_pred hcCcCCCCCCC
Q psy9090 161 LEHPFITSLPE 171 (488)
Q Consensus 161 l~hp~f~~~~~ 171 (488)
++||||+....
T Consensus 256 l~h~~~~~~~~ 266 (279)
T 3fdn_A 256 LEHPWITANSS 266 (279)
T ss_dssp HHCHHHHHHCS
T ss_pred hhCccccCCcc
Confidence 99999986543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-31 Score=268.93 Aligned_cols=168 Identities=24% Similarity=0.423 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE----ccCCcEEEEecCCcccccccc---CccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL----TKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aP 73 (488)
|++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... ......+||+.|+||
T Consensus 125 l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 204 (405)
T 3rgf_A 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204 (405)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCc
Confidence 5788999999999999999999999999999999999 677899999999998654321 223456899999999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---------HHHHHHHHh---CCCCCCCC----------
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---------TRALFQIVR---NPPPGLYR---------- 131 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---------~~~~~~~~~---~~~~~~~~---------- 131 (488)
|++.+. ..|+.++|||||||++|+|++|.+||.+... ...+.++.. .+....+.
T Consensus 205 E~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 280 (405)
T 3rgf_A 205 ELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHST 280 (405)
T ss_dssp HHHTTC----CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHH
T ss_pred hhhcCC----CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhh
Confidence 999752 4588999999999999999999999976543 123333321 11111000
Q ss_pred ----------------------CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 132 ----------------------ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 132 ----------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
....++.+.+||.+||..||.+|||++++|+||||...++.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 281 LMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP 343 (405)
T ss_dssp HHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred hhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCC
Confidence 01126788999999999999999999999999999886554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=260.07 Aligned_cols=166 Identities=29% Similarity=0.485 Sum_probs=140.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC----cEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG----EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...... .......||+.|+|||++
T Consensus 112 ~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~ 190 (321)
T 2a2a_A 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIV 190 (321)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcc-ccccccCCCCCccCcccc
Confidence 46789999999999999999999999999999999999888 7999999999866543 233456799999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL-YRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.+ ..++.++|||||||++|+|++|..||.+.........+........ ..+..+++.+.+||.+||..||.+||
T Consensus 191 ~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 265 (321)
T 2a2a_A 191 NY-----EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265 (321)
T ss_dssp TT-----CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSC
T ss_pred cC-----CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCc
Confidence 76 5688999999999999999999999998887766666654332111 11246789999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCC
Q psy9090 156 YMSELLEHPFITSLPEN 172 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~ 172 (488)
|+.++++||||+..++.
T Consensus 266 s~~e~l~hp~~~~~~~~ 282 (321)
T 2a2a_A 266 TIQEALRHPWITPVDNQ 282 (321)
T ss_dssp CHHHHHHSTTTSCSSHH
T ss_pred CHHHHhcCccccCCCcc
Confidence 99999999999876653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=266.62 Aligned_cols=164 Identities=26% Similarity=0.464 Sum_probs=137.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc-cCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+.
T Consensus 138 l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 216 (383)
T 3eb0_A 138 IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGA 216 (383)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCC
Confidence 57889999999999999999999999999999999998 6889999999999866443 334456789999999998752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-------------------CCC-------CCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-------------------PGL-------YRAS 133 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-------------------~~~-------~~~~ 133 (488)
..|+.++||||+||++|+|++|++||.+......+.+++.... +.. ..+.
T Consensus 217 ----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (383)
T 3eb0_A 217 ----TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292 (383)
T ss_dssp ----SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCT
T ss_pred ----CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCC
Confidence 4589999999999999999999999999887776666653100 000 0134
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
..++.+.+||.+||..||.+|||+.++++||||+.+
T Consensus 293 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp TCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 468899999999999999999999999999999865
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=258.14 Aligned_cols=165 Identities=38% Similarity=0.662 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++...... .......||+.|+|||++...
T Consensus 106 ~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 184 (290)
T 3fme_A 106 IPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPE 184 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCC
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc-ccccccCCCccccChhhcChh
Confidence 57889999999999999999998 9999999999999999999999999999765443 233445799999999997421
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCC-ChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDM-HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
. ....++.++||||+||++|+|++|..||... ..............+.. ....+++.+.++|.+||..||++|||+.
T Consensus 185 ~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 262 (290)
T 3fme_A 185 L-NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL-PADKFSAEFVDFTSQCLKKNSKERPTYP 262 (290)
T ss_dssp T-TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC-CTTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred h-cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc-ccccCCHHHHHHHHHHhhcChhhCcCHH
Confidence 1 1256889999999999999999999999863 44445555555544333 3456899999999999999999999999
Q ss_pred HHhcCcCCCC
Q psy9090 159 ELLEHPFITS 168 (488)
Q Consensus 159 ell~hp~f~~ 168 (488)
++++||||+.
T Consensus 263 e~l~hp~f~~ 272 (290)
T 3fme_A 263 ELMQHPFFTL 272 (290)
T ss_dssp HHTTSHHHHH
T ss_pred HHHhCccccc
Confidence 9999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=259.73 Aligned_cols=167 Identities=22% Similarity=0.395 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .......||+.|+|||++.+.
T Consensus 127 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 205 (330)
T 3nsz_A 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDY 205 (330)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCGGGCCHHHHTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-CccccccccccccChhhhcCC
Confidence 57889999999999999999999999999999999999777 8999999999765443 334456799999999998652
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC-hHHHHHHHHh-------------CCCC------------------
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PTRALFQIVR-------------NPPP------------------ 127 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~-~~~~~~~~~~-------------~~~~------------------ 127 (488)
..++.++|||||||++|+|++|..||.... ....+..+.. ....
T Consensus 206 ----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (330)
T 3nsz_A 206 ----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 281 (330)
T ss_dssp ----CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGG
T ss_pred ----CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchh
Confidence 458899999999999999999999995432 2222222111 0000
Q ss_pred ---CCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 128 ---GLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 128 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
....+..+++.+.+||.+||..||.+|||++++++||||+++.++
T Consensus 282 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329 (330)
T ss_dssp GGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred hhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence 000112268999999999999999999999999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=266.88 Aligned_cols=167 Identities=23% Similarity=0.456 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... .....+||+.|+|||++.+
T Consensus 152 ~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 152 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhh
Confidence 46788999999999999999999999999999999995 68999999999986643211 2345679999999999864
Q ss_pred ccc------CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 79 GHK------EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 79 ~~~------~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
... ....|+.++|||||||++|+|++|.+||...... ..+..++.. ......+...++.+.+||.+||..||
T Consensus 231 ~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP 309 (390)
T 2zmd_A 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-NHEIEFPDIPEKDLQDVLKCCLKRDP 309 (390)
T ss_dssp C------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT-TSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred ccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc-cccCCCCccchHHHHHHHHHHcccCh
Confidence 211 0135889999999999999999999999875433 333444432 22223345568899999999999999
Q ss_pred CCCCCHHHHhcCcCCCCC
Q psy9090 152 EHRPYMSELLEHPFITSL 169 (488)
Q Consensus 152 ~~Rps~~ell~hp~f~~~ 169 (488)
.+|||+.++++||||+..
T Consensus 310 ~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 310 KQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TTSCCHHHHHTSHHHHSC
T ss_pred hhCCCHHHHhhCcCcccc
Confidence 999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=263.87 Aligned_cols=166 Identities=25% Similarity=0.469 Sum_probs=134.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE-------------------ccCCcEEEEecCCccccccccCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL-------------------TKDGEVKIVDFGLSRETANTFDKK 61 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl-------------------~~~~~vkL~Dfg~a~~~~~~~~~~ 61 (488)
+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.... ..
T Consensus 120 ~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~ 196 (355)
T 2eu9_A 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE---HH 196 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS---CC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc---cc
Confidence 5788999999999999999999999999999999999 5678999999999976432 23
Q ss_pred ccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh--CCCCC-----------
Q psy9090 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR--NPPPG----------- 128 (488)
Q Consensus 62 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~--~~~~~----------- 128 (488)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.. ...|.
T Consensus 197 ~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 271 (355)
T 2eu9_A 197 TTIVATRHYRPPEVILE-----LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKY 271 (355)
T ss_dssp CSSCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGG
T ss_pred cCCcCCCcccCCeeeec-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhh
Confidence 45679999999999976 5789999999999999999999999988776554433322 11110
Q ss_pred ----------------------------CCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCCcc
Q psy9090 129 ----------------------------LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174 (488)
Q Consensus 129 ----------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~ 174 (488)
.......+..+.+||.+||..||++|||+.++++||||+.+.++..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 272 FYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEER 345 (355)
T ss_dssp EETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHHHH
T ss_pred hcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCChhhc
Confidence 0001112457889999999999999999999999999998876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=255.84 Aligned_cols=162 Identities=35% Similarity=0.577 Sum_probs=112.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..............||+.|+|||++.+
T Consensus 109 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 186 (278)
T 3cok_A 109 FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR-- 186 (278)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC--
Confidence 578999999999999999999999999999999999999999999999999866543333445679999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||||+++|+|++|..||...........+... ....+..++.++.++|.+||..||.+|||++++
T Consensus 187 ---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 260 (278)
T 3cok_A 187 ---SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA---DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260 (278)
T ss_dssp --------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc---ccCCccccCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 56788999999999999999999999876544433332221 222355679999999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
++||||....
T Consensus 261 l~h~~~~~~~ 270 (278)
T 3cok_A 261 LDHPFMSRNS 270 (278)
T ss_dssp TTSTTTC---
T ss_pred hcCccccCCC
Confidence 9999998644
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=262.78 Aligned_cols=159 Identities=25% Similarity=0.416 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-------------------------CCcEEEEecCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-------------------------DGEVKIVDFGLSRETA 55 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-------------------------~~~vkL~Dfg~a~~~~ 55 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 134 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~ 213 (360)
T 3llt_A 134 FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecC
Confidence 578899999999999999999999999999999999975 7889999999997644
Q ss_pred cccCccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC------
Q psy9090 56 NTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL------ 129 (488)
Q Consensus 56 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------ 129 (488)
. ......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||...........+.....+..
T Consensus 214 ~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 285 (360)
T 3llt_A 214 D---YHGSIINTRQYRAPEVILN-----LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYE 285 (360)
T ss_dssp S---CCCSCCSCGGGCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHH
T ss_pred C---CCcCccCcccccCcHHHcC-----CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhh
Confidence 3 2345679999999999986 5789999999999999999999999988776655544432111000
Q ss_pred -----------------CCC--------------------CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q psy9090 130 -----------------YRA--------------------SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167 (488)
Q Consensus 130 -----------------~~~--------------------~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 167 (488)
..+ ...++.+.+||.+||..||.+|||+.++|+||||+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 286 ATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 000 01136778999999999999999999999999995
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=261.55 Aligned_cols=168 Identities=26% Similarity=0.461 Sum_probs=138.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC--cEEEEecCCccccccccC----ccccccCCCccccchh
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG--EVKIVDFGLSRETANTFD----KKKTFLGSPSWMAPEI 75 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~ 75 (488)
++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....... ......||+.|+|||+
T Consensus 166 ~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 245 (345)
T 3hko_A 166 REKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchh
Confidence 4678899999999999999999999999999999998776 899999999976533211 2345679999999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
+.+. ...++.++|||||||++|+|++|..||.+........++....... .+....+++.+.+||.+||..||.+|
T Consensus 246 ~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 246 LNTT---NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HTCS---SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred hccC---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 8642 2468899999999999999999999999988877777777654322 22233479999999999999999999
Q ss_pred CCHHHHhcCcCCCCCCCC
Q psy9090 155 PYMSELLEHPFITSLPEN 172 (488)
Q Consensus 155 ps~~ell~hp~f~~~~~~ 172 (488)
||+.++++||||+++.+.
T Consensus 323 ps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 323 FDAMRALQHPWISQFSDK 340 (345)
T ss_dssp CCHHHHHHSHHHHTTSSC
T ss_pred CCHHHHhcChhhccChHh
Confidence 999999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=261.73 Aligned_cols=154 Identities=23% Similarity=0.503 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+
T Consensus 127 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-- 203 (335)
T 3dls_A 127 LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMG-- 203 (335)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC-CceeccCCCccccChhhhcC--
Confidence 578999999999999999999999999999999999999999999999999866543 33445679999999999976
Q ss_pred cCCCCC-CCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGY-DNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~-~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..+ +.++|||||||++|+|++|..||..... ... .....+..+++.+.+||.+||..||.+|||+.+
T Consensus 204 ---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~---~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e 271 (335)
T 3dls_A 204 ---NPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE---AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEK 271 (335)
T ss_dssp ---CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT---TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh---hccCCCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 344 7889999999999999999999976332 111 122234567999999999999999999999999
Q ss_pred HhcCcCCCCC
Q psy9090 160 LLEHPFITSL 169 (488)
Q Consensus 160 ll~hp~f~~~ 169 (488)
+++||||++.
T Consensus 272 ll~hp~~~~~ 281 (335)
T 3dls_A 272 LVTDPWVTQP 281 (335)
T ss_dssp HHHCTTTTCC
T ss_pred HhcCccccCC
Confidence 9999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=268.21 Aligned_cols=163 Identities=23% Similarity=0.451 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 124 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-- 200 (371)
T 2xrw_A 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG-- 200 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----------------CTTCCHHHHTT--
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc-cccCCceecCCccCHHHhcC--
Confidence 578899999999999999999999999999999999999999999999999765432 23345679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC---------------------C---------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL---------------------Y--------- 130 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---------------------~--------- 130 (488)
..|+.++|||||||++|+|++|..||.+.+....+..+......+. .
T Consensus 201 ---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (371)
T 2xrw_A 201 ---MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP 277 (371)
T ss_dssp ---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSC
T ss_pred ---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcc
Confidence 5688999999999999999999999998887766666654321110 0
Q ss_pred ---CCC------CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 131 ---RAS------NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 131 ---~~~------~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
.+. ..++.+++||.+||..||.+|||++++++||||+..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 278 DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp GGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 000 014678999999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=250.72 Aligned_cols=166 Identities=20% Similarity=0.366 Sum_probs=134.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... .......||+.|+|||++.+
T Consensus 102 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 181 (276)
T 2yex_A 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc
Confidence 5788999999999999999999999999999999999999999999999987653221 22345678999999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
. ..++.++|+||||+++|+|++|..||.........................+++.+.+||.+||..||.+|||+.
T Consensus 182 ~----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 257 (276)
T 2yex_A 182 R----EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257 (276)
T ss_dssp S----SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred C----CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHH
Confidence 2 223678999999999999999999998765432222322222222223456799999999999999999999999
Q ss_pred HHhcCcCCCCCC
Q psy9090 159 ELLEHPFITSLP 170 (488)
Q Consensus 159 ell~hp~f~~~~ 170 (488)
++++||||+...
T Consensus 258 ~il~~~~~~~~~ 269 (276)
T 2yex_A 258 DIKKDRWYNKPL 269 (276)
T ss_dssp HHTTCTTTTCCC
T ss_pred HHhcCccccChh
Confidence 999999998753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=262.54 Aligned_cols=167 Identities=27% Similarity=0.436 Sum_probs=137.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--HCCCeecccCCCCEEEcc-CCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLH--ENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|||+++..... .......||+.|+|||++.
T Consensus 126 ~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 204 (360)
T 3e3p_A 126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIF 204 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC-CCcccccCCcceeCHHHHc
Confidence 467889999999999999999 999999999999999996 899999999999876543 3344567899999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC----------------C------------
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG----------------L------------ 129 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------------~------------ 129 (488)
+. ..++.++|||||||++|+|++|.+||.+.........+.+....+ .
T Consensus 205 ~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
T 3e3p_A 205 GN----QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVF 280 (360)
T ss_dssp TC----SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHT
T ss_pred CC----CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCccccc
Confidence 52 458899999999999999999999999888776666654310000 0
Q ss_pred -CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 130 -YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 130 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
......++.+++||.+||..||.+|||+.++++||||+++...
T Consensus 281 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 281 SDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp TTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred chhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 0112246789999999999999999999999999999987554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=262.04 Aligned_cols=167 Identities=30% Similarity=0.573 Sum_probs=139.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .......||+.|+|||++.+..
T Consensus 197 l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 275 (365)
T 2y7j_A 197 LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSM 275 (365)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccc
Confidence 578899999999999999999999999999999999999999999999998766543 3345668999999999986521
Q ss_pred c-CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 K-EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~-~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
. ....++.++|||||||++|+|++|..||...........+....... .+.....++.+.+||.+||..||++|||+.
T Consensus 276 ~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 355 (365)
T 2y7j_A 276 DETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAE 355 (365)
T ss_dssp CTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred cccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 1 12358889999999999999999999998887766666655543221 112246789999999999999999999999
Q ss_pred HHhcCcCCCC
Q psy9090 159 ELLEHPFITS 168 (488)
Q Consensus 159 ell~hp~f~~ 168 (488)
++++||||+.
T Consensus 356 ell~hp~f~r 365 (365)
T 2y7j_A 356 QALQHPFFER 365 (365)
T ss_dssp HHHHSGGGCC
T ss_pred HHhcCcccCC
Confidence 9999999963
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=266.61 Aligned_cols=162 Identities=29% Similarity=0.484 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--HCCCeecccCCCCEEEc--cCCcEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLH--ENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~--~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||+++.... ......||+.|+|||++
T Consensus 154 ~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~ 230 (382)
T 2vx3_A 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVL 230 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc---ccccccCCccccChHHH
Confidence 578899999999999999999 57999999999999995 477899999999976643 23456899999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC--CCCCC-------------------------
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN--PPPGL------------------------- 129 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~--~~~~~------------------------- 129 (488)
.+ ..|+.++|||||||++|+|++|++||.+......+..+... .++..
T Consensus 231 ~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (382)
T 2vx3_A 231 LG-----MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKT 305 (382)
T ss_dssp TT-----CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCC
T ss_pred cC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccc
Confidence 86 56899999999999999999999999988877666555431 00000
Q ss_pred ------CCCCC----------------------------cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 130 ------YRASN----------------------------WSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 130 ------~~~~~----------------------------~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
..+.. .++.+++||.+||..||++|||++++|+||||++..
T Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 306 KDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp CTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred cccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence 00000 013789999999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=260.32 Aligned_cols=162 Identities=20% Similarity=0.306 Sum_probs=118.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC--------CCeecccCCCCEEEccCCcEEEEecCCccccccccC----ccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN--------HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~--------givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~ 68 (488)
++++.+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++....... .....+||+
T Consensus 97 l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~ 176 (303)
T 3hmm_A 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccc
Confidence 46788999999999999999987 999999999999999999999999999986543321 223458999
Q ss_pred ccccchhhccccc-CCCCCCCccchhhhHHHHHHHhcCCCCCCCCC--------------hHHHHHHHHh-CC-CCCCC-
Q psy9090 69 SWMAPEIMRCGHK-EVDGYDNRIDVWALGITAIELGDGKPPFEDMH--------------PTRALFQIVR-NP-PPGLY- 130 (488)
Q Consensus 69 ~y~aPE~l~~~~~-~~~~~~~~~DiwslGvil~elltg~~Pf~~~~--------------~~~~~~~~~~-~~-~~~~~- 130 (488)
.|+|||++.+... ....|+.++|||||||++|||+||.+||.... ....+.+.+. .. .|..+
T Consensus 177 ~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~ 256 (303)
T 3hmm_A 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 256 (303)
T ss_dssp GGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred cccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCc
Confidence 9999999975211 01246789999999999999999987653211 1122333322 21 12221
Q ss_pred --CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy9090 131 --RASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 131 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 162 (488)
.....++.+.+|+.+||..||++|||+.++++
T Consensus 257 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 257 RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11123456889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=261.61 Aligned_cols=165 Identities=30% Similarity=0.543 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||+.|+|||++.+.
T Consensus 121 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 199 (331)
T 4aaa_A 121 LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD- 199 (331)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCC-
Confidence 5788999999999999999999999999999999999999999999999997665443444566799999999999752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---------------------CCCCCC-------CC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---------------------PPPGLY-------RA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---------------------~~~~~~-------~~ 132 (488)
..++.++|||||||++|+|++|.+||.+.........+... ..+... ..
T Consensus 200 ---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
T 4aaa_A 200 ---VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRY 276 (331)
T ss_dssp ---TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHS
T ss_pred ---CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcc
Confidence 36889999999999999999999999988776655544321 000000 12
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 277 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 277 PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 3568999999999999999999999999999999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=252.68 Aligned_cols=159 Identities=29% Similarity=0.524 Sum_probs=137.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..... .......|++.|+|||++.+
T Consensus 111 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~-- 186 (284)
T 2vgo_A 111 FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEG-- 186 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--SCBCCCCSCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc--cccccccCCCCcCCHHHhcc--
Confidence 57889999999999999999999999999999999999999999999999865543 22345679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||||+++|+|++|..||...........+..... ..+..++..++++|.+||..||.+|||++++
T Consensus 187 ---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 260 (284)
T 2vgo_A 187 ---KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260 (284)
T ss_dssp ---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ---CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHH
Confidence 5678899999999999999999999998877666655554322 2345689999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++||||+..
T Consensus 261 l~h~~~~~~ 269 (284)
T 2vgo_A 261 MEHPWVKAN 269 (284)
T ss_dssp HTCHHHHHH
T ss_pred hhCHHHHhh
Confidence 999999754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=261.58 Aligned_cols=166 Identities=30% Similarity=0.497 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+.
T Consensus 131 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~- 208 (362)
T 3pg1_A 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQF- 208 (362)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCC-
Confidence 578899999999999999999999999999999999999999999999999754433 233456789999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC-----------------------CCCCC------CC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN-----------------------PPPGL------YR 131 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~-----------------------~~~~~------~~ 131 (488)
..++.++|||||||++|+|++|..||.+.........+... ..... ..
T Consensus 209 ---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
T 3pg1_A 209 ---KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAV 285 (362)
T ss_dssp ---TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHH
T ss_pred ---CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhh
Confidence 45889999999999999999999999988766655554321 00000 01
Q ss_pred CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 132 ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 132 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
....++.+.+||.+||..||.+|||+.++++||||+++..
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 286 VPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp STTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 2345888999999999999999999999999999998743
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-30 Score=251.66 Aligned_cols=172 Identities=28% Similarity=0.521 Sum_probs=140.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .......||+.|+|||++.+..
T Consensus 121 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 199 (298)
T 1phk_A 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSM 199 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCC-cccccccCCccccCHHHhcccc
Confidence 578899999999999999999999999999999999999999999999999765543 3344567999999999986311
Q ss_pred c-CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 K-EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~-~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
. ....++.++||||||+++|+|++|..||...........+....... ......+++.+.+||.+||..||.+|||+.
T Consensus 200 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (298)
T 1phk_A 200 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279 (298)
T ss_dssp CTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred ccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHH
Confidence 1 12457889999999999999999999998887766666655543221 122246789999999999999999999999
Q ss_pred HHhcCcCCCCCCCCc
Q psy9090 159 ELLEHPFITSLPEND 173 (488)
Q Consensus 159 ell~hp~f~~~~~~~ 173 (488)
++++||||++..++.
T Consensus 280 ~ll~h~~~~~~~~~~ 294 (298)
T 1phk_A 280 EALAHPFFQQYVVEE 294 (298)
T ss_dssp HHTTSGGGCTTC---
T ss_pred HHHhChHhhhccchh
Confidence 999999999876554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=258.32 Aligned_cols=171 Identities=26% Similarity=0.425 Sum_probs=126.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc---EEEEecCCcccccccc-------CccccccCCCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRETANTF-------DKKKTFLGSPSW 70 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y 70 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....... ......+||+.|
T Consensus 108 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y 187 (316)
T 2ac3_A 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCc
Confidence 578899999999999999999999999999999999998776 9999999987543211 112345699999
Q ss_pred ccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---------------HHHHHHHHhCCCCCCC--CCC
Q psy9090 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---------------TRALFQIVRNPPPGLY--RAS 133 (488)
Q Consensus 71 ~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---------------~~~~~~~~~~~~~~~~--~~~ 133 (488)
+|||++.........++.++|||||||++|+|++|..||.+... ......+..... ..+ ...
T Consensus 188 ~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~ 266 (316)
T 2ac3_A 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKDWA 266 (316)
T ss_dssp CCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC-CCCHHHHT
T ss_pred cChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc-ccCchhcc
Confidence 99999864211113478899999999999999999999976532 122233333221 111 113
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
.+++.+++||.+||..||.+|||+.++++||||+...+.
T Consensus 267 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305 (316)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence 578999999999999999999999999999999976543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=250.66 Aligned_cols=161 Identities=26% Similarity=0.442 Sum_probs=137.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE---ccCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL---TKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...... .......||+.|+|||++.
T Consensus 103 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~ 181 (277)
T 3f3z_A 103 FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLE 181 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cchhccCCCCCccChHHhc
Confidence 5788999999999999999999999999999999999 78889999999999766543 3345567999999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL-YRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ .++.++||||||+++|+|++|..||...........+........ .....+++.+.+||.+||..||.+|||
T Consensus 182 ~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s 255 (277)
T 3f3z_A 182 G------LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT 255 (277)
T ss_dssp T------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred c------cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcC
Confidence 4 478899999999999999999999999887777777666533211 112357999999999999999999999
Q ss_pred HHHHhcCcCCCC
Q psy9090 157 MSELLEHPFITS 168 (488)
Q Consensus 157 ~~ell~hp~f~~ 168 (488)
+.++++||||++
T Consensus 256 ~~~~l~h~~~~~ 267 (277)
T 3f3z_A 256 SLQALEHEWFEK 267 (277)
T ss_dssp HHHHTTSHHHHH
T ss_pred HHHHhcCHHHhc
Confidence 999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=258.03 Aligned_cols=162 Identities=28% Similarity=0.497 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-------------------CCcEEEEecCCccccccccCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-------------------DGEVKIVDFGLSRETANTFDKK 61 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-------------------~~~vkL~Dfg~a~~~~~~~~~~ 61 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... ..
T Consensus 115 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~ 191 (339)
T 1z57_A 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE---HH 191 (339)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS---CC
T ss_pred CcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc---cc
Confidence 468899999999999999999999999999999999987 66899999999876432 23
Q ss_pred ccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh--CCCCC-----------
Q psy9090 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR--NPPPG----------- 128 (488)
Q Consensus 62 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~--~~~~~----------- 128 (488)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.. ...+.
T Consensus 192 ~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 266 (339)
T 1z57_A 192 STLVSTRHYRAPEVILA-----LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKY 266 (339)
T ss_dssp CSSCSCGGGCCHHHHTT-----SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGG
T ss_pred ccccCCccccChHHhhC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhH
Confidence 45679999999999976 5689999999999999999999999988776554433321 11110
Q ss_pred ----------------------------CCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 129 ----------------------------LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 129 ----------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
.......++.+.+||.+||..||.+|||+.++++||||+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 267 FHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp EETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 001112356788999999999999999999999999998754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=251.75 Aligned_cols=162 Identities=35% Similarity=0.590 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..............||+.|+|||++.+
T Consensus 112 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 189 (294)
T 2rku_A 112 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-- 189 (294)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhcc--
Confidence 578899999999999999999999999999999999999999999999999876543344455679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++|+||||+++|+|++|..||...........+..... ..+..+++.+.++|.+||..||++|||++++
T Consensus 190 ---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 263 (294)
T 2rku_A 190 ---KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---SIPKHINPVAASLIQKMLQTDPTARPTINEL 263 (294)
T ss_dssp ---SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---CCccccCHHHHHHHHHHcccChhhCcCHHHH
Confidence 5678899999999999999999999998876666555554322 2355789999999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
++||||.+..
T Consensus 264 l~~~~~~~~~ 273 (294)
T 2rku_A 264 LNDEFFTSGY 273 (294)
T ss_dssp GGSHHHHTSC
T ss_pred hhChheecCC
Confidence 9999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=258.11 Aligned_cols=168 Identities=28% Similarity=0.487 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC----------ccccccCCCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----------KKKTFLGSPSW 70 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~----------~~~~~~gt~~y 70 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......||+.|
T Consensus 109 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 188 (353)
T 2b9h_A 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccc
Confidence 57889999999999999999999999999999999999999999999999976542211 12235789999
Q ss_pred ccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCC--------------------C
Q psy9090 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPP--------------------P 127 (488)
Q Consensus 71 ~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~--------------------~ 127 (488)
+|||++... ..++.++|||||||++|+|++|.+||.+.........+.. .+. +
T Consensus 189 ~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (353)
T 2b9h_A 189 RAPEVMLTS----AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLP 264 (353)
T ss_dssp CCHHHHHSC----CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSC
T ss_pred cCCeeeccC----CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhccc
Confidence 999988642 5688999999999999999999999998876554443322 110 0
Q ss_pred CCC------CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 128 GLY------RASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 128 ~~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
... ....+++.+.+||.+||..||++|||+.++++||||+...+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 265 MYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp CCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred CCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 000 023578999999999999999999999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=267.92 Aligned_cols=166 Identities=28% Similarity=0.520 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC---cEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG---EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ......+||+.|+|||++.
T Consensus 236 ~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 314 (419)
T 3i6u_A 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLV 314 (419)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeee
Confidence 57899999999999999999999999999999999997654 4999999999876543 3345678999999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCC--CCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLY--RASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
+.. ...|+.++|||||||++|+|++|.+||............+........ ....+++.+.+||.+||..||.+||
T Consensus 315 ~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 392 (419)
T 3i6u_A 315 SVG--TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 392 (419)
T ss_dssp ------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred cCC--CCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCc
Confidence 411 156788999999999999999999999765433223333332221111 1245799999999999999999999
Q ss_pred CHHHHhcCcCCCCC
Q psy9090 156 YMSELLEHPFITSL 169 (488)
Q Consensus 156 s~~ell~hp~f~~~ 169 (488)
|++++++||||+..
T Consensus 393 s~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 393 TTEEALRHPWLQDE 406 (419)
T ss_dssp CHHHHHHSGGGCCH
T ss_pred CHHHHhCCcccCCh
Confidence 99999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-31 Score=271.03 Aligned_cols=156 Identities=17% Similarity=0.184 Sum_probs=125.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc---
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG--- 79 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~--- 79 (488)
+..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+.
T Consensus 205 ~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~ 280 (377)
T 3byv_A 205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATI 280 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTST
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccc
Confidence 477888999999999999999999999999999999999999999999986432 3345577 999999999762
Q ss_pred ---ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 80 ---HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 80 ---~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
......|+.++|||||||++|+|++|+.||.+.........+. .....+++.+.+||.+||..||.+|||
T Consensus 281 ~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 281 SYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-------RSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-------SSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred cccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-------hhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 0000168999999999999999999999997654322211111 123567999999999999999999999
Q ss_pred HHHHhcCcCCCCC
Q psy9090 157 MSELLEHPFITSL 169 (488)
Q Consensus 157 ~~ell~hp~f~~~ 169 (488)
+.++++||||+++
T Consensus 354 ~~e~l~hp~f~~~ 366 (377)
T 3byv_A 354 PLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHTSHHHHHH
T ss_pred HHHHhhChHHHHH
Confidence 9999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=254.38 Aligned_cols=168 Identities=33% Similarity=0.629 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+|||++...... .......||+.|+|||++...
T Consensus 121 ~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 199 (318)
T 2dyl_A 121 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPP 199 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-ccccccCCCccccChhhcccc
Confidence 57889999999999999999995 9999999999999999999999999998765433 233455799999999999643
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCC-ChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDM-HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
......++.++|||||||++|+|++|..||... ........+.....+..+....+++.+.+||.+||..||.+|||+.
T Consensus 200 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (318)
T 2dyl_A 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYN 279 (318)
T ss_dssp ------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred cccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 222356889999999999999999999999874 4445566666665555544556899999999999999999999999
Q ss_pred HHhcCcCCCCC
Q psy9090 159 ELLEHPFITSL 169 (488)
Q Consensus 159 ell~hp~f~~~ 169 (488)
++++||||+..
T Consensus 280 ~ll~h~~~~~~ 290 (318)
T 2dyl_A 280 KLLEHSFIKRY 290 (318)
T ss_dssp HHTTSHHHHHH
T ss_pred HHhhCHHHHhc
Confidence 99999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=257.29 Aligned_cols=162 Identities=35% Similarity=0.590 Sum_probs=140.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||+.|+|||++.+
T Consensus 138 l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 215 (335)
T 2owb_A 138 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-- 215 (335)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhcc--
Confidence 578899999999999999999999999999999999999999999999999876543344456679999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++||||||+++|+|++|..||...........+..... ..+..+++.+.+||.+||..||.+|||+.++
T Consensus 216 ---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 289 (335)
T 2owb_A 216 ---KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---SIPKHINPVAASLIQKMLQTDPTARPTINEL 289 (335)
T ss_dssp ---SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred ---CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 5678899999999999999999999998876666655555432 2345689999999999999999999999999
Q ss_pred hcCcCCCCCC
Q psy9090 161 LEHPFITSLP 170 (488)
Q Consensus 161 l~hp~f~~~~ 170 (488)
++||||.+..
T Consensus 290 l~~~~~~~~~ 299 (335)
T 2owb_A 290 LNDEFFTSGY 299 (335)
T ss_dssp GGSHHHHTSC
T ss_pred hcCccccCCC
Confidence 9999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=251.97 Aligned_cols=161 Identities=46% Similarity=0.910 Sum_probs=140.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..............||+.|+|||++.+
T Consensus 116 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 193 (303)
T 3a7i_A 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-- 193 (303)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhc--
Confidence 578899999999999999999999999999999999999999999999999776544334456689999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++||||||+++|+|++|..||...........+.....+. .+..++..+.+||.+||..||.+|||+.++
T Consensus 194 ---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 268 (303)
T 3a7i_A 194 ---SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT--LEGNYSKPLKEFVEACLNKEPSFRPTAKEL 268 (303)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCSSCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ---CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC--CccccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 567889999999999999999999999888776666665554333 345789999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
++||||..
T Consensus 269 l~~~~~~~ 276 (303)
T 3a7i_A 269 LKHKFILR 276 (303)
T ss_dssp TTCHHHHH
T ss_pred hhChhhhc
Confidence 99999965
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-31 Score=270.73 Aligned_cols=159 Identities=13% Similarity=0.197 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccccCCCCC
Q psy9090 7 AFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGY 86 (488)
Q Consensus 7 ~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~ 86 (488)
..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... .....+|+.|+|||++.+. ...|
T Consensus 197 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~---~~~~ 270 (371)
T 3q60_A 197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNAS---TATF 270 (371)
T ss_dssp HHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCS---EEEC
T ss_pred HHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCC---CCCc
Confidence 455699999999999999999999999999999999999999999865432 2245677999999999641 1458
Q ss_pred CCccchhhhHHHHHHHhcCCCCCCCCChHHHH--HH----HHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 87 DNRIDVWALGITAIELGDGKPPFEDMHPTRAL--FQ----IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 87 ~~~~DiwslGvil~elltg~~Pf~~~~~~~~~--~~----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
+.++|||||||++|+|++|+.||.+..+.... .. ..............+++.+.+||.+||..||++|||+.++
T Consensus 271 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 271 THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350 (371)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 89999999999999999999999776432100 00 0001111222235779999999999999999999999999
Q ss_pred hcCcCCCCCCC
Q psy9090 161 LEHPFITSLPE 171 (488)
Q Consensus 161 l~hp~f~~~~~ 171 (488)
++||||+++.+
T Consensus 351 l~hp~f~~~~~ 361 (371)
T 3q60_A 351 METPEFLQLQN 361 (371)
T ss_dssp TTSHHHHHHHH
T ss_pred hcCHHHHHHHH
Confidence 99999987544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=252.18 Aligned_cols=162 Identities=29% Similarity=0.540 Sum_probs=138.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE---ccCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL---TKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .......||+.|+|||++.
T Consensus 103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~ 180 (304)
T 2jam_A 103 YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLA 180 (304)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--BTTHHHHSCCCBCCTTTBS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--CccccccCCCCccChHHhc
Confidence 5788999999999999999999999999999999999 7788999999999875433 2234457999999999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|||||||++|+|++|..||...........+...... .......+++.+.+||.+||..||.+|||
T Consensus 181 ~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 255 (304)
T 2jam_A 181 Q-----KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT 255 (304)
T ss_dssp S-----CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCC
T ss_pred c-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC
Confidence 6 56889999999999999999999999988877766666654322 12234567999999999999999999999
Q ss_pred HHHHhcCcCCCCC
Q psy9090 157 MSELLEHPFITSL 169 (488)
Q Consensus 157 ~~ell~hp~f~~~ 169 (488)
+.++++||||...
T Consensus 256 ~~~~l~h~~~~~~ 268 (304)
T 2jam_A 256 CEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHTSHHHHSS
T ss_pred HHHHhcCccccCC
Confidence 9999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=252.67 Aligned_cols=168 Identities=42% Similarity=0.799 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-----CccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-----DKKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~ 75 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... .......||+.|+|||+
T Consensus 118 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (303)
T 2vwi_A 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197 (303)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHH
Confidence 4788999999999999999999999999999999999999999999999886543221 12234579999999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCC-------CCCCcCHHHHHHHHHhcc
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLY-------RASNWSQHYVDFIAECLE 148 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~~li~~~L~ 148 (488)
+.+. ..++.++||||||+++|+|++|..||.................+... ....+++.+.++|.+||.
T Consensus 198 ~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 273 (303)
T 2vwi_A 198 MEQV----RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQ 273 (303)
T ss_dssp HHHH----HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCC
T ss_pred hccc----cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHcc
Confidence 8642 35788999999999999999999999887766555555443322211 134578999999999999
Q ss_pred cCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 149 KNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 149 ~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
.||.+|||+.++++||||++..+.
T Consensus 274 ~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 274 KDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp SSGGGSCCHHHHHTSTTC------
T ss_pred CChhhCcCHHHHhhChhhhcCCCC
Confidence 999999999999999999886554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=250.93 Aligned_cols=164 Identities=37% Similarity=0.720 Sum_probs=130.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-CCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++..............||+.|+|||++.+..
T Consensus 120 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 199 (295)
T 2clq_A 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199 (295)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGG
T ss_pred cHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCC
Confidence 57889999999999999999999999999999999987 89999999999976654333345567999999999987521
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH-HHHH-HhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA-LFQI-VRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||||+++|+|++|..||........ .... .....+. .+..+++.+.++|.+||..||++|||+.
T Consensus 200 ---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~ 274 (295)
T 2clq_A 200 ---RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE--IPESMSAEAKAFILKCFEPDPDKRACAN 274 (295)
T ss_dssp ---GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC--CCTTSCHHHHHHHHHTTCSSTTTSCCHH
T ss_pred ---CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc--ccccCCHHHHHHHHHHccCChhhCCCHH
Confidence 2378899999999999999999999976433222 2221 2222222 3467899999999999999999999999
Q ss_pred HHhcCcCCCCCC
Q psy9090 159 ELLEHPFITSLP 170 (488)
Q Consensus 159 ell~hp~f~~~~ 170 (488)
++++||||+...
T Consensus 275 ~ll~~~~~~~~~ 286 (295)
T 2clq_A 275 DLLVDEFLKVSS 286 (295)
T ss_dssp HHHTSGGGCC--
T ss_pred HHhcChhhhhcc
Confidence 999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=248.61 Aligned_cols=165 Identities=22% Similarity=0.375 Sum_probs=138.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ........||+.|+|||++.+
T Consensus 106 ~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (305)
T 2wtk_C 106 FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185 (305)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccC
Confidence 578899999999999999999999999999999999999999999999999765422 122345578999999999875
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
.. ..++.++||||||+++|+|++|..||.+.........+..... ..+..+++.+.+||.+||..||.+|||+.
T Consensus 186 ~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 259 (305)
T 2wtk_C 186 LD---TFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY---AIPGDCGPPLSDLLKGMLEYEPAKRFSIR 259 (305)
T ss_dssp CS---CEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC---CCCSSSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred cc---cCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC---CCCCccCHHHHHHHHHHccCChhhCCCHH
Confidence 21 2246789999999999999999999998877666666555432 23557899999999999999999999999
Q ss_pred HHhcCcCCCCCCC
Q psy9090 159 ELLEHPFITSLPE 171 (488)
Q Consensus 159 ell~hp~f~~~~~ 171 (488)
++++||||+....
T Consensus 260 ~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 260 QIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHSHHHHSCCC
T ss_pred HHhcCcccccCCC
Confidence 9999999987544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=264.50 Aligned_cols=160 Identities=25% Similarity=0.451 Sum_probs=127.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEccCC--------------------------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDG-------------------------------------- 41 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~-------------------------------------- 41 (488)
+++.+++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 143 ~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (397)
T 1wak_A 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLV 222 (397)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccc
Confidence 57889999999999999999998 999999999999998775
Q ss_pred -----------cEEEEecCCccccccccCccccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCC
Q psy9090 42 -----------EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE 110 (488)
Q Consensus 42 -----------~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~ 110 (488)
.+||+|||++...... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.
T Consensus 223 ~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~ 294 (397)
T 1wak_A 223 NPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIG-----SGYNTPADIWSTACMAFELATGDYLFE 294 (397)
T ss_dssp CTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHT-----SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccceEecccccccccccc---CccCCCCCcccCChhhcC-----CCCCcHHHHHHHHHHHHHHhhCCCCCC
Confidence 7999999999765432 345579999999999986 568999999999999999999999997
Q ss_pred CCCh------HHHHHHH---HhCCCC--------------------CC----------------CCCCCcCHHHHHHHHH
Q psy9090 111 DMHP------TRALFQI---VRNPPP--------------------GL----------------YRASNWSQHYVDFIAE 145 (488)
Q Consensus 111 ~~~~------~~~~~~~---~~~~~~--------------------~~----------------~~~~~~s~~~~~li~~ 145 (488)
.... ...+..+ ....+. .. ..+...++.+.+||.+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 374 (397)
T 1wak_A 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLP 374 (397)
T ss_dssp CCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGG
T ss_pred CCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHH
Confidence 5442 1222222 111100 00 0011224568899999
Q ss_pred hcccCCCCCCCHHHHhcCcCCCC
Q psy9090 146 CLEKNPEHRPYMSELLEHPFITS 168 (488)
Q Consensus 146 ~L~~dP~~Rps~~ell~hp~f~~ 168 (488)
||..||++|||+.++|+||||++
T Consensus 375 ~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 375 MLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp GGCSSGGGSCCHHHHHTSGGGGC
T ss_pred HhccChhhcCCHHHHhhCccccC
Confidence 99999999999999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=253.02 Aligned_cols=170 Identities=25% Similarity=0.439 Sum_probs=126.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......+++.|+|||++.+
T Consensus 134 ~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (323)
T 3qup_A 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD 213 (323)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence 5788999999999999999999999999999999999999999999999997654321 12223456789999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC-
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY- 156 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps- 156 (488)
..++.++|||||||++|+|++ |.+||.+.........+....... .+..+++.+.+||.+||..||.+|||
T Consensus 214 -----~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~ 286 (323)
T 3qup_A 214 -----NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK--QPPECMEEVYDLMYQCWSADPKQRPSF 286 (323)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred -----CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC--CCCccCHHHHHHHHHHccCChhhCcCH
Confidence 568899999999999999999 999999888777766666554332 35678999999999999999999999
Q ss_pred ------HHHHhcCcCCCCCCCCccccc
Q psy9090 157 ------MSELLEHPFITSLPENDLHLS 177 (488)
Q Consensus 157 ------~~ell~hp~f~~~~~~~~~~~ 177 (488)
+++++.|||+.....+++...
T Consensus 287 ~~l~~~l~~~l~~~~~~~~~~~pl~~~ 313 (323)
T 3qup_A 287 TCLRMELENILGHLSVLSTSQDPLYIN 313 (323)
T ss_dssp HHHHHHHHHHHHC--------------
T ss_pred HHHHHHHHHHHHHhhhcCCCCCCCCCC
Confidence 677889999988766655433
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=256.08 Aligned_cols=165 Identities=27% Similarity=0.448 Sum_probs=136.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||+ +|++||||||+||+++.++.+||+|||++...... ......||+.|+|||++.+.
T Consensus 148 ~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSC
T ss_pred CCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCC
Confidence 5788999999999999999999 99999999999999999999999999999765432 34456799999999999752
Q ss_pred ccCCCCCCC-ccchhhhHHHHHHHhcCCCCCCCCCh-HHHHHHHHhCCCCCCCC-----------------CCCcCHHHH
Q psy9090 80 HKEVDGYDN-RIDVWALGITAIELGDGKPPFEDMHP-TRALFQIVRNPPPGLYR-----------------ASNWSQHYV 140 (488)
Q Consensus 80 ~~~~~~~~~-~~DiwslGvil~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~-----------------~~~~s~~~~ 140 (488)
..++. ++|||||||++|+|++|..||..... ......+... ....+. ...+++.+.
T Consensus 226 ----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 300 (348)
T 2pml_X 226 ----SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300 (348)
T ss_dssp ----CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHH
T ss_pred ----CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHH
Confidence 24555 89999999999999999999988766 4444444333 222211 156789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 141 DFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 141 ~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
+||.+||..||.+|||+.++++||||++.++.
T Consensus 301 ~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~ 332 (348)
T 2pml_X 301 DFLKLFLRKNPAERITSEDALKHEWLADTNIE 332 (348)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHH
T ss_pred HHHHHHccCChhhCCCHHHHhcCccccCCCHH
Confidence 99999999999999999999999999987654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=260.08 Aligned_cols=166 Identities=30% Similarity=0.655 Sum_probs=133.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++...... ......||+.|+|||++.+
T Consensus 128 ~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~- 204 (360)
T 3eqc_A 128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG- 204 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTT-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcC-
Confidence 47889999999999999999996 9999999999999999999999999998755332 2345679999999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHH----------------------------------------
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF---------------------------------------- 119 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~---------------------------------------- 119 (488)
..++.++|||||||++|+|++|..||..........
T Consensus 205 ----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
T 3eqc_A 205 ----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280 (360)
T ss_dssp ----CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHH
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhh
Confidence 568899999999999999999999998765433211
Q ss_pred --HHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCCcc
Q psy9090 120 --QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174 (488)
Q Consensus 120 --~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~ 174 (488)
.+.....+ ......++..+.+||.+||..||.+|||++++++||||+...++.+
T Consensus 281 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 281 LDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp HHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred hhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence 11122211 1223457899999999999999999999999999999987655544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=253.19 Aligned_cols=168 Identities=26% Similarity=0.456 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc-cCCcEEEEecCCcccccccc---CccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l 76 (488)
+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...... .......+|+.|+|||++
T Consensus 117 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (320)
T 2i6l_A 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL 196 (320)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHh
Confidence 57889999999999999999999999999999999997 56789999999998654221 123345679999999998
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC---------------------------C
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG---------------------------L 129 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------------------------~ 129 (488)
... ..++.++|||||||++|+|++|+.||.+.........+....... .
T Consensus 197 ~~~----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
T 2i6l_A 197 LSP----NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT 272 (320)
T ss_dssp HCT----TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHH
T ss_pred cCc----ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChh
Confidence 642 468899999999999999999999999887766555554321100 0
Q ss_pred CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 130 YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 130 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
.....+++.+++||.+||..||.+|||+.++++||||+..++.
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 273 QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred HhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 0124578999999999999999999999999999999987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=247.66 Aligned_cols=161 Identities=26% Similarity=0.441 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .......||+.|+|||++.+.
T Consensus 108 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~- 185 (276)
T 2h6d_A 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGR- 185 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTTS-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-cceecccCCccccCHHHHcCC-
Confidence 578899999999999999999999999999999999999999999999998765443 223455789999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
...+.++|+||||+++|+|++|..||...........+..... ..+..++..+.++|.+||..||.+|||+.++
T Consensus 186 ---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 259 (276)
T 2h6d_A 186 ---LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF---YIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259 (276)
T ss_dssp ---CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---cCchhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 2235789999999999999999999988776665555554432 2345678999999999999999999999999
Q ss_pred hcCcCCCCC
Q psy9090 161 LEHPFITSL 169 (488)
Q Consensus 161 l~hp~f~~~ 169 (488)
++||||++.
T Consensus 260 l~h~~~~~~ 268 (276)
T 2h6d_A 260 REHEWFKQD 268 (276)
T ss_dssp HHSHHHHTT
T ss_pred HhChhhccC
Confidence 999999763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=255.82 Aligned_cols=159 Identities=23% Similarity=0.389 Sum_probs=126.0
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc------------CccccccCCCc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF------------DKKKTFLGSPS 69 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~------------~~~~~~~gt~~ 69 (488)
++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......||+.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 345688999999999999999999999999999999999999999999998654431 12234579999
Q ss_pred cccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhccc
Q psy9090 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEK 149 (488)
Q Consensus 70 y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 149 (488)
|+|||++.+ ..++.++|||||||++|+|++|..|+... ............+. .....++.+.+||.+||..
T Consensus 242 y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 242 YMSPEQIHG-----NNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPL--LFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp GSCHHHHHC-----CCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCH--HHHHHCHHHHHHHHHHHCS
T ss_pred ccChHHhcC-----CCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCc--ccccCChhHHHHHHHHccC
Confidence 999999976 57899999999999999999998775321 12222222222111 1234578889999999999
Q ss_pred CCCCCCCHHHHhcCcCCCCC
Q psy9090 150 NPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 150 dP~~Rps~~ell~hp~f~~~ 169 (488)
||.+|||+.++++||||+++
T Consensus 313 ~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 313 SPTERPEATDIIENAIFENL 332 (332)
T ss_dssp SGGGSCCHHHHHHSTTCCCC
T ss_pred CCCcCCCHHHHhhchhhhcC
Confidence 99999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-30 Score=248.22 Aligned_cols=161 Identities=30% Similarity=0.501 Sum_probs=136.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC-----CeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH-----VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g-----ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~ 75 (488)
+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++..............||+.|+|||+
T Consensus 108 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 187 (279)
T 2w5a_A 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHH
Confidence 578899999999999999999999 999999999999999999999999998765443222344578999999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
+.+ ..++.++||||||+++|+|++|..||...........+.....+. .+..+++.+.++|.+||..||.+||
T Consensus 188 ~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp 260 (279)
T 2w5a_A 188 MNR-----MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--IPYRYSDELNEIITRMLNLKDYHRP 260 (279)
T ss_dssp HHC-----C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hcc-----CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc--CCcccCHHHHHHHHHHcCCCcccCC
Confidence 976 568899999999999999999999999888766666666554433 3457899999999999999999999
Q ss_pred CHHHHhcCcCCCC
Q psy9090 156 YMSELLEHPFITS 168 (488)
Q Consensus 156 s~~ell~hp~f~~ 168 (488)
|+.++++|+|+..
T Consensus 261 s~~~ll~~~~~~~ 273 (279)
T 2w5a_A 261 SVEEILENPLILE 273 (279)
T ss_dssp CHHHHHTSTTCCG
T ss_pred CHHHHHhChhhhh
Confidence 9999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=250.11 Aligned_cols=165 Identities=28% Similarity=0.496 Sum_probs=135.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC----cEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG----EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++...... .......||+.|+|||++
T Consensus 105 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~ 183 (283)
T 3bhy_A 105 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIV 183 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCC-CcccccCCCcCccCccee
Confidence 57889999999999999999999999999999999998877 7999999999765443 233455799999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.+ ..++.++|+||||+++|+|++|..||.+.........+....... .......++.+.+||.+||..||.+||
T Consensus 184 ~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 258 (283)
T 3bhy_A 184 NY-----EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM 258 (283)
T ss_dssp TT-----CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred cC-----CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCc
Confidence 76 568899999999999999999999999887766655554432211 111246789999999999999999999
Q ss_pred CHHHHhcCcCCCCCCC
Q psy9090 156 YMSELLEHPFITSLPE 171 (488)
Q Consensus 156 s~~ell~hp~f~~~~~ 171 (488)
|+.++++||||+.+.+
T Consensus 259 s~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 259 TIAQSLEHSWIKAIRR 274 (283)
T ss_dssp CHHHHHHCHHHHHHHH
T ss_pred CHHHHHhCHHHHHHHH
Confidence 9999999999987543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=244.99 Aligned_cols=156 Identities=20% Similarity=0.360 Sum_probs=126.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC-------------------CcEEEEecCCccccccccCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-------------------GEVKIVDFGLSRETANTFDKK 61 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-------------------~~vkL~Dfg~a~~~~~~~~~~ 61 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++......
T Consensus 112 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---- 187 (289)
T 1x8b_A 112 FKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---- 187 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS----
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc----
Confidence 5789999999999999999999999999999999999844 47999999998765432
Q ss_pred ccccCCCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHH
Q psy9090 62 KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVD 141 (488)
Q Consensus 62 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 141 (488)
....||+.|+|||++.+. ..++.++|||||||++|+|++|.+|+.... ....+.....+. .+..+++.+.+
T Consensus 188 ~~~~gt~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~ 258 (289)
T 1x8b_A 188 QVEEGDSRFLANEVLQEN----YTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPR--IPQVLSQEFTE 258 (289)
T ss_dssp CCCCCCGGGCCHHHHTTC----CTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCCC--CSSCCCHHHHH
T ss_pred cccCCCccccChhHhcCC----CCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCCC--CCcccCHHHHH
Confidence 234689999999999752 356679999999999999999998876543 233444443333 34578999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 142 FIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 142 li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
||.+||..||.+|||+.++++||||.+.
T Consensus 259 li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 259 LLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 9999999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=248.36 Aligned_cols=167 Identities=24% Similarity=0.474 Sum_probs=127.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 124 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhh
Confidence 46789999999999999999999999999999999996 58999999999976543211 2234578999999999865
Q ss_pred ccc------CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 79 GHK------EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 79 ~~~------~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
... ....++.++||||||+++|+|++|..||...... .....+.. .......+...++.+.++|.+||..||
T Consensus 203 ~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp 281 (313)
T 3cek_A 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEFPDIPEKDLQDVLKCCLKRDP 281 (313)
T ss_dssp CC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-TTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred cccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh-cccccCCcccchHHHHHHHHHHccCCc
Confidence 211 0136788999999999999999999999876433 23333332 222223345568999999999999999
Q ss_pred CCCCCHHHHhcCcCCCCC
Q psy9090 152 EHRPYMSELLEHPFITSL 169 (488)
Q Consensus 152 ~~Rps~~ell~hp~f~~~ 169 (488)
.+|||+.++++||||+..
T Consensus 282 ~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 282 KQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp TTSCCHHHHHTSHHHHCC
T ss_pred ccCcCHHHHhcCccccCC
Confidence 999999999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=268.04 Aligned_cols=157 Identities=18% Similarity=0.184 Sum_probs=129.0
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc-
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH- 80 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~- 80 (488)
++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+..
T Consensus 209 ~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~ 284 (413)
T 3dzo_A 209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERML 284 (413)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTS
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhcccc
Confidence 45678889999999999999999999999999999999999999999998765432 445678 9999999994210
Q ss_pred ----cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 81 ----KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 81 ----~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
.....|+.++|||||||++|+|++|+.||...........+. .....+|+.+.+||.+||..||.+|||
T Consensus 285 ~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF-------RSCKNIPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp TTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG-------SSCCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH-------hhcccCCHHHHHHHHHHccCChhhCcC
Confidence 012457889999999999999999999998765433222221 123467899999999999999999999
Q ss_pred HHHHhcCcCCCCC
Q psy9090 157 MSELLEHPFITSL 169 (488)
Q Consensus 157 ~~ell~hp~f~~~ 169 (488)
+.++++||||+.+
T Consensus 358 ~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 358 PLQAMETPEYEQL 370 (413)
T ss_dssp HHHHTTSHHHHHH
T ss_pred HHHHHhCHHHHHH
Confidence 9999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-30 Score=253.08 Aligned_cols=166 Identities=30% Similarity=0.509 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc---EEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...... .......||+.|+|||++.
T Consensus 111 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc-cccccccCCcCccCchhhc
Confidence 578899999999999999999999999999999999987665 999999999765432 2233457999999999985
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH-HHHHHHhCCCCCCC-CCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR-ALFQIVRNPPPGLY-RASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
+.. ...++.++|||||||++|+|++|..||....... ....+........+ ....+++.+.+||.+||..||.+||
T Consensus 190 ~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 267 (322)
T 2ycf_A 190 SVG--TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 267 (322)
T ss_dssp HTT--TTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred cCC--CCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCC
Confidence 311 1568899999999999999999999997654322 22223332221111 1245789999999999999999999
Q ss_pred CHHHHhcCcCCCCC
Q psy9090 156 YMSELLEHPFITSL 169 (488)
Q Consensus 156 s~~ell~hp~f~~~ 169 (488)
|+.++++||||+..
T Consensus 268 s~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 268 TTEEALRHPWLQDE 281 (322)
T ss_dssp CHHHHHTSGGGCCH
T ss_pred CHHHHhhCcCcCCH
Confidence 99999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=247.46 Aligned_cols=162 Identities=30% Similarity=0.580 Sum_probs=126.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 134 ~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (309)
T 3p86_A 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213 (309)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcC
Confidence 578899999999999999999999 999999999999999999999999999765444334456689999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|||||||++|+|++|..||...........+..... ....+..+++.+.+||.+||..||.+|||+.
T Consensus 214 -----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 287 (309)
T 3p86_A 214 -----EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFA 287 (309)
T ss_dssp -----CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred -----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 5688999999999999999999999998887666655543322 2234567899999999999999999999999
Q ss_pred HHhc--CcCCCC
Q psy9090 159 ELLE--HPFITS 168 (488)
Q Consensus 159 ell~--hp~f~~ 168 (488)
++++ ++++++
T Consensus 288 ~ll~~L~~~~~~ 299 (309)
T 3p86_A 288 TIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHHC-
T ss_pred HHHHHHHHHHHh
Confidence 9987 455543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=247.49 Aligned_cols=164 Identities=32% Similarity=0.564 Sum_probs=137.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC---CcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD---GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++...... .......||+.|+|||++.
T Consensus 118 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 196 (287)
T 2wei_A 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLR 196 (287)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-CccccccCcccccChHHhc
Confidence 5788999999999999999999999999999999999764 46999999998765443 2334456899999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ .++.++|+||||+++|+|++|..||.+.........+...... .......+++.+.++|.+||..||.+|||
T Consensus 197 ~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 270 (287)
T 2wei_A 197 G------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270 (287)
T ss_dssp T------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred C------CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC
Confidence 4 4789999999999999999999999988877666666654332 22223567999999999999999999999
Q ss_pred HHHHhcCcCCCCCCC
Q psy9090 157 MSELLEHPFITSLPE 171 (488)
Q Consensus 157 ~~ell~hp~f~~~~~ 171 (488)
+.++++||||++..+
T Consensus 271 ~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 271 ATQCLEHPWIQKYSS 285 (287)
T ss_dssp HHHHHHSHHHHHHCC
T ss_pred HHHHhcCHHHhcccc
Confidence 999999999986544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=255.96 Aligned_cols=162 Identities=21% Similarity=0.360 Sum_probs=125.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEcc------CCcEEEEecCCccccccccCccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTK------DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~------~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 73 (488)
+++..++.++.||+.||+|||++ ||+||||||+|||++. .+.+||+|||++...... .....||+.|+||
T Consensus 128 ~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aP 204 (373)
T 1q8y_A 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSP 204 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCH
T ss_pred CcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCc
Confidence 57889999999999999999998 9999999999999953 347999999999765432 3445789999999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh------HHHHHHHHh--CCCCC-----------------
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP------TRALFQIVR--NPPPG----------------- 128 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~------~~~~~~~~~--~~~~~----------------- 128 (488)
|++.+ ..++.++|||||||++|+|++|..||..... ...+.++.. +..|.
T Consensus 205 E~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 279 (373)
T 1q8y_A 205 EVLLG-----APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 279 (373)
T ss_dssp HHHHT-----CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--
T ss_pred HHHhC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcc
Confidence 99986 5689999999999999999999999975431 222222211 10000
Q ss_pred --------------------CCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 129 --------------------LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 129 --------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
...+...++.+.+||.+||..||.+|||+.++++||||++..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 280 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 001123457789999999999999999999999999998753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=250.66 Aligned_cols=155 Identities=26% Similarity=0.500 Sum_probs=130.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc-cCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++.+.
T Consensus 146 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 223 (320)
T 3a99_A 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYH 223 (320)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccC
Confidence 57889999999999999999999999999999999999 7899999999999766532 33456799999999998752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|||||||++|+|++|..||.... .+.... ...+..+++.+.+||.+||..||.+|||+++
T Consensus 224 ----~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 290 (320)
T 3a99_A 224 ----RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ---VFFRQRVSSECQHLIRWCLALRPSDRPTFEE 290 (320)
T ss_dssp ----CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccc---ccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 223678999999999999999999997632 122221 1234568999999999999999999999999
Q ss_pred HhcCcCCCCCC
Q psy9090 160 LLEHPFITSLP 170 (488)
Q Consensus 160 ll~hp~f~~~~ 170 (488)
+++||||++..
T Consensus 291 ll~hp~~~~~~ 301 (320)
T 3a99_A 291 IQNHPWMQDVL 301 (320)
T ss_dssp HHTSGGGSSCC
T ss_pred HhcCHhhcCcc
Confidence 99999998764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-30 Score=263.36 Aligned_cols=166 Identities=23% Similarity=0.398 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc---C--CcEEEEecCCcccccccc---CccccccCCCccccch
Q psy9090 3 EQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---D--GEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPE 74 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~--~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE 74 (488)
+.+++.++.||+.||.|||++||+||||||+|||++. + ..+||+|||+++...... .......||+.|+|||
T Consensus 117 ~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE 196 (432)
T 3p23_A 117 GLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196 (432)
T ss_dssp SSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGG
T ss_pred chhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChh
Confidence 3456789999999999999999999999999999953 2 358899999997654321 2234567999999999
Q ss_pred hhcccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 75 IMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 75 ~l~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
++.+.. ...++.++|||||||++|+|++ |.+||........ ......... ........+..+++||.+||..||.
T Consensus 197 ~l~~~~--~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 273 (432)
T 3p23_A 197 MLSEDC--KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQ 273 (432)
T ss_dssp GTSCC-----CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGG
T ss_pred hhhccc--ccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhccCCccccCccccccHHHHHHHHHHHhCCHh
Confidence 997421 1457789999999999999999 9999976554332 223222221 1222233466789999999999999
Q ss_pred CCCCHHHHhcCcCCCCCCC
Q psy9090 153 HRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 153 ~Rps~~ell~hp~f~~~~~ 171 (488)
+|||+.++++||||+.+.+
T Consensus 274 ~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 274 KRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp GSCCHHHHHTSTTTCCHHH
T ss_pred hCCCHHHHHhCccccChHH
Confidence 9999999999999987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=255.93 Aligned_cols=161 Identities=29% Similarity=0.473 Sum_probs=109.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc---CCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..... .......||+.|+|||++.
T Consensus 125 l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~ 202 (336)
T 3fhr_A 125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLG 202 (336)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc--cccccCCCCcCccChhhhC
Confidence 578899999999999999999999999999999999986 44599999999976543 2334567899999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHH---hCC--CCCCCCCCCcCHHHHHHHHHhcccCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV---RNP--PPGLYRASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~---~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~ 152 (488)
+ ..++.++|||||||++|+|++|..||............. ... ..+......+++.+++||.+||..||.
T Consensus 203 ~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 277 (336)
T 3fhr_A 203 P-----EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPT 277 (336)
T ss_dssp ------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGG
T ss_pred C-----CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChh
Confidence 5 567889999999999999999999997655433211111 111 111122346799999999999999999
Q ss_pred CCCCHHHHhcCcCCCC
Q psy9090 153 HRPYMSELLEHPFITS 168 (488)
Q Consensus 153 ~Rps~~ell~hp~f~~ 168 (488)
+|||+.++++||||+.
T Consensus 278 ~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 278 ERLTITQFMNHPWINQ 293 (336)
T ss_dssp GSCCHHHHHHSHHHHT
T ss_pred HCcCHHHHhcCccccc
Confidence 9999999999999976
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=250.79 Aligned_cols=164 Identities=27% Similarity=0.502 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 192 (311)
T 3ork_A 113 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhc
Confidence 5788999999999999999999999999999999999999999999999997654321 1233457899999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|||||||++|+|++|..||.+........+....... .......+++.+.++|.+||..||.+||+
T Consensus 193 ~-----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~ 267 (311)
T 3ork_A 193 G-----DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 267 (311)
T ss_dssp T-----CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCS
T ss_pred C-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChh
Confidence 6 57889999999999999999999999998877776666654322 22224568999999999999999999999
Q ss_pred HHHHhcCcCCCCC
Q psy9090 157 MSELLEHPFITSL 169 (488)
Q Consensus 157 ~~ell~hp~f~~~ 169 (488)
..+++.|+|++..
T Consensus 268 ~~~~l~~~l~~~~ 280 (311)
T 3ork_A 268 TAAEMRADLVRVH 280 (311)
T ss_dssp SHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHh
Confidence 9999999998743
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=249.40 Aligned_cols=170 Identities=36% Similarity=0.661 Sum_probs=114.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN-HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++...
T Consensus 122 ~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 200 (327)
T 3aln_A 122 IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPS 200 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------
T ss_pred CcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc-cccccCCCCccccCceeeccc
Confidence 47889999999999999999999 9999999999999999999999999999766443 223344799999999998431
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-HHHHHHHhCCCCCCC--CCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVRNPPPGLY--RASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
. ....++.++|||||||++|+|++|..||...... .....+.....+... ....+++.+.+||.+||..||.+|||
T Consensus 201 ~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 279 (327)
T 3aln_A 201 A-SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK 279 (327)
T ss_dssp ------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred c-CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcC
Confidence 1 1156889999999999999999999999875432 112222222222211 12457899999999999999999999
Q ss_pred HHHHhcCcCCCCCCCC
Q psy9090 157 MSELLEHPFITSLPEN 172 (488)
Q Consensus 157 ~~ell~hp~f~~~~~~ 172 (488)
+.++++||||....+.
T Consensus 280 ~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 280 YKELLKHPFILMYEER 295 (327)
T ss_dssp HHHHTTSHHHHHHHHS
T ss_pred HHHHHhChHHHHhHhh
Confidence 9999999999765443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=250.10 Aligned_cols=156 Identities=27% Similarity=0.473 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+
T Consensus 200 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 279 (370)
T 2psq_A 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 279 (370)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence 4678899999999999999999999999999999999999999999999998654321 12234467889999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|+|++ |..||.+.........+.....+. .+..+++.+.++|.+||..||.+|||+
T Consensus 280 -----~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~ 352 (370)
T 2psq_A 280 -----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD--KPANCTNELYMMMRDCWHAVPSQRPTF 352 (370)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 678999999999999999999 999999887666655555543332 356789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 353 ~ell~~ 358 (370)
T 2psq_A 353 KQLVED 358 (370)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=241.39 Aligned_cols=162 Identities=22% Similarity=0.410 Sum_probs=122.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--------------cCccccccCC
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--------------FDKKKTFLGS 67 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--------------~~~~~~~~gt 67 (488)
++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ........||
T Consensus 114 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (303)
T 1zy4_A 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGT 193 (303)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------
T ss_pred chHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCc
Confidence 57889999999999999999999999999999999999999999999998765321 1122345789
Q ss_pred CccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC--CCCCCCcCHHHHHHHHH
Q psy9090 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG--LYRASNWSQHYVDFIAE 145 (488)
Q Consensus 68 ~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~li~~ 145 (488)
+.|+|||++.+. ..++.++|||||||++|+|++ ||............+...... ...+...++.++++|.+
T Consensus 194 ~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 266 (303)
T 1zy4_A 194 AMYVATEVLDGT----GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL 266 (303)
T ss_dssp CTTSCHHHHTSC----SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHH
T ss_pred ccccCcccccCC----CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHH
Confidence 999999998752 468899999999999999998 554332222223333322111 11234567889999999
Q ss_pred hcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 146 CLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 146 ~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
||..||.+|||+.++++||||+...
T Consensus 267 ~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 267 LIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHhcCcccCcCHHHHhCCCCcCCCC
Confidence 9999999999999999999997643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-29 Score=246.67 Aligned_cols=164 Identities=20% Similarity=0.476 Sum_probs=128.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE----ccCCcEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL----TKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..... .......||+.|+|||++
T Consensus 109 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~ 187 (319)
T 4euu_A 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMY 187 (319)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC-CceeecccCCCccCHHHh
Confidence 5788999999999999999999999999999999999 77888999999999876543 334456799999999998
Q ss_pred cccc---cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC----hHHHHHHHHhCCCCC------------------CCC
Q psy9090 77 RCGH---KEVDGYDNRIDVWALGITAIELGDGKPPFEDMH----PTRALFQIVRNPPPG------------------LYR 131 (488)
Q Consensus 77 ~~~~---~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~----~~~~~~~~~~~~~~~------------------~~~ 131 (488)
.... .....++.++|||||||++|+|++|..||.... ....+..+....++. .+.
T Consensus 188 ~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 267 (319)
T 4euu_A 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267 (319)
T ss_dssp HHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCT
T ss_pred hhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCc
Confidence 6310 012568899999999999999999999996432 234445554433211 111
Q ss_pred ----CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcC
Q psy9090 132 ----ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPF 165 (488)
Q Consensus 132 ----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 165 (488)
...+++.+.+||.+||..||++|||++++++||-
T Consensus 268 ~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 268 SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1223567889999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=245.53 Aligned_cols=156 Identities=23% Similarity=0.367 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 112 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (325)
T 3kex_A 112 LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191 (325)
T ss_dssp SCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc
Confidence 46788999999999999999999999999999999999999999999999986543211 2244567889999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+.........+...... ..+..++..+.++|.+||..||.+|||+
T Consensus 192 -----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~ 264 (325)
T 3kex_A 192 -----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENIRPTF 264 (325)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC--CCCTTBCTTTTHHHHHHTCSCTTTSCCH
T ss_pred -----CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC--CCCCcCcHHHHHHHHHHcCCChhhCcCH
Confidence 568999999999999999999 99999887766655555544322 2345678899999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 265 ~el~~~ 270 (325)
T 3kex_A 265 KELANE 270 (325)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=244.05 Aligned_cols=157 Identities=19% Similarity=0.367 Sum_probs=125.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE---ccCCcEEEEecCCccccccccC-------ccccccCCCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL---TKDGEVKIVDFGLSRETANTFD-------KKKTFLGSPSW 70 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y 70 (488)
+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|
T Consensus 102 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y 181 (296)
T 4hgt_A 102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181 (296)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccc
Confidence 5789999999999999999999999999999999999 7899999999999986543211 22356799999
Q ss_pred ccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH---HHHHHHHhC--CCCCCCCCCCcCHHHHHHHHH
Q psy9090 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---RALFQIVRN--PPPGLYRASNWSQHYVDFIAE 145 (488)
Q Consensus 71 ~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~---~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~ 145 (488)
+|||++.+ ..++.++|||||||++|+|++|+.||.+.... .....+... ..+.......+++.+.++|.+
T Consensus 182 ~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 256 (296)
T 4hgt_A 182 ASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 256 (296)
T ss_dssp CCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHH
T ss_pred cchHHhcC-----CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHH
Confidence 99999986 56889999999999999999999999764321 112222111 011111225678999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy9090 146 CLEKNPEHRPYMSELLE 162 (488)
Q Consensus 146 ~L~~dP~~Rps~~ell~ 162 (488)
||..||++|||+.++++
T Consensus 257 ~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 257 CRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTSCTTCCCCHHHHHH
T ss_pred HHhcCCCCCCCHHHHHH
Confidence 99999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-29 Score=249.90 Aligned_cols=157 Identities=28% Similarity=0.492 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 269 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC
Confidence 4688999999999999999999999999999999999999999999999997653321 12344568899999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+..........+..... ...+..+++.+.++|.+||..||.+|||+
T Consensus 270 -----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 343 (359)
T 3vhe_A 270 -----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTF 343 (359)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 678999999999999999998 99999887654444444432221 22356689999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.++++|
T Consensus 344 ~ell~~ 349 (359)
T 3vhe_A 344 SELVEH 349 (359)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=251.07 Aligned_cols=160 Identities=26% Similarity=0.459 Sum_probs=134.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC---cEEEEecCCccccccc--cCccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG---EVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~ 75 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+++..... ........||+.|+|||+
T Consensus 178 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~ 257 (367)
T 3l9p_A 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 257 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHH
Confidence 46788999999999999999999999999999999999655 4999999999754322 123345578999999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
+.+ ..++.++|||||||++|+|++ |..||...........+....... .+..+++.+.+||.+||..||.+|
T Consensus 258 ~~~-----~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~R 330 (367)
T 3l9p_A 258 FME-----GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDR 330 (367)
T ss_dssp HHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCccCCHHHHHHHHHHcCCCHhHC
Confidence 976 578999999999999999998 999999988777666666554332 356789999999999999999999
Q ss_pred CCHHHHhcCcCCC
Q psy9090 155 PYMSELLEHPFIT 167 (488)
Q Consensus 155 ps~~ell~hp~f~ 167 (488)
||+.+++++.++.
T Consensus 331 ps~~eil~~l~~~ 343 (367)
T 3l9p_A 331 PNFAIILERIEYC 343 (367)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHH
Confidence 9999999987764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=240.86 Aligned_cols=162 Identities=21% Similarity=0.428 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+
T Consensus 108 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 186 (294)
T 4eqm_A 108 LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG- 186 (294)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHT-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcC-
Confidence 5788999999999999999999999999999999999999999999999997654321 22344579999999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC--CCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL--YRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||||+++|+|++|+.||.+........+......+.. ..+..+++.+.++|.+||..||.+||+.
T Consensus 187 ----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~ 262 (294)
T 4eqm_A 187 ----EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKT 262 (294)
T ss_dssp ----CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSS
T ss_pred ----CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHcccc
Confidence 5678899999999999999999999999887776666666544332 1245689999999999999999999955
Q ss_pred HHHhcCcCCC
Q psy9090 158 SELLEHPFIT 167 (488)
Q Consensus 158 ~ell~hp~f~ 167 (488)
.+.+.+.|..
T Consensus 263 ~~~l~~~l~~ 272 (294)
T 4eqm_A 263 IQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHH
Confidence 5555555544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=239.19 Aligned_cols=156 Identities=24% Similarity=0.438 Sum_probs=122.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 191 (281)
T 1mp8_A 113 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF- 191 (281)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhccc-
Confidence 47889999999999999999999999999999999999999999999999976543211 2233456789999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||||+++|+|++ |.+||.+.........+....... .+..+++.+.++|.+||..||.+|||+.
T Consensus 192 ----~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ 265 (281)
T 1mp8_A 192 ----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRPRFT 265 (281)
T ss_dssp ----CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 568899999999999999996 999999887776666666544332 3567899999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++++
T Consensus 266 ~l~~~ 270 (281)
T 1mp8_A 266 ELKAQ 270 (281)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=255.56 Aligned_cols=162 Identities=25% Similarity=0.461 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC-------------CcEEEEecCCccccccccC----ccccccCC
Q psy9090 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-------------GEVKIVDFGLSRETANTFD----KKKTFLGS 67 (488)
Q Consensus 5 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-------------~~vkL~Dfg~a~~~~~~~~----~~~~~~gt 67 (488)
.++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... ......||
T Consensus 116 ~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt 195 (434)
T 2rio_A 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195 (434)
T ss_dssp CHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------C
T ss_pred hHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCC
Confidence 457799999999999999999999999999999754 4799999999987654321 12345799
Q ss_pred Cccccchhhccccc--CCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCC--CC--CCCCCcCHHHH
Q psy9090 68 PSWMAPEIMRCGHK--EVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPP--GL--YRASNWSQHYV 140 (488)
Q Consensus 68 ~~y~aPE~l~~~~~--~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~--~~--~~~~~~s~~~~ 140 (488)
+.|+|||++.+... ....++.++|||||||++|+|++ |..||....... ..+...... .. .....+++++.
T Consensus 196 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~ 273 (434)
T 2rio_A 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEAT 273 (434)
T ss_dssp CTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHH
T ss_pred CCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHH
Confidence 99999999965211 12468899999999999999999 999997665433 233332211 11 11223468899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcCCCC
Q psy9090 141 DFIAECLEKNPEHRPYMSELLEHPFITS 168 (488)
Q Consensus 141 ~li~~~L~~dP~~Rps~~ell~hp~f~~ 168 (488)
+||.+||..||.+|||+.++++||||+.
T Consensus 274 ~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 274 DLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 9999999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=243.78 Aligned_cols=155 Identities=25% Similarity=0.391 Sum_probs=125.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+
T Consensus 114 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3lzb_A 114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcC
Confidence 57889999999999999999999999999999999999999999999999976543211 1233456789999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |.+||.+.........+...... ..+..++..+.++|.+||..||.+|||+
T Consensus 194 -----~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~ 266 (327)
T 3lzb_A 194 -----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPPICTIDVYMIMRKCWMIDADSRPKF 266 (327)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--CCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence 678999999999999999999 99999888766655555444322 2356689999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 267 ~ell~ 271 (327)
T 3lzb_A 267 RELII 271 (327)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=245.05 Aligned_cols=156 Identities=24% Similarity=0.391 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+
T Consensus 114 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3poz_A 114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc
Confidence 57889999999999999999999999999999999999999999999999976543221 1223456889999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+.........+...... ..+..++..+.+++.+||..+|.+|||+
T Consensus 194 -----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~ 266 (327)
T 3poz_A 194 -----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPPICTIDVYMIMVKCWMIDADSRPKF 266 (327)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--CCCTTBCHHHHHHHHHHTCSCGGGSCCH
T ss_pred -----CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCChhhCCCH
Confidence 678999999999999999999 99999887766555444443322 2456689999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 267 ~ell~~ 272 (327)
T 3poz_A 267 RELIIE 272 (327)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=236.45 Aligned_cols=156 Identities=27% Similarity=0.501 Sum_probs=132.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......+|+.|+|||++.+
T Consensus 103 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 181 (269)
T 4hcu_A 103 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF- 181 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcC-
Confidence 5788999999999999999999999999999999999999999999999987654321 12334457788999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||||+++|+|++ |.+||...........+.....+ ..+...++.+.+++.+||..||.+|||+.
T Consensus 182 ----~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 255 (269)
T 4hcu_A 182 ----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPAFS 255 (269)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC--CCCCcCCHHHHHHHHHHccCCcccCcCHH
Confidence 568899999999999999999 99999998877776666654332 23556799999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
++++|
T Consensus 256 ~ll~~ 260 (269)
T 4hcu_A 256 RLLRQ 260 (269)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=247.64 Aligned_cols=156 Identities=28% Similarity=0.476 Sum_probs=133.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+
T Consensus 188 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 267 (382)
T 3tt0_A 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 267 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence 5788999999999999999999999999999999999999999999999998654321 22334467889999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+.........+.....+. .+..+++.+.+||.+||..||++|||+
T Consensus 268 -----~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~ 340 (382)
T 3tt0_A 268 -----RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTF 340 (382)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC--CCSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCccCCHHHHHHHHHHcCCChhhCcCH
Confidence 678899999999999999999 999999888766666555544332 356789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 341 ~ell~~ 346 (382)
T 3tt0_A 341 KQLVED 346 (382)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=242.89 Aligned_cols=156 Identities=26% Similarity=0.484 Sum_probs=132.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... .......+|+.|+|||++.+
T Consensus 135 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 214 (322)
T 1p4o_A 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 214 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc
Confidence 3678899999999999999999999999999999999999999999999997654321 12234457889999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||||+++|+|++ |..||.+.........+.....+. .+..+++.+.++|.+||..||.+|||+
T Consensus 215 -----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~ 287 (322)
T 1p4o_A 215 -----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD--KPDNCPDMLFELMRMCWQYNPKMRPSF 287 (322)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 568899999999999999999 899999888766666665544332 356789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 288 ~e~l~~ 293 (322)
T 1p4o_A 288 LEIISS 293 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=241.29 Aligned_cols=156 Identities=25% Similarity=0.468 Sum_probs=128.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc-cCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...... ......||+.|+|||++.+.
T Consensus 136 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 213 (312)
T 2iwi_A 136 LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRH 213 (312)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecC
Confidence 57889999999999999999999999999999999999 8899999999998766542 33456799999999998752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++||||||+++|+|++|+.||.... .+.... ...+..+++.+.++|.+||..||++|||+.+
T Consensus 214 ----~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 280 (312)
T 2iwi_A 214 ----QYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAE---LHFPAHVSPDCCALIRRCLAPKPSSRPSLEE 280 (312)
T ss_dssp ----CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTC---CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ----CCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhc---cCCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 223458999999999999999999997632 122221 1234568999999999999999999999999
Q ss_pred HhcCcCCCCCCC
Q psy9090 160 LLEHPFITSLPE 171 (488)
Q Consensus 160 ll~hp~f~~~~~ 171 (488)
+++||||+...+
T Consensus 281 ~l~~~~~~~~~~ 292 (312)
T 2iwi_A 281 ILLDPWMQTPAE 292 (312)
T ss_dssp HHHSTTTCC---
T ss_pred HhcChhhcCchh
Confidence 999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=235.13 Aligned_cols=155 Identities=30% Similarity=0.600 Sum_probs=125.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---CeecccCCCCEEEcc--------CCcEEEEecCCccccccccCccccccCCCc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH---VIHRDLRGSNVLLTK--------DGEVKIVDFGLSRETANTFDKKKTFLGSPS 69 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~--------~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~ 69 (488)
+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++...... ......||+.
T Consensus 102 ~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~ 179 (271)
T 3dtc_A 102 IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAYA 179 (271)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------CCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc--cccCCCCccc
Confidence 578899999999999999999999 899999999999986 778999999999765432 2234579999
Q ss_pred cccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhccc
Q psy9090 70 WMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEK 149 (488)
Q Consensus 70 y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 149 (488)
|+|||++.+ ..++.++||||||+++|+|++|..||.+............... ....+..+++.+.++|.+||..
T Consensus 180 y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~ 253 (271)
T 3dtc_A 180 WMAPEVIRA-----SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL-ALPIPSTCPEPFAKLMEDCWNP 253 (271)
T ss_dssp GSCHHHHHH-----CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC-CCCCCTTCCHHHHHHHHHHTCS
T ss_pred eeCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC-CCCCCcccCHHHHHHHHHHhcC
Confidence 999999976 5688999999999999999999999998887666666554432 2234567899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy9090 150 NPEHRPYMSELLEH 163 (488)
Q Consensus 150 dP~~Rps~~ell~h 163 (488)
||.+|||+.+++++
T Consensus 254 ~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 254 DPHSRPSFTNILDQ 267 (271)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=235.25 Aligned_cols=156 Identities=28% Similarity=0.482 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......+|+.|+|||++.+
T Consensus 101 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 179 (268)
T 3sxs_A 101 LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY- 179 (268)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-
Confidence 5788999999999999999999999999999999999999999999999987654321 12233456778999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||||+++|+|++ |..||...........+...... ..+...++.+.++|.+||..||.+|||+.
T Consensus 180 ----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 253 (268)
T 3sxs_A 180 ----FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL--YRPHLASDTIYQIMYSCWHELPEKRPTFQ 253 (268)
T ss_dssp ----SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCTTSCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred ----cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC--CCCCcChHHHHHHHHHHcCCChhhCcCHH
Confidence 567889999999999999999 99999988877766666654432 23456799999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++++
T Consensus 254 ~ll~~ 258 (268)
T 3sxs_A 254 QLLSS 258 (268)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=239.42 Aligned_cols=157 Identities=18% Similarity=0.298 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc-----EEEEecCCccccccccC-------ccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE-----VKIVDFGLSRETANTFD-------KKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-----vkL~Dfg~a~~~~~~~~-------~~~~~~gt~ 68 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....... ......||+
T Consensus 103 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~ 182 (298)
T 1csn_A 103 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCc
Confidence 578999999999999999999999999999999999987776 99999999986543311 234567999
Q ss_pred ccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC---hHHHHHHHHhCC--CCCCCCCCCcCHHHHHHH
Q psy9090 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH---PTRALFQIVRNP--PPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 69 ~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~---~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li 143 (488)
.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. .......+.... .+.......+++.+.++|
T Consensus 183 ~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (298)
T 1csn_A 183 RYMSINTHLG-----REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 257 (298)
T ss_dssp TTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHH
T ss_pred ccCCchhhcC-----CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHH
Confidence 9999999976 568899999999999999999999997743 223333322211 111112346799999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy9090 144 AECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~ 162 (488)
.+||..||++|||++++++
T Consensus 258 ~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 258 HYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHCCTTCCCCHHHHHH
T ss_pred HHHhcCCcccCCCHHHHHH
Confidence 9999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=244.67 Aligned_cols=158 Identities=25% Similarity=0.417 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+
T Consensus 169 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 248 (344)
T 1rjb_A 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 248 (344)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc
Confidence 46788999999999999999999999999999999999999999999999976543321 1234467889999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+..........+..... ...+..+++.+.+||.+||..||.+|||+
T Consensus 249 -----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 249 -----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 568899999999999999998 99999887665555555554322 22355679999999999999999999999
Q ss_pred HHHhcCc
Q psy9090 158 SELLEHP 164 (488)
Q Consensus 158 ~ell~hp 164 (488)
.+++++.
T Consensus 323 ~~l~~~l 329 (344)
T 1rjb_A 323 PNLTSFL 329 (344)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=243.52 Aligned_cols=156 Identities=26% Similarity=0.435 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+
T Consensus 171 l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 250 (343)
T 1luf_A 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 250 (343)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence 4678899999999999999999999999999999999999999999999987653321 22334568899999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+.........+.....+. .+..+++.+.++|.+||..||.+|||+
T Consensus 251 -----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 251 -----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA--CPENCPLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCC--CCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 568899999999999999999 999999888777666666554332 356789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 324 ~~~~~~ 329 (343)
T 1luf_A 324 CSIHRI 329 (343)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=235.97 Aligned_cols=156 Identities=26% Similarity=0.473 Sum_probs=132.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......+|+.|+|||++.+
T Consensus 117 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 195 (283)
T 3gen_A 117 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY- 195 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhcc-
Confidence 5788999999999999999999999999999999999999999999999987653321 12233456788999999986
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||||+++|+|++ |..||...........+...... ..+...++.+.++|.+||..+|.+|||+.
T Consensus 196 ----~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (283)
T 3gen_A 196 ----SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--YRPHLASEKVYTIMYSCWHEKADERPTFK 269 (283)
T ss_dssp ----CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--CCCCcCCHHHHHHHHHHccCChhHCcCHH
Confidence 568899999999999999998 99999988877766666654332 23456789999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
++++|
T Consensus 270 ~ll~~ 274 (283)
T 3gen_A 270 ILLSN 274 (283)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=236.96 Aligned_cols=160 Identities=31% Similarity=0.559 Sum_probs=121.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ........||+.|+|||++..
T Consensus 117 ~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (289)
T 3og7_A 117 FEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcc
Confidence 478899999999999999999999999999999999999999999999998754321 122344579999999999863
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC-CCCC--CCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN-PPPG--LYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~-~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.. ...++.++||||||+++|+|++|..||............+.. .... ......+++.+.+||.+||..+|.+||
T Consensus 197 ~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 274 (289)
T 3og7_A 197 QD--SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274 (289)
T ss_dssp -----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cC--CCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCC
Confidence 21 156788999999999999999999999886665555544432 2111 112356789999999999999999999
Q ss_pred CHHHHhc
Q psy9090 156 YMSELLE 162 (488)
Q Consensus 156 s~~ell~ 162 (488)
|+.++++
T Consensus 275 s~~ell~ 281 (289)
T 3og7_A 275 SFPRILA 281 (289)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=240.23 Aligned_cols=156 Identities=26% Similarity=0.475 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......+|+.|+|||++.+
T Consensus 147 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 226 (314)
T 2ivs_A 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD 226 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC
Confidence 36788999999999999999999999999999999999999999999999976543211 2234467889999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+.........+.....+ ..+..+++.+.++|.+||..||.+|||+
T Consensus 227 -----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~ 299 (314)
T 2ivs_A 227 -----HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM--ERPDNCSEEMYRLMLQCWKQEPDKRPVF 299 (314)
T ss_dssp -----CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC--CCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 568899999999999999999 99999888766655555444332 2356789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 300 ~~l~~~ 305 (314)
T 2ivs_A 300 ADISKD 305 (314)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=237.32 Aligned_cols=157 Identities=25% Similarity=0.428 Sum_probs=133.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......+|+.|+|||++.
T Consensus 107 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (287)
T 1u59_A 107 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 186 (287)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhc
Confidence 57889999999999999999999999999999999999999999999999976543211 123345688999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++||||||+++|+|++ |..||...........+.....+. .+..+++.+.++|.+||..||.+|||
T Consensus 187 ~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps 259 (287)
T 1u59_A 187 F-----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME--CPPECPPELYALMSDCWIYKWEDRPD 259 (287)
T ss_dssp H-----CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred c-----CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC--CCCCcCHHHHHHHHHHcCCChhhCcC
Confidence 5 567889999999999999998 999999887766666665544333 35678999999999999999999999
Q ss_pred HHHHhcCc
Q psy9090 157 MSELLEHP 164 (488)
Q Consensus 157 ~~ell~hp 164 (488)
+.+++++.
T Consensus 260 ~~~l~~~l 267 (287)
T 1u59_A 260 FLTVEQRM 267 (287)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=241.35 Aligned_cols=155 Identities=23% Similarity=0.411 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.
T Consensus 148 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 227 (325)
T 3kul_A 148 FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhc
Confidence 57889999999999999999999999999999999999999999999999986543211 122334677899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|||||||++|+|++ |..||.+.........+....... .+..+++.+.+||.+||..||.+|||
T Consensus 228 ~-----~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps 300 (325)
T 3kul_A 228 F-----RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--APMGCPHALHQLMLDCWHKDRAQRPR 300 (325)
T ss_dssp H-----CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred C-----CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC--CCCCcCHHHHHHHHHHccCChhhCcC
Confidence 6 568899999999999999999 999999988777776666553332 35678999999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 301 ~~eil~ 306 (325)
T 3kul_A 301 FSQIVS 306 (325)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999886
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=235.06 Aligned_cols=156 Identities=22% Similarity=0.379 Sum_probs=128.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......+|+.|+|||++.+
T Consensus 110 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 188 (281)
T 3cc6_A 110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF- 188 (281)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhcc-
Confidence 57888999999999999999999999999999999999999999999999876543211 2234457889999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||||+++|+|++ |+.||...........+....... .+..+++.+.++|.+||..||.+|||+.
T Consensus 189 ----~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ 262 (281)
T 3cc6_A 189 ----RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP--KPDLCPPVLYTLMTRCWDYDPSDRPRFT 262 (281)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 568899999999999999998 999998776666555555443322 3456799999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++++
T Consensus 263 ell~~ 267 (281)
T 3cc6_A 263 ELVCS 267 (281)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=241.10 Aligned_cols=157 Identities=19% Similarity=0.365 Sum_probs=125.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE---ccCCcEEEEecCCccccccccC-------ccccccCCCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL---TKDGEVKIVDFGLSRETANTFD-------KKKTFLGSPSW 70 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y 70 (488)
+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........ ......||+.|
T Consensus 102 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y 181 (296)
T 3uzp_A 102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181 (296)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccccccc
Confidence 5788999999999999999999999999999999999 4889999999999976543321 12456799999
Q ss_pred ccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---HHHHHHHHhC--CCCCCCCCCCcCHHHHHHHHH
Q psy9090 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---TRALFQIVRN--PPPGLYRASNWSQHYVDFIAE 145 (488)
Q Consensus 71 ~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~ 145 (488)
+|||++.+ ..++.++|||||||++|+|++|+.||.+... ......+... ..+.......+++.+.++|.+
T Consensus 182 ~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 256 (296)
T 3uzp_A 182 ASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 256 (296)
T ss_dssp CCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHH
T ss_pred CChhhhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHH
Confidence 99999976 5688999999999999999999999976432 1122222111 001111235679999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy9090 146 CLEKNPEHRPYMSELLE 162 (488)
Q Consensus 146 ~L~~dP~~Rps~~ell~ 162 (488)
||..||.+|||+.++++
T Consensus 257 ~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 257 CRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTSCTTCCCCHHHHHH
T ss_pred HHhcCcCcCCCHHHHHH
Confidence 99999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=239.21 Aligned_cols=156 Identities=24% Similarity=0.419 Sum_probs=127.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......+++.|+|||++.+
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 223 (313)
T 3brb_A 144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 223 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC
Confidence 5788999999999999999999999999999999999999999999999987654321 12233457889999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||||+++|+|++ |.+||.+.........+.....+. .+..+++.+.++|.+||..||.+|||+
T Consensus 224 -----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~ 296 (313)
T 3brb_A 224 -----RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK--QPEDCLDELYEIMYSCWRTDPLDRPTF 296 (313)
T ss_dssp -----SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC--CBTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred -----CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC--CCccccHHHHHHHHHHcCCChhhCcCH
Confidence 678899999999999999999 999998887766666666554333 346789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 297 ~~l~~~ 302 (313)
T 3brb_A 297 SVLRLQ 302 (313)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=241.82 Aligned_cols=155 Identities=27% Similarity=0.447 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+++.|+|||++.+
T Consensus 139 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-- 215 (327)
T 1fvr_A 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-- 215 (327)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhcc--
Confidence 478899999999999999999999999999999999999999999999998754332 22334467889999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|||||||++|+|++ |..||.+.........+...... ..+..+++.+.+||.+||..||.+|||+.+
T Consensus 216 ---~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 290 (327)
T 1fvr_A 216 ---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQ 290 (327)
T ss_dssp ---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC--CCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 567899999999999999998 99999988876666555544322 235578999999999999999999999999
Q ss_pred HhcC
Q psy9090 160 LLEH 163 (488)
Q Consensus 160 ll~h 163 (488)
++++
T Consensus 291 ll~~ 294 (327)
T 1fvr_A 291 ILVS 294 (327)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=239.10 Aligned_cols=157 Identities=27% Similarity=0.473 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......+|+.|+|||++.+
T Consensus 142 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 221 (313)
T 1t46_A 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC
Confidence 47889999999999999999999999999999999999999999999999876544321 1234457889999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||||+++|+|++ |..||.+................. ..+..+++.+.++|.+||..||.+|||+
T Consensus 222 -----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~ 295 (313)
T 1t46_A 222 -----CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTF 295 (313)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCH
Confidence 568899999999999999998 999998776555555544432222 2345679999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 296 ~ell~~ 301 (313)
T 1t46_A 296 KQIVQL 301 (313)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=247.82 Aligned_cols=157 Identities=19% Similarity=0.274 Sum_probs=124.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc--cCCcEEEEecCCccccccccC-------ccccccCCCccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTFD-------KKKTFLGSPSWM 71 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~--~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~ 71 (488)
|++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....... ......||+.|+
T Consensus 149 l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 228 (364)
T 3op5_A 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCcc
Confidence 57899999999999999999999999999999999999 889999999999976543211 123456999999
Q ss_pred cchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh----CCCC----CCCCCCCcCHHHHHHH
Q psy9090 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR----NPPP----GLYRASNWSQHYVDFI 143 (488)
Q Consensus 72 aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~----~~~~----~~~~~~~~s~~~~~li 143 (488)
|||++.+ ..++.++|||||||++|+|++|+.||.+............ ...+ .......+++++.++|
T Consensus 229 aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 303 (364)
T 3op5_A 229 SIDAHNG-----VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYM 303 (364)
T ss_dssp CHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHH
T ss_pred CHHHhCC-----CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHH
Confidence 9999976 5689999999999999999999999975332222111110 0000 0112256789999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy9090 144 AECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~ 162 (488)
..||..+|.+||++.++++
T Consensus 304 ~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 304 ETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCCCCCCCHHHHHH
Confidence 9999999999999998864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=244.07 Aligned_cols=158 Identities=18% Similarity=0.255 Sum_probs=124.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC--cEEEEecCCcccccccc-------CccccccCCCccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG--EVKIVDFGLSRETANTF-------DKKKTFLGSPSWM 71 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~ 71 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... .......||+.|+
T Consensus 148 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 227 (345)
T 2v62_A 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCcccc
Confidence 57899999999999999999999999999999999999887 99999999997653321 1124557999999
Q ss_pred cchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh-HHHHHHHH---hCCCCC----CCCCCCcCHHHHHHH
Q psy9090 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP-TRALFQIV---RNPPPG----LYRASNWSQHYVDFI 143 (488)
Q Consensus 72 aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~-~~~~~~~~---~~~~~~----~~~~~~~s~~~~~li 143 (488)
|||++.+ ..++.++|||||||++|+|++|..||.+... ........ ....+. ......+++.+.++|
T Consensus 228 aPE~~~~-----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 302 (345)
T 2v62_A 228 SLDAHKG-----VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFL 302 (345)
T ss_dssp CHHHHHT-----CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHH
T ss_pred CHHHhcC-----CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHH
Confidence 9999986 5689999999999999999999999954221 11111111 111111 001226789999999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q psy9090 144 AECLEKNPEHRPYMSELLEH 163 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~h 163 (488)
.+||..||++|||++++++.
T Consensus 303 ~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 303 VCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcCcccCCCHHHHHHH
Confidence 99999999999999998863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=241.24 Aligned_cols=156 Identities=20% Similarity=0.326 Sum_probs=123.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc-----EEEEecCCccccccccC-------ccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE-----VKIVDFGLSRETANTFD-------KKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-----vkL~Dfg~a~~~~~~~~-------~~~~~~gt~ 68 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....... ......||+
T Consensus 102 ~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~ 181 (330)
T 2izr_A 102 FSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181 (330)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCc
Confidence 578999999999999999999999999999999999998887 99999999986543211 124668999
Q ss_pred ccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---HHHHHHHHhCC--CCCCCCCCCcCHHHHHHH
Q psy9090 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---TRALFQIVRNP--PPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 69 ~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---~~~~~~~~~~~--~~~~~~~~~~s~~~~~li 143 (488)
.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+.... .+.......++ ++.++|
T Consensus 182 ~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li 255 (330)
T 2izr_A 182 RYMSINTHLG-----KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYL 255 (330)
T ss_dssp TTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHH
T ss_pred cccChHHHcC-----CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHH
Confidence 9999999986 6688999999999999999999999987432 22222322111 11100112234 999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy9090 144 AECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~ 162 (488)
..||..+|.+||+++++++
T Consensus 256 ~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 256 RYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhCCCCCCCCHHHHHH
Confidence 9999999999999988765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=232.87 Aligned_cols=155 Identities=23% Similarity=0.451 Sum_probs=127.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc----cCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT----FDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... ........+|+.|+|||.+
T Consensus 121 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 200 (298)
T 3pls_A 121 PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200 (298)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhh
Confidence 467889999999999999999999999999999999999999999999999755332 1223345678899999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.+ ..++.++||||||+++|+|++ |.+||...........+...... ..+..+++.+.++|.+||..||.+||
T Consensus 201 ~~-----~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp 273 (298)
T 3pls_A 201 QT-----YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL--PQPEYCPDSLYQVMQQCWEADPAVRP 273 (298)
T ss_dssp TT-----CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cc-----CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--CCCccchHHHHHHHHHHccCChhhCc
Confidence 76 568899999999999999999 55556666655555444444322 23566899999999999999999999
Q ss_pred CHHHHhc
Q psy9090 156 YMSELLE 162 (488)
Q Consensus 156 s~~ell~ 162 (488)
|+.++++
T Consensus 274 s~~~ll~ 280 (298)
T 3pls_A 274 TFRVLVG 280 (298)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=243.48 Aligned_cols=152 Identities=29% Similarity=0.549 Sum_probs=122.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc--------------cccccC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK--------------KKTFLG 66 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~--------------~~~~~g 66 (488)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....|
T Consensus 105 ~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 184 (310)
T 3s95_A 105 YPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184 (310)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCC
Confidence 578899999999999999999999999999999999999999999999999765332111 125679
Q ss_pred CCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH-----HHHHHHhCCCCCCCCCCCcCHHHHH
Q psy9090 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR-----ALFQIVRNPPPGLYRASNWSQHYVD 141 (488)
Q Consensus 67 t~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~s~~~~~ 141 (488)
|+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ........ ..+..+++.+.+
T Consensus 185 t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~ 254 (310)
T 3s95_A 185 NPYWMAPEMING-----RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-----YCPPNCPPSFFP 254 (310)
T ss_dssp CGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-----TCCTTCCTTHHH
T ss_pred CcceeCHHHhcC-----CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-----cCCCCCCHHHHH
Confidence 999999999976 678999999999999999999999986532211 01111111 124567889999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q psy9090 142 FIAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 142 li~~~L~~dP~~Rps~~ell~ 162 (488)
+|.+||..||++|||+.++++
T Consensus 255 li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 255 ITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=230.45 Aligned_cols=156 Identities=27% Similarity=0.501 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... .......+++.|+|||++.+
T Consensus 101 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 179 (267)
T 3t9t_A 101 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF- 179 (267)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcC-
Confidence 4788999999999999999999999999999999999999999999999987653321 12234457789999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|+||||+++|+|++ |.+||...........+.....+ ..+..+++.+.+++.+||..||.+|||+.
T Consensus 180 ----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 253 (267)
T 3t9t_A 180 ----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPAFS 253 (267)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC--CCCccCcHHHHHHHHHHccCChhhCcCHH
Confidence 568899999999999999999 99999988877666666554332 23456799999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
+++++
T Consensus 254 ~ll~~ 258 (267)
T 3t9t_A 254 RLLRQ 258 (267)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=233.21 Aligned_cols=155 Identities=25% Similarity=0.446 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......+++.|+|||++.
T Consensus 114 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 193 (291)
T 1xbb_A 114 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193 (291)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhc
Confidence 57889999999999999999999999999999999999999999999999976543211 122334678899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++||||||+++|+|++ |..||.+.........+.....+. .+..+++.+.++|.+||..||.+|||
T Consensus 194 ~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps 266 (291)
T 1xbb_A 194 Y-----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--CPAGCPREMYDLMNLCWTYDVENRPG 266 (291)
T ss_dssp H-----CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred c-----CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 6 557889999999999999999 999999888766665555544332 35678999999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 267 ~~~l~~ 272 (291)
T 1xbb_A 267 FAAVEL 272 (291)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-28 Score=234.04 Aligned_cols=156 Identities=27% Similarity=0.470 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........ ......+|+.|+|||++.
T Consensus 118 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (291)
T 1u46_A 118 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197 (291)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhc
Confidence 47889999999999999999999999999999999999999999999999876543211 123446778899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++||||||+++|+|++ |..||.+.........+..... ....+..+++.+.++|.+||..||.+|||
T Consensus 198 ~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps 271 (291)
T 1u46_A 198 T-----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271 (291)
T ss_dssp H-----CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred C-----CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC-CCCCCcCcCHHHHHHHHHHccCCcccCcC
Confidence 6 557889999999999999999 9999998887776666654432 23345678999999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 272 ~~~l~~ 277 (291)
T 1u46_A 272 FVALRD 277 (291)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=231.45 Aligned_cols=152 Identities=24% Similarity=0.454 Sum_probs=123.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .....+++.|+|||++.+
T Consensus 114 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~-- 188 (278)
T 1byg_A 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALRE-- 188 (278)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHH--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCC--
Confidence 467889999999999999999999999999999999999999999999998755432 233467889999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++||||||+++|+|++ |..||...........+.....+ ..+..+++.+.++|.+||..||.+|||+.+
T Consensus 189 ---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 263 (278)
T 1byg_A 189 ---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQ 263 (278)
T ss_dssp ---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCcccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 568899999999999999998 99999887766655555444322 235678999999999999999999999999
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
+++
T Consensus 264 l~~ 266 (278)
T 1byg_A 264 LRE 266 (278)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=230.63 Aligned_cols=155 Identities=27% Similarity=0.496 Sum_probs=131.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......+++.|+|||++.+
T Consensus 106 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 184 (279)
T 1qpc_A 106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY- 184 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc-
Confidence 5788999999999999999999999999999999999999999999999997654321 12233456789999999975
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||||+++|+|++ |..||.+.........+...... ..+..+++.+.++|.+||..||++|||+.
T Consensus 185 ----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 258 (279)
T 1qpc_A 185 ----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM--VRPDNCPEELYQLMRLCWKERPEDRPTFD 258 (279)
T ss_dssp ----CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC--CCcccccHHHHHHHHHHhccChhhCCCHH
Confidence 567889999999999999999 99999988876666666554332 23567899999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 259 ~l~~ 262 (279)
T 1qpc_A 259 YLRS 262 (279)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=238.88 Aligned_cols=155 Identities=29% Similarity=0.495 Sum_probs=128.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~~ 79 (488)
++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 146 ~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 224 (316)
T 2xir_A 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD- 224 (316)
T ss_dssp EHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-
Confidence 5788999999999999999999999999999999999999999999999976543211 2234567889999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHH-hCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIV-RNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+..........+ ..... ..+..+++.+.++|.+||..||.+|||+
T Consensus 225 ----~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~ 298 (316)
T 2xir_A 225 ----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTF 298 (316)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ----ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC--CCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 668899999999999999998 999998766444433333 33222 2345679999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.++++|
T Consensus 299 ~ell~~ 304 (316)
T 2xir_A 299 SELVEH 304 (316)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=231.58 Aligned_cols=155 Identities=23% Similarity=0.468 Sum_probs=126.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEccCCc-----EEEEecCCccccccccCccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGE-----VKIVDFGLSRETANTFDKKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~-----vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 73 (488)
+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||+++.... ......||+.|+||
T Consensus 119 ~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aP 195 (287)
T 4f0f_A 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAP 195 (287)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCCCCTTSCG
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc---cccccCCCccccCc
Confidence 578899999999999999999999 999999999999988776 99999999875433 33456799999999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH--HHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA--LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
|++... ...++.++|||||||++|+|++|..||........ ...+..... ....+..+++.+.++|.+||..||
T Consensus 196 E~~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp 271 (287)
T 4f0f_A 196 ETIGAE---EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL-RPTIPEDCPPRLRNVIELCWSGDP 271 (287)
T ss_dssp GGSSCS---SCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC-CCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred hhhccC---CCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC-CCCCCcccCHHHHHHHHHHhcCCh
Confidence 998531 14578899999999999999999999976543332 333333222 222456789999999999999999
Q ss_pred CCCCCHHHHhc
Q psy9090 152 EHRPYMSELLE 162 (488)
Q Consensus 152 ~~Rps~~ell~ 162 (488)
.+|||+.++++
T Consensus 272 ~~Rps~~~ll~ 282 (287)
T 4f0f_A 272 KKRPHFSYIVK 282 (287)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=233.18 Aligned_cols=155 Identities=25% Similarity=0.451 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc----CccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF----DKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... .......+|+.|+|||++
T Consensus 125 ~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (298)
T 3f66_A 125 PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHh
Confidence 4678899999999999999999999999999999999999999999999997654321 122344678899999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.+ ..++.++|+||||+++|+|++ |.+||...........+...... ..+..+++.+.++|.+||..||.+||
T Consensus 205 ~~-----~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp 277 (298)
T 3f66_A 205 QT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRP 277 (298)
T ss_dssp HH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cC-----CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC--CCCccCCHHHHHHHHHHcCCChhhCc
Confidence 76 568899999999999999999 77788777666655555554432 23556799999999999999999999
Q ss_pred CHHHHhc
Q psy9090 156 YMSELLE 162 (488)
Q Consensus 156 s~~ell~ 162 (488)
|+.++++
T Consensus 278 s~~ell~ 284 (298)
T 3f66_A 278 SFSELVS 284 (298)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=247.75 Aligned_cols=155 Identities=26% Similarity=0.480 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++..
T Consensus 281 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 359 (454)
T 1qcf_A 281 QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF- 359 (454)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-
Confidence 4677899999999999999999999999999999999999999999999998654321 11223456788999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|||||||++|+|++ |..||.+.........+......+ .+..+++.+.+||.+||..||++|||++
T Consensus 360 ----~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~ 433 (454)
T 1qcf_A 360 ----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP--RPENCPEELYNIMMRCWKNRPEERPTFE 433 (454)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 568999999999999999999 999999988777777766654332 3567899999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 434 ~i~~ 437 (454)
T 1qcf_A 434 YIQS 437 (454)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=253.04 Aligned_cols=172 Identities=18% Similarity=0.312 Sum_probs=134.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE---ccCCcEEEEecCCccccccccC-------ccccccCCCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL---TKDGEVKIVDFGLSRETANTFD-------KKKTFLGSPSW 70 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y 70 (488)
|++.+++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... ......||+.|
T Consensus 100 l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y 179 (483)
T 3sv0_A 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179 (483)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccc
Confidence 5789999999999999999999999999999999999 6889999999999986543321 12356799999
Q ss_pred ccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---HHHHHHHHhCCC--CCCCCCCCcCHHHHHHHHH
Q psy9090 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---TRALFQIVRNPP--PGLYRASNWSQHYVDFIAE 145 (488)
Q Consensus 71 ~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 145 (488)
+|||++.+ ..++.++|||||||++|+|++|+.||.+... ......+..... ........+++++.+||..
T Consensus 180 ~aPE~~~~-----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~ 254 (483)
T 3sv0_A 180 ASVNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHY 254 (483)
T ss_dssp CCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHH
T ss_pred cCHHHhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHH
Confidence 99999986 5688999999999999999999999976543 222222221110 0001124678999999999
Q ss_pred hcccCCCCCCCHHHHhc----------CcCCCCCCCCccccc
Q psy9090 146 CLEKNPEHRPYMSELLE----------HPFITSLPENDLHLS 177 (488)
Q Consensus 146 ~L~~dP~~Rps~~ell~----------hp~f~~~~~~~~~~~ 177 (488)
||..+|.+||++.+|++ ++|+..++|+.+...
T Consensus 255 cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 255 CRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp HHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred HhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 99999999999988753 677777777654433
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=237.44 Aligned_cols=156 Identities=27% Similarity=0.465 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+
T Consensus 154 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 233 (334)
T 2pvf_A 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 233 (334)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC
Confidence 46788999999999999999999999999999999999999999999999976543211 2233457789999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||||+++|+|++ |..||.+.........+.....+. .+..+++.+.++|.+||..+|.+|||+
T Consensus 234 -----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~ 306 (334)
T 2pvf_A 234 -----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD--KPANCTNELYMMMRDCWHAVPSQRPTF 306 (334)
T ss_dssp -----CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC--CCccCCHHHHHHHHHHccCChhhCcCH
Confidence 567899999999999999999 999999887766665555544332 346789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
.+++++
T Consensus 307 ~ell~~ 312 (334)
T 2pvf_A 307 KQLVED 312 (334)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=243.19 Aligned_cols=155 Identities=25% Similarity=0.432 Sum_probs=128.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......+++.|+|||++..
T Consensus 210 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 289 (377)
T 3cbl_A 210 LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289 (377)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc
Confidence 57889999999999999999999999999999999999999999999999875433211 1112235678999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+.........+...... +.+..+++.+.+||.+||..||++|||+
T Consensus 290 -----~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~ 362 (377)
T 3cbl_A 290 -----GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL--PCPELCPDAVFRLMEQCWAYEPGQRPSF 362 (377)
T ss_dssp -----CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 568889999999999999998 99999988876665555544332 2356689999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 363 ~~i~~ 367 (377)
T 3cbl_A 363 STIYQ 367 (377)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-28 Score=239.78 Aligned_cols=156 Identities=28% Similarity=0.474 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 240 (333)
T 2i1m_A 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 240 (333)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc
Confidence 47788999999999999999999999999999999999999999999999976543211 1234457889999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|++ |..||.+................ ...+...++.+.++|.+||..||.+|||+
T Consensus 241 -----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 314 (333)
T 2i1m_A 241 -----CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ-MAQPAFAPKNIYSIMQACWALEPTHRPTF 314 (333)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCcCH
Confidence 568899999999999999998 99999877655555555443222 12345678999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 315 ~~l~~ 319 (333)
T 2i1m_A 315 QQICS 319 (333)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=232.40 Aligned_cols=155 Identities=25% Similarity=0.468 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......+|+.|+|||++.+
T Consensus 108 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 186 (288)
T 3kfa_A 108 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 186 (288)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH-
T ss_pred ccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhcc-
Confidence 4788999999999999999999999999999999999999999999999997654332 12233457789999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||||+++|+|++ |.+||...........+...... ..+..+++.+.+||.+||..||.+|||+.
T Consensus 187 ----~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 260 (288)
T 3kfa_A 187 ----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFA 260 (288)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC--CCCCCCCHHHHHHHHHHhCCChhhCcCHH
Confidence 568899999999999999999 99999887766555555444332 23567899999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 261 ~~~~ 264 (288)
T 3kfa_A 261 EIHQ 264 (288)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=234.51 Aligned_cols=157 Identities=24% Similarity=0.323 Sum_probs=119.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......||+.|+|||++.+
T Consensus 131 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 209 (309)
T 2h34_A 131 LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE- 209 (309)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC-
Confidence 5788999999999999999999999999999999999999999999999987654321 22335578999999999876
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-CHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP-YMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-s~~ 158 (488)
..++.++||||||+++|+|++|..||...........+..........+..+++.+.++|.+||..||.+|| |++
T Consensus 210 ----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~ 285 (309)
T 2h34_A 210 ----SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCG 285 (309)
T ss_dssp --------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHH
T ss_pred ----CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHH
Confidence 567889999999999999999999998876543333333333333334567899999999999999999999 888
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 286 ~l~~ 289 (309)
T 2h34_A 286 DLSA 289 (309)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8775
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=233.19 Aligned_cols=155 Identities=25% Similarity=0.364 Sum_probs=121.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......+++.|+|||++.
T Consensus 111 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (295)
T 3ugc_A 111 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190 (295)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc
Confidence 5788999999999999999999999999999999999999999999999998654321 1123345777899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH----------------HHHHHHHhCCCCCCCCCCCcCHHHHH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT----------------RALFQIVRNPPPGLYRASNWSQHYVD 141 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~s~~~~~ 141 (488)
+ ..++.++||||||+++|+|++|..||...... .....+.... ....+..+++.+.+
T Consensus 191 ~-----~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 263 (295)
T 3ugc_A 191 E-----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG--RLPRPDGCPDEIYM 263 (295)
T ss_dssp H-----CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC--CCCCCTTCCHHHHH
T ss_pred C-----CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccC--cCCCCcCcCHHHHH
Confidence 6 56899999999999999999999998653211 1111112222 22345678999999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q psy9090 142 FIAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 142 li~~~L~~dP~~Rps~~ell~ 162 (488)
+|.+||..||++|||+.++++
T Consensus 264 li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 264 IMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-28 Score=239.59 Aligned_cols=162 Identities=23% Similarity=0.345 Sum_probs=122.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC----------CCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN----------HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~----------givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~ 68 (488)
+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....... ......||+
T Consensus 118 ~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~ 197 (322)
T 3soc_A 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197 (322)
T ss_dssp BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCc
Confidence 47889999999999999999999 999999999999999999999999999976543222 233467999
Q ss_pred ccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---------------HHHHHHHH-hCCCCC-CC-
Q psy9090 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---------------TRALFQIV-RNPPPG-LY- 130 (488)
Q Consensus 69 ~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---------------~~~~~~~~-~~~~~~-~~- 130 (488)
.|+|||++.+.......++.++|||||||++|+|++|+.||.+... ........ .....+ ..
T Consensus 198 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (322)
T 3soc_A 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277 (322)
T ss_dssp GGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred cccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccc
Confidence 9999999976322223456788999999999999999999965321 11222222 111111 10
Q ss_pred --CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy9090 131 --RASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 131 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 162 (488)
.....++.+.+||.+||..||++|||+.++++
T Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 278 YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11122456999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=242.62 Aligned_cols=156 Identities=25% Similarity=0.454 Sum_probs=121.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc----CccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF----DKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~l 76 (488)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++
T Consensus 189 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 268 (373)
T 3c1x_A 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268 (373)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHh
Confidence 3678899999999999999999999999999999999999999999999997553221 112334577899999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.+ ..++.++|||||||++|+|++ |.+||...........+...... ..+..+++.+.++|.+||..||.+||
T Consensus 269 ~~-----~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~dp~~RP 341 (373)
T 3c1x_A 269 QT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRP 341 (373)
T ss_dssp HH-----CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cC-----CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 76 678999999999999999999 78888776655555555544332 23566899999999999999999999
Q ss_pred CHHHHhcC
Q psy9090 156 YMSELLEH 163 (488)
Q Consensus 156 s~~ell~h 163 (488)
|+.+++++
T Consensus 342 s~~ell~~ 349 (373)
T 3c1x_A 342 SFSELVSR 349 (373)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=231.39 Aligned_cols=154 Identities=25% Similarity=0.422 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......||+.|+|||++.+
T Consensus 119 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-- 195 (284)
T 2a19_B 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISS-- 195 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHC--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecccc-ccccccCCcccccChhhhcc--
Confidence 578899999999999999999999999999999999999999999999998766543 23345579999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..++.++||||||+++|+|++|..|+... ......+.... .+..+++.+.++|.+||..||.+|||+.++
T Consensus 196 ---~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 265 (284)
T 2a19_B 196 ---QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI-----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265 (284)
T ss_dssp ---SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc-----ccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 56889999999999999999999987532 12222222221 235678999999999999999999999999
Q ss_pred hcCcCCC
Q psy9090 161 LEHPFIT 167 (488)
Q Consensus 161 l~hp~f~ 167 (488)
++++|..
T Consensus 266 l~~l~~~ 272 (284)
T 2a19_B 266 LRTLTVW 272 (284)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=235.51 Aligned_cols=156 Identities=22% Similarity=0.411 Sum_probs=125.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (333)
T 1mqb_A 144 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223 (333)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcc
Confidence 57889999999999999999999999999999999999999999999999976543211 112234678899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|||||||++|+|++ |..||...........+......+ .+..+++.+.++|.+||..+|.+||+
T Consensus 224 ~-----~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps 296 (333)
T 1mqb_A 224 Y-----RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP--TPMDCPSAIYQLMMQCWQQERARRPK 296 (333)
T ss_dssp S-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--CCTTCBHHHHHHHHHHTCSSTTTSCC
T ss_pred c-----CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC--CcccCCHHHHHHHHHHcCCChhhCcC
Confidence 6 568899999999999999998 999999888766666665543322 34578999999999999999999999
Q ss_pred HHHHhcC
Q psy9090 157 MSELLEH 163 (488)
Q Consensus 157 ~~ell~h 163 (488)
+.+++++
T Consensus 297 ~~~l~~~ 303 (333)
T 1mqb_A 297 FADIVSI 303 (333)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=238.21 Aligned_cols=160 Identities=25% Similarity=0.427 Sum_probs=132.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC---CcEEEEecCCcccccccc--CccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD---GEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~ 75 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++....... .......||+.|+|||+
T Consensus 137 ~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 216 (327)
T 2yfx_A 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHH
T ss_pred ccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhH
Confidence 4678899999999999999999999999999999999854 459999999987543221 22334568899999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
+.+ ..++.++||||||+++|+|++ |..||...........+.....+. .+..+++.+.++|.+||..||.+|
T Consensus 217 ~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~R 289 (327)
T 2yfx_A 217 FME-----GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDR 289 (327)
T ss_dssp HHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHhcCChhhC
Confidence 976 568899999999999999998 999999887766666665543332 345789999999999999999999
Q ss_pred CCHHHHhcCcCCC
Q psy9090 155 PYMSELLEHPFIT 167 (488)
Q Consensus 155 ps~~ell~hp~f~ 167 (488)
||+.++++++|+.
T Consensus 290 ps~~~ll~~l~~~ 302 (327)
T 2yfx_A 290 PNFAIILERIEYC 302 (327)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHH
Confidence 9999999998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=238.09 Aligned_cols=157 Identities=16% Similarity=0.291 Sum_probs=125.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC--cEEEEecCCccccccccC-------ccccccCCCccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG--EVKIVDFGLSRETANTFD-------KKKTFLGSPSWM 71 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~ 71 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... ......||+.|+
T Consensus 156 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 235 (352)
T 2jii_A 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235 (352)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCcccc
Confidence 57899999999999999999999999999999999999998 899999999976543211 123457999999
Q ss_pred cchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC-hHHHHHHHH---hCCCCCCCC----CCCcCHHHHHHH
Q psy9090 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMH-PTRALFQIV---RNPPPGLYR----ASNWSQHYVDFI 143 (488)
Q Consensus 72 aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~-~~~~~~~~~---~~~~~~~~~----~~~~s~~~~~li 143 (488)
|||++.+ ..++.++|||||||++|+|++|..||.... ....+.... ....+.... ...+++.+.+||
T Consensus 236 aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 310 (352)
T 2jii_A 236 SMDLHKG-----CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYL 310 (352)
T ss_dssp CHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHH
T ss_pred CHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHH
Confidence 9999976 568899999999999999999999997653 222222222 111111111 124689999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy9090 144 AECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~ 162 (488)
.+||..||.+|||++++++
T Consensus 311 ~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 311 KVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhCChhhCCCHHHHHH
Confidence 9999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=233.07 Aligned_cols=156 Identities=24% Similarity=0.501 Sum_probs=116.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..............|++.|+|||++.+
T Consensus 133 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 210 (310)
T 2wqm_A 133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-- 210 (310)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC--
Confidence 478899999999999999999999999999999999999999999999998765543333445678999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCC--hHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMH--PTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||||+++|+|++|..||.+.. .......+.....+. .....+++.+.+||.+||..||.+|||+.
T Consensus 211 ---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 286 (310)
T 2wqm_A 211 ---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-LPSDHYSEELRQLVNMCINPDPEKRPDVT 286 (310)
T ss_dssp ---CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-CCTTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-CcccccCHHHHHHHHHHcCCChhhCCCHH
Confidence 568899999999999999999999997543 222333333322222 22356899999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 287 ~il~ 290 (310)
T 2wqm_A 287 YVYD 290 (310)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=245.83 Aligned_cols=152 Identities=25% Similarity=0.461 Sum_probs=128.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+
T Consensus 286 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~-- 360 (450)
T 1k9a_A 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALRE-- 360 (450)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHS--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcC--
Confidence 477889999999999999999999999999999999999999999999999754332 223367889999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|||||||++|+|++ |..||...........+..+... ..+..+++.+.+||.+||..||.+|||+.+
T Consensus 361 ---~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~ 435 (450)
T 1k9a_A 361 ---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--DAPDGCPPAVYDVMKNCWHLDAATRPTFLQ 435 (450)
T ss_dssp ---SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 678999999999999999998 99999887766666666554433 245678999999999999999999999999
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
+++
T Consensus 436 l~~ 438 (450)
T 1k9a_A 436 LRE 438 (450)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=234.81 Aligned_cols=162 Identities=25% Similarity=0.448 Sum_probs=122.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--------HCCCeecccCCCCEEEccCCcEEEEecCCccccccccC----ccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLH--------ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH--------~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~ 68 (488)
+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++....... ......||+
T Consensus 102 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 181 (301)
T 3q4u_A 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181 (301)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCG
T ss_pred cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccccc
Confidence 478899999999999999999 99999999999999999999999999999875543211 123457999
Q ss_pred ccccchhhcccccCC-CCCCCccchhhhHHHHHHHhcC----------CCCCCCCCh----HHHHHHHHhCC--CCCCC-
Q psy9090 69 SWMAPEIMRCGHKEV-DGYDNRIDVWALGITAIELGDG----------KPPFEDMHP----TRALFQIVRNP--PPGLY- 130 (488)
Q Consensus 69 ~y~aPE~l~~~~~~~-~~~~~~~DiwslGvil~elltg----------~~Pf~~~~~----~~~~~~~~~~~--~~~~~- 130 (488)
.|+|||++.+..... ..++.++|||||||++|+|++| ..||..... ........... .+..+
T Consensus 182 ~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (301)
T 3q4u_A 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN 261 (301)
T ss_dssp GGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred ceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCCh
Confidence 999999997631100 0345789999999999999999 889854321 22333333221 11111
Q ss_pred --CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy9090 131 --RASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 131 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 162 (488)
.....++.+.+||.+||..||++|||+.++++
T Consensus 262 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 262 RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 11224578999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=226.84 Aligned_cols=154 Identities=18% Similarity=0.351 Sum_probs=128.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.+++.++.||+.||+|||++| ++||||||+||+++.++.++|+|||++.... .....||+.|+|||++.+
T Consensus 108 ~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 108 VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQK 182 (271)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHS
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec-----ccCccCCccccChhhhcc
Confidence 578999999999999999999999 9999999999999999999999888765432 234578999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
... ..++.++|||||||++|+|++|..||.+.........+....... ..+..+++.+.++|.+||..||++|||++
T Consensus 183 ~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 259 (271)
T 3kmu_A 183 KPE--DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSKLMKICMNEDPAKRPKFD 259 (271)
T ss_dssp CGG--GSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCC--CCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 211 234458999999999999999999999888777666666543322 23567899999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 260 ~il~ 263 (271)
T 3kmu_A 260 MIVP 263 (271)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=232.72 Aligned_cols=152 Identities=28% Similarity=0.558 Sum_probs=119.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCCeecccCCCCEEEccCCc-EEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE---NHVIHRDLRGSNVLLTKDGE-VKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~-vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++...... .....||+.|+|||++
T Consensus 99 ~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~ 175 (307)
T 2eva_A 99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVF 175 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhh
Confidence 3578889999999999999999 89999999999999998887 799999998755432 2344689999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP--TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
.+ ..++.++||||||+++|+|++|+.||..... ............+. .+..+++.+.++|.+||..||.+|
T Consensus 176 ~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~R 248 (307)
T 2eva_A 176 EG-----SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP--LIKNLPKPIESLMTRCWSKDPSQR 248 (307)
T ss_dssp TC-----CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC--CBTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CC-----CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC--cccccCHHHHHHHHHHhcCChhhC
Confidence 76 5788999999999999999999999975432 22223333333222 345679999999999999999999
Q ss_pred CCHHHHhc
Q psy9090 155 PYMSELLE 162 (488)
Q Consensus 155 ps~~ell~ 162 (488)
||+.++++
T Consensus 249 ps~~ell~ 256 (307)
T 2eva_A 249 PSMEEIVK 256 (307)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=239.96 Aligned_cols=155 Identities=21% Similarity=0.417 Sum_probs=119.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc---cccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK---KKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~l~ 77 (488)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (373)
T 2qol_A 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223 (373)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhc
Confidence 467889999999999999999999999999999999999999999999999765432111 11223567899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|||||||++|+|++ |..||...........+...... ..+..++..+.++|.+||..||.+||+
T Consensus 224 ~-----~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs 296 (373)
T 2qol_A 224 Y-----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL--PPPMDCPAALYQLMLDCWQKDRNNRPK 296 (373)
T ss_dssp H-----CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC--CCCTTCBHHHHHHHHHHTCSSGGGSCC
T ss_pred c-----CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCccccHHHHHHHHHHhCcChhhCcC
Confidence 6 578999999999999999997 99999988876666555544222 234567899999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 297 ~~~i~~ 302 (373)
T 2qol_A 297 FEQIVS 302 (373)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=245.08 Aligned_cols=161 Identities=27% Similarity=0.471 Sum_probs=130.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......+++.|+|||++..
T Consensus 277 ~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 355 (452)
T 1fmk_A 277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 355 (452)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhc-
Confidence 4678999999999999999999999999999999999999999999999997654321 11223456789999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|||||||++|+|++ |..||.+.........+......+ .+..+++.+.+||.+||..||++|||++
T Consensus 356 ----~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 429 (452)
T 1fmk_A 356 ----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPECPESLHDLMCQCWRKEPEERPTFE 429 (452)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 568999999999999999999 999999988777776666554332 3567899999999999999999999999
Q ss_pred HHhc--CcCCCC
Q psy9090 159 ELLE--HPFITS 168 (488)
Q Consensus 159 ell~--hp~f~~ 168 (488)
++++ ..++..
T Consensus 430 ~l~~~L~~~~~~ 441 (452)
T 1fmk_A 430 YLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHTTTSC
T ss_pred HHHHHHHHHhcc
Confidence 9886 245543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=230.99 Aligned_cols=151 Identities=23% Similarity=0.463 Sum_probs=122.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc--------EEEEecCCccccccccCccccccCCCcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE--------VKIVDFGLSRETANTFDKKKTFLGSPSWMA 72 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--------vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~a 72 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..... .....||+.|+|
T Consensus 110 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~a 185 (289)
T 4fvq_A 110 INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----KDILQERIPWVP 185 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC----HHHHHHTTTTSC
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC----ccccCCcCcccC
Confidence 578889999999999999999999999999999999998887 99999999865432 234468899999
Q ss_pred chhhcccccCCCCCCCccchhhhHHHHHHHhcC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 73 PEIMRCGHKEVDGYDNRIDVWALGITAIELGDG-KPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 73 PE~l~~~~~~~~~~~~~~DiwslGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
||++.+. ..++.++|||||||++|+|++| .+||....... ......... ..+...++.+.+||.+||..||
T Consensus 186 PE~~~~~----~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp 257 (289)
T 4fvq_A 186 PECIENP----KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDRH---QLPAPKAAELANLINNCMDYEP 257 (289)
T ss_dssp HHHHHCG----GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTC---CCCCCSSCTTHHHHHHHSCSSG
T ss_pred HHHhCCC----CCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhccC---CCCCCCCHHHHHHHHHHcCCCh
Confidence 9999752 4578999999999999999995 55555544433 333333221 1234568889999999999999
Q ss_pred CCCCCHHHHhcC
Q psy9090 152 EHRPYMSELLEH 163 (488)
Q Consensus 152 ~~Rps~~ell~h 163 (488)
.+|||+.+++++
T Consensus 258 ~~Rps~~~ll~~ 269 (289)
T 4fvq_A 258 DHRPSFRAIIRD 269 (289)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=237.00 Aligned_cols=159 Identities=23% Similarity=0.341 Sum_probs=123.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+
T Consensus 136 ~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2qkw_B 136 MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC
Confidence 4688999999999999999999999999999999999999999999999987543221 12234568999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH------HHHHHhC-CCCCC-------CCCCCcCHHHHHHHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA------LFQIVRN-PPPGL-------YRASNWSQHYVDFIA 144 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~------~~~~~~~-~~~~~-------~~~~~~s~~~~~li~ 144 (488)
..++.++|||||||++|+|++|+.||....+... ....... ..... ..+...+..+.+++.
T Consensus 216 -----~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (321)
T 2qkw_B 216 -----GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAV 290 (321)
T ss_dssp -----CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHH
T ss_pred -----CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHH
Confidence 5688999999999999999999999975433211 0111111 10000 112234567899999
Q ss_pred HhcccCCCCCCCHHHHhcCc
Q psy9090 145 ECLEKNPEHRPYMSELLEHP 164 (488)
Q Consensus 145 ~~L~~dP~~Rps~~ell~hp 164 (488)
+||..||++|||+.+++++.
T Consensus 291 ~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 291 KCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHTCSSGGGSCCHHHHHHHH
T ss_pred HHcCCCcccCcCHHHHHHHH
Confidence 99999999999999998763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-27 Score=230.03 Aligned_cols=160 Identities=28% Similarity=0.438 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc-----cCccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT-----FDKKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~ 75 (488)
+++.+++.++.||+.||+|||++|++||||||+||+++ ++.+||+|||++...... ........||+.|+|||+
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 205 (319)
T 2y4i_B 127 LDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205 (319)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHH
Confidence 46789999999999999999999999999999999998 689999999997654211 122334568999999999
Q ss_pred hccccc----CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCC
Q psy9090 76 MRCGHK----EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNP 151 (488)
Q Consensus 76 l~~~~~----~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 151 (488)
+..... ....++.++|||||||++|+|++|..||...........+.....+.. ....+++.+.++|.+||..||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL-SQIGMGKEISDILLFCWAFEQ 284 (319)
T ss_dssp HSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC-CCSSCCTTHHHHHHHHHCSST
T ss_pred hhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC-CcCCCCHHHHHHHHHHhcCCh
Confidence 875211 124578899999999999999999999998887766666655544332 334678999999999999999
Q ss_pred CCCCCHHHHhc
Q psy9090 152 EHRPYMSELLE 162 (488)
Q Consensus 152 ~~Rps~~ell~ 162 (488)
.+|||+.++++
T Consensus 285 ~~Rpt~~~l~~ 295 (319)
T 2y4i_B 285 EERPTFTKLMD 295 (319)
T ss_dssp TTSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=236.22 Aligned_cols=157 Identities=25% Similarity=0.371 Sum_probs=108.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEccCCcEEEEecCCccccccccC------------ccccccC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD------------KKKTFLG 66 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~------------~~~~~~g 66 (488)
+++.+++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....... ......|
T Consensus 133 ~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (337)
T 3ll6_A 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccC
Confidence 578899999999999999999999 99999999999999999999999999976543211 1124568
Q ss_pred CCccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHh
Q psy9090 67 SPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAEC 146 (488)
Q Consensus 67 t~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 146 (488)
|+.|+|||++.... ...++.++|||||||++|+|++|..||............. ........+..+.+||.+|
T Consensus 213 t~~y~aPE~~~~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~ 285 (337)
T 3ll6_A 213 TPMYRTPEIIDLYS--NFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY-----SIPPHDTQYTVFHSLIRAM 285 (337)
T ss_dssp -----------CCT--TSCSSHHHHHHHHHHHHHHHHHSSCCC------------C-----CCCTTCCSSGGGHHHHHHH
T ss_pred CCCcCChhhhhccc--cCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCcc-----cCCcccccchHHHHHHHHH
Confidence 99999999984211 1567889999999999999999999997654433222211 1223455678899999999
Q ss_pred cccCCCCCCCHHHHhcCc
Q psy9090 147 LEKNPEHRPYMSELLEHP 164 (488)
Q Consensus 147 L~~dP~~Rps~~ell~hp 164 (488)
|..||.+|||+.+++++.
T Consensus 286 l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 286 LQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp SCSSGGGSCCHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHH
Confidence 999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-27 Score=253.10 Aligned_cols=155 Identities=25% Similarity=0.442 Sum_probs=129.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.
T Consensus 466 l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~ 545 (635)
T 4fl3_A 466 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 545 (635)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhc
Confidence 5788999999999999999999999999999999999999999999999997654321 1122335678899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|||||||++|+|++ |..||.+.........+....... .+..+++++.+||.+||..||++|||
T Consensus 546 ~-----~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RPs 618 (635)
T 4fl3_A 546 Y-----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--CPAGCPREMYDLMNLCWTYDVENRPG 618 (635)
T ss_dssp H-----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred C-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCCHhHCcC
Confidence 6 678999999999999999998 999999988777666666554333 35678999999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 619 ~~~l~~ 624 (635)
T 4fl3_A 619 FAAVEL 624 (635)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=250.78 Aligned_cols=155 Identities=25% Similarity=0.432 Sum_probs=128.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.
T Consensus 433 l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~ 512 (613)
T 2ozo_A 433 IPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512 (613)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhc
Confidence 57889999999999999999999999999999999999999999999999986543211 112234568999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|||||||++|+|++ |..||.+.........+..+.... .+..+++.+.+||.+||..+|++||+
T Consensus 513 ~-----~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RPs 585 (613)
T 2ozo_A 513 F-----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME--CPPECPPELYALMSDCWIYKWEDRPD 585 (613)
T ss_dssp H-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSTTTSCC
T ss_pred C-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--CCCcCCHHHHHHHHHHcCCChhHCcC
Confidence 6 678999999999999999998 999999888777776666554332 35678999999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 586 ~~~l~~ 591 (613)
T 2ozo_A 586 FLTVEQ 591 (613)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999854
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=229.63 Aligned_cols=156 Identities=25% Similarity=0.362 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.
T Consensus 123 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (302)
T 4e5w_A 123 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202 (302)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeec
Confidence 5788999999999999999999999999999999999999999999999997654432 1233456888899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCC--------------ChHHHHHHHHhCCCCCCCCCCCcCHHHHHHH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM--------------HPTRALFQIVRNPPPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~--------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 143 (488)
+ ..++.++||||||+++|+|++|..|+... .............. ....+..+++.+.+||
T Consensus 203 ~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 276 (302)
T 4e5w_A 203 Q-----SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK-RLPCPPNCPDEVYQLM 276 (302)
T ss_dssp H-----CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred C-----CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC-CCCCCCCCCHHHHHHH
Confidence 6 56788999999999999999999986432 11112222222211 2224567899999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy9090 144 AECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~ 162 (488)
.+||..||.+|||+.++++
T Consensus 277 ~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 277 RKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHTTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCCCHHHHHH
Confidence 9999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=234.70 Aligned_cols=157 Identities=23% Similarity=0.390 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.
T Consensus 124 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (327)
T 3lxl_A 124 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhc
Confidence 57889999999999999999999999999999999999999999999999976543211 223446888899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH--------------HHHHHHHhCCCCCCCCCCCcCHHHHHHH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT--------------RALFQIVRNPPPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~s~~~~~li 143 (488)
+ ..++.++||||||+++|+|++|..||...... ......+.... ....+..+++.+.+||
T Consensus 204 ~-----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 277 (327)
T 3lxl_A 204 D-----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ-RLPAPPACPAEVHELM 277 (327)
T ss_dssp H-----CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred c-----CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc-CCCCCCcccHHHHHHH
Confidence 6 56788999999999999999999998653321 11222222211 2223567899999999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q psy9090 144 AECLEKNPEHRPYMSELLEH 163 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~h 163 (488)
.+||..||.+|||+.+++++
T Consensus 278 ~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 278 KLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=233.17 Aligned_cols=162 Identities=23% Similarity=0.355 Sum_probs=124.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN---HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l 76 (488)
+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++
T Consensus 128 ~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (326)
T 3uim_A 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 207 (326)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHh
Confidence 46789999999999999999999 99999999999999999999999999997654322 223445699999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCC----ChHHHHHHHHhCCCCC-----C-------CCCCCcCHHHH
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM----HPTRALFQIVRNPPPG-----L-------YRASNWSQHYV 140 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~----~~~~~~~~~~~~~~~~-----~-------~~~~~~s~~~~ 140 (488)
.+ ..++.++|||||||++|+|++|..||... .........+...... . ..+...++.+.
T Consensus 208 ~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 282 (326)
T 3uim_A 208 ST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLI 282 (326)
T ss_dssp HH-----SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHH
T ss_pred cc-----CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHH
Confidence 76 56789999999999999999999999521 1111111122111100 0 01112246789
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcCCC
Q psy9090 141 DFIAECLEKNPEHRPYMSELLEHPFIT 167 (488)
Q Consensus 141 ~li~~~L~~dP~~Rps~~ell~hp~f~ 167 (488)
+++.+||..||.+|||+.++++|..-.
T Consensus 283 ~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 283 QVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 999999999999999999999876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=246.18 Aligned_cols=155 Identities=24% Similarity=0.463 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......+++.|+|||++..
T Consensus 315 ~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 393 (495)
T 1opk_A 315 VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 393 (495)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc-
Confidence 4678899999999999999999999999999999999999999999999998654321 12233456788999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|||||||++|+|++ |..||.+.........+...... ..+..+++.+.+||.+||..||.+|||+.
T Consensus 394 ----~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 467 (495)
T 1opk_A 394 ----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFA 467 (495)
T ss_dssp ----CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCcChhHCcCHH
Confidence 568899999999999999999 99999988766655555444322 24567899999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 468 el~~ 471 (495)
T 1opk_A 468 EIHQ 471 (495)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-27 Score=232.29 Aligned_cols=158 Identities=22% Similarity=0.432 Sum_probs=119.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC--------CCeecccCCCCEEEccCCcEEEEecCCccccccccCc----cccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHEN--------HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK----KKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~--------givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~gt~ 68 (488)
+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......... .....||+
T Consensus 131 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 210 (337)
T 3mdy_A 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210 (337)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCc
Confidence 47889999999999999999999 9999999999999999999999999999765432111 23557999
Q ss_pred ccccchhhcccccCCCCCCC------ccchhhhHHHHHHHhcC----------CCCCCCCCh----HHHHHHHHhCC--C
Q psy9090 69 SWMAPEIMRCGHKEVDGYDN------RIDVWALGITAIELGDG----------KPPFEDMHP----TRALFQIVRNP--P 126 (488)
Q Consensus 69 ~y~aPE~l~~~~~~~~~~~~------~~DiwslGvil~elltg----------~~Pf~~~~~----~~~~~~~~~~~--~ 126 (488)
.|+|||++.+ ..++. ++|||||||++|+|++| ..||..... ........... .
T Consensus 211 ~y~aPE~~~~-----~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
T 3mdy_A 211 RYMPPEVLDE-----SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285 (337)
T ss_dssp GGCCHHHHTT-----CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC
T ss_pred ceeChhhccc-----ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccC
Confidence 9999999976 22333 48999999999999999 777754321 22223322211 1
Q ss_pred CCCC---CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy9090 127 PGLY---RASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163 (488)
Q Consensus 127 ~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 163 (488)
+..+ ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 286 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1111 122456779999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=235.73 Aligned_cols=160 Identities=23% Similarity=0.406 Sum_probs=123.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---------ccccccCCCccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---------KKKTFLGSPSWM 71 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---------~~~~~~gt~~y~ 71 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......||+.|+
T Consensus 131 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 210 (317)
T 2buj_A 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccC
Confidence 57889999999999999999999999999999999999999999999998875432111 112345799999
Q ss_pred cchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH-HHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccC
Q psy9090 72 APEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT-RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKN 150 (488)
Q Consensus 72 aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 150 (488)
|||++.+.. ...++.++||||||+++|+|++|..||...... .......... ...+.+..+++.+.++|.+||..|
T Consensus 211 aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~d 287 (317)
T 2buj_A 211 APELFSVQS--HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ-LSIPQSPRHSSALWQLLNSMMTVD 287 (317)
T ss_dssp CGGGSSCCS--EEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSS
T ss_pred CHhHhccCC--CcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-CCCCccccCCHHHHHHHHHHhhcC
Confidence 999986521 123688999999999999999999999531100 0111122221 122234567999999999999999
Q ss_pred CCCCCCHHHHhcC
Q psy9090 151 PEHRPYMSELLEH 163 (488)
Q Consensus 151 P~~Rps~~ell~h 163 (488)
|.+|||+.+++++
T Consensus 288 p~~Rps~~~ll~~ 300 (317)
T 2buj_A 288 PHQRPHIPLLLSQ 300 (317)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-27 Score=230.37 Aligned_cols=157 Identities=25% Similarity=0.463 Sum_probs=122.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......||+.|+|||++.+
T Consensus 130 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 209 (307)
T 2nru_A 130 LSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG 209 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence 46788999999999999999999999999999999999999999999999876543211 2234578999999999864
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHH---HHHHHhCCCC--------CC-CCCCCcCHHHHHHHHHh
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA---LFQIVRNPPP--------GL-YRASNWSQHYVDFIAEC 146 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~---~~~~~~~~~~--------~~-~~~~~~s~~~~~li~~~ 146 (488)
.++.++||||||+++|+|++|.+||........ +......... .. ..+...++.+.+++.+|
T Consensus 210 ------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 283 (307)
T 2nru_A 210 ------EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQC 283 (307)
T ss_dssp ------EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHH
T ss_pred ------CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHH
Confidence 478899999999999999999999976543221 1111111100 00 11223457789999999
Q ss_pred cccCCCCCCCHHHHhcC
Q psy9090 147 LEKNPEHRPYMSELLEH 163 (488)
Q Consensus 147 L~~dP~~Rps~~ell~h 163 (488)
|..+|.+|||+.+++++
T Consensus 284 l~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 284 LHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp TCSSTTTSCCHHHHHHH
T ss_pred cCCCcccCcCHHHHHHH
Confidence 99999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-27 Score=232.51 Aligned_cols=167 Identities=20% Similarity=0.279 Sum_probs=120.0
Q ss_pred CHHHHHHHHHHHHHHHHHHHHC---------CCeecccCCCCEEEccCCcEEEEecCCccccccc--------cCccccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHEN---------HVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--------FDKKKTF 64 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~---------givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--------~~~~~~~ 64 (488)
++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... .......
T Consensus 109 ~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 188 (336)
T 3g2f_A 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCT
T ss_pred chhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccC
Confidence 5678899999999999999999 9999999999999999999999999999765422 1122345
Q ss_pred cCCCccccchhhcccccC--CCCCCCccchhhhHHHHHHHhcCCCCCCCCCh-----------------HHHHHHHHhCC
Q psy9090 65 LGSPSWMAPEIMRCGHKE--VDGYDNRIDVWALGITAIELGDGKPPFEDMHP-----------------TRALFQIVRNP 125 (488)
Q Consensus 65 ~gt~~y~aPE~l~~~~~~--~~~~~~~~DiwslGvil~elltg~~Pf~~~~~-----------------~~~~~~~~~~~ 125 (488)
.||+.|+|||++.+.... ...++.++|||||||++|+|++|..||..... ...........
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (336)
T 3g2f_A 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE 268 (336)
T ss_dssp TSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS
T ss_pred CCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhccc
Confidence 799999999999752110 02456789999999999999999777632111 11122222211
Q ss_pred CCCCCCCCC------cCHHHHHHHHHhcccCCCCCCCHHHHhc------CcCCCC
Q psy9090 126 PPGLYRASN------WSQHYVDFIAECLEKNPEHRPYMSELLE------HPFITS 168 (488)
Q Consensus 126 ~~~~~~~~~------~s~~~~~li~~~L~~dP~~Rps~~ell~------hp~f~~ 168 (488)
......+.. .++.+.+||.+||..||++|||+.++++ ++|-++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 269 KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 111111222 3457999999999999999999999954 555543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=244.61 Aligned_cols=161 Identities=27% Similarity=0.467 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......+++.|+|||++..
T Consensus 360 l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 438 (535)
T 2h8h_A 360 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 438 (535)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhcc-
Confidence 4678999999999999999999999999999999999999999999999997654321 11223456788999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|||||||++|+|++ |..||.+....+....+...... ..+..+++.+.+||.+||..||++|||++
T Consensus 439 ----~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 512 (535)
T 2h8h_A 439 ----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--PCPPECPESLHDLMCQCWRKEPEERPTFE 512 (535)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 568999999999999999999 99999998877777666655332 23567899999999999999999999999
Q ss_pred HHhcC--cCCCC
Q psy9090 159 ELLEH--PFITS 168 (488)
Q Consensus 159 ell~h--p~f~~ 168 (488)
++++. .++..
T Consensus 513 ~l~~~L~~~~~~ 524 (535)
T 2h8h_A 513 YLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHHHTSSCC
T ss_pred HHHHHHHHHhhc
Confidence 98863 44443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-27 Score=230.82 Aligned_cols=156 Identities=27% Similarity=0.449 Sum_probs=124.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.
T Consensus 131 ~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 210 (318)
T 3lxp_A 131 IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence 57889999999999999999999999999999999999999999999999986643321 223456788899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH--------------HHHHHHHhCCCCCCCCCCCcCHHHHHHH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT--------------RALFQIVRNPPPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~s~~~~~li 143 (488)
+ ..++.++||||||+++|+|++|..||...... ......+... .....+..+++.+.+||
T Consensus 211 ~-----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 284 (318)
T 3lxp_A 211 E-----YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG-ERLPRPDKCPAEVYHLM 284 (318)
T ss_dssp H-----CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred C-----CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc-cCCCCCccccHHHHHHH
Confidence 6 56788999999999999999999999653211 0111222221 12234567899999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy9090 144 AECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~ 162 (488)
.+||..||.+|||+.++++
T Consensus 285 ~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 285 KNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-27 Score=229.20 Aligned_cols=142 Identities=29% Similarity=0.486 Sum_probs=111.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc---CCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 114 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--------------------- 172 (299)
T 3m2w_A 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--------------------- 172 (299)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc---------------------
Confidence 578899999999999999999999999999999999998 78899999998754321
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCC----CCcCHHHHHHHHHhcccCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRA----SNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~----~~~s~~~~~li~~~L~~dP~ 152 (488)
..++.++|||||||++|+|++|..||................... ...+ ..+++.+.+||.+||..||.
T Consensus 173 ------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 246 (299)
T 3m2w_A 173 ------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 246 (299)
T ss_dssp ------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTT
T ss_pred ------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChh
Confidence 346678999999999999999999997755432211111111111 1111 45799999999999999999
Q ss_pred CCCCHHHHhcCcCCCCC
Q psy9090 153 HRPYMSELLEHPFITSL 169 (488)
Q Consensus 153 ~Rps~~ell~hp~f~~~ 169 (488)
+|||+.++++||||++.
T Consensus 247 ~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 247 QRMTITEFMNHPWIMQS 263 (299)
T ss_dssp TSCCHHHHHTSHHHHTG
T ss_pred hCCCHHHHhcChhhccc
Confidence 99999999999999764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-27 Score=249.77 Aligned_cols=163 Identities=25% Similarity=0.393 Sum_probs=126.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCc---EEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE---VKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++...... .......||+.|+|||++.
T Consensus 118 lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~ 196 (676)
T 3qa8_A 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLE 196 (676)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccc-cccccccCCcccCChHHhc
Confidence 467789999999999999999999999999999999997765 999999999876543 3345568999999999987
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh----------CC-----------CCCCCCCCCcC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR----------NP-----------PPGLYRASNWS 136 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~----------~~-----------~~~~~~~~~~s 136 (488)
+ ..++.++|||||||++|+|++|..||........+..... .. +.+......++
T Consensus 197 ~-----~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls 271 (676)
T 3qa8_A 197 Q-----KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILA 271 (676)
T ss_dssp C-----SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGH
T ss_pred c-----CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhh
Confidence 6 6788999999999999999999999976533221110000 00 00000122356
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 137 QHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 137 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
+.+.+||.+||..||.+|||+.++++||||+.+
T Consensus 272 ~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 272 GKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp HHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred HHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 889999999999999999999999999999764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=248.28 Aligned_cols=155 Identities=25% Similarity=0.438 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+
T Consensus 488 l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 566 (656)
T 2j0j_A 488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF- 566 (656)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-
Confidence 46788999999999999999999999999999999999999999999999986543211 1223456789999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++|||||||++|+|++ |.+||.+.........+.....+. .+..+++.+.++|.+||..||.+|||+.
T Consensus 567 ----~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~RPs~~ 640 (656)
T 2j0j_A 567 ----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRPRFT 640 (656)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--CCccccHHHHHHHHHHcCCChhHCcCHH
Confidence 578999999999999999997 999999988877777776654433 3567899999999999999999999999
Q ss_pred HHhc
Q psy9090 159 ELLE 162 (488)
Q Consensus 159 ell~ 162 (488)
++++
T Consensus 641 el~~ 644 (656)
T 2j0j_A 641 ELKA 644 (656)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-27 Score=235.55 Aligned_cols=149 Identities=16% Similarity=0.207 Sum_probs=117.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-----------CCcEEEEecCCcccccc--ccCccccccCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-----------DGEVKIVDFGLSRETAN--TFDKKKTFLGS 67 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-----------~~~vkL~Dfg~a~~~~~--~~~~~~~~~gt 67 (488)
|++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... ........+||
T Consensus 169 l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 248 (365)
T 3e7e_A 169 MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248 (365)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCT
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCC
Confidence 578899999999999999999999999999999999998 89999999999975432 12234556899
Q ss_pred CccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhc
Q psy9090 68 PSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECL 147 (488)
Q Consensus 68 ~~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 147 (488)
+.|+|||++.+ ..|+.++|||||||++|+|++|+.||....... ... .........++.+.+++..||
T Consensus 249 ~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~-~~~~~~~~~~~~~~~~~~~~l 316 (365)
T 3e7e_A 249 SGFQCVEMLSN-----KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------CKP-EGLFRRLPHLDMWNEFFHVML 316 (365)
T ss_dssp TSCCCHHHHTT-----CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE------EEE-CSCCTTCSSHHHHHHHHHHHH
T ss_pred CCCCChHHhcC-----CCCCccccHHHHHHHHHHHHhCCCccccCCCCc------eee-chhccccCcHHHHHHHHHHHc
Confidence 99999999976 568999999999999999999999995432210 000 011112234677899999999
Q ss_pred ccCCCCCCCHHHHh
Q psy9090 148 EKNPEHRPYMSELL 161 (488)
Q Consensus 148 ~~dP~~Rps~~ell 161 (488)
..+|.+|++..+.+
T Consensus 317 ~~~p~~r~~~~~~l 330 (365)
T 3e7e_A 317 NIPDCHHLPSLDLL 330 (365)
T ss_dssp CCCCTTCCCCHHHH
T ss_pred CCCCCCcchHHHHH
Confidence 99999996544433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=237.27 Aligned_cols=162 Identities=20% Similarity=0.474 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEE----ccCCcEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL----TKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..... .......||+.|+|||++
T Consensus 109 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~ 187 (396)
T 4eut_A 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMY 187 (396)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG-GGSSCSSSCCTTCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC-CccccccCCccccCHHHh
Confidence 5789999999999999999999999999999999999 77788999999999876543 334456799999999998
Q ss_pred cccccC---CCCCCCccchhhhHHHHHHHhcCCCCCCCC----ChHHHHHHHHhCCCCCC------------------CC
Q psy9090 77 RCGHKE---VDGYDNRIDVWALGITAIELGDGKPPFEDM----HPTRALFQIVRNPPPGL------------------YR 131 (488)
Q Consensus 77 ~~~~~~---~~~~~~~~DiwslGvil~elltg~~Pf~~~----~~~~~~~~~~~~~~~~~------------------~~ 131 (488)
...... ...++.++|||||||++|+|++|+.||... .....+.++....++.. +.
T Consensus 188 ~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 267 (396)
T 4eut_A 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267 (396)
T ss_dssp HHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCT
T ss_pred hccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCc
Confidence 641100 034678999999999999999999999632 23455566665443211 11
Q ss_pred C----CCcCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy9090 132 A----SNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163 (488)
Q Consensus 132 ~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 163 (488)
. ..++..+.++|.+||..||++|||+.+++++
T Consensus 268 ~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 268 SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1 1234677899999999999999999998663
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=227.27 Aligned_cols=156 Identities=25% Similarity=0.390 Sum_probs=123.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......+++.|+|||++.
T Consensus 142 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 221 (326)
T 2w1i_A 142 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221 (326)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhc
Confidence 47888999999999999999999999999999999999999999999999976543321 122345777899999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH---------------HHHHHHHhCCCCCCCCCCCcCHHHHHH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT---------------RALFQIVRNPPPGLYRASNWSQHYVDF 142 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~s~~~~~l 142 (488)
+ ..++.++||||||+++|+|++|..||...... ..+...+.... ....+..+++.+.++
T Consensus 222 ~-----~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 295 (326)
T 2w1i_A 222 E-----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG-RLPRPDGCPDEIYMI 295 (326)
T ss_dssp H-----CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC-CCCCCTTCCHHHHHH
T ss_pred C-----CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCC-CCCCCCcccHHHHHH
Confidence 6 45788999999999999999999998643110 01112222211 122356789999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy9090 143 IAECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 143 i~~~L~~dP~~Rps~~ell~ 162 (488)
|.+||..||.+|||+.++++
T Consensus 296 i~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 296 MTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=228.39 Aligned_cols=163 Identities=21% Similarity=0.374 Sum_probs=122.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--------HCCCeecccCCCCEEEccCCcEEEEecCCccccccccC----ccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLH--------ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH--------~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~ 68 (488)
+++.+++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||++........ ......||+
T Consensus 136 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~ 215 (342)
T 1b6c_B 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215 (342)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCG
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCc
Confidence 468899999999999999999 89999999999999999999999999999976543321 234557999
Q ss_pred ccccchhhcccccCC-CCCCCccchhhhHHHHHHHhcC----------CCCCCCCCh----HHHHHHHHh-CCC-CCCC-
Q psy9090 69 SWMAPEIMRCGHKEV-DGYDNRIDVWALGITAIELGDG----------KPPFEDMHP----TRALFQIVR-NPP-PGLY- 130 (488)
Q Consensus 69 ~y~aPE~l~~~~~~~-~~~~~~~DiwslGvil~elltg----------~~Pf~~~~~----~~~~~~~~~-~~~-~~~~- 130 (488)
.|+|||++.+..... ..++.++|||||||++|+|++| ..||..... ...+...+. ... +..+
T Consensus 216 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (342)
T 1b6c_B 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 295 (342)
T ss_dssp GGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred ccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcc
Confidence 999999997521100 0233689999999999999999 788865421 223333332 211 1111
Q ss_pred --CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy9090 131 --RASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163 (488)
Q Consensus 131 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 163 (488)
.....++.+.+||.+||..||++|||+.++++|
T Consensus 296 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 296 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 112334678999999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-26 Score=228.43 Aligned_cols=151 Identities=20% Similarity=0.244 Sum_probs=118.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HCCCeecccCCCCEEEccCC--------------------cEEEEecCCccccccccC
Q psy9090 1 MSEQHIAFILKEIITGMVFLH-ENHVIHRDLRGSNVLLTKDG--------------------EVKIVDFGLSRETANTFD 59 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH-~~givHrDlkp~NILl~~~~--------------------~vkL~Dfg~a~~~~~~~~ 59 (488)
+++.+++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 158 ~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-- 235 (336)
T 2vuw_A 158 SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-- 235 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--
Confidence 578999999999999999999 99999999999999999987 8999999999865432
Q ss_pred ccccccCCCccccchhhcccccCCCCCCCccchhhhHHH-HHHHhcCCCCCCCCCh-HHHHHHHHhCCCCCCC----CCC
Q psy9090 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGIT-AIELGDGKPPFEDMHP-TRALFQIVRNPPPGLY----RAS 133 (488)
Q Consensus 60 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwslGvi-l~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~----~~~ 133 (488)
..+||+.|+|||++.+ .. +.++||||++++ .+++++|..||..... ......+......... .+.
T Consensus 236 ---~~~gt~~y~aPE~~~g-----~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (336)
T 2vuw_A 236 ---IVVFCDVSMDEDLFTG-----DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMK 306 (336)
T ss_dssp ---EEECCCCTTCSGGGCC-----CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHH
T ss_pred ---cEEEeecccChhhhcC-----CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhh
Confidence 4589999999999975 22 779999998776 7889999999854211 1122233322111111 122
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHh-cCcCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELL-EHPFIT 167 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell-~hp~f~ 167 (488)
.+++++++||.+||..| |++++| +||||+
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 46889999999999976 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-24 Score=237.36 Aligned_cols=147 Identities=21% Similarity=0.346 Sum_probs=121.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..... ....||+.|+|||++.+
T Consensus 179 l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~-- 251 (681)
T 2pzi_A 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRT-- 251 (681)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHH--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcC--
Confidence 5789999999999999999999999999999999999875 8999999999765432 45679999999999875
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.++.++|||||||++|+|++|.+||.+.... ..+........++.+.++|.+||..||.+||+..+.
T Consensus 252 ----~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 318 (681)
T 2pzi_A 252 ----GPTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEE 318 (681)
T ss_dssp ----CSCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred ----CCCCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccccccCHHHHHHHhhhccCChhhCCCHHHH
Confidence 3478999999999999999999998653210 011111111246789999999999999999999888
Q ss_pred hcCcCCC
Q psy9090 161 LEHPFIT 167 (488)
Q Consensus 161 l~hp~f~ 167 (488)
+.|+|+.
T Consensus 319 l~~~l~~ 325 (681)
T 2pzi_A 319 MSAQLTG 325 (681)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8888874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-22 Score=196.39 Aligned_cols=128 Identities=15% Similarity=0.063 Sum_probs=100.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccccc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHK 81 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 81 (488)
.+.++..++.||+.||+|||++||+||||||+|||++.+|.+||++++ |++
T Consensus 127 ~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------------------~~~--------- 177 (286)
T 3uqc_A 127 SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMP--------- 177 (286)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------------CCT---------
T ss_pred ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------------ccC---------
Confidence 355788899999999999999999999999999999999999997443 222
Q ss_pred CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHH---HHHhCC-CCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 82 EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF---QIVRNP-PPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 82 ~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~---~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
+++.++|||||||++|+|++|+.||.+......+. +..... .+.......+++.+.++|.+||..||.+| |+
T Consensus 178 ---~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~ 253 (286)
T 3uqc_A 178 ---DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SA 253 (286)
T ss_dssp ---TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CH
T ss_pred ---CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CH
Confidence 25689999999999999999999998765422110 011111 11111235679999999999999999999 99
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 254 ~el~~ 258 (286)
T 3uqc_A 254 STLLN 258 (286)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-21 Score=209.22 Aligned_cols=96 Identities=16% Similarity=0.144 Sum_probs=68.0
Q ss_pred HHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccccCCCCC
Q psy9090 7 AFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGY 86 (488)
Q Consensus 7 ~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~ 86 (488)
..|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+++..........+.+||+.|+|||++.+ .+
T Consensus 342 ~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g------~~ 415 (569)
T 4azs_A 342 EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE------NK 415 (569)
T ss_dssp HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC----------
T ss_pred HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC------CC
Confidence 458999999999999999999999999999999999999999999877655455667789999999999974 35
Q ss_pred CCccchhhhHHHHHHHhcCCCC
Q psy9090 87 DNRIDVWALGITAIELGDGKPP 108 (488)
Q Consensus 87 ~~~~DiwslGvil~elltg~~P 108 (488)
..++|+||+|++++.+.++..|
T Consensus 416 ~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 416 SWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -------------CCCCTTHHH
T ss_pred CCcccccccccchhhhccccch
Confidence 6789999999998888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=6.9e-15 Score=155.66 Aligned_cols=99 Identities=29% Similarity=0.373 Sum_probs=81.4
Q ss_pred HHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCc-------cccccCCCccccchhhcc
Q psy9090 6 IAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK-------KKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 6 ~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~l~~ 78 (488)
+..++.||+.||+|||++||+||||||+|||++. .+||+|||+++........ .....||+.|+|||++..
T Consensus 433 ~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 433 NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 3578999999999999999999999999999998 9999999999876543111 246689999999999975
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCC
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPF 109 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf 109 (488)
. ...|+..+|+|+..+-..+.+.++.+|
T Consensus 511 ~---~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 511 F---LEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp H---HHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred H---HHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2 134777899999988888777776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=2.8e-11 Score=117.24 Aligned_cols=59 Identities=25% Similarity=0.289 Sum_probs=52.4
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 5 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+...++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++. +..+.|||.+.
T Consensus 194 ~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 194 NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 4567999999999999999999999999999999 99999999999853 34568899875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=6.1e-10 Score=106.25 Aligned_cols=50 Identities=22% Similarity=0.400 Sum_probs=45.8
Q ss_pred HHHHHHHHHHHHHHHHHHH-HCCCeecccCCCCEEEccCCcEEEEecCCcccc
Q psy9090 3 EQHIAFILKEIITGMVFLH-ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET 54 (488)
Q Consensus 3 e~~~~~i~~qil~aL~~LH-~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~ 54 (488)
+..+..++.||+.+|.||| ++||+||||||+|||++. .++|+|||++...
T Consensus 169 ~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp GSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred hHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 3467899999999999999 999999999999999998 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.43 E-value=8.5e-08 Score=96.15 Aligned_cols=49 Identities=20% Similarity=0.311 Sum_probs=43.4
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC----------cEEEEecCCccc
Q psy9090 5 HIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG----------EVKIVDFGLSRE 53 (488)
Q Consensus 5 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----------~vkL~Dfg~a~~ 53 (488)
.+..++.||+.+|.+||++|||||||||.|||++.+| .+.|+||+-+..
T Consensus 206 ~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 206 DPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 4567899999999999999999999999999998877 388999986654
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.21 E-value=2.3e-08 Score=89.55 Aligned_cols=97 Identities=11% Similarity=0.160 Sum_probs=76.8
Q ss_pred ccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChh----hHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHH
Q psy9090 221 YSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPH----IYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLK 295 (488)
Q Consensus 221 yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph----~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k 295 (488)
...+..++..+++++.+.+.+.+|+..+........++. +|+++|.+++|.|+..+++.++. ..|-. ..+.++
T Consensus 46 ~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~--~~g~~~~~~ei~ 123 (176)
T 2lhi_A 46 EAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLT--SIGEKLTDAEVD 123 (176)
T ss_dssp HHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSHHHHHHHHHHHHHCSSCSSSBCHHHHHHHHH--TTTCCCCHHHHH
T ss_pred HHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHH--HcCcccchHHHH
Confidence 344556677788999999999999987765544332222 99999999999999999998883 33322 367899
Q ss_pred HHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 296 HLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 296 ~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.||+.++ ++||.|+|+||+.+|.+
T Consensus 124 ~l~~~~d-d~dG~I~~~EF~~~m~k 147 (176)
T 2lhi_A 124 DMLREVS-DGSGEINIQQFAALLSK 147 (176)
T ss_dssp HHHHHHH-TTSSCBCTTHHHHHHTC
T ss_pred HHHHhhc-CCCCeEeHHHHHHHHHh
Confidence 9999999 99999999999999865
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=97.88 E-value=1.3e-07 Score=81.76 Aligned_cols=97 Identities=13% Similarity=0.169 Sum_probs=75.5
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKH 296 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~ 296 (488)
..+..++..+++++.+.+.+.+|+..+........+. .+|+.+|.+++|.|+..+.+.++.+ |+ .-..+.++.
T Consensus 46 ~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~--~~~~~e~~~ 123 (148)
T 2lmt_A 46 AELQDLIAEAENNNNGQLNFTEFCGIMAKQMRETDTEEEMREAFKIFDRDGDGFISPAELRFVMINLGE--KVTDEEIDE 123 (148)
T ss_dssp HHHHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTTHHHHHHHHHHHHSSCSSEECHHHHHHHHHHHTC--CCCHHHHHH
T ss_pred HHHHHHHHhcccCCCCcccHHHHHHHHHHHhcccCcHHHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCc--cccHHHHHH
Confidence 3445556678888889999999997765443333322 2999999999999999999988743 43 123678999
Q ss_pred HHHHHHHhcCCCchhhhHhhhcch
Q psy9090 297 LLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 297 i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
|++.+|.++||.|+|+||+.+|.+
T Consensus 124 l~~~~D~d~dG~I~~~EF~~~m~~ 147 (148)
T 2lmt_A 124 MIREADFDGDGMINYEEFVWMISQ 147 (148)
T ss_dssp HHHHHCCSCCSSEEHHHHHHHHTT
T ss_pred HHHHhCCCCCCeEeHHHHHHHHhc
Confidence 999999999999999999998754
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.83 E-value=3.7e-07 Score=77.73 Aligned_cols=94 Identities=13% Similarity=0.041 Sum_probs=55.5
Q ss_pred CCceeeeCCCCCCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEcccccC-C-chhhHHHHH
Q psy9090 225 GDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLAGETLA-G-KTTSLKHLL 298 (488)
Q Consensus 225 ~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~sgesga-g-kte~~k~i~ 298 (488)
..++..+|+++++.|.+.||+..+......... ..+|..+|++.+|.|+..+.+.++ ...|. . ..+.++.++
T Consensus 6 ~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l--~~~g~~~~~~~e~~~~~ 83 (135)
T 3h4s_E 6 KSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNS--GILGIEGMSKEDAQGMV 83 (135)
T ss_dssp -------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHG--GGGTCCCCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHH--HHhCCCCCCHHHHHHHH
Confidence 456788899999999999999877553221111 239999999999999999998877 33331 2 267799999
Q ss_pred HHHHHhcCCCchhhhHhhhcch
Q psy9090 299 KHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 299 ~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+.+|.+++|.|+++||+..+..
T Consensus 84 ~~~D~d~dG~I~~~EF~~~~~~ 105 (135)
T 3h4s_E 84 REGDLDGDGALNQTEFCVLMVR 105 (135)
T ss_dssp HHHCSSCSSSBCHHHHHHHHHH
T ss_pred HHhCCCCCCCCcHHHHHHHHHH
Confidence 9999999999999999988765
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=97.74 E-value=2.3e-07 Score=84.41 Aligned_cols=115 Identities=17% Similarity=0.112 Sum_probs=75.1
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh---hhHHHHHHHHHHHHhcCCCc
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP---HIYAVADSAYQDMMHHEEAQ 278 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p---h~f~~~d~~~~~~~~~~~~q 278 (488)
++..++...+... ........+..++..+|.++++.|.+.||+..+.......... .+|..+|.+.+|.|+..+.+
T Consensus 74 Is~~El~~~l~~~-g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~El~ 152 (197)
T 3pm8_A 74 LSSQEILDGLKKI-GYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCLIPFKFFDIDGNGKISVEELK 152 (197)
T ss_dssp ECHHHHHHHHHHH-C----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCSHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred CCHHHHHHHHHHh-CCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 4444444444322 2223345566777888999999999999998876543322222 39999999999999999999
Q ss_pred EEEEcccc--cCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 279 HIVLAGET--LAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 279 ~i~~sges--gagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
.++ ... |-+- .+.++.|++.+|.++||.|+++||+.+|.
T Consensus 153 ~~l--~~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~ 194 (197)
T 3pm8_A 153 RIF--GRDDIENPLIDKAIDSLLQEVDLNGDGEIDFHEFMLMMS 194 (197)
T ss_dssp HHH--C----CCHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHH--HhcccCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 887 333 2222 56799999999999999999999998875
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=97.72 E-value=5.1e-07 Score=90.15 Aligned_cols=115 Identities=11% Similarity=0.171 Sum_probs=84.2
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCC-Ch---hhHHHHHHHHHHHHhcCCC
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDN-EP---HIYAVADSAYQDMMHHEEA 277 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~-~p---h~f~~~d~~~~~~~~~~~~ 277 (488)
++..++...|+. +........+..++..+|.++++.|++.||+..+........ .. .+|+.+|.+.+|.|+..++
T Consensus 319 IS~eELk~aLrs-LG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms~~lk~~d~eeeLreAFk~fDkDgdG~IS~eEL 397 (440)
T 3u0k_A 319 ITTKELGTVMRS-LGQNPTEAELQDMINEVDADGDGTIDFPEFLIMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAEL 397 (440)
T ss_dssp ECHHHHHHHHHH-TTCCCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHHTC------CHHHHHHHHHHCTTCSSEECHHHH
T ss_pred ECHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCChHHHHHHHHHHHCCCCcCcCCHHHH
Confidence 555555554443 233334456677888899999999999999987755432222 22 2899999999999999999
Q ss_pred cEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 278 QHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 278 q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+.++-+ |+. -..+.++.||+.+|.++||.|+|+||+.+|.
T Consensus 398 r~vL~~lGe~--LSdeEIdeLfke~D~DgDGkIsyeEFvkmMt 438 (440)
T 3u0k_A 398 RHVMTNLGEK--LTDEEVDEMIREADIDGDGQVNYEEFVQMMT 438 (440)
T ss_dssp HHHHHHHTCC--CCHHHHHHHHHHHCTTCSSSEEHHHHHHHHC
T ss_pred HHHHHHhCCC--CCHHHHHHHHHHhCCCCCCcEeHHHHHHHhC
Confidence 988743 431 1267899999999999999999999999875
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=97.64 E-value=1.7e-07 Score=80.40 Aligned_cols=95 Identities=8% Similarity=0.031 Sum_probs=72.2
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCC----ChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDN----EPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHL 297 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~----~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i 297 (488)
.+..++..+|+++.+.|.+.||+..+........ --.+|+.+|.+.+|.|+..+.+.++- ..|..- .+.++.|
T Consensus 43 ~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~~~~~~ 120 (143)
T 2obh_A 43 EIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAK--ELGENLTDEELQEM 120 (143)
T ss_dssp HHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHH--HTTCCCCHHHHHHH
T ss_pred HHHHHHHHhCCCCCCeeeHHHHHHHHHHHhccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH--HhCCCCCHHHHHHH
Confidence 3445566778899999999999977643211111 11399999999999999999988773 333222 6789999
Q ss_pred HHHHHHhcCCCchhhhHhhhcc
Q psy9090 298 LKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 298 ~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
++.++.++||.|+++||+.+|.
T Consensus 121 ~~~~D~d~dG~I~~~eF~~~~~ 142 (143)
T 2obh_A 121 IDEADRDGDGEVSEQEFLRIMK 142 (143)
T ss_dssp HHHHCTTSSSSBCHHHHHHHHC
T ss_pred HHHhCCCCCCcEeHHHHHHHHc
Confidence 9999999999999999998764
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=97.62 E-value=6e-07 Score=78.75 Aligned_cols=88 Identities=11% Similarity=0.060 Sum_probs=66.3
Q ss_pred eeCCCCCCCCCCchhhhhccCCCC--CCCCh----hhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHH
Q psy9090 230 FINPNTHLNLYGTKYHFKYKFKSR--SDNEP----HIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLI 302 (488)
Q Consensus 230 ~Inp~~~~~i~~~ef~~~~~~~~~--~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~ 302 (488)
.++.++.+.|.+.+|+..+..... ....+ .+|+++|++++|.|+..+++.++.+ |+. -..+.++.||+.++
T Consensus 54 ~~d~~~~g~i~f~eFl~~~~~~~~~~~~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~--ls~~e~~~l~~~~D 131 (159)
T 3i5g_C 54 GTKKMGEKAYKLEEILPIYEEMSSKDTGTAADEFMEAFKTFDREGQGLISSAEIRNVLKMLGER--ITEDQCNDIFTFCD 131 (159)
T ss_dssp CCSSTTSCEECHHHHHHHHHHHTTCCTTCCHHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSC--CCHHHHHHHHHHTT
T ss_pred cccccCCCcccHHHHHHHHHHhhcccccchHHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCC--CCHHHHHHHHHHhC
Confidence 346667788999999987743211 11122 2899999999999999999998843 431 12677999999998
Q ss_pred H--hcCCCchhhhHhhhcc
Q psy9090 303 F--LGQGAAKVGEKIEKCV 319 (488)
Q Consensus 303 ~--~~~g~~~~~e~i~~~~ 319 (488)
. +++|.|+|+||+.+|.
T Consensus 132 ~~~d~dG~I~~~EF~~~m~ 150 (159)
T 3i5g_C 132 IREDIDGNIKYEDLMKKVM 150 (159)
T ss_dssp CCCCSSCCEEHHHHHHHHH
T ss_pred cCCCCCCeEeHHHHHHHHH
Confidence 5 7899999999998764
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=97.60 E-value=1.4e-06 Score=78.77 Aligned_cols=116 Identities=16% Similarity=0.101 Sum_probs=82.4
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCC--CChhhHHHHHHHHHHHHhcCCCcE
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSD--NEPHIYAVADSAYQDMMHHEEAQH 279 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~--~~ph~f~~~d~~~~~~~~~~~~q~ 279 (488)
++..++...+... ..... ..+..++..+|.++++.|.+.||+..+....... .-..+|..+|.+++|.|+..+.+.
T Consensus 69 i~~~El~~~l~~~-g~~~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~El~~ 146 (191)
T 3k21_A 69 ITKEQLKKGLEKD-GLKLP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDRKQLSKKLIYCAFRVFDVDNDGEITTAELAH 146 (191)
T ss_dssp ECHHHHHHHHHHT-TCCCC-TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGGGCCHHHHHHHHHHHSTTCSSCBCHHHHHH
T ss_pred CcHHHHHHHHHHc-CCCcH-HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhhhccHHHHHHHHHHhCCCCCCcCCHHHHHH
Confidence 4444444444432 11122 5566678888999999999999998875543211 111389999999999999999998
Q ss_pred EEEcccccCCch----hhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 280 IVLAGETLAGKT----TSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 280 i~~sgesgagkt----e~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
++-.+..|..-+ +.++.+++.+|.++||.|+++||+.+|.
T Consensus 147 ~l~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~ 190 (191)
T 3k21_A 147 ILYNGNKKGNITQRDVNRVKRMIRDVDKNNDGKIDFHEFSEMMK 190 (191)
T ss_dssp HHHHSSSCSCCCHHHHHHHHHHHHHHCSSSSSSBCHHHHHHHHC
T ss_pred HHHhcCCCCCCCHhHHHHHHHHHHHhcCCCCCeECHHHHHHHHc
Confidence 884433332223 3589999999999999999999998764
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=97.58 E-value=2.5e-06 Score=68.64 Aligned_cols=67 Identities=6% Similarity=-0.047 Sum_probs=53.5
Q ss_pred hhHHHHH-HHHH-HHHhcCCCcEEEEc--cc-ccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhh
Q psy9090 259 HIYAVAD-SAYQ-DMMHHEEAQHIVLA--GE-TLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAI 325 (488)
Q Consensus 259 h~f~~~d-~~~~-~~~~~~~~q~i~~s--ge-sgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leaf 325 (488)
.+|..+| +++. |.|+..|++.++-+ |+ -|... .+.++.||+.+|.++||.|+|+||+.+|..+.-|.
T Consensus 14 ~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~~~~~~ 86 (101)
T 3nso_A 14 CTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLCLYC 86 (101)
T ss_dssp HHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHHHHH
Confidence 3899998 8886 99999999988832 11 12223 67799999999999999999999999988766553
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=97.57 E-value=8.3e-07 Score=77.33 Aligned_cols=82 Identities=10% Similarity=0.082 Sum_probs=64.5
Q ss_pred CCCCCCchhhhhccCCCCCCCChh----hHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCch
Q psy9090 236 HLNLYGTKYHFKYKFKSRSDNEPH----IYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAK 310 (488)
Q Consensus 236 ~~~i~~~ef~~~~~~~~~~~~~ph----~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~ 310 (488)
.+.|++++|+..+........++. +|+++|++++|.|+..+++.++.+ |+. -..+.++.||+.++.+ ||.|+
T Consensus 62 ~~~i~f~ef~~~~~~~~~~~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~--ls~~ei~~~~~~~D~~-dG~I~ 138 (153)
T 3i5g_B 62 PGQLNFTAFLTLFGEKVSGTDPEDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDN--FSKEEIKNVWKDAPLK-NKQFN 138 (153)
T ss_dssp SSCCCSHHHHHTTTTTTTTCCCHHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSC--CCHHHHHHHHTTCCEE-TTEEC
T ss_pred cCCccHHHHHHHHHhhhcccccHHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCc--CCHHHHHHHHHHhCCC-cCEEc
Confidence 345889999988866544443332 999999999999999999998843 431 1267799999999976 99999
Q ss_pred hhhHhhhcch
Q psy9090 311 VGEKIEKCVN 320 (488)
Q Consensus 311 ~~e~i~~~~~ 320 (488)
|+||+.+|.+
T Consensus 139 y~EF~~~m~~ 148 (153)
T 3i5g_B 139 YNKMVDIKGK 148 (153)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHhcC
Confidence 9999998853
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.40 E-value=6.4e-05 Score=72.82 Aligned_cols=86 Identities=15% Similarity=0.189 Sum_probs=49.4
Q ss_pred CCeecccCCCCEEEcc--CCcEEEEecCCccccccccCccccccCCCccccchhhc----ccccCC-----CCCCCccch
Q psy9090 24 HVIHRDLRGSNVLLTK--DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR----CGHKEV-----DGYDNRIDV 92 (488)
Q Consensus 24 givHrDlkp~NILl~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~-----~~~~~~~Di 92 (488)
.++|+|++|.||+++. .+.+.++||+.+.......+........ .-..|+... ...... .......+.
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~ 270 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKY 270 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHH
Confidence 3799999999999998 4567899999876533211111100000 002222211 100000 001122589
Q ss_pred hhhHHHHHHHhcCCCCCC
Q psy9090 93 WALGITAIELGDGKPPFE 110 (488)
Q Consensus 93 wslGvil~elltg~~Pf~ 110 (488)
|+++.++|.+.+|..+|.
T Consensus 271 ~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 271 WSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHHcCCHHHH
Confidence 999999999999988763
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.39 E-value=2.3e-06 Score=68.81 Aligned_cols=59 Identities=14% Similarity=0.118 Sum_probs=50.6
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|..+|++.+|.|+..+.+.++-+ .|-. ..+.++.|++.+|.+++|.|+|+||+.+|.|
T Consensus 41 ~F~~~D~d~~G~I~~~El~~~l~~--lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m~P 100 (100)
T 2lv7_A 41 AFKVFDRDGNGFISKQELGTAMRS--LGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLLGP 100 (100)
T ss_dssp HHHHTCSSCSSCBCHHHHHHHHHH--HTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHTCC
T ss_pred HHHHHcCCCCCcCCHHHHHHHHHH--hCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHhCc
Confidence 899999999999999999988733 2322 2677999999999999999999999999876
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.31 E-value=3e-06 Score=75.51 Aligned_cols=97 Identities=6% Similarity=-0.000 Sum_probs=74.8
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccc----cCCc-hhhHHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGET----LAGK-TTSLKHL 297 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sges----gagk-te~~k~i 297 (488)
.+..++..+|.++++.|.+.||+..+.... .-..+|..+| +.+|.|+..+.+.++ ... |-.- .+.++.|
T Consensus 47 ~~~~l~~~~D~d~~G~I~f~EF~~~~~~~~---~l~~aF~~fD-d~~G~I~~~El~~~l--~~l~~~~G~~~~~~~~~~l 120 (174)
T 2i7a_A 47 ECRSLVALMELKVNGRLDQEEFARLWKRLV---HYQHVFQKVQ-TSPGVLLSSDLWKAI--ENTDFLRGIFISRELLHLV 120 (174)
T ss_dssp HHHHHHHHHCSSCSSEECHHHHHHHHHHHH---HHHHHHHHHC-SBTTBEEGGGHHHHH--HTCGGGTTCCCCHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCCHHHHHHHHHHHH---HHHHHHHHhc-CCCCcCCHHHHHHHH--HHhHhccCCCCCHHHHHHH
Confidence 455677788999999999999998764321 1124999999 999999999999887 332 3222 5778999
Q ss_pred HHHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 298 LKHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 298 ~~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
++.++ +++|.|+++||+.++.. +.+||-
T Consensus 121 ~~~~d-d~dG~I~~~EF~~~~~~~~~~~~~F~ 151 (174)
T 2i7a_A 121 TLRYS-DSVGRVSFPSLVCFLMRLEAMAKTFR 151 (174)
T ss_dssp HHHHS-CTTSEECHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHc-CCCCeEcHHHHHHHHHHHHHHHHHHH
Confidence 99999 99999999999988764 445553
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=97.22 E-value=2.5e-06 Score=79.44 Aligned_cols=105 Identities=10% Similarity=0.154 Sum_probs=75.7
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEc-cc-c--------cC
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLA-GE-T--------LA 288 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~s-ge-s--------ga 288 (488)
.++..++..+|.++++.|.+.||............. ..+|..+|.+++|.|+..+...++.+ |+ . |.
T Consensus 102 ~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~ 181 (229)
T 3dd4_A 102 TYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKE 181 (229)
T ss_dssp HHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSCHHHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC---------
T ss_pred HHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCChHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcch
Confidence 344556777889999999999999876433221111 23999999999999999888876643 10 1 11
Q ss_pred -CchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 289 -GKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 289 -gkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
-..+.++.+++.+|.++||.++++||+..+.. ++++|.
T Consensus 182 ~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~~~~~~~~ 223 (229)
T 3dd4_A 182 DAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDENIMRSMQ 223 (229)
T ss_dssp --CCTHHHHHHHHHCSSCSSBCCHHHHHHHHHTCHHHHHHHH
T ss_pred hhHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhCHHHHHHHH
Confidence 12577999999999999999999999987764 555553
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=97.20 E-value=4.1e-06 Score=67.96 Aligned_cols=85 Identities=13% Similarity=0.100 Sum_probs=63.4
Q ss_pred CCCCCCCchhhhhccCCCCCC-CChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCC-chhhHHHHHHHHHHhcCCCchh
Q psy9090 235 THLNLYGTKYHFKYKFKSRSD-NEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAG-KTTSLKHLLKHLIFLGQGAAKV 311 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~-~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgag-kte~~k~i~~~~~~~~~g~~~~ 311 (488)
+++.|.+.||+..+....... .-..+|..+|.+.+|.|+..+.+.++-+ |..|.. ..+.++.+++.+|.+++|.+++
T Consensus 21 ~~g~i~~~eF~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~ 100 (109)
T 3fs7_A 21 AADSFNYKSFFSTVGLSSKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDTDGDGKIGV 100 (109)
T ss_dssp STTCCCHHHHHHHHTCTTCCHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCH
T ss_pred CCCcCcHHHHHHHHhcCCCcHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHHHHHhCCCCCCcCcH
Confidence 567899999998875422110 0113999999999999999998887732 211322 2678999999999999999999
Q ss_pred hhHhhhcc
Q psy9090 312 GEKIEKCV 319 (488)
Q Consensus 312 ~e~i~~~~ 319 (488)
+||+..+.
T Consensus 101 ~EF~~~~~ 108 (109)
T 3fs7_A 101 EEFQSLVK 108 (109)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHh
Confidence 99998764
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.20 E-value=8.4e-06 Score=67.69 Aligned_cols=64 Identities=11% Similarity=0.103 Sum_probs=50.7
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEc---ccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLA---GETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~s---gesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
+|..+|.+ .|.|+..|++.++-+ .--|... .+.++.||+.+|.|+||.|+|+||+.+|..+.-|
T Consensus 20 ~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l~~~ 87 (121)
T 4drw_A 20 TFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTIA 87 (121)
T ss_dssp TTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHH
Confidence 77777777 799999999887732 0012223 6789999999999999999999999999887743
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.16 E-value=3.9e-06 Score=77.87 Aligned_cols=107 Identities=11% Similarity=0.154 Sum_probs=78.9
Q ss_pred ccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEc-----cccc-----
Q psy9090 221 YSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLA-----GETL----- 287 (488)
Q Consensus 221 yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~s-----gesg----- 287 (488)
...+..++..+|.++++.|.+.||...+......... ..+|+.+|.+.+|.|+..+.+.++.. |+..
T Consensus 88 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~ 167 (224)
T 1s1e_A 88 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLK 167 (224)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGC
T ss_pred HHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCHHHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCC
Confidence 3455567788899999999999999876533211111 13899999999999999988877643 3210
Q ss_pred -CCchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhhc
Q psy9090 288 -AGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIGN 327 (488)
Q Consensus 288 -agkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafgn 327 (488)
....+.++.+++.+|.++||.|+++||+..+.. ++++|+.
T Consensus 168 ~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~~l~~~l~~ 211 (224)
T 1s1e_A 168 EDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDDNIMRSLQL 211 (224)
T ss_dssp SSSHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHTCHHHHHHHHH
T ss_pred HhHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCHHHHHHhcC
Confidence 001377999999999999999999999988764 7788774
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=97.16 E-value=1.6e-06 Score=74.47 Aligned_cols=94 Identities=11% Similarity=0.137 Sum_probs=71.0
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCC----ChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDN----EPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLL 298 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~----~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~ 298 (488)
+..++..+|.++++.|.+.||+..+........ --.+|..+|.+++|.|+..+.+.++- ..|-. ..+.++.|+
T Consensus 48 ~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~~~~~~~ 125 (148)
T 1exr_A 48 LQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMT--NLGEKLTDDEVDEMI 125 (148)
T ss_dssp HHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCSSCBCHHHHHHHHH--HTTCCCCHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCCcHHHHHHHHHHhCCCCCCcCCHHHHHHHHH--HhCCCCCHHHHHHHH
Confidence 445566778888899999999987643211110 11399999999999999999988772 22222 267899999
Q ss_pred HHHHHhcCCCchhhhHhhhcc
Q psy9090 299 KHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 299 ~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+.++.+++|.|+++||+.+|.
T Consensus 126 ~~~d~d~dg~i~~~eF~~~~~ 146 (148)
T 1exr_A 126 READIDGDGHINYEEFVRMMV 146 (148)
T ss_dssp HHHCSSSSSSBCHHHHHHHHH
T ss_pred HHhCCCCCCcEeHHHHHHHHc
Confidence 999999999999999998874
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=97.14 E-value=3.1e-06 Score=68.70 Aligned_cols=85 Identities=12% Similarity=0.089 Sum_probs=63.5
Q ss_pred CCCCCCchhhhhccCCCCC-CCChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchhh
Q psy9090 236 HLNLYGTKYHFKYKFKSRS-DNEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKVG 312 (488)
Q Consensus 236 ~~~i~~~ef~~~~~~~~~~-~~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~~ 312 (488)
++.|.+.||+..+...... ..-..+|..+|.+.+|.|+..+.+.++-+ +..|... .+.++.+++.+|.+++|.++++
T Consensus 21 ~g~i~~~eF~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~ 100 (109)
T 5pal_A 21 PGTFDYKRFFHLVGLKGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGAD 100 (109)
T ss_dssp TTCCCHHHHHHHHTCTTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHH
T ss_pred CCcCcHHHHHHHHhhccCcHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHH
Confidence 5778999999887543111 00123999999999999999998877733 2113222 6779999999999999999999
Q ss_pred hHhhhcch
Q psy9090 313 EKIEKCVN 320 (488)
Q Consensus 313 e~i~~~~~ 320 (488)
||+..+..
T Consensus 101 eF~~~~~~ 108 (109)
T 5pal_A 101 EFAKMVAQ 108 (109)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99988754
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.12 E-value=1.9e-05 Score=63.82 Aligned_cols=65 Identities=6% Similarity=-0.013 Sum_probs=51.5
Q ss_pred hHHHHH-HHHH-HHHhcCCCcEEEEc--cc-ccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 260 IYAVAD-SAYQ-DMMHHEEAQHIVLA--GE-TLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 260 ~f~~~d-~~~~-~~~~~~~~q~i~~s--ge-sgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
+|..+| +++. |.|+..+++.++-+ |+ .|... .+.++.||+.+|.++||.|+|+||+.+|..++-|
T Consensus 18 aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~~~~~ 88 (104)
T 3zwh_A 18 TFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSSIAMM 88 (104)
T ss_dssp HHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHHH
Confidence 899998 6774 79999999988832 22 12222 6789999999999999999999999998876644
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=97.11 E-value=6.3e-06 Score=71.45 Aligned_cols=117 Identities=9% Similarity=0.064 Sum_probs=80.1
Q ss_pred ccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCC---CCCC----hhhHHHHHHHHHHHHh
Q psy9090 201 TISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSR---SDNE----PHIYAVADSAYQDMMH 273 (488)
Q Consensus 201 ~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~---~~~~----ph~f~~~d~~~~~~~~ 273 (488)
.++..++...+... ........+..++..+|.++++.|.+.||+..+..... .... ..+|..+|.+.+|.|+
T Consensus 35 ~i~~~e~~~~l~~~-~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~ 113 (161)
T 1dtl_A 35 SISTKELGKVMRML-GQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYID 113 (161)
T ss_dssp SBCHHHHHHHHHHT-TCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHHHHHHHHHHHHCTTCSSEEE
T ss_pred cCcHHHHHHHHHHc-CCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcccccchHHHHHHHHHHHhCCCCCCcCc
Confidence 34444444444321 22223334556677888999999999999987754321 1111 2299999999999999
Q ss_pred cCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 274 HEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 274 ~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
..+.+.++ ...|.. ..+.++.+++.++.+++|.++++||+..+..
T Consensus 114 ~~El~~~l--~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 159 (161)
T 1dtl_A 114 LEELKIML--QATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 159 (161)
T ss_dssp HHHHGGGG--TTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC
T ss_pred HHHHHHHH--HHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHc
Confidence 99888776 222322 2677999999999999999999999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0035 Score=57.03 Aligned_cols=110 Identities=14% Similarity=0.085 Sum_probs=71.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|+|+++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|-+.+ ..+. .....+.|||...
T Consensus 46 lsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~~~~~~pe~~~-- 110 (229)
T 2yle_A 46 INEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGEPPPVAGKLGY-- 110 (229)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------------CCSS--
T ss_pred cCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccccCCCChhhcc--
Confidence 6899999999999999877622 2222444567899999999987654 1110 1122456888763
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhccc
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEK 149 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 149 (488)
...+.+.-|||||+++|.-+--..|= ..+..+|+.+.+||..|...
T Consensus 111 ----~~~te~~~IysLG~tLY~ALDygL~e--------------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 111 ----SQCMETEVIESLGIIIYKALDYGLKE--------------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ----SSSCHHHHHHHHHHHHHHHHTTTCCT--------------------TEEECCCHHHHHHHHHHTTC
T ss_pred ----ccchHHHHHHHHHHHHHHHhhcCCCc--------------------ccchhhCHHHHHHHHHHHhc
Confidence 23457888999999999987533221 12456799999999999765
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.10 E-value=7.6e-06 Score=73.62 Aligned_cols=95 Identities=9% Similarity=0.041 Sum_probs=73.5
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCC---CChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSD---NEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLK 299 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~---~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~ 299 (488)
.+..++..+|.++++.|.+.||+..+....... .-..+|..+|.+.+|.|+..+.+.++ ...|. ..+.++.+++
T Consensus 47 ~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l--~~~g~-~~~~~~~~~~ 123 (188)
T 1s6i_A 47 EIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQAC--KDFGL-DDIHIDDMIK 123 (188)
T ss_dssp HHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCSTHHHHHHTTTTCSSEEEHHHHHHTT--TTTTC-CTTHHHHHHH
T ss_pred HHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCHHHHHHHHHHHHCCCCCCcCcHHHHHHHH--HHcCC-CHHHHHHHHH
Confidence 344566777888899999999998775433222 22349999999999999999888776 33331 3567999999
Q ss_pred HHHHhcCCCchhhhHhhhcch
Q psy9090 300 HLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 300 ~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|.+++|.++++||+..+..
T Consensus 124 ~~D~d~dG~Is~~EF~~~~~~ 144 (188)
T 1s6i_A 124 EIDQDNDGQIDYGEFAAMMRK 144 (188)
T ss_dssp HHCSSSSSEEETTHHHHTTSC
T ss_pred HHCCCCCCcEeHHHHHHHHHH
Confidence 999999999999999998753
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=97.10 E-value=5.3e-06 Score=71.74 Aligned_cols=96 Identities=8% Similarity=0.059 Sum_probs=73.3
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCC--------CCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhh
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSR--------SDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTS 293 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~--------~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~ 293 (488)
.+..++..+|.++.+.|.+.||+..+..... ...-..+|..+|.+.+|.|+..+.+.++- ..|.. ..+.
T Consensus 51 ~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~~ 128 (158)
T 2jnf_A 51 TIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEVNPEQMQQELREAFRLYDKEGNGYISTDVMREILA--ELDETLSSED 128 (158)
T ss_dssp HHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCCCCTTTTSSTHHHHHHHHCSSSSSSEEHHHHHHHHH--HHCTTCCHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccccchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHH--HhCCcCCHHH
Confidence 4455667778888999999999987753221 11122399999999999999999888773 33322 2678
Q ss_pred HHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 294 LKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 294 ~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
++.+++.++.+++|.++++||+..+..
T Consensus 129 ~~~~~~~~D~d~dg~i~~~eF~~~~~~ 155 (158)
T 2jnf_A 129 LDAMIDEIDADGSGTVDFEEFMGVMTG 155 (158)
T ss_dssp HHHHHHHHCSSCCSEECSHHHHHHTSS
T ss_pred HHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 999999999999999999999988753
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=97.08 E-value=1.3e-05 Score=68.96 Aligned_cols=97 Identities=12% Similarity=0.099 Sum_probs=73.8
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEc--ccccCCchhhHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLA--GETLAGKTTSLKH 296 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~s--gesgagkte~~k~ 296 (488)
.+..++..+|.++++.|.+.||+..+.......... .+|..+|.+.+|.|+..+.+.++-. |+ .-..+.++.
T Consensus 39 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~--~~~~~~~~~ 116 (155)
T 3ll8_B 39 LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGN--NLKDTQLQQ 116 (155)
T ss_dssp THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGG--GSCHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcc--CCCHHHHHH
Confidence 455567778899999999999998876543222222 2999999999999999998887733 33 112567788
Q ss_pred HHHH----HHHhcCCCchhhhHhhhcchh
Q psy9090 297 LLKH----LIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 297 i~~~----~~~~~~g~~~~~e~i~~~~~~ 321 (488)
+++. ++.+++|.++++||+..+..+
T Consensus 117 ~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 145 (155)
T 3ll8_B 117 IVDKTIINADKDGDGRISFEEFCAVVGGL 145 (155)
T ss_dssp HHHHHHHHHCTTSSSSBCHHHHHHHHGGG
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHhcc
Confidence 8888 999999999999999887653
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.07 E-value=3.3e-06 Score=71.66 Aligned_cols=95 Identities=6% Similarity=0.015 Sum_probs=72.1
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKH 296 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~ 296 (488)
..+..++..+|.++.+.|.+.||+..+......... ..+|..+|.+.+|.|+..+.+.++ ...|.. ..+.++.
T Consensus 42 ~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l--~~~g~~~~~~~~~~ 119 (142)
T 2bl0_C 42 AAFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTSEDILRQAFRTFDPEGTGYIPKAALQDAL--LNLGDRLKPHEFAE 119 (142)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCCHHHHHHHHHHTCCSSCSCEEHHHHHHHH--HHSSSCCCHHHHHH
T ss_pred HHHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCChHHHHHHHHHHHCCCCCCcCcHHHHHHHH--HHcCCCCCHHHHHH
Confidence 345556777888899999999999877642111111 239999999999999999988777 233322 3677999
Q ss_pred HHHHHHHhcCCCchhhhHhhhcc
Q psy9090 297 LLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 297 i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+++.++ +++|.++++||+..+.
T Consensus 120 ~~~~~d-~~dg~i~~~eF~~~~~ 141 (142)
T 2bl0_C 120 FLGITE-TEKGQIRYDNFINTMF 141 (142)
T ss_dssp HHHHHC-CSSSEECSHHHHTTTC
T ss_pred HHHHhC-CCCCcEeHHHHHHHHc
Confidence 999999 9999999999998875
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=97.05 E-value=3.9e-06 Score=74.72 Aligned_cols=126 Identities=10% Similarity=0.121 Sum_probs=85.1
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCc
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQ 278 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q 278 (488)
++..++...+............+..++..+|.++++.|.+.||...+......... ..+|..+|.+.+|.|+..+.+
T Consensus 36 i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~ 115 (183)
T 1s6c_A 36 VNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMM 115 (183)
T ss_dssp ECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSCEEHHHHH
T ss_pred CCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 44444444444332222334455667788899999999999999876532211111 239999999999999988888
Q ss_pred EEEEc-----cccc------CCchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhhc
Q psy9090 279 HIVLA-----GETL------AGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIGN 327 (488)
Q Consensus 279 ~i~~s-----gesg------agkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafgn 327 (488)
.++.. |+.. ....+.++.+++.+|.+++|.++++||+..+.. ++++|+.
T Consensus 116 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~~~~~~~l~~ 178 (183)
T 1s6c_A 116 DIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQEDDNIMRSLQL 178 (183)
T ss_dssp HHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHhcChHHHHHHHH
Confidence 77633 3210 011377999999999999999999999988764 7777764
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=2.1e-05 Score=62.13 Aligned_cols=66 Identities=6% Similarity=-0.025 Sum_probs=51.0
Q ss_pred hhHHHHH-HHH-HHHHhcCCCcEEEEc--cc-ccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 259 HIYAVAD-SAY-QDMMHHEEAQHIVLA--GE-TLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 259 h~f~~~d-~~~-~~~~~~~~~q~i~~s--ge-sgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
.+|..+| +++ .|.|+..+++.++-+ |+ .|..+ .+.++.||+.+|.++||.|+|+||+.+|..+.-|
T Consensus 14 ~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~~~~~ 85 (93)
T 4eto_A 14 STFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAMM 85 (93)
T ss_dssp HHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHHH
T ss_pred HHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHHHH
Confidence 3899998 577 479999999988742 22 12122 6679999999999999999999999998876544
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=97.02 E-value=2.3e-06 Score=79.58 Aligned_cols=88 Identities=9% Similarity=-0.073 Sum_probs=65.9
Q ss_pred CCCCCCCCCCchhhhhccCCCCCC---CChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCC
Q psy9090 232 NPNTHLNLYGTKYHFKYKFKSRSD---NEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQG 307 (488)
Q Consensus 232 np~~~~~i~~~ef~~~~~~~~~~~---~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g 307 (488)
|.++++.|.+.||+..+....... .-..+|..+|.+.+|.|+..+.+.++-. ++.|.-. +.++.+++.+|.++||
T Consensus 107 D~d~~G~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~-~e~~~~~~~~D~d~dG 185 (226)
T 2lvv_A 107 KVKGVGEEDLVEFLEFRLMLCYIYDIFELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDI-TDATTVFNEIDTNGSG 185 (226)
T ss_dssp HHSCCCCCSCBCHHHHHHHHHHHHHHHHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCC-CSCHHHHHHHCCSCSS
T ss_pred CCCCCCcCCHHHHHHHHHHHHhccCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCH-HHHHHHHHHhCCCCCC
Confidence 788889999999998432211111 1123899999999999999999988743 3323322 3489999999999999
Q ss_pred CchhhhHhhhcch
Q psy9090 308 AAKVGEKIEKCVN 320 (488)
Q Consensus 308 ~~~~~e~i~~~~~ 320 (488)
.|+++||+.+|..
T Consensus 186 ~Is~~EF~~~~~~ 198 (226)
T 2lvv_A 186 VVTFDEFSCWAVT 198 (226)
T ss_dssp CEEHHHHHHHHHH
T ss_pred cEeHHHHHHHHHh
Confidence 9999999988754
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=97.02 E-value=1.6e-05 Score=66.35 Aligned_cols=80 Identities=4% Similarity=-0.072 Sum_probs=47.9
Q ss_pred CCCCCCchhhh-----hccCCCCCC----CChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcC
Q psy9090 236 HLNLYGTKYHF-----KYKFKSRSD----NEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQ 306 (488)
Q Consensus 236 ~~~i~~~ef~~-----~~~~~~~~~----~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~ 306 (488)
++.|+++||+. .+....... .--.+|+++| |.|+..+.+.++ ...|. ..+.++.|++.+|.+++
T Consensus 22 ~g~i~f~EF~~~~~~~~~~~~~~~~~~~~~l~~aF~~fD----G~I~~~El~~~l--~~lG~-t~~ei~~~~~~~D~d~d 94 (123)
T 2kld_A 22 KAEMELSDLIRKGYHKALVKLKLKKNTVDDISESLRQGG----GKLNFDELRQDL--KGKGH-TDAEIEAIFTKYDQDGD 94 (123)
T ss_dssp -----------------------------CCSCSSTTTT----TCEEHHHHHHHT--TTCCS-SHHHHHHHHHHHSSSSC
T ss_pred CCCccHHHHHhHhHHHHHHHhhcChhHHHHHHHHHHHhC----CCCCHHHHHHHH--HHhCC-CHHHHHHHHHHHcCCCC
Confidence 46788999998 433221111 1123899998 899999988877 33333 56779999999999999
Q ss_pred CCchhhhHhhhcchhh
Q psy9090 307 GAAKVGEKIEKCVNVI 322 (488)
Q Consensus 307 g~~~~~e~i~~~~~~l 322 (488)
|.++++||+.+|..+.
T Consensus 95 G~I~~~EF~~~~~~~~ 110 (123)
T 2kld_A 95 QELTEHEHQQMRDDLE 110 (123)
T ss_dssp CEECSHHHHHCSCTTT
T ss_pred CcCcHHHHHHHHHHHH
Confidence 9999999999986655
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=96.99 E-value=5.5e-06 Score=67.05 Aligned_cols=85 Identities=13% Similarity=0.085 Sum_probs=62.7
Q ss_pred CCCCCCCchhhhhccCCCCC-CCChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCC-chhhHHHHHHHHHHhcCCCchh
Q psy9090 235 THLNLYGTKYHFKYKFKSRS-DNEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAG-KTTSLKHLLKHLIFLGQGAAKV 311 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~-~~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgag-kte~~k~i~~~~~~~~~g~~~~ 311 (488)
+++.|.+.||+..+...... ..-..+|..+|.+.+|.|+..+.+.++-. |..|.. ..+.++.+++.++.+++|.+++
T Consensus 20 ~~g~i~~~eF~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~ 99 (108)
T 1rro_A 20 DPDTFEPQKFFQTSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGA 99 (108)
T ss_dssp STTCCCHHHHHHHHSGGGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEH
T ss_pred CCCCcCHHHHHHHHhcCcccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCCCCCcCcH
Confidence 55778999999877422110 00123999999999999999998877732 221322 2678999999999999999999
Q ss_pred hhHhhhcc
Q psy9090 312 GEKIEKCV 319 (488)
Q Consensus 312 ~e~i~~~~ 319 (488)
+||+..+.
T Consensus 100 ~eF~~~~~ 107 (108)
T 1rro_A 100 DEFQEMVH 107 (108)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHc
Confidence 99998764
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=96.97 E-value=3.9e-06 Score=75.14 Aligned_cols=95 Identities=12% Similarity=0.052 Sum_probs=73.8
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLK 299 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~ 299 (488)
+..++..+|.++++.|.+.||+..+......... ..+|..+|.+.+|.|+..+.+.++- |.+ ..+.++.+++
T Consensus 89 ~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~----~~~~~~~~~~~~~~ 164 (191)
T 3khe_A 89 VDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERLLAAFQQFDSDGSGKITNEELGRLFG----VTEVDDETWHQVLQ 164 (191)
T ss_dssp HHHHHHHTCTTCSSSEEHHHHHHHHSCHHHHCCHHHHHHHHHHHCTTCSSEECHHHHHHHTT----SSCCCHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHHhcccchHHHHHHHHHHHCCCCcCcCCHHHHHHHHc----cCCCCHHHHHHHHH
Confidence 3445566788888999999999876543222211 2399999999999999999888772 333 3677999999
Q ss_pred HHHHhcCCCchhhhHhhhcchhh
Q psy9090 300 HLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 300 ~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|.+++|.|+++||+..+..++
T Consensus 165 ~~D~~~dg~i~~~eF~~~~~~~~ 187 (191)
T 3khe_A 165 ECDKNNDGEVDFEEFVEMMQKIC 187 (191)
T ss_dssp HHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999999999999987764
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=96.95 E-value=3.8e-06 Score=72.79 Aligned_cols=96 Identities=10% Similarity=0.103 Sum_probs=73.5
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCC----ChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDN----EPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKH 296 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~----~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~ 296 (488)
..+..++..+|+++.+.|.+.||+..+........ -..+|..+|.+.+|.|+..+.+.++ ...|.. ..+.++.
T Consensus 59 ~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l--~~~~~~~~~~~~~~ 136 (161)
T 3fwb_A 59 REILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDPLDEIKRAFQLFDDDHTGKISIKNLRRVA--KELGETLTDEELRA 136 (161)
T ss_dssp HHHHHHHHHHCTTSSSCEEHHHHHHHHHHHHHTCCHHHHHHHHHHHHCTTCSSEECHHHHHHHH--HHTTCCCCHHHHHH
T ss_pred HHHHHHHHHhCcCCCCeEeHHHHHHHHHHHHhcCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHH--HHhCCCCCHHHHHH
Confidence 34555677778899999999999987754321111 1239999999999999999988877 233322 3678999
Q ss_pred HHHHHHHhcCCCchhhhHhhhcc
Q psy9090 297 LLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 297 i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+++.++.+++|.|+++||+..+.
T Consensus 137 ~~~~~d~~~~g~i~~~eF~~~~~ 159 (161)
T 3fwb_A 137 MIEEFDLDGDGEINENEFIAICT 159 (161)
T ss_dssp HHHTTCSSSSSSEEHHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHHh
Confidence 99999999999999999998775
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=96.94 E-value=8.1e-06 Score=66.04 Aligned_cols=85 Identities=15% Similarity=0.130 Sum_probs=62.3
Q ss_pred CCCCCCCchhhhhccCCCCC-CCChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchh
Q psy9090 235 THLNLYGTKYHFKYKFKSRS-DNEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKV 311 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~-~~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~ 311 (488)
+++.|.+.||+..+...... ..-..+|..+|.+.+|.|+..+.+.++-. |..|... .+.++.+++.++.+++|.+++
T Consensus 20 ~~g~i~~~eF~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~ 99 (108)
T 2pvb_A 20 AADSFKHKEFFAKVGLASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGV 99 (108)
T ss_dssp STTCCCHHHHHHHHTGGGSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCH
T ss_pred CCCcCcHHHHHHHHhCChhHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHHHHHHhCCCCCCcEeH
Confidence 45678999999877432110 00123999999999999999998877732 2113222 677999999999999999999
Q ss_pred hhHhhhcc
Q psy9090 312 GEKIEKCV 319 (488)
Q Consensus 312 ~e~i~~~~ 319 (488)
+||+..+.
T Consensus 100 ~eF~~~~~ 107 (108)
T 2pvb_A 100 DEFAAMIK 107 (108)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99998753
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=96.94 E-value=3.1e-06 Score=74.16 Aligned_cols=117 Identities=8% Similarity=0.027 Sum_probs=81.0
Q ss_pred ccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCC----CCChhhHHHHHHHHHHHHhcCC
Q psy9090 201 TISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRS----DNEPHIYAVADSAYQDMMHHEE 276 (488)
Q Consensus 201 ~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~----~~~ph~f~~~d~~~~~~~~~~~ 276 (488)
.++..++...+.. .........+..++..+|.++++.|.+.||+..+...... ..-..+|..+|.+.+|.|+..+
T Consensus 44 ~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e 122 (169)
T 3qrx_A 44 TIDAKELKVAMRA-LGFEPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSREEILKAFRLFDDDNSGTITIKD 122 (169)
T ss_dssp EECHHHHHHHHHH-TSCCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSBCHHH
T ss_pred cCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccCcHHHHHHHHHHhCCCCCCcCCHHH
Confidence 3444444444432 2222233445566777888999999999999876532111 1112389999999999999999
Q ss_pred CcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 277 AQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 277 ~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+.++ ...|..- .+.++.+++.+|.+++|.++++||+..+.+
T Consensus 123 l~~~l--~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~ 165 (169)
T 3qrx_A 123 LRRVA--KELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKK 165 (169)
T ss_dssp HHHHH--HHTTCCCCHHHHHHHHHHHCCSSSSCBCHHHHHHHHC-
T ss_pred HHHHH--HHcCCCCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence 88877 3333222 678999999999999999999999988754
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=96.91 E-value=1.6e-05 Score=71.07 Aligned_cols=127 Identities=14% Similarity=0.131 Sum_probs=85.6
Q ss_pred ccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh---hhHHHHHHHHHHHHhcCCC
Q psy9090 201 TISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP---HIYAVADSAYQDMMHHEEA 277 (488)
Q Consensus 201 ~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p---h~f~~~d~~~~~~~~~~~~ 277 (488)
.++..++...+............+..++..+|.++++.|...||...+.......... .+|..+|.+.+|.|+..+.
T Consensus 42 ~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef 121 (190)
T 1fpw_A 42 QLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEM 121 (190)
T ss_dssp CEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHH
T ss_pred cCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCcHHHHHHHHHHhcCCCCCcCcHHHH
Confidence 3444444444443322222334456678888999999999999998765332222222 3899999999998888887
Q ss_pred cEEEEc-----ccc-----c-CCchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhhc
Q psy9090 278 QHIVLA-----GET-----L-AGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIGN 327 (488)
Q Consensus 278 q~i~~s-----ges-----g-agkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafgn 327 (488)
..++.. |.. + .-..+.++.+++.+|.+++|.|+++||+..+.. +++.|+.
T Consensus 122 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~ 185 (190)
T 1fpw_A 122 LTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDPSIIGALNL 185 (190)
T ss_dssp HHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSSTTHHHHHHH
T ss_pred HHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhChHHHHHHhh
Confidence 766632 211 0 012567899999999999999999999987654 6676664
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.00083 Score=66.50 Aligned_cols=53 Identities=23% Similarity=0.364 Sum_probs=45.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH----------------------------------------------------------
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE---------------------------------------------------------- 22 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~---------------------------------------------------------- 22 (488)
+++.+...++.+++..|..||+
T Consensus 136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 215 (359)
T 3dxp_A 136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL 215 (359)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence 3567788899999999999997
Q ss_pred CCCeecccCCCCEEEccCCc--EEEEecCCccc
Q psy9090 23 NHVIHRDLRGSNVLLTKDGE--VKIVDFGLSRE 53 (488)
Q Consensus 23 ~givHrDlkp~NILl~~~~~--vkL~Dfg~a~~ 53 (488)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998864
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=96.91 E-value=1.8e-05 Score=71.18 Aligned_cols=122 Identities=11% Similarity=0.062 Sum_probs=85.9
Q ss_pred hccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcE
Q psy9090 200 ETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQH 279 (488)
Q Consensus 200 ~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~ 279 (488)
..++.+++...+. ..........+..++..+|.++++.|.+.||...+... ..-..+|..+|.+.+|.|+..+.+.
T Consensus 42 G~I~~~El~~~l~-~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~---~~~~~~F~~~D~d~~G~i~~~e~~~ 117 (191)
T 1y1x_A 42 GAISVPELNAALS-SAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHFI---LSMREGFRKRDSSGDGRLDSNEVRA 117 (191)
T ss_dssp SSBCHHHHHHHHC-BTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH---HHHHHHHHHHCTTSSSCBCHHHHHH
T ss_pred CcCcHHHHHHHHH-HcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHH---HHHHHHHHHhCCCCCCeEcHHHHHH
Confidence 3455555555552 12122233445566778899999999999999876532 1123499999999999999999888
Q ss_pred EEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhhc
Q psy9090 280 IVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIGN 327 (488)
Q Consensus 280 i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafgn 327 (488)
++ ...|.. ..+.++.+++.++.+++|.++++||+..+.. +.++|-.
T Consensus 118 ~l--~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~~~~~~F~~ 167 (191)
T 1y1x_A 118 AL--LSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFVCRVRNVFAF 167 (191)
T ss_dssp HH--HTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHH
T ss_pred HH--HHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHHHHHHHHHHH
Confidence 77 222322 3678999999999999999999999988763 4455543
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=96.90 E-value=1.1e-05 Score=65.50 Aligned_cols=85 Identities=14% Similarity=0.137 Sum_probs=62.4
Q ss_pred CCCCCCCchhhhhccCCCCC-CCChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchh
Q psy9090 235 THLNLYGTKYHFKYKFKSRS-DNEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKV 311 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~-~~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~ 311 (488)
+++.|.+.||+..+...... ..-..+|..+|.+.+|.|+..+.+.++-. |..|... .+.++.+++.++.+++|.+++
T Consensus 21 ~~g~i~~~ef~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~d~~~dg~i~~ 100 (110)
T 1pva_A 21 AEGSFNHKKFFALVGLKAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGI 100 (110)
T ss_dssp STTCCCHHHHHHHHTCTTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCH
T ss_pred CCCcCcHHHHHHHHccCcchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEcH
Confidence 45678899999877421100 00113999999999999999998887732 2113222 678999999999999999999
Q ss_pred hhHhhhcc
Q psy9090 312 GEKIEKCV 319 (488)
Q Consensus 312 ~e~i~~~~ 319 (488)
+||+..+.
T Consensus 101 ~eF~~~~~ 108 (110)
T 1pva_A 101 DEFETLVH 108 (110)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998764
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=96.89 E-value=2.4e-05 Score=69.96 Aligned_cols=107 Identities=13% Similarity=0.139 Sum_probs=78.3
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh---hhHHHHHHHHHHHHhcCCCcEEEEc-----ccc-----cC-
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP---HIYAVADSAYQDMMHHEEAQHIVLA-----GET-----LA- 288 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p---h~f~~~d~~~~~~~~~~~~q~i~~s-----ges-----ga- 288 (488)
.+..++..+|.++++.|.+.||...+.......... .+|..+|.+.+|.|+..+...++.. |+. +.
T Consensus 64 ~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~ 143 (190)
T 2l2e_A 64 FAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDED 143 (190)
T ss_dssp HHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred HHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccc
Confidence 445567778899999999999998776543322111 2899999999999988888776633 221 11
Q ss_pred CchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhhccc
Q psy9090 289 GKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIGNAG 329 (488)
Q Consensus 289 gkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafgna~ 329 (488)
-..+.++.+++.+|.+++|.|+++||+..+.. ++++|+.--
T Consensus 144 ~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~l~~~d 187 (190)
T 2l2e_A 144 TPEKRVNKIFNMMDKNKDGQLTLEEFCEGSKRDPTIVSALSLYD 187 (190)
T ss_dssp CTHHHHHHHHHHHTCCSSCCBCHHHHHHHHHTCTHHHHHHHTTC
T ss_pred cHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCcHHHHHHHHHh
Confidence 12567999999999999999999999987653 777776543
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=96.86 E-value=3.8e-06 Score=71.82 Aligned_cols=95 Identities=12% Similarity=0.073 Sum_probs=69.2
Q ss_pred ccCCceeee-CCCCCCCCCCchhhhhccCC------CCCCCCh---hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-ch
Q psy9090 223 FVGDVLLFI-NPNTHLNLYGTKYHFKYKFK------SRSDNEP---HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KT 291 (488)
Q Consensus 223 ~v~~il~~I-np~~~~~i~~~ef~~~~~~~------~~~~~~p---h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kt 291 (488)
.+..++..+ |+++++.|.+.||+..+... ....... .+|..+|.+.+|.|+..+.+.++- ..|.. ..
T Consensus 41 ~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~ 118 (148)
T 1m45_A 41 LVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLT--GLGEKLTD 118 (148)
T ss_dssp HHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHHHHHHHHTTCSSSSSEEEHHHHHHHHH--HSTTCCCH
T ss_pred HHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhccccccccHHHHHHHHHHhCCCCCCcCCHHHHHHHHH--HcCCCCCH
Confidence 344556667 88888999999999877654 2112222 289999999999999998887773 22222 26
Q ss_pred hhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 292 TSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 292 e~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+.++.|++.++.+++|.++++||+..+.
T Consensus 119 ~~~~~~~~~~d~d~dg~i~~~eF~~~~~ 146 (148)
T 1m45_A 119 AEVDELLKGVEVDSNGEIDYKKFIEDVL 146 (148)
T ss_dssp HHHHHHHTTCCCCTTSEEEHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 7799999999999999999999998764
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=96.85 E-value=1.2e-05 Score=68.81 Aligned_cols=117 Identities=9% Similarity=-0.018 Sum_probs=79.7
Q ss_pred ccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCC--------ChhhHHHHHHHHHHHH
Q psy9090 201 TISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDN--------EPHIYAVADSAYQDMM 272 (488)
Q Consensus 201 ~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~--------~ph~f~~~d~~~~~~~ 272 (488)
.++..++...+.. .........+..++..+|+++.+.|.+.||+..+........ -..+|..+|.+.+|.|
T Consensus 27 ~i~~~el~~~l~~-~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i 105 (153)
T 3ox6_A 27 YINCRDLGNCMRT-MGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEI 105 (153)
T ss_dssp SCCHHHHHHHHHH-TTCCCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCCHHHHCHHHHHHHHHHHCTTCSSSB
T ss_pred cCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhccccccccHHHHHHHHHHhCCCCCCcC
Confidence 3444444444332 112222333445666778888899999999987743322211 1238999999999999
Q ss_pred hcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 273 HHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 273 ~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+..+.+.++-.- .|.. ..+.++.+++.++.+++|.|+++||+..+.
T Consensus 106 ~~~el~~~l~~~-~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~ 152 (153)
T 3ox6_A 106 STSELREAMRAL-LGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMS 152 (153)
T ss_dssp CHHHHHHHHHHH-HSSCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHTC
T ss_pred cHHHHHHHHHHH-hcCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 999998877320 2222 267899999999999999999999998775
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=96.85 E-value=3e-05 Score=68.97 Aligned_cols=95 Identities=7% Similarity=-0.001 Sum_probs=72.6
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCC--CChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSD--NEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLL 298 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~--~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~ 298 (488)
..+..++..+|.++++.|.+.||+..+....... .-..+|..+|.+.+|.|+..+.+.++- |.+- .+.++.++
T Consensus 73 ~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~----~~~~~~~~~~~~~ 148 (180)
T 3mse_B 73 WDINRILQALDINDRGNITYTEFMAGCYRWKNIESTFLKAAFNKIDKDEDGYISKSDIVSLVH----DKVLDNNDIDNFF 148 (180)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHSCCTTC--CHHHHHHHHHCTTCSSCBCHHHHHHHTT----TSSCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHhcccCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHc----CCCCCHHHHHHHH
Confidence 4455667788899999999999998776543222 112499999999999999999988872 2223 67799999
Q ss_pred HHHHHhcC--------CCchhhhHhhhcch
Q psy9090 299 KHLIFLGQ--------GAAKVGEKIEKCVN 320 (488)
Q Consensus 299 ~~~~~~~~--------g~~~~~e~i~~~~~ 320 (488)
+.++.+++ |.|+++||+..+.+
T Consensus 149 ~~~d~~~d~~~~~~~~G~i~~~eF~~~l~~ 178 (180)
T 3mse_B 149 LSVHSIKKGIPREHIINKISFQEFKDYMLS 178 (180)
T ss_dssp HHHHTC---------CCCBCHHHHHHHHHT
T ss_pred HHhhhccCcccccccCCeeeHHHHHHHHHh
Confidence 99999988 99999999988754
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=96.84 E-value=7.4e-06 Score=66.34 Aligned_cols=86 Identities=14% Similarity=0.145 Sum_probs=63.2
Q ss_pred CCCCCCCchhhhhccCCCC-CCCChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchh
Q psy9090 235 THLNLYGTKYHFKYKFKSR-SDNEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKV 311 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~-~~~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~ 311 (488)
+++.|.+.||+..+..... ...-..+|..+|.+.+|.|+..+.+.++-. |..|... .+.++.+++.++.+++|.+++
T Consensus 20 ~~g~i~~~eF~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~ 99 (109)
T 1rwy_A 20 AADSFDHKKFFQMVGLKKKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGV 99 (109)
T ss_dssp STTCCCHHHHHHHHTGGGSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEH
T ss_pred CCCcEeHHHHHHHHhcCcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHHHHHHCCCCCCcCCH
Confidence 5677899999987743210 001123999999999999999998877732 2113222 677999999999999999999
Q ss_pred hhHhhhcch
Q psy9090 312 GEKIEKCVN 320 (488)
Q Consensus 312 ~e~i~~~~~ 320 (488)
+||+..+..
T Consensus 100 ~eF~~~~~~ 108 (109)
T 1rwy_A 100 EEFSTLVAE 108 (109)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHc
Confidence 999987643
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=96.82 E-value=2.4e-05 Score=66.33 Aligned_cols=84 Identities=8% Similarity=0.053 Sum_probs=65.2
Q ss_pred CCCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCc
Q psy9090 235 THLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAA 309 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~ 309 (488)
+.+.|.+.+|+..+........++ .+|..+|.+.+|.|+..+.+.++- ..|.. ..+.++.+++.++.+++|.+
T Consensus 52 ~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~--~~g~~~~~~~~~~~~~~~D~d~dg~i 129 (143)
T 3j04_B 52 APGPINFTMFLTMFGEKLNGTDPEDVIRNAFACFDEEASGFIHEDHLRELLT--TMGDRFTDEEVDEMYREAPIDKKGNF 129 (143)
T ss_dssp SSSCCCHHHHHHHHHHTTTSSCCHHHHHHHHTTSCSSSCCCCCTTTHHHHHH--TSSSCCCHHHHHHHHHHTTCCSSSCC
T ss_pred CCCCcCHHHHHHHHHHHhccCCcHHHHHHHHHHHCCCCCCeEcHHHHHHHHH--HcCCCCCHHHHHHHHHHcCCCCCCcC
Confidence 557789999998876543322222 289999999999999999998883 32322 26789999999999999999
Q ss_pred hhhhHhhhcch
Q psy9090 310 KVGEKIEKCVN 320 (488)
Q Consensus 310 ~~~e~i~~~~~ 320 (488)
+++||+..+..
T Consensus 130 ~~~eF~~~~~~ 140 (143)
T 3j04_B 130 NYVEFTRILKH 140 (143)
T ss_dssp CSTHHHHHHHS
T ss_pred cHHHHHHHHhc
Confidence 99999988753
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=96.81 E-value=3.1e-05 Score=63.44 Aligned_cols=63 Identities=6% Similarity=0.009 Sum_probs=50.9
Q ss_pred hHHHHH-HHHHH-HHhcCCCcEEEEc--cc-ccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVAD-SAYQD-MMHHEEAQHIVLA--GE-TLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d-~~~~~-~~~~~~~q~i~~s--ge-sgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|.++| ++++| .|+..+++.++-+ |+ .|... .+.++.||+.+|.++||.|+|+||+.+|....
T Consensus 27 aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~~~~ 95 (113)
T 2lnk_A 27 TFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA 95 (113)
T ss_dssp HHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHHHHH
T ss_pred HHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHH
Confidence 999999 88887 9999999988732 22 22222 56899999999999999999999999887654
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=96.80 E-value=8.1e-06 Score=66.16 Aligned_cols=85 Identities=16% Similarity=0.128 Sum_probs=62.5
Q ss_pred CCCCCCCchhhhhccCCCCC-CCChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchh
Q psy9090 235 THLNLYGTKYHFKYKFKSRS-DNEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKV 311 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~-~~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~ 311 (488)
+++.|.+.||+..+...... ..-..+|..+|.+.+|.|+..+.+.++-. |..|... .+.++.+++.++.+++|.+++
T Consensus 21 ~~g~i~~~eF~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~ 100 (109)
T 1bu3_A 21 AADSFNYKAFFAKVGLTAKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDSDGDGAIGV 100 (109)
T ss_dssp STTCCCHHHHHHHHTGGGSCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHHHHHHCTTCSSEECH
T ss_pred CCCcCcHHHHHHHHHcChhhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHHHHHhCCCCCCcEeH
Confidence 45778999999877432110 00123999999999999999998877732 2113222 678999999999999999999
Q ss_pred hhHhhhcc
Q psy9090 312 GEKIEKCV 319 (488)
Q Consensus 312 ~e~i~~~~ 319 (488)
+||+..+.
T Consensus 101 ~eF~~~~~ 108 (109)
T 1bu3_A 101 DEWAALVK 108 (109)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHh
Confidence 99998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.00067 Score=63.39 Aligned_cols=28 Identities=21% Similarity=0.236 Sum_probs=24.5
Q ss_pred CeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 25 VIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 25 ivHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
++|+|++|.||+++.++.+.|+||+.+.
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999764
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.79 E-value=2.3e-05 Score=70.97 Aligned_cols=94 Identities=9% Similarity=0.007 Sum_probs=69.3
Q ss_pred CCceeeeCCCCCCCCCCchhhhhccCCCC----------------CCCC----hhhHHHHHHHHHHHHhcCCCcEEEEcc
Q psy9090 225 GDVLLFINPNTHLNLYGTKYHFKYKFKSR----------------SDNE----PHIYAVADSAYQDMMHHEEAQHIVLAG 284 (488)
Q Consensus 225 ~~il~~Inp~~~~~i~~~ef~~~~~~~~~----------------~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~sg 284 (488)
..++..+|.++++.|.+.||+..+..... .... ..+|..+|.+.+|.|+..+.+.++-
T Consensus 64 ~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~-- 141 (202)
T 2bec_A 64 DRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLR-- 141 (202)
T ss_dssp HHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHHHHC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHH--
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHHhcccchhcccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHH--
Confidence 34455678888899999999987754432 1111 1299999999999999999887772
Q ss_pred cc-cCC-chhhHHHHHHH----HHHhcCCCchhhhHhhhcch
Q psy9090 285 ET-LAG-KTTSLKHLLKH----LIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 285 es-gag-kte~~k~i~~~----~~~~~~g~~~~~e~i~~~~~ 320 (488)
.. |.. ..+.++.+++. +|.+++|.|+++||+..+..
T Consensus 142 ~~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~~ 183 (202)
T 2bec_A 142 LMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTKSLEK 183 (202)
T ss_dssp HSCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHHHHHTTTT
T ss_pred HhcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHH
Confidence 22 321 25667777777 99999999999999988764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0007 Score=63.69 Aligned_cols=30 Identities=27% Similarity=0.346 Sum_probs=24.9
Q ss_pred CCCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 23 NHVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 23 ~givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
..++|+|++|.||+++..+.+.|+||+.+.
T Consensus 183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999875556799998764
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=96.77 E-value=4.2e-05 Score=65.03 Aligned_cols=84 Identities=10% Similarity=0.052 Sum_probs=64.6
Q ss_pred CCCCCCCCCCchhhhhccCCC--CCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHh
Q psy9090 232 NPNTHLNLYGTKYHFKYKFKS--RSDNE----PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFL 304 (488)
Q Consensus 232 np~~~~~i~~~ef~~~~~~~~--~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~ 304 (488)
|.++ +.|.+.+|+..+.... ..... ..+|..+|.+.+|.|+..+.+.++- ..|-. ..+.++.+++. +.+
T Consensus 57 d~~~-g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~--~~g~~~~~~~~~~~~~~-d~~ 132 (149)
T 2mys_C 57 EMNA-AAITFEEFLPMLQAAANNKDQGTFEDFVEGLRVFDKEGNGTVMGAELRHVLA--TLGEKMTEEEVEELMKG-QED 132 (149)
T ss_pred cccC-CcCcHHHHHHHHHHHhccCCcchHHHHHHHHHHhCCCCCceEcHHHHHHHHH--HhCCCCCHHHHHHHHhh-CCC
Confidence 7777 8899999998775541 11111 1299999999999999999988773 22222 36779999999 999
Q ss_pred cCCCchhhhHhhhcc
Q psy9090 305 GQGAAKVGEKIEKCV 319 (488)
Q Consensus 305 ~~g~~~~~e~i~~~~ 319 (488)
++|.++++||+..+.
T Consensus 133 ~dg~i~~~eF~~~~~ 147 (149)
T 2mys_C 133 SNGCINYEAFVKHIM 147 (149)
T ss_pred CCCcEeHHHHHHHHh
Confidence 999999999998875
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=2e-05 Score=70.15 Aligned_cols=94 Identities=10% Similarity=0.069 Sum_probs=68.1
Q ss_pred ceeeeCCCCCCC-CCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEc-cccc-CCc--hhhHH--
Q psy9090 227 VLLFINPNTHLN-LYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLA-GETL-AGK--TTSLK-- 295 (488)
Q Consensus 227 il~~Inp~~~~~-i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~s-gesg-agk--te~~k-- 295 (488)
++..+|.++++. |.+.||+..+......... ..+|..+|.+.+|.|+..+.+.++.. |... ..+ .+.++
T Consensus 65 l~~~~D~d~~G~~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~ 144 (183)
T 1dgu_A 65 ICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQL 144 (183)
T ss_dssp HHHHHSCSSSSCCCCHHHHHHHHHHHSTTCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHH
T ss_pred HHHHhCCCCCCCEecHHHHHHHHHHhcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHH
Confidence 455568888999 9999999877543322211 12999999999999999998887732 2210 012 34444
Q ss_pred --HHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 296 --HLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 296 --~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+++.++.+++|.++++||+..+..
T Consensus 145 ~~~~~~~~D~d~dG~I~~~EF~~~~~~ 171 (183)
T 1dgu_A 145 IDNILEESDIDRDGTINLSEFQHVISR 171 (183)
T ss_dssp HHHHHHHHCTTSSSEEEHHHHHHHHCS
T ss_pred HHHHHHHhCCCCCCeEcHHHHHHHHHh
Confidence 3999999999999999999988764
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=96.74 E-value=8.4e-06 Score=77.16 Aligned_cols=127 Identities=10% Similarity=0.148 Sum_probs=87.6
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh---hhHHHHHHHHHHHHhcCCCc
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP---HIYAVADSAYQDMMHHEEAQ 278 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p---h~f~~~d~~~~~~~~~~~~q 278 (488)
++..++...+...........++..++..+|.++++.|.+.||...+.......... .+|..+|.+.+|.|+..+..
T Consensus 109 I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~Ef~ 188 (256)
T 2jul_A 109 VDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGCITKEEML 188 (256)
T ss_dssp EEHHHHHHHHHHHCCSSCCHHHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCHHHHHHHHHHHTCCSSSSCBCHHHHH
T ss_pred CCHHHHHHHHHHHcccCCcHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccChHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 444444444444332333334566678889999999999999998765332211111 28999999999999988888
Q ss_pred EEEEc-----ccc------cCCchhhHHHHHHHHHHhcCCCchhhhHhhhcc---hhhhhhhcc
Q psy9090 279 HIVLA-----GET------LAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCV---NVIHAIGNA 328 (488)
Q Consensus 279 ~i~~s-----ges------gagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~---~~leafgna 328 (488)
.++.. |.. ..-..+.++.+++.+|.++||.|+++||+..+. .++++|+..
T Consensus 189 ~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~~l~~~l~~~ 252 (256)
T 2jul_A 189 AIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQKDENIMNSMQLF 252 (256)
T ss_dssp HHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHHHHCSSHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhCHHHHHHHHhh
Confidence 76632 210 001357789999999999999999999998876 378887754
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=96.72 E-value=6.6e-06 Score=69.97 Aligned_cols=95 Identities=11% Similarity=0.124 Sum_probs=71.0
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCC----CCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRS----DNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKH 296 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~----~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~ 296 (488)
..+..++..+|.++.+.|.+.||+..+...... ..-..+|..+|.+.+|.|+..+.+.++ ...|..- .+.++.
T Consensus 47 ~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l--~~~~~~~~~~~~~~ 124 (147)
T 4ds7_A 47 AEVADLMNEIDVDGNHAIEFSEFLALMSRQLKCNDSEQELLEAFKVFDKNGDGLISAAELKHVL--TSIGEKLTDAEVDE 124 (147)
T ss_dssp HHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHTHHHHHHHHHHHHHHCTTCSSEECHHHHHHHH--HHTTCCCCHHHHHH
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHHhccCCCcHHHHHHHHHHhCCCCCCeECHHHHHHHH--HHcCCCCCHHHHHH
Confidence 334556667788888999999999877533111 111238999999999999998888877 3333222 677899
Q ss_pred HHHHHHHhcCCCchhhhHhhhcc
Q psy9090 297 LLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 297 i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+++.++ +++|.++++||+..+.
T Consensus 125 ~~~~~d-~~dg~i~~~eF~~~l~ 146 (147)
T 4ds7_A 125 MLREVS-DGSGEINIKQFAALLS 146 (147)
T ss_dssp HHHHHS-SSCSSEEHHHHHHHTT
T ss_pred HHHHhc-CCCCcCcHHHHHHHHh
Confidence 999999 9999999999998764
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=96.70 E-value=9.9e-06 Score=74.88 Aligned_cols=92 Identities=10% Similarity=0.063 Sum_probs=70.4
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHL 301 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~ 301 (488)
.+..++..+|.++++.|.+.||+..+... ..-..+|..+|++++|.|+..+.+.++- +.|.. ..+.++.+++.+
T Consensus 88 ~~~~l~~~~D~d~dg~I~~~EF~~~~~~~---~~l~~~F~~~D~d~~G~I~~~El~~~l~--~~g~~~~~~~~~~l~~~~ 162 (220)
T 3sjs_A 88 TALRMMRIFDTDFNGHISFYEFMAMYKFM---ELAYNLFVMNARARSGTLEPHEILPALQ--QLGFYINQRTSLLLHRLF 162 (220)
T ss_dssp HHHHHHHHHCTTCSSCBCHHHHHHHHHHH---HHHHHHHHHHCCSSTTEECHHHHHHHHH--HHTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHHHHHHH---HHHHHHHHHHCCCCCCCCcHHHHHHHHH--HhCCCCCHHHHHHHHHHh
Confidence 34455667788899999999999877542 1123499999999999999999988773 33322 367899999999
Q ss_pred HHhcCCCchhhhHhhhcch
Q psy9090 302 IFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 302 ~~~~~g~~~~~e~i~~~~~ 320 (488)
+ ++||.++++||+..|..
T Consensus 163 d-d~dg~I~~~eF~~~~~~ 180 (220)
T 3sjs_A 163 A-RGMAFCDLNCWIAICAF 180 (220)
T ss_dssp C---CCSEEHHHHHHHHHH
T ss_pred c-CCCCcCcHHHHHHHHHH
Confidence 9 99999999999988765
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=96.70 E-value=3.9e-05 Score=70.99 Aligned_cols=103 Identities=11% Similarity=0.095 Sum_probs=72.9
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEc--ccccCCc-hhhHHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLA--GETLAGK-TTSLKH 296 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~s--gesgagk-te~~k~ 296 (488)
+..++..+|.++++.|.+.||+..+.......... .+|..+|.+.+|.|+..+.+.++.. .+.|..- .+.++.
T Consensus 87 ~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~ 166 (226)
T 2zfd_A 87 ADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIED 166 (226)
T ss_dssp HHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHH
T ss_pred HHHHHHHHcCCCCCcCcHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHH
Confidence 34467788999999999999998775443222111 2999999999999999998877731 1222222 344544
Q ss_pred HH----HHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 297 LL----KHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 297 i~----~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
++ +.+|.++||.|+++||+..+.. ++++|+
T Consensus 167 ~~~~~f~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~ 203 (226)
T 2zfd_A 167 IIDKTFEEADTKHDGKIDKEEWRSLVLRHPSLLKNMT 203 (226)
T ss_dssp HHHHHHHHHCSSCSSEECHHHHHHHHHHSGGGGGGGC
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHhChHHHHHhc
Confidence 44 5899999999999999987653 555554
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=96.69 E-value=1.4e-05 Score=69.01 Aligned_cols=95 Identities=14% Similarity=0.032 Sum_probs=71.1
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCC-CCCh----hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRS-DNEP----HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKH 296 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~-~~~p----h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~ 296 (488)
.+..+ ..+|.++.+.|.+.||+..+...... ..+. .+|..+|.+.+|.|+..+.+.++- ..|.. ..+.++.
T Consensus 48 ~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~~~~~ 124 (156)
T 1wdc_C 48 DVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLT--ALGERLSDEDVDE 124 (156)
T ss_dssp HHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCCCCHHHHHHHHHTTCSSSSSEEEHHHHHHHHH--HSSSCCCHHHHHH
T ss_pred HHHHH-HhhCCCCCCeeeHHHHHHHHHHHhhccCChHHHHHHHHHHhCCCCCCcCcHHHHHHHHH--HcCCCCCHHHHHH
Confidence 34444 56788888999999999877544321 1111 289999999999999999888773 22322 3677999
Q ss_pred HHHH--HHHhcCCCchhhhHhhhcch
Q psy9090 297 LLKH--LIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 297 i~~~--~~~~~~g~~~~~e~i~~~~~ 320 (488)
+++. ++.+++|.++++||+..+..
T Consensus 125 ~~~~~~~D~d~dg~i~~~eF~~~~~~ 150 (156)
T 1wdc_C 125 IIKLTDLQEDLEGNVKYEDFVKKVMA 150 (156)
T ss_dssp HHHHHTCCCCTTSEEEHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCcEeHHHHHHHHhc
Confidence 9999 99999999999999987753
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=96.69 E-value=3.8e-05 Score=62.22 Aligned_cols=62 Identities=16% Similarity=0.064 Sum_probs=49.8
Q ss_pred hHHHHH-HHHH-HHHhcCCCcEEEEcccccC-Cc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVAD-SAYQ-DMMHHEEAQHIVLAGETLA-GK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d-~~~~-~~~~~~~~q~i~~sgesga-gk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+| +++. |.|+..+++.++-+ +.|. .. .+.++.||+.+|.++||.|+|+||+.+|....
T Consensus 27 aF~~fD~~dg~~G~Is~~EL~~~l~~-~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~~~~ 92 (106)
T 2h2k_A 27 TFFTFARQEGRKDSLSVNEFKELVTQ-QLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELA 92 (106)
T ss_dssp HHHHHHTSSSSTTEECHHHHHHHHHH-HCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHcccCCCCCEECHHHHHHHHHH-HcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHH
Confidence 999999 7886 79999999988732 1221 12 26799999999999999999999999887654
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=96.69 E-value=6.8e-05 Score=65.30 Aligned_cols=83 Identities=7% Similarity=-0.026 Sum_probs=63.2
Q ss_pred CCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCch
Q psy9090 236 HLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAK 310 (488)
Q Consensus 236 ~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~ 310 (488)
++.|.+.||+..+........+ ..+|..+|.+.+|.|+..+.+.++- ..|-. ..+.++.+++.+|.+++|.|+
T Consensus 72 dg~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~~~~~~~~~~D~d~dg~I~ 149 (166)
T 2mys_B 72 SGPINFTVFLTMFGEKLKGADPEDVIMGAFKVLDPDGKGSIKKSFLEELLT--TGGGRFTPEEIKNMWAAFPPDVAGNVD 149 (166)
T ss_pred CCCcCHHHHHHHHHHHhccCCcHHHHHHHHHHhCCCCCcceeHHHHHHHHH--HcCCCCCHHHHHHHHHhcCCCCCCeEe
Confidence 4668899998877543221111 2399999999999999999998873 22322 267799999999999999999
Q ss_pred hhhHhhhcch
Q psy9090 311 VGEKIEKCVN 320 (488)
Q Consensus 311 ~~e~i~~~~~ 320 (488)
++||+.++..
T Consensus 150 ~~eF~~~~~~ 159 (166)
T 2mys_B 150 YKNICYVITH 159 (166)
T ss_pred HHHHHHHHHh
Confidence 9999988754
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=96.69 E-value=7.9e-06 Score=66.09 Aligned_cols=85 Identities=13% Similarity=0.102 Sum_probs=63.7
Q ss_pred CCCCCCCchhhhhccCCCC-CCCChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchh
Q psy9090 235 THLNLYGTKYHFKYKFKSR-SDNEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKV 311 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~-~~~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~ 311 (488)
+++.|.+.||+..+..... ...-..+|..+|.+.+|.|+..+.+.++-. |..|... .+.++.+++.++.+++|.+++
T Consensus 20 ~~g~i~~~eF~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~ 99 (108)
T 2kyc_A 20 APDSFSPKKFFQISGMSKKSSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARVLTASETKTFLAAADHDGDGKIGA 99 (108)
T ss_dssp STTTCCHHHHHHHHTCTTCCSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCCCTTTTHHHHTTTCCSSSSCCCS
T ss_pred CCCcCCHHHHHHHHhhCcccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCCCCCcCCH
Confidence 5677999999988743211 111234999999999999999999988732 2213222 677899999999999999999
Q ss_pred hhHhhhcc
Q psy9090 312 GEKIEKCV 319 (488)
Q Consensus 312 ~e~i~~~~ 319 (488)
+||+..+.
T Consensus 100 ~eF~~~~~ 107 (108)
T 2kyc_A 100 EEFQEMVQ 107 (108)
T ss_dssp SHHHHHHH
T ss_pred HHHHHHHh
Confidence 99998763
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=96.67 E-value=1.9e-05 Score=71.81 Aligned_cols=125 Identities=13% Similarity=0.137 Sum_probs=84.4
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCc
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQ 278 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q 278 (488)
++..++...+............+..++..+|.++++.|.+.||...+......... ..+|..+|.+.+|.|+..+..
T Consensus 51 i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~ 130 (207)
T 2d8n_A 51 ITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVL 130 (207)
T ss_dssp EEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCTTCSSEECHHHHH
T ss_pred CCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcCCCCCeEcHHHHH
Confidence 44444444444332222233445667788899999999999999776533221111 239999999999999998888
Q ss_pred EEEEc-----c----ccc----CCchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 279 HIVLA-----G----ETL----AGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 279 ~i~~s-----g----esg----agkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
.++.. | +.= ....+.++.+++.+|.+++|.|+++||+..+.. +++.|.
T Consensus 131 ~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~ 194 (207)
T 2d8n_A 131 EIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFIEGTLANKEILRLIQ 194 (207)
T ss_dssp HHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTCCTTCCEEHHHHHHHHHHCHHHHHHHS
T ss_pred HHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHhChHHHHHHh
Confidence 77643 3 100 012366999999999999999999999988763 566664
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.67 E-value=2.8e-05 Score=70.25 Aligned_cols=100 Identities=11% Similarity=0.030 Sum_probs=74.2
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEc-c----cccCCc-hhh
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLA-G----ETLAGK-TTS 293 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~s-g----esgagk-te~ 293 (488)
.+..++..+|.++++.|.+.||+..+......... ..+|..+|.+.+|.|+..+.+.++-. | ..|... .+.
T Consensus 74 ~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~ 153 (204)
T 3e3r_A 74 EAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEV 153 (204)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHH
T ss_pred HHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHH
Confidence 34455667788899999999999887654322111 13999999999999999998887732 1 122222 466
Q ss_pred HHHHHHHHHH-hcCCCchhhhHhhhcchhh
Q psy9090 294 LKHLLKHLIF-LGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 294 ~k~i~~~~~~-~~~g~~~~~e~i~~~~~~l 322 (488)
++.+++.+|. ++||.++++||+..+..+-
T Consensus 154 ~~~~~~~~D~~d~dg~Is~~EF~~~~~~~~ 183 (204)
T 3e3r_A 154 LRRFLDNFDSSEKDGQVTLAEFQDYYSGVS 183 (204)
T ss_dssp HHHHHHHHSCSSCCSCEEHHHHHHHHHHHH
T ss_pred HHHHHHHhhccCCCCcCcHHHHHHHHHHcC
Confidence 9999999998 9999999999998876643
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=96.65 E-value=4.7e-05 Score=69.20 Aligned_cols=91 Identities=9% Similarity=-0.000 Sum_probs=70.3
Q ss_pred eeeCCCCCCCCCCchhhhhcc---------CCCCCCC-----ChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhH
Q psy9090 229 LFINPNTHLNLYGTKYHFKYK---------FKSRSDN-----EPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSL 294 (488)
Q Consensus 229 ~~Inp~~~~~i~~~ef~~~~~---------~~~~~~~-----~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~ 294 (488)
..+|.++++.|.+.||+..+. ....... -..+|..+|.+.+|.|+..+.+.++ ...| -..+.+
T Consensus 88 ~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l--~~~g-~~~~~~ 164 (208)
T 2hpk_A 88 LHKGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMM--KAFD-VPQEAA 164 (208)
T ss_dssp HHTTCBTTTBEEGGGHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSSBCHHHHHHHH--HHTT-SCTTHH
T ss_pred HHhCCCCCCeEcHHHHHHHHHHHhhhhhhhhccCChHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHH--HHhC-cCHHHH
Confidence 567888889999999998764 1111111 1238999999999999999998877 3334 346779
Q ss_pred HHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 295 KHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 295 k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+.+++.+|.++||.|+++||+..+...+
T Consensus 165 ~~~~~~~D~d~dG~I~~~EF~~~~~~~~ 192 (208)
T 2hpk_A 165 YTFFEKADTDKSGKLERTELVHLFRKFW 192 (208)
T ss_dssp HHHHHHHCTTCCSSBCHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHHHh
Confidence 9999999999999999999999887653
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=96.64 E-value=2.8e-05 Score=71.50 Aligned_cols=94 Identities=10% Similarity=0.076 Sum_probs=67.4
Q ss_pred ceeeeCCCCCCC-CCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEc-ccc-cCCc--hhhHH--
Q psy9090 227 VLLFINPNTHLN-LYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLA-GET-LAGK--TTSLK-- 295 (488)
Q Consensus 227 il~~Inp~~~~~-i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~s-ges-gagk--te~~k-- 295 (488)
++..+|.++++. |.+.||+..+.......... .+|.++|.+.+|.|+..+.+.++.. |+. +..+ .+.++
T Consensus 96 lf~~~D~d~dG~~I~f~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~ 175 (214)
T 2l4h_A 96 ICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQL 175 (214)
T ss_dssp HHHHHCCSSSCCSEEHHHHHHHHHHTSSCSCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHH
T ss_pred HHHHhCcCCCCCEecHHHHHHHHHHHcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHH
Confidence 344557788898 99999998775443222212 2999999999999999999887743 321 0011 23344
Q ss_pred --HHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 296 --HLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 296 --~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+++.+|.++||.|+++||+..+..
T Consensus 176 ~~~~~~~~D~d~dG~Is~~EF~~~~~~ 202 (214)
T 2l4h_A 176 IDNILEESDIDRDGTINLSEFQHVISR 202 (214)
T ss_dssp HHHHHHHHCCSCCSSBCSHHHHHHHHT
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHh
Confidence 5999999999999999999987753
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=96.63 E-value=4.2e-05 Score=67.33 Aligned_cols=124 Identities=10% Similarity=0.049 Sum_probs=85.3
Q ss_pred hhhccchhhHHHHHHhhhc-------cCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHH
Q psy9090 198 ALETISEDNIVQELEERHN-------SKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQD 270 (488)
Q Consensus 198 ~l~~l~e~~l~~~L~~r~~-------~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~ 270 (488)
.-..++..++...+...+. .......+..++..+|.++++.|.+.||...+... ..-..+|..+|.+.+|
T Consensus 16 ~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~---~~~~~~F~~~D~d~~G 92 (173)
T 1alv_A 16 DDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNI---KKWQAIYKQFDVDRSG 92 (173)
T ss_dssp GGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH---HHHHHHHHHHCTTCCS
T ss_pred CCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHHHHH---HHHHHHHHHHCCCCCC
Confidence 3344555555555544321 12223345566778899999999999999777532 1112399999999999
Q ss_pred HHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhhc
Q psy9090 271 MMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIGN 327 (488)
Q Consensus 271 ~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafgn 327 (488)
.|+..+.+.++- ..|-. ..+.++.+++.++ +++|.++++||+..+.. +.++|-.
T Consensus 93 ~i~~~el~~~l~--~~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~~~~~~~~~~~~~F~~ 150 (173)
T 1alv_A 93 TIGSSELPGAFE--AAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCLVRLDAMFRAFKS 150 (173)
T ss_dssp SBCTTTHHHHHH--HHTCCCCHHHHHHHHHHHT-CSSSCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHH--HcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHHHHHHHHHHH
Confidence 999999988773 22322 2577899999998 99999999999988754 4455543
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=96.62 E-value=3.7e-05 Score=61.59 Aligned_cols=66 Identities=11% Similarity=0.076 Sum_probs=52.0
Q ss_pred hHHHHHHHH---HHHHhcCCCcEEEEc--cc-ccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhh
Q psy9090 260 IYAVADSAY---QDMMHHEEAQHIVLA--GE-TLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAI 325 (488)
Q Consensus 260 ~f~~~d~~~---~~~~~~~~~q~i~~s--ge-sgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leaf 325 (488)
+|..+|++. +|.|+..+++.++-+ |+ .+... .+.++.||+.+|.++||.|+|+||+.+|..+.-+.
T Consensus 16 ~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m~~~~~~~ 88 (100)
T 3nxa_A 16 NFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGGITGPI 88 (100)
T ss_dssp HHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHHHHHHGGG
T ss_pred HHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHHHHH
Confidence 899998863 699999999988732 21 11112 46799999999999999999999999998876654
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=96.62 E-value=9.9e-05 Score=58.00 Aligned_cols=65 Identities=11% Similarity=0.146 Sum_probs=50.0
Q ss_pred hhHHHHHHHHHH---HHhcCCCcEEEEc--cc-ccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 259 HIYAVADSAYQD---MMHHEEAQHIVLA--GE-TLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 259 h~f~~~d~~~~~---~~~~~~~q~i~~s--ge-sgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
.+|..+| +..| .|+..+++.++-+ +. -|... .+.++.|++.+|.++||.|+|+||+.++..+.-+
T Consensus 13 ~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~l~~~ 84 (92)
T 3rm1_A 13 DVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFVAMITTA 84 (92)
T ss_dssp HHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHHH
T ss_pred HHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHHH
Confidence 3888888 5555 8999998887733 10 23222 6789999999999999999999999998877654
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=96.62 E-value=1.1e-05 Score=71.38 Aligned_cols=97 Identities=9% Similarity=0.114 Sum_probs=71.8
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCC----CCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRS----DNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHL 297 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~----~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i 297 (488)
.+..++..+|.++++.|.+.||+..+...... ..-..+|..+|.+.+|.|+..+.+.++- ..|.. ..+.++.+
T Consensus 48 ~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~g~~~~~~~~~~~ 125 (179)
T 2f2o_A 48 ELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMT--NLGEKLTDEEVDEM 125 (179)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHH--HC--CCCHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCcHHHHHHHHHHHccCcccHHHHHHHHHHhCCCCCCcCcHHHHHHHHH--HhCCCCCHHHHHHH
Confidence 34456677888999999999999776432110 1112389999999999999988887762 22222 26779999
Q ss_pred HHHHHHhcCCCchhhhHhhhcchh
Q psy9090 298 LKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 298 ~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
++.+|.+++|.++++||+..+...
T Consensus 126 ~~~~D~~~dg~i~~~eF~~~~~~~ 149 (179)
T 2f2o_A 126 IREADIDGDGQVNYEEFVQMMTAK 149 (179)
T ss_dssp HHHHCTTCSSSEEHHHHHHHSCC-
T ss_pred HHHcCCCCCCcCcHHHHHHHHHHc
Confidence 999999999999999999988654
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=96.61 E-value=4.2e-05 Score=77.87 Aligned_cols=115 Identities=9% Similarity=0.121 Sum_probs=81.1
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCC
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEA 277 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~ 277 (488)
++..++...+.. .........+..++..+|.++++.|.+.||+..+.......... .+|+.+|.+.+|.|+..+.
T Consensus 329 Is~~EL~~~L~~-lg~~~s~eel~~Lf~~~D~DgdG~IsfeEFl~ll~~~~~~~~~~e~l~~aFk~fD~D~dG~Is~eEL 407 (450)
T 3sg6_A 329 ITTKELGTVMRS-LGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAEL 407 (450)
T ss_dssp ECHHHHHHHHHH-TTCCCCHHHHHHHHHTTCTTSSSSEEHHHHHHHHHC------CHHHHHHHHHHHCTTCSSEECHHHH
T ss_pred CcHHHHHHHHHH-hCCCCCHHHHHHHHHHhccCCCCcccHHHHHHHHHhhccccchhhHHHHHHHHhCCCCCCeEeHHHH
Confidence 444444444433 22223334456677788999999999999998876543222222 3999999999999999999
Q ss_pred cEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 278 QHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 278 q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+.++- ..|.. ..+.++.+++.+|.++||.|+++||+..+.
T Consensus 408 r~~L~--~lG~~ls~eei~~Lf~~~D~D~DG~IsfdEFv~~L~ 448 (450)
T 3sg6_A 408 RHVMT--NLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT 448 (450)
T ss_dssp HHHHH--HHTCCCCHHHHHHHHHHHCTTSSSSEEHHHHHHHHC
T ss_pred HHHHH--HhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 88773 32322 367899999999999999999999998875
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=96.59 E-value=5.5e-05 Score=60.47 Aligned_cols=60 Identities=12% Similarity=0.015 Sum_probs=51.1
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|++++|.|+..+.+.++ ..+|. ..+.++.|++.+|.+++|.++++||+.+|..+
T Consensus 15 ~~F~~~D~d~dG~Is~~el~~~l--~~~~l-~~~~l~~i~~~~D~d~dG~i~~~EF~~~~~~~ 74 (99)
T 1qjt_A 15 KYYRQVEAGNTGRVLALDAAAFL--KKSGL-PDLILGKIWDLADTDGKGVLSKQEFFVALRLV 74 (99)
T ss_dssp HHHHHHCCTTSSCCCSHHHHHHH--HTSSS-CHHHHHHHHHHHCCSSSSSCCSHHHHHHHHHH
T ss_pred HHHHHHCCCCCCcCCHHHHHHHH--HHcCC-CHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH
Confidence 49999999999999999998887 33442 36789999999999999999999999988654
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.59 E-value=1.6e-05 Score=69.30 Aligned_cols=95 Identities=9% Similarity=0.047 Sum_probs=67.1
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLK 299 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~ 299 (488)
.+..++..+|.++.+.|.+.||+..+......... ..+|..+|.+.+|.|+..+.+.++- ..|. ..+.++.+++
T Consensus 64 ~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~--~~~~-~~~~~~~~~~ 140 (166)
T 2aao_A 64 EILDLMQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFAAFTYFDKDGSGYITPDELQQACE--EFGV-EDVRIEELMR 140 (166)
T ss_dssp HHHHHHHHHCTTCCSSBCHHHHHHHHTTCHHHHTTHHHHHHHHHHCTTCSSSBCHHHHHHHTC--C---------CCHHH
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhcccHHHHHHHHHHhCCCCCCcCcHHHHHHHHH--HcCC-CHHHHHHHHH
Confidence 34455667788888999999999877543221112 2399999999999999888887762 2221 2566889999
Q ss_pred HHHHhcCCCchhhhHhhhcch
Q psy9090 300 HLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 300 ~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.++.+++|.++++||+..+..
T Consensus 141 ~~d~~~dg~i~~~eF~~~~~~ 161 (166)
T 2aao_A 141 DVDQDNDGRIDYNEFVAMMQK 161 (166)
T ss_dssp HHCTTCSSSBCHHHHHHHHC-
T ss_pred HhCCCCCCcEeHHHHHHHHHh
Confidence 999999999999999988754
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.00012 Score=56.27 Aligned_cols=82 Identities=11% Similarity=0.132 Sum_probs=58.1
Q ss_pred CCCCCCCchhhhhcc-CCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhh
Q psy9090 235 THLNLYGTKYHFKYK-FKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVG 312 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~-~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~ 312 (488)
+++.|++.|++.... .......-..+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++
T Consensus 2 ~~G~i~~~e~~~~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l--~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~ 79 (87)
T 1s6j_A 2 SSGHIDDDDKHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGL--KRVGSELMESEIKDLMDAADIDKSGTIDYG 79 (87)
T ss_dssp CSSSSSSHHHHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHH--HTTTSSCCHHHHHHHHHHHCTTCSSEECHH
T ss_pred CCCccCccHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH--HHhCCCCCHHHHHHHHHHhCCCCCCcCcHH
Confidence 456677777432211 11111222359999999999999998888777 3333322 6779999999999999999999
Q ss_pred hHhhhc
Q psy9090 313 EKIEKC 318 (488)
Q Consensus 313 e~i~~~ 318 (488)
||+..+
T Consensus 80 eF~~~~ 85 (87)
T 1s6j_A 80 EFIAAT 85 (87)
T ss_dssp HHTTCC
T ss_pred HHHHHH
Confidence 998765
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=96.56 E-value=4.1e-05 Score=69.50 Aligned_cols=104 Identities=10% Similarity=0.021 Sum_probs=73.4
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEc--ccccCCc-hhhHHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLA--GETLAGK-TTSLKH 296 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~s--gesgagk-te~~k~ 296 (488)
+..++..+|.++++.|.+.||+..+......... ..+|..+|.+.+|.|+..+.+.++.+ .+.|..- .+.++.
T Consensus 76 ~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~ 155 (207)
T 2ehb_A 76 ADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEV 155 (207)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHH
T ss_pred HHHHHHHhcCCCCCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHH
Confidence 3446778899999999999999877654322111 12899999999999999998877631 1223222 344444
Q ss_pred ----HHHHHHHhcCCCchhhhHhhhcch---hhhhhhc
Q psy9090 297 ----LLKHLIFLGQGAAKVGEKIEKCVN---VIHAIGN 327 (488)
Q Consensus 297 ----i~~~~~~~~~g~~~~~e~i~~~~~---~leafgn 327 (488)
+++.+|.+++|.|+++||+..+.. ++++|+-
T Consensus 156 ~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~ 193 (207)
T 2ehb_A 156 MVDKAFVQADRKNDGKIDIDEWKDFVSLNPSLIKNMTL 193 (207)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHHCGGGGGGGCC
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHhChHHHHHhcc
Confidence 446999999999999999987663 5666643
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=96.50 E-value=1.3e-05 Score=71.61 Aligned_cols=126 Identities=13% Similarity=0.123 Sum_probs=83.5
Q ss_pred ccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCC
Q psy9090 201 TISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEA 277 (488)
Q Consensus 201 ~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~ 277 (488)
.++..++...+............+..++..+|.++++.|.+.||...+......... ..+|+.+|.+.+|.|+..+.
T Consensus 42 ~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~ 121 (190)
T 1g8i_A 42 QLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEM 121 (190)
T ss_dssp EEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHH
T ss_pred cCCHHHHHHHHHHhCCCCChHHHHHHHHHHHhcCCCCeEeHHHHHHHHHHhcCCCHHHHHHHHHHhhcCCCCCeECHHHH
Confidence 344444444444332222233446667788899999999999999776433211111 12899999999999888888
Q ss_pred cEEEEc-----ccc-----cC-CchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 278 QHIVLA-----GET-----LA-GKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 278 q~i~~s-----ges-----ga-gkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
..++.. |+. |. ...+.++.+++.+|.+++|.|+++||+..+.. +++.|+
T Consensus 122 ~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~ef~~~~~~~~~~~~~~~ 184 (190)
T 1g8i_A 122 LDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPSIVQALS 184 (190)
T ss_dssp HHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHCHHHHHHHC
T ss_pred HHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhChHHHHHHh
Confidence 776633 321 11 12567999999999999999999999987653 555554
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=96.50 E-value=5.6e-05 Score=68.82 Aligned_cols=91 Identities=9% Similarity=0.040 Sum_probs=66.4
Q ss_pred eeeeCCCCCCCCCCchhhhhccCCCCCCC---------------C----hhhHHHHHHHHHHHHhcCCCcEEEEc--ccc
Q psy9090 228 LLFINPNTHLNLYGTKYHFKYKFKSRSDN---------------E----PHIYAVADSAYQDMMHHEEAQHIVLA--GET 286 (488)
Q Consensus 228 l~~Inp~~~~~i~~~ef~~~~~~~~~~~~---------------~----ph~f~~~d~~~~~~~~~~~~q~i~~s--ges 286 (488)
+..+|.++++.|.+.||+..+........ . ..+|..+|.+.+|.|+..+.+.++-. |+.
T Consensus 67 ~~~~d~~~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~ 146 (208)
T 2ct9_A 67 INAFFSEGEDQVNFRGFMRTLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVN 146 (208)
T ss_dssp HHTTSCTTCSCEEHHHHHHHHHTTSCCC-----------CCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTT
T ss_pred HHHHcCCCCCcCcHHHHHHHHHhhccccchhhhcccccccccccHHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCC
Confidence 33457777888999999987754322111 1 12899999999999999999887732 431
Q ss_pred cCCchhhHHHH----HHHHHHhcCCCchhhhHhhhcch
Q psy9090 287 LAGKTTSLKHL----LKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 287 gagkte~~k~i----~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
-..+.++.+ ++.+|.++||.|+++||+..+..
T Consensus 147 --~s~~~~~~l~~~~~~~~D~d~dG~Is~~EF~~~~~~ 182 (208)
T 2ct9_A 147 --ISDEQLGSIADRTIQEADQDGDSAISFTEFVKVLEK 182 (208)
T ss_dssp --CCHHHHHHHHHHHHHHHCSSSSSSEEHHHHHHTTTT
T ss_pred --CCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHhc
Confidence 124556666 99999999999999999988754
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=96.47 E-value=6.7e-05 Score=59.41 Aligned_cols=60 Identities=15% Similarity=0.054 Sum_probs=49.9
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|++.+|.|+..+.+.++ ...|. ..+.++.|++.+|.+++|.++++||+.+|..+
T Consensus 14 ~~F~~~D~d~dG~I~~~el~~~l--~~~g~-~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~ 73 (95)
T 1c07_A 14 EIFLKTDKDMDGFVSGLEVREIF--LKTGL-PSTLLAHIWSLCDTKDCGKLSKDQFALAFHLI 73 (95)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHH--HTTTC-CHHHHHHHHHHHCTTCSSSEETTTHHHHHHHH
T ss_pred HHHHHhCCCCCCcEeHHHHHHHH--HHcCC-CHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH
Confidence 39999999999999999988877 33332 35678999999999999999999999987543
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=96.46 E-value=3e-05 Score=66.51 Aligned_cols=95 Identities=7% Similarity=-0.034 Sum_probs=42.1
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCC---CCCCh-----hhHHHHHHHHHHHHhcCCCcEEEEc-cc-----ccC-
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSR---SDNEP-----HIYAVADSAYQDMMHHEEAQHIVLA-GE-----TLA- 288 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~---~~~~p-----h~f~~~d~~~~~~~~~~~~q~i~~s-ge-----sga- 288 (488)
...++..+|.++++.|.+.||...+..... ....+ .+|+.+|.+.+|.|+..+.+.++.+ +. .|.
T Consensus 29 ~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~ 108 (143)
T 3a4u_B 29 SFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPL 108 (143)
T ss_dssp ----------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------
T ss_pred CHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCC
Confidence 345677889999999999999877654321 11122 2799999999999998887766632 11 011
Q ss_pred CchhhHHHHH----HHHHHhcCCCchhhhHhhhc
Q psy9090 289 GKTTSLKHLL----KHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 289 gkte~~k~i~----~~~~~~~~g~~~~~e~i~~~ 318 (488)
-..+.+..++ +.+|.++||.|+++||+.++
T Consensus 109 ~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 142 (143)
T 3a4u_B 109 MSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSL 142 (143)
T ss_dssp CCHHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred CCHHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 1144555555 88999999999999999765
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=96.44 E-value=5.2e-05 Score=61.90 Aligned_cols=60 Identities=8% Similarity=0.010 Sum_probs=50.7
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+|++.+|.|+..+.+.++ ...|. ..+.++.|++.+|.+++|.++++||+.+|..+-
T Consensus 27 ~F~~~D~d~dG~Is~~el~~~l--~~~gl-~~~el~~i~~~~D~d~dG~I~~~EF~~~m~~~~ 86 (110)
T 1iq3_A 27 QFRSLQPDPSSFISGSVAKNFF--TKSKL-SIPELSYIWELSDADCDGALTLPEFCAAFHLIV 86 (110)
T ss_dssp HHHHHCCSSSSEEEHHHHHHHC--CSSSC-SSCCHHHHHHHHCSSSCSEEEHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCeEcHHHHHHHH--HHcCC-CHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHH
Confidence 9999999999999999999888 33332 256799999999999999999999999886543
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.00011 Score=58.66 Aligned_cols=64 Identities=8% Similarity=0.105 Sum_probs=50.6
Q ss_pred hhHHHHH-HHHHH-HHhcCCCcEEEEc--cc-ccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVAD-SAYQD-MMHHEEAQHIVLA--GE-TLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d-~~~~~-~~~~~~~q~i~~s--ge-sgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|..+| ++++| .|+..+++.++-+ |+ -|.. ..+.++.||+.+|.++||.|+|+||+.++..+.
T Consensus 14 ~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~ 83 (99)
T 2y5i_A 14 TVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLVAALT 83 (99)
T ss_dssp HHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHH
Confidence 3899998 88887 9999999988732 22 1211 256799999999999999999999998887654
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=96.38 E-value=4.9e-05 Score=67.90 Aligned_cols=91 Identities=7% Similarity=0.001 Sum_probs=70.1
Q ss_pred eeeCCCCCCCCCCchhhhhccCCCC-----CCCC-------hhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHH
Q psy9090 229 LFINPNTHLNLYGTKYHFKYKFKSR-----SDNE-------PHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKH 296 (488)
Q Consensus 229 ~~Inp~~~~~i~~~ef~~~~~~~~~-----~~~~-------ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~ 296 (488)
..+|.++++.|.+.||+..+..... ...+ ..+|..+|.+.+|.|+..+.+.++ ...| -..+.++.
T Consensus 71 ~~~D~d~dG~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l--~~~g-~~~~~~~~ 147 (191)
T 2ccm_A 71 KYADENEDEQVTKEEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVY--MSYG-IPKSDCDA 147 (191)
T ss_dssp HHHCTTCSSCEEHHHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHH--HTTT-CCHHHHHH
T ss_pred HhcCCCCCCeECHHHHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH--HHhC-CCHHHHHH
Confidence 6788899999999999877643210 0111 128999999999999999988776 2223 24677999
Q ss_pred HHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 297 LLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 297 i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+++.+|.++||.|+++||+..+....
T Consensus 148 ~~~~~D~d~dG~i~~~Ef~~~~~~~~ 173 (191)
T 2ccm_A 148 AFDTLSDGGKTMVTREIFARLWTEYF 173 (191)
T ss_dssp HHHHHTTTTTSCCBHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCcCHHHHHHHHHHHh
Confidence 99999999999999999999886554
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=5e-05 Score=67.98 Aligned_cols=92 Identities=8% Similarity=-0.005 Sum_probs=65.1
Q ss_pred ceeeeCCCCCCCCCCchhhhhccCCCC--------CC--CCh----hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-ch
Q psy9090 227 VLLFINPNTHLNLYGTKYHFKYKFKSR--------SD--NEP----HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KT 291 (488)
Q Consensus 227 il~~Inp~~~~~i~~~ef~~~~~~~~~--------~~--~~p----h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kt 291 (488)
++..+|.++++.|.+.||+..+..... .. .-. .+|..+|.+++|.|+..+.+.++- ..|.. ..
T Consensus 71 l~~~~D~d~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~--~~g~~~~~ 148 (195)
T 1qv0_A 71 FFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGK--ISGISPSQ 148 (195)
T ss_dssp HHHHTTCCTTCCBCHHHHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHH--HHSSCCCH
T ss_pred HHHHcCCCCCceEcHHHHHHHHHHHHhhhhhcccccHHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHH--HhCCCCCH
Confidence 344567788889999999976532210 01 011 689999999999999999988773 22322 26
Q ss_pred hhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 292 TSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 292 e~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+.++.+++.+|.+++|.++++||+..+..
T Consensus 149 ~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 177 (195)
T 1qv0_A 149 EDCEATFRHCDLDNAGDLDVDEMTRQHLG 177 (195)
T ss_dssp HHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 77999999999999999999999988754
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=96.34 E-value=7.8e-05 Score=59.03 Aligned_cols=64 Identities=16% Similarity=0.177 Sum_probs=48.5
Q ss_pred hhHHHHH-HHH-HHHHhcCCCcEEEEc--cc-ccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVAD-SAY-QDMMHHEEAQHIVLA--GE-TLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d-~~~-~~~~~~~~~q~i~~s--ge-sgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|..+| +++ .|.|+..+++.++-+ |+ .|.. ..+.++.||+.+|.++||.|+|+||+.++..+.
T Consensus 13 ~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~ 82 (95)
T 1j55_A 13 DVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAIT 82 (95)
T ss_dssp HHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHH
Confidence 3899999 688 579999999888732 11 1211 246799999999999999999999998887654
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=96.33 E-value=1.9e-05 Score=68.52 Aligned_cols=92 Identities=9% Similarity=-0.018 Sum_probs=70.1
Q ss_pred eeeeCCCCCCCCCCchhhhhccCCCCCCC----------ChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHH
Q psy9090 228 LLFINPNTHLNLYGTKYHFKYKFKSRSDN----------EPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHL 297 (488)
Q Consensus 228 l~~Inp~~~~~i~~~ef~~~~~~~~~~~~----------~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i 297 (488)
+..+|+++++.|.+.||+..+........ -..+|+.+|.+.+|.|+..+.+.++ ...| -..+.++.+
T Consensus 61 f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~E~~~~l--~~~~-~~~~~~~~~ 137 (166)
T 3akb_A 61 AGIADRDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARAL--TAFG-VPEDLARQA 137 (166)
T ss_dssp HHHHCTTSSSCEEHHHHHHTHHHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCCBHHHHHHHH--HHTT-CCHHHHHHH
T ss_pred HHHhCCCCCCcCcHHHHHHHHHHHhccCccchHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHH--HHhC-CCHHHHHHH
Confidence 45678888899999999876643321110 1238999999999999999888777 3334 346789999
Q ss_pred HHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 298 LKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 298 ~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
++.+|.+++|.++++||+..+...+
T Consensus 138 ~~~~D~d~dg~i~~~ef~~~~~~~~ 162 (166)
T 3akb_A 138 AAALDTDGDGKVGETEIVPAFARYF 162 (166)
T ss_dssp HHHHCTTCSSBCCHHHHHHHHHHHT
T ss_pred HHHhCCCCCCcCcHHHHHHHHHHHh
Confidence 9999999999999999998876543
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=96.31 E-value=1.1e-05 Score=69.14 Aligned_cols=94 Identities=10% Similarity=-0.001 Sum_probs=69.4
Q ss_pred ccCCceeeeCCC--CCCCCCCchhhhhccCCCC------CCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhh
Q psy9090 223 FVGDVLLFINPN--THLNLYGTKYHFKYKFKSR------SDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTS 293 (488)
Q Consensus 223 ~v~~il~~Inp~--~~~~i~~~ef~~~~~~~~~------~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~ 293 (488)
.+..++..+|.+ +++.|.+.||+..+..... ...-..+|..+|.+.+|.|+..+.+.++- ..|.. ..+.
T Consensus 47 ~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~~ 124 (151)
T 1w7j_B 47 EVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVLT--TLGEKMTEEE 124 (151)
T ss_dssp HHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCHHHHHTTCTTSSSEEEHHHHHHHHH--HSSSCCCHHH
T ss_pred HHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccCCCCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHH--HcCCCCCHHH
Confidence 344455566777 7888999999987754321 11223399999999999999999888772 22322 2677
Q ss_pred HHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 294 LKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 294 ~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
++.+++.++ +++|.++++||+..+.
T Consensus 125 ~~~~~~~~d-~~dg~i~~~eF~~~~~ 149 (151)
T 1w7j_B 125 VETVLAGHE-DSNGCINYEAFLKHIL 149 (151)
T ss_dssp HHHHHTTCC-CTTSEEEHHHHHHHTC
T ss_pred HHHHHHhcc-CCCCeEeHHHHHHHHh
Confidence 999999999 9999999999998775
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.31 E-value=1.8e-05 Score=72.43 Aligned_cols=103 Identities=9% Similarity=0.078 Sum_probs=74.8
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEc-cccc--CC--chhhHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLA-GETL--AG--KTTSLK 295 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~s-gesg--ag--kte~~k 295 (488)
+..++..+|.++++.|.+.||...+......... ..+|+.+|.+.+|.|+..+.+.++.. |..+ .. ..+.++
T Consensus 59 ~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~ 138 (211)
T 2ggz_A 59 IDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFIN 138 (211)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHH
T ss_pred HHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHH
Confidence 4455667788899999999999877533221111 12899999999999999998877732 2111 11 135589
Q ss_pred HHHHHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 296 HLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 296 ~i~~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
.+++.+|.+++|.|+++||+..+.. +.+.|.
T Consensus 139 ~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~ 172 (211)
T 2ggz_A 139 LVFHKIDINNDGELTLEEFINGMAKDQDLLEIVY 172 (211)
T ss_dssp HHHHHHCTTCSSSBCHHHHHHHHHTTTTTHHHHH
T ss_pred HHHHHhCCCCCCCCcHHHHHHHHHhCHHHHHHHh
Confidence 9999999999999999999988764 556665
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=96.26 E-value=7.7e-05 Score=56.23 Aligned_cols=60 Identities=13% Similarity=0.159 Sum_probs=48.3
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+.+|.|+..+.+.++- ..|.-..+.++.+++.++.+++|.++++||+..+..
T Consensus 7 ~~F~~~D~~~~G~i~~~el~~~l~--~~g~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~ 66 (78)
T 1k9u_A 7 RIFKRFDTNGDGKISLSELTDALR--TLGSTSADEVQRMMAEIDTDGDGFIDFNEFISFCNA 66 (78)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHH--HHHTCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHH--HhCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 489999999999888888887763 223113677999999999999999999999987654
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.25 E-value=3.7e-05 Score=69.66 Aligned_cols=99 Identities=13% Similarity=0.124 Sum_probs=73.3
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh---hhHHHHHHHHHHHHhcCCCcEEEEc-----ccc-------
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP---HIYAVADSAYQDMMHHEEAQHIVLA-----GET------- 286 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p---h~f~~~d~~~~~~~~~~~~q~i~~s-----ges------- 286 (488)
..+..++..+|.++++.|.+.||...+.......... .+|..+|.+.+|.|+..+...++.. |..
T Consensus 59 ~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~ 138 (204)
T 1jba_A 59 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAE 138 (204)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSS
T ss_pred HHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCcccccc
Confidence 3455667788999999999999998775433222222 2899999999999988888776632 211
Q ss_pred --cC--CchhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 287 --LA--GKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 287 --ga--gkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
|. ...+.++.+++.+|.+++|.|+++||+..+..
T Consensus 139 ~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~ 176 (204)
T 1jba_A 139 QQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARR 176 (204)
T ss_dssp TTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTT
T ss_pred ccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHc
Confidence 00 12467999999999999999999999988763
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=96.23 E-value=9.3e-05 Score=64.78 Aligned_cols=90 Identities=11% Similarity=0.044 Sum_probs=67.7
Q ss_pred eeeeCCCCCCCCCCchhhhhccCCCCCC--------CChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHH
Q psy9090 228 LLFINPNTHLNLYGTKYHFKYKFKSRSD--------NEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLK 299 (488)
Q Consensus 228 l~~Inp~~~~~i~~~ef~~~~~~~~~~~--------~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~ 299 (488)
+..+| +++.|.+.||+..+....... .-..+|+.+|.+.+|.|+..+.+.++ ...| -..+.++.+++
T Consensus 61 ~~~~D--~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l--~~~g-~~~~~~~~~~~ 135 (174)
T 1q80_A 61 LTAVA--GGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFF--GMLG-LDKTMAPASFD 135 (174)
T ss_dssp GGGTT--TTSCEEHHHHHHHHHHHTTSTTCHHHHHTHHHHHHHHHCTTSSSSBCHHHHHHHH--HHHT-CCGGGHHHHHH
T ss_pred HHhcC--CCCeEcHHHHHHHHHHHcCcccHHHHHHHHHHHHHHHhCCCCCCcccHHHHHHHH--HHcC-CCHHHHHHHHH
Confidence 33445 667889999987765432211 11229999999999999999988877 2223 13677999999
Q ss_pred HHHHhcCCCchhhhHhhhcchhh
Q psy9090 300 HLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 300 ~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|.+++|.|+++||+..+...+
T Consensus 136 ~~D~d~dg~i~~~ef~~~~~~~~ 158 (174)
T 1q80_A 136 AIDTNNDGLLSLEEFVIAGSDFF 158 (174)
T ss_dssp HHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HhCCCCCceEeHHHHHHHHHHHh
Confidence 99999999999999999987665
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=96.23 E-value=0.00011 Score=56.59 Aligned_cols=59 Identities=10% Similarity=0.084 Sum_probs=48.3
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|..+|.+.+|.|+..+.+.++ ...|.-..+.++.+++.+|.+++|.++++||+..+..
T Consensus 16 ~F~~~D~d~~G~i~~~el~~~l--~~~g~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~ 74 (86)
T 2opo_A 16 IFKRFDTNGDGKISSSELGDAL--KTLGSVTPDEVRRMMAEIDTDGDGFISFDEFTDFARA 74 (86)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHH--HTTTTCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHCCCCCCCcCHHHHHHHH--HHcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 8999999999999988888777 3333113677999999999999999999999987653
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=96.21 E-value=1.8e-05 Score=70.65 Aligned_cols=85 Identities=11% Similarity=0.080 Sum_probs=59.7
Q ss_pred CCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC--------chhhHHHHHHHHHH
Q psy9090 235 THLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG--------KTTSLKHLLKHLIF 303 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag--------kte~~k~i~~~~~~ 303 (488)
..+.|.+.+|...+......... ..+|.++|.+++|.|+..+.+.++-. .-|.. ..+.++.|++.+|.
T Consensus 75 ~~~~i~~~ef~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~-~~g~~~~~~~~~~~~~~~~~~~~~~D~ 153 (179)
T 3a8r_A 75 VKQVLTKDELKDFYEQLTDQGFDNRLRTFFDMVDKNADGRLTAEEVKEIIAL-SASANKLSKIKERADEYTALIMEELDP 153 (179)
T ss_dssp CSSEECHHHHHHHHHHHHCCCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH-HHHTTHHHHHHHHHHHHHHHHHHHHST
T ss_pred CCCCcCHHHHHHHHHHHcCCCHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH-HhccccccccccchHHHHHHHHHHhCC
Confidence 34557777777654321111111 13999999999999999999988730 11222 34678999999999
Q ss_pred hcCCCchhhhHhhhcch
Q psy9090 304 LGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 304 ~~~g~~~~~e~i~~~~~ 320 (488)
++||.|+++||+.++..
T Consensus 154 d~dG~I~~~EF~~~~~~ 170 (179)
T 3a8r_A 154 TNLGYIEMEDLEALLLQ 170 (179)
T ss_dssp TCCSEECHHHHHHHHC-
T ss_pred CCCCcCcHHHHHHHHHh
Confidence 99999999999988764
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0001 Score=64.23 Aligned_cols=98 Identities=8% Similarity=0.077 Sum_probs=74.0
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKH 300 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~ 300 (488)
..+..++..+|+++++.|.+.||+..+... ..-..+|..+|.+.+|.|+..+.+.++- ..|.. ..+.++.+++.
T Consensus 40 ~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~---~~~~~~F~~~D~d~~G~i~~~el~~~l~--~~g~~~~~~~~~~~~~~ 114 (165)
T 1k94_A 40 ETCRIMIAMLDRDHTGKMGFNAFKELWAAL---NAWKENFMTVDQDGSGTVEHHELRQAIG--LMGYRLSPQTLTTIVKR 114 (165)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH---HHHHHHHHHHCTTCCSBCCHHHHHHHHH--HTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHH---HHHHHHHHHhCCCCCceECHHHHHHHHH--HhCCCCCHHHHHHHHHH
Confidence 345566777899999999999999876542 1123499999999999999999887773 22322 35778899998
Q ss_pred HHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 301 LIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 301 ~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
+ +++|.++++||+..+.. +.++|-
T Consensus 115 ~--d~dg~i~~~eF~~~~~~~~~~~~~F~ 141 (165)
T 1k94_A 115 Y--SKNGRIFFDDYVACCVKLRALTDFFR 141 (165)
T ss_dssp H--CBTTBCBHHHHHHHHHHHHHHHHHHH
T ss_pred h--CCCCeEcHHHHHHHHHHHHHHHHHHH
Confidence 8 89999999999988764 455564
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.14 E-value=8.9e-05 Score=53.81 Aligned_cols=61 Identities=8% Similarity=0.097 Sum_probs=48.4
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|.+.+|.|+..+.+.++ ...|.. ..+.++.+++.++.+++|.++++||+..+...
T Consensus 5 ~~F~~~D~d~~G~i~~~el~~~l--~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~ 66 (67)
T 1tiz_A 5 RVFEKFDKNKDGKLSLDEFREVA--LAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEKM 66 (67)
T ss_dssp HHHHHHCTTSSSCEEHHHHHHHH--HHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHTC
T ss_pred HHHHHHCCCCCCcCcHHHHHHHH--HHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHH
Confidence 47888898888888888887766 222322 26778999999999999999999999887654
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=96.10 E-value=6.3e-05 Score=59.59 Aligned_cols=66 Identities=9% Similarity=0.053 Sum_probs=51.2
Q ss_pred hhHHHHH-HHHHH-HHhcCCCcEEEEc--cc-ccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 259 HIYAVAD-SAYQD-MMHHEEAQHIVLA--GE-TLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 259 h~f~~~d-~~~~~-~~~~~~~q~i~~s--ge-sgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
.+|..+| ++++| .|+..+++.++-+ |+ -|.. ..+.++.||+.+|.+++|.|+|+||+.++..+..+
T Consensus 16 ~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~~~~~ 87 (95)
T 2wcb_A 16 NIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIALKA 87 (95)
T ss_dssp HHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSSTTSEEEHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHH
Confidence 3899999 78887 9999999988732 11 1211 25679999999999999999999999988765443
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=96.09 E-value=2.2e-05 Score=67.99 Aligned_cols=95 Identities=9% Similarity=0.094 Sum_probs=70.4
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCC-------CCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRS-------DNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLK 295 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~-------~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k 295 (488)
+..++..+|.++.+.|.+.||+..+...... ..-..+|..+|.+.+|.|+..+.+.++ ...|..- .+.++
T Consensus 58 ~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l--~~~g~~~~~~~~~ 135 (162)
T 1top_A 58 LDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEIL--RATGEHVTEEDIE 135 (162)
T ss_dssp HHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHH--HTTTCCCCHHHHH
T ss_pred HHHHHHHHcCCCCCcEeHHHHHHHHHHHhccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHH--HHhCCCCCHHHHH
Confidence 3445666778888889999999776432110 111238999999999999999888777 2223222 57799
Q ss_pred HHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 296 HLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 296 ~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+++.++.+++|.++++||+..+..
T Consensus 136 ~~~~~~d~~~dg~i~~~eF~~~~~~ 160 (162)
T 1top_A 136 DLMKDSDKNNDGRIDFDEFLKMMEG 160 (162)
T ss_dssp HHHHHHCTTCSSSBCHHHHHHHHHS
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHhh
Confidence 9999999999999999999987754
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.00026 Score=57.91 Aligned_cols=63 Identities=10% Similarity=0.083 Sum_probs=50.8
Q ss_pred hHHHHH-HHHHH-HHhcCCCcEEEEcccccC---C---chhhHHHHHHHHHHhcCCCchhhhHhhhcchhhh
Q psy9090 260 IYAVAD-SAYQD-MMHHEEAQHIVLAGETLA---G---KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIH 323 (488)
Q Consensus 260 ~f~~~d-~~~~~-~~~~~~~q~i~~sgesga---g---kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~le 323 (488)
+|..+| ++.+| .|+..+++.++-. +.|. . ..+.++.||+.+|.++||.|+|+||+.++..+..
T Consensus 17 ~F~~fD~~dgdG~~Is~~El~~~l~~-~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~~ 87 (113)
T 1xk4_C 17 TFHQYSVKLGHPDTLNQGEFKELVRK-DLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLTW 87 (113)
T ss_dssp HHHHHHTTSSSTTSBCHHHHHHHHHH-HTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCEECHHHHHHHHHH-HhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHHHH
Confidence 899999 49999 9999999887731 2221 1 2567899999999999999999999998877653
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.07 E-value=4.3e-05 Score=67.05 Aligned_cols=94 Identities=9% Similarity=-0.009 Sum_probs=71.5
Q ss_pred CceeeeCCCCCCCCCCchhhhhccCCCCCCCC-----------hhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhH
Q psy9090 226 DVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE-----------PHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSL 294 (488)
Q Consensus 226 ~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~-----------ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~ 294 (488)
.++..+|.++++.|.+.||+..+......... ..+|..+|.+.+|.|+..+.+.++ ...| -..+.+
T Consensus 62 ~lf~~~D~d~dg~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l--~~~g-~~~~~~ 138 (176)
T 1nya_A 62 YLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWL--TALG-MSKAEA 138 (176)
T ss_dssp HHHHHHTSCTTCCBCHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHH--HHTT-CCHHHH
T ss_pred HHHHHhCCCCCCeEcHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHH--HHhC-CCHHHH
Confidence 45567788899999999999877543222211 138999999999999888888766 2233 246779
Q ss_pred HHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 295 KHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 295 k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+.+++.+|.+++|.|+++||+..+....
T Consensus 139 ~~~~~~~D~d~dg~i~~~ef~~~~~~~~ 166 (176)
T 1nya_A 139 AEAFNQVDTNGNGELSLDELLTAVRDFH 166 (176)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHSCCS
T ss_pred HHHHHHhCCCCCCCCcHHHHHHHHHHHh
Confidence 9999999999999999999999886543
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=96.06 E-value=0.00017 Score=56.55 Aligned_cols=63 Identities=11% Similarity=-0.016 Sum_probs=50.2
Q ss_pred hHHHHH-HHHHH-HHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVAD-SAYQD-MMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d-~~~~~-~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+| ++++| .|+..+.+.++-+ +..|.-..+.++.|++.+|.+++|.|+++||+..+..+.
T Consensus 15 ~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~~~~~~i~~~~~~~D~d~dG~I~f~EF~~~~~~~~ 80 (92)
T 2kax_A 15 TFHKYSGREGSKLTLSRKELKELIKKELCLGEMKESSIDDLMKSLDKNSDQEIDFKEYSVFLTMLC 80 (92)
T ss_dssp HHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTTTCCTTHHHHHHHHTTTCSSEEEHHHHHHHHHHHH
T ss_pred HHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 899999 99999 9999998887732 111111356799999999999999999999999887654
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=96.05 E-value=6.3e-05 Score=59.14 Aligned_cols=60 Identities=13% Similarity=0.129 Sum_probs=49.1
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|+.+|++.+|.|+..+.+.++ ...|. ..+.++.|++.+|.+++|.++++||+.+|..+
T Consensus 13 ~~F~~~D~d~dG~I~~~el~~~l--~~~g~-~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~ 72 (92)
T 1fi6_A 13 NQFKTIQPDLNGFIPGSAAKEFF--TKSKL-PILELSHIWELSDFDKDGALTLDEFCAAFHLV 72 (92)
T ss_dssp HHHTTTCCSTTCEEEHHHHHHHH--HHHSS-CHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCcCcHHHHHHHH--HHcCC-CHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 38889999999999988888777 23332 35678999999999999999999999988654
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=96.03 E-value=2.8e-05 Score=68.34 Aligned_cols=93 Identities=11% Similarity=0.198 Sum_probs=71.1
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHL 301 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~ 301 (488)
.+..++..+|.++++.|.+.||...+... ..-..+|..+|.+.+|.|+..+.+.++ ...|.. ..+.++.+++.+
T Consensus 45 ~~~~l~~~~D~~~~g~i~~~ef~~~~~~~---~~~~~~F~~~D~d~~G~i~~~el~~~l--~~~g~~~~~~~~~~~~~~~ 119 (172)
T 2znd_A 45 TVRSIISMFDRENKAGVNFSEFTGVWKYI---TDWQNVFRTYDRDNSGMIDKNELKQAL--SGFGYRLSDQFHDILIRKF 119 (172)
T ss_dssp HHHHHHHHHCSSSSSEECHHHHHHHHHHH---HHHHHHHHHHCTTCSSEECHHHHHHHH--HHTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHHHHHHH---HHHHHHHHHHCCCCCCccCHHHHHHHH--HHcCCCCCHHHHHHHHHHh
Confidence 34455667788888999999999776432 112348999999999999999888776 222322 367799999999
Q ss_pred HHhcCCCchhhhHhhhcch
Q psy9090 302 IFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 302 ~~~~~g~~~~~e~i~~~~~ 320 (488)
+.+++|.++++||+..+..
T Consensus 120 d~~~dg~i~~~eF~~~~~~ 138 (172)
T 2znd_A 120 DRQGRGQIAFDDFIQGCIV 138 (172)
T ss_dssp CTTCSSSEEHHHHHHHHHH
T ss_pred CCCCCCcCcHHHHHHHHHH
Confidence 9999999999999988754
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=96.02 E-value=4.4e-05 Score=68.01 Aligned_cols=95 Identities=7% Similarity=-0.006 Sum_probs=70.6
Q ss_pred CceeeeCCCCCCCCCCchhhhhccCCCC--------CCCC------hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-c
Q psy9090 226 DVLLFINPNTHLNLYGTKYHFKYKFKSR--------SDNE------PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-K 290 (488)
Q Consensus 226 ~il~~Inp~~~~~i~~~ef~~~~~~~~~--------~~~~------ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-k 290 (488)
.++..+|.++++.|.+.||+..+..... .... ..+|..+|.+.+|.|+..+.+.++- ..|.. .
T Consensus 66 ~l~~~~D~d~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~--~~g~~~~ 143 (191)
T 1uhk_A 66 AFFGGAGMKYGVETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTK--AAGIIQS 143 (191)
T ss_dssp HHHHHTTCCTTCEEEHHHHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHH--HHTSCCS
T ss_pred HHHHHhCcCCCCcCcHHHHHHHHHHHhcchhhhhhhhhHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHH--HhCCCCC
Confidence 3455567888888999999876543211 1111 1699999999999999999988773 22322 2
Q ss_pred hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 291 TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 291 te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+.++.+++.+|.+++|.++++||+..+....
T Consensus 144 ~~~~~~~~~~~D~d~dG~i~~~eF~~~~~~~~ 175 (191)
T 1uhk_A 144 SEDCEETFRVCDIDESGQLDVDEMTRQHLGFW 175 (191)
T ss_dssp HHHHHHHHHHSCCCTTSCEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHh
Confidence 67799999999999999999999999887543
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=96.02 E-value=7.3e-05 Score=67.46 Aligned_cols=82 Identities=10% Similarity=0.073 Sum_probs=64.3
Q ss_pred CCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCch
Q psy9090 236 HLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAK 310 (488)
Q Consensus 236 ~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~ 310 (488)
++.|.+.+|+..+.......... .+|..+|.+.+|.|+..+.+.++ . |+ .-..+.+..|++.++.+++|.|+
T Consensus 103 ~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~--~~~~~~~~~l~~~~D~d~dG~I~ 179 (196)
T 3dtp_E 103 PGPINFTMFLTIFGDRIAGTDEEDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGE--KFSQDEVDQALSEAPIDGNGLID 179 (196)
T ss_dssp SSCCBHHHHHHHHHHCCCSSCCHHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSS--CCCHHHHHHHHHSSCEETTEECH
T ss_pred cCCCcHHHHHHHHHHHhcCCCcHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCC--CCCHHHHHHHHHHcCCCCCCEEe
Confidence 56788999998875443222222 39999999999999999999888 4 43 11367899999999999999999
Q ss_pred hhhHhhhcch
Q psy9090 311 VGEKIEKCVN 320 (488)
Q Consensus 311 ~~e~i~~~~~ 320 (488)
|+||+..|..
T Consensus 180 ~~EF~~~l~~ 189 (196)
T 3dtp_E 180 IKKFAQILTK 189 (196)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHHHc
Confidence 9999988754
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0003 Score=54.87 Aligned_cols=68 Identities=10% Similarity=0.162 Sum_probs=52.8
Q ss_pred hhHHHHH-HHHHH-HHhcCCCcEEEEc--cc-ccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhh
Q psy9090 259 HIYAVAD-SAYQD-MMHHEEAQHIVLA--GE-TLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIG 326 (488)
Q Consensus 259 h~f~~~d-~~~~~-~~~~~~~q~i~~s--ge-sgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafg 326 (488)
.+|..+| ++.+| .|+..+.+.++-. ++ .|.. ..+.++.+++.++.+++|.++++||+..+..+..+..
T Consensus 13 ~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~~~~~ 86 (93)
T 1k2h_A 13 NVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALTVACN 86 (93)
T ss_dssp HHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHHHCTTSCCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHHH
Confidence 3899999 79888 8888888877621 00 3322 2677999999999999999999999999888766543
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=95.99 E-value=3.1e-05 Score=69.82 Aligned_cols=103 Identities=11% Similarity=0.100 Sum_probs=74.6
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEc-cccc---CCc--hhhH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLA-GETL---AGK--TTSL 294 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~s-gesg---agk--te~~ 294 (488)
+..++..+|.++++.|.+.||...+......... ..+|+.+|.+.+|.|+..+...++.. |..+ ... .+.+
T Consensus 54 ~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~ 133 (198)
T 2r2i_A 54 VEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFT 133 (198)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHH
T ss_pred HHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHH
Confidence 5556778899999999999999877533221111 23899999999999999888877632 2111 111 3458
Q ss_pred HHHHHHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 295 KHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 295 k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
+.+++.+|.+++|.|+++||+..+.. +.+.+.
T Consensus 134 ~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~ 168 (198)
T 2r2i_A 134 NMVFDKIDINGDGELSLEEFMEGVQKDEVLLDILT 168 (198)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHTTCHHHHHHHH
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHcCHHHHHHHh
Confidence 99999999999999999999988764 555554
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=95.97 E-value=8.6e-05 Score=64.90 Aligned_cols=97 Identities=9% Similarity=0.105 Sum_probs=72.9
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKH 300 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~ 300 (488)
..+..++..+|.++++.|.+.||+..+... ..-..+|..+|.+.+|.|+..+.+.++- ..|.. ..+.++.+++.
T Consensus 42 ~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~---~~~~~~F~~~D~d~~G~i~~~el~~~l~--~~g~~~~~~~~~~~~~~ 116 (167)
T 1gjy_A 42 ETCRLMVSMLDRDMSGTMGFNEFKELWAVL---NGWRQHFISFDSDRSGTVDPQELQKALT--TMGFRLNPQTVNSIAKR 116 (167)
T ss_dssp HHHHHHHHHHCTTCCSCBCHHHHHHHHHHH---HHHHHHHHHHCTTCCSEECHHHHHHHHH--TTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHHH---HHHHHHHHHhCCCCCCcCCHHHHHHHHH--HcCCCCCHHHHHHHHHH
Confidence 345566777889999999999999877542 1123489999999999999998887773 22322 36778899988
Q ss_pred HHHhcCCCchhhhHhhhcch---hhhhh
Q psy9090 301 LIFLGQGAAKVGEKIEKCVN---VIHAI 325 (488)
Q Consensus 301 ~~~~~~g~~~~~e~i~~~~~---~leaf 325 (488)
+ +++|.++++||+..+.. +.++|
T Consensus 117 ~--d~dg~i~~~eF~~~~~~~~~~~~~F 142 (167)
T 1gjy_A 117 Y--STSGKITFDDYIACCVKLRALTDSF 142 (167)
T ss_dssp T--CBTTBEEHHHHHHHHHHHHHHHHHH
T ss_pred h--CcCCcCcHHHHHHHHHHHHHHHHHH
Confidence 8 89999999999987764 44555
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=95.96 E-value=6e-05 Score=60.33 Aligned_cols=64 Identities=6% Similarity=-0.001 Sum_probs=47.9
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEc------ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLA------GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~s------gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
+|..+|.+ .|.|+..+++.++-+ |+-|.-..+.++.||+.+|.++||.|+|+||+.+|.....+
T Consensus 15 ~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~d~dG~I~f~EF~~~~~~~~~~ 84 (100)
T 1psr_A 15 MFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIATD 84 (100)
T ss_dssp HHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHHHHH
T ss_pred HHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHH
Confidence 88888865 678888888887732 21001124578999999999999999999999988765433
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.95 E-value=5.7e-05 Score=66.76 Aligned_cols=92 Identities=10% Similarity=0.005 Sum_probs=68.8
Q ss_pred eeeeCCCCCCCCCCchhhhhccCCCCC-------CCC-----hhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHH
Q psy9090 228 LLFINPNTHLNLYGTKYHFKYKFKSRS-------DNE-----PHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLK 295 (488)
Q Consensus 228 l~~Inp~~~~~i~~~ef~~~~~~~~~~-------~~~-----ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k 295 (488)
+..+|.++++.|.+.||...+...... ... ..+|+.+|.+.+|.|+..+.+.++ ...| -..+.++
T Consensus 66 f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l--~~~g-~~~~~~~ 142 (185)
T 2sas_A 66 KGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYC--KNFQ-LQCADVP 142 (185)
T ss_dssp HHHHCTTCSSCEEHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHT--TSSC-CCCSSHH
T ss_pred HHhcCCCCCCeEcHHHHHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHH--HHhC-CCHHHHH
Confidence 556778888889999998765432110 011 129999999999999988887766 2233 2367899
Q ss_pred HHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 296 HLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 296 ~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+++.+|.+++|.++++||+..+...+
T Consensus 143 ~~~~~~D~d~dG~i~~~ef~~~~~~~~ 169 (185)
T 2sas_A 143 AVYNVITDGGKVTFDLNRYKELYYRLL 169 (185)
T ss_dssp HHHHHHHTTTTSCCSHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHHh
Confidence 999999999999999999999887654
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.95 E-value=0.00012 Score=61.71 Aligned_cols=83 Identities=13% Similarity=0.121 Sum_probs=63.5
Q ss_pred CCCCCCCCchhhhhccCCCCCCCC---h---hhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcC
Q psy9090 234 NTHLNLYGTKYHFKYKFKSRSDNE---P---HIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQ 306 (488)
Q Consensus 234 ~~~~~i~~~ef~~~~~~~~~~~~~---p---h~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~ 306 (488)
++++.|.+.||+..+........+ . .+|..+|.+.+|.|+..+.+.++-+ |+. -..+.++.+++.++. ++
T Consensus 49 ~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~--~~~~~~~~~~~~~d~-~d 125 (140)
T 1ggw_A 49 TLPAEVDMEQFLQVLNRPNGFDMPGDPEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEK--LSNEEMDELLKGVPV-KD 125 (140)
T ss_dssp TSCSSEEHHHHHHHHCTTSSSSSSCCHHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSC--SCHHHHHHHHHHTTC-SS
T ss_pred CCCCcCcHHHHHHHHHHHhcccCcccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCC--CCHHHHHHHHHhccC-CC
Confidence 456778899999887655432222 1 2899999999999999998887732 331 136779999999999 99
Q ss_pred CCchhhhHhhhcc
Q psy9090 307 GAAKVGEKIEKCV 319 (488)
Q Consensus 307 g~~~~~e~i~~~~ 319 (488)
|.++++||+..+.
T Consensus 126 g~i~~~eF~~~~~ 138 (140)
T 1ggw_A 126 GMVNYHDFVQMIL 138 (140)
T ss_dssp CCSTTTHHHHHHH
T ss_pred CcEeHHHHHHHHh
Confidence 9999999998764
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=95.87 E-value=0.0002 Score=54.23 Aligned_cols=60 Identities=13% Similarity=0.161 Sum_probs=49.5
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEccccc-CC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETL-AG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesg-ag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
+|..+|.+.+|.|+..+.+.++- ..| .. ..+.++.+++.++.+++|.++++||+..+...
T Consensus 13 ~F~~~D~d~~G~i~~~el~~~l~--~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 74 (81)
T 1c7v_A 13 AFKVFDANGDGVIDFDEFKFIMQ--KVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKKS 74 (81)
T ss_dssp HHHHHSCSGGGEECHHHHHHHSS--TTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHCC
T ss_pred HHHHHCCCCCCcCCHHHHHHHHH--HhCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhh
Confidence 89999999999999998887772 223 22 26779999999999999999999999887654
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=95.81 E-value=0.00024 Score=55.19 Aligned_cols=61 Identities=11% Similarity=0.104 Sum_probs=49.8
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+...+
T Consensus 25 ~F~~~D~d~~G~i~~~el~~~l--~~~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~~~~ 86 (90)
T 1avs_A 25 AFDMFDADGGGDISTKELGTVM--RMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQM 86 (90)
T ss_dssp HHHHHCTTCSSEECHHHHHHHH--HHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHH--HHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHHh
Confidence 8999999999988888888776 3333222 67799999999999999999999999887654
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=95.79 E-value=0.00011 Score=69.09 Aligned_cols=94 Identities=10% Similarity=0.021 Sum_probs=69.7
Q ss_pred ceeeeCCCCCCCCCCchhhhhccCCC-------CCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEc-cccc--CCchh
Q psy9090 227 VLLFINPNTHLNLYGTKYHFKYKFKS-------RSDNE----PHIYAVADSAYQDMMHHEEAQHIVLA-GETL--AGKTT 292 (488)
Q Consensus 227 il~~Inp~~~~~i~~~ef~~~~~~~~-------~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~s-gesg--agkte 292 (488)
++..+|+++.+.|.+.||+..+.... ..... ..+|..+|.+.+|.|+..+.+.++-. |++. .-..+
T Consensus 152 ~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~El~~~l~~~~~~~~~~~~~~ 231 (263)
T 2f33_A 152 MLKLFDSNNDGKLELTEMARLLPVQENFLLKFQGIKMCGKEFNKAFELYDQDGNGYIDENELDALLKDLCEKNKQELDIN 231 (263)
T ss_dssp HHHHTCSSSSSCBCHHHHHHHSCTTTCSHHHHHHTCCCHHHHHHHHHHHCCSSSSCEEHHHHHHHHHHHHHHCTTTCCTT
T ss_pred HHHhcCCCCCCeEcHHHHHHHHHHHHHHHHHhcCcchHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHhcCCCCCHH
Confidence 66778899999999999998775421 01111 23999999999999999998877743 3321 11256
Q ss_pred hHHHHHHH-HHHhcCCCchhhhHhhhcch
Q psy9090 293 SLKHLLKH-LIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 293 ~~k~i~~~-~~~~~~g~~~~~e~i~~~~~ 320 (488)
.++.+++. +|.++||.++++||+..+.+
T Consensus 232 e~~~~~~~~~D~d~dG~i~~~EF~~~~~~ 260 (263)
T 2f33_A 232 NISTYKKNIMALSDGGKLYRTDLALILSA 260 (263)
T ss_dssp THHHHHHHHHTTSBTTEECGGGTHHHHCC
T ss_pred HHHHHHHHhhccCCCCeEcHHHHHHHHhc
Confidence 78888887 79999999999999988754
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=95.78 E-value=0.00016 Score=54.18 Aligned_cols=62 Identities=10% Similarity=0.080 Sum_probs=50.0
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+...+
T Consensus 11 ~~F~~~D~d~~G~i~~~el~~~l--~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~ 73 (77)
T 2joj_A 11 EAFDLFDTNKTGSIDYHELKVAM--RALGFDVKKPEILELMNEYDREGNGYIGFDDFLDIMTEKI 73 (77)
T ss_dssp HHHHHHCCSSSSEEEHHHHHHHH--HHHTCCCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTHHH
T ss_pred HHHHHhCCCCCCCCcHHHHHHHH--HHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHh
Confidence 38889999988988888888766 2333322 66789999999999999999999999887655
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=95.77 E-value=0.00013 Score=60.55 Aligned_cols=91 Identities=12% Similarity=0.138 Sum_probs=66.4
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCC--CCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKS--RSDNE----PHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKH 296 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~--~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~ 296 (488)
.+..++..+|.++++.|.+.||...+.... ....+ ..+|+.+|.+.+|.|+..+.+.++ .. .|... ++.
T Consensus 37 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~l--~~--~~~~~-~~~ 111 (134)
T 1jfj_A 37 LLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYKLMDVDGDGKLTKEEVTSFF--KK--HGIEK-VAE 111 (134)
T ss_dssp HHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHH--TT--TTCHH-HHH
T ss_pred HHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHHHHHHHHHHCCCCCCccCHHHHHHHH--HH--hCHHH-HHH
Confidence 344556677888888999999998774211 11111 238999999999988888888777 22 22322 899
Q ss_pred HHHHHHHhcCCCchhhhHhhhc
Q psy9090 297 LLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 297 i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
+++.++.+++|.++++||+..+
T Consensus 112 ~~~~~D~~~dg~i~~~ef~~~l 133 (134)
T 1jfj_A 112 QVMKADANGDGYITLEEFLEFS 133 (134)
T ss_dssp HHHHHHCSSSSEEEHHHHHHHH
T ss_pred HHHHhCCCCCCcEeHHHHHHHh
Confidence 9999999999999999998764
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=95.77 E-value=0.00014 Score=58.88 Aligned_cols=61 Identities=10% Similarity=0.039 Sum_probs=49.6
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
+|+.+|+ .+|.|+..+.+.++ ..+|- ..+.+..|++.+|.++||.++++||+.+|..+--+
T Consensus 20 ~F~~~D~-~dG~Is~~el~~~l--~~~gl-~~~el~~i~~~~D~d~dG~id~~EF~~~m~~~~~~ 80 (106)
T 1eh2_A 20 IFDSLSP-VNGFLSGDKVKPVL--LNSKL-PVDILGRVWELSDIDHDGMLDRDEFAVAMFLVYCA 80 (106)
T ss_dssp HHTTSCC-SSSCCBHHHHHHHH--HTTTC-CHHHHHHHHHHHCSSCSSBCCHHHHHHHHHHHHHH
T ss_pred HHHHhCC-CCCeEcHHHHHHHH--HHcCC-CHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHH
Confidence 8888898 88999988888877 33442 36679999999999999999999999998654433
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=95.76 E-value=0.00051 Score=54.37 Aligned_cols=63 Identities=6% Similarity=0.049 Sum_probs=47.0
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEc--cc-ccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLA--GE-TLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~s--ge-sgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|..+|. ..|.|+..+++.++-+ |+ -|.. ..+.++.||+.+|.++||.|+|+||+.++..+.
T Consensus 13 ~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D~d~dG~I~f~EF~~~~~~~~ 79 (96)
T 1a4p_A 13 FTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLT 79 (96)
T ss_dssp HHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 38999993 2358888888887732 21 1111 256799999999999999999999998887644
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=95.75 E-value=0.00014 Score=61.83 Aligned_cols=88 Identities=9% Similarity=0.044 Sum_probs=62.6
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLL 298 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~ 298 (488)
+..++..+|.+ |.+.+|+..+........+ ..+|..+|.+++|.|+..+.+.++- ..|.. ..+.++.++
T Consensus 53 ~~~l~~~~d~~----i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~~~~~~~ 126 (146)
T 2qac_A 53 EKKIKELYGDN----LTYEQYLEYLSICVHDKDNVEELIKMFAHFDNNCTGYLTKSQMKNILT--TWGDALTDQEAIDAL 126 (146)
T ss_dssp HHHHHHHHCSE----ECHHHHHHHHHHTCCTTCCHHHHHHHHHTTCTTCSSEEEHHHHHHHHH--HSSSCCCHHHHHHHH
T ss_pred HHHHHHHhCCC----CCHHHHHHHHHHHhcCcchHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhCCCCCHHHHHHHH
Confidence 33344444544 7889999877543222212 1399999999999999999988773 22322 267789999
Q ss_pred HHHHHhcCCCchhhhHhhhcc
Q psy9090 299 KHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 299 ~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+.+ +++|.++++||+..+.
T Consensus 127 ~~~--d~dg~i~~~eF~~~l~ 145 (146)
T 2qac_A 127 NAF--SSEDNIDYKLFCEDIL 145 (146)
T ss_dssp HHH--CSSSEEEHHHHHHHHT
T ss_pred HHc--CCCCcCcHHHHHHHHh
Confidence 988 9999999999998764
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=95.75 E-value=4.9e-05 Score=74.60 Aligned_cols=113 Identities=13% Similarity=0.060 Sum_probs=81.4
Q ss_pred ccchhhHHHHHHhhhccCCcccccCC-ceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcE
Q psy9090 201 TISEDNIVQELEERHNSKNHYSFVGD-VLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQH 279 (488)
Q Consensus 201 ~l~e~~l~~~L~~r~~~~~~yt~v~~-il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~ 279 (488)
.++...+...+ .........+.. ++..+|+++++.|.+.+|+..+.... .-..+|..+|.+.+|.|+..+.+.
T Consensus 204 ~Is~~El~~~l---~g~~~~~~ei~~~l~~~~D~d~dG~Is~~EF~~~l~~~~---~l~~~F~~~D~d~dG~Is~~El~~ 277 (323)
T 1ij5_A 204 TLSRKEFREHF---VRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLL---VLRILYAFADFDKSGQLSKEEVQK 277 (323)
T ss_dssp EECHHHHHHHH---HHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH---HHHHHHHHTCSSSCSSEEHHHHHH
T ss_pred cCcHHHHHHHH---cCCCCCHHHHHHHHHHHhcCCCCCEEeHHHHHHHHHHHH---HHHHHHHHhCCCCCCCccHHHHHH
Confidence 34555554444 222222344556 77788999999999999997765432 223499999999999999988877
Q ss_pred EE-Ec-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 280 IV-LA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 280 i~-~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
++ -. |+. -..+.++.|++.+|.++||.|+++||+..+...
T Consensus 278 ~l~~~~g~~--ls~~e~~~l~~~~D~d~dG~Is~~EF~~~~~~~ 319 (323)
T 1ij5_A 278 VLEDAHIPE--SARKKFEHQFSVVDVDDSKSLSYQEFVMLVLLM 319 (323)
T ss_dssp HHHHTTCCG--GGCSTHHHHHHHHTTTTCSEECHHHHHHHHHHH
T ss_pred HHHHHcCCC--CCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHh
Confidence 66 32 431 135679999999999999999999999987654
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.75 E-value=0.00013 Score=59.48 Aligned_cols=61 Identities=13% Similarity=0.099 Sum_probs=50.2
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
+|..+|++.+|.|+..+.+.++. |.+. .+.++.|++.+|.+++|.++++||+.+|..+--+
T Consensus 19 ~F~~~D~d~dG~I~~~El~~~l~----~~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~~~~~~ 80 (111)
T 2kgr_A 19 LFNSHDKTMSGHLTGPQARTILM----QSSLPQAQLASIWNLSDIDQDGKLTAEEFILAMHLIDVA 80 (111)
T ss_dssp HHHTTSCSSCCEEEHHHHHHHHH----TTCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHHH----hCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHHHH
Confidence 89999999999999888887772 3333 5678999999999999999999999988665433
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=95.71 E-value=7.6e-05 Score=56.94 Aligned_cols=64 Identities=13% Similarity=0.081 Sum_probs=49.9
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEccccc--CCc-hhhHHH----HHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETL--AGK-TTSLKH----LLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesg--agk-te~~k~----i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
.+|..+|.+.+|.|+..+.+.++- ..| .+. .+.++. +++.+|.+++|.|+++||+..+..++.+
T Consensus 11 ~~F~~~D~d~~G~i~~~el~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~I~~~eF~~~~~~~~~~ 81 (83)
T 1yx7_A 11 AAFKKLDANGDGYVTALELQTFMV--TLDAYKALSKDKVKEASAKLIKMADKNSDGKISKEEFLNANAELLCQ 81 (83)
T ss_dssp HHHHHHSSSCSSSCSHHHHHHHHH--HHTTCTTTTTTTTHHHHHHHHTTTCSSSCSCCSHHHHHHHHHHHHCC
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHH--HHccccCCCHHHHHHHHHHHHHHhCCCCCCCCcHHHHHHhhHHHHHH
Confidence 489999999989888888887763 223 222 456777 9999999999999999999887777654
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.68 E-value=7e-05 Score=66.94 Aligned_cols=97 Identities=14% Similarity=0.165 Sum_probs=70.5
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEc-----cccc------C
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLA-----GETL------A 288 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~s-----gesg------a 288 (488)
.+..++..+|.++++.|.+.||...+......... ..+|..+|.+.+|.|+..+...++.. |+.. .
T Consensus 64 ~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~ 143 (193)
T 1bjf_A 64 FAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDES 143 (193)
T ss_dssp HHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGS
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccc
Confidence 45566778889999999999999876533221111 12899999999999988888776632 3100 0
Q ss_pred CchhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 289 GKTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 289 gkte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
...+.++.+++.+|.+++|.|+++||+..+.
T Consensus 144 ~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~ 174 (193)
T 1bjf_A 144 TPEKRTEKIFRQMDTNRDGKLSLEEFIRGAK 174 (193)
T ss_dssp SHHHHHHHHHHHSCTTCSSEECHHHHHHHHH
T ss_pred cHHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 1134588999999999999999999998775
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=95.67 E-value=1.6e-05 Score=73.25 Aligned_cols=87 Identities=14% Similarity=-0.011 Sum_probs=63.4
Q ss_pred CCCCCCCCchhhhhccCCCCCC---CChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCc
Q psy9090 234 NTHLNLYGTKYHFKYKFKSRSD---NEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAA 309 (488)
Q Consensus 234 ~~~~~i~~~ef~~~~~~~~~~~---~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~ 309 (488)
++++.|.+.||+..+....... .-..+|..+|.+.+|.|+..+.+.++.. |+.+ -..+.++.+++.+|.+++|.|
T Consensus 106 d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~-~~~~e~~~l~~~~D~d~dG~I 184 (219)
T 3cs1_A 106 ENKGSEDFVEFLEFRLMLCYIYDFFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWG-AKVEDPAALFKELDKNGTGSV 184 (219)
T ss_dssp HTSCCCSSBCHHHHHHHHHHHHHHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHT-CCCSCHHHHHHHHCTTSSSEE
T ss_pred CCCCcCCHHHHHHHHHHHhccchHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccC-CCHHHHHHHHHHhCCCCCCcE
Confidence 4567788999987643221111 1123899999999999999999887732 3311 124668999999999999999
Q ss_pred hhhhHhhhcchh
Q psy9090 310 KVGEKIEKCVNV 321 (488)
Q Consensus 310 ~~~e~i~~~~~~ 321 (488)
+++||+..+...
T Consensus 185 ~~~EF~~~~~~~ 196 (219)
T 3cs1_A 185 TFDEFAAWASAV 196 (219)
T ss_dssp EHHHHHHHHHHH
T ss_pred eHHHHHHHHHHh
Confidence 999999988753
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.00029 Score=55.47 Aligned_cols=59 Identities=12% Similarity=0.210 Sum_probs=48.2
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
.+|..+|.+.+|.|+..+.+.++- ..|.. ..+.++.+++.+|.+++|.++++||+..+.
T Consensus 33 ~~F~~~D~d~~G~I~~~El~~~l~--~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~ 92 (94)
T 2kz2_A 33 EAFRVEDKDGNGYISAAELRHVMT--NLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT 92 (94)
T ss_dssp HHHHHHCTTCCSCBCHHHHHHHHH--HHTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHCCCCcCcCCHHHHHHHHH--HhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 389999999999999888887772 23322 267799999999999999999999998764
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=95.59 E-value=0.00026 Score=55.47 Aligned_cols=64 Identities=11% Similarity=0.063 Sum_probs=50.5
Q ss_pred hhHHHHHH-HHHH-HHhcCCCcEEE-Ec-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 259 HIYAVADS-AYQD-MMHHEEAQHIV-LA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 259 h~f~~~d~-~~~~-~~~~~~~q~i~-~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
.+|..+|. +++| .|+..+.+.++ -+ |.. -..+.++.+++.+|.+++|.|+++||+..+..+..+
T Consensus 14 ~~F~~~D~~d~dG~~I~~~El~~~l~~~~g~~--~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~ 81 (93)
T 1xk4_A 14 DVYHKYSLIKGNFHAVYRDDLKKLLETESPQY--IRKKGADVWFKELDINTDGAVNFQEFLILVIKMGVA 81 (93)
T ss_dssp HHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHH--HHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCcCeECHHHHHHHHHHHCccc--CCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHHHH
Confidence 38999999 9999 99999988776 21 321 013668999999999999999999999988765543
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=95.56 E-value=0.00022 Score=60.48 Aligned_cols=58 Identities=12% Similarity=0.016 Sum_probs=49.5
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
+|..+| +.+|.|+..+.+.++.+ +|- ..+.++.|++.+|.++||.++++||+.+|..+
T Consensus 56 ~F~~fD-d~dG~Is~~El~~~l~~--~gl-~~~el~~I~~~~D~d~dG~Ld~~EF~~am~li 113 (139)
T 2jq6_A 56 IFYTLS-PVNGKITGANAKKEMVK--SKL-PNTVLGKIWKLADVDKDGLLDDEEFALANHLI 113 (139)
T ss_dssp HHHHSC-CSSSEEEHHHHHHHHHH--TTC-CHHHHHHHHHHHCSSCCSEEEHHHHHHHHHHH
T ss_pred HHHHhC-CCCCeECHHHHHHHHHH--hCc-CHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 999999 99999999999888833 442 36779999999999999999999999988644
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=95.55 E-value=0.00015 Score=62.40 Aligned_cols=82 Identities=10% Similarity=0.002 Sum_probs=61.7
Q ss_pred CCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCch
Q psy9090 236 HLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAK 310 (488)
Q Consensus 236 ~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~ 310 (488)
++.|.+.+|+..+........+. .+|..+|.+.+|.|+..+.+.++- ..|-. ..+.++.|++.++.+ +|.++
T Consensus 64 ~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~~~~~~~~~~d~~-dg~i~ 140 (156)
T 1wdc_B 64 PGPLNFTMFLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLE--NMGDNFNKDEMRMTFKEAPVE-GGKFD 140 (156)
T ss_dssp SSCCCHHHHHHHHHHHTCSCCCHHHHHHHHHTTCTTCCSCEEHHHHHHHHH--HSSSCCCHHHHHHHHHHCCEE-TTEEC
T ss_pred CCcCcHHHHHHHHHHHhcCCChHHHHHHHHHHHCcCCCCccCHHHHHHHHH--HhCCCCCHHHHHHHHHhcCCC-CCEEe
Confidence 57788999998775432212122 289999999999999999888773 22322 267799999999999 99999
Q ss_pred hhhHhhhcch
Q psy9090 311 VGEKIEKCVN 320 (488)
Q Consensus 311 ~~e~i~~~~~ 320 (488)
|+||+..+..
T Consensus 141 ~~eF~~~~~~ 150 (156)
T 1wdc_B 141 YVKFTAMIKG 150 (156)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHhc
Confidence 9999988753
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.54 E-value=0.00025 Score=55.35 Aligned_cols=59 Identities=15% Similarity=0.195 Sum_probs=47.2
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
+|..+|.+.+|.|+..+.+.++ ...|. ..+.++.+++.+|.+++|.++++||+..+..+
T Consensus 32 ~F~~~D~d~~G~I~~~El~~~l--~~~g~-~~~~~~~~~~~~D~d~dg~I~~~EF~~~~~~~ 90 (91)
T 2pmy_A 32 VFAACDANRSGRLEREEFRALC--TELRV-RPADAEAVFQRLDADRDGAITFQEFARGFLGS 90 (91)
T ss_dssp HHHHHCTTCSSSEEHHHHHHHH--HHTTC-CHHHHHHHHHHHCTTCSSEECHHHHTHHHHHT
T ss_pred HHHHHCCCCCCCCcHHHHHHHH--HHcCc-CHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHH
Confidence 8888888888888888887766 22232 35678999999999999999999999877543
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=95.50 E-value=0.00015 Score=52.55 Aligned_cols=60 Identities=18% Similarity=0.117 Sum_probs=44.3
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+.+|.|+..+.+.++-. .|... .+.++.+++.+|.+++|.++++||+..+..
T Consensus 4 ~~F~~~D~d~~G~i~~~e~~~~l~~--~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 64 (66)
T 3li6_A 4 ALFKEIDVNGDGAVSYEEVKAFVSK--KRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGS 64 (66)
T ss_dssp HHHHHHCTTCSSSCCHHHHHHHHHH--HHHHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHTC
T ss_pred HHHHHHCCCCCCcccHHHHHHHHHH--ccCCCcHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 4677777777777777776665522 12112 567899999999999999999999987754
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=95.48 E-value=0.00011 Score=62.10 Aligned_cols=85 Identities=12% Similarity=0.193 Sum_probs=63.2
Q ss_pred CCCCCCCCchhhhhccCCC-CCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCC
Q psy9090 234 NTHLNLYGTKYHFKYKFKS-RSDNE----PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQG 307 (488)
Q Consensus 234 ~~~~~i~~~ef~~~~~~~~-~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g 307 (488)
++.+.|.+.||+..+.... ..... ..+|..+|.+.+|.|+..+.+.++- ..|.. ..+.++.+++.++.+++|
T Consensus 50 ~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~--~~g~~~~~~~~~~~~~~~d~~~dg 127 (145)
T 2bl0_B 50 LNAKEFDLATFKTVYRKPIKTPTEQSKEMLDAFRALDKEGNGTIQEAELRQLLL--NLGDALTSSEVEELMKEVSVSGDG 127 (145)
T ss_dssp HTSSEECHHHHHHHHTSCCCCGGGGHHHHHHHHHHHCSSSSSEEEHHHHHHHHH--HSSSCCCHHHHHHHHTTCCCCTTS
T ss_pred cCCCeEcHHHHHHHHHHHhhcCcccHHHHHHHHHHhCCCCCCeEcHHHHHHHHH--HcCCCCCHHHHHHHHHHcCCCCCC
Confidence 4456788999998776542 11111 2299999999999999998887772 22322 267789999999999999
Q ss_pred CchhhhHhhhcch
Q psy9090 308 AAKVGEKIEKCVN 320 (488)
Q Consensus 308 ~~~~~e~i~~~~~ 320 (488)
.++++||+..+..
T Consensus 128 ~i~~~eF~~~~~~ 140 (145)
T 2bl0_B 128 AINYESFVDMLVT 140 (145)
T ss_dssp EEEHHHHHHHHHH
T ss_pred cEeHHHHHHHHHh
Confidence 9999999988753
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=95.34 E-value=0.00039 Score=54.10 Aligned_cols=61 Identities=15% Similarity=0.216 Sum_probs=49.5
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+|.+.+|.|+..+.+.++ ...|.. ..+.++.+++.++.+++|.|+++||+..+....
T Consensus 14 ~F~~~D~d~~G~i~~~el~~~l--~~~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~~~ 75 (92)
T 2kn2_A 14 AFKVFDKDQNGYISASELRHVM--INLGEKLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMTVR 75 (92)
T ss_dssp HHHHHCTTCSSEECHHHHHHHH--HHTTCCCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHHHT
T ss_pred HHHHHCCCCCCeEcHHHHHHHH--HHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhcc
Confidence 8999999999999988888777 233322 267799999999999999999999998776543
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=95.24 E-value=0.00044 Score=73.72 Aligned_cols=97 Identities=9% Similarity=0.028 Sum_probs=55.2
Q ss_pred ccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEc--ccccCCchhhHHHHH
Q psy9090 221 YSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLA--GETLAGKTTSLKHLL 298 (488)
Q Consensus 221 yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~s--gesgagkte~~k~i~ 298 (488)
...+..++..+|.++++.|+++||+..+......+.-..+|+.+|++ +|.|+..+++.++.. ||.+. ..+.++.||
T Consensus 46 ~~el~~lf~~~D~d~~G~I~f~EF~~~~~~l~~~~el~~aF~~fD~~-~G~Is~~EL~~fL~~~qge~~l-s~ee~~~ii 123 (624)
T 1djx_A 46 DGYARKIFRECDHSQTDSLEDEEIETFYKMLTQRAEIDRAFEEAAGS-AETLSVERLVTFLQHQQREEEA-GPALALSLI 123 (624)
T ss_dssp ----------------------CTTHHHHHHTCCHHHHHHHHHHHTT-SSSEEHHHHHHHHHHTSCCSSC-SHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhccHHHHHHHHHHhcCC-CCeecHHHHHHHHHHHhCCCCC-CHHHHHHHH
Confidence 35677788899999999999999998876432211112499999986 889999998887742 55322 367799999
Q ss_pred HHHHHh----cCCCchhhhHhhhcc
Q psy9090 299 KHLIFL----GQGAAKVGEKIEKCV 319 (488)
Q Consensus 299 ~~~~~~----~~g~~~~~e~i~~~~ 319 (488)
+.++.+ ++|.++++||+..|.
T Consensus 124 ~~~d~d~~~~~dG~Is~deF~~~L~ 148 (624)
T 1djx_A 124 ERYEPSETAKAQRQMTKDGFLMYLL 148 (624)
T ss_dssp HHHCCCHHHHHTTEECHHHHHHHHH
T ss_pred HHhCCChhhccCCCCCHHHHHHHhc
Confidence 999876 789999999998764
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=95.24 E-value=0.0003 Score=56.37 Aligned_cols=62 Identities=8% Similarity=0.083 Sum_probs=47.1
Q ss_pred hhhHHHHHHHHHHHHhcCCCcEEEEc--c-cccCCch------------hhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 258 PHIYAVADSAYQDMMHHEEAQHIVLA--G-ETLAGKT------------TSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 258 ph~f~~~d~~~~~~~~~~~~q~i~~s--g-esgagkt------------e~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
..+|+.+|.+++|.|+..+...++-. + -.|.+.+ ..++.+++.+|.++||.|+++||+..+.
T Consensus 23 ~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~~~~~~~~~~~~e~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~ 99 (103)
T 1snl_A 23 KTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQ 99 (103)
T ss_dssp HHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHH
T ss_pred HHHHHHHcCCCCCcccHHHHHHHHHHHHHHHhccCCCCccHHHHHHHHHHHHHHHHHHcCCCCCCcCCHHHHHHHHh
Confidence 35999999999999998888877632 0 0122222 2388899999999999999999998764
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=95.21 E-value=0.00075 Score=52.05 Aligned_cols=62 Identities=10% Similarity=0.090 Sum_probs=48.4
Q ss_pred hhHHHHH-HHHHH-HHhcCCCcEEEEccc--ccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVAD-SAYQD-MMHHEEAQHIVLAGE--TLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d-~~~~~-~~~~~~~q~i~~sge--sgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+| ++.+| .|+..+.+.++-. + .|.. ..+.++.+++.+|.+++|.++++||+..+..+
T Consensus 14 ~~F~~~D~~d~~G~~i~~~el~~~l~~-~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 80 (90)
T 1k8u_A 14 AIFHKYSGREGDKHTLSKKELKELIQK-ELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGAL 80 (90)
T ss_dssp HHHHHHHTSSSCTTEEEHHHHHHHHHH-HSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCcCCHHHHHHHHHH-hcccCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 4899999 59999 8888888776621 0 2211 25679999999999999999999999887654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.20 E-value=0.021 Score=55.40 Aligned_cols=30 Identities=20% Similarity=0.408 Sum_probs=26.8
Q ss_pred CCCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 23 NHVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 23 ~givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
..++|+|++|.|||++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888889999998753
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=95.13 E-value=0.0002 Score=64.57 Aligned_cols=118 Identities=9% Similarity=0.081 Sum_probs=81.5
Q ss_pred hhhhhccchhhHHHHHHhhhc----cCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 196 LAALETISEDNIVQELEERHN----SKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 196 l~~l~~l~e~~l~~~L~~r~~----~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
...-..++.+++...++.... .......+..++..+|.++++.|.+.||+..+... ..-..+|..+|.+.+|.
T Consensus 43 ~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~~~~---~~~~~~F~~~D~d~~G~ 119 (198)
T 1juo_A 43 AGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL---NGWRQHFISFDTDRSGT 119 (198)
T ss_dssp HTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH---HHHHHHHHTTCTTCCSE
T ss_pred CCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHHHHH---HHHHHHHHHhCCCCCCc
Confidence 333444565555555544221 01223345567778899999999999999877532 11224899999999999
Q ss_pred HhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 272 MHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
|+..+.+.++- ..|.. ..+.++.+++.+ +++|.++++||+..+..
T Consensus 120 I~~~el~~~l~--~~g~~~~~~~~~~l~~~~--d~dg~i~~~eF~~~~~~ 165 (198)
T 1juo_A 120 VDPQELQKALT--TMGFRLSPQAVNSIAKRY--STNGKITFDDYIACCVK 165 (198)
T ss_dssp ECHHHHHHHHH--HTTCCCCHHHHHHHHHHT--CSSSSEEHHHHHHHHHH
T ss_pred CCHHHHHHHHH--HhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHH
Confidence 99999887773 22322 367789999988 89999999999987764
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=94.95 E-value=0.00032 Score=52.22 Aligned_cols=63 Identities=14% Similarity=0.230 Sum_probs=48.4
Q ss_pred hhHHHH-HHHHH-HHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVA-DSAYQ-DMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~-d~~~~-~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+ |.+.+ |.|+..+.+.++-. |..-....+.++.+++.++.+++|.++++||+..+..+
T Consensus 9 ~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~ 74 (76)
T 1qx2_A 9 GAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp HHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh
Confidence 388888 99988 88888888877632 32100034679999999999999999999999887654
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=94.92 E-value=0.00069 Score=58.24 Aligned_cols=66 Identities=8% Similarity=0.036 Sum_probs=51.3
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch----hhhhhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN----VIHAIG 326 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~----~leafg 326 (488)
.+|..+|.+.+|.|+..+.+.++- ..|... .+.++.+++.++.+++|.++++||+..+.. +.+||-
T Consensus 54 ~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~e~~~l~~~~D~d~dg~I~~~eF~~~~~~~~~~i~~aF~ 124 (150)
T 2jjz_A 54 EKYMEFDLNNEGEIDLMSLKRMME--KLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGKRSAVLKLVM 124 (150)
T ss_dssp HHHTTSCCCTTSSBCHHHHHHHHH--HTTCCCCHHHHHHHHHHHHTTSCSSBCHHHHHHHHHSSSCCHHHHHH
T ss_pred HHHHHhCCCCcCcCCHHHHHHHHH--HcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHhHHHHHHHHH
Confidence 388888888888888888887762 223222 567999999999999999999999988765 555553
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.88 E-value=0.00017 Score=52.97 Aligned_cols=59 Identities=8% Similarity=0.047 Sum_probs=44.7
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|..+|.+.+|.|+..+.+.++ ...|.. ..+.++.+++.++.+++|.++++||+..+.+
T Consensus 11 ~F~~~D~d~~G~i~~~el~~~l--~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 70 (71)
T 2b1u_A 11 AFRAFDQDGDGHITVDELRRAM--AGLGQPLPQEELDAMIREADVDQDGRVNYEEFARMLAQ 70 (71)
T ss_dssp HHTTSCCSSSSEEEHHHHHHHG--GGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHHHTC
T ss_pred HHHHHCCCCCCcCcHHHHHHHH--HHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence 6777777777777777777666 222322 2567899999999999999999999987653
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=94.72 E-value=0.00053 Score=74.50 Aligned_cols=93 Identities=9% Similarity=-0.016 Sum_probs=73.2
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccC-CchhhHHHHHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLA-GKTTSLKHLLKH 300 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesga-gkte~~k~i~~~ 300 (488)
..+..++..+|.++++.|.+.||...+... ..-..+|+.+|.+.+|.|+..+.+.++- ..|. -..+.++.|++.
T Consensus 575 ~~~~~l~~~~D~d~~G~I~f~EF~~l~~~~---~~l~~~F~~~D~d~dG~Is~~El~~~L~--~~G~~ls~~~~~~l~~~ 649 (714)
T 3bow_A 575 ETCKIMVDMLDEDGSGKLGLKEFYILWTKI---QKYQKIYREIDVDRSGTMNSYEMRKALE--EAGFKLPCQLHQVIVAR 649 (714)
T ss_dssp HHHHHHHHHHCCSSCSSBCHHHHHHHHHHH---HHHHHHHHHHCTTCCSSEEHHHHHHHHH--HTTEECCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHH---HHHHHHHHHhCCCCCCeECHHHHHHHHH--HcCCCCCHHHHHHHHHH
Confidence 345567778899999999999999877543 1123499999999999999999988773 2221 126779999999
Q ss_pred HHHhcCCCchhhhHhhhcch
Q psy9090 301 LIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 301 ~~~~~~g~~~~~e~i~~~~~ 320 (488)
++ ++||.|+++||+..+..
T Consensus 650 ~D-d~dG~Isf~EF~~~l~~ 668 (714)
T 3bow_A 650 FA-DDELIIDFDNFVRCLVR 668 (714)
T ss_dssp HS-CTTCEECHHHHHHHHHH
T ss_pred hC-CCCCeEcHHHHHHHHHH
Confidence 99 99999999999988864
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=94.51 E-value=0.0014 Score=51.67 Aligned_cols=63 Identities=13% Similarity=0.101 Sum_probs=48.7
Q ss_pred hhHHHHH-HHHHH-HHhcCCCcEEEEccccc----C-CchhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVAD-SAYQD-MMHHEEAQHIVLAGETL----A-GKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d-~~~~~-~~~~~~~q~i~~sgesg----a-gkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|..+| .+++| .|+..+.+.++-. +.| . -..+.++.+++.+|.+++|.|+++||+..+..+.
T Consensus 17 ~~F~~~Dd~d~~G~~I~~~el~~~l~~-~~~~~~~~~~~~~~~~~l~~~~D~~~dg~I~~~EF~~~~~~~~ 86 (99)
T 1qls_A 17 AIFQKHAGRDGNNTKISKTEFLIFMNT-ELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLA 86 (99)
T ss_dssp HHHHHHHTTSSCTTCBCHHHHHHHHTT-TSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCcCeeCHHHHHHHHHH-HcchhccccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 3888888 88888 8888888877631 111 1 1256799999999999999999999998876654
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=94.38 E-value=0.00076 Score=51.67 Aligned_cols=61 Identities=7% Similarity=0.052 Sum_probs=48.6
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhh---HHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTS---LKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~---~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|..+|.+.+|.|+..+.+.++- ..|... .+. ++.+++.++.+++|.+++ ||+..+...+
T Consensus 18 ~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~~~~~~~ 82 (86)
T 1j7q_A 18 KIFDIFDRNAENIAPVSDTMDMLT--KLGQTYTKRETEAIMKEARGPKGDKKNIGPE-EWLTLCSKWV 82 (86)
T ss_dssp HHHHHHSTTTTSCBCHHHHHHHHH--HTSCCCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHH--HHcCCCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHHHHHHHH
Confidence 389999999999999988887772 223222 456 888999999999999999 9998887654
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=94.22 E-value=0.00035 Score=68.44 Aligned_cols=95 Identities=6% Similarity=-0.059 Sum_probs=70.1
Q ss_pred ccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHH-HHH
Q psy9090 221 YSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKH-LLK 299 (488)
Q Consensus 221 yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~-i~~ 299 (488)
...+..++..+|+++++.|.+.+|...+.. ...--.+|..+|.+++|.|+..+.+.++ .|.. -..+.++. +++
T Consensus 157 ~~~i~~l~~~~D~d~~G~I~f~ef~~l~~~---~~~l~~~F~~~D~d~dG~Is~~El~~~l-~g~~--~~~~ei~~~l~~ 230 (323)
T 1ij5_A 157 EGPLKKLFVMVENDTKGRMSYITLVAVAND---LAALVADFRKIDTNSNGTLSRKEFREHF-VRLG--FDKKSVQDALFR 230 (323)
T ss_dssp SSHHHHHHHHHHHCCSSTHHHHHHTTSHHH---HHTSCCCHHHHCTTCCSEECHHHHHHHH-HHTT--CCCHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHhhhhH---HHHHHHHHHHHCCCCCCcCcHHHHHHHH-cCCC--CCHHHHHHHHHH
Confidence 344556677778888888887777754311 1112238999999999999998888877 4431 12567889 999
Q ss_pred HHHHhcCCCchhhhHhhhcchh
Q psy9090 300 HLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 300 ~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.++.+++|.++++||+..+...
T Consensus 231 ~~D~d~dG~Is~~EF~~~l~~~ 252 (323)
T 1ij5_A 231 YADEDESDDVGFSEYVHLGLCL 252 (323)
T ss_dssp HHCTTCSSCEEHHHHHHHHHHH
T ss_pred HhcCCCCCEEeHHHHHHHHHHH
Confidence 9999999999999999988764
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=93.97 E-value=0.001 Score=62.58 Aligned_cols=94 Identities=15% Similarity=0.040 Sum_probs=67.9
Q ss_pred CceeeeCCCCCCCCCCchhhhhccCCCCCC---------------CChhhHHHHHHHHHHHHhcCCCcEEEEc-ccc-cC
Q psy9090 226 DVLLFINPNTHLNLYGTKYHFKYKFKSRSD---------------NEPHIYAVADSAYQDMMHHEEAQHIVLA-GET-LA 288 (488)
Q Consensus 226 ~il~~Inp~~~~~i~~~ef~~~~~~~~~~~---------------~~ph~f~~~d~~~~~~~~~~~~q~i~~s-ges-ga 288 (488)
.++..+|+++++.|.+.||...+....... .-..+|..+|.+.+|.|+..+.+.++-. |.+ |.
T Consensus 152 ~~~~~~D~~~dg~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~ 231 (272)
T 2be4_A 152 AMMKIFDKNKDGRLDLNDLARILALQENFLLQFKMDASSQVERKRDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRP 231 (272)
T ss_dssp HHHHHHCSSCSSEEEHHHHGGGSCCSSCSSTTSCCCHHHHHHHHHHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSS
T ss_pred HHHHHhccCCCCcCcHHHHHHHHhhhHHHHhhhhhhhccccccHHHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCC
Confidence 467778899999999999998775421100 0122899999999999999998877632 321 11
Q ss_pred Cc-hhhHHH----HHHHHHHhcCCCchhhhHhhhcc
Q psy9090 289 GK-TTSLKH----LLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 289 gk-te~~k~----i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
.. .+.++. +++.+|.++||.++++||+..+.
T Consensus 232 ~~~~~~~~~~~~~l~~~~D~d~dG~is~~EF~~~~~ 267 (272)
T 2be4_A 232 SISGGDLDKFRECLLTHCDMNKDGKIQKSELALCLG 267 (272)
T ss_dssp SCCHHHHHHHHHHHHHHHCCSTTCEEEHHHHHHHTT
T ss_pred CCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHc
Confidence 12 344444 99999999999999999998764
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=93.89 E-value=0.0015 Score=53.80 Aligned_cols=58 Identities=7% Similarity=-0.009 Sum_probs=46.9
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
+|..+|. .+|.|+..+.+.++ ..||- ..+.+..|++.+|.++||.++++||+.+|.-+
T Consensus 38 iF~~lD~-~dG~Isg~elr~~~--~~sgL-p~~~L~~Iw~laD~d~dG~Ld~~EF~~aM~Li 95 (121)
T 3fia_A 38 QFHSLKP-ISGFITGDQARNFF--FQSGL-PQPVLAQIWALADMNNDGRMDQVEFSIAMKLI 95 (121)
T ss_dssp HHHHTCC-BTTBEEHHHHHHHH--GGGCC-CHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHhCC-CCCeECHHHHHHHH--HHcCC-CHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence 7888887 67888888877777 23432 26779999999999999999999999988654
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=93.78 E-value=0.00082 Score=53.66 Aligned_cols=60 Identities=12% Similarity=0.155 Sum_probs=46.9
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+.+|.|+..+.+.++- ..|.. ..+.++.+++.++.+++|.++++||+..+..
T Consensus 28 ~~F~~~D~d~~G~i~~~el~~~l~--~~g~~~~~~e~~~l~~~~d~~~~g~i~~~eF~~~~~~ 88 (105)
T 1wlz_A 28 QEFENFDTMKTNTISREEFRAICN--RRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRFSS 88 (105)
T ss_dssp HHHHHHCTTCSSCBCHHHHHHHHH--HHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHHC-
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHH--HhCCCCCHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc
Confidence 488888888888888888877662 22222 2567899999999999999999999988764
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=93.77 E-value=0.0011 Score=56.73 Aligned_cols=60 Identities=8% Similarity=0.019 Sum_probs=46.1
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+.+|.|+..+.+.++ ...|.. ..+.++.+++.++.+++|.++++||+..+..
T Consensus 52 ~~F~~~D~d~dG~I~~~El~~~l--~~~g~~~~~~~~~~l~~~~D~d~dg~I~~~eF~~~~~~ 112 (147)
T 1wy9_A 52 VKYMEFDLNGNGDIDIMSLKRML--EKLGVPKTHLELKRLIREVSSGSEETFSYSDFLRMMLG 112 (147)
T ss_dssp HHHTTSCCCTTSSEEHHHHHHHH--HHTTCCCCHHHHHHHHHHHCSSCTTEECHHHHHHHHCS
T ss_pred HHHHHHCCCCCCcCcHHHHHHHH--HHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence 37777788888887777777666 222322 2567899999999999999999999988764
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.64 E-value=0.00083 Score=54.02 Aligned_cols=59 Identities=10% Similarity=-0.000 Sum_probs=45.7
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+..
T Consensus 37 ~F~~~D~d~~G~I~~~el~~~l--~~~g~~~~~~~~~~l~~~~D~d~dg~i~~~eF~~~~~~ 96 (107)
T 2d58_A 37 KYMEFDLNGNGDIDIMSLKRML--EKLGVPKTHLELKKLIGEVSSGSGETFSYPDFLRMMLG 96 (107)
T ss_dssp HHTTSCCCTTSCEEHHHHHHHH--HHTTCCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHSS
T ss_pred HHHHHCCCCCCcCcHHHHHHHH--HHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 7777888888887777777666 2223222 567899999999999999999999987754
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=93.56 E-value=0.0011 Score=62.04 Aligned_cols=98 Identities=10% Similarity=-0.012 Sum_probs=68.4
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCC--------CCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEc-cc-ccC
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKS--------RSDNEP----HIYAVADSAYQDMMHHEEAQHIVLA-GE-TLA 288 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~--------~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~s-ge-sga 288 (488)
.+..++..+|.++++.|.+.||...+.... ....+. .+|..+|.+.+|.|+..+.+.++-+ +. .|.
T Consensus 59 ~~~~l~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~ 138 (263)
T 2f33_A 59 EMKTFVDQYGQRDDGKIGIVELAHVLPTEENFLLLFRCQQLKSCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANK 138 (263)
T ss_dssp HHHHHHHHHTTGGGCCBCHHHHHHHTTSCTTHHHHHGGGTSSCHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHhhhhhHHHHHHHhhccHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCC
Confidence 344556677888889999999998765431 111111 2899999999999999888877632 10 032
Q ss_pred Cc-hhhHHH----HHHHHHHhcCCCchhhhHhhhcch
Q psy9090 289 GK-TTSLKH----LLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 289 gk-te~~k~----i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.. .+.++. +++.++.+++|.++++||+..+..
T Consensus 139 ~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 175 (263)
T 2f33_A 139 TVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPV 175 (263)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSSSSCBCHHHHHHHSCT
T ss_pred CCCHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHH
Confidence 22 333444 899999999999999999988764
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=93.51 E-value=0.00081 Score=50.23 Aligned_cols=62 Identities=15% Similarity=0.148 Sum_probs=48.7
Q ss_pred hhHHHHHH-HHHH-HHhcCCCcEEEE--cccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADS-AYQD-MMHHEEAQHIVL--AGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~-~~~~-~~~~~~~q~i~~--sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|. +.+| .|+..+.+.++- .|.. .+..+.++.+++.++.+++|.++++||+..+..+
T Consensus 11 ~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~-~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 76 (78)
T 1cb1_A 11 SIFEKYAAKEGDPNQLSKEELKQLIQAEFPSL-LKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKKI 76 (78)
T ss_dssp HHHHHHHTTSSSTTEECHHHHHHHHHHHCSSC-CSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHHH
T ss_pred HHHHHHhccCCCcCEeCHHHHHHHHHHHhhhh-cccHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHh
Confidence 48999999 9999 999888887762 1321 1145668899999999999999999999877543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=93.45 E-value=0.094 Score=50.38 Aligned_cols=31 Identities=29% Similarity=0.432 Sum_probs=25.5
Q ss_pred CCeecccCCCCEEEcc---CCc-EEEEecCCcccc
Q psy9090 24 HVIHRDLRGSNVLLTK---DGE-VKIVDFGLSRET 54 (488)
Q Consensus 24 givHrDlkp~NILl~~---~~~-vkL~Dfg~a~~~ 54 (488)
.++|+|++|.||+++. ++. +.|+||+.+...
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 4699999999999987 455 489999987643
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=93.17 E-value=0.0014 Score=71.73 Aligned_cols=89 Identities=7% Similarity=0.010 Sum_probs=52.6
Q ss_pred CCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEc--ccccC-------CchhhHHHHHHHHH
Q psy9090 232 NPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLA--GETLA-------GKTTSLKHLLKHLI 302 (488)
Q Consensus 232 np~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~s--gesga-------gkte~~k~i~~~~~ 302 (488)
|.++.+.|+++||+..|......+.--.+|..+|++..|.|+..+++.+|.. ||... -..+.++.||+.++
T Consensus 196 D~d~~g~idf~EF~~~~~~l~~r~el~~aF~~fD~d~~g~Is~~eL~~fL~~~Qge~~~~~~~~~~~t~ee~~~iI~~~d 275 (799)
T 2zkm_X 196 DAINPEDFPEPVYKSFLMSLCPRPEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYE 275 (799)
T ss_dssp CEECGGGCCHHHHHHHHHHHSCCHHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHC
T ss_pred ccCCCCcCCHHHHHHHHHHccCHHHHHHHHHHhccCCCCeEcHHHHHHHHHHhcCCcccccccccCCCHHHHHHHHHHhh
Confidence 3456678999999998865432111123999999999999999998888853 55321 23577999999999
Q ss_pred Hh----cCCCchhhhHhhhcch
Q psy9090 303 FL----GQGAAKVGEKIEKCVN 320 (488)
Q Consensus 303 ~~----~~g~~~~~e~i~~~~~ 320 (488)
.+ ++|.++++||+.+|..
T Consensus 276 ~d~~~~~dg~is~eeF~~~L~S 297 (799)
T 2zkm_X 276 PSGINAQRGQLSPEGMVWFLCG 297 (799)
T ss_dssp CC--------CCHHHHHHHHHS
T ss_pred cccccccCCccchhhhhhcccC
Confidence 87 8899999999998853
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=93.04 E-value=0.0016 Score=72.46 Aligned_cols=90 Identities=6% Similarity=0.005 Sum_probs=69.4
Q ss_pred ccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCC-Ch---hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHH
Q psy9090 221 YSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDN-EP---HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKH 296 (488)
Q Consensus 221 yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~-~p---h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~ 296 (488)
...+..++..+|+++++.|++.||+..+........ .. .+|+.+ .+++|+|+..+.+.++ +.+.+..
T Consensus 760 ~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~~l~~aF~~~-~d~~G~Is~~El~~~l--------~~~~~~~ 830 (863)
T 1sjj_A 760 EAEFARIMSIVDPNRMGVVTFQAFIDFMSRETADTDTADQVMASFKIL-AGDKNYITVDELRREL--------PPDQAEY 830 (863)
T ss_dssp THHHHHHHHHHCTTSCSEEETTHHHHTHHHHSTTCSSSHHHHHHHHGG-GTSSSEEEHHHHHHHS--------CHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHH-hCCCCcCcHHHHHHHC--------CHHHHHH
Confidence 345566778889999999999999987754322111 22 288888 7888888888888777 2577999
Q ss_pred HHHHHHHh-----cCCCchhhhHhhhcc
Q psy9090 297 LLKHLIFL-----GQGAAKVGEKIEKCV 319 (488)
Q Consensus 297 i~~~~~~~-----~~g~~~~~e~i~~~~ 319 (488)
|++.++.+ +||.++|+||+.+|.
T Consensus 831 l~~~~d~~~~~~~~dg~I~~~eF~~~~~ 858 (863)
T 1sjj_A 831 CIARMAPYNGRDAVPGALDYMSFSTALY 858 (863)
T ss_dssp HHHHSEECCSSCCCTTEEESHHHHHHHS
T ss_pred HHHHcchhcCCCCCCCceeHHHHHHHHh
Confidence 99999987 689999999998874
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=93.02 E-value=0.0029 Score=53.42 Aligned_cols=61 Identities=11% Similarity=0.150 Sum_probs=48.9
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|.+.+|.|+..+.+.++ ...|.. ..+.++.|++.++.+++|.++++||+..+...
T Consensus 10 ~~F~~~D~d~~G~I~~~el~~~l--~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 71 (143)
T 2obh_A 10 EAFDLFDADGTGTIDVKELKVAM--RALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQK 71 (143)
T ss_dssp HHHHTTCTTCCSEEEGGGHHHHH--HHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHH--HHcCCCCCHHHHHHHHHHhCCCCCCeeeHHHHHHHHHHH
Confidence 48889999999999999888776 222322 25678999999999999999999999887554
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=92.91 E-value=0.019 Score=61.08 Aligned_cols=60 Identities=8% Similarity=-0.020 Sum_probs=6.0
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|++.+|.|+.++.+.++-+ -|.. ..+.++.|++.+|.+++|.++++||+..+..
T Consensus 15 ~~F~~fD~d~dG~Is~~El~~~l~~--lg~~~s~~el~~lf~~~D~d~~G~I~f~EF~~~~~~ 75 (624)
T 1djx_A 15 SCLRKADKNKDNKMNFKELKDFLKE--LNIQVDDGYARKIFRECDHSQTDSLEDEEIETFYKM 75 (624)
T ss_dssp -------------------------------------------------------CTTHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 3888889999999999988888743 2211 2466888899999999999999998877654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.91 E-value=0.057 Score=54.42 Aligned_cols=33 Identities=27% Similarity=0.434 Sum_probs=28.3
Q ss_pred HHCCCeecccCCCCEEEccCCcEEEEecCCcccc
Q psy9090 21 HENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET 54 (488)
Q Consensus 21 H~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~ 54 (488)
+...++|+|++|.|||++.++ +.++||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456799999999999998776 999999987653
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=92.79 E-value=0.0037 Score=55.81 Aligned_cols=57 Identities=16% Similarity=0.130 Sum_probs=33.5
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhc
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
+|..+|.+.+|.|+..+.+.++ ...|...++.++.+++.+|.+++|.++++||+..+
T Consensus 57 ~F~~~D~d~~G~i~~~El~~~l--~~~g~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~ 113 (191)
T 3k21_A 57 TFLVLDEDGKGYITKEQLKKGL--EKDGLKLPYNFDLLLDQIDSDGSGKIDYTEFIAAA 113 (191)
T ss_dssp HHHHHCTTCSSEECHHHHHHHH--HHTTCCCCTTHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHCCCCCCCCcHHHHHHHH--HHcCCCcHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 5555555555555555554444 22222224567777777777777777777777665
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=92.40 E-value=0.002 Score=60.57 Aligned_cols=93 Identities=9% Similarity=-0.028 Sum_probs=64.9
Q ss_pred eeeeCCCCCCCCCCchhhhhccC-----------CCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEc-c-cccCCc-
Q psy9090 228 LLFINPNTHLNLYGTKYHFKYKF-----------KSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLA-G-ETLAGK- 290 (488)
Q Consensus 228 l~~Inp~~~~~i~~~ef~~~~~~-----------~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~s-g-esgagk- 290 (488)
+..+|.++++.|.+.||...+.. ....... ..+|..+|.+.+|.|+..+.+.++-. + ..|...
T Consensus 63 f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~ 142 (272)
T 2be4_A 63 MSAYDATFDGRLQIEELANMILPQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIP 142 (272)
T ss_dssp SCHHHHTCCSEEEHHHHHHHHSCHHHHHHHHHHHHSCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCC
T ss_pred HHHhcCCCCCcEeHHHHHHHHhhhhHHHHHHHhhccCcccHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCC
Confidence 45667788888999999987432 1111111 12999999999999999998877732 0 013222
Q ss_pred hhh----HHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 291 TTS----LKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 291 te~----~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+. ++.+++.++.+++|.++++||+..+..
T Consensus 143 ~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~ 176 (272)
T 2be4_A 143 PNKLDEYTDAMMKIFDKNKDGRLDLNDLARILAL 176 (272)
T ss_dssp HHHHHHHHHHHHHHHCSSCSSEEEHHHHGGGSCC
T ss_pred HHHHHHHHHHHHHHhccCCCCcCcHHHHHHHHhh
Confidence 223 355999999999999999999988753
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=92.11 E-value=0.014 Score=49.07 Aligned_cols=62 Identities=8% Similarity=0.013 Sum_probs=50.3
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+.+.+
T Consensus 15 ~~F~~~D~d~~G~i~~~el~~~l--~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~ 77 (153)
T 3ox6_A 15 EAFREFDKDKDGYINCRDLGNCM--RTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKL 77 (153)
T ss_dssp HHHHHHHHHCSSSCCHHHHHHHH--HHTTCCCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHH--HHcCCCCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHh
Confidence 38999999999999998888766 3333323 56788999999999999999999999886654
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=91.95 E-value=0.051 Score=45.93 Aligned_cols=66 Identities=9% Similarity=-0.084 Sum_probs=27.0
Q ss_pred CChhhHHHHHHHHHHHHhcCCCcEEEEcc--c--ccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 256 NEPHIYAVADSAYQDMMHHEEAQHIVLAG--E--TLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 256 ~~ph~f~~~d~~~~~~~~~~~~q~i~~sg--e--sgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+++.|..+|.+.+|.|+..+...++..- + +.....+.++.+++.+|.+++|.|+.+|+...+..+
T Consensus 28 ~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~ 97 (143)
T 3a4u_B 28 ASFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHV 97 (143)
T ss_dssp -----------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC--
T ss_pred CCHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHH
Confidence 35679999999999999999998776421 1 111235678899999999999999999999877654
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=91.92 E-value=0.011 Score=54.21 Aligned_cols=59 Identities=7% Similarity=-0.109 Sum_probs=45.6
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|..+|.+.+|.|+..+.+.++-+ .|... .+.++.+++.+|.+++|.++++||+..+..
T Consensus 56 ~F~~~D~d~~G~I~~~El~~~l~~--~g~~~~~~~~~~l~~~~D~d~dg~I~~~EF~~~~~~ 115 (220)
T 3sjs_A 56 WFMGVDRDRSGTLEINELMMGQFP--GGIRLSPQTALRMMRIFDTDFNGHISFYEFMAMYKF 115 (220)
T ss_dssp HHHHHCTTCCSSBCHHHHHHCCBG--GGBCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 788888888888888887777632 23222 567888999999999999999999887765
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=91.14 E-value=0.013 Score=49.64 Aligned_cols=59 Identities=10% Similarity=0.034 Sum_probs=43.9
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|..+|.+++|.|+..+.+.++- ..|.. ..+.+..++..++.+++|.+++.||+..+..
T Consensus 15 ~F~~~D~d~~G~I~~~El~~~l~--~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~ 74 (148)
T 2lmt_A 15 AFVQFDKEGTGKIATRELGTLMR--TLGQNPTEAELQDLIAEAENNNNGQLNFTEFCGIMAK 74 (148)
T ss_dssp HHHHHHCSSCCEEEGGGHHHHHH--HHTCCCCHHHHHHHHHHHHTTSTTEEEHHHHHHHHHH
T ss_pred HHHHHcCCCCCeECHHHHHHHHH--hcCCCchHHHHHHHHHhcccCCCCcccHHHHHHHHHH
Confidence 78888888888888888876652 22222 2566788888888888888888888876644
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=90.70 E-value=0.013 Score=49.91 Aligned_cols=61 Identities=10% Similarity=0.112 Sum_probs=49.0
Q ss_pred hHHHHHHHH-HHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVADSAY-QDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d~~~-~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+|.++ +|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+...+
T Consensus 23 ~F~~~D~~~~~G~i~~~e~~~~l--~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 85 (161)
T 1dtl_A 23 AFDIFVLGAEDGSISTKELGKVM--RMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSM 85 (161)
T ss_dssp HHHHHTTTCGGGSBCHHHHHHHH--HHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCcCcHHHHHHHH--HHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHh
Confidence 888889888 8888888887766 2233322 56789999999999999999999999887664
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=90.57 E-value=0.0054 Score=53.86 Aligned_cols=91 Identities=8% Similarity=0.047 Sum_probs=63.6
Q ss_pred CCCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCc
Q psy9090 235 THLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAA 309 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~ 309 (488)
+++.|...||...+........+ ..+|+.+|.+++|.|+..+...++.. +. ....+.++.+++.+|.+++|.+
T Consensus 32 ~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~--~~~~~~~~~~f~~~D~d~~G~i 109 (183)
T 1s6c_A 32 PSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLR--GTVHEKLRWTFNLYDINKDGYI 109 (183)
T ss_dssp TTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHH--CCHHHHHHHHHHHHCTTCSSCE
T ss_pred CCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcC--CCHHHHHHHHHHHhCCCCCCeE
Confidence 45667788888766533221112 23889999988888877776655521 11 1135778999999999999999
Q ss_pred hhhhHhhhcchhhhhhhc
Q psy9090 310 KVGEKIEKCVNVIHAIGN 327 (488)
Q Consensus 310 ~~~e~i~~~~~~leafgn 327 (488)
+++||...+..+.+..|.
T Consensus 110 ~~~e~~~~~~~~~~~~g~ 127 (183)
T 1s6c_A 110 NKEEMMDIVKAIYDMMGK 127 (183)
T ss_dssp EHHHHHHHHHHHHHHTC-
T ss_pred cHHHHHHHHHHHHHHhcc
Confidence 999999998887766553
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=90.48 E-value=0.0085 Score=50.66 Aligned_cols=61 Identities=11% Similarity=0.143 Sum_probs=47.3
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|.+.+|.|+..+.+.++- ..|.. ..+.++.+++.++.+++|.++++||+..+...
T Consensus 14 ~~F~~~D~d~~G~i~~~el~~~l~--~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~ 75 (148)
T 1exr_A 14 EAFALFDKDGDGTITTKELGTVMR--SLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARK 75 (148)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHH--HHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHH--HcCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhc
Confidence 388888988888888888776662 22322 25678899999999999999999999877543
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=90.48 E-value=0.021 Score=49.15 Aligned_cols=62 Identities=15% Similarity=0.023 Sum_probs=49.6
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEc-cccc--CC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLA-GETL--AG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~s-gesg--ag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+.+|.|+..+.+.++-+ |..+ .. ..+.++.+++.++.+++|.++++||+..+..
T Consensus 3 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~ 68 (165)
T 1k94_A 3 YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAA 68 (165)
T ss_dssp HHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH
T ss_pred HHHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 4799999999999999999887733 3211 01 2577899999999999999999999987765
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=90.39 E-value=0.0062 Score=55.87 Aligned_cols=98 Identities=10% Similarity=0.074 Sum_probs=68.6
Q ss_pred eeeeCCC--CCCCCCCchhhhhccCCCCCCCCh---hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHH
Q psy9090 228 LLFINPN--THLNLYGTKYHFKYKFKSRSDNEP---HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLI 302 (488)
Q Consensus 228 l~~Inp~--~~~~i~~~ef~~~~~~~~~~~~~p---h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~ 302 (488)
+..+|.+ +++.|...|+..+.... ...... .+|+.+|.+.+|.|+..+-..++..-.......+.++.+++.+|
T Consensus 54 F~~~D~d~~~~G~I~~~El~~~l~~~-~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D 132 (226)
T 2zfd_A 54 FKKISSAVIDDGLINKEEFQLALFKT-NKKESLFADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYD 132 (226)
T ss_dssp HHHHHTSSSCSSSBCHHHHHHHHHSC-SSCCCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHC
T ss_pred HHHhCcccCCCCeEcHHHHHHHHhcc-CcccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHccCCCHHHHHHHHHHHhC
Confidence 4456666 88889999998776542 112222 28899998888877776665444211111223667999999999
Q ss_pred HhcCCCchhhhHhhhcchhhhhhh
Q psy9090 303 FLGQGAAKVGEKIEKCVNVIHAIG 326 (488)
Q Consensus 303 ~~~~g~~~~~e~i~~~~~~leafg 326 (488)
.+++|.|+.+|+...+..++...|
T Consensus 133 ~d~~G~Is~~E~~~~l~~~~~~~g 156 (226)
T 2zfd_A 133 LKQQGFIERQEVKQMVVATLAESG 156 (226)
T ss_dssp TTSSSSEEHHHHHHHHHHHHHHTT
T ss_pred CCCCCcccHHHHHHHHHHHHHHcC
Confidence 999999999999998887766655
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=90.25 E-value=0.0022 Score=56.78 Aligned_cols=95 Identities=13% Similarity=0.109 Sum_probs=66.1
Q ss_pred eCCC-CCCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHh
Q psy9090 231 INPN-THLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFL 304 (488)
Q Consensus 231 Inp~-~~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~ 304 (488)
.|.+ +++.|...||...+........+. .+|+.+|.+.+|.|+..+...++. ..|.+ ..+.++.+++.+|.+
T Consensus 34 ~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~--~~~~~~~~~~~~~~f~~~D~d 111 (190)
T 2l2e_A 34 FFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFDADKNGYIDFKEFICALS--VTSRGELNDKLIWAFQLYDLD 111 (190)
T ss_dssp HHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHCSSSTTCEEHHHHHHHHT--TSSCSCSHHHHHHHHHHHCTT
T ss_pred HHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhcCCCCCeEeHHHHHHHHH--HHcCCCHHHHHHHHHhHccCC
Confidence 3444 466778888887665332111111 289999999888888777765552 22222 257789999999999
Q ss_pred cCCCchhhhHhhhcchhhhhhhc
Q psy9090 305 GQGAAKVGEKIEKCVNVIHAIGN 327 (488)
Q Consensus 305 ~~g~~~~~e~i~~~~~~leafgn 327 (488)
++|.|+++||...+..+....|.
T Consensus 112 ~~G~i~~~e~~~~~~~~~~~~g~ 134 (190)
T 2l2e_A 112 NNGLISYDEMLRIVDAIYKMVGS 134 (190)
T ss_dssp SCSCBCHHHHHHHHHHHHHHHHH
T ss_pred CCCcCcHHHHHHHHHHHHHHhcc
Confidence 99999999999988877665564
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=90.10 E-value=0.0092 Score=53.63 Aligned_cols=98 Identities=13% Similarity=0.085 Sum_probs=67.5
Q ss_pred eeeeCCC--CCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHH
Q psy9090 228 LLFINPN--THLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLI 302 (488)
Q Consensus 228 l~~Inp~--~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~ 302 (488)
+..+|.+ +++.|...||....... ..... .++|+.+|.+.+|.|+..+-..++..-.......+.++.+++.+|
T Consensus 43 F~~~D~d~~~~G~i~~~e~~~~l~~~-~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D 121 (207)
T 2ehb_A 43 FKKLSSSIIDDGLIHKEEFQLALFRN-RNRRNLFADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYD 121 (207)
T ss_dssp HHHHTTSSSCSSCEEHHHHHHHHHSC-TTCCCHHHHHHHHHHCTTCSSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHC
T ss_pred HHHhccccCCCCccCHHHHHHHHhcc-ccccHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhC
Confidence 4456666 78888888988776542 11222 238889998888877766655444211111123567999999999
Q ss_pred HhcCCCchhhhHhhhcchhhhhhh
Q psy9090 303 FLGQGAAKVGEKIEKCVNVIHAIG 326 (488)
Q Consensus 303 ~~~~g~~~~~e~i~~~~~~leafg 326 (488)
.+++|.|+.+|+...+..++...|
T Consensus 122 ~d~~G~I~~~E~~~~l~~~~~~~g 145 (207)
T 2ehb_A 122 LRQTGFIEREELKEMVVALLHESE 145 (207)
T ss_dssp TTCCSSEEHHHHHHHHHHHHHHHT
T ss_pred CCCCCcCcHHHHHHHHHHHHHHcc
Confidence 999999999999988877665544
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=89.85 E-value=0.011 Score=59.10 Aligned_cols=58 Identities=10% Similarity=0.133 Sum_probs=48.9
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+|..+|.+.+|.|+..+++.++- .-|..- .+.++.|++.+|.+++|.|+|+||+..+.
T Consensus 307 aF~~fDkDgdG~IS~eELk~aLr--sLG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms 365 (440)
T 3u0k_A 307 AFSLFDKDGDGTITTKELGTVMR--SLGQNPTEAELQDMINEVDADGDGTIDFPEFLIMMA 365 (440)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHH--HTTCCCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHH
T ss_pred HHHHHcCCCCCEECHHHHHHHHH--HcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 99999999999999999988773 223222 56799999999999999999999998764
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=89.80 E-value=0.024 Score=49.20 Aligned_cols=61 Identities=11% Similarity=0.003 Sum_probs=47.7
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEc--ccc----cCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLA--GET----LAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~s--ges----gagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+| +.+|.|+..+.+.++-+ |.. +.+- .+.++.+++.++.+++|.++++||+..+..
T Consensus 8 ~~F~~~D-d~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~ 75 (173)
T 1alv_A 8 RLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNN 75 (173)
T ss_dssp HHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHh-CCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHHHH
Confidence 4888999 99999998888877733 310 0222 567899999999999999999999987764
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=89.80 E-value=0.0098 Score=52.26 Aligned_cols=59 Identities=14% Similarity=0.109 Sum_probs=47.6
Q ss_pred HHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 262 AVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 262 ~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+++|.+.+|.|+..+.+.++.. |+ .-..+.++.+++.+|.+++|.|+++||+..+....
T Consensus 109 ~~fD~d~~G~I~~~E~~~~l~~~g~--~~~~~~~~~~~~~~D~d~dG~i~~~ef~~~~~~~~ 168 (186)
T 2hps_A 109 DCIDTDKDGYVSLPEFKAFLQAVGP--DLTDDKAITCFNTLDFNKNGQISRDEFLVTVNDFL 168 (186)
T ss_dssp HHHCTTCSSEEEHHHHHHHHHHHCT--TCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHH
T ss_pred HHccCCCCCcCCHHHHHHHHHHhCC--CCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHh
Confidence 8889999998888888877632 32 11367799999999999999999999999887654
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=89.73 E-value=0.013 Score=53.72 Aligned_cols=92 Identities=8% Similarity=0.039 Sum_probs=65.4
Q ss_pred CCCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCc
Q psy9090 235 THLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAA 309 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~ 309 (488)
+++.|...||...+........+ ..+|+.+|.+.+|.|+..+...++.. +. ....+.++.+++.+|.+++|.|
T Consensus 65 ~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~--~~~~~~l~~~F~~~D~d~dG~I 142 (224)
T 1s1e_A 65 PSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLR--GTVHEKLRWTFNLYDINKDGYI 142 (224)
T ss_dssp TTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHH--CCHHHHHHHHHHHHCTTCCSEE
T ss_pred CCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHcc--CCHHHHHHHHHHHHcCCCCCeE
Confidence 45678888888777644322122 22889999988888777776655421 11 1135678999999999999999
Q ss_pred hhhhHhhhcchhhhhhhcc
Q psy9090 310 KVGEKIEKCVNVIHAIGNA 328 (488)
Q Consensus 310 ~~~e~i~~~~~~leafgna 328 (488)
+++||...+..+.+..|..
T Consensus 143 s~~E~~~~l~~~~~~~g~~ 161 (224)
T 1s1e_A 143 NKEEMMDIVKAIYDMMGKY 161 (224)
T ss_dssp CHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHHHHhccc
Confidence 9999999888877666643
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=89.71 E-value=0.011 Score=50.02 Aligned_cols=93 Identities=10% Similarity=0.004 Sum_probs=61.2
Q ss_pred ceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcC
Q psy9090 227 VLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQ 306 (488)
Q Consensus 227 il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~ 306 (488)
++..+|.++++.|...|+ ..+........-..+|+.+|.+..|.|+..+-..++..-.......+.++.+.+.+|.+++
T Consensus 11 ~F~~~D~d~~G~i~~~el-~~l~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 89 (155)
T 3ll8_B 11 RFKKLDLDNSGSLSVEEF-MSLPELQQNPLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKD 89 (155)
T ss_dssp HHHHHCTTCSSSBCHHHH-TTSGGGTTCTTHHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTTCS
T ss_pred HHHHhCcCCCCeEcHHHH-HHhhccccchHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCCCC
Confidence 345567888888888888 4443322212223488888888777666665544442111111235788999999999999
Q ss_pred CCchhhhHhhhcch
Q psy9090 307 GAAKVGEKIEKCVN 320 (488)
Q Consensus 307 g~~~~~e~i~~~~~ 320 (488)
|.++.+|+...+..
T Consensus 90 G~i~~~e~~~~l~~ 103 (155)
T 3ll8_B 90 GYISNGELFQVLKM 103 (155)
T ss_dssp SCBCHHHHHHHHHH
T ss_pred CcCcHHHHHHHHHH
Confidence 99999999877655
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=89.68 E-value=0.0092 Score=49.78 Aligned_cols=61 Identities=11% Similarity=0.134 Sum_probs=47.9
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|.+.+|.|+..+...++- ..|... .+.++.+++.++.+++|.++++||+..+...
T Consensus 10 ~~F~~~D~d~~G~i~~~el~~~l~--~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~ 71 (142)
T 2bl0_C 10 EAFELFDSERTGFITKEGLQTVLK--QFGVRVEPAAFNEMFNEADATGNGKIQFPEFLSMMGRR 71 (142)
T ss_dssp HHHHHHCTTCSSEEEHHHHHHHHH--HHTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHH--HhCCCCCHHHHHHHHHHhCcCCCCeeeHHHHHHHHHHH
Confidence 378888888888888877776652 233333 5668999999999999999999999988764
|
| >1eg3_A Dystrophin; EF-hand like domain, WW domain, structural protein; 2.00A {Homo sapiens} SCOP: a.39.1.7 a.39.1.7 b.72.1.1 PDB: 1eg4_A | Back alignment and structure |
|---|
Probab=89.65 E-value=0.0092 Score=55.94 Aligned_cols=91 Identities=7% Similarity=0.039 Sum_probs=67.1
Q ss_pred CceeeeCCCCCCCCCCchhhhhccCCCCCCCChh---hHHHHHHHHHHHHhcCCCcEEEE--------cccccC-C---c
Q psy9090 226 DVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPH---IYAVADSAYQDMMHHEEAQHIVL--------AGETLA-G---K 290 (488)
Q Consensus 226 ~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph---~f~~~d~~~~~~~~~~~~q~i~~--------sgesga-g---k 290 (488)
-++..-|+++++.|.+.||+.+..--.+....+. +|++.| |.+|+|+.++.-.|+- -||+-+ | -
T Consensus 136 ~lf~~FD~~~~G~I~f~ef~~aLs~l~rG~leeKL~w~F~lyD-D~~G~I~~~El~~il~~i~~i~~~vge~~~~~~~~~ 214 (261)
T 1eg3_A 136 WLLNVYDTGRTGRIRVLSFKTGIISLCKAHLEDKYRYLFKQVA-SSTGFCDQRRLGLLLHDSIQIPRQLGEVASFGGSNI 214 (261)
T ss_dssp HHHHHHCTTCCSEEEHHHHHHHHHHTSSSCHHHHHHHHHHHHS-CTTSCBCHHHHHHHHHHHHHHHHHTTCGGGGTCSCC
T ss_pred HHHHHccCCCCceEeHHHHHHHHHHHcCCCHHHHHHHHHheee-CCCCCCcHHHHHHHHHHHHHHHHhcCCcccCCCCCH
Confidence 3566778999999999999987755444443343 999999 9999999988777662 255422 2 2
Q ss_pred hhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 291 TTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 291 te~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
.+.++.+.+.++ +||.++.+||+..+.
T Consensus 215 e~~v~~~F~~~d--~dg~It~~EFl~~~~ 241 (261)
T 1eg3_A 215 EPSVRSCFQFAN--NKPEIEAALFLDWMR 241 (261)
T ss_dssp HHHHHHHHHHTT--TCSCBCHHHHHHHHH
T ss_pred HHHHHHHHHhCC--CCCcCCHHHHHHHHH
Confidence 556777887774 899999999997654
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=89.55 E-value=0.013 Score=59.60 Aligned_cols=61 Identities=10% Similarity=0.152 Sum_probs=49.7
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.+|.+++|.++++||+..+..++
T Consensus 317 ~F~~fD~D~dG~Is~~EL~~~L--~~lg~~~s~eel~~Lf~~~D~DgdG~IsfeEFl~ll~~~~ 378 (450)
T 3sg6_A 317 AFSLFDKDGDGTITTKELGTVM--RSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKM 378 (450)
T ss_dssp HHHHHCTTCSSEECHHHHHHHH--HHTTCCCCHHHHHHHHHTTCTTSSSSEEHHHHHHHHHC--
T ss_pred HHHHHCCCCCCcCcHHHHHHHH--HHhCCCCCHHHHHHHHHHhccCCCCcccHHHHHHHHHhhc
Confidence 8999999999999999998877 3333333 67799999999999999999999998876543
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=89.47 E-value=0.013 Score=49.94 Aligned_cols=61 Identities=10% Similarity=0.008 Sum_probs=48.8
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+...+
T Consensus 28 ~F~~~D~~~~G~i~~~e~~~~l--~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~ 89 (161)
T 3fwb_A 28 AFSLFDMNNDGFLDYHELKVAM--KALGFELPKREILDLIDEYDSEGRHLMKYDDFYIVMGEKI 89 (161)
T ss_dssp HHHHHCTTSSSEECHHHHHHHH--HHTTCCCCHHHHHHHHHHHCTTSSSCEEHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHH--HHcCCCCCHHHHHHHHHHhCcCCCCeEeHHHHHHHHHHHH
Confidence 8888888888888888877766 3334333 57799999999999999999999998887543
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=89.42 E-value=0.012 Score=50.80 Aligned_cols=61 Identities=10% Similarity=0.109 Sum_probs=48.8
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+...+
T Consensus 33 ~F~~~D~d~~G~i~~~el~~~l--~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~ 94 (169)
T 3qrx_A 33 AFDLFDTDGSGTIDAKELKVAM--RALGFEPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKM 94 (169)
T ss_dssp HHHHHCTTCCSEECHHHHHHHH--HHTSCCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHH--HHcCCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHh
Confidence 8888888888888888877666 2333333 57789999999999999999999999887655
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=89.25 E-value=0.019 Score=50.92 Aligned_cols=60 Identities=10% Similarity=-0.016 Sum_probs=47.6
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+.+|.|+..+.+.++. ..|.. ..+.++.+++.+|.+++|.++++||+..+..
T Consensus 31 ~~F~~~D~d~~G~I~~~El~~~l~--~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~ 91 (191)
T 1y1x_A 31 EWFRAVDTDGSGAISVPELNAALS--SAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF 91 (191)
T ss_dssp HHHHHHCTTCSSSBCHHHHHHHHC--BTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHcCCCCCcCcHHHHHHHHH--HcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 489999999999998888887772 12221 2677889999999999999999999987754
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.14 E-value=0.015 Score=51.83 Aligned_cols=59 Identities=8% Similarity=0.040 Sum_probs=37.4
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
.+|..+|.+.+|.|+..+.+.++ ...|.. ..+.++.+++.+|.+++|.++++||+..+.
T Consensus 41 ~~F~~~D~d~~G~i~~~e~~~~l--~~~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~ 100 (204)
T 3e3r_A 41 RFFRQLDRDGSRSLDADEFRQGL--AKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFLRALR 100 (204)
T ss_dssp HHHHHHCTTCCSSBCHHHHHHHH--HTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHTS
T ss_pred HHHHHHccCCCCCcCHHHHHHHH--HHcCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHH
Confidence 36666666666666665555544 112211 245677788888888888888888887664
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=89.11 E-value=0.15 Score=48.93 Aligned_cols=30 Identities=33% Similarity=0.428 Sum_probs=25.5
Q ss_pred CCCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 23 NHVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 23 ~givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
.+++|+|++|.|||++.++.+.++||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 369999999999999876656899998764
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=88.84 E-value=0.01 Score=53.36 Aligned_cols=90 Identities=16% Similarity=0.181 Sum_probs=63.3
Q ss_pred CCCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCc
Q psy9090 235 THLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAA 309 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~ 309 (488)
+.+.|...||...+........++ .+|+.+|.+..|.|+..+...++.. -|.+ ..+.++.+++.+|.+++|.|
T Consensus 47 ~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~--~~~~~~~~~~~~~f~~~D~d~~G~I 124 (207)
T 2d8n_A 47 PTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNLDGTLDFKEYVIALHM--TTAGKTNQKLEWAFSLYDVDGNGTI 124 (207)
T ss_dssp TTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH--HSCSSSSTTHHHHHHHHCTTCSSEE
T ss_pred CCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCCCCeEeHHHHHHHHHH--HcCCCHHHHHHHHHHHhcCCCCCeE
Confidence 456677888887765432211122 2889999988888877776655522 1111 25679999999999999999
Q ss_pred hhhhHhhhcchhhhhhh
Q psy9090 310 KVGEKIEKCVNVIHAIG 326 (488)
Q Consensus 310 ~~~e~i~~~~~~leafg 326 (488)
+++||+..+..+....|
T Consensus 125 ~~~E~~~~l~~~~~~~g 141 (207)
T 2d8n_A 125 SKNEVLEIVMAIFKMIT 141 (207)
T ss_dssp CHHHHHHHHHHHHHHSC
T ss_pred cHHHHHHHHHHHHHHhc
Confidence 99999998877655444
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=88.62 E-value=0.013 Score=48.90 Aligned_cols=62 Identities=11% Similarity=0.135 Sum_probs=48.9
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIH 323 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~le 323 (488)
+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+...+.
T Consensus 16 ~F~~~D~~~~G~i~~~e~~~~l--~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~ 78 (147)
T 4ds7_A 16 AFALFDKDNSGSISASELATVM--RSLGLSPSEAEVADLMNEIDVDGNHAIEFSEFLALMSRQLK 78 (147)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHH--HHTTCCCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCcCHHHHHHHH--HHhCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHhcc
Confidence 8888888888888888877666 2233333 567899999999999999999999998876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=88.59 E-value=0.18 Score=46.99 Aligned_cols=28 Identities=21% Similarity=0.351 Sum_probs=24.7
Q ss_pred CeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 25 VIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 25 ivHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
++|+|+.|.||+++..+.+-|+||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 8999999999999987767799998764
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=88.48 E-value=0.0089 Score=66.75 Aligned_cols=98 Identities=9% Similarity=0.075 Sum_probs=55.3
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLI 302 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~ 302 (488)
+..++..+|.++++.|.+.||...+.... .-..+|..+|++.+|.|+..|...++- ..|.. ..+.++.|++.++
T Consensus 776 ~~~l~~~~D~d~dG~Is~~EF~~l~~~~~---~l~~~F~~~D~d~dG~Is~~El~~~l~--~~g~~ls~~~~~~l~~~~d 850 (900)
T 1qxp_A 776 CRSMVAVMDSDTTGKLGFEEFKYLWNNIK---KWQGIYKRFETDRSGTIGSNELPGAFE--AAGFHLNQHIYSMIIRRYS 850 (900)
T ss_dssp HHHHHHHHCCSSSSSBCSHHHHHHHHHHH---HHSSCC----CCSCC-------CCTTG--GGTCCCCSCCCC-------
T ss_pred HHHHHHHHCCCCCCeECHHHHHHHHHHHH---HHHHHHHHhCCCCCCccCHHHHHHHHH--hcCCCCCHHHHHHHHHHhc
Confidence 34456678889999999999987764321 112489999999999999999998883 22311 2567788999999
Q ss_pred HhcCCCchhhhHhhhcch---hhhhhhc
Q psy9090 303 FLGQGAAKVGEKIEKCVN---VIHAIGN 327 (488)
Q Consensus 303 ~~~~g~~~~~e~i~~~~~---~leafgn 327 (488)
+++|.++++||+..+.. +.++|-.
T Consensus 851 -d~dg~Is~~EF~~~~~~l~~~~~~F~~ 877 (900)
T 1qxp_A 851 -DETGNMDFDNFISCLVRLDAMFRAFRS 877 (900)
T ss_dssp --CCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred -CCCCeECHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999988765 3455543
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=88.41 E-value=0.016 Score=51.17 Aligned_cols=90 Identities=16% Similarity=0.128 Sum_probs=62.0
Q ss_pred CCCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCc
Q psy9090 235 THLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAA 309 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~ 309 (488)
+++.|...||...+........+ ..+|..+|.+.+|.|+..+...++. ..+.+. .+.++.+++.+|.+++|.|
T Consensus 39 ~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~--~~~~~~~~~~~~~~f~~~D~d~~G~I 116 (193)
T 1bjf_A 39 PSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFIIALS--VTSRGKLEQKLKWAFSMYDLDGNGYI 116 (193)
T ss_dssp TTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHHHHH--HHTSSCHHHHHHHHHHHHCTTCSSCE
T ss_pred CCCCcCHHHHHHHHHHhcCcCChHHHHHHHHHHhCCCCCCcCcHHHHHHHHH--HHcCCCHHHHHHHHHhhcCCCCCCeE
Confidence 44667777887766543221212 2388888888888777777655441 112223 5678899999999999999
Q ss_pred hhhhHhhhcchhhhhhh
Q psy9090 310 KVGEKIEKCVNVIHAIG 326 (488)
Q Consensus 310 ~~~e~i~~~~~~leafg 326 (488)
+++||...+..+....|
T Consensus 117 ~~~E~~~~~~~~~~~~g 133 (193)
T 1bjf_A 117 SKAEMLEIVQAIYKMVS 133 (193)
T ss_dssp EHHHHHHHHHHHHTTCC
T ss_pred CHHHHHHHHHHHHHHhc
Confidence 99999998877665555
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=88.28 E-value=0.0051 Score=68.71 Aligned_cols=98 Identities=7% Similarity=-0.000 Sum_probs=71.6
Q ss_pred CCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHH
Q psy9090 225 GDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIF 303 (488)
Q Consensus 225 ~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~ 303 (488)
..++..+|.++++.|.+.||+..+... ..-..+|..+|.+.+|.|+..+.+.++- ..|.. ..+.++.+++.++
T Consensus 580 ~~l~~~~D~d~~G~I~~~EF~~~~~~~---~~l~~~F~~~D~d~~G~Is~~El~~~l~--~~g~~l~~~~~~~l~~~~d- 653 (900)
T 1qxp_A 580 RSMVNLMDRDGNGKLGLVEFNILWNRI---RNYLTIFRKFDLDKSGSMSAYEMRMAIE--AAGFKLPCQLHQVIVARFA- 653 (900)
T ss_dssp HHHHHHHCC--CCCCCSSSHHHHHHHH---HHHHHHHGGGCTTCCSCCBHHHHHHHHH--HTTEECCHHHHHHHHHHTS-
T ss_pred HHHHHHhCCCCCCcCCHHHHHHHHHHH---HHHHHHHHhhCCCCCCeECHHHHHHHHH--HhCCCCCHHHHHHHHHHhC-
Confidence 344556788888899999999776543 1123499999999999999999887772 22211 2677899999999
Q ss_pred hcCCCchhhhHhhhcch---hhhhhhcc
Q psy9090 304 LGQGAAKVGEKIEKCVN---VIHAIGNA 328 (488)
Q Consensus 304 ~~~g~~~~~e~i~~~~~---~leafgna 328 (488)
+++|.++++||+..+.. +.++|-..
T Consensus 654 d~dg~I~~~eF~~~~~~~~~l~~~F~~~ 681 (900)
T 1qxp_A 654 DDELIIDFDNFVRCLVRLEILFKIFKQL 681 (900)
T ss_dssp CSSSBCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred CCCCeEcHHHHHHHHHHHHHHHHHHHhh
Confidence 99999999999988764 56677554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=88.21 E-value=0.56 Score=44.57 Aligned_cols=29 Identities=28% Similarity=0.235 Sum_probs=24.6
Q ss_pred CCeecccCCCCEEEccCCcEEEEecCCccc
Q psy9090 24 HVIHRDLRGSNVLLTKDGEVKIVDFGLSRE 53 (488)
Q Consensus 24 givHrDlkp~NILl~~~~~vkL~Dfg~a~~ 53 (488)
.++|+|+.|.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5667889999987753
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=88.18 E-value=0.02 Score=49.84 Aligned_cols=61 Identities=10% Similarity=0.152 Sum_probs=45.3
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+...+
T Consensus 16 ~F~~~D~d~~G~i~~~e~~~~l--~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~ 77 (179)
T 2f2o_A 16 AFSLFDKDGDGTITTKELGTVM--RSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKM 77 (179)
T ss_dssp HHHHHCTTCSSCBCHHHHHHHH--HHTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHH--HHcCCCCCHHHHHHHHHHhccCCCCCCcHHHHHHHHHHHc
Confidence 7778888888877777776655 2223222 56688899999999999999999998876543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=88.15 E-value=0.19 Score=48.70 Aligned_cols=31 Identities=26% Similarity=0.479 Sum_probs=26.8
Q ss_pred CCCeecccCCCCEEEccC----CcEEEEecCCccc
Q psy9090 23 NHVIHRDLRGSNVLLTKD----GEVKIVDFGLSRE 53 (488)
Q Consensus 23 ~givHrDlkp~NILl~~~----~~vkL~Dfg~a~~ 53 (488)
..++|||+.|.||+++.+ +.+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999874 6799999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=87.73 E-value=0.33 Score=46.65 Aligned_cols=28 Identities=29% Similarity=0.360 Sum_probs=24.2
Q ss_pred CCCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 23 NHVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 23 ~givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
..++|+|++|.||+++ + .+.++||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4589999999999998 4 89999998764
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=87.43 E-value=0.015 Score=51.97 Aligned_cols=30 Identities=7% Similarity=0.210 Sum_probs=15.8
Q ss_pred hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 291 TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 291 te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+.++.+++.+|.+++|.++++||+..+..
T Consensus 92 ~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~ 121 (197)
T 3pm8_A 92 PPDIHQVLRDIDSNASGQIHYTDFLAATID 121 (197)
T ss_dssp CHHHHHHHHC-------CEEHHHHHHTTCC
T ss_pred HHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 455677777777777777777777766544
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=87.06 E-value=0.014 Score=49.01 Aligned_cols=61 Identities=5% Similarity=0.000 Sum_probs=45.6
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHH-HHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHL-IFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~-~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|.+.+|.|+..+.+.++- ..|... .+.++.+++.+ +.+++|.++++||+..+...
T Consensus 8 ~~F~~~D~d~~G~i~~~el~~~l~--~~g~~~~~~~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~ 70 (148)
T 1m45_A 8 DIFTLFDKKGQGAIAKDSLGDYLR--AIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVN 70 (148)
T ss_dssp TCHHHHCTTCCSEEEGGGHHHHHH--HTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHH--HhCCCCCHHHHHHHHHHhhCCCCCCeEcHHHHHHHHHHH
Confidence 588889988888888888876662 223222 56788999999 99999999999999887765
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=86.94 E-value=0.019 Score=50.39 Aligned_cols=57 Identities=16% Similarity=0.246 Sum_probs=37.1
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+|..+|.+.+|.|+..+.+.++- ..|. ..+.++.+++.++.+++|.++++||+..+.
T Consensus 44 ~F~~~D~d~~G~i~~~El~~~l~--~~g~-~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~ 100 (180)
T 3mse_B 44 LFYKLDTNHNGSLSHREIYTVLA--SVGI-KKWDINRILQALDINDRGNITYTEFMAGCY 100 (180)
T ss_dssp HHHHHCTTCSSSEEHHHHHHHHH--HTTC-CHHHHHHHHHHHCTTCCSEECHHHHHHHHS
T ss_pred HHHHhCCCCCCcCCHHHHHHHHH--HcCC-CHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 55555555555555555554441 1121 246688899999999999999999986554
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=86.88 E-value=0.029 Score=48.33 Aligned_cols=62 Identities=13% Similarity=0.006 Sum_probs=48.9
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEc-cccc--CC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLA-GETL--AG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~s-gesg--ag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+.+|.|+..+.+.++-+ |..+ .. ..+.++.+++.++.+++|.++++||+..+..
T Consensus 5 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~ 70 (167)
T 1gjy_A 5 YGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAV 70 (167)
T ss_dssp HHHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHH
T ss_pred HHHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence 5789999999999998888877633 3211 11 2567899999999999999999999988755
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=86.75 E-value=0.017 Score=50.77 Aligned_cols=62 Identities=10% Similarity=0.046 Sum_probs=46.9
Q ss_pred hhHHHHHHHHHHHHhcCCCc-----EEEEcccccCCchh------hHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQ-----HIVLAGETLAGKTT------SLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q-----~i~~sgesgagkte------~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|..+|.+.+|.|+..+.+ .++ -..|...++ .++.+++.++.+++|.++++||+..+...+
T Consensus 20 ~~F~~~D~d~~G~i~~~El~~~~~~~~l--~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~ 92 (191)
T 1uhk_A 20 HMFNFLDVNHNGKISLDEMVYKASDIVI--NNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKKLA 92 (191)
T ss_dssp HHHHHHCTTCCSEEEHHHHHHHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHHHH
T ss_pred HHHhhccCCCCCcCcHHHHHHHHHHHHH--HHcCCCchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHHHHHHHh
Confidence 38888999888888888887 444 222322333 488899999999999999999998876643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=86.69 E-value=0.21 Score=48.79 Aligned_cols=31 Identities=23% Similarity=0.265 Sum_probs=25.6
Q ss_pred CCCeecccCCCCEEEccCCcEEEEecCCccc
Q psy9090 23 NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE 53 (488)
Q Consensus 23 ~givHrDlkp~NILl~~~~~vkL~Dfg~a~~ 53 (488)
..++|+|++|.||+++..+.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4699999999999999644578999987653
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=86.64 E-value=0.022 Score=50.31 Aligned_cols=61 Identities=7% Similarity=0.027 Sum_probs=45.9
Q ss_pred hHHHHHHHHHHHHhcCCCc-----EEEEcccccCCchh------hHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQ-----HIVLAGETLAGKTT------SLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q-----~i~~sgesgagkte------~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+|.+.+|.|+..+.+ .++ -..|...++ .++.+++.++.+++|.++++||+..+...+
T Consensus 25 ~F~~~D~d~~G~i~~~El~~~~~~~~l--~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~ 96 (195)
T 1qv0_A 25 MFDFLDINGNGKITLDEIVSKASDDIC--AKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLA 96 (195)
T ss_dssp HHHHHCTTCSSCBCHHHHHHHHHHTHH--HHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHHHHHHH
T ss_pred HHhHcCCCCCCcCcHHHHHHHHHHHHH--HHcCCCccHHHHHHHHHHHHHHHcCCCCCceEcHHHHHHHHHHHH
Confidence 8888888888888888877 343 122322233 488899999999999999999999876654
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=86.46 E-value=0.021 Score=48.68 Aligned_cols=61 Identities=11% Similarity=0.104 Sum_probs=43.7
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+|.+..|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+...+
T Consensus 25 ~F~~~D~d~~G~i~~~e~~~~l--~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 86 (162)
T 1top_A 25 AFDMFDADGGGDISTKELGTVM--RMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQM 86 (162)
T ss_dssp HHHTTTCSCSSEEEGGGHHHHH--HHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCcCCHHHHHHHH--HHcCCCCCHHHHHHHHHHHcCCCCCcEeHHHHHHHHHHHh
Confidence 6666666666666666665555 2223222 56788999999999999999999998887654
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=86.41 E-value=0.012 Score=55.14 Aligned_cols=91 Identities=12% Similarity=0.111 Sum_probs=63.6
Q ss_pred CCCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCc
Q psy9090 235 THLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAA 309 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~ 309 (488)
+++.|...||...+......... ..+|..+|.+.+|.|+..+...++.. -+.+ ..+.++.+++.+|.+++|.|
T Consensus 105 ~~G~I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~--~~~~~~~~~l~~~F~~~D~d~dG~I 182 (256)
T 2jul_A 105 PTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSI--LLRGTVHEKLKWAFNLYDINKDGCI 182 (256)
T ss_dssp TTSSEEHHHHHHHHHHHCCSSCCHHHHHHHHHHSSCSCCSEECSHHHHHHHHH--HHSCCHHHHHHHHHHHTCCSSSSCB
T ss_pred CCCcCCHHHHHHHHHHHcccCCcHHHHHHHHHHhccCCCCcCcHHHHHHHHHH--HhccChHHHHHHHHHHhCCCCCCcC
Confidence 34667778887766532211112 23888888888888777776655521 1122 36778999999999999999
Q ss_pred hhhhHhhhcchhhhhhhc
Q psy9090 310 KVGEKIEKCVNVIHAIGN 327 (488)
Q Consensus 310 ~~~e~i~~~~~~leafgn 327 (488)
+++||...+..+.+..|.
T Consensus 183 ~~~Ef~~~l~~~~~~~g~ 200 (256)
T 2jul_A 183 TKEEMLAIMKSIYDMMGR 200 (256)
T ss_dssp CHHHHHHHHHHHHHHCCC
T ss_pred cHHHHHHHHHHHHHHhCC
Confidence 999999998888776663
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=86.37 E-value=0.016 Score=50.20 Aligned_cols=94 Identities=7% Similarity=-0.070 Sum_probs=59.8
Q ss_pred ceeeeCCCCCCCCCCchhhhh----ccCCCCCCCCh--------------hhHHHHHHHHHHHHhcCCCcEEEEcccccC
Q psy9090 227 VLLFINPNTHLNLYGTKYHFK----YKFKSRSDNEP--------------HIYAVADSAYQDMMHHEEAQHIVLAGETLA 288 (488)
Q Consensus 227 il~~Inp~~~~~i~~~ef~~~----~~~~~~~~~~p--------------h~f~~~d~~~~~~~~~~~~q~i~~sgesga 288 (488)
++..+|.++++.|...|+... ..........+ .+|+.+|.+..|.|+..+-..++..-..+.
T Consensus 12 ~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~~~~~~~~~~~ 91 (176)
T 1nya_A 12 RFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQ 91 (176)
T ss_dssp HHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHHHHHHHSSS
T ss_pred HHHHHcCCCCCcccHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcCC
Confidence 345668888899999999873 32222222222 467777777777666666544432111111
Q ss_pred Cc-------hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 289 GK-------TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 289 gk-------te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.. .+.++.+++.+|.+++|.++.+|+...+..
T Consensus 92 ~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~ 130 (176)
T 1nya_A 92 GEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTA 130 (176)
T ss_dssp CHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 11 245888899999999999999999876543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=86.34 E-value=0.34 Score=47.18 Aligned_cols=31 Identities=23% Similarity=0.394 Sum_probs=27.2
Q ss_pred CCCeecccCCCCEEEccCCcEEEEecCCccc
Q psy9090 23 NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE 53 (488)
Q Consensus 23 ~givHrDlkp~NILl~~~~~vkL~Dfg~a~~ 53 (488)
..++|+|+.|.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999987654
|
| >3bos_A Putative DNA replication factor; P-loop containing nucleoside triphosphate hydrolases, struct genomics; HET: MSE CDP; 1.75A {Shewanella amazonensis} PDB: 3sc3_A | Back alignment and structure |
|---|
Probab=86.12 E-value=1.3 Score=39.96 Aligned_cols=32 Identities=22% Similarity=0.172 Sum_probs=27.3
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHHh
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIFL 304 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~~ 304 (488)
.....+.+++.|++|+|||.-++.+.+.+...
T Consensus 48 ~~~~~~~~ll~G~~G~GKT~la~~l~~~~~~~ 79 (242)
T 3bos_A 48 SGDGVQAIYLWGPVKSGRTHLIHAACARANEL 79 (242)
T ss_dssp HTCSCSEEEEECSTTSSHHHHHHHHHHHHHHT
T ss_pred hCCCCCeEEEECCCCCCHHHHHHHHHHHHHHc
Confidence 33467899999999999999999999888765
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=86.05 E-value=0.03 Score=48.50 Aligned_cols=60 Identities=7% Similarity=0.095 Sum_probs=46.9
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEccccc-CC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETL-AG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesg-ag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+.+|.|+..+.+.++-+ .| .. ..+.++.+++.++.+++|.++++||+..+..
T Consensus 11 ~~F~~~D~d~~G~i~~~e~~~~l~~--~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~~~~~~ 72 (172)
T 2znd_A 11 NVFQRVDKDRSGVISDTELQQALSN--GTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKY 72 (172)
T ss_dssp HHHHHHCTTCSSCEEHHHHHHHCCC--SSSSCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHh--cCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 3888999999998888888877732 22 11 2567889999999999999999999987654
|
| >1ex7_A Guanylate kinase; substrate-induced FIT, domain movement, GMP, ATP, substrate specificity, X-RAY diffraction, transferase; HET: 5GP; 1.90A {Saccharomyces cerevisiae} SCOP: c.37.1.1 PDB: 1ex6_A* 1gky_A* 3sqk_A 4f4j_A | Back alignment and structure |
|---|
Probab=85.81 E-value=0.37 Score=42.64 Aligned_cols=24 Identities=38% Similarity=0.513 Sum_probs=20.2
Q ss_pred EEEEcccccCCchhhHHHHHHHHH
Q psy9090 279 HIVLAGETLAGKTTSLKHLLKHLI 302 (488)
Q Consensus 279 ~i~~sgesgagkte~~k~i~~~~~ 302 (488)
-|+|||.||+|||.-++.+++...
T Consensus 3 pIVi~GPSG~GK~Tl~~~L~~~~~ 26 (186)
T 1ex7_A 3 PIVISGPSGTGKSTLLKKLFAEYP 26 (186)
T ss_dssp CEEEECCTTSSHHHHHHHHHHHCT
T ss_pred EEEEECCCCCCHHHHHHHHHHhCC
Confidence 488999999999988888887653
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=85.81 E-value=0.0098 Score=53.36 Aligned_cols=94 Identities=12% Similarity=0.094 Sum_probs=65.1
Q ss_pred eCCC-CCCCCCCchhhhhccCCCCCCCCh---hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhc
Q psy9090 231 INPN-THLNLYGTKYHFKYKFKSRSDNEP---HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLG 305 (488)
Q Consensus 231 Inp~-~~~~i~~~ef~~~~~~~~~~~~~p---h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~ 305 (488)
.|.+ +++.|...||.............+ .+|..+|.+.+|.|+..+...++.. .+.+ ..+.++.+++.+|.++
T Consensus 31 ~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~--~~~~~~~~~~~~~F~~~D~d~ 108 (204)
T 1jba_A 31 FLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNL--VLRGTLEHKLKWTFKIYDKDR 108 (204)
T ss_dssp HHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHH--HSSCCCTHHHHHHHHHHCSSC
T ss_pred HHhhCCCCCcCHHHHHHHHHHhcCCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHH--HccCCHHHHHHHHHHHhCCCC
Confidence 3445 567788888887765443311111 2888888888887777766655421 1111 3567899999999999
Q ss_pred CCCchhhhHhhhcchhhhhhh
Q psy9090 306 QGAAKVGEKIEKCVNVIHAIG 326 (488)
Q Consensus 306 ~g~~~~~e~i~~~~~~leafg 326 (488)
+|.|+.+|+...+..+....|
T Consensus 109 ~G~I~~~E~~~~l~~~~~~~g 129 (204)
T 1jba_A 109 NGCIDRQELLDIVESIYKLKK 129 (204)
T ss_dssp SSCBCHHHHHHHHHHHHHHHH
T ss_pred CCcCcHHHHHHHHHHHHHHhC
Confidence 999999999998877765444
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=85.72 E-value=0.011 Score=52.04 Aligned_cols=58 Identities=10% Similarity=0.134 Sum_probs=41.5
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+|..+|.+++|.|+..+.+.++ ...|-. ..+.+..+++.++.+++|.++++||+..+.
T Consensus 16 ~F~~~D~d~dG~I~~~El~~~l--~~lg~~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~ 74 (176)
T 2lhi_A 16 AFALFDKDNNGSISSSELATVM--RSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMS 74 (176)
T ss_dssp HHHTTCSSCSSCBCHHHHHHHH--HHHTCCCCHHHHHHHHTTTCSSCSSSBCTTHHHHHHT
T ss_pred HHHHHCCCCCCCCCHHHHHHHH--HHcCCChhHHHHHHHHHHhCcCCCccchHHHHHHHHH
Confidence 7777888888888777777665 222222 255677888888888888888888887654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=85.71 E-value=0.62 Score=45.72 Aligned_cols=28 Identities=29% Similarity=0.532 Sum_probs=23.7
Q ss_pred CCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 24 HVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 24 givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
.++|+|++|.|||++.++ +.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 599999999999998654 8999998765
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=85.47 E-value=0.038 Score=47.30 Aligned_cols=59 Identities=14% Similarity=0.146 Sum_probs=33.9
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|..+|.+..|.|+..+.+.++ ...|... .+.+..+++.++.+++|.++++||+..+..
T Consensus 32 ~F~~~D~~~~G~i~~~e~~~~l--~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~ 91 (166)
T 2aao_A 32 MFNMIDADKSGQITFEELKAGL--KRVGANLKESEILDLMQAADVDNSGTIDYKEFIAATLH 91 (166)
T ss_dssp HHHHHCTTCCSSBCHHHHHHHG--GGGTCCCCHHHHHHHHHHHCTTCCSSBCHHHHHHHHTT
T ss_pred HHHHhCCCCCCeEeHHHHHHHH--HHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 4555555555555544444433 1112222 345677777788888888888888776644
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=85.39 E-value=0.024 Score=46.27 Aligned_cols=60 Identities=18% Similarity=0.140 Sum_probs=41.9
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+.+|.|+..+.+.++ ...|... .+.++.+++.++.+++|.++++||+..+..
T Consensus 4 ~~F~~~D~~~~g~i~~~e~~~~l--~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 64 (134)
T 1jfj_A 4 ALFKEIDVNGDGAVSYEEVKAFV--SKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGS 64 (134)
T ss_dssp HHHHHHCTTCSSEEEHHHHHHHH--HTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTC
T ss_pred HHHHHHCCCCCCcCCHHHHHHHH--HHcCCCCCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHH
Confidence 46777777777777766666554 2222222 556788888888888899999998887754
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=85.14 E-value=0.011 Score=52.05 Aligned_cols=91 Identities=16% Similarity=0.178 Sum_probs=61.9
Q ss_pred CCCCCCCchhhhhccCCCCC-CCC---hhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCc
Q psy9090 235 THLNLYGTKYHFKYKFKSRS-DNE---PHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAA 309 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~-~~~---ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~ 309 (488)
+++.|...||...+...... ... ..+|..+|.+.+|.|+..+...++.. |. ....+.++.+++.+|.+++|.|
T Consensus 39 ~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~--~~~~~~~~~~f~~~D~d~~G~i 116 (190)
T 1fpw_A 39 PSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSR--GTLEEKLSWAFELYDLNHDGYI 116 (190)
T ss_dssp TTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHHHHHSC--CCSTHHHHHHHHHHCSSCSSEE
T ss_pred CCCcCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHHcc--CCcHHHHHHHHHHhcCCCCCcC
Confidence 45667778887766432111 112 23888888888887777766655421 21 1135678999999999999999
Q ss_pred hhhhHhhhcchhhhhhhc
Q psy9090 310 KVGEKIEKCVNVIHAIGN 327 (488)
Q Consensus 310 ~~~e~i~~~~~~leafgn 327 (488)
+++||+..+..+....|.
T Consensus 117 ~~~ef~~~~~~~~~~~g~ 134 (190)
T 1fpw_A 117 TFDEMLTIVASVYKMMGS 134 (190)
T ss_dssp EHHHHHHHHHHHHTTSCS
T ss_pred cHHHHHHHHHHHHHHhcc
Confidence 999999988777655554
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=85.10 E-value=0.018 Score=48.87 Aligned_cols=61 Identities=7% Similarity=0.058 Sum_probs=46.0
Q ss_pred hHHHHH-HHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVAD-SAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~d-~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+| .+.+|.|+..+.+.++- ..|.. ..+.++.+++.++.+++|.++++||+..+...+
T Consensus 18 ~F~~~D~~~~~G~i~~~e~~~~l~--~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~ 80 (158)
T 2jnf_A 18 AFRDFETPEGSGRVSTDQIGIILE--VLGIQQTKSTIRQLIDEFDPFGNGDIDFDSFKIIGARFL 80 (158)
T ss_dssp HHHHSBCSSSCSSEEHHHHHHHHH--HTTCSCSHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHC
T ss_pred HHHHhCCCCCCCcCcHHHHHHHHH--HhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHh
Confidence 777777 77777777777766552 22222 356789999999999999999999999876553
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=84.48 E-value=0.063 Score=47.74 Aligned_cols=60 Identities=15% Similarity=0.055 Sum_probs=48.4
Q ss_pred HHHHHHHHHHHHhcCCCcEEEEc-ccccC--C-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 261 YAVADSAYQDMMHHEEAQHIVLA-GETLA--G-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 261 f~~~d~~~~~~~~~~~~q~i~~s-gesga--g-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
|..+|.+.+|.|+..+.+.++-+ |..+. . ..+.++.+++.+|.+++|.++++||+..+..
T Consensus 38 F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~~~ 101 (198)
T 1juo_A 38 YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAV 101 (198)
T ss_dssp HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH
T ss_pred HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHHHH
Confidence 99999999999999998887743 32111 1 2567899999999999999999999987764
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=84.20 E-value=0.025 Score=49.60 Aligned_cols=87 Identities=7% Similarity=-0.075 Sum_probs=58.0
Q ss_pred CC-C--CCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH-HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCc
Q psy9090 234 NT-H--LNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM-MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAA 309 (488)
Q Consensus 234 ~~-~--~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~-~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~ 309 (488)
++ + +.|...|+.. ............+|+.+|.+..|. |+..+-..++..-..+....+.++.+.+.+|.+++|.|
T Consensus 37 ~~~~~~G~i~~~el~~-l~~~g~~~~~~~l~~~~D~d~~G~~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I 115 (183)
T 1dgu_A 37 VESSLRAQVPFEQILS-LPELKANPFKERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTL 115 (183)
T ss_dssp SCCCTTTCSCHHHHHT-STTSSSCTTHHHHHHHHSCSSSSCCCCHHHHHHHHHHHSTTCCHHHHHHHHHHHHCTTCSSEE
T ss_pred ccccccCcCcHHHHHH-HHhhhcCcHHHHHHHHhCCCCCCCEecHHHHHHHHHHhcCCCCHHHHHHHHHHHhCCCCCCcC
Confidence 45 6 7788888877 433222223345888888888777 76666544332111122234689999999999999999
Q ss_pred hhhhHhhhcchh
Q psy9090 310 KVGEKIEKCVNV 321 (488)
Q Consensus 310 ~~~e~i~~~~~~ 321 (488)
+.+|+...+..+
T Consensus 116 ~~~El~~~l~~~ 127 (183)
T 1dgu_A 116 NREDLSRLVNCL 127 (183)
T ss_dssp EHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999998766543
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=83.95 E-value=0.019 Score=48.37 Aligned_cols=61 Identities=5% Similarity=-0.039 Sum_probs=48.6
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHh--cCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFL--GQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~--~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|.+.+|.|+..+.+.++- ..|... .+.++.+++.++.+ ++|.++++||+..+...
T Consensus 14 ~~F~~~D~d~~G~i~~~el~~~l~--~~g~~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~ 77 (151)
T 1w7j_B 14 EAFELFDRVGDGKILYSQCGDVMR--ALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAV 77 (151)
T ss_dssp HHHHHHCCSSSSEEESTTHHHHHH--HTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHH--HcCCCCCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHHHHH
Confidence 489999999999999988887662 233222 56788899999988 99999999999887654
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=83.94 E-value=0.091 Score=46.57 Aligned_cols=60 Identities=10% Similarity=0.058 Sum_probs=45.9
Q ss_pred hhHHHHHHH-HHHHHhcCCCcEEEEcccccCCc--hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSA-YQDMMHHEEAQHIVLAGETLAGK--TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~-~~~~~~~~~~q~i~~sgesgagk--te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+ .+|.|+..+.+.++ ...|... .+.++.+++.+|.+++|.|+++||+..+..
T Consensus 18 ~~f~~fd~~~~~G~i~~~e~~~~l--~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~ 80 (198)
T 2r2i_A 18 QWYKKFMTECPSGQLTLYEFKQFF--GLKNLSPSANKYVEQMFETFDFNKDGYIDFMEYVAALSL 80 (198)
T ss_dssp HHHHHHHHHCTTSEECHHHHHHHH--TCCSCCHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCcCCHHHHHHHH--HHhCCCcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHH
Confidence 488999988 78888888887766 3333222 245888999999999999999999987654
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=83.64 E-value=0.035 Score=46.16 Aligned_cols=93 Identities=5% Similarity=0.029 Sum_probs=59.6
Q ss_pred ceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEccc-ccCCchhhHHHHHHHHHHhc
Q psy9090 227 VLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGE-TLAGKTTSLKHLLKHLIFLG 305 (488)
Q Consensus 227 il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sge-sgagkte~~k~i~~~~~~~~ 305 (488)
++..+|.++++.|...|+.............+.+..+++.+..|.|+..+-..++..-- ......+.++.+.+.+|.++
T Consensus 10 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~~~D~d~ 89 (145)
T 2bl0_B 10 CFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQLNAKEFDLATFKTVYRKPIKTPTEQSKEMLDAFRALDKEG 89 (145)
T ss_dssp HHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTSSEECHHHHHHHHTSCCCCGGGGHHHHHHHHHHHCSSS
T ss_pred HHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCCeEcHHHHHHHHHHHhhcCcccHHHHHHHHHHhCCCC
Confidence 45567788888888889887665443333344566666665555544444332221100 11123577889999999999
Q ss_pred CCCchhhhHhhhcc
Q psy9090 306 QGAAKVGEKIEKCV 319 (488)
Q Consensus 306 ~g~~~~~e~i~~~~ 319 (488)
+|.++.+|+...+.
T Consensus 90 ~G~i~~~e~~~~l~ 103 (145)
T 2bl0_B 90 NGTIQEAELRQLLL 103 (145)
T ss_dssp SSEEEHHHHHHHHH
T ss_pred CCeEcHHHHHHHHH
Confidence 99999999987664
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=83.54 E-value=0.039 Score=48.60 Aligned_cols=63 Identities=5% Similarity=-0.065 Sum_probs=43.4
Q ss_pred hHHHH-HHHHHHHHhcCCCcEEEEcc--cccCCc-hhhHHHHH-----------HHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYAVA-DSAYQDMMHHEEAQHIVLAG--ETLAGK-TTSLKHLL-----------KHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~~~-d~~~~~~~~~~~~q~i~~sg--esgagk-te~~k~i~-----------~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|..+ |.+.+|.|+..+.+.++-.- ..|... .+.++.++ +.+|.+++|.++++||+..+....
T Consensus 17 ~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~~~~ 94 (191)
T 2ccm_A 17 VFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQVTKEEWLKMWAECV 94 (191)
T ss_dssp HHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH
T ss_pred hccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeECHHHHHHHHHHHh
Confidence 77777 77777777777766555210 002222 44566666 899999999999999998876643
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=83.30 E-value=0.081 Score=44.04 Aligned_cols=60 Identities=8% Similarity=0.050 Sum_probs=46.5
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHH---HHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHL---IFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~---~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|.+.+|.|+..+.+.++- ..|.. ..+.+..+++.+ +.++ |.++++||+..+...
T Consensus 12 ~~F~~~D~~~~G~i~~~el~~~l~--~~~~~~~~~~~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~ 75 (149)
T 2mys_C 12 EAFLLFDRTGDAKITASQVGDIAR--ALGQNPTNAEINKILGNPSKEEMNA-AAITFEEFLPMLQAA 75 (149)
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHH--HhCCCCCHHHHHHHHHHhhhccccC-CcCcHHHHHHHHHHH
Confidence 488888998888888888877652 22322 256788899999 8899 999999999877654
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=83.22 E-value=0.26 Score=40.87 Aligned_cols=61 Identities=7% Similarity=-0.095 Sum_probs=29.9
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
.+|+.+|.+.+|.|+..+-..++..--......+.++.+.+.+|.+++|.|+.+|+...+.
T Consensus 7 ~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~ 67 (135)
T 3h4s_E 7 SMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSG 67 (135)
T ss_dssp ------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHGG
T ss_pred HHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHHH
Confidence 4889999999999999998877732111112356789999999999999999999887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=82.87 E-value=0.76 Score=45.55 Aligned_cols=30 Identities=23% Similarity=0.455 Sum_probs=25.0
Q ss_pred HCCCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 22 ENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 22 ~~givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
...++|+|+.|.||+++.+ .++++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 3579999999999999865 48899997654
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=82.78 E-value=0.022 Score=50.08 Aligned_cols=30 Identities=20% Similarity=0.432 Sum_probs=23.2
Q ss_pred hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 291 TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 291 te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+.++.+++.+|.+++|.++++||+..+..
T Consensus 86 ~~~~~~~~~~~D~d~~g~i~~~ef~~~~~~ 115 (191)
T 3khe_A 86 EAEVDHILQSVDFDRNGYIEYSEFVTVCMD 115 (191)
T ss_dssp HHHHHHHHHHTCTTCSSSEEHHHHHHHHSC
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 456777888888888888888888877643
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=82.68 E-value=0.03 Score=50.26 Aligned_cols=61 Identities=8% Similarity=-0.039 Sum_probs=46.5
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHH-------HHHHHhcCCCchhhhHhhhcc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLL-------KHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~-------~~~~~~~~g~~~~~e~i~~~~ 319 (488)
.+|..+|.+.+|.|+..+.+.++-+ |..+.-..+.++.++ +.+|.+++|.++++||+..+.
T Consensus 40 ~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~~~ 108 (208)
T 2hpk_A 40 KRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEANR 108 (208)
T ss_dssp HHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 4888899999998888888776632 221111256688888 999999999999999998764
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=82.65 E-value=0.081 Score=46.36 Aligned_cols=62 Identities=11% Similarity=-0.084 Sum_probs=45.1
Q ss_pred hhHHHHHHH-HHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSA-YQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~-~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|.+ .+|.|+..+.+.++-+ +..| ..++.++.+++.+|.+++|.++++||+..+..+
T Consensus 29 ~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~-~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~ 92 (190)
T 1g8i_A 29 QWYKGFIKDCPSGQLDAAGFQKIYKQFFPFG-DPTKFATFVFNVFDENKDGRIEFSEFIQALSVT 92 (190)
T ss_dssp HHHHHHHHHCTTSEEEHHHHHHHHHHHCTTS-CTHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCcCCHHHHHHHHHHhCCCC-ChHHHHHHHHHHHhcCCCCeEeHHHHHHHHHHh
Confidence 388888888 7788887777766532 2222 135678889999999999999999998776543
|
| >2eyu_A Twitching motility protein PILT; pilus retraction motor, C-terminal domain PILT, protein transport; 1.87A {Aquifex aeolicus} | Back alignment and structure |
|---|
Probab=82.55 E-value=0.82 Score=42.75 Aligned_cols=39 Identities=18% Similarity=0.189 Sum_probs=31.4
Q ss_pred cCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhh
Q psy9090 274 HEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312 (488)
Q Consensus 274 ~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~ 312 (488)
....+.++|.|++|+|||...+.++..+.....|.+.+.
T Consensus 22 i~~g~~v~i~Gp~GsGKSTll~~l~g~~~~~~~G~I~~~ 60 (261)
T 2eyu_A 22 HRKMGLILVTGPTGSGKSTTIASMIDYINQTKSYHIITI 60 (261)
T ss_dssp GCSSEEEEEECSTTCSHHHHHHHHHHHHHHHCCCEEEEE
T ss_pred hCCCCEEEEECCCCccHHHHHHHHHHhCCCCCCCEEEEc
Confidence 456677888999999999999999999887646766443
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=82.39 E-value=0.027 Score=49.89 Aligned_cols=57 Identities=14% Similarity=0.197 Sum_probs=30.9
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhc
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
+|..+|.+..|.|+..+.+.++ ...|... .+.++.+++.+|.+++|.++++||+..+
T Consensus 15 ~F~~~D~d~dG~I~~~E~~~~l--~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~ 72 (188)
T 1s6i_A 15 LFKMIDTDNSGTITFDELKDGL--KRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAAT 72 (188)
T ss_dssp HHHTTSSSSSSCEEHHHHHHHH--TTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHH
T ss_pred HHHHHCCCCCCcCCHHHHHHHH--HHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHH
Confidence 5555555555555555554444 1112111 3455666666666666666666666554
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=82.25 E-value=0.034 Score=47.08 Aligned_cols=61 Identities=5% Similarity=0.008 Sum_probs=47.4
Q ss_pred hhHHHHHH--HHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVADS--AYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d~--~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|..+|. +.+|.|+..+.+.++- ..|... .+.++.+ +.++.+++|.++++||+..+...+
T Consensus 13 ~~F~~~D~~~d~~G~i~~~el~~~l~--~~g~~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~ 76 (156)
T 1wdc_C 13 DVFELFDFWDGRDGAVDAFKLGDVCR--CLGINPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLM 76 (156)
T ss_dssp HHHHHHHHHTCSSSCEEGGGHHHHHH--HTTCCCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHT
T ss_pred HHHHHHccCCCCCCCCcHHHHHHHHH--HcCCCCCHHHHHHH-HhhCCCCCCeeeHHHHHHHHHHHh
Confidence 38999999 9999999999887763 223222 4557777 888889999999999998877653
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=82.10 E-value=0.012 Score=51.37 Aligned_cols=93 Identities=17% Similarity=0.141 Sum_probs=59.4
Q ss_pred eeee-CCCCCCCCCCchhhhhccCCC----CCCCChh--------------hHHHHHHHHHHHHhcCCCcEEEEc--cc-
Q psy9090 228 LLFI-NPNTHLNLYGTKYHFKYKFKS----RSDNEPH--------------IYAVADSAYQDMMHHEEAQHIVLA--GE- 285 (488)
Q Consensus 228 l~~I-np~~~~~i~~~ef~~~~~~~~----~~~~~ph--------------~f~~~d~~~~~~~~~~~~q~i~~s--ge- 285 (488)
+..+ |.++++.|...||..+..... .....+. +|+.+|.+..|.|+..+...++.. ++
T Consensus 14 F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~ 93 (185)
T 2sas_A 14 FDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLAMWEKTIATC 93 (185)
T ss_dssp HHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHTC
T ss_pred HHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHHHhccc
Confidence 4456 778888888888865543221 1112222 288888887777666665443321 11
Q ss_pred ---cc--CCchhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 286 ---TL--AGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 286 ---sg--agkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.. ....+.++.+++.+|.+++|.|+.+||...+..
T Consensus 94 ~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~ 133 (185)
T 2sas_A 94 KSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKN 133 (185)
T ss_dssp CSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTS
T ss_pred cchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHH
Confidence 00 112367889999999999999999999977643
|
| >1jbk_A CLPB protein; beta barrel, chaperone; 1.80A {Escherichia coli} SCOP: c.37.1.20 | Back alignment and structure |
|---|
Probab=81.06 E-value=1.5 Score=37.55 Aligned_cols=31 Identities=29% Similarity=0.377 Sum_probs=25.9
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHH
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIF 303 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~ 303 (488)
.......+++.|++|.|||.-++.+.+.+..
T Consensus 39 ~~~~~~~~ll~G~~G~GKT~l~~~~~~~~~~ 69 (195)
T 1jbk_A 39 QRRTKNNPVLIGEPGVGKTAIVEGLAQRIIN 69 (195)
T ss_dssp TSSSSCEEEEECCTTSCHHHHHHHHHHHHHH
T ss_pred hcCCCCceEEECCCCCCHHHHHHHHHHHHHh
Confidence 3356788999999999999999999888754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 488 | ||||
| d1lkxa_ | 684 | c.37.1.9 (A:) Myosin S1, motor domain {Dictyosteli | 3e-65 | |
| d1d0xa2 | 712 | c.37.1.9 (A:2-33,A:80-759) Myosin S1, motor domain | 7e-63 | |
| d1w7ja2 | 730 | c.37.1.9 (A:63-792) Myosin S1, motor domain {Chick | 1e-61 | |
| d1kk8a2 | 789 | c.37.1.9 (A:1-28,A:77-837) Myosin S1, motor domain | 3e-61 | |
| d2mysa2 | 794 | c.37.1.9 (A:4-33,A:80-843) Myosin S1, motor domain | 4e-59 | |
| d1br2a2 | 710 | c.37.1.9 (A:80-789) Myosin S1, motor domain {Chick | 4e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-45 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-39 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-36 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-32 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-30 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-09 |
| >d1lkxa_ c.37.1.9 (A:) Myosin S1, motor domain {Dictyostelium discoideum, class-I myosin MyoE [TaxId: 44689]} Length = 684 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Dictyostelium discoideum, class-I myosin MyoE [TaxId: 44689]
Score = 221 bits (563), Expect = 3e-65
Identities = 88/298 (29%), Positives = 146/298 (48%), Gaps = 16/298 (5%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
V D L I+E+ ++ L RH S N Y+++GDV++ NP +LN+Y Y +
Sbjct: 2 VPDFVLLNQITENAFIENLTMRHKSDNIYTYIGDVVISTNPFKNLNIYKESDIKAYNGRY 61
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312
+ + PH+YA+A+ AY+ M +E Q ++++GE+ AGKT + K +++ L F+ + G
Sbjct: 62 KYEMPPHMYALANDAYRSMRQSQENQCVIISGESGAGKTEASKKIMQFLTFVSSNQSPNG 121
Query: 313 EKIEKCV----NVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRV 368
E+I K + ++ A GNA T N NS+R YM++ F + G G Y LEK RV
Sbjct: 122 ERISKMLLDSNPLLEAFGNAKTLRNDNSSRFGKYMEMQFNAVGSPIGGKITNYLLEKSRV 181
Query: 369 TGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDT 428
G + +FHIFY + + + Y YL+ G +
Sbjct: 182 VGRTQG-ERSFHIFYQMLKGLSQSKLDELGLTPNAPAYEYLKKS--------GCFDVSTI 232
Query: 429 N-VAKFQEIYQNLIDIEF-DDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVA 484
+ +F+ I + + + + Q I+ +LAAIL IG + F +AE +V+
Sbjct: 233 DDSGEFKIIVKAMETLGLKESDQNSIWR-ILAAILHIGNITFAEAAEQRTGTTTVKVS 289
|
| >d1d0xa2 c.37.1.9 (A:2-33,A:80-759) Myosin S1, motor domain {Dictyostelium discoideum [TaxId: 44689]} Length = 712 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Dictyostelium discoideum [TaxId: 44689]
Score = 215 bits (548), Expect = 7e-63
Identities = 78/299 (26%), Positives = 144/299 (48%), Gaps = 14/299 (4%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
VED++ L ++E + L R+N Y++ G L+ +NP + +Y + +K +
Sbjct: 41 VEDMSELSYLNEPAVFHNLRVRYNQDLIYTYSGLFLVAVNPFKRIPIYTQEMVDIFKGRR 100
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQ-----G 307
R++ PHI+A++D AY+ M+ + Q +++ GE+ AGKT + K ++++L + G
Sbjct: 101 RNEVAPHIFAISDVAYRSMLDDRQNQSLLITGESGAGKTENTKKVIQYLASVAGRNQANG 160
Query: 308 AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWR 367
+ + ++I + ++ A GNA T N NS+R ++++ F ++G +SGA Y LEK R
Sbjct: 161 SGVLEQQILQANPILEAFGNAKTTRNNNSSRFGKFIEIQFNNAGFISGASIQSYLLEKSR 220
Query: 368 VTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPD 427
V + + N+HIFY A E L+ + YL D
Sbjct: 221 VVF-QSETERNYHIFYQLLAGATAE-EKKALHLAGPESFNYLNQSGCVD-------IKGV 271
Query: 428 TNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAAN 486
++ +F+ Q + + F + ++A IL +G ++FE A A L +
Sbjct: 272 SDSEEFKITRQAMDIVGFSQEEQMSIFKIIAGILHLGNIKFEKGAGEGAVLKDKTALNA 330
|
| >d1w7ja2 c.37.1.9 (A:63-792) Myosin S1, motor domain {Chicken (Gallus gallus), Va isoform [TaxId: 9031]} Length = 730 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Chicken (Gallus gallus), Va isoform [TaxId: 9031]
Score = 211 bits (539), Expect = 1e-61
Identities = 86/297 (28%), Positives = 135/297 (45%), Gaps = 12/297 (4%)
Query: 193 VEDLAALETISEDNIVQELEER-HNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFK 251
DL AL + E ++ L+ R +SK Y++ G VL+ INP L +YG Y +
Sbjct: 9 ENDLTALSYLHEPAVLHNLKVRFIDSKLIYTYCGIVLVAINPYEQLPIYGEDIINAYSGQ 68
Query: 252 SRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGA--A 309
+ D +PHI+AVA+ AY+ M E Q I+++GE+ AGKT S K+ +++ + A A
Sbjct: 69 NMGDMDPHIFAVAEEAYKQMARDERNQSIIVSGESGAGKTVSAKYAMRYFATVSGSASEA 128
Query: 310 KVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVT 369
V EK+ ++ +IGNA T N NS+R Y+++ F ++ GA Y LEK RV
Sbjct: 129 NVEEKVLASNPIMESIGNAKTTRNDNSSRFGKYIEIGFDKRYRIIGANMRTYLLEKSRVV 188
Query: 370 GNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDTN 429
+ + N+HIFY + A E L + Y + + P +
Sbjct: 189 -FQAEEERNYHIFYQLCASA-ALPEFKTLRLGNANYFHYTKQGGS-------PVIDGIDD 239
Query: 430 VAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAAN 486
+ Q + D +LA IL +G VEF S ++ +
Sbjct: 240 AKEMVNTRQACTLLGISDSYQMGIFRILAGILHLGNVEFASRDSDSCAIPPKHDPLT 296
|
| >d1kk8a2 c.37.1.9 (A:1-28,A:77-837) Myosin S1, motor domain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 789 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 211 bits (539), Expect = 3e-61
Identities = 85/322 (26%), Positives = 153/322 (47%), Gaps = 32/322 (9%)
Query: 184 KDQELQTMH------VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHL 237
K+Q M+ +ED+A + ++E +++ L R+ S Y++ G + +NP L
Sbjct: 22 KEQTAAFMNPPKFEKLEDMANMTYLNEASVLYNLRSRYTSGLIYTYSGLFCIAVNPYRRL 81
Query: 238 NLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHL 297
+Y KY+ K +++ PH+++VAD+AYQ+M+ E Q ++ GE+ AGKT + K +
Sbjct: 82 PIYTDSVIAKYRGKRKTEIPPHLFSVADNAYQNMVTDRENQSCLITGESGAGKTENTKKV 141
Query: 298 LKHLIFLGQGAAK------------VGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQV 345
+ +L + K + ++I + V+ A GNA T N NS+R ++++
Sbjct: 142 IMYLAKVACAVKKKDEEASDKKEGSLEDQIIQANPVLEAYGNAKTTRNNNSSRFGKFIRI 201
Query: 346 TFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRK 405
FG +GK++GA Y LEK RVT + + N+HIFY D ++P
Sbjct: 202 HFGPTGKIAGADIETYLLEKSRVT-YQQSAERNYHIFYQICSNAIPE-LNDVMLVTPDSG 259
Query: 406 YRYLRADVTDDKLPKGPRETPDTN-VAKFQEIYQNLIDIEF-DDIQMEIFSNVLAAILLI 463
+ +G + + V +F+ + + F + + +F A+IL +
Sbjct: 260 LYSF--------INQGCLTVDNIDDVEEFKLCDEAFDILGFTKEEKQSMFKCT-ASILHM 310
Query: 464 GEVEF-ESSAENTAELANPEVA 484
GE++F + E AE A
Sbjct: 311 GEMKFKQRPREEQAESDGTAEA 332
|
| >d2mysa2 c.37.1.9 (A:4-33,A:80-843) Myosin S1, motor domain {Chicken (Gallus gallus), pectoral muscle [TaxId: 9031]} Length = 794 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Chicken (Gallus gallus), pectoral muscle [TaxId: 9031]
Score = 206 bits (524), Expect = 4e-59
Identities = 80/310 (25%), Positives = 145/310 (46%), Gaps = 28/310 (9%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
+ED+A + + E ++ L+ER+ + Y++ G + +NP L +Y K Y+ K
Sbjct: 39 IEDMAMMTHLHEPAVLYNLKERYAAWMIYTYSGLFCVTVNPYKWLPVYNPKVVLAYRGKK 98
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAK-- 310
R + PHI++++D+AYQ M+ E Q I++ GE+ AGKT + K ++++ + K
Sbjct: 99 RQEAPPHIFSISDNAYQFMLTDRENQSILITGESGAGKTVNTKRVIQYFATIAASGEKKK 158
Query: 311 ----------VGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGAIFWL 360
+ ++I ++ A GNA T N NS+R ++++ FG++GKL+ A
Sbjct: 159 EEQSGKMQGTLEDQIISANPLLEAFGNAKTVRNDNSSRFGKFIRIHFGATGKLASADIET 218
Query: 361 YQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRK-YRYLRADVTDDKLP 419
Y LEK RVT + P + ++HIFY + +D ++ Y Y+
Sbjct: 219 YLLEKSRVT-FQLPAERSYHIFYQIMSNKKPE-LIDMLLITTNPYDYHYVS--------- 267
Query: 420 KGPRETPDTN-VAKFQEIYQNLIDIEFDDI-QMEIFSNVLAAILLIGEVEF-ESSAENTA 476
+G P + + + + F + I+ A++ G ++F + E A
Sbjct: 268 EGEITVPSIDDQEELMATDSAIDILGFSADEKTAIYKL-TGAVMHYGNLKFKQKQREEQA 326
Query: 477 ELANPEVAAN 486
E EVA
Sbjct: 327 EPDGTEVADK 336
|
| >d1br2a2 c.37.1.9 (A:80-789) Myosin S1, motor domain {Chicken (Gallus gallus), pectoral muscle [TaxId: 9031]} Length = 710 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Chicken (Gallus gallus), pectoral muscle [TaxId: 9031]
Score = 204 bits (521), Expect = 4e-59
Identities = 82/311 (26%), Positives = 138/311 (44%), Gaps = 28/311 (9%)
Query: 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKS 252
VED+A L ++E +++ L ER+ S Y++ G + INP L +Y K YK K
Sbjct: 7 VEDMAELTCLNEASVLHNLRERYFSGLIYTYSGLFCVVINPYKQLPIYSEKIIDMYKGKK 66
Query: 253 RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG----- 307
R + PHIYA+AD+AY+ M+ E Q I+ GE+ AGKT + K ++++L +
Sbjct: 67 RHEMPPHIYAIADTAYRSMLQDREDQSILCTGESGAGKTENTKKVIQYLAVVASSHKGKK 126
Query: 308 -----------AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFGSSGKLSGA 356
++ +++ + ++ A GNA T N NS+R ++++ F +G + GA
Sbjct: 127 DTSITQGPSFSYGELEKQLLQANPILEAFGNAKTVKNDNSSRFGKFIRINFDVTGYIVGA 186
Query: 357 IFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDD 416
Y LEK R + + FHIFYY + L Y +L
Sbjct: 187 NIETYLLEKSRAI-RQAKDERTFHIFYYLIAGAS-EQMRNDLLLEGFNNYTFLS------ 238
Query: 417 KLPKGPRETPDTNVAK-FQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENT 475
G P + FQE + + + F + + V++++L +G + F+
Sbjct: 239 ---NGHVPIPAQQDDEMFQETLEAMTIMGFTEEEQTSILRVVSSVLQLGNIVFKKERNTD 295
Query: 476 AELANPEVAAN 486
AA
Sbjct: 296 QASMPDNTAAQ 306
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-54
Identities = 69/167 (41%), Positives = 113/167 (67%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++E I + K+ + + +LH+N +IHRDL+ N+L T DG++K+ DFG+S + T +
Sbjct: 107 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ +F+G+P WMAPE++ C + YD + DVW+LGIT IE+ + +PP +++P R L +
Sbjct: 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 226
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
I ++ PP L + S WS ++ DF+ +CLEKN + R S+LL+HPF+T
Sbjct: 227 IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-48
Identities = 65/166 (39%), Positives = 96/166 (57%), Gaps = 5/166 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
M E IA + +E + + FLH N VIHRD++ N+LL DG VK+ DFG + K
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T +G+P WMAPE++ Y ++D+W+LGI AIE+ +G+PP+ + +P RAL+
Sbjct: 173 RSTMVGTPYWMAPEVVTRKA-----YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I N P L S + DF+ CL+ + E R ELL+H F+
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (415), Expect = 6e-48
Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
EQ A + E+ + + H VIHRD++ N+LL GE+KI DFG S ++ +
Sbjct: 103 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--R 160
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ T G+ ++ PE++ +D ++D+W+LG+ E GKPPFE +
Sbjct: 161 RTTLCGTLDYLPPEMIEGR-----MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 215
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168
I R ++ D I+ L+ NP RP + E+LEHP+IT+
Sbjct: 216 ISRVEFT---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 5e-47
Identities = 62/167 (37%), Positives = 103/167 (61%), Gaps = 7/167 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E IA + + G+ +LH +++IHRD++ N+LL++ G VK+ DFG +
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAP 167
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+F+G+P WMAPE++ + YD ++DVW+LGIT IEL + KPP +M+ AL+
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEG--QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
I +N P L ++ +WS+++ +F+ CL+K P+ RP LL+H F+
Sbjct: 226 IAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 6e-45
Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 12/171 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHE-----NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA 55
+ E+ + ++ ++ + H + V+HRDL+ +NV L VK+ DFGL+R
Sbjct: 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165
Query: 56 NTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT 115
+ K F+G+P +M+PE M Y+ + D+W+LG EL PPF
Sbjct: 166 HDTSFAKAFVGTPYYMSPEQMNRMS-----YNEKSDIWSLGCLLYELCALMPPFTAFSQK 220
Query: 116 RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+I + +S + I L HRP + E+LE+P I
Sbjct: 221 ELAGKIREGKFRRI--PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 9e-45
Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 11/169 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANT 57
M + + ++I+ G+ FLH +IHRDL+ N+ +T G VKI D GL+ +
Sbjct: 109 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
F K +G+P +MAPE+ + YD +DV+A G+ +E+ + P+ +
Sbjct: 169 FAK--AVIGTPEFMAPEMYE------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+++ V + + I C+ +N + R + +LL H F
Sbjct: 221 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 6e-44
Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTF 58
+ I ++ GM +LH +IHRDL+ +N+ L +D VKI DFGL+ +
Sbjct: 101 FEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
+ + GS WMAPE++R K + Y + DV+A GI EL G+ P+ +++ +
Sbjct: 161 HQFEQLSGSILWMAPEVIRMQDK--NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 119 FQIVRN---PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH--PFITSLPE 171
+V P SN + +AECL+K + RP ++L SLP+
Sbjct: 219 IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-42
Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 6/169 (3%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTF 58
M E +++ G+V+LH + HRD++ N+LL + +KI DFGL+ N
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
G+ ++APE+++ + +DVW+ GI + G+ P++ +
Sbjct: 160 RLLNKMCGTLPYVAPELLKRRE----FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT 167
+ + L + + + L +NP R + ++ + +
Sbjct: 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (376), Expect = 4e-42
Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 3/168 (1%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+SE+ I++ ++ + LH+ +++HRDL+ N+LL D +K+ DFG S + + +K
Sbjct: 107 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEK 165
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVD-GYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ G+PS++APEI+ C + GY +D+W+ G+ L G PPF L
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 225
Query: 120 QIVR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
I+ N G ++S D ++ L P+ R E L HPF
Sbjct: 226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 147 bits (373), Expect = 6e-41
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 9/225 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTF 58
MSE ++++ G+ +HEN+ +H DL+ N++ T + E+K++DFGL+ +
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPK 179
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
K G+ + APE+ D+W++G+ + L G PF + L
Sbjct: 180 QSVKVTTGTAEFAAPEVAEGKP-----VGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234
Query: 119 FQIVRNPPPGLYRA-SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS 177
+ A S S+ DFI + L +P R + + LEHP++T
Sbjct: 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 294
Query: 178 TVNCQYKDQELQTMHVEDLAALETISEDNIVQELEERHNSKNHYS 222
+ +Y D I R + YS
Sbjct: 295 IPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYS 339
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-39
Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 16/183 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETA--NTF 58
E F EI++ + +LH +IHRDL+ N+LL +D ++I DFG ++ + +
Sbjct: 105 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
+ +F+G+ +++PE++ D+WALG +L G PPF +
Sbjct: 165 ARANSFVGTAQYVSPELLTEKS-----ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE------LLEHPFITSLPEN 172
+I++ + D + + L + R E L HPF S+
Sbjct: 220 QKIIKLEYD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276
Query: 173 DLH 175
+LH
Sbjct: 277 NLH 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 143 bits (361), Expect = 3e-39
Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 9/175 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLL--TKDGEVKIVDFGLSRETANTF 58
MSE + +++ G+ +HE+ ++H D++ N++ K VKI+DFGL+ +
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
+ K + + APEI+ D+WA+G+ L G PF L
Sbjct: 183 EIVKVTTATAEFAAPEIVDRE-----PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237
Query: 119 FQIVR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
+ R + S+ S DFI L+K P R + + LEHP++ N
Sbjct: 238 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-39
Identities = 54/219 (24%), Positives = 103/219 (47%), Gaps = 49/219 (22%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD 59
+ EQ + + +I G+ +L E H ++HRD++ SN+L+ GE+K+ DFG+S + ++
Sbjct: 101 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE--------- 110
+F+G+ S+M+PE ++ H Y + D+W++G++ +E+ G+ P
Sbjct: 159 MANSFVGTRSYMSPERLQGTH-----YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
Query: 111 -----------------------------DMHPTRALFQI---VRNPPPGLYRASNWSQH 138
D P A+F++ + N PP + +S
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273
Query: 139 YVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHLS 177
+ DF+ +CL KNP R + +L+ H FI ++ +
Sbjct: 274 FQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFA 312
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-38
Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 9/185 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
F EII G+ FLH +++RDL+ N+LL KDG +KI DFG+ +E K
Sbjct: 100 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
TF G+P ++APEI+ Y++ +D W+ G+ E+ G+ PF
Sbjct: 160 TNTFCGTPDYIAPEILLGQK-----YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 214
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP-YMSELLEHPFITSLPENDLHLSTV 179
I + P + D + + + PE R ++ +HP + +L +
Sbjct: 215 IRMDNPF---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 271
Query: 180 NCQYK 184
+ ++
Sbjct: 272 DPPFR 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-37
Identities = 41/175 (23%), Positives = 76/175 (43%), Gaps = 9/175 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTF 58
++E+ I + ++ + FLH +++ H D+R N++ + +KI++FG +R+
Sbjct: 99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL 118
D + +P + APE+ + D+W+LG L G PF + +
Sbjct: 158 DNFRLLFTAPEYYAPEVHQHD-----VVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 119 FQIVRNPPPGLYRA-SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172
I+ A S +DF+ L K + R SE L+HP++ E
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (341), Expect = 1e-36
Identities = 49/180 (27%), Positives = 90/180 (50%), Gaps = 10/180 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANT 57
+E+ + ++ +++ + +LH+ ++HRDL+ N+L +D ++ I DFGLS+ +
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-DP 162
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
T G+P ++APE++ Y +D W++G+ A L G PPF D + +
Sbjct: 163 GSVLSTACGTPGYVAPEVLAQKP-----YSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217
Query: 118 LFQIVR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDLHL 176
QI++ + S DFI +EK+PE R + L+HP+I D ++
Sbjct: 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNI 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 1e-36
Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 19/229 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---DGEVKIVDFGLSRETANT 57
+E+ + I+K I + +LH ++ HRD++ N+L T + +K+ DFG ++ET +
Sbjct: 108 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TS 166
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
+ T +P ++APE++ YD D+W+LG+ L G PPF H
Sbjct: 167 HNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221
Query: 118 LFQIVRNPPPGLYR-----ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFIT---SL 169
+ G Y S S+ I L+ P R ++E + HP+I +
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281
Query: 170 PENDLHLSTV--NCQYKDQELQTMHVEDLAALETISEDNIVQELEERHN 216
P+ LH S V + + ++++ LA + E ++++E+ N
Sbjct: 282 PQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 330
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 25/243 (10%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+E+ F EI++ + +LH V++RD++ N++L KDG +KI DFGL +E +
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
KTF G+P ++APE++ Y +D W LG+ E+ G+ PF + R
Sbjct: 162 MKTFCGTPEYLAPEVLEDN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM-----SELLEHPFITSLPENDLH 175
I+ S +A L+K+P+ R E++EH F S+ D+
Sbjct: 217 ILMEEIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273
Query: 176 L------------STVNCQYKDQELQTMHVEDLAALETISEDNIVQELEERHNSKNHYSF 223
S V+ +Y D E + S + + E + +
Sbjct: 274 QKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDY 333
Query: 224 VGD 226
+ D
Sbjct: 334 IAD 336
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 8e-36
Identities = 41/178 (23%), Positives = 77/178 (43%), Gaps = 14/178 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR---ETANT 57
+ +++I ++ ++ GM +L E++ +HRDL NVLL KI DFGLS+ N
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTR 116
+ + W APE + + ++ DVW+ G+ E G+ P+ M +
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYK-----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 117 ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL---LEHPFITSLPE 171
+ + G + + D + C + E+RP + + L + + + E
Sbjct: 219 VTAMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 9e-36
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 11/175 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE-TANTFD 59
+ + + +I +GM ++ + +HRDLR +N+L+ ++ K+ DFGL+R N +
Sbjct: 110 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELG-DGKPPFEDMHPTRAL 118
++ W APE G + + DVW+ GI EL G+ P+ M L
Sbjct: 170 ARQGAKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE--HPFITSLPE 171
Q+ R + D + +C K PE RP L + TS
Sbjct: 225 DQVERGYRMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (331), Expect = 2e-35
Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 18/218 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
F E+ + +LH +I+RDL+ N+LL K+G +KI DFG ++ D
Sbjct: 101 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DV 157
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
T G+P ++APE++ Y+ ID W+ GI E+ G PF D + + +
Sbjct: 158 TYTLCGTPDYIAPEVVSTKP-----YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 212
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY-----MSELLEHPFITSLPENDLH 175
I+ +++ D ++ + ++ R ++ HP+ + L
Sbjct: 213 ILNAELR---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLL 269
Query: 176 LSTVNCQYKDQELQTMHVEDLAALETISEDNIVQELEE 213
+ Y+ Q D + + E++I ++
Sbjct: 270 SRNIETPYEPPIQQ--GQGDTSQFDKYPEEDINYGVQG 305
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-35
Identities = 40/165 (24%), Positives = 65/165 (39%), Gaps = 9/165 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
Q + + K++ M +L +HRDL N L+ G VK+ DFGLSR +
Sbjct: 97 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156
Query: 61 KKT-FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRAL 118
W PE++ + ++ D+WA G+ E+ GK P+E +
Sbjct: 157 SSVGSKFPVRWSPPEVLMYSK-----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 211
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
I + YR S+ + C + + RP LL +
Sbjct: 212 EHIAQGLRL--YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-34
Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 11/164 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + ++ M +L N+ +HRDL NVL+++D K+ DFGL++E ++T D
Sbjct: 100 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 158
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRALF 119
T W APE +R + + DVW+ GI E G+ P+ + +
Sbjct: 159 --TGKLPVKWTAPEALREKK-----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
++ + + + C + RP +L E
Sbjct: 212 RVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-34
Identities = 40/195 (20%), Positives = 77/195 (39%), Gaps = 29/195 (14%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
++ HI + + G+ +LH++ ++HRDL+ +N+LL ++G +K+ DFGL++ +
Sbjct: 97 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ + + APE++ Y +D+WA+G EL P L +
Sbjct: 157 YTHQVVTRWYRAPELLFGAR----MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212
Query: 121 IVR-------------------------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155
I P + S +D I NP R
Sbjct: 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272
Query: 156 YMSELLEHPFITSLP 170
++ L+ + ++ P
Sbjct: 273 TATQALKMKYFSNRP 287
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-34
Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 9/166 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE--TANTF 58
++ + + ++ GM FL +HRDL NVL+T VKI DFGL+R+ + + +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRA 117
+ WMAPE + G Y + DVW+ GI E G P+ +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGI-----YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+++++N + + ++ + C + RP L
Sbjct: 276 FYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-34
Identities = 42/182 (23%), Positives = 74/182 (40%), Gaps = 14/182 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR---ETANT 57
+ ++A +L ++ GM +L E + +HRDL NVLL KI DFGLS+ +
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTR 116
+ + W APE + + +R DVW+ G+T E L G+ P++ M
Sbjct: 166 YTARSAGKWPLKWYAPECINFRK-----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220
Query: 117 ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL---LEHPFITSLPEND 173
+ I + +++C E RP + + + + + +
Sbjct: 221 VMAFIEQGKRMEC--PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
Query: 174 LH 175
H
Sbjct: 279 GH 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-34
Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 11/172 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE-TANTFD 59
++ + + +I GM F+ E + IHRDLR +N+L++ KI DFGL+R N +
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRAL 118
++ W APE + G + + DVW+ GI E + G+ P+ M +
Sbjct: 166 AREGAKFPIKWTAPEAINYGT-----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE--HPFITS 168
+ R R N + + C ++ PE RP L F T+
Sbjct: 221 QNLERGYRM--VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-34
Identities = 41/203 (20%), Positives = 78/203 (38%), Gaps = 37/203 (18%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE----TAN 56
+ I +++ ++ G+ ++H N ++HRD++ +NVL+T+DG +K+ DFGL+R +
Sbjct: 114 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 173
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR 116
++ + + + PE++ Y ID+W G E+ P +
Sbjct: 174 QPNRYTNRVVTLWYRPPELLLGER----DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
Query: 117 ALFQIVR-----------------------------NPPPGLYRASNWSQHYVDFIAECL 147
L I + +A + +D I + L
Sbjct: 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289
Query: 148 EKNPEHRPYMSELLEHPFITSLP 170
+P R + L H F S P
Sbjct: 290 VLDPAQRIDSDDALNHDFFWSDP 312
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 7e-34
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 10/167 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR---ETANT 57
++ ++ GM +L IHRDL N+LL VKI DFGL R + +
Sbjct: 108 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTR 116
+ ++ +W APE ++ + + D W G+T E G+ P+ ++ ++
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRT-----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222
Query: 117 ALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
L +I + L R + Q + + +C PE RP L +
Sbjct: 223 ILHKIDKEGER-LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-33
Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 20/181 (11%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD-GEVKIVDFGLSRETANTFD 59
+ E+ +++ + H V+HRD++ N+L+ + GE+K++DFG +T
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV- 165
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
F G+ + PE +R + VW+LGI ++ G PFE
Sbjct: 166 -YTDFDGTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS--LPEN--DLH 175
+I+R ++ S I CL P RP E+ HP++ LP+ ++H
Sbjct: 215 EIIRGQ---VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 271
Query: 176 L 176
L
Sbjct: 272 L 272
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-33
Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 35/227 (15%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR---ETANT 57
+S HI + L +I+ G+ ++H +V+HRDL+ SN+LL ++KI DFGL+R +
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
++ + + APEIM GY ID+W++G E+ +P F H
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSK----GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 221
Query: 118 LFQIVR----------------------------NPPPGLYRASNWSQHYVDFIAECLEK 149
L I+ N P N +D + + L
Sbjct: 222 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 281
Query: 150 NPEHRPYMSELLEHPFITSLPENDLHLSTVNCQYKDQELQTMHVEDL 196
NP R + + L HP++ + D EL + E L
Sbjct: 282 NPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 328
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 2e-33
Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 13/169 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR-----ETA 55
+ + +L+ I GM +L + + +HRDL N+L+ + K+ DFGLSR +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 56 NTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHP 114
T+ W APE ++ + + DVW+ GI E + G+ P+ DM
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 115 TRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ I ++ L + + +C +K+ HRP +++
Sbjct: 240 QDVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-33
Identities = 44/193 (22%), Positives = 82/193 (42%), Gaps = 30/193 (15%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + I ++ +++ G+ FLH + V+HRDL+ N+L+T G++K+ DFGL+R +
Sbjct: 113 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMA 171
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ + + + APE++ Y +D+W++G E+ KP F L +
Sbjct: 172 LTSVVVTLWYRAPEVLLQSS-----YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 226
Query: 121 IVR------------------------NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156
I+ + P ++ + D + +CL NP R
Sbjct: 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286
Query: 157 MSELLEHPFITSL 169
L HP+ L
Sbjct: 287 AYSALSHPYFQDL 299
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-33
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 9/165 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE-TANTFD 59
+ + + + ++ GM +L E VIHRDL N L+ ++ +K+ DFG++R + +
Sbjct: 98 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRAL 118
W +PE+ Y ++ DVW+ G+ E +GK P+E+ + +
Sbjct: 158 SSTGTKFPVKWASPEVFSFSR-----YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
I Y+ S H + C ++ PE RP S LL
Sbjct: 213 EDISTGFRL--YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 5e-33
Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 19/218 (8%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
SE H F +I+ +LH +I+RDL+ N+L+ + G +++ DFG ++ +
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGR 194
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
T G+P +APEI+ GY+ +D WALG+ E+ G PPF P + +
Sbjct: 195 TWTLCGTPEALAPEIILSK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY-----MSELLEHPFITSLPENDLH 175
IV S++S D + L+ + R ++++ H + + ++
Sbjct: 250 IVSGKVR---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 176 LSTVNCQYKDQELQTMHVEDLAALETISEDNIVQELEE 213
V + + D + + E+ I + E
Sbjct: 307 QRKVEAPFIP---KFKGPGDTSNFDDYEEEEIRVSINE 341
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 8e-33
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 11/179 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGE----VKIVDFGLSRETAN 56
++E+ LK+I+ G+ +LH + H DL+ N++L +KI+DFGL+ +
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR 116
++ K G+P ++APEI+ D+W++G+ L G PF
Sbjct: 170 G-NEFKNIFGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQE 223
Query: 117 ALFQIVR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174
L + N SN S DFI L K+P+ R + + L+HP+I
Sbjct: 224 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (311), Expect = 9e-33
Identities = 44/192 (22%), Positives = 81/192 (42%), Gaps = 30/192 (15%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ L +++ G+ + H+ V+HRDL+ N+L+ ++GE+KI DFGL+R K
Sbjct: 97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ + + AP+++ K Y ID+W++G E+ +G P F + L +
Sbjct: 157 YTHEIVTLWYRAPDVLMGSKK----YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 121 IVR--------------------------NPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154
I R P P + +D +++ L+ +P R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 155 PYMSELLEHPFI 166
+ LEH +
Sbjct: 273 ITAKQALEHAYF 284
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-32
Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 10/191 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRE-TANTFD 59
+E + + EI+ + LH+ +I+RD++ N+LL +G V + DFGLS+E A+ +
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ F G+ +MAP+I+R G G+D +D W+LG+ EL G PF +
Sbjct: 186 RAYDFCGTIEYMAPDIVRGGDS---GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 242
Query: 120 QIVRNPPPGLYRA-SNWSQHYVDFIAECLEKNPEHRPYM-----SELLEHPFITSLPEND 173
+I R S D I L K+P+ R E+ EH F + +D
Sbjct: 243 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302
Query: 174 LHLSTVNCQYK 184
L V +K
Sbjct: 303 LAAKKVPAPFK 313
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 123 bits (309), Expect = 1e-32
Identities = 45/170 (26%), Positives = 85/170 (50%), Gaps = 9/170 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR---ETANT 57
M+ + ++ + + F H+N +IHRD++ +N++++ VK++DFG++R ++ N+
Sbjct: 108 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167
Query: 58 FDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
+ +G+ +++PE R D R DV++LG E+ G+PPF P
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDS-----VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222
Query: 118 LFQIVR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFI 166
+Q VR +P P R S + + L KNPE+R + + +
Sbjct: 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-32
Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 13/216 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTF 58
+ Q++ +I GM +L + ++HRDL NVL+ VKI DFGL++
Sbjct: 108 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIEL-GDGKPPFEDMHPTRA 117
+ WMA E + Y ++ DVW+ G+T EL G P++ +
Sbjct: 168 YHAEGGKVPIKWMALESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SE 221
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHP-FITSLPENDLHL 176
+ I+ L + + + +C + + RP EL+ + P+ +L
Sbjct: 222 ISSILEKGER-LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR--YL 278
Query: 177 STVNCQYKDQELQTMHVEDLAALETISEDNIVQELE 212
+ T A ++ D++V E
Sbjct: 279 VIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 314
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (309), Expect = 2e-32
Identities = 42/165 (25%), Positives = 63/165 (38%), Gaps = 10/165 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTF 58
+S I +++ GM +L E +HRDL N L+ ++ VKI DFGLSR +A+ +
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRA 117
WM PE + Y DVWA G+ E G P+ M
Sbjct: 197 KADGNDAIPIRWMPPESIFYNR-----YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
++ + N + + C K P RP +
Sbjct: 252 IYYVRDGNILAC--PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-32
Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 9/164 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S Q + ++ GM +L + IHRDL N+L+ ++ KI DFGLSR + K
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVK 182
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRALF 119
K WMA E + Y DVW+ G+ E + G P+ M
Sbjct: 183 KTMGRLPVRWMAIESLNYSV-----YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
++ + + N D + +C + P RP +++L
Sbjct: 238 KLPQGYRL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 122 bits (308), Expect = 9e-32
Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
SE + F EII G+ +H V++RDL+ +N+LL + G V+I D GL+ + + K
Sbjct: 104 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--K 161
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+G+ +MAPE+++ G YD+ D ++LG +L G PF
Sbjct: 162 PHASVGTHGYMAPEVLQKGV----AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217
Query: 121 IVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM-----SELLEHPFITSLPENDLH 175
+ ++S + L+++ R E+ E PF SL +
Sbjct: 218 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF 277
Query: 176 L 176
L
Sbjct: 278 L 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-31
Identities = 45/202 (22%), Positives = 77/202 (38%), Gaps = 30/202 (14%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ I L +++ G+ F H + V+HRDL+ N+L+ +G +K+ DFGL+R
Sbjct: 99 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ + + APEI+ Y +D+W+LG E+ + F LF+
Sbjct: 159 YTHEVVTLWYRAPEILLGCKY----YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 121 IVRN---PPPGLYRASNWSQHY-----------------------VDFIAECLEKNPEHR 154
I R P ++ Y +++ L +P R
Sbjct: 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 274
Query: 155 PYMSELLEHPFITSLPENDLHL 176
L HPF + + HL
Sbjct: 275 ISAKAALAHPFFQDVTKPVPHL 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-31
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + ++ T + +L +HRD+ NVL++ + VK+ DFGLSR ++
Sbjct: 105 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164
Query: 61 KKT-FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRAL 118
K + WMAPE + + + DVW G+ E L G PF+ + +
Sbjct: 165 KASKGKLPIKWMAPESINFRR-----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
Query: 119 FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+I + N + +C +P RP +EL
Sbjct: 220 GRIENGERLPM--PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 9e-31
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETAN--TF 58
++ +H+ ++ GM FL IHRDL N+LL++ VKI DFGL+R+ +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDG-KPPFEDMHPTRA 117
+K WMAPE + Y + DVW+ G+ E+ P+ +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRV-----YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+ ++ + + + +C P RP SEL+EH
Sbjct: 246 FCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-30
Identities = 34/165 (20%), Positives = 64/165 (38%), Gaps = 9/165 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
S + +L+ I GM +L + +HRDL N+L+ + K+ DFGLSR + +
Sbjct: 107 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166
Query: 61 KKTF---LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRA 117
T W APE + + + DVW+ GI E+
Sbjct: 167 TYTTSGGKIPIRWTAPEAISYRK-----FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+ + + + L + + +C ++ RP ++++
Sbjct: 222 VMKAINDGFR-LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (293), Expect = 3e-30
Identities = 36/163 (22%), Positives = 67/163 (41%), Gaps = 7/163 (4%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S + ++ +I + M +L + + IHRDL N L+ ++ VK+ DFGLSR
Sbjct: 112 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171
Query: 61 KKTF-LGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
W APE + + + DVWA G+ E+ ++
Sbjct: 172 AHAGAKFPIKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
Query: 120 QIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+++ + R + + + C + NP RP +E+ +
Sbjct: 227 ELLEKDYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-30
Identities = 43/223 (19%), Positives = 80/223 (35%), Gaps = 37/223 (16%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEV-KIVDFGLSRETANTFD 59
+ ++ + ++ + ++H + HRD++ N+LL D V K+ DFG +++ +
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-E 177
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+++ S + APE++ Y + IDVW+ G EL G+P F L
Sbjct: 178 PNVSYICSRYYRAPELIFGAT----DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 120 QIVR--------------------------NPPPGLYRASNWSQHYVDFIAECLEKNPEH 153
+I++ P + + LE P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 154 RPYMSELLEHPFITSLPENDLHLSTVNC-----QYKDQELQTM 191
R E H F L + ++ L + QEL +
Sbjct: 294 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 336
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 8e-30
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 10/166 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+S + + ++ GM +L IHRDL NVL+T+D +KI DFGL+R+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 61 KKT--FLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRA 117
KKT WMAPE + Y ++ DVW+ G+ E G P+ + P
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRI-----YTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 245
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
LF++++ + + SN + + +C P RP +L+E
Sbjct: 246 LFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-29
Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 12/168 (7%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR----ETAN 56
+ + + ++ GM FL +HRDL N +L + VK+ DFGL+R + +
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 57 TFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPT 115
+ K WMA E ++ + + DVW+ G+ E + G PP+ D++
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241
Query: 116 RALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
+++ + + + +C E RP SEL+
Sbjct: 242 DITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (281), Expect = 1e-28
Identities = 31/191 (16%), Positives = 67/191 (35%), Gaps = 23/191 (12%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG---EVKIVDFGLSR----- 52
S + + + ++I+ + ++H + IHRD++ N L+ V I+DFGL++
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 53 --ETANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE 110
+ + K G+ + + R D+ +LG + G P++
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIE-----QSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 111 DMHPTRALFQIVRN-----PPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS---ELLE 162
+ + R P + + ++ C + +P S +L
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 163 HPFITSLPEND 173
+ F D
Sbjct: 275 NLFHRQGFSYD 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-28
Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 10/166 (6%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRET--ANTF 58
S + + EI GM +L+ N +HRDL N ++ +D VKI DFG++R+ + +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRA 117
K L WM+PE ++ G + DVW+ G+ E + P++ + +
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGV-----FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163
L ++ + N + + C + NP+ RP E++
Sbjct: 245 LRFVMEGGLLD--KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 6e-28
Identities = 42/165 (25%), Positives = 69/165 (41%), Gaps = 9/165 (5%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSR--ETANTF 58
+ + + ++ GM FL + IHRDL N+LLT KI DFGL+R + + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 59 DKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIE-LGDGKPPFEDMHPTRA 117
K WMAPE + Y DVW+ GI E G P+ M
Sbjct: 202 VVKGNARLPVKWMAPESIFNCV-----YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 118 LFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
+++++ L + D + C + +P RP ++++
Sbjct: 257 FYKMIKEGFRMLSP-EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-27
Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 35/201 (17%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ E I F++ +++ G+ ++H +IHRDL+ N+ + +D E+KI+DFGL+R+ +
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-- 175
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
++ + + APE++ + Y +D+W++G E+ GK F+ L +
Sbjct: 176 -TGYVVTRWYRAPEVILNWMR----YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230
Query: 121 IVR---NPPPGLYRA-------------------------SNWSQHYVDFIAECLEKNPE 152
I++ PP + +N S V+ + + L + E
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 153 HRPYMSELLEHPFITSLPEND 173
R E L HP+ SL + +
Sbjct: 291 QRVTAGEALAHPYFESLHDTE 311
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-27
Identities = 36/197 (18%), Positives = 73/197 (37%), Gaps = 31/197 (15%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + + L +++ G+ F H +V+HRDL+ N+L+ ++GE+K+ +FGL+R
Sbjct: 98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
+ + + P+++ Y ID+W+ G EL + P + +
Sbjct: 158 YSAEVVTLWYRPPDVLFGAKL----YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
Query: 121 IVRN---------------------------PPPGLYRASNWSQHYVDFIAECLEKNPEH 153
+ + + D + L+ NP
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 154 RPYMSELLEHPFITSLP 170
R E L+HP+ +
Sbjct: 274 RISAEEALQHPYFSDFC 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 108 bits (270), Expect = 5e-27
Identities = 28/179 (15%), Positives = 64/179 (35%), Gaps = 22/179 (12%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-----DGEVKIVDFGLSRETA 55
S + +A K+++ + +HE +++RD++ N L+ + + +VDFG+ +
Sbjct: 98 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157
Query: 56 NTFDKK-------KTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPP 108
+ K+ K G+ +M+ R D+ ALG + G P
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR-----EQSRRDDLEALGHVFMYFLRGSLP 212
Query: 109 FEDMHPTRALFQIVR-----NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLE 162
++ + + R P + + + + ++ + P L
Sbjct: 213 WQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 5e-27
Identities = 33/194 (17%), Positives = 66/194 (34%), Gaps = 32/194 (16%)
Query: 1 MSEQHIAFILKEIITGMVFLHE--------NHVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52
++ + + + +G+ LH + HRDL+ N+L+ K+G I D GL+
Sbjct: 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156
Query: 53 ----ETANTFDKKKTFLGSPSWMAPEIMRCGHKEVDG-YDNRIDVWALGITAIELGDGKP 107
T +G+ +MAPE++ R D++A+G+ E+
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
Query: 108 PFEDMHPTRALF-------------------QIVRNPPPGLYRASNWSQHYVDFIAECLE 148
+ + Q +R P +++ + + EC
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276
Query: 149 KNPEHRPYMSELLE 162
N R + +
Sbjct: 277 ANGAARLTALRIKK 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (261), Expect = 1e-25
Identities = 37/208 (17%), Positives = 80/208 (38%), Gaps = 41/208 (19%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANTFD 59
+++ I F + EI+ + + H ++HRD++ NV++ + +++++D+GL+
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q 184
Query: 60 KKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALF 119
+ + S + PE++ YD +D+W+LG + K PF H
Sbjct: 185 EYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240
Query: 120 QIV--------------------------------RNPPPGLYRASNW---SQHYVDFIA 144
+ R + N S +DF+
Sbjct: 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300
Query: 145 ECLEKNPEHRPYMSELLEHPFITSLPEN 172
+ L + + R E +EHP+ ++ ++
Sbjct: 301 KLLRYDHQSRLTAREAMEHPYFYTVVKD 328
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-24
Identities = 40/210 (19%), Positives = 84/210 (40%), Gaps = 45/210 (21%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ + ++++L +++ G+ LH +IHRDL+ SN+++ D +KI+DFGL+R +
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FM 174
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
++ + + APE++ GY +D+W++G E+ K F +
Sbjct: 175 MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 121 IVRN---PPPGLYRASNW------------------------------------SQHYVD 141
++ P P + + D
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289
Query: 142 FIAECLEKNPEHRPYMSELLEHPFITSLPE 171
+++ L +P R + + L+HP+I +
Sbjct: 290 LLSKMLVIDPAKRISVDDALQHPYINVWYD 319
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 4e-24
Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 35/201 (17%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+++ H+ F++ +I+ G+ ++H +IHRDL+ SN+ + +D E+KI+DFGL+R T +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-- 175
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQ 120
++ + + APEIM Y+ +D+W++G EL G+ F L
Sbjct: 176 -TGYVATRWYRAPEIMLNWMH----YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 121 IVR---NPPPGLYRA-------------------------SNWSQHYVDFIAECLEKNPE 152
I+R P L + + VD + + L + +
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290
Query: 153 HRPYMSELLEHPFITSLPEND 173
R ++ L H + + D
Sbjct: 291 KRITAAQALAHAYFAQYHDPD 311
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.0 bits (201), Expect = 1e-17
Identities = 35/225 (15%), Positives = 77/225 (34%), Gaps = 60/225 (26%)
Query: 1 MSEQHIAFILKEIITGMVFLHENH-VIHRDLRGSNVLLTKDG------EVKIVDFGLSRE 53
+ ++ I K+++ G+ ++H +IH D++ NVL+ ++KI D G +
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181
Query: 54 TANTFDKKKTFLGSPSWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFE--- 110
+ + + + +PE++ + D+W+ EL G FE
Sbjct: 182 Y---DEHYTNSIQTREYRSPEVLLGAP-----WGCGADIWSTACLIFELITGDFLFEPDE 233
Query: 111 ------DMHPTRALFQIVRNPPPGLYRASNWSQHY------------------------- 139
D + +++ P L R +++ +
Sbjct: 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 293
Query: 140 -----------VDFIAECLEKNPEHRPYMSELLEHPFITSLPEND 173
DF++ L+ +P R L+ HP++ +
Sbjct: 294 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.8 bits (131), Expect = 2e-09
Identities = 19/106 (17%), Positives = 42/106 (39%), Gaps = 19/106 (17%)
Query: 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDK 60
+ ++ +L I+ + + ++H DL NVL++++G + I+DF S E
Sbjct: 100 VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEE--- 155
Query: 61 KKTFLGSPSWMAPEIMRCGHKEVDGYDNR-----IDVWALGITAIE 101
EI+ + + Y +R D+ + ++
Sbjct: 156 ----------GWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 488 | |||
| d1d0xa2 | 712 | Myosin S1, motor domain {Dictyostelium discoideum | 100.0 | |
| d1kk8a2 | 789 | Myosin S1, motor domain {Bay scallop (Aequipecten | 100.0 | |
| d2mysa2 | 794 | Myosin S1, motor domain {Chicken (Gallus gallus), | 100.0 | |
| d1br2a2 | 710 | Myosin S1, motor domain {Chicken (Gallus gallus), | 100.0 | |
| d1lkxa_ | 684 | Myosin S1, motor domain {Dictyostelium discoideum, | 100.0 | |
| d1w7ja2 | 730 | Myosin S1, motor domain {Chicken (Gallus gallus), | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.98 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.98 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.98 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.98 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.98 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.98 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.98 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.98 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.3 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.06 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 97.99 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 97.58 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 97.45 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 97.4 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 97.33 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 97.32 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 97.24 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 97.22 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 97.19 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.13 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 97.11 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 97.08 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 97.06 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 97.02 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.0 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 96.99 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 96.98 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 96.94 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 96.93 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 96.89 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 96.85 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 96.8 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 96.79 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 96.79 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 96.72 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 96.72 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 96.71 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 96.61 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 96.61 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 96.58 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 96.56 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 96.55 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 96.55 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 96.54 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 96.51 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 96.5 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 96.46 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 96.42 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 96.38 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 96.35 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 96.35 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 96.29 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 96.19 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 96.17 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 96.15 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 96.11 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 96.11 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 96.02 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 95.72 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 95.71 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 95.66 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 95.45 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 95.23 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 95.1 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 94.89 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 94.75 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 94.55 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 94.3 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 94.26 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 94.21 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 94.18 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 94.14 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 94.12 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 93.6 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 93.59 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 93.44 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 92.98 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 92.9 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 92.41 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 92.07 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 91.84 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.0 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 90.98 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 90.8 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 90.7 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 90.57 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 89.82 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 89.79 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 89.6 | |
| d2i3ba1 | 189 | Cancer-related NTPase, C1orf57 {Human (Homo sapien | 88.99 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 88.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 88.04 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 88.03 | |
| d1iqpa2 | 231 | Replication factor C {Archaeon Pyrococcus furiosus | 86.71 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 86.3 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 85.39 | |
| d1np6a_ | 170 | Molybdopterin-guanine dinucleotide biosynthesis pr | 84.64 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 84.64 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 84.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 84.06 | |
| d1ye8a1 | 178 | Hypothetical kinase-like protein Aq_1292 {Aquifex | 83.09 | |
| d1sxjd2 | 237 | Replication factor C2 {Baker's yeast (Saccharomyce | 83.08 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 82.88 | |
| d1gkya_ | 186 | Guanylate kinase {Baker's yeast (Saccharomyces cer | 82.87 | |
| d1lvga_ | 190 | Guanylate kinase {Mouse (Mus musculus) [TaxId: 100 | 82.12 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 81.69 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 81.56 | |
| d1khta_ | 190 | Adenylate kinase {Archaeon Methanococcus voltae [T | 81.25 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 80.89 | |
| d1znwa1 | 182 | Guanylate kinase {Mycobacterium tuberculosis [TaxI | 80.75 | |
| d1m8pa3 | 183 | ATP sulfurylase C-terminal domain {Fungus (Penicil | 80.56 | |
| d1qhxa_ | 178 | Chloramphenicol phosphotransferase {Streptomyces v | 80.55 | |
| d1sxjc2 | 227 | Replication factor C3 {Baker's yeast (Saccharomyce | 80.23 | |
| d1ly1a_ | 152 | Polynucleotide kinase, kinase domain {Bacteriophag | 80.06 |
| >d1d0xa2 c.37.1.9 (A:2-33,A:80-759) Myosin S1, motor domain {Dictyostelium discoideum [TaxId: 44689]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Dictyostelium discoideum [TaxId: 44689]
Probab=100.00 E-value=4.5e-77 Score=640.66 Aligned_cols=285 Identities=27% Similarity=0.433 Sum_probs=266.6
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++|+.++.+|+.||..+.+|||+|+++++|||++.+++|.++++..|.++.....|||+|++|++||+.|
T Consensus 40 ~v~Dl~~L~~l~E~~vl~~L~~Ry~~~~iYT~~G~iLiavNP~k~l~iy~~~~~~~y~~~~~~~~~PHifaiA~~Ay~~m 119 (712)
T d1d0xa2 40 GVEDMSELSYLNEPAVFHNLRVRYNQDLIYTYSGLFLVAVNPFKRIPIYTQEMVDIFKGRRRNEVAPHIFAISDVAYRSM 119 (712)
T ss_dssp TCSBGGGCSSCCHHHHHHHHHHHHHTTCCEEEETTEEEEECCSSCCSCCSHHHHHHHTTCCGGGSCCCHHHHHHHHHHHH
T ss_pred CCchhhcCCCCCHHHHHHHHHHHHcCCCceeeECCEEEEECCCCCCCCCCHHHHHHHcCCCcCCCCCcHHHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcC-----CCchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEE
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQ-----GAAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVT 346 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~-----g~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~ 346 (488)
++.+++|+|||||||||||||++|.||+|++..+. +...+++.|++++|+|||||||||+|||||||||||++|+
T Consensus 120 ~~~~~nQsIiisGeSGaGKTe~~k~il~yL~~~s~~~~~~~~~~i~~~i~~~n~iLEAFGNAkT~~N~NSSRFGk~~~l~ 199 (712)
T d1d0xa2 120 LDDRQNQSLLITGESGAGKTENTKKVIQYLASVAGRNQANGSGVLEQQILQANPILEAFGNAKTTRNNNSSRFGKFIEIQ 199 (712)
T ss_dssp HHHTCCEEEEEECSTTSSHHHHHHHHHHHHHHHHSCC-----CHHHHHHHHHHHHHHHHHEECCSSCTTEESSEEEEEEE
T ss_pred HHhCCCceEEEeCCCCCCHHHHHHHHHHHHHHHhCCCcccccchHHHHHHhhhhHHHHhcCcCcCCCCCccceeEEEEEE
Confidence 99999999999999999999999999999998754 3456999999999999999999999999999999999999
Q ss_pred ECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCC
Q psy9090 347 FGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETP 426 (488)
Q Consensus 347 ~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~ 426 (488)
|+..|.|+||+|.+|||||||||. |.+||||||||||||+|++. ++++.+.|.++..|+||+++.+ ...++
T Consensus 200 f~~~g~i~ga~i~~yLLEksRvv~-~~~gErnfHIFYqll~g~~~-~~~~~~~l~~~~~~~yL~~~~~-------~~~~~ 270 (712)
T d1d0xa2 200 FNNAGFISGASIQSYLLEKSRVVF-QSETERNYHIFYQLLAGATA-EEKKALHLAGPESFNYLNQSGC-------VDIKG 270 (712)
T ss_dssp ECTTSCEEEEEEEEECCCGGGGTC-CCTTCCSBHHHHHHHHHSCH-HHHHHHTCCCGGGCTTTSSSSC-------CCCTT
T ss_pred EcCCCccccceeEEeccCCceEEe-eccccccHHHHHHHHhCCCH-HHHHHhCCCCchhcccccCCCC-------cccCC
Confidence 999999999999999999999995 99999999999999999987 5678889999999999987743 23567
Q ss_pred CccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecCCcccccCChhhhc
Q psy9090 427 DTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSAENTAELANPEVAA 485 (488)
Q Consensus 427 ~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~~~~~~~~~~~~~~ 485 (488)
.+|+++|+++++||+.|||+++|+..||+|||||||||||+|.+.+.+.+.+.+++.++
T Consensus 271 ~dd~~~f~~~~~al~~lgfs~~e~~~i~~iLaaILhLGNi~F~~~~~~~~~i~~~~~l~ 329 (712)
T d1d0xa2 271 VSDSEEFKITRQAMDIVGFSQEEQMSIFKIIAGILHLGNIKFEKGAGEGAVLKDKTALN 329 (712)
T ss_dssp CCHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCCBCCSSSSCBCSCCHHHH
T ss_pred cChHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhccceEeecCCcceecCCHHHHH
Confidence 88999999999999999999999999999999999999999988777788888876654
|
| >d1kk8a2 c.37.1.9 (A:1-28,A:77-837) Myosin S1, motor domain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=100.00 E-value=6.5e-75 Score=631.72 Aligned_cols=283 Identities=28% Similarity=0.429 Sum_probs=258.2
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++|+.++++|+.||..+.+|||+|+++++|||++.+++|.++.+..|.++...+.|||+|+||++||+.|
T Consensus 36 ~v~Dl~~L~~l~E~~vl~~L~~Ry~~~~iYT~~G~iLiavNP~k~l~iy~~~~~~~y~~~~~~~~~PHiyavA~~Ay~~m 115 (789)
T d1kk8a2 36 KLEDMANMTYLNEASVLYNLRSRYTSGLIYTYSGLFCIAVNPYRRLPIYTDSVIAKYRGKRKTEIPPHLFSVADNAYQNM 115 (789)
T ss_dssp TCSBGGGSSCCSHHHHHHHHHHHHHTTCCEEEETTEEEEECCSSCCSTTSHHHHHHHTTCCGGGSCCCHHHHHHHHHHHH
T ss_pred CcchhccCCCCCHHHHHHHHHHHHcCCCceEeECCEEEEECCCCCCCCCCHHHHHHHcCCCCCCCCCcHHHHHHHHHHHH
Confidence 57999999999999999999999999999999999999999999999999999999999998999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC------------CchhhhHhhhcchhhhhhhccccCCCCCCCcc
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG------------AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRH 339 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g------------~~~~~e~i~~~~~~leafgna~t~~n~nssrf 339 (488)
...+++|||+|||||||||||++|.||+|++..+.+ ..++++.|+.+||+|||||||||++|||||||
T Consensus 116 ~~~~~nQ~IiisGESGaGKTe~~K~il~yL~~~~~~~~~~~~~~~~~~~~~i~~~il~~npiLEAFGNAkT~~N~NSSRF 195 (789)
T d1kk8a2 116 VTDRENQSCLITGESGAGKTENTKKVIMYLAKVACAVKKKDEEASDKKEGSLEDQIIQANPVLEAYGNAKTTRNNNSSRF 195 (789)
T ss_dssp HHHTSEEEEEEECSTTSSHHHHHHHHHHHHHHHSCCCCCC--------CCCHHHHHHHHHHHHHHHHEECCSSCTTEESS
T ss_pred HHhCCCcEEEEEeCCCCCHHHHHHHHHHHHHHHhcccccccccccccccccHHHHHHHHhHHHHhccccCCCCCCccCCc
Confidence 999999999999999999999999999999987643 24589999999999999999999999999999
Q ss_pred ceeEEEEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccC-CCCCCCcccccCccCCCC
Q psy9090 340 VLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFL-SPGRKYRYLRADVTDDKL 418 (488)
Q Consensus 340 gk~~~~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l-~~~~~~~yl~~~~~~~~~ 418 (488)
|||++|+|+..|.|+||+|.+|||||||||. |.+||||||||||||+|++++ ++..+.+ ..+..|.|++++.
T Consensus 196 Gk~~~l~f~~~g~i~ga~i~~yLLEksRvv~-~~~gErnfHIFY~ll~G~~~~-~~~~~~l~~~~~~~~~l~~~~----- 268 (789)
T d1kk8a2 196 GKFIRIHFGPTGKIAGADIETYLLEKSRVTY-QQSAERNYHIFYQICSNAIPE-LNDVMLVTPDSGLYSFINQGC----- 268 (789)
T ss_dssp EEEEEEEECTTSSEEEEEEEEECCCGGGGTC-CCTTCCSBHHHHHHTSCSSGG-GHHHHTCCSCGGGCTTTCSSC-----
T ss_pred ceeEEEEECCCCCCccceeEEecCCCceeee-cccccchhHHHHHHHcCCCHH-HHHHhCCCCchhhhHhhcCCC-----
Confidence 9999999999999999999999999999995 999999999999999999874 4556665 4567899997652
Q ss_pred CCCCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCChhhh
Q psy9090 419 PKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVA 484 (488)
Q Consensus 419 ~~~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~~~~~ 484 (488)
...++.+|+++|+++..||+.|||+++|++.||+|||||||||||+|.+.+ ++.+.+.+.+.+
T Consensus 269 ---~~~~~~~d~~~f~~~~~al~~lg~~~~e~~~i~~ilaaILhLGni~F~~~~~~~~~~~~~~~~~ 332 (789)
T d1kk8a2 269 ---LTVDNIDDVEEFKLCDEAFDILGFTKEEKQSMFKCTASILHMGEMKFKQRPREEQAESDGTAEA 332 (789)
T ss_dssp ---SCBTTBCHHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHTTCCEEC----CCCEESCSHHH
T ss_pred ---cccCCcchHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHhccccceeeccCCccccccCChHHH
Confidence 235778999999999999999999999999999999999999999998654 556777776554
|
| >d2mysa2 c.37.1.9 (A:4-33,A:80-843) Myosin S1, motor domain {Chicken (Gallus gallus), pectoral muscle [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Chicken (Gallus gallus), pectoral muscle [TaxId: 9031]
Probab=100.00 E-value=5.2e-75 Score=632.93 Aligned_cols=284 Identities=27% Similarity=0.434 Sum_probs=262.3
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++|+.++++|+.||..+.+|||+|+++++|||++.+++|.++++..|.++...+.|||+|+||++||+.|
T Consensus 38 ~veDl~~L~~lnE~~vL~~L~~Ry~~~~iYT~~G~iLiavNPyk~l~ly~~~~~~~y~~~~~~~~pPHifaiA~~Ay~~m 117 (794)
T d2mysa2 38 KIEDMAMMTHLHEPAVLYNLKERYAAWMIYTYSGLFCVTVNPYKWLPVYNPKVVLAYRGKKRQEAPPHIFSISDNAYQFM 117 (794)
T ss_dssp SCSBGGGCSCCCHHHHHHHHHHTTTTTCCEEECSSCEEEECCSSCCGGGCTTHHHHTTTCCTTSSCSCHHHHHHHHHHHH
T ss_pred CcchhcCCCCCCHHHHHHHHHHHHcCCCceeeECCEEEEECCCCCCCCCCHHHHHHHcCCCCCCCCCcHHHHHHHHHHHH
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC------------CchhhhHhhhcchhhhhhhccccCCCCCCCcc
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG------------AAKVGEKIEKCVNVIHAIGNAGTPINQNSTRH 339 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g------------~~~~~e~i~~~~~~leafgna~t~~n~nssrf 339 (488)
.+.+++|+|||||||||||||++|.||+|++..+.+ ..++++.|..++|||||||||||++|||||||
T Consensus 118 ~~~~~~QsIiisGeSGaGKTe~~K~il~yL~~~~~~~~~~~~~~~~~~~~~i~~~i~~~npiLEAFGNAkT~~N~NSSRF 197 (794)
T d2mysa2 118 LTDRENQSILITGESGAGKTVNTKRVIQYFATIAASGEKKKEEQSGKMQGTLEDQIISANPLLEAFGNAKTVRNDNSSRF 197 (794)
T ss_dssp HHHTCCEEEEEEECTTSCHHHHHHHHHHHHHHHTCCCC-----------CCHHHHHHHHHHHHHHHHEECCSSCSSEECS
T ss_pred HHcCCCcEEEEEcCCCCCHHHHHHHHHHHHHHHcCCCCCccccccccccCcHHHHHHHhhhHHHHhcCCcccccCChhhh
Confidence 999999999999999999999999999999987532 24689999999999999999999999999999
Q ss_pred ceeEEEEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccC-CCCCCCcccccCccCCCC
Q psy9090 340 VLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFL-SPGRKYRYLRADVTDDKL 418 (488)
Q Consensus 340 gk~~~~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l-~~~~~~~yl~~~~~~~~~ 418 (488)
|||++|+|+..|.|+||+|.+|||||||||. |.+||||||||||||+|+++ ++++.+.+ .++..|+||+++..
T Consensus 198 gk~~~l~f~~~g~i~ga~i~~ylLEksRv~~-~~~gErnfHIFYqll~g~~~-~~~~~~~l~~~~~~y~yl~~~~~---- 271 (794)
T d2mysa2 198 GKFIRIHFGATGKLASADIETYLLEKSRVTF-QLPAERSYHIFYQIMSNKKP-ELIDMLLITTNPYDYHYVSEGEI---- 271 (794)
T ss_dssp EEEEEEEECSSSSEEECCEEEECCCGGGGTC-CCTTCCCBHHHHHHTTCSSH-HHHHHHTCCSCGGGCGGGCSSCC----
T ss_pred heeeeeEECCCCCEeeEEEEEEecCCceEEe-cCcccccHHHHHHHHcCCCH-HHHHHhccCCCHHHhhhcCCCCc----
Confidence 9999999999999999999999999999995 99999999999999999977 45666766 57899999987522
Q ss_pred CCCCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCChhhhc
Q psy9090 419 PKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVAA 485 (488)
Q Consensus 419 ~~~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~~~~~~ 485 (488)
..++.+|+++|+.+..||+.|||+++|+..||+|||||||||||+|.+.+ ++.+++.+.+.++
T Consensus 272 ----~~~~~~d~~~f~~~~~al~~lg~s~~e~~~i~~ilaaILhLGni~f~~~~~~~~~~~~~~~~~~ 335 (794)
T d2mysa2 272 ----TVPSIDDQEELMATDSAIDILGFSADEKTAIYKLTGAVMHYGNLKFKQKQREEQAEPDGTEVAD 335 (794)
T ss_dssp ----CCTTCCHHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHTTCCEEECTTSCCEEESCSSHHH
T ss_pred ----ccCCCChHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHhcccceeEeecCCcccccccchHHHH
Confidence 35678899999999999999999999999999999999999999998765 5567777776554
|
| >d1br2a2 c.37.1.9 (A:80-789) Myosin S1, motor domain {Chicken (Gallus gallus), pectoral muscle [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Chicken (Gallus gallus), pectoral muscle [TaxId: 9031]
Probab=100.00 E-value=1.4e-74 Score=624.03 Aligned_cols=283 Identities=28% Similarity=0.458 Sum_probs=258.6
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDM 271 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~ 271 (488)
.++|+..+..++|+.++++|+.||..+.+|||+|+++++|||++.+++|.++++..|.++.....|||+|+||++||+.|
T Consensus 6 ~veDl~~L~~l~e~~vl~~L~~Ry~~~~iYT~~G~iLiavNP~k~l~~y~~~~~~~y~~~~~~~~~PHif~vA~~Ay~~m 85 (710)
T d1br2a2 6 KVEDMAELTCLNEASVLHNLRERYFSGLIYTYSGLFCVVINPYKQLPIYSEKIIDMYKGKKRHEMPPHIYAIADTAYRSM 85 (710)
T ss_dssp TCSBTTSCSSCSHHHHHHHHHHHHHTTCCEEECSSSEEEECCSSCCTTCCHHHHHHTTTCCGGGSCCCHHHHHHHHHHHH
T ss_pred cCchhhcCCCCCHHHHHHHHHHHHcCCCceeeECCEEEEECCCCCCCCCCHHHHHHHcCCCCCCCCChHHHHHHHHHHHH
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC----------------CchhhhHhhhcchhhhhhhccccCCCCC
Q psy9090 272 MHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG----------------AAKVGEKIEKCVNVIHAIGNAGTPINQN 335 (488)
Q Consensus 272 ~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g----------------~~~~~e~i~~~~~~leafgna~t~~n~n 335 (488)
.+.+++|+|||||||||||||++|.||+|++..+.+ ..+++++|..++|+|||||||||++|+|
T Consensus 86 ~~~~~~Q~IiisGeSGaGKTe~~k~il~yL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~n~iLeaFGnakT~~N~N 165 (710)
T d1br2a2 86 LQDREDQSILCTGESGAGKTENTKKVIQYLAVVASSHKGKKDTSITQGPSFSYGELEKQLLQANPILEAFGNAKTVKNDN 165 (710)
T ss_dssp HHHTCCEEEEEECSTTSSHHHHHHHHHHHHHHHHC------------------CHHHHHHTTHHHHHHHHHEECCSSCTT
T ss_pred HHhCCCcEEEEEeCCCCCHHHHHHHHHHHHHHHhccCCCccccccccccccccchHHHHHHHHHHHHHHhCCCccCCCCC
Confidence 999999999999999999999999999999976532 1358999999999999999999999999
Q ss_pred CCccceeEEEEECCCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccC
Q psy9090 336 STRHVLYMQVTFGSSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTD 415 (488)
Q Consensus 336 ssrfgk~~~~~~~~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~ 415 (488)
|||||||++|+||..|.|+||+|.+|||||||||. |.+||||||||||||+|++. +++..++|.++.+|+||+++..
T Consensus 166 SSRfgk~~~l~f~~~g~i~ga~i~~ylLEksRv~~-~~~~ErnfHIFY~ll~G~~~-~~~~~l~l~~~~~y~yL~~~~~- 242 (710)
T d1br2a2 166 SSRFGKFIRINFDVTGYIVGANIETYLLEKSRAIR-QAKDERTFHIFYYLIAGASE-QMRNDLLLEGFNNYTFLSNGHV- 242 (710)
T ss_dssp EESSEEEEEEEECTTSCEEEEEEEEECCCGGGGTC-CCTTCCCBHHHHHHHHHCCH-HHHTTTTCCCTTTCTTSTTSCC-
T ss_pred CCCcceeeeeEEcCCCcEEEEEEEEecccCceeeE-ecCCCCcceeHHHHHcCCCH-HHHHhhhcCChhhceeccCCCc-
Confidence 99999999999999999999999999999999996 99999999999999999986 5678888999999999987532
Q ss_pred CCCCCCCCCCCCccHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCChhhh
Q psy9090 416 DKLPKGPRETPDTNVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVA 484 (488)
Q Consensus 416 ~~~~~~~~~~~~~d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~~~~~ 484 (488)
..++.+|+++|+++.+||..|||+++++..||+|||||||||||+|+... ++.+...+++.+
T Consensus 243 -------~~~~~~d~~~f~~l~~Al~~lGf~~~e~~~i~~vlaaILhLGni~F~~~~~~~~~~~~~~~~~ 305 (710)
T d1br2a2 243 -------PIPAQQDDEMFQETLEAMTIMGFTEEEQTSILRVVSSVLQLGNIVFKKERNTDQASMPDNTAA 305 (710)
T ss_dssp -------CCSSCCHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHCCCBCC----CCBCSCCHHH
T ss_pred -------ccCCccHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcceeeeeccccccccccChHHH
Confidence 25677899999999999999999999999999999999999999997654 444555555443
|
| >d1lkxa_ c.37.1.9 (A:) Myosin S1, motor domain {Dictyostelium discoideum, class-I myosin MyoE [TaxId: 44689]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Dictyostelium discoideum, class-I myosin MyoE [TaxId: 44689]
Probab=100.00 E-value=1.9e-73 Score=612.11 Aligned_cols=285 Identities=29% Similarity=0.480 Sum_probs=259.5
Q ss_pred hhhhhhhhccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q psy9090 193 VEDLAALETISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMM 272 (488)
Q Consensus 193 v~dl~~l~~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~ 272 (488)
++|+..|..++++.+++.|+.||..+.+||++|+++++|||++.+++|.++++..|.++...+.|||+|+||++||+.|.
T Consensus 2 v~Dl~~L~~l~e~~vl~~L~~Ry~~~~iYT~~G~iLiavNP~~~l~~y~~~~~~~y~~~~~~~~~PHif~iA~~Ay~~l~ 81 (684)
T d1lkxa_ 2 VPDFVLLNQITENAFIENLTMRHKSDNIYTYIGDVVISTNPFKNLNIYKESDIKAYNGRYKYEMPPHMYALANDAYRSMR 81 (684)
T ss_dssp CSSGGGCSSCSHHHHHHHHHHHHHTTCCEEESSSCEEEECCSSCCSCCSHHHHHHHSSCCGGGSCCCHHHHHHHHHHHHH
T ss_pred cccccCCCCCCHHHHHHHHHHHHcCCCceeeECCEEEEECCCCCCCCCCHHHHHHHcCCCCCCCCChHHHHHHHHHHHHH
Confidence 67999999999999999999999999999999999999999999999999999999999989999999999999999999
Q ss_pred hcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCc----hhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEEC
Q psy9090 273 HHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAA----KVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFG 348 (488)
Q Consensus 273 ~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~----~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~ 348 (488)
+.+++|+|+|||||||||||++|.||+|++..+.+.. ++++.|..++|+|||||||||++|+||||||||++|+|+
T Consensus 82 ~~~~~QsIiisGeSGsGKTe~~k~il~yL~~~s~~~~~~~~~i~~~i~~~n~iLeaFGNAkT~~N~NSSRfgk~~~l~f~ 161 (684)
T d1lkxa_ 82 QSQENQCVIISGESGAGKTEASKKIMQFLTFVSSNQSPNGERISKMLLDSNPLLEAFGNAKTLRNDNSSRFGKYMEMQFN 161 (684)
T ss_dssp HHCCCEEEEEECSTTSSHHHHHHHHHHHHHHHSCSSCHHHHHHHHHHHHHHHHHHHHHBBCCSSCSSCBCSEEEEEEEEC
T ss_pred HcCCCeEEEEEcCCCCCHHHHHHHHHHHHHHHcCCCCCccchHHHHHHhhhhhhhhcccccccCCCCcCceeeEEEEEec
Confidence 9999999999999999999999999999998876543 489999999999999999999999999999999999999
Q ss_pred CCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCc
Q psy9090 349 SSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDT 428 (488)
Q Consensus 349 ~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~ 428 (488)
..|.|+||+|.+|||||||||. |.+|||||||||||++|++.+++.+.+.+.++..|+||+++.+ ...++.+
T Consensus 162 ~~g~i~ga~i~~ylLEksRv~~-~~~gErnfHIFYqll~g~~~~~~~~l~~~~~~~~y~~l~~~~~-------~~~~~~d 233 (684)
T d1lkxa_ 162 AVGSPIGGKITNYLLEKSRVVG-RTQGERSFHIFYQMLKGLSQSKLDELGLTPNAPAYEYLKKSGC-------FDVSTID 233 (684)
T ss_dssp TTCCEEEEEEEEECCCGGGGTC-CCTTCCCBHHHHHHHTTSCHHHHHHHTCCSCGGGSHHHHHTTC-------CCCTTCC
T ss_pred CCCcEeeEEEEEeeeccccccc-ccccccchhhHHHHHhCCCHHHHHhhccCCccchhhhhcCCCC-------ccCCCcC
Confidence 9999999999999999999995 9999999999999999998754433345678899999987643 2356788
Q ss_pred cHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-----CcccccCChhhhc
Q psy9090 429 NVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-----ENTAELANPEVAA 485 (488)
Q Consensus 429 d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-----~~~~~~~~~~~~~ 485 (488)
|+++|+++..||+.|||+++|+..||+|||||||||||+|.... .+.+++.+++.++
T Consensus 234 d~~~f~~l~~al~~lg~~~~e~~~i~~ilaaILhLGni~F~~~~~~~~~~~~~~~~~~~~l~ 295 (684)
T d1lkxa_ 234 DSGEFKIIVKAMETLGLKESDQNSIWRILAAILHIGNITFAEAAEQRTGTTTVKVSDTKSLA 295 (684)
T ss_dssp HHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHTTCCEEEETTC----CEEEESSHHHHH
T ss_pred hHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHhhcceeEeeccccccCcceeecCCHHHHH
Confidence 99999999999999999999999999999999999999997543 3345666665543
|
| >d1w7ja2 c.37.1.9 (A:63-792) Myosin S1, motor domain {Chicken (Gallus gallus), Va isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Motor proteins domain: Myosin S1, motor domain species: Chicken (Gallus gallus), Va isoform [TaxId: 9031]
Probab=100.00 E-value=4.5e-73 Score=615.29 Aligned_cols=284 Identities=30% Similarity=0.416 Sum_probs=261.4
Q ss_pred hhhhhhhhhccchhhHHHHHHhhhc-cCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHH
Q psy9090 192 HVEDLAALETISEDNIVQELEERHN-SKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQD 270 (488)
Q Consensus 192 ~v~dl~~l~~l~e~~l~~~L~~r~~-~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~ 270 (488)
.++|+..+..++++.++++|+.||. .+.+||++|+++++|||++.+++|.++.+..|.++...+.|||+|+||++||+.
T Consensus 8 ~~~Dl~~L~~l~e~~vl~~L~~Ry~~~~~iYT~~G~iLiaiNP~~~~~~y~~~~~~~y~~~~~~~~~PHif~vA~~Ay~~ 87 (730)
T d1w7ja2 8 GENDLTALSYLHEPAVLHNLKVRFIDSKLIYTYCGIVLVAINPYEQLPIYGEDIINAYSGQNMGDMDPHIFAVAEEAYKQ 87 (730)
T ss_dssp TCSSSTTCSCCSHHHHHHHHHHHHHHHCCCEEEETTEEEEECCSSCCSCCSHHHHHHHTTCCGGGSCCCHHHHHHHHHHH
T ss_pred CcchhhcCCCCCHHHHHHHHHHHhccCCceeeeECCEEEEECCCCCCCCCCHHHHHHHcCCCcCCCCCcHHHHHHHHHHH
Confidence 4789999999999999999999996 566999999999999999999999999999999999899999999999999999
Q ss_pred HHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcC--CCchhhhHhhhcchhhhhhhccccCCCCCCCccceeEEEEEC
Q psy9090 271 MMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQ--GAAKVGEKIEKCVNVIHAIGNAGTPINQNSTRHVLYMQVTFG 348 (488)
Q Consensus 271 ~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~--g~~~~~e~i~~~~~~leafgna~t~~n~nssrfgk~~~~~~~ 348 (488)
|...+++|+|+|||||||||||++|.||+|++..+. ....+++.|..++|||||||||||++||||||||||++|+|+
T Consensus 88 l~~~~~~Q~IiisGeSGsGKTe~~k~il~~l~~~s~~~~~~~~~~~i~~~n~ileaFGnAkT~~N~NSSRfgk~~~l~f~ 167 (730)
T d1w7ja2 88 MARDERNQSIIVSGESGAGKTVSAKYAMRYFATVSGSASEANVEEKVLASNPIMESIGNAKTTRNDNSSRFGKYIEIGFD 167 (730)
T ss_dssp HHHHTCCEEEEEECSTTSSHHHHHHHHHHHHHHHTCCSSSSCHHHHHHHHHHHHHHHHEECCSSCTTEECSEEEEEEEEC
T ss_pred HHHhCCCeEEEEEeCCCCCHHHHHHHHHHHHHHHcCCCccccHHHHHHHHHHHHHHhcccccCCCCCcccceeeeeeeec
Confidence 999999999999999999999999999999998754 356799999999999999999999999999999999999999
Q ss_pred CCCceeceEEeeeecccceecccCCCCCcchHHHHHHHhhcchhhhhhhccCCCCCCCcccccCccCCCCCCCCCCCCCc
Q psy9090 349 SSGKLSGAIFWLYQLEKWRVTGNRDPLQANFHIFYYFYDAMEAAGELDKYFLSPGRKYRYLRADVTDDKLPKGPRETPDT 428 (488)
Q Consensus 349 ~~~~~~~~~~~~yllek~rv~~~~~~~ernfHiFY~l~~g~~~~~~~~~~~l~~~~~~~yl~~~~~~~~~~~~~~~~~~~ 428 (488)
..|.|+||+|.+|||||||||. |.+||||||||||||+|++. ++++.+.+.++..|+||+++.+ ...++.+
T Consensus 168 ~~g~i~ga~i~~ylLEksRv~~-~~~~ErnfHIFY~ll~g~~~-~~~~~l~l~~~~~~~yl~~~~~-------~~~~~~~ 238 (730)
T d1w7ja2 168 KRYRIIGANMRTYLLEKSRVVF-QAEEERNYHIFYQLCASAAL-PEFKTLRLGNANYFHYTKQGGS-------PVIDGID 238 (730)
T ss_dssp TTSCEEEEEEEEECCCGGGGTC-CCTTCCSBHHHHHHHHTTTS-GGGGGGCCCCTTTSHHHHTTSC-------CCCTTCC
T ss_pred CCCCEEEEEEEEccccccceee-ecCCCCcchhHHHHHcCCCH-HHHHHhCCCChhhhhhhccCCC-------ceeCCcc
Confidence 9999999999999999999996 99999999999999999976 5677888999999999987632 2367888
Q ss_pred cHHHHHHHHHHhhhcCCCHHHHHHHHHHHHHHHHhcCceEeecC-CcccccCChhhh
Q psy9090 429 NVAKFQEIYQNLIDIEFDDIQMEIFSNVLAAILLIGEVEFESSA-ENTAELANPEVA 484 (488)
Q Consensus 429 d~~~~~~~~~a~~~lgf~~~~~~~i~~ilaaiLhlGni~F~~~~-~~~~~~~~~~~~ 484 (488)
|+++|+++.+||+.|||+++|+..||+|||||||||||+|.+.+ ++.+.+.+.+.+
T Consensus 239 d~~~f~~~~~al~~lG~~~ee~~~i~~iLaaILhLGni~f~~~~~~~~~~~~~~~~l 295 (730)
T d1w7ja2 239 DAKEMVNTRQACTLLGISDSYQMGIFRILAGILHLGNVEFASRDSDSCAIPPKHDPL 295 (730)
T ss_dssp HHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHHTCCCEEEETTEEECCTTCHHH
T ss_pred hHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHheeceeEEEecCCcceeecCCHHHH
Confidence 99999999999999999999999999999999999999998765 444555555544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=316.99 Aligned_cols=163 Identities=40% Similarity=0.776 Sum_probs=147.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++............+||+.|+|||++.+
T Consensus 113 l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-- 190 (293)
T d1yhwa1 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-- 190 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcC--
Confidence 689999999999999999999999999999999999999999999999999877655455567789999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..|+.++|||||||++|+|++|.+||.+.+....+..+.....+....+..+|+.+++||.+||.+||.+|||++|+
T Consensus 191 ---~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 267 (293)
T d1yhwa1 191 ---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (293)
T ss_dssp ---SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ---CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 67899999999999999999999999998888877777776656555667789999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
|+||||+.
T Consensus 268 l~Hp~~~~ 275 (293)
T d1yhwa1 268 LQHQFLKI 275 (293)
T ss_dssp TTCGGGGG
T ss_pred hcCHhhCC
Confidence 99999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=316.43 Aligned_cols=168 Identities=41% Similarity=0.880 Sum_probs=150.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..........+..||+.|+|||++....
T Consensus 107 l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 186 (288)
T d2jfla1 107 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186 (288)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcc
Confidence 68999999999999999999999999999999999999999999999999976654434445678999999999997644
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
.....|+.++|||||||++|+|++|++||.+.+..+.+.++.....+....+..+|+++++||.+||+.||++|||++++
T Consensus 187 ~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~el 266 (288)
T d2jfla1 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266 (288)
T ss_dssp TTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 44467899999999999999999999999998888888888887766666677899999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
++||||+.
T Consensus 267 l~hp~~~~ 274 (288)
T d2jfla1 267 LQHPFVTV 274 (288)
T ss_dssp TTSGGGCC
T ss_pred hcCcccCC
Confidence 99999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-39 Score=319.80 Aligned_cols=177 Identities=30% Similarity=0.516 Sum_probs=155.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
++|+.++.+++||+.||+|||++|||||||||+|||++.+|.+||+|||+++............+||+.|+|||++.+
T Consensus 102 ~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~-- 179 (337)
T d1o6la_ 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-- 179 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS--
T ss_pred CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccC--
Confidence 589999999999999999999999999999999999999999999999999876554455667899999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
.+|+.++|||||||++|+|++|++||.+.+.......+..... ..|..+|+++++||.+||++||.+|++
T Consensus 180 ---~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~ 253 (337)
T d1o6la_ 180 ---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253 (337)
T ss_dssp ---SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred ---CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC---CCCccCCHHHHHHHHhhccCCchhhcccccc
Confidence 6799999999999999999999999999988777776666542 235678999999999999999999994
Q ss_pred -HHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 157 -MSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
++++++||||+.++|+.+......+++.+
T Consensus 254 ~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P 283 (337)
T d1o6la_ 254 DAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283 (337)
T ss_dssp THHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred cHHHHHcCcccccCCHHHHHhCCCCCCCCC
Confidence 89999999999999887655555555443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-39 Score=306.66 Aligned_cols=158 Identities=34% Similarity=0.598 Sum_probs=140.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......||+.|+|||++.+
T Consensus 103 l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--~~~~~~~Gt~~Y~APE~~~~-- 178 (263)
T d2j4za1 103 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEG-- 178 (263)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--CCCEETTEEGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC--CcccccCCCCcccCHHHHcC--
Confidence 68999999999999999999999999999999999999999999999999976543 23456689999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
..|+.++|||||||++|+|++|++||.+.+......++..... ..+..+|+++++||.+||.+||++|||++++
T Consensus 179 ---~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dp~~R~t~~ei 252 (263)
T d2j4za1 179 ---RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---TFPDFVTEGARDLISRLLKHNPSQRPMLREV 252 (263)
T ss_dssp ---CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 6789999999999999999999999999887777666665432 2356789999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
|+||||++
T Consensus 253 l~hp~~~~ 260 (263)
T d2j4za1 253 LEHPWITA 260 (263)
T ss_dssp HTCHHHHH
T ss_pred HcCcCcCC
Confidence 99999963
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-39 Score=307.79 Aligned_cols=163 Identities=21% Similarity=0.400 Sum_probs=137.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .......+||+.|+|||++.+
T Consensus 100 l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 179 (271)
T d1nvra_ 100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179 (271)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC
Confidence 689999999999999999999999999999999999999999999999999865432 123456789999999999976
Q ss_pred cccCCCCC-CCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGY-DNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~-~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..+ +.++||||+||++|+|++|++||.........................+|+++++||.+||..||++|||+
T Consensus 180 -----~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (271)
T d1nvra_ 180 -----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 254 (271)
T ss_dssp -----SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred -----CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 444 67899999999999999999999776554444444444333333445779999999999999999999999
Q ss_pred HHHhcCcCCCC
Q psy9090 158 SELLEHPFITS 168 (488)
Q Consensus 158 ~ell~hp~f~~ 168 (488)
+++++||||+.
T Consensus 255 ~eil~hpwf~~ 265 (271)
T d1nvra_ 255 PDIKKDRWYNK 265 (271)
T ss_dssp HHHTTCTTTTC
T ss_pred HHHhcCHhhCc
Confidence 99999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=308.59 Aligned_cols=169 Identities=27% Similarity=0.470 Sum_probs=145.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++..... .....+.+||+.|+|||++.+
T Consensus 105 l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 184 (288)
T d1uu3a_ 105 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184 (288)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeecc
Confidence 689999999999999999999999999999999999999999999999999876432 123345689999999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..|+.++|||||||++|+|++|.+||.+.+......++..... ..+..+|+++++||.+||..||.+|||++
T Consensus 185 -----~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~ 256 (288)
T d1uu3a_ 185 -----KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---DFPEKFFPKARDLVEKLLVLDATKRLGCE 256 (288)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---CCCTTCCHHHHHHHHTTSCSSGGGSTTSG
T ss_pred -----CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC---CCCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 6789999999999999999999999999888777777766532 23567899999999999999999999998
Q ss_pred H------HhcCcCCCCCCCCccccc
Q psy9090 159 E------LLEHPFITSLPENDLHLS 177 (488)
Q Consensus 159 e------ll~hp~f~~~~~~~~~~~ 177 (488)
| +++||||++++|+.+...
T Consensus 257 e~~~~~~i~~Hpff~~i~w~~l~~~ 281 (288)
T d1uu3a_ 257 EMEGYGPLKAHPFFESVTWENLHQQ 281 (288)
T ss_dssp GGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred HHcCCHHHHcCCccCCCCHHHhhcC
Confidence 7 588999999999876543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-38 Score=316.04 Aligned_cols=174 Identities=26% Similarity=0.493 Sum_probs=152.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.... ...+..||+.|+|||++.+
T Consensus 138 l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~~~~-- 212 (350)
T d1rdqe_ 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILS-- 212 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---ccccccCccccCCHHHHcC--
Confidence 68999999999999999999999999999999999999999999999999987653 2346789999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..|+.++|||||||++|+|+||++||.+.+......++...... .+..+|+++.+||++||..||.+|+
T Consensus 213 ---~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~ 286 (350)
T d1rdqe_ 213 ---KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKN 286 (350)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTT
T ss_pred ---CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC---CCccCCHHHHHHHHHHhhhCHHhccccccc
Confidence 67899999999999999999999999998887777777765432 3567899999999999999999995
Q ss_pred CHHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
|++++++||||++++|..+......+++.+
T Consensus 287 t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p 316 (350)
T d1rdqe_ 287 GVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316 (350)
T ss_dssp TTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred cHHHHHcCccccCCCHHHHHhcCCCcCccC
Confidence 899999999999999987765555444443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-38 Score=316.78 Aligned_cols=179 Identities=26% Similarity=0.408 Sum_probs=147.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++..... .....+||+.|+|||++..+
T Consensus 104 ~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~- 180 (364)
T d1omwa3 104 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKG- 180 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTT-
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcC-
Confidence 578999999999999999999999999999999999999999999999999876542 34566899999999999642
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY---- 156 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---- 156 (488)
..|+.++|||||||++|+|+||+.||.+....................+..+|+++++||.+||..||.+|||
T Consensus 181 ---~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~ 257 (364)
T d1omwa3 181 ---VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGR 257 (364)
T ss_dssp ---CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSS
T ss_pred ---CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCccc
Confidence 5689999999999999999999999976543322221222222233345678999999999999999999999
Q ss_pred -HHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 157 -MSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 157 -~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
++++++||||++++|..+......+++.+
T Consensus 258 ~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p 287 (364)
T d1omwa3 258 GAQEVKESPFFRSLDWQMVFLQKYPPPLIP 287 (364)
T ss_dssp THHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CHHHHHcCccccCCCHHHHhcCCCCcCcCC
Confidence 79999999999999987766665555544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-38 Score=309.82 Aligned_cols=173 Identities=24% Similarity=0.496 Sum_probs=151.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... ...+.+||+.|+|||++.+
T Consensus 101 ~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~l~~-- 175 (316)
T d1fota_ 101 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVST-- 175 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTT--
T ss_pred ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc---ccccccCcccccCHHHHcC--
Confidence 46889999999999999999999999999999999999999999999999987643 3446789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-----
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP----- 155 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----- 155 (488)
..|+.++|||||||++|+|++|+.||.+.+......++...... .+..+|++++++|.+||.+||.+|+
T Consensus 176 ---~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~L~~dp~~R~~~~r~ 249 (316)
T d1fota_ 176 ---KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---FPPFFNEDVKDLLSRLITRDLSQRLGNLQN 249 (316)
T ss_dssp ---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTT
T ss_pred ---CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHHhhhCHHhccccchh
Confidence 67899999999999999999999999999888888887765432 3567899999999999999999996
Q ss_pred CHHHHhcCcCCCCCCCCcccccccccccc
Q psy9090 156 YMSELLEHPFITSLPENDLHLSTVNCQYK 184 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~~~~~~~~~~~ 184 (488)
|++++++||||+++.|+.+......+++.
T Consensus 250 t~~~il~Hp~f~~i~~~~l~~~~~~~p~~ 278 (316)
T d1fota_ 250 GTEDVKNHPWFKEVVWEKLLSRNIETPYE 278 (316)
T ss_dssp TTHHHHTSGGGSSCCHHHHHTTCSCCSCC
T ss_pred hHHHHHcCcccccCCHHHHHhCCCCcCCC
Confidence 89999999999999998765555544443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-38 Score=302.02 Aligned_cols=159 Identities=28% Similarity=0.543 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCCEEEc-cCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH--VIHRDLRGSNVLLT-KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
+++.+++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++.... ....+.+||+.|+|||++.
T Consensus 109 ~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~ 186 (270)
T d1t4ha_ 109 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYE 186 (270)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGG
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--CccCCcccCccccCHHHhC
Confidence 578999999999999999999999 99999999999996 578999999999975433 3345678999999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|+|++|+.||.+......+.+.+.....+...+...++++++||.+||..||++|||+
T Consensus 187 ------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~ 260 (270)
T d1t4ha_ 187 ------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSI 260 (270)
T ss_dssp ------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred ------CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCH
Confidence 35899999999999999999999999877665555555544333333445678999999999999999999999
Q ss_pred HHHhcCcCCC
Q psy9090 158 SELLEHPFIT 167 (488)
Q Consensus 158 ~ell~hp~f~ 167 (488)
+|+|+||||+
T Consensus 261 ~ell~Hp~fk 270 (270)
T d1t4ha_ 261 KDLLNHAFFQ 270 (270)
T ss_dssp HHHHTSGGGC
T ss_pred HHHhCCcccC
Confidence 9999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-38 Score=303.42 Aligned_cols=159 Identities=30% Similarity=0.506 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC-----CeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENH-----VIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~g-----ivHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~ 75 (488)
|++.+++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.............||+.|+|||+
T Consensus 106 l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~ 185 (269)
T d2java1 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHH
Confidence 578999999999999999999976 999999999999999999999999999877654445566789999999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
+.+ ..|+.++|||||||++|+|+||++||.+.+......++.....+. .+..+|+++++||.+||..||.+||
T Consensus 186 l~~-----~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~li~~~L~~dp~~Rp 258 (269)
T d2java1 186 MNR-----MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--IPYRYSDELNEIITRMLNLKDYHRP 258 (269)
T ss_dssp HTT-----CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HcC-----CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--CCcccCHHHHHHHHHHcCCChhHCc
Confidence 976 678999999999999999999999999988877777777665443 3567899999999999999999999
Q ss_pred CHHHHhcCcCC
Q psy9090 156 YMSELLEHPFI 166 (488)
Q Consensus 156 s~~ell~hp~f 166 (488)
|++|+++|||+
T Consensus 259 s~~ell~hp~i 269 (269)
T d2java1 259 SVEEILENPLI 269 (269)
T ss_dssp CHHHHHTSTTC
T ss_pred CHHHHHhCCcC
Confidence 99999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-37 Score=305.53 Aligned_cols=161 Identities=39% Similarity=0.802 Sum_probs=143.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.... .....||+.|+|||++.+..
T Consensus 112 l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~ 187 (309)
T d1u5ra_ 112 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMD 187 (309)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----CCccccCccccCHHHHhccC
Confidence 68999999999999999999999999999999999999999999999999976543 34568999999999997532
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSEL 160 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 160 (488)
...|+.++|||||||++|+|++|.+||.+......+.++.....+.. .+..+|+.+++||.+||..||.+|||++++
T Consensus 188 --~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 264 (309)
T d1u5ra_ 188 --EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264 (309)
T ss_dssp --SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 14689999999999999999999999999888888888877665543 356789999999999999999999999999
Q ss_pred hcCcCCCC
Q psy9090 161 LEHPFITS 168 (488)
Q Consensus 161 l~hp~f~~ 168 (488)
|+||||..
T Consensus 265 l~Hp~~~~ 272 (309)
T d1u5ra_ 265 LKHRFVLR 272 (309)
T ss_dssp TTCHHHHS
T ss_pred HhCHHhcC
Confidence 99999965
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-38 Score=307.46 Aligned_cols=176 Identities=28% Similarity=0.555 Sum_probs=152.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 100 ~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 177 (320)
T d1xjda_ 100 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-- 177 (320)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcC--
Confidence 578999999999999999999999999999999999999999999999999876655455566789999999999987
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH-H
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS-E 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~-e 159 (488)
..|+.++||||+||++|+|++|+.||.+.+......++....+ ..+..+|+++++||.+||..||.+|||+. +
T Consensus 178 ---~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~ 251 (320)
T d1xjda_ 178 ---QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGD 251 (320)
T ss_dssp ---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred ---CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCccCCHHHHHHHHHhcccCCCCCcCHHHH
Confidence 6799999999999999999999999999888777777765532 23567899999999999999999999995 8
Q ss_pred HhcCcCCCCCCCCcccccccccccc
Q psy9090 160 LLEHPFITSLPENDLHLSTVNCQYK 184 (488)
Q Consensus 160 ll~hp~f~~~~~~~~~~~~~~~~~~ 184 (488)
+++||||++++|+.+......+++.
T Consensus 252 l~~hpff~~~~~~~l~~~~~~pp~~ 276 (320)
T d1xjda_ 252 IRQHPLFREINWEELERKEIDPPFR 276 (320)
T ss_dssp GGGSGGGTTCCHHHHHTTCSCC---
T ss_pred HHhCchhccCCHHHHHhcCCCCCCC
Confidence 9999999999887765555544443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-37 Score=300.26 Aligned_cols=165 Identities=27% Similarity=0.478 Sum_probs=141.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 113 ~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~-- 189 (305)
T d1blxa_ 113 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ-- 189 (305)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc-ccCCCcccChhhcCcchhcC--
Confidence 578999999999999999999999999999999999999999999999998765443 34556789999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CC---------------------CCCCCCCCcC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PP---------------------PGLYRASNWS 136 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~---------------------~~~~~~~~~s 136 (488)
.+|+.++||||+||++|+|++|++||.+.+....+.++... +. +.......++
T Consensus 190 ---~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 266 (305)
T d1blxa_ 190 ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 266 (305)
T ss_dssp ---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC
T ss_pred ---CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCC
Confidence 67999999999999999999999999998877766665431 00 0001134568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 137 QHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 137 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
+.+++||.+||.+||++|||++|+|+||||+++..
T Consensus 267 ~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 267 ELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 89999999999999999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-37 Score=300.99 Aligned_cols=163 Identities=29% Similarity=0.518 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc---cCCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT---KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
|++.+++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+++..... ....+.+||+.|+|||++.
T Consensus 104 l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~ 182 (307)
T d1a06a_ 104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLA 182 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------------CTTSCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHc
Confidence 68999999999999999999999999999999999995 5789999999999866443 3445678999999999998
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..|+.++|||||||++|+|++|.+||.+.........+...... ..+.+..+|+++++||.+||.+||++|||
T Consensus 183 ~-----~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 257 (307)
T d1a06a_ 183 Q-----KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT 257 (307)
T ss_dssp T-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred C-----CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcC
Confidence 6 67899999999999999999999999998887777777765432 22334678999999999999999999999
Q ss_pred HHHHhcCcCCCCC
Q psy9090 157 MSELLEHPFITSL 169 (488)
Q Consensus 157 ~~ell~hp~f~~~ 169 (488)
++|+++||||++.
T Consensus 258 ~~eil~hp~~~~~ 270 (307)
T d1a06a_ 258 CEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHSTTTTSS
T ss_pred HHHHhcCHhhCCC
Confidence 9999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=307.85 Aligned_cols=166 Identities=30% Similarity=0.641 Sum_probs=133.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|++.+++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.... ....+.+||+.|+|||++.+
T Consensus 101 l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~GT~~Y~APEvl~~- 177 (322)
T d1s9ja_ 101 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQG- 177 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--HTC---CCSSCCCCHHHHHC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--CccccccCCccccCchHHcC-
Confidence 5789999999999999999997 5999999999999999999999999999986543 23456789999999999987
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHH-----------------------------------------
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRAL----------------------------------------- 118 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~----------------------------------------- 118 (488)
..|+.++||||+||++|+|++|+.||.+.+.....
T Consensus 178 ----~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (322)
T d1s9ja_ 178 ----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFEL 253 (322)
T ss_dssp ----SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHH
T ss_pred ----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHH
Confidence 67999999999999999999999999765432110
Q ss_pred -HHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCCcc
Q psy9090 119 -FQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPENDL 174 (488)
Q Consensus 119 -~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~ 174 (488)
..+....++ ......+|.++++||.+||..||.+|||++|+|+||||++.+++..
T Consensus 254 ~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 254 LDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp HHHHHTSCCC-CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred HhhhhccCCc-cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccc
Confidence 111111111 1122346899999999999999999999999999999987655433
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-37 Score=300.05 Aligned_cols=167 Identities=24% Similarity=0.389 Sum_probs=141.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+.|+|||++...
T Consensus 97 l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 175 (299)
T d1ua2a_ 97 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA- 175 (299)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccC-
Confidence 5778999999999999999999999999999999999999999999999998776554555667899999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCCCCC----------------------CCCCc
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPPGLY----------------------RASNW 135 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~~----------------------~~~~~ 135 (488)
..|+.++||||+||++|+|++|.+||.+....+.+.++... +..... .....
T Consensus 176 ---~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (299)
T d1ua2a_ 176 ---RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 252 (299)
T ss_dssp ---SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTC
T ss_pred ---CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccC
Confidence 56899999999999999999999999998887776666531 110000 01245
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 136 SQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 136 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
++++++||.+||..||++|||++|+|+||||++.+.
T Consensus 253 s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 253 GDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 789999999999999999999999999999997654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-36 Score=303.20 Aligned_cols=163 Identities=28% Similarity=0.444 Sum_probs=143.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc--cCCcEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~--~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|+|.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 124 l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~ 202 (352)
T d1koba_ 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDR 202 (352)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcC
Confidence 58999999999999999999999999999999999998 5789999999999876543 34456789999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|+|+||.+||.+.+....+.++.....+ +...+..+|+++++||.+||..||.+|||+
T Consensus 203 -----~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~ 277 (352)
T d1koba_ 203 -----EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277 (352)
T ss_dssp -----CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred -----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCH
Confidence 67899999999999999999999999998888877777765432 223346789999999999999999999999
Q ss_pred HHHhcCcCCCCC
Q psy9090 158 SELLEHPFITSL 169 (488)
Q Consensus 158 ~ell~hp~f~~~ 169 (488)
.++|+||||+..
T Consensus 278 ~eil~Hp~~~~~ 289 (352)
T d1koba_ 278 HDALEHPWLKGD 289 (352)
T ss_dssp HHHHTSTTTSSC
T ss_pred HHHhcCHhhCCC
Confidence 999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-36 Score=302.91 Aligned_cols=166 Identities=27% Similarity=0.436 Sum_probs=143.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEc--cCCcEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLT--KDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~--~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.+++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+++..... ....+..||+.|+|||++.+
T Consensus 121 l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~ 199 (350)
T d1koaa2 121 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEG 199 (350)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-cccceecCcccccCHHHHcC
Confidence 58999999999999999999999999999999999996 4678999999999876543 34456789999999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP-GLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|+|++|..||.+.+....+.++...... .......+|+++++||.+||..||++|||+
T Consensus 200 -----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 274 (350)
T d1koaa2 200 -----KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 274 (350)
T ss_dssp -----CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred -----CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCH
Confidence 67899999999999999999999999998887777777665432 222234679999999999999999999999
Q ss_pred HHHhcCcCCCCCCCC
Q psy9090 158 SELLEHPFITSLPEN 172 (488)
Q Consensus 158 ~ell~hp~f~~~~~~ 172 (488)
+++|+||||+...+.
T Consensus 275 ~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 275 HQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHSTTTSCTTCC
T ss_pred HHHhcCcccCCCCCC
Confidence 999999999876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-36 Score=291.21 Aligned_cols=168 Identities=30% Similarity=0.550 Sum_probs=144.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+.+..
T Consensus 107 l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~ 185 (277)
T d1phka_ 107 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSM 185 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCC-CceeeeeccCCCCCHHHhhccc
Confidence 689999999999999999999999999999999999999999999999999876554 3445678999999999997532
Q ss_pred c-CCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 81 K-EVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 81 ~-~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
. ....++.++||||+||++|+|++|++||.+.+.......+..... ........+|+++++||.+||++||.+|||++
T Consensus 186 ~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ 265 (277)
T d1phka_ 186 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265 (277)
T ss_dssp CTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred cccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 1 224578999999999999999999999999988777777776543 23333457899999999999999999999999
Q ss_pred HHhcCcCCCCC
Q psy9090 159 ELLEHPFITSL 169 (488)
Q Consensus 159 ell~hp~f~~~ 169 (488)
++++||||+..
T Consensus 266 eil~h~~~~~~ 276 (277)
T d1phka_ 266 EALAHPFFQQY 276 (277)
T ss_dssp HHTTSGGGCTT
T ss_pred HHHcCHHHHHh
Confidence 99999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=295.54 Aligned_cols=168 Identities=28% Similarity=0.470 Sum_probs=141.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC----cEEEEecCCccccccccCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG----EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l 76 (488)
|++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ....+..||+.|+|||++
T Consensus 110 l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~ 188 (293)
T d1jksa_ 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIV 188 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS-CBCSCCCCCGGGCCHHHH
T ss_pred cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCC-ccccccCCCCcccCHHHH
Confidence 68999999999999999999999999999999999998776 4999999999876543 344566899999999999
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.+ ..|+.++||||+||++|+|++|..||.+.+.......+....... ...+..+|+.+++||++||..||++||
T Consensus 189 ~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 263 (293)
T d1jksa_ 189 NY-----EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 263 (293)
T ss_dssp TT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred cC-----CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCc
Confidence 76 678999999999999999999999999988877777776643321 112356799999999999999999999
Q ss_pred CHHHHhcCcCCCCCCCCcc
Q psy9090 156 YMSELLEHPFITSLPENDL 174 (488)
Q Consensus 156 s~~ell~hp~f~~~~~~~~ 174 (488)
|++++++||||+..+++..
T Consensus 264 s~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 264 TIQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp CHHHHHHSTTTCC------
T ss_pred CHHHHhcCcccCCCChhHh
Confidence 9999999999998776543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-35 Score=290.32 Aligned_cols=167 Identities=25% Similarity=0.461 Sum_probs=141.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.............||+.|+|||++...
T Consensus 99 l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~- 177 (298)
T d1gz8a_ 99 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC- 177 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTC-
T ss_pred CCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccc-
Confidence 6899999999999999999999999999999999999999999999999998766554556667899999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CCCCCC-----------------------CCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PPPGLY-----------------------RASN 134 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~~-----------------------~~~~ 134 (488)
..++.++|+||+||++|+|++|+.||.+.+....+.++... +..... ....
T Consensus 178 ---~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T d1gz8a_ 178 ---KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254 (298)
T ss_dssp ---SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTT
T ss_pred ---cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccC
Confidence 34678999999999999999999999988877766665431 100000 0124
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
+|+++++||.+||.+||++|||++|+++||||++++.
T Consensus 255 ~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 255 LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 5789999999999999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-36 Score=287.73 Aligned_cols=154 Identities=26% Similarity=0.497 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-CCcEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|++++++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.... ....+..||+.|+|||++.+.
T Consensus 107 l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~ 184 (273)
T d1xwsa_ 107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYH 184 (273)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc--ccccccccCCCcCCHHHHcCC
Confidence 689999999999999999999999999999999999985 47999999999976543 334567899999999999762
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|||||||++|+|++|+.||...+ .+.+.. ...+..+|+++++||.+||..||++|||++|
T Consensus 185 ----~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 251 (273)
T d1xwsa_ 185 ----RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ---VFFRQRVSSECQHLIRWCLALRPSDRPTFEE 251 (273)
T ss_dssp ----CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc---cCCCCCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 234677999999999999999999997632 233332 2234578999999999999999999999999
Q ss_pred HhcCcCCCCC
Q psy9090 160 LLEHPFITSL 169 (488)
Q Consensus 160 ll~hp~f~~~ 169 (488)
+++||||+++
T Consensus 252 il~hp~~~~~ 261 (273)
T d1xwsa_ 252 IQNHPWMQDV 261 (273)
T ss_dssp HHTSGGGSSC
T ss_pred HhcCHhhCCC
Confidence 9999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=298.17 Aligned_cols=162 Identities=28% Similarity=0.471 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc---CCcEEEEecCCccccccccCccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---DGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~ 77 (488)
|+|.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+++..... ......+||+.|+|||++.
T Consensus 108 l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 186 (335)
T d2ozaa1 108 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLG 186 (335)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC-CccccccCCcccCCcHHHc
Confidence 578999999999999999999999999999999999985 567999999999876543 3445678999999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCC---C--CCCCcCHHHHHHHHHhcccCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGL---Y--RASNWSQHYVDFIAECLEKNPE 152 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~--~~~~~s~~~~~li~~~L~~dP~ 152 (488)
+ ..|+.++|||||||++|+|+||++||.+.........+........ + ....+|+++++||++||..||+
T Consensus 187 ~-----~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 261 (335)
T d2ozaa1 187 P-----EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 261 (335)
T ss_dssp G-----GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTT
T ss_pred C-----CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChh
Confidence 6 5689999999999999999999999977655444433333221111 1 1124689999999999999999
Q ss_pred CCCCHHHHhcCcCCCC
Q psy9090 153 HRPYMSELLEHPFITS 168 (488)
Q Consensus 153 ~Rps~~ell~hp~f~~ 168 (488)
+|||+.++++||||.+
T Consensus 262 ~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 262 QRMTITEFMNHPWIMQ 277 (335)
T ss_dssp TSCCHHHHHHSHHHHT
T ss_pred HCcCHHHHHcCHHhhC
Confidence 9999999999999965
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-35 Score=287.09 Aligned_cols=164 Identities=26% Similarity=0.516 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||.+..............|++.|+|||.+.+.
T Consensus 97 l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~- 175 (286)
T d1ob3a_ 97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS- 175 (286)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTC-
T ss_pred cchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCC-
Confidence 6899999999999999999999999999999999999999999999999998765544445566799999999999752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---CC-----------------------CCCCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---PP-----------------------PGLYRASN 134 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~~-----------------------~~~~~~~~ 134 (488)
..++.++||||+||++|+|++|++||.+.+....+.++... +. +.......
T Consensus 176 ---~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T d1ob3a_ 176 ---KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKG 252 (286)
T ss_dssp ---CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCS
T ss_pred ---CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhccc
Confidence 56789999999999999999999999988877766665421 00 00111345
Q ss_pred cCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q psy9090 135 WSQHYVDFIAECLEKNPEHRPYMSELLEHPFITS 168 (488)
Q Consensus 135 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 168 (488)
+++.+++||++||.+||++|||++|+++||||++
T Consensus 253 ~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 253 LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 6889999999999999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-35 Score=290.39 Aligned_cols=167 Identities=23% Similarity=0.405 Sum_probs=139.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|++.+++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ....+.+||+.|+|||.+.+.
T Consensus 119 l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 197 (350)
T d1q5ka_ 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGA 197 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC-cccccccccccccChHHhhcc
Confidence 68899999999999999999999999999999999999876 8999999999876543 344566899999999998752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC-------------------CCCCC-------CCCC
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN-------------------PPPGL-------YRAS 133 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~-------------------~~~~~-------~~~~ 133 (488)
..|+.++||||+||++|+|++|.+||........+..+... ..+.. ....
T Consensus 198 ----~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (350)
T d1q5ka_ 198 ----TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 273 (350)
T ss_dssp ----SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCT
T ss_pred ----cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhccc
Confidence 56899999999999999999999999888776666555420 00000 1123
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
.+++++.+||.+||..||++|||+.|+|+||||+++...
T Consensus 274 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 568999999999999999999999999999999876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-35 Score=288.50 Aligned_cols=180 Identities=31% Similarity=0.509 Sum_probs=146.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc-cCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT-FDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... .....+..|++.|+|||.+.+.
T Consensus 126 ~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~ 205 (322)
T d1vzoa_ 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcC
Confidence 468899999999999999999999999999999999999999999999999765332 2334566899999999999752
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCCCCCCCcCHHHHHHHHHhcccCCCCCC-
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGLYRASNWSQHYVDFIAECLEKNPEHRP- 155 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 155 (488)
...++.++|||||||++|+|++|..||.+.........+.. ...+ ..+..+|+++++||.+||.+||.+||
T Consensus 206 ---~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~~~~~s~~~~~li~~~l~~dP~~R~s 280 (322)
T d1vzoa_ 206 ---DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKRLG 280 (322)
T ss_dssp ---C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred ---CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--CCcccCCHHHHHHHHHHcccCHHHcCC
Confidence 13578899999999999999999999976644333222222 2222 23557899999999999999999999
Q ss_pred ----CHHHHhcCcCCCCCCCCccccccccccccc
Q psy9090 156 ----YMSELLEHPFITSLPENDLHLSTVNCQYKD 185 (488)
Q Consensus 156 ----s~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 185 (488)
|++|+++||||+.++|..+....+.+++.|
T Consensus 281 ~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p 314 (322)
T d1vzoa_ 281 CGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP 314 (322)
T ss_dssp SSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCC
Confidence 489999999999999988877777777654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-34 Score=285.38 Aligned_cols=165 Identities=28% Similarity=0.509 Sum_probs=137.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||+++.... ......||+.|+|||++.+.
T Consensus 118 l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~- 193 (346)
T d1cm8a_ 118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNW- 193 (346)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTT-
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC---ccccccccccccCHHHHcCC-
Confidence 68999999999999999999999999999999999999999999999999987643 34566899999999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC--CC--------------------------CCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN--PP--------------------------PGLYRA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~--~~--------------------------~~~~~~ 132 (488)
..++.++||||+||++|+|++|++||.+.+....+..+... .. ......
T Consensus 194 ---~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (346)
T d1cm8a_ 194 ---MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL 270 (346)
T ss_dssp ---TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTC
T ss_pred ---CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhc
Confidence 45788999999999999999999999887765554443320 00 001123
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
...++.+++||.+||..||.+|||++++|+||||+.+.+.
T Consensus 271 ~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 271 TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 4568999999999999999999999999999999987543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=278.44 Aligned_cols=161 Identities=30% Similarity=0.514 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc--cCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT--FDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~l~~ 78 (488)
+++.++..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+
T Consensus 101 ~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 180 (276)
T d1uwha_ 101 FEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhc
Confidence 578899999999999999999999999999999999999999999999999765432 123345689999999999975
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh-CCCCC--CCCCCCcCHHHHHHHHHhcccCCCCCC
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR-NPPPG--LYRASNWSQHYVDFIAECLEKNPEHRP 155 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~-~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rp 155 (488)
.. ...|+.++|||||||++|||+||+.||.+......+...+. ...++ ...+..+|+.+++||.+||..||.+||
T Consensus 181 ~~--~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP 258 (276)
T d1uwha_ 181 QD--KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP 258 (276)
T ss_dssp CS--SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cc--CCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCc
Confidence 32 24689999999999999999999999988776655544443 32222 123567899999999999999999999
Q ss_pred CHHHHhcC
Q psy9090 156 YMSELLEH 163 (488)
Q Consensus 156 s~~ell~h 163 (488)
|+++++++
T Consensus 259 t~~~il~~ 266 (276)
T d1uwha_ 259 LFPQILAS 266 (276)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-34 Score=284.50 Aligned_cols=167 Identities=31% Similarity=0.554 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
|++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.
T Consensus 106 l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 185 (345)
T d1pmea_ 106 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhh
Confidence 6899999999999999999999999999999999999999999999999997654321 2235567999999999986
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhC---C-------------------CCCC------
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRN---P-------------------PPGL------ 129 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~---~-------------------~~~~------ 129 (488)
.. ..|+.++||||+||++|+|++|++||.+............. + .+..
T Consensus 186 ~~----~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (345)
T d1pmea_ 186 NS----KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 261 (345)
T ss_dssp TB----CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred cC----CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHH
Confidence 52 56789999999999999999999999887655444333210 0 0000
Q ss_pred CCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 130 YRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 130 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
.....+|+++++||.+||..||.+|||++++|+||||+....
T Consensus 262 ~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 012356889999999999999999999999999999986543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-35 Score=288.24 Aligned_cols=162 Identities=25% Similarity=0.421 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccC--CcEEEEecCCccccccccCccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKD--GEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~--~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 78 (488)
|+|.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .......||+.|+|||.+.+
T Consensus 99 l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~~~~~~~t~~y~ape~~~~ 177 (321)
T d1tkia_ 99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-CcccccccccccccchhccC
Confidence 6899999999999999999999999999999999999854 47999999999876543 33456689999999999876
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPG-LYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|+|++|.+||.+.+......++....... ......+|+++++||.+||..||.+|||+
T Consensus 178 -----~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~ 252 (321)
T d1tkia_ 178 -----DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTA 252 (321)
T ss_dssp -----CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred -----CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCH
Confidence 668899999999999999999999999998888777777654321 11234679999999999999999999999
Q ss_pred HHHhcCcCCCC
Q psy9090 158 SELLEHPFITS 168 (488)
Q Consensus 158 ~ell~hp~f~~ 168 (488)
+++++||||++
T Consensus 253 ~eil~hp~~~~ 263 (321)
T d1tkia_ 253 SEALQHPWLKQ 263 (321)
T ss_dssp HHHHHSHHHHS
T ss_pred HHHhcCHhhcc
Confidence 99999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-34 Score=281.59 Aligned_cols=165 Identities=24% Similarity=0.437 Sum_probs=134.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccc----cCccccccCCCccccchhh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANT----FDKKKTFLGSPSWMAPEIM 76 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~l 76 (488)
+++.+++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....+.+||+.|+|||++
T Consensus 114 ~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 193 (318)
T d3blha1 114 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHH
T ss_pred cccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHH
Confidence 578899999999999999999999999999999999999999999999999755422 1223445799999999998
Q ss_pred cccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHh---CCCCCCCCC---------------------
Q psy9090 77 RCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVR---NPPPGLYRA--------------------- 132 (488)
Q Consensus 77 ~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~~~~--------------------- 132 (488)
.+. ..|+.++||||+||++|+|++|++||.+.........+.. ...+.....
T Consensus 194 ~~~----~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T d3blha1 194 LGE----RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 269 (318)
T ss_dssp TTC----SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHH
T ss_pred cCC----CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccch
Confidence 752 4689999999999999999999999998877665554432 111110000
Q ss_pred -----CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 133 -----SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 133 -----~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
...++.+++||.+||.+||++|||++|+|+||||+..
T Consensus 270 ~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp HHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 0126678899999999999999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=285.27 Aligned_cols=157 Identities=25% Similarity=0.425 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....... ...+..||+.|+|||++.+
T Consensus 161 l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (325)
T d1rjba_ 161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240 (325)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence 57889999999999999999999999999999999999999999999999986544322 2235578999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|||+| |.+||.+......+.+++..... ...+..+|+++++||.+||+.||++|||+
T Consensus 241 -----~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 241 -----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 678999999999999999997 89999887766667777665432 23456789999999999999999999999
Q ss_pred HHHhcC
Q psy9090 158 SELLEH 163 (488)
Q Consensus 158 ~ell~h 163 (488)
++|++|
T Consensus 315 ~ei~~~ 320 (325)
T d1rjba_ 315 PNLTSF 320 (325)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5e-34 Score=282.12 Aligned_cols=167 Identities=23% Similarity=0.406 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCC-cEEEEecCCccccccccCccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDG-EVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|++.+++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ......+||+.|+|||++.+.
T Consensus 126 l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 204 (328)
T d3bqca1 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDY 204 (328)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-CcccccccCccccCcccccCC
Confidence 68999999999999999999999999999999999998755 6999999999876543 345566899999999998763
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHH-HHHHHHh--------------CCC------------------
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTR-ALFQIVR--------------NPP------------------ 126 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~-~~~~~~~--------------~~~------------------ 126 (488)
..|+.++||||+||++|+|++|..||....... ....+.. ...
T Consensus 205 ----~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (328)
T d3bqca1 205 ----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280 (328)
T ss_dssp ----CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGG
T ss_pred ----CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchh
Confidence 457899999999999999999999997654321 1111110 000
Q ss_pred --CCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCC
Q psy9090 127 --PGLYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPEN 172 (488)
Q Consensus 127 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 172 (488)
........+++++++||++||..||.+|||++|+|+||||+++.|+
T Consensus 281 ~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328 (328)
T ss_dssp GGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred hcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 0000112358899999999999999999999999999999998774
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-34 Score=275.64 Aligned_cols=159 Identities=24% Similarity=0.447 Sum_probs=134.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
|++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.
T Consensus 104 l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~ 183 (277)
T d1xbba_ 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhc
Confidence 57899999999999999999999999999999999999999999999999986543211 223457899999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..|+.++|||||||++|||+| |.+||.+....+....+..+..+. .+..+|+++.+||.+||..||++|||
T Consensus 184 ~-----~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~--~p~~~~~~~~~li~~cl~~dp~~RPs 256 (277)
T d1xbba_ 184 Y-----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--CPAGCPREMYDLMNLCWTYDVENRPG 256 (277)
T ss_dssp H-----CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred C-----CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC--CCcccCHHHHHHHHHHcCCCHhHCcC
Confidence 6 568899999999999999997 899999988777666666554443 35678999999999999999999999
Q ss_pred HHHHh---cCcCC
Q psy9090 157 MSELL---EHPFI 166 (488)
Q Consensus 157 ~~ell---~hp~f 166 (488)
+++++ +|+|+
T Consensus 257 ~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 257 FAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHhhCHHh
Confidence 99984 56554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-34 Score=277.66 Aligned_cols=156 Identities=28% Similarity=0.463 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+
T Consensus 131 l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 210 (299)
T d1ywna1 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 210 (299)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc
Confidence 4788999999999999999999999999999999999999999999999997654322 23345679999999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcC-CCCCCCCChHHHHHHHHh-CCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDG-KPPFEDMHPTRALFQIVR-NPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg-~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
..|+.++||||+||++|+|++| .+||.+........+.+. +..+ ..+..+++++++||.+||..||++|||
T Consensus 211 -----~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt 283 (299)
T d1ywna1 211 -----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPT 283 (299)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -----CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--CCCccCCHHHHHHHHHHcCCChhHCcC
Confidence 6789999999999999999986 568877665555544443 3333 235678999999999999999999999
Q ss_pred HHHHhcC
Q psy9090 157 MSELLEH 163 (488)
Q Consensus 157 ~~ell~h 163 (488)
++++++|
T Consensus 284 ~~eil~~ 290 (299)
T d1ywna1 284 FSELVEH 290 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-34 Score=275.07 Aligned_cols=160 Identities=25% Similarity=0.435 Sum_probs=137.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
|++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.
T Consensus 106 l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 185 (285)
T d1u59a_ 106 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185 (285)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHh
Confidence 5789999999999999999999999999999999999999999999999998654321 2223456899999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
. ..|+.++|||||||++|||+| |.+||.+....+....+..+..+. .+..+|+++.+||.+||..||++|||
T Consensus 186 ~-----~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~--~p~~~~~~l~~li~~cl~~~p~~RPs 258 (285)
T d1u59a_ 186 F-----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME--CPPECPPELYALMSDCWIYKWEDRPD 258 (285)
T ss_dssp H-----CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred C-----CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCCcCCHHHHHHHHHHcCCCHhHCcC
Confidence 6 568999999999999999998 999999888777766666655443 35678999999999999999999999
Q ss_pred HHHH---hcCcCCC
Q psy9090 157 MSEL---LEHPFIT 167 (488)
Q Consensus 157 ~~el---l~hp~f~ 167 (488)
+.++ |+|+|+.
T Consensus 259 ~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 259 FLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 9887 5677763
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-33 Score=271.72 Aligned_cols=161 Identities=27% Similarity=0.480 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|++.++..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++..
T Consensus 106 l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~- 184 (272)
T d1qpca_ 106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY- 184 (272)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhC-
Confidence 5788999999999999999999999999999999999999999999999998764332 22345578999999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDG-KPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..|+.++|||||||++|||+|| .+||...........+.....+. .+..+++++.+||.+||+.||++|||++
T Consensus 185 ----~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~Rpt~~ 258 (272)
T d1qpca_ 185 ----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV--RPDNCPEELYQLMRLCWKERPEDRPTFD 258 (272)
T ss_dssp ----CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--CcccChHHHHHHHHHHcCCCHhHCcCHH
Confidence 5689999999999999999995 55666666666666665544333 3567899999999999999999999999
Q ss_pred HHhc--CcCCCC
Q psy9090 159 ELLE--HPFITS 168 (488)
Q Consensus 159 ell~--hp~f~~ 168 (488)
++++ |+||++
T Consensus 259 ei~~~L~~~fts 270 (272)
T d1qpca_ 259 YLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHhhhhhhc
Confidence 9987 778753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-33 Score=269.70 Aligned_cols=165 Identities=24% Similarity=0.438 Sum_probs=133.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.............+++.|+|||++...
T Consensus 98 ~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~- 176 (292)
T d1unla_ 98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA- 176 (292)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTC-
T ss_pred cchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccC-
Confidence 4788999999999999999999999999999999999999999999999998766544445555788899999998752
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCC-ChHHHHHHHHh---CCC-----------------------CCCCCCC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDM-HPTRALFQIVR---NPP-----------------------PGLYRAS 133 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~-~~~~~~~~~~~---~~~-----------------------~~~~~~~ 133 (488)
..++.++||||+||++|+|++|+.||... +.......+.. .+. .......
T Consensus 177 ---~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (292)
T d1unla_ 177 ---KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP 253 (292)
T ss_dssp ---SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTST
T ss_pred ---CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccc
Confidence 44789999999999999999999986544 33333333321 100 0001123
Q ss_pred CcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 134 NWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 134 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
.+++.+++||.+||.+||.+|||++|+|+||||+++
T Consensus 254 ~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 568899999999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-33 Score=271.72 Aligned_cols=156 Identities=24% Similarity=0.440 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-----ccccccCCCccccchh
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-----KKKTFLGSPSWMAPEI 75 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~ 75 (488)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||+
T Consensus 125 l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 204 (299)
T d1jpaa_ 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204 (299)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHH
Confidence 57889999999999999999999999999999999999999999999999986543211 1122457899999999
Q ss_pred hcccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCC
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHR 154 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 154 (488)
+.+ ..|+.++|||||||++|||+| |.+||.+.........+..+..++ .+..+++.+.+||.+||..||++|
T Consensus 205 ~~~-----~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~R 277 (299)
T d1jpaa_ 205 IQY-----RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP--PPMDCPSALHQLMLDCWQKDRNHR 277 (299)
T ss_dssp HHS-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred Hhc-----CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--CCccchHHHHHHHHHHcCCCHhHC
Confidence 976 678999999999999999998 899999988877777776654433 356789999999999999999999
Q ss_pred CCHHHHhcC
Q psy9090 155 PYMSELLEH 163 (488)
Q Consensus 155 ps~~ell~h 163 (488)
||+.+++++
T Consensus 278 Ps~~ei~~~ 286 (299)
T d1jpaa_ 278 PKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999998764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.4e-33 Score=268.95 Aligned_cols=156 Identities=24% Similarity=0.438 Sum_probs=125.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+
T Consensus 105 l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~- 183 (273)
T d1mp8a_ 105 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF- 183 (273)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhcc-
Confidence 5789999999999999999999999999999999999999999999999998654322 22345568999999999986
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..|+.++|||||||++|+|++ |.+||.+........++..+..++ .+..+|+.+.+||.+||..||++|||+.
T Consensus 184 ----~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~ 257 (273)
T d1mp8a_ 184 ----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRPRFT 257 (273)
T ss_dssp ----CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCCHhHCcCHH
Confidence 678999999999999999987 899999988877777777655443 4567899999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
++++|
T Consensus 258 ei~~~ 262 (273)
T d1mp8a_ 258 ELKAQ 262 (273)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.4e-33 Score=266.02 Aligned_cols=156 Identities=26% Similarity=0.472 Sum_probs=123.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
++++.+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 98 ~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~- 176 (263)
T d1sm2a_ 98 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF- 176 (263)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTT-
T ss_pred CCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC-
Confidence 46888999999999999999999999999999999999999999999999986543322 2234578999999999976
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..|+.++||||+||++|||+| |.+||...........+.....+. .+...++++.+||.+||..||++|||++
T Consensus 177 ----~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~--~p~~~~~~l~~li~~cl~~~p~~Rps~~ 250 (263)
T d1sm2a_ 177 ----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY--KPRLASTHVYQIMNHCWKERPEDRPAFS 250 (263)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC--CccccCHHHHHHHHHHccCCHhHCcCHH
Confidence 679999999999999999999 577777777666666666554332 3567799999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
++++|
T Consensus 251 ~il~~ 255 (263)
T d1sm2a_ 251 RLLRQ 255 (263)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=7.2e-33 Score=268.42 Aligned_cols=156 Identities=23% Similarity=0.405 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 112 ~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 190 (287)
T d1opja_ 112 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 190 (287)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH-
T ss_pred hHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcC-
Confidence 57889999999999999999999999999999999999999999999999987644322 2233458899999999986
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..|+.++||||+||++|+|++|..||........+.+.+..... ...+..+|+.+++||.+||..||++|||+++
T Consensus 191 ----~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 265 (287)
T d1opja_ 191 ----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAE 265 (287)
T ss_dssp ----CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC-CCCCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 67899999999999999999976665444434444444443321 2245678999999999999999999999999
Q ss_pred Hhc
Q psy9090 160 LLE 162 (488)
Q Consensus 160 ll~ 162 (488)
+++
T Consensus 266 i~~ 268 (287)
T d1opja_ 266 IHQ 268 (287)
T ss_dssp HHH
T ss_pred HHH
Confidence 976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-32 Score=266.56 Aligned_cols=163 Identities=26% Similarity=0.446 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc-CccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF-DKKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 79 (488)
|++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++..
T Consensus 110 l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 188 (285)
T d1fmka3 110 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 188 (285)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-
T ss_pred chHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhC-
Confidence 5789999999999999999999999999999999999999999999999997654322 22334578999999999986
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhcC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGDG-KPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..++.++||||+||++|+|++| .+|+........+..+.....++ .+..+++++++||.+||..||++|||++
T Consensus 189 ----~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ 262 (285)
T d1fmka3 189 ----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPECPESLHDLMCQCWRKEPEERPTFE 262 (285)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--CCcccCHHHHHHHHHHcccCHhHCcCHH
Confidence 6789999999999999999995 55556666555666665554333 4567899999999999999999999999
Q ss_pred HHhc--CcCCCCCC
Q psy9090 159 ELLE--HPFITSLP 170 (488)
Q Consensus 159 ell~--hp~f~~~~ 170 (488)
++++ ++||++..
T Consensus 263 ~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 263 YLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHTTTSCSC
T ss_pred HHHHHHhhhhcCCC
Confidence 9987 88997653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.2e-32 Score=262.56 Aligned_cols=156 Identities=26% Similarity=0.467 Sum_probs=135.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC-ccccccCCCccccchhhccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD-KKKTFLGSPSWMAPEIMRCG 79 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 79 (488)
+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 97 ~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 175 (258)
T d1k2pa_ 97 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY- 175 (258)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-
T ss_pred CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC-
Confidence 46889999999999999999999999999999999999999999999999976543322 2334578999999999986
Q ss_pred ccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHH
Q psy9090 80 HKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMS 158 (488)
Q Consensus 80 ~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 158 (488)
..|+.++||||+||++|||+| |+.||.+.+..+...++.....+ ..|...++.+++||.+||+.||++|||++
T Consensus 176 ----~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPt~~ 249 (258)
T d1k2pa_ 176 ----SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--YRPHLASEKVYTIMYSCWHEKADERPTFK 249 (258)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred ----CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC--CCcccccHHHHHHHHHHccCCHhHCcCHH
Confidence 678999999999999999998 89999999887777767665433 34567899999999999999999999999
Q ss_pred HHhcC
Q psy9090 159 ELLEH 163 (488)
Q Consensus 159 ell~h 163 (488)
++++|
T Consensus 250 eil~~ 254 (258)
T d1k2pa_ 250 ILLSN 254 (258)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=8.7e-33 Score=275.35 Aligned_cols=163 Identities=27% Similarity=0.497 Sum_probs=132.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.+++.+++||+.||+|||++||+||||||+|||++.+|.+|++|||++..... ...+..||+.|+|||++.+.
T Consensus 118 l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~---~~~~~~g~~~y~apE~~~~~- 193 (348)
T d2gfsa1 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNW- 193 (348)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG---GGSSSCHHHHTSCHHHHTTC-
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc---ccccccccccccCchhhcCC-
Confidence 68999999999999999999999999999999999999999999999999876543 34456799999999997652
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCCC----------------------CCC------CC
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPPP----------------------GLY------RA 132 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~----------------------~~~------~~ 132 (488)
..++.++|||||||++|+|++|.+||.+.+.......+...... ... ..
T Consensus 194 ---~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (348)
T d2gfsa1 194 ---MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 270 (348)
T ss_dssp ---SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHS
T ss_pred ---ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhc
Confidence 45688999999999999999999999988766555554431100 000 01
Q ss_pred CCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q psy9090 133 SNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLP 170 (488)
Q Consensus 133 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 170 (488)
...++++++||.+||..||.+|||++|+|+||||++..
T Consensus 271 ~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 271 IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 34689999999999999999999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.98 E-value=5.1e-33 Score=268.25 Aligned_cols=160 Identities=29% Similarity=0.549 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc---CccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF---DKKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~l~ 77 (488)
|++.+++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+....... ......+||+.|+|||++.
T Consensus 108 l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 187 (277)
T d1o6ya_ 108 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHc
Confidence 5789999999999999999999999999999999999999999999999886543221 2344568999999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCcCHHHHHHHHHhcccCCCCCC-
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP-PGLYRASNWSQHYVDFIAECLEKNPEHRP- 155 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 155 (488)
+ ..|+.++|||||||++|+|+||.+||.+.+......+++.... ++......+|+.+.+||.+||.+||.+||
T Consensus 188 ~-----~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 188 G-----DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262 (277)
T ss_dssp T-----CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS
T ss_pred C-----CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh
Confidence 6 6789999999999999999999999999888887777776543 23334567899999999999999999999
Q ss_pred CHHHHhcCcCC
Q psy9090 156 YMSELLEHPFI 166 (488)
Q Consensus 156 s~~ell~hp~f 166 (488)
|+++++ |+|.
T Consensus 263 sa~~l~-~~l~ 272 (277)
T d1o6ya_ 263 TAAEMR-ADLV 272 (277)
T ss_dssp SHHHHH-HHHH
T ss_pred HHHHHH-HHHH
Confidence 566554 5554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6.6e-33 Score=272.65 Aligned_cols=157 Identities=24% Similarity=0.383 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 108 ~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 187 (317)
T d1xkka_ 108 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhc
Confidence 57889999999999999999999999999999999999999999999999986543222 2234468999999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|||+| |.+||.+....+....+..+..++ .+..+++.+.+||.+||..||.+|||+
T Consensus 188 -----~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--~p~~~~~~~~~li~~cl~~dP~~RPs~ 260 (317)
T d1xkka_ 188 -----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--QPPICTIDVYMIMVKCWMIDADSRPKF 260 (317)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC--CCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--CCcccCHHHHHHHHHhCCCChhhCcCH
Confidence 678999999999999999998 899998887666655555554333 356789999999999999999999999
Q ss_pred HHHhcCc
Q psy9090 158 SELLEHP 164 (488)
Q Consensus 158 ~ell~hp 164 (488)
.++++|.
T Consensus 261 ~eil~~l 267 (317)
T d1xkka_ 261 RELIIEF 267 (317)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.6e-33 Score=277.53 Aligned_cols=163 Identities=24% Similarity=0.465 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++.+++.+++||+.||+|||++||+||||||+|||++.++.+|++|||+++..... ......+||+.|+|||++.+
T Consensus 116 ~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~-- 192 (355)
T d2b1pa1 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG-- 192 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------CCTTCCHHHHTT--
T ss_pred CCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc-cccccccccccccChhhhcC--
Confidence 578999999999999999999999999999999999999999999999998765543 34456689999999999986
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHHhCCC---------------------CCCC---------
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIVRNPP---------------------PGLY--------- 130 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~~~~~---------------------~~~~--------- 130 (488)
..+++++||||+||++|+|++|++||.+.+......++..... +...
T Consensus 193 ---~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (355)
T d2b1pa1 193 ---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269 (355)
T ss_dssp ---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSC
T ss_pred ---CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccc
Confidence 6789999999999999999999999988876655544432100 0000
Q ss_pred ---C------CCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q psy9090 131 ---R------ASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSL 169 (488)
Q Consensus 131 ---~------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 169 (488)
. ....|+++++||++||..||++|||++|+|+||||+..
T Consensus 270 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0 01125678999999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-32 Score=263.26 Aligned_cols=155 Identities=22% Similarity=0.391 Sum_probs=121.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.
T Consensus 107 ~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 186 (283)
T d1mqba_ 107 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186 (283)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHH
T ss_pred ccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHc
Confidence 57889999999999999999999999999999999999999999999999986543211 223346899999999997
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCC-CCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGK-PPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..|+.++|||||||++|||++|. +|+...........+..+..++ .+..+++.+.+||.+||..||++|||
T Consensus 187 ~-----~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt 259 (283)
T d1mqba_ 187 Y-----RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP--TPMDCPSAIYQLMMQCWQQERARRPK 259 (283)
T ss_dssp S-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--CCTTCBHHHHHHHHHHTCSSTTTSCC
T ss_pred c-----CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC--CchhhHHHHHHHHHHHCcCCHhHCcC
Confidence 6 67899999999999999999954 4555555555544444443333 35678999999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 260 ~~eil~ 265 (283)
T d1mqba_ 260 FADIVS 265 (283)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-32 Score=261.76 Aligned_cols=156 Identities=27% Similarity=0.470 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC---ccccccCCCccccchhhc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD---KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~l~ 77 (488)
|++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......|++.|+|||++.
T Consensus 108 l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 187 (273)
T d1u46a_ 108 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187 (273)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHh
Confidence 57899999999999999999999999999999999999999999999999987643322 223446788999999998
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
+ ..++.++|||||||++|||+| |.+||.+.+..+...++.+.... .+.+..+|+.+++||.+||..||++|||
T Consensus 188 ~-----~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt 261 (273)
T d1u46a_ 188 T-----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-LPRPEDCPQDIYNVMVQCWAHKPEDRPT 261 (273)
T ss_dssp H-----CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred C-----CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC-CCCcccccHHHHHHHHHHcCCChhHCcC
Confidence 6 568899999999999999998 89999999888877777665432 2345678999999999999999999999
Q ss_pred HHHHhc
Q psy9090 157 MSELLE 162 (488)
Q Consensus 157 ~~ell~ 162 (488)
+.++++
T Consensus 262 ~~ei~~ 267 (273)
T d1u46a_ 262 FVALRD 267 (273)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=4.9e-32 Score=264.46 Aligned_cols=155 Identities=26% Similarity=0.422 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+++...... ....+..||+.|+|||++.+
T Consensus 137 l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 5678899999999999999999999999999999999999999999999997553321 22345678999999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcCC-CCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDGK-PPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|||++|. +||.+....+....+.....+. .+..+++++.+||.+||+.+|++|||+
T Consensus 217 -----~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~--~p~~~~~~~~~li~~cl~~~P~~RPt~ 289 (301)
T d1lufa_ 217 -----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA--CPENCPLELYNLMRLCWSKLPADRPSF 289 (301)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC--CCccchHHHHHHHHHHcCCChhHCcCH
Confidence 67999999999999999999985 7898888887777776655443 356789999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 290 ~ev~~ 294 (301)
T d1lufa_ 290 CSIHR 294 (301)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=260.71 Aligned_cols=155 Identities=28% Similarity=0.478 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+
T Consensus 132 l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~ 211 (299)
T d1fgka_ 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 211 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC
Confidence 5789999999999999999999999999999999999999999999999998664432 22344578999999999976
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..|+.++|||||||++|+|++ |.+||.+.........+..+..+. .+..+++.+++||.+||+.||++|||+
T Consensus 212 -----~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~Rps~ 284 (299)
T d1fgka_ 212 -----RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTF 284 (299)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC--CCSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCC--CCccchHHHHHHHHHHccCCHhHCcCH
Confidence 679999999999999999998 799998888766555554443333 456789999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
.++++
T Consensus 285 ~eil~ 289 (299)
T d1fgka_ 285 KQLVE 289 (299)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-31 Score=253.60 Aligned_cols=153 Identities=24% Similarity=0.459 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+
T Consensus 100 l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~-- 174 (262)
T d1byga_ 100 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALRE-- 174 (262)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHH--
T ss_pred CCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC---CccccccccCCChHHHhC--
Confidence 578899999999999999999999999999999999999999999999999865432 334568899999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..++.++|||||||++|||+| |++||...........+..+..+.. +..+++.+++||.+||..||.+|||+.+
T Consensus 175 ---~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~ 249 (262)
T d1byga_ 175 ---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRPSFLQ 249 (262)
T ss_dssp ---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC--CccCCHHHHHHHHHHcccCHhHCcCHHH
Confidence 678999999999999999998 7999988877777777665554443 5678999999999999999999999999
Q ss_pred HhcC
Q psy9090 160 LLEH 163 (488)
Q Consensus 160 ll~h 163 (488)
++++
T Consensus 250 l~~~ 253 (262)
T d1byga_ 250 LREQ 253 (262)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-31 Score=260.37 Aligned_cols=155 Identities=26% Similarity=0.427 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccchhhcccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAPEIMRCGH 80 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 80 (488)
|++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+..
T Consensus 124 l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-- 200 (309)
T d1fvra_ 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-- 200 (309)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH--
T ss_pred CCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccccccccc-ccccceecCCcccchHHhcc--
Confidence 578899999999999999999999999999999999999999999999999765443 23345578999999999976
Q ss_pred cCCCCCCCccchhhhHHHHHHHhcCC-CCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCHHH
Q psy9090 81 KEVDGYDNRIDVWALGITAIELGDGK-PPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYMSE 159 (488)
Q Consensus 81 ~~~~~~~~~~DiwslGvil~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 159 (488)
..|+.++|||||||++|+|++|. +||.+.+.......+..+..+. .+..+++++++||.+||..||++|||+++
T Consensus 201 ---~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~e 275 (309)
T d1fvra_ 201 ---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQ 275 (309)
T ss_dssp ---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC--CCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC--CCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 67899999999999999999965 6788888777766666654433 35678999999999999999999999999
Q ss_pred HhcC
Q psy9090 160 LLEH 163 (488)
Q Consensus 160 ll~h 163 (488)
++++
T Consensus 276 il~~ 279 (309)
T d1fvra_ 276 ILVS 279 (309)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.8e-31 Score=257.08 Aligned_cols=155 Identities=26% Similarity=0.472 Sum_probs=133.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC--ccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD--KKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 78 (488)
+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+
T Consensus 130 ~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~ 209 (308)
T d1p4oa_ 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 209 (308)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc
Confidence 36778899999999999999999999999999999999999999999999986543322 2334468999999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhcC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGDG-KPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++||||+||++|||+|| .+||.+.+..+....+.....+. .+..+++.+.++|.+||+.+|++|||+
T Consensus 210 -----~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~ 282 (308)
T d1p4oa_ 210 -----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD--KPDNCPDMLFELMRMCWQYNPKMRPSF 282 (308)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC--CcccchHHHHHHHHHHcCCChhHCcCH
Confidence 6788999999999999999998 58888888777777766654433 356789999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
+++++
T Consensus 283 ~~il~ 287 (308)
T d1p4oa_ 283 LEIIS 287 (308)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-30 Score=256.18 Aligned_cols=156 Identities=28% Similarity=0.469 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCcccccccc--CccccccCCCccccchhhcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTF--DKKKTFLGSPSWMAPEIMRC 78 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 78 (488)
|++.++..++.||+.||+|||++|+|||||||+|||++.++.+|++|||+++...... .......||+.|+|||++.+
T Consensus 142 l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 221 (311)
T d1t46a_ 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC
Confidence 5788999999999999999999999999999999999999999999999998654321 22344578999999999986
Q ss_pred cccCCCCCCCccchhhhHHHHHHHhc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCCH
Q psy9090 79 GHKEVDGYDNRIDVWALGITAIELGD-GKPPFEDMHPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPYM 157 (488)
Q Consensus 79 ~~~~~~~~~~~~DiwslGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 157 (488)
..++.++|||||||++|+|+| |.+||........+.+++...... ..+..+++.+.+||.+||..||.+|||+
T Consensus 222 -----~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 295 (311)
T d1t46a_ 222 -----CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTF 295 (311)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCH
Confidence 678999999999999999998 677777766666666665443322 2356789999999999999999999999
Q ss_pred HHHhc
Q psy9090 158 SELLE 162 (488)
Q Consensus 158 ~ell~ 162 (488)
+++++
T Consensus 296 ~~il~ 300 (311)
T d1t46a_ 296 KQIVQ 300 (311)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1.6e-30 Score=253.33 Aligned_cols=162 Identities=18% Similarity=0.338 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc---CCcEEEEecCCcccccccc-------CccccccCCCcc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK---DGEVKIVDFGLSRETANTF-------DKKKTFLGSPSW 70 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y 70 (488)
+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+++...... .......||+.|
T Consensus 100 ~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y 179 (299)
T d1ckia_ 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSS
T ss_pred CcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccc
Confidence 578999999999999999999999999999999999864 4569999999998654321 123456899999
Q ss_pred ccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChHHHHHHHH---hC--CCCCCCCCCCcCHHHHHHHHH
Q psy9090 71 MAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPTRALFQIV---RN--PPPGLYRASNWSQHYVDFIAE 145 (488)
Q Consensus 71 ~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~~~~~~~~---~~--~~~~~~~~~~~s~~~~~li~~ 145 (488)
+|||++.+ ..|+.++|||||||++|+|++|..||...........+. .. ..+.......+|+++.++|.+
T Consensus 180 ~aPE~~~~-----~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~ 254 (299)
T d1ckia_ 180 ASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 254 (299)
T ss_dssp CCHHHHTT-----BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHH
T ss_pred cCHHHHhC-----CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHH
Confidence 99999986 678999999999999999999999997765433222211 10 111111245689999999999
Q ss_pred hcccCCCCCCCHHH---HhcCcCCC
Q psy9090 146 CLEKNPEHRPYMSE---LLEHPFIT 167 (488)
Q Consensus 146 ~L~~dP~~Rps~~e---ll~hp~f~ 167 (488)
||..+|++||++++ +|+|+|.+
T Consensus 255 cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 255 CRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HccCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999874 46676653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.9e-30 Score=259.47 Aligned_cols=163 Identities=20% Similarity=0.335 Sum_probs=125.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCCEEEccCCc------EEEEecCCccccccccCccccccCCCccccc
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE-NHVIHRDLRGSNVLLTKDGE------VKIVDFGLSRETANTFDKKKTFLGSPSWMAP 73 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~------vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 73 (488)
+++..++.++.||+.||+|||+ .||+||||||+|||++.++. ++++|||.+..... .....+||+.|+||
T Consensus 122 ~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aP 198 (362)
T d1q8ya_ 122 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSP 198 (362)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCH
T ss_pred CcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc---ccccccccccccCh
Confidence 4688999999999999999998 89999999999999987653 99999999875543 33566899999999
Q ss_pred hhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCChH------HHHHHH---HhCC-------------------
Q psy9090 74 EIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHPT------RALFQI---VRNP------------------- 125 (488)
Q Consensus 74 E~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~~------~~~~~~---~~~~------------------- 125 (488)
|++.+ ..|+.++|+||+||++++|++|+.||...... ..+... +...
T Consensus 199 E~~~~-----~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~ 273 (362)
T d1q8ya_ 199 EVLLG-----APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 273 (362)
T ss_dssp HHHHT-----CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--
T ss_pred hhccc-----cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccch
Confidence 99986 67899999999999999999999999644221 111111 1000
Q ss_pred ----CCC-------------CCCCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q psy9090 126 ----PPG-------------LYRASNWSQHYVDFIAECLEKNPEHRPYMSELLEHPFITSLPE 171 (488)
Q Consensus 126 ----~~~-------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 171 (488)
... .......++.+++||.+||..||.+|||++|+|+||||++...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred hhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC
Confidence 000 0001123577899999999999999999999999999996643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.8e-30 Score=251.88 Aligned_cols=155 Identities=23% Similarity=0.363 Sum_probs=125.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccC----ccccccCCCccccchhhc
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGSPSWMAPEIMR 77 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~l~ 77 (488)
++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.
T Consensus 128 ~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 207 (311)
T d1r0pa_ 128 TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207 (311)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHH
T ss_pred hHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHh
Confidence 4677889999999999999999999999999999999999999999999986543211 123346899999999998
Q ss_pred ccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCC-ChHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHHhcccCCCCCCC
Q psy9090 78 CGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDM-HPTRALFQIVRNPPPGLYRASNWSQHYVDFIAECLEKNPEHRPY 156 (488)
Q Consensus 78 ~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 156 (488)
. ..++.++||||||+++|||+||..||... ........+..+..+. .+..+++.+.+||.+||..||++|||
T Consensus 208 ~-----~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~--~p~~~~~~l~~li~~cl~~dP~~RPs 280 (311)
T d1r0pa_ 208 T-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL--QPEYCPDPLYEVMLKCWHPKAEMRPS 280 (311)
T ss_dssp H-----CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred c-----CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--CcccCcHHHHHHHHHHcCCCHhHCcC
Confidence 6 67899999999999999999977777543 3333344444444333 35678999999999999999999999
Q ss_pred HHHHhcC
Q psy9090 157 MSELLEH 163 (488)
Q Consensus 157 ~~ell~h 163 (488)
+.|+++|
T Consensus 281 ~~ei~~~ 287 (311)
T d1r0pa_ 281 FSELVSR 287 (311)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=3.6e-29 Score=243.04 Aligned_cols=157 Identities=18% Similarity=0.298 Sum_probs=123.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEcc-----CCcEEEEecCCcccccccc-------CccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTK-----DGEVKIVDFGLSRETANTF-------DKKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-----~~~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~ 68 (488)
+++.++..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++...... ......+||+
T Consensus 98 ~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~ 177 (293)
T d1csna_ 98 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred hhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEch
Confidence 578899999999999999999999999999999999974 5789999999998654321 1234568999
Q ss_pred ccccchhhcccccCCCCCCCccchhhhHHHHHHHhcCCCCCCCCCh---HHHHHHHHhC--CCCCCCCCCCcCHHHHHHH
Q psy9090 69 SWMAPEIMRCGHKEVDGYDNRIDVWALGITAIELGDGKPPFEDMHP---TRALFQIVRN--PPPGLYRASNWSQHYVDFI 143 (488)
Q Consensus 69 ~y~aPE~l~~~~~~~~~~~~~~DiwslGvil~elltg~~Pf~~~~~---~~~~~~~~~~--~~~~~~~~~~~s~~~~~li 143 (488)
.|+|||++.+ ..+++++|||||||++|+|++|..||.+... .....++... ..+.......+|+++.+++
T Consensus 178 ~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii 252 (293)
T d1csna_ 178 RYMSINTHLG-----REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252 (293)
T ss_dssp TTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHH
T ss_pred hhcCHHHhcC-----CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHH
Confidence 9999999986 6789999999999999999999999975433 2222222111 1111112356789999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy9090 144 AECLEKNPEHRPYMSELLE 162 (488)
Q Consensus 144 ~~~L~~dP~~Rps~~ell~ 162 (488)
..|+..+|++||+++.+.+
T Consensus 253 ~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 253 HYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHCCTTCCCCHHHHHH
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999776543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.8e-28 Score=239.16 Aligned_cols=163 Identities=20% Similarity=0.294 Sum_probs=118.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH--------CCCeecccCCCCEEEccCCcEEEEecCCccccccccC----ccccccCCC
Q psy9090 1 MSEQHIAFILKEIITGMVFLHE--------NHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFD----KKKTFLGSP 68 (488)
Q Consensus 1 L~e~~~~~i~~qil~aL~~LH~--------~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~ 68 (488)
+++.++..++.|++.||+|||+ +|||||||||+|||++.++.+||+|||+++....... ......||+
T Consensus 97 l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~ 176 (303)
T d1vjya_ 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceeccc
Confidence 4678889999999999999996 5999999999999999999999999999986643321 234567999
Q ss_pred ccccchhhcccccC-CCCCCCccchhhhHHHHHHHhcCCCCCCCCC--------------hHHHHHHHHhC-C-CCCCC-
Q psy9090 69 SWMAPEIMRCGHKE-VDGYDNRIDVWALGITAIELGDGKPPFEDMH--------------PTRALFQIVRN-P-PPGLY- 130 (488)
Q Consensus 69 ~y~aPE~l~~~~~~-~~~~~~~~DiwslGvil~elltg~~Pf~~~~--------------~~~~~~~~~~~-~-~~~~~- 130 (488)
.|+|||++.+.... ...++.++|||||||++|||+||.+||.... ........... . .|..+
T Consensus 177 ~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 256 (303)
T d1vjya_ 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 256 (303)
T ss_dssp GGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred CcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCc
Confidence 99999998752110 1135678999999999999999988773211 11222233221 1 11111
Q ss_pred --CCCCcCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy9090 131 --RASNWSQHYVDFIAECLEKNPEHRPYMSELLEH 163 (488)
Q Consensus 131 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 163 (488)
.....+..+.+|+.+||..||++|||+.+++++
T Consensus 257 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 257 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111223458899999999999999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.30 E-value=1.1e-13 Score=124.14 Aligned_cols=81 Identities=19% Similarity=0.199 Sum_probs=60.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCCEEEccCCcEEEEecCCccccccccCccccccCCCccccc------hh
Q psy9090 2 SEQHIAFILKEIITGMVFLHENHVIHRDLRGSNVLLTKDGEVKIVDFGLSRETANTFDKKKTFLGSPSWMAP------EI 75 (488)
Q Consensus 2 ~e~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aP------E~ 75 (488)
++..+..++.||+.+|+|||++||+||||||+|||++.+ .++|+|||++....++.. ..|... +.
T Consensus 101 ~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~--------~~~l~rd~~~~~~~ 171 (191)
T d1zara2 101 RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW--------REILERDVRNIITY 171 (191)
T ss_dssp CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTH--------HHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCc--------HHHHHHHHHHHHHH
Confidence 445678899999999999999999999999999999865 589999999876543211 112111 12
Q ss_pred hcccccCCCCCCCccchhhhHH
Q psy9090 76 MRCGHKEVDGYDNRIDVWALGI 97 (488)
Q Consensus 76 l~~~~~~~~~~~~~~DiwslGv 97 (488)
+. ..|+.++|+||+.-
T Consensus 172 f~------r~y~~~~d~~s~~~ 187 (191)
T d1zara2 172 FS------RTYRTEKDINSAID 187 (191)
T ss_dssp HH------HHHCCCCCHHHHHH
T ss_pred Hc------CCCCCcccHHHHHH
Confidence 21 45788899999753
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.06 E-value=4.2e-08 Score=78.38 Aligned_cols=85 Identities=15% Similarity=0.152 Sum_probs=64.4
Q ss_pred CCCCCCCchhhhhccCCCCCCCC-hhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchh
Q psy9090 235 THLNLYGTKYHFKYKFKSRSDNE-PHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKV 311 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~~~-ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~ 311 (488)
..|.|++.||+..+......... -.+|..+|.+++|.|+..+++.++-+ +..|..- .+.++.||+.+|.++||.|+|
T Consensus 20 ~dG~idf~EF~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d~dG~I~~ 99 (109)
T d1pvaa_ 20 AEGSFNHKKFFALVGLKAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGI 99 (109)
T ss_dssp STTCCCHHHHHHHHTCTTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCH
T ss_pred CCCCCcHHHHHHHHHHccCCHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCCCcCcEeH
Confidence 45779999998776433222111 13999999999999999998877643 3333222 577999999999999999999
Q ss_pred hhHhhhcc
Q psy9090 312 GEKIEKCV 319 (488)
Q Consensus 312 ~e~i~~~~ 319 (488)
+||+.+|.
T Consensus 100 ~EF~~~m~ 107 (109)
T d1pvaa_ 100 DEFETLVH 107 (109)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998875
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=97.99 E-value=4.9e-08 Score=77.97 Aligned_cols=85 Identities=13% Similarity=0.104 Sum_probs=63.6
Q ss_pred CCCCCCchhhhhccCCCCCCC-ChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchhh
Q psy9090 236 HLNLYGTKYHFKYKFKSRSDN-EPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKVG 312 (488)
Q Consensus 236 ~~~i~~~ef~~~~~~~~~~~~-~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~~ 312 (488)
.+.|++.||+..+..+...+. --.+|..+|++.+|.|+..+++.++.+ +..|..- .+.++.|++.+|.++||.|+|+
T Consensus 21 ~G~idf~eF~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~d~dG~I~~~ 100 (109)
T d5pala_ 21 PGTFDYKRFFHLVGLKGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGAD 100 (109)
T ss_dssp TTCCCHHHHHHHHTCTTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHH
T ss_pred CCcCcHHHHHHHHHhcCCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCCCCCCCEeHH
Confidence 366899999976643222110 112999999999999999999987743 2223222 5679999999999999999999
Q ss_pred hHhhhcch
Q psy9090 313 EKIEKCVN 320 (488)
Q Consensus 313 e~i~~~~~ 320 (488)
||+.+|.+
T Consensus 101 EF~~~m~~ 108 (109)
T d5pala_ 101 EFAKMVAQ 108 (109)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99998753
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=97.58 E-value=6.9e-07 Score=70.82 Aligned_cols=83 Identities=14% Similarity=0.099 Sum_probs=62.0
Q ss_pred CCCCCchhhhhccCCCCCCC-ChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchhhh
Q psy9090 237 LNLYGTKYHFKYKFKSRSDN-EPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKVGE 313 (488)
Q Consensus 237 ~~i~~~ef~~~~~~~~~~~~-~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~~e 313 (488)
+.+++.+|+....-...... --.+|.++|.+++|.|+..+...++-+ |+.|..- .+.++.|++.+|.++||.|+|+|
T Consensus 21 gsi~~~eF~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~E 100 (107)
T d2pvba_ 21 DSFKHKEFFAKVGLASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDE 100 (107)
T ss_dssp TCCCHHHHHHHHTGGGSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHH
T ss_pred CCcCHHHHHHHHhcccCCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCCCCCCcEeHHH
Confidence 45788999876643221110 012899999999999999998877644 4444222 67899999999999999999999
Q ss_pred Hhhhcc
Q psy9090 314 KIEKCV 319 (488)
Q Consensus 314 ~i~~~~ 319 (488)
|+.+|.
T Consensus 101 F~~~m~ 106 (107)
T d2pvba_ 101 FAAMIK 106 (107)
T ss_dssp HHHHHH
T ss_pred HHHHHc
Confidence 998874
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=97.45 E-value=9.7e-07 Score=70.23 Aligned_cols=83 Identities=14% Similarity=0.150 Sum_probs=61.6
Q ss_pred CCCCCchhhhhccCCCCCCCC-hhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchhhh
Q psy9090 237 LNLYGTKYHFKYKFKSRSDNE-PHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKVGE 313 (488)
Q Consensus 237 ~~i~~~ef~~~~~~~~~~~~~-ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~~e 313 (488)
+.|.+.+|...+.-....... -.+|.++|++++|.|+..+.+.++-+ |..|..- .+.++.|++.+|.++||.++++|
T Consensus 22 ~~i~f~eF~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D~d~dG~i~~~E 101 (109)
T d1rwya_ 22 DSFDHKKFFQMVGLKKKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEE 101 (109)
T ss_dssp TCCCHHHHHHHHTGGGSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHH
T ss_pred CCcCHHHHHHHHccccCCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhCCCCCCeEeHHH
Confidence 457889998766433221111 12999999999999999999887733 3322212 57799999999999999999999
Q ss_pred Hhhhcc
Q psy9090 314 KIEKCV 319 (488)
Q Consensus 314 ~i~~~~ 319 (488)
|+.+|.
T Consensus 102 F~~~m~ 107 (109)
T d1rwya_ 102 FSTLVA 107 (109)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998874
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.40 E-value=1.1e-06 Score=77.14 Aligned_cols=125 Identities=14% Similarity=0.106 Sum_probs=85.2
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh---hhHHHHHHHHHHHHhcCCCc
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP---HIYAVADSAYQDMMHHEEAQ 278 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p---h~f~~~d~~~~~~~~~~~~q 278 (488)
++.......+...........++..++..+|.++++.|++.||+............. .+|+++|.+..|.|+..+..
T Consensus 43 i~~~ef~~~~~~~~~~~~~~~~~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D~d~dG~is~~E~~ 122 (190)
T d1fpwa_ 43 LAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEML 122 (190)
T ss_dssp EEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHHH
T ss_pred ccHHHHHHHHHHHCCCCChHHHHHHHHHHhCcCCCCcccHHHHHHHHHHHccCchHHHHHHHHHHhccCCCCcCcHHHHH
Confidence 333344444444443444445566778889999999999999997765433322223 39999999999998888776
Q ss_pred EEEEc-c-ccc---------CCchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 279 HIVLA-G-ETL---------AGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 279 ~i~~s-g-esg---------agkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
.++.. + ..+ .-..+.++.+++.+|.++||.|+++||+.++.. ++++|+
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p~i~~~l~ 184 (190)
T d1fpwa_ 123 TIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDPSIIGALN 184 (190)
T ss_dssp HHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSSTTHHHHHH
T ss_pred HHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCHHHHHHhh
Confidence 65532 1 111 111356889999999999999999999987653 777764
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=97.33 E-value=2.2e-06 Score=61.75 Aligned_cols=60 Identities=17% Similarity=0.227 Sum_probs=50.7
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
++|..+|++.+|.|+..+++.++.+ |+... ..+.++.|++.+|.+++|.++|+||+.+|.
T Consensus 6 ~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~-s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~ 66 (68)
T d1c7va_ 6 RAFKVFDANGDGVIDFDEFKFIMQKVGEEPL-TDAEVEEAMKEADEDGNGVIDIPEFMDLIK 66 (68)
T ss_dssp HHHHHHSCSGGGEECHHHHHHHSSTTTTCCC-CHHHHHHHHHHHCSSGGGSEEHHHHHHHHH
T ss_pred HHHHHHcCCCcCeEcHHHHHHHHHHhCCCCC-CHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 4899999999999999999988844 33211 267899999999999999999999999875
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=97.32 E-value=1.5e-06 Score=62.45 Aligned_cols=63 Identities=10% Similarity=0.150 Sum_probs=52.5
Q ss_pred hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 258 PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 258 ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.++|..+|.+.+|.|+..+.+.++- .-|-. ..+.++.+++.+|.+++|.|+++||+..|.++|
T Consensus 4 r~~F~~~D~d~~G~I~~~El~~~l~--~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~~l 67 (67)
T d1tiza_ 4 KRVFEKFDKNKDGKLSLDEFREVAL--AFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEKML 67 (67)
T ss_dssp HHHHHHHCTTSSSCEEHHHHHHHHH--HTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHTC-
T ss_pred HHHHHHHCCCCcCcCcHHHHHHHHH--HhccccchHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhC
Confidence 3699999999999999999998773 22322 368899999999999999999999999887764
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.24 E-value=8.4e-06 Score=67.91 Aligned_cols=85 Identities=11% Similarity=0.092 Sum_probs=62.3
Q ss_pred CCCCCCCCCchhhhhccCCCCCCCC------hhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhc
Q psy9090 233 PNTHLNLYGTKYHFKYKFKSRSDNE------PHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLG 305 (488)
Q Consensus 233 p~~~~~i~~~ef~~~~~~~~~~~~~------ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~ 305 (488)
..+.+.+.+.+|...+......... .++|+.+|.+.+|.|+..+.+.++.+ |+. =..+.++.|++. +.++
T Consensus 53 ~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~--~~~~e~~~l~~~-~~d~ 129 (145)
T d2mysc_ 53 EMNAAAITFEEFLPMLQAAANNKDQGTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEK--MTEEEVEELMKG-QEDS 129 (145)
T ss_pred ccccCccchhHHHHHHhhhhhccccchHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCC--CCHHHHHHHHhh-cCCC
Confidence 3345678888998766433221111 24999999999999999999998843 331 126778889985 7799
Q ss_pred CCCchhhhHhhhcch
Q psy9090 306 QGAAKVGEKIEKCVN 320 (488)
Q Consensus 306 ~g~~~~~e~i~~~~~ 320 (488)
+|.|+|+||+.++..
T Consensus 130 dG~I~y~eF~~~ll~ 144 (145)
T d2mysc_ 130 NGCINYEAFVKHIMS 144 (145)
T ss_pred CCeEEHHHHHHHHhc
Confidence 999999999988754
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.22 E-value=1.6e-05 Score=66.27 Aligned_cols=83 Identities=8% Similarity=0.001 Sum_probs=64.3
Q ss_pred CCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCch
Q psy9090 236 HLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAK 310 (488)
Q Consensus 236 ~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~ 310 (488)
.+.+.+++|+..+......... ..+|+++|++.+|.|+..+.+.++.+ |+ .-..+.+..|+++++.+++|.|+
T Consensus 54 ~g~i~~~eF~~~~~~~~~~~~~~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~--~ls~~e~~~~~~~~d~d~dg~I~ 131 (145)
T d2mysb_ 54 SGPINFTVFLTMFGEKLKGADPEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGG--RFTPEEIKNMWAAFPPDVAGNVD 131 (145)
T ss_pred cCceeechhhhhhhhcccccchHHHHHHHHHhhhhcccchhhHHHHHHHHHHcCC--CCCHHHHHHHHHHhCCCCCCeEe
Confidence 4567888999877554332222 23999999999999999999998833 43 12378899999999999999999
Q ss_pred hhhHhhhcch
Q psy9090 311 VGEKIEKCVN 320 (488)
Q Consensus 311 ~~e~i~~~~~ 320 (488)
|.+|+..|..
T Consensus 132 y~eF~~~l~~ 141 (145)
T d2mysb_ 132 YKNICYVITH 141 (145)
T ss_pred HHHHHHHhcc
Confidence 9999988753
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.19 E-value=2.7e-06 Score=67.43 Aligned_cols=82 Identities=13% Similarity=0.097 Sum_probs=59.5
Q ss_pred CCCCchhhhhccCCCCCC-CChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCc-hhhHHHHHHHHHHhcCCCchhhhH
Q psy9090 238 NLYGTKYHFKYKFKSRSD-NEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGK-TTSLKHLLKHLIFLGQGAAKVGEK 314 (488)
Q Consensus 238 ~i~~~ef~~~~~~~~~~~-~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagk-te~~k~i~~~~~~~~~g~~~~~e~ 314 (488)
.+.+.+|........... .--.+|+.+|++.+|.|+..+.+.++.. |..|.-- .+.++.|++.+|.++||.|+++||
T Consensus 23 s~~~~~F~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d~dG~I~~~EF 102 (108)
T d1rroa_ 23 TFEPQKFFQTSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEF 102 (108)
T ss_dssp CCCHHHHHHHHSGGGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHH
T ss_pred CccHHHHHHHHccCcCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCCCCCeEeHHHH
Confidence 456778765443221111 1113999999999999999998887743 3333222 578999999999999999999999
Q ss_pred hhhcc
Q psy9090 315 IEKCV 319 (488)
Q Consensus 315 i~~~~ 319 (488)
+.+|.
T Consensus 103 ~~~m~ 107 (108)
T d1rroa_ 103 QEMVH 107 (108)
T ss_dssp HHHHT
T ss_pred HHHHc
Confidence 99874
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.13 E-value=3.4e-06 Score=62.05 Aligned_cols=59 Identities=17% Similarity=0.151 Sum_probs=50.5
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|+.+|++.+|.|+..+.+.++-+ .|-. ..+.++.|++.+|.+++|.++|+||+.+|..
T Consensus 14 ~F~~fD~~~~G~I~~~el~~~l~~--lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~~ 73 (75)
T d1jc2a_ 14 CFRIFDKNADGFIDIEELGEILRA--TGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG 73 (75)
T ss_dssp HHHHHCCSTTSSEEHHHHHHHHHH--SSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHHHT
T ss_pred HHHHHcCCCcCeEcHHHHHHHHHh--cCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 999999999999999999988833 2222 2778999999999999999999999988753
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.11 E-value=3.1e-06 Score=60.40 Aligned_cols=58 Identities=12% Similarity=0.188 Sum_probs=49.3
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
.+|+.+|.+.+|.|+..+.+.++- .-|-.. .+.++.+++.++.+++|.|+|+||+.+|
T Consensus 7 ~aF~~fD~d~~G~I~~~el~~~l~--~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 7 EAFRVFDKDGNGYISAAELRHVMT--NLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHH--HTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHcCCCCCcCCHHHHHHHHH--HhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 489999999999999999998873 333233 6779999999999999999999999875
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.08 E-value=5.1e-06 Score=61.24 Aligned_cols=63 Identities=14% Similarity=0.234 Sum_probs=49.0
Q ss_pred hhHHHHHHH--HHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSA--YQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~--~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|.+ .+|.|+..+++.++-+ |+.=.-..+.++.|++.+|.+++|.|+|+||+.+|.++
T Consensus 9 ~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~ 74 (76)
T d1qx2a_ 9 GAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp HHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHHH
Confidence 389988764 3689999999988843 43211123469999999999999999999999998765
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.06 E-value=1.4e-06 Score=76.23 Aligned_cols=103 Identities=13% Similarity=0.106 Sum_probs=73.6
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChh---hHHHHHHHHHHHHhcCCCcEEEEc--cccc------CCc--
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPH---IYAVADSAYQDMMHHEEAQHIVLA--GETL------AGK-- 290 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph---~f~~~d~~~~~~~~~~~~q~i~~s--gesg------agk-- 290 (488)
+..++..+|.++++.|.+.||+............++ +|+++|.++.|.|+..+.+.++-+ +..+ ..+
T Consensus 62 ~~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~ 141 (187)
T d1g8ia_ 62 ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENT 141 (187)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSS
T ss_pred HHHHHHHhCcCCCCCCcHHHHHHHHHHhccCchhhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhcc
Confidence 344667778888899999999876543332222222 999999999999998887765421 1000 011
Q ss_pred -hhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 291 -TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 291 -te~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
.+.++.|++.+|.++||.|+++||+..+.. +||+|.
T Consensus 142 ~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p~~~~~l~ 181 (187)
T d1g8ia_ 142 PEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPSIVQALS 181 (187)
T ss_dssp HHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHCHHHHHHHC
T ss_pred HHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCHHHHHHHH
Confidence 356888999999999999999999998763 777763
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.02 E-value=4.7e-06 Score=61.57 Aligned_cols=59 Identities=8% Similarity=0.058 Sum_probs=50.6
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|+++|++.+|.|+..+.+.++ ..-|..- .+.++.|++.+|.+++|.|+|+||+.+|.+
T Consensus 14 ~F~~~D~d~~G~I~~~el~~~l--~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k 73 (77)
T d1oqpa_ 14 AFRLFDDDNSGTITIKDLRRVA--KELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKK 73 (77)
T ss_dssp HHHHHCTTCSSSEEHHHHHHHH--HHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred HHHHHcCCCCCEechHHHHHHH--HHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHc
Confidence 9999999999999999999888 3333333 678999999999999999999999988754
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.00 E-value=7.4e-06 Score=61.12 Aligned_cols=62 Identities=11% Similarity=0.095 Sum_probs=51.4
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+|..+|.+++|.|+..+.+.++- ..|.. ..+.++.|++.+|.+++|.|+|+||+..|.+.|
T Consensus 18 ~~F~~~D~d~~G~I~~~el~~~l~--~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~~k~ 80 (81)
T d1avsa_ 18 AAFDMFDADGGGDISTKELGTVMR--MLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQM 80 (81)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHH--HTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCeEchhHHHHHHH--HcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhc
Confidence 389999999999999999998883 23322 266789999999999999999999999886543
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=96.99 E-value=4.7e-06 Score=68.19 Aligned_cols=91 Identities=13% Similarity=0.129 Sum_probs=68.6
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC------hhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE------PHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKH 296 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~------ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~ 296 (488)
.+..++..+|.++++.|.+.||...+......... .++|+++|.+.+|.|+..+.+.++ .+.| .+.+..
T Consensus 37 ~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~~----~~~~-~~~~~~ 111 (134)
T d1jfja_ 37 LLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYKLMDVDGDGKLTKEEVTSFF----KKHG-IEKVAE 111 (134)
T ss_dssp HHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHH----TTTT-CHHHHH
T ss_pred HHHHHHHHhhhcccccccccccccccccccccccccccccccccccccccccCCcccHHHHHHHH----HhcC-cHHHHH
Confidence 44455677889999999999999877544332221 238999998888888888777665 2223 357888
Q ss_pred HHHHHHHhcCCCchhhhHhhhc
Q psy9090 297 LLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 297 i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
+++.+|.++||.|+++||+..|
T Consensus 112 ~~~~~D~d~dG~is~~EF~~~~ 133 (134)
T d1jfja_ 112 QVMKADANGDGYITLEEFLEFS 133 (134)
T ss_dssp HHHHHHCSSSSEEEHHHHHHHH
T ss_pred HHHHHCCCCCCCCCHHHHHHHh
Confidence 9999999999999999999876
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.98 E-value=2.4e-06 Score=74.37 Aligned_cols=101 Identities=10% Similarity=0.075 Sum_probs=68.9
Q ss_pred CceeeeCCC-CCCCCCCchhhhhccCCC-CCC---CChhhHHHHHHHHHHHHhcCCCcEEEEc--ccc-cCC-chh----
Q psy9090 226 DVLLFINPN-THLNLYGTKYHFKYKFKS-RSD---NEPHIYAVADSAYQDMMHHEEAQHIVLA--GET-LAG-KTT---- 292 (488)
Q Consensus 226 ~il~~Inp~-~~~~i~~~ef~~~~~~~~-~~~---~~ph~f~~~d~~~~~~~~~~~~q~i~~s--ges-gag-kte---- 292 (488)
.++..+|.+ +++.|.+.||+..+.... ... .-..+|+++|.+++|.|+..+...++-. |.. +.. ..+
T Consensus 61 rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~ 140 (180)
T d1xo5a_ 61 RICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQ 140 (180)
T ss_dssp HHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHH
T ss_pred HHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHH
Confidence 345556665 467899999997763221 111 1223899999999999999988876532 221 111 122
Q ss_pred hHHHHHHHHHHhcCCCchhhhHhhhcc--h-hhhhhh
Q psy9090 293 SLKHLLKHLIFLGQGAAKVGEKIEKCV--N-VIHAIG 326 (488)
Q Consensus 293 ~~k~i~~~~~~~~~g~~~~~e~i~~~~--~-~leafg 326 (488)
-+..+++.+|.++||.|+++||..++. | ++++|.
T Consensus 141 ~v~~~~~~~D~d~dG~Is~~EF~~~~~~~P~~~~~f~ 177 (180)
T d1xo5a_ 141 LIDNILEESDIDRDGTINLSEFQHVISRSPDFASSFK 177 (180)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHHHCHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHhCHHHHhhCe
Confidence 356688899999999999999998776 3 888883
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.94 E-value=5.3e-06 Score=70.08 Aligned_cols=117 Identities=11% Similarity=0.079 Sum_probs=76.5
Q ss_pred ccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCC----CCCCCCh---hhHHHHHHHHHHHHh
Q psy9090 201 TISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFK----SRSDNEP---HIYAVADSAYQDMMH 273 (488)
Q Consensus 201 ~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~----~~~~~~p---h~f~~~d~~~~~~~~ 273 (488)
.++...+...++. +........+..++..++++..+.+...++....... ......+ ++|+.+|.+.+|.|+
T Consensus 31 ~I~~~e~~~~l~~-lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~ 109 (156)
T d1dtla_ 31 SISTKELGKVMRM-LGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYID 109 (156)
T ss_dssp SBCHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHHHHHHHHHHHHCTTCSSEEE
T ss_pred eECHHHHHHHHHH-cCCCCCHHHHHHHHHHhhccCCCccchhhhhhhhhhcccccccccHHHHHHHHHHHhCcCCCCcCc
Confidence 3444444444432 2223333444555667777777777776666433221 1111111 389999999999999
Q ss_pred cCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 274 HEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 274 ~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
..+.+.++ ...|... .+.++.+++.++.++||.|+|+||+.+|.-
T Consensus 110 ~~e~~~~~--~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l~g 155 (156)
T d1dtla_ 110 LEELKIML--QATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 155 (156)
T ss_dssp HHHHGGGG--TTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC
T ss_pred HHHHHHHH--hhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHcC
Confidence 99998877 4444344 677899999999999999999999988753
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=96.93 E-value=8e-06 Score=60.92 Aligned_cols=60 Identities=10% Similarity=0.084 Sum_probs=50.4
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|+.+|.+.+|.|+..+.+.++-+ -|.-..+.++.|++.+|.+++|.|+++||+.+|..
T Consensus 10 ~~F~~~D~d~~G~I~~~El~~~l~~--lg~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~ 69 (81)
T d2opoa1 10 RIFKRFDTNGDGKISSSELGDALKT--LGSVTPDEVRRMMAEIDTDGDGFISFDEFTDFARA 69 (81)
T ss_dssp HHHHHHCTTCSSEEEHHHHHHHHHT--TTTCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCcHHHHHHHHHH--hhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 4899999999999999999887733 23224677999999999999999999999998754
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=96.89 E-value=7.9e-06 Score=60.96 Aligned_cols=59 Identities=20% Similarity=0.213 Sum_probs=50.3
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|+.+|.+++|.|+..+++.++-+ |+. -..+.++.|++.+|.+++|.|+|+||+.+|..
T Consensus 20 ~F~~~D~d~~G~I~~~el~~~l~~~g~~--~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~~ 79 (81)
T d1fi5a_ 20 LFRMFDKNADGYIDLEELKIMLQATGET--ITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 79 (81)
T ss_dssp HHHHHCSSCSSEECHHHHHHHHHTSSSC--CCHHHHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred HHHHHcCCCCCcccHHHHHHHHHhcCCC--CCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence 999999999999999999988743 331 12677999999999999999999999998764
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.85 E-value=6.3e-06 Score=72.08 Aligned_cols=105 Identities=13% Similarity=0.142 Sum_probs=74.9
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCCh---hhHHHHHHHHHHHHhcCCCcEEEEc-----cc--------
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEP---HIYAVADSAYQDMMHHEEAQHIVLA-----GE-------- 285 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p---h~f~~~d~~~~~~~~~~~~q~i~~s-----ge-------- 285 (488)
..+..++..+|.++++.|.+.||+..+.......... .+|+++|.+..|.++..+...++-+ +.
T Consensus 58 ~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~ 137 (189)
T d1jbaa_ 58 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAE 137 (189)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSS
T ss_pred HHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhh
Confidence 4566778899999999999999998775443333222 3999999998888877665543321 00
Q ss_pred -ccC--CchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 286 -TLA--GKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 286 -sga--gkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
.+. ...+.++.|++.+|.++||.|+++||+.+|.. +++.|.
T Consensus 138 ~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~~~~~~~p~i~~~l~ 184 (189)
T d1jbaa_ 138 QQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKWVMKMLQ 184 (189)
T ss_dssp TTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTTTTHHHHHH
T ss_pred hhccccchHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCHHHHHHhc
Confidence 000 01356789999999999999999999998863 666653
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.80 E-value=2.1e-06 Score=73.19 Aligned_cols=115 Identities=10% Similarity=0.080 Sum_probs=79.9
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCC----C---ChhhHHHHHHHHHHHHhc
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSD----N---EPHIYAVADSAYQDMMHH 274 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~----~---~ph~f~~~d~~~~~~~~~ 274 (488)
++..++...+. ..........+..++..+++++.+.+.+.+|+..+....... . .-.+|+.+|.+.+|.|+.
T Consensus 37 Is~~el~~~l~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~aF~~~D~d~~G~Is~ 115 (162)
T d1topa_ 37 ISTKELGTVMR-MLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDI 115 (162)
T ss_dssp EEGGGHHHHHH-HTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSCBCH
T ss_pred EcHHHHHHHHh-ccCCchhHHHHHhhhheeccCCCCCeeeehhhhhhhhhhhhhcccCcHHHHHHHHHHHCCCCCCCCcH
Confidence 44444443333 223333344555667778888888888888876664332111 0 112899999999999999
Q ss_pred CCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 275 EEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 275 ~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
.+.+.++ .+.|-.. .+.++.|++++|.++||.++++||+..|.
T Consensus 116 ~e~~~~l--~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~ 159 (162)
T d1topa_ 116 EELGEIL--RATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMME 159 (162)
T ss_dssp HHHHHHH--HTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHH--HhhCCCCCHHHHHHHHHHhCCCCCCcEEHHHHHHHHH
Confidence 9988777 4444333 77889999999999999999999998764
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=96.79 E-value=9.3e-06 Score=70.59 Aligned_cols=94 Identities=10% Similarity=0.027 Sum_probs=72.6
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCC---CCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHH
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRS---DNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLK 299 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~---~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~ 299 (488)
.+..++...+++..+.+.+.+|+......... +.-..+|..+|.+..|+|+..+.+.++ .+-| -..+.++.|++
T Consensus 47 ~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~e~l~~aF~~~D~d~~G~i~~~el~~~l--~~~g-l~~~ev~~~f~ 123 (182)
T d1s6ia_ 47 EIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQAC--KDFG-LDDIHIDDMIK 123 (182)
T ss_dssp HHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCSTHHHHHHTTTTCSSEEEHHHHHHTT--TTTT-CCTTHHHHHHH
T ss_pred cchhhhhhhhccccccchHHHHHHHHHhhcccccHHHHHHHHHHHhhcCCCccchhhhhhhh--hhcC-ccHHHHHHHHH
Confidence 34455667788888889999998766544332 233459999999999999888887776 3333 24678999999
Q ss_pred HHHHhcCCCchhhhHhhhcc
Q psy9090 300 HLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 300 ~~~~~~~g~~~~~e~i~~~~ 319 (488)
.+|.++||.++|+||+..|.
T Consensus 124 ~~D~d~DG~Is~~EF~~~m~ 143 (182)
T d1s6ia_ 124 EIDQDNDGQIDYGEFAAMMR 143 (182)
T ss_dssp HHCSSSSSEEETTHHHHTTS
T ss_pred HhhcCCCCeEeHHHHHHHHH
Confidence 99999999999999999876
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.79 E-value=5.3e-06 Score=73.33 Aligned_cols=124 Identities=12% Similarity=0.096 Sum_probs=80.0
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCC---CChhhHHHHHHHHHHHHhcCCCc
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSD---NEPHIYAVADSAYQDMMHHEEAQ 278 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~---~~ph~f~~~d~~~~~~~~~~~~q 278 (488)
++.++....+...........++..++..+|.++++.|++.||+.++....... .-..+|.++|.++.|.|+..+..
T Consensus 43 is~~EF~~~l~~~~~~~~~~~~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~is~~E~~ 122 (201)
T d1omra_ 43 ITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNEVL 122 (201)
T ss_dssp EEHHHHHHHHHHHCTTSCCHHHHHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCGGGSHHHHHHHHCTTCSSSBCHHHHH
T ss_pred ccHHHHHHHHHHhcCCCCHHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHHHHccCCCCccCHHHHH
Confidence 444444444443333333334455667788889999999999997664322222 12239999999999999888766
Q ss_pred EEEEc-cc-----cc--CC-----chhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhh
Q psy9090 279 HIVLA-GE-----TL--AG-----KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAI 325 (488)
Q Consensus 279 ~i~~s-ge-----sg--ag-----kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leaf 325 (488)
.++-+ ++ .. .. ..+.+..|++.+|.++||.|+++||+..+.. +++.+
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~~~~~~~~~l 185 (201)
T d1omra_ 123 EIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKKDDDKLTEKEFIEGTLANKEILRLI 185 (201)
T ss_dssp HHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCCTTCCBCHHHHHHHHHHCHHHHHHH
T ss_pred HHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHCHHHHHHh
Confidence 55432 11 00 00 1234678999999999999999999976543 55554
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=96.72 E-value=1.6e-05 Score=57.91 Aligned_cols=59 Identities=10% Similarity=0.155 Sum_probs=49.6
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|..+|.+.+|.|+..+...++-+ -|-. ..+.++.+++.+|.+++|.|+|+||+.+|.+
T Consensus 13 ~F~~~D~d~~G~I~~~el~~~l~~--~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~~ 72 (73)
T d2pq3a1 13 AFSLFDKDGDGTITTKELGTVMRS--LGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR 72 (73)
T ss_dssp HHHHTCTTSSSEEEGGGHHHHHHH--TTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHcCCCCceEeHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 899999999999999998887733 2211 2678999999999999999999999988754
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=96.72 E-value=1.2e-05 Score=69.86 Aligned_cols=103 Identities=10% Similarity=0.080 Sum_probs=72.8
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCC-CCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEc--ccccCCc-----hh
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKS-RSDNE---PHIYAVADSAYQDMMHHEEAQHIVLA--GETLAGK-----TT 292 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~-~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~s--gesgagk-----te 292 (488)
+..++...+.++++.|++.||+..+.... ..... .-+|.++|.+++|.|+..+...++.. ++.|.-. .+
T Consensus 56 ~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~ 135 (183)
T d2zfda1 56 ADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIED 135 (183)
T ss_dssp HHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHH
Confidence 34556777888889999999997653321 11111 12999999999999998888776542 2323111 23
Q ss_pred hHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhhh
Q psy9090 293 SLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAIG 326 (488)
Q Consensus 293 ~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leafg 326 (488)
.++.+++.+|.++||.++++||...+.. ++++|.
T Consensus 136 ~~~~if~~~D~d~dG~Is~~EF~~~~~~~p~~~~~~~ 172 (183)
T d2zfda1 136 IIDKTFEEADTKHDGKIDKEEWRSLVLRHPSLLKNMT 172 (183)
T ss_dssp HHHHHHHHHCSSCSSEECHHHHHHHHHHSGGGGGGGC
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHHHCHHHHHHcC
Confidence 3667889999999999999999988754 677764
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=96.71 E-value=1.3e-05 Score=59.94 Aligned_cols=59 Identities=12% Similarity=0.183 Sum_probs=49.4
Q ss_pred hHHHHHHHH-HHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAY-QDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~-~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|..+|.++ +|.|+..+++.++-+ |.. -..+.++.|++++|.+++|.++|+||+..|.+
T Consensus 20 ~F~~fD~d~~~G~I~~~el~~~l~~lg~~--~t~~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 20 AFDIFVLGAEDGSISTKELGKVMRMLGQN--PTPEELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHHTTTCTTSSBCHHHHHHHHHHTTCC--CCHHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHHcCcCCCCeEeHHHHHHHHHHcCCC--CCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 899999996 589999999988832 331 13778999999999999999999999998864
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.61 E-value=1.1e-05 Score=66.90 Aligned_cols=86 Identities=15% Similarity=0.178 Sum_probs=64.9
Q ss_pred eCCCCCCCCCCchhhhhccCCCCCCC--Ch----hhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHH
Q psy9090 231 INPNTHLNLYGTKYHFKYKFKSRSDN--EP----HIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIF 303 (488)
Q Consensus 231 Inp~~~~~i~~~ef~~~~~~~~~~~~--~p----h~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~ 303 (488)
++.+..+.+.+.+|+..+........ .+ ++|+++|.+.+|.|+..+.+.++-+ |+. =..+.++.|++.++.
T Consensus 46 ~~~~~~~~i~~~eF~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~--lt~~e~~~l~~~~d~ 123 (140)
T d1ggwa_ 46 IESTLPAEVDMEQFLQVLNRPNGFDMPGDPEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEK--LSNEEMDELLKGVPV 123 (140)
T ss_dssp HHTTSCSSEEHHHHHHHHCTTSSSSSSCCHHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSC--SCHHHHHHHHHHTTC
T ss_pred hhccccccccchhhhhhhhhhhhcchhhHHHHHHHHHHHHhccCCCcchHHHHHHHHHHcCCC--CCHHHHHHHHHhhCC
Confidence 34555677889999987754433222 22 3899999999999999999998832 431 136779999999997
Q ss_pred hcCCCchhhhHhhhcc
Q psy9090 304 LGQGAAKVGEKIEKCV 319 (488)
Q Consensus 304 ~~~g~~~~~e~i~~~~ 319 (488)
+ +|.|+|+||+.+|.
T Consensus 124 ~-dG~I~y~eF~~~m~ 138 (140)
T d1ggwa_ 124 K-DGMVNYHDFVQMIL 138 (140)
T ss_dssp S-SCCSTTTHHHHHHH
T ss_pred C-CCEEeHHHHHHHHh
Confidence 7 99999999998764
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=96.61 E-value=4.7e-05 Score=57.38 Aligned_cols=59 Identities=15% Similarity=0.205 Sum_probs=49.5
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
.+|..+|.+.+|.|+..+.+.++-+ .|.- ..+.++.|++.+|.+++|.++|+||+.+|.
T Consensus 27 ~~F~~~D~d~~G~I~~~el~~~l~~--lg~~~s~~e~~~l~~~~D~d~~g~I~~~EFl~am~ 86 (87)
T d1s6ja_ 27 ELFKMIDTDNSGTITFDELKDGLKR--VGSELMESEIKDLMDAADIDKSGTIDYGEFIAATV 86 (87)
T ss_dssp THHHHHCTTCSSCEEHHHHHHHHHT--TTSSCCHHHHHHHHHHHCTTCSSEECHHHHTTCCC
T ss_pred HHHHHHcCCCCCcCcHHHHHHHHHH--cCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHc
Confidence 4999999999999999999888733 2211 267899999999999999999999998773
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.58 E-value=1.1e-05 Score=68.82 Aligned_cols=95 Identities=9% Similarity=0.043 Sum_probs=68.5
Q ss_pred CceeeeCCCCCCCCCCchhhhhccCCCCCCCC----hhhHHHHHHHHHHHHhcCCCcEEEEc--ccccCC--chhhHHHH
Q psy9090 226 DVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE----PHIYAVADSAYQDMMHHEEAQHIVLA--GETLAG--KTTSLKHL 297 (488)
Q Consensus 226 ~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~----ph~f~~~d~~~~~~~~~~~~q~i~~s--gesgag--kte~~k~i 297 (488)
.++..+|+++.+.|++.||+..+......... ..+|+.+|.+.+|.|+..+...++.. |+.-.. ..+.++.+
T Consensus 52 ~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~ 131 (165)
T d1auib_ 52 RVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKT 131 (165)
T ss_dssp HHHHHHCTTCSSSEEHHHHHHHHGGGCTTCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHH
T ss_pred HHHHHHccccchhhhhhhhhhhccccccchhhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHH
Confidence 34556688888999999999877654333222 22899999999998888877766532 321111 14447789
Q ss_pred HHHHHHhcCCCchhhhHhhhcch
Q psy9090 298 LKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 298 ~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
++++|.++||.++++||+.+|..
T Consensus 132 ~~~~D~~~dG~Is~~EF~~i~~~ 154 (165)
T d1auib_ 132 IINADKDGDGRISFEEFCAVVGG 154 (165)
T ss_dssp HHHHCTTSSSSEEHHHHHHHHGG
T ss_pred HHHcCCCCCCcEeHHHHHHHHhc
Confidence 99999999999999999987763
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=96.56 E-value=1.1e-05 Score=67.82 Aligned_cols=88 Identities=13% Similarity=0.092 Sum_probs=64.9
Q ss_pred eeCCCCCCCCCCchhhhhccCCCCCC-CC-h---hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHH
Q psy9090 230 FINPNTHLNLYGTKYHFKYKFKSRSD-NE-P---HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIF 303 (488)
Q Consensus 230 ~Inp~~~~~i~~~ef~~~~~~~~~~~-~~-p---h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~ 303 (488)
..++++.+.|.+.+|+..+....... .. . ++|+.+|.+.+|.|+..+.+.++-+ .|-.- .+.++.|++.++.
T Consensus 52 ~~~~~~~~~i~~~eFl~~~~~~~~~~~~~~~~l~~aF~~~D~~~~G~I~~~el~~~l~~--~g~~ls~~e~~~l~~~~d~ 129 (152)
T d1wdcc_ 52 GTHKMGEKSLPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLTA--LGERLSDEDVDEIIKLTDL 129 (152)
T ss_dssp CCSSTTSCEECHHHHHHHHHHHTTSCCCCHHHHHHHHHTTCSSSSSEEEHHHHHHHHHH--SSSCCCHHHHHHHHHHHTC
T ss_pred hhhccccccccccccccccccccccchhHHHhhhhhhhccccccCccchHHHHHHHHHH--cCCCCCHHHHHHHHHHhcc
Confidence 45666777899999998775432221 11 1 3899999999999999999988832 23222 6679999999986
Q ss_pred h--cCCCchhhhHhhhcc
Q psy9090 304 L--GQGAAKVGEKIEKCV 319 (488)
Q Consensus 304 ~--~~g~~~~~e~i~~~~ 319 (488)
+ ++|.++|+||+..|.
T Consensus 130 ~~d~~G~I~y~eF~~~~~ 147 (152)
T d1wdcc_ 130 QEDLEGNVKYEDFVKKVM 147 (152)
T ss_dssp CCCTTSEEEHHHHHHHHH
T ss_pred CCCCCCEEEHHHHHHHHh
Confidence 5 457899999997753
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=96.55 E-value=3.3e-05 Score=58.88 Aligned_cols=64 Identities=8% Similarity=0.046 Sum_probs=49.7
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEc-cc--ccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLA-GE--TLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~s-ge--sgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
+|..+|.+ .|.|+..+.+.++-. +. .+.. ..+.++.||+.+|.++||.|+++||+.++..+.-|
T Consensus 14 ~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~~~ 81 (92)
T d1a4pa_ 14 TFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTIA 81 (92)
T ss_dssp HHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHHHHH
T ss_pred HHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHH
Confidence 77777877 799999999988742 11 1111 25678999999999999999999999998877644
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=96.55 E-value=8.5e-06 Score=60.11 Aligned_cols=61 Identities=10% Similarity=0.121 Sum_probs=50.9
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|..+|.+.+|.|+..++..++-+ .|-. ..+.++.|++.++.+++|.|+++||+.+|.+.
T Consensus 14 ~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~~~ 75 (77)
T d1f54a_ 14 EAFALFDKDNNGSISSSELATVMRS--LGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQ 75 (77)
T ss_dssp HHHHHTCTTCSSEEEHHHHHHHHHH--HTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHTTS
T ss_pred HHHHHHcCCCCCeEChHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 3899999999999999999887732 2322 26779999999999999999999999988654
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.54 E-value=7e-06 Score=71.16 Aligned_cols=98 Identities=14% Similarity=0.134 Sum_probs=69.4
Q ss_pred ccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCC---hhhHHHHHHHHHHHHhcCCCcEEEEc------ccc----c-C
Q psy9090 223 FVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNE---PHIYAVADSAYQDMMHHEEAQHIVLA------GET----L-A 288 (488)
Q Consensus 223 ~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~---ph~f~~~d~~~~~~~~~~~~q~i~~s------ges----g-a 288 (488)
.+..++...+.++++.+++.||+............ -++|..+|.+..|.|+..+...++-+ +.. + .
T Consensus 60 ~~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~ 139 (181)
T d1bjfa_ 60 FAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDES 139 (181)
T ss_dssp HHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGS
T ss_pred HHHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccc
Confidence 34556778888888899999998765443322211 23999999999888877766554421 000 1 1
Q ss_pred CchhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 289 GKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 289 gkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.-.+.++.|++.+|.++||.|+++||+..+..
T Consensus 140 ~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~~ 171 (181)
T d1bjfa_ 140 TPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKS 171 (181)
T ss_dssp SHHHHHHHHHHHSCTTCSSEECHHHHHHHHHH
T ss_pred cHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 12457889999999999999999999988753
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=96.51 E-value=7.1e-06 Score=68.46 Aligned_cols=90 Identities=10% Similarity=0.152 Sum_probs=64.1
Q ss_pred eeeeCCCCCCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHH
Q psy9090 228 LLFINPNTHLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLI 302 (488)
Q Consensus 228 l~~Inp~~~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~ 302 (488)
+...+.++...+.+.+|............+. .+|..+|++.+|.|+..+.+.++. .-|.. ..+.++.|+++++
T Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aF~~~D~d~~G~I~~~el~~~l~--~~g~~~~~~~~~~~~~~~d 129 (146)
T d1lkja_ 52 MNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLT--SIGEKLTDAEVDDMLREVS 129 (146)
T ss_dssp HHHHCSSSCCEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHCSSSSCEEEHHHHHHHHH--HHTCSCCHHHHHHHHHHHC
T ss_pred HHHhccCCcccccHHHHHHHHHHhhccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH--HcCCcccHHHHHHHHHhcc
Confidence 3334444455556667766554333322222 399999999999999999988773 33322 3778999999999
Q ss_pred HhcCCCchhhhHhhhcch
Q psy9090 303 FLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 303 ~~~~g~~~~~e~i~~~~~ 320 (488)
+++|.|+|+||+.+|++
T Consensus 130 -d~dG~I~~~eF~~~m~k 146 (146)
T d1lkja_ 130 -DGSGEINIQQFAALLSK 146 (146)
T ss_dssp -CSSSEEEHHHHHHHHCC
T ss_pred -CCCCeEeHHHHHHHhCC
Confidence 99999999999998864
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=96.50 E-value=3.4e-05 Score=59.01 Aligned_cols=66 Identities=11% Similarity=0.159 Sum_probs=49.9
Q ss_pred hHHHH-HHHHH-HHHhcCCCcEEEEc-cccc---CCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhh
Q psy9090 260 IYAVA-DSAYQ-DMMHHEEAQHIVLA-GETL---AGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAI 325 (488)
Q Consensus 260 ~f~~~-d~~~~-~~~~~~~~q~i~~s-gesg---agkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leaf 325 (488)
+|..+ |+++. |.|+..|++.++.. +... ....+.++.||+.+|.++||.|+|+||+.+|..+.-++
T Consensus 14 ~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~~~~ 85 (93)
T d1zfsa1 14 VFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALTVAC 85 (93)
T ss_dssp HHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHHHHHH
T ss_pred HHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHHHH
Confidence 55543 77764 78999999888743 2222 12368899999999999999999999999988776553
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.46 E-value=9.6e-06 Score=56.88 Aligned_cols=56 Identities=14% Similarity=0.125 Sum_probs=47.6
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIE 316 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~ 316 (488)
.+|..+|++.+|+|+..+.+.++-. -|... .+.++.|++.++.+++|.|+|+|||.
T Consensus 5 ~aF~~fD~~~~G~I~~~el~~~l~~--~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 5 KAFQVFDKESTGKVSVGDLRYMLTG--LGEKLTDAEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHCTTCCSCEEHHHHHHHHHH--TTCCCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred HHHHHHCCCCCCeEeHHHHHHHHHH--cCCCCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 4899999999999999999988843 22222 78899999999999999999999984
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=96.42 E-value=6.1e-06 Score=68.73 Aligned_cols=114 Identities=9% Similarity=0.107 Sum_probs=79.4
Q ss_pred cchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCC----CCChhhHHHHHHHHHHHHhcCCC
Q psy9090 202 ISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRS----DNEPHIYAVADSAYQDMMHHEEA 277 (488)
Q Consensus 202 l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~----~~~ph~f~~~d~~~~~~~~~~~~ 277 (488)
++.+++...+.. .........+..++..+|.++.+.+.+.+|+......... ..-..+|..+|.+.+|.|+..+.
T Consensus 26 Is~~e~~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~ 104 (146)
T d1exra_ 26 ITTKELGTVMRS-LGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAEL 104 (146)
T ss_dssp ECHHHHHHHHHH-HTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCSSCBCHHHH
T ss_pred ECHHHHHHHHHh-cCCCCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccChHHHHHHHHHHhCCCCCCcCCHHHH
Confidence 444444443332 2233334455666777889999999999998765322111 11123999999999999999998
Q ss_pred cEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhc
Q psy9090 278 QHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 278 q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
+.++ ...|-. ..+.+..++++++.++||.++|+||+..+
T Consensus 105 ~~~l--~~~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~~~l 144 (146)
T d1exra_ 105 RHVM--TNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMM 144 (146)
T ss_dssp HHHH--HHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHH
T ss_pred HHHH--HHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHh
Confidence 8877 333322 36789999999999999999999999865
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.38 E-value=9.1e-06 Score=70.21 Aligned_cols=125 Identities=11% Similarity=0.164 Sum_probs=80.3
Q ss_pred ccchhhHHHHHHhhhccCCcccccCCceeeeCCCCCCCCCCchhhhhccCCCCCC---CChhhHHHHHHHHHHHHhcCCC
Q psy9090 201 TISEDNIVQELEERHNSKNHYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSD---NEPHIYAVADSAYQDMMHHEEA 277 (488)
Q Consensus 201 ~l~e~~l~~~L~~r~~~~~~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~---~~ph~f~~~d~~~~~~~~~~~~ 277 (488)
.++.++...-+...........++..++..+|.++++.|.+.||+..+....... .-.++|.++|.+..|.++..+.
T Consensus 30 ~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~e~ 109 (178)
T d1s6ca_ 30 VVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEM 109 (178)
T ss_dssp EECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred CccHHHHHHHHHHhCCCCCHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHHhccchHHHHHHHHHhhccCCCCeecHHHH
Confidence 4555555555554444444444556678888999999999999987663222111 1223999999988887776655
Q ss_pred cEEEEc-----cc------ccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcch---hhhhh
Q psy9090 278 QHIVLA-----GE------TLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN---VIHAI 325 (488)
Q Consensus 278 q~i~~s-----ge------sgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~---~leaf 325 (488)
...+-+ +. +-....+.++.|++.+|.++||.|+++||..++.. +|+++
T Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~Is~~EF~~~i~~~~~~~~~l 171 (178)
T d1s6ca_ 110 MDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDDNIMRSL 171 (178)
T ss_dssp HHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCCHHHHHH
T ss_pred HHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCHHHHHHh
Confidence 432211 10 00112456788999999999999999999987664 45543
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.35 E-value=9.6e-06 Score=70.41 Aligned_cols=94 Identities=11% Similarity=0.182 Sum_probs=72.7
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccC-CchhhHHHHHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLA-GKTTSLKHLLKH 300 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesga-gkte~~k~i~~~ 300 (488)
..+..++..+|.++.+.|.+.||+..+.... ....+|..+|.+++|.|+..+.+.++.+ .|. -..+.++.+++.
T Consensus 56 ~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~~---~~~~~f~~~D~~~~G~i~~~el~~~l~~--~~~~l~~e~~~~~~~~ 130 (181)
T d1hqva_ 56 VTVRSIISMFDRENKAGVNFSEFTGVWKYIT---DWQNVFRTYDRDNSGMIDKNELKQALSG--FGYRLSDQFHDILIRK 130 (181)
T ss_dssp HHHHHHHHHHCCSSSSSBCHHHHHHHHHHHH---HHHHHHHHHCTTCCSSBCHHHHHHHHHH--HTBCCCHHHHHHHHHH
T ss_pred HHHHHHhhccccccccchhhhHHHhhhhhcc---ccccccccccccccchhhhHHHHHHHHH--cCCcchhHHHHHHHHH
Confidence 3444556677888889999999998775432 1235999999999999999998887733 222 237788999999
Q ss_pred HHHhcCCCchhhhHhhhcch
Q psy9090 301 LIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 301 ~~~~~~g~~~~~e~i~~~~~ 320 (488)
++.+++|.++|+||+..+..
T Consensus 131 ~d~~~dg~Is~~eF~~~~~~ 150 (181)
T d1hqva_ 131 FDRQGRGQIAFDDFIQGCIV 150 (181)
T ss_dssp HCSSCSSCBCHHHHHHHHHH
T ss_pred hCCCCCCcCcHHHHHHHHHH
Confidence 99999999999999987753
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=96.35 E-value=4.4e-05 Score=58.90 Aligned_cols=65 Identities=17% Similarity=0.081 Sum_probs=47.3
Q ss_pred HHHH-HHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhhccc
Q psy9090 265 DSAY-QDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNAG 329 (488)
Q Consensus 265 d~~~-~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafgna~ 329 (488)
|+++ .|.|+..+++.++-. +.......+.++.||+.+|.|+||.|+|+||+.++..+.-+.=.++
T Consensus 25 d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l~~~~~k~~ 91 (98)
T d1yuta1 25 RQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELAKEIRKKK 91 (98)
T ss_dssp TTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHHHHHHHHHTB
T ss_pred ccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHhHHH
Confidence 4555 488999998887732 1111112456999999999999999999999999988766543333
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=96.29 E-value=6.9e-05 Score=57.11 Aligned_cols=63 Identities=8% Similarity=0.043 Sum_probs=45.5
Q ss_pred hHH-HHHHHHHH-HHhcCCCcEEEEc-ccccCC---chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 260 IYA-VADSAYQD-MMHHEEAQHIVLA-GETLAG---KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 260 ~f~-~~d~~~~~-~~~~~~~q~i~~s-gesgag---kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
+|. .+|+++.+ .|+..+.+.+|-+ +.+..| ..+.++.||+.+|.|+||.|+|+||+.+|..+.
T Consensus 14 vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l~ 82 (93)
T d1ksoa_ 14 TFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC 82 (93)
T ss_dssp HHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHHH
T ss_pred HHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 443 34666776 4888888876632 111112 377899999999999999999999998887654
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=96.19 E-value=2.6e-05 Score=64.65 Aligned_cols=82 Identities=11% Similarity=0.036 Sum_probs=61.7
Q ss_pred CCCCCCCchhhhhccCCCCCCCCh----hhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHHHHHhcCCCc
Q psy9090 235 THLNLYGTKYHFKYKFKSRSDNEP----HIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKHLIFLGQGAA 309 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~~~p----h~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~~~~~~~g~~ 309 (488)
..+.+.+.+|+..+..+.....+. .+|+.+|++.+|.|+..+.+.++.+ |+. =..+.+..|++.++.+ +|.|
T Consensus 52 ~~~~i~~~eF~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~--lt~~e~~~l~~~~d~~-~G~I 128 (142)
T d1wdcb_ 52 APGPLNFTMFLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDN--FNKDEMRMTFKEAPVE-GGKF 128 (142)
T ss_dssp SSSCCCHHHHHHHHHHHTCSCCCHHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSC--CCHHHHHHHHHHCCEE-TTEE
T ss_pred ccCccccccccccccccccccchhhhHHHhhhhhcccCCCcccHHHHHHHHHHcccc--CCHHHHHHHHHHhCCC-CCEE
Confidence 346688899998775443332222 2899999999999999999988732 331 1367799999999877 6999
Q ss_pred hhhhHhhhcc
Q psy9090 310 KVGEKIEKCV 319 (488)
Q Consensus 310 ~~~e~i~~~~ 319 (488)
+|+||+.+|.
T Consensus 129 ~y~eF~~~l~ 138 (142)
T d1wdcb_ 129 DYVKFTAMIK 138 (142)
T ss_dssp CHHHHHHHHH
T ss_pred cHHHHHHHHh
Confidence 9999998874
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=96.17 E-value=9.6e-06 Score=70.92 Aligned_cols=92 Identities=8% Similarity=-0.007 Sum_probs=65.6
Q ss_pred CCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHh
Q psy9090 225 GDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFL 304 (488)
Q Consensus 225 ~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~ 304 (488)
..++..+|.+++|.|.+.||...+..... --.+|..+|++.+|.|+..+.+.++- +.|..-++....+|-..+.+
T Consensus 66 ~~li~~~D~d~~G~i~~~EF~~l~~~~~~---~~~~F~~~D~d~sG~i~~~El~~~l~--~~g~~~~~~~~~~l~~~~~~ 140 (188)
T d1qxpa2 66 RSMVNLMDRDGNGKLGLVEFNILWNRIRN---YLTIFRKFDLDKSGSMSAYEMRMAIE--AAGFKLPCQLHQVIVARFAD 140 (188)
T ss_dssp HHHHHHHCC--CCCCCSSSHHHHHHHHHH---HHHHHGGGCTTCCSCCBHHHHHHHHH--HTTEECCHHHHHHHHHHTSC
T ss_pred HHHHHHhcCCCCCcccHHHHHHHHhhhHH---HHHHHHHhCCCCCCEECHHHHHHHHH--HhhhcCCHHHHHHHHHHhcC
Confidence 44566778889999999999977643211 12489999999999999999998883 32322244455555555678
Q ss_pred cCCCchhhhHhhhcchh
Q psy9090 305 GQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 305 ~~g~~~~~e~i~~~~~~ 321 (488)
++|.++|+|||.+|..+
T Consensus 141 ~dg~i~f~eFi~~~~~l 157 (188)
T d1qxpa2 141 DELIIDFDNFVRCLVRL 157 (188)
T ss_dssp SSSBCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHH
Confidence 99999999999987653
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.15 E-value=2.2e-05 Score=60.83 Aligned_cols=62 Identities=11% Similarity=0.146 Sum_probs=47.1
Q ss_pred hh-hHHHHHHHHHHHHhcCCCcEEEEc-cc--ccCC------------chhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 258 PH-IYAVADSAYQDMMHHEEAQHIVLA-GE--TLAG------------KTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 258 ph-~f~~~d~~~~~~~~~~~~q~i~~s-ge--sgag------------kte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
|. +|+.+|.+++|.|+..+.+.++.+ ++ +.+. ..+.++.+++.+|.|+||.|+++||+.++.
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~~~ 95 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQ 95 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHh
Confidence 44 999999999999999988877632 11 0000 123477899999999999999999998875
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=96.11 E-value=1.6e-05 Score=69.25 Aligned_cols=92 Identities=9% Similarity=-0.006 Sum_probs=69.4
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIF 303 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~ 303 (488)
+..++..+|.++++.|.+.||...+.... .--.+|+.+|++.+|.|+..+.+.++-. .|---+.....++...+.
T Consensus 63 ~~~l~~~~D~d~~G~I~~~EF~~~~~~~~---~~~~~F~~~D~d~sG~I~~~El~~~l~~--~g~~~~~~~~~~~~~~d~ 137 (186)
T d1df0a1 63 CKIMVDMLDEDGSGKLGLKEFYILWTKIQ---KYQKIYREIDVDRSGTMNSYEMRKALEE--AGFKLPCQLHQVIVARFA 137 (186)
T ss_dssp HHHHHHHHCCSSSSEECHHHHHHHHHHHH---HHHHHHHHHCTTCCSCEEGGGHHHHHHH--TTEECCHHHHHHHHHHHC
T ss_pred HHHHHHHHcCCCCCcccHHHHHHHHHhHH---HHHHHHHhhCCCCCCcccHHHHHHHHHH--HHhcccHHHHHHHHHHHc
Confidence 45566778889999999999997764321 1124999999999999999999988832 221124455567777899
Q ss_pred hcCCCchhhhHhhhcch
Q psy9090 304 LGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 304 ~~~g~~~~~e~i~~~~~ 320 (488)
+++|.++|+||+..|..
T Consensus 138 d~dg~I~f~eFi~~~~~ 154 (186)
T d1df0a1 138 DDELIIDFDNFVRCLVR 154 (186)
T ss_dssp CSTTEECHHHHHHHHHH
T ss_pred CCCCeEeHHHHHHHHHH
Confidence 99999999999987765
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.11 E-value=5.5e-05 Score=64.44 Aligned_cols=90 Identities=10% Similarity=0.131 Sum_probs=68.5
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLI 302 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~ 302 (488)
+..++...|.++++.|.+.||...+.... .-..+|+.+|++.+|.|+..+.+.++ -+.|-- ..+.++.|++..+
T Consensus 42 ~~~li~~~D~~~~G~i~~~EF~~l~~~~~---~~~~~F~~fD~d~sG~I~~~El~~~l--~~~G~~l~~~~~~~l~~~~d 116 (165)
T d1k94a_ 42 CRIMIAMLDRDHTGKMGFNAFKELWAALN---AWKENFMTVDQDGSGTVEHHELRQAI--GLMGYRLSPQTLTTIVKRYS 116 (165)
T ss_dssp HHHHHHHHCTTCSSCBCHHHHHHHHHHHH---HHHHHHHHHCTTCCSBCCHHHHHHHH--HHTTCCCCHHHHHHHHHHHC
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHhhccc---hhHHHHHHhCCCCCCeEcHHHHHHHH--HHhhhcCCHHHHHHHHHHcC
Confidence 44556668999999999999998764321 11349999999999999999999888 333321 2677888988774
Q ss_pred HhcCCCchhhhHhhhcch
Q psy9090 303 FLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 303 ~~~~g~~~~~e~i~~~~~ 320 (488)
.+|.++|+||+..|..
T Consensus 117 --~~g~i~~~eFi~~~~~ 132 (165)
T d1k94a_ 117 --KNGRIFFDDYVACCVK 132 (165)
T ss_dssp --BTTBCBHHHHHHHHHH
T ss_pred --CCCcCcHHHHHHHHHH
Confidence 6789999999986654
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.02 E-value=1.2e-05 Score=66.29 Aligned_cols=97 Identities=8% Similarity=0.021 Sum_probs=71.0
Q ss_pred cccccCCceeeeCCCCCCCCCCchhhhhccCCCCCC----CChhhHHHHHHHHHHHHhcCCCcEEEEccccc-CCchhhH
Q psy9090 220 HYSFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSD----NEPHIYAVADSAYQDMMHHEEAQHIVLAGETL-AGKTTSL 294 (488)
Q Consensus 220 ~yt~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~----~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesg-agkte~~ 294 (488)
....+..++..+|+++.+.+.+.+|...+....... .--.+|..+|.+.+|.++..+.+.++ ...| .-..+.+
T Consensus 40 ~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~~f~~~d~~~~G~i~~~el~~~l--~~~g~~l~~~e~ 117 (141)
T d2obha1 40 KKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVA--KELGENLTDEEL 117 (141)
T ss_dssp CHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHH--HHTTCCCCHHHH
T ss_pred hHHHHHHHHHhhccCCCCeechHHHHHHHHHHHhhhccHHHHHHHHHHhcccCCCCccHHHHHHHH--HHhCCCCCHHHH
Confidence 334445556677788888888889887664332111 11249999999999999998888777 3333 1237789
Q ss_pred HHHHHHHHHhcCCCchhhhHhhhc
Q psy9090 295 KHLLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 295 k~i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
..+++.++.+++|.++|+||+.+|
T Consensus 118 ~~l~~~~D~d~dG~i~~~EF~~~m 141 (141)
T d2obha1 118 QEMIDEADRDGDGEVSEQEFLRIM 141 (141)
T ss_dssp HHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred HHHHHHHCCCCCCCEeHHHHHHhC
Confidence 999999999999999999999875
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=95.72 E-value=4.8e-05 Score=65.87 Aligned_cols=94 Identities=12% Similarity=0.127 Sum_probs=70.7
Q ss_pred cccCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEc-ccccCCchhhHHHHHHH
Q psy9090 222 SFVGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLA-GETLAGKTTSLKHLLKH 300 (488)
Q Consensus 222 t~v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~s-gesgagkte~~k~i~~~ 300 (488)
..+..++..+|.++.+.|.+.+|...+.... .-.++|..+|.+.+|.|+..+.+.++.. |. .-..+.++.+++.
T Consensus 54 ~~~~~l~~~~d~d~~~~i~~~ef~~~~~~~~---~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~--~ls~~e~~~i~~~ 128 (182)
T d1y1xa_ 54 ATTEKLLHMYDKNHSGEITFDEFKDLHHFIL---SMREGFRKRDSSGDGRLDSNEVRAALLSSGY--QVSEQTFQALMRK 128 (182)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH---HHHHHHHHHCTTSSSCBCHHHHHHHHHTTSC--CCCHHHHHHHHHH
T ss_pred hhhhhhhcccccccccccccccccccccccc---ccccchhccccccchhhhhHHHHHHHHHhCC--chhHHHHHHHHhh
Confidence 3344555566777788899999986554321 1245899999999999998888777732 32 1237889999999
Q ss_pred HHHhcCCCchhhhHhhhcch
Q psy9090 301 LIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 301 ~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|.+++|.++++||+..|..
T Consensus 129 ~d~~~dg~I~~~eF~~~~~~ 148 (182)
T d1y1xa_ 129 FDRQRRGSLGFDDYVELSIF 148 (182)
T ss_dssp HCTTCSSSBCHHHHHHHHHH
T ss_pred cccCCCCCcCHHHHHHHHHH
Confidence 99999999999999998864
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=95.71 E-value=6.7e-05 Score=64.25 Aligned_cols=92 Identities=11% Similarity=0.036 Sum_probs=69.4
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIF 303 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~ 303 (488)
+..++...+.++++.|.+.+|...+.... ....+|+.+|.+.+|.|+..+...++ ...|-.-++....++...+.
T Consensus 49 ~~~l~~~~d~d~~g~i~~~ef~~~~~~~~---~~~~~f~~~D~d~~G~I~~~el~~~L--~~~g~~~~~~~~~~~~~~d~ 123 (173)
T d1alva_ 49 CRSMVAVMDSDTTGKLGFEEFKYLWNNIK---KWQAIYKQFDVDRSGTIGSSELPGAF--EAAGFHLNEHLYSMIIRRYS 123 (173)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHHH---HHHHHHHHHCTTCCSSBCTTTHHHHH--HHHTCCCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccCCCCcccchhhhhhhhhhh---HHHHHHHHhccCCCCeecHHHHHHHH--HHHHHhhHHHHHHHhhcccc
Confidence 34456677888889999999987664321 12359999999999999999998877 33333345666666667788
Q ss_pred hcCCCchhhhHhhhcch
Q psy9090 304 LGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 304 ~~~g~~~~~e~i~~~~~ 320 (488)
+++|.++++||+.+|..
T Consensus 124 d~~G~i~~~EF~~~~~~ 140 (173)
T d1alva_ 124 DEGGNMDFDNFISCLVR 140 (173)
T ss_dssp CSSSCBCHHHHHHHHHH
T ss_pred CCCCeEeHHHHHHHHHH
Confidence 99999999999998865
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=95.66 E-value=4.7e-05 Score=56.09 Aligned_cols=62 Identities=18% Similarity=0.177 Sum_probs=44.8
Q ss_pred hHHHHHH--HHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 260 IYAVADS--AYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 260 ~f~~~d~--~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
+|..+|. +..|.|+..+.+.++-+=-.+-.+ .+.++.||+.+|.++||.|+|+||+.+|.++
T Consensus 12 ~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~l 76 (78)
T d1cb1a_ 12 IFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKKI 76 (78)
T ss_dssp HHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHHH
T ss_pred HHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 7776653 335788888888777331011122 4568999999999999999999999988664
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.45 E-value=0.00024 Score=54.31 Aligned_cols=64 Identities=14% Similarity=0.060 Sum_probs=51.4
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhh
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAI 325 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leaf 325 (488)
++|..+|++.+|.|+..+...++ -.+|. ..+.++.|++.+|.+++|.++++||+.+|.-+-.+-
T Consensus 14 ~~F~~~D~d~~G~is~~e~~~~l--~~~~l-~~~~l~~i~~~~D~d~dG~l~~~EF~~am~Li~~~~ 77 (95)
T d1c07a_ 14 EIFLKTDKDMDGFVSGLEVREIF--LKTGL-PSTLLAHIWSLCDTKDCGKLSKDQFALAFHLISQKL 77 (95)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHH--HTTTC-CHHHHHHHHHHHCTTCSSSEETTTHHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCcHHHHHHHH--HhcCC-CHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHH
Confidence 48999999999999988888777 33443 256799999999999999999999998885443333
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=95.23 E-value=0.00022 Score=61.10 Aligned_cols=87 Identities=11% Similarity=0.052 Sum_probs=61.4
Q ss_pred CCCCCCCCCCchhhhhccCCC-----CCCC-------ChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHH
Q psy9090 232 NPNTHLNLYGTKYHFKYKFKS-----RSDN-------EPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLK 299 (488)
Q Consensus 232 np~~~~~i~~~ef~~~~~~~~-----~~~~-------~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~ 299 (488)
++++.+.+..++|..++.... .... -..+|+.+|.+.+|.|+..+.+.++- ..|. ..+.++.|++
T Consensus 70 d~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~--~~~l-~~~~~~~~f~ 146 (185)
T d2sasa_ 70 DINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCK--NFQL-QCADVPAVYN 146 (185)
T ss_dssp CTTCSSCEEHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTT--SSCC-CCSSHHHHHH
T ss_pred CcCCCCcEeeeHhhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHH--HcCC-CHHHHHHHHH
Confidence 344455566677776553211 0000 12399999999999999999888762 2221 2477999999
Q ss_pred HHHHhcCCCchhhhHhhhcchh
Q psy9090 300 HLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 300 ~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
.+|.+++|.++++||+.+....
T Consensus 147 ~~D~d~dG~i~~~EF~~~~~~f 168 (185)
T d2sasa_ 147 VITDGGKVTFDLNRYKELYYRL 168 (185)
T ss_dssp HHHTTTTSCCSHHHHHHHHHHH
T ss_pred HcCCCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999877554
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=95.10 E-value=0.0048 Score=46.04 Aligned_cols=60 Identities=7% Similarity=0.006 Sum_probs=41.2
Q ss_pred HHHHHH-HHhcCCCcEEEEcc-cccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 265 DSAYQD-MMHHEEAQHIVLAG-ETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 265 d~~~~~-~~~~~~~q~i~~sg-esgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
|+++.+ .++..+.+..+-+- ..|..+ .++++.||+.+|.|+||+|+|+||+.++..+.-+
T Consensus 20 ~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~la~~ 82 (89)
T d1k8ua_ 20 GREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGALALI 82 (89)
T ss_dssp TSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHHHHH
T ss_pred ccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHHHH
Confidence 555554 35555555544220 012222 6779999999999999999999999999877644
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=94.89 E-value=0.0049 Score=45.74 Aligned_cols=54 Identities=11% Similarity=0.063 Sum_probs=40.6
Q ss_pred HHhcCCCcEEEEc-ccccC--Cc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 271 MMHHEEAQHIVLA-GETLA--GK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 271 ~~~~~~~q~i~~s-gesga--gk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
.++..+++.++-+ ..+.. .+ .+.++.+|+.+|.|+||.++|+||+.++..++-|
T Consensus 26 ~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l~~~ 83 (87)
T d1e8aa_ 26 TLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIALKA 83 (87)
T ss_dssp EECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHH
T ss_pred eEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHHHHH
Confidence 4677777766632 11111 12 6889999999999999999999999999887654
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=94.75 E-value=0.00029 Score=59.86 Aligned_cols=84 Identities=11% Similarity=0.068 Sum_probs=59.5
Q ss_pred CCCCCCchhhhhccCCCCCC-CC-------hhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCC
Q psy9090 236 HLNLYGTKYHFKYKFKSRSD-NE-------PHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQG 307 (488)
Q Consensus 236 ~~~i~~~ef~~~~~~~~~~~-~~-------ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g 307 (488)
...+...+|+..+....... .+ ..+|+.+|.+++|.|+..+...++ ...|.. .+.+..+++.+|.++||
T Consensus 67 ~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l--~~~~~~-~~~~~~~f~~~D~d~dG 143 (174)
T d2scpa_ 67 GKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFF--GMLGLD-KTMAPASFDAIDTNNDG 143 (174)
T ss_dssp TSCEEHHHHHHHHHHHTSCGGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHH--HHTTCC-GGGHHHHHHHHCTTCSS
T ss_pred CCcCcHHHHHHHHHhhhcchhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHH--HHHhhh-hHHHHHHHhhcCCCCCC
Confidence 34456667776553321111 11 128999999999999999888765 333432 45688999999999999
Q ss_pred CchhhhHhhhcchhh
Q psy9090 308 AAKVGEKIEKCVNVI 322 (488)
Q Consensus 308 ~~~~~e~i~~~~~~l 322 (488)
.|+++||+..+...+
T Consensus 144 ~Is~~Ef~~~~~~f~ 158 (174)
T d2scpa_ 144 LLSLEEFVIAGSDFF 158 (174)
T ss_dssp EECHHHHHHHHHHHH
T ss_pred cEeHHHHHHHHHHHh
Confidence 999999999876543
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=94.55 E-value=0.0057 Score=45.41 Aligned_cols=59 Identities=12% Similarity=0.005 Sum_probs=40.4
Q ss_pred HHHHHHHH-hcCCCcEEEEccccc-CCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 265 DSAYQDMM-HHEEAQHIVLAGETL-AGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 265 d~~~~~~~-~~~~~q~i~~sgesg-agkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
|+++.|.+ +..+.+.++ ..|.| .-+.+.++.||+.+|.++||.|+|+||+.++..+.=|
T Consensus 21 ~~dG~~~~l~~~Elk~ll-~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~la~~ 81 (87)
T d1xk4a1 21 LIKGNFHAVYRDDLKKLL-ETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMGVA 81 (87)
T ss_dssp TSSSCTTCBCHHHHHHHH-HHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHH
T ss_pred ccCCCCCccCHHHHHHHH-HHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHH
Confidence 45555533 445555444 22222 1136679999999999999999999999999876543
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.30 E-value=0.00017 Score=54.74 Aligned_cols=56 Identities=13% Similarity=0.140 Sum_probs=44.2
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhc
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
+|..+|.+.+|.|+..+...++ -.+|. .++.++.|++.+|.+++|.++++||+.+|
T Consensus 14 ~F~~~D~d~~G~i~~~e~~~~l--~~~~l-~~~~l~~i~~~~D~d~dG~l~~~EF~~a~ 69 (92)
T d1fi6a_ 14 QFKTIQPDLNGFIPGSAAKEFF--TKSKL-PILELSHIWELSDFDKDGALTLDEFCAAF 69 (92)
T ss_dssp HHTTTCCSTTCEEEHHHHHHHH--HHHSS-CHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHhCCCcccchhHHHHHHHH--HHccC-CHHHHHHHHHHhCCCCCCeecHHHHHHHH
Confidence 6777777777777777777666 33443 36789999999999999999999999665
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.26 E-value=0.00024 Score=52.71 Aligned_cols=58 Identities=12% Similarity=0.161 Sum_probs=46.6
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccC-CchhhHHHHHHHHHHhcCCCchhhhHhhhc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLA-GKTTSLKHLLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesga-gkte~~k~i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
.+|+.+|.+.+|.|+..+.+.++- ..|- -..+.++.+++.++.+++|.|+|.||+.+.
T Consensus 24 ~~F~~~D~~~~G~i~~~ef~~~l~--~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 24 QEFENFDTMKTNTISREEFRAICN--RRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp HHHHHHCTTCSSCBCHHHHHHHHH--HHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHHCCCCCceEChhHHHHHHH--HhCCCCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence 388888888888888888887762 2221 136789999999999999999999999864
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.21 E-value=0.00013 Score=59.74 Aligned_cols=80 Identities=8% Similarity=-0.015 Sum_probs=55.4
Q ss_pred CCCCCCchhhhhccCCC------CCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCC
Q psy9090 236 HLNLYGTKYHFKYKFKS------RSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGA 308 (488)
Q Consensus 236 ~~~i~~~ef~~~~~~~~------~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~ 308 (488)
.+.+++.+|........ ..+.--++|+.+|.+.+|.|+..+.+.++.+ .|-.. .+.++.|++. +.+++|.
T Consensus 52 ~~~i~~~ef~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~e~~~l~~~-~~d~dg~ 128 (139)
T d1w7jb1 52 SRRVDFETFLPMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTT--LGEKMTEEEVETVLAG-HEDSNGC 128 (139)
T ss_dssp TCEEEHHHHHHHHHHHCC--------CCHHHHHTTCTTSSSEEEHHHHHHHHHH--SSSCCCHHHHHHHHTT-CCCTTSE
T ss_pred CCceeeeccchhhHhhhhhccccHHHHHHHhhhhccCCCCCeEeHHHHHHHHHH--hCCCCCHHHHHHHHhh-CCCCCCe
Confidence 34466677765443211 1112235999999999999999999998833 33333 5667777764 7789999
Q ss_pred chhhhHhhhc
Q psy9090 309 AKVGEKIEKC 318 (488)
Q Consensus 309 ~~~~e~i~~~ 318 (488)
|+|.||+.+|
T Consensus 129 I~~~eF~~~l 138 (139)
T d1w7jb1 129 INYEAFLKHI 138 (139)
T ss_dssp EEHHHHHHHT
T ss_pred EeHHHHHHHh
Confidence 9999999876
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.18 E-value=0.00063 Score=52.24 Aligned_cols=58 Identities=10% Similarity=0.013 Sum_probs=48.1
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
++|..+|++.+|.|+..+.+.++ ..+|- ..+.++.|++.+|.+++|.++++||+.+|.
T Consensus 15 ~~F~~~D~d~~G~i~~~e~~~~l--~~s~L-~~~~L~~i~~~~D~d~dG~L~~~EF~~am~ 72 (99)
T d1qjta_ 15 KYYRQVEAGNTGRVLALDAAAFL--KKSGL-PDLILGKIWDLADTDGKGVLSKQEFFVALR 72 (99)
T ss_dssp HHHHHHCCTTSSCCCSHHHHHHH--HTSSS-CHHHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred HHHHHHCCCCCCcccHHHHHHHH--HHcCC-cHHHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence 58888899999988888887777 33443 267799999999999999999999998774
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=94.14 E-value=0.00075 Score=58.00 Aligned_cols=60 Identities=10% Similarity=0.085 Sum_probs=45.4
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+.+|.|+..+...++- ..|-+ ..+.++.|++.+|.++||.|+++||+.++..
T Consensus 111 ~~F~~~D~d~~G~is~~E~~~~l~--~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~~ 171 (189)
T d1qv0a_ 111 AVFDIFDKDGSGTITLDEWKAYGK--ISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHLG 171 (189)
T ss_dssp HHHHHTC----CEECHHHHHHHHH--HHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred HHHHHHccCCCCcccchhhHHHHH--hcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence 389999999999999998887763 33322 3677999999999999999999999987743
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=94.12 E-value=0.0095 Score=44.74 Aligned_cols=66 Identities=6% Similarity=-0.037 Sum_probs=46.5
Q ss_pred hHHHH-HHHHH-HHHhcCCCcEEEEc-ccc--c-CCchhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhh
Q psy9090 260 IYAVA-DSAYQ-DMMHHEEAQHIVLA-GET--L-AGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAI 325 (488)
Q Consensus 260 ~f~~~-d~~~~-~~~~~~~~q~i~~s-ges--g-agkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leaf 325 (488)
+|..+ ++++. |.|+..+.+.++-+ +.+ + .-..+.++.||+.+|.|+||.|+|+||+.+|..+..+.
T Consensus 14 ~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l~~~~ 85 (93)
T d3c1va1 14 TFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAMMC 85 (93)
T ss_dssp HHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHH
T ss_pred HHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHH
Confidence 45543 44443 35788887777733 111 1 11267799999999999999999999999998876543
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=93.60 E-value=0.00071 Score=57.98 Aligned_cols=58 Identities=9% Similarity=0.078 Sum_probs=48.5
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKC 318 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~ 318 (488)
.+|+++|.+.+|.|+..+.+.++ ...|-.. .+.++.+++.+|.++||.|+++||+.+.
T Consensus 109 ~~F~~~D~d~~G~Is~~El~~~l--~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~ 167 (187)
T d1uhka1 109 ALFDIVDKDQNGAITLDEWKAYT--KAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQH 167 (187)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHH--HHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHHH
T ss_pred HHHHHHccCCCcccchHHHHHHH--HHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHHHHH
Confidence 48999999999999999988777 3334333 6789999999999999999999998654
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.59 E-value=0.00066 Score=53.24 Aligned_cols=58 Identities=9% Similarity=-0.001 Sum_probs=48.5
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
++|..+|.+.+|+|+..+.+.++ ..+|. ..+.++.|++.+|.+++|.++++||+.+|.
T Consensus 26 ~lF~~~D~d~~G~Is~~e~~~~l--~~s~L-~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~ 83 (110)
T d1iq3a_ 26 NQFRSLQPDPSSFISGSVAKNFF--TKSKL-SIPELSYIWELSDADCDGALTLPEFCAAFH 83 (110)
T ss_dssp HHHHHHCCSSSSEEEHHHHHHHC--CSSSC-SSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred HHHHHhCCCcccchhHHHHHHHH--Hhhcc-chHHHHHHHHHhccCCCCeECHHHHHHHHH
Confidence 49999999999999988888877 33442 256799999999999999999999998764
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=93.44 E-value=0.00027 Score=58.35 Aligned_cols=58 Identities=14% Similarity=0.135 Sum_probs=48.4
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+|+.+|.+.+|.|+..+.+.++- ..|.. ..+.++.|+++++.+++|.|+|+||+.++.
T Consensus 86 ~F~~~D~~~~G~I~~~el~~~l~--~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i~ 144 (146)
T d1m45a_ 86 AFQVFDKESTGKVSVGDLRYMLT--GLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVL 144 (146)
T ss_dssp HHHTTCSSSSSEEEHHHHHHHHH--HSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHH
T ss_pred HHHhhccccccccchhhhhhhhc--ccCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHHHH
Confidence 79999999999999999988873 23322 267799999999999999999999997764
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.98 E-value=0.0012 Score=50.20 Aligned_cols=56 Identities=7% Similarity=0.036 Sum_probs=43.7
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+|..+| +.+|.|+..+...++ ..+|- ..+.++.|++.+|.+++|.++++||+..|.
T Consensus 15 ~F~~~D-~~~G~i~~~el~~~l--~~~gl-~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~ 70 (95)
T d2jxca1 15 IFDSLS-PVNGFLSGDKVKPVL--LNSKL-PVDILGRVWELSDIDHDGMLDRDEFAVAMF 70 (95)
T ss_dssp HHHHTC-CBTTEEEHHHHHHHH--TTSSC-CHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred HHHHhC-CCCCceeHHHHHHHH--HHcCC-CHHHHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence 777777 677877777777666 33442 256799999999999999999999987653
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=92.90 E-value=0.011 Score=45.02 Aligned_cols=65 Identities=9% Similarity=0.020 Sum_probs=46.1
Q ss_pred hHHHHHH--HHHHHHhcCCCcEEEEc-ccc-c---CCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhh
Q psy9090 260 IYAVADS--AYQDMMHHEEAQHIVLA-GET-L---AGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHA 324 (488)
Q Consensus 260 ~f~~~d~--~~~~~~~~~~~q~i~~s-ges-g---agk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~lea 324 (488)
+|.+|++ +..|.|+..|++.++-+ +.. . -.+ .+.++.||+.+|.|+||.|+|+||+.++..+.-+
T Consensus 12 l~~~F~~y~~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~~~ 84 (100)
T d1psra_ 12 MIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIATD 84 (100)
T ss_dssp HHHHHHHTCCTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHH
Confidence 5666665 55677777777776633 110 0 011 3468999999999999999999999998876544
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=92.41 E-value=0.029 Score=42.03 Aligned_cols=33 Identities=15% Similarity=0.166 Sum_probs=29.5
Q ss_pred chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 290 KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 290 kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
..+.++.||+.+|.|+||.++|+||+.++..+.
T Consensus 50 d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~la 82 (95)
T d1qlsa_ 50 DPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLA 82 (95)
T ss_dssp CTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence 478899999999999999999999998877654
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.07 E-value=0.0058 Score=51.29 Aligned_cols=62 Identities=13% Similarity=0.057 Sum_probs=47.0
Q ss_pred hHHHHHH--HHHHHHhcCCCcEEEEc-ccccCCc---hhhHHHHHHHHHHhcCCCchhhhHhhhcchh
Q psy9090 260 IYAVADS--AYQDMMHHEEAQHIVLA-GETLAGK---TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNV 321 (488)
Q Consensus 260 ~f~~~d~--~~~~~~~~~~~q~i~~s-gesgagk---te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~ 321 (488)
+|.+|++ +..|.|+..|+|.++-. |...... .+.++.||+.+|.+++|.++++||+..+..+
T Consensus 2 ~~~~F~~~a~~dG~I~~~EL~~~L~~~g~~~~~~~~s~~~~~~li~~~D~~~~G~i~~~EF~~l~~~~ 69 (165)
T d1k94a_ 2 VYTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAAL 69 (165)
T ss_dssp HHHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH
T ss_pred hHHHHHHhcCCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHhhcc
Confidence 4667775 55778999999988732 3322221 4789999999999999999999999877654
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=91.84 E-value=0.037 Score=40.97 Aligned_cols=32 Identities=13% Similarity=0.156 Sum_probs=28.8
Q ss_pred hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 291 TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 291 te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.+.++.+|+.+|.|+||+++|+||+..+..+.
T Consensus 51 ~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~la 82 (90)
T d3cr5x1 51 QEVVDKVMETLDSDGDGECDFQEFMAFVAMIT 82 (90)
T ss_dssp HHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 67899999999999999999999998876654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.00 E-value=0.03 Score=51.69 Aligned_cols=30 Identities=33% Similarity=0.428 Sum_probs=26.3
Q ss_pred CCCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 23 NHVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 23 ~givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
.|+||+|+.++||+++.+...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899998763
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.98 E-value=0.00055 Score=58.24 Aligned_cols=90 Identities=9% Similarity=0.097 Sum_probs=67.1
Q ss_pred cCCceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHH
Q psy9090 224 VGDVLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLI 302 (488)
Q Consensus 224 v~~il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~ 302 (488)
+..++...|.++++.|.+.||...+.... .-..+|+.+|.+.+|.|+..+.+.++- ..|.. ..+.++.+++..
T Consensus 49 v~~l~~~~D~d~~G~I~f~EF~~~~~~~~---~~~~~f~~~D~d~sG~i~~~El~~~l~--~~g~~ls~~~~~~l~~~~- 122 (172)
T d1juoa_ 49 CRLMVSMLDRDMSGTMGFNEFKELWAVLN---GWRQHFISFDTDRSGTVDPQELQKALT--TMGFRLSPQAVNSIAKRY- 122 (172)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHH---HHHHHHHTTCTTCCSEECHHHHHHHHH--HTTCCCCHHHHHHHHHHT-
T ss_pred HHHHHHHHCCCCCCceehHHHHHHHHhhh---hhhHHHHHhCcCCCCcCCHHHHHHHHH--HHHHhhhHHHHHHHHHHH-
Confidence 45566778899999999999997664321 123489999999999999888887762 22222 366788888887
Q ss_pred HhcCCCchhhhHhhhcch
Q psy9090 303 FLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 303 ~~~~g~~~~~e~i~~~~~ 320 (488)
+.+|.+++++|+.+|..
T Consensus 123 -d~~g~i~~~eF~~~~~~ 139 (172)
T d1juoa_ 123 -STNGKITFDDYIACCVK 139 (172)
T ss_dssp -CSSSSEEHHHHHHHHHH
T ss_pred -HhcCCcCHHHHHHHHHH
Confidence 46788999999988865
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=90.80 E-value=0.0022 Score=53.82 Aligned_cols=59 Identities=10% Similarity=0.109 Sum_probs=46.8
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+..|.|+..+.+.++ ...|. -.+.++.+++.+|.+++|.++++||+..+..
T Consensus 106 ~~F~~~D~d~dG~Is~~E~~~~~--~~~~~-~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~ 164 (176)
T d1nyaa_ 106 GIVGMCDKNADGQINADEFAAWL--TALGM-SKAEAAEAFNQVDTNGNGELSLDELLTAVRD 164 (176)
T ss_dssp HHHHHTCSSCCSEEEHHHHHHHH--HHTTC-CHHHHHHHHHHHCTTCSSEEEHHHHHHHHSC
T ss_pred HHHHHHccCCChhhhHHHHHHHH--HhcCC-cHHHHHHHHHHHCCCCCCcEeHHHHHHHHHH
Confidence 38888888888888888887655 22232 2577899999999999999999999987654
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=90.70 E-value=0.0031 Score=50.40 Aligned_cols=60 Identities=17% Similarity=0.105 Sum_probs=46.9
Q ss_pred hhhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcc
Q psy9090 258 PHIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCV 319 (488)
Q Consensus 258 ph~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~ 319 (488)
+.+|..+|.+++|.|+..+.+.++- .-|.. ..+.++.+++.++.+++|.++++||+..+.
T Consensus 3 e~~F~~~D~d~dG~is~~E~~~~l~--~~~~~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~ 63 (134)
T d1jfja_ 3 EALFKEIDVNGDGAVSYEEVKAFVS--KKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYG 63 (134)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHH--TTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTT
T ss_pred HHHHHHHcCCCcCCCcHHHHHHHHH--HcCCCCCHHHHHHHHHHhhhcccccccccccccccc
Confidence 4588899999999888888877662 22222 256788899999999999999999997653
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=90.57 E-value=0.0058 Score=52.03 Aligned_cols=61 Identities=8% Similarity=0.093 Sum_probs=49.4
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|..+|.+++|.|+..+.+.++-+.-.-.-..+.++.+++.++.+++|.++++||+..+..
T Consensus 24 iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~ 84 (181)
T d1hqva_ 24 VFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKY 84 (181)
T ss_dssp HHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHHHHHHH
T ss_pred HHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHHhhhhh
Confidence 9999999999999999998877442110123578899999999999999999999987754
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=89.82 E-value=0.004 Score=57.73 Aligned_cols=88 Identities=11% Similarity=0.079 Sum_probs=63.4
Q ss_pred ceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccC--CchhhHHHHHHHHHHh
Q psy9090 227 VLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLA--GKTTSLKHLLKHLIFL 304 (488)
Q Consensus 227 il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesga--gkte~~k~i~~~~~~~ 304 (488)
++...+.+..+.+.+.+|...+.... ....+|+.+|.+.+|.|+..+.+.++ ...|. -..+.+..|++.+|.+
T Consensus 228 ~~~~~~~~~~~~i~~~ef~~~~~~~~---~~~~~F~~~D~d~~G~Is~~E~~~~l--~~~~~~~~~~~~~~~l~~~~D~d 302 (321)
T d1ij5a_ 228 LFRYADEDESDDVGFSEYVHLGLCLL---VLRILYAFADFDKSGQLSKEEVQKVL--EDAHIPESARKKFEHQFSVVDVD 302 (321)
T ss_dssp HHHHHCTTCSSCEEHHHHHHHHHHHH---HHHHHHHHTCSSSCSSEEHHHHHHHH--HHTTCCGGGCSTHHHHHHHHTTT
T ss_pred HHHhhhcccccccccccccchhhhhh---HHHHHHHHHhcCCCCCCcHHHHHHHH--HHcCCCcCcHHHHHHHHHHhCCC
Confidence 34455566666666777765443221 12348889999999999998888887 23332 1256789999999999
Q ss_pred cCCCchhhhHhhhcc
Q psy9090 305 GQGAAKVGEKIEKCV 319 (488)
Q Consensus 305 ~~g~~~~~e~i~~~~ 319 (488)
+||.|+|+||+.+|.
T Consensus 303 ~dG~Is~~EF~~~ml 317 (321)
T d1ij5a_ 303 DSKSLSYQEFVMLVL 317 (321)
T ss_dssp TCSEECHHHHHHHHH
T ss_pred CCCcCcHHHHHHHHH
Confidence 999999999999874
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=89.79 E-value=0.064 Score=38.91 Aligned_cols=30 Identities=13% Similarity=0.104 Sum_probs=26.5
Q ss_pred hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 291 TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 291 te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
...+..+|+.+|.|+||+++|+||+..+..
T Consensus 53 ~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~ 82 (83)
T d1xk4c1 53 EKVIEHIMEDLDTNADKQLSFEEFIMLMAR 82 (83)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence 456899999999999999999999987643
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=89.60 E-value=0.051 Score=40.51 Aligned_cols=32 Identities=22% Similarity=0.220 Sum_probs=28.4
Q ss_pred hhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 291 TTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 291 te~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
.++++.+|+.+|.++||+++|+||+..+..+.
T Consensus 51 ~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~la 82 (94)
T d1j55a_ 51 KDAVDKLLKDLDANGDAQVDFSEFIVFVAAIT 82 (94)
T ss_dssp -CHHHHHHHHHCSSSSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 67799999999999999999999999887654
|
| >d2i3ba1 c.37.1.11 (A:1-189) Cancer-related NTPase, C1orf57 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: RecA protein-like (ATPase-domain) domain: Cancer-related NTPase, C1orf57 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.99 E-value=0.1 Score=43.02 Aligned_cols=28 Identities=32% Similarity=0.399 Sum_probs=24.7
Q ss_pred cEEEEcccccCCchhhHHHHHHHHHHhc
Q psy9090 278 QHIVLAGETLAGKTTSLKHLLKHLIFLG 305 (488)
Q Consensus 278 q~i~~sgesgagkte~~k~i~~~~~~~~ 305 (488)
++|+|+|+.|+|||.-++.+++.+...+
T Consensus 2 k~v~ItG~~GtGKTtl~~~i~~~l~~~~ 29 (189)
T d2i3ba1 2 RHVFLTGPPGVGKTTLIHKASEVLKSSG 29 (189)
T ss_dssp CCEEEESCCSSCHHHHHHHHHHHHHHTT
T ss_pred cEEEEECCCCCcHHHHHHHHHHHHHHCC
Confidence 5689999999999999999999887654
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.84 E-value=0.017 Score=48.45 Aligned_cols=64 Identities=11% Similarity=0.033 Sum_probs=47.0
Q ss_pred ChhhHHHHHH--HHHHHHhcCCCcEEEEcccccC---C---chhhHHHHHHHHHHhcCCCchhhhHhhhcchhh
Q psy9090 257 EPHIYAVADS--AYQDMMHHEEAQHIVLAGETLA---G---KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVI 322 (488)
Q Consensus 257 ~ph~f~~~d~--~~~~~~~~~~~q~i~~sgesga---g---kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~l 322 (488)
++.++..|++ +.+|.|+..|+|.++- +.|. + ..+.++.+++.++.+++|.|+++||+.++....
T Consensus 6 ~~~~~~~F~~~~~~dG~Is~~EL~~~L~--~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~~~~~~~~ 77 (172)
T d1juoa_ 6 QDPLYGYFAAVAGQDGQIDADELQRCLT--QSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVLN 77 (172)
T ss_dssp CCTTHHHHHHHHTTTTEECHHHHHHHHH--HHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCHHHHHHHHH--HcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHHHHHHhhh
Confidence 3444444443 4568999999998873 3331 1 147899999999999999999999998876543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=88.04 E-value=0.097 Score=46.32 Aligned_cols=29 Identities=28% Similarity=0.392 Sum_probs=24.7
Q ss_pred CCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 24 HVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 24 givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
.++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEEeeccCcceeecCCceEEEeechhcc
Confidence 38999999999999876666799998764
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=88.03 E-value=0.057 Score=43.54 Aligned_cols=92 Identities=11% Similarity=-0.053 Sum_probs=65.3
Q ss_pred ceeeeCCCCCCCCCCchhhhhccCCCCCCCChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcC
Q psy9090 227 VLLFINPNTHLNLYGTKYHFKYKFKSRSDNEPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQ 306 (488)
Q Consensus 227 il~~Inp~~~~~i~~~ef~~~~~~~~~~~~~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~ 306 (488)
++...|+++++.|...++..++.........+......+.+.+|.++..+-..++..--......+.++.+.+.+|.+++
T Consensus 12 ~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~aF~~fD~~~~ 91 (145)
T d2mysb_ 12 AFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEASGPINFTVFLTMFGEKLKGADPEDVIMGAFKVLDPDGK 91 (145)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHHHHHHHHHhccCceeechhhhhhhhcccccchHHHHHHHHHhhhhccc
Confidence 36667889999999999988775443333345567777777777777666655553222222235678899999999999
Q ss_pred CCchhhhHhhhc
Q psy9090 307 GAAKVGEKIEKC 318 (488)
Q Consensus 307 g~~~~~e~i~~~ 318 (488)
|.|+.+++...+
T Consensus 92 g~I~~~el~~~l 103 (145)
T d2mysb_ 92 GSIKKSFLEELL 103 (145)
T ss_pred chhhHHHHHHHH
Confidence 999999988754
|
| >d1iqpa2 c.37.1.20 (A:2-232) Replication factor C {Archaeon Pyrococcus furiosus [TaxId: 2261]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Extended AAA-ATPase domain domain: Replication factor C species: Archaeon Pyrococcus furiosus [TaxId: 2261]
Probab=86.71 E-value=0.27 Score=42.55 Aligned_cols=34 Identities=26% Similarity=0.410 Sum_probs=28.5
Q ss_pred HHHHhcCCCcEEEEcccccCCchhhHHHHHHHHH
Q psy9090 269 QDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLI 302 (488)
Q Consensus 269 ~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~ 302 (488)
..++.......++++|++|.|||..++.+.+++-
T Consensus 37 ~~~i~~~~~~~lll~Gp~G~GKTtla~~iak~l~ 70 (231)
T d1iqpa2 37 KHYVKTGSMPHLLFAGPPGVGKTTAALALARELF 70 (231)
T ss_dssp HHHHHHTCCCEEEEESCTTSSHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCeEEEECCCCCcHHHHHHHHHHHHH
Confidence 3345666778899999999999999999999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=86.30 E-value=0.11 Score=45.66 Aligned_cols=29 Identities=21% Similarity=0.205 Sum_probs=24.8
Q ss_pred CCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 24 HVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 24 givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
.++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 38999999999999976667899998764
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=85.39 E-value=0.0079 Score=51.54 Aligned_cols=94 Identities=16% Similarity=0.151 Sum_probs=64.2
Q ss_pred CCCCCchhhhhccCCCCCCC----ChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhh
Q psy9090 237 LNLYGTKYHFKYKFKSRSDN----EPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312 (488)
Q Consensus 237 ~~i~~~ef~~~~~~~~~~~~----~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~ 312 (488)
+.+...+|...+........ ..++|..+|.+.+|.|+..+..+.+ +.-+..-..+.++.+.+.+|.+++|.++.+
T Consensus 41 G~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~D~~~~G~I~~~Ef~~~~-~~~~~~~~~e~~~~~F~~~D~d~dG~is~~ 119 (190)
T d1fpwa_ 41 GQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVL-STTSRGTLEEKLSWAFELYDLNHDGYITFD 119 (190)
T ss_dssp CCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHH-HHHSCCCSTHHHHHHHHHHCSSCSSEEEHH
T ss_pred CCccHHHHHHHHHHHCCCCChHHHHHHHHHHhCcCCCCcccHHHHHHHH-HHHccCchHHHHHHHHHHhccCCCCcCcHH
Confidence 44566777766543221111 2358999999988887777765433 111112247889999999999999999999
Q ss_pred hHhhhcchhhhhhhccccC
Q psy9090 313 EKIEKCVNVIHAIGNAGTP 331 (488)
Q Consensus 313 e~i~~~~~~leafgna~t~ 331 (488)
|+...+..+....+...+.
T Consensus 120 E~~~~~~~~~~~~~~~~~~ 138 (190)
T d1fpwa_ 120 EMLTIVASVYKMMGSMVTL 138 (190)
T ss_dssp HHHHHHHHHHTTSCSTTSS
T ss_pred HHHHHHHHHHHhcccccCC
Confidence 9999888887766655443
|
| >d1np6a_ c.37.1.10 (A:) Molybdopterin-guanine dinucleotide biosynthesis protein MobB {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Nitrogenase iron protein-like domain: Molybdopterin-guanine dinucleotide biosynthesis protein MobB species: Escherichia coli [TaxId: 562]
Probab=84.64 E-value=0.26 Score=39.92 Aligned_cols=27 Identities=37% Similarity=0.374 Sum_probs=23.3
Q ss_pred EEEEcccccCCchhhHHHHHHHHHHhc
Q psy9090 279 HIVLAGETLAGKTTSLKHLLKHLIFLG 305 (488)
Q Consensus 279 ~i~~sgesgagkte~~k~i~~~~~~~~ 305 (488)
.|.|+|.+|||||--++.+++++...|
T Consensus 4 vi~itG~~GSGKTTL~~~L~~~l~~~g 30 (170)
T d1np6a_ 4 LLAFAAWSGTGKTTLLKKLIPALCARG 30 (170)
T ss_dssp EEEEECCTTSCHHHHHHHHHHHHHHTT
T ss_pred EEEEEcCCCCCHHHHHHHHHHHHHHCC
Confidence 467889999999999999999988654
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=84.64 E-value=0.02 Score=48.46 Aligned_cols=92 Identities=10% Similarity=0.097 Sum_probs=61.4
Q ss_pred CCCCCCCchhhhhccCCCCCCC--ChhhHHHHHHHHHHHHhcCCCcEEEEcccccCCchhhHHHHHHHHHHhcCCCchhh
Q psy9090 235 THLNLYGTKYHFKYKFKSRSDN--EPHIYAVADSAYQDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLIFLGQGAAKVG 312 (488)
Q Consensus 235 ~~~~i~~~ef~~~~~~~~~~~~--~ph~f~~~d~~~~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~~~~~g~~~~~ 312 (488)
+++.+...+|...+........ ..++|..+|.+.+|.|+..+--..+-.-...+...+.++.+.+.+|.+++|.|+.+
T Consensus 32 ~~G~i~~~ef~~~l~~~~~~~~~~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~ 111 (183)
T d2zfda1 32 DDGLINKEEFQLALFKTNKKESLFADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQ 111 (183)
T ss_dssp CSSSBCHHHHHHHHHSCSSCCCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHH
T ss_pred CCCcCcHHHHHHHHHhcCCCCCHHHHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccCCCCCccHH
Confidence 4567778888665533322221 24589999988877766555432221111122246779999999999999999999
Q ss_pred hHhhhcchhhhhhh
Q psy9090 313 EKIEKCVNVIHAIG 326 (488)
Q Consensus 313 e~i~~~~~~leafg 326 (488)
|+...+..++...|
T Consensus 112 e~~~~~~~~~~~~~ 125 (183)
T d2zfda1 112 EVKQMVVATLAESG 125 (183)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhhhh
Confidence 99998888776544
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=84.15 E-value=0.018 Score=49.11 Aligned_cols=59 Identities=8% Similarity=0.005 Sum_probs=33.6
Q ss_pred hHHHHHHHH-HHHHhcCCCcEEEEcccccCCc-hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 260 IYAVADSAY-QDMMHHEEAQHIVLAGETLAGK-TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 260 ~f~~~d~~~-~~~~~~~~~q~i~~sgesgagk-te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
+|+-|.++. +|.|+..+.+.++ +..|... ...++.|++.+|.+++|.|++.||+..+..
T Consensus 26 ~~~~F~~~~~~G~i~~~Ef~~~l--~~~~~~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~ 86 (189)
T d1jbaa_ 26 WYKKFLEECPSGTLFMHEFKRFF--KVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNL 86 (189)
T ss_dssp HHHHHHSSSTTCCEEHHHHHHHH--HCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred HHHHhcccCCCCeeeHHHHHHHH--HHcCCCccHHHHHHHHHHhccCCCCeEeehhHHHHHHh
Confidence 445544432 4555555555554 3333333 445667777777777777777777766543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=84.06 E-value=0.27 Score=45.15 Aligned_cols=27 Identities=30% Similarity=0.439 Sum_probs=22.1
Q ss_pred CCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 24 HVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 24 givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
++||+|+.|.|||++. + ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 6899999999999974 3 4589998764
|
| >d1ye8a1 c.37.1.11 (A:1-178) Hypothetical kinase-like protein Aq_1292 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: RecA protein-like (ATPase-domain) domain: Hypothetical kinase-like protein Aq 1292 species: Aquifex aeolicus [TaxId: 63363]
Probab=83.09 E-value=0.25 Score=40.58 Aligned_cols=27 Identities=33% Similarity=0.449 Sum_probs=23.0
Q ss_pred EEEEcccccCCchhhHHHHHHHHHHhc
Q psy9090 279 HIVLAGETLAGKTTSLKHLLKHLIFLG 305 (488)
Q Consensus 279 ~i~~sgesgagkte~~k~i~~~~~~~~ 305 (488)
.|+|.|++|+|||.-++.|+..+....
T Consensus 2 ki~I~G~~G~GKSTLl~~i~~~l~~~~ 28 (178)
T d1ye8a1 2 KIIITGEPGVGKTTLVKKIVERLGKRA 28 (178)
T ss_dssp EEEEECCTTSSHHHHHHHHHHHHGGGE
T ss_pred EEEEECCCCcHHHHHHHHHHhcCCCCc
Confidence 378899999999999999998887553
|
| >d1sxjd2 c.37.1.20 (D:26-262) Replication factor C2 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Extended AAA-ATPase domain domain: Replication factor C2 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=83.08 E-value=0.42 Score=41.19 Aligned_cols=34 Identities=24% Similarity=0.407 Sum_probs=28.2
Q ss_pred HHHHhcCCCcEEEEcccccCCchhhHHHHHHHHH
Q psy9090 269 QDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLI 302 (488)
Q Consensus 269 ~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~ 302 (488)
..++.......++++|++|.|||..++.+.+++.
T Consensus 25 ~~~i~~~~~~~lll~Gp~G~GKTtl~~~i~~~l~ 58 (237)
T d1sxjd2 25 KKTLKSANLPHMLFYGPPGTGKTSTILALTKELY 58 (237)
T ss_dssp HHHTTCTTCCCEEEECSTTSSHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCeEEEECCCCCChHHHHHHHHHHHc
Confidence 3455566667799999999999999999999875
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=82.88 E-value=0.011 Score=47.82 Aligned_cols=67 Identities=10% Similarity=0.145 Sum_probs=47.9
Q ss_pred hHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcchhhhhhhcc
Q psy9090 260 IYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVNVIHAIGNA 328 (488)
Q Consensus 260 ~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~~leafgna 328 (488)
+|..+|.+.+|.|+..+.+.++ ..-|.. ....++.+++.++.+++|.+++++|+..+...+....++
T Consensus 14 ~F~~~D~~~~G~Is~~e~~~~l--~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~ 81 (146)
T d1exra_ 14 AFALFDKDGDGTITTKELGTVM--RSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSE 81 (146)
T ss_dssp HHHHHCTTCSSEECHHHHHHHH--HHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCeECHHHHHHHH--HhcCCCCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccChH
Confidence 6777777777777777776655 333322 256678899999999999999999998876655444433
|
| >d1gkya_ c.37.1.1 (A:) Guanylate kinase {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Nucleotide and nucleoside kinases domain: Guanylate kinase species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=82.87 E-value=0.28 Score=41.09 Aligned_cols=24 Identities=38% Similarity=0.513 Sum_probs=20.2
Q ss_pred EEEEcccccCCchhhHHHHHHHHH
Q psy9090 279 HIVLAGETLAGKTTSLKHLLKHLI 302 (488)
Q Consensus 279 ~i~~sgesgagkte~~k~i~~~~~ 302 (488)
-|+++|.||+||+.-.+.+++...
T Consensus 3 pIvl~GpsG~GK~tl~~~L~~~~~ 26 (186)
T d1gkya_ 3 PIVISGPSGTGKSTLLKKLFAEYP 26 (186)
T ss_dssp CEEEECCTTSSHHHHHHHHHHHCT
T ss_pred eEEEECCCCCCHHHHHHHHHHhCC
Confidence 388999999999988888887654
|
| >d1lvga_ c.37.1.1 (A:) Guanylate kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Nucleotide and nucleoside kinases domain: Guanylate kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=82.12 E-value=0.33 Score=40.83 Aligned_cols=23 Identities=43% Similarity=0.593 Sum_probs=20.2
Q ss_pred EEEcccccCCchhhHHHHHHHHH
Q psy9090 280 IVLAGETLAGKTTSLKHLLKHLI 302 (488)
Q Consensus 280 i~~sgesgagkte~~k~i~~~~~ 302 (488)
|+|+|.||+||+.-++.+++...
T Consensus 3 Ivl~GPsGsGK~tl~~~L~~~~~ 25 (190)
T d1lvga_ 3 VVLSGPSGAGKSTLLKKLFQEHS 25 (190)
T ss_dssp EEEECCTTSSHHHHHHHHHHHHT
T ss_pred EEEECCCCCCHHHHHHHHHHhCC
Confidence 78899999999988888888765
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=81.69 E-value=0.035 Score=46.91 Aligned_cols=60 Identities=10% Similarity=-0.011 Sum_probs=48.2
Q ss_pred hhHHHHHHHHHHHHhcCCCcEEEEcccccCC-chhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 259 HIYAVADSAYQDMMHHEEAQHIVLAGETLAG-KTTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 259 h~f~~~d~~~~~~~~~~~~q~i~~sgesgag-kte~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.+|..+|.+++|.|+..+.+.++-+ .|.. ..+.++.+++.++.+++|.+++++|+..+..
T Consensus 22 ~~F~~~D~d~dG~Is~~El~~~l~~--l~~~~s~~~~~~l~~~~d~d~~~~i~~~ef~~~~~~ 82 (182)
T d1y1xa_ 22 EWFRAVDTDGSGAISVPELNAALSS--AGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF 82 (182)
T ss_dssp HHHHHHCTTCSSSBCHHHHHHHHCB--TTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHcCCCcCCCCHHHHHHHHHH--hcccCchhhhhhhhcccccccccccccccccccccc
Confidence 3999999999999999988876632 2221 2677899999999999999999999876654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=81.56 E-value=0.27 Score=46.64 Aligned_cols=28 Identities=21% Similarity=0.425 Sum_probs=24.2
Q ss_pred CCeecccCCCCEEEccCCcEEEEecCCcc
Q psy9090 24 HVIHRDLRGSNVLLTKDGEVKIVDFGLSR 52 (488)
Q Consensus 24 givHrDlkp~NILl~~~~~vkL~Dfg~a~ 52 (488)
.++|+|+.|.|||++.++ ++++||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 599999999999998754 8999997764
|
| >d1khta_ c.37.1.1 (A:) Adenylate kinase {Archaeon Methanococcus voltae [TaxId: 2188]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Nucleotide and nucleoside kinases domain: Adenylate kinase species: Archaeon Methanococcus voltae [TaxId: 2188]
Probab=81.25 E-value=0.44 Score=38.99 Aligned_cols=29 Identities=28% Similarity=0.293 Sum_probs=24.6
Q ss_pred CcEEEEcccccCCchhhHHHHHHHHHHhc
Q psy9090 277 AQHIVLAGETLAGKTTSLKHLLKHLIFLG 305 (488)
Q Consensus 277 ~q~i~~sgesgagkte~~k~i~~~~~~~~ 305 (488)
|+-|+|+|-+|+|||..++.+-+.+...+
T Consensus 1 ~kiI~i~G~~GsGKsT~~~~L~~~l~~~~ 29 (190)
T d1khta_ 1 NKVVVVTGVPGVGSTTSSQLAMDNLRKEG 29 (190)
T ss_dssp CCEEEEECCTTSCHHHHHHHHHHHHHTTT
T ss_pred CCEEEEECCCCCCHHHHHHHHHHHHHHcC
Confidence 46789999999999999999988886544
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=80.89 E-value=0.022 Score=48.66 Aligned_cols=30 Identities=13% Similarity=-0.035 Sum_probs=24.7
Q ss_pred hhhHHHHHHHHHHhcCCCchhhhHhhhcch
Q psy9090 291 TTSLKHLLKHLIFLGQGAAKVGEKIEKCVN 320 (488)
Q Consensus 291 te~~k~i~~~~~~~~~g~~~~~e~i~~~~~ 320 (488)
.|.++.||+.+|.+++|.++++||+.++..
T Consensus 62 ~e~~~~li~~~D~d~~G~i~~~EF~~l~~~ 91 (188)
T d1qxpa2 62 LESCRSMVNLMDRDGNGKLGLVEFNILWNR 91 (188)
T ss_dssp HHHHHHHHHHHCC--CCCCCSSSHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcccHHHHHHHHhh
Confidence 578999999999999999999999987654
|
| >d1znwa1 c.37.1.1 (A:20-201) Guanylate kinase {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Nucleotide and nucleoside kinases domain: Guanylate kinase species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=80.75 E-value=0.37 Score=39.99 Aligned_cols=25 Identities=28% Similarity=0.500 Sum_probs=20.1
Q ss_pred cEEEEcccccCCchhhHHHHHHHHH
Q psy9090 278 QHIVLAGETLAGKTTSLKHLLKHLI 302 (488)
Q Consensus 278 q~i~~sgesgagkte~~k~i~~~~~ 302 (488)
+-|+++|.||+||+.-++.+++...
T Consensus 3 ~iivl~GpsG~GK~tl~~~L~~~~~ 27 (182)
T d1znwa1 3 RVVVLSGPSAVGKSTVVRCLRERIP 27 (182)
T ss_dssp CEEEEECSTTSSHHHHHHHHHHHST
T ss_pred eEEEEECCCCCCHHHHHHHHHhhCC
Confidence 4578899999999888888877643
|
| >d1m8pa3 c.37.1.15 (A:391-573) ATP sulfurylase C-terminal domain {Fungus (Penicillium chrysogenum) [TaxId: 5076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: ATP sulfurylase C-terminal domain domain: ATP sulfurylase C-terminal domain species: Fungus (Penicillium chrysogenum) [TaxId: 5076]
Probab=80.56 E-value=0.6 Score=37.82 Aligned_cols=29 Identities=24% Similarity=0.204 Sum_probs=24.1
Q ss_pred CCCcEEEEcccccCCchhhHHHHHHHHHH
Q psy9090 275 EEAQHIVLAGETLAGKTTSLKHLLKHLIF 303 (488)
Q Consensus 275 ~~~q~i~~sgesgagkte~~k~i~~~~~~ 303 (488)
.+...|+++|-||+|||.-++.+-+.+..
T Consensus 4 ~~g~~I~l~G~~GsGKTTia~~La~~L~~ 32 (183)
T d1m8pa3 4 TQGFTIFLTGYMNSGKDAIARALQVTLNQ 32 (183)
T ss_dssp TCCEEEEEECSTTSSHHHHHHHHHHHHHH
T ss_pred CCCeEEEEECCCCCCHHHHHHHHHHHHhh
Confidence 35567888999999999999998888754
|
| >d1qhxa_ c.37.1.3 (A:) Chloramphenicol phosphotransferase {Streptomyces venezuelae [TaxId: 54571]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Chloramphenicol phosphotransferase domain: Chloramphenicol phosphotransferase species: Streptomyces venezuelae [TaxId: 54571]
Probab=80.55 E-value=0.39 Score=38.98 Aligned_cols=26 Identities=31% Similarity=0.452 Sum_probs=22.0
Q ss_pred CCcEEEEcccccCCchhhHHHHHHHH
Q psy9090 276 EAQHIVLAGETLAGKTTSLKHLLKHL 301 (488)
Q Consensus 276 ~~q~i~~sgesgagkte~~k~i~~~~ 301 (488)
..+-|+++|-||+|||..++.+-+.+
T Consensus 2 ~~kiI~l~G~~GsGKsTva~~L~~~l 27 (178)
T d1qhxa_ 2 TTRMIILNGGSSAGKSGIVRCLQSVL 27 (178)
T ss_dssp CCCEEEEECCTTSSHHHHHHHHHHHS
T ss_pred CCeEEEEECCCCCCHHHHHHHHHHHc
Confidence 35678899999999998888887765
|
| >d1sxjc2 c.37.1.20 (C:12-238) Replication factor C3 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Extended AAA-ATPase domain domain: Replication factor C3 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=80.23 E-value=0.68 Score=39.63 Aligned_cols=34 Identities=18% Similarity=0.407 Sum_probs=28.3
Q ss_pred HHHHhcCCCcEEEEcccccCCchhhHHHHHHHHH
Q psy9090 269 QDMMHHEEAQHIVLAGETLAGKTTSLKHLLKHLI 302 (488)
Q Consensus 269 ~~~~~~~~~q~i~~sgesgagkte~~k~i~~~~~ 302 (488)
+.++.......++++|..|.|||..++.+.+++.
T Consensus 27 ~~~i~~~~~~~lLl~Gp~G~GKttl~~~la~~l~ 60 (227)
T d1sxjc2 27 RKFVDEGKLPHLLFYGPPGTGKTSTIVALAREIY 60 (227)
T ss_dssp HHHHHTTCCCCEEEECSSSSSHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCeEEEECCCCCChhHHHHHHHHHhh
Confidence 3345666777899999999999999999999875
|
| >d1ly1a_ c.37.1.1 (A:) Polynucleotide kinase, kinase domain {Bacteriophage T4 [TaxId: 10665]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Nucleotide and nucleoside kinases domain: Polynucleotide kinase, kinase domain species: Bacteriophage T4 [TaxId: 10665]
Probab=80.06 E-value=0.47 Score=37.62 Aligned_cols=23 Identities=22% Similarity=0.303 Sum_probs=18.8
Q ss_pred cEEEEcccccCCchhhHHHHHHH
Q psy9090 278 QHIVLAGETLAGKTTSLKHLLKH 300 (488)
Q Consensus 278 q~i~~sgesgagkte~~k~i~~~ 300 (488)
+-|++.|-+|||||.-++.+++.
T Consensus 3 klIii~G~pGsGKTTla~~L~~~ 25 (152)
T d1ly1a_ 3 KIILTIGCPGSGKSTWAREFIAK 25 (152)
T ss_dssp EEEEEECCTTSSHHHHHHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHHHHh
Confidence 45778999999999888887654
|